PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ishida, O; Hagino, I; Nagaya, N; Shimizu, T; Okano, T; Sawa, Y; Mori, H; Yagihara, T				Ishida, Osamu; Hagino, Ikuo; Nagaya, Noritoshi; Shimizu, Tatsuya; Okano, Teruo; Sawa, Yoshiki; Mori, Hidezo; Yagihara, Toshikatsu			Adipose-derived stem cell sheet transplantation therapy in a porcine model of chronic heart failure	TRANSLATIONAL RESEARCH			English	Article							MYOCARDIAL-INFARCTION; CARDIOMYOCYTE SHEETS; IMPAIRED MYOCARDIUM; ENDOTHELIAL-CELLS; CULTURE SURFACES; TISSUE; SURVIVAL; REPAIR; TRIAL	Adipose-derived stem cells (ASCs) are a promising resource for cell transplantation therapy for damaged heart tissue. Cell death in the graft early after transplantation represents the main cause of unsatisfactory therapeutic efficacy, but tissue-engineered cell sheets grown in temperature-responsive cell culture dishes may enable improved engraftment of transplanted cells. We investigated the therapeutic potential of this method in chronic myocardial ischemia in swine. We created a porcine model of chronic heart failure by implanting an ameroid constrictor around the main trunk of the left anterior descending artery, just distal to the circumflex branch. Simultaneously, ASCs were obtained from a piece of subcutaneous adipose tissue and expanded to form ASC sheets using temperature-responsive dishes. Four weeks after ameroid constrictor placement, triple-layered ASC sheets were transplanted onto the area of the ischemic myocardium (sheet group, n = 7). Controls (n = 7) received no sheet. Just before and 4 weeks after transplantation, left ventriculography (LVG) and coronary angiography (CAG) were performed. LVG revealed a significant improvement in the left ventricular ejection fraction of the sheet group compared with controls (47.6 +/- 2.9% vs 41.4 +/- 2.8%, P < 0.05). Furthermore, development of collateral vessels was only detected in the sheet group with right CAG. Histologic analysis demonstrated that engrafted ASC sheets grew to form a thickened layer that included newly formed vessels. ASC sheet transplantation therapy is an intriguing therapeutic method for ischemic heart failure.	Natl Cardiovasc Ctr, Res Inst, Dept Regenerat Med & Tissue Engn, Osaka, Japan; Kawasaki Municipal Hosp, Dept Cardiovasc Surg, Kawasaki, Kanagawa 2100013, Japan; Chiba Children Hosp, Dept Cardiovasc Surg, Chiba, Japan; Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; Osaka Univ, Grad Sch Med, Dept Surg, Div Cardiovasc Surg, Osaka, Japan; Tokai Univ, Grad Sch Med, Dept Physiol, Isehara, Kanagawa, Japan; Natl Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka, Japan	Ishida, O (reprint author), Kawasaki Municipal Hosp, Dept Cardiovasc Surg, Kawasaki Ku, 12-1 Shinkawadori, Kawasaki, Kanagawa 2100013, Japan.	oishida2000@gmail.com			New Energy and Industrial Technology Development Organization (NEDO), Japan	The present study was supported by grants for the Research and Development on Myocardial Regenerative Medicine Program from the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46; Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961; Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Teramoto N, 2011, J NUCL MED, V52, P761, DOI 10.2967/jnumed.110.084848; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miyagawa S, 2010, TRANSPLANTATION, V90, P364, DOI 10.1097/TP.0b013e3181e6f201; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Rigol M, 2010, J CARD FAIL, V16, P357, DOI 10.1016/j.cardfail.2009.12.006; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Baer PC, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/812693; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; Hamdi H, 2011, CARDIOVASC RES, V91, P483, DOI 10.1093/cvr/cvr099; Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	MAY	2015	165	5					631	639		10.1016/j.trsl.2014.12.005		9	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CH6JP	WOS:000354143200008		
J	Hara, Y; Kuwahara, M				Hara, Yusuke; Kuwahara, Masao			Traffic Monitoring immediately after a major natural disaster as revealed by probe data - A case in Ishinomaki after the Great East Japan Earthquake	TRANSPORTATION RESEARCH PART A-POLICY AND PRACTICE			English	Article						Traffic Monitoring; Evacuation behavior; Probe data; Map matching	EVACUATION	This study analyzes how people behaved and traffic congestion expanded immediately after the Great East Japan Earthquake on March 11, 2011 using information such as probe vehicle and smartphone GPS data. One of the cities most seriously damaged during the earthquake was Ishinomaki. Understanding human evacuation behavior and observing road network conditions are key for the creation of effective evacuation support plans and operations. In many cases, however, a major natural disaster destroys most infrastructure sensors and detailed dynamic information on people's movements cannot be recorded. Following the Great East Japan Earthquake, vehicle detectors did not work due to the severe tsunami and electric power failure. Therefore, information was only available from individuals' probe vehicles and smartphone GPS data. These probe data, along with disaster measurements such as water immersion levels, revealed the sudden transition of vehicle speed (i.e., it eventually slowed to less than walking speed and a serious gridlock phenomenon in the Ishinomaki central area occurred). These quantitative findings, which could not be identified without probe data, should be utilized during future disaster mitigation planning. (C) 2015 Elsevier Ltd. All rights reserved.	[Hara, Yusuke; Kuwahara, Masao] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 980, Japan	Hara, Y (reprint author), Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, 6-6-06 Aoba, Sendai, Miyagi 980, Japan.				Honda Motor Co., Ltd.; Zenrin Data Corn Co., Ltd. (KONZATSU-TOUKEI); Japan Weather Association; NHK (Japan Broadcasting Corporation)	We specially thank Honda Motor Co., Ltd., Zenrin Data Corn Co., Ltd. (KONZATSU-TOUKEI), Japan Weather Association and NHK (Japan Broadcasting Corporation) for their support.	Abe H., 2014, NHK SPECIAL DISASTER; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; LACHMAN R, 1961, SCIENCE, V133, P1405, DOI 10.1126/science.133.3462.1405; Lindell MK, 2007, J URBAN PLAN D-ASCE, V133, P18, DOI 10.1061/(ASCE)0733-9488(2007)133:1(18); Barrett B, 2000, TRANSPORT RES REC, P115; Central Disaster Management Council, 2011, REP COMM TECHN INV C; Charnkol T., 2006, J IATSS RES, V30, P83; Drebek T.E., 1986, HUMAN SYSTEM RESPONS; Lou Y., 2009, P 17 ACM SIGSPATIAL, P352, DOI 10.1145/1653771.1653820; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Miwa T., 2012, TRANSPORT RES C-EMER, V22, P145; Sorensen JH, 1991, INT J MASS EMERGENCI, V9, P153; Urbanik T., 1979, HURRICANES COASTAL S, P32; Yahoo, JAPAN E JAP EARTHQ P	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-8564			TRANSPORT RES A-POL	Transp. Res. Pt. A-Policy Pract.	MAY	2015	75						1	15		10.1016/j.tra.2015.03.002		15	Economics; Transportation; Transportation Science & Technology	Business & Economics; Transportation	CI2PH	WOS:000354589000001		
J	Xiao, Y; Fukuda, D				Xiao, Yu; Fukuda, Daisuke			On the cost of misperceived travel time variability	TRANSPORTATION RESEARCH PART A-POLICY AND PRACTICE			English	Article						Travel time variability; Schedule delay; Departure time choice; Rank-dependent utility	ANTICIPATED UTILITY; EXPECTED UTILITY; RELIABILITY; PROBABILITY; VARIANCE; MODELS; RISK; ROAD	Because individuals may misperceive travel time distributions, using the implied reduced form of the scheduling model might fall short of capturing all costs of travel time variability. We reformulate a general scheduling model employing rank-dependent utility theory and derive two special cases as econometric specifications to study these uncaptured costs. It is found that reduced-form expected cost functions still have a mean-variance form when misperception is considered, but the value of travel time variability is higher. We estimate these two models with stated-preference data and calculate the empirical cost of misperception. We find that: (i) travelers are mostly pessimistic and thus tend to choose departure times too early to achieve a minimum cost, (ii) scheduling preferences elicited using a stated-choice method can be relatively biased if probability weighting is not considered, and (iii) the extra cost of misperceiving the travel time distribution might be nontrivial when time is valued differently over the time of day and is substantial for some people. (C) 2015 Elsevier Ltd. All rights reserved.	[Xiao, Yu; Fukuda, Daisuke] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 1528552, Japan	Xiao, Y (reprint author), Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, 2-12-1 O-Okayama, Tokyo 1528552, Japan.	xiaoyu@plan.cv.titech.ac.jp; fukuda@plan.cv.titech.ac.jp			Japan Society for the Promotion of Science [25289160]; Committee on Advanced Road Technology (CART), Ministry of Land, Infrastructure, Transport, and Tourism, Japan	The authors are indebted to Mogens Fosgerau, Paul Koster, the participants at the Kuhmo Nectar Conference, 2012 and two anonymous reviewers for their constructive comments. Any mistakes that remain are exclusively the authors' responsibility. This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (B) #25289160 and by the Committee on Advanced Road Technology (CART), Ministry of Land, Infrastructure, Transport, and Tourism, Japan.	Small KA, 2005, ECONOMETRICA, V73, P1367, DOI 10.1111/j.1468-0262.2005.00619.x; Koster P, 2012, J TRANSP ECON POLICY, V46, P123; Bates J, 2001, TRANSPORT RES E-LOG, V37, P191, DOI 10.1016/S1366-5545(00)00011-9; Brownstone D, 2005, TRANSPORT RES A-POL, V39, P279, DOI 10.1016/j.tra.2004.11.001; Armstrong P, 2001, TRANSPORT RES E-LOG, V37, P143, DOI 10.1016/S1366-5545(00)00019-3; SMALL KA, 1982, AM ECON REV, V72, P467; Engelson L, 2011, TRANSPORT RES B-METH, V45, P1560, DOI 10.1016/j.trb.2011.07.002; Xu XD, 2013, TRANSPORTATION, V40, P525, DOI 10.1007/s11116-012-9433-6; Greene WH, 2003, TRANSPORT RES B-METH, V37, P681, DOI 10.1016/S0191-2615(02)00046-2; SCHMEIDLER D, 1989, ECONOMETRICA, V57, P571, DOI 10.2307/1911053; Allais M, 1953, ECONOMETRICA, V21, P503, DOI 10.2307/1907921; DESERPA AC, 1971, ECON J, V81, P828, DOI 10.2307/2230320; Fosgerau M, 2012, TRANSPORT RES C-EMER, V24, P83, DOI 10.1016/j.trc.2012.02.008; de Palma A, 2008, MARKET LETT, V19, P269, DOI 10.1007/s11002-008-9047-0; Carrion C, 2012, TRANSPORT RES A-POL, V46, P720, DOI 10.1016/j.tra.2012.01.003; HADAR J, 1969, AM ECON REV, V59, P25; Tseng YY, 2008, TRANSPORT RES B-METH, V42, P607, DOI 10.1016/j.trb.2007.12.001; Fosgerau M, 2010, TRANSPORT RES B-METH, V44, P38, DOI 10.1016/j.trb.2009.05.002; Fosgerau M, 2011, TRANSPORT RES B-METH, V45, P1, DOI 10.1016/j.trb.2010.06.001; Prelec D, 1998, ECONOMETRICA, V66, P497, DOI 10.2307/2998573; Borjesson M, 2012, TRANSPORT RES B-METH, V46, P855, DOI 10.1016/j.trb.2012.02.004; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Bierlaire M., 2009, SWISS TRANSP RES C S; Carrion C., 2013, TRANSP RES BOARD 92; Hensher DA, 2012, J TRANSP ECON POLICY, V46, P293; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kouwenhoven M, 2014, RES TRANSP ECON, V47, P37, DOI 10.1016/j.retrec.2014.09.017; Nolan J.P., 1997, COMMUN STAT STOCHAST, V13, P759, DOI DOI 10.1080/15326349708807450; Peer S., 2010, TRANSPORT RES A-POL, V69, P476; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; Small K.A., 1995, TRANSPORT RES REC, V1493, P150; Tseng Y. Y., 2009, J CHOICE MODELLING, V2, P8; Vickrey W.S., 1973, HIGHWAY RES REC; Wakker P., 2010, PROSPECT THEORY RISK; WAKKER P, 1990, THEOR DECIS, V29, P119, DOI 10.1007/BF00126589; Wang Q, 2014, PROCD SOC BEHV, V111, P301, DOI 10.1016/j.sbspro.2014.01.063; Zolotarev V. M., 1986, ONE DIMENSIONAL STAB, V65	37	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-8564			TRANSPORT RES A-POL	Transp. Res. Pt. A-Policy Pract.	MAY	2015	75						96	112		10.1016/j.tra.2015.03.014		17	Economics; Transportation; Transportation Science & Technology	Business & Economics; Transportation	CI2PH	WOS:000354589000008		
J	Quinn, DI; Shore, ND; Egawa, S; Gerritsen, WR; Fizazi, K				Quinn, David I.; Shore, Neal D.; Egawa, Shin; Gerritsen, Winald R.; Fizazi, Karim			Immunotherapy for castration-resistant prostate cancer: Progress and new paradigms	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS			English	Article						Prostate cancer; Immunotherapy; Vaccine; T cell; Immune system	T-CELL RESPONSES; DOSE-ESCALATION TRIAL; SIPULEUCEL-T; PHASE-II; ADVANCED MELANOMA; IMMUNE-RESPONSES; ACID-PHOSPHATASE; DOUBLE-BLIND; OPEN-LABEL; IPILIMUMAB	Background: The approval of sipuleucel-T in conjunction with data from other immunotherapeutic trials for prostate cancer and other solid tumors demonstrates the potential of harnessing the patient's immune system for long-term survival. Thus, a range of therapeutic approaches are under evaluation. This review describes the rationale for immunotherapy for prostate cancer, summarizes the approaches under evaluation, and discusses sequencing options for immunotherapy in the current treatment paradigm. Design: References for this review were identified through searches of PubMed with the search terms "prostate cancer," "immune system," "vaccine," "immunotherapy," and "T cells." Articles were also identified through searches of the authors' own files. The final reference list was generated based on originality and relevance. Results: The immune system can recognize and respond to prostate tumor antigens, effected through tumor-associated antigens and tumor infiltration of immune effector cells. However, evidence also suggests that prostate tumors are adept at escaping immunological recognition, thus hypothesizing multiple therapeutic strategies. Therapeutic approaches could include vaccination and modulation of T-cell function via the blockade of checkpoint receptors such as cytotoxic T-lymphocyte antigen-4 and programmed death 1. In phase III trials, sipuleucel-T improved overall survival for an M1 patient population with castration-resistant prostate cancer and ipilimumab also did so when given after radiotherapy in a subset of better risk patients. In randomized phase II trials, prostate-specific antigen-TRICOM improved overall survival and tasquinimod improved progression-free survival. Conclusion: Although immunotherapy has the potential to affect advanced prostate cancer, additional research is needed to (1) identify predictive or surrogate markers of activity, (2) understand which agents are clinically effective alone or in combination with other therapies, and (3) define the optimal timing for an immunotherapy to achieve maximal benefit. (C) 2015 The Authors. Published by Elsevier Inc.	[Quinn, David I.] Univ So Calif, Div Med Oncol, Norris Comprehens Canc, Los Angeles, CA 90089 USA; [Shore, Neal D.] Carolina Urol Res Ctr, Myrtle Beach, SC USA; [Egawa, Shin] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan; [Gerritsen, Winald R.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [Fizazi, Karim] Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, Villejuif, France	Quinn, DI (reprint author), Univ So Calif, Div Med Oncol, Norris Comprehens Canc, Los Angeles, CA 90089 USA.	diquinn@usc.edu	Gerritsen, W.R./H-8031-2014; Quinn, David/F-4343-2015	Quinn, David/0000-0002-1411-0417	Bristol-Myers Squibb; National Cancer Institute; Millennium Takeda; GlaxoSmithKline; Sanofi-Aventis; Astellas; AstraZeneca; Takeda	The authors take full responsibility for the content of this publication and confirm that it reflects their viewpoint and medical expertise. The authors also wish to acknowledge Rebecca Turner, StemScientific, funded by Bristol-Myers Squibb, for providing writing and editorial support. Neither Bristol-Myers Squibb nor StemScientific influenced the content of the manuscript, nor did the authors receive financial compensation for authoring the manuscript.; D.Q. discloses payment for scientific advisory board participation from Amgen, Astellas, Bayer Healthcare, BMS, Dendreon, Fresenius Kabi, Millennium Takeda, Novartis, Janssen, Medivation, and Teva. He has received clinical trial funding from the National Cancer Institute, Millennium Takeda, GlaxoSmithKline, and Sanofi-Aventis. N.S. discloses involvement in research or consultancy for Algeta, Amgen, Bayer, Dendreon, Genomic Health, Myriad, Janssen, Medivation, Pfizer, and Sanofi-Aventis. SE. discloses research finding from Astellas, AstraZeneca, and Takeda. K.F. discloses participation in advisory board or speaker for Dendreon, CureVac, Janssen, Astellas, Amgen, Bayer, Sanofi, Novartis, and Bristol-Myers Squibb.	Ascierto PA, 2013, CLIN CANCER RES, V19, P1009, DOI 10.1158/1078-0432.CCR-12-2982; Huber ML, 2012, J NATL CANCER I, V104, P273, DOI 10.1093/jnci/djr514; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Madan RA, 2010, ONCOLOGIST, V15, P969, DOI 10.1634/theoncologist.2010-0129; Kantoff PW, 2012, J NATL CANCER I, V104, P1107, DOI 10.1093/jnci/djs279; Sheikh NA, 2013, CANCER IMMUNOL IMMUN, V62, P137, DOI 10.1007/s00262-012-1317-2; Beer TM, 2011, CLIN CANCER RES, V17, P4558, DOI 10.1158/1078-0432.CCR-10-3223; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Yuan JD, 2011, P NATL ACAD SCI USA, V108, P16723, DOI 10.1073/pnas.1110814108; Sfanos KS, 2009, PROSTATE, V69, P1694, DOI 10.1002/pros.21020; Madan RA, 2012, LANCET ONCOL, V13, P501, DOI 10.1016/S1470-2045(12)70006-2; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Hoos A, 2010, J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Harris TJ, 2008, PROSTATE, V68, P1319, DOI 10.1002/pros.20794; Liu G, 2013, J CLIN INVEST, V123, P4410, DOI [10.1172/JCI69369, 10.1172/JC169369]; Mercader M, 2001, P NATL ACAD SCI USA, V98, P14565, DOI 10.1073/pnas.251140998; Pili R, 2011, J CLIN ONCOL, V29, P4022, DOI 10.1200/JCO.2011.35.6295; Schellhammer PF, 2013, UROLOGY, V81, P1297, DOI 10.1016/j.urology.2013.01.061; van den Eertwegh AJM, 2012, LANCET ONCOL, V13, P509, DOI 10.1016/S1470-2045(12)70007-4; Santegoets SJAM, 2013, CANCER IMMUNOL IMMUN, V62, P245, DOI 10.1007/s00262-012-1330-5; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; McNeel DG, 2009, J CLIN ONCOL, V27, P4047, DOI 10.1200/JCO.2008.19.9968; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Noguchi M, 2012, PROSTATE, V72, P834, DOI 10.1002/pros.21485; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Slovin SF, 2013, ANN ONCOL, V24, P1813, DOI 10.1093/annonc/mdt107; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Hadaschik B, 2012, J UROLOGY, V187, P1458, DOI 10.1016/j.juro.2011.11.083; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Small EJ, 2000, J CLIN ONCOL, V18, P3894; Bratt O, 2009, BRIT J CANCER, V101, P1233, DOI 10.1038/sj.bjc.6605322; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Becker JT, 2010, J IMMUNOTHER, V33, P639, DOI 10.1097/CJI.0b013e3181dda23e; Callahan MK, 2013, J CLIN ONCOL S, V31; Drake CG, 2014, J CLIN ONCOL S, V32; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Garcia JA, 2014, UROL ONCOL, V32; Gati Asma, 2011, Tunis Med, V89, P779; Gerritsen WR, 2012, J CLIN IMMUNOL, V32, P25, DOI 10.1007/s10875-011-9595-6; Graff JN, 2013, UROLOGY, V81, P381, DOI 10.1016/j.urology.2012.10.044; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harzstark AL, 2010, J CLIN ONCOL S, V28; Higano C, 2009, GEN CANC S; Horwich A, 2013, ANN ONCOL, V24, P1141, DOI 10.1093/annonc/mds624; Hsu DS, 2010, CANCER INVEST, V28, P765, DOI 10.3109/07357900903095755; Kubler H, 2011, J CLIN ONCOL S, V29; Morse MD, 2010, HUM IMMUNOL, V71, P496, DOI 10.1016/j.humimm.2010.02.007; Mouraviev V, 2014, J CLIN ONCOL S, V32; Nabhan C, 2014, CLIN GENITOURIN CANC, V12, P27, DOI 10.1016/j.clgc.2013.09.001; Nabhan C, 2012, CLIN GENITOURIN CANC, V10, P141, DOI 10.1016/j.clgc.2012.03.005; Olson BM, 2011, CANCER IMMUNOL IMMUN, V60, P781, DOI 10.1007/s00262-011-0987-5; Petrylak DP, 2012, EMSO C; Quinn DI, 2014, J CLIN ONCOL S, V32; Rathkopf DE, 2014, EUR UROL, V66, P815, DOI 10.1016/j.eururo.2014.02.056; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Small E, 2006, J CLIN ONCOL S18, V24; Small E, 2009, GEN CANC S; Small EJ, 2013, J CLIN ONCOL S, V31; Sonpavde G, 2011, GEN CANC S; Spisek R, 2013, J CLIN ONCOL S, V31; Tollefson MK, 2010, GEN CANC S; Trepel M, 2011, J CLIN ONCOL S, V29; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	69	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1078-1439	1873-2496		UROL ONCOL-SEMIN ORI	Urol. Oncol.-Semin. Orig. Investig.	MAY	2015	33	5					245	260		10.1016/j.urolonc.2014.10.009		16	Oncology; Urology & Nephrology	Oncology; Urology & Nephrology	CI4WP	WOS:000354754900007		
J	Neumann, G; Kawaoka, Y				Neumann, Gabriele; Kawaoka, Yoshihiro			Transmission of influenza A viruses	VIROLOGY			English	Review						Influenza virus; Transmission; Virus lineage; HA; PB2; NA; Receptor-binding; Gain-of-function	HEMAGGLUTININ RECEPTOR SPECIFICITY; LOWER RESPIRATORY-TRACT; AMINO-ACID-RESIDUES; PANDEMIC H1N1 2009; POLYMERASE SUBUNIT PB2; JANUARY-FEBRUARY 1976; GUINEA-PIG MODEL; H5N1 INFLUENZA; SWINE INFLUENZA; HUMAN INFECTION	Influenza A viruses cause respiratory infections that range from asymptomatic to deadly in humans. Widespread outbreaks (pandemics) are attributable to 'novel' viruses that possess a viral hemagglutinin (HA) gene to which humans lack immunity. After a pandemic, these novel viruses form stable virus lineages in humans and circulate until they are replaced by other novel viruses. The factors and mechanisms that facilitate virus transmission among hosts and the establishment of novel lineages are not completely understood, but the HA and basic polymerase 2 (PB2) proteins are thought to play essential roles in these processes by enabling avian influenza viruses to infect mammals and replicate efficiently in their new host. Here, we summarize our current knowledge of the contributions of HA, P82, and other viral components to virus transmission and the formation of new virus lineages. (C) 2015 Elsevier Inc. All rights reserved.	[Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan	Kawaoka, Y (reprint author), Univ Wisconsin, Sch Vet Med, Influenza Res Inst, 575 Sci Dr, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu			Center for Research on Influenza Pathogenesis (CRIP); NIAID [HHSN272201400008C]; Japan Initiative for Global Research Network on Infectious Diseases; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; Japanese Science and Technology Agency	We thank Sue Watson for editing the manuscript. Funding support came from the Center for Research on Influenza Pathogenesis (CRIP) funded by the NIAID Contract HHSN272201400008C; the Japan Initiative for Global Research Network on Infectious Diseases; Grants-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid from the Ministry of Health, Labour and Welfare, Japan; and from Strategic Basic Research Programs of the Japanese Science and Technology Agency.	Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Lopez-Martinez I, 2013, EMERG INFECT DIS, V19, P1531, DOI 10.3201/eid1909.130087; Ito T, 1998, J VIROL, V72, P7367; Sutton TC, 2014, J VIROL, V88, P6623, DOI 10.1128/JVI.02765-13; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Matrosovich M, 1999, J VIROL, V73, P1146; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Gabbard JD, 2014, J VIROL, V88, P1502, DOI 10.1128/JVI.02959-13; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Liu QF, 2012, ARCH VIROL, V157, P555, DOI 10.1007/s00705-011-1203-9; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Watanabe T, 2014, CELL HOST MICROBE, V15, P692, DOI 10.1016/j.chom.2014.05.006; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Ramos I, 2013, J GEN VIROL, V94, P2417, DOI 10.1099/vir.0.056184-0; Blumenkrantz D, 2013, J VIROL, V87, P10539, DOI 10.1128/JVI.00967-13; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Kobasa D, 1999, J VIROL, V73, P6743; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12; [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P21; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844; Ma WJ, 2012, J GEN VIROL, V93, P1261, DOI 10.1099/vir.0.040535-0; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Ito T, 2000, VET MICROBIOL, V74, P71, DOI 10.1016/S0378-1135(00)00167-X; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid/1706.101488, 10.3201/eid1706.101488]; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; [Anonymous], 2013, CHINA WHO JOINT MISS; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Russell CJ, 2014, CURR TOP MICROBIOL, V385, P93, DOI 10.1007/82_2014_393; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Nelson MI, 2012, J VIROL, V86, P8872, DOI 10.1128/JVI.00259-12; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Lu XS, 2013, PROTEIN CELL, V4, P502, DOI 10.1007/s13238-013-3906-z; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI [10.3201/eid1709.110338, 10.3201/1709.110338]; Zhou NN, 1999, J VIROL, V73, P8851; Zaraket H, 2013, J VIROL, V87, P9911, DOI 10.1128/JVI.01175-13; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Campbell PJ, 2014, J VIROL, V88, P3802, DOI 10.1128/JVI.03607-13; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Wang GJ, 2014, J VIROL, V88, P3953, DOI 10.1128/JVI.03292-13; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Barman S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002791; BAUM LG, 1991, VIROLOGY, V180, P10, DOI 10.1016/0042-6822(91)90003-T; Baum L G, 1990, Acta Histochem Suppl, V40, P35; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser J.A., 2013, NATURE, V501, P556; Burke DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112302; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; NELSON J, 1993, VIRUS RES, V29, P155; DOWDLE WR, 1978, MED CLIN N AM, V62, P1047; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; DuBois RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002398; Freidl GS, 2014, EUROSURVEILLANCE, V19, P1; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garcia JM, 2014, INFLUENZA OTHER RESP, V8, P235, DOI 10.1111/irv.12184; GAYDOS JC, 1977, J INFECT DIS, V136, pS356; Giannecchini S, 2006, J GEN VIROL, V87, P171, DOI 10.1099/vir.0.81187-0; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Goldfield M., 1976, J INFECT DIS, V136, pS347; Hai R., NAT COMMUN, V4, P2854; HODDER RA, 1977, J INFECT DIS, V136, pS369; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; KENDAL AP, 1977, J INFECT DIS, V136, pS381; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; LAMBLIN G, 1993, RESP MED, V87, P421, DOI 10.1016/0954-6111(93)90067-A; Li CJ, 2014, CURR TOP MICROBIOL, V385, P185, DOI 10.1007/82_2014_389; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Linster M, 2014, CELL, V157, P329, DOI 10.1016/j.cell.2014.02.040; Liu T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-98; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Miller R.R., 2010, EUROSURVEILLANCE, P15; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; NAEVE CW, 1984, J VIROL, V51, P567; Nelli Rahul K, 2010, BMC Vet Res, V6, P4, DOI 10.1186/1746-6148-6-4; Neumann G, 2010, J GEN VIROL, V91, P1984, DOI 10.1099/vir.0.020750-0; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Pascua PNQ, 2012, P NATL ACAD SCI USA, V109, P15900, DOI 10.1073/pnas.1205576109; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schrauwen EJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059889; Shaw ML, 2013, FIELDS VIROLOGY, V1, P1151; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Srinivasan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049597; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; SUBBARAO EK, 1993, J VIROL, V67, P7223; Taubenberger J.K., 2012, MBIO, P3; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Trebbien R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-434; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Wright P.F., 2013, FIELDS VIROLOGY, P1186; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Xu LL, 2014, J INFECT DIS, V209, P551, DOI 10.1093/infdis/jit474; Yamada S, 2012, J VIROL, V86, P1411, DOI 10.1128/JVI.06100-11; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yamaji R, 2015, J VIROL, V89, P3947, DOI 10.1128/JVI.03328-14; Yang H., 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1152; Yen HL, 2014, J INFECT DIS, V210, P1900, DOI 10.1093/infdis/jiu353; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	203	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	MAY	2015	479				SI		234	246		10.1016/j.virol.2015.03.009		13	Virology	Virology	CI6YG	WOS:000354909500022		
J	Ghabrial, SA; Caston, JR; Jiang, DH; Nibert, ML; Suzuki, N				Ghabrial, Said A.; Caston, Jose R.; Jiang, Daohong; Nibert, Max L.; Suzuki, Nobuhiro			50-plus years of fungal viruses	VIROLOGY			English	Review						Mycoviruses; Totiviridae; Chrysoviridae; Partitiviridae; dsRNA viruses; Hypovirulence; Biological control; Capsid structure	DOUBLE-STRANDED-RNA; CHESTNUT BLIGHT FUNGUS; PLANT-PATHOGENIC FUNGUS; PENICILLIUM-CHRYSOGENUM-VIRUS; MUSHROOM BACILLIFORM VIRUS; OPEN READING FRAME; HELMINTHOSPORIUM COCHLIOBOLUS VICTORIAE; PHYTOPATHOGENIC FILAMENTOUS FUNGUS; PROTOTYPIC HYPOVIRUS CHV1-EP713; ROD-SHAPED MYCOVIRUS	Mycoviruses are widespread in all major taxa of fungi. They are transmitted intracellularly during cell division, sporogenesis, and/or cell-to-cell fusion (hyphal anastomosis), and thus their life cycles generally lack an extracellular phase. Their natural host ranges are limited to individuals within the same or closely related vegetative compatibility groups, although recent advances have established expanded experimental host ranges for some mycoviruses. Most known mycoviruses have dsRNA genomes packaged in isometric particles, but an increasing number of positive- or negative-strand ssRNA and ssDNA viruses have been isolated and characterized. Although many mycoviruses do not have marked effects on their hosts, those that reduce the virulence of their phytopathogenic fungal hosts are of considerable interest for development of novel biocontrol strategies. Mycoviruses that infect endophytic fungi and those that encode killer toxins are also of special interest. Structural analyses of mycoviruses have promoted better understanding of vieus assembly, function, and evolution. (C) 2015 Elsevier Inc. All rights reserved.	[Ghabrial, Said A.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Caston, Jose R.] Ctr Nacl Biotecnol CSIC, Dept Struct Macromol, Madrid, Spain; [Jiang, Daohong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Nibert, Max L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Suzuki, Nobuhiro] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Ghabrial, SA (reprint author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	saghab00@email.uky.edu	Suzuki, Nobuhiro/B-2517-2011				Urayama S, 2014, VIROLOGY, V448, P265, DOI 10.1016/j.virol.2013.10.022; Tanaka T, 2011, J GEN VIROL, V92, P1949, DOI 10.1099/vir.0.031138-0; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; Kanematsu S, 2004, PHYTOPATHOLOGY, V94, P561, DOI 10.1094/PHYTO.2004.94.6.561; HOLLINGS M, 1962, NATURE, V196, P962, DOI 10.1038/196962a0; Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Reinisch KM, 2000, NATURE, V404, P960; Bao XD, 2013, ADV VIRUS RES, V86, P37, DOI 10.1016/B978-0-12-394315-6.00002-7; Ochoa WF, 2008, STRUCTURE, V16, P776, DOI 10.1016/j.str.2008.02.014; Wickner RB, 2013, ADV VIRUS RES, V86, P1, DOI 10.1016/B978-0-12-394315-6.00001-5; Hillman BI, 2004, ADV VIRUS RES, V63, P423, DOI 10.1016/S0065-3527(04)63007-7; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Ghabrial SA, 2013, ADV VIRUS RES, V86, P289, DOI 10.1016/B978-0-12-394315-6.00011-8; Tang JH, 2010, BIOPHYS J, V99, P685, DOI 10.1016/j.bpj.2010.04.058; Pan JH, 2009, P NATL ACAD SCI USA, V106, P4225, DOI 10.1073/pnas.0812071106; Gomez-Blanco J, 2012, J VIROL, V86, P8314, DOI 10.1128/JVI.00802-12; Xie JT, 2011, VIROLOGY, V418, P49, DOI 10.1016/j.virol.2011.07.008; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Luque D, 2010, J VIROL, V84, P7256, DOI 10.1128/JVI.00432-10; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Choi GH, 2012, GENETICS, V190, P113, DOI 10.1534/genetics.111.133983; Bohm J, 2013, P NATL ACAD SCI USA, V110, P1476, DOI 10.1073/pnas.1217943110; Nibert ML, 2014, VIRUS RES, V188, P128, DOI 10.1016/j.virusres.2014.04.007; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Zhang DX, 2014, GENETICS, V197, P701, DOI 10.1534/genetics.114.164574; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; Salaipeth L, 2014, J GEN VIROL, V95, P740, DOI 10.1099/vir.0.058164-0; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Du ZG, 2014, ARCH VIROL, V159, P1527, DOI 10.1007/s00705-013-1890-5; Luque D, 2014, P NATL ACAD SCI USA, V111, P7641, DOI 10.1073/pnas.1404330111; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Herrero N, 2011, ANN APPL BIOL, V159, P192, DOI 10.1111/j.1744-7348.2011.00485.x; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hacker CV, 2005, J GEN VIROL, V86, P1561, DOI 10.1099/vir.0.80808-0; Urayama S, 2010, J GEN VIROL, V91, P3085, DOI 10.1099/vir.0.025411-0; Liu HQ, 2009, J VIROL, V83, P1981, DOI 10.1128/JVI.01897-08; Sikorski A, 2013, VIRUS RES, V177, P209, DOI 10.1016/j.virusres.2013.08.008; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1; Yaegashi H, 2012, VIRUS RES, V165, P143, DOI 10.1016/j.virusres.2012.02.008; Kondo H, 2013, ADV VIRUS RES, V86, P177, DOI 10.1016/B978-0-12-394315-6.00007-6; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Dawe AL, 2013, ADV VIRUS RES, V86, P109, DOI 10.1016/B978-0-12-394315-6.00005-2; Urayama S, 2012, J VIROL, V86, P8287, DOI 10.1128/JVI.00871-12; Tang JH, 2010, J STRUCT BIOL, V172, P363, DOI 10.1016/j.jsb.2010.06.022; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Eusebio-Cope A, 2010, VIROLOGY, V397, P399, DOI 10.1016/j.virol.2009.11.035; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Faruk MI, 2008, J VIROL, V82, P740, DOI 10.1128/JVI.02015-07; Stielow B, 2010, ARCH VIROL, V155, P2075, DOI 10.1007/s00705-010-0824-8; Milgroom MG, 2004, ANNU REV PHYTOPATHOL, V42, P311, DOI 10.1146/annurev.phyto.42.040803.140325; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Duquerroy S, 2009, EMBO J, V28, P1655, DOI 10.1038/emboj.2009.109; KOHN LM, 1990, EXP MYCOL, V14, P255, DOI 10.1016/0147-5975(90)90023-M; Baeza M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-140; BEVAN EA, 1973, NATURE, V245, P81, DOI 10.1038/245081b0; Boeke J.D., 2011, VIRUS TAXONOMY, P467; Bryner SF, 2014, PHYTOPATHOLOGY, V104, P918, DOI 10.1094/PHYTO-03-13-0069-R; Bryner SF, 2012, PHYTOPATHOLOGY, V102, P1161, DOI 10.1094/PHYTO-01-12-0013-R; BUCK KW, 1971, J GEN VIROL, V12, P131, DOI 10.1099/0022-1317-12-2-131; Caston JR, 2006, VIROLOGY, V347, P323, DOI 10.1016/j.virol.2005.11.038; Caston JR, 2003, J MOL BIOL, V331, P417, DOI 10.1016/S0022-2836(03)00695-8; Caston JR, 2013, ADV VIRUS RES, V86, P87, DOI 10.1016/B978-0-12-394315-6.00004-0; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Chen BS, 1999, J VIROL, V73, P985; DAWE VH, 1983, VIROLOGY, V130, P21, DOI 10.1016/0042-6822(83)90114-9; de Sa PB, 2010, PHYTOPATHOLOGY, V100, P880, DOI 10.1094/PHYTO-100-9-0880; de Sa PB, 2010, PHYTOPATHOLOGY, V100, P890, DOI 10.1094/PHYTO-100-9-0890; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dunn SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003225; Eickbush T., 2011, VIRUS TAXONOMY, P457; ELLIS LF, 1967, NATURE, V215, P649, DOI 10.1038/215649a0; ENEBAK SA, 1994, MOL PLANT MICROBE IN, V7, P590, DOI 10.1094/MPMI-7-0590; Eusebio-Cope A., 2015, VIROLOGY; Fujimura T, 2012, J BIOL CHEM, V287, P12797, DOI 10.1074/jbc.M111.327676; Ghabrial S. A., 2008, ENCY VIROLOGY, V5, P163; Ghabrial SA, 2009, ARCH VIROL, V154, P373, DOI 10.1007/s00705-008-0272-x; Ghabrial S.A., 2011, VIRUS TAXONOMY, P509; Guo LH, 2009, NUCLEIC ACIDS RES, V37, P3645, DOI 10.1093/nar/gkp224; Herrero N, 2009, ARCH VIROL, V154, P327, DOI 10.1007/s00705-008-0293-5; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Howitt RLJ, 2001, J GEN VIROL, V82, P67; Howitt RLJ, 2006, ARCH VIROL, V151, P563, DOI 10.1007/s00705-005-0621-y; Hu ZJ, 2014, VIROLOGY, V464, P450, DOI 10.1016/j.virol.2014.07.007; Huang SH, 1996, P NATL ACAD SCI USA, V93, P12541, DOI 10.1073/pnas.93.22.12541; Ikeda K, 2013, APPL ENVIRON MICROB, V79, P3684, DOI 10.1128/AEM.00426-13; Janssen MEW, 2015, J VIROL, V89, P1182, DOI [10.1128/JVI.02745-14, 10.1128/JVI02745-14]; Jiang DH, 2004, J GEN VIROL, V85, P2111, DOI 10.1099/vir.0.79842-0; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Kanematsu S., 2014, VIROLOGY, V451, P308; Kang JG, 2001, VIRUS RES, V76, P183, DOI 10.1016/S0168-1702(01)00250-7; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khalifa ME, 2014, VIROLOGY, V464, P441, DOI 10.1016/j.virol.2014.07.005; Khalifa ME, 2013, VIROLOGY, V441, P22, DOI [10.1016/j.virol.2013.03.002, 10.1016/j.viro1.2013.03.002]; KLEINSCHMIDT WJ, 1964, P NATL ACAD SCI USA, V52, P741, DOI 10.1073/pnas.52.3.741; Koloniuk I, 2014, ARCH VIROL, V159, P1861, DOI 10.1007/s00705-014-1992-8; Kondo H, 2013, VIROLOGY, V435, P201, DOI [10.1016/j.virol.2012.10.002, 10.1016/j.viro1.2012.10.002]; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Lesnaw JA, 2000, PLANT DIS, V84, P1052, DOI 10.1094/PDIS.2000.84.10.1052; Li H, 2011, J VIROL, V85, P7343, DOI 10.1128/JVI.00364-11; Li H, 2015, VIROLOGY, V474, P131, DOI 10.1016/j.virol.2014.10.022; Li LQ, 2013, VIRUS RES, V176, P169, DOI 10.1016/j.virusres.2013.06.004; Lin YH, 2012, VIROLOGY, V426, P42, DOI 10.1016/j.virol.2012.01.013; Lin YH, 2013, ARCH VIROL, V158, P1093, DOI 10.1007/s00705-012-1580-8; Liu LJ, 2014, P NATL ACAD SCI USA, V111, P12205, DOI 10.1073/pnas.1401786111; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; MCFADDEN JJP, 1983, J GEN VIROL, V64, P927, DOI 10.1099/0022-1317-64-4-927; Nuss D.L., 2011, VIRUS TAXONOMY, P1029; Nuss DL, 2011, ADV VIRUS RES, V80, P25, DOI 10.1016/B978-0-12-385987-7.00002-6; Parent KN, 2013, MBIO, V4, DOI 10.1128/mBio.00056-13; Park CM, 1996, MOL MICROBIOL, V20, P957, DOI 10.1111/j.1365-2958.1996.tb02537.x; Pearson MN, 2013, ADV VIRUS RES, V86, P249, DOI 10.1016/B978-0-12-394315-6.00009-X; Revill P.A., 2011, VIRUS TAXONOMY, P961; Revill PA, 1999, VIROLOGY, V260, P273, DOI 10.1006/viro.1999.9839; REVILL PA, 1994, VIROLOGY, V202, P904, DOI 10.1006/viro.1994.1412; Revill PA, 1998, VIROLOGY, V249, P231, DOI 10.1006/viro.1998.9345; SCHMITT MJ, 1994, J VIROL, V68, P1765; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; SINDEN J. W., 1950, Mushroom Science, V1, P96; Soldevila AI, 2000, J VIROL, V74, P997, DOI 10.1128/JVI.74.2.997-1003.2000; Sun LY, 2008, RNA, V14, P2557, DOI 10.1261/rna.1125408; Sun QH, 2009, P NATL ACAD SCI USA, V106, P17927, DOI 10.1073/pnas.0907552106; Supyani S, 2007, J GEN VIROL, V88, P342, DOI 10.1099/vir.0.82318-0; Tanaka T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00186; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; Taylor DJ, 2013, PEERJ, V1, DOI 10.7717/peerj.50; VanDerLende TR, 1996, VIROLOGY, V217, P88, DOI 10.1006/viro.1996.0096; Wang LP, 2014, J VIROL, V88, P7517, DOI 10.1128/JVI.00538-14; Wang SC, 2013, VIRUS RES, V174, P69, DOI 10.1016/j.virusres.2013.03.002; Wei CZ, 2004, ARCH VIROL, V149, P773, DOI 10.1007/s00705-003-0259-6; Wickner RB, 2011, VIRUS TAXONOMY; Wu MD, 2012, J VIROL, V86, P6605, DOI 10.1128/JVI.00292-12; Xiao XQ, 2014, J VIROL, V88, P10120, DOI 10.1128/JVI.01036-14; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Xie JT, 2014, ANNU REV PHYTOPATHOL, V52, P45, DOI 10.1146/annurev-phyto-102313-050222; Xie JT, 2012, VIROLOGY, V428, P77, DOI 10.1016/j.virol.2012.03.015; Zhang DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108653; Zhang R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00360; Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07	139	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	MAY	2015	479				SI		356	368		10.1016/j.virol.2015.02.034		13	Virology	Virology	CI6YG	WOS:000354909500032		
J	Kasuya, T; Izawa, T; Kakeshita, T; Kumagai, T; Watanabe, K				Kasuya, Tadashi; Izawa, Takahiro; Kakeshita, Tomoyuki; Kumagai, Tatsuya; Watanabe, Koutaro			Hydrogen evolution of Cu precipitation 780 MPa grade steel HAZ with consideration of its cold cracking susceptibility	WELDING IN THE WORLD			English	Article						High-strength steels; Cold cracking; Hydrogen; Diffusion	ALLOYS; METALS; WELDS; IRON	The Cu precipitation 780 MPa grade steel has higher resistance to cold cracking than the conventional steels. To study this, we have investigated the hydrogen evolution characteristics of the Cu steel heat-affected zone (HAZ) by the thermal desorption spectroscopy method and compared with those of conventional 780 MPa steel HAZ. The thermal cycle tests were conducted to obtain the HAZ microstructures, and the peak temperatures were selected from 500 to 1400 degrees C at intervals of 100 degrees C. Hydrogen was then charged, and the hydrogen evolution curves were measured at a heating rate of 100 degrees C/h. The results show that the amounts of hydrogen released from the specimens whose peak temperatures of the thermal cycle tests were 1000 degrees C or higher are lower, while the results of the conventional steels have the opposite tendency. We numerically calculated the hydrogen evolution curves to determine physical constants, and using these constants, we also calculated the hydrogen concentration profiles of the y-groove weld cracking test and found that the hydrogen concentration of the Cu steel HAZ near the fusion line tends to become lower than those of the conventional steel HAZ. This phenomenon is considered one of the reasons for the higher cold cracking resistance of the Cu steel.	[Kasuya, Tadashi; Kumagai, Tatsuya; Watanabe, Koutaro] Nippon Steel & Sumitomo Met Corp, Tokyo, Japan; [Izawa, Takahiro; Kakeshita, Tomoyuki] Osaka Univ, Osaka, Japan	Kasuya, T (reprint author), Nippon Steel & Sumitomo Met Corp, Tokyo, Japan.	kasuya.b62.tadashi@jp.nssmc.com					HIRTH JP, 1980, METALL TRANS A, V11, P861, DOI 10.1007/BF02654700; MCNABB A, 1963, T METALL SOC AIME, V227, P618; Kannengiesser T, 2013, WELD WORLD, V57, P3, DOI 10.1007/s40194-012-0001-7; Bailey N, 1973, WELDING STEELS HYDRO; Carslaw, 1946, CONDUCTION HEAT SOLI; Gordine J, 1983, WELDJ WELD RES S, V62, p179s; KASUYA T, 1993, WELD J, V72, pS263; Kasuya T, 2012, WELD WORLD, V56, P76; Kasuya T, 2013, WELD WORLD, V57, P581, DOI 10.1007/s40194-013-0056-0; Kromm A, 2011, WELD WORLD, V55, P48; Kromm A, 2014, WELD WORLD, V58, P729, DOI 10.1007/s40194-014-0155-6; Okamura N, 1995, NIPPON STEEL TECH RE, V66, P65; Pickering F. B., 1960, J IRON STEEL I, V194, P137; Schwedler O, 2014, WELD WORLD, V58, P339, DOI 10.1007/s40194-014-0119-x; Steppan E, 2013, WELD WORLD, V57, P359, DOI 10.1007/s40194-013-0036-4; Wongpanya P, 2009, WELD WORLD, V53, pR34; Yurioka N, 1979, JWS, V48, P726	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0043-2288	1878-6669		WELD WORLD	Weld. World	MAY	2015	59	3					353	364		10.1007/s40194-014-0204-1		12	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CI4SG	WOS:000354742900004		
J	Takashima, Y; Yamada, YS; Handa, T; Igi, S; Oi, K; Minami, F				Takashima, Yasuhito; Yamada, Yugo S.; Handa, Tsunehisa; Igi, Satoshi; Oi, Kenji; Minami, Fumiyoshi			Numerical analysis of strength mismatch effect on stress field in Charpy specimen	WELDING IN THE WORLD			English	Article						Impact toughness; Mismatch; Dynamic loading; Brittle fracture; Dissimilar materials	IMPACT TEST; TOUGHNESS	The influence of strength mismatch adjacent to the V-notch in Charpy specimen on stress field has been numerically analyzed with a 3D finite element method. It is found that the softer material adjacent to the V-notch provides a "shielding effect" from high-speed straining introduced by impact loading. As this leads to reduction in flow stress ahead of the V-notch, lower opening stress compared with homogeneous specimen is found in the case of the V-notch within the harder material in heterogeneous specimen. By contrast, in the case of the V-notch within the softer material, plastic strain is concentrated near the V-notch and the opening stress is elevated by constraint due to hard material adjacent to the V-notch. The Charpy impact test was conducted with the Charpy specimen extracted from the clad steel consisted of low-and high-strength steels in order to investigate the strength mismatch effect Charpy absorbed energy K-V. It is found that K-V value is affected by strength mismatch adjacent to the V-notch and the Weibull stress criterion can be applied to the quantitative evaluation of the strength mismatch effect on K-V.	[Takashima, Yasuhito; Yamada, Yugo S.; Minami, Fumiyoshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Handa, Tsunehisa; Igi, Satoshi; Oi, Kenji] JFE Steel Corp, Chiba, Japan	Takashima, Y (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	takasima@mapse.eng.osaka-u.ac.jp					BENNETT PE, 1966, J BASIC ENG-T ASME, V88, P518; Takashima Y, 2006, MATER SCI FORUM, V512, P61; MATHUR KK, 1993, MODEL SIMUL MATER SC, V1, P467, DOI 10.1088/0965-0393/1/4/010; Besson J, 2005, MAT SCI ENG A-STRUCT, V397, P84, DOI 10.1016/j.msea.2005.01.056; MINAMI F, 1992, INT J FRACTURE, V54, P197; Rossoll A, 2002, INT J FRACTURE, V115, P205, DOI 10.1023/A:1016323522441; Beremin F. M., 1983, Metallurgical Transactions A (Physical Metallurgy and Materials Science), V14A, DOI 10.1007/BF02663302; Japan Welding Engineering Society, 1975, BE COMM RES REP; Minami F, 2002, EUR STRUCT INTEGR SO, V30, P411; Minami F, 1990, P 8 EUR C FRACT ECF8, P76; NAKAMURA T, 1986, ENG FRACT MECH, V25, P323, DOI 10.1016/0013-7944(86)90129-3; Ruggieri C, 1992, J SOC NAVAL ARCHITEC, V171, P493; Satoh K, 1982, T JPN WELD SOC, V13, P30; Satoh K, 1985, T JPN WELD SOC, V16, P170; Seo K., 1986, Journal of the Society of Materials Science, Japan, V35; Seo K, 1982, J JPN WELD SOC, V51, P291; Seo K, 1983, Q J JPN WELD SOC, V1, P123; Tamura H., 1966, J JPN WELD SOC, V35, P710; Toyosada M, 1991, J SOC NAVAL ARCHITEC, V170, P651; Vargas PM, 1995, ASTM STP, V1256, P715	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0043-2288	1878-6669		WELD WORLD	Weld. World	MAY	2015	59	3					433	441		10.1007/s40194-014-0217-9		9	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CI4SG	WOS:000354742900013		
J	Seror, R; Theander, E; Brun, JG; Ramos-Casals, M; Valim, V; Dorner, T; Bootsma, H; Tzioufas, A; Solans-Laque, R; Mandl, T; Gottenberg, JE; Hachulla, E; Sivils, KL; Ng, WF; Fauchais, AL; Bombardieri, S; Valesini, G; Bartoloni, E; Saraux, A; Tomsic, M; Sumida, T; Nishiyama, S; Caporali, R; Kruize, AA; Vollenweider, C; Ravaud, P; Vitali, C; Mariette, X; Bowman, SJ				Seror, Raphaele; Theander, Elke; Brun, Johan G.; Ramos-Casals, Manel; Valim, Valeria; Doerner, Thomas; Bootsma, Hendrika; Tzioufas, Athanasios; Solans-Laque, Roser; Mandl, Thomas; Gottenberg, Jacques-Eric; Hachulla, Eric; Sivils, Kathy L.; Ng, Wan-Fai; Fauchais, Anne-Laure; Bombardieri, Stefano; Valesini, Guido; Bartoloni, Elena; Saraux, Alain; Tomsic, Matija; Sumida, Takayuki; Nishiyama, Susumu; Caporali, Roberto; Kruize, Aike A.; Vollenweider, Cristina; Ravaud, Philippe; Vitali, Claudio; Mariette, Xavier; Bowman, Simon J.		EULAR Sjogrens Task Force	Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)	ANNALS OF THE RHEUMATIC DISEASES			English	Article							HEALTH-STATUS INSTRUMENTS; CONTROLLED-TRIAL; EUROPEAN LEAGUE; REPORTED INDEX; RESPONSIVENESS; RITUXIMAB	Objectives To validate the two recently developed disease activity indexes for assessment of primary Sjogren's syndrome (SS): the European League Against Rheumatism (EULAR) SS Patient Reported Index (ESSPRI) and the EULAR SS Disease Activity Index (ESSDAI). Methods A prospective international 6-month duration validation study was conducted in 15 countries. At each visit, physicians completed ESSDAI, SS disease activity index (SSDAI), Sjogren's Systemic Clinical Activity Index (SCAI) and physician global assessment (PhGA); and patients completed ESSPRI, Sicca Symptoms Inventory (SSI), Profile of Fatigue and Discomfort (PROFAD) and patient global assessment (PGA). Psychometric properties (construct validity, responsiveness and reliability) were evaluated and compared between scores. Results Of the 395 patients included, 145 (37%) and 251 (64%) had currently active or current or past systemic manifestations, respectively. EULAR scores had higher correlation with the gold standard than other scores (ESSDAI with PhGA: r= 0.59; ESSRPI with PGA: r= 0.70). Correlations between patient and systemic scores were very low (ranging from 0.07 to 0.29). All systemic scores had similar large responsiveness in improved patients. Responsiveness of patient scores was low but was significantly higher for ESSPRI compared with SSI and PROFAD. Reliability was very good for all scores. Conclusions ESSDAI and ESSPRI had good construct validity. All scores were reliable. Systemic scores had a large sensitivity to change in patients whose disease activity improves. Patient scores had a small sensitivity to change, however, significantly better for ESSPRI. Systemic and patient scores poorly correlated, suggesting that they are 2 complementary components that should be both evaluated, but separately.	[Seror, Raphaele; Mariette, Xavier] Hop Hotel Dieu, Ctr Clin Epidemiol, F-75181 Paris, France; [Seror, Raphaele; Mariette, Xavier] Univ Paris 05, INSERM, U738, Paris, France; [Seror, Raphaele; Ravaud, Philippe] Hop Bicetre, AP HP, INSERM, Dept Rheumatol,U802, F-94275 Le Kremlin Bicetre, France; [Seror, Raphaele; Ravaud, Philippe] Univ Paris 11, Le Kremlin Bicetre, France; [Seror, Raphaele; Ravaud, Philippe] INSERM, U1012, F-94275 Le Kremlin Bicetre, France; [Theander, Elke; Mandl, Thomas] Lund Univ, Skane Univ Hosp Malmo, Dept Rheumatol, Malmo, Sweden; [Brun, Johan G.] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway; [Ramos-Casals, Manel] Hosp Clin Barcelona, ICMiD, IDIBAPS, Lab Autoimmune Dis Josep Font, Barcelona, Spain; [Valim, Valeria] Univ Fed Espirito Santo, Dept Med, Div Rheumatol, Vitoria, ES, Brazil; [Doerner, Thomas] Univ Hosp, Charite, Dept Rheumatol, Berlin, Germany; [Bootsma, Hendrika] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Tzioufas, Athanasios] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Solans-Laque, Roser] Vall Hebron Univ Hosp, Dept Autoimmune Syst Dis, Barcelona, Spain; [Gottenberg, Jacques-Eric] Univ Strasbourg, Ctr Natl Reference Malad Autoimmunes Rares, Strasbourg Univ Hosp, Dept Rheumatol,INSERM,UMRS 1109,FMTS, Strasbourg, France; [Hachulla, Eric] Univ Nord France, Claude Huriez Hosp, Dept Internal Med, Lille, France; [Sivils, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol, Oklahoma City, OK 73104 USA; [Ng, Wan-Fai] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Fauchais, Anne-Laure] Univ Hosp, Dept Rheumatol, Limoges, France; [Bombardieri, Stefano] Univ Pisa, Dept Internal Med, Rheumatol Unit, Pisa, Italy; [Valesini, Guido] Univ Roma La Sapienza, Dept Internal Med, Rheumatol, I-00185 Rome, Italy; [Bartoloni, Elena] Perugia Univ Hosp, Dept Rheumatol, Perugia, Italy; [Saraux, Alain] Univ Bretagne Occidentale, Hop Cavale Blanche, Dept Rheumatol, Brest, France; [Saraux, Alain] Univ Bretagne Occidentale, EA 2216, Brest, France; [Tomsic, Matija] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Sumida, Takayuki] Univ Tsukuba, Dept Internal Med, Tsukuba, Ibaraki 305, Japan; [Nishiyama, Susumu] Kurashiki Med Ctr, Rheumat Dis Ctr, Kurashiki, Okayama, Japan; [Caporali, Roberto] Univ Pavia, IRCCS S Matteo Fdn, Dept Rheumatol, I-27100 Pavia, Italy; [Kruize, Aike A.] Univ Med Ctr Utrecht, Dept Rheumatol, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Vollenweider, Cristina] German Hosp, Dept Rheumatol, Buenos Aires, DF, Argentina; [Vitali, Claudio] Inst San Giuseppe, Rheumatol Sect, Lecce, Italy; [Bowman, Simon J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham, W Midlands, England	Seror, R (reprint author), Hop Bicetre, Dept Rheumatol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	raphaele.se@gmail.com		Ramos-Casals, Manuel/0000-0001-5709-6734; Ravaud, Philippe/0000-0001-8264-9206	European League Against Rheumatism (EULAR) [CLI 010]	This collaborative project (project code CLI 010) received a grant from the European League Against Rheumatism (EULAR).	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Bowman SJ, 2007, RHEUMATOLOGY, V46, P1845, DOI 10.1093/rheumatology/kem280; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Bowman SJ, 2004, RHEUMATOLOGY, V43, P758, DOI 10.1093/rheumatology/keh170; Seror R, 2010, ARTHRIT CARE RES, V62, P551, DOI 10.1002/acr.20173; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Meiners PM, 2012, ANN RHEUM DIS, V71, P1297, DOI 10.1136/annrheumdis-2011-200460; Vitali C, 2007, ARTHRITIS RHEUM, V56, P2223, DOI 10.1002/art.22658; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Seror R, 2013, ARTHRIT CARE RES, V65, P1358, DOI 10.1002/acr.21991; Bowman SJ, 2003, J RHEUMATOL, V30, P1259; Devauchelle-Pensec V, 2012, ANN RHEUM DIS, V71, P75; Efron B., 1993, INTRO BOOTSTRAP; Streiner DL, 2008, HLTH MEASUREMENT SCA	19	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	MAY	2015	74	5					859	866		10.1136/annrheumdis-2013-204615		8	Rheumatology	Rheumatology	CE9IV	WOS:000352158500017		
J	Furumiya, J; Hashimoto, Y				Furumiya, Junichi; Hashimoto, Yoshiaki			A Descriptive Study of Elderly Patients With Dementia Who Died Wandering Outdoors in Kochi Prefecture, Japan	AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS			English	Article						dementia; wandering; missing incident; preventive medicine; forensic autopsy; aging society	COMMUNITY; PREVALENCE	This was a descriptive study of elderly persons with dementia who were found dead after becoming lost in the community. Nineteen forensic autopsy cases were performed at Kochi Medical School, Japan. The mean age of the patients (9 males and 10 females) was 82.1 +/- 6.6 years. Causes of death were drowning (n = 8), trauma (n = 5), hypothermia (n = 2), and debilitation possibly due to fatigue (n = 1) or were unknown (n = 3). Thirteen (68%) individuals had been reported missing, most at least 6 hours after they had left. They moved on foot (n = 14), by car (n = 3), or by bicycle (n = 2). Distances from residences to spots of death ranged from 20 to 5800 m for 11 patients on foot. In 8 cases, it was less than 500 m. The study has potential implications for enabling their early discovery and protection.	[Furumiya, Junichi; Hashimoto, Yoshiaki] Kochi Univ, Kochi Med Sch, Dept Legal Med, Nankoku, Kochi 7838505, Japan	Furumiya, J (reprint author), Kochi Univ, Kochi Med Sch, Dept Legal Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	furumiya@kochi-u.ac.jp					Algase DL, 2007, AGING MENT HEALTH, V11, P686, DOI 10.1080/13607860701366434; Algase DL, 2010, AM J ALZHEIMERS DIS, V25, P340, DOI 10.1177/1533317510365342; Algase DL, 2009, RES GERONTOL NURS, V2, P58, DOI 10.3928/19404921-20090101-02; Alzheimer's Association Japan, 2000, ALZH ASS JAP 20 ANN; Alzheimer's Foundation of America, LOST FOUND REV AV ME; Carr D, 2010, GERONTOLOGIST, V50, P149, DOI 10.1093/geront/gnp102; Rowe MA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-28; Algase DL, 2009, J AM GERIATR SOC, V57, P2037, DOI 10.1111/j.1532-5415.2009.02491.x; Nakanishi M, 2014, ALZHEIMERS DEMENT, V10, P468, DOI 10.1016/j.jalz.2013.06.005; Robinson L, 2007, INT J GERIATR PSYCH, V22, P9, DOI 10.1002/gps.1643; Fox NC, 2013, LANCET, V382, P1968, DOI 10.1016/S0140-6736(13)62426-5; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Yao L, 2008, J NEUROSCI NURS, V40, P106; Bachman D, 2006, ANNU REV MED, V57, P499, DOI 10.1146/annurev.med.57.071604.141451; BECKER JT, 1993, NEUROPSYCHOLOGIA, V31, P137, DOI 10.1016/0028-3932(93)90042-X; Bowen ME, 2011, DEMENT GERIATR COGN, V31, P406, DOI 10.1159/000329792; Cabinet Office, 2013, ANN REP AG SOC; Japanese Society of Neurology, JAP TREATM GUID DEM; Ministry of Health Labour and Welfare Japan, ABR LIF TABL JAP 201; Ministry of Health Labour and Welfare Japan, REG STAT PROBL; Ministry of Health Labour and Welfare Japan, NUMB ELD PERS DEM; Mizohata M, 1990, IATSS REV, V16, P49; Rowe Meredeth A, 2003, Am J Alzheimers Dis Other Demen, V18, P343, DOI 10.1177/153331750301800612; Rowe MA, 2004, MAYO CLIN PROC, V79, P1417; Yamazaki K, 2011, RES PRACT FORENS MED, V54, P263	25	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-3175	1938-2731		AM J ALZHEIMERS DIS	Am. J. Alzheimers Dis. Other Dement.	MAY	2015	30	3					307	312		10.1177/1533317514545826		6	Geriatrics & Gerontology; Clinical Neurology	Geriatrics & Gerontology; Neurosciences & Neurology	CI0FD	WOS:000354411000010		
J	Higashijima, M; Shiozu, H				Higashijima, Misako; Shiozu, Hiroyasu			Using Party Horns to Test Respiratory Function in Patients With Dementia	AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS			English	Article						dementia; respiratory function tests; party horn; Mini-Mental State Examination; forced vital capacity	REFLEX	This study assessed the utility of party horns for quick, simple respiratory function testing in 66 inpatients with dementia to maintain safe eating activity. Relationships of forced vital capacity (FVC) to Mini-Mental State Examination (MMSE) score and complete extension when blowing 40- and 80-cm party horns were examined. The FVC differed significantly by both MMSE score (P = .000) and party horn score (P = .000). Significant differences in FVC were found between groups categorized by MMSE score and in groups categorized by the ability to extend both party horns. Multiple regression analyses performed on possible FVC indicators identified a significant correlation for the party horn examination (regression coefficient: .562). Breathing is always coordinated with swallowing. Party horns seem highly effective as a simple tool for testing respiratory function in patients with early-stage dementia, and the ability to offer breathing rehabilitation for patients in need is likely to result in safer eating activity.	[Higashijima, Misako] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528520, Japan; [Shiozu, Hiroyasu] Kawasaki Univ Med Welf, Grad Sch Hlth Sci & Technol, Doctoral Program Rehabil, Kurashiki, Okayama, Japan; [Shiozu, Hiroyasu] Geriatr Hlth Serv Facil KIRARI, Tokyo, Japan	Higashijima, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528520, Japan.	higajima@nagasaki-u.ac.jp					Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Shaker R, 2003, GERONTOLOGY, V49, P12, DOI 10.1159/000066504; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; ASHLEY F, 1975, ANN INTERN MED, V82, P739; BLOUNT RL, 1994, BEHAV MODIF, V18, P6, DOI 10.1177/01454455940181002; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Higashijima M, 2011, 45 JAP OCC THER C EX; Higashijima M., 2010, J JPN ASS OCCUP THER, V29, P345; Higashijima M., 2008, J JAPANESE ASS OCCUP, V27, P290; Higashijima M., 2009, J JPN SOC DEMEN CARE, V8, P428; Jacqueline K., 2002, FEEDING SWALLOWING D, P53; KATSUMATA U, 1995, CHEST, V107, P290, DOI 10.1378/chest.107.1.290-b; Kobayashi H, 1997, CHEST, V111, P1466, DOI 10.1378/chest.111.5.1466; MANNE SL, 1994, HEALTH PSYCHOL, V13, P556, DOI 10.1037/0278-6133.13.6.556; Sokoloff LG, 1997, DYSPHAGIA, V12, P177, DOI 10.1007/PL00009533; Viegi G, 2009, EUR RESPIR MONOGR, P1	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-3175	1938-2731		AM J ALZHEIMERS DIS	Am. J. Alzheimers Dis. Other Dement.	MAY	2015	30	3					326	329		10.1177/1533317514545982		4	Geriatrics & Gerontology; Clinical Neurology	Geriatrics & Gerontology; Neurosciences & Neurology	CI0FD	WOS:000354411000013		
J	Fujiwara, A; Kobata, H				Fujiwara, Atsushi; Kobata, Hitoshi			Paroxysmal sympathetic hyperactivity after near-hanging	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Editorial Material							ACQUIRED BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; OUTCOMES	Paroxysmal sympathetic hyperactivity (PSH) is a relatively common early complication after severe brain injury. It is characterized by episodic generalized sympathetic hyperactivity. We herein present a case of a 29-year-old woman who developed PSH after near-hanging with uncertainty of cardiac arrest. The patient attempted suicide by hanging herself. Her mother found her pulseless and in a deep coma and started chest compressions. Upon arrival at our hospital, spontaneous breathing was restored and her vital signs stabilized; however, she remained in a deep coma. After admission to the intensive care unit, generalized tonic-clonic convulsions developed and her body temperature increased to 39.2 degrees C despite surface cooling. We presumed that she had been in cardiac arrest when her mother discovered her and initiated 24-hour therapeutic hypothermia (TH) and 24-hour rewarming. After rewarming, her temperature increased to 38.7 degrees C again despite the disappearance of her convulsions, and she suddenly exhibited a decerebrate posture, muscle stiffness, pupillary dilatation, elevated blood pressure, and tachycardia by repeated extrinsic stimulation. She was diagnosed with PSH, and medical treatment and fever management were begun. The PSH began to resolve, and she was transferred to another hospital for rehabilitation in a persistent vegetative state without PSH on the 42nd hospital day. In this case, TH was utilized for anoxic brain injury after near-hanging with uncertain cardiac arrest. A clinical course of PSH after near-hanging is presented with a brief review of TH indication.	[Fujiwara, Atsushi; Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Takatsuki, Osaka, Japan	Fujiwara, A (reprint author), Osaka Med Coll, Dept Anesthesiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	ane077@poh.osaka-med.ac.jp					Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Baldursdottir S, 2010, ACTA ANAESTH SCAND, V54, P821, DOI 10.1111/j.1399-6576.2010.02248.x; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Jehle O, 2010, AM J EMERG MED, V28; Kattwinkel J, 2010, CIRCULATION, V122, P909; Lee BK, 2012, EMERG MED J, V29, P748, DOI 10.1136/emermed-2011-200493; Peberdy MA, 2010, CIRCULATION, V122, P768; Sadaka F, 2013, THER HYPOTHERMIA TEM, V3, P13, DOI 10.1089/ther.2012.0022; Shin J, 2014, RESUSCITATION, V85, P1047, DOI 10.1016/j.resuscitation.2014.04.012; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8	12	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5							735.e1	10.1016/j.ajem.2014.10.033		2	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600045		
J	Yoshida, H; Yaguchi, S; Matsumoto, A; Hanada, H; Niwa, H; Kitayama, M				Yoshida, Hitoshi; Yaguchi, Shinya; Matsumoto, Atsufumi; Hanada, Hiroyuki; Niwa, Hidetomo; Kitayama, Masatou			A modified paravertebral block to reduce risk of mortality in a patient with multiple rib fractures	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Editorial Material							REGIONAL ANESTHESIA; LAMINA TECHNIQUE; PNEUMONIA; TRAUMA	The risk of mortality due to multiple rib fractures elevates with increasing age or severity of injury. Although sufficient pain relief with thoracic epidural block or paravertebral block has been recommended for prevention of critical pneumonia that causes late death, their indications are limited in patients with coagulation disorder. We tested a new modified ultrasound-guided paravertebral block, retrolaminar block (RB)/costovertebral canal block (CVCB), instead of the recommended regional analgesic techniques in a 79-year-old multiple-injured man with routine antiplatelet therapy. He had rib fractures (mainly left Th5, 6) and other multiple injuries. Despite initial pain management with systemic fentanyl, maintenance of arterial oxygen saturation greater than 90% had become difficult due to left chest pain when coughing. On the third day, the ultrasound-guided RB/CVCB was started with 30 mL of 0.5% ropivacaine 3 times a day through a catheter placed on the Th5 lamina, which reduced the intractable pain down to numerical rating scale of 1-2/10. With this improved pain management, he was able to avoid tracheal intubation and mechanical ventilation and had gradual recovery of oxygenation. Because the ultrasound-guided RB/CVCB is based on a concept of injecting local anesthetics above the lamina, accidental hemorrhage due to puncture of vessels located beyond the transverse process can be prevented. In addition, visualizing the tip of advancing needle with ultrasound guidance allows operators to safely accomplish the block without requiring particular positioning. Thus, the ultrasound-guided RB/CVCB may be an alternative analgesic technique to reduce the risk of mortality in patients with multiple rib fractures.	[Yoshida, Hitoshi; Yaguchi, Shinya; Hanada, Hiroyuki] Hirosaki Univ, Grad Sch Med, Dept Emergency & Disaster Med, Hirosaki, Aomori 0368562, Japan; [Matsumoto, Atsufumi] Hirosaki Univ, Grad Sch Med, Dept Endocrinol & Metab, Hirosaki, Aomori 0368562, Japan; [Niwa, Hidetomo; Kitayama, Masatou] Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori 0368562, Japan	Yoshida, H (reprint author), Hirosaki Univ, Grad Sch Med, Dept Emergency & Disaster Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	hyoshida@cc.hirosaki-u.ac.jp					Brasel KJ, 2006, CRIT CARE MED, V34, P1642, DOI 10.1097/01.CCM.0000217926.40975.4B; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Choi JJ, 2013, CURR OPIN ANESTHESIO, V26, P495, DOI 10.1097/ACO.0b013e3283625ce3; Ho AMH, 2011, CURR OPIN CRIT CARE, V17, P323, DOI 10.1097/MCC.0b013e328348bf6f; Juttner T, 2011, J CLIN ANESTH, V23, P443, DOI 10.1016/j.jclinane.2010.12.015; Pfeiffer G, 2006, ANAESTHESIST, V55, P423, DOI 10.1007/s00101-005-0969-0; Satoh Y, 2013, MINERVA ANESTESIO S1, V79, P75; Voscopoulos C, 2013, CAN J ANESTH, V60, P888, DOI 10.1007/s12630-013-9983-x	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5							735.e3	10.1016/j.ajem.2014.10.032		2	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600046		
J	Taira, T; Morita, S; Umebachi, R; Miura, N; Icimura, A; Inoue, S; Nakagawa, Y; Inokuchi, S				Taira, Takayuki; Morita, Seiji; Umebachi, Rimako; Miura, Naoya; Icimura, Atsushi; Inoue, Shigeaki; Nakagawa, Yoshihide; Inokuchi, Sadaki			Risk factors for ground-level falls differ by sex	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							GENDER-DIFFERENCES; TRAUMA PATIENTS; OLDER-ADULTS; MORTALITY; INJURIES; OUTCOMES; AGE	Background: The populations of many developed countries have been aging in recent years, resulting in increasing numbers of elderly-related injuries. Conventionally regarded as minor, injuries from ground-level falls are now associated with a higher risk of death for elderly people. Methods: The subjects of this study were 15662 adult patients with injuries from ground-level falls who were registered in the Japan Trauma Data Bank between 2007 and 2013. Logistic regression analysis was used to evaluate the effects of age, sex, Injury Severity Score, and Revised Trauma Score (RTS) on inhospital mortality. Patients aged 60 years or older were further categorized into 4 subgroups by age and sex, and the effect of the presence of injuries of Abbreviated Injury Scale greater than or equal to 3 in each region on inhospital mortality was analyzed. Results: Logistic regression analysis for inhospital mortality showed significant interactions between sex and age and between sex and RTS, and subgroup analysis by sex was, therefore, performed. The odds ratio (95% confidence interval) for inhospital mortality compared with patients older than 60 years was 2.75 (1.90-3.96) for men aged 60 to 79 years and 5.44 (3.77-7.85) for men 80 years or older and 1.46 (0.83-2.58) for women aged 60 to 79 years and 2.32 (1.35-4.01) for women 80 years or older. The odds ratios (95% confidence interval) for RTS less than 7.840 was 6.89 (5.56-8.55) for men and 9.97 (7.59-13.10) for women. Conclusions: The effects of age and RTS on inhospital mortality of patients after ground-level falls differed by sex. (C) 2015 Elsevier Inc. All rights reserved.	[Taira, Takayuki; Morita, Seiji; Umebachi, Rimako; Miura, Naoya; Icimura, Atsushi; Inoue, Shigeaki; Nakagawa, Yoshihide; Inokuchi, Sadaki] Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, Isehara, Kanagawa 2591193, Japan	Taira, T (reprint author), Tokai Univ, Sch Med, Dept Emergency & Crit Care Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	rain_dog1998@yahoo.co.jp; ermorita@msn.com; emu_rima@yahoo.co.jp; qq9n9c99@plum.ocn.ne.jp; ichimura@is.icc.u-tokai.ac.jp; sg-inoue@is.icc.u-tokai.ac.jp; yoshihide@is.icc.u-tokai.ac.jp; inokuchi@is.icc.u-tokai.ac.jp					O'Neill S, 2012, ARCH GERONTOL GERIAT, V54, pE426, DOI 10.1016/j.archger.2012.01.007; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/01.TA.0000020257.29911.70; Yeoh HT, 2013, ERGONOMICS, V56, P153, DOI 10.1080/00140139.2012.746739; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Cox S, 2014, INJURY, V45, P1312, DOI 10.1016/j.injury.2014.02.028; Gelbard R, 2014, AM J SURG, V208, P249, DOI 10.1016/j.amjsurg.2013.12.034; Wang HW, 2014, ARCH GERONTOL GERIAT, V59, P657, DOI 10.1016/j.archger.2014.05.004; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Cox S, 2012, INJURY, V43, P573, DOI 10.1016/j.injury.2010.10.003; Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; WOLFSON L, 1994, J GERONTOL, V49, pM160; Caserotti P, 2001, EUR J APPL PHYSIOL, V84, P206, DOI 10.1007/s004210170006; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Kannus P, 2007, J GERONTOL A-BIOL, V62, P180; Lee HN, 2014, ANZ J SURG, P1; Lehmann R, 2009, AM J SURG, V197, P574; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; OECD, 2014, LIF EXP BIRTH FEM; Pfortmueller CA, 2014, FALL  RELATED EMERGE, P1; Roche JJ, BMJ, V331, P1; Rosen Tony, 2013, J Inj Violence Res, V5, P61, DOI 10.5249/jivr.v5i1.177; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Wang Hao, 2013, J Clin Med Res, V5, P75, DOI 10.4021/jocmr1227w	26	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5					640	644		10.1016/j.ajem.2015.01.052		5	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600007		
J	Arima, T; Nagata, O; Sakaida, K; Miura, T; Kakuchi, H; Ikeda, K; Mizushima, T; Takahashi, A				Arima, Takahiro; Nagata, Osamu; Sakaida, Koji; Miura, Takeshi; Kakuchi, Hiroyuki; Ikeda, Katsuki; Mizushima, Tomoya; Takahashi, Azusa			Relationship between duration of prehospital resuscitation and favorable prognosis in ventricular fibrillation	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							HOSPITAL CARDIAC-ARREST; EXTRACORPOREAL MEMBRANE-OXYGENATION; CONVENTIONAL CARDIOPULMONARY-RESUSCITATION; UTSTEIN STYLE; LIFE-SUPPORT; MYOCARDIAL-INFARCTION; NEUROLOGIC RECOVERY; PROPENSITY ANALYSIS; SURVIVAL; BYPASS	Objective: There appears to be an optimal point in balancing the relative benefits of extending the resuscitation time to obtain return of spontaneous circulation in the prehospital setting and the initiation of therapies such as extracorporeal cardiopulmonary resuscitation (CPR). This study investigated how prehospital CPR duration is related to survival and neurologic outcome in ventricular fibrillation (VF) and tried to find the tolerable time for prehospital resuscitation. Materials and methods: Out-of-hospital cardiac arrest patients with VF in Funabashi City, Japan, from January 2009 to December 2013 were reviewed. Resuscitation teams that included physicians were dispatched to incident sites. Survival rate at 24 hours and neurologic outcome at 30 days were analyzed with respect to prehospital CPR duration. Results: A total of 172 patients were evaluated. Seventy-three patients were alive at 24 hours. Thirty-four patients had favorable neurologic outcomes after 30 days. Of the 69 patients who required prolonged prehospital CPR (>30 minutes), 6 were alive at 24 hours, and only 1 had a favorable neurologic outcome at 30 days. Logistic regression model showed that both survival rate at 24 hours and neurologic outcome at 30 days deteriorated with the increase in prehospital CPR duration (both P < .001). Conclusion: The prognosis of out-of-hospital cardiac arrest patients with VF deteriorated with the increase in prehospital CPR duration. Favorable results are less likely especially in cases of prolonged prehospital CPR (>30 minutes). Therefore, it may be necessary to consider transportation to a more definitive treatment facility rather than extending conventional CPR in the prehospital setting. (C) 2015 Elsevier Inc. All rights reserved.	[Arima, Takahiro; Sakaida, Koji; Miura, Takeshi; Kakuchi, Hiroyuki; Ikeda, Katsuki; Mizushima, Tomoya; Takahashi, Azusa] Funabashi Municipal Med Ctr, Emergency Dept, Funabashi, Chiba 2608677, Japan; [Nagata, Osamu] Canc Inst Hosp JFCR, Dept Anesthesiol, Koto Ward, Tokyo, Japan	Arima, T (reprint author), Funabashi Municipal Med Ctr, Emergency Dept, 1-21-1 Kanasugi, Funabashi, Chiba 2608677, Japan.	arimataka64@gmail.com					Fagnoul D, 2014, CURR OPIN CRIT CARE, V20, P259, DOI [10.1097/MCC.0000000000000098, 10.1097/MCC.0000000000000086]; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Tanno K, 2008, AM J EMERG MED, V26, P649, DOI 10.1016/j.ajem.2007.09.019; Nagao K, 2000, J AM COLL CARDIOL, V36, P776, DOI 10.1016/S0735-1097(00)00779-8; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Kagawa E, 2012, CIRCULATION, V126, P1605, DOI 10.1161/CIRCULATIONAHA.111.067538; Cardarelli MG, 2009, ASAIO J, V55, P581, DOI 10.1097/MAT.0b013e3181bad907; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; ABRAMSON NS, 1985, CRIT CARE MED, V13, P930, DOI 10.1097/00003246-198511000-00020; Chou TH, 2014, EMERG MED J, V31, P441, DOI 10.1136/emermed-2012-202173; Schwarz B, 2003, CRIT CARE MED, V31, P758, DOI 10.1097/01.CCM.0000053522.55711.E3; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Chen YS, 2003, J AM COLL CARDIOL, V41, P197, DOI 10.1016/S0735-1097(02)02716-X; Idris AH, 2003, CIRCULATION, V108, P2565, DOI 10.1161/01.CIR.0000099581.70012.68; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Chen YS, 2008, CRIT CARE MED, V36, P2529, DOI 10.1097/CCM.0b013e318183f491; Haukoos JS, 2010, ACAD EMERG MED, V17, P391, DOI 10.1111/j.1553-2712.2010.00707.x; Charapov I, 2012, CAN J ANESTH, V59, P578, DOI 10.1007/s12630-012-9698-4; Chung CH., 2005, HONG KONG J EMERG ME, V12, P28; Chung JW, 2012, KOREAN CIRC J, V42, P423, DOI 10.4070/kcj.2012.42.6.423; Fabbri LP, 2001, RESUSCITATION, V48, P175, DOI 10.1016/S0300-9572(00)00327-0; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Herlitz J, 2005, AM HEART J, V149, P61, DOI 10.1016/j.ahj.2004.07.014; Liakopoulos OJ, 2010, ANN THORAC SURG, V89, P1972, DOI 10.1016/j.athoracsur.2010.02.052; Nagao K, 1999, INTERNAL MED, V38, P710, DOI 10.2169/internalmedicine.38.710; PIONKOWSKI RS, 1983, ANN EMERG MED, V12, P733, DOI 10.1016/S0196-0644(83)80245-5; Schultz SC, 1996, RESUSCITATION, V33, P13, DOI 10.1016/S0300-9572(96)00986-0; Shin JS, 2007, RESUSCITATION, V73, P309, DOI 10.1016/j.resuscitation.2006.09.011; Stub D, 2013, HEART LUNG CIRC, V22, P421, DOI 10.1016/j.hlc.2012.11.020; WEAVER WD, 1982, NEW ENGL J MED, V307, P1101, DOI 10.1056/NEJM198210283071801	36	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAY	2015	33	5					677	681		10.1016/j.ajem.2015.02.031		5	Emergency Medicine	Emergency Medicine	CH8MX	WOS:000354291600016		
J	Oishi, M				Oishi, Motoi			Enzyme-free and isothermal detection of microRNA based on click-chemical ligation-assisted hybridization coupled with hybridization chain reaction signal amplification	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Click-chemical ligation; DNA; Hybridization chain reaction; Magnetic bead; MicroRNA	LABEL-FREE; CIRCULATING MICRORNAS; PCR INHIBITORS; RT-PCR; DNA; CANCER; QUANTIFICATION; NANOPARTICLES; FAMILY; BLOOD	An enzyme-free and isothermal microRNA (miRNA) detection method has been developed based on click-chemical ligation-assisted hybridization coupled with hybridization chain reaction (HCR) on magnetic beads (MBs). The click-chemical ligation between an azide-modified probe DNA and a dibenzocyclooctyne-modified probe DNA occurred through the hybridization of target miRNA (miR-141). HCR on MBs was performed by the addition of DNA hairpin monomers (H1 and H2). After magnetic separation and denaturation/rehybridization of HCR products ([H1/H2] (n) ), the resulting HCR products were analyzed by the fluorescence emitted from an intercalative dye, allowing amplification of the fluorescent signal. The proposed assay had a limit of detection of 0.55 fmol, which was 230-fold more sensitive than that of the HCR on the MBs coupled with a conventional sandwich hybridization assay (without click-chemical ligation) (limit of detection 127 fmol). Additionally, the proposed assay could discriminate between miR-141 and other miR-200 family members. In contrast to quantitative reverse transcription polymerase chain reaction techniques using enzymes and thermal cycling, this is an enzyme-free assay that can be conducted under isothermal conditions and can specifically detect miR-141 in fetal bovine serum.	Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan	Oishi, M (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	oishi@ims.tsukuba.ac.jp			Japan Society for the Promotion of Science [24510165]	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (no. 24510165) from the Japan Society for the Promotion of Science.	Ambros A, 2004, NATURE, V431, P350; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Qiu X, 2014, BIOSENS BIOELECTRON, V60, P351, DOI 10.1016/j.bios.2014.04.040; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Song CX, 2014, ANAL CHIM ACTA, V827, P74, DOI 10.1016/j.aca.2014.04.006; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Venkataraman S, 2007, NAT NANOTECHNOL, V2, P490, DOI 10.1038/nnano.2007.225; Favis R, 2000, NAT BIOTECHNOL, V18, P561; Shelbourne M, 2011, CHEM COMMUN, V47, P6257, DOI 10.1039/c1cc10743g; Kato D, 2014, ACS NANO, V8, P9988, DOI 10.1021/nn503150w; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Cai S, 2014, ANALYST, V139, P6022, DOI 10.1039/c4an01178c; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Konet DS, 2000, J VIROL METHODS, V84, P95, DOI 10.1016/S0166-0934(99)00131-7; Nilsson M, 2000, NAT BIOTECHNOL, V18, P791, DOI 10.1038/77367; Oishi M, 2014, CHEM COMMUN, V50, P991, DOI 10.1039/c3cc48064j; Radstrom P, 2000, J CLIN MICROBIOL, V38, P4463; Stahlhut-Espinosa CE, 2006, J BIOL MED, V79, P131; Yang CY, 2015, ACS APPL MATER INTER, V7, P1188, DOI 10.1021/am506933r	28	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	MAY	2015	407	14					4165	4172		10.1007/s00216-015-8629-y		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CH7BJ	WOS:000354190300027		
J	Koda, N; Watanabe, G; Miyaji, Y; Ishida, A; Miyaji, C				Koda, N.; Watanabe, G.; Miyaji, Y.; Ishida, A.; Miyaji, C.			Stress levels in dogs, and its recognition by their handlers, during animal-assisted therapy in a prison	ANIMAL WELFARE			English	Article						animal-assisted therapy; animal welfare; behaviour; cortisol; dogs; stress	SALIVA CORTISOL; RESPONSES; SHELTER; BEHAVIOR; PLASMA; REDUCE	The stress on dogs and their handlers during animal-assisted therapy in a prison programme was evaluated using questionnaires and measurement of the dogs' saliva cortisol concentrations before and after the sessions. Their handlers were volunteers who underwent training classes with their pet dogs. Overall, the dogs did not show serious signs of stress in the programme, which was also the impression of their handlers. In most cases, the dogs' saliva cortisol values decreased following their participation in the sessions. There was an association between the dogs' stress levels and the handlers' self-reported stress. In 11% of cases, the dogs were evaluated as stressed during the session, but their saliva cortisol values did not change significantly from before to after the session. Some handlers might have misconstrued their dogs' behavioural states. Improvement of the dogs' welfare may be achievable through giving feedback to the handlers to more accurately evaluate their dogs' behaviours, by strengthening the selection of appropriate units and classes prior the programme, by developing a programme and handling methods less burdensome to the animals, and by enhancing the aftercare of animals when they are stressed in a session. Achievement of these goals would also strengthen the bonds between dogs and handlers, contributing to a more effective programme for clients.	[Koda, N.; Watanabe, G.] Tokyo Univ Agr & Technol, Sch Agr, Fuchu, Tokyo 1838509, Japan; [Miyaji, Y.; Miyaji, C.] Japan Anim Assisted Therapy Council, Inami, Hyogo 6751101, Japan; [Ishida, A.] Harima Rehabil Program Ctr, Kakogawa, Hyogo 6751201, Japan	Koda, N (reprint author), Tokyo Univ Agr & Technol, Sch Agr, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	koda@cc.tuat.ac.jp	Koda, Naoko/C-2049-2013		Moritani Scholarship Foundation; Mitsubishi Foundation; Career-Advance Team Funds of the Women's Future Development Organization of Tokyo University of Agriculture and Technology; JSPS KAKENHI [22730431, 25380735]	The authors wish to thank the staff of Harima Rehabilitation Program Center and the Ministry of Justice for their timely decisions and kind co-operation to initiate and continue this programme. The authors also thank the participants for their consent in allowing use of their data. The Biosignal Research Center at Gunma University kindly provided the cortisol antiserum. This study was supported by the Moritani Scholarship Foundation, the Mitsubishi Foundation, Career-Advance Team Funds of the Women's Future Development Organization of Tokyo University of Agriculture and Technology, and JSPS KAKENHI Grants (22730431, 25380735). We wish to also thank Dr Reinhold J Hutz of the University of Wisconsin, Milwaukee, USA, for the careful editing of this manuscript and for his helpful suggestions.	Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Pastore C, 2011, J VET BEHAV, V6, P188, DOI 10.1016/j.jveb.2011.01.001; VINCENT IC, 1992, RES VET SCI, V53, P342, DOI 10.1016/0034-5288(92)90137-Q; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Coppola CL, 2006, PHYSIOL BEHAV, V87, P537, DOI 10.1016/j.physbeh.2005.12.001; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Beerda B, 1996, HORM BEHAV, V30, P272, DOI 10.1006/hbeh.1996.0033; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Handlin L, 2011, ANTHROZOOS, V24, P301, DOI 10.2752/175303711X13045914865385; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Oyama D, 2014, DOMEST ANIM ENDOCRIN, V46, P20, DOI 10.1016/j.domaniend.2013.09.008; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; Fournier A. K., 2007, BEHAV SOCIAL ISSUES, V16, P89; Fredrickson M., 1995, WALTHAM BOOK HUMAN A, P60; Furst G., 2011, ANIMAL PROGRAMS PRIS; Haubenhofer DK, 2007, SOC ANIM, V15, P127, DOI 10.1163/156853007X187090; Horii T, 2003, NIHON CHIKUSAN GAKKA, V74, P375, DOI 10.2508/chikusan.74.375; King C, 2011, J VET BEHAV, V6, P232, DOI 10.1016/j.jveb.2011.01.007; Koda N, 2013, C ABSTR BOOK 22 ANN, P61; Koda N, 2013, 2013 TRIENN C INT AS; Martin P, 1990, MEASURING BEHAV INTR; Moneymaker JM, 1991, J OFFENDER REHABILIT, V16, P133, DOI 10.1300/J076v16n03_09; Taya K, 1985, JAPANESE J ANIMAL RE, V31, P186; Uetake K, 2007, ANIM BEHAV MANAGE, V43, P192	24	0	0	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	MAY	2015	24	2					203	209		10.7120/09627286.24.2.203		7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CH5GC	WOS:000354062300008		
J	Hou, JG; Fujino, M; Cai, SJ; Ding, Q; Li, XK				Hou, Jiangang; Fujino, Masayuki; Cai, Songjie; Ding, Qiang; Li, Xiao-Kang			Noninvasive monitoring of mouse renal allograft rejection using micro-CT	ANNALS OF SURGICAL TREATMENT AND RESEARCH			English	Article						Kidney transplant; Micro-CT; Noninvasive monitoring	COMPUTED-TOMOGRAPHY; KIDNEY; MODEL; LIVE	Purpose: Acute renal graft rejection can only be definitively diagnosed by renal biopsy. However, biopsies carry a risk of renal transplant injury and loss. Micro-CT is widely used in preclinical studies of small animals. Here, we propose micro-CT could noninvasively monitor and evaluate renallocation and function in a mouse kidney transplant model. Methods: Orthotopic kidney transplantation was performed in a BALB/c -to- C57BL/6j or C57BL/6j-to- C57BL/6j mouse model. After optimizing imaging techniques, five mice were imaged with micro-CT and the findings were verified histologically. Results: Micro-CT can monitor and evaluate renal location and function after orthotopic kidney transplantation. There were no mice deaths while renal transplants were failure. Conclusion: We propose that graft micro-CT imaging is a new option that is noninvasive and specific, and can aid in early detection and follow-up of acute renal rejection. This method is potentially useful to improve posttransplant rejection monitoring.	[Hou, Jiangang; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Hou, Jiangang; Fujino, Masayuki; Cai, Songjie; Li, Xiao-Kang] Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Setagaya Ku, Tokyo 1578535, Japan; [Fujino, Masayuki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Li, XK (reprint author), Natl Res Inst Child Hlth & Dev, Div Transplantat Immunol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ri-k@ncchd.go.jp					Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Tse GH, 2013, TRANSPL INT, V26, P1149, DOI 10.1111/tri.12129; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Abe T, 2012, TRANSPLANTATION, V94, P14, DOI 10.1097/TP.0b013e318255f8be; Azuma H, 2010, TRANSPLANTATION, V90, P1328, DOI 10.1097/TP.0b013e3182007b59; Cai QY, 2012, NANOMED-NANOTECHNOL, V8, P365, DOI 10.1016/j.nano.2011.06.019; Ge FM, 2011, EXP CLIN TRANSPLANT, V9, P287; Maehara N, 2003, EUR RADIOL, V13, P1559, DOI 10.1007/s00330-002-1729-z; Marx J, 2003, SCIENCE, V302, P1880, DOI 10.1126/science.302.5652.1880; Masyuk TV, 2012, GASTROENTEROLOGY, V142, P622, DOI 10.1053/j.gastro.2011.11.036; Reuter S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005296; Soltysiak P, 2009, J TISSUE ENG REGEN M, V3, P573, DOI 10.1002/term.202; Vierling John M, 2011, Trans Am Clin Climatol Assoc, V122, P326	14	0	0	KOREAN SURGICAL SOCIETY	SEOUL	3304HO, 101 DONG, BROWNSTONE SEOUL, 335, JUNGMIN-DONG, JUNG-GU, SEOUL, 100-859, SOUTH KOREA	2288-6575	2288-6796		ANN SURG TREAT RES	Ann. Surg. Treat. Res.	MAY	2015	88	5					276	280		10.4174/astr.2015.88.5.276		5	Surgery	Surgery	CI0HZ	WOS:000354419000006		
J	Battaia, FA; Yang, YJ; Hennawi, JF; Prochaska, JX; Matsuda, Y; Yamada, T; Hayashino, T				Battaia, Fabrizio Arrigoni; Yang, Yujin; Hennawi, Joseph F.; Prochaska, J. Xavier; Matsuda, Yuichi; Yamada, Toru; Hayashino, Tomoki			A DEEP NARROWBAND IMAGING SEARCH FOR C IV AND He II EMISSION FROM Ly alpha BLOBS	ASTROPHYSICAL JOURNAL			English	Article						galaxies: formation; galaxies: high-redshift; intergalactic medium	REDSHIFT RADIO GALAXIES; ACTIVE GALACTIC NUCLEI; STAR-FORMING GALAXIES; RADIATION PRESSURE CONFINEMENT; SPECTRAL ENERGY-DISTRIBUTIONS; OPTICALLY THICK ABSORBERS; BARYONIC STRUCTURE SURVEY; LARGE-SCALE STRUCTURE; APPROXIMATE-TO 2.4; CIRCUMGALACTIC MEDIUM	We conduct a deep narrowband imaging survey of 13 Ly alpha blobs (LABs) located in the SSA22 proto-cluster at z similar to 3.1 in the C IV. and He II. emission lines in an effort to constrain the physical process powering the Ly alpha emission in LABs. Our observations probe down to unprecedented surface brightness (SB) limits of (2.1-3.4) x 10(-18) erg s(-1) cm(-2) arcsec(-2) per 1 arcsec(2) aperture (5 sigma) for the He II lambda 1640 and C IV lambda 1549 lines, respectively. We do not detect extended He II. and C IV. emission in any of the LABs, placing strong upper limits on the He II/Ly alpha and C IV/Ly alpha line ratios, of 0.11 and 0.16, for the brightest two LABs in the field. We conduct detailed photoionization modeling of the expected line ratios and find that, although our data constitute the deepest ever observations of these lines, they are still not deep enough to rule out a scenario where the Ly alpha emission is powered by the ionizing radiation from an obscured active galactic nucleus. Our models can accommodate He II/Ly alpha and C IV/Ly alpha ratios as low as similar or equal to 0.05 and similar or equal to 0.07, respectively, implying that one needs to reach SB as low as (1-1.5) x 10(-18) erg s(-1) cm(-2) arcsec(-2). (at 5 sigma) in order to rule out a photoionization scenario. These depths will be achievable with the new generation of image-slicing integral field units such as the Multi Unit Spectroscopic Explorer (MUSE) on VLT and the Keck Cosmic Web Imager (KCWI). We also model the expected He II/Ly alpha and C IV/Ly alpha in a different scenario, where Ly alpha emission is powered by shocks generated in a large-scale superwind, but find that our observational constraints can only be met for shock velocities v(s) greater than or similar to 250 km s(-1), which appear to be in conflict with recent observations of quiescent kinematics in LABs.	[Battaia, Fabrizio Arrigoni; Yang, Yujin; Hennawi, Joseph F.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Yang, Yujin] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Yang, Yujin] Korea Astron & Space Sci Inst, Taejon, South Korea; [Prochaska, J. Xavier] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Prochaska, J. Xavier] Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Matsuda, Yuichi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Matsuda, Yuichi] Grad Univ Adv Studies, SOKENDAI, Mitaka, Tokyo 1810015, Japan; [Yamada, Toru] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Hayashino, Tomoki] Tohoku Univ, Grad Sch Sci, Res Ctr Neutrino Sci, Sendai, Miyagi 9808578, Japan	Battaia, FA (reprint author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	arrigoni@mpia.de			Alexander von Humboldt Foundation; German Federal Ministry for Education and Research; BMBF/DLR grant [50 OR 1306]; JSPS KAKENHI Grant [20647268]	We thank the referee for providing useful and constructive comments that improved this paper. We thank the members of the ENIGMA group<SUP>20</SUP> at the Max Planck Institute for Astronomy (MPIA) for helpful discussions, in particular Jonathan Stern. We thank Andrew Humphrey for helpful discussion about HzRGs and for sharing his data during the early stages of this work. J.F.H. acknowledges generous support from the Alexander von Humboldt Foundation in the context of the Sofja Kovalevskaja Award. The Humboldt Foundation is funded by the German Federal Ministry for Education and Research. Y.Y. acknowledges support from the BMBF/DLR grant Nr. 50 OR 1306. Y.M. acknowledges support from JSPS KAKENHI Grant Number 20647268.	Allen MG, 1998, ASTROPHYS J, V493, P571, DOI 10.1086/305145; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; vanOjik R, 1997, ASTRON ASTROPHYS, V317, P358; Bertin E, 2002, ASTR SOC P, V281, P228; Steidel CC, 2000, ASTROPHYS J, V532, P170, DOI 10.1086/308568; Adelberger KL, 2005, ASTROPHYS J, V629, P636, DOI 10.1086/431753; Erb DK, 2010, ASTROPHYS J, V719, P1168, DOI 10.1088/0004-637X/719/2/1168; Taniguchi Y, 2001, ASTROPHYS J, V562, pL15, DOI 10.1086/338101; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Steidel CC, 2010, ASTROPHYS J, V717, P289, DOI 10.1088/0004-637X/717/1/289; Yang YJ, 2010, ASTROPHYS J, V719, P1654, DOI 10.1088/0004-637X/719/2/1654; Nilsson KK, 2006, ASTRON ASTROPHYS, V452, pL23, DOI [10.1051/0004-6361:200600025, 10.1051/004-6361:200600025]; Hayes M, 2011, NATURE, V476, P304, DOI 10.1038/nature10320; Baskin A, 2014, MON NOT R ASTRON SOC, V438, P604, DOI 10.1093/mnras/stt2230; Ohyama Y, 2003, ASTROPHYS J, V591, pL9, DOI 10.1086/376959; Stern J, 2014, MON NOT R ASTRON SOC, V438, P901, DOI 10.1093/mnras/stt1843; Saito T, 2006, ASTROPHYS J, V648, P54, DOI 10.1086/505678; Dijkstra M, 2006, ASTROPHYS J, V649, P14, DOI 10.1086/506243; Strateva IV, 2005, ASTRON J, V130, P387, DOI 10.1086/431247; Yang YJ, 2009, ASTROPHYS J, V693, P1579, DOI 10.1088/0004-637X/693/2/1579; Humphrey A, 2006, MON NOT R ASTRON SOC, V369, P1103, DOI 10.1111/j.1365-2966.2006.10224.x; Dijkstra M, 2009, MON NOT R ASTRON SOC, V400, P1109, DOI 10.1111/j.1365-2966.2009.15533.x; Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Humphrey A, 2008, MON NOT R ASTRON SOC, V383, P11, DOI 10.1111/j.1365-2966.2007.12506.x; Dey A, 2005, ASTROPHYS J, V629, P654, DOI 10.1086/430775; De Breuck C, 2000, ASTRON ASTROPHYS, V362, P519; Nesvadba NPH, 2006, ASTROPHYS J, V650, P693, DOI 10.1086/507266; HECKMAN TM, 1991, ASTROPHYS J, V381, P373, DOI 10.1086/170660; Wilman RJ, 2005, NATURE, V436, P227, DOI 10.1038/nature03718; Prochaska JX, 2009, ASTROPHYS J, V690, P1558, DOI 10.1088/0004-637X/690/2/1558; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; Ouchi M, 2009, ASTROPHYS J, V696, P1164, DOI 10.1088/0004-637X/696/2/1164; Dijkstra M, 2008, MON NOT R ASTRON SOC, V386, P492, DOI 10.1111/j.1365-2966.2008.13066.x; Groves BA, 2004, ASTROPHYS J SUPPL S, V153, P75, DOI 10.1086/421114; Dopita MA, 2002, ASTROPHYS J, V572, P753, DOI 10.1086/340429; Cantalupo S, 2014, NATURE, V506, P63, DOI 10.1038/nature12898; Farina EP, 2013, MON NOT R ASTRON SOC, V429, P1267, DOI 10.1093/mnras/sts410; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; Matsuda Y, 2005, ASTROPHYS J, V634, pL125, DOI 10.1086/499071; Furlanetto SR, 2005, ASTROPHYS J, V622, P7, DOI 10.1086/426808; Hopkins PF, 2007, ASTROPHYS J, V654, P731, DOI 10.1086/509629; Geach JE, 2009, ASTROPHYS J, V700, P1, DOI 10.1088/0004-637X/700/1/1; Matsuda Y, 2006, ASTROPHYS J, V640, pL123, DOI 10.1086/503362; Miyazaki S, 2002, PUBL ASTRON SOC JPN, V54, P833; Goerdt T, 2010, MON NOT R ASTRON SOC, V407, P613, DOI 10.1111/j.1365-2966.2010.16941.x; Yang YJ, 2006, ASTROPHYS J, V640, P539, DOI 10.1086/497898; Christensen L, 2006, ASTRON ASTROPHYS, V459, P717, DOI 10.1051/0004-6361:20065318; Haiman Z, 2000, ASTROPHYS J, V537, pL5, DOI 10.1086/312754; Rosdahl J, 2012, MON NOT R ASTRON SOC, V423, P344, DOI 10.1111/j.1365-2966.2012.20883.x; Haiman Z, 2001, ASTROPHYS J, V556, P87, DOI 10.1086/321567; Fardal MA, 2001, ASTROPHYS J, V562, P605, DOI 10.1086/323519; Reuland M, 2003, ASTROPHYS J, V592, P755, DOI 10.1086/375619; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; Miley G, 2008, ASTRON ASTROPHYS REV, V15, P67, DOI 10.1007/S00159-007-0008-Z; Bennert N, 2006, ASTRON ASTROPHYS, V456, P953, DOI 10.1051/0004-6361:20065319; Matsuda Y, 2004, ASTRON J, V128, P569, DOI 10.1086/422020; Nagao T, 2006, ASTRON ASTROPHYS, V459, P85, DOI 10.1051/0004-6361:20065216; Venemans BP, 2007, ASTRON ASTROPHYS, V461, P823, DOI 10.1051/0004-6361:20053941; Hennawi JF, 2007, ASTROPHYS J, V655, P735, DOI 10.1086/509770; HECKMAN TM, 1991, ASTROPHYS J, V370, P78, DOI 10.1086/169794; Prescott MKM, 2009, ASTROPHYS J, V702, P554, DOI 10.1088/0004-637X/702/1/554; Crighton NHM, 2015, MON NOT R ASTRON SOC, V446, P18, DOI 10.1093/mnras/stu2088; Matsuoka K, 2009, ASTRON ASTROPHYS, V503, P721, DOI 10.1051/0004-6361/200811478; Geach JE, 2007, ASTROPHYS J, V655, pL9, DOI 10.1086/511676; De Breuck C, 2001, ASTRON J, V121, P1241, DOI 10.1086/319392; Reuland M, 2007, ASTRON J, V133, P2607, DOI 10.1086/516571; Smith DJB, 2007, MON NOT R ASTRON SOC, V378, pL49, DOI 10.1111/j.1745-3933.2007.00318.x; Taniguchi Y, 2000, ASTROPHYS J, V532, pL13, DOI 10.1086/312557; White M, 2012, MON NOT R ASTRON SOC, V424, P933, DOI 10.1111/j.1365-2966.2012.21251.x; ANTONUCCI R, 1993, ANNU REV ASTRON ASTR, V31, P473, DOI 10.1146/annurev.aa.31.090193.002353; Arrigoni Battaia F., 2013, P INT ASTRONOMICAL U, P253; Arrigoni Battaia F., 2015, APJ UNPUB; Bacon R, 2004, P SOC PHOTO-OPT INS, V5492, P1145, DOI 10.1117/12.549009; Barrio FE, 2008, MON NOT R ASTRON SOC, V389, P792, DOI 10.1111/j.1365-2966.2008.13576.x; Basu-Zych A, 2004, ASTROPHYS J, V615, pL85, DOI 10.1086/426390; Bertin E., 2006, ASP C SER, V351, P112; BINETTE L, 1985, ASTROPHYS J, V297, P476, DOI 10.1086/163544; Binette L, 1996, ASTRON ASTROPHYS, V312, P365; Bowen DV, 2006, ASTROPHYS J, V645, pL105, DOI 10.1086/506274; Cen RY, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/112; Crighton NHM, 2011, MON NOT R ASTRON SOC, V414, P28, DOI 10.1111/j.1365-2966.2011.17247.x; Crighton NHM, 2013, ASTROPHYS J LETT, V776, DOI 10.1088/2041-8205/776/2/L18; DEY A, 1995, ASTROPHYS J, V440, P515, DOI 10.1086/175293; Elvis M, 2000, ASTROPHYS J, V545, P63, DOI 10.1086/317778; Fabian AC, 1999, MON NOT R ASTRON SOC, V308, pL39, DOI 10.1046/j.1365-8711.1999.03017.x; Faucher-Giguere CA, 2010, ASTROPHYS J, V725, P633, DOI 10.1088/0004-637X/725/1/633; Ferland GJ, 2003, ANNU REV ASTRON ASTR, V41, P517, DOI 10.1146/annurev.astro.41.011802.094836; FERLAND GJ, 1984, ASTROPHYS J, V281, P194, DOI 10.1086/162088; Francis PJ, 2001, ASTROPHYS J, V554, P1001, DOI 10.1086/321417; Fumagalli M, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/74; Hainline KN, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/65; Hayashino T, 2004, ASTRON J, V128, P2073, DOI 10.1086/424935; Hennawi JF, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/58; Hennawi JF, 2006, ASTROPHYS J, V651, P61, DOI 10.1086/507069; Hu E. M., 1987, AP J, V317, pL7, DOI 10.1086/184902; Humphrey A, 2013, MON NOT R ASTRON SOC, V428, P563, DOI 10.1093/mnras/sts055; Keel WC, 1999, ASTRON J, V118, P2547, DOI 10.1086/301139; King A, 2003, ASTROPHYS J, V596, pL27, DOI 10.1086/379143; Lusso E., 2015, ARXIV150302075; Matsuda Y, 2011, MON NOT R ASTRON SOC, V410, pL13, DOI 10.1111/j.1745-3933.2010.00969.x; MCCARTHY PJ, 1993, ANNU REV ASTRON ASTR, V31, P639; McLinden EM, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/48; Mori M, 2006, NEW ASTRON REV, V50, P199, DOI 10.1016/j.newar.2005.11.035; North PL, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201015153; OKE JB, 1974, ASTROPHYS J SUPPL S, V27, P21, DOI 10.1086/190287; Overzier RA, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/89; Prescott MKM, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/125; Prescott MKM, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/38; Prescott MKM, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/62; Prochaska JX, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/136; Prochaska JX, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/2/L19; Prochaska JX, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/140; Rakic O, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/94; REES MJ, 1988, MON NOT R ASTRON SOC, V231, pP91; Roettgering H. J. A., 1997, ASTRON ASTROPHYS, V326, P505; Rudie GC, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/67; Smith DJB, 2009, MON NOT R ASTRON SOC, V393, P309, DOI 10.1111/j.1365-2966.2008.14232.x; Steidel CC, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/160; van Dokkum PG, 2001, PUBL ASTRON SOC PAC, V113, P1420, DOI 10.1086/323894; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; VANOJIK R, 1994, ASTRON ASTROPHYS, V289, P54; Vernet J, 2001, ASTRON ASTROPHYS, V366, P7, DOI 10.1051/0004-6361:20000076; Villar-Martin M, 2003, MON NOT R ASTRON SOC, V346, P273, DOI 10.1046/j.1365-2966.2003.07090.x; Villar-Martin M, 2003, NEW ASTRON REV, V47, P291, DOI 10.1016/S1387-6473(03)00041-1; Villar-Martin M, 2007, MON NOT R ASTRON SOC, V375, P1299, DOI 10.1111/j.1365-2966.2006.11371.x; Wilman RJ, 2004, MON NOT R ASTRON SOC, V351, P1109, DOI 10.1111/j.1365-2966.2004.07857.x; Yang YJ, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/87; Yang YJ, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/2/114; Yang YJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/171	130	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							26	10.1088/0004-637X/804/1/26		20	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500026		
J	Dobos, V; Turner, EL				Dobos, Vera; Turner, Edwin L.			VISCOELASTIC MODELS OF TIDALLY HEATED EXOMOONS	ASTROPHYSICAL JOURNAL			English	Article						planets and satellites: general	SOUTH-POLE; ENCELADUS; HABITABILITY; PLANETS; MOONS; MASS; IO; DISSIPATION; EXOPLANETS; SYSTEM	Tidal heating of exomoons may play a key role in their habitability, since the elevated temperature can melt the ice on the body even without significant solar radiation. The possibility of life has been intensely studied on solar system moons such as Europa or Enceladus where the surface ice layer covers a tidally heated water ocean. Tidal forces may be even stronger in extrasolar systems, depending on the properties of the moon and its orbit. To study the tidally heated surface temperature of exomoons, we used a viscoelastic model for the first time. This model is more realistic than the widely used, so-called fixed Q models because it takes into account the temperature dependence of the tidal heat flux and the melting of the inner material. Using this model, we introduced the circumplanetary Tidal Temperate Zone (TTZ), which strongly depends on the orbital period of the moon and less on its radius. We compared the results with the fixed Q model and investigated the statistical volume of the TTZ using both models. We have found that the viscoelastic model predicts 2.8 times more exomoons in the TTZ with orbital periods between 0.1 and 3.5 days than the fixed Q model for plausible distributions of physical and orbital parameters. The viscoelastic model provides more promising results in terms of habitability because the inner melting of the body moderates the surface temperature, acting like a thermostat.	[Dobos, Vera] Hungarian Acad Sci, Res Ctr Astron & Earth Sci, Konkoly Thege Miklos Astron Inst, H-1121 Budapest, Hungary; [Dobos, Vera; Turner, Edwin L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Turner, Edwin L.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2278583, Japan	Dobos, V (reprint author), Hungarian Acad Sci, Res Ctr Astron & Earth Sci, Konkoly Thege Miklos Astron Inst, Konkoly Thege Miklos Ut 15-17, H-1121 Budapest, Hungary.	dobos@konkoly.hu			World Premier International Research Center Initiative, MEXT, Japan; Hungarian OTKA grants [K83790, K104607]; Hungarian Academy of Sciences; ESA PECS [4000110889/14/NL/NDe]	We thank Amy Barr, Rene Heller, Edwin Kite, and Omer Bromberg for useful conversations. We are also grateful to Laszlo L. Kiss and Darren Williams for useful comments that greatly improved the manuscript. This research has been supported in part by the World Premier International Research Center Initiative, MEXT, Japan. V.D. has been supported by the Hungarian OTKA grants K83790, K104607 and the Lendulet-2009 Young Researchers Program of the Hungarian Academy of Sciences, and the ESA PECS contract No. 4000110889/14/NL/NDe.	Iess L, 2014, SCIENCE, V344, P78, DOI 10.1126/science.1250551; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; FISCHER HJ, 1990, ICARUS, V83, P39, DOI 10.1016/0019-1035(90)90005-T; Simon AE, 2010, MON NOT R ASTRON SOC, V406, P2038, DOI 10.1111/j.1365-2966.2010.16818.x; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Heller R, 2014, ASTROBIOLOGY, V14, P798, DOI 10.1089/ast.2014.1147; Collins GC, 2007, ICARUS, V189, P72, DOI 10.1016/j.icarus.2007.01.010; Heller R, 2013, ASTROBIOLOGY, V13, P18, DOI 10.1089/ast.2012.0859; SEGATZ M, 1988, ICARUS, V75, P187, DOI 10.1016/0019-1035(88)90001-2; Roth L, 2014, SCIENCE, V343, P171, DOI 10.1126/science.1247051; Simon AE, 2012, MON NOT R ASTRON SOC, V419, P164, DOI 10.1111/j.1365-2966.2011.19682.x; Henning WG, 2009, ASTROPHYS J, V707, P1000, DOI 10.1088/0004-637X/707/2/1000; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Barr AC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003114; Bennett DP, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/155; GOLDREIC.P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Hinkel NR, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/27; Kaltenegger L, 2010, ASTROPHYS J LETT, V712, pL125, DOI 10.1088/2041-8205/712/2/L125; Kipping DM, 2009, MON NOT R ASTRON SOC, V392, P181, DOI 10.1111/j.1365-2966.2008.13999.x; Kipping DM, 2009, MON NOT R ASTRON SOC, V396, P1797, DOI 10.1111/j.1365-2966.2009.14869.x; Kipping DM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/115; Lodders K., 1998, PLANETARY SCI COMPAN; Moore WB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001943; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Ogihara M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/60; Peters MA, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/98; Remus F, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118595; Reynolds R T, 1987, Adv Space Res, V7, P125, DOI 10.1016/0273-1177(87)90364-4; ROSS MN, 1989, ICARUS, V78, P90, DOI 10.1016/0019-1035(89)90071-7; Scharf CA, 2006, ASTROPHYS J, V648, P1196, DOI 10.1086/505256; Shoji D, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/3; Simon A, 2007, ASTRON ASTROPHYS, V470, P727, DOI 10.1051/0004-6361:20066560; Spencer JR, 2000, SCIENCE, V288, P1198, DOI 10.1126/science.288.5469.1198; Sullivan III W. T., 2007, PLANETS AND LIFE; Williams DM, 2013, ASTROBIOLOGY, V13, P315, DOI 10.1089/ast.2012.0892	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							41	10.1088/0004-637X/804/1/41		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500041		
J	Iwai, K; Shimojo, M				Iwai, Kazumasa; Shimojo, Masumi			OBSERVATION OF THE CHROMOSPHERIC SUNSPOT AT MILLIMETER RANGE WITH THE NOBEYAMA 45 m TELESCOPE	ASTROPHYSICAL JOURNAL			English	Article						sunspots; Sun: chromosphere; Sun: radio radiation	SEMIEMPIRICAL MODELS; SUN; SUBMILLIMETER; WAVELENGTHS	The brightness temperature of the radio free-free emission at millimeter range is an effective tool for characterizing the vertical structure of the solar chromosphere. In this paper, we report on the first single-dish observation of a sunspot at 85 and 115 GHz with sufficient spatial resolution for resolving the sunspot umbra using the Nobeyama 45 m telescope. We used radio attenuation material, i.e., a solar filter, to prevent the saturation of the receivers. Considering the contamination from the plage by the side lobes, we found that the brightness temperature of the umbra should be lower than that of the quiet region. This result is inconsistent with the preexisting atmospheric models. We also found that the brightness temperature distribution at millimeter range strongly corresponds to the ultraviolet continuum emission at 1700 angstrom, especially at the quiet region.	[Iwai, Kazumasa] Natl Inst Nat Sci, Natl Astron Observ Japan, Nobeyama Solar Radio Observ, Minamimaki, Nagano 3841305, Japan; [Shimojo, Masumi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Iwai, K (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, Nobeyama Solar Radio Observ, 462-2 Nobeyama, Minamimaki, Nagano 3841305, Japan.	kazumasa.iwai@nao.ac.jp					Wedemeyer-Bohm S, 2007, ASTRON ASTROPHYS, V471, P977, DOI 10.1051/0004-6361:20077588; Lemen James R., 2012, Solar Physics, V275, DOI 10.1007/s11207-011-9776-8; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; Fontenla JM, 2009, ASTROPHYS J, V707, P482, DOI 10.1088/0004-637X/707/1/482; White SM, 2006, ASTRON ASTROPHYS, V456, P697, DOI 10.1051/0004-6361:20052854; MALTBY P, 1986, ASTROPHYS J, V306, P284, DOI 10.1086/164342; Avrett E.H., 1981, PHYSICS SUNSPOTS, P235; BASTIAN TS, 1993, ASTROPHYS J, V415, P364, DOI 10.1086/173170; DULK GA, 1985, ANNU REV ASTRON ASTR, V23, P169, DOI 10.1146/annurev.aa.23.090185.001125; EWELL MW, 1993, ASTROPHYS J, V403, P426, DOI 10.1086/172213; IRIMAJIRI Y, 1995, SOL PHYS, V156, P363, DOI 10.1007/BF00670232; KOSUGI T, 1986, PUBL ASTRON SOC JPN, V38, P1; LINDSEY C, 1995, ASTROPHYS J, V453, P517, DOI 10.1086/176413; LINDSEY C, 1995, ASTROPHYS J, V453, P511, DOI 10.1086/176412; Loukitcheva M., 2014, ASTRON ASTROPHYS, V561, P133; PENZIAS AA, 1973, ANNU REV ASTRON ASTR, V11, P51, DOI 10.1146/annurev.aa.11.090173.000411; Selhorst CL, 2005, ASTRON ASTROPHYS, V433, P365, DOI 10.1051/0004-6361:20042043; Severino G., 1994, P NATO ADV RES WORKS, P169; Socas-Navarro H, 2007, ASTROPHYS J SUPPL S, V169, P439, DOI 10.1086/510336	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							48	10.1088/0004-637X/804/1/48		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500048		
J	Jeong, J; Park, H; Han, C; Gould, A; Udalski, A; Szymanski, MK; Pietrzynski, G; Soszynski, I; Poleski, R; Ulaczyk, K; Wyrzykowski, L; Abe, F; Bennett, DP; Bond, IA; Botzler, CS; Freeman, M; Fukui, A; Fukunaga, D; Itow, Y; Koshimoto, N; Masuda, K; Matsubara, Y; Muraki, Y; Namba, S; Ohnishi, K; Rattenbury, NJ; Saito, T; Sullivan, DJ; Sweatman, WL; Sumi, T; Suzuki, D; Tristram, PJ; Tsurumi, N; Wada, K; Yamai, N; Yock, PCM; Yonehara, A; Albrow, MD; Batista, V; Beaulieu, JP; Caldwell, JAR; Cassan, A; Cole, A; Coutures, C; Dieters, S; Dominik, M; Prester, DD; Donatowicz, J; Fouque, P; Greenhill, J; Hoffman, M; Huber, M; Jorgensen, UG; Kane, SR; Kubas, D; Martin, R; Marquette, JB; Menzies, J; Pitrou, C; Pollard, K; Sahu, KC; Vinter, C; Wambsganss, J; Williams, A; Allen, W; Bolt, G; Choi, JY; Christie, GW; DePoy, DL; Drummond, J; Gaudi, BS; Hwang, KH; Jung, YK; Lee, CU; Mallia, F; Maoz, D; Maury, A; McCormick, J; Monard, LAG; Moorhouse, D; Natusch, T; Ofek, EO; Park, BG; Pogge, RW; Santallo, R; Shin, IG; Thornley, G; Yee, JC; Bramich, DM; Burgdorf, M; Horne, K; Hundertmark, M; Kains, N; Snodgrass, C; Steele, I; Street, R; Tsapras, Y				Jeong, J.; Park, H.; Han, C.; Gould, A.; Udalski, A.; Szymanski, M. K.; Pietrzynski, G.; Soszynski, I.; Poleski, R.; Ulaczyk, K.; Wyrzykowski, L.; Abe, F.; Bennett, D. P.; Bond, I. A.; Botzler, C. S.; Freeman, M.; Fukui, A.; Fukunaga, D.; Itow, Y.; Koshimoto, N.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Namba, S.; Ohnishi, K.; Rattenbury, N. J.; Saito, To.; Sullivan, D. J.; Sweatman, W. L.; Sumi, T.; Suzuki, D.; Tristram, P. J.; Tsurumi, N.; Wada, K.; Yamai, N.; Yock, P. C. M.; Yonehara, A.; Albrow, M. D.; Batista, V.; Beaulieu, J. -P.; Caldwell, J. A. R.; Cassan, A.; Cole, A.; Coutures, C.; Dieters, S.; Dominik, M.; Prester, D. Dominis; Donatowicz, J.; Fouque, P.; Greenhill, J.; Hoffman, M.; Huber, M.; Jorgensen, U. G.; Kane, S. R.; Kubas, D.; Martin, R.; Marquette, J. -B.; Menzies, J.; Pitrou, C.; Pollard, K.; Sahu, K. C.; Vinter, C.; Wambsganss, J.; Williams, A.; Allen, W.; Bolt, G.; Choi, J. -Y.; Christie, G. W.; DePoy, D. L.; Drummond, J.; Gaudi, B. S.; Hwang, K. -H.; Jung, Y. K.; Lee, C. -U.; Mallia, F.; Maoz, D.; Maury, A.; McCormick, J.; Monard, L. A. G.; Moorhouse, D.; Natusch, T.; Ofek, E. O.; Park, B. -G.; Pogge, R. W.; Santallo, R.; Shin, I. -G.; Thornley, G.; Yee, J. C.; Bramich, D. M.; Burgdorf, M.; Horne, K.; Hundertmark, M.; Kains, N.; Snodgrass, C.; Steele, I.; Street, R.; Tsapras, Y.		OGLE Collaboration; MOA Collaboration; PLANET Collaboration; mFUN Collaboration; RoboNet Collaboration	REANALYSES OF ANOMALOUS GRAVITATIONAL MICROLENSING EVENTS IN THE OGLE-III EARLY WARNING SYSTEM DATABASE WITH COMBINED DATA	ASTROPHYSICAL JOURNAL			English	Article						binaries: close; gravitational lensing: micro	BINARY LENSES; GALACTIC BULGE; EWS DATABASE; SEARCH; MASS; PERTURBATIONS; STELLAR; LIMITS; HALO	We reanalyze microlensing events in the published list of anomalous events that were observed from the Optical Gravitational Lensing Experiment (OGLE) lensing survey conducted during the 2004-2008 period. In order to check the existence of possible degenerate solutions and extract extra information, we conduct analyses based on combined data from other survey and follow-up observation and consider higher-order effects. Among the analyzed events, we present analyses of eight events for which either new solutions are identified or additional information is obtained. We find that the previous binary-source interpretations of five events are better interpreted by binary-lens models. These events include OGLE-2006-BLG-238, OGLE-2007-BLG-159, OGLE-2007-BLG-491, OGLE-2008-BLG-143, and OGLE-2008-BLG-210. With additional data covering caustic crossings, we detect finite-source effects for six events including OGLE-2006-BLG-215, OGLE-2006-BLG-238, OGLE-2006-BLG-450, OGLE-2008-BLG-143, OGLE-2008-BLG-210, and OGLE-2008-BLG-513. Among them, we are able to measure the Einstein radii of three events for which multi-band data are available. These events are OGLE-2006-BLG-238, OGLE-2008-BLG-210, and OGLE-2008-BLG-513. For OGLE-2008-BLG-143, we detect higher-order effects induced by the changes of the observer's position caused by the orbital motion of the Earth around the Sun. In addition, we present degenerate solutions resulting from the known close/wide or ecliptic degeneracy. Finally, we note that the masses of the binary companions of the lenses of OGLE-2006-BLG-450 and OGLE-2008-BLG-210 are in the brown-dwarf regime.	[Jeong, J.; Park, H.; Han, C.; Choi, J. -Y.; Hwang, K. -H.; Jung, Y. K.; Shin, I. -G.] Chungbuk Natl Univ, Inst Astrophys, Dept Phys, Cheongju 361763, South Korea; [Gould, A.; Poleski, R.; Batista, V.; Pogge, R. W.; Yee, J. C.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Udalski, A.; Szymanski, M. K.; Pietrzynski, G.; Soszynski, I.; Poleski, R.; Ulaczyk, K.; Wyrzykowski, L.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 OHA, England; [Abe, F.; Fukunaga, D.; Itow, Y.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Sumi, T.; Tsurumi, N.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Bennett, D. P.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Bond, I. A.; Sweatman, W. L.] Massey Univ, Inst Informat & Math Sci, North Shore Mail Ctr, Auckland, New Zealand; [Botzler, C. S.; Freeman, M.; Rattenbury, N. J.; Yock, P. C. M.] Univ Auckland, Dept Phys, Auckland 1001, New Zealand; [Fukui, A.] Natl Astron Observ Japan, Okayama Astrophys Observ, Asakuchi, Okayama 7190232, Japan; [Koshimoto, N.; Namba, S.; Suzuki, D.; Wada, K.] Osaka Univ, Dept Earth & Space Sci, Osaka 5600043, Japan; [Ohnishi, K.] Nagano Natl Coll Technol, Nagano 3818550, Japan; [Saito, To.; Gaudi, B. S.] Tokyo Metropolitan Coll Aeronaut, Tokyo 1168523, Japan; [Sullivan, D. J.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand; [Tristram, P. J.] Mt John Univ Observ, Lake Tekapo 8770, New Zealand; [Yamai, N.; Yonehara, A.] Kyoto Sangyo Univ, Fac Sci, Dept Phys, Kyoto 6038555, Japan; [Albrow, M. D.; Pollard, K.] Univ Canterbury, Dept Phys & Astron, Christchurch 8020, New Zealand; [Beaulieu, J. -P.; Cassan, A.; Coutures, C.; Dieters, S.; Kubas, D.; Marquette, J. -B.; Pitrou, C.] Univ Paris 06, CNRS UMR7095, Inst Astrophys Paris, F-75014 Paris, France; [Caldwell, J. A. R.; Cole, A.] McDonald Observ, Ft Davis, TX 79734 USA; [Dominik, M.; Horne, K.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Prester, D. Dominis] Univ Rijeka, Fac Arts & Sci, Dept Phys, Rijeka 51000, Croatia; [Donatowicz, J.] Vienna Univ Technol, Dept Comp, A-1040 Vienna, Austria; [Fouque, P.] Univ Toulouse, CNRS, UMR 5277, IRAP, F-31400 Toulouse, France; [Fouque, P.] Canada France Hawaii Telescope Corp, Kamuela, HI 96743 USA; [Greenhill, J.] Univ Tasmania, Sch Math & Phys, Hobart, Tas 7001, Australia; [Hoffman, M.] Univ Orange Free State, Fac Nat & Agr Sci, Dept Phys, ZA-9300 Bloemfontein, South Africa; [Huber, M.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Jorgensen, U. G.; Vinter, C.; Hundertmark, M.] Niels Bohr Inst, Astron Observ, DK-2100 Copenhagen, Denmark; [Kane, S. R.] San Francisco State Univ, Dept Phys & Astron, San Francisco, CA 94132 USA; [Martin, R.; Williams, A.] Perth Observ, Perth, WA 6076, Australia; [Menzies, J.] S African Astron Observ, ZA-7935 Observatory, South Africa; [Sahu, K. C.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Wambsganss, J.] Astron Rech Inst, D-69120 Heidelberg, Germany; [Allen, W.] Vintage Lane Observ, Blenheim, New Zealand; [Bolt, G.] Craigie Observ, Craigie, WA, Australia; [Christie, G. W.; Natusch, T.] Auckland Observ, Auckland, New Zealand; [DePoy, D. L.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Drummond, J.] Possum Observ, Patutahi, Gisbourne, New Zealand; [Lee, C. -U.; Park, B. -G.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Mallia, F.; Maury, A.] Campo Catino Austral Observ, San Pedro De Atacama, Chile; [Maoz, D.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Maoz, D.] Tel Aviv Univ, Wise Observ, IL-69978 Tel Aviv, Israel; [McCormick, J.] Ctr Backyard Astrophys, Farm Cove Observ, Auckland, New Zealand; [Monard, L. A. G.] Klein Karoo Observ, Calitzdorp, South Africa; [Monard, L. A. G.] Bronberg Observ, Pretoria, South Africa; [Moorhouse, D.; Thornley, G.] Kumeu Observ, Kumeu, New Zealand; [Natusch, T.] AUT Univ, Inst Radiophys & Space Res, Auckland, New Zealand; [Ofek, E. O.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Santallo, R.] Southern Stars Observ, Faaa, Tahiti, Fr Polynesia; [Yee, J. C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Bramich, D. M.; Kains, N.] European So Observ, D-85748 Garching, Germany; [Burgdorf, M.] Univ Hamburg, Meterol Inst, D-20146 Hamburg, Germany; [Snodgrass, C.] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Steele, I.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool CH41 1LD, Merseyside, England; [Street, R.; Tsapras, Y.] Las Cumbres Observ, Global Telescope Network, Goleta, CA 93117 USA; [Tsapras, Y.] Univ London, Sch Math Sci, Astron Unit, London E1 4NS, England	Han, C (reprint author), Chungbuk Natl Univ, Inst Astrophys, Dept Phys, Cheongju 361763, South Korea.		Hundertmark, Markus/C-6190-2015	Hundertmark, Markus/0000-0003-0961-5231	Creative Research Initiative Program of the National Research Foundation of Korea [2009-0081561]; European Research Council under the European Community's Seventh Framework Programme (FP7) / ERC [246678]; JSPS [JSPS23340044, JSPS24253004]; NSF [AST 110347]; NASA [NNX12AB99G]; NASA through the Sagan Fellowship Program;  [JSPS18253002];  [JSPS20340052];  [NASA-NNX12AF54G];  [JPL-RSA 1453175];  [NSF AST-1211875]	Work by C.H. was supported by the Creative Research Initiative Program (2009-0081561) of the National Research Foundation of Korea. The OGLE project has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no. 246678 to AU. The MOA project is supported by the grants JSPS18253002 and JSPS20340052. T.S. acknowledges the financial support from the JSPS, JSPS23340044 and JSPS24253004. D.P.B. was supported by grants NASA-NNX12AF54G, JPL-RSA 1453175, and NSF AST-1211875. B.S.G. and A.G. were supported by NSF grant AST 110347. B.S.G., A.G., and R.P.G. were supported by NASA grant NNX12AB99G. Work by J.C.Y. was performed in part under contract with the California Institute of Technology (Caltech) funded by NASA through the Sagan Fellowship Program.	Alcock C, 2001, ASTROPHYS J, V552, P259, DOI 10.1086/320457; An JH, 2005, MON NOT R ASTRON SOC, V356, P1409, DOI 10.1111/j.1365-2966.2004.08581.x; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Griest K, 1998, ASTROPHYS J, V500, P37, DOI 10.1086/305729; NEMIROFF RJ, 1994, ASTROPHYS J, V424, pL21, DOI 10.1086/187265; Albrow MD, 2000, ASTROPHYS J, V535, P176, DOI 10.1086/308842; Yoo J, 2004, ASTROPHYS J, V603, P139, DOI 10.1086/381241; MAO S, 1991, ASTROPHYS J, V374, pL37, DOI 10.1086/186066; Tsapras Y, 2009, ASTRON NACHR, V330, P4, DOI 10.1002/asna.200811130; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Dominik M, 1999, ASTRON ASTROPHYS, V349, P108; Gaudi BS, 1998, ASTROPHYS J, V506, P533, DOI 10.1086/306256; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Gould A., 2006, APJ, V644, P37; GRIEST K, 1992, ASTROPHYS J, V397, P362, DOI 10.1086/171793; HAN CH, 1995, ASTROPHYS J, V447, P53, DOI 10.1086/175856; Jaroszynski M, 2010, ACTA ASTRONOM, V60, P197; Jaroszynski M, 2006, ACTA ASTRONOM, V56, P307; Kim D, 2008, ASTROPHYS J, V689, P1084, DOI 10.1086/592771; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; Park H, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/134; Skowron J, 2007, ACTA ASTRONOM, V57, P281; Skowron J, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/87; Sumi T, 2003, ASTROPHYS J, V591, P204, DOI 10.1086/375212; Udalski A, 2003, ACTA ASTRONOM, V53, P291	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							38	10.1088/0004-637X/804/1/38		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500038		
J	Nakazato, K; Mochida, E; Niino, Y; Suzuki, H				Nakazato, Ken'ichiro; Mochida, Eri; Niino, Yuu; Suzuki, Hideyuki			SPECTRUM OF THE SUPERNOVA RELIC NEUTRINO BACKGROUND AND METALLICITY EVOLUTION OF GALAXIES	ASTROPHYSICAL JOURNAL			English	Article						diffuse radiation; galaxies: evolution; neutrinos; supernovae: general	STAR-FORMATION RATE; CORE-COLLAPSE SUPERNOVAE; EQUATION-OF-STATE; BLACK-HOLE FORMATION; GAMMA-RAY BURSTS; FORMING GALAXIES; FORMATION HISTORY; NUCLEAR-MATTER; HOST GALAXIES; MASSIVE STARS	The spectrum of the supernova relic neutrino (SRN) background from past stellar collapses including black hole formation (failed supernovae) is calculated. The redshift dependence of the black hole formation rate is considered on the basis of the metallicity evolution of galaxies. Assuming the mass and metallicity ranges of failed supernova progenitors, their contribution to SRNs is quantitatively estimated for the first time. Using this model, the dependences of SRNs on the cosmic star formation rate density (CSFRD), shock revival time, and equation of state (EOS) are investigated. The shock revival time is introduced as a parameter that should depend on the still unknown explosion mechanism of core collapse supernovae. The dependence on EOS is considered for failed supernovae, whose collapse dynamics and neutrino emission are certainly affected. It is found that the low-energy spectrum of SRNs is mainly determined by the CSFRD. These low-energy events will be observed in the Super-Kamiokande experiment with gadolinium-loaded water.	[Nakazato, Ken'ichiro; Mochida, Eri; Suzuki, Hideyuki] Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, Noda, Chiba 2788510, Japan; [Niino, Yuu] Natl Astron Observ Japan, Div Opt & Infrared Astron, Mitaka, Tokyo 1818588, Japan	Nakazato, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Phys, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	nakazato@rs.tus.ac.jp			MEXT in Japan [24105008, 26104006, 26105515, 26870615]	The authors are grateful to Makoto Sakuda and Tomonori Totani for valuable comments. We would also like to thank Yusuke Koshio for providing us the data of upper limits from Super-Kamiokande. In this work, numerical computations were partially performed on the supercomputers at Research Center for Nuclear Physics (RCNP) in Osaka University. This work was partially supported by Grants-in-Aids for the Scientific Research (No. 24105008, No. 26104006, No. 26105515, and No. 26870615) from MEXT in Japan.	Alexeyev E. N., 1998, PHLB, V205, P209; Prieto CA, 2001, ASTROPHYS J, V556, pL63, DOI 10.1086/322874; Ando S, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/170; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; Nakazato K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.083012; Lunardini C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.231101; Poelarends AJT, 2008, ASTROPHYS J, V675, P614, DOI 10.1086/520872; Drory N, 2005, ASTROPHYS J, V619, pL131, DOI 10.1086/428044; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Kotake K, 2012, ADV ASTRON, DOI 10.1155/2012/428757; Dighe AS, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.033007; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; Beacom JF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171101; Beacom JF, 2010, ANNU REV NUCL PART S, V60, P439, DOI 10.1146/annurev.nucl.010909.083331; Doherty CL, 2015, MON NOT R ASTRON SOC, V446, P2599, DOI 10.1093/mnras/stu2180; Strumia A, 2003, PHYS LETT B, V564, P42, DOI 10.1016/S0370-2693(03)00616-6; Fischer T, 2009, ASTRON ASTROPHYS, V499, P1, DOI 10.1051/0004-6361/200811055; Tremonti CA, 2004, ASTROPHYS J, V613, P898, DOI 10.1086/423264; LATTIMER JM, 1991, NUCL PHYS A, V535, P331, DOI 10.1016/0375-9474(91)90452-C; Chakraborty S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.151101; Shen H, 1998, PROG THEOR PHYS, V100, P1013, DOI 10.1143/PTP.100.1013; Lien A, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.083001; Dasgupta B, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.065008; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Sumiyoshi K, 2005, ASTROPHYS J, V629, P922, DOI 10.1086/431788; Aharmim B, 2006, ASTROPHYS J, V653, P1545, DOI 10.1086/508768; Mannucci F, 2011, MON NOT R ASTRON SOC, V414, P1263, DOI 10.1111/j.1365-2966.2011.18459.x; Bays K, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.052007; Shen H, 1998, NUCL PHYS A, V637, P435, DOI 10.1016/S0375-9474(98)00236-X; Malek M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.061101; Maiolino R, 2008, ASTRON ASTROPHYS, V488, P463, DOI 10.1051/0004-6361:200809678; Watanabe H, 2009, ASTROPART PHYS, V31, P320, DOI 10.1016/j.astropartphys.2009.03.002; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; Langer N, 2006, ASTROPHYS J, V638, pL63, DOI 10.1086/500363; Galais S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.053002; Mannucci F, 2010, MON NOT R ASTRON SOC, V408, P2115, DOI 10.1111/j.1365-2966.2010.17291.x; Belczynski K, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/91; Burrows A, 2013, REV MOD PHYS, V85, P245, DOI 10.1103/RevModPhys.85.245; Drory N, 2008, ASTROPHYS J, V680, P41, DOI 10.1086/588006; Gando A, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/193; Horiuchi S, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/154; Horiuchi S, 2014, MON NOT R ASTRON SOC, V445, pL99, DOI 10.1093/mnrasl/slu146; Janka HT, 2012, ANNU REV NUCL PART S, V62, P407, DOI 10.1146/annurev-nucl-102711-094901; Kawagoe S, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.123014; Kobayashi MAR, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/3; Levesque EM, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/23; Liebendorfer M, 2004, ASTROPHYS J SUPPL S, V150, P263, DOI 10.1086/380191; Lunardini C, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/07/012; Mathews GJ, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/115; Nakazato K, 2006, ASTROPHYS J, V645, P519, DOI 10.1086/504282; Nakazato K, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.083009; Nakazato K, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/1/2; Niino Y., 2012, MNRAS, V413, P567; Niino Y., 2014, MNRAS IN PRESS; Niino Y., 2011, APJ, V761, P126; O'Connor E, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/70; Sanders NE, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/132; Sumiyoshi K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.091101; Suzuki H., 2005, P 5 INT WORKSH NEUTR, P332; Suzuki H., 1994, PHYSICS ASTROPHYSICS, P763; Taddia F, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322276; Totani T, 1996, ASTROPHYS J, V460, P303, DOI 10.1086/176970; Umeda H., 2012, PTEP, V2012; Yabe K, 2012, PUBL ASTRON SOC JPN, V64; Yabe K, 2014, MON NOT R ASTRON SOC, V437, P3647, DOI 10.1093/mnras/stt2185; Yamada S, 1999, ASTRON ASTROPHYS, V344, P533; Yamada S, 1997, ASTROPHYS J, V475, P720, DOI 10.1086/303548; Yamamoto Y, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/27; Yuksel H., 2012, ARXIV12124844; Yuksel H, 2008, ASTROPHYS J LETT, V683, pL5, DOI 10.1086/591449; Zahid HJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/75; Zhang H, 2015, ASTROPART PHYS, V60, P41, DOI 10.1016/j.astropartphys.2014.05.004	75	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							75	10.1088/0004-637X/804/1/75		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500075		
J	Novati, SC; Gould, A; Udalski, A; Menzies, JW; Bond, IA; Shvartzvald, Y; Street, RA; Hundertmark, M; Beichman, CA; Yee, JC; Carey, S; Poleski, R; Skowron, J; Kozlowski, S; Mroz, P; Pietrukowicz, P; Pietrzynski, G; Szymanski, MK; Soszynski, I; Ulaczyk, K; Wyrzykowski, L; Albrow, M; Beaulieu, JP; Caldwell, JAR; Cassan, A; Coutures, C; Danielski, C; Prester, DD; Donatowicz, J; Loncaric, K; McDougall, A; Morales, JC; Ranc, C; Zhu, W; Abe, F; Barry, RK; Bennett, DP; Bhattacharya, A; Fukunaga, D; Inayama, K; Koshimoto, N; Namba, S; Sumi, T; Suzuki, D; Tristram, PJ; Wakiyama, Y; Yonehara, A; Maoz, D; Kaspi, S; Friedmann, M; Bachelet, E; Jaimes, RF; Bramich, DM; Tsapras, Y; Horne, K; Snodgrass, C; Wambsganss, J; Steele, IA; Kains, N; Bozza, V; Dominik, M; Jorgensen, UG; Alsubai, KA; Ciceri, S; D'Ago, G; Haugbolle, T; Hessman, FV; Hinse, TC; Juncher, D; Korhonen, H; Mancini, L; Popovas, A; Rabus, M; Rahvar, S; Scarpetta, G; Schmidt, RW; Skottfelt, J; Southworth, J; Starkey, D; Surdej, J; Wertz, O; Zarucki, M; Gaudi, BS; Pogge, RW; De Poy, DL; The OGLE Collaboration				Novati, S. Calchi; Gould, A.; Udalski, A.; Menzies, J. W.; Bond, I. A.; Shvartzvald, Y.; Street, R. A.; Hundertmark, M.; Beichman, C. A.; Yee, J. C.; Carey, S.; Poleski, R.; Skowron, J.; Kozlowski, S.; Mroz, P.; Pietrukowicz, P.; Pietrzynski, G.; Szymanski, M. K.; Soszynski, I.; Ulaczyk, K.; Wyrzykowski, L.; Albrow, M.; Beaulieu, J. P.; Caldwell, J. A. R.; Cassan, A.; Coutures, C.; Danielski, C.; Prester, D. Dominis; Donatowicz, J.; Loncaric, K.; McDougall, A.; Morales, J. C.; Ranc, C.; Zhu, W.; Abe, F.; Barry, R. K.; Bennett, D. P.; Bhattacharya, A.; Fukunaga, D.; Inayama, K.; Koshimoto, N.; Namba, S.; Sumi, T.; Suzuki, D.; Tristram, P. J.; Wakiyama, Y.; Yonehara, A.; Maoz, D.; Kaspi, S.; Friedmann, M.; Bachelet, E.; Jaimes, R. Figuera; Bramich, D. M.; Tsapras, Y.; Horne, K.; Snodgrass, C.; Wambsganss, J.; Steele, I. A.; Kains, N.; Bozza, V.; Dominik, M.; Jorgensen, U. G.; Alsubai, K. A.; Ciceri, S.; D'Ago, G.; Haugbolle, T.; Hessman, F. V.; Hinse, T. C.; Juncher, D.; Korhonen, H.; Mancini, L.; Popovas, A.; Rabus, M.; Rahvar, S.; Scarpetta, G.; Schmidt, R. W.; Skottfelt, J.; Southworth, J.; Starkey, D.; Surdej, J.; Wertz, O.; Zarucki, M.; Gaudi, B. S.; Pogge, R. W.; De Poy, D. L.; Collaboration, The O. G. L. E.		The PLANET Collaboration; The MOA Collaboration; The Wise Grp; The RoboNet Collaboration; The MiNDSTEp Consortium; The FUN Collaboration	PATHWAY TO THE GALACTIC DISTRIBUTION OF PLANETS: COMBINED SPITZER AND GROUND-BASED MICROLENS PARALLAX MEASUREMENTS OF 21 SINGLE-LENS EVENTS	ASTROPHYSICAL JOURNAL			English	Article						gravitational lensing: micro; planetary systems; planets and satellites: dynamical evolution and stability	SPACE-TELESCOPE; ISOLATED STAR; MASS; BULGE; COMPANIONS; PHOTOMETRY; FREQUENCY; NETWORK; SYSTEMS; MACHOS	We present microlens parallax measurements for 21 (apparently) isolated lenses observed toward the Galactic bulge that were imaged simultaneously from Earth and Spitzer, which was similar to 1 AU west of Earth in projection. We combine these measurements with a kinematic model of the Galaxy to derive distance estimates for each lens, with error bars that are small compared to the Sun's galactocentric distance. The ensemble therefore yields a well-defined cumulative distribution of lens distances. In principle, it is possible to compare this distribution against a set of planets detected in the same experiment in order to measure the Galactic distribution of planets. Since these Spitzer observations yielded only one planet, this is not yet possible in practice. However, it will become possible as larger samples are accumulated.	[Novati, S. Calchi; Beichman, C. A.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Novati, S. Calchi; Bozza, V.; D'Ago, G.; Scarpetta, G.] Univ Salerno, Dipartimento Fis ER Caianiello, I-84084 Fisciano, SA, Italy; [Novati, S. Calchi; Scarpetta, G.; Zarucki, M.] IIASS, I-84019 Vietri Sul Mare, SA, Italy; [Gould, A.; Poleski, R.; Zhu, W.; Gaudi, B. S.; Pogge, R. W.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Udalski, A.; Poleski, R.; Skowron, J.; Kozlowski, S.; Mroz, P.; Pietrukowicz, P.; Pietrzynski, G.; Szymanski, M. K.; Soszynski, I.; Ulaczyk, K.; Wyrzykowski, L.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Menzies, J. W.] S African Astron Observ, Observ 7935, Cape Town, South Africa; [Bond, I. A.] Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, Auckland, New Zealand; [Shvartzvald, Y.; Maoz, D.; Kaspi, S.; Friedmann, M.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Street, R. A.; Tsapras, Y.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Hundertmark, M.; Jorgensen, U. G.; Haugbolle, T.; Juncher, D.; Korhonen, H.; Popovas, A.; Skottfelt, J.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Hundertmark, M.; Jaimes, R. Figuera; Horne, K.; Dominik, M.; Starkey, D.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Yee, J. C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Carey, S.] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Pietrzynski, G.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Albrow, M.; McDougall, A.] Univ Canterbury, Dept Phys & Astron, Christchurch 8020, New Zealand; [Beaulieu, J. P.; Cassan, A.; Coutures, C.; Ranc, C.] UPMC, CNRS, Inst Astrophys, UMR 7095, F-75014 Paris, France; [Beaulieu, J. P.; Morales, J. C.] LESIA, Sect Meudon 5, Observ Paris, F-92195 Meudon, France; [Caldwell, J. A. R.] McDonald Observ, Ft Davis, TX 79734 USA; [Danielski, C.] Univ Paris 11, Inst Astrophys Spatiale, UMR 8617, F-91405 Orsay, France; [Prester, D. Dominis; Loncaric, K.] Univ Rijeka, Dept Phys, Rijeka 51000, Croatia; [Donatowicz, J.] Vienna Univ Technol, Dept Comp, A-1040 Vienna, Austria; [Abe, F.; Fukunaga, D.; Wakiyama, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Barry, R. K.] NASA Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Bennett, D. P.; Bhattacharya, A.; Suzuki, D.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Inayama, K.; Yonehara, A.] Kyoto Sangyo Univ, Fac Sci, Dept Phys, Kyoto 6038555, Japan; [Koshimoto, N.; Namba, S.; Sumi, T.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Tristram, P. J.] Mt John Univ Observ, Lake Tekapo, New Zealand; [Bachelet, E.; Bramich, D. M.; Alsubai, K. A.] Qatar Fdn, Qatar Environm & Energy Res Inst, Doha, Qatar; [Jaimes, R. Figuera; Kains, N.] European So Observ, D-85748 Garching, Germany; [Tsapras, Y.] Queen Mary Univ London, Sch Phys & Astron, London E1 4NS, England; [Snodgrass, C.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Snodgrass, C.] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Wambsganss, J.; Schmidt, R. W.] Zentrum Astron Univ Heidelberg ZAH, Astron Rechen Inst, D-69120 Heidelberg, Germany; [Steele, I. A.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool CH41 1LD, Merseyside, England; [Bozza, V.; D'Ago, G.; Scarpetta, G.] Ist Nazl Fis Nucl, Sez Napoli, I-80126 Naples, Italy; [Ciceri, S.; Mancini, L.; Rabus, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Hessman, F. V.] Univ Gottingen, Inst Astrophys, D-37073 Gottingen, Germany; [Hinse, T. C.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [Korhonen, H.] Turku Univ, Finnish Ctr Astron ESO, FI-21500 Piikkio, Finland; [Rabus, M.] Pontificia Univ Catolica Chile, Fac Fis, Inst Astrophys, Santiago 22, Chile; [Rahvar, S.] Sharif Univ Technol, Dept Phys, Tehran, Iran; [Southworth, J.] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Surdej, J.; Wertz, O.] Univ Liege, Inst Astrophys & Geophys, B-4000 Cointe Ougree, Belgium; [De Poy, D. L.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA	Novati, SC (reprint author), CALTECH, NASA Exoplanet Sci Inst, MS 100-22, Pasadena, CA 91125 USA.		Morales, Juan Carlos/H-5548-2015; Hundertmark, Markus/C-6190-2015; 	Morales, Juan Carlos/0000-0003-0061-518X; Hundertmark, Markus/0000-0003-0961-5231; Kozlowski, Szymon/0000-0003-4084-880X	JPL grant [1500811]; NSF [AST 1103471]; NASA [NNX12AB99G]; European Research Council under the European Community's Seventh Framework Programme (FP7)/ ERC grant [246678]; NASA through the Sagan Fellowship Program; University of Rijeka project [13.12.1.3.02]; Marsden Fund of the Royal Society of New Zealand [MAU1104]; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [1829/12]; US-Israel Binational Science Foundation; Danish Natural Science Foundation (FNU); NPRP grants from the Qatar National Research Fund (a member of Qatar Foundation) [09-476-1-078, X-019-1-006]; Communaute francaise de Belgique-Actions de recherche concertees-Academie Wallonie-Europe; Villum Foundation; European Union Seventh Framework Programme (FP7) [268421];  [JSPS23103002];  [JSPS24253004];  [JSPS26247023];  [JSPS25103508];  [JSPS23340064]	Work by C.A.B. was carried out in part at the Jet Propulsion Laboratory (JPL), California Institute of Technology, under a contract with the National Aeronautics and Space Administration. Work by J.C.Y. A.G., and S.C. was supported by JPL grant 1500811. A.G. and B.S.G. were supported by NSF grant AST 1103471. A.G., B.S.G., and R. W.P. were supported by NASA grant NNX12AB99G. The OGLE project has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ ERC grant agreement no. 246678 to A.U. Work by J.C.Y. was performed under contract with the California Institute of Technology (Caltech)/Jet Propulsion Laboratory (JPL) funded by NASA through the Sagan Fellowship Program executed by the NASA Exoplanet Science Institute. Work by D.D.P. and K.L. was supported by the University of Rijeka project 13.12.1.3.02. Work by T.S. is supported by grants JSPS23103002, JSPS24253004, and JSPS26247023. Work by I.A.B. was supported by the Marsden Fund of the Royal Society of New Zealand, contract no. MAU1104. The MOA project is supported by the grant JSPS25103508 and 23340064. Work by D.M. is supported by the I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation, Grant 1829/12. D.M. and A.G. acknowledge support by the US-Israel Binational Science Foundation. The operation of the Danish 1.54 m telescope at ESO's La Silla Observatory is financed by a grant to U.G.J. from the Danish Natural Science Foundation (FNU). This publication was made possible by NPRP grants 09-476-1-078 and X-019-1-006 from the Qatar National Research Fund (a member of Qatar Foundation). O.W. (FNRS research fellow) and J. Surdej acknowledge support from the Communaute francaise de Belgique-Actions de recherche concertees-Academie Wallonie-Europe. M.H. acknowledges support from the Villum Foundation. C.S. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 268421. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. The research described in this publication was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	Poindexter S, 2005, ASTROPHYS J, V633, P914, DOI 10.1086/468182; Yee JC, 2009, ASTROPHYS J, V703, P2082, DOI 10.1088/0004-637X/703/2/2082; Gould A, 2010, ASTROPHYS J, V720, P1073, DOI 10.1088/0004-637X/720/2/1073; Dong S, 2007, ASTROPHYS J, V664, P862, DOI 10.1086/518536; Alard C, 1998, ASTROPHYS J, V503, P325, DOI 10.1086/305984; Dominik M, 2010, ASTRON NACHR, V331, P671, DOI 10.1002/asna.201011400; Gould A, 2009, ASTROPHYS J LETT, V698, pL147, DOI 10.1088/0004-637X/698/2/L147; SCHECHTER PL, 1993, PUBL ASTRON SOC PAC, V105, P1342, DOI 10.1086/133316; Makovoz D, 2005, PUBL ASTRON SOC PAC, V117, P1113, DOI 10.1086/432977; Tsapras Y, 2009, ASTRON NACHR, V330, P4, DOI 10.1002/asna.200811130; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Gaudi BS, 2002, ASTROPHYS J, V566, P463, DOI 10.1086/337987; Shvartzvald Y, 2012, MON NOT R ASTRON SOC, V419, P3631, DOI 10.1111/j.1365-2966.2011.20014.x; Albrow M, 1998, ASTROPHYS J, V509, P687, DOI 10.1086/306513; DePoy DL, 2003, P SOC PHOTO-OPT INS, V4841, P827, DOI 10.1117/12.459907; Gaudi BS, 2012, ANNU REV ASTRON ASTR, V50, P411, DOI 10.1146/annurev-astro-081811-125518; Gould A, 2013, ASTROPHYS J LETT, V779, DOI 10.1088/2041-8205/779/2/L28; Gould A, 1999, ASTROPHYS J, V514, P869, DOI 10.1086/306981; Gould A, 1997, ASTROPHYS J, V480, P188, DOI 10.1086/303942; GOULD A, 1994, ASTROPHYS J, V421, pL71, DOI 10.1086/187190; Gould A, 2004, ASTROPHYS J, V606, P319, DOI 10.1086/382782; Gould A, 2000, ASTROPHYS J, V542, P785, DOI 10.1086/317037; Gould A, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/107; HAN CH, 1995, ASTROPHYS J, V447, P53, DOI 10.1086/175856; Henderson CB, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/1/52; Jiang GF, 2004, ASTROPHYS J, V617, P1307, DOI 10.1086/425678; Liebes Jr S., 1964, PHYS REV B, V133, P835, DOI DOI 10.1103/PHYSREV.133.B835; Muraki Y, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/22; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; REFSDAL S, 1966, MON NOT R ASTRON SOC, V134, P315; REFSDAL S, 1964, MON NOT R ASTRON SOC, V128, P295; Simpson T., 1740, ESSAYS SEVERAL CURIO; Skowron J, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/87; Sumi T, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/150; Udalski A, 2003, ACTA ASTRONOM, V53, P291; UDALSKI A, 1994, ACTA ASTRONOM, V44, P227; Udalski A, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/237; Yee JC, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/76; Yee JC, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/102	41	4	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							20	10.1088/0004-637X/804/1/20		25	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500020		
J	Skowron, J; Shin, IG; Udalski, A; Han, C; Sumi, T; Shvartzvald, Y; Gould, A; Prester, DD; Street, RA; Jorgensen, UG; Bennett, DP; Bozza, V; Szymanski, MK; Kubiak, M; Pietrzynski, G; Soszynski, I; Poleski, R; Kozlowski, S; Pietrukowicz, P; Ulaczyk, K; Wyrzykowski, L; Abe, F; Bhattacharya, A; Bond, IA; Botzler, CS; Freeman, M; Fukui, A; Fukunaga, D; Itow, Y; Ling, CH; Koshimoto, N; Masuda, K; Matsubara, Y; Muraki, Y; Namba, S; Ohnishi, K; Philpott, LC; Rattenbury, N; Saito, T; Sullivan, DJ; Suzuki, D; Tristram, PJ; Yock, PCM; Maoz, D; Kaspi, S; Friedmann, M; Almeida, LA; Batista, V; Christie, G; Choi, JY; Depoy, DL; Gaudi, BS; Henderson, C; Hwang, KH; Jablonski, F; Jung, YK; Lee, CU; McCormick, J; Natusch, T; Ngan, H; Park, H; Pogge, RW; Yee, JC; Albrow, MD; Bachelet, E; Beaulieu, JP; Brillant, S; Caldwell, JAR; Cassan, A; Cole, A; Corrales, E; Coutures, CH; Dieters, S; Donatowicz, J; Fouque, P; Greenhill, J; Kains, N; Kane, SR; Kubas, D; Marquette, JB; Martin, R; Menzies, J; Pollard, KR; Ranc, C; Sahu, KC; Wambsganss, J; Williams, A; Wouters, D; Tsapras, Y; Bramich, DM; Horne, K; Hundertmark, M; Snodgrass, C; Steele, IA; Alsubai, KA; Browne, P; Burgdorf, MJ; Novati, SC; Dodds, P; Dominik, M; Dreizler, S; Fang, XS; Gu, CH; Hardis; Harpsoe, K; Hessman, FV; Hinse, TC; Hornstrup, A; Jessen-Hansen, J; Kerins, E; Liebig, C; Lund, M; Lundkvist, M; Mancini, L; Mathiasen, M; Penny, MT; Rahvar, S; Ricci, D; Scarpetta, G; Skottfelt, J; Southworth, J; Surdej, J; Tregloan-Reed, J; Wertz, O				Skowron, J.; Shin, I. -G.; Udalski, A.; Han, C.; Sumi, T.; Shvartzvald, Y.; Gould, A.; Prester, D. Dominis; Street, R. A.; Jorgensen, U. G.; Bennett, D. P.; Bozza, V.; Szymanski, M. K.; Kubiak, M.; Pietrzynski, G.; Soszynski, I.; Poleski, R.; Kozlowski, S.; Pietrukowicz, P.; Ulaczyk, K.; Wyrzykowski, L.; Abe, F.; Bhattacharya, A.; Bond, I. A.; Botzler, C. S.; Freeman, M.; Fukui, A.; Fukunaga, D.; Itow, Y.; Ling, C. H.; Koshimoto, N.; Masuda, K.; Matsubara, Y.; Muraki, Y.; Namba, S.; Ohnishi, K.; Philpott, L. C.; Rattenbury, N.; Saito, T.; Sullivan, D. J.; Suzuki, D.; Tristram, P. J.; Yock, P. C. M.; Maoz, D.; Kaspi, S.; Friedmann, M.; Almeida, L. A.; Batista, V.; Christie, G.; Choi, J. -Y.; Depoy, D. L.; Gaudi, B. S.; Henderson, C.; Hwang, K. -H.; Jablonski, F.; Jung, Y. K.; Lee, C. -U.; McCormick, J.; Natusch, T.; Ngan, H.; Park, H.; Pogge, R. W.; Yee, J. C.; Albrow, M. D.; Bachelet, E.; Beaulieu, J. -P.; Brillant, S.; Caldwell, J. A. R.; Cassan, A.; Cole, A.; Corrales, E.; Coutures, C. H.; Dieters, S.; Donatowicz, J.; Fouque, P.; Greenhill, J.; Kains, N.; Kane, S. R.; Kubas, D.; Marquette, J. -B.; Martin, R.; Menzies, J.; Pollard, K. R.; Ranc, C.; Sahu, K. C.; Wambsganss, J.; Williams, A.; Wouters, D.; Tsapras, Y.; Bramich, D. M.; Horne, K.; Hundertmark, M.; Snodgrass, C.; Steele, I. A.; Alsubai, K. A.; Browne, P.; Burgdorf, M. J.; Novati, S. Calchi; Dodds, P.; Dominik, M.; Dreizler, S.; Fang, X. -S.; Gu, C. -H.; Hardis; Harpsoe, K.; Hessman, F. V.; Hinse, T. C.; Hornstrup, A.; Jessen-Hansen, J.; Kerins, E.; Liebig, C.; Lund, M.; Lundkvist, M.; Mancini, L.; Mathiasen, M.; Penny, M. T.; Rahvar, S.; Ricci, D.; Scarpetta, G.; Skottfelt, J.; Southworth, J.; Surdej, J.; Tregloan-Reed, J.; Wertz, O.		OGLE Collaboration; MOA Collaboration; Wise Grp; FUN Collaboration; PLANET Collaboration; RoboNet Collaboration; MiNDSTEp Consortium	OGLE-2011-BLG-0265Lb: A JOVIAN MICROLENSING PLANET ORBITING AN M DWARF	ASTROPHYSICAL JOURNAL			English	Article						gravitational lensing: micro; planetary systems	SURFACE BRIGHTNESS RELATIONS; GRAVITATIONAL BINARY-LENS; GALACTIC BULGE; MASS PLANET; OGLE-III; JUPITER/SATURN ANALOG; ANGULAR SIZES; GIANT PLANETS; SNOW LINE; STARS	We report the discovery of a Jupiter-mass planet orbiting an M-dwarf star that gave rise to the microlensing event OGLE-2011-BLG-0265. Such a system is very rare among known planetary systems and thus the discovery is important for theoretical studies of planetary formation and evolution. High-cadence temporal coverage of the planetary signal, combined with extended observations throughout the event, allows us to accurately model the observed light curve. However, the final microlensing solution remains degenerate, yielding two possible configurations of the planet and the host star. In the case of the preferred solution, the mass of the planet is M-p = 0.9 +/- 0.3 M-J, and the planet is orbiting a star with a mass M = 0.22 +/- 0.06 M-circle dot. The second possible configuration (2 sigma away) consists of a planet with M-p = 0.6 +/- 0.3M(J) and host star with M = 0.14 +/- 0.06M(circle dot). The system is located in the Galactic disk 3-4 kpc toward the Galactic bulge. In both cases, with an orbit size of 1.5-2.0 AU, the planet is a "cold Jupiter"-located well beyond the "snow line" of the host star. Currently available data make the secure selection of the correct solution difficult, but there are prospects for lifting the degeneracy with additional follow-up observations in the future, when the lens and source star separate.	[Skowron, J.; Udalski, A.; Szymanski, M. K.; Kubiak, M.; Pietrzynski, G.; Poleski, R.; Kozlowski, S.; Pietrukowicz, P.; Ulaczyk, K.; Wyrzykowski, L.] Univ Warsaw Observ, PL-00478 Warsaw, Poland; [Shin, I. -G.; Han, C.; Choi, J. -Y.; Hwang, K. -H.; Jung, Y. K.; Park, H.] Chungbuk Natl Univ, Inst Astrophys, Dept Phys, Cheongju 371763, South Korea; [Sumi, T.; Koshimoto, N.; Namba, S.; Suzuki, D.] Osaka Univ, Grad Sch Sci, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Shvartzvald, Y.; Maoz, D.; Kaspi, S.; Friedmann, M.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Gould, A.; Poleski, R.; Batista, V.; Gaudi, B. S.; Henderson, C.; Pogge, R. W.; Yee, J. C.; Penny, M. T.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Prester, D. Dominis] Univ Rijeka, Fac Arts & Sci, Dept Phys, Rijeka 51000, Croatia; [Street, R. A.; Tsapras, Y.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Jorgensen, U. G.; Hardis; Harpsoe, K.; Hinse, T. C.; Mathiasen, M.; Skottfelt, J.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Jorgensen, U. G.; Harpsoe, K.; Skottfelt, J.] Ctr Star & Planet Format, Geol Museum, DK-1350 Copenhagen, Denmark; [Bennett, D. P.; Bhattacharya, A.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Bozza, V.; Novati, S. Calchi; Scarpetta, G.] Univ Salerno, Dipartimento Fis ER Caianiello, I-84084 Fisciano, SA, Italy; [Bozza, V.; Scarpetta, G.] Ist Nazl Fis Nucl, Sezione Napoli, Italy; [Soszynski, I.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Wyrzykowski, L.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Abe, F.; Fukunaga, D.; Itow, Y.; Masuda, K.; Matsubara, Y.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Bond, I. A.; Ling, C. H.] Massey Univ, Inst Informat & Math Sci, North Shore Mail Ctr, Auckland, New Zealand; [Botzler, C. S.; Freeman, M.; Rattenbury, N.; Yock, P. C. M.] Univ Auckland, Dept Phys, Auckland 1, New Zealand; [Fukui, A.] Natl Astron Observ Japan, Okayama Astrophys Observ, Okayama 7190232, Japan; [Muraki, Y.] Konan Univ, Dept Phys, Kobe, Hyogo 6588501, Japan; [Ohnishi, K.] Nagano Natl Coll Technol, Nagano 3818550, Japan; [Philpott, L. C.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V6T 1Z4, Canada; [Saito, T.] Tokyo Metropolitan Coll Ind Technol, Tokyo 1168523, Japan; [Sullivan, D. J.; Tristram, P. J.] Victoria Univ, Sch Chem & Phys Sci, Wellington, New Zealand; [Almeida, L. A.; Jablonski, F.] Inst Nacl Pesquisas Espaciais, Div Astrofis, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Christie, G.; Natusch, T.; Ngan, H.] Auckland Observ, Auckland 1023, New Zealand; [Depoy, D. L.] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Lee, C. -U.; Hinse, T. C.] Korea Astron & Space Sci Inst, Taejon 305348, South Korea; [McCormick, J.] Ctr Backyard Astrophys, Farm Cove Observ, Auckland, New Zealand; [Natusch, T.] AUT Univ, Inst Radiophys & Space Res, Auckland, New Zealand; [Yee, J. C.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Albrow, M. D.; Pollard, K. R.] Univ Canterbury, Dept Phys & Astron, Christchurch 8020, New Zealand; [Bachelet, E.; Dieters, S.; Fouque, P.] Univ Toulouse, IRAP, UPS OMP, F-31400 Toulouse, France; [Beaulieu, J. -P.; Cassan, A.; Corrales, E.; Coutures, C. H.; Kubas, D.; Marquette, J. -B.; Ranc, C.; Wouters, D.] UPMC, CNRS, Inst Astrophys Paris, UMR7095, F-75014 Paris, France; [Brillant, S.; Kubas, D.] European So Observ, Santiago 19001 19, Chile; [Caldwell, J. A. R.] McDonald Observ, Ft Davis, TX 79734 USA; [Cole, A.; Greenhill, J.] Univ Tasmania, Sch Math & Phys, Hobart, Tas 7001, Australia; [Donatowicz, J.] Vienna Univ Technol, Dept Comp, A-1060 Vienna, Austria; [Fouque, P.] CFHT Corp, Kamuela, HI 96743 USA; [Kains, N.] European So Observ, D-85748 Garching, Germany; [Kains, N.; Sahu, K. C.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kane, S. R.; Novati, S. Calchi] CALTECH, Exoplanet Sci Inst, NASA, Pasadena, CA 91125 USA; [Martin, R.] Perth Observ, Perth, WA 6076, Australia; [Menzies, J.] S African Astron Observ, ZA-7935 Observatory, South Africa; [Wambsganss, J.; Williams, A.] Zentrum Astron Univ Heidelberg ZAH, Astron Rech Inst, D-69120 Heidelberg, Germany; [Tsapras, Y.] Queen Mary Univ London, Sch Phys & Astron, London E1 4NS, England; [Bramich, D. M.] Qatar Fdn, Qatar Environm & Energy Res Inst, Doha, Qatar; [Horne, K.; Hundertmark, M.; Browne, P.; Dodds, P.; Dominik, M.; Liebig, C.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Hundertmark, M.; Dreizler, S.; Hessman, F. V.] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Snodgrass, C.] Max Planck Inst Solar Syst Res, D-37077 Gottingen, Germany; [Steele, I. A.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool CH41 1LD, Merseyside, England; [Alsubai, K. A.] Qatar Fdn, Doha, Qatar; [Burgdorf, M. J.] HE Space Operat GmbH, D-28199 Bremen, Germany; [Novati, S. Calchi; Scarpetta, G.] IIASS, I-84019 Vietri Sul Mare Salerno, Italy; [Fang, X. -S.; Gu, C. -H.; Hornstrup, A.] Chinese Acad Sci, Key Lab Struct & Evolut Celestial Objects, Natl Astron Observat Yunnan Observ, Kunming 650011, Peoples R China; [Hinse, T. C.] Armagh Observ, Armagh BT61 9DG, North Ireland; [Kerins, E.; Penny, M. T.] Univ Manchester, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Jessen-Hansen, J.; Lund, M.; Lundkvist, M.] Aarhus Univ, Dept Phys & Astron, Aarhus C, Denmark; [Lundkvist, M.] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark; [Mancini, L.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Rahvar, S.] Sharif Univ Technol, Dept Phys, Tehran, Iran; [Rahvar, S.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Ricci, D.; Surdej, J.] Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Ricci, D.] Ist Astrofis Spaziale & Fis Cosm, INAF, Bologna, Italy; [Ricci, D.] UNAM, Inst Astron, Ensenada 22800, Baja California, Mexico; [Southworth, J.] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Tregloan-Reed, J.; Wertz, O.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Tregloan-Reed, J (reprint author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.		Hundertmark, Markus/C-6190-2015; Almeida, L./G-7188-2012; 	Hundertmark, Markus/0000-0003-0961-5231; Kozlowski, Szymon/0000-0003-4084-880X	European Research Council under the European Community's Seventh Framework Programme (FP7) / ERC [246678]; Polish Ministry of Science and Higher Education (MNiSW) through the program "Iuventus Plus" [IP2011 026771]; Creative Research Initiative Program of National Research Foundation of Korea [2009-0081561]; JSPS [24253004, JSPS23540339, JSPS19340058]; Distinguished University Fellowship from The Ohio State University and in part under contract with the California Institute of Technology (Caltech) - NASA through the Sagan Fellowship Program; NSF [AST 1103471]; NASA [NNX12AB99G]; European Union [268421]; Danish Natural Science Foundation (FNU); German Research Foundation (DFG); Communaute francaise de Belgique-Actions de recherche concertees-Academie universitaire Wallonie-Europe; Qatar National Research Fund (QNRF), Qatar Foundation [NPRP 09-476-1-078]; University of Rijeka Project [13.12.1.3.02]; I-CORE program of the Planning and Budgeting Committee; Israel Science Foundation [1829/12]; US-Israel Binational Science Foundation;  [JSPS22403003];  [JSPS23340064];  [JSPS23340044];  [JSPS24253004]	The OGLE project has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement No. 246678 to A.U. This research was partly supported by the Polish Ministry of Science and Higher Education (MNiSW) through the program "Iuventus Plus" award No. IP2011 026771. Work by C.H. was supported by Creative Research Initiative Program (2009-0081561) of National Research Foundation of Korea. The MOA experiment was supported by grants JSPS22403003 and JSPS23340064. T.S. acknowledges the support of JSPS 24253004. T.S. is supported by the grant JSPS23340044. Y.M. acknowledges support from JSPS grants JSPS23540339 and JSPS19340058. Work by J.C.Y. is supported in part by a Distinguished University Fellowship from The Ohio State University and in part under contract with the California Institute of Technology (Caltech) funded by NASA through the Sagan Fellowship Program. Work by A.G. and B.S.G was supported by NSF grant AST 1103471. Work by A.G., B.S.G., and RWP was supported by NASA grant NNX12AB99G. T.S. acknowledges support from the grants JSPS23340044 and JSPS24253004. C.S. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 268421. This work is based in part on data collected by MiNDSTEp with the Danish 1.54 m telescope at the ESO La Silla Observatory. The Danish 1.54 m telescope is operated based on a grant from the Danish Natural Science Foundation (FNU). The MiNDSTEp monitoring campaign is powered by ARTEMiS (Automated Terrestrial Exoplanet Microlensing Search; Dominik et al. 2008, AN 329, 248). M.H. acknowledges support by the German Research Foundation (DFG). D.R. (boursier FRIA) and J.S. acknowledge support from the Communaute francaise de Belgique-Actions de recherche concertees-Academie universitaire Wallonie-Europe. K.A., D.M.B., M.D., K.H., M.H., C.L., C.S., R.A.S., and Y.T. are thankful to the Qatar National Research Fund (QNRF), member of Qatar Foundation, for support by grant NPRP 09-476-1-078. Work by D.D.P. was supported by the University of Rijeka Project 13.12.1.3.02. This research was supported by the I-CORE program of the Planning and Budgeting Committee and the Israel Science Foundation, grant 1829/12. D.M. and A.G. acknowledge support by the US-Israel Binational Science Foundation.	Bennett DP, 1996, ASTROPHYS J, V472, P660, DOI 10.1086/178096; Dong SB, 2006, ASTROPHYS J, V642, P842, DOI 10.1086/501224; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Ida S, 2005, ASTROPHYS J, V626, P1045, DOI 10.1086/429953; Gould A, 2010, ASTROPHYS J, V720, P1073, DOI 10.1088/0004-637X/720/2/1073; Alard C, 1998, ASTROPHYS J, V503, P325, DOI 10.1086/305984; Bennett DP, 2010, ASTROPHYS J, V713, P837, DOI 10.1088/0004-637X/713/2/837; Dominik M, 2010, ASTRON NACHR, V331, P671, DOI 10.1002/asna.201011400; Sumi T, 2010, ASTROPHYS J, V710, P1641, DOI 10.1088/0004-637X/710/2/1641; Dong SB, 2009, ASTROPHYS J, V695, P970, DOI 10.1088/0004-637X/695/2/970; Nataf DM, 2010, ASTROPHYS J LETT, V721, pL28, DOI 10.1088/2041-8205/721/1/L28; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Gould A, 2006, ASTROPHYS J, V644, pL37, DOI 10.1086/505421; GOULD A, 1992, ASTROPHYS J, V396, P104, DOI 10.1086/171700; Albrow MD, 2000, ASTROPHYS J, V534, P894, DOI 10.1086/308798; Yoo J, 2004, ASTROPHYS J, V603, P139, DOI 10.1086/381241; Albrow MD, 2009, MON NOT R ASTRON SOC, V397, P2099, DOI 10.1111/j.1365-2966.2009.15098.x; SCHECHTER PL, 1993, PUBL ASTRON SOC PAC, V105, P1342, DOI 10.1086/133316; MAO S, 1991, ASTROPHYS J, V374, pL37, DOI 10.1086/186066; Kervella P, 2008, ASTRON ASTROPHYS, V491, P855, DOI 10.1051/0004-6361:200810317; Tsapras Y, 2009, ASTRON NACHR, V330, P4, DOI 10.1002/asna.200811130; Kervella P, 2004, ASTRON ASTROPHYS, V426, P297, DOI 10.1051/0004-6361:20035930; Penny MT, 2011, MON NOT R ASTRON SOC, V412, P607, DOI 10.1111/j.1365-2966.2010.17933.x; Udalski A, 2005, ASTROPHYS J, V628, pL109, DOI 10.1086/432795; Gaudi BS, 2008, SCIENCE, V319, P927, DOI 10.1126/science.1151947; Pejcha O, 2009, ASTROPHYS J, V690, P1772, DOI 10.1088/0004-637X/690/2/1772; Laughlin G, 2004, ASTROPHYS J, V612, pL73, DOI 10.1086/424384; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; Bond IA, 2001, MON NOT R ASTRON SOC, V327, P868, DOI 10.1046/j.1365-8711.2001.04776.x; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Shvartzvald Y, 2012, MON NOT R ASTRON SOC, V419, P3631, DOI 10.1111/j.1365-2966.2011.20014.x; KAYSER R, 1986, ASTRON ASTROPHYS, V166, P36; Batista V, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016111; Bennett DP, 2008, ASTROPHYS J, V684, P663, DOI 10.1086/589940; Bensby T., 2013, ASTRON ASTROPHYS, V549, P147; Bensby T, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117059; Bonfils X., 2011, ASTRON ASTROPHYS, V528, P111; Boss AP, 2006, ASTROPHYS J, V643, P501, DOI 10.1086/501522; Bramich DM, 2008, MON NOT R ASTRON SOC, V386, pL77, DOI 10.1111/j.1745-3933.2008.00464.x; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Delfosse X, 1998, ASTRON ASTROPHYS, V338, pL67; Di Benedetto GP, 2005, MON NOT R ASTRON SOC, V357, P174, DOI 10.1111/j.1365-2966.2005.08632.x; Gould A, 2008, ASTROPHYS J, V681, P1593, DOI 10.1086/588601; GOULD A, 1992, ASTROPHYS J, V392, P442, DOI 10.1086/171443; Kains N, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220626; Kubas D., 2012, ASTRON ASTROPHYS, V540, P78; Marcy GW, 1998, ASTROPHYS J, V505, pL147, DOI 10.1086/311623; Montet BT, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/28; Nataf DM, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/88; PACZYNSKI B, 1986, ASTROPHYS J, V304, P1, DOI 10.1086/164140; Park H, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/134; Poleski R, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/47; Shin IG, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/85; Shvartzvald Y, 2014, MON NOT R ASTRON SOC, V439, P604, DOI 10.1093/mnras/stt2477; Skowron J., 2012, ARXIV12031034; Skowron J, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/87; Street RA, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/67; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Tsapras Y, 2003, MON NOT R ASTRON SOC, V343, P1131, DOI 10.1046/j.1365-8711.2003.06720.x; Tsapras Y, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/48; Udalski A, 2003, ACTA ASTRONOM, V53, P291; Wambsganss J, 1997, MON NOT R ASTRON SOC, V284, P172; SCHNEIDER P, 1986, ASTRON ASTROPHYS, V164, P237	63	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	MAY 1	2015	804	1							33	10.1088/0004-637X/804/1/33		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CH7BB	WOS:000354189500033		
J	Saito, R; Tolstikhin, OI; Madsen, LB; Morishita, T				Saito, Ryoichi; Tolstikhin, Oleg I.; Madsen, Lars Bojer; Morishita, Tom			Structure factors for tunneling ionization rates of diatomic molecules	ATOMIC DATA AND NUCLEAR DATA TABLES			English	Article						Tunneling ionization; Weak-field asymptotic theory; Structure factors; Diatomic molecules; Hartree-Fock oribitals	FIELD	Within the leading-order, single-active-electron, and frozen-nuclei approximation of the weak-field asymptotic theory, the rate of tunneling ionization of a molecule in an external static uniform electric field is determined by the structure factor for the highest occupied molecular orbital. We present the results of systematic calculations of structure factors for 40 homonuclear and heteronuclear diatomic molecules by the Hartree-Fock method using a numerical grid-based approach implemented in the program X2DHF. (C) 2015 Elsevier Inc. All rights reserved.	[Saito, Ryoichi; Morishita, Tom] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Tolstikhin, Oleg I.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Madsen, Lars Bojer] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Morishita, T (reprint author), Univ Electrocommun, Dept Engn Sci, 1-5-1 Chofu Fa Oka, Chofu, Tokyo 1828585, Japan.	toru@pc.uec.ac.jp	Tolstikhin, Oleg/L-1899-2013	Tolstikhin, Oleg/0000-0001-7603-2322	Ministry of Education, Culture, Sports, Science and Technology, Japan; Russian Foundation for Basic Research [14-02-92110]; Ministry of Education and Science of Russia [3.679.2014/K]; ERC-StG [277767-TDMET]	This work was supported in part by Grants-in-Aid for Scientific Research (A), (B), and (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. O. I. T. acknowledges the support from the Russian Foundation for Basic Research (Grant No. 14-02-92110) and the Ministry of Education and Science of Russia (State assignment No. 3.679.2014/K). L. B. M. acknowledges support from an ERC-StG (Project No. 277767-TDMET).	ABRAMOWITZ M., 1972, HDB MATH FUNCTIONS; Madsen LB, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053404; Hamonou L, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013412; Dehghanian E, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.061403; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Trinh VH, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.043426; Madsen LB, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013406; Son SK, 2009, CHEM PHYS, V366, P91, DOI 10.1016/j.chemphys.2009.09.006; Scrinzi A, 1999, PHYS REV LETT, V83, P706, DOI 10.1103/PhysRevLett.83.706; Tolstikhin OI, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.153003; Chu X, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.013409; Madsen LB, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033412; Penka EF, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023414; Tolstikhin OI, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.043417; YAMABE T, 1977, PHYS REV A, V16, P877, DOI 10.1103/PhysRevA.16.877; Kobus J, 1996, COMPUT PHYS COMMUN, V98, P346, DOI 10.1016/0010-4655(96)00098-7; Morishita T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013903; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Dehghanian E, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818528; Edmonds A. R., 1957, ANGULAR MOMENTUM QUA; Jin YJ, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063409; Johnson R D., 2013, NIST STANDARD REFERE, V101; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Landau L. D., 1977, QUANTUM MECH NONRELA; Parker JS, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/13/134011; Pham VNT, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033426; Saenz A, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.063408; Slavyanov S.Yu., 1970, PROBLEMS MATH PHYSIC, V4, P125; SMIRNOV BM, 1966, SOV PHYS JETP-USSR, V22, P585; Themelis S.I., 1999, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.024101; Themelis SI, 2000, J PHYS B-AT MOL OPT, V33, P5561, DOI 10.1088/0953-4075/33/24/308; THEMELIS SI, 1994, PHYS REV A, V49, P3089, DOI 10.1103/PhysRevA.49.3089; Tolstikhin OI, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013421; Tolstikhin OI, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053423; Tolstikhin OI, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.041401; Tolstikhina IY, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.053413; Trinh V.H., UNPUB	37	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0092-640X	1090-2090		ATOM DATA NUCL DATA	Atom. Data Nucl. Data Tables	MAY-JUN	2015	103						4	49		10.1016/j.adt.2015.02.001		46	Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Physics	CI2OF	WOS:000354586200002		
J	Aslanova, A; Takagi, R; Yamato, M; Okano, T; Yamamoto, M				Aslanova, Afag; Takagi, Ryo; Yamato, Masayuki; Okano, Teruo; Yamamoto, Masakazu			A chemically defined culture medium containing Rho kinase inhibitor Y-27632 for the fabrication of stratified squamous epithelial cell grafts	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Rho kinase inhibitor Y-27632; Keratinocytes; Chemically defined medium	ENDOSCOPIC SUBMUCOSAL DISSECTION; HUMAN EPIDERMAL-KERATINOCYTES; STEM-CELLS; ROCK INHIBITOR; GROWTH-FACTOR; SHEETS; DIFFERENTIATION; INVITRO	With the development of a culture method for stratified squamous epithelial cells, tissue-engineered epithelial cell sheets have been successfully applied as clinical cell grafts. However, the implementation of these cell sheets without the use of any animal-derived materials is highly desirable. In this study, Rho-associated protein kinase inhibitor Y-27632 was used to develop a chemically defined culture medium for the fabrication of stratified epithelial cell grafts consisting of human epidermal and oral keratinocytes, and the proliferation activity, cell morphology, and gene expressions of the keratinocytes were analyzed. The results of a colorimetric assay indicated that Y-27632 significantly promoted the proliferation of the keratinocytes in culture media both with and without fetal bovine serum (FBS), although there were no indications of Y-27632 efficacy on cell morphology and stratification of the keratinocytes in culture medium without any animal-derived materials. The results of quantitative RTPCR revealed that gene expressions correlated with cell adhesion, cell-cell junction, proliferation markers, and stem/progenitor markers in cultured keratinocytes were not strongly affected by the addition of Y-27632 to the culture medium. Moreover, gene expressions of differentiation markers in stratified keratinocytes cultured in medium without FBS were nearly identical to those of keratinocytes co-cultured with 3T3 feeder cells. Interestingly, the expressions of differentiation markers in cultured stratified keratinocytes were suppressed by FBS, whereas they were reconstructed by either co-culture of a 3T3 feeder layer or addition of Y-27632 into the culture medium containing FBS. These findings indicate that Y-27632 is a useful supplement for the development of a chemically defined culture medium for fabrication of stratified epithelial cell grafts for clinical applications for the purpose of developing the culture medium with a lower risk of pathogen transmission that might arise from animal-derived materials. (C) 2015 Elsevier Inc. All rights reserved.	[Aslanova, Afag; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo 1628666, Japan; [Aslanova, Afag; Takagi, Ryo; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan	Yamamoto, M (reprint author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.ige@twmu.ac.jp			Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology 'Cell Sheet Tissue Engineering Center (CSTEC)'; Global Center of Excellence Program's Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM)	This work was supported by the Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology 'Cell Sheet Tissue Engineering Center (CSTEC)' and by the Global Center of Excellence Program's Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Prof. Teruo Okano is a founder and director of the board of CellSeed Inc., licensing technologies and patents from Tokyo Women's Medical University. Prof. Masayuki Yamato and Prof. Teruo Okano are shareholders of CellSeed Inc.	Terunuma A, 2010, TISSUE ENG PT A, V16, P1363, DOI 10.1089/ten.TEA.2009.0339; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Tsai CY, 1997, J CRANIO MAXILL SURG, V25, P4, DOI 10.1016/S1010-5182(97)80017-0; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Miyashita H, 2013, STEM CELL TRANSL MED, V2, P758, DOI 10.5966/sctm.2012-0156; Takagi R, 2011, PATHOBIOLOGY, V78, P311, DOI 10.1159/000322575; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007; Mathor MB, 1996, P NATL ACAD SCI USA, V93, P10371, DOI 10.1073/pnas.93.19.10371; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Bonnenkoh A., 1989, ARCH DERMATOL RES, V281, P487; Champan S., 2014, STEM CELL RES THER, V5, P60; DELUCA M, 1990, TRANSPLANTATION, V50, P454; GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Hata K, 1996, Hum Cell, V9, P91; MULLERGLAUSER W, 1983, ARCH ORAL BIOL, V28, P765, DOI 10.1016/0003-9969(83)90113-9; Murakami Daisuke, 2006, J Artif Organs, V9, P185, DOI 10.1007/s10047-006-0342-3; OCONNOR NE, 1981, LANCET, V1, P75; PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2; Takagi R, 2011, BIOCHEM BIOPH RES CO, V412, P226, DOI 10.1016/j.bbrc.2011.07.069; van den Bogaard EH, 2012, TISSUE ENG PT A, V18, P1827, DOI [10.1089/ten.TEA.2011.0616, 10.1089/ten.tea.2011.0616]; Yugaw T, 2013, MOL CELL BIOL, V33, P4434, DOI 10.1128/MCB.00577-13	31	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					123	129		10.1016/j.bbrc.2015.02.120		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300001		
J	Schmid, E; Yan, J; Hosseinzadeh, Z; Almilaji, A; Shumilina, E; Kuro-o, M; Borst, O; Gawaz, M; Lang, F				Schmid, Evi; Yan, Jing; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Shumilina, Ekaterina; Kuro-o, Makoto; Borst, Oliver; Gawaz, Meinrad; Lang, Florian			Up-regulation of megakaryocytic Na+/Ca2+ exchange in klotho-deficient mice	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Megakaryocytes; Platelets; Patch clamp; Cytosolic Ca2+	VITAMIN-D-RECEPTOR; DOWN-REGULATION; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; DENDRITIC CELLS; OLDER-ADULTS; PLATELETS; GENE; INFLAMMATION; ACTIVATION	The active form of vitamin D, 1,25(OH)(2)D-3, is a powerful regulator of cytosolic Ca2+-concentration ([Ca2+](i)) in a variety of cell types. The formation of 1,25(OH)(2)D-3 is inhibited by FGF23, an effect requiring presence of klotho. 1,25(OH)(2)D-3 plasma levels are excessive in klotho-deficient mice (kl/kl). A previous study revealed that klotho-deficiency is followed by decreased activation of platelets, an effect at least in part due to blunted store operated Ca2+ entry (SOCE). In other cell types 1,25(OH)(2)D-3 has been shown to up-regulate the Na+/Ca2+-exchanger, which could, depending on cell membrane potential and cytosolic Na+ concentration, either decrease or increase [Ca2+](i). The present study explored whether Na+/Ca2+-exchanger activity is different in megakaryocytes isolated from kl/kl mice than in megakaryocytes isolated from wild type mice. Na+/Ca2+-exchanger induced currents were determined by whole cell patch clamp and the Na+/Ca2+-exchanger induced alterations of [Ca2+](i) by Fura-2 fluorescence. As a result, the inward current and the increase of [Ca2+](i) following replacement of extracellular Na+ by NMDG were higher in kl/kl megakaryocytes than in wild type megakaryocytes, a difference abrogated by treatment of the mice with low Vitamin D diet. Pretreatment of wild type megakaryocytes with 1,25(OH)(2)D-3 (100 nM, 48 h) was followed by enhancement of both, inward current and increase of [Ca2+](i) following replacement of extracellular Na+ by NMDG. In conclusion, the present observations reveal a powerful stimulating effect of 1,25(OH)(2)D-3 on Na+/Ca2+-exchanger activity in megakaryocytes. (C) 2015 Elsevier Inc. All rights reserved.	[Schmid, Evi; Yan, Jing; Hosseinzadeh, Zohreh; Almilaji, Ahmad; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Schmid, Evi] Univ Childrens Hosp Tubingen, Dept Pediat Surg & Pediat Urol, D-72076 Tubingen, Germany; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Borst, Oliver; Gawaz, Meinrad] Univ Tubingen, Dept Cardiol & Cardiovasc Med, D-72076 Tubingen, Germany	Lang, F (reprint author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [KFO 274, Transregio SFB19, 2133-0]; Tuebingen Platelet Investigative Consortium (TuePIC)	This study has been supported by the Deutsche Forschungsgemeinschaft (KFO 274 'Platelets - Molecular Mechanisms and Translational Implications' and the Transregio SFB19), a fortfune research grant (2133-0) to O.B. and the Tuebingen Platelet Investigative Consortium (TuePIC).	Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Almilaji A, 2013, CELL PHYSIOL BIOCHEM, V31, P638, DOI 10.1159/000350083; Borst O, 2014, FASEB J, V28, P2108, DOI 10.1096/fj.13-239277; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Bhavsar SK, 2013, CELL PHYSIOL BIOCHEM, V32, P687, DOI 10.1159/000354472; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Hosseinzadeh Z, 2013, CELL PHYSIOL BIOCHEM, V31, P673, DOI 10.1159/000350086; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Koyama T, 1998, BLOOD, V92, P160; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Borst O, 2012, CIRC RES, V111, P1297, DOI 10.1161/CIRCRESAHA.112.276444; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Ohsawa M, 2000, CIRCULATION, V102, P2867; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Authi KS, 2009, BLOOD, V113, P1872, DOI 10.1182/blood-2008-11-185959; Gupta S, 2012, CIRC RES, V111, P1410, DOI 10.1161/CIRCRESAHA.112.264754; Okada S, 2000, INT IMMUNOL, V12, P861, DOI 10.1093/intimm/12.6.861; Pulcinelli FM, 2013, PLATELETS, V24, P554, DOI 10.3109/09537104.2012.750718; Roberts DE, 2012, BRIT J PHARMACOL, V165, P922, DOI 10.1111/j.1476-5381.2011.01600.x; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Shumilina E, 2010, FASEB J, V24, P1989, DOI 10.1096/fj.09-142265; Shumilina E, 2013, AM J PHYSIOL-CELL PH, V305, pC70, DOI 10.1152/ajpcell.00355.2012; Silvagno F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008670; Wallis DE, 2008, CIRCULATION, V118, P1476, DOI 10.1161/CIRCULATIONAHA.107.713339	40	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					177	182		10.1016/j.bbrc.2015.03.002		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300009		
J	An, CY; Sato, K; Wu, TY; Bao, M; Bao, L; Tobo, M; Damirin, A				An, Caiyan; Sato, Koichi; Wu, Taoya; Bao, Muqiri; Bao, Liang; Tobo, Masayuki; Damirin, Alatangaole			Extracellular acidification synergizes with PDGF to stimulate migration of mouse embryo fibroblasts through activation of p38MAPK with a PTX-sensitive manner	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Extracellular acidification; P38MAPK; Proton-sensing G protein-coupled receptors; PDGF; Mouse embryo fibroblasts (MEFs) migration	LYSOPHOSPHATIDIC ACID; CELL-MIGRATION; KINASE; RECEPTORS; PATHWAY; LPA(1); PH	The elucidation of the functional mechanisms of extracellular acidification stimulating intracellular signaling pathway is of great importance for developing new targets of treatment for solid tumors, and inflammatory disorders characterized by extracellular acidification. In the present study, we focus on the regulation of extracellular acidification on intracellular signaling pathways in mouse embryo fibroblasts (MEFs). We found extracellular acidification was at least partly involved in stimulating p38MAPK pathway through PTX-sensitive behavior to enhance cell migration in the presence or absence of platelet-derived growth factor (PDGF). Statistical analysis showed that the actions of extracellular acidic pH and PDGF on inducing enhancement of cell migration were not an additive effect. However, we also found extracellular acidic pH did inhibit the viability and proliferation of MEFs, suggesting that extracellular acidification stimulates cell migration probably through proton-sensing mechanisms within MEFs. Using OGR1-, GPR4-, and TDAG8-gene knock out technology, and real-time qPCR, we found known proton-sensing G protein-coupled receptors (GPCRs), transient receptor potential vanilloid subtype 1 (TRPV1), and acid-sensing ion channels (ASICs) were unlikely to be involved in the regulation of acidification on cell migration. In conclusion, our present study validates that extracellular acidification stimulates chemotactic migration of MEFs through activation of p38MAPK with a PTX-sensitive mechanism either by itself, or synergistically with PDGF, which was not regulated by the known proton-sensing GPCRs, TRPV1, or ASICs. Our results suggested that others proton-sensing GPCRs or ion channels might exist in MEFs, which mediates cell migration induced by extracellular acidification in the presence or absence of PDGF. (C) 2015 Published by Elsevier Inc.	[An, Caiyan; Wu, Taoya; Bao, Muqiri; Bao, Liang; Damirin, Alatangaole] Inner Mongolia Univ, Coll Life Sci, Dept Biochem & Mol Biol, Hohhot, Inner Mongolia, Peoples R China; [An, Caiyan; Sato, Koichi; Tobo, Masayuki] Gunma Univ, Lab Signal Transduct, Inst Mol & Cellular Regulat, Maebashi, Gumma 371, Japan; [An, Caiyan] Inner Mongolia Univ, Affiliated Hosp, Clin Med Res Ctr, Hohhot, Inner Mongolia, Peoples R China	Damirin, A (reprint author), Inner Mongolia Univ, Coll Life Sci, Dept Biochem & Mol Biol, Hohhot, Inner Mongolia, Peoples R China.	bigaole@imu.edu.cn			National Natural Science Foundation of China [31160184]	We are grateful to Prof. Fumikazu Okajima and Dr. Chihiro Mogi at Gunma University for providing us OGR1-and GPR4-deficient MEFs. TDAG8-deficient MEFs were also supplied by Prof. Fumikazu Okajima, who obtained TDAG8<SUP>TP/TP</SUP> mice from Drs. Kyoji Hone and Junji Takeda of Osaka University, Dr. Takao Shimizu of University of Tokyo, and Dr. Satoshi Ishii of Akita University. This work was supported by National Natural Science Foundation of China (No. 31160184).	Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; Damirin A, 2005, MOL PHARMACOL, V67, P1177, DOI 10.1124/mol.104.004317; Malchinkhuu E, 2005, ONCOGENE, V24, P6676, DOI 10.1038/sj.onc.1208805; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Zhou ZB, 2009, INT J MOL SCI, V10, P3194, DOI 10.3390/ijms10073194; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Malchinkhuu E, 2009, MOL BIOL CELL, V20, P5156, DOI 10.1091/mbc.E09-08-0692; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Kim EK, 2008, CELL SIGNAL, V20, P2030, DOI 10.1016/j.cellsig.2008.07.012; Nakakura T, 2012, ENDOCRINOLOGY, V153, P4171, DOI 10.1210/en.2012-1164; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; Yu Jin Lee K.H., 2013, CANCER RES, V73, P3950	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					191	197		10.1016/j.bbrc.2015.03.006		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300011		
J	Kato, N; Nogawa, T; Hirota, H; Jang, JH; Takahashi, S; Ahn, JS; Osada, H				Kato, Naoki; Nogawa, Toshihiko; Hirota, Hiroshi; Jang, Jae-Hyuk; Takahashi, Shunji; Ahn, Jong Seog; Osada, Hiroyuki			A new enzyme involved in the control of the stereochemistry in the decalin formation during equisetin biosynthesis	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Biosynthesis; Decalin; Diels-Alder cycloaddition; Fusarium PKS-NRPS hybrid; Secondary metabolite	DIELS-ALDER REACTION; INHIBITOR; SYNTHASE; FUNGUS; METABOLITES; LOVASTATIN; IDENTIFICATION; PATHWAY	Tetramic acid containing a decalin ring such as equisetin and phomasetin is one of the characteristic scaffolds found in fungal bioactive secondary metabolites. Polyketide (PKS)-nonribosomal peptide synthetase (NRPS) hybrid enzyme is responsible for the synthesis of the polyketide scaffold conjugated with an amino acid. PKS-NRPS hybrid complex programs to create structural diversity in the polyketide backbone have begun to be investigated, yet mechanism of control of the stereochemistry in a decalin formation via a Diels-Alder cycloaddition remains uncertain. Here, we demonstrate that fsa2, which showed no homology to genes encoding proteins of known function, in the fsa cluster responsible for equisetin and fusarisetin A biosynthesis in Fusarium sp. FN080326, is involved in the control of stereochemistry in decalin formation via a Diels-Alder reaction in the equisetin biosynthetic pathway. (C) 2015 Elsevier Inc. All rights reserved.	[Kato, Naoki; Nogawa, Toshihiko; Hirota, Hiroshi; Takahashi, Shunji; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Wako, Saitama 3510198, Japan; [Hirota, Hiroshi; Takahashi, Shunji] RIKEN, KRIBB Joint Res Unit, Global Res Cluster, Wako, Saitama 3510198, Japan; [Jang, Jae-Hyuk; Ahn, Jong Seog] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, Cheongwon 363883, Chungbuk, South Korea	Osada, H (reprint author), RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hisyo@riken.jp			Japan Society for the Promotion of Science; science and technology research promotion program for agriculture, forestry, fisheries and food industry; Global R&D Center (GRDC) programs of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning of Korea (MSIFP) [NRF-2010-00719]; KRIBB Research Initiative Program	We are grateful to Dr. J. Ishikawa for the prediction of the secondary metabolite biosynthetic gene cluster, Dr. Y. Hongo for high resolution ESI-MS measurements, Dr. M. Ueki for compound preparation, and K. Kinugasa and A. Okano for technical assistance. We also thank GeNAS for genome sequence data production. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, the science and technology research promotion program for agriculture, forestry, fisheries and food industry, grants from the Global R&D Center (GRDC, NRF-2010-00719) programs of the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning of Korea (MSIFP) and a grants from the KRIBB Research Initiative Program.	Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; Kakule TB, 2013, ACS CHEM BIOL, V8, P1549, DOI 10.1021/cb400159f; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Motoyama T, 2012, CHEM BIOL, V19, P1611, DOI 10.1016/j.chembiol.2012.10.010; Xu J, 2012, J AM CHEM SOC, V134, P5072, DOI 10.1021/ja300807e; Boettger D, 2013, CHEMBIOCHEM, V14, P28, DOI 10.1002/cbic.201200624; Campbell CD, 2010, BIOPOLYMERS, V93, P755, DOI 10.1002/bip.21428; Brown SG, 2012, J NAT PROD, V75, P1326, DOI 10.1021/np300248w; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Singh SB, 1998, TETRAHEDRON LETT, V39, P2243, DOI 10.1016/S0040-4039(98)00269-X; VESONDER RF, 1979, J ANTIBIOT, V32, P759; Inokoshi J, 2013, J ANTIBIOT, V66, P549, DOI 10.1038/ja.2013.44; Jang JH, 2011, J AM CHEM SOC, V133, P6865, DOI 10.1021/ja1110688; Koyama N, 2005, J ANTIBIOT, V58, P338; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/nchembio.1366, 10.1038/NCHEMBIO.1366]; Kato N, 2009, CHEMBIOCHEM, V10, P920, DOI 10.1002/cbic.200800787; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Sugie Y, 2002, J ANTIBIOT, V55, P25; Jadulco RC, 2014, J NAT PROD, V77, P2537, DOI 10.1021/np500617u; Kakule T.B., 2015, ACS SYNTH B IN PRESS; Mundt K, 2012, CHEMBIOCHEM, V13, P2583, DOI 10.1002/cbic.201200523; Nogawa T, 2013, J ANTIBIOT, V66, P621, DOI 10.1038/ja.2013.55; PHILLIPS NJ, 1989, J AM CHEM SOC, V111, P8223, DOI 10.1021/ja00203a025	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					210	215		10.1016/j.bbrc.2015.03.011		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300014		
J	Hiraoka, K; Hayashi, T; Kaneko, R; Nasu-Nishimura, Y; Koyama-Nasu, R; Kawasaki, Y; Akiyama, T				Hiraoka, Koji; Hayashi, Tomoatsu; Kaneko, Ryusuke; Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Kawasaki, Yoshihiro; Akiyama, Tetsu			SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Glioblastoma; Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5); Sry-related high-mobility group (HMG) box 9 (SOX9); Tumorigenicity	COUPLED RECEPTOR GPR49; STEM-CELLS; WNT/BETA-CATENIN; PROLIFERATION; GLIOMA	LGR5 plays an important role in the self-renewal of stem cells and is used as a marker identifying self-renewing stem cells in small intestine and hair follicles. Moreover, LGR5 has been reported to be over-expressed in several cancers. SOX9 is a transcription factor that plays a key role in development, differentiation and lineage commitment in various tissues. It has also been reported that SOX9 is over-expressed in a variety of cancers and contributes to their malignant phenotype. Here we show that LGR5 is required for the tumorigenicity of glioblastoma cells. We further show that SOX9 is upregulated in glioblastoma cells and directly enhances the expression of LGR5. We also demonstrate that knockdown of SOX9 suppresses the proliferation and tumorigenicity of glioblastoma cells. These results suggest that SOX9-mediated transcriptional regulation of LGR5 is critical for the tumorigenicity of glioblastoma cells. We speculate that the SOX9-LGR5 pathway could be a potentially promising target for the therapy of glioblastoma. (C) 2015 Elsevier Inc. All rights reserved.	[Hiraoka, Koji; Hayashi, Tomoatsu; Kaneko, Ryusuke; Nasu-Nishimura, Yukiko; Koyama-Nasu, Ryo; Kawasaki, Yoshihiro; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Akiyama, T (reprint author), Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	akiyama@iam.u-tokyo.ac.jp			Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic SignalingNetworks); Integrative Research on Cancer Microenvironment Network; Project for Development of Innovative Research on Cancer Therapeutics; Takeda Science Foundation; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan	This work was supported by Research Program of Innovative Cell Biology by Innovative Technology (Integrated Systems Analysis of Cellular Oncogenic SignalingNetworks), Grants-in-Aid for Scientific Research on Innovative Areas (Integrative Research on Cancer Microenvironment Network), Project for Development of Innovative Research on Cancer Therapeutics, Takeda Science Foundation and in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan.	de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Nakata S, 2013, BRAIN PATHOL, V23, P60, DOI 10.1111/j.1750-3639.2012.00618.x; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Wang DL, 2014, ONCOL REP, V31, P41, DOI 10.3892/or.2013.2826; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; McClanahan T, 2006, CANCER BIOL THER, V5, P419; Wang L, 2012, MED ONCOL, V29, P3484, DOI 10.1007/s12032-012-0267-z; Echizen K, 2014, BIOCHEM BIOPH RES CO, V444, P13, DOI 10.1016/j.bbrc.2013.12.138; Furukawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080609; Koyama-Nasu R, 2014, ONCOGENE, V33, P2236, DOI 10.1038/onc.2013.168; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Tsuji S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4150	20	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					216	221		10.1016/j.bbrc.2015.03.012		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300015		
J	Izumikawa, T; Kitagawa, H				Izumikawa, Tomomi; Kitagawa, Hiroshi			Amino acid sequence surrounding the chondroitin sulfate attachment site of thrombomodulin regulates chondroitin polymerization	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Chondroitin sulfate; Extracellular matrix; Glycosaminoglycan; Glycosyltransferase; Proteoglycan	HUMAN SOLUBLE THROMBOMODULIN; PROTEIN LINKAGE REGION; MOLECULAR-CLONING; HEPARAN-SULFATE; N-ACETYLGALACTOSAMINYLTRANSFERASE; EXPRESSION; TETRASACCHARIDE; IDENTIFICATION; PROTEOGLYCANS; SYNTHASE	Thrombomodulin (TM) is a cell-surface glycoprotein and a critical mediator of endothelial anticoagulant function. TM exists as both a chondroitin sulfate (CS) proteoglycan (PG) form and a non-PG form lacking a CS chain (alpha-TM); therefore, TM can be described as a part-time PG. Previously, we reported that a-TM bears an immature, truncated linkage tetrasaccharide structure (GicA beta 1-3Gal beta 1-3Gal beta 1-4Xyl). However, the biosynthetic mechanism to generate part-time PGs remains unclear. In this study, we used several mutants to demonstrate that the amino acid sequence surrounding the CS attachment site influences the efficiency of chondroitin polymerization. In particular, the presence of acidic residues surrounding the CS attachment site was indispensable for the elongation of CS. In addition, mutants defective in CS elongation did not exhibit anti-coagulant activity, as in the case with alpha-TM. Together, these data support a model for CS chain assembly in which specific core protein determinants are recognized by a key biosynthetic enzyme involved in chondroitin polymerization. (C) 2015 Elsevier Inc. All rights reserved.	[Izumikawa, Tomomi; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kitagawa, H (reprint author), 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp			Ministry of Education, Culture, Sports, Science & Technology, Japan [25293014, 23110003]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology, Japan	We thank Ayaka Takase and Kayoko Mori for their technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research (B) #25293014 (to H. K.) and for Scientific Research on Innovative Areas #23110003 (to H. K.) and by the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) from the Ministry of Education, Culture, Sports, Science & Technology, Japan.	Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Moll S, 2004, J THROMB HAEMOST, V2, P1745, DOI 10.1111/j.1538-7836.2004.00927.x; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; FRANSSON LA, 1987, TRENDS BIOCHEM SCI, V12, P406, DOI 10.1016/0968-0004(87)90197-6; GERLITZ B, 1993, BIOCHEM J, V295, P131; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; PREISSNER KT, 1990, J BIOL CHEM, V265, P4915; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107; Yamakawa K, 2011, CRIT CARE, V15, DOI 10.1186/cc10228	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					233	237		10.1016/j.bbrc.2015.03.016		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300018		
J	Funahashi, N; Hirota, Y; Nakagawa, K; Sawada, N; Watanabe, M; Suhara, Y; Okano, T				Funahashi, Nobuaki; Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natumi; Watanabe, Masato; Suhara, Yoshitomo; Okano, Toshio			YY1 positively regulates human UBIAD1 expression	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						UBIAD1; Gene regulation; YY1; Vitamin K	YIN YANG 1; DNA-BINDING; VITAMIN-K; C-MYC; PROMOTER; PROTEIN; GROWTH; TERE1; TRANSCRIPTION; CARCINOMA	Vitamin K is involved in bone formation and blood coagulation. Natural vitamin K compounds are composed of the plant form phylloquinone (vitamin K-1) and a series of bacterial menaquionones (MK-n; vitamin K-2). Menadione (vitamin K-3) is an artificial vitamin K compound. MK-4 contains 4-isoprenyl as a side group in the 2-methyl-1,4-naphthoquinone common structure and has various bioactivities. UbiA prenyltransferase domain containing 1 (UBIAD1 or TERE1) is the menaquinone-4 biosynthetic enzyme. UBIAD1 transcript expression significantly decreases in patients with prostate carcinoma and over-expressing UBIAD1 inhibits proliferation of a tumour cell line. UBIAD1 mRNA expression is ubiquitous in mouse tissues, and higher UBIAD1 mRNA expression levels are detected in the brain, heart, kidneys and pancreas. Several functions of UBIAD1 have been reported; however, regulation of the human UBIAD1 gene has not been elucidated. Here we report cloning and characterisation of the human UBIAD1 promoter. A 5' rapid amplification of cDNA ends analysis revealed that the main transcriptional start site was 306 nucleotides upstream of the translation initiation codon. Deletion and mutation analyses revealed the functional importance of the YY1 consensus motif. Electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that YY1 binds the UBIAD1 promoter in vitro and in vivo. In addition, YY1 small interfering RNA decreased endogenous UBIAD1 mRNA expression and UBIAD1 conversion activity. These results suggest that YY1 up-regulates UBIAD1 expression and UBIAD1 conversion activity through the UBIAD1 promoter. (C) 2015 Elsevier Inc. All rights reserved.	[Funahashi, Nobuaki; Hirota, Yoshihisa; Nakagawa, Kimie; Sawada, Natumi; Watanabe, Masato; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 6588558, Japan; [Funahashi, Nobuaki] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst, Tokyo, Japan; [Hirota, Yoshihisa] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama, Japan	Funahashi, N (reprint author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakitamachi, Kobe, Hyogo 6588558, Japan.	nfunahashi@ri.ncgm.go.jp			JSPS [23390022, 2379110];  [24-7941]	We thank Ryouta Katagiri and Kazuya Nishibayashi for technical support. This study was supported, in part, by a Grant-in-Aid for Scientific Research (B) (grant number 23390022 to T.O.) from JSPS, a Grant-in-Aid for Scientific Research (Young Scientists-B) (grant number 2379110 to K.N) from JSPS and a Grant-in-Aid for JSPS Fellows (grant number 24-7941 to Y.H.).	Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Baritaki S, 2007, MOL CANCER THER, V6, P1387, DOI 10.1158/1535-7163.MCT-06-0521; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958; Ishii H, 2012, INT J ONCOL, V40, P1575, DOI 10.3892/ijo.2012.1362; Do Kim J, 2009, GENOMICS, V93, P152, DOI 10.1016/j.ygeno.2008.09.013; Lee MH, 2012, ONCOGENE, V31, P116, DOI 10.1038/onc.2011.217; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487; Yakovleva T, 2004, BIOCHEM BIOPH RES CO, V318, P615, DOI 10.1016/j.bbrc.2004.04.065	20	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					238	244		10.1016/j.bbrc.2015.03.018		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300019		
J	Nishikado, H; Fujimura, T; Taka, H; Mineki, R; Ogawa, H; Okumura, K; Takai, T				Nishikado, Hideto; Fujimura, Tsutomu; Taka, Hikari; Mineki, Reiko; Ogawa, Hideoki; Okumura, Ko; Takai, Toshiro			Cysteine protease antigens cleave CD123, the alpha subunit of murine IL-3 receptor, on basophils and suppress IL-3-mediated basophil expansion	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Cysteine protease; Papain; Basophil; IL-3; CD123	AIRWAY INFLAMMATION; MITE ALLERGEN; IMMUNE CELLS; INTERLEUKIN-3; MALARIA; MICE; INFECTION; RESPONSES; PARASITES; PAPAIN	Th2 type immune responses are essential for protective immunity against parasites and play crucial roles in allergic disorders. Helminth parasites secrete a variety of proteases for their infectious cycles including for host entry, tissue migration, and suppression of host immune effector cell function. Furthermore, a number of pathogen-derived antigens, as well as allergens such as papain, belong to the family of cysteine proteases. Although the link between protease activity and Th2 type immunity is well documented, the mechanisms by which proteases regulate host immune responses are largely unknown. Here, we demonstrate that the cysteine proteases papain and bromelain selectively cleave the cc subunit of the IL-3 receptor (IL-3R alpha/CD123) on the surface of murine basophils. The decrease in CD123 expression on the cell surface, and the degradation of the extracellular domain of recombinant CD123 were dependent on the protease activity of papain and bromelain. Pre-treatment of murine basophils with papain resulted in inhibition of IL-3-IL-3R signaling and suppressed IL-3- but not thymic stromal lymphopoietin-induced expansion of basophils in vitro. Our unexpected findings illuminate a novel mechanism for the regulation of basophil functions by protease antigens. Because IL-3 plays pivotal roles in the activation and proliferation of basophils and in protective immunity against helminth parasites, pathogen-derived proteases might contribute to the pathogenesis of infections by regulating IL-3-mediated functions in basophils. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.	[Nishikado, Hideto; Ogawa, Hideoki; Okumura, Ko; Takai, Toshiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo 1138421, Japan; [Fujimura, Tsutomu; Taka, Hikari; Mineki, Reiko] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Prote & Biomol Sci, Tokyo 1138421, Japan	Takai, T (reprint author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	t-takai@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported Program for Strategic Research Foundation [S1101010]	The authors thank Seiji Kamijo for comments and technical advice and Michiyo Matsumoto for secretarial assistance. This study was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT)-supported Program for Strategic Research Foundation at Private Universities (S1101010).	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Takai Toshiro, 2011, Allergology International, V60, P25, DOI 10.2332/allergolint.10-RAI-0273; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI 10.1093/nar/gkr987; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Robinson MW, 2008, TRENDS BIOCHEM SCI, V33, P601, DOI 10.1016/j.tibs.2008.09.001; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; NOVEY HS, 1979, J ALLERGY CLIN IMMUN, V63, P98, DOI 10.1016/0091-6749(79)90198-2; Iida H, 2014, ALLERGOL INT, V63, P219, DOI 10.2332/allergolint.13-OA-0621; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; VALENT P, 1989, BLOOD, V73, P1763; Burgmann H, 1997, CLIN DIAGN LAB IMMUN, V4, P226; Daines MO, 2007, J ALLERGY CLIN IMMUN, V119, P375, DOI 10.1016/j.jaci.2006.09.039; Fujimura T, 2008, INT J CANCER, V122, P39, DOI 10.1002/ije.22958; HARA T, 1992, EMBO J, V11, P1875; Helmby H, 1998, EUR J IMMUNOL, V28, P2559, DOI 10.1002/(SICI)1521-4141(199808)28:08<2559::AID-IMMU2559>3.0.CO;2-M; IHLE JN, 1992, CHEM IMMUNOL, V51, P65; Karasuyama H, 2011, TRENDS IMMUNOL, V32, P125, DOI 10.1016/j.it.2010.11.006; Korenaga M, 1996, PARASITOL RES, V82, P108, DOI 10.1007/s004360050079; Lantz CS, 2008, LAB INVEST, V88, P1134, DOI 10.1038/labinvest.2008.88; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Meyer CG, 2011, HUM MOL GENET, V20, P1173, DOI 10.1093/hmg/ddq562; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Takai T, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3055, DOI 10.1016/B978-0-12-382219-2.00671-2; Takai T, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1957, DOI 10.1016/B978-0-12-382219-2.00445-2; Yamamoto E, 2014, BIOCHEM BIOPH RES CO, V453, P19, DOI 10.1016/j.bbrc.2014.09.040	42	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					261	266		10.1016/j.bbrc.2015.03.022		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300023		
J	Fujiwara, Y; Hase, K; Wada, K; Kabuta, T				Fujiwara, Yuuki; Hase, Katsunori; Wada, Keiji; Kabuta, Tomohiro			An RNautophagy/DNautophagy receptor, LAMP2C, possesses an arginine-rich motif that mediates RNA/DNA-binding	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Lysosome; RNautophagy; DNautophagy; Arginine-rich motif; LAMP2C	DNA-BINDING; CRYSTAL-STRUCTURE; RNA RECOGNITION; PROTEIN; LYSOSOMES; PEPTIDES; MEMBRANE; CELLS; GLYCOPROTEIN; DEGRADATION	Lysosomes are sites for the degradation of diverse cellular components. We recently discovered novel lysosomal systems we termed RNautophagy and DNautophagy. In these systems, RNA and DNA, respectively, are directly imported into lysosomes and degraded. A lysosomal membrane protein, LAMP2C was identified as a receptor for these pathways. The short C-terminal cytosolic tail of LAMP2C binds directly to both RNA and DNA. In this study, we examined the mechanisms underlying recognition of nucleic acids by the cytosolic sequence of LAMP2C. We found that the sequence possesses features of the arginine-rich motif, an RNA-recognition motif found in a wide range of RNA-binding proteins. Substitution of arginine residues in the LAMP2C cytosolic sequence completely abolished its binding capacity for nucleic acids. A scrambled form of the sequence showed affinity to RNA and DNA equivalent to that of the wild-type sequence, as is the case for other arginine-rich motifs. We also found that cytosolic sequences of other LAMP family proteins, LAMP1 and CD68/LAMP4, also possess arginine residues, and show affinity for nucleic acids. Our results provide further insight into the mechanisms underlying RNautophagy and DNautophagy, and may contribute to a better understanding of lysosome function. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license.	[Fujiwara, Yuuki; Hase, Katsunori; Wada, Keiji; Kabuta, Tomohiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Fujiwara, Yuuki; Hase, Katsunori] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo, Japan	Kabuta, T (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kabuta@ncnp.go.jp			Japan Society for the Promotion of Science [24680038, 26111526]; Uehara Foundation; Japan Society for the Promotion of Science	We thank Dr. Yoshitaka Nagai (National Center of Neurology and Psychiatry) for helpful discussions. This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24680038 and 26111526 to T.K.), and a research grant from the Uehara Foundation (to T.K.), and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to K.W.).	Cuervo AM, 2000, J CELL SCI, V113, P4441; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; HOLNESS CL, 1993, J BIOL CHEM, V268, P9661; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Ye XM, 1999, CHEM BIOL, V6, P657, DOI 10.1016/S1074-5521(99)80117-3; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; AUKERMAN MJ, 1991, GENE DEV, V5, P310, DOI 10.1101/gad.5.2.310; DALY TJ, 1990, BIOCHEMISTRY-US, V29, P9791, DOI 10.1021/bi00494a005; David A, 2007, J CELL SCI, V120, P353, DOI 10.1242/jcs.03316; DE DUVE C., 1955, BIOCHEM JOUR, V60, P604; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; Frankel AD, 2000, CURR OPIN STRUC BIOL, V10, P332, DOI 10.1016/S0959-440X(00)00092-0; Harada K, 1996, NATURE, V380, P175, DOI 10.1038/380175a0; Hiriart E, 2003, J BIOL CHEM, V278, P37790, DOI 10.1074/jbc.M305925200; NOVIKOFF ALEX B., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179; Patel Dinshaw J., 1999, Current Opinion in Structural Biology, V9, P74, DOI 10.1016/S0959-440X(99)80010-4; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; Tan RY, 1998, P NATL ACAD SCI USA, V95, P4247, DOI 10.1073/pnas.95.8.4247; Venter PA, 2009, J VIROL, V83, P2872, DOI 10.1128/JVI.01780-08; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Xie B, 2004, J VIROL, V78, P1456, DOI 10.1128/JVI.78.3.1456-1463.2004	31	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					281	286		10.1016/j.bbrc.2015.03.025		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300026		
J	Kiyomiya, H; Ariyoshi, W; Okinaga, T; Kaneuji, T; Mitsugi, S; Sakurai, T; Habu, M; Yoshioka, I; Tominaga, K; Nishihara, T				Kiyomiya, Hiroyasu; Ariyoshi, Wataru; Okinaga, Toshinori; Kaneuji, Takeshi; Mitsugi, Sho; Sakurai, Takuma; Habu, Manabu; Yoshioka, Izumi; Tominaga, Kazuhiro; Nishihara, Tatsuji			IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Osteoclastogenesis; IL-33; Blimp-1; IRF-8	NF-KAPPA-B; BONE HOMEOSTASIS; DIFFERENTIATION; RECEPTOR; PROTEIN; INTERLEUKIN-33; ACTIVATION; NFATC1; CELLS; OSTEOBLASTS	Interleukin (IL)-33 is a recently discovered proinflammatory cytokine that belongs to the IL-1 family. Several studies have reported that IL-33 inhibits osteoclast differentiation. However, the mechanism of IL-33 regulation of osteoclastogenesis remains unclear. In the present study, we examined the effect of IL-33 on osteoclast formation in vitro. IL-33 suppressed osteoclast formation in both mouse bone marrow cells and monocyte/macrophage cell line RAW264.7 cells induced by receptor activator of NF-kappa B ligand (RANKL) and/or macrophage stimulating factor (M-CSF). IL-33 also inhibited the expression of RANKL-induced nuclear factor of activated T-cell cytoplasmic 1 (NFATc1), thereby decreasing the expression of osteoclastogenesis-related marker genes, including Cathepsin K, Osteoclast stimulatory transmembrane protein (Oc-stamp) and Tartrate-resistant acid phosphatase (Trap). Blockage of IL-33-ST2 binding suppressed the IL-33-mediated inhibition of NFATc1. RANKL-induced B-lymphocyte-induced maturation protein-1 (Blimp-1) expression was also suppressed by IL-33, which was followed by the stimulation of anti-osteoclastic genes such as interferon regulatory factor-8 (IRF-8). These results suggest that IL-33-ST2 interactions down-regulate both RANKL-induced NFATc1 activation and osteoclast differentiation via the regulation of Blimp-1 and IRF-8 expression. (C) 2015 Elsevier Inc. All rights reserved.	[Kiyomiya, Hiroyasu; Ariyoshi, Wataru; Okinaga, Toshinori; Sakurai, Takuma; Nishihara, Tatsuji] Kyushu Dent Univ, Dept Hlth Promot, Div Infect & Mol Biol, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Kiyomiya, Hiroyasu; Mitsugi, Sho; Sakurai, Takuma; Habu, Manabu; Tominaga, Kazuhiro] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral & Maxillofacial Surg, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Kaneuji, Takeshi; Yoshioka, Izumi] Kyushu Dent Univ, Dept Sci Phys Funct, Div Oral Med, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	Nishihara, T (reprint author), Kyushu Dent Univ, Dept Hlth Promot, Div Infect & Mol Biol, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	tatsujin@kyu-dent.ac.jp					Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Park-Min KH, 2013, J BONE MINER RES, V28, P135, DOI 10.1002/jbmr.1739; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Palmer G, 2009, ARTHRITIS RHEUM, V60, P738, DOI 10.1002/art.24305; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zaiss MM, 2011, J IMMUNOL, V186, P6097, DOI 10.4049/jimmunol.1003487; Saleh H, 2011, ENDOCRINOLOGY, V152, P1911, DOI 10.1210/en.2010-1268; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Keller J, 2012, BIOCHEM BIOPH RES CO, V417, P217, DOI 10.1016/j.bbrc.2011.11.088; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; Saidi S, 2011, CYTOKINE, V53, P347, DOI 10.1016/j.cyto.2010.11.021; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Ishikawa T, 2001, MOL CARCINOGEN, V32, P84, DOI 10.1002/mc.1067; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355	30	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					320	326		10.1016/j.bbrc.2015.03.033		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300032		
J	Assaha, DVM; Mekawy, AMM; Ueda, A; Saneoka, H				Assaha, Dekoum V. M.; Mekawy, Ahmad Mohammad M.; Ueda, Akihiro; Saneoka, Hirofumi			Salinity-induced expression of HKT may be crucial for Na+ exclusion in the leaf blade of huckleberry (Solanum scabrum Mill.), but not of eggplant (Solanum melongena L.)	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Na+ distribution; SsHKT expression; SmHKT expression; K+/Na+ ratio; Yeast complementation	TRANSPORTER GENE; STRESS; PLANTS; POTASSIUM; SODIUM; GROWTH; SALT; ACCUMULATION; GERMINATION; TOLERANCE	Reduced Na+ accumulation in the leaf blade is an important aspect of salinity tolerance and high affinity K+ transporters (HKTs) are known to play a significant role in the process. Huckleberry and eggplant have previously been shown to display 'excluder' and Includer' characteristics, respectively, under salt stress, but the underlying mechanisms have not been investigated. Here, we isolated the cDNA of the HKT homologs, Solanum scabrum HKT (SsHKT) from huckleberry and Solanum melongena HKT (SmHKT) from eggplant, and analyzed their expressions in different tissues under salt stress. SsHKT expression was markedly induced in the root (28-fold) and stem (7-fold), with a corresponding increase in Na+ accumulation of 52% and 29%, respectively. Conversely, eggplant accumulated 60% total Na+ in the leaf blade, with a lower SmHKT expression level in the root (3-fold). Huckleberry also maintained a higher K+/Na+ ratio in the leaf blade compared to eggplant, due to the reduction of its Na+ concentration and unaltered K+ concentration. Functional analysis demonstrated that SsHKT-mediated Na+ influx inhibited yeast growth under Na+ stress, and that SsHKT did not complement the growth of the K+ uptake-deficient CY162 strain under K+-limiting conditions. These results suggest that the Na+ accumulation characteristics of both plants are caused by the differential expression of HKT genes, with SsHKT exerting a greater control over the ability of Na+ to reach the leaf blade in huckleberry, than SmHKT does in eggplant. (C) 2015 Elsevier Inc. All rights reserved.	[Assaha, Dekoum V. M.; Mekawy, Ahmad Mohammad M.; Ueda, Akihiro; Saneoka, Hirofumi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Ueda, A (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	akiueda@hiroshima-u.ac.jp					Akinci IE, 2004, NEW ZEAL J CROP HORT, V32, P193; Ali Z, 2012, PLANT PHYSIOL, V158, P1463, DOI 10.1104/pp.111.193110; Almeida P, 2014, J PLANT PHYSIOL, V171, P438, DOI 10.1016/j.jplph.2013.12.001; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Golldack D, 2002, PLANT J, V31, P529, DOI 10.1046/j.1365-313X.2002.01374.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Plett DC, 2010, PLANT CELL ENVIRON, V33, P612, DOI 10.1111/j.1365-3040.2009.02086.x; Assaha DVM, 2013, SOIL SCI PLANT NUTR, V59, P912, DOI 10.1080/00380768.2013.858300; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Kato N, 2007, CHANNELS, V1, P161; Wang TT, 2014, J INTEGR PLANT BIOL, V56, P315, DOI 10.1111/jipb.12144; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Byrt CS, 2014, PLANT J, V80, P516, DOI 10.1111/tpj.12651; Chartzoulakis KS, 1997, AGR WATER MANAGE, V32, P215, DOI 10.1016/S0378-3774(96)01276-0; Cotsaftis O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039865; Hone K., 2009, TRENDS PLANT SCI, V14, P660; Kinclova-Zimmermannova O, 2006, FEMS YEAST RES, V6, P792, DOI 10.1111/j.1567-1364.2006.00062.x; Mekawy AMM, 2015, PLANT PHYSIOL BIOCH, V87, P17, DOI 10.1016/j.plaphy.2014.12.007; Mibei E.K., 2011, ANN FOOD SCI TECHNOL, V12, P146; Moller S.I., 2009, PLANT CELL, V21, P2163; Muthomi J., 2009, Journal of Agricultural and Biological Science, V4, P24; Ogunnaike B. F., 2013, Journal of Natural Product and Plant Resources, V3, P59; Shaheen S., 2012, J PLANT INTERACT, V12, P1; Adams E, 2014, J INTEGR PLANT BIOL, V56, P231, DOI 10.1111/jipb.12159; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x	29	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					416	421		10.1016/j.bbrc.2015.03.048		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300047		
J	Terawaki, S; Yoshikane, A; Higuchi, Y; Wakamatsu, K				Terawaki, Shin-ichi; Yoshikane, Asuka; Higuchi, Yoshiki; Wakamatsu, Kaori			Structural basis for cargo binding and autoinhibition of Bicaudal-D1 by a parallel coiled-coil with homotypic registry	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Retrograde transport; Bicaudal-D; Rab6; RanBP2	SPINAL MUSCULAR-ATROPHY; DYNEIN MOTOR DOMAIN; CYTOPLASMIC DYNEIN; DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; DYNACTIN; MUTATIONS; TRANSPORT; COMPLEX; ADAPTER	Bicaudal-D1 (BICD1) is an alpha-helical coiled-coil protein mediating the attachment of specific cargo to cytoplasmic dynein. It plays an essential role in minus end-directed intracellular transport along microtubules. The third C-terminal coiled-coil region of BICD1 (BICD1 CD) has an important role in cargo sorting, including intracellular vesicles associating with the small GTPase Rab6 and the nuclear pore complex Ran binding protein 2 (RanBP2), and inhibiting the association with cytoplasmic dynein by binding to the first N-terminal coiled-coil region (CC1). The crystal structure of BICD1 CD revealed a parallel homodimeric coiled-coil with asymmetry and complementary knobs-into-holes interactions, differing from Drosophila BicD CD. Furthermore, our binding study indicated that BICD1 CD possesses a binding surface for two distinct cargos, Rab6 and RanBP2, and that the CC1-binding site overlaps with the Rab6-binding site. These findings suggest a molecular basis for cargo recognition and autoinhibition of BICD proteins during dynein-dependent intracellular retrograde transport. (C) 2015 Elsevier Inc. All rights reserved.	[Terawaki, Shin-ichi; Yoshikane, Asuka; Wakamatsu, Kaori] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gumma 3768515, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, Kamigori, Hyogo 6781297, Japan; [Terawaki, Shin-ichi; Yoshikane, Asuka; Higuchi, Yoshiki; Wakamatsu, Kaori] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Terawaki, S (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	terawaki@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23121527, 25121705]; JSPS; Uehara Memorial Foundation; Takeda Medical Science; Inamori Foundation	This work was supported by a Grant-in-Aid for Scientific Research on Innovation Areas for 'Structural Cell Biology' (23121527 and 25121705) and a Leave a Nest Grants Caliper Life Science Award to ST, and was partially supported by Grant-in-Aid for Science Research for Scientific Research Category C to KW and Young Scientists B to ST from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, from JSPS and a Research Grant from the Uehara Memorial Foundation, and Takeda Medical Science, Inamori Foundation to ST. This work has been performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2011G629 and No. 2013G168). We acknowledge the contributions of the staff at beamlines BL-1A and BL-17A, the Photon Factory, Japan.	Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Wanschers BFJ, 2007, EXP CELL RES, V313, P3408, DOI 10.1016/j.yexcr.2007.05.032; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; MOHLER J, 1986, GENETICS, V112, P803; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Peeters K, 2013, AM J HUM GENET, V92, P955, DOI 10.1016/j.ajhg.2013.04.013; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28; Neveling K, 2013, AM J HUM GENET, V92, P946, DOI 10.1016/j.ajhg.2013.04.011; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018; Lipka J, 2013, BIOCHEM SOC T, V41, P1605, DOI 10.1042/BST20130188; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Baens M, 1997, GENOMICS, V45, P601, DOI 10.1006/geno.1997.4971; Jaarsma D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4411; KARKI S, 1995, J BIOL CHEM, V270, P28806; Schmidt H, 2015, NATURE, V518, DOI 10.1038/nature14023; Schmidt H., 2012, NAT STRUCT MOL BIOL, V484, P345; Splinter D., 2001, MOL BIOL CELL, V20, P4041; Splinter D.L., 2007, PLOS BIOL, V313, P3408; STEWARD R, 1986, GENETICS, V113, P665; Terawaki S, 2014, ACTA CRYSTALLOGR F, V70, P1103, DOI 10.1107/S2053230X1401276X; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507	35	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					451	456		10.1016/j.bbrc.2015.03.054		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300053		
J	Hirose, N; Kawabata, Y; Kawabata, F; Nishimura, S; Tabata, S				Hirose, Nozomi; Kawabata, Yuko; Kawabata, Fuminori; Nishimura, Shotaro; Tabata, Shoji			Bitter taste receptor T2R1 activities were compatible with behavioral sensitivity to bitterness in chickens	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Bitter; T2R1; Taste receptor; Chicken	PROTEIN	Clarification of the mechanism of the sense of taste in chickens will provide information useful for creating and improving new feedstuffs for chickens, because the character of the taste receptors in oral tissues affects feeding behavior in animals. In this study, we focused on the sensitivity to bitterness in chickens. We cloned one of the bitter taste receptors, T2R1, from the chicken palate, constructed several biosensor-cells expressing chicken T2R1 (cT2R1), and determined a highly sensitive biosensor of cT2R1 among them. By using Ca2+ imaging methods, we identified two agonists of cT2R1, dextromethorphan (Dex) and diphenidol (Dip). Dex was a new agonist of cT2R1 that was more potent than Dip. In a behavioral drinking study, the intake volumes of solutions of these compounds were significantly lower than that of water in chickens. These aversive concentrations were identical to the concentrations that could activate cT2R1 in a cell-based assay. These results suggest that the cT2R1 activities induced by these agonists are linked to behavioral sensitivity to bitterness in chickens. (C) 2015 Elsevier Inc. All rights reserved.	[Hirose, Nozomi; Nishimura, Shotaro; Tabata, Shoji] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Bioresource Sci, Funct Anat Lab, Fukuoka 8128581, Japan; [Kawabata, Yuko] Kyushu Univ, Sch Agr, Fukuoka 8128581, Japan; [Kawabata, Fuminori] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Nishimura, Shotaro; Tabata, Shoji] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Kawabata, F (reprint author), Kyushu Univ, Inst Adv Study, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	kawabata@agr.kyushu-u.ac.jp			Funds for the Development of Human Resources in Science and Technology; Japan Science and Technology Agency; JSPS KAKENHI [26850207]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development [26703]	We thank Dr Takashi Ueda (Nagoya City University) for providing the G alpha<INF>16/gust44</INF> plasmid. We appreciate the technical assistance of The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences. This study was supported in part by a grant to F.K. from the Funds for the Development of Human Resources in Science and Technology, the Japan Science and Technology Agency; a grant to F.K. from JSPS KAKENHI (#26850207); and a grant to F.K. from Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (#26703).	Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Ueda T, 2003, J NEUROSCI, V23, P7376; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Roura E, 2013, ANIM FEED SCI TECH, V180, P1, DOI 10.1016/j.anifeedsci.2012.11.001; Behrens M, 2014, MOL BIOL EVOL, V31, P3216, DOI 10.1093/molbev/msu254; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Boland MJ, 2013, TRENDS FOOD SCI TECH, V29, P62, DOI 10.1016/j.tifs.2012.07.002; Cheled-Shoval SL, 2014, J AGR FOOD CHEM, V62, P12512, DOI 10.1021/jf502219a; Kudo K, 2010, ANIM SCI J, V81, P666, DOI 10.1111/j.1740-0929.2010.00796.x; Sawamura R, 2015, BIOCHEM BIOPH RES CO, V458, P387, DOI 10.1016/j.bbrc.2015.01.125	10	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					464	468		10.1016/j.bbrc.2015.03.056		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300055		
J	Yoneda, A; Watanabe, T				Yoneda, Akihiro; Watanabe, Tomomasa			Involvement of mouse and porcine PLC zeta-induced calcium oscillations in preimplantation development of mouse embryos	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						PLC zeta; Calcium oscillations; Round spermatids	PHOSPHOLIPASE-C-ZETA; INTRACYTOPLASMIC SPERM INJECTION; EGG-ACTIVATING FACTOR; CA2+ OSCILLATIONS; NUCLEAR TRANSLOCATION; ROUND SPERMATIDS; OOCYTES; FERTILIZATION; HYDROLYSIS; EXPRESSION	In mammals, phospholipase C zeta (PLC zeta) has the ability to trigger calcium (Ca2+) oscillations in oocytes, leading to oocyte activation. Although there is a species-specific difference in the PLC-induced Ca2+ oscillatory pattern, whether PLC zeta-induced Ca2+ oscillations affect preimplantation embryonic development remains unclear. Here, we show that Ca2+ oscillations in mouse PLC zeta cRNA-injected oocytes stopped just before pronuclear formation, while that in porcine PLC zeta cRNA-injected oocytes continued for several hours after pronuclei had been formed. This difference of Ca2+ oscillations in oocytes after pronuclear formation was dependent on the difference in the nuclear localization signal (NLS) sequence of PLC zeta between the mouse and pig. However, mouse and porcine PLC zeta cRNA-injected oocytes parthenogenetically developed to blastocysts regardless of the absence or presence of Ca2+ oscillations after pronuclear formation. Furthermore, the developmental rate of mouse or porcine PLC zeta-activated oocytes injected with round spermatids to the blastocyst stage was not significantly different from that of strontium-activated oocytes injected with round spermatids. These results suggest that the PLC zeta-induced Ca2+ oscillatory pattern in mouse oocytes is dependent on the NLS sequence of PLC zeta and injection of PLC zeta may be a useful method for activation of round spermatid-injected and somatic nuclear transferred oocytes. (C) 2015 Elsevier Inc. All rights reserved.	[Yoneda, Akihiro; Watanabe, Tomomasa] Hokkaido Univ, Grad Sch Agr, Lab Anim Breeding & Reprod, Sapporo, Hokkaido 0010021, Japan; [Yoneda, Akihiro] Hokkaido Univ, Ctr Food & Med Innovat, Div Mol Therapeut, Sapporo, Hokkaido 0010021, Japan	Yoneda, A (reprint author), Hokkaido Univ, Ctr Food & Med Innovat, Div Mol Therapeut, Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan.	ayoneda@sci.hokudai.ac.jp					Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Nomikos M, 2011, BIOCHEM J, V434, P211, DOI 10.1042/BJ20101772; Ito M, 2008, CELL CALCIUM, V44, P400, DOI 10.1016/j.ceca.2008.02.003; Kishigami S, 2004, BIOL REPROD, V70, P1863, DOI 10.1095/biolreprod.103.025171; Ito M, 2008, BIOL REPROD, V78, P1081, DOI 10.1095/biolreprod.108.067801; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; SWANN K, 1990, DEVELOPMENT, V110, P1295; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Yu YS, 2012, MOL BIOL CELL, V23, P371, DOI 10.1091/mbc.E11-08-0687; Ozil JP, 2005, DEV BIOL, V282, P39, DOI 10.1016/j.ydbio.2005.02.035; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Coward K, 2005, REPRODUCTION, V130, P157, DOI 10.1530/rep.1.00707; Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Cooney MA, 2010, BIOL REPROD, V83, P92, DOI 10.1095/biolreprod.109.079814; Kim NH, 1999, THERIOGENOLOGY, V51, P1441, DOI 10.1016/S0093-691X(99)00088-6; Kuroda K, 2006, J BIOL CHEM, V281, P27794, DOI 10.1074/jbc.M603473200; Larman MG, 2004, J CELL SCI, V117, P2513, DOI 10.1242/jcs.01109; Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294; Ogura A, 2003, THERIOGENOLOGY, V59, P87, DOI 10.1016/S0093-691X(02)01276-1; Parrington J., 2000, BIOL CELL, V92, P1; Sato K, 2013, ANIM SCI J, V84, P359, DOI 10.1111/asj.12044; Sone Y, 2005, BIOCHEM BIOPH RES CO, V330, P690, DOI 10.1016/j.bbrc.2005.03.032; Stricker S. A., 1999, DEV BIOL, V211, P57; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; Yanagimachi R, 2001, REPROD FERT DEVELOP, V13, P3, DOI 10.1071/RD00047; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018	32	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 1	2015	460	2					476	481		10.1016/j.bbrc.2015.03.058		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CH7PY	WOS:000354230300057		
J	Ogata, F; Fujiu, K; Koshima, I; Nagai, R; Manabe, I				Ogata, F.; Fujiu, K.; Koshima, I.; Nagai, R.; Manabe, I.			Phenotypic modulation of smooth muscle cells in lymphoedema	BRITISH JOURNAL OF DERMATOLOGY			English	Article							LYMPHATICOVENULAR ANASTOMOSIS; LIMB LYMPHEDEMA; BREAST CANCER; ATHEROSCLEROSIS; LYMPHOSCINTIGRAPHY; PROLIFERATION; EXTREMITIES; PHYSIOLOGY; APOPTOSIS; PATHOLOGY	Background Lymphoedema is a debilitating progressive condition that is frequently observed following cancer surgery and severely restricts quality of life. Although it is known that lymphatic dysfunction and obstruction underlie lymphoedema, the pathogenic mechanism is poorly understood. Smooth muscle cells (SMCs) play pivotal roles in the pathogenesis of various vascular diseases, including atherosclerosis. Objectives We analysed SMCs in lymphatic vessels from the lymphoedematous legs of 29 patients. Methods Expression of smooth muscle alpha-actin (SM alpha A) and smooth muscle myosin heavy chain (SM-MHC) isoforms SM1 and SM2 was investigated using immunohistochemistry. Results Compared with normal lymphatic vessels, all affected lymphatic vessels in chronic lymphoedema showed marked wall thickening. In addition to increases in the numbers of rows of SM alpha A(+) SM1(+) SMCs in the tunica media, SMCs were also observed in the subendothelial region (tunica intima). While most intimal and medial cells were positive for SM alpha A and SM1, staining for SM1 and particularly SM2, a marker of mature SMCs, progressively declined in lymphatic vessels in increasingly severe lymphoedema lesions. Consequently, the SM1(+) and SM2(+) cell fractions were significantly reduced in the tunica media and intima of lymphatic vessels. Conclusions These observations indicate that the lymphatic tunica media and tunica intima consist mainly of phenotypically modulated SMCs, and that SMCs play a key role in the development of lymphoedema.	[Ogata, F.; Fujiu, K.; Manabe, I.] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ogata, F.; Koshima, I.] Univ Tokyo, Grad Sch Med, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Fujiu, K.] Univ Tokyo, Grad Sch Med, Translat Syst Biol & Med Initiat, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, R.] Jichi Med Univ, Shimotsuke, Tochigi 3290498, Japan	Manabe, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	manabe-tky@umin.ac.jp			'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'; Council for Science and Technology Policy; Japanese Society for the Promotion Science; Japanese Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Institute; Sumitomo Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported by the 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)', initiated by the Council for Science and Technology Policy (to R.N.); Grants-in-Aid for Scientific Research (S) and (B) from the Japanese Society for the Promotion Science (to R.N. and I.M.); a grant for Translational Systems Biology and Medicine Initiative (to R.N.) from the Japanese Science and Technology Agency; a Grant-in-Aid for Scientific Research on Innovative Areas 'Homeostatic Inflammation' (to I.M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and research grants from the Japan Science and Technology Institute, Sumitomo Foundation, Takeda Science Foundation, SENSHIN Medical Research Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research (to I.M.).	Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; DARBY I, 1990, LAB INVEST, V63, P21; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; AIKAWA M, 1993, CIRC RES, V73, P1000; Iwata H, 2013, CIRC RES, V112, P1634, DOI 10.1161/CIRCRESAHA.113.301384; Ogata F, 2007, ANN PLAS SURG, V59, P180, DOI 10.1097/01.sap.0000253341.70866.54; Ryan M, 2003, AUST NZ J OBSTET GYN, V43, P148, DOI 10.1046/j.0004-8666.2003.00040.x; Perrotta I, 2013, ULTRASTRUCT PATHOL, V37, P43, DOI 10.3109/01913123.2011.592721; Williams AF, 2005, PALLIATIVE MED, V19, P300, DOI 10.1191/0269216305pm1020oa; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437; Szuba A, 2002, NUCL MED COMMUN, V23, P1171, DOI 10.1097/01.mnm.0000046208.83338.da; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622; Koshima I, 2004, ANN PLAS SURG, V53, P261, DOI 10.1097/01.sap.0000120319.89926.07; Koshima I, 1996, PLAST RECONSTR SURG, V97, P397, DOI 10.1097/00006534-199602000-00018; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Carvalho J P, 1994, Sao Paulo Med J, V112, P539; Daroczy J, 1995, CLIN DERMATOL, V13, P433, DOI 10.1016/0738-081X(95)00086-U; FITZPATR.PJ, 1969, CAN J SURG, V12, P172; Gebousky P, 2009, COMPUT BIOL MED, V39, P1, DOI 10.1016/j.compbiomed.2008.10.003; Ikomi F, 2006, MICROCIRCULATION, V13, P365, DOI 10.1080/10739680600745810; International Society of Lymphology, 2009, LYMPHOLOGY, V42, P51; Lee BB, 2011, PHLEBOLOGY, V26, P177, DOI 10.1258/phleb.2011.011e01; Manabe Ichiro, 2003, Curr Atheroscler Rep, V5, P214, DOI 10.1007/s11883-003-0027-9; OLSZEWSKI WL, 1990, LYMPHOLOGY, V23, P23; Ross R, 1999, NEW ENGL J MED, V340, P115; SCHIRGER A, 1962, JAMA, V182, P14; Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209; Wang Yingdi, 2014, Vasc Cell, V6, P14, DOI 10.1186/2045-824X-6-14	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	MAY	2015	172	5					1286	1293		10.1111/bjd.13482		8	Dermatology	Dermatology	CH9XU	WOS:000354390800077		
J	Takeichi, T; Nanda, A; Aristodemou, S; McMillan, JR; Lee, J; Akiyama, M; Al-Ajmi, H; Simpson, MA; McGrath, JA				Takeichi, T.; Nanda, A.; Aristodemou, S.; McMillan, J. R.; Lee, J.; Akiyama, M.; Al-Ajmi, H.; Simpson, M. A.; McGrath, J. A.			Whole-exome sequencing diagnosis of two autosomal recessive disorders in one family	BRITISH JOURNAL OF DERMATOLOGY			English	Article							EYELASH GROWTH; CANCER-PATIENTS; PARALLEL-GROUP; BIMATOPROST; MULTICENTER; ALOPECIA	Autosomal recessive congenital ichthyosis (ARCI) is a genetically heterogeneous disorder for which subtyping through molecular analysis can help determine the eventual phenotype and prognosis. We used whole-exome sequencing to identify a new homozygous splice-site mutation in ST14 (IVS5+1G>A), encoding matriptase, in a 4-year-old girl with ARCI from a consanguineous Kuwaiti family. Clinically, she also had hypotrichosis, which supported a diagnosis of ARCI type 11. Only four previous examples of pathogenic mutations in ST14 have been reported, and our findings expand the genotype-phenotype correlation for this subtype of ARCI. Our patient was the second child born to these parents; the first (deceased) and third children had congenital brain and eye abnormalities, of uncertain aetiology and with no precise diagnosis. Further analysis of our patient's exome dataset revealed heterozygosity for a splice-site mutation in POMT1 (IVS4+1G>T), encoding the protein O-mannosyltransferase, a gene implicated in Walker-Warburg syndrome. DNA sequencing in the third child showed homozygosity for this mutation in POMT1. The first-cousin parents were both heterozygous for the splice-site mutations in ST14 and POMT1. In this family, whole-exome sequencing provided accurate subtyping of a form of ARCI in one child and provide an explanation for an undiagnosed developmental disorder in two other children, findings that improve the prospects for diagnostic accuracy and genetic counselling, and demonstrate the impact of next-generation sequencing technologies on clinical genetics.	[Takeichi, T.; Lee, J.; McGrath, J. A.] Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England; [Simpson, M. A.] Kings Coll London, Guys Hosp, Dept Genet & Mol Med, London SE1 9RT, England; [Takeichi, T.; Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Nanda, A.; Al-Ajmi, H.] Al Sabah Hosp, Asad Al Hamad Dermatol Ctr, Kuwait, Kuwait; [Aristodemou, S.; McMillan, J. R.] St Thomas Hosp, Natl Diagnost EB Lab, London, England	McGrath, JA (reprint author), Kings Coll London, Guys Hosp, St Johns Inst Dermatol, London SE1 9RT, England.	john.mcgrath@kcl.ac.uk	McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science [S2404]	The authors acknowledge financial support from the Department of Health via the U.K. National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This study was also supported in part by the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (S2404) from the Japan Society for the Promotion of Science.	Wang J, 2006, PHARM RES, V23, P2505, DOI 10.1007/s11095-006-9105-3; Yoelin S, 2010, DERMATOL SURG, V36, P638, DOI 10.1111/j.1524-4725.2010.01519.x; Woodward DF, 2008, BRIT J PHARMACOL, V153, P410, DOI 10.1038/sj.bjp.0707434; Liu JHK, 2005, OPHTHALMOLOGY, V112, P1670, DOI 10.1016/j.ophtha.2005.05.007; Dorr VJ, 1998, SEMIN ONCOL, V25, P562; Dang J, 2009, VALUE HEALTH, V12, pA458, DOI 10.1016/S1098-3015(10)75269-4; DRANCE SM, 1960, ARCH OPHTHALMOL-CHIC, V64, P494; Fagien S, 2013, AESTHET SURG J, V33, P789, DOI 10.1177/1090820X13495887; Harii K, 2014, AESTHET PLAST SURG, V38, P451, DOI 10.1007/s00266-014-0293-7; Hazin R, 2009, CURR OPIN OPHTHALMOL, V20, P308, DOI 10.1097/ICU.0b013e32832c9007; Law Simon K, 2010, Clin Ophthalmol, V4, P349; Smid Scott D, 2009, Clin Ophthalmol, V3, P663; Smith S, 2012, J AM ACAD DERMATOL, V66, P801, DOI 10.1016/j.jaad.2011.06.005	13	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	MAY	2015	172	5					1407	1411		10.1111/bjd.13473		5	Dermatology	Dermatology	CH9XU	WOS:000354390800092		
J	Takahashi, T; Asano, Y; Shibata, S; Nakamura, K; Nakao, M; Shida, R; Mitsui, A; Araki, M; Watanabe, R; Fujita, H; Tada, Y; Sato, S				Takahashi, T.; Asano, Y.; Shibata, S.; Nakamura, K.; Nakao, M.; Shida, R.; Mitsui, A.; Araki, M.; Watanabe, R.; Fujita, H.; Tada, Y.; Sato, S.			Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							GENERALIZED EXANTHEMATOUS PUSTULOSIS		[Takahashi, T.; Asano, Y.; Shibata, S.; Nakamura, K.; Nakao, M.; Shida, R.; Mitsui, A.; Araki, M.; Watanabe, R.; Fujita, H.; Tada, Y.; Sato, S.] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					AHLUWALIA A, 1993, BRIT J DERMATOL, V128, P45, DOI 10.1111/j.1365-2133.1993.tb00146.x; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Hellberg L, 2013, J INVEST DERMATOL, V133, P2390, DOI 10.1038/jid.2013.91; Hotz C, 2013, BRIT J DERMATOL, V169, P1223, DOI 10.1111/bjd.12502; Mokhtari F, 2013, J AM ACAD DERMATOL, V19, P720; ROUJEAU JC, 1991, ARCH DERMATOL, V127, P1333, DOI 10.1001/archderm.127.9.1333; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Valeyrie-Allanore L, 2007, DRUG SAFETY, V30, P1011	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	MAY	2015	172	5					1458	1460		10.1111/bjd.13587		3	Dermatology	Dermatology	CH9XU	WOS:000354390800112		
J	Abdul-Wahab, A; Takeichi, T; Lwin, SM; Liu, L; Stephens, C; Akiyama, M; McGrath, JA				Abdul-Wahab, A.; Takeichi, T.; Lwin, S. M.; Liu, L.; Stephens, C.; Akiyama, M.; McGrath, J. A.			Intrafamilial phenotypic heterogeneity of epidermolytic ichthyosis associated with a new missense mutation in keratin 10	BRITISH JOURNAL OF DERMATOLOGY			English	Meeting Abstract	94th Annual Meeting of the British-Association-of-Dermatologists	JUL 01-03, 2014	Glasgow, SCOTLAND	British Assoc Dermatologists					[Abdul-Wahab, A.; Takeichi, T.; Lwin, S. M.; McGrath, J. A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Liu, L.] St Thomas Hosp, London, England; [Stephens, C.] Poole Hosp NHS Fdn Trust, Dept Dermatol, Poole, Dorset, England; [Akiyama, M.] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan			McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	MAY	2015	172	5				P15	E35	E36				2	Dermatology	Dermatology	CH9XU	WOS:000354390800015		
J	Abdul-Wahab, A; Takeichi, T; Rashidghamat, E; Liu, L; Lomas, D; Hughes, B; Akiyama, M; McGrath, J; Mellerio, J				Abdul-Wahab, A.; Takeichi, T.; Rashidghamat, E.; Liu, L.; Lomas, D.; Hughes, B.; Akiyama, M.; McGrath, J.; Mellerio, J.			Autosomal dominant diffuse nonepidermolytic palmoplantar keratoderma due to a recurrent mutation in aquaporin-5	BRITISH JOURNAL OF DERMATOLOGY			English	Meeting Abstract	94th Annual Meeting of the British-Association-of-Dermatologists	JUL 01-03, 2014	Glasgow, SCOTLAND	British Assoc Dermatologists					[Abdul-Wahab, A.; Rashidghamat, E.; McGrath, J.; Mellerio, J.] Kings Coll London, St Johns Inst Dermatol, London, England; [Takeichi, T.; Akiyama, M.] Nagoya Univ, Dept Dermatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Liu, L.] St Thomas Hosp, London, England; [Lomas, D.] Great Ormond St Hosp Children NHS Fdn Trust, Dept Dermatol, London, England; [Hughes, B.] Worthing & Southlands NHS Trust, Dept Dermatol, Portsmouth, Hants, England			McGrath, John/D-6824-2012; Mellerio, Jemima/G-3681-2012	McGrath, John/0000-0002-3708-9964; 				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	MAY	2015	172	5				P16	E36	E36				1	Dermatology	Dermatology	CH9XU	WOS:000354390800016		
J	Chey, H				Chey, Hyoung-kyu			Renminbi in Ordinary Economies: A Demand-side Study of Currency Globalization	CHINA & WORLD ECONOMY			English	Article						currency internationalization; global currency; international currency; renminbi internationalization	GLOBAL CURRENCY; NUMBER ONE; INTERNATIONALIZATION; WILL; CHINA	Most studies of renminbi internationalization focus on the supply side, by examining China's own economic and political conditions. In contrast, this study addresses the demand side of renminbi internationalization, by providing an in-depth analysis of renminbi use in ordinary foreign economies from both economic and political perspectives, with a particular focus on South Korea, China's next-door neighbor. The study finds that sustainable indigenous market forces facilitating renminbi use in South Korea remain weak, despite the country's close economic ties with China. This research also shows, however, that the Korean Government has itself recently been able, through its policy measures, to generate new domestic support for greater use of the renminbi. These findings ultimately highlight the significant impact on the internationalization of a currency of the politics in the foreign countries using it.	Natl Grad Inst Policy Studies GRIPS, Minato Ku, Tokyo, Japan	Chey, H (reprint author), Natl Grad Inst Policy Studies GRIPS, Minato Ku, Tokyo, Japan.	hyoung-kyu@grips.ac.jp					Chen XL, 2011, CHINA WORLD ECON, V19, P1, DOI 10.1111/j.1749-124X.2011.01232.x; Cohen BJ, 2012, NEW POLIT ECON, V17, P361, DOI 10.1080/13563467.2011.615915; Helleiner E, 2012, OPEN ECON REV, V23, P33, DOI 10.1007/s11079-011-9225-1; Chey HK, 2012, INT STUD REV, V14, P51, DOI 10.1111/j.1468-2486.2012.01104.x; Chinn M, 2008, INT FINANC, V11, P49, DOI 10.1111/j.1468-2362.2008.00215.x; Wu F, 2010, CHINA WORLD ECON, V18, P63, DOI 10.1111/j.1749-124X.2010.01181.x; Dobson W, 2009, CHINA ECON REV, V20, P124, DOI 10.1016/j.chieco.2008.05.005; Campanella M., 2014, 012014 ECIPE; Chey HK, 2014, HBK RES INT POLIT EC, P39; Chey HK, 2013, ASIAN SURV, V53, P348; Choi H., 2014, EC PLUS          NOV; Choi K. H., 2014, WORDS ENCOURAGEMENT; Cohen B. J., 2014, ADBI WORKING PAPER S, V453; Eichengreen B, 2014, 454 ADBI; Eichengreen B, 2013, WORLD ECON, V36, P363, DOI 10.1111/twec.12037; Euromoney, 2013, EUROMONEY        JUL; FRANZEN JL, 1994, SENCKENBERG BUCH, V70, P295; Hornby L., 2013, FINANCIAL TIMES; Hwang Jaeho, 2014, International Journal of Korean Unification Studies, V23, P103; Ito T, 2010, ASIAN ECON POLICY R, V5, P249, DOI 10.1111/j.1748-3131.2010.01169.x; Kawai M., 2014, ADBI WORKING PAPER S, V467; Kim K., 2014, MK NEWS         1009; Kirshner J., 2014, GREAT WALL MONEY POL, P213; Kwon D, 2014, MONEYTODAY      0808; Lee H, 2014, HANKOOKILBO     1230; Lee JW, 2014, WORLD ECON, V37, P42, DOI 10.1111/twec.12092; Lee S, 2012, ASIAN EC        1021; Mehl A., 2011, 1392 ECB; Muk E, 2013, ASIANINVESTOR   1023; Mundy S, 2015, FINANCIAL TIMES; Park YC, 2010, CHINA WORLD ECON, V18, P1, DOI 10.1111/j.1749-124X.2010.01186.x; Song J, 2013, FINANCEASIA     1204; Subacchi P, 2013, ADBI WORKING PAPER S; Subramanian A., 2011, ECLIPSE LIVING SHADO; Subramanian A, 2011, 1114 WP PET I INT EC; Subramanian A., 2012, 1219 WP PET I INT EC; SWIFT, 2014, RMB BREAKS TOP 10 MO; Yiu T., 2015, ASIANINVESTOR   0313; Yu Y., 2014, ADBI WORKING PAPER S, V461	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1671-2234	1749-124X		CHINA WORLD ECON	China World Econ.	MAY-JUN	2015	23	3					1	21		10.1111/cwe.12111		21	Economics	Business & Economics	CI1IY	WOS:000354498400001		
J	Cong, H; Chen, QJ; Geng, QX; Tao, Z; Yamato, T				Cong, Hang; Chen, Qiuju; Geng, Qingxia; Tao, Zhu; Yamato, Takehiko			IBX Oxidation of Benzenedimethanols in the Presence of Cucurbit[8]uril	CHINESE JOURNAL OF CHEMISTRY			English	Article						cucurbituril; oxidation; supramolecular catalysis; benzenedimethanol; o-iodoxybenzoic acid	HYPERVALENT IODINE REAGENT; 2-IODOXYBENZOIC ACID IBX; SUPRAMOLECULAR CATALYSIS; ALCOHOLS; PHOTOCYCLODIMERIZATION; CYCLODEXTRIN; ALDEHYDES; HOST	The cucurbit[8]uril (Q[8]) mediated oxidation of benzenedimethanols with o-iodoxybenzoic acid (IBX) in aqueous solution has been investigated, and the results reveal the supramolecular catalysis depends on the electronic and geometric structure of substrate. In the cases of o-benzenedimethanol (1a) and m-benzenedimethanol (1b), the IBX oxidation could be obviously enhanced by the addition of Q[8] at different extent. There is no observation of the catalytic activity of Q[8] when p-benzenedimethanol (1c) is subjected to the IBX oxidation. The addition amount of Q[8] is discussed herein, and the addition of more than 10% mol catalyst cannot improve the oxidation much more. The investigation of host-guest interactions by isothermal titration calorimetry implies the supramolecular catalysis is related to the formation of complexes between benzenedimethanols and cucurbit[8]uril.	[Cong, Hang; Chen, Qiuju; Geng, Qingxia; Tao, Zhu] Guizhou Univ, Key Lab Macrocycl & Supramol Chem Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China; [Cong, Hang; Yamato, Takehiko] Saga Univ, Fac Sci & Engn, Dept Appl Chem, Saga 8408502, Japan	Cong, H (reprint author), Guizhou Univ, Key Lab Macrocycl & Supramol Chem Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China.	ecnuc@163.com			National Natural Science Foundation of China [21162003]; International Collaboration Project of Guizhou Province [[2011]7003]; Natural Science Foundation of Guizhou Province [[2008]75]	We acknowledge the support of National Natural Science Foundation of China (No. 21162003), the International Collaboration Project of Guizhou Province (No. [2011]7003), and the Natural Science Foundation of Guizhou Province (No. [2008]75).	Duschek A, 2011, ANGEW CHEM INT EDIT, V50, P1524, DOI 10.1002/anie.201000873; Zhang GL, 2003, CHINESE J INORG CHEM, V19, P655; Bernini R, 2008, J AGR FOOD CHEM, V56, P8897, DOI 10.1021/jf801558z; Pemberton BC, 2012, CHEM-EUR J, V18, P12178, DOI 10.1002/chem.201202083; Nicolaou KC, 2004, J AM CHEM SOC, V126, P5192, DOI 10.1021/ja0400382; Koner AL, 2011, ANGEW CHEM INT EDIT, V50, P545, DOI 10.1002/anie.201005317; Moorthy JN, 2004, TETRAHEDRON LETT, V45, P5419, DOI 10.1016/j.tetlet.2004.05.044; Jon SY, 2001, CHEM COMMUN, P1938, DOI 10.1039/b105153a; Wang YH, 2011, CATAL COMMUN, V12, P1127, DOI 10.1016/j.catcom.2011.03.029; Frigerio M, 1999, J ORG CHEM, V64, P4537, DOI 10.1021/jo9824596; de Lima SM, 2010, POLYHEDRON, V29, P3008, DOI 10.1016/j.poly.2010.08.001; MOCK WL, 1989, J ORG CHEM, V54, P5302, DOI 10.1021/jo00283a024; Lu XY, 2010, ORG LETT, V12, P2310, DOI 10.1021/ol100667z; Yang C, 2011, J AM CHEM SOC, V133, P13786, DOI 10.1021/ja202020x; Yang C, 2008, J AM CHEM SOC, V130, P8574, DOI 10.1021/ja8032923; Satam V, 2010, TETRAHEDRON, V66, P7659, DOI 10.1016/j.tet.2010.07.014; Murthy SN, 2011, TETRAHEDRON LETT, V52, P4481, DOI 10.1016/j.tetlet.2011.06.077; Wu AH, 2010, TETRAHEDRON, V66, P2111, DOI 10.1016/j.tet.2009.12.022; Assaf KI, 2015, CHEM SOC REV, V44, P394, DOI 10.1039/c4cs00273c; Masson E, 2012, RSC ADV, V2, P1213, DOI 10.1039/c1ra00768h; Carlqvista P., 2007, CHEM COMMUN, P748; Cong H, 2009, CATAL COMMUN, V11, P167, DOI 10.1016/j.catcom.2009.09.018; Cong H, 2011, CURR ORG CHEM, V15, P86, DOI 10.2174/138527211793797783; Cong H, 2012, CHINESE J ORG CHEM, V32, P1093, DOI 10.6023/cjoc1109211; Cong H, 2013, NEW J CHEM, V37, P3778, DOI 10.1039/c3nj00660c; Cong H, 2013, J MOL CATAL A-CHEM, V374, P32, DOI 10.1016/j.molcata.2013.03.010; Magdziak D., 2002, ORG LETT, V4, P3339; Thottumkara AP, 2002, TETRAHEDRON LETT, V43, P569, DOI 10.1016/S0040-4039(01)02217-1; Zhao GK, 2014, TETRAHEDRON LETT, V55, P5319, DOI 10.1016/j.tetlet.2014.07.060	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1001-604X	1614-7065		CHINESE J CHEM	Chin. J. Chem.	MAY	2015	33	5					545	549		10.1002/cjoc.201400886		5	Chemistry, Multidisciplinary	Chemistry	CI2JK	WOS:000354572800008		
J	Iwata, Y; Tomita, K; Uchida, T; Matsuhata, H				Iwata, Yasushi; Tomita, Kanako; Uchida, Takeyuki; Matsuhata, Hirofumi			Crystallographic Coalescence of Crystalline Silicon Clusters into Superlattice Structures	CRYSTAL GROWTH & DESIGN			English	Article							ENERGY-LOSS SPECTROSCOPY; TRANSMISSION ELECTRON-MICROSCOPY; QUANTUM DOTS; NANOCRYSTAL SUPERLATTICES; OPTICAL-PROPERTIES; FILMS; DEPOSITION; ASSEMBLIES; LATTICE; NANOPARTICLES	The crystallographic coalescence of crystalline silicon dusters into superlattice structures, generated by direct deposition of a silicon cluster beam on a graphene substrate, has been observed. High-resolution transmission electron microscopy and transmission electron diffraction analyses revealed that adjacent silicon clusters in the superlattices, having a mean diameter of 1.61 +/- 0.05 nm (n = 109, n indicating the cluster size, Si-n) and an sp(3) diamond structure, form sp3 covalent bonds between Si atoms on their surfaces and align their atomic crystalline axes, forming crystallographic rows to coalesce into bcc superlattice structures with a lattice constant of 2.134 +/- 0.002 rim. The hcp configuration of the silicon dusters with the same lattice constant as the bcc superlattice unit cell is commensurate with the crystallographic structure of the graphene substrate. The absorption spectra confirm the sp3 diamond structure of the silicon clusters under well-quantized conditions. Oxygen-free unoccupied electronic states (UDOS) in the conduction band of the silicon cluster superlattices appeared at 99.8 eV in the electron energy loss spectroscopy spectra. The s + d UDOS at 107.5 eV in SiO2 became conspicuous as the oxidation of the specimen advanced. The collective bulk plasmon loss of the virtually oxygen-free silicon cluster superlattice appeared at 16.7 eV.	[Iwata, Yasushi; Tomita, Kanako] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Matsuhata, Hirofumi] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Uchida, Takeyuki] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Osaka 5638577, Japan	Iwata, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba Cent 2, Tsukuba, Ibaraki 3058568, Japan.	y.iwata@aist.go.jp			JUST; Murata Manufacturing Co., Ltd.	The authors thank Dr. O. Nakagawara, Dr. K. Murayama, Prof. M. Yaga, Dr. T. Takiya, Prof. P. Milani, Prof. M. Han for discussion, Dr. M. Hirata and Dr. S. Horiuchi (for their support on the preparation of graphene), and Dr. K. Kawasaki (for his support on the HRTEM experiments). This work was supported by the cooperative research program of JUST and Murata Manufacturing Co., Ltd.	Amelinckx S., 1984, Bulletin of Materials Science, V6, DOI 10.1007/BF02744075; Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c; Erogbogbo F, 2010, ACS NANO, V4, P5131, DOI 10.1021/nn101016f; Wang ZW, 2013, NANO LETT, V13, P1303, DOI 10.1021/nl400084k; Korgel BA, 1998, J PHYS CHEM B, V102, P8379, DOI 10.1021/jp981598o; Yoo S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841080; Hao XJ, 2009, SOL ENERG MAT SOL C, V93, P1524, DOI 10.1016/j.solmat.2009.04.002; JARROLD MF, 1991, PHYS REV LETT, V67, P2994, DOI 10.1103/PhysRevLett.67.2994; TARRIO C, 1993, J OPT SOC AM B, V10, P952, DOI 10.1364/JOSAB.10.000952; Ehbrecht M, 1997, PHYS REV B, V56, P6958, DOI 10.1103/PhysRevB.56.6958; Luo JW, 2011, ENERG ENVIRON SCI, V4, P2546, DOI 10.1039/c1ee01026c; Liu JW, 2013, ACS NANO, V7, P7303, DOI 10.1021/nn4029234; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; STAFFORD CA, 1994, PHYS REV LETT, V72, P3590, DOI 10.1103/PhysRevLett.72.3590; Howe JY, 2003, POWDER DIFFR, V18, P150, DOI 10.1154/1.1536926; Horiuchi S, 2003, JPN J APPL PHYS 2, V42, pL1073, DOI 10.1143/JJAP.42.L1073; Markovich G, 1999, ACCOUNTS CHEM RES, V32, P415, DOI 10.1021/ar980039x; van Huis MA, 2008, NANO LETT, V8, P3959, DOI 10.1021/nl8024467; Hofmeister H, 1999, EUR PHYS J D, V9, P137, DOI 10.1007/s100530050413; Garvie LAJ, 1999, AM MINERAL, V84, P946; Garvie LAJ, 2000, AM MINERAL, V85, P732; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Pileni MP, 2001, J PHYS CHEM B, V105, P3358, DOI 10.1021/jp0039520; Mastronardi ML, 2011, J AM CHEM SOC, V133, P11928, DOI 10.1021/ja204865t; Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008; Lin KH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115302; Dhakal S, 2013, ACS NANO, V7, P10948, DOI 10.1021/nn404476f; Sun XH, 2001, J APPL PHYS, V90, P6379, DOI 10.1063/1.1417997; Ho KM, 1998, NATURE, V392, P582; Yu X, 2013, NANO TODAY, V8, P480, DOI 10.1016/j.nantod.2013.09.001; Bachels T, 2000, CHEM PHYS LETT, V324, P365, DOI 10.1016/S0009-2614(00)00622-9; Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012; Mangolini L, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4794789; BATSON PE, 1993, PHYS REV LETT, V71, P911, DOI 10.1103/PhysRevLett.71.911; Berbezier I, 1996, APPL SURF SCI, V102, P417, DOI 10.1016/0169-4332(96)00090-6; Berger M. J., 2005, NIST PHYS REFERENCE; Bernal JD, 1928, NATURE, V122, P54, DOI 10.1038/122054a0; Gillet JN, 2010, J ELECTRON MATER, V39, P2154, DOI 10.1007/s11664-009-0977-y; GOLDSTEIN AN, 1996, APPL PHYS A, V62, P37; Han M, 2002, PHYS LETT A, V302, P182, DOI 10.1016/S0375-9601(02)01116-7; Heidenreich R. D., 1964, FUNDAMENTALS TRANSMI; Honda Y, 2005, J LUMIN, V113, P279, DOI 10.1016/j.jlumin.2004.10.023; Iwata Y., 2009, 2009 ANN M PHYS SOC, p[64, 828]; Iwata Y, 2002, CHEM PHYS LETT, V358, P36, DOI 10.1016/S0009-2614(02)00556-0; Korgel BA, 1999, PHYS REV B, V59, P14191, DOI 10.1103/PhysRevB.59.14191; Kusova K, 2012, J NON-CRYST SOLIDS, V358, P2130, DOI 10.1016/j.jnoncrysol.2011.11.027; Loper P, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195317; Melinon P, 1998, J CHEM PHYS, V108, P4607, DOI 10.1063/1.475871; Melinon P, 1997, J CHEM PHYS, V107, P10278, DOI 10.1063/1.474168; Pearson W.B., 1958, HDB LATTICE SPACINGS, V1; Saito N, 1996, SURF REV LETT, V3, P161, DOI 10.1142/S0218625X96000322; Sato S, 2002, CHEM PHYS LETT, V365, P421, DOI 10.1016/S0009-2614(02)01501-4; Sayle DC, 2008, ACS NANO, V2, P1237, DOI 10.1021/nn800065g; TAKAGAHARA T, 1992, SURF SCI, V267, P310, DOI 10.1016/0039-6028(92)91144-Z; Takahashi Y., 2006, P 26 ANN M LAS SOC J; Wang J, 2007, PHILOS MAG, V87, P11, DOI 10.1080/14786430600863047; Weaver KE, 2008, OPTIK, V119, P276, DOI 10.1016/j.ijleo.2007.01.001; Yaga M, 2005, SHOCK WAVES, V14, P403, DOI 10.1007/s00193-005-0278-1; Yu DK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245417; Yu YX, 2013, CHEMPHYSCHEM, V14, P84, DOI 10.1002/cphc.201200738	60	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	MAY	2015	15	5					2119	2128		10.1021/cg5016753		10	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CH9EK	WOS:000354338600011		
J	Hayashi, Y; Maruyama, M; Yoshimura, M; Okada, S; Yoshikawa, HY; Sugiyama, S; Adachi, H; Matsumura, H; Inoue, T; Takano, K; Murakami, S; Mori, Y				Hayashi, Yuki; Maruyama, Mihoko; Yoshimura, Masashi; Okada, Shino; Yoshikawa, Hiroshi Y.; Sugiyama, Shigeru; Adachi, Hiroaki; Matsumura, Hiroyoshi; Inoue, Tsuyoshi; Takano, Kazufumi; Murakami, Satoshi; Mori, Yusuke			Spiral Growth Can Enhance Both the Normal Growth Rate and Quality of Tetragonal Lysozyme Crystals Grown under a Forced Solution Flow	CRYSTAL GROWTH & DESIGN			English	Article							TRACKING VELOCIMETRY PTV; EGG-WHITE LYSOZYME; PROTEIN CRYSTALS; INHIBITOR KNI-272; STIRRING METHOD; CRYSTALLIZATION; MICROGRAVITY; MICROSCOPY; TRANSPORT; KINETICS	We measured the normal growth rate of the {110} face (R-110) of tetragonal lysozyme crystals grown by the spiral growth mechanism or the two-dimensional (2D) nucleation growth mechanism under various solution flow rates (0, 8.0, 30, 140, 210 mu m/s), and observed the step morphology using laser confocal microscopy combined with differential interference contrast microscopy (LCM-DIM). The R-110 of crystals grown by the spiral growth mechanism was enhanced by solution stirring at all solution flow rates. The aspect ratio, which was defined as the ratio of the long axis to the short axis of the hillock shape, increased at a flow rate under 140 mu m/s with increasing flow rate; that is, impurities were adsorbed less onto the crystal surface at <140 mu m/s. In contrast to spiral hillocks, the R-110 of crystals grown by the 2D nucleation growth mechanism was inhibited at >140 mu m/s, and the aspect ratio decreased monotonically as the solution flow rate increased; that is, the impurity effect became more significant. These results indicate that spiral hillocks are less affected by impurities transported by a forced solution flow. We concluded that in the case of the spiral growth mechanism, a flow rate of 30 to 140 mu m/s is suitable for high quality crystal growth with a faster growth rate.	[Hayashi, Yuki; Maruyama, Mihoko; Yoshimura, Masashi; Adachi, Hiroaki; Matsumura, Hiroyoshi; Inoue, Tsuyoshi; Mori, Yusuke] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Sugiyama, Shigeru] Osaka Univ, Grad Sch Sci, Suita, Osaka 5650871, Japan; [Yoshikawa, Hiroshi Y.] Saitama Univ, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Okada, Shino; Adachi, Hiroaki; Matsumura, Hiroyoshi; Inoue, Tsuyoshi; Takano, Kazufumi; Murakami, Satoshi; Mori, Yusuke] SOSHO Inc, Suita, Osaka 5650871, Japan; [Takano, Kazufumi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan; [Murakami, Satoshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan	Maruyama, M (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	maruyama@cryst.eei.eng.osaka-u.ac.jp	Mori, Yusuke/C-3302-2014; Yoshimura, Masashi/N-7222-2013; Maruyama, Mihoko/L-7671-2015		JSAP KAKENHI [23360011]	We gratefully acknowledge funding in the form of a JSAP KAKENHI Grant-in Aid for Scientific Research B (Grant No. 23360011). We would like to thank Dr. Katou (Satake, Ltd.) for analyzing the flow pattern of the protein-precipitant solution. We would like to thank Mr. Kakinouchi (Osaka Univ.) for his experimental support.	Adachi H, 2006, J BIOSCI BIOENG, V101, P83, DOI 10.1263/jbb.101.83; Adachi H, 2003, JPN J APPL PHYS 2, V42, pL1161, DOI 10.1143/JJAP.42.L1161; Adachi H, 2004, JPN J APPL PHYS 2, V43, pL522, DOI 10.1143/JJAP.43.L522; Adachi H, 2003, JPN J APPL PHYS 2, V42, pL314, DOI 10.1143/JJAP.42.L314; ADAMCZYK AA, 1988, EXP FLUIDS, V6, P373; Adawy A, 2015, CRYSTENGCOMM, V17, P2602, DOI 10.1039/c4ce01814a; Thomas BR, 1996, ACTA CRYSTALLOGR D, V52, P776, DOI 10.1107/S090744499600279X; GarciaRuiz JM, 1997, J CRYST GROWTH, V178, P393, DOI 10.1016/S0022-0248(96)01188-8; Otalora F, 2009, PROG BIOPHYS MOL BIO, V101, P26, DOI 10.1016/j.pbiomolbio.2009.12.004; Shimizu N, 2010, CRYST GROWTH DES, V10, P2990, DOI 10.1021/cg100054s; Van Driessche AES, 2009, CRYST GROWTH DES, V9, P3062, DOI 10.1021/cg8006684; Kadowaki A, 2006, CRYST GROWTH DES, V6, P2398, DOI 10.1021/cg050587z; Tanabe K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.125501; Sugiyama S, 2012, J AM CHEM SOC, V134, P5786, DOI 10.1021/ja301584y; Maruyama M, 2012, CRYST GROWTH DES, V12, P2856, DOI 10.1021/cg300025b; Sleutel M, 2012, CRYST GROWTH DES, V12, P2367, DOI 10.1021/cg300024f; DURBIN SD, 1992, J CRYST GROWTH, V122, P71, DOI 10.1016/0022-0248(92)90228-B; Sugiyama S, 2009, JPN J APPL PHYS, V48, DOI [10.1143/JJAP.48.105502, 10.1143/JJAP.48.075502]; Matsumura H, 2008, ACTA CRYSTALLOGR F, V64, P1003, DOI 10.1107/S1744309108029679; Sato M, 2006, MICROGRAVITY SCI TEC, V18, P184, DOI 10.1007/BF02870406; Sauter C, 2001, ACTA CRYSTALLOGR D, V57, P1119, DOI 10.1107/S0907444901008873; Adachi H, 2005, ACTA CRYSTALLOGR D, V61, P759, DOI 10.1107/S0907444905013466; Vekilov PG, 1998, J PHYS CHEM B, V102, P5208, DOI 10.1021/jp973123n; DURBIN SD, 1990, J MOL BIOL, V212, P763, DOI 10.1016/0022-2836(90)90235-E; Shimizu N, 2009, CRYST GROWTH DES, V9, P5227, DOI 10.1021/cg900740n; Aoki Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.065502; BRUCKER C, 1992, EXP FLUIDS, V13, P339; Chernov AA, 2003, J STRUCT BIOL, V142, P3, DOI 10.1016/S1047-8477(03)00034-0; Dold P, 2006, J CRYST GROWTH, V293, P102, DOI 10.1016/j.jcrysgro.2006.04.116; Li M., 1999, ACTA CRYSTALLOGR D, VD55, P1012; Maruyama M, 2010, J CRYST GROWTH, V312, P2771, DOI 10.1016/j.jcrysgro.2010.06.025; Matsumura H, 2011, CRYST GROWTH DES, V11, P1486, DOI 10.1021/cg101361n; Mori Y., 2011, SUMMARY REPORT CREST; Otalora F, 1997, J CRYST GROWTH, V182, P141, DOI 10.1016/S0022-0248(97)00325-4; Reviakine I, 2003, J AM CHEM SOC, V125, P11684, DOI 10.1021/ja030194t; Sazaki G, 2004, J CRYST GROWTH, V262, P536, DOI 10.1016/j.jcrysgro.2003.10.049; Sugiyama S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.025502; Tanaka H, 2007, ACTA CRYSTALLOGR F, V63, P69, DOI 10.1107/S1744309106054625; Vekilov PG, 1998, J CRYST GROWTH, V186, P251, DOI 10.1016/S0022-0248(97)00521-6	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	MAY	2015	15	5					2137	2143		10.1021/cg501722d		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CH9EK	WOS:000354338600013		
J	Miura, H; Kobayashi, R				Miura, Hitoshi; Kobayashi, Ryo			Phase-Field Modeling of Step Dynamics on Growing Crystal Surface: Direct Integration of Growth Units to Step Front	CRYSTAL GROWTH & DESIGN			English	Article							ATOMIC-FORCE MICROSCOPY; 101 ADP FACE; IN-SITU; KINETIC COEFFICIENT; SPIRAL GROWTH; SIMULATIONS; SOLIDIFICATION; ANISOTROPY; MOTION	We propose a new formulation for numerically simulating step dynamics on growing crystal surfaces in the framework of a phase-field technique. The step advancement rate is proportional to a supersaturation at the crystal surface when the growth units in the ambient phase are integrated to the step front directly (direct integration hypothesis). We conduct numerical simulations of some standard step dynamics problems: the advancement of a straight step, the growth or dissolution of a two-dimensional island, and the vertical growth of the crystal surface due to single or multiple screw dislocations. During evaluations, our phase-field model accurately calculated the rate of advancement of a straight step for various supersaturations. The calculated time variation of the radius of the two-dimensional island showed good agreement with the exact solution. The vertical growth rate due to screw dislocations qualitatively agreed with the predictions of the classical theory of Burton, Cabrera, and Frank. Our simple formulation requires only a single parabolic partial differential equation to be solved numerically. Thus, our phase-field model provides a simple numerical tool for a quantitative step-by-step trajectory calculation, when the advancing velocity of each step follows the direct integration hypothesis.	[Miura, Hitoshi] Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan; [Kobayashi, Ryo] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398526, Japan	Miura, H (reprint author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, Yamamohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	miurah@nsc.nagoya-cu.ac.jp			JSPS KAKENHI [25108004]	We thank Dr. A. Tokumitsu for helpful suggestions on the solvability condition. We are grateful to Prof. K. Tsukamoto, Prof. A. Uwaha, and Dr. T. Ohtsuka for useful discussions on the results of the phase-field calculations. This work was partially supported by JSPS KAKENHI, Grant 25108004.	DURBIN SD, 1993, J PHYS D APPL PHYS, V26, pB128, DOI 10.1088/0022-3727/26/8B/020; VEKILOV PG, 1992, J CRYST GROWTH, V121, P643, DOI 10.1016/0022-0248(92)90571-Y; Van Driessche AES, 2008, CRYST GROWTH DES, V8, P4316, DOI 10.1021/cg800782r; Van Driessche AES, 2010, CRYST GROWTH DES, V10, P3909, DOI 10.1021/cg100323e; Eggleston JJ, 2001, PHYSICA D, V150, P91, DOI 10.1016/S0167-2789(00)00222-0; Van Driessche AES, 2007, CRYST GROWTH DES, V7, P1980, DOI 10.1021/cg060945d; Sleutel M, 2012, CRYST GROWTH DES, V12, P2367, DOI 10.1021/cg300024f; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; WHEELER AA, 1995, ADV SPACE RES, V16, P163, DOI 10.1016/0273-1177(95)00153-6; CHERNOV AA, 1986, J CRYST GROWTH, V74, P101, DOI 10.1016/0022-0248(86)90252-6; Yu YM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035416; BURTON WK, 1949, NATURE, V163, P398, DOI 10.1038/163398a0; VEKILOV PG, 1992, J CRYST GROWTH, V119, P248, DOI 10.1016/0022-0248(92)90677-B; Maiwa K, 1998, J CRYST GROWTH, V186, P214, DOI 10.1016/S0022-0248(97)00446-6; Karma A, 1998, PHYS REV LETT, V81, P4444, DOI 10.1103/PhysRevLett.81.4444; Malkin AJ, 1999, J CRYST GROWTH, V196, P471, DOI 10.1016/S0022-0248(98)00823-9; Miura H, 2013, J CRYST GROWTH, V367, P8, DOI 10.1016/j.jcrysgro.2013.01.014; Karma A, 1996, PHYS REV E, V53, pR3017, DOI 10.1103/PhysRevE.53.R3017; VEKILOV PG, 1992, J CRYST GROWTH, V121, P44, DOI 10.1016/0022-0248(92)90174-H; Cabrera N., 1958, PERFECTION CRYSTALS, P393; CABRERA N, 1956, PHILOS MAG, V1, P450, DOI 10.1080/14786435608238124; Chernov A. A., 1984, MODERN CRYSTALLOGRAP; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; Kobayashi R, 2010, AIP CONF PROC, V1270, P282, DOI 10.1063/1.3476232; Land TA, 2000, J CRYST GROWTH, V208, P623, DOI 10.1016/S0022-0248(99)00470-4; LIU F, 1994, PHYS REV E, V49, P2601, DOI 10.1103/PhysRevE.49.2601; MAIWA K, 1990, J CRYST GROWTH, V102, P43, DOI 10.1016/0022-0248(90)90887-Q; Meca E., 2013, J PHYS REV E, V88; Plapp M, 2010, AIP CONF PROC, V1270, P247, DOI 10.1063/1.3476229; Redinger A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035506; Uehara T, 2003, J CRYST GROWTH, V254, P251, DOI 10.1016/S0022-0248(03)01120-5; Yu YM, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021601; Yu YM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235317	33	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	MAY	2015	15	5					2165	2175		10.1021/cg501806d		11	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CH9EK	WOS:000354338600017		
J	Wei, J; Ogawa, D; Fukumura, T; Hirose, Y; Hasegawa, T				Wei, Jie; Ogawa, Daisuke; Fukumura, Tomoteru; Hirose, Yasushi; Hasegawa, Tetsuya			Epitaxial Strain-Controlled Ionic Conductivity in Li-Ion Solid Electrolyte Li0.33La0.56TiO3 Thin Films	CRYSTAL GROWTH & DESIGN			English	Article							PULSED-LASER DEPOSITION; LITHIUM-LANTHANUM-TITANATE; OXIDES	Ionic conductive Li0.33La0.56TiO3 (LLT) epitaxial thin films were grown on perovskite SrTiO3 (100), NdGaO3 (HO), and (LaAlO3)(0.3)-(SrAl0.5Ta0.5O3)(0.7) (100) single crystal substrates by pulsed laser deposition. The use of Li-rich Li0.84La0.56TiO3+delta target together with an optimized laser fluence resulted in the growth of phase pure LLT thin films with high growth rate of 2 nm/min. The a-axis and c-axis oriented films were selectively grown by choosing the substrates. Ionic conductivity at room temperature of LLT epitaxial film on NdGaO3 (110) substrate was close to that of bulk previously reported, representing the highly crystalline quality. In addition, the unequally strained lattice due to different inplane lattice constants of orthorhombic NdGaO3 substrate resulted in laterally anisotropic ionic conductivity with different activation energy perpendicular to NdGaO3 [110] and [001], 6.7 x 10(-4) S.cm(-1) with 0.34 eV and 4.3 x 10(-4) S.cm(-1) with 0.36 eV, respectively. This result suggests that the lattice engineering can provide a way to control Li ionic conduction.	[Wei, Jie; Ogawa, Daisuke; Fukumura, Tomoteru; Hirose, Yasushi; Hasegawa, Tetsuya] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Fukumura, Tomoteru; Hirose, Yasushi; Hasegawa, Tetsuya] Japan Sci & Technol Agcy JST, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Fukumura, T (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	fukumura@chem.s.u-tokyo.ac.jp	Fukumura, Tomoteru/C-2081-2009; Hirose, Yasushi/A-7771-2013	Fukumura, Tomoteru/0000-0002-8957-3520; Hirose, Yasushi/0000-0002-0792-4631	MEXT, Japan; JSPS through the NEXT Program; CSTP [GR029]; JSPS [26105002]	We would like to thank S. Sakae for technical support in chemical composition measurements. X-ray photoemission spectroscopy, impedance measurement, and photolithography process were conducted in Research Hub for Advanced Nano Characterization and in Center for Nano Lithography & Analysis, The University of Tokyo, supported by MEXT, Japan. This research was in part supported by JSPS through the NEXT Program initiated by CSTP (GR029) and JSPS Grant-in-Aid for Scientific Research (26105002).	Maqueda O, 2008, THIN SOLID FILMS, V516, P1651, DOI 10.1016/j.tsf.2007.05.004; Aaltonen T, 2010, J MATER CHEM, V20, P2877, DOI 10.1039/b923490j; Inaguma Y, 1996, SOLID STATE IONICS, V86-8, P257, DOI 10.1016/0167-2738(96)00100-2; Kitaoka K, 1997, J MATER SCI, V32, P2063, DOI 10.1023/A:1018566620564; INAGUMA Y, 1993, SOLID STATE COMMUN, V86, P689, DOI 10.1016/0038-1098(93)90841-A; Morales M, 2002, THIN SOLID FILMS, V418, P119, DOI 10.1016/S0040-6090(02)00624-7; Stramare S, 2003, CHEM MATER, V15, P3974, DOI 10.1021/cm0300516; Schou J, 2009, APPL SURF SCI, V255, P5191, DOI 10.1016/j.apsusc.2008.10.101; Harada Y, 1999, SOLID STATE IONICS, V121, P245, DOI 10.1016/S0167-2738(99)00043-0; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Cho YH, 2012, J MATER SCI, V47, P5970, DOI 10.1007/s10853-012-6500-5; Gao X, 2014, J MATER CHEM A, V2, P843, DOI 10.1039/c3ta13726k; INAGUMA Y, 1995, J ELECTROCHEM SOC, V142, pL8, DOI 10.1149/1.2043988; Kim DH, 2013, J CRYST GROWTH, V372, P9, DOI 10.1016/j.jcrysgro.2013.02.028; Kim S, 2014, CRYSTENGCOMM, V16, P1044, DOI 10.1039/c3ce42003e; Kim S., 2013, SOLID STATE IONICS, V262, P578; Ohnishi T, 2010, J MATER RES, V25, P1886, DOI 10.1557/JMR.2010.0250; Ohnishi T, 2012, SOLID STATE IONICS, V228, P80, DOI 10.1016/j.ssi.2012.10.001; Ohnishi T., 2012, APPL PHYS EXPRESS, V5, P1; Okumura T, 2011, J MATER CHEM, V21, P10061, DOI 10.1039/c0jm04367b; Okumura T, 2011, J MATER CHEM, V21, P10195, DOI 10.1039/c0jm04372a; Okumura T, 2009, J POWER SOURCES, V189, P536, DOI 10.1016/j.jpowsour.2008.10.056; SAENGER KL, 1991, J APPL PHYS, V70, P5629, DOI 10.1063/1.350178	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	MAY	2015	15	5					2187	2191		10.1021/cg501834s		5	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CH9EK	WOS:000354338600019		
J	Hisamatsu, S; Masu, H; Takahashi, M; Kishikawa, K; Kohmoto, S				Hisamatsu, Shugo; Masu, Hyuma; Takahashi, Masahiro; Kishikawa, Keiki; Kohmoto, Shigeo			Pairwise Packing of Anthracene Fluorophore: Hydrogen-Bonding-Assisted Dimer Emission in Solid State	CRYSTAL GROWTH & DESIGN			English	Article							AGGREGATION-INDUCED EMISSION; CRYSTALLIZATION-INDUCED EMISSION; LIGHT-EMITTING-DIODES; C-N ROTATION; CRYSTAL-STRUCTURES; MOLECULAR PACKING; PHOTOPHYSICAL PROPERTIES; MULTIPLE CHROMISMS; MECHANICAL STIMULI; ENHANCED EMISSION	Anthracene derivatives possessing a carbamate group and an ester group at their 9- and 10-positions, respectively, were prepared to furnish pairwise packing of anthracene fluorophores in their crystal structures. They were nonluminescent in ethanol solution and showed AIE (aggregation-induced emission) in aqueous ethanol solution and in solid state. Crystal structure analysis of them showed that the H-bonding networks involved in their crystal structures could be classified into four patterns, H-bonding between the carbamate and the ester carbonyl (motif A), H-bonding between the carbamate and the ester oxygen atom (motif B), H-bonded cyclic dimer of carbamate moieties (motif C), and H-bonded chain among carbamate moieties (motif D). Compounds with pairwisely packed anthracene fluorophores showed dimer emission with the longer fluorescence wavelength than others without the pair formation. Fluorescence maximum wavelengths and lifetimes become longer proportional to the degree of overlapping of two facing anthracene pi-planes.	[Hisamatsu, Shugo] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Actinide Coordinat Chem Grp, Tokai, Ibaraki 3191195, Japan; [Masu, Hyuma; Takahashi, Masahiro; Kishikawa, Keiki; Kohmoto, Shigeo] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan; [Masu, Hyuma] Chiba Univ, Ctr Analyt Instrumentat, Inage Ku, Chiba 2638522, Japan	Kohmoto, S (reprint author), Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	kohmoto@faculty.chiba-u.jp			Japan Society for the Promotion of Science (JSPS) [2541008]	This research is supported in part by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (No. 2541008). S.H. is grateful for JSPS Research Fellowships for Young Scientists.	Liu Y, 2007, J PHYS CHEM C, V111, P6544, DOI 10.1021/JP070288f; Leung CWT, 2013, J AM CHEM SOC, V135, P62, DOI 10.1021/ja310324q; Yuan WZ, 2012, CHEM-EUR J, V18, P2847, DOI 10.1002/chem.201103151; An P, 2010, ORG LETT, V12, P4364, DOI 10.1021/ol101847w; Chung JW, 2009, ANGEW CHEM INT EDIT, V48, P7030, DOI 10.1002/anie.200902777; Galer P, 2014, J AM CHEM SOC, V136, P7383, DOI 10.1021/ja501977a; Li RH, 2014, CHEM SCI, V5, P3922, DOI 10.1039/c4sc01243g; Abe Y, 2012, CHEM-EUR J, V18, P15038, DOI 10.1002/chem.201201213; Lewis FD, 1997, J PHYS CHEM B, V101, P1775, DOI 10.1021/jp9630939; Mutai T, 2005, NAT MATER, V4, P685, DOI 10.1038/nmat1454; An BK, 2002, J AM CHEM SOC, V124, P14410, DOI 10.1021/ja0269082; Deans R, 2000, J AM CHEM SOC, V122, P8565, DOI 10.1021/ja0007298; Modarresi-Alam AR, 2007, J ORG CHEM, V72, P2208, DOI 10.1021/jo061301f; Wang WZ, 2010, J PHYS CHEM B, V114, P5983, DOI 10.1021/jp911311j; Qian Y, 2011, CHEMPHYSCHEM, V12, P397, DOI 10.1002/cphc.201000457; Wu YT, 2008, ANGEW CHEM INT EDIT, V47, P9891, DOI 10.1002/anie.200802560; Hong YN, 2009, CHEM COMMUN, P4332, DOI 10.1039/b904665h; Srinivasan S, 2009, J AM CHEM SOC, V131, P15122, DOI 10.1021/ja9072035; Varughese S, 2014, J MATER CHEM C, V2, P3499, DOI 10.1039/c3tc32414a; Ning ZJ, 2007, ADV FUNCT MATER, V17, P3799, DOI 10.1002/adfm.200700649; Chen J, 2010, CHEM COMMUN, V46, P8282, DOI 10.1039/c0cc03011b; Bhalla V, 2012, CHEM-EUR J, V18, P3765, DOI 10.1002/chem.201103131; Mizobe Y, 2009, CHEM-EUR J, V15, P8175, DOI 10.1002/chem.200900773; Yan DP, 2014, MATER HORIZONS, V1, P46, DOI 10.1039/c3mh00023k; Wang YL, 2013, J MATER CHEM C, V1, P856, DOI 10.1039/c2tc00470d; Wang M, 2010, J MATER CHEM, V20, P1858, DOI 10.1039/b921610c; Hirose T, 2011, CHEM-ASIAN J, V6, P1057, DOI 10.1002/asia.201000824; Harada N, 2012, ORG LETT, V14, P6282, DOI 10.1021/ol302963e; Liu SJ, 2010, ORG ELECTRON, V11, P613, DOI 10.1016/j.orgel.2009.12.026; Liu Y, 2008, J PHYS CHEM C, V112, P3975, DOI 10.1021/jp7117373; Wakamiya A, 2007, ANGEW CHEM INT EDIT, V46, P4273, DOI 10.1002/anie.200604935; Davis R, 2008, J PHYS CHEM C, V112, P2137, DOI 10.1021/jp710352m; Shimizu M, 2010, CHEM-ASIAN J, V5, P1516, DOI 10.1002/asia.200900727; Shi HB, 2012, J AM CHEM SOC, V134, P9569, DOI 10.1021/ja302369e; Lowe C, 2002, ADV MATER, V14, P1625, DOI 10.1002/1521-4095(20021118)14:22<1625::AID-ADMA1625>3.0.CO;2-Q; Luo XL, 2011, ADV MATER, V23, P3261, DOI 10.1002/adma.201101059; Liu W, 2013, CHEM COMMUN, V49, P6042, DOI 10.1039/c3cc42636j; Tang XY, 2014, CHEM-EUR J, V20, P7589, DOI 10.1002/chem.201402152; Zhang RX, 2009, ORG LETT, V11, P4302, DOI 10.1021/ol901607g; Kamino S, 2010, CHEM COMMUN, V46, P9013, DOI 10.1039/c0cc03407j; Chi ZG, 2012, CHEM SOC REV, V41, P3878, DOI 10.1039/c2cs35016e; Ajayaghosh A, 2007, ANGEW CHEM INT EDIT, V46, P6260, DOI 10.1002/anie.200701925; Shen JS, 2012, LUMINESCENCE, V27, P317, DOI 10.1002/bio.1369; Zhang XQ, 2013, J MATER CHEM C, V1, P3376, DOI 10.1039/c3tc30316k; Zheng M, 2014, J MATER CHEM C, V2, P1913, DOI 10.1039/c3tc32035a; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d; Rablen PR, 2000, J ORG CHEM, V65, P7930, DOI 10.1021/jo000945z; Zhao ZJ, 2010, CHEM COMMUN, V46, P686, DOI 10.1039/b915271g; Deetz MJ, 2002, J ORG CHEM, V67, P3949, DOI 10.1021/jo025554u; An BK, 2012, ACCOUNTS CHEM RES, V45, P544, DOI 10.1021/ar2001952; Cai MM, 2012, PHYS CHEM CHEM PHYS, V14, P5289, DOI 10.1039/c2cp23040b; Hinoue T, 2012, ANGEW CHEM INT EDIT, V51, P155, DOI 10.1002/anie.201106849; Gao BR, 2010, J PHYS CHEM B, V114, P128, DOI 10.1021/jp909063d; Wang J, 2012, J AM CHEM SOC, V134, P9956, DOI 10.1021/ja208883h; Zhang HY, 2006, ADV MATER, V18, P2369, DOI 10.1002/adma.200600704; Anthony SP, 2012, CHEMPLUSCHEM, V77, P518, DOI 10.1002/cplu.201200073; Zhao J, 2014, ANGEW CHEM INT EDIT, V53, P6632, DOI 10.1002/anie.201402169; Yuan MS, 2014, CHEM MATER, V26, P2467, DOI 10.1021/cm500441r; Wang B, 2011, CHEM-EUR J, V17, P2647, DOI 10.1002/chem.201002821; Qian Y, 2007, J PHYS CHEM B, V111, P5861, DOI 10.1021/jp070076i; He T, 2011, CHEM COMMUN, V47, P2907, DOI 10.1039/c0cc04827e; Park SJ, 2010, J AM CHEM SOC, V132, P9931, DOI 10.1021/ja1004569; Lei YL, 2012, ADV MATER, V24, P5345, DOI 10.1002/adma.201201493; Lamere JF, 2010, LANGMUIR, V26, P10210, DOI 10.1021/la100349d; Hu R, 2011, PHYS CHEM CHEM PHYS, V13, P2044, DOI 10.1039/c0cp01181a; Scott JL, 2004, B CHEM SOC JPN, V77, P1697, DOI 10.1246/bcsj.77.1697; Lewis FD, 1996, J AM CHEM SOC, V118, P12029, DOI 10.1021/ja962986b; Li CH, 2012, ANGEW CHEM INT EDIT, V51, P455, DOI 10.1002/anie.201105735; BECKER HD, 1981, J PHYS CHEM-US, V85, P2930, DOI 10.1021/j150620a016; Belton C, 2001, APPL PHYS LETT, V78, P1059, DOI 10.1063/1.1345840; Chen KH, 2008, ORG LETT, V10, P4401, DOI 10.1021/ol8014418; Chien RH, 2011, J PHYS CHEM C, V115, P12358, DOI 10.1021/jp203261s; Cu X., 2012, ADV FUNCT MATER, V22, P4862; D'Andrade B. W., 2004, ADV MATER, V16, P1585; Deng CM, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3606579; Ding D., 2014, ACCOUNTS CHEM RES, V46, P2441; Dong YQ, 2007, CHEM COMMUN, P40, DOI 10.1039/b613157c; Endo K, 1997, J AM CHEM SOC, V119, P499, DOI 10.1021/ja960292x; ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005; Garden SJ, 2007, ACTA CRYSTALLOGR C, V63, pO234, DOI 10.1107/S0108270107008682; Gosh K., 2006, MOL STRUCT, V785, P63; Holzer W, 2001, POLYMER, V42, P3183, DOI 10.1016/S0032-3861(00)00522-X; Ito H., 2013, NAT COMMUN, V4; Jasser M., 2010, J PHOTOCH PHOTOBIO A, V214, P248; Khanna S, 2006, J PHYS CHEM B, V110, P15251, DOI 10.1021/jp0619843; Kohmoto S, 2011, CHEM COMMUN, V47, P9158, DOI 10.1039/c1cc12431e; Li YP, 2007, CHEM COMMUN, P231, DOI 10.1039/b612732k; Luo JD, 2001, CHEM COMMUN, P1740, DOI 10.1039/b105159h; MarcoviciMizrahi D, 1996, J ORG CHEM, V61, P8402, DOI 10.1021/jo961446u; Mei J, 2013, CHEM-EUR J, V19, P612, DOI 10.1002/chem.201202969; Mizobe Y, 2006, ORG LETT, V8, P4295, DOI 10.1021/ol616440; Mizobe Y, 2007, B CHEM SOC JPN, V80, P1162, DOI 10.1246/bcsj.80.1162; Molla MR, 2012, CHEM-EUR J, V18, P1290, DOI 10.1002/chem.201103600; Moraczewski AL, 1998, J ORG CHEM, V63, P7258, DOI 10.1021/jo980644d; Mori Y, 2007, CRYST GROWTH DES, V7, P1356, DOI 10.1021/cg070366o; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith BD, 2004, TETRAHEDRON LETT, V45, P2747, DOI 10.1016/j.tetlet.2004.02.037; Venkata K., 2013, ADV MATER, V25, P1713; Wang Y., 2012, J PHYS CHEM C, V16, P15576; Wishkerman S, 2008, CHEM-EUR J, V14, P197, DOI 10.1002/chem.200700463; Wu J., 2011, CHEM SOC REV, V40, P483; Yoshii R., 2013, CHEM-EUR J, V19, P406; Yu C, 2009, CHEM COMMUN, P1347, DOI 10.1039/b820397k; Yuan W. Z., 2011, ADV MATER, V40, P5361; Zhang GQ, 2007, CHEM-EUR J, V13, P3630, DOI 10.1002/chem.200600514	106	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	MAY	2015	15	5					2291	2302		10.1021/acs.cgd.5b00081		12	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CH9EK	WOS:000354338600030		
J	Katsumata, N				Katsumata, Noriyuki			Dose-Dense Approaches to Ovarian Cancer Treatment	CURRENT TREATMENT OPTIONS IN ONCOLOGY			English	Article						Advanced ovarian cancer; Dose-dense therapy; Paclitaxel	OPEN-LABEL; CARBOPLATIN; PACLITAXEL; TRIAL	Currently, paclitaxel and carboplatin are administered every 3 weeks as the standard agents for the first-line treatment of advanced ovarian cancer. The concept of "dose-dense therapy" is based on the Norton-Simon hypothesis that a shorter interval between the doses of cytotoxic agents is more effective in reducing tumor burden than dose escalation. The results of phase III clinical trials demonstrating the superiority of weekly paclitaxel administration, compared with a 3-week schedule in breast cancer in both the metastatic and adjuvant settings support the hypothesis. The Japanese Gynecologic Oncology Group reported the results from a phase III study comparing the conventional paclitaxel and carboplatin every 3-week administration vs dose-dense weekly administration of paclitaxel combined with the every 3-week administration of carboplatin in advanced epithelial ovarian cancer, Fallopian tube, or primary peritoneal cancer. The median progression-free survival (PFS), the primary endpoint of this study, was substantially improved in the dose-dense treatment group (28 vs 17.2 months, hazard ratio [HR]: 0.71, 95 % CI: 0.58-0.88, P=0.0015), and the overall survival (OS) at 3 years was also higher in the dose-dense treatment group (72.1 %) than in the conventional treatment group (65.1 %; HR 0.75, 0.57-0.98; P=0.03). The long-term outcomes at a median follow-up period of 76.8 months were reported. The median PFS was significantly longer in the dose-dense regimen than in the conventional regimen (28.2 vs 17.5 months; hazard ratio [HR], 0.76; 95 % CI, 0.62-0.91; P=0.0037), and the median OS was 100.5 months (95 % CI 65.2-infinity) in the dose-dense regimen and 62.2 months (52.1-82.6) in the conventional regimen (HR, 0.79; 95 % CI, 0.63-0.99; P=0.039; log-rank test). Dose-dense treatment offers a potential new standard of care for first-line chemotherapy for patients with advanced epithelial ovarian cancer. Ongoing studies will clarify the best dose, schedule, and route of administration.	Nippon Med Sch Musashikosugi Hosp, Dept Med Oncol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan	Katsumata, N (reprint author), Nippon Med Sch Musashikosugi Hosp, Dept Med Oncol, Nakahara Ku, 1-396 Kosugi Machi, Kawasaki, Kanagawa 2118533, Japan.	nkatsuma@nms.ac.jp					Thigpen T, 2011, INT J GYNECOL CANCER, V21, P756, DOI 10.1097/IGC.0b013e31821ce75d; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1527-2729	1534-6277		CURR TREAT OPTION ON	Curr. Treat. Options Oncol.	MAY	2015	16	5							21	10.1007/s11864-015-0338-4		5	Oncology	Oncology	CI0VF	WOS:000354456200003		
J	Kato, H; O'Rourke, BE; Suzuki, R				Kato, Hidetoshi; O'Rourke, Brian E.; Suzuki, Ryoichi			Stable and high current density electron emission using coniferous carbon nano-structured emitter	DIAMOND AND RELATED MATERIALS			English	Article						Carbon nano-structures; Electron emission; High current density; Long lifetime	FIELD-EMISSION; NANOTUBES	The electron emission properties of a coniferous carbon nano-structure (CCNS) based field emission electron gun have been measured. The CCNS was grown on a stainless steel substrate using chemical vapor deposition (CVD) and biased to about 50 kV. Stable, high-current-density electron emission (102 mA/cm(2)) was measured continuously for more than 1300 h. This result compares favorably to printed and directly grown carbon nanotube (CNT) based emitters. A wide range of potential applications are foreseen for CCNS based electron emitters, such as high intensity X-ray sources. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Hidetoshi; O'Rourke, Brian E.; Suzuki, Ryoichi] Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Tsukuba, Ibaraki 3058568, Japan	Kato, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Instrumentat Frontier, Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	katou-h@aist.go.jp					IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Furuta H, 2013, DIAM RELAT MATER, V35, P29, DOI 10.1016/j.diamond.2013.03.003; Fujii S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721876; CHERNOZATONSKII LA, 1995, CHEM PHYS LETT, V233, P63, DOI 10.1016/0009-2614(94)01418-U; Saito Y, 2000, CARBON, V38, P169, DOI 10.1016/S0008-6223(99)00139-6; Pandey A, 2013, ACS NANO, V7, P117, DOI 10.1021/nn303351g; Guglielmotti V, 2013, CARBON, V52, P356, DOI 10.1016/j.carbon.2012.09.037; Deng JH, 2012, CARBON, V50, P4732, DOI 10.1016/j.carbon.2012.05.065; Perea-Lopez N, 2011, ACS NANO, V5, P5072, DOI 10.1021/nn201149y; Iwai Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.105102; RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550; Choi Young Chul, 2009, Carbon Letters, V10, P234; de Heer Walt A., 1995, SCIENCE, V270, P1179; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Hiraki A., 2013, U.S. Patent, Patent No. 8518542; Hiraki A, 2008, REV MEX FIS, V54, P44; Jeong JW, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/8/085201; Kato H., 2014, JJAP C P, V2; Kim JW, 2015, CARBON, V82, P245, DOI 10.1016/j.carbon.2014.10.068; Kim YC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2952771; Machida H, 2007, JPN J APPL PHYS 1, V46, P867, DOI 10.1143/JJAP.46.867; Nam J.-W., 2005, 2005 INT VAC NAN C I, P292, DOI 10.1109/IVNC.2005.1619601; Suzuki R., 2010, ADV XRAY CHEM ANAL J, V41, P201	23	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	MAY	2015	55						41	44		10.1016/j.diamond.2015.03.001		4	Materials Science, Multidisciplinary	Materials Science	CI2OA	WOS:000354585700006		
J	Sabirov, DS; Osawa, E				Sabirov, Denis Sh.; Osawa, Eiji			Dipole polarizability of nanodiamonds and related structures	DIAMOND AND RELATED MATERIALS			English	Article						Nanodiamond; Fluorinated nanodiamond; Hydroxylated nanodiamond; Nitrogen vacancy centers; Dipole polarizability; Density functional theory	ELECTRONIC-PROPERTIES; SOLAR-CELLS; NANOSCALE DIAMOND; C-60 FULLERENE; AB-INITIO; SURFACE; FUNCTIONALIZATION; DFT; DERIVATIVES; MOLECULES	In the present work, mean dipole polarizabilities of the nanodiamonds and the related nanostructures modified with nitrogen vacancy centers or surface functional groups F and OH have been studied by DFT methods. Linear correlation between the mean polarizability and the size of nanodiamonds has been justified. It opens opportunities for prediction of polarizabilities of larger nanodiamond particles without high-cost quantum-chemical calculations. Introducing nitrogen vacancy centers slightly increases the resulting mean polarizability due to the repulsive interactions of lone pairs of N atoms (in A, B, and N3 centers) or unpaired electron (C center). Mean polarizabilities of polyfluorinated and polyhydroxylated nanodiamonds have been calculated for model structures with isolated, focal, and compact arrangements of the F/OHs on the surface. The enhancement of polarizability over the expected additive value has been found for nanodiamonds with compact placement of F/OH and in the case of the polyhydroxylated nanodiamond with the isolated OH groups. (C) 2015 Elsevier B.V. All rights reserved.	[Sabirov, Denis Sh.] Russian Acad Sci, Inst Petrochem & Catalysis, Ufa 450075, Russia; [Osawa, Eiji] Shinshu Univ, AREC, Fac Text Sci & Technol, NanoCarbon Res Inst, Ueda, Nagano 3868567, Japan	Sabirov, DS (reprint author), Russian Acad Sci, Inst Petrochem & Catalysis, Ufa 450075, Russia.	diozno@mail.ru		Sabirov, Denis/0000-0002-6928-5070	Presidium of the Russian Academy of Sciences [24]; Interdisciplinary Program on Material Efficiency of the G8 Research Councils Initiative on Multilateral Research Funding	Denis Sabirov is grateful to the Presidium of the Russian Academy of Sciences for the financial support (Program No. 24 'Foundations of basic research of nanotechnologies and nanomaterials'). Eiji Osawa acknowledges Interdisciplinary Program on Material Efficiency of the G8 Research Councils Initiative on Multilateral Research Funding for US-Japan-Russia Joint Proposal, 'Nanodiamond-based Nanospacer Lubricants' 2011-2015.	Lai L, 2011, J PHYS CHEM C, V115, P6218, DOI 10.1021/jp1111026; Sabirov DS, 2010, FULLER NANOTUB CAR N, V18, P455, DOI 10.1080/1536383X.2010.487777; Blair SA, 2013, CHEM PHYS LETT, V556, P346, DOI 10.1016/j.cplett.2012.11.048; Marenich AV, 2013, CHEM SCI, V4, P2349, DOI 10.1039/c3sc50242b; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Laikov DN, 2005, RUSS CHEM B+, V54, P820, DOI 10.1007/s11172-005-0329-x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Laikov DN, 2005, CHEM PHYS LETT, V416, P116, DOI 10.1016/j.cplett.2005.09.046; Barras A, 2011, LANGMUIR, V27, P12451, DOI 10.1021/la202571d; Maroulis G, 2001, J CHEM PHYS, V115, P7957, DOI 10.1063/1.1410392; Pankratyev EY, 2011, J COMPUT CHEM, V32, P1993, DOI 10.1002/jcc.21786; Kuznetsov VV, 2014, RUSS J ORG CHEM+, V50, P1534, DOI 10.1134/S1070428014100200; Xiao J, 2014, NANO LETT, V14, P3645, DOI 10.1021/nl5014234; Kratochvilova I, 2011, J MATER CHEM, V21, P18248, DOI 10.1039/c1jm13525b; Sabirov DS, 2013, J PHYS CHEM C, V117, P9148, DOI 10.1021/jp401944x; Mochalin VN, 2009, J AM CHEM SOC, V131, P4594, DOI 10.1021/ja9004514; Zheng WW, 2009, J MATER CHEM, V19, P8432, DOI 10.1039/b904302k; Xu Q, 2012, J MATER CHEM, V22, P16416, DOI 10.1039/c2jm32918b; Barnard AS, 2008, J MATER CHEM, V18, P4038, DOI 10.1039/b809188a; Sabirov DS, 2008, FULLER NANOTUB CAR N, V16, P534, DOI 10.1080/15363830802286194; TUCKER OD, 1994, PHYS REV B, V50, P15586, DOI 10.1103/PhysRevB.50.15586; Panich AM, 2010, J PHYS CHEM C, V114, P774, DOI 10.1021/jp9078629; Krueger A, 2008, LANGMUIR, V24, P4200, DOI 10.1021/la703482v; Liu Y, 2004, CHEM MATER, V16, P3924, DOI 10.1021/cm048875q; Krueger A, 2008, J MATER CHEM, V18, P1485, DOI 10.1039/b716673g; Thakkar AJ, 2012, AIP CONF PROC, V1504, P586, DOI 10.1063/1.4771764; Sabirov DS, 2014, RSC ADV, V4, P44996, DOI 10.1039/c4ra06116k; Huang LCL, 2004, LANGMUIR, V20, P5879, DOI 10.1021/la0495736; Sabirov DS, 2012, CHEM PHYS LETT, V523, P92, DOI 10.1016/j.cplett.2011.12.012; Osawa E, 2009, DIAM RELAT MATER, V18, P904, DOI 10.1016/j.diamond.2009.01.025; Osawa E, 2007, DIAM RELAT MATER, V16, P2018, DOI 10.1016/j.diamond.2007.08.008; Tao R, 2014, ACS APPL MATER INTER, V6, P17313, DOI 10.1021/am5058794; Williams OA, 2008, DIAM RELAT MATER, V17, P1080, DOI 10.1016/j.diamond.2008.01.103; Shenderova O, 2011, J PHYS CHEM C, V115, P9827, DOI 10.1021/jp1102466; Krueger A, 2011, J MATER CHEM, V21, P12571, DOI 10.1039/c1jm11674f; Broyer M, 2002, CR PHYS, V3, P301, DOI 10.1016/S1631-0705(02)01318-X; Bishop DM, 2000, CHEM PHYS LETT, V317, P322, DOI 10.1016/S0009-2614(99)01337-8; Brown N, 2014, J PHYS CHEM C, V118, P5530, DOI 10.1021/jp409236t; CHAMPAGNE B, 1994, J CHEM PHYS, V101, P10796, DOI 10.1063/1.467830; Collins AT, 1999, DIAM RELAT MATER, V8, P1455, DOI 10.1016/S0925-9635(99)00013-8; Delaney P, 2004, APPL PHYS LETT, V84, P431, DOI 10.1063/1.1640783; Gali A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025016; Hu W, 2013, COMPUT THEOR CHEM, V1021, P49, DOI 10.1016/j.comptc.2013.06.015; Lai L, 2012, J PHYS CHEM LETT, V3, P896, DOI 10.1021/jz300066j; Lai L, 2012, NANOSCALE, V4, P1130, DOI 10.1039/c1nr11102g; Macutkevic J., 2014, POLYM COMPOS; Mar N, 2014, COMPUT THEOR CHEM, V1035, P1, DOI 10.1016/j.comptc.2014.02.017; Nagata A, 2010, PROG NAT SCI, V20, P38; Osawa E, 2013, HANDBOOK OF ADVANCED CERAMICS: MATERIALS, APPLICATIONS, PROCESSING, AND PROPERTIES, 2ND EDITION, P89, DOI 10.1016/B978-0-12-385469-8.00004-6; Osawa E., 2012, DEAGGLOMERATION DETO, P165; Rivelino R, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013201; Sabirov DS, 2013, RSC ADV, V3, P19430, DOI 10.1039/c3ra42498g; Sabirov DS, 2014, PHYS CHEM CHEM PHYS, V16, P14594, DOI 10.1039/c3cp55528c; Sabirov DS, 2014, COMPUT THEOR CHEM, V1030, P81, DOI 10.1016/j.comptc.2014.01.001; Saito T, 1998, J CHEM SOC FARADAY T, V94, P929, DOI 10.1039/a707905b; Sorkin A, 2011, J PHYS CHEM A, V115, P8327, DOI 10.1021/jp200449f; Swart M, 2015, J MATER CHEM C, V3, P23, DOI 10.1039/c4tc02060j; Wen B, 2007, CHEM PHYS LETT, V441, P318, DOI 10.1016/j.cplett.2007.05.054; Zeinalipour-Yazdi CD, 2008, J PHYS CHEM B, V112, P7377, DOI 10.1021/jp800302s; Zhang DJ, 2005, J PHYS CHEM B, V109, P9006, DOI 10.1021/jp046330d	60	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	MAY	2015	55						64	69		10.1016/j.diamond.2015.03.009		6	Materials Science, Multidisciplinary	Materials Science	CI2OA	WOS:000354585700009		
J	Kadoya, T; Inoue, T				Kadoya, Taku; Inoue, Tomomi			Spatio-temporal pattern of specific gravity of mangrove diaspore: implications for upstream dispersal	ECOGRAPHY			English	Article							EARLY GROWTH; PROPAGULES; VIVIPARY; HYDROCHORY; AUSTRALIA; SEEDLINGS; EVOLUTION; ECOLOGY	Mangrove plants, which develop highly productive forests on tropical-subtropical coastlines and river estuaries, rely mainly on river and sea water currents for their diaspore dispersal. Mangrove diaspores are basically dispersed in brackish to sea waters; thus whether they sink or float during the dispersal period could be changed dynamically, both spatially and temporally, depending on the salinity to which they are exposed, as well as on their specific gravity (SG). We found that the SG of diaspores of two mangrove species, Rhizophora stylosa and Bruguiera gymnorrhiza, which are dominant species and form a typical zonation (B. gymnorrhiza in inland areas and R. stylosa in more seaward areas) in the study area, changed spatially and temporally. Bruguiera gymnorrhiza gradually lost its SG in accordance with elapsed time, while R. stylosa lost its SG in the first 6 h and gained gradually according to elapsed time. Hydrodynamic simulation of dispersal patterns, in combination with observed specific gravity changes of both diaspores and river water, demonstrated that the spatio-temporal pattern of specific gravity change was closely related to the difference in dispersal behaviors between the species. The diaspore of B. gymnorrhiza generally disperses upstream, and covers wider ranges than that of R. stylosa, at least in the early phase of dispersal. These dispersal behaviors agreed well with the distribution pattern of the species across estuaries in the study site. To date, hydrochory has been considered to be a mostly passive process governed by the dynamics of water current and subsequent sediment movement, with fixed diaspore characteristics such as shape and buoyancy. The present study shed new light on an active and dynamic process in hydrochory and found that the buoyancy of diaspores may be controlled by changes in their spatial and temporal SG.	[Kadoya, Taku; Inoue, Tomomi] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan; [Kadoya, Taku] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Kadoya, T (reprint author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	kadoya@nies.go.jp			Japan Society for the Promotion of Science [H25-330]	We thank Shigeyuki Baba and Yoshihiro Mazuda for their comments and advice. We also thank Kayo Fukuda, Shin Watanabe, Shinya Imura, and Keiichi Ishigaki for their field work supports. TK was partly supported by funding from the Japan Society for the Promotion of Science (H25-330). TK and TI contributed equally to this manuscript.	Andrewartha H. G., 1954, DISTRIBUTION ABUNDAN; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cota-Sanchez JH, 2007, AM J BOT, V94, P1577, DOI 10.3732/ajb.94.9.1577; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Tomlinson PB, 2000, BOT J LINN SOC, V134, P215, DOI 10.1006/bojl.2000.0371; Sousa WP, 2007, ECOL MONOGR, V77, P53, DOI 10.1890/05-1935; Elmqvist T, 1996, OIKOS, V77, P3, DOI 10.2307/3545579; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; CLARKE LD, 1970, J ECOL, V58, P351, DOI 10.2307/2258276; Speirs DC, 2001, ECOLOGY, V82, P1219, DOI 10.1890/0012-9658(2001)082[1219:PPIRAE]2.0.CO;2; JOHANSSON ME, 1993, J ECOL, V81, P81, DOI 10.2307/2261226; Clarke PJ, 2001, J ECOL, V89, P648, DOI 10.1046/j.0022-0477.2001.00584.x; RABINOWITZ D, 1978, BIOTROPICA, V10, P47, DOI 10.2307/2388105; KREBS CJ, 1969, ECOLOGY, V50, P587, DOI 10.2307/1936248; BURCHETT MD, 1989, PHYSIOL PLANTARUM, V75, P299, DOI 10.1111/j.1399-3054.1989.tb06185.x; CLARKE PJ, 1991, AUST J BOT, V39, P77, DOI 10.1071/BT9910077; HUTCHINSON G. E., 1951, ECOLOGY, V32, P571, DOI 10.2307/1931745; MacArthur RH, 1967, THEORY ISLAND BIOGEO; MACNAE W, 1968, ADV MAR BIOL, V6, P73; RABINOWITZ D, 1978, J BIOGEOGR, V5, P113, DOI 10.2307/3038167; Spalding M., 2010, WORLD ATLAS MANGROVE; Stieglitz T, 2001, MAR ECOL PROG SER, V211, P131, DOI 10.3354/meps211131; Tomlinson P. B., 1986, BOT MANGROVES	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	MAY	2015	38	5					472	479		10.1111/ecog.01074		8	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CH6XN	WOS:000354179900005		
J	Maruyama, M; Zennyo, Y				Maruyama, Masayoshi; Zennyo, Yusuke			Application compatibility and affiliation in two-sided markets	ECONOMICS LETTERS			English	Article						Compatibility; Application; Affiliation; Platform; Two-sided markets		This paper analyzes the unilateral choices of application compatibility by platforms and the endogenous affiliations of two different groups (content providers and users). We find a novel result that for both platforms to unilaterally choose application compatibility is not an equilibrium unless the cost for achieving application compatibility is zero. We also find that asymmetric equilibria exist with regard to other content, where one platform chooses incompatibility while the other platform chooses compatibility and that, these asymmetric equilibria are harmful both to the content providers and to users, compared to the (out-of-equilibrium) outcome where both platforms choose application compatibility. (C) 2015 Elsevier B.V. All rights reserved.	[Maruyama, Masayoshi] Kobe Univ, Grad Sch Business Adm, Kobe, Hyogo, Japan; [Zennyo, Yusuke] Osaka Univ Econ, Fac Econ, Osaka, Japan	Maruyama, M (reprint author), Kobe Univ, Grad Sch Business Adm, Kobe, Hyogo, Japan.	mmaru@kobe-u.ac.jp			Japan Center for Economic Research [24330080]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	We would like to thank David Flath for very helpful comments. The research for this study was supported by a grant from the Japan Center for Economic Research, a Grant-in-Aid for Scientific Research (B) no. 24330080, and a Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government.	Armstrong M, 2006, RAND J ECON, V37, P668, DOI 10.1111/j.1756-2171.2006.tb00037.x; Casadesus-Masanell R., 2008, 0832 NET I; Doganoglu T, 2006, INT J IND ORGAN, V24, P45, DOI 10.1016/j.ijindorg.2005.07.004; Maruyama M, 2013, REV NETW ECON, V12, P131, DOI 10.1515/rne-2013-0011; Rasch A, 2014, ECON LETT, V124, P478, DOI 10.1016/j.econlet.2014.07.012; Viecens M., 2011, REV NETW ECON, V10, P1	6	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	MAY	2015	130						39	42		10.1016/j.econlet.2015.02.019		4	Economics	Business & Economics	CI1JU	WOS:000354501300011		
J	Miyamoto, H				Miyamoto, Hiroaki			Cyclical behavior of real wages in Japan	ECONOMICS LETTERS			English	Article						Real wages; Business cycle; Correlation; Japanese economy	BUSINESS-CYCLE; COMOVEMENT; TIME	This paper studies the cyclicality of aggregate real wages in Japan. By using both static and dynamic approaches, I measure comovements between real wages and business cycle indicators. This paper finds that while real wages constructed using the consumer price index and the GDP deflator are procyclical, real wages constructed using the producer price index are countercyclical. This result is robust to the data and methods used to compute the comovements. (C) 2015 Elsevier B.V. All rights reserved.	Univ Tokyo, Grad Sch Publ Policy, Bunkyo Ku, Tokyo 1130033, Japan	Miyamoto, H (reprint author), Univ Tokyo, Grad Sch Publ Policy, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyamoto@pp.u-tokyo.ac.jp			Kakenhi [26380248]	Part of this research was supported by the Grant-in-Aid for Scientific Research (C) (Kakenhi No. 26380248).	ABRAHAM KG, 1995, J ECON LIT, V33, P1215; Croux C, 2001, REV ECON STAT, V83, P232, DOI 10.1162/00346530151143770; Baxter M, 1999, REV ECON STAT, V81, P575, DOI 10.1162/003465399558454; den Haan WJ, 2000, J MONETARY ECON, V46, P3, DOI 10.1016/S0304-3932(00)00016-7; Hausman JK, 2014, BROOKINGS PAP ECO AC, P1; Ito T., 2013, JAPAN SPOTLIGHT  SEP, P4; Marczak M, 2013, EMPIR ECON, V44, P469, DOI 10.1007/s00181-011-0542-4; Messina J, 2009, J ECON DYN CONTROL, V33, P1183, DOI 10.1016/j.jedc.2008.11.005; Stock JH, 1999, HANDB ECON, V15, P3	9	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0165-1765	1873-7374		ECON LETT	Econ. Lett.	MAY	2015	130						56	59		10.1016/j.econlet.2015.03.002		4	Economics	Business & Economics	CI1JU	WOS:000354501300015		
J	Felizola, SJA; Katsu, K; Ise, K; Nakamura, Y; Arai, Y; Satoh, F; Sasano, H				Felizola, Saulo J. A.; Katsu, Koshin; Ise, Kazue; Nakamura, Yasuhiro; Arai, Yoichi; Satoh, Fumitoshi; Sasano, Hironobu			Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues	ENDOCRINE PATHOLOGY			English	Article						Adrenal cortex; Aldosterone; B lymphocyte; Cerebellum; Purkinje cells	ALDOSTERONE-PRODUCING ADENOMAS; GENE-EXPRESSION; GLUTAMATE-RECEPTOR; SYNAPTIC PLASTICITY; CEREBELLAR-ATAXIA; CELLS; MICE; HYPERTENSION; MUTATIONS; BRAIN	The pre-B lymphocyte protein 3 (VPREB3) is expressed during B cell differentiation and in subsets of mature B lymphocytes and is mainly found in bone marrow and lymphoid tissue germinative centers. So far, its function in B cells remains to be clarified. The messenger RNA (mRNA) of VPREB3 was previously detected in aldosterone-producing adenomas (APA); however, further information about this protein in human adrenocortical cells and tissues is currently unavailable. Therefore, in the present study, we, for the first time, investigate the protein expression of VPREB3 in human adrenocortical tissues. In addition, we approach the previously suggested similarities in expression patterns of aldosterone-producing cells and Purkinje neurons. Immunohistochemical analysis of VPREB3 was performed in 13 nonpathological adrenals (NA), 6 adrenal glands with idiopathic hyperaldosteronism (IHA), 18 APA, 5 cortisol-producing adenomas (CPA), and 5 nonpathological human cerebellum specimens. The mRNA levels of VPREB3, steroidogenic enzymes, and other aldosterone biosynthesis markers were detected in 53 APA samples using real-time RT-PCR (qPCR) and compared to the clinical data of APA patients. In our results, the VPREB3 protein was diffusely detected in APA, partially or weakly detected in CPA, and immunolocalized in the zona glomerulosa of NA and IHA, as well as in the cytoplasm of cerebellar Purkinje cells. In APA, VPREB3 mRNA levels were significantly correlated to plasma aldosterone (P = 0.026; R = 0.30), KCNJ5 mutations (P = 0.0061; mutated 34:19 wild type), CYP11B2 (P < 0.0001; R = 0.65), Purkinje cell protein 4 (PCP4; P < 0.0001; R = 0.53), and voltage-dependent calcium channels CaV1.3 (P = 0.023; R = 0.31) and CaV3.2 (P = 0.0019; R = 0.42). Based on our data, we hypothesize a possible role for VPREB3 in aldosterone biosynthesis, and present ideas for future functional studies.	[Felizola, Saulo J. A.; Katsu, Koshin; Ise, Kazue; Nakamura, Yasuhiro; Sasano, Hironobu] Tohoku Univ, Dept Pathol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Arai, Yoichi] Tohoku Univ, Dept Urol, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Satoh, Fumitoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan	Felizola, SJA (reprint author), Tohoku Univ, Dept Pathol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	felizola@med.tohoku.ac.jp					Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Ganor Y, 2003, J IMMUNOL, V170, P4362; Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3; Satoh F, 2007, HYPERTENS RES, V30, P1083, DOI 10.1291/hypres.30.1083; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Hu CL, 2012, J CLIN INVEST, V122, P2046, DOI 10.1172/JCI61996; Wang XX, 2012, IMMUNOGENETICS, V64, P647, DOI 10.1007/s00251-012-0626-0; Wang T, 2011, EUR J ENDOCRINOL, V164, P613, DOI 10.1530/EJE-10-1085; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; Utine GE, 2013, J CHILD NEUROL, V28, P926, DOI 10.1177/0883073813484967; Nakamura Y, 2011, J CLIN ENDOCR METAB, V96, pE1272, DOI 10.1210/jc.2010-2785; Sukor N, 2009, J CLIN ENDOCR METAB, V94, P2437, DOI 10.1210/jc.2008-2803; Nogueira EF, 2007, J MOL ENDOCRINOL, V39, P365, DOI 10.1677/JME-07-0094; Beranova M, 2002, ACTA VET BRNO, V71, P23, DOI 10.2754/avb200271010023; Bouillet P, 2003, J NEUROSCI RES, V74, P777, DOI 10.1002/jnr.10805; Breese CR, 1996, J MOL NEUROSCI, V7, P277, DOI 10.1007/BF02737065; Doi M, 2014, J CLIN ENDOCR METAB, V99, pE257, DOI 10.1210/jc.2013-3279; Felizola SJA, 2014, ENDOCR PATHOL, V25, P229, DOI 10.1007/s12022-013-9280-9; Felizola SJA, 2014, J MOL ENDOCRINOL, V52, P159, DOI 10.1530/JME-13-0248; Felizola SJA, 2014, MOL CELL ENDOCRINOL, V382, P170, DOI 10.1016/j.mce.2013.09.025; Felizola SJA, 2014, J STEROID BIOCHEM, V144, P410, DOI 10.1016/j.jsbmb.2014.08.012; Glynne R, 2000, IMMUNOL REV, V176, P216; Kakegawa W, 2007, J PHYSIOL-LONDON, V579, P729, DOI 10.1113/jphysiol.2006.127100; Konosu-Fukaya S, 2014, MOL CELLULA IN PRESS, DOI [10.1016/j.mce.2014.10.008, DOI 10.1016/J.MCE.2014.10.008]; Nakamura Y, 2014, PATHOL INT, V64, P482, DOI 10.1111/pin.12200; Rodig SJ, 2010, HAEMATOL-HEMATOL J, V95, P2056, DOI 10.3324/haematol.2010.025767; Rosnet O, 1999, CYTOGENET CELL GENET, V87, P205, DOI 10.1159/000015468; Rosnet O, 2004, J BIOL CHEM, V279, P10228, DOI 10.1074/jbc.M312169-A200; Selimi F, 2003, NEURON, V37, P813, DOI 10.1016/S0896-6273(03)00093-X; Van Schil K, 2015, GENET MED, V17, P291, DOI 10.1038/gim.2014.95; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Zennaro MC, 2011, CIRC RES, V108, P1417, DOI 10.1161/RES.0b013e318224a359	35	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	MAY	2015	26	2					119	128		10.1007/s12022-015-9366-7		10	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	CI2ZR	WOS:000354617600004		
J	Jia, XF; Harada, Y; Tagawa, M; Naito, H; Hayashi, Y; Yetti, H; Kato, M; Sasaki, S; Araki, A; Miyashita, C; Ikeno, T; Kishi, R; Nakajima, T				Jia, Xiaofang; Harada, Yukiko; Tagawa, Masahiro; Naito, Hisao; Hayashi, Yumi; Yetti, Husna; Kato, Masashi; Sasaki, Seiko; Araki, Atsuko; Miyashita, Chihiro; Ikeno, Tamiko; Kishi, Reiko; Nakajima, Tamie			Prenatal maternal blood triglyceride and fatty acid levels in relation to exposure to di(2-ethylhexyl)phthalate: a cross-sectional study	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Di(2-ethylhexyl)phthalate; Prenatal exposure; Triglycerides; Fatty acids; Infant birth outcomes	LIPOPROTEIN METABOLISM; PHTHALATE EXPOSURE; PREGNANCY; HEALTH; SERUM; DEHP; RATS; DI-(2-ETHYLHEXYL)PHTHALATE; TISSUES; COHORT	The hypolipidemic effects of di(2-ethylhexyl)phthalate (DEHP) exposure in humans have not been investigated. And the influences of maternal prenatal DEHP exposure on birth outcomes are not well-known. We aimed to estimate prenatal DEHP exposure in maternal blood, and evaluate its relationships to maternal blood triglyceride (TG) and fatty acid (FA) levels and to birth outcomes. We studied 318 mother-newborn pairs residing in Sapporo, Japan. Blood was taken one time during pregnancy for each mother. Maternal and infant characteristics were obtained from medical records and questionnaire survey. We measured DEHP metabolite, mono(2-ethylhexyl) phthalate (MEHP), along with TG and 9 FAs using maternal blood, and analyzed associations of MEHP level with maternal blood TG/FA levels and infant birth dimensions. Maternal blood TG and palmitoleic/oleic acid levels were higher, but stearic/docosahexaenoic acids and MEHP were lower during late pregnancy. Maternal blood MEHP levels inversely correlated with TG and palmitic/palmitoleic/oleic/linoleic/alpha-linolenic acids. After adjustment for confounders, we found that a tenfold increase in blood MEHP levels correlated with a decrease in TG of 25.1 mg/dl [95 % confidence interval (CI) 4.8-45.3 mg/dl], and similar relations in palmitic (beta = -581.8; 95 % CI -906.5, -257.0), oleic (beta = -304.2; 95 % CI -518.0, -90.5), linoleic (beta = -348.6; 95 % CI -510.6, -186.6), and alpha-linolenic (beta = -6.3; 95 % CI -9.5, -3.0) acids. However, we observed no correlations between maternal blood MEHP levels and infant birth weight, length, chest circumference, or head circumference. Ambient DEHP exposure during pregnancy inversely correlated with maternal blood TG and 4 FA levels, but not birth outcomes.	[Jia, Xiaofang; Tagawa, Masahiro; Naito, Hisao; Yetti, Husna; Kato, Masashi; Nakajima, Tamie] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Showa Ku, Nagoya, Aichi 4668550, Japan; [Jia, Xiaofang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing 100050, Peoples R China; [Harada, Yukiko] Shinshu Univ, Grad Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Hayashi, Yumi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Sasaki, Seiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth Sci, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Araki, Atsuko; Miyashita, Chihiro; Ikeno, Tamiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm Hlth & Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Nakajima, Tamie] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Nakajima, T (reprint author), Chubu Univ, Coll Life & Hlth Sci, 1200 Matsumoto Cho, Kasugai, Aichi 4878501, Japan.	tnasu23@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science [25253050]	This work was funded by Grants-in-Aid for Health Scientific Research from the Japan Society for the Promotion of Science (25253050). Additionally, we would like to thank the medical staff and the participants at Sapporo Toho Hospital, and staff of the "Hokkaido Study on Environment and Children's Health". We also thank Ms Aiko Tajima at the Department of Occupational and Environmental Health of Nagoya University Graduate School of Medicine for the maternal blood TG and FA measurements.	Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x; AL MDM, 1995, BRIT J NUTR, V74, P55, DOI 10.1079/BJN19950106; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Herrera E, 2002, PLACENTA, V23, pS9, DOI 10.1053/plac.2002.0771; KNOPP RH, 1986, BIOL NEONATE, V50, P297; Konishi K, 2009, ENVIRON RES, V109, P906, DOI 10.1016/j.envres.2009.07.010; Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x; Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Zhang YH, 2009, J PEDIATR-US, V155, P500, DOI 10.1016/j.jpeds.2009.04.007; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Haggarty P, 2004, EUR J CLIN NUTR, V58, P1559, DOI 10.1038/sj.ejcn.1602016; Nakashima R, 2013, TOXICOLOGY, V309, P52, DOI 10.1016/j.tox.2013.04.010; Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012; Bamai YA, 2014, SCI TOTAL ENVIRON, V468, P147, DOI 10.1016/j.scitotenv.2013.07.107; BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382; Dirix CEH, 2009, BRIT J NUTR, V101, P399, DOI 10.1017/S0007114508006740; DIRVEN HAAM, 1990, TOXICOLOGY, V65, P199, DOI 10.1016/0300-483X(90)90089-Y; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frederiksen MC, 2001, SEMIN PERINATOL, V25, P120, DOI 10.1053/sper.2001.24565; Fujimaki Kayumi, 2006, Nihon Eiseigaku Zasshi, V61, P340; Hayashi Y, 2011, TOXICOLOGY, V289, P1, DOI 10.1016/j.tox.2011.02.007; Ito Y, 2014, ENVIRON HEALTH PREV, V19, P117, DOI 10.1007/s12199-013-0362-6; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Itsuki-Yoneda A, 2007, BIOSCI BIOTECH BIOCH, V71, P414, DOI 10.1271/bbb.60478; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; OISHI S, 1984, TOXICOL LETT, V23, P67; Philibert A, 2006, AM J CLIN NUTR, V84, P1299; REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4; SAKURAI T, 1978, J BIOCHEM-TOKYO, V83, P313; Simon JA, 1996, AM J EPIDEMIOL, V144, P325; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887; Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAY	2015	20	3					168	178		10.1007/s12199-014-0440-4		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CI3AA	WOS:000354618500002		
J	Azuma, K; Uchiyama, I; Tanigawa, M; Bamba, I; Azuma, M; Takano, H; Yoshikawa, T; Sakabe, K				Azuma, Kenichi; Uchiyama, Iwao; Tanigawa, Mari; Bamba, Ikuko; Azuma, Michiyo; Takano, Hirohisa; Yoshikawa, Toshikazu; Sakabe, Kou			Assessment of cerebral blood flow in patients with multiple chemical sensitivity using near-infrared spectroscopy-recovery after olfactory stimulation: a case-control study	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Cerebral blood flow; Multiple chemical sensitivity; Near-infrared spectroscopy; Olfactory stimulation; Orbitofrontal cortex; Recovery	POPULATION-BASED SURVEY; GENERAL-POPULATION; AIRBORNE CHEMICALS; PREFRONTAL CORTEX; BRAIN ACTIVATION; AGE DEPENDENCY; NERVOUS-SYSTEM; PREVALENCE; SCALE; PERCEPTION	Multiple chemical sensitivity (MCS) is a chronic acquired disorder characterized by non-specific symptoms in multiple organ systems associated with exposure to odorous chemicals. We previously observed significant activations in the prefrontal cortex (PFC) during olfactory stimulation using several different odorants in patients with MCS by near-infrared spectroscopy (NIRS) imaging. We also observed that the patients with MCS did not adequately distinguish non-odorant in the late stage of the repeated olfactory stimulation test. The sensory recovery of the olfactory system in the patients with MCS may process odors differently from healthy subjects after olfactory stimulation. We examined the recovery process of regional cerebral blood flow (rCBF) after olfactory stimulation in patients with MCS. NIRS imaging was performed in 6 patients with MCS and in 6 controls. The olfactory stimulation test was continuously repeated 10 times. The study also included a subjective assessment of the physical and psychological status and of the perception of irritating and hedonic odors. After olfactory stimulation, significant activations were observed in the PFC of patients with MCS on both the right and left sides compared with controls. The activations were specifically strong in the orbitofrontal cortex (OFC). Compared with controls, autonomic perception and feelings identification were poorer in patients with MCS. OFC is associated with stimuli response and the representation of preferences. These results suggest that a past strong exposure to hazardous chemicals activates the PFC during olfactory stimuli in patients with MCS, and a strong activation in the OFC remains after the stimuli.	[Azuma, Kenichi; Bamba, Ikuko] Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka 5898511, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Basic Res Div, Kyoto 6068225, Japan; [Uchiyama, Iwao] Hyakumanben Clin, Outpatient Dept Sick House Syndrome, Kyoto, Japan; [Tanigawa, Mari] Louis Pasteur Ctr Med Res, Clin Immune Funct Lab, Basic Res Div, Kyoto 6068225, Japan; [Tanigawa, Mari] Hyakumanben Clin, Div Internal Med, Kyoto, Japan; [Azuma, Michiyo] Kio Univ, Fac Hlth Sci, Dept Human Environm Design, Koryo, Nara 6350832, Japan; [Takano, Hirohisa] Kyoto Univ, Dept Environm Engn, Grad Sch Engn, Kyoto 6158530, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Kyoto 6028566, Japan; [Sakabe, Kou] Tokai Univ, Sch Med, Dept Anat & Cellular Biol, Isehara, Kanagawa 2591193, Japan	Azuma, K (reprint author), Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osaka 5898511, Japan.	kenazuma@med.kindai.ac.jp; iwao-u@cyber.ocn.ne.jp; maritanigawa@louis-pasteur.or.jp; i-banba@med.kindai.ac.jp; m.azuma@kio.ac.jp; htakano@health.env.kyoto-u.ac.jp; toshi@koto.kpu-m.ac.jp; sakabek@tokai-u.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [22590568]; Japan Ministry of the Environment [H25-5962]; Japan Ministry of Health, Labour and Welfare [H25-008]	This study was financially supported by a Grant-in-Aid for Scientific Research (ID: 22590568) provided by the Japan Ministry of Education, Culture, Sports, Science and Technology. This study was also financially supported by a health science research grant (H25-5962) from the Japan Ministry of the Environment and a Grant-in-Aid for Health and Labour Sciences Research Grant (H25-008) provided by the Japan Ministry of Health, Labour and Welfare. We express our sincere appreciation to the staff members of the Hyakumanben Clinic for their assistance in data collection.	Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Sorg BA, 1999, CRIT REV NEUROBIOL, V13, P283; Caress SM, 2004, AM J PUBLIC HEALTH, V94, P746, DOI 10.2105/AJPH.94.5.746; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Bartha L, 1999, ARCH ENVIRON HEALTH, V54, P147; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Meggs WJ, 1996, ARCH ENVIRON HEALTH, V51, P275; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Berg ND, 2008, INT ARCH OCC ENV HEA, V81, P881, DOI 10.1007/s00420-007-0282-0; Hausteiner C, 2005, INT J HYG ENVIR HEAL, V208, P271, DOI 10.1016/j.ijheh.2005.03.006; Berg ND, 2009, INT ARCH OCC ENV HEA, V82, P509, DOI 10.1007/s00420-008-0352-y; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73; Winder C, 2002, TOXICOL LETT, V128, P85, DOI 10.1016/S0378-4274(01)00536-7; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Tanida M, 2004, NEUROSCI LETT, V369, P69, DOI 10.1016/j.neulet.2004.07.076; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Nordin S, 2004, INT ARCH OCC ENV HEA, V77, P249, DOI 10.1007/s00420-004-0504-7; Kreutzer R, 1999, AM J EPIDEMIOL, V150, P1; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Azuma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080567; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; BENDIG AW, 1956, J CONSULT PSYCHOL, V20, P384, DOI 10.1037/h0045580; CULLEN MR, 1987, OCCUP MED, V2, P655; Elsberg CA, 1939, J NEUROPHYSIOL, V2, P227; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103; Horaguchi T, 2008, NEUROSCI RES, V61, P294, DOI 10.1016/j.neures.2008.03.011; Krusemark Elizabeth A, 2013, J Neurosci, V33, P15324, DOI 10.1523/JNEUROSCI.1835-13.2013; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; McKeown-Eyssen GE, 2001, ARCH ENVIRON HEALTH, V56, P406; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAY	2015	20	3					185	194		10.1007/s12199-015-0448-4		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CI3AA	WOS:000354618500004		
J	Daitoku, S; Yuasa, T; Tsunenari, H; Maenohara, S; Mine, K; Tamatsu, Y; Shimada, K; Koriyama, C; Ohishi, M; Horiuchi, M				Daitoku, Satoshi; Yuasa, Toshinori; Tsunenari, Hiroshi; Maenohara, Shigeho; Mine, Kazuharu; Tamatsu, Yuichi; Shimada, Kazuyuki; Koriyama, Chihaya; Ohishi, Mitsuru; Horiuchi, Masahisa			Angle between the common and internal carotid arteries detected by ultrasound is related to intima-media thickness among those with atherosclerotic disease	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Atherosclerotic risk; Cross-sectional study; Intima-media thickness; Vessel structural variations	CARDIOVASCULAR RISK; PROGRESSION; KINKING; TWIN; ASSOCIATION; CHOLESTEROL; TORTUOSITY; PREVENTION; STIFFNESS; COILING	Although carotid artery structural variations have been detected by ultrasound, their clinical significance is not fully understood. The objective of this study was to determine whether the angle between the common carotid artery (CCA) and the internal carotid artery (ICA), designated angle alpha, an ultrasound-detectable carotid artery structural variation, is related to carotid artery intima-media thickness (IMT), a surrogate marker for carotid atherosclerosis. As a cross-sectional study, we measured angle alpha in routine carotid artery ultrasounds from 176 subjects (130 men) with atherosclerotic disease/risk factors that attended Kouseiren Hospital in Kagoshima City, Japan between August 2007 and April 2009. We evaluated the correlation between the angle alpha and CCA- or ICA-IMT. Angle alpha was weakly correlated with age but significantly correlated with ICA-IMT. The correlation was stronger in subjects with an ICA-IMT a parts per thousand yen 0.5 mm than in those with an ICA-IMT < 0.5 mm (Right side r = 0.475 vs. 0.246, Left side r = 0.498 vs. 0.301, respectively). Upon multivariate logistic regression analysis, angle alpha and serum low-density lipoprotein cholesterol were independent explanatory variables for ICA-IMT. Angle alpha is related to ICA-IMT in subjects with atherosclerotic disease or risk factors in this study.	[Daitoku, Satoshi; Horiuchi, Masahisa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Hyg & Hlth Promot Med, Kagoshima 8908544, Japan; [Daitoku, Satoshi; Yuasa, Toshinori; Horiuchi, Masahisa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Med & Hypertens, Kagoshima 8908544, Japan; [Daitoku, Satoshi; Tsunenari, Hiroshi; Maenohara, Shigeho] Kagoshima Kouseiren Hosp, Kagoshima, Japan; [Mine, Kazuharu; Tamatsu, Yuichi; Shimada, Kazuyuki] Kagoshima Univ, Dept Gross, Anat Sect, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Koriyama, Chihaya] Kagoshima Univ, Dept Epidemiol & Prevent Med, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Horiuchi, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Hyg & Hlth Promot Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	ohishi@m2.kufm.kagoshima-u.ac.jp; masakun@m.kufm.kagoshima-u.ac.jp			Kagoshima University	We would like to thank the late Prof. Toru Takeuchi for encouraging us to continue with this work and Mr. Daniel Mrozek and Ms. Rinko Kawakami for copyediting. This research was supported by a research fund from Kagoshima University.	Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7; Del Corso L, 1998, ANGIOLOGY, V49, P361, DOI 10.1177/000331979804900505; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Simons PCG, 1999, CIRCULATION, V100, P951; Lehmann ED, 1998, HYPERTENSION, V32, P565; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; van Popele NM, 2001, STROKE, V32, P454; Okamura T, 2009, ATHEROSCLEROSIS, V203, P587, DOI 10.1016/j.atherosclerosis.2008.07.020; Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916; Anderson GB, 2000, STROKE, V31, P2168; Krishnaswamy A, 2010, CATHETER CARDIO INTE, V75, P530, DOI 10.1002/ccd.22299; Payen T, 2013, ULTRASOUND MED BIOL, V39, P1826, DOI 10.1016/j.ultrasmedbio.2013.03.022; SALONEN R, 1995, CIRCULATION, V92, P1758; Aristokleous N, 2011, IEEE T INF TECHNOL B, V15, P148, DOI 10.1109/TITB.2010.2091417; Ikkruthi S, 2014, ACTA PHYSIOL HUNG, V101, P13, DOI 10.1556/APhysiol.100.2013.017; Jartti L, 2002, ARTERIOSCL THROM VAS, V22, P832, DOI 10.1161/01.ATV.0000013313.70875.A7; Kweon SS, 2012, CIRC J, V76, P2041, DOI 10.1253/circj.CJ-11-1353; Liang LR, 2009, PREV MED, V49, P62, DOI 10.1016/j.ypmed.2009.05.006; Le Bret E, 2000, CIRCULATION, V102, pE173; PERKTOLD K, 1990, J BIOMED ENG, V12, P111, DOI 10.1016/0141-5425(90)90131-6; Sawabe M, 2005, ATHEROSCLEROSIS, V179, P345, DOI 10.1016/j.atherosclerosis.2004.09.023; Schulz UGR, 2001, STROKE, V32, P2522, DOI 10.1161/hs1101.097391; Sehirli US, 2005, SURG RADIOL ANAT, V27, P292, DOI 10.1007/s00276-005-0322-y; Sitzer M, 2003, STROKE, V34, P950, DOI 10.1161/01.STR.0000060895.38298.C4; Tokita A, 2009, ATHEROSCLEROSIS, V206, P168, DOI 10.1016/j.atherosclerosis.2009.01.046; WEIBEL J, 1965, NEUROLOGY, V15, P462; WILSON PWF, 1985, CLIN CHIM ACTA, V151, P285, DOI 10.1016/0009-8981(85)90091-9; Zhao JY, 2008, ATHEROSCLEROSIS, V197, P814, DOI 10.1016/j.atheroselerosis.2007.07.030; Ziegelbauer K, 2013, EUR J PREV CARDIOL, V20, P837, DOI 10.1177/2047487312449589	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAY	2015	20	3					216	223		10.1007/s12199-015-0453-7		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CI3AA	WOS:000354618500007		
J	Narisada, A; Hasegawa, T; Nakahigashi, M; Hirobe, T; Ikemoto, T; Ushida, T; Kobayashi, F				Narisada, Akihiko; Hasegawa, Tomomi; Nakahigashi, Maki; Hirobe, Takaaki; Ikemoto, Tatsunori; Ushida, Takahiro; Kobayashi, Fumio			Inverse association of des-acyl ghrelin with worksite blood pressure in overweight/obese male workers	ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE			English	Article						Worksite blood pressure; Des-acyl ghrelin; Job strain; Obesity; Ambulatory blood pressure monitoring	MALE JAPANESE WORKERS; SLEEP QUALITY INDEX; BODY-MASS INDEX; JOB STRAIN; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; WORKPLACE HYPERTENSION; PSYCHOLOGICAL STRESS; ABDOMINAL ADIPOSITY; PSYCHOSOCIAL STRESS	Job strain, defined as a combination of high job demands and low job control, has been reported to elevate blood pressure (BP) during work. Meanwhile, a recent experimental study showed that ghrelin blunted the BP response to such mental stress. In the present study, we examined the hypothesis that des-acyl ghrelin may have some beneficial effects on worksite BP through modulating the BP response to work-related mental stress, i.e., job strain. Subjects were 34 overweight/obese male day-shift workers (mean age 41.7 +/- A 6.7 years). No subjects had received any anti-hypertensive medication. A 24-h ambulatory BP monitoring was recorded every 30 min on a regular working day. The average BP was calculated for Work BP, Morning BP, and Home BP. Job strain was assessed using the short version of the Japanese Job Content Questionnaire. Des-acyl ghrelin showed significant inverse correlations with almost all BPs except Morning SBP, Morning DBP, and Home DBP. In multiple regression analysis, des-acyl ghrelin inversely correlated with Work SBP after adjusting for confounding factors. Des-acyl ghrelin was also negatively associated with BP changes from Sleep to Morning, Sleep to Work, and Sleep to Home. Des-acyl ghrelin was inversely associated with Worksite BP, suggesting a unique beneficial effect of des-acyl ghrelin on Worksite BP in overweight/obese male day-shift workers.	[Narisada, Akihiko; Hasegawa, Tomomi; Nakahigashi, Maki; Hirobe, Takaaki; Kobayashi, Fumio] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagakute, Aichi 4801195, Japan; [Hasegawa, Tomomi; Ikemoto, Tatsunori; Ushida, Takahiro] Aichi Med Univ, Inst Phys Fitness Sports Med & Rehabil, Nagakute, Aichi 4801195, Japan	Narisada, A (reprint author), Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	akihikonarisada@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460820]	This research was supported in part by Grants-in-Aid for Scientific Research (25460820) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Carroll D, 2008, PSYCHOSOM MED, V70, P653, DOI 10.1097/PSY.0b013e31817b9382; Kario K, 2002, HYPERTENS RES, V25, P499; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Steptoe A, 2005, INT J OBESITY, V29, P1329, DOI 10.1038/sj.ijo.0803011; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Hamer M, 2012, PSYCHOSOM MED, V74, P896, DOI 10.1097/PSY.0b013e31827457f4; Ishizaki M, 2008, SCAND J WORK ENV HEA, V34, P288; Lambert E, 2011, HYPERTENSION, V58, P43, DOI 10.1161/HYPERTENSIONAHA.111.171025; Tsutsumi A, 2003, INT J BEHAV MED, V10, P125, DOI 10.1207/S15327558IJBM1002_03; Nishitani N, 2009, NUTRITION, V25, P45, DOI 10.1016/j.nut.2008.07.008; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cederberg H, 2011, EUR J ENDOCRINOL, V165, P243, DOI 10.1530/EJE-11-0334; Akamizu T, 2005, J CLIN ENDOCR METAB, V90, P6, DOI 10.1210/jc.2004-1640; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Tong J, 2013, EUR J ENDOCRINOL, V168, P821, DOI 10.1530/EJE-13-0072; Chandola T, 2006, BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Mancia G, 2000, HYPERTENSION, V36, P894; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Nomura K, 2010, AM J IND MED, V53, P1128, DOI 10.1002/ajim.20859; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Hiro H, 2007, IND HEALTH, V45, P415, DOI 10.2486/indhealth.45.415; Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058; DEVEREUX RB, 1983, CIRCULATION, V68, P470; Rosenthal T, 2012, J AM SOC HYPERTENS, V6, P2, DOI 10.1016/j.jash.2011.09.002; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Tesauro M, 2009, HYPERTENSION, V54, P995, DOI 10.1161/HYPERTENSIONAHA.109.137729; Siervo M, 2009, HORM METAB RES, V41, P261, DOI 10.1055/s-0028-1119377; Chuang J.C., 2010, INT J PEPT, V2010, DOI DOI 10.1155/2010/460549; Foster-Schubert KE, 2005, J CLIN ENDOCR METAB, V90, P820, DOI 10.1210/jc.2004-2081; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; Harada K, 2006, HYPERTENS RES, V29, P969, DOI 10.1291/hypres.29.969; Inoue Y, 2013, BIOCHEM BIOPH RES CO, V430, P278, DOI 10.1016/j.bbrc.2012.10.137; Isgaard J, 2011, MOL CELL ENDOCRINOL, V340, P59, DOI 10.1016/j.mce.2011.03.006; JCS Joint Working Group, 2010, GUID CLIN US 24 HOUR; Kawakami N, 2006, J EPIDEMIOL, V16, P79, DOI 10.2188/jea.16.79; Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, P61; Pacifico L, 2009, EUR J ENDOCRINOL, V161, P861, DOI 10.1530/EJE-09-0375; Rodriguez A, 2010, J HYPERTENS, V28, P560, DOI 10.1097/HJH.0b013e328334327c; Stengel A, 2010, PEPTIDES, V31, P1689, DOI 10.1016/j.peptides.2010.06.015; Stengel A, 2011, PEPTIDES, V32, P2208, DOI 10.1016/j.peptides.2011.07.002; Sung BH, 1997, HYPERTENSION, V30, P848; Ando T, 2012, NUTRITION, V28, P967, DOI 10.1016/j.nut.2011.11.023; Camm AJ, 1996, CIRCULATION, V93, P1043; Tesauro M, 2010, INT J PEPTIDES, V2010; Tsubota Y, 2005, NEUROREPORT, V16, P163, DOI 10.1097/00001756-200502080-00019; Uno H, 2006, HYPERTENS RES, V29, P937, DOI 10.1291/hypres.29.937; Yano Y, 2014, AM J HYPERTENS, V27, P727, DOI 10.1093/ajh/hpt232; Yano Y, 2009, ATHEROSCLEROSIS, V204, P590, DOI 10.1016/j.atherosclerosis.2008.10.013	51	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-078X	1347-4715		ENVIRON HEALTH PREV	Environ. Health Prev.	MAY	2015	20	3					224	231		10.1007/s12199-015-0454-6		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CI3AA	WOS:000354618500008		
J	Li, JL; Lim, JCH; Tay, FW; Goh, CC; Lee, B; Malleret, B; Tanizaki, H; Bakocevic, N; Chong, SZ; Lim, HY; Renia, L; Poidinger, M; Weninger, W; Angeli, V; St John, AL; Harris, JE; Kabashima, K; Tan, SM; Karjalainen, KE; Larbi, A; Ng, LG				Li, J. L.; Lim, J. C. H.; Tay, F. W.; Goh, C. C.; Lee, B.; Malleret, B.; Tanizaki, H.; Bakocevic, N.; Chong, S. Z.; Lim, H. Y.; Renia, L.; Poidinger, M.; Weninger, W.; Angeli, V.; St John, A. L.; Harris, J. E.; Kabashima, K.; Tan, S. M.; Karjalainen, K. E.; Larbi, A.; Ng, L. G.			CXCL2 acts as an autocrine/paracrine mediator of neutrophil recruitment and function during murine immune complex-mediated inflammation	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Meeting Abstract									[Li, J. L.; Lim, J. C. H.; Tay, F. W.; Goh, C. C.; Lee, B.; Malleret, B.; Bakocevic, N.; Chong, S. Z.; Renia, L.; Poidinger, M.; Larbi, A.; Ng, L. G.] ASTAR, Biopolis, Singapore Immunol Network SIgN, Singapore, Singapore; [Li, J. L.; Lim, J. C. H.; Tay, F. W.; Tan, S. M.; Karjalainen, K. E.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Tanizaki, H.; Kabashima, K.] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Lim, H. Y.; Angeli, V.] Natl Univ Singapore, Dept Microbiol, Yoon Loo Lin Sch Med, Immunol Programme, Singapore 117548, Singapore; [St John, A. L.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Dept Pathol, Singapore, Singapore; [Weninger, W.] Centenary Inst Canc Med & Cell Biol, Newtown, NSW, Australia; [Harris, J. E.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	MAY	2015	45			2	SI	5.02	47	48				2	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CH6CZ	WOS:000354124800128		
J	Gyori, D; Csete, D; Szita, VR; Kato, S; Tarakhovsky, A; Mocsai, A				Gyori, D.; Csete, D.; Szita, V. R.; Kato, S.; Tarakhovsky, A.; Mocsai, A.			The Syk tyrosine kinase regulates in vivo bone homeostasis	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Meeting Abstract									[Gyori, D.; Csete, D.; Szita, V. R.; Mocsai, A.] Semmelweis Univ, Sch Med, Dept Physiol, MTA SE Lendulet Inflammat Physiol Res Grp, Budapest, Hungary; [Kato, S.] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Tarakhovsky, A.] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	MAY	2015	45			2	SI	6.06	64	64				1	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	CH6CZ	WOS:000354124800175		
J	Sato, H; Yamaguchi, M; Onuki, T; Noguchi, M; Newton, GN; Shiga, T; Oshio, H				Sato, Hiroki; Yamaguchi, Momoyo; Onuki, Tatsuya; Noguchi, Mao; Newton, Graham N.; Shiga, Takuya; Oshio, Hiroki			Pentanuclear and Octanuclear Manganese Helices	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Supramolecular chemistry; Polynuclear complexes; Helical structures; Magnetic properties; Manganese	SINGLE-MOLECULE MAGNETS; WATER OXIDATION; GROUND-STATE; CLUSTERS; COMPLEXES; EVOLUTION; CATALYSTS; SYMMETRY; DESIGN; LIGAND	Two helical manganese complexes, [Mn-5(L)(3)((3)-O)(NO3)(OMe)(2)(MeOH)](NO3)4MeOHH(2)O (1) and [Mn-8(L)(6)((3)-Cl)(2)]Cl(2)3C(2)H(4)Cl(2)60H(2)O2DMF (2, DMF = N,N-dimethylformamide), were obtained by the reaction of the multidentate polypyridine ligand 2,6-bis[5-(2-pyridinyl)-1H-pyrazole-3-yl]-pyridine (H2L) with manganese nitrate and chloride, respectively. The compounds were characterized by elemental analyses and single-crystal X-ray structural analyses. The pentanuclear complex 1 is composed of three ligands and five manganese ions with (3)-oxido bridges, whereas the octanuclear complex 2 is constructed from six ligands and eight manganese ions with two (3)-chlorido bridges. Both compounds have helix-type structures. The manganese ions in 1 are present in a mixture of +2 and +3 valence states, whereas 2 is homovalent and contains only +2 ions. The magnetic properties of both compounds were investigated in the temperature range 1.8-300 K, and antiferromagnetic interactions between the manganese ions are dominant in both complexes.	[Sato, Hiroki; Yamaguchi, Momoyo; Onuki, Tatsuya; Noguchi, Mao; Newton, Graham N.; Shiga, Takuya; Oshio, Hiroki] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan	Oshio, H (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	oshio@chem.tsukuba.ac.jp	Newton, Graham/A-3667-2013		Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2107]	The authors gratefully acknowledge a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (scientific research with the framework of the Priority Area "Coordination Programming", area 2107).	Taguchi T, 2008, INORG CHEM, V47, P4095, DOI 10.1021/ic701756p; Kirillov AM, 2012, COORDIN CHEM REV, V256, P2741, DOI 10.1016/j.ccr.2012.07.022; Sato H, 2013, INORG CHEM, V52, P9714, DOI 10.1021/ic401445u; Jones LE, 2002, ANGEW CHEM INT EDIT, V41, P4318, DOI 10.1002/1521-3773(20021115)41:22<4318::AID-ANIE4318>3.0.CO;2-I; Chilton NF, 2013, J COMPUT CHEM, V34, P1164, DOI 10.1002/jcc.23234; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Shiga T, 2009, CHEM-ASIAN J, V4, P1660, DOI 10.1002/asia.200900216; Ueno T, 2007, COORDIN CHEM REV, V251, P2717, DOI 10.1016/j.ccr.2007.04.007; Ungur L, 2014, CHEM SOC REV, V43, P6894, DOI 10.1039/c4cs00095a; Hoshino N, 2009, INORG CHEM, V48, P3396, DOI 10.1021/ic801776w; Bagai R, 2009, CHEM SOC REV, V38, P1011, DOI 10.1039/b811963e; Ruettinger W, 2000, J AM CHEM SOC, V122, P10353, DOI 10.1021/ja0005587; Brechin EK, 2005, INORG CHEM, V44, P502, DOI 10.1021/ic048857a; Ishikawa R, 2010, CHEM-EUR J, V16, P11139, DOI 10.1002/chem.201000676; Bao X, 2013, INORG CHEM, V52, P1099, DOI 10.1021/ic3024056; Klingele J, 2009, COORDIN CHEM REV, V253, P2698, DOI 10.1016/j.ccr.2009.03.026; Boskovic C, 2002, J AM CHEM SOC, V124, P3725, DOI 10.1021/ja012403k; Shiga T, 2013, DALTON T, V42, P16185, DOI 10.1039/c3dt51480c; Ding CX, 2013, CHEM-EUR J, V19, P9961, DOI 10.1002/chem.201301041; Hou JZ, 2008, ANGEW CHEM INT EDIT, V47, P1711, DOI 10.1002/anie.200704874; Tandon SS, 2012, INORG CHEM, V51, P3270, DOI 10.1021/ic202732k; Lippert B, 2011, CHEM SOC REV, V40, P4475, DOI 10.1039/c1cs15090a; Newton GN, 2011, ANGEW CHEM INT EDIT, V50, P4844, DOI 10.1002/anie.201007388; Wang WG, 2007, J AM CHEM SOC, V129, P1014, DOI 10.1021/ja065707l; Mezei G, 2007, CHEM REV, V107, P4933, DOI 10.1021/cr078200h; Zeng YF, 2009, CHEM SOC REV, V38, P469, DOI 10.1039/b718581m; Kostakis GE, 2010, CHEM SOC REV, V39, P2238, DOI 10.1039/b918192j; DuBois MR, 2009, CHEM SOC REV, V38, P62, DOI 10.1039/b801197b; Rebilly JN, 2006, STRUCT BOND, V122, P103, DOI 10.1007/430032; Miras HN, 2012, CHEM SOC REV, V41, P7403, DOI 10.1039/c2cs35190k; Escuer A, 2014, COORDIN CHEM REV, V275, P87, DOI 10.1016/j.ccr.2014.04.001; Borras-Almenar JJ, 2001, J COMPUT CHEM, V22, P985, DOI 10.1002/jcc.1059; Aromi G, 2006, STRUCT BOND, V122, P1, DOI 10.1007/430_022; Brechin EK, 2002, CHEM COMMUN, P2252, DOI 10.1039/b206386g; Foguet-Albiol D., 2005, ANGEW CHEM INT EDIT, V44, P897; Foguet-Albiol D., 2005, ANGEW CHEM, V117, P919; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Hou Z., 2008, ANGEW CHEM, V120, P1735; Inglis R, 2009, DALTON T, P3403, DOI 10.1039/b822235e; Jones L. F., 2002, ANGEW CHEM, V114, P4494, DOI 10.1002/1521-3757(20021115)114:22<4494::AID-ANGE4494>3.0.CO;2-#; Inglis R, 2012, CHEM COMMUN, V48, P181, DOI 10.1039/c1cc13558a; Newton G. N., 2011, ANGEW CHEM, V123, P4946, DOI 10.1002/ange.201007388; Romain S., 2011, INORG CHEM, V50, P5427; Saalfrank RW, 1998, EUR J INORG CHEM, P559; Sheldrick G. M., 1997, SADABS; Sheldrick G.M., 1997, SHELXS97 SHELXL97	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	MAY	2015		13					2193	2198		10.1002/ejic.201500096		6	Chemistry, Inorganic & Nuclear	Chemistry	CH7KE	WOS:000354214300002		
J	Mochida, T; Funasako, Y; Nezu, Y; Hagiwara, K; Horikoshi, R				Mochida, Tomoyuki; Funasako, Yusuke; Nezu, Yukiko; Hagiwara, Koji; Horikoshi, Ryo			Ferrocenyl-Bipyridinium Cations and Their Platinum Complexes Related to Viologens - Preparation, Redox Properties, and Crystal Structures	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Metallocenes; Viologens; Platinum; Donor-acceptor systems; Electrochemistry	INTRAMOLECULAR ELECTRON-TRANSFER; CHARGE-TRANSFER SALTS; BEHAVIOR; SYSTEMS; REDUCTION; ACCEPTOR; DELOCALIZATION; CONDUCTIVITY; LIGAND	N-R-1-N-R-2-4,4-Bipyridinium and N-R-1-4,4-bipyridinium salts containing ferrocenyl substituents were prepared as donor-acceptor compounds (R-1 = ferrocenyl, ferrocenylphenyl; R-2 = ferrocenyl, ferrocenylphenyl, phenyl, methyl). Platinum(II)-bridged diferrocene compounds were prepared by using the N-R-1-4,4-bipyridinium ligands. These compounds display multistage redox properties. The redox potentials of the ferrocenyl and bipyridinium moieties in these compounds are independently affected by molecular modifications, which indicates that conjugation between the donor and acceptor moieties is less effective. Single-crystal X-ray diffraction analyses revealed large twist angles between the two moieties in the solid state. The compounds exhibit broad charge-transfer absorption bands in the range 450-800 nm. No electronic communication was observed between the terminal ferrocenes in the diferrocene complexes.	[Mochida, Tomoyuki; Funasako, Yusuke] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Mochida, Tomoyuki; Nezu, Yukiko; Hagiwara, Koji; Horikoshi, Ryo] Toho Univ, Fac Sci, Dept Chem, Chiba 2748510, Japan; [Horikoshi, Ryo] Osaka Sangyo Univ, Coll Gen Educ, Dept Chem, Daito, Osaka 5748530, Japan	Mochida, T (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan.	tmochida@platinum.kobe-u.ac.jp	Mochida, Tomoyuki/F-8555-2012	Mochida, Tomoyuki/0000-0002-3446-2145	KAKENHI from Japan Society for the Promotion of Science [26104524]	This work was financially supported by KAKENHI from Japan Society for the Promotion of Science (grant number 26104524). The authors thank K. Okazawa and T. Akasaka (Toho University) for their help with X-ray crystallography.	Adams RD, 2002, ORGANOMETALLICS, V21, P2970, DOI 10.1021/om0201213; Alain V, 1996, INORG CHIM ACTA, V242, P43, DOI 10.1016/0020-1693(95)04847-2; Allen J. G., 1971, ALLEN JG, Patent No. 1399595; BIRD CL, 1981, CHEM SOC REV, V10, P49, DOI 10.1039/cs9811000049; Butler IR, 2013, INORG CHIM ACTA, V396, P1, DOI 10.1016/j.ica.2012.11.007; ABE M, 1995, INORG CHEM, V34, P4490, DOI 10.1021/ic00121a030; Dengiz C, 2015, J ORG CHEM, V80, P882, DOI 10.1021/jo502367h; Trabolsi A, 2010, NAT CHEM, V2, P42, DOI [10.1038/nchem.479, 10.1038/NCHEM.479]; Shoji T, 2015, CHEM-EUR J, V21, P402, DOI 10.1002/chem.201405004; BOCKMAN TM, 1990, J ORG CHEM, V55, P4127, DOI 10.1021/jo00300a033; Kaur P, 2012, J MATER CHEM, V22, P10597, DOI 10.1039/c2jm31387a; Kurihara M, 2002, COORDIN CHEM REV, V226, P125, DOI 10.1016/S0010-8545(01)00421-0; ASHWELL GJ, 1984, PHYS STATUS SOLIDI A, V82, P301, DOI 10.1002/pssa.2210820138; Mochida T, 2012, INORG CHIM ACTA, V384, P111, DOI 10.1016/j.ica.2011.11.043; Iordache A, 2012, J AM CHEM SOC, V134, P2653, DOI 10.1021/ja209766e; Zhu YB, 2000, J AM CHEM SOC, V122, P10121, DOI 10.1021/ja0008564; MILLER JS, 1988, CHEM REV, V88, P201, DOI 10.1021/cr00083a010; Ashwell G. J., 1983, J CHEM SOC PERK T, V2, P1787; CARUGO O, 1992, INORG CHEM, V31, P765, DOI 10.1021/ic00031a014; CHEN PY, 1989, INORG CHEM, V28, P2271, DOI 10.1021/ic00311a007; Coe BJ, 2013, COORDIN CHEM REV, V257, P1438, DOI 10.1016/j.ccr.2012.06.025; Coe BJ, 1998, INORG CHEM, V37, P3391, DOI 10.1021/ic971411s; Coe BJ, 2011, ORGANOMETALLICS, V30, P5731, DOI 10.1021/om200604f; Colbert MCB, 1997, J CHEM SOC DALTON, P99, DOI 10.1039/a605177d; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Geiger W. E., 2010, ACCOUNTS CHEM RES, V43, P1130; HENDRICKSON DN, 1991, NATO ADV SCI I C-MAT, V343, P67; HUNIG S, 1980, TOP TOP CURR CHEM, V92, P1; HUNIG S, 1979, LIEBIGS ANN CHEM, P1523; Ippolitova V. P., 1969, ZH OBSHCH KHIM+, V39, P826; Jonsson M., 1999, J CHEM SOC P2, P425; KAMOGAWA H, 1991, B CHEM SOC JPN, V64, P321, DOI 10.1246/bcsj.64.321; KISCH H, 1993, COORDIN CHEM REV, V125, P155, DOI 10.1016/0010-8545(93)85015-V; Kowalski K., 2013, ORGANOMETALLICS, V33, P4697; Leventis N, 2004, J PHYS CHEM B, V108, P11228, DOI 10.1021/jp049608a; Lloveras V, 2005, EUR J INORG CHEM, P2436; Long N.J., 1998, METALLOCENES INTRO S; MARVELL EN, 1970, J AM CHEM SOC, V92, P5641, DOI 10.1021/ja00722a016; Mercier N, 2013, EUR J INORG CHEM, P19, DOI 10.1002/ejic.201201125; Mochida T, 2006, J ORGANOMET CHEM, V691, P4882, DOI 10.1016/j.jorganchem.2006.08.020; Mochida T, 2002, J CHEM SOC DALTON, P3559, DOI 10.1039/b204168e; Monk P. M. S., 1998, VIOLOGENS PHYSICOCHE; Moriuchi T, 2003, B CHEM SOC JPN, V76, P595; Nishikitani Y, 2008, J PHYS CHEM C, V112, P4372, DOI 10.1021/jp711103h; Proter III W. W., 2005, J ORG CHEM, V70, P5028; Ribou AC, 1996, INORG CHEM, V35, P3735, DOI 10.1021/ic951376u; Sheldrick G M, 1997, SHELXS 97 PROGRAM SO; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shoji T, 2013, CHEM-EUR J, V19, P5721, DOI 10.1002/chem.201202257; SHU CF, 1988, INORG CHEM, V27, P4326, DOI 10.1021/ic00296a051; Togni A., 1995, FERROCENES HOMOGENEO; Yip JHK, 2002, ORGANOMETALLICS, V21, P5292, DOI 10.1021/om020513+; Zhu YB, 1998, J AM CHEM SOC, V120, P1812, DOI 10.1021/ja9732486	53	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	MAY	2015		13					2330	2337		10.1002/ejic.201500077		8	Chemistry, Inorganic & Nuclear	Chemistry	CH7KE	WOS:000354214300019		
J	Tamura, K; Kumagai, N; Shibasaki, M				Tamura, Keiji; Kumagai, Naoya; Shibasaki, Masakatsu			Direct Catalytic Asymmetric Mannich-Type Reaction of Benzyl Isocyanide: Stereoselective Synthesis of 1,2-Diarylethylenediamines	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Isocyanides; Asymmetric catalysis; Chiral diamines; Mannich reaction; Imidazoline	ENANTIOSELECTIVE SYNTHESIS; CONTROLLER SYSTEM; ORGANIC-SYNTHESIS; VICINAL DIAMINES; N-SULFONYLIMINES; PRACTICAL METHOD; KETIMINES; ISOCYANOACETATES; COMPLEX; CONVENIENT	A direct catalytic asymmetric Mannich-type reaction of benzyl isocyanide using a Cu-I catalyst and N-(diphenylthiophosphinoyl)imines was developed. The simultaneous activation strategy by soft-soft interaction was the key to promote the reaction using a weakly acidic pronucleophile, benzyl isocyanide. The spontaneous cyclization of the Mannich adduct afforded the corresponding enantioenriched imidazolines, which could be precursors for a variety of 1,2-diarylethylenediamines.	[Tamura, Keiji; Kumagai, Naoya; Shibasaki, Masakatsu] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 1410021, Japan; [Shibasaki, Masakatsu] JST, ACT C, Shinagawa Ku, Tokyo 1410021, Japan	Kumagai, N (reprint author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	nkumagai@bikaken.or.jp; mshibasa@bikaken.or.jp			JST; ACT-C; KAKENHI from JSPS [25713002]	This work was financially supported by JST, ACT-C, and KAKENHI (no. 25713002) from JSPS.	Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Paull DH, 2008, ACCOUNTS CHEM RES, V41, P655, DOI 10.1021/ar700261a; Elders N, 2007, J ORG CHEM, V72, P6135, DOI 10.1021/jo070840x; Chen IH, 2010, ORG LETT, V12, P4098, DOI 10.1021/ol101691p; Park JK, 2010, ORG LETT, V12, P5008, DOI 10.1021/ol1021756; Stollenz M, 2012, ORGANOMETALLICS, V31, P7708, DOI 10.1021/om3007689; Funk TW, 2006, J AM CHEM SOC, V128, P1840, DOI 10.1021/ja055994d; Arai T, 2014, ORG LETT, V16, P2768, DOI 10.1021/ol501085y; TSUDA T, 1981, J ORG CHEM, V46, P192, DOI 10.1021/jo00314a048; Sureshkumar D, 2014, CHEM-EUR J, V20, P15723, DOI 10.1002/chem.201404808; Shao PL, 2014, ANGEW CHEM INT EDIT, V53, P5435, DOI 10.1002/anie.201402788; Kobayashi S, 2002, J AM CHEM SOC, V124, P5640, DOI 10.1021/ja026094p; Bon RS, 2003, ORG LETT, V5, P3759, DOI 10.1021/ol035521g; Yin L, 2013, ANGEW CHEM INT EDIT, V52, P7310, DOI 10.1002/anie.201303119; Kumagai N, 2011, ANGEW CHEM INT EDIT, V50, P4760, DOI 10.1002/anie.201100918; Shibasaki M, 2002, CHEM REV, V102, P2187, DOI 10.1021/cr010297z; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; Yin L, 2013, ORG LETT, V15, P698, DOI 10.1021/ol3035609; IRIE R, 1991, TETRAHEDRON LETT, V32, P1055, DOI 10.1016/S0040-4039(00)74486-8; Fujii A, 1996, J AM CHEM SOC, V118, P2521, DOI 10.1021/ja954126l; Kobayashi S, 2003, J AM CHEM SOC, V125, P2507, DOI 10.1021/ja0281840; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394; Hayashi M, 2014, ANGEW CHEM INT EDIT, V53, P8411, DOI 10.1002/anie.201404629; Zhao MX, 2014, ORG LETT, V16, P4566, DOI 10.1021/ol502123z; Aydin J, 2008, TETRAHEDRON-ASYMMETR, V19, P1867, DOI 10.1016/j.tetasy.2008.07.027; Gulevich AV, 2010, CHEM REV, V110, P5235, DOI 10.1021/cr900411f; Kawato Y, 2013, CHEM COMMUN, V49, P11227, DOI 10.1039/c3cc47117a; COREY EJ, 1989, J AM CHEM SOC, V111, P5493, DOI 10.1021/ja00196a081; Xu XY, 2006, LETT ORG CHEM, V3, P640, DOI 10.2174/157017806778559446; Zhang ZW, 2010, TETRAHEDRON-ASYMMETR, V21, P1715, DOI 10.1016/j.tetasy.2010.04.029; Kim HJ, 2005, J AM CHEM SOC, V127, P16776, DOI 10.1021/ja0557785; Xu XY, 2008, HETEROATOM CHEM, V19, P238, DOI 10.1002/hc.20412; Kim H, 2008, J AM CHEM SOC, V130, P12184, DOI 10.1021/ja803951u; Yin L, 2013, J AM CHEM SOC, V135, P10338, DOI 10.1021/ja4059316; Zhong YW, 2004, ORG LETT, V6, P4747, DOI 10.1021/ol0479803; Arrayas RG, 2009, CHEM SOC REV, V38, P1940, DOI 10.1039/b820303b; Zhou XT, 1999, J ORG CHEM, V64, P1331, DOI 10.1021/jo980949s; Nakamura S, 2012, ORG LETT, V14, P2960, DOI 10.1021/ol301256q; COREY EJ, 1989, J AM CHEM SOC, V111, P9243, DOI 10.1021/ja00208a025; GUST R, 1990, J MED CHEM, V33, P2535, DOI 10.1021/jm00171a031; Hayashi M., 2014, ANGEW CHEM, V126, P8551; Honey MA, 2014, CHEM COMMUN, V50, P3288, DOI 10.1039/c3cc49808e; Kanai M, 2005, SYNLETT, P1491, DOI 10.1055/s-2005-869831; Kumagai N., 2011, ANGEW CHEM, V123, P4856; Lucet D., 1998, ANGEW CHEM INT EDIT, V37, P2580, DOI DOI 10.1002/(SICI)1521-3773(19981016)37:19<2580::AID-ANIE2580>3.0.CO;2; Lucet D., 1998, ANGEW CHEM, V110, P2724, DOI 10.1002/(SICI)1521-3757(19981002)110:19<2724::AID-ANGE2724>3.0.CO;2-4; Ortin I, 2014, ANGEW CHEM INT EDIT, V53, P3462, DOI 10.1002/anie.201309719; Ortin I., 2014, ANGEW CHEM, V126, P3530; ROSKAMP EJ, 1987, J AM CHEM SOC, V109, P3152, DOI 10.1021/ja00244a052; Shao P.-L., 2014, ANGEW CHEM, V126, P5539; Weinreb SM, 2005, SYNTHESIS-STUTTGART, P1205, DOI 10.1055/s-2005-865315; Yamamoto H., 2005, ANGEW CHEM, V117, P1958, DOI 10.1002/ange.200460394; Yamamoto H., 2008, ACID CATALYSIS MODER; Yin L., 2013, ANGEW CHEM, V125, P7451	54	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	MAY	2015		14					3026	3031		10.1002/ejoc.201500336		6	Chemistry, Organic	Chemistry	CH7JK	WOS:000354212000004		
J	Matsuda, T; Suzuki, K				Matsuda, Takanori; Suzuki, Kentaro			Rhodium(III)-Catalyzed [2+2+2] Cyclotrimerization of Diynes with Maleic Anhydrides as Alkyne Equivalents	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Homogeneous catalysis; Rhodium; Cyclotrimerization; Anhydrides; Alkynes	C-H ACTIVATION; DIRECTED CYCLOADDITION REACTIONS; N BOND FORMATION; DECARBOXYLATIVE CYCLOADDITION; SYNTHETIC APPLICATIONS; ORGANIC-SYNTHESIS; DIELS-ALDER; COMPLEXES; CATALYSTS; PYRIDINES	Substituted maleic anhydrides function as synthetic equivalents of alkynes in a rhodium(III)-catalyzed reaction with 1,6-diynes to achieve a formal [2+2+2] cyclotrimerization. This approach is useful for reactions involving alkynes with low boiling points or severe ring strain. Hard-to-access [2+2+2] cycloadducts are available through this new cycloaddition strategy by employing easy-to-handle alkyne equivalents.	[Matsuda, Takanori; Suzuki, Kentaro] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan	Matsuda, T (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	mtd@rs.tus.ac.jp	Matsuda, Takanori/A-9118-2010	Matsuda, Takanori/0000-0002-9927-3599	Japan Society for the Promotion of Science (JSPS) [25410054]; Sumitomo Foundation	This work was supported by Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for Scientific Research (C) No. 25410054] and the Sumitomo Foundation.	Dominguez G, 2011, CHEM SOC REV, V40, P3430, DOI 10.1039/c1cs15029d; Patureau FW, 2012, ALDRICHIM ACTA, V45, P31; Kuhl N, 2014, ADV SYNTH CATAL, V356, P1443, DOI 10.1002/adsc.201400197; Weding N, 2011, CHEM SOC REV, V40, P4525, DOI 10.1039/c0cs00189a; Tanaka K, 2009, CHEM-ASIAN J, V4, P508, DOI 10.1002/asia.200800378; Goel A, 2009, TETRAHEDRON, V65, P7865, DOI 10.1016/j.tet.2009.06.031; Itoh M, 2013, J ORG CHEM, V78, P11427, DOI 10.1021/jo401992d; Perreault S, 2009, CHEM SOC REV, V38, P3149, DOI 10.1039/b816702h; Zhu C, 2012, CHEM-ASIAN J, V7, P1502, DOI 10.1002/asia.201200035; Okamoto S, 2012, HETEROCYCLES, V85, P1579, DOI 10.3987/REV-12-737; Kirkham JD, 2012, ANGEW CHEM INT EDIT, V51, P6402, DOI 10.1002/anie.201200917; Shibata T, 2008, ORG BIOMOL CHEM, V6, P1317, DOI 10.1039/b720031e; Shibata Y, 2012, SYNTHESIS-STUTTGART, V44, P323, DOI 10.1055/s-0031-1289665; Chopade PR, 2006, ADV SYNTH CATAL, V348, P2307, DOI 10.1002/adsc.200600325; Cabrera-Pardo JR, 2013, NAT CHEM, V5, P423, DOI 10.1038/nchem.1612; Colby DA, 2012, ACCOUNTS CHEM RES, V45, P814, DOI 10.1021/ar200190g; Pena D, 2007, CHEM REC, V7, P326, DOI 10.1002/tcr.20132; Galan BR, 2009, ANGEW CHEM INT EDIT, V48, P2830, DOI 10.1002/anie.200804651; Tanaka K, 2012, HETEROCYCLES, V85, P1017, DOI 10.3987/REV-12-729; Hara H, 2008, ORG LETT, V10, P2537, DOI 10.1021/ol800813g; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; Song GY, 2012, CHEM SOC REV, V41, P3651, DOI 10.1039/c2cs15281a; Broere DLJ, 2012, SYNTHESIS-STUTTGART, V44, P2639, DOI 10.1055/s-0032-1316757; Crepin DF, 2013, ORG LETT, V15, P4222, DOI 10.1021/ol401952k; Fan FF, 2014, ADV SYNTH CATAL, V356, P1337, DOI 10.1002/adsc.201301037; Galan B. R., 2009, ANGEW CHEM, V121, P2870; Kirkham J. D., 2012, ANGEW CHEM, V124, P6508; Kotha S, 2005, EUR J ORG CHEM, P4741, DOI 10.1002/ejoc.200500411; Matsuda T, 2014, RSC ADV, V4, P37138, DOI 10.1039/c4ra06452f; Mohamed AB, 2003, CHEM COMMUN, P2936, DOI 10.1039/b310511c; Nakai K, 2013, CHEM LETT, V42, P1238, DOI 10.1246/cl.130578; Okura K, 2014, CHEM LETT, V43, P1349, DOI 10.1246/cl.140427; Reus C, 2012, J ORG CHEM, V77, P3518, DOI 10.1021/jo3002936; Sato Y, 2011, TETRAHEDRON LETT, V52, P626, DOI 10.1016/j.tetlet.2010.11.153; Stefane B, 2010, EUR J ORG CHEM, P5870, DOI 10.1002/ejoc.201000236; Tanaka K, 2013, TRANSITION-METAL-MEDIATED AROMATIC RING CONSTRUCTION, P1, DOI 10.1002/9781118629871; Tanaka K, 2007, SYNLETT, P1977, DOI 10.1055/s-2007-984541; Hara H, 2009, ORG LETT, V11, P1337, DOI 10.1021/ol900123d; Varela JA, 2008, SYNLETT, P2571, DOI 10.1055/s-2008-1078275; Zhang KN, 2011, J ORG CHEM, V76, P4686, DOI 10.1021/jo200236h	40	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	MAY	2015		14					3032	3035		10.1002/ejoc.201500252		4	Chemistry, Organic	Chemistry	CH7JK	WOS:000354212000005		
J	Wang, L; Yoshida, T; Muto, Y; Murai, Y; Tachrim, ZP; Ishida, A; Nakagawa, S; Sakihama, Y; Hashidoko, Y; Masuda, K; Hatanaka, Y; Hashimoto, M				Wang, Lei; Yoshida, Takuma; Muto, Yasuyuki; Murai, Yuta; Tachrim, Zetryana Puteri; Ishida, Akiko; Nakagawa, Shiori; Sakihama, Yasuko; Hashidoko, Yasuyuki; Masuda, Katsuyoshi; Hatanaka, Yasumaru; Hashimoto, Makoto			Synthesis of Diazirine-Based Photoreactive Saccharin Derivatives for the Photoaffinity Labeling of Gustatory Receptors	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Photoaffinity labeling; Receptors; Nitrogen heterocycles; Saccharin	TASTE RECEPTORS; TRIFLIC ACID; ACESULFAME-K; SWEET; CHEMISTRY; SUBUNITS; PROTEIN; PROBES; CELLS	Saccharin is one of the most common artificial sweeteners that has a bitter taste at high concentrations. Currently, there are no detailed functional analyses of these gustatory receptors. Therefore, we designed and synthesized photoreactive saccharin derivatives that contain a (trifluoromethyl) diazirinyl moiety at the 5- or 6-position for use as functional analysis tools for photoaffinity labeling.	[Wang, Lei; Yoshida, Takuma; Muto, Yasuyuki; Murai, Yuta; Tachrim, Zetryana Puteri; Ishida, Akiko; Nakagawa, Shiori; Sakihama, Yasuko; Hashidoko, Yasuyuki; Hashimoto, Makoto] Hokkaido Univ, Grad Sch Agr, Div Appl Sci, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Masuda, Katsuyoshi] Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan; [Hatanaka, Yasumaru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Hashimoto, M (reprint author), Hokkaido Univ, Grad Sch Agr, Div Appl Sci, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	hasimoto@abs.agr.hokudai.ac.jp	Hashimoto, Makoto/B-7837-2012		Japanese Suhara Memorial Foundation	The authors are very grateful to Professor G. D. Holman (University of Bath, UK) for valuable advice throughout the manuscript. M. H. thanks the Japanese Suhara Memorial Foundation for financial support. Part of this work was performed under the Cooperative Research Program of "Network Joint Research Center for Materials and Devices".	Tomohiro T, 2005, CHEM REC, V5, P385, DOI 10.1002/tcr.20058; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Moeker J, 2014, J MED CHEM, V57, P3522, DOI 10.1021/jm500255y; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.040384101; Ueda T, 2003, J NEUROSCI, V23, P7376; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Hashimoto M, 2008, EUR J ORG CHEM, P2513, DOI 10.1002/ejoc.200701069; NASSAL M, 1983, LIEBIGS ANN CHEM, P1510; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Hosoya T, 2004, ORG BIOMOL CHEM, V2, P637, DOI 10.1039/b316221d; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Blencowe A, 2007, MACROMOLECULES, V40, P939, DOI 10.1021/ma0619511; Hashimoto M, 2006, ANAL BIOCHEM, V348, P154, DOI 10.1016/j.ab.2005.10.015; Hatanaka Y, 2015, CHEM PHARM BULL, V63, P1, DOI 10.1248/cpb.c14-00645; HATANAKA Y, 1994, J ORG CHEM, V59, P383, DOI 10.1021/jo00081a017; Jakopin Z, 2010, CURR MED CHEM, V17, P651; Masuda K, 2010, BIOORG MED CHEM LETT, V20, P1081, DOI 10.1016/j.bmcl.2009.12.029; Moss RA, 2001, ORG LETT, V3, P2305, DOI 10.1021/ol010091k; Murai Y, 2012, J ORG CHEM, V77, P8581, DOI [10.1021/jo301552m, 10.1021/j0301552m]; Murashige R, 2009, BIOSCI BIOTECH BIOCH, V73, P1377, DOI 10.1271/bbb.90027; Nakajima K, 2006, APPL ENVIRON MICROB, V72, P3716, DOI 10.1128/AEM.72.5.3716-3723.2006; Suami T, 1998, FOOD CHEM, V63, P391, DOI 10.1016/S0308-8146(97)00241-0; Wang L, 2015, ORG LETT, V17, P616, DOI 10.1021/ol503630z; Wang L, 2014, BIOSCI BIOTECH BIOCH, V78, P1129, DOI 10.1080/09168451.2014.917267; Xia Y, 2013, CHEM REV, V113, P7880, DOI 10.1021/cr300419p; Xu LA, 2006, TETRAHEDRON, V62, P7902, DOI 10.1016/j.tet.2006.05.038	27	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	MAY	2015		14					3129	3134		10.1002/ejoc.201500184		6	Chemistry, Organic	Chemistry	CH7JK	WOS:000354212000021		
J	Miyamaru, S; Umezu, K; Ito, A; Shimizu, M				Miyamaru, Satoru; Umezu, Kazuto; Ito, Akinori; Shimizu, Makoto			Synthesis of Multisubstituted Dihydroquinoxaline Derivatives by Tandem N-Alkylation and Addition Reactions of 3-Oxoquinoxaline-2-carboxylates	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Tandem reactions; Umpolung; Metathesis; Alkylation; Nucleophilic addition; Nitrogen heterocycles	ALPHA-AMINO ESTERS; QUINOXALINE DERIVATIVES; IMINO ESTERS; RECEPTOR; METATHESIS; INHIBITORS; POTENT; HETEROCYCLES; MODEL; ACIDS	This report describes a one-pot synthesis of multisubstituted dihydroquinoxalin-2-ones using an umpolung N-alkylation followed by oxidation and C-alkylation reactions. Moreover, the synthesis of tricyclic compounds containing a dihydroquinoxaline skeleton was carried out by ring closing metathesis (RCM) of the resulting N,C-bis-addition products containing olefins.	[Miyamaru, Satoru; Shimizu, Makoto] Mie Univ, Grad Sch Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan; [Umezu, Kazuto; Ito, Akinori] Ihara Chem Ind Co Ltd, Taito Ku, Tokyo 1100008, Japan	Shimizu, M (reprint author), Mie Univ, Grad Sch Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.	mshimizu@chem.mie-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was supported by Grant-in-Aid for Scientific Research (B) and on Innovative Areas "Organic Synthesis Based on Reaction Integration, Development of New Methods and Creation of New Substances" from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Abu Shuheil MY, 2007, HETEROCYCLES, V71, P2155, DOI 10.1016/S0385-5414(07)81092-6; Erb W, 2009, J ORG CHEM, V74, P3109, DOI 10.1021/jo900210x; Kalinski C, 2006, TETRAHEDRON LETT, V47, P3423, DOI 10.1016/j.tetlet.2006.03.069; Gazit A, 1996, J MED CHEM, V39, P2170, DOI 10.1021/jm950727b; Shimizu M, 2011, CHEM LETT, V40, P351, DOI 10.1246/cl.2011.351; Oble J, 2007, HETEROCYCLES, V73, P503; Seitz LE, 2002, J MED CHEM, V45, P5604, DOI 10.1021/jm020310n; Hata S, 2011, J ORG CHEM, V76, P9670, DOI 10.1021/jo201692x; Patel M, 2000, BIOORG MED CHEM LETT, V10, P1729, DOI 10.1016/S0960-894X(00)00321-8; Abraham CJ, 2006, J AM CHEM SOC, V128, P13370, DOI 10.1021/ja065754d; Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882; SAKATA G, 1988, HETEROCYCLES, V27, P2481; Cai SX, 1997, J MED CHEM, V40, P730, DOI 10.1021/jm960654b; Curto JM, 2014, J ORG CHEM, V79, P5359, DOI 10.1021/jo500707t; Shimizu M, 2009, CHEM LETT, V38, P732, DOI 10.1246/cl.2009.732; CARTER GA, 1983, PESTIC SCI, V14, P135, DOI 10.1002/ps.2780140207; Cass L. M., 2001, J CLIN PHARMACOL, V10, P528; Cruz LA, 2008, J MED CHEM, V51, P5856, DOI 10.1021/jm701517b; Hata S, 2012, B CHEM SOC JPN, V85, P1203, DOI 10.1246/bcsj.20120195; Luo XH, 2010, ORG LETT, V12, P3574, DOI 10.1021/ol101454x; Mahaney PE, 2006, BIOORGAN MED CHEM, V14, P3455, DOI 10.1016/j.bmc.2006.01.001; Mizota I, 2013, ORG LETT, V15, P4206, DOI 10.1021/ol401934x; Niwa Y, 2003, J AM CHEM SOC, V125, P3720, DOI 10.1021/ja029639o; Shimizu M, 2005, J AM CHEM SOC, V127, P3296, DOI 10.1021/ja042330f; Smil DV, 2009, BIOORG MED CHEM LETT, V19, P688, DOI 10.1016/j.bmcl.2008.12.045; Su DS, 2003, J AM CHEM SOC, V125, P7516, DOI 10.1021/ja0353457; Tanimori S, 2009, BIOORG MED CHEM LETT, V19, P4119, DOI 10.1016/j.bmcl.2009.06.007; Tjen KCMF, 2000, CHEM COMMUN, P699, DOI 10.1039/b001253j; Xu LT, 2010, SYNLETT, P2285, DOI 10.1055/s-0030-1258030	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	MAY	2015		15					3327	3337		10.1002/ejoc.201500225		11	Chemistry, Organic	Chemistry	CI0HD	WOS:000354416800015		
J	Yamasaki, E; Kawakita, A; Sakai, S				Yamasaki, Eri; Kawakita, Atsushi; Sakai, Shoko			Diversity and evolution of pollinator rewards and protection by Macaranga (Euphorbiaceae) bracteoles	EVOLUTIONARY ECOLOGY			English	Article						Ant-plants; Euphorbiaceae; Extrafloral nectary; Hemipteran pollination; Macaranga; Thrips pollination	WIND POLLINATION; HUMMINGBIRD POLLINATION; SPECIES EUPHORBIACEAE; FLORAL TRAITS; SEQUENCE DATA; SYSTEMS; ANT; PHYLOGENY; HERBIVORE; MYRMECOPHYTISM	Flowering plants have modified their floral organs in remarkably diverse ways to optimize their interaction with pollinators. Although floral organs represent a major source of floral diversity, many plants also use extrafloral organs, such as bracts and bracteoles, in interacting with pollinators; however, the evolutionary dynamics of non-floral organs involved in pollination are poorly studied. The genus Macaranga is characterized by protective mutualisms with ants that potentially interfere with pollinators on flowers. Macaranga flowers lack perianths and, notably, bracteoles serve the dual function of rewarding pollinators and protecting them from guarding ants; in one group of species, bracteoles provide a nectar reward to generalist pollinators, while in another group, bracteole "chambers" protect thrips or hemipteran pollinators that use these structures as feeding and breeding sites. We examined the diversity and evolutionary dynamics of inflorescence morphology in Macaranga, focusing on bracteoles. We recognized three inflorescence types based on examination of herbarium materials: Discoid-gland, which possess disc-shaped glands on the bracteole surfaces (including all the generalist-pollinated species); Enclosing, in which bracteoles cover flowers (including all the thrips- and hemipteran-pollinated species); and Inconspicuous, in which bracteoles are small, narrow or absent. Ancestral state reconstruction indicated that inflorescence morphologies have changed multiple times in the genus. These findings suggest that morphological changes in non-floral characters (bracteoles) of Macaranga species have occurred as frequently as in the floral structures of many flowering plants. The multiple evolutions of the Enclosing bracteoles, which protect pollinators, might have been facilitated by pollination interference from mutualistic ants.	[Yamasaki, Eri; Kawakita, Atsushi; Sakai, Shoko] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Yamasaki, Eri] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland	Yamasaki, E (reprint author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	yamasakiebi@gmail.com			Research Institute for Humanity and Nature [D-04]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21570028]; Japan Society for the Promotion of Science [24-1464]; Kyoto University	We are grateful to herbaria of Royal Botanic Gardens, Kew (K), Leiden Naturalis Biodiversity Center (L), Kyoto University (KYO) and Department of Forestry, Sarawak (SAR) for providing Macaranga specimens. This study was financially supported by the Research Institute for Humanity and Nature (Project D-04), Grants-in-Aid No. 21570028 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to S.S., Grants-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (No. 24-1464 to E.Y.), and Kyoto University Global COE program "Formation of a strategic base for biodiversity and evolutionary research: from genome to ecosystem''.	Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Wragg PD, 2011, NEW PHYTOL, V191, P1128, DOI 10.1111/j.1469-8137.2011.03762.x; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1554/03-361; Moog U, 2002, AM J BOT, V89, P50, DOI 10.3732/ajb.89.1.50; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sakai S, 2013, AM J BOT, V100, P546, DOI 10.3732/ajb.1200359; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Kulju KKM, 2007, AM J BOT, V94, P1726, DOI 10.3732/ajb.94.10.1726; Johnson SD, 1998, AM J BOT, V85, P402, DOI 10.2307/2446333; Blattner FR, 2001, MOL PHYLOGENET EVOL, V19, P331, DOI 10.1006/mpev.2001.0941; Davies SJ, 1999, AM J BOT, V86, P1786, DOI 10.2307/2656675; Fiala B, 2011, BIOL J LINN SOC, V103, P935, DOI 10.1111/j.1095-8312.2011.01680.x; Culley TM, 2002, TRENDS ECOL EVOL, V17, P361, DOI 10.1016/S0169-5347(02)02540-5; Beardsley PM, 2003, EVOLUTION, V57, P1397; Okuyama Y, 2008, MOL PHYLOGENET EVOL, V46, P560, DOI 10.1016/j.ympev.2007.09.020; Davies SJ, 2001, EVOLUTION, V55, P1542; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Armbruster WS, 1997, ECOLOGY, V78, P1661; ARMBRUSTER WS, 1993, EVOLUTION, V47, P1480, DOI 10.2307/2410162; Broderbauer D, 2012, AM J BOT, V99, P1666, DOI 10.3732/ajb.1200274; BULLOCK SH, 1994, BIOTROPICA, V26, P172, DOI 10.2307/2388806; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; EHRENFELD JG, 1979, AM MIDL NAT, V101, P87, DOI 10.2307/2424904; Faegri K., 1979, PRINCIPLES POLLINATI; FIALA B, 1991, BIOL J LINN SOC, V44, P287, DOI 10.1111/j.1095-8312.1991.tb00621.x; Itioka T, 2005, ECOL STU AN, V174, P158; Lewis T., 1973, THRIPS THEIR BIOL EC; MACKAY DA, 1991, ANT - PLANT INTERACTIONS, P238; Okuyama Y, 2012, BIOL SPECIES INTERAC, P273; Proctor M, 2006, NATURAL HIST POLLINA; R Development Core Team, 2013, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; WHALEN MA, 1988, BIOTROPICA, V20, P294, DOI 10.2307/2388319; Wheeler AG, 2001, BIOL PLANT BUGS HEMI; Whitmore TC, 2008, GENUS MACARANGA PROD; Willmer PG, 1997, NATURE, V388, P165, DOI 10.1038/40610; Wilson P, 2007, NEW PHYTOL, V176, P883, DOI 10.1111/j.1469-8137.2007.02219.x; Yamasaki E, 2014, PLANT SPEC BIOL, V29, P232, DOI 10.1111/1442-1984.12015	46	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0269-7653	1573-8477		EVOL ECOL	Evol. Ecol.	MAY	2015	29	3			SI		379	390		10.1007/s10682-014-9750-7		12	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CI3AD	WOS:000354618900005		
J	Davis, T; Edstrand, A; Alvi, F; Cattafesta, L; Yorita, D; Asai, K				Davis, Timothy; Edstrand, Adam; Alvi, Farrukh; Cattafesta, Louis; Yorita, Daisuke; Asai, Keisuke			Investigation of impinging jet resonant modes using unsteady pressure-sensitive paint measurements	EXPERIMENTS IN FLUIDS			English	Article							NOISE GENERATION; FIELD; DYNAMICS; FLOW	At given nozzle to plate spacings, the flow field of high-speed impinging jets is known to be characterized by a resonance phenomenon. Large coherent structures that convect downstream and impinge on the surface create strong acoustic waves that interact with the inherently unstable shear layer at the nozzle exit. This feedback mechanism, driven by the coherent structures in the jet shear layer, can either be axisymmetric or helical in nature. Fast-response pressure-sensitive paint (PSP) is applied to the impingement surface to map the unsteady pressure distribution associated with these resonant modes. Phase-averaged results acquired at several kHz are obtained using a flush mounted unsteady pressure transducer on the impingement plate as a reference signal. Tests are conducted on a Mach 1.5 jet at nozzle to plate spacings of h/D-j = 4 and 4.5. The resulting phase-averaged distribution reveals dramatically different flow fields at the corresponding impingement heights. The existence of a purely axisymmetric mode with a frequency of 6.3 kHz is identified at h/Dj = 4.5 and is characterized by concentric rings of higher/lower pressure that propagate radially with increasing phase. Two simultaneous modes are observed at h/D-j = 4 with one being a dominant symmetric mode at 7.1 kHz and the second a subdominant helical mode at 4.3 kHz. Complimentary phase-conditioned Schlieren images are also obtained visualizing the flow structures associated with each mode and are consistent with the PSP results.	[Davis, Timothy; Edstrand, Adam; Alvi, Farrukh; Cattafesta, Louis] Florida State Univ, Dept Mech Engn, FCAAP, Tallahassee, FL 32310 USA; [Yorita, Daisuke; Asai, Keisuke] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan	Davis, T (reprint author), Florida State Univ, Dept Mech Engn, FCAAP, Tallahassee, FL 32310 USA.	tbdavis@fsu.edu			NSF-PIRE [OISE-0968313]; Florida Center for Advanced Aero-Propulsion	The authors would like to acknowledge support provided by NSF-PIRE Grant OISE-0968313 and the Florida Center for Advanced Aero-Propulsion.	Alvi FS, 2002, AIAA J, V40, P599, DOI 10.2514/2.1709; Gudmundsson K, 2011, J FLUID MECH, V689, P97, DOI 10.1017/jfm.2011.401; Krothapalli A, 1999, J FLUID MECH, V392, P155, DOI 10.1017/S0022112099005406; POWELL A, 1953, ACUSTICA, V3, P233; Bell JH, 2001, ANNU REV FLUID MECH, V33, P155, DOI 10.1146/annurev.fluid.33.1.155; Suzuki T, 2006, J FLUID MECH, V565, P197, DOI 10.1017/S0022112006001613; Alvi FS, 2008, J FLUID MECH, V613, P55, DOI 10.1017/S0022112008003091; HO CM, 1981, J FLUID MECH, V105, P119, DOI 10.1017/S0022112081003133; Gregory JW, 2014, ANNU REV FLUID MECH, V46, P303, DOI 10.1146/annurev-fluid-010313-141304; TAM CKW, 1990, J FLUID MECH, V214, P67, DOI 10.1017/S0022112090000052; Gregory JW, 2008, P I MECH ENG G-J AER, V222, P249, DOI 10.1243/09544100JAERO243; Stern O, 1919, PHYS Z, V20, P183; Kumar R, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4811401; Asai K, 2011, 49 AIAA AER SCI M, P847; Bitter M, 2012, EXP FLUIDS, V53, P1737, DOI 10.1007/s00348-012-1380-7; Crafton J, 2011, 29 AIAA APPL AER C, P27; Davis TB, 2015, SHOCK WAVES, V25, P507, DOI 10.1007/s00193-014-0540-5; Flaherty W, 2014, AIAA J, V52, P2462, DOI 10.2514/1.J052864; Gregory JW, 2003, AIAA PAP, P23; Gregory JW, 2007, AIAA J, V45, P568, DOI 10.2514/1.26127; Liu T., 2004, PRESSURE TEMPERATURE; Liu T., 1997, APPL MECH REV, V50-4, P227, DOI DOI 10.1115/1.3101703; Liu TS, 2001, AIAA J, V39, P103, DOI 10.2514/2.1276; Michalke A., 1984, PROGR AEROSPACE SCI, V21, P159, DOI 10.1016/0376-0421(84)90005-8; Neuwerth G, 1974, TTF15719 NASA; NOSSEIR NS, 1982, J FLUID MECH, V116, P379, DOI 10.1017/S0022112082000512; Panickar P, 2007, PHYS FLUIDS, V19, p[106, 103]; Sugimoto T, 2012, P 50 AIAA AER SCI M, P9; Uzun A, 2013, AIAA J, V51, P1593, DOI 10.2514/1.J051839; Wagner F, 1971, SOUND FLOW FIELD AXI; Yorita D, 2010, P 48 AIAA AER SCI M, V307	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	MAY	2015	56	5							101	10.1007/s00348-015-1976-9		13	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CI1BA	WOS:000354473900015		
J	Jiang, LL; Liu, Y; Song, YC; Yang, MJ; Xue, ZQ; Zhao, YC; Zhao, JF; Zhang, Y; Suekane, T; Shen, ZJ				Jiang, Lanlan; Liu, Yu; Song, Yongchen; Yang, Mingjun; Xue, Ziqiu; Zhao, Yuechao; Zhao, Jiafei; Zhang, Yi; Suekane, Tetsuya; Shen, Zijian			Application of X-ray CT investigation of CO2-brine flow in porous media	EXPERIMENTS IN FLUIDS			English	Article							COMPUTED-TOMOGRAPHY; MULTIPHASE FLOW; 2-PHASE FLOW; CO2; NETWORK; HETEROGENEITY; BRINE; ROCKS; WET	A clear understanding of two-phase flows in porous media is important for investigating CO2 geological storage. In this study, we conducted an experiment of CO2/brine flow process in porous media under sequestration conditions using X-ray CT technique. The flow properties of relative permeability, porosity heterogeneity, and CO2 saturation were observed in this experiment. The porous media was packed with glass beads having a diameter of 0.2 mm. The porosity distribution along the flow direction is heterogeneous owing to the diameter and shape of glass beads along the flow direction. There is a relationship between CO2 saturation and porosity distribution, which changes with different flow rates and fractional flows. The heterogeneity of the porous media influences the distribution of CO2; moreover, gravity, fractional flows, and flow rates influence CO2 distribution and saturation. The relative permeability curve was constructed using the steady-state method. The results agreed well with the relative permeability curve simulated using pore-network model.	[Jiang, Lanlan; Liu, Yu; Song, Yongchen; Yang, Mingjun; Zhao, Yuechao; Zhao, Jiafei; Zhang, Yi; Shen, Zijian] Dalian Univ Technol, Key Lab Ocean Energy Utilizat & Energy Conservat, Minist Educ, Dalian 116024, Peoples R China; [Xue, Ziqiu] Res Inst Innovat Technol Earth, Kizugawa City, Kyoto 6190292, Japan; [Suekane, Tetsuya] Tokyo Inst Technol, Dept Energy Sci, Yokohama, Kanagawa 2268502, Japan	Liu, Y (reprint author), Dalian Univ Technol, Key Lab Ocean Energy Utilizat & Energy Conservat, Minist Educ, Dalian 116024, Peoples R China.	lanlan@dlut.edu.cn; liuyu@dlut.edu.cn			National Natural Science Foundation of China [51106019]; National Program on Key Basic Research Project (973 Program) of China [2011CB707304]; Fundamental Research Funds for the Central Universities [DUT13LAB01]	Thanks to the National Natural Science Foundation of China (Grant No. 51106019), the National Program on Key Basic Research Project (973 Program) of China (Grant No. 2011CB707304). This work was also supported by the Fundamental Research Funds for the Central Universities (DUT13LAB01).	Ali JK, 1997, LAT AM CAR PETR ENG; Chalbaud C, 2009, ADV WATER RESOUR, V32, P98, DOI 10.1016/j.advwatres.2008.10.012; HASSANIZADEH SM, 1993, WATER RESOUR RES, V29, P3389, DOI 10.1029/93WR01495; Perrin JC, 2010, TRANSPORT POROUS MED, V82, P93, DOI 10.1007/s11242-009-9426-x; Al-Raoush RI, 2005, J HYDROL, V300, P44, DOI 10.1016/j.jhydrol.2004.05.005; Krevor SCM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010859; Berg S, 2013, INT J GREENH GAS CON, V12, P478, DOI 10.1016/j.ijggc.2011.04.005; Uemura S, 2011, ENRGY PROCED, V4, P5102, DOI 10.1016/j.egypro.2011.02.485; Akin S, 2003, GEOL SOC SPEC PUBL, V215, P23, DOI 10.1144/GSL.SP.2003.215.01.03; Valvatne PH, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002627; Mees F, 2003, GEOL SOC SPEC PUBL, V215, P1, DOI 10.1144/GSL.SP.2003.215.01.01; Hesse MA, 2008, J FLUID MECH, V611, P35, DOI 10.1017/S002211200800219X; Pruess K, 2002, ENVIRON GEOL, V42, P282, DOI 10.1007/s00254-001-0498-3; Knackstedt MA, 2001, ADV WATER RESOUR, V24, P257, DOI 10.1016/S0309-1708(00)00057-9; LENORMAND R, 1983, J FLUID MECH, V135, P337, DOI 10.1017/S0022112083003110; Shi JQ, 2011, INT J GREENH GAS CON, V5, P75, DOI 10.1016/j.ijggc.2010.07.003; Georgiadis A, 2010, J CHEM ENG DATA, V55, P4168, DOI 10.1021/je100198g; Davidson O, 2005, IPCC SPECIAL REPORT; Dullien F. A., 1991, POROUS MEDIA FLUID T; Hirasaki GJ, 1992, SPE25290MS; KAMATH J, 1995, SPE FORMATION EVAL, V10, P4; Kuo C, 2010, SPE W REG M AN CAL U; Kuo C-W, 2010, SPE W REG M; Kuo CW, 2011, ENRGY PROCED, V4, P4516, DOI 10.1016/j.egypro.2011.02.408; Metz B., 2005, CARBON DIOXIDE CAPTU; Perrin JC, 2009, ENRGY PROCED, V1, P3515, DOI 10.1016/j.egypro.2009.02.144; Suekane T, 2008, T JAPAN SOC MECH E B, V74, P2501; Virnovsky GA, 1995, 8 EUR S IMPR OIL REC, DOI [10.3997/2214-4609.201406916, DOI 10.3997/2214-4609.201406916]; Zhou D, 1994, SPE DOE 9 S ENH OIL, V27833	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	MAY	2015	56	5							91	10.1007/s00348-015-1959-x		10	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CI1BA	WOS:000354473900005		
J	Yamamoto, S; Tagawa, Y; Kameda, M				Yamamoto, Shota; Tagawa, Yoshiyuki; Kameda, Masaharu			Application of background-oriented schlieren (BOS) technique to a laser-induced underwater shock wave	EXPERIMENTS IN FLUIDS			English	Article							INDUCED LIQUID JET; DENSITY-MEASUREMENTS; OPTICAL-BREAKDOWN; WATER; FIELD; PRESSURE	An ultra-high-speed imaging system based on the background-oriented schlieren (BOS) technique has been built in order to capture a laser-induced underwater shock wave. This BOS technique is able to provide two-dimensional density-gradient field of fluid and requires a simple setup. The imaging system consists of an ultra-high-speed video camera, a laser stroboscope, and a patterned background. This system takes images every 0.2 mu s. Furthermore, since the density change of water disturbed by the shock is exceedingly small, the system has high spatial resolution similar to 10 mu m/pixel. Using this BOS system, temporal position of a shock wave is examined. The position agrees well with that measured by conventional shadow-graph, which indicates that the high-speed imaging system can successfully capture the instantaneous position of the underwater shock wave that propagates with the speed of about 1500 m/s. The local density gradient can be determined up to O(10(3) kg/m(4)), which is confirmed by the gradient estimated from the pressure time history measured by a hydrophone.	[Yamamoto, Shota; Tagawa, Yoshiyuki; Kameda, Masaharu] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Tokyo, Japan	Tagawa, Y (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Tokyo, Japan.	tagawayo@cc.tuat.ac.jp	Kameda, Masaharu/B-9965-2013; Tagawa, Yoshiyuki/C-8748-2013	Kameda, Masaharu/0000-0002-1928-1338; Tagawa, Yoshiyuki/0000-0002-0049-1984	JSPS KAKENHI [26709007]	This work was supported by JSPS KAKENHI Grant Number 26709007. We thank Keisuke Hayasaka for his assistance with the experiments.	Dalziel SB, 2000, EXP FLUIDS, V28, P322, DOI 10.1007/s003480050391; Goldhahn E, 2007, EXP FLUIDS, V43, P241, DOI 10.1007/s00348-007-0331-1; Hargather MJ, 2010, EXP FLUIDS, V48, P59, DOI 10.1007/s00348-009-0709-3; Noack J, 1998, APPL OPTICS, V37, P4092, DOI 10.1364/AO.37.004092; Richard H, 2001, MEAS SCI TECHNOL, V12, P1576, DOI 10.1088/0957-0233/12/9/325; Venkatakrishnan L, 2004, EXP FLUIDS, V37, P237, DOI 10.1007/s00348-004-0807-1; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; Brujan EA, 2008, EXP THERM FLUID SCI, V32, P1188, DOI 10.1016/j.expthermflusci.2008.01.006; Meier GEA, 2002, EXP FLUIDS, V33, P181, DOI 10.1007/s00348-002-0450-7; Tagawa Y, 2013, LAB CHIP, V13, P1357, DOI 10.1039/c2lc41204g; Tominaga T, 2006, SHOCK WAVES, V15, P55, DOI 10.1007/s00193-005-0005-y; BELL CE, 1967, APPL PHYS LETT, V10, P46, DOI 10.1063/1.1754840; Dewey J. M., 2001, HDB SHOCK WAVES, V2, P441, DOI 10.1016/B978-012086430-0/50029-4; Fomin N, 1998, SPECKLE PHOTOGRAPHY; Hargather MJ, 2013, SHOCK WAVES, V23, P529, DOI 10.1007/s00193-013-0446-7; Hirano T, 2002, LASER MED SCI, V17, P165, DOI 10.1007/s101030200026; KIHM KD, 1993, J HEAT TRANS-T ASME, V115, P140, DOI 10.1115/1.2910640; Lauterborn W, 2013, SHOCK WAVE EMISSION; Murphy MJ, 2011, EXP FLUIDS, V50, P847, DOI 10.1007/s00348-010-0934-9; Ota M, 2011, J JPN SOC AERONAUT S, V59, P154; Petkovsek R, 2005, OPT EXPRESS, V13, P4107, DOI 10.1364/OPEX.13.004107; Sankin G, 2005, PHYS REV LETT, V95, P034; Sankin GN, 2008, J ACOUST SOC AM, V123, P4071, DOI 10.1121/1.2903865; Settles G.S., 2001, SCHLIEREN SHADOWGRAP; Suriyanarayanan P, 2012, 28 INT S SHOCK WAV S, P705; Tagawa Y, 2012, PHYS REV X, V2, P031; Turangan CK, 2013, 8 INT C MULT FLOW 20, P232; Venkatakrishnan L, 2013, J VISUAL-JAPAN, V16, P177, DOI 10.1007/s12650-013-0164-3	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	MAY	2015	56	5							93	10.1007/s00348-015-1960-4		7	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CI1BA	WOS:000354473900007		
J	Wang, Z; Ichikawa, S; Kozu, H; Neves, MA; Nakajima, M; Uemura, K; Kobayashi, I				Wang, Zheng; Ichikawa, Sosaku; Kozu, Hiroyuki; Neves, Marcos A.; Nakajima, Mitsutoshi; Uemura, Kunihiko; Kobayashi, Isao			Direct observation and evaluation of cooked white and brown rice digestion by gastric digestion simulator provided with peristaltic function	FOOD RESEARCH INTERNATIONAL			English	Article						Cooked white rice; Cooked brown rice; Gastric digestion simulator; Rice disintegration; Direct observation	FOOD DIGESTION; HUMAN STOMACH; DISINTEGRATION	This study evaluates physical digestion for cooked white rice and cooked brown rice using a novel in vitro gastric digestion simulator (GDS). The GDS enabled direct observation of the disintegration of cooked rice in the presence of simulated human gastric peristalsis.The experiments confirmed a steep increase in the disintegration of cooked white rice during the initial 30 mitt, after which disintegrated contents slowly increased. However, the appearance of liquid phase had little effect on cooked brown rice up to 180 min digestion, likely due to the protective action of the bran layer. Our results indicated that cooked rice particles gradually disintegrated into smaller fractions, depending on the type of cooked rice. The present research uses GDS to provide a better understanding of solid food digestion. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Zheng; Ichikawa, Sosaku; Kozu, Hiroyuki; Neves, Marcos A.; Nakajima, Mitsutoshi; Uemura, Kunihiko; Kobayashi, Isao] Natl Food Res Inst, NARO, Food Engn Div, Tsukuba, Ibaraki 3058642, Japan; [Wang, Zheng; Neves, Marcos A.; Nakajima, Mitsutoshi; Uemura, Kunihiko; Kobayashi, Isao] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan; [Ichikawa, Sosaku; Kozu, Hiroyuki; Neves, Marcos A.; Nakajima, Mitsutoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Kobayashi, I (reprint author), Natl Food Res Inst, NARO, Food Engn Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	isaok@affrc.go.jp			Skylark Food Science Institute of Japan [2013-1]	This work was financially supported in part by the Skylark Food Science Institute of Japan (2013-1).	Blanquet-Diot S, 2009, J NUTR, V139, P876, DOI 10.3945/jn.108.103655; Kong F, 2008, J FOOD SCI, V73, pR67, DOI 10.1111/j.1750-3841.2008.00766.x; Chen JS, 2011, FOOD FUNCT, V2, P174, DOI 10.1039/c0fo00159g; Pal A, 2004, P ROY SOC B-BIOL SCI, V271, P2587, DOI 10.1098/rspb.2004.2886; Kozu H, 2014, FOOD SCI TECHNOL RES, V20, P225, DOI 10.3136/fstr.20.225; Bornhorst GM, 2012, COMPR REV FOOD SCI F, V11, P101, DOI 10.1111/j.1541-4337.2011.00172.x; McClements DJ, 2010, ADV COLLOID INTERFAC, V159, P213, DOI 10.1016/j.cis.2010.06.010; Kong FB, 2010, J FOOD SCI, V75, pE627, DOI 10.1111/j.1750-3841.2010.01856.x; MINEKUS M, 1995, ATLA-ALTERN LAB ANIM, V23, P197; Tian S, 2004, J AGR FOOD CHEM, V52, P4808, DOI 10.1021/jf049776f; Kong F, 2011, J FOOD SCI, V76, pE450, DOI 10.1111/j.1750-3841.2011.02271.x; Lu S, 2013, LWT-FOOD SCI TECHNOL, V54, P224, DOI 10.1016/j.lwt.2013.05.028; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Bornhorst G. M., 2010, J FOOD SCI, V78, pE1383; Bornhorst GM, 2013, FOOD BIOPHYS, V8, P12, DOI 10.1007/s11483-012-9277-9; Gani A., 2012, J FOOD PROCESSING TE, V3, P2; Han JA, 2008, FOOD SCI BIOTECHNOL, V17, P180; Hellström Per M, 2006, Best Pract Res Clin Anaesthesiol, V20, P397, DOI 10.1016/j.bpa.2006.02.002; Hur S.J., 2010, FOOD CHEM, V125, P1; Marciani L, 2000, J NUTR, V130, P122; Mercuri A, 2008, J PHARM PHARMACOL, V60, pA2; Steel R., 1997, PRINCIPLES PROCEDURE, P422; Stotzer PO, 2000, NEUROGASTROENT MOTIL, V12, P415	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	MAY	2015	71						16	22		10.1016/j.foodres.2015.03.002		7	Food Science & Technology	Food Science & Technology	CI1LL	WOS:000354505600003		
J	Mizuno, T; Suzuki, N; Makino, H; Furui, T; Morii, E; Aoki, H; Kunisada, T; Yano, M; Kuji, S; Hirashima, Y; Arakawa, A; Nishio, S; Ushijima, K; Ito, K; Itani, Y; Morishige, K				Mizuno, T.; Suzuki, N.; Makino, H.; Furui, T.; Morii, E.; Aoki, H.; Kunisada, T.; Yano, M.; Kuji, S.; Hirashima, Y.; Arakawa, A.; Nishio, S.; Ushijima, K.; Ito, K.; Itani, Y.; Morishige, K.			Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species	GYNECOLOGIC ONCOLOGY			English	Article						Ovarian clear cell carcinoma; Chemoresistance; Cancer stem-like cell; Aldehyde dehydrogenase; Reactive oxygen species; Nrf2-antioxidant pathway	DISTINCT-HISTOLOGIC-TYPE; DRUG-RESISTANCE; POOR-PROGNOSIS; CHEMOTHERAPY; EXPRESSION; RADIORESISTANCE; ADENOCARCINOMA; IDENTIFICATION; MECHANISM; BIOLOGY	Objective. In ovarian cancer cases, recurrence after chemotherapy is frequently observed, suggesting the involvement of ovarian cancer stem-like cells (CSCs). The chemoresistance of ovarian clear cell carcinomas is particularly strong in comparison to other epithelial ovarian cancer subtypes. We investigated the relationship between a CSC marker, aldehyde dehydrogenase 1 (ALDH1), and clinical prognosis using ovarian clear cell carcinoma tissue samples. Furthermore, we investigated the antioxidant mechanism by which CSCs maintain a lower reactive oxygen species (ROS) level, which provides protection from chemotherapeutic agents. Methods. Immunohistochemical staining was performed to examine the CSC markers (CD 133, CD44, ALDH1) using ovarian clear cell carcinoma tissue samples (n = 81). Clear cell carcinoma cell lines (KOC-7C, OVTOKO) are separated into the ALDH-high and ALDH-low populations by ALDEFLUOR assay and fluorescence-activated cell sorting (FACS). We compared the intracellular ROS level, mRNA level of the antioxidant enzymes and Nrf2 expression of the two populations. Results. High ALDH1 expression levels are related to advanced stage in clear cell carcinoma cases. ALDH1 expression significantly reduced progression free survival. Other markers are not related to clinical stage and prognosis. ALDH-high cells contained a lower ROS level than ALDH-low cells. Antioxidant enzymes were upregulated in ALDH-high cells. ALDH-high cells showed increased expression of Nrf2, a key transcriptional factor of the antioxidant system. Conclusions. ALDH-positive CSCs might have increased Nrf2-induced antioxidant scavengers, which lower ROS level relevant to chemoresistance in ovarian clear cell carcinoma. (C) 2014 Elsevier Inc. All rights reserved.	[Mizuno, T.; Suzuki, N.; Makino, H.; Furui, T.; Morishige, K.] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu, Japan; [Morii, E.] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 565, Japan; [Kunisada, T.] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan; [Yano, M.] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita, Japan; [Kuji, S.; Hirashima, Y.] Shizuoka Canc Ctr, Div Gynecol, Nagaizumi, Shizuoka, Japan; [Arakawa, A.] Nagoya City Univ, Grad Sch Med, Dept Obstet & Gynecol, Aichi, Japan; [Nishio, S.] Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka, Japan; [Ito, K.] Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan; [Itani, Y.] Nara Prefecture Gen Med Ctr, Dept Obstet & Gynecol, Nara, Japan	Mizuno, T (reprint author), 1-1 Yanagido, Gifu 5011194, Japan.	mizutomo@gifu-u.ac.jp		Kunisada, Takahiro/0000-0003-1651-2716			Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Hara H, 2002, MOL PHARMACOL, V61, P194, DOI 10.1124/mol.61.1.194; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Galic V, 2013, CURR CANCER DRUG TAR, V13, P698; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Yeung BHY, 2008, BRIT J CANCER, V99, P283, DOI 10.1038/sj.bjc.6604477; Saga Y, 2008, ONCOL REP, V20, P1299, DOI 10.3892/or_00000144; Utsunomiya H, 2006, INT J GYNECOL CANCER, V16, P52, DOI 10.1111/j.1525-1438.2006.00289.x; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015; Buyse ME, 2008, J CLIN ONCOL, V26; Buyse ME, 2005, J CLIN ONCOL S, V23, P3513; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Kim HM, 2012, ANN SURG ONCOL, V3, P539; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kuroda T, 2014, PLOS ONE, V8; Liu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081050; Ricci F, 2013, AM J CANCER RES, V3, P221; Tiligada E, 2006, ENDOCR-RELAT CANCER, V13, P115	31	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0090-8258	1095-6859		GYNECOL ONCOL	Gynecol. Oncol.	MAY	2015	137	2					299	305		10.1016/j.ygyno.2014.12.005		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CI1KW	WOS:000354504100018		
J	Vorob'ev, MS; Denisov, VV; Koval', NN; Shugurov, VV; Yakovlev, VV; Uemura, K; Raharjo, P				Vorob'ev, M. S.; Denisov, V. V.; Koval', N. N.; Shugurov, V. V.; Yakovlev, V. V.; Uemura, K.; Raharjo, P.			Radiation processing of natural latex using a wide-aperture electron accelerator with a plasma emitter	HIGH ENERGY CHEMISTRY			English	Article								Experiments on the processing of natural latex have been performed using an electron accelerator based on the plasma cathode with the grid-stabilized edge of plasma emission and beam exit into the atmosphere. The result of radiation treatment has been assessed as a change in the strength characteristics of rubber samples made from the processed latex after thermal curing. The maximum tensile strength of 21 MPa has been found for the samples received a total dose of about 27 Mrad, values that are promising for the environmentally clean vulcanization of natural rubber latex used for medical purposes.	[Vorob'ev, M. S.; Denisov, V. V.; Koval', N. N.; Shugurov, V. V.; Yakovlev, V. V.] Russian Acad Sci, Inst High Current Elect, Siberian Branch, Tomsk 634055, Russia; [Uemura, K.; Raharjo, P.] ITAC Ltd, Niigata 9590181, Japan	Vorob'ev, MS (reprint author), Russian Acad Sci, Inst High Current Elect, Siberian Branch, Akad Skii Pr 2-3, Tomsk 634055, Russia.	vorobyovms@yandex.ru					Abdullin E. N., 1978, PISMA ZH TEKH FIZ, V4, P213; Alimov A. S., 2011, PREPRINT RES I NUCL; KOVAL NN, 1985, IEEE T ELECTR INSUL, V20, P735, DOI 10.1109/TEI.1985.348898; Blackley D.C., 1997, POLYM LATICES SCI TE, V2; Bugaev S.P., 1984, ELEKT PUCHKI BOLSHOG; Haque MDE, 2005, POLYM J, V37, P333, DOI 10.1295/polymj.37.333; Raharjo P., 2008, 15 INT S HIGH CURR E, P497	7	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0018-1439	1608-3148		HIGH ENERG CHEM+	High Energy Chem.	MAY	2015	49	3					143	145		10.1134/S0018143915030169		3	Chemistry, Physical	Chemistry	CH5TZ	WOS:000354099500003		
J	Zhu, YW; Huang, ZQ; Huang, LS; Takagi, T				Zhu, Youwen; Huang, Zhiqiu; Huang, Liusheng; Takagi, Tsuyoshi			On the Security of A Privacy-Preserving Product Calculation Scheme	IEEE TRANSACTIONS ON DEPENDABLE AND SECURE COMPUTING			English	Editorial Material						Privacy-preserving; data aggregation; product calculation		Recently, Jung and Li [1] propose a highly efficient privacy-preserving product calculation scheme without requiring secure communication channels. Then, they present secure approaches to solve several application problems using the product calculation protocol. In this work, we observe several security flaws in their privacy-preserving product calculation scheme and some application protocols. We show the security vulnerabilities will result in the disclosure of private data. In two application protocols, almost all the private numbers will be revealed. We further suggest solutions to fix the security problems.	[Zhu, Youwen; Huang, Zhiqiu] Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing 210016, Jiangsu, Peoples R China; [Zhu, Youwen; Takagi, Tsuyoshi] Kyushu Univ, Inst Math Ind, Fukuoka 8190395, Japan; [Huang, Liusheng] Univ Sci & Technol Chiha, Sch Comp Sci & Technol, Hefei 230027, Peoples R China	Zhu, YW (reprint author), Nanjing Univ Aeronaut & Astronaut, Coll Comp Sci & Technol, Nanjing 210016, Jiangsu, Peoples R China.	zhuyouwen@gmail.com; zhuyw@nuaa.edu.cn; lshuang@ustc.edu.cn; takagi@imi.kyushu-u.ac.jp					Jung T., 2014, IEEE T DEPENDABLE SE	1	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1545-5971	1941-0018		IEEE T DEPEND SECURE	IEEE Trans. Dependable Secur. Comput.	MAY-JUN	2015	12	3					373	374		10.1109/TDSC.2014.2345404		2	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	CI0ZJ	WOS:000354468900010		
J	Chen, R; Gao, WL; Wang, X; Aizin, GR; Mikalopas, J; Arikawa, T; Tanaka, K; Eason, DB; Strasser, G; Kono, J; Bird, JP				Chen, Rui; Gao, Weilu; Wang, Xuan; Aizin, Gregory R.; Mikalopas, John; Arikawa, Takashi; Tanaka, Koichiro; Eason, David B.; Strasser, Gottfried; Kono, Junichiro; Bird, Jonathan P.			High-Voltage Breakdown and the Gunn Effect in GaAs/AlGaAs Nanoconstrictions	IEEE TRANSACTIONS ON NANOTECHNOLOGY			English	Article						Gunn effect; nano-constrictions; nonequilibrium transport; terahertz devices	FIELD-EFFECT TRANSISTORS; HOT-ELECTRON DIODES; IMPACT IONIZATION; SWITCHING MECHANISM; GALLIUM-ARSENIDE; TRANSPORT; GAAS; ELECTROLUMINESCENCE; OSCILLATIONS; RESISTANCE	We demonstrate dramatic breakdown behavior in the current through GaAs/AlGaAs nanoconstrictions (NCs), and find that this exhibits multiple signatures characteristic of the Gunn effect. These include current fluctuations and hysteresis, and electroluminescence that are consistent with the formation of Gunn domains. An analytical model is developed to describe the current-voltage characteristics of the NCs prior to the onset of the breakdown, and reveals the conduction through them to be barrier limited under low bias. A comparison of the results of these calculations with experiment furthermore suggests that the Gunn effect in these devices is triggered, once the phenomenon of drain-induced barrier lowering becomes sufficiently developed to support the injection of large numbers of electrons into the NC. Our paper, therefore, demonstrates how the Gunn effect may be manipulated through nanoscale tailoring of semiconductors, a result that may have implications for the development of solid-state terahertz technology.	[Chen, Rui; Eason, David B.; Bird, Jonathan P.] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA; [Gao, Weilu; Wang, Xuan; Kono, Junichiro] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA; [Aizin, Gregory R.; Mikalopas, John] CUNY, Dept Phys Sci, Kingsborough Coll, Brooklyn, NY 11235 USA; [Arikawa, Takashi; Tanaka, Koichiro] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Strasser, Gottfried] Vienna Univ Technol, Ctr Micro & Nanostruct, A-1040 Vienna, Austria; [Strasser, Gottfried] Vienna Univ Technol, Inst Solid State Elect, A-1040 Vienna, Austria	Chen, R (reprint author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	rchen8@buffalo.edu; weilu.gao@rice.edu; xw@iphy.ac.cn; Y-Gregory.Aizin@kbcc.cuny.edu; John.Mikalopas@kbcc.cuny.edu; arikawa@scphys.kyoto-u.ac.jp; tanaka-g@icems.kyoto-u.ac.jp; dbeason@buffalo.edu; gottfried.strasser@tuwien.ac.at; kono@rice.edu; jbird@buffalo.edu	Strasser, Gottfried/E-3274-2010; Arikawa, Takashi/E-2461-2011; Bird, Jonathan/G-4068-2010	Strasser, Gottfried/0000-0003-0147-0883; Bird, Jonathan/0000-0002-6966-9007	National Science Foundation [OISE0968405]	This work was supported by the National Science Foundation under Award OISE0968405.	Williams BS, 2007, NAT PHOTONICS, V1, P517, DOI 10.1038/nphoton.2007.166; Balocco C, 2005, NANO LETT, V5, P1423, DOI 10.1021/nl050779g; Klappenberger F, 2003, APPL PHYS LETT, V83, P704, DOI 10.1063/1.1595712; CHKLOVSKII DB, 1992, PHYS REV B, V46, P4026, DOI 10.1103/PhysRevB.46.4026; GUNN JB, 1963, SOLID STATE COMMUN, V1, P88, DOI 10.1016/0038-1098(63)90041-3; Dyakonova N, 1998, APPL PHYS LETT, V72, P2562, DOI 10.1063/1.121418; ARNOLD D, 1988, APPL PHYS LETT, V53, P373, DOI 10.1063/1.99898; Chen R, 2013, IEEE SENS J, V13, DOI 10.1109/JSEN.2012.2216522; Dayeh SA, 2008, NANO LETT, V8, P3114, DOI 10.1021/nl801256p; EMANUEL MA, 1988, SOLID STATE ELECTRON, V31, P589, DOI 10.1016/0038-1101(88)90347-4; Garcia S., 2013, J APPL PHYS, V114; GLAZMAN LI, 1991, SEMICOND SCI TECH, V6, P32, DOI 10.1088/0268-1242/6/1/006; GRUBIN HL, 1980, SOLID STATE ELECTRON, V23, P157, DOI 10.1016/0038-1101(80)90153-7; HEEKS JS, 1966, IEEE T ELECTRON DEV, VED13, P68, DOI 10.1109/T-ED.1966.15637; HESS K, 1986, J APPL PHYS, V60, P3775, DOI 10.1063/1.337540; HIGMAN TK, 1987, J APPL PHYS, V62, P1495, DOI 10.1063/1.339630; HIGMAN TK, 1988, APPL PHYS LETT, V53, P1623, DOI 10.1063/1.99931; Hirori H., 2011, NATURE COMMUN, V2; Hobson G. S., 1974, THE GUNN EFFECT; Iniguez-de-la-Torre A., 2012, J APPL PHYS, V111; Iniguez-de-la-Torre A., 2011, APPL PHYS LETT, V99; Khalid A., 2014, J APPL PHYS, V115; LEVINSHT.ME, 1972, SOV PHYS SEMICOND+, V5, P1561; LIU SG, 1966, APPL PHYS LETT, V9, P79, DOI 10.1063/1.1754651; Montes Bajo M., 2013, J APPL PHYS, V113; Novoselov KS, 2000, EUROPHYS LETT, V52, P660, DOI 10.1209/epl/i2000-00489-5; RIDLEY BK, 1963, P PHYS SOC LOND, V82, P954, DOI 10.1088/0370-1328/82/6/315; Sangare P., 2013, J APPL PHYS, V113; Shaw M. P., 1979, GUNN HILSUM EFFECT; Smoliner J, 2004, REP PROG PHYS, V67, P1863, DOI 10.1088/0034-4885/67/10/R04; SOUTHGAT.PD, 1967, J APPL PHYS, V38, P4589, DOI 10.1063/1.1709190; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Tsividis Y., 1999, OPERATIONAL MODELING, V2nd; Vitiello M. S., 2011, NANO LETT, V12, P96; WU JC, 1992, APPL PHYS LETT, V61, P2425, DOI 10.1063/1.108186; Xu K. Y., 2014, AIP ADV, V4; Xu K. Y., 2008, APPL PHYS LETT, V93; ZANONI E, 1993, APPL PHYS LETT, V62, P402, DOI 10.1063/1.108943; ZAPPE HP, 1990, J APPL PHYS, V68, P2501, DOI 10.1063/1.346515	39	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-125X	1941-0085		IEEE T NANOTECHNOL	IEEE Trans. Nanotechnol.	MAY	2015	14	3					524	530		10.1109/TNANO.2015.2414902		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CI0UL	WOS:000354453800015		
J	Murakami, Y; Kawata, A; Ito, S; Katayama, T; Fujisawa, S				Murakami, Yukio; Kawata, Akifumi; Ito, Shigeru; Katayama, Tadashi; Fujisawa, Seiichiro			The Radical Scavenging Activity and Cytotoxicity of Resveratrol, Orcinol and 4-Allylphenol and their Inhibitory Effects on Cox-2 Gene Expression and Nf-kappa b Activation in RAW264.7 Cells Stimulated with Porphyromonas gingivalis-fimbriae	IN VIVO			English	Article						Resveratrol; anti-inflammatory activity; cytotoxicity; RAW264.7 cells; Pg-fimbriae-stimulator; DPPH activity; quantum chemical calculations	BUTYLATED HYDROXYANISOLE; ORAL ANAEROBE; ORTHO DIMER; ANTIOXIDANT; MACROPHAGES; PROOXIDANT; CURCUMIN; BIOAVAILABILITY; PREVENTION; PHENOL	Background/Aim: Resveratrol is a polyphenol with efficient anti-oxidative and anti-inflammatory activity. To clarify the molecular mechanism responsible for its anti-inflammatory action, we investigated the radical scavenging activity, cytotoxicity and anti-inflammatory activity of resveratrol and its related compounds, orcinol and 4-allylphenol. Materials and Methods: The radical scavenging activities of these compounds were determined by the DPPH (2,2'-diphenyl-1-picrylhydrazyl) assay and their cytotoxicities against RAW264.7 cells were determined using a cell-counting kit (CCK-8). The inhibitory effects of these compounds on cyclooxygenase-2 (Cox2) expression in RAW264.7 cells stimulated with Porphyromonas gingivalis (Pg) fimbriae were also determined using real-time polymerase chain reaction and western blot analysis, while inhibition of the fimbria-stimulated activation of nuclear factor-kappa B (Nf-kappa b) was evaluated using western blot analysis and enzyme-linked immunosorbent assay-like microwell colorimetric transcription factor activity assay, respectively. The quantum chemical parameters were calculated on the basis of the density function theory (DFT) BLYP/6-31G*. Results: DPPH radical scavenging activity declined in the order resveratrol > orcinol > 4-allylphenol. The cytotoxicity of the compounds was in the order 4-allylphenol > resveratrol > orcinol. The inhibitory effect on Pg fimbria-stimulated Cox2 expression and Nf-kappa b activation was enhanced by resveratrol-alone. Resveratrol showed high electronegativity (chi) and softness (sigma) values, as determined by quantum chemical calculations. Conclusion: Resveratrol exerts potent anti-inflammatory activity in RAW264.7 cells stimulated with Pg-fimbriae and may be applicable as a therapeutic agent for inflammatory periodontal disease as a manifestation of systemic disease.	[Murakami, Yukio; Kawata, Akifumi; Katayama, Tadashi; Fujisawa, Seiichiro] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Diag, Sakado, Saitama 3500283, Japan; [Ito, Shigeru] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan	Murakami, Y (reprint author), Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Diag, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.	ymura@dent.meikai.ac.jp					SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Vincent C, 2009, J BONE MINER METAB, V27, P114, DOI 10.1007/s00774-008-0018-6; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; Ahmad KA, 2003, ANN NY ACAD SCI, V1010, P365, DOI 10.1196/annals.1299.067; Kovacic P, 2010, OXID MED CELL LONGEV, V3, P86, DOI 10.4161/oxim.3.2.11147; HANAZAWA S, 1995, INFECT IMMUN, V63, P2374; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Dubois RN, 1998, FASEB J, V12, P1063; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Neves AR, 2012, CURR MED CHEM, V19, P1663; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Murakami Y, 2008, ANTICANCER RES, V28, P699; Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200; YOSHIMURA F, 1984, J BACTERIOL, V160, P949; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Neves AR, 2013, INT J NANOMED, V8, P177, DOI 10.2147/IJN.S37840; HANAZAWA S, 1991, INFECT IMMUN, V59, P1972; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Koopmans T, 1934, PHYSICA, V1, P104, DOI 10.1016/S0031-8914(34)90011-2; Zhang HY, 2003, CHEM-EUR J, V9, P502, DOI 10.1002/chem.200390052; He X, 2010, BIOCHEM BIOPH RES CO, V401, P356, DOI 10.1016/j.bbrc.2010.09.053; Murakami Y, 2012, IN VIVO, V26, P941; Hansch C, 2000, CHEM-BIOL INTERACT, V127, P61, DOI 10.1016/S0009-2797(00)00171-X; Bertrand F, 1997, CHEM RES TOXICOL, V10, P335, DOI 10.1021/tx960087v; Cao H, 2003, BIOORG MED CHEM LETT, V13, P1869, DOI 10.1016/S0960-894X(03)00283-X; Fujisawa S, 2006, CHEMOSPHERE, V62, P71, DOI 10.1016/j.chemosphere.2005.04.006; Fujisawa S, 2007, IN VIVO, V21, P181; Gadacha W, 2009, REDOX REP, V14, P154, DOI 10.1179/135100009X466131; Khazaei Saber, 2012, Dent Res J (Isfahan), V9, P655; Murakami Y, 2009, ANTICANCER RES, V29, P2403; Murakami Y, 2006, ANTICANCER RES, V26, P2915; Murakami Y, 2014, IN VIVO, V28, P719; Murakami Y, 2006, ARCH BIOCHEM BIOPHYS, V449, P171, DOI 10.1016/j.abb.2006.02.005; Putz MV, 2011, INT J MOL SCI, V12, P5098, DOI 10.3390/ijms12085098; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rizzo Antonietta, 2012, Cytokine, V60, P197, DOI 10.1016/j.cyto.2012.06.004; Shishodia S, 2003, CARCINOGENESIS, V24, P1269, DOI 10.1093/carcin/bgg078; Xu XC, 2002, ANTI-CANCER DRUG, V13, P127, DOI 10.1097/00001813-200202000-00003	40	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	MAY-JUN	2015	29	3					341	349				9	Medicine, Research & Experimental	Research & Experimental Medicine	CI1CS	WOS:000354479100004		
J	Masuda, H; Hirota, S; Ushiyama, A; Hirata, A; Arima, T; Kawai, H; Wake, K; Watanabe, S; Taki, M; Nagai, A; Ohkubo, C				Masuda, Hiroshi; Hirota, Shogo; Ushiyama, Akira; Hirata, Akimasa; Arima, Takuji; Kawai, Hiroki; Wake, Kanako; Watanabe, Soichi; Taki, Masao; Nagai, Akiko; Ohkubo, Chiyoji			No Dynamic Changes in Blood-brain Barrier Permeability Occur in Developing Rats During Local Cortex Exposure to Microwaves	IN VIVO			English	Article						Radiofrequency electromagnetic field; local exposure; blood-brain barrier; temperature; juvenile; young adult; development stage	MHZ ELECTROMAGNETIC-FIELD; MICROCIRCULATORY PARAMETERS; THERMOREGULATORY BEHAVIOR; RADIATION; TEMPERATURE; SENSITIVITY; IRRADIATION; IMMATURE; ETHANOL; CELLS	Little information is available about the effects of exposure to radiofrequency electromagnetic fields (RF) on cerebral microcirculation during rat developmental stages. We investigated whether the permeability of the blood-brain barrier (BBB) in juvenile and young adult rats was modified during local cortex exposure to RF under non-thermal conditions. The cortex tissue targeted was locally exposed to 1457 MHz RF at an average specific absorption rate of 2.0 W/kg in the target area for 50 min and permeability changes in the BBB of the pia mater were measured directly, using intravital fluorescence microscopy. There was no significant difference in extravasation of intravenously-injected dye between exposed and sham-exposed groups of either category of rats. No histological evidence of albumin leakage was found in any of the brains just after exposure, indicating that no traces of BBB disruption remained. These findings suggest that no dynamic changes occurred in BBB permeability of the rats at either of these developmental stages, even during local RF exposure at non-thermal levels.	[Masuda, Hiroshi; Nagai, Akiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Masuda, Hiroshi; Hirota, Shogo; Ushiyama, Akira] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan; [Hirata, Akimasa] Nagoya Inst Technol, Dept Comp Sci & Engn, Aichi, Japan; [Arima, Takuji] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Tokyo, Japan; [Kawai, Hiroki; Wake, Kanako; Watanabe, Soichi] Natl Inst Informat & Commun Technol, Appl Electromagnet Res Inst, Electromagnet Compatibil Lab, Tokyo, Japan; [Taki, Masao] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Tokyo 158, Japan; [Ohkubo, Chiyoji] Japan EMF Informat Ctr, Tokyo, Japan	Masuda, H (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.	bdxmsd@yahoo.co.jp	arima, takuji/C-8878-2013; Hirata, Akimasa/I-8245-2012	Hirata, Akimasa/0000-0001-8336-1140	Ministry of Internal Affairs and Communications, Japan	This study was supported by the Ministry of Internal Affairs and Communications, Japan. The Authors thank Mrs.' Miyuki Takahashi, Kasumi Yamanaka, and Minako Segawa for their helpful assistance.	ADAIR ER, 1984, BIOELECTROMAGNETICS, V5, P13, DOI 10.1002/bem.2250050103; Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039; Masuda H, 2007, IN VIVO, V21, P471; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; Kumlin T, 2007, RADIAT RES, V168, P471, DOI 10.1667/RR1002.1; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Tsurita G, 2000, BIOELECTROMAGNETICS, V21, P364, DOI 10.1002/1521-186X(200007)21:5<364::AID-BEM5>3.0.CO;2-Q; SALFORD LG, 1994, MICROSC RES TECHNIQ, V27, P535, DOI 10.1002/jemt.1070270608; Arima T, 2011, IEEE T BIO-MED ENG, V58, P2740, DOI 10.1109/TBME.2010.2103942; DANDREA JA, 1986, BIOELECTROMAGNETICS, V7, P45, DOI 10.1002/bem.2250070106; de Gannes FP, 2009, RADIAT RES, V172, P359, DOI 10.1667/RR1578.1; Guy AW, 2002, MICROWAVE THEORY TEC, V23, P492; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Klose M, 2014, RADIAT RES, V182, P435, DOI 10.1667/RR13695.1; Kuribayashi M, 2005, BIOELECTROMAGNETICS, V26, P578, DOI 10.1002/bem.20138; Masuda H, 2009, RADIAT RES, V172, P66, DOI 10.1667/RR1542.1; Masuda H, 2015, IN VIVO, V29, P207; Masuda H, 2011, J APPL PHYSIOL, V110, P142, DOI 10.1152/japplphysiol.01035.2010; Masuda H, 2007, IN VIVO, V21, P555; McQuade JMS, 2009, RADIAT RES, V171, P615, DOI 10.1667/RR1507.1; Paulraj R, 2006, ELECTROMAGN BIOL MED, V25, P61, DOI 10.1080/15368370600581939; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; STERN S, 1979, SCIENCE, V206, P1198, DOI 10.1126/science.505008; Watilliaux A, 2011, NEUROTOX RES, V20, P109, DOI 10.1007/s12640-010-9225-8; World Health Organization, 2010, WHO RES AGENDA RADIO	26	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0258-851X	1791-7549		IN VIVO	In Vivo	MAY-JUN	2015	29	3					351	357				7	Medicine, Research & Experimental	Research & Experimental Medicine	CI1CS	WOS:000354479100005		
J	Savage, AM; Hackett, B; Guenard, B; Youngsteadt, EK; Dunn, RR				Savage, Amy M.; Hackett, Britne; Guenard, Benoit; Youngsteadt, Elsa K.; Dunn, Robert R.			Fine-scale heterogeneity across Manhattan's urban habitat mosaic is associated with variation in ant composition and richness	INSECT CONSERVATION AND DIVERSITY			English	Article						Ants; chronic environmental stress; community structure; diversity; exotic species; Lasius; Tapinoma; Tetramorium; unique species; urban ecology	ENVIRONMENTAL-STRESS; HYMENOPTERA-FORMICIDAE; SPECIES-DIVERSITY; ASSEMBLAGES HYMENOPTERA; COMMUNITY STRUCTURE; RURAL GRADIENT; CLIMATE-CHANGE; GLOBAL CHANGE; ECOLOGY; BIRDS	Global urbanisation is rapidly expanding and most of the world's humans now live in cities. Most ecological studies have, however, focused on protected areas. To address this issue, we tested predictions from studies of protected areas in urban ecosystems. Because most cities are heterogeneous habitat mosaics which include habitats with varying levels of chronic environmental stress, we focused on predictions from studies of less modified ecosystems about community-wide responses to variation in chronic stress. We sampled ants across Manhattan's urban habitat mosaic, at sites with varying levels of chronic environmental stress. Many predictions derived from less modified ecosystems were supported by our findings: despite being the most intensively sampled habitat, high stress urban medians had less variability in ant composition -both within and among sites - than either urban parks or urban forests, the lowest stress habitat - urban forests-had significantly more accumulated species and a higher number of unique species than higher stress habitats, and urban parks, which have intermediate levels of chronic environmental stress, also had intermediate levels of variation in among-site species composition, accumulated species richness, and the incidence of unique species. The most common species also differed across Manhattan's urban habitat mosaic. Nevertheless, the prediction that exotic species would occur more frequently in higher stress habitats was not supported; exotic species were equally common across all habitats. These findings suggest that fine-scale heterogeneity in the chronic stress of urban habitats may be an underappreciated, but important structuring force for urban animal communities.	[Savage, Amy M.; Hackett, Britne; Dunn, Robert R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Savage, Amy M.; Hackett, Britne; Dunn, Robert R.] N Carolina State Univ, Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Guenard, Benoit] Okinawa Inst Sci & Technol Grad Univ, Kunigami, Okinawa, Japan; [Youngsteadt, Elsa K.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	Savage, AM (reprint author), N Carolina State Univ, Dept Biol Sci, Campus Box 7617, Raleigh, NC 27695 USA.	amy_savage@ncsu.edu			NSF Career Grant [0953390]	We thank Brian Parham, Nancy Falxa-Raymond, Andrew Collins, and Carly Tribull for field assistance and Lauren Nichols, Shelby Anderson and Clint Penick for laboratory assistance. The NYC Department of Parks and Recreation graciously allowed us to access to study sites. Thanks to James Danoff-Burg for logistical assistance. Ants were collected under NY State Department of Environmental Conservation Scientific License to Permit or Collect #1822. Thanks also to the staff at the Fort Totten NYC Urban Field Station. This research was supported by NSF Career Grant #0953390 to RRD. None of the authors of this manuscript have any conflicts of interest to report.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Lutinski JA, 2013, BIOTA NEOTROP, V13, P332, DOI 10.1590/S1676-06032013000300033; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Dostal P, 2005, PEDOBIOLOGIA, V49, P127, DOI 10.1016/j.pedobi.2004.09.004; Heterick BE, 2013, URBAN ECOSYST, V16, P145, DOI 10.1007/s11252-012-0257-0; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolysis.33.010802.150444; Palomino D, 2006, LANDSCAPE URBAN PLAN, V77, P276, DOI 10.1016/j.landurbplan.2005.04.003; BARRETT GW, 1976, BIOSCIENCE, V26, P192, DOI 10.2307/1297248; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Bengtsson J, 2002, EUR J SOIL BIOL, V38, P119, DOI 10.1016/S1164-5563(02)01133-0; Bauer JT, 2012, BIOL INVASIONS, V14, P1295, DOI 10.1007/s10530-011-0165-x; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Minor Emily, 2010, Urban Ecosystems, V13, P51, DOI 10.1007/s11252-009-0103-1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Saito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065464; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; HALPERN CB, 1995, ECOL APPL, V5, P913, DOI 10.2307/2269343; Kingsolver JG, 2013, FUNCT ECOL, V27, P1415, DOI 10.1111/1365-2435.12145; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Stringer Lloyd D., 2009, Urban Ecosystems, V12, P503, DOI 10.1007/s11252-009-0100-4; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Leveau LM, 2013, J ORNITHOL, V154, P655, DOI 10.1007/s10336-012-0928-x; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Uno Shinsuke, 2010, Urban Ecosystems, V13, P425, DOI 10.1007/s11252-010-0136-5; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; KLOTZ JH, 1995, FLA ENTOMOL, V78, P109, DOI 10.2307/3495674; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.2307/2641176; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Teets NM, 2014, J EXP BIOL, V217, P84, DOI 10.1242/jeb.089490; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Bonier F, 2007, BIOLOGY LETT, V3, P670, DOI 10.1098/rsbl.2007.0349; Antonov IA, 2013, RUSS J ECOL+, V44, P523, DOI 10.1134/S1067413613050020; Bestelmeyer Brandon T., 2000, P122; Carpintero S., 2013, ENTOMOLOGICAL SCI, V17, P41; Cilliers S., 2010, URBAN BIODIVERSITY D, P103; Clarke K. R., 2009, PRIMER VERSION 6 1 1; Cox W., 2014, DEMOGRAPHIA WORLD UR; DELABIE JHC, 1995, FLA ENTOMOL, V78, P264, DOI 10.2307/3495899; de Souza DR, 2012, SOCIOBIOLOGY, V59, P703; Dunn Robert R., 2007, Myrmecological News, V10, P77; Ellison A. M., 2012, FIELD GUIDE ANTS NEW; Fitzgerald TL, 2011, P NATL ACAD SCI USA, V108, P21140, DOI 10.1073/pnas.1115203108; Fuller RA, 2009, DIVERS DISTRIB, V15, P328, DOI 10.1111/j.1472-4642.2008.00537.x; Fulton CJ, 2013, CORAL REEFS, V32, P685, DOI 10.1007/s00338-013-1039-8; GRAY JS, 1989, BIOL J LINN SOC, V37, P19; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Holldobler B., 1990, ANTS; Ishitani M, 2003, ECOGRAPHY, V26, P481, DOI 10.1034/j.1600-0587.2003.03436.x; Lessard JP, 2005, CAN ENTOMOL, V137, P215; Marzluff John M., 2005, Urban Ecosystems, V8, P157, DOI 10.1007/s11252-005-4378-6; McDonnell M.J., 1997, URBAN ECOSYST, V1, P85, DOI 10.1023/A:1018598708346; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Menke SB, 2011, URBAN ECOSYST, V14, P135, DOI 10.1007/s11252-010-0150-7; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; O'Neil-Dunne J., 2012, REPORT CITY NEW YORK; Occhipinti-Ambrogi A, 2003, MAR POLLUT BULL, V46, P542, DOI 10.1016/S0025-326X(02)00363-6; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Pickett S. T. A., 1997, URBAN ECOSYST, V1, P185, DOI DOI 10.1023/A:1018531712889; Pickett S.T.A., 2013, ECOLOGICAL SYSTEMS, P273; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; RAPPORT DJ, 1985, AM NAT, V125, P617, DOI 10.1086/284368; Ribeiro FM, 2012, SOCIOBIOLOGY, V59, P971; Rosenweig C., 2006, MIGITGATING NEW YORK; Rybczynski W., 1999, CLEARING DISTANCE FL; SAS Institute Inc, 2012, SAS STAT SOFTW V 9 3; Scrosati R.A., 2007, ECOGRAPHY, V34, P151; Slipinski P, 2012, EUR J ENTOMOL, V109, P197; US Census Bureau, 2010, CENS POP HOUS DEM PR; Von Holle B, 2013, BIOL INVASIONS, V15, P417, DOI 10.1007/s10530-012-0297-7; Watt CA, 2013, MAR ECOL PROG SER, V491, P91, DOI 10.3354/meps10521; WILSON EO, 1966, ECOLOGY, V47, P485, DOI 10.2307/1932989; Youngsteadt E., GLOBAL CHAN IN PRESS; Zelikova T.J., 2011, ECOSPHERE, V2, P1; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806	87	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-458X	1752-4598		INSECT CONSERV DIVER	Insect. Conserv. Divers.	MAY	2015	8	3					216	228		10.1111/icad.12098		13	Biodiversity Conservation; Entomology	Biodiversity & Conservation; Entomology	CI2IG	WOS:000354569100003		
J	Kim, YH; Yang, X; Yamashita, S; Kumazoe, M; Huang, YH; Nakahara, K; Won, YS; Murata, M; Lin, IC; Tachibana, H				Kim, Yoon Hee; Yang, Xue; Yamashita, Shuya; Kumazoe, Motofumi; Huang, Yuhui; Nakahara, Kanami; Won, Yeong Seon; Murata, Motoki; Lin, I-Chian; Tachibana, Hirofumi			1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose increases a population of T regulatory cells and inhibits IgE production in ovalbumin-sensitized mice	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						PGG; Gallotannin; IgE; T regulatory cell	GLUCOSE-TRANSPORT; IMMUNE REGULATION; TYPE-2 RESPONSES; TANNIC-ACID; SERUM IGE; ASTHMA; EXPRESSION; INDUCTION; INTERLEUKIN-10; INFLAMMATION	1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) is a gallotannin isolated from various plants. In a previous study, it was reported that PGG suppressed interleukin (IL)-4 induced signal pathway in B cell which is indispensable for immunoglobulin E (IgE) production. However, the suppressive effect of PGG on IgE production in allergen-sensitized mice remains unclear. Therefore, the aim of this study was to investigate the inhibitory effect of PGG on IgE production in ovalbumin (OVA)-sensitized mice. Mice orally administered PGG showed a decrease in total and OVA-specific IgE levels in serum. Oral administration of PGG strongly suppressed production of type 2 T helper (IL-4 and IL-13), type IT helper (IFN-gamma), and pro-inflammatory cytokines (TNF-alpha and IL-6), but not anti-inflammatory cytokine (IL-10) from splenocytes of OVA-sensitized mice against OVA re-stimulation. A population of T regulatory (Treg) cells with immunosuppressive properties was increased in mesenteric lymph nodes and spleen of PGG-fed mice. PGG administration not only reduced expression levels of eotaxin, tissue inhibitors of metalloproteinases-1, and TNF-alpha, which assisted with IgE production, but also increased the expression of insulin-like growth factor binding protein-3 which inhibits IgE production. Additionally, PGG increased the levels of Treg cell-inducing factors such as IL-2, IL-10 and platelet factor-4 in serum. These data suggest that the inhibitory effect of PGG on IgE production could be partially caused by increasing a population of Treg cells in conjunction with Treg-inducing factors. (C) 2015 Elsevier B.V. All rights reserved.	[Kim, Yoon Hee; Yang, Xue; Yamashita, Shuya; Kumazoe, Motofumi; Huang, Yuhui; Nakahara, Kanami; Won, Yeong Seon; Murata, Motoki; Lin, I-Chian; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Higashi Ku, Fukuoka 8128581, Japan	Tachibana, H (reprint author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Kumazoe, Motofumi/0000-0002-3002-2994	JSPS KAKENHI [22228002]	This work was supported in part by a Grants for project research (Development of fundamental technology for analysis and evaluation of functional agricultural products and functional foods), JSPS KAKENHI (Grants Number 22228002), and a Grant-in-Aid for JSPS Fellows (25.2691). We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University.	Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; PUNNONEN J, 1993, J IMMUNOL, V151, P1280; Kim SR, 2012, ALLERGY, V67, P869, DOI 10.1111/j.1398-9995.2012.02837.x; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Polhill T, 2012, J AM SOC NEPHROL, V23, P1303, DOI 10.1681/ASN.2011111130; Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Emson CL, 1998, J EXP MED, V188, P399, DOI 10.1084/jem.188.2.399; Liu XQ, 2005, J NUTR, V135, P165; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Li XN, 2012, J ALLERGY CLIN IMMUN, V129, P575, DOI 10.1016/j.jaci.2011.09.040; Li YS, 2005, BIOCHEM BIOPH RES CO, V336, P430, DOI 10.1016/j.bbrc.2005.08.103; Yu WS, 2011, MOL CELLS, V32, P123, DOI 10.1007/s10059-011-2254-1; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Holgate ST, 1999, NATURE, V402, pB2; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Corry DB, 1999, NATURE, V402, pB18; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Braga M, 2011, Int J Immunopathol Pharmacol, V24, p55S; Garraud O, 1999, J ALLERGY CLIN IMMUN, V103, P333, DOI 10.1016/S0091-6749(99)70510-5; Hard D, 2007, J ALLERGY CLIN IMMUN, V119, P1258; Katoh N, 2002, CLIN EXP IMMUNOL, V127, P283, DOI 10.1046/j.1365-2249.2002.01740.x; Kim YH, 2013, FEBS OPEN BIO, V3, P341, DOI [10.1016/j.fob.2013.07.008, 10.1016/j.fob.2013.08.008]; Kobayashi W, 2002, BIOL PHARM BULL, V25, P1049, DOI 10.1248/bpb.25.1049; Lee HJ, 2011, KIDNEY INT, V79, P538, DOI 10.1038/ki.2010.458; Lee HJ, 2011, CARCINOGENESIS, V32, P804, DOI 10.1093/carcin/bgr015; Lee SH, 2007, PLANTA MED, V73, P769, DOI 10.1055/s-2007-981553; Liu CY, 2005, J IMMUNOL, V174, P2680; PENE J, 1988, EUR J IMMUNOL, V18, P929, DOI 10.1002/eji.1830180615; Raby BA, 2006, J ALLERGY CLIN IMMUN, V117, P298, DOI 10.1016/j.jaci.2005.10.041; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; Wu MJ, 2009, EVID-BASED COMPL ALT, V6, P57, DOI 10.1093/ecam/nem066	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAY	2015	26	1					30	36		10.1016/j.intimp.2015.02.025		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CI2MR	WOS:000354582200005		
J	Kato, Y; Kamiya, H; Koide, N; Odkhuu, E; Komatsu, T; Watarai, A; Kondo, M; Kato, K; Nakamura, J; Yokochi, T				Kato, Yoshiro; Kamiya, Hideki; Koide, Naoki; Odkhuu, Erdenezaya; Komatsu, Takayuki; Watarai, Atsuko; Kondo, Masaki; Kato, Koichi; Nakamura, Jiro; Yokochi, Takashi			Irbesartan attenuates production of high-mobility group box 1 in response to lipopolysaccharide via downregulation of interferon-beta production	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						High-mobility group box 1; Interferon-beta; Irbesartan; Lipopolysaccharide; Nitric oxide	SIGNALING PATHWAY; RAW264.7 CELLS; HMGB1; PROTEIN; EXPRESSION; RELEASE; DISEASE; IFN; DNA	High-mobility group box 1 (HMGB1) is suggested to participate in development of local and systemic inflammatory disorders. Irbesartan (IRB), an angiotensin II type1 receptor blocker, is widely used for treatment of hypertension, especially in patients with diabetic nephropathy. The effect of IRB on lipopolysaccharide (LPS)-induced HMGB1 and nitric oxide (NO) production was examined using RAW 264.7 macrophage-like cells. IRB inhibited LPS-induced HMGB1 production. IRB also reduced LPS-induced expression of an inducible NO synthase, and inhibited LPS-induced NO production. The expression levels of IFN-beta protein and mRNA, which is a key molecule in MyD88-independent pathway of LPS signaling, were exclusively inhibited by IRB. Peroxisome proliferator-activated receptor-gamma and angiotensin II type 1 receptor were not involved in the inhibitory action of IRB on LPS-induced HMCB1 and NO production. Collectively, IRB was suggested to inhibit LPS-induced HMGB1 production via downregulation of IFN-beta production in the MyD88-independent pathway. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Yoshiro; Kamiya, Hideki; Watarai, Atsuko; Kondo, Masaki; Nakamura, Jiro] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, Nagakute, Aichi 4801195, Japan; [Koide, Naoki; Odkhuu, Erdenezaya; Komatsu, Takayuki; Yokochi, Takashi] Aichi Med Univ, Sch Med, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan; [Kato, Koichi] Aichi Gakuin Univ, Sch Pharm, Lab Med, Nagoya, Aichi 4640037, Japan	Kato, Y (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	ykato4@aichi-med-u.ac.jp					Abu El-Asrar A.M., 2014, MEDIAT INFLAMM, V2014; Aldra S., 2003, J BIOL CHEM, V278, P38105; HANELT M, 1994, MYCOPATHOLOGIA, V128, P167, DOI 10.1007/BF01138479; Devaraj S, 2009, DIABETOLOGIA, V52, P1665, DOI 10.1007/s00125-009-1394-8; Kim J, 2011, AM J NEPHROL, V33, P524, DOI 10.1159/000327992; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Chen XL, 2013, BRIT J OPHTHALMOL, V97, P1598, DOI 10.1136/bjophthalmol-2013-303736; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Clasen R, 2005, HYPERTENSION, V46, P137, DOI 10.1161/01.HYP.0000168046.19884.6a; Nin JWM, 2012, DIABETOLOGIA, V55, P2489, DOI 10.1007/s00125-012-2622-1; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Mohammad G, 2013, EXP EYE RES, V107, P101, DOI 10.1016/j.exer.2012.12.009; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Hagiwara S, 2009, INTENS CARE MED, V35, P1471, DOI 10.1007/s00134-009-1545-x; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Persson F, 2006, DIABETES, V55, P3550, DOI 10.2337/db06-0827; Pindado J, 2007, J IMMUNOL, V179, P4821; Tsuruoka S, 2013, INTERNAL MED, V52, P303, DOI 10.2169/internalmedicine.52.9066; Tumurkhuu G, 2009, INT J MED MICROBIOL, V299, P554, DOI 10.1016/j.ijmm.2009.04.003; Yang Y, 2014, CELL PHYSIOL BIOCHEM, V33, P1283, DOI 10.1159/000358696; Yang Y, 2014, INT IMMUNOPHARMACOL, V19, P81, DOI 10.1016/j.intimp.2014.01.003	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAY	2015	26	1					97	102		10.1016/j.intimp.2015.03.015		6	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CI2MR	WOS:000354582200015		
J	Minami, T; Minami, T; Shimizu, N; Yamamoto, Y; De Velasco, MA; Nozawa, M; Yoshimura, K; Harashima, N; Harada, M; Uemura, H				Minami, Takafumi; Minami, Tomoko; Shimizu, Nobutaka; Yamamoto, Yutaka; De Velasco, Marco A.; Nozawa, Masahiro; Yoshimura, Kazuhiro; Harashima, Nanae; Harada, Mamoru; Uemura, Hirotsugu			New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HIA-A3 supertype alleles	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Prostate cancer; EZH2; CTL; Peptide; HLA-A3 supertype allele	HISTONE H3; METHYLATION; IDENTIFICATION; RECOGNITION; PROGRESSION; LYSINE-27; BINDING; CELLS; CTL	Analyses on reactivity of anti-cancer cytotoxic T lymphocytes (CTLs) and clinical application of peptide-based anti-cancer vaccine have been mainly focused on patients with HLA-A2 or -A24 alleles. In this study, we identified an enhancer of zeste homolog (EZH) 2-derived peptide applicable for anti-cancer vaccine for prostate cancer patients with HLA-A3 supertype alleles. Five EZH2-derived peptides that were prepared based on the binding motif to the HLA-A3 supertype alleles (HLA-A11, -A31, and -A33) were functionally screened for their potential to induce peptide-specific CTLs from peripheral blood mononuclear cells (PBMCs) of HLA-A3 supertype allele prostate cancer patients. As a result, EZH2(733-741) peptide was found to efficiently induce peptide-specific CTLs. The EZH2(733-741) peptide-stimulated and purified CD8(+) T cells from PBMCs of HLA-A3 supertype allele + prostate cancer patients showed higher cytotoxicity against HLA-A3 supertype allele-expressing LNCaP prostate cancer cells than against parental LNCaP cells. This cytotoxicity against HLA-A3 supertype allele-expressing LNCaP cells was partially but significantly inhibited by the addition of EZH2(733-741) peptide-pulsed competitive cells. These results indicate that the EZH2(733-741) peptide could be a promising candidate for peptide-based immunotherapy for HLAA3 supertype allele(+) prostate cancer patients. (C) 2015 Elsevier B.V. All rights reserved.	[Minami, Tomoko; Shimizu, Nobutaka; Yamamoto, Yutaka; De Velasco, Marco A.; Nozawa, Masahiro; Yoshimura, Kazuhiro; Uemura, Hirotsugu] Kinki Univ, Sch Med, Dept Urol, Osaka 589, Japan; [Harashima, Nanae; Harada, Mamoru] Shimane Univ, Sch Med, Dept Immunol, Izumo, Shimane, Japan	Minami, T (reprint author), Kinki Univ, Sch Med, Dept Urol, Osaka 589, Japan.	minami@med.kindai.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592416]	This study was supported in part by KAKENHI (Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan) (No.24592416 to T. Minami).	Aizawa M., 1986, P 3 AS OC HIST WORKS, P1090; akedatsu H., 2004, CLIN CANCER RES, V10, P1112; Alexander J, 1997, J IMMUNOL, V159, P4753; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; PARKER KC, 1994, J IMMUNOL, V152, P163; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; Jacobs JJL, 1999, NATURE, V397, P164; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; SAFRIT JT, 1994, J EXP MED, V179, P463, DOI 10.1084/jem.179.2.463; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Yang YA, 2013, PROTEIN CELL, V4, P331, DOI 10.1007/s13238-013-2093-2; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Hida N, 2002, CANCER IMMUNOL IMMUN, V51, P219, DOI 10.1007/s00262-002-0273-7; Imanishi T., 1992, HLA 1991, V1, P1065; Itoh Y, 2007, ONCOL REP, V18, P1231; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Matsueda S, 2005, CLIN CANCER RES, V11, P6933, DOI 10.1158/1078-0432.CCR-05-0682; Minami T, 2007, CANCER IMMUNOL IMMUN, V56, P689, DOI 10.1007/s00262-006-0216-9; Ogata R, 2004, PROSTATE, V60, P273, DOI 10.1002/pros.20078; Renkvist N, 2001, CANCER IMMUNOL IMMUN, V50, P3, DOI 10.1007/s002620000169; Sidney J, 1996, HUM IMMUNOL, V45, P79, DOI 10.1016/0198-8859(95)00173-5; Wang RF, 1998, J IMMUNOL, V160, P890	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	MAY	2015	26	1					133	138		10.1016/j.intimp.2015.03.023		6	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CI2MR	WOS:000354582200020		
J	Sejima, T; Iwamoto, H; Masago, T; Morizane, S; Yao, A; Umekita, Y; Honda, M; Takenaka, A				Sejima, T.; Iwamoto, H.; Masago, T.; Morizane, S.; Yao, A.; Umekita, Y.; Honda, M.; Takenaka, A.			Initial evidence demonstrating the association between the vascular status in surgically resected renal parenchymal pathology and sexual function	INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH			English	Article							CHRONIC KIDNEY-DISEASE; TUMOR NEPHRECTOMY SPECIMENS; ERECTILE DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; RADICAL NEPHRECTOMY; FAILURE; RISK	Our goal is to evaluate the association between histopathology of glomerulosclerosis (GS) and atherosclerosis (AS) in the nephrectomized normal parenchyma together with patients' background, and erectile dysfunction (ED) of patients treated with radical nephrectomy (RN) for renal cell carcinoma (RCC). ED was assessed with the International Index of Erectile Function in 65 patients who were less than age 70 years at the time of questionnaire. Glomeruli status was assessed by the extent of global GS. AS was graded based on lumen occlusion and frequency of involvement. Patients' backgrounds included any comorbidities, post-RN renal insufficiency, tumor pathology, demographics and social status. The presence of diabetes mellitus and lack of a spouse were independent predictors for severe ED, whereas G0/1 AS was an independent predictor for mild/no ED. The extent of global GS was significantly lower in patients with mild/no ED than in other patients. Our study represents the first report identifying healthy arterial status in the renal parenchyma as a significant indicator of favorable erectile function and that the evaluation of AS severity is not a superior indicator of severe ED in the presence of comorbidities or social status among patients treated with RN.	[Sejima, T.; Iwamoto, H.; Masago, T.; Morizane, S.; Yao, A.; Honda, M.; Takenaka, A.] Tottori Univ, Fac Med, Dept Surg, Div Urol, Yonago, Tottori 683, Japan; [Umekita, Y.] Tottori Univ, Fac Med, Dept Pathol, Div Organ Pathol, Yonago, Tottori 683, Japan	Sejima, T (reprint author), Div Urol, 36-1 Nishimachi, Yonago, Tottori 6838504, Japan.	sejimat@grape.med.tottori-u.ac.jp					Abdel-Gawad M, 1999, MOL UROL, V3, P117; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Bijol V, 2006, AM J SURG PATHOL, V30, P575, DOI 10.1097/01.pas.0000194296.74097.87; Ponholzer A, 2012, INT J IMPOT RES, V24, P137, DOI 10.1038/ijir.2012.3; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Lane BR, 2013, J UROLOGY, V189, P1649, DOI 10.1016/j.juro.2012.11.121; Costa C, 2009, J SEX MED, V6, P2390, DOI 10.1111/j.1743-6109.2009.01356.x; Gautam G, 2010, J UROLOGY, V184, P1872, DOI 10.1016/j.juro.2010.06.145; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Bellinghieri G, 2006, SEMIN NEPHROL, V26, P42, DOI 10.1016/j.semnephrol.2005.06.009; Bonsib SM, 2010, ADV ANAT PATHOL, V17, P235, DOI 10.1097/PAP.0b013e3181e3c02d; de Araujo AC, 2009, J SEX MED, V6, P3440, DOI 10.1111/j.1743-6109.2009.01496.x; Guay AT, 2007, ENDOCRIN METAB CLIN, V36, P453, DOI 10.1016/j.ecl.2007.03.007; Guo P, 2010, UROLOGY, V76, P370, DOI 10.1016/j.urology.2010.03.079; Keddis MT, 2010, NEPHROL DIAL TRANSPL, V25, P3615, DOI 10.1093/ndt/gfq269; Kopp RP, 2013, BJU INT, V111, pE98, DOI 10.1111/j.1464-410X.2012.11346.x; Leavey SF, 2002, ENDOCRIN METAB CLIN, V31, P107, DOI 10.1016/S0889-8529(01)00006-8; Mehrsai Abdolrasoul, 2006, Urol J, V3, P240; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; Wang Y, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-26	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0955-9930	1476-5489		INT J IMPOT RES	Int. J. Impot. Res.	MAY-JUN	2015	27	3					90	94		10.1038/ijir.2014.38		5	Urology & Nephrology	Urology & Nephrology	CI0HX	WOS:000354418800003		
J	Hirose, N; Nakahori, C				Hirose, Norikazu; Nakahori, Chikako			Age Differences in Change-of-Direction Performance and Its Subelements in Female Football Players	INTERNATIONAL JOURNAL OF SPORTS PHYSIOLOGY AND PERFORMANCE			English	Article						agility; athletes; body weight; Japan; muscle strength	TALENT IDENTIFICATION; SOCCER PLAYERS; SKELETAL MATURATION; PHYSICAL-FITNESS; AGILITY; GROWTH; GIRLS; POWER; STRENGTH; CHILDREN	Purpose:To describe cross-sectional age differences in change-of-direction performance (CODp) in female football players and investigate the relationship between CODp and linear-sprint speed, muscle power, and body size. Methods: A sample of 135 well-trained female football players was divided into 8 age groups. Anthropometry (height, body mass, and lean body mass) and athletic performance (10-m sprint speed, 10-m x 5-CODp, and 5-step bounding distance) were compared to determine interage differences using ANOVA. Then, the participants were divided into 3 age groups: 12- to 14-y-olds, 15- to 17-y-olds, and >= 18 y-olds. Simple- and multiple-regression analyses were conducted to determine the correlation between CODp and the other measurement variables in each age group. Results: Age-related differences were found for CODp (F = 10.41, P < .01), sprint speed (F = 3.27, P < .01), and bounding distance (F = 4.20, P < .01). Post hoc analysis revealed that the CODp of 17-y-old players was faster than that of 16-y-old players (P < .01), with no interage differences in sprint speed and bounding distance. Sprint speed and bounding distance were weakly correlated with CODp in 15- to >= 18-y-old players, but only sprint speed was correlated with CODp in 12- to 14-y-old players. Conclusions: CODp improves from 16 to 17 y of age in female players. Linear-sprint speed, muscle power, and body size were weakly correlated with the age differences in CODp.	[Hirose, Norikazu] Waseda Univ, Fac Sport Sci, Tokyo, Japan; [Nakahori, Chikako] JFA Acad Sakai, Osaka, Japan	Hirose, N (reprint author), Waseda Univ, Fac Sport Sci, Tokyo, Japan.	toitsu_hirose@waseda.jp			Japan Society for the Promotion of Sciences [24500764]	The funding for this study was provided as a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (No: 24500764).	Miller MG, 2006, J SPORT SCI MED, V5, P459; Hoare DG, 2000, J SPORT SCI, V18, P751; Young WB, 2001, J STRENGTH COND RES, V15, P315; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282; Mirkov DM, 2010, J STRENGTH COND RES, V24, P2677, DOI 10.1519/JSC.0b013e3181e27245; Negrete R, 2000, J SPORT REHABIL, V9, P46; Peterson MD, 2006, J STRENGTH COND RES, V20, P867; Pauole K, 2000, J STRENGTH COND RES, V14, P443; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120078; Vescovi JD, 2008, J SPORT SCI, V26, P97, DOI 10.1080/02640410701348644; DOCHERTY D, 1988, J HUM MOVEMENT STUD, V14, P269; Temfemo A, 2009, EUR J PEDIATR, V168, P457, DOI 10.1007/s00431-008-0771-5; Malisoux L, 2006, J APPL PHYSIOL, V100, P771, DOI 10.1152/japplphysiol.01027.2005; Kubo T, 2010, ASIA PAC J CLIN NUTR, V19, P594; Vescovi JD, 2011, SCAND J MED SCI SPOR, V21, P670, DOI 10.1111/j.1600-0838.2009.01081.x; Meir R, 2001, J STRENGTH COND RES, V15, P450; Ashizawa K, 1996, ANN HUM BIOL, V23, P457, DOI 10.1080/03014469600004682; Beunen GP, 1997, INT J SPORTS MED, V18, P413; Borms J, 1996, INT PREOL SCI C DALL; Draper JA, 1985, AUSTR J SCI MED SPOR, V17, P15; FIFA Communication Division. Information Service, 2007, FIFA BIG COUNT 2006; Japan Football Association, 2006, PHYS FITN TEST GUID; Keogh JWL, 2003, CAN J APPL PHYSIOL, V28, P397; Loko J, 2003, AM J HUM BIOL, V15, P72, DOI 10.1002/ajhb.10114; Ministry of Education C Sports Science and Technology-Japan, ALM DAT JAP CHILDR 2; Shalfawi SAI, 2013, J STRENGTH COND RES, V27, P2966, DOI 10.1519/JSC.0b013e31828c2889; Stolen T, 2005, SPORTS MED, V35, P501; Tsukoshi T, 2010, JAPAN J PHYS ED HLTH, V55, P565; Valquer W, 1998, 4 WORLD C NOT AN SPO, V80, P23	30	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1555-0265	1555-0273		INT J SPORT PHYSIOL	Int. J. Sport Physiol. Perform.	MAY	2015	10	4					440	445		10.1123/ijspp.2014-0214		6	Physiology; Sport Sciences	Physiology; Sport Sciences	CI3RY	WOS:000354666300006		
J	Sonoda, A; Jeudy, J; White, CS; Kligerman, SJ; Nitta, N; Lempel, J; Frazier, AA				Sonoda, Akinaga; Jeudy, Jean; White, Charles S.; Kligerman, Seth J.; Nitta, Norihisa; Lempel, Jason; Frazier, Aletta Ann			Pleurodesis: indications and radiologic appearance	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Pleurodesis; Clinical indication; Talc; Chemical stimulation; Mechanical stimulation	MALIGNANT PLEURAL EFFUSIONS; TALC PLEURODESIS; CHEMICAL PLEURODESIS; PNEUMOTHORAX; MANAGEMENT; DISEASE	Pleurodesis is frequently performed to prevent recurrence of pneumothorax or recurrent pleural effusion in benign or malignant conditions. In essence, it involves producing an area of adhesion between the parietal and the visceral layers of the pleura. The approach to this procedure can be divided into chemical and mechanical methods. Chemical pleurodesis is performed by introducing various substances such as talc, bleomycin, povidone iodine or other chemicals into the pleural space typically using a pleural catheter. The instilled substances cause inflammation of the parietal and the visceral layers of the pleura and leads to adhesion of the pleural surfaces, preventing further fluid or air accumulation. Mechanical pleurodesis, which is performed with thoracotomy or thoracoscopy, involves mechanical irritation of the pleura or removal of parietal pleura. It is important for the radiologist to develop an understanding of the clinical indications for pleurodesis, methods for the procedure and post-procedure imaging appearance so the radiologist can provide a correct interpretation and avoid misdiagnosis of the radiologic appearance as chronic infection, tumor or other entities with a similar appearance. Thus, the aim of this article is to review the indications, techniques and post-procedural appearances of pleurodesis from an imaging perspective.	[Sonoda, Akinaga; Jeudy, Jean; White, Charles S.; Kligerman, Seth J.; Lempel, Jason; Frazier, Aletta Ann] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, Baltimore, MD 21201 USA; [Sonoda, Akinaga; Nitta, Norihisa] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 5202192, Japan	Sonoda, A (reprint author), Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA.	akinaga@belle.shiga-med.ac.jp					Ahmadzadehfar H, 2007, LUNG CANCER, V58, P418, DOI 10.1016/j.lungcan.2007.05.015; Alavi Ali Asghar, 2011, Acta Med Iran, V49, P584; Nasreen N, 2000, AM J RESP CRIT CARE, V161, P595; Kilic D, 2005, SURG TODAY, V35, P634, DOI 10.1007/s00595-005-2996-5; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Cao GQ, 2012, ANN THORAC SURG, V93, P1652, DOI 10.1016/j.athoracsur.2012.01.093; KENNEDY L, 1994, CHEST, V106, P1215, DOI 10.1378/chest.106.4.1215; Kwek BH, 2004, CHEST, V125, P2356, DOI 10.1378/chest.125.6.2356; Marchi E, 2010, J BRAS PNEUMOL, V36, P759, DOI 10.1590/S1806-37132010000600014; Matsubara N, 2012, INT J CLIN ONCOL, V17, P470, DOI 10.1007/s10147-011-0312-5; MCLOUD TC, 1980, RADIOLOGY, V135, P313; Rodriguez-Panadero F, 2012, RESPIRATION, V83, P91, DOI 10.1159/000335419; Vaz Marcelo Costa, 2006, J Bras Pneumol, V32, P347, DOI 10.1590/S1806-37132006000400014; WALLACH HW, 1975, CHEST, V68, P510, DOI 10.1378/chest.68.4.510	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	MAY	2015	33	5					241	245		10.1007/s11604-015-0412-7		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3FM	WOS:000354633000001		
J	Yoshida, R; Kaji, Y; Tamaki, Y; Katsube, T; Kitagaki, H; Kanbara, T; Kamai, T				Yoshida, Rika; Kaji, Yasushi; Tamaki, Yukihisa; Katsube, Takashi; Kitagaki, Hajime; Kanbara, Tsunehito; Kamai, Takao			Information of prostate biopsy positive core: does it affect MR detection of prostate cancer on using 3T-MRI?	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Prostate biopsy; Prostate cancer; 3TMRI	RADICAL PROSTATECTOMY; 3 T; GLEASON SCORE; TUMOR; AGGRESSIVENESS; CARCINOMA	We assessed which information from a prostate biopsy had the strongest relationship with prostate cancer detection by 3T-MRI. Sixty-one consecutive patients with biopsy-proven prostate cancer who underwent 3T-MRI before biopsy were enrolled in this retrospective study. Two radiologists independently reviewed T2-weighted and diffusion-weighted images. When the cancer lesions were revealed by biopsy and MRI depicted them at corresponding sites, we classified these lesions as MRI-detectable cancer. If the cancer lesions were revealed by biopsy, but any cancers had not been detected, we classified these lesions as MRI-undetectable cancer. We compared the Gleason score (GS), cancer ratio (CaR) and cancer length (CaL) from core biopsies between the two groups. GS, CaR and CaL differed significantly between the MRI-detectable group (N = 70), and the MRI-undetectable group (N = 73). 3T-MRI could detect cancer cores with a sensitivity of 90.5 % in cores with CaR a parts per thousand yen 60 %, and with a sensitivity of 81.8 % in those with CaL a parts per thousand yen 5 mm. Receiver operating characteristic analysis showed that CaR (P = 0.006) and CaL (P = 0.010) significantly associated with the prostate cancer detection using MRI rather than GS. CaR and CaL from the core biopsies showed a stronger relationship to detection of the prostate cancer on 3T-MRI than the GS did.	[Yoshida, Rika; Katsube, Takashi; Kitagaki, Hajime] Shimane Univ, Dept Radiol, Fac Med, Izumo, Shimane 6938501, Japan; [Kaji, Yasushi] Dokkyo Med Univ, Sch Med, Dept Radiol, Mibu, Tochigi, Japan; [Tamaki, Yukihisa] Shimane Univ, Dept Radiat Oncol, Fac Med, Izumo, Shimane 6938501, Japan; [Kanbara, Tsunehito; Kamai, Takao] Dokkyo Med Univ, Sch Med, Dept Urol, Mibu, Tochigi, Japan	Yoshida, R (reprint author), Shimane Univ, Dept Radiol, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	ryoshida0917@yahoo.co.jp					Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; CATALONA WJ, 1993, J UROLOGY, V150, P905; Wallner K, 1996, J CLIN ONCOL, V14, P449; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686; CATALONA WJ, 1990, J UROLOGY, V143, P538; Vargas HA, 2012, RADIOLOGY, V265, P478, DOI 10.1148/radiol.12120041; Eberhardt SC, 2013, J AM COLL RADIOL, V10, P83, DOI 10.1016/j.jacr.2012.10.021; Kitajima K, 2010, J MAGN RESON IMAGING, V31, P625, DOI 10.1002/jmri.22075; Zakian KL, 2005, RADIOLOGY, V234, P804, DOI 10.1148/radiol.2343040363; Roethke MC, 2014, EUR RADIOL, V24, P344, DOI 10.1007/s00330-013-3017-5; Vargas HA, 2011, RADIOLOGY, V259, P775, DOI 10.1148/radiol.11102066; Moore CM, 2013, EUR UROL, V63, P125, DOI 10.1016/j.eururo.2012.06.004; Wang L, 2008, RADIOLOGY, V246, P168, DOI 10.1148/radiol.2461070057; Grossklaus DJ, 2002, UROL ONCOL, V7, P195, DOI 10.1016/S1078-1439(02)00190-4; Grossklaus DJ, 2002, J UROLOGY, V167, P2032, DOI 10.1016/S0022-5347(05)65077-X; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.3.CO;2-2; Ito K, 2009, INT J UROL, V16, P458, DOI 10.1111/j.1442-2042.2009.02293.x; PILEPICH MV, 1987, INT J RADIAT ONCOL, V13, P659; WHITMORE WF, 1994, SEMIN ONCOL, V21, P560; Woodfield CA, 2010, AM J ROENTGENOL, V194, pW316, DOI 10.2214/AJR.09.2651; ZINCKE H, 1994, J CLIN ONCOL, V12, P2254	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	MAY	2015	33	5					246	252		10.1007/s11604-015-0407-4		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3FM	WOS:000354633000002		
J	Nishie, A; Kakihara, D; Nojo, T; Nakamura, K; Kuribayashi, S; Kadoya, M; Ohtomo, K; Sugimura, K; Honda, H				Nishie, Akihiro; Kakihara, Daisuke; Nojo, Takeshi; Nakamura, Katsumasa; Kuribayashi, Sachio; Kadoya, Masumi; Ohtomo, Kuni; Sugimura, Kazuro; Honda, Hiroshi			Current radiologist workload and the shortages in Japan: how many full-time radiologists are required?	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Full-time certified radiologist; CT; MRI; Radiation therapy; Japan		To clarify the workload of certified radiologists and to estimate the current manpower shortages in Japan. We conducted a questionnaire survey for accredited training institutions. The contents included the radiologist employment pattern (full vs. part time), the number of computed tomography (CT) and magnetic resonance imaging (MRI) examinations and their radiology reports, the number of radiation therapy planning sessions, and the time per week spent for each work activity. We also used the hospital survey reports of Japan's Ministry of Health, Labor, and Welfare in our analyses. The estimated numbers of CT and MRI interpretation reports and radiation treatment plans that one full-time radiologist could complete within 1 hospital day (8 h) were 19.9 and 1.22, respectively. To complete all CT and MRI reports, at least 2.09 times more full-time diagnostic radiologists are needed in Japan. For radiation therapy, at least 1.23 times more full-time radiation oncologists are necessary at large- and medium-scale hospitals, although the number of radiation oncologists needed in Japan is balanced to the current number. The number of full-time certified diagnostic radiologists for CT and MRI interpretation in Japan is insufficient. Centralized radiation therapy facilities may be more efficient for meeting the increasing demand.	[Nishie, Akihiro; Kakihara, Daisuke; Nakamura, Katsumasa; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Nojo, Takeshi] New Tokyo Hosp, Dept Radiol, Matsudo, Chiba 2702232, Japan; [Kuribayashi, Sachio] Keio Univ, Dept Diagnost Radiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Kadoya, Masumi] Shinshu Univ, Dept Radiol, Sch Med, Matsumoto, Nagano 3908621, Japan; [Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; [Sugimura, Kazuro] Kobe Univ, Dept Radiol, Grad Sch Med, Chou Ku, Kobe, Hyogo 6500017, Japan	Nishie, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	anishie@radiol.med.kyushu-u.ac.jp			Daiichi-Sankyo Co.	Dr. Ohtomo received a research grant from Daiichi-Sankyo Co. The other authors have no conflict of interest.	Nakajima Y, 2008, RADIAT MED, V26, P455, DOI 10.1007/s11604-008-0259-2; Imamura K., 2006, JPN J MED PHYS, V26, P85; Imamura K, 2005, JJMRM, V25, P154; Katada K., 2006, JPN J RADIOL TECHNOL, V62, P649; Nojo T, 2010, RES REPORT ACTUAL CO	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	MAY	2015	33	5					266	272		10.1007/s11604-015-0413-6		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3FM	WOS:000354633000005		
J	Michimoto, K; Shimizu, K; Kameoka, Y; Kurata, N; Tokashiki, T; Sadaoka, S; Fukuda, K				Michimoto, Kenkichi; Shimizu, Kanichiro; Kameoka, Yoshihiko; Kurata, Naoki; Tokashiki, Tadashi; Sadaoka, Shunichi; Fukuda, Kunihiko			A successful case of liver biopsy via the right femoral vein using the Quick-Core biopsy needle	JAPANESE JOURNAL OF RADIOLOGY			English	Article						Right femoral access; Transfemoral liver biopsy; Transjugular liver biopsy; Quick-Core biopsy needle	CONSECUTIVE PROCEDURES	A 35-year-old male with ascites and coagulopathy underwent transjugular liver biopsy (TJLB) for severe hepatic dysfunction. However, the acute angle of the inferior vena cava and hepatic veins (HVs) prevented insertion of a 14-gauge inner stiffening metallic cannula into the HV. He then underwent successful liver biopsy by right femoral vein access (transfemoral liver biopsy) using a TJLB device without complications and was pathologically diagnosed with nonalcoholic steatohepatitis.	[Michimoto, Kenkichi; Shimizu, Kanichiro; Kameoka, Yoshihiko; Kurata, Naoki; Tokashiki, Tadashi; Sadaoka, Shunichi] Jikei Univ, Sch Med, Dept Radiol, Kashiwa Hosp, Kashiwa, Chiba 2778567, Japan; [Fukuda, Kunihiko] Jikei Univ, Dept Radiol, Sch Med, Tokyo 1058471, Japan; [Fukuda, Kunihiko] Univ Hosp, Minato Ku, Tokyo 1058471, Japan	Michimoto, K (reprint author), Jikei Univ, Sch Med, Dept Radiol, Kashiwa Hosp, 163-1 Kashiwa Shita, Kashiwa, Chiba 2778567, Japan.	kenkichi.m@gmail.com					Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Bruzzi JF, 2002, ABDOM IMAGING, V27, P711, DOI 10.1007/s00261-002-0020-8; Jana Manisha, 2012, Trop Gastroenterol, V33, P168; Li FQ, 2014, LIVER TRANSPLANT, V20, P1178, DOI 10.1002/lt.23928; Smith TP, 2003, AM J ROENTGENOL, V180, P167; Takashina T, 1996, JPN J INTERVENT RADI, V11, P237; TEARE JP, 1994, CARDIOVASC INTER RAD, V17, P252; Thakrar PD, 2013, J VASC INTERV RADIOL, V16, P161; Yavuz K, 2007, J VASC INTERV RADIOL, V18, P237, DOI 10.1016/j.jvir.2006.12.730	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1071	1867-108X		JPN J RADIOL	Jpn. J. Radiol.	MAY	2015	33	5					295	297		10.1007/s11604-015-0414-5		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3FM	WOS:000354633000010		
J	Nakagomi, D; Suzuki, K; Meguro, K; Hosokawa, J; Tamachi, T; Takatori, H; Suto, A; Matsue, H; Ohara, O; Nakayama, T; Shimada, S; Nakajima, H				Nakagomi, Daiki; Suzuki, Kotaro; Meguro, Kazuyuki; Hosokawa, Junichi; Tamachi, Tomohiro; Takatori, Hiroaki; Suto, Akira; Matsue, Hiroyuki; Ohara, Osamu; Nakayama, Toshinori; Shimada, Shinji; Nakajima, Hiroshi			Matrix metalloproteinase 12 is produced by M2 macrophages and plays important roles in the development of contact hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Nakagomi, Daiki; Suzuki, Kotaro; Meguro, Kazuyuki; Hosokawa, Junichi; Tamachi, Tomohiro; Takatori, Hiroaki; Suto, Akira; Nakajima, Hiroshi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Matsue, Hiroyuki] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shimada, Shinji] Yamanashi Univ, Dept Dermatol, Grad Sch Med, Yamanashi, Japan	Nakagomi, D (reprint author), Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan.	suzuki_k@faculty.chiba-u.jp; nakajimh@faculty.chiba-u.jp					Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568; Li W, 2009, J MED CHEM, V52, P1799, DOI 10.1021/jm900093d	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1397	+		10.1016/j.jaci.2014.10.055		4	Allergy; Immunology	Allergy; Immunology	CH4DA	WOS:000353980700039		
J	Adami, A; Koga, S; Kondo, N; Cannon, DT; Kowalchuk, JM; Amano, T; Rossiter, HB				Adami, Alessandra; Koga, Shunsaku; Kondo, Narihiko; Cannon, Daniel T.; Kowalchuk, John M.; Amano, Tatsuro; Rossiter, Harry B.			Changes in whole tissue heme concentration dissociates muscle deoxygenation from muscle oxygen extraction during passive head-up tilt	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						time-resolved near-infrared spectroscopy; echo-Doppler; blood flow; tissue saturation; vascular compliance	NEAR-INFRARED SPECTROSCOPY; TIME-RESOLVED SPECTROSCOPY; BLOOD-VOLUME CHANGES; PULMONARY O-2 UPTAKE; SKELETAL-MUSCLE; UPTAKE KINETICS; DYNAMIC HETEROGENEITY; OXIDATIVE-METABOLISM; RAMP EXERCISE; FIBER TYPES	Skeletal muscle deoxygenated hemoglobin and myoglobin concentration ([HHb]), assessed by near-infrared spectroscopy (NIRS), is commonly used as a surrogate of regional O-2 extraction (reflecting the O-2 delivery-to-consumption ratio, (Q) over dot/(V) over dot O-2). However, [HHb] change (Delta[HHb]) is also influenced by capillary-venous heme concentration, and/or small blood vessel volume (reflected in total heme; [THb]). We tested the hypotheses that Delta[HHb] is associated with O-2 extraction, and insensitive to [THb], over a wide range of (Q) over dot/(V) over dot O-2 elicited by passive head-up tilt (HUT; 10-min, 15 degrees increments, between -10 degrees and 75 degrees). Steady-state common femoral artery blood flow (FBF) was measured by echo-Doppler, and time-resolved NIRS measured [HHb] and [THb] of vastus lateralis (VL) and gastrocnemius (GS) in 13 men. EMG confirmed muscles were inactive. During HUT in VL [HHb] increased linearly (57 +/- 10 to 101 +/- 16 mu M; P < 0.05 above 15 degrees) and was associated (r(2) similar to 0.80) with the reduction in FBF (618 +/- 75 ml/min at 0 degrees to 268 +/- 52 ml/min at 75 degrees; P < 0.05 above 30 degrees) and the increase in [THb] (228 +/- 30 vs. 252 +/- 32 mu M; P < 0.05 above 15 degrees). GS response was qualitatively similar to VL. However, there was wide variation within and among individuals, such that the overall limits of agreement between Delta[HHb] and Delta FBF ranged from -35 to + 19% across both muscles. Neither knowledge of tissue O-2 saturation nor vascular compliance could appropriately account for the Delta[HHb]- FBF dissociation. Thus, under passive tilt, [HHb] is influenced by (Q) over dot/(V) over dot O-2, as well as microvascular hematocrit and/or tissue blood vessel volume, complicating its use as a noninvasive surrogate for muscle microvascular O-2 extraction.	[Adami, Alessandra; Cannon, Daniel T.; Rossiter, Harry B.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Rehabil Clin Trials Ctr, Div Resp & Crit Care Physiol & Med, Torrance, CA 90502 USA; [Koga, Shunsaku] Kobe Design Univ, Appl Physiol Lab, Kobe, Hyogo, Japan; [Kondo, Narihiko; Amano, Tatsuro] Kobe Univ, Grad Sch Human Dev & Environm, Lab Appl Human Physiol, Kobe, Hyogo 657, Japan; [Kowalchuk, John M.] Univ Western Ontario, Sch Kinesiol, London, ON, Canada; [Kowalchuk, John M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Rossiter, HB (reprint author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Rehabil Clin Trials Ctr, Div Resp & Crit Care Physiol & Med, 1124 W Carson St CDCRC Bldg, Torrance, CA 90502 USA.	hrossiter@ucla.edu			Biotechnology and Biological Sciences Research Council, UK [BB/I024798/1]; Japan Society for the Promotion of Science [24247046]	This study was supported by Biotechnology and Biological Sciences Research Council, UK (BB/I024798/1), and a grant for scientific research from the Japan Society for the Promotion of Science (Grant-in-Aid 24247046) to S. Koga.	Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; Grassi B, 1996, J APPL PHYSIOL, V80, P988; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Ferreira LF, 2005, J APPL PHYSIOL, V98, P1820, DOI 10.1152/japplphysiol.00907.2004; Binzoni T, 2000, J APPL PHYSIOL, V88, P369; Takakura H, 2010, EXP PHYSIOL, V95, P630, DOI 10.1113/expphysiol.2009.050344; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; SEIYAMA A, 1988, J BIOCHEM-TOKYO, V103, P419; Ferrari M, 1997, PHILOS T ROY SOC B, V352, P677; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566; Truijen J, 2012, EXP PHYSIOL, V97, P353, DOI 10.1113/expphysiol.2011.061051; Murias JM, 2014, EXERC SPORT SCI REV, V42, P4, DOI 10.1249/JES.0000000000000005; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Koga S, 2012, J APPL PHYSIOL, V112, P26, DOI 10.1152/japplphysiol.00925.2011; MacDonald MJ, 1999, J APPL PHYSIOL, V86, P687; Ferreira LF, 2007, J APPL PHYSIOL, V103, P1999, DOI 10.1152/japplphysiol.01414.2006; Davies RC, 2008, J APPL PHYSIOL, V105, P1413, DOI 10.1152/japplphysiol.90743.2008; Ryan TE, 2012, J APPL PHYSIOL, V113, P175, DOI 10.1152/japplphysiol.00319.2012; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Hogan MC, 2001, J APPL PHYSIOL, V90, P1871; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Behnke BJ, 2002, J PHYSL, V126, P53; Bowen ST, 2013, EXP PHYSIOL, V98, P1585; Bowen TS, 2012, J APPL PHYSIOL, V112, P378, DOI 10.1152/japplphysiol.00779.2011; De Roia G, 2012, AM J PHYSIOL-REG I, V302, pR1158, DOI 10.1152/ajpregu.00269.2011; Ferrari M, 2012, J NEAR INFRARED SPEC, V20, P1, DOI 10.1255/jnirs.973; Goodwin ML, 2012, J APPL PHYSIOL, V112, P9, DOI 10.1152/japplphysiol.01480.2010; Grassi B., 2005, OXYGEN UPTAKE KINETI; Hoshino T, 2006, SURG NEUROL, V65, P569, DOI 10.1016/j.surneu.2005.09.028; Imadojemu VA, 2001, AM J PHYSIOL-HEART C, V281, pH371; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jones AM, 2009, J APPL PHYSIOL, V107, P372, DOI 10.1152/japplphysiol.00314.2009; Koga S, 2015, EUR J APPL PHYSIOL, V115, P335, DOI 10.1007/s00421-014-3019-2; Kowalchuk JM, 2002, EXP PHYSIOL, V87, P601, DOI 10.1113/eph8702456; Maehara K, 1997, AM J RESP CRIT CARE, V155, P229; Mason MG, 2014, BBA-BIOENERGETICS, V1837, P1882, DOI 10.1016/j.bbabio.2014.08.005; Masuda K, 2010, ADV EXP MED BIOL, V662, P323, DOI 10.1007/978-1-4419-1241-1_46; Medeiros WM, 2015, AM J PHYSIOL-REG I, V308, pR105, DOI 10.1152/ajpregu.00404.2014; Messere A, 2013, PHYSL REP, V1, P1, DOI DOI 10.1002/PHY2.179; Niwayama M, 2000, REV SCI INSTRUM, V71, P4571, DOI 10.1063/1.1322578; Oda M, 1999, P SOC PHOTO-OPT INS, V3597, P611, DOI 10.1117/12.356809; Pogliaghi S, 2013, MED SCI SPORT EXER, V45, P1218, DOI 10.1249/MSS.0b013e318290bb29; Quaresima V, 2002, EUR J APPL PHYSIOL, V88, P294, DOI 10.1007/s00421-002-0680-7; Quaresima V, 2013, MED SCI SPORT EXER, V45, P1217, DOI 10.1249/MSS.0b013e318290bb0e; Quaresima V, 2009, J APPL PHYSIOL, V107, P371, DOI 10.1152/japplphysiol.00215.2009; Vogiatzis I, 2015, J APPL PHYS IN PRESS, DOI [10.1152/japplphysiol.00458.2014, DOI 10.1152/JAPPLPHYSIOL.00458.2014]; Whipp BJ, 2005, OXYGEN UPTAKE KINETI; Wust RCI, 2014, J PHYSIOL-LONDON, V592, P1857, DOI 10.1113/jphysiol.2013.267476	51	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	MAY 1	2015	118	9					1091	1099		10.1152/japplphysiol.00918.2014		9	Physiology; Sport Sciences	Physiology; Sport Sciences	CI4CB	WOS:000354693100001		
J	Koecklin, KHU; Kato, C; Funaki, Y; Hiranuma, M; Ishida, T; Fujita, K; Yabushita, T; Kokai, S; Ono, T				Koecklin, Karin Harumi Uchima; Kato, Chiho; Funaki, Yukiha; Hiranuma, Maya; Ishida, Takayoshi; Fujita, Koichi; Yabushita, Tadachika; Kokai, Satoshi; Ono, Takashi			Effect of unilateral nasal obstruction on tongue protrusion forces in growing rats	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						muscle contraction; electric stimulation; mouth breathing; hypoglossal nerve	MOUTH-BREATHING CHILDREN; MUSCLE-ACTIVITY; CONTRACTILE PROPERTIES; GENIOGLOSSUS MUSCLE; UPPER AIRWAY; MOTOR UNITS; RETRACTOR MUSCLES; ORAL RESPIRATION; FATIGUABILITY; COORDINATION	Mouth breathing caused by nasal obstruction affects the normal growth and development of craniofacial structures, including changes in the orofacial muscles. Tongue muscles play an important role in patency of the pharyngeal airway, and changes in the breathing pattern may influence tongue function. The purpose of this study was to evaluate the effect of unilateral nasal obstruction during growth on contractile properties of the tongue-protruding muscles. Sixty 6-day-old male Wistar albino rats were divided randomly into control (n = 30) and experimental (n = 30) groups. Rats in the experimental group underwent a unilateral nasal obstruction after cauterization of the external nostril at the age of 8 days, and muscle contractile characteristics were measured at 5, 7, and 9 wk of age. The specific parameters measured were twitch force, contraction time, half-decay time, tetanic force, and fatigue index. Repeated-measures multivariate analysis of variance was used for intergroup and intragroup statistical comparisons. Twitch contraction force and half-decay time were significantly increased in the experimental group at all ages. Tetanic forces at 60 and 80 Hz were significantly higher in the experimental group at all ages. The fatigue index was decreased significantly in the experimental group at the age of 5 wk. These results suggest that early unilateral nasal obstruction may increase the contraction force of the tongue-protruding muscles and prolong the duration of muscle contraction, which may influence the shape and development of the craniofacial complex.	[Koecklin, Karin Harumi Uchima; Kato, Chiho; Funaki, Yukiha; Hiranuma, Maya; Ishida, Takayoshi; Fujita, Koichi; Yabushita, Tadachika; Kokai, Satoshi; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Orthodont Sci, Tokyo 1138549, Japan	Koecklin, KHU (reprint author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	kuchima.orts@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [24593081]	This study was financially supported in part by Grants-in-Aid for Scientific Research (24593081) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Fuller D, 1998, J PHYSIOL-LONDON, V507, P265, DOI 10.1111/j.1469-7793.1998.265bu.x; Ota F, 2005, ANN OTO RHINOL LARYN, V114, P799; BROUILLETTE RT, 1980, J APPL PHYSIOL, V49, P801; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Sousa JBR, 2005, INT J PEDIATR OTORHI, V69, P311, DOI 10.1016/j.ijporl.2004.10.010; Chamberlin NL, 2007, J PHYSIOL-LONDON, V579, P515, DOI 10.1113/jphysiol.2006.121889; MILLER AJ, 1984, AM J ORTHOD DENTOFAC, V85, P385, DOI 10.1016/0002-9416(84)90159-3; Connor NP, 2008, J SPEECH LANG HEAR R, V51, P818, DOI 10.1044/1092-4388(2008/059); UNG N, 1990, AM J ORTHOD DENTOFAC, V98, P523; Mortimore IL, 2000, J SLEEP RES, V9, P389, DOI 10.1046/j.1365-2869.2000.00222.x; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723; Fregosi RF, 1997, RESP PHYSIOL, V110, P295, DOI 10.1016/S0034-5687(97)00095-9; Hureau TJ, 2014, EXP PHYSIOL, V99, P951, DOI 10.1113/expphysiol.2014.077974; Knosel M, 2012, DYSPHAGIA, V27, P401, DOI 10.1007/s00455-011-9383-8; Funaki Y, 2014, ARCH ORAL BIOL, V59, P530, DOI 10.1016/j.archoralbio.2014.02.013; Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bailey EF, 2006, J APPL PHYSIOL, V101, P1377, DOI 10.1152/japplphysiol.00379.2006; Bailey EF, 2001, J PHYSIOL-LONDON, V532, P525, DOI 10.1111/j.1469-7793.2001.0525f.x; DORAN GA, 1972, ACTA ANAT, V83, P403; Dutra EH, 2006, AM J ORTHOD DENTOFAC, V129; Fuller DD, 2000, J APPL PHYSIOL, V88, P2123; Gelhaye M, 2006, RESP PHYSIOL NEUROBI, V154, P443, DOI 10.1016/j.resp.2005.12.010; Gross RB, 1974, ANGLE ORTHOD, V44, P39; HARDING R, 1987, RESP PHYSIOL, V68, P177, DOI 10.1016/S0034-5687(87)80004-X; HARVOLD EP, 1981, AM J ORTHOD DENTOFAC, V79, P359, DOI 10.1016/0002-9416(81)90379-1; John J, 2005, AM J RESP CRIT CARE, V172, P1331, DOI 10.1164/rccm.200505-790OC; Korfage JAM, 2005, J DENT RES, V84, P774; LOWE AA, 1980, PROG NEUROBIOL, V15, P295, DOI 10.1016/0301-0082(80)90008-8; MacIntosh BR, 2006, SKELETAL MUSCLE FORM, P166; MILLER AJ, 1978, ARCH ORAL BIOL, V23, P145, DOI 10.1016/0003-9969(78)90210-8; Mortimore IL, 1999, EUR RESPIR J, V14, P191, DOI 10.1034/j.1399-3003.1999.14a32.x; Nagai H, 2008, DYSPHAGIA, V23, P116, DOI 10.1007/s00455-007-9103-6; Periard JD, 2014, MUSCLE NERVE, V50, P822, DOI 10.1002/mus.24228; Proffit W, 2007, CONT ORTHODONTICS, P130; Roy R R, 1991, Exerc Sport Sci Rev, V19, P269; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18; Sokoloff AJ, 2004, J APPL PHYSIOL, V96, P438, DOI 10.1152/japplphysiol.01079.2003; Song HG, 2001, AM J ORTHOD DENTOFAC, V119, P436, DOI 10.1067/mod.2001.112667; Stutzig N, 2015, MUSCLE NERVE, V51, P259, DOI 10.1002/mus.24305; Sutlive TG, 1999, J NEUROPHYSIOL, V82, P584; Sutlive TG, 2000, MUSCLE NERVE, V23, P416, DOI 10.1002/(SICI)1097-4598(200003)23:3<416::AID-MUS14>3.0.CO;2-#; Takahashi S, 1999, AM J ORTHOD DENTOFAC, V115, P239, DOI 10.1016/S0889-5406(99)70324-0; Trabalon M., 2012, INT J PEDIAT, V2012; Worsnop C, 1998, J APPL PHYSIOL, V85, P908	44	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	MAY 1	2015	118	9					1128	1135		10.1152/japplphysiol.01152.2014		8	Physiology; Sport Sciences	Physiology; Sport Sciences	CI4CB	WOS:000354693100005		
J	Seto, S; Iguchi, T				Seto, Shinta; Iguchi, Toshio			Intercomparison of Attenuation Correction Methods for the GPM Dual-Frequency Precipitation Radar	JOURNAL OF ATMOSPHERIC AND OCEANIC TECHNOLOGY			English	Article							SURFACE REFERENCE TECHNIQUE; RAIN-PROFILING ALGORITHM; RETRIEVAL ALGORITHM; PERFORMANCE; CONSTRAINT; AIRBORNE	A new attenuation correction method has been developed for the dual-frequency precipitation radar (DPR) on the core satellite of the Global Precipitation Measurement (GPM) mission. The new method is based on Hitschfeld and Bordan's attenuation correction method (HB method), but the relationship between the specific attenuation k and the effective radar reflectivity factor Z(e) (k-Z(e) relationship) is modified by using the dual-frequency ratio (DFR) of Z(e) and the surface reference technique (SRT). Therefore, the new method is called the HB-DFR-SRT method (H-D-S method). The previous attenuation correction method, called the HB-DFR method (H-D method), results in an underestimation of precipitation rates for heavy precipitation, but the H-D-S method mitigates the negative bias by means of the SRT. When only a single-frequency measurement is available, the H-D-S method is identical to the HB-SRT method (H-S method). The attenuation correction methods were tested with a simple synthetic DPR dataset. As long as the SRT gives perfect estimates of path-integrated attenuation and the adjustment factor of the k-Z(e) relationship (denoted by epsilon) is vertically constant, the H-S method is much better than the dual-frequency methods. Tests with SRT error and vertical variation in epsilon showed that the H-D method was better than the H-S method for weak precipitation, whereas the H-S method was better than the H-D method for heavy precipitation. The H-D-S method did not produce the best results for both weak and heavy precipitation, but the results are stable. Quantitative evaluation should be done with real DPR measurement datasets.	[Seto, Shinta] Nagasaki Univ, Grad Sch Engn, Nagasaki, Nagasaki 8528521, Japan; [Iguchi, Toshio] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Seto, S (reprint author), Nagasaki Univ, Grad Sch Engn, 1-14 Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan.	seto@nagasaki-u.ac.jp			Japan Aerospace Exploration Agency	This study is supported by the Japan Aerospace Exploration Agency under the 7th Precipitation Measurement Mission Research Announcement.	Adhikari NB, 2007, IEEE T GEOSCI REMOTE, V45, P2612, DOI 10.1109/TGRS.2007.893555; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; IGUCHI T, 1994, J ATMOS OCEAN TECH, V11, P1507, DOI 10.1175/1520-0426(1994)011<1507:IOSFMF>2.0.CO;2; GUNN R, 1949, J METEOROL, V6, P243, DOI 10.1175/1520-0469(1949)006<0243:TTVOFF>2.0.CO;2; HITSCHFELD W, 1954, J METEOROL, V11, P58, DOI 10.1175/1520-0469(1954)011<0058:EIITRM>2.0.CO;2; Meneghini R, 2000, J APPL METEOROL, V39, P2053, DOI 10.1175/1520-0450(2001)040<2053:UOTSRT>2.0.CO;2; Meneghini R, 1997, IEEE T GEOSCI REMOTE, V35, P487, DOI 10.1109/36.581956; Iguchi T, 2009, J METEOROL SOC JPN, V87A, P1, DOI 10.2151/jmsj.87A.1; Kubota T, 2014, IEEE J-STARS, V7, P3931, DOI 10.1109/JSTARS.2014.2320960; Seto S, 2013, IEEE T GEOSCI REMOTE, V51, P5239, DOI 10.1109/TGRS.2012.2231686; Meneghini R, 2004, J ATMOS OCEAN TECH, V21, P1645, DOI 10.1175/JTECH1664.1; Seto S, 2007, J ATMOS OCEAN TECH, V24, P1693, DOI 10.1175/JTECH2088.1; Mardiana R, 2004, IEEE T GEOSCI REMOTE, V42, P2214, DOI 10.1109/TGRS.2004.834647; MENEGHINI R, 1992, J ATMOS OCEAN TECH, V9, P364, DOI 10.1175/1520-0426(1992)009<0364:ASOREM>2.0.CO;2; Rose CR, 2006, IEEE T GEOSCI REMOTE, V44, P328, DOI 10.1109/TGRS.2005.861410; Rose CR, 2005, IEEE T GEOSCI REMOTE, V43, P1816, DOI 10.1109/TGRS.2005.851165; Rose CR, 2006, J ATMOS OCEAN TECH, V23, P1372, DOI 10.1175/JTECH1921.1; Seto S, 2011, IEEE T GEOSCI REMOTE, V49, P1827, DOI 10.1109/TGRS.2010.2102766	18	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0739-0572	1520-0426		J ATMOS OCEAN TECH	J. Atmos. Ocean. Technol.	MAY	2015	32	5					915	926		10.1175/JTECH-D-14-00065.1		12	Engineering, Ocean; Meteorology & Atmospheric Sciences	Engineering; Meteorology & Atmospheric Sciences	CI5DF	WOS:000354772400004		
J	Sakai, K; Aoki, S; Matsumoto, K				Sakai, Katsuya; Aoki, Shunsuke; Matsumoto, Kunio			Hepatocyte growth factor and Met in drug discovery	JOURNAL OF BIOCHEMISTRY			English	Review						drug resistance; growth factor; molecular targeted drugs; receptor tyrosine kinase; regenerative medicine	CELL LUNG-CANCER; PERIPHERAL ARTERIAL-DISEASE; RECEPTOR TYROSINE KINASE; CRITICAL LIMB ISCHEMIA; C-MET; LIVER-REGENERATION; FACTOR/SCATTER FACTOR; INSULIN-SECRETION; ENDOTHELIAL-CELLS; MOLECULAR-CLONING	Activation of the hepatocyte growth factor (HGF)-Met pathway evokes dynamic biological responses that support the morphogenesis, regeneration and survival of cells and tissues. A characterization of conditional Met knockout mice indicates that the HGF-Met pathway plays important roles in the regeneration, protection and homeostasis of cells such as hepatocytes, renal tubular cells and neurons. Preclinical studies in disease models have indicated that recombinant HGF protein and expression plasmid for HGF are biological drug candidates for the treatment of patients with diseases or injuries that involve impaired tissue function. The phase-I and phase-I/II clinical trials of the intrathecal administration of HGF protein for the treatment of patients with amyotrophic lateral sclerosis and spinal cord injury, respectively, are ongoing. Biological actions of HGF that promote the dynamic movement, morphogenesis and survival of cells also closely participate in invasion-metastasis and resistance to the molecular-targeted drugs in tumour cells. Different types of HGF-Met pathway inhibitors are now in clinical trials for treatment of malignant tumours. Basic research on HGF and Met has lead to drug discoveries in regenerative medicine and tumour biology.	[Sakai, Katsuya; Matsumoto, Kunio] Kanazawa Univ, Div Tumor Dynam & Regulat, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Aoki, Shunsuke] Kyushu Inst Technol, Grad Sch Comp Sci & Syst Engn, Dept Biosci & Bioinformat, Iizuka, Fukuoka 8208502, Japan	Matsumoto, K (reprint author), Kanazawa Univ, Div Tumor Dynam & Regulat, Canc Res Inst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	kmatsu@staff.kanazawa-u.ac.jp	Aoki, Shunsuke/A-3059-2011		Ministry of Education, Culture, Science, Sports, and Technology of Japan [23790221, 26460145, 20390077, 24300329]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	The studies from the authors' laboratories were supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (No. 23790221 to K.S.; No. 26460145 to S.A.; No. 20390077 and No. 24300329 to K.M.) and a grant for Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Judson MC, 2010, J COMP NEUROL, V518, P4463, DOI 10.1002/cne.22467; Van Belle E, 1998, CIRCULATION, V97, P381; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Cecchi F, 2012, EXPERT OPIN THER TAR, V16, P553, DOI 10.1517/14728222.2012.680957; Matsumoto K, 2006, INT J CANCER, V119, P477, DOI 10.1002/ijc.21808; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Morishita R, 2004, HYPERTENSION, V44, P203, DOI 10.1161/01.HYP.0000136394.08900.ed; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; Qiu SF, 2011, J NEUROSCI, V31, P5855, DOI 10.1523/JNEUROSCI.6569-10.2011; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Arechederra M, 2013, BBA-MOL BASIS DIS, V1832, P2204, DOI 10.1016/j.bbadis.2013.08.008; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012; Shigematsu H, 2011, INT ANGIOL, V30, P140; Basilico C, 2008, J BIOL CHEM, V283, P21267, DOI 10.1074/jbc.M800727200; Taniyama Y, 2001, GENE THER, V8, P181, DOI 10.1038/sj.gt.3301379; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; del Castillo G, 2008, AM J PATHOL, V172, P1238, DOI 10.2353/ajpath.2008.070793; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Shigematsu H, 2010, GENE THER, V17, P1152, DOI 10.1038/gt.2010.51; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Yano S, 2012, CANCER SCI, V103, P1189, DOI 10.1111/j.1349-7006.2012.02279.x; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; NALDINI L, 1991, ONCOGENE, V6, P501; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Sun W, 2002, J NEUROSCI, V22, P6537; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; De Bacco F, 2012, CANCER RES, V72, P4537, DOI 10.1158/0008-5472.CAN-11-3490; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Canadas I, 2014, CLIN CANCER RES, V20, P938, DOI 10.1158/1078-0432.CCR-13-1330; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Funakoshi F., 2011, CURR SIGNAL TRANSD T, V6, P156; Giebeler A, 2009, GASTROENTEROLOGY, V137, P297, DOI 10.1053/j.gastro.2009.01.068; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Ido A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-55; Ishigaki A, 2007, J NEUROPATH EXP NEUR, V66, P1037, DOI 10.1097/nen.0b013e318159886b; Ito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7373; Ito K, 2013, MOLECULES, V18, P3502, DOI 10.3390/molecules18033502; Judson MC, 2011, J NEURODEV DISORD, V3, P282, DOI 10.1007/s11689-011-9081-8; Kitamura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027706; Kosai K, 1998, BIOCHEM BIOPH RES CO, V244, P683, DOI 10.1006/bbrc.1998.8293; Ma H, 2009, KIDNEY INT, V76, P868, DOI 10.1038/ki.2009.304; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2; MATSUMOTO K, 1989, J ORAL PATHOL MED, V18, P498, DOI 10.1111/j.1600-0714.1989.tb01350.x; MORIMOTO A, 1991, BIOCHEM BIOPH RES CO, V179, P1042, DOI 10.1016/0006-291X(91)91924-2; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Nakayama M, 2013, CYTOKINE, V62, P446, DOI 10.1016/j.cyto.2013.04.006; Nayeri F, 2002, J DERMATOL TREAT, V13, P81, DOI 10.1080/095466302317584449; ROSEN EM, 1991, J CELL PHYSIOL, V146, P325, DOI 10.1002/jcp.1041460218; Yano S., 2008, CANCER RES, V68, P6479; Yoshida S, 2004, GROWTH FACTORS, V22, P111, DOI 10.1080/08977190410001701005; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	88	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					271	284		10.1093/jb/mvv027		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500001		
J	Shirakawa, R; Horiuchi, H				Shirakawa, Ryutaro; Horiuchi, Hisanori			Ral GTPases: crucial mediators of exocytosis and tumourigenesis	JOURNAL OF BIOCHEMISTRY			English	Review						exocyst; exocytosis; Ral; Ras; tumourigenesis	GTP-BINDING PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; TUBEROUS SCLEROSIS COMPLEX; VON-WILLEBRAND-FACTOR; WEIBEL-PALADE BODIES; HUMAN TUMOR-CELLS; NF-KAPPA-B; EXOCYST COMPLEX; ACTIVATING PROTEIN; ENDOTHELIAL-CELLS	The Ral guanosine triphosphatases (GTPases), RalA and RalB, are members of the Ras superfamily of small GTPases. Research on Ral GTPases and their functions over the past 25 years has revealed the essential involvement of these GTPases in unique and diverse cellular processes including exocyst-mediated exocytosis and related cellular activities. Moreover, it is increasingly appreciated that the aberrant activation of Ral GTPases is one of the major causes of human tumourigenesis induced by oncogenic Ras. Recent evidence suggests that Ral signalling pathways may be potential therapeutic targets for the treatment of human cancers. This review summarizes recent advance in the investigation of Ral GTPases.	[Shirakawa, Ryutaro; Horiuchi, Hisanori] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Shirakawa, R (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, Seiryo Machi 4-1, Sendai, Miyagi 9808575, Japan.	shirakawa@idac.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to R.S. and H.H.	Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Saito R, 2013, ONCOGENE, V32, P894, DOI 10.1038/onc.2012.101; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; ALBRIGHT CF, 1993, EMBO J, V12, P339; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Chen QL, 2014, CELL SIGNAL, V26, P1636, DOI 10.1016/j.cellsig.2014.04.012; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; van den Berg MCW, 2013, J BIOL CHEM, V288, P21729, DOI 10.1074/jbc.M113.463885; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Saito T, 2008, BIOMED RES-TOKYO, V29, P85, DOI 10.2220/biomedres.29.85; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/i.devcel.2007.07.007; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Hernandez-Munoz I, 2000, ONCOGENE, V19, P2745, DOI 10.1038/sj.onc.1203586; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; de Bruyn KMT, 2000, J BIOL CHEM, V275, P29761, DOI 10.1074/jbc.M001160200; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Gridley S, 2006, CELL SIGNAL, V18, P1626, DOI 10.1016/j.cellsig.2006.01.002; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Lee S, 2012, CANCER RES, V72, P5165, DOI 10.1158/0008-5472.CAN-12-0468; Yan C, 2014, NATURE, V515, P443, DOI 10.1038/nature13713; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; CHARDIN P, 1986, EMBO J, V5, P2203; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Leto D, 2013, J BIOL CHEM, V288, P9272, DOI 10.1074/jbc.M112.426106; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Hahn WC, 1999, NATURE, V400, P464; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Bodempudi V, 2009, MOL CELL BIOL, V29, P3964, DOI 10.1128/MCB.01153-08; Ceriani M, 2007, EXP CELL RES, V313, P2293, DOI 10.1016/j.yexcr.2007.03.016; CHARDIN P, 1989, NUCLEIC ACIDS RES, V17, P4380, DOI 10.1093/nar/17.11.4380; Chen CXJ, 2011, J BIOL CHEM, V286, P11724, DOI 10.1074/jbc.M110.154203; Das A, 2014, J CELL SCI, V127, P686, DOI 10.1242/jcs.145037; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; de Gorter DJJ, 2008, BLOOD, V111, P3364, DOI 10.1182/blood-2007-08-106583; de Leeuw HPJC, 2001, ARTERIOSCL THROM VAS, V21, P899; de Leeuw HPJC, 1999, THROMB HAEMOSTASIS, V82, P1177; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Ezzeldin M, 2014, MOL ONCOL, V8, P1043, DOI 10.1016/j.molonc.2014.03.020; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Issaq SH, 2010, MOL CANCER RES, V8, P223, DOI 10.1158/1541-7786.MCR-09-0189; Jimenez M, 2004, CANCER RES, V64, P6041, DOI 10.1158/0008-5472.CAN-03-3389; Li G, 2007, J NEUROSCI, V27, P190, DOI 10.1523/JNEUROSCI.2537-06.2007; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Morinaka K, 1999, ONCOGENE, V18, P5915, DOI 10.1038/sj.onc.1202974; NGSEE JK, 1991, J BIOL CHEM, V266, P2675; Oeckinghaus A, 2014, CELL REP, V8, P1793, DOI 10.1016/j.celrep.2014.08.015; Osei-Sarfo K, 2011, ONCOGENE, V30, P3661, DOI 10.1038/onc.2011.93; Peschard P, 2012, CURR BIOL, V22, P2063, DOI 10.1016/j.cub.2012.09.013; Peterson SN, 1996, J BIOL CHEM, V271, P29903; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Rondaij MG, 2004, ARTERIOSCL THROM VAS, V24, P1315, DOI 10.1161/01.ATV.0000131267.13425.45; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sanchez-Ruiz J, 2011, J IMMUNOL, V187, P2433, DOI 10.4049/jimmunol.1003089; Sawamoto K, 1999, J CELL BIOL, V146, P361, DOI 10.1083/jcb.146.2.361; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shirai Y, 2011, MOL BIOL CELL, V22, P1340, DOI 10.1091/mbc.E10-09-0754; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Tecleab A, 2014, J BIOL CHEM, V289, P31296, DOI 10.1074/jbc.M114.565796; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Wang K., 2013, ONCOTARGET; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Yaoita N, 2014, ARTERIOSCL THROM VAS, V34, P2486, DOI 10.1161/ATVBAHA.114.304404; Zipfel PA, 2010, ONCOGENE, V29, P4859, DOI 10.1038/onc.2010.224	136	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					285	299		10.1093/jb/mvv029		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500002		
J	Onodera, T; Futai, E; Kan, E; Abe, N; Uchida, T; Kamio, Y; Kaneko, J				Onodera, Tomoko; Futai, Eugene; Kan, Eiichiro; Abe, Naoki; Uchida, Takafumi; Kamio, Yoshiyuki; Kaneko, Jun			Phosphatidylethanolamine plasmalogen enhances the inhibiting effect of phosphatidylethanolamine on gamma-secretase activity	JOURNAL OF BIOCHEMISTRY			English	Article						Alzheimer's disease; amyloid-beta; gamma-secretase activity; phosphatidylethanolamine plasmalogen; yeast microsomes	ALZHEIMERS-DISEASE; SELENOMONAS-RUMINANTIUM; ER MEMBRANES; AMYLOID-BETA; IN-VITRO; RECONSTITUTION; CHOLESTEROL; DEFICIENCY; PRESENILIN; LIPIDS	Plasmalogens (Pls) are widely distributed in the biological membrane of animals and certain anaerobic bacteria, but their functions in the cell membrane are still poorly understood. Decrease of phosphatidylethanolamine plasmalogen (PEPls) in the brain tissue of patients with Alzheimer's disease prompted us to investigate the effect of the membrane phosphorus lipid composition on the activity of gamma-secretase that produces amyloid-beta protein (A beta). To clarify the effect of phospholipids, including PEPls, on A beta production, gamma-secretase activity was measured in an in vitro assay using yeast microsomes and reconstituted liposomes. The presence of ethanolamine phospholipids in the proteoliposome weakened gamma-secretase activity. In addition, increased PEPls content in total ethanolamine phospholipids further decreased the enzyme activity, indicating that gamma-secretase activity is affected by the membrane phospholipid PEPls/PE ratio. Furthermore, PEPls from anaerobic bacterial cell membrane induced the same effect on gamma-secretase activity.	[Onodera, Tomoko; Kan, Eiichiro; Abe, Naoki; Kaneko, Jun] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Sendai, Miyagi 9818555, Japan; [Futai, Eugene; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 9818555, Japan; [Kamio, Yoshiyuki] Shokei Gakuin Univ, Grad Sch Comprehens Human Sci, Dept Human Hlth & Nutr, Natori, Miyagi 9811295, Japan	Kaneko, J (reprint author), Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	jkaneko@biochem.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [23658066]	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (JSPS) (Grant Number 23658066 to Y.K.).	Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Rothhaar TL, 2012, SCI WORLD J, DOI 10.1100/2012/141240; Grimm MOW, 2011, J NEUROCHEM, V116, P916, DOI 10.1111/j.1471-4159.2010.07070.x; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.M700023-JLR200; Farooqui AA, 2010, MOL NEUROBIOL, V41, P267, DOI 10.1007/s12035-009-8091-y; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Bartzokis G, 2007, ALZHEIMERS DEMENT, V3, P122, DOI 10.1016/j.jalz.2007.01.019; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011; Yonemura Y, 2011, J BIOL CHEM, V286, P44569, DOI 10.1074/jbc.M111.270108; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Fiske CH, 1925, J BIOL CHEM, V66, P375; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; GOLDFINE H, 1964, J BIOL CHEM, V239, P2130; Horrocks LA, 1982, NEW COMPREHENSIVE BI, V4, P51, DOI 10.1016/S0167-7306(08)60006-X; Janssen MJFW, 2000, YEAST, V16, P641, DOI 10.1002/(SICI)1097-0061(200005)16:7<641::AID-YEA578>3.0.CO;2-U; KAMIO Y, 1980, J BACTERIOL, V141, P888; KAMIO Y, 1969, J GEN APPL MICROBIOL, V15, P439, DOI 10.2323/jgam.15.439; KAMIO Y, 1970, J GEN APPL MICROBIOL, V16, P29, DOI 10.2323/jgam.16.1_29; Mawatari S, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-161; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; Selkoe DJ, 2011, COLD SPRING HARB PER, V3; WEGNER GH, 1963, J BACTERIOL, V85, P53; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090	42	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					301	309		10.1093/jb/mvu074		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500003		
J	Nikaido, Y; Koyama, Y; Yoshikawa, Y; Furuya, T; Takeda, S				Nikaido, Yoshiaki; Koyama, Yuuta; Yoshikawa, Yasushi; Furuya, Toshio; Takeda, Shigeki			Mutation analysis and molecular modeling for the investigation of ligand-binding modes of GPR84	JOURNAL OF BIOCHEMISTRY			English	Article						diindolylmethane; free fatty acid receptor; G protein-coupled receptor; G protein-coupled receptor-G alpha fusion proteins; positive allosteric modulator	PROTEIN-COUPLED RECEPTORS; CHAIN FATTY-ACIDS; LIPID-TRANSFER PROTEIN; CRYSTAL-STRUCTURE; INSULIN-SECRETION; STRUCTURAL BASIS; DISCOVERY; MAIZE; IDENTIFICATION; SEQUENCE	GPR84 is a G protein-coupled receptor for medium-chain fatty acids. Capric acid and 3,3'-diindolylmethane are specific agonists for GPR84. We built a homology model of a GPR84-capric acid complex to investigate the ligand-binding mode using the crystal structure of human active-state beta 2-adrenergic receptor. We performed site-directed mutagenesis to subject ligand-binding sites to our model using GPR84-Gi alpha fusion proteins and a [S-35]GTP gamma S-binding assay. We compared the activity of the wild type and mutated forms of GPR84 by [S-35]GTP gamma S binding to capric acid and diindolylmethane. The mutations L100D `Ballesteros-Weinstein numbering: 3.32), F101Y (3.33) and N104Q (3.36) in the transmembrane helix III and N357D (7.39) in the transmembrane helix VII resulted in reduced capric acid activity but maintained the diindolylmethane responses. Y186F (5.46) and Y186H (5.46) mutations had no characteristic effect on capric acid but with diindolylmethane they significantly affected the G protein activation efficiency. The L100D (3.32) mutant responded to decylamine, a fatty amine, instead of a natural agonist, the fatty acid capric acid, suggesting that we have identified a mutated G protein-coupled receptor-artificial ligand pairing. Our molecular model provides an explanation for these results and interactions between GPR84 and capric acid. Further, from the results of a double stimulation assay, we concluded that diindolylmethane was a positive allosteric modulator for GPR84.	[Nikaido, Yoshiaki; Koyama, Yuuta; Takeda, Shigeki] Gunma Univ, Div Mol Sci, Fac Sci & Technol, Kiryu, Gumma 3768515, Japan; [Yoshikawa, Yasushi; Furuya, Toshio] PharmaDesign Inc, Div Res & Dev, Drug Discovery Dept, Tokyo 1040032, Japan	Takeda, S (reprint author), Gunma Univ, Div Mol Sci, Fac Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	stakeda@gunma-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Agri-Health Translational Research Project).	Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Yoshikawa Y, 2012, BIOORG MED CHEM LETT, V22, P2146, DOI 10.1016/j.bmcl.2012.01.134; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Sabirsh A, 2006, BIOCHEMISTRY-US, V45, P5733, DOI 10.1021/bi060076t; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Jacobson KA, 2007, TRENDS PHARMACOL SCI, V28, P111, DOI 10.1016/j.tips.2007.01.006; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Han GW, 2001, J MOL BIOL, V308, P263, DOI 10.1006/jmbi.2001.4559; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; GROSE KR, 1992, CHEM RES TOXICOL, V5, P188, DOI 10.1021/tx00026a007; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Takeda S, 2004, J BIOCHEM, V135, P597, DOI 10.1093/jb/mvh073; Lerche MH, 1998, PROTEIN SCI, V7, P2490; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Yoshikawa Y, 2013, J MED CHEM, V56, P4236, DOI 10.1021/jm400307y; Hanson MA, 2012, SCIENCE, V335, P851, DOI 10.1126/science.1215904; Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1015/j.jmb.2005.12.047; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Kogure R, 2011, BIOCHEM BIOPH RES CO, V416, P58, DOI 10.1016/j.bbrc.2011.10.141; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Xue L, 2008, J NUTR BIOCHEM, V19, P336, DOI 10.1016/j.jnutbio.2007.05.004; Zhao Q, 2012, ACTA PHARMACOL SIN, V33, P324, DOI 10.1038/aps.2011.187	41	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					311	320		10.1093/jb/mvu075		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500004		
J	Shiwa, Y; Yoshikawa, H; Tanaka, T; Ogura, M				Shiwa, Yuh; Yoshikawa, Hirofumi; Tanaka, Teruo; Ogura, Mitsuo			Bacillus subtilis degSU operon is regulated by the ClpXP-Spx regulated proteolysis system	JOURNAL OF BIOCHEMISTRY			English	Article						glucose induction; proteolysis; response regulator; Spx; whole-genome sequencing	CIS-ACTING ELEMENT; OXIDATIVE STRESS; GENE DEGU; TRANSCRIPTION INITIATION; COMPETENCE DEVELOPMENT; POSITIVE REGULATOR; BIOFILM FORMATION; TERMINAL DOMAIN; EXPRESSION; PROTEIN	The DegS-DegU two-component regulatory system regulates many cellular events in Bacillus subtilis. Genes for DegSU constitutes an operon directed by the P1 promoter and downstream degU is autoregulated via the P3 promoter activated by phosphorylated DegU. In the Gram-positive bacteria, Spx plays a major role in the protection system against oxidative stresses as a transcriptional regulator. Spx is a substrate of the ATP-dependent ClpXP protease. It regulates diamide-stress regulon in addition to many genes with unknown functions. We have found that null mutations for clpX and clpP, which encode the subunits for the protease ClpXP, enhanced the DegU level through activation of the P1 promoter. We isolated four suppressors for the clpP-enhancing effect. Whole-genome sequencing of the suppressors revealed that two have a point mutation in spx and the rest have a deletion of spx. The clpP-enhancing effect on degS-lacZ expression was abolished in the spx disruptant. These results show that the degSU operon is a new target of Spx-mediated positive regulation. Furthermore, we found that the P1 promoter was induced by glucose and that this induction was greatly reduced in the spx mutant. These results suggested that Spx-mediated glucose induction at the P1 promoter.	[Shiwa, Yuh; Yoshikawa, Hirofumi] Tokyo Univ Agr, Nodai Res Inst, Genome Res Ctr, Tokyo 1568502, Japan; [Tanaka, Teruo; Ogura, Mitsuo] Tokai Univ, Inst Ocean Res & Dev, Shizuoka 4248610, Japan	Shiwa, Y (reprint author), Iwate Med Univ, Iwate Tohoku Med Megabank Org, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	oguram@scc.u-tokai.ac.jp			JSPS KAKENHI [24580123]; MEXT [S0801025]; Institute of Oceanic Research and Development, Tokai University	This work was supported by JSPS KAKENHI (24580123), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (S0801025), and Research Program of Institute of Oceanic Research and Development, Tokai University.	Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Ohsawa T, 2009, BIOSCI BIOTECH BIOCH, V73, P2096, DOI 10.1271/bbb.90341; Tsukahara K, 2008, FEMS MICROBIOL LETT, V280, P8, DOI 10.1111/j.1574-6968.2007.01019.x; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Ogura M, 2003, MOL MICROBIOL, V49, P1685, DOI 10.1046/j.1365-2958.2003.03665.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Stanley NR, 2005, MOL MICROBIOL, V57, P1143, DOI 10.1111/j.1365-2958.2005.04746.x; Hsueh YH, 2011, MOL MICROBIOL, V81, P1092, DOI 10.1111/j.1365-2958.2011.07755.x; Hamoen LW, 2000, P NATL ACAD SCI USA, V97, P9246, DOI 10.1073/pnas.160010597; Cairns LS, 2013, MOL MICROBIOL, V90, P6, DOI 10.1111/mmi.12342; Ogura M, 2004, J BACTERIOL, V186, P3056, DOI 10.1128/JB.186.10.3056-3064.2004; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; MSADEK T, 1990, J BACTERIOL, V172, P824; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rochat T, 2012, NUCLEIC ACIDS RES, V40, P9571, DOI 10.1093/nar/gks755; Ishii H, 2013, J BACTERIOL, V195, P193, DOI 10.1128/JB.01881-12; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Kunst F., 1994, BACILLUS SUBTILIS RE, V1-20; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Lin AA, 2013, J BACTERIOL, V195, P3967, DOI 10.1128/JB.00645-13; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; Mordini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085065; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008664; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nanamiya H, 2003, J BIOCHEM, V133, P295, DOI 10.1093/jb/mvg040; Ogura M, 2014, J BACTERIOL, V196, P873, DOI 10.1128/JB.01321-13; Ogura M, 1996, J BACTERIOL, V178, P216; Ogura M, 2012, J BIOCHEM, V151, P643, DOI 10.1093/jb/mvs036; Ogura M, 2010, MOL MICROBIOL, V75, P1244, DOI 10.1111/j.1365-2958.2010.07047.x; Ogura M, 1997, J BACTERIOL, V179, P6244; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; Ruvolo MV, 2006, MOL MICROBIOL, V60, P1490, DOI 10.1111/j.1365-2958.2006.05167.x; SCHAEFFE.P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shimane K, 2004, J BIOCHEM, V136, P387, DOI 10.1093/jb/mvh127; Shiwa Y, 2013, BIOSCI BIOTECH BIOCH, V77, P2073, DOI 10.1271/bbb.130438; Tsukahara K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-8; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Yasumura A, 2008, J BACTERIOL, V190, P5162, DOI 10.1128/JB.00368-08; Zhang Y, 2007, J BACTERIOL, V189, P7669, DOI 10.1128/JB.00745-07	52	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					321	330		10.1093/jb/mvu076		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500005		
J	Suzuki, K; Mizushima, H; Abe, H; Iwamoto, R; Nakamura, H; Mekada, E				Suzuki, Keisuke; Mizushima, Hiroto; Abe, Hiroyuki; Iwamoto, Ryo; Nakamura, Haruki; Mekada, Eisuke			Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF	JOURNAL OF BIOCHEMISTRY			English	Article						cancer; CRM197; diphtheria toxin; EGF receptor; HB-EGF	EPIDERMAL-GROWTH-FACTOR; FACTOR (EGF)-LIKE DOMAIN; OVARIAN-CANCER; CLINICAL-SIGNIFICANCE; CRYSTAL-STRUCTURE; CELL-MIGRATION; GASTRIC-CANCER; BINDING; RECEPTOR; EXPRESSION	Heparin-binding epidermal growth factor-like growth factor (HB-EGF), a ligand of EGF receptor, is involved in the growth and malignant progression of cancers. Cross-reacting material 197, CRM197, a non-toxic mutant of diphtheria toxin (DT), specifically binds to the EGF-like domain of HB-EGF and inhibits its mitogenic activity, thus CRM197 is currently under evaluation in clinical trials for cancer therapy. To develop more potent DT mutants than CRM197, we screened various mutant proteins of R domain of DT, the binding site for HB-EGF. A variety of R-domain mutant proteins fused with maltose-binding protein were produced and their inhibitory activity was evaluated in vitro. We found four R domain mutants that showed much higher inhibitory activity against HB-EGF than wild-type (WT) R domain. These R domain mutants suppressed HB-EGF-dependent cell proliferation more effectively than WT R domain. Surface plasmon resonance revealed their higher affinity to HB-EGF than WT R domain. CRM197(R460H) carrying the newly identified mutation showed increased cell proliferation inhibitory activity and affinity to HB-EGF. These results suggest that CRM197(R460H) or other recombinant proteins carrying newly identified mutation(s) in the R domain are potential therapeutics targeting HB-EGF.	[Suzuki, Keisuke; Mizushima, Hiroto; Iwamoto, Ryo; Mekada, Eisuke] Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, Suita, Osaka 5650871, Japan; [Abe, Hiroyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Suita, Osaka 5650871, Japan; [Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Mekada, E (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Cell Biol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	emekada@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23240126, 26250033]	This work was supported by a Grant-in aid for Scientific Research (A) (23240126 and 26250033 to E.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; Yagi H, 2009, INT J CANCER, V124, P1429, DOI 10.1002/ijc.24031; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Ito Y, 2001, BREAST CANCER RES TR, V67, P81, DOI 10.1023/A:1010667108371; Yagi H, 2005, BRIT J CANCER, V92, P1737, DOI 10.1038/sj.bjc.6602536; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Louie GV, 1997, MOL CELL, V1, P67, DOI 10.1016/S1097-2765(00)80008-8; SHEN WH, 1994, J BIOL CHEM, V269, P29077; Ito Y, 2001, INT J PANCREATOL, V29, P47, DOI 10.1385/IJGC:29:1:47; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; HONJO T, 1968, J BIOL CHEM, V243, P3553; Seto Y, 2008, JPN J INFECT DIS, V61, P116; Prenzel N, 1999, NATURE, V402, P884; MITAMURA T, 1995, J BIOL CHEM, V270, P1015; Kinjo AR, 2012, NUCLEIC ACIDS RES, V40, pD453, DOI 10.1093/nar/gkr811; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; COLLIER RJ, 1975, BACTERIOL REV, V39, P54; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Hamaoka M, 2010, J BIOCHEM, V148, P55, DOI 10.1093/jb/mvq033; INUI Y, 1994, GASTROENTEROLOGY, V107, P1799; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; IWAMOTO R, 1994, EMBO J, V13, P2322; Kageyama T, 2007, J BIOCHEM, V142, P95, DOI 10.1093/jb/mvm116; KANEI C, 1977, INFECT IMMUN, V18, P203; Kimura Y, 2007, J BIOCHEM, V142, P105, DOI 10.1093/jb/mvm115; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; LORY S, 1980, P NATL ACAD SCI-BIOL, V77, P267, DOI 10.1073/pnas.77.1.267; Minami S, 2008, DEV DYNAM, V237, P247, DOI 10.1002/dvdy.21398; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mitamura T, 1997, J BIOL CHEM, V272, P27084, DOI 10.1074/jbc.272.43.27084; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Naef M, 1996, INT J CANCER, V66, P315; NAGLICH JG, 1992, P NATL ACAD SCI USA, V89, P2170, DOI 10.1073/pnas.89.6.2170; Oram D.M., 2006, COMPREHENSIVE SOURCE, P245, DOI 10.1016/B978-012088445-2/50018-4; Oram M, 2007, GENE, V391, P53, DOI 10.1016/j.gene.2006.12.003; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Sanui A, 2010, ANTICANCER RES, V30, P3143; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578; Takazaki R, 2004, J BIOL CHEM, V279, P47335, DOI 10.1074/jbc.M408556200; UCHIDA T, 1971, NATURE-NEW BIOL, V233, P8; UCHIDA T, 1973, J BIOL CHEM, V248, P3838; UCHIDA T, 1972, SCIENCE, V175, P901, DOI 10.1126/science.175.4024.901; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999	53	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					331	343		10.1093/jb/mvu079		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500006		
J	Tsutsui, S; Dotsuta, Y; Ono, A; Suzuki, M; Tateno, H; Hirabayashi, J; Nakamura, O				Tsutsui, Shigeyuki; Dotsuta, Yuma; Ono, Ayaka; Suzuki, Masanari; Tateno, Hiroaki; Hirabayashi, Jun; Nakamura, Osamu			A C-type lectin isolated from the skin of Japanese bullhead shark (Heterodontus japonicus) binds a remarkably broad range of sugars and induces blood coagulation	JOURNAL OF BIOCHEMISTRY			English	Article						blood clotting; C-type lectin; self-defence; shark skin; sugar specificity	CONGER-MYRIASTER BREVOORT; ANGUILLA-JAPONICA; ANIMAL LECTINS; MUCUS LECTIN; EEL; RECOGNITION; GALECTIN; PROTEINS; PURIFICATION; RUBRIPES	The aim of this study was to determine the physiological role of skin lectins of the Japanese bullhead shark (Heterodontus japonicus). A skin extract was subjected to affinity chromatography using seven different sugars as ligands. Molecular mass and N-terminal amino acid sequence analyses indicated elution of the same protein by each of the seven respective cognate ligands from sugar affinity columns. The predicted amino acid sequence encoded by the cDNA of this protein [designated as H. japonicus C-type-lectin (HjCL)] identified it as a novel fish subgroup VII C-type lectin evolutionarily related to snake venom lectins. HjCL was predicted to bind to mannose because of the presence of a Glu-Pro-Asn (EPN) motif; however, haemagglutination inhibition assays and glycoconjugate microarray analysis demonstrated its binding to numerous structurally diverse sugars. Competitive sugar-binding assays using affinity chromatography indicated that HjCL bound multiple sugars via a common carbohydrate-recognition domain. The mRNA encoding HjCL was specifically detected in the skin, and immunohistochemical analysis detected its expression in uncharacterized large cells in the epidermis. HjCL agglutinated the bacterial pathogen Edwardsiella tarda and promoted immediate clotting of shark blood, indicating that HjCL is involved in host defence on the skin surface especially when the shark is injured and bleeds.	[Tsutsui, Shigeyuki; Dotsuta, Yuma; Ono, Ayaka; Suzuki, Masanari; Nakamura, Osamu] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan	Tsutsui, S (reprint author), Kitasato Univ, Sch Marine Biosci, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	tsutsui@kitasato-u.ac.jp					Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Clemetson KJ, 2009, J THROMB HAEMOST, V7, P360, DOI 10.1111/j.1538-7836.2008.03233.x; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; Tsutsui S, 2007, MOL IMMUNOL, V44, P691, DOI 10.1016/j.molimm.2006.04.023; INGRAM GA, 1980, J FISH BIOL, V16, P23, DOI 10.1111/j.1095-8649.1980.tb03685.x; DRICKAMER K, 1993, PROG NUCLEIC ACID RE, V45, P207, DOI 10.1016/S0079-6603(08)60870-3; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029; KAMIYA H, 1988, DEV COMP IMMUNOL, V12, P309, DOI 10.1016/0145-305X(88)90007-9; Tasumi S, 2004, DEV COMP IMMUNOL, V28, P325, DOI 10.1016/j.dci.2003.08.006; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; Nakamura O, 2006, FISH SHELLFISH IMMUN, V20, P433, DOI 10.1016/j.fsi.2005.06.004; Wang LL, 2012, DEV COMP IMMUNOL, V36, P591, DOI 10.1016/j.dci.2011.10.002; Hennemann R.M, 2001, HETERODONTUS JAPONIC, P18; Huang MM, 2013, DEV COMP IMMUNOL, V39, P363, DOI 10.1016/j.dci.2012.12.002; KODAMA M, 1986, TOXICON, V24, P819, DOI 10.1016/0041-0101(86)90107-8; KUBO T, 1990, INSECT BIOCHEM, V20, P585, DOI 10.1016/0020-1790(90)90070-B; Nakamura O, 2001, DEV COMP IMMUNOL, V25, P431, DOI 10.1016/S0145-305X(01)00012-X; Ni Y, 1996, VET IMMUNOL IMMUNOP, V55, P205, DOI 10.1016/S0165-2427(96)05718-2; Springer SA, 2008, INT J DEV BIOL, V52, P759, DOI 10.1387/ijdb.082581ss; Stevens J.D., 1987, P50; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Tsutsui S, 2003, J BIOL CHEM, V278, P20882, DOI 10.1074/jbc.M301038200; Tsutsui S, 2011, J BIOCHEM, V150, P501, DOI 10.1093/jb/mvr085; Tsutsui S, 2006, FISHERIES SCI, V72, P455, DOI 10.1111/j.1444-2906.2006.01172.x	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					345	356		10.1093/jb/mvu080		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500007		
J	Miura, Y; Yoshimitsu, K; Takatani, N; Watanabe, Y; Nakajima, H				Miura, Yukio; Yoshimitsu, Kyohei; Takatani, Nobuyuki; Watanabe, Yoshihito; Nakajima, Hiroshi			Effect of nitric oxide on VnfA, a transcriptional activator of VFe-nitrogenase in Azotobacter vinelandii	JOURNAL OF BIOCHEMISTRY			English	Article						dinitrosyl-iron; complex; iron; sulphur; cluster; nitric; oxide; nitrogenase; transcriptional activator	FE-S CLUSTER; PROTEIN-PROTEIN INTERACTIONS; DINITROSYL-IRON COMPLEXES; ESCHERICHIA-COLI; HERBASPIRILLUM-SEROPEDICAE; FLUORESCENCE POLARIZATION; FUNCTIONAL-ANALYSIS; REGULATORY PROTEIN; MOLECULAR-BIOLOGY; TERMINAL DOMAIN	The transcriptional activator, VnfA, is necessary for the expression of the structural genes encoding vanadium-dependent nitrogenase in Azotobacter vinelandii. We have previously reported that VnfA harbours a Fe-S cluster as a prosthetic group, presumably a 3Fe-4S type, which is vital for the transcriptionally active VnfA. A plausible effector molecule is a reactive oxygen species (ROS), which disassembles the Fe-S cluster switching the active VnfA to become fully inactive. This finding prompted us to investigate the effect of nitric oxide (NO), another physiologically important radical species on the VnfA activity. Unlike ROS, the VnfA activity was moderately inhibited and converged to 70% of the maximum by NO irrespective of its concentration. The Fe-S cluster of VnfA was found to react with NO to form a dinitrosyl-iron complex, either in the dimeric or monomeric form, dependent on the relative stoichiometry of NO to the Fe-S cluster. The VnfA species harbouring the dinitrosyl-iron complexes in each form exhibited 50% ATPase activity compared to the active VnfA. The findings of this study would open an argument about a biological effect of NO on nitrogenase in light of its transcriptional regulatory system.	[Miura, Yukio; Yoshimitsu, Kyohei; Nakajima, Hiroshi] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Takatani, Nobuyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Watanabe, Yoshihito] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nakajima, H (reprint author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	nakajima.hiroshi@f.mbox.nagoya-u.ac.jp			JSPS KAKENHI [18560753, 18065012]	This work was supported by JSPS KAKENHI Grant Numbers 18560753 and 18065012.	Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tonzetich ZJ, 2010, J AM CHEM SOC, V132, P6914, DOI 10.1021/ja101002f; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Kato K, 2010, J PLANT PHYSIOL, V167, P238, DOI 10.1016/j.jplph.2009.08.006; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Lee CC, 2009, P NATL ACAD SCI USA, V106, P9209, DOI 10.1073/pnas.0904408106; Martinez-Argudo I, 2004, J BACTERIOL, V186, P601, DOI 10.1128/JB.186.3.601-610.2004; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Timoshin AA, 2007, NITRIC OXIDE-BIOL CH, V16, P286, DOI 10.1016/j.niox.2006.09.005; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Liu RZ, 2003, EUR J BIOCHEM, V270, P715, DOI 10.1046/j.1432-1033.2003.03432.x; Fay AW, 2010, J AM CHEM SOC, V132, P12612, DOI 10.1021/ja1019657; AUSTIN S, 1994, J BIOL CHEM, V269, P18141; Barrett J, 2001, MOL MICROBIOL, V39, P480, DOI 10.1046/j.1365-2958.2001.02243.x; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Bishop P. E., 1992, BIOL NITROGEN FIXATI, P736; BISHOP PE, 1990, ANNU REV PLANT PHYS, V41, P109; CABALLERO FJ, 1992, ARCH MICROBIOL, V158, P14, DOI 10.1007/BF00249059; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; CONRAD R, 1990, FEMS SYMP, P105; FISCHER HM, 1988, NUCLEIC ACIDS RES, V16, P2207, DOI 10.1093/nar/16.5.2207; Flint DH, 1996, J BIOL CHEM, V271, P16068; Foster HW, 1999, J AM CHEM SOC, V121, P4093; FRISE E, 1994, J BACTERIOL, V176, P6545; HYMAN MR, 1992, BIOCHEMISTRY-US, V31, P2947, DOI 10.1021/bi00126a015; JACOB J, 1993, MOL MICROBIOL, V10, P813, DOI 10.1111/j.1365-2958.1993.tb00951.x; JOERGER RD, 1989, J BACTERIOL, V171, P3258; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Klassen G, 1999, FEMS MICROBIOL LETT, V181, P165, DOI 10.1016/S0378-1097(99)00533-9; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Macheroux P, 1998, BIOCHEM J, V332, P413; Martinez-Argudo I, 2004, MOL MICROBIOL, V52, P1731, DOI 10.1111/j.1365-2958.2004.04089.x; Money T, 2001, J BACTERIOL, V183, P1359, DOI 10.1128/JB.183.4.1359-1368.2001; Monteiro RA, 1999, FEBS LETT, V447, P283, DOI 10.1016/S0014-5793(99)00314-2; MORETT E, 1991, J BACTERIOL, V173, P3478; Nakajima H, 2010, FEBS J, V277, P817, DOI 10.1111/j.1742-4658.2009.07530.x; Premakumar R, 1998, FEMS MICROBIOL LETT, V164, P63, DOI 10.1016/S0378-1097(98)00195-5; Reyes-Ramirez F, 2002, J BACTERIOL, V184, P6777, DOI 10.1128/JB.184.24.6777-6785.2002; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; VAUGHN SA, 1989, BIOCHEMISTRY-US, V28, P419, DOI 10.1021/bi00428a002; Yoshimitsu K, 2011, FEBS J, V278, P3287, DOI 10.1111/j.1742-4658.2011.08245.x; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					365	375		10.1093/jb/mvu083		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500009		
J	Tran, DH; Shishido, Y; Chung, SP; Trinh, HTT; Yorita, K; Sakai, T; Fukui, K				Tran, Diem Hong; Shishido, Yuji; Chung, Seong Pil; Huong Thi Thanh Trinh; Yorita, Kazuko; Sakai, Takashi; Fukui, Kiyoshi			Identification of two promoters for human d-amino acid oxidase gene: implication for the differential promoter regulation mediated by PAX5/PAX2	JOURNAL OF BIOCHEMISTRY			English	Article						d-amino acid oxidase; promoter; transcription factor; PAX5; PAX2	FREE D-ASPARTATE; MOLECULAR-CLONING; CEREBELLUM DEVELOPMENT; SEQUENCE-ANALYSIS; D-SERINE; KIDNEY; SCHIZOPHRENIA; EXPRESSION; MIDBRAIN; PAX-5	d-Amino acid oxidase (DAO) is a flavoenzyme that metabolizes d-amino acids. Until now, the DAO expression mechanism is still unclear. Our assessment of human DAO (hDAO) promoter activity using luciferase reporter system indicated the proximal upstream region of exon1 (-237/+1) has promoter activity (P1). Interestingly, we identified an alternative promoter in the proximal upstream region of exon2 (+4,126/+4,929) (P2). This alternative promoter has stronger activity than that of P1. Our results also revealed a negative regulatory segment (+1,163/+1,940) in intron1; that would act in concert with P1 and P2. Bioinformatics analyses elucidated the conservation of transcription factor PAX5 family binding sites among species. These sites (-60/-31) and (+4,464/+4,493), locate in P1 and P2 of hDAO, respectively. Gel shift assays demonstrated P1 contains a site (-60/-31) for PAX5 binding while P2 has three sites for both paired box gene 2 (PAX2) and paired box gene 5 (PAX5) binding. The dual roles of PAX5 family in regulating hDAO transcription by modulating promoter activity of P1 and activating promoter activity of P2 were implicated based on the site-directed mutagenesis experiment. Altogether, our data suggested the differential regulation of hDAO expression by two promoters whose activities may be modulated by the binding of PAX2 and PAX5.	[Tran, Diem Hong; Chung, Seong Pil; Huong Thi Thanh Trinh; Yorita, Kazuko; Sakai, Takashi; Fukui, Kiyoshi] Univ Tokushima, Inst Enzyme Res KOSOKEN, Div Enzyme Pathophysiol, Tokushima 7708503, Japan; [Shishido, Yuji; Fukui, Kiyoshi] Univ Tokushima, Inst Enzyme Res KOSOKEN, Div Enzyme Literacy, Tokushima 7708503, Japan; [Fukui, Kiyoshi] Japan Sci & Technol Agcy, CREST, Tokushima 7708503, Japan	Chung, SP (reprint author), LMO Res Safety Ctr, 30 Yeongudanji Ro, Cheongwon Gun 363883, Chungcheongbuk, South Korea.	kiyo.fukui@tokushima-u.ac.jp			Japan Science and Technology Agency, CREST (Core Research for Evolutionary Science and Technology); Japanese Government (MONBUKAGAKUSHO: MEXT)	This work was supported in part by Japan Science and Technology Agency, CREST (Core Research for Evolutionary Science and Technology). A Japanese Government (MONBUKAGAKUSHO: MEXT) Scholarship was awarded to D.H.T.	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Fuchs SA, 2005, MOL GENET METAB, V85, P168, DOI 10.1016/j.ymgme.2005.03.003; Wood LS, 2007, BIOL PSYCHIAT, V61, P1195, DOI 10.1016/j.biopsych.2006.07.005; Urbanek P, 1997, P NATL ACAD SCI USA, V94, P5703, DOI 10.1073/pnas.94.11.5703; El Sayed SM, 2012, J BIOENERG BIOMEMBR, V44, P513, DOI 10.1007/s10863-012-9455-y; El Sayed SM, 2012, J BIOENERG BIOMEMBR, V44, P61, DOI 10.1007/s10863-012-9409-4; MOMOI K, 1988, FEBS LETT, V238, P180, DOI 10.1016/0014-5793(88)80252-7; DUNLOP DS, 1986, BIOCHEM BIOPH RES CO, V141, P27, DOI 10.1016/S0006-291X(86)80329-1; Dziarmaga A, 2006, PEDIATR NEPHROL, V21, P26, DOI 10.1007/s00467-005-2039-x; Boks MPM, 2007, EUR NEUROPSYCHOPHARM, V17, P567, DOI 10.1016/j.euroneuro.2006.12.003; HASHIMOTO A, 1993, J NEUROCHEM, V61, P348, DOI 10.1111/j.1471-4159.1993.tb03575.x; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; El Sayed SM, 2012, CANCER GENE THER, V19, P1, DOI 10.1038/cgt.2011.59; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; NORNES HO, 1990, DEVELOPMENT, V109, P797; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Ono K, 2009, J NEURAL TRANSM, V116, P1335, DOI 10.1007/s00702-009-0289-7; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; FISHER GH, 1991, BRAIN RES BULL, V26, P983, DOI 10.1016/0361-9230(91)90266-M; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; CHAN AWK, 1979, J HISTOCHEM CYTOCHEM, V27, P751; FUKUI K, 1988, BIOCHEMISTRY-US, V27, P6693, DOI 10.1021/bi00418a008; FUKUI K, 1987, BIOCHEMISTRY-US, V26, P3612, DOI 10.1021/bi00386a054; FUKUI K, 1992, J BIOL CHEM, V267, P18631; FUKUI K, 1986, BIOCHEM BIOPH RES CO, V141, P1222, DOI 10.1016/S0006-291X(86)80175-9; Hasegawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE160, DOI 10.1152/ajpendo.00397.2003; HORIIKE K, 1985, ACTA HISTOCHEM CYTOC, V18, P539; MOMOI K, 1990, J BIOCHEM-TOKYO, V108, P406; NAGATA Y, 1989, EXPERIENTIA, V45, P330, DOI 10.1007/BF01957466; Qiu P, 2003, BIOCHEM BIOPH RES CO, V309, P495, DOI 10.1016/j.bbrc.2003.08.052; Schwarz M, 1997, P NATL ACAD SCI USA, V94, P14518, DOI 10.1073/pnas.94.26.14518	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					377	387		10.1093/jb/mvu084		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500010		
J	Fujikawa, M; Kobayashi, K; Kozawa, T				Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro			Redox-dependent DNA distortion in a SoxR protein-promoter complex studied using fluorescent probes	JOURNAL OF BIOCHEMISTRY			English	Article						DNA-protein complex; fluorescence; iron-sulfur cluster; redox regulation; transcription factor	OXIDATIVE-STRESS SENSOR; ESCHERICHIA-COLI; MERR-FAMILY; TRANSCRIPTIONAL ACTIVATION; CRYSTAL-STRUCTURE; 2FE-2S CLUSTER; RESPONSE REGULON; APO-SOXR; IN-VIVO; 2-AMINOPURINE	The [2Fe-2S] transcriptional factor SoxR, a member of the MerR family, is regulated by the reversible oxidation and reduction of [2Fe-2S] clusters and functions as a sensor of oxidative stress in Escherichia coli. In the oxidized state, distortion of the target DNA promoter region initiates transcription by RNA polymerase, thereby activating transcription. The inactive reduced state of the protein has remained uncharacterized. Here, we directly observed redox-dependent conformational changes in the promoter DNA by site-specifically replacing selected adenine (A) and cytosine (C) bases in the promoter oligonucleotide with the fluorescent probes 2-aminopurine (2Ap) and pyrrolocytosine (pyrrolo-dC), respectively. Reduction of the [2Fe-2S] cluster in the SoxR-DNA complex dramatically weakened the fluorescence intensity of the 2Ap moieties incorporated into the central part of the DNA. In contrast, the fluorescence of 2Ap moieties incorporated at A in other regions and the fluorescence of pyrrolo-dC moieties in the central region of the DNA (C3 and C3') were only slightly decreased by the reduction. These results strongly suggest that the redox change causes a large conformational change within a region confined to the central A-T base pairs in the promoter region of the DNA.	[Fujikawa, Mayu; Kobayashi, Kazuo; Kozawa, Takahiro] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Kobayashi, K (reprint author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Osaka 5670047, Japan.	kobayasi@sanken.osaka-u.ac.jp	Kobayashi, Kazuo/H-9279-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan [23570136]	This work was supported by a grant-in aid for Scientific Research (C) (23570136 to KK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Joshi CP, 2012, P NATL ACAD SCI USA, V109, P15121, DOI 10.1073/pnas.1208508109; TSANEVA IR, 1990, J BACTERIOL, V172, P4197; Chen P, 2004, J AM CHEM SOC, V126, P728, DOI 10.1021/ja0383975; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; XU DG, 1994, BIOCHEMISTRY-US, V33, P9592, DOI 10.1021/bi00198a027; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; Fujikawa M, 2012, J BIOL CHEM, V287, P35702, DOI 10.1074/jbc.M112.395079; Gaudu P, 1997, J BIOL CHEM, V272, P5082; Liu CH, 2012, BIOCHEMISTRY-US, V51, P937, DOI 10.1021/bi201196s; FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; Liang JX, 2011, J AM CHEM SOC, V133, P6799, DOI 10.1021/ja2007998; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P946, DOI 10.1021/bi001664o; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Ansari A.Z., 1993, SCIENCE, V261, P715; Blanchard JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001186; Ding HG, 1996, J BIOL CHEM, V271, P33173; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837; Fassler J.S., 1997, METHOD ENZYMOL, V273, P3; Fujikawa M, 2014, J BIOCHEM, V156, P163, DOI 10.1093/jb/mvu029; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Hardman SJO, 2006, BIOCHEMISTRY-US, V45, P9145, DOI 10.1021/bi060479t; Hidalgo E, 1996, J BIOL CHEM, V271, P7269; HIDALGO E, 1994, EMBO J, V13, P138; Hochschild A, 1998, CELL, V92, P597, DOI 10.1016/S0092-8674(00)81126-5; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; Kobayashi K, 2014, J INORG BIOCHEM, V133, P87, DOI 10.1016/j.jinorgbio.2013.11.008; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Kobayashi K, 2011, BIOCHEMISTRY-US, V50, P9468, DOI 10.1021/bi201526y; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; Martin CT, 2003, METHOD ENZYMOL, V371, P13; Nakamura M, 1999, J BIOCHEM, V126, P10; Ptashne N, 1988, NATURE, V335, P683; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205; Thompson KC, 2005, J PHYS CHEM B, V109, P6012, DOI 10.1021/jp046177n; Watanabe S, 2006, ACTA CRYSTALLOGR F, V62, P1275, DOI 10.1107/S1744309106048482; WU J, 1995, J BIOL CHEM, V270, P10323; ZINKEL SS, 1991, J MOL BIOL, V219, P201, DOI 10.1016/0022-2836(91)90562-K	45	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					389	397		10.1093/jb/mvu085		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500011		
J	Yamazaki, S; Akira, S; Sumimoto, H				Yamazaki, Soh; Akira, Shizuo; Sumimoto, Hideki			Glucocorticoid augments lipopolysaccharide-induced activation of the I kappa B zeta-dependent genes encoding the anti-microbial glycoproteins lipocalin 2 and pentraxin 3	JOURNAL OF BIOCHEMISTRY			English	Article						dexamethasone; glucocorticoid; lipocalin 2; pentraxin 3; signal transduction	TUMOR-NECROSIS-FACTOR; MESSENGER-RNA STABILIZATION; INNATE IMMUNE-RESPONSE; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; INFLAMMATORY GENES; PROTEIN; PTX3; EXPRESSION; RECRUITMENT	Bacterial lipopolysaccharide (LPS), one of the most potent inducers of inflammation, activates the transcription factor NF-kappa B to induce expression of both proinflammatory mediators and anti-microbial glycoproteins such as lipocalin 2 (Lcn2) and pentraxin 3 (PTX3) in macrophages. Glucocorticoids are known to inhibit LPS-induced expression of proinflammatory cytokines via glucocorticoid receptor (GR)-mediated transrepression of NF-kappa B, whereas their effect on induction of anti-microbial effectors has remained to be elucidated. Here we show that the synthetic glucocorticoid dexamethasone (Dex) strongly enhances LPS-induced transcription of Lcn2 and Ptx3, although Dex by itself fails to trigger their transcription. In macrophages deficient in I kappa B zeta (an inducible coactivator of NF-kappa B), Lcn2 and Ptx3 are not activated by LPS either alone or in combination with Dex. Association of GR as well as Brg1 (a subunit of the chromatin remodelling Swi/Snf complex) with a functional glucocorticoid response element in Lcn2 requires both the costimulation with LPS and the presence of I kappa B zeta. Although Ptx3 does not contain the element, LPS induces recruitment of Dex-liganded GR to NF-kappa B-binding sites in regulatory regions of Ptx3, an event that does not occur in I kappa B zeta-deficient macrophages. Thus glucocorticoids likely regulate infection-induced inflammation by increasing anti-microbial effectors in an I kappa B zeta-dependent manner, while repressing proinflammatory genes.	[Yamazaki, Soh; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Yamazaki, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	syamaz@mailserver.med.kyushu-u.ac.jp; hsumi@med.kyushu-u.ac.jp	Akira, Shizuo/C-3134-2009		MEXT (the Ministry of Education, Culture, Sports, Science and Technology) KAKENHI [26111009]; Uehara Memorial Foundation; Sankyo Foundation of Life Science; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development	This work was supported in part by MEXT (the Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant Number 26111009, by grants from The Uehara Memorial Foundation and Sankyo Foundation of Life Science, and by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked 'advertisement' in accordance with 18 U.S.C. Section 1,734 solely to indicate this fact.	Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Introna M, 1996, BLOOD, V87, P1862; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007; LIU QS, 1995, J BIOL CHEM, V270, P22565; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; ALLES VV, 1994, BLOOD, V84, P3483; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; LEE GW, 1993, J IMMUNOL, V150, P1804; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Hakim O, 2009, J BIOL CHEM, V284, P6048, DOI 10.1074/jbc.C800212200; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Aittomaki S, 2000, J IMMUNOL, V164, P5689; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; ALTMEYER A, 1995, J BIOL CHEM, V270, P25584; Kawai T, 2011, NAT IMMUNOL, V11, P373; Lyss G., 1998, J BIOL CHEM, V273, P33508; Stoecklin E, 1997, MOL CELL BIOL, V17, P6708; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607	54	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					399	410		10.1093/jb/mvu086		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500012		
J	Kazayama, A; Yamagami, R; Yokogawa, T; Hori, H				Kazayama, Ai; Yamagami, Ryota; Yokogawa, Takashi; Hori, Hiroyuki			Improved solid-phase DNA probe method for tRNA purification: large-scale preparation and alteration of DNA fixation	JOURNAL OF BIOCHEMISTRY			English	Article						purification; solid-phase DNA probe; thermophiles; tRNA; tRNA modification	MITOCHONDRIAL TRANSFER-RNAS; THERMUS-THERMOPHILUS HB8; MODIFIED NUCLEOTIDES; EXTREME THERMOPHILE; POSITION; METHYLTRANSFERASE; CHROMATOGRAPHY; HYBRIDIZATION; BIOSYNTHESIS; STABILITY	The solid-phase DNA probe method, in which a target transfer RNA (tRNA) is hybridized with a complementary DNA oligomer, is generally used for tRNA purification. However, purification of tRNAs from thermophiles by this method is not easy because of their high melting temperatures. To overcome this problem, the use of tetraalkylammonium salts was previously reported [Yokogawa, T., Kitamura, Y., Nakamura, D., Ohno, S., and Nishikawa, K. (2010) Optimization of the hybridization-based method for purification of thermostable tRNAs in the presence of tetraalkylammonium salts. Nucleic Acids Res. 38, e89]. In this study, we initially devised a large-scale purification system using tetraalkylammonium salts. The yield of tRNA was increased more than 10-fold and the manual steps were decreased as compared with the previous procedure. However, deterioration of column was very rapid owing to shedding of the biotinylated DNA probe. We therefore devised a method of covalent DNA fixation, in which a 5'-aminohexyl (dT)(8) oligomer was fixed onto the N-hydroxysuccinimide-activated agarose, and then a DNA oligomer containing the tRNA and repeated A(8) sequences was annealed. The probe sequence for tRNA purification was synthesized in column with Klenow enzyme. This DNA fixation method enabled us to use the column repeatedly and to wash the column with warmed buffers. Thus, this DNA fixation method is economical as compared with the previous method using the biotinylated DNA probe.	[Kazayama, Ai; Yamagami, Ryota; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Yokogawa, Takashi] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan	Hori, H (reprint author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp			Japan Society for the Promotion Science [23350081]	This work was partly supported by a Grant-in-aid for Science Research (B) (23350081 to H.H.) from the Japan Society for the Promotion Science.	Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; KUMAZAWA Y, 1992, NUCLEIC ACIDS RES, V20, P2223, DOI 10.1093/nar/20.9.2223; Suzuki T, 2007, METHOD ENZYMOL, V425, P231, DOI 10.1016/S0076-6879(07)25010-4; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; HOPPER AK, 1978, CELL, V14, P211, DOI 10.1016/0092-8674(78)90108-3; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; EDMONDS CG, 1991, J BACTERIOL, V173, P3138; GRAWUNDER U, 1992, NUCLEIC ACIDS RES, V20, P137, DOI 10.1093/nar/20.1.137; Hirata A, 2011, NUCLEIC ACIDS RES, V39, P9376, DOI 10.1093/nar/gkr615; HORIE N, 1985, BIOCHEMISTRY-US, V24, P5711, DOI 10.1021/bi00342a004; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Ohtsuki T, 2002, NAT STRUCT BIOL, V9, P669, DOI 10.1038/nsb826; PACHMANN U, 1978, NUCLEIC ACIDS RES, V5, P961, DOI 10.1093/nar/5.3.961; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Suzuki T, 1996, FEBS LETT, V381, P195, DOI 10.1016/0014-5793(96)00107-X; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Tomikawa C, 2013, FEBS LETT, V587, P3575, DOI 10.1016/j.febslet.2013.09.021; TSURUI H, 1994, ANAL BIOCHEM, V221, P166, DOI 10.1006/abio.1994.1393; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182; Yokoyama S, 1987, Adv Biophys, V23, P115, DOI 10.1016/0065-227X(87)90006-2	31	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	MAY	2015	157	5					411	418		10.1093/jb/mvu089		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI4DI	WOS:000354696500013		
J	Ueda, T; Yoshiura, C; Matsumoto, M; Kofuku, Y; Okude, J; Kondo, K; Shiraishi, Y; Takeuchi, K; Shimada, I				Ueda, Takumi; Yoshiura, Chie; Matsumoto, Masahiko; Kofuku, Yutaka; Okude, Junya; Kondo, Keita; Shiraishi, Yutaro; Takeuchi, Koh; Shimada, Ichio			Development of a method for reconstruction of crowded NMR spectra from undersampled time-domain data	JOURNAL OF BIOMOLECULAR NMR			English	Article						Sparse sampling; Non-uniform sampling; Transferred cross-saturation; Membrane proteins	MAXIMUM-ENTROPY RECONSTRUCTION; LEAST-SQUARES PROCEDURE; PARAMAGNETIC RELAXATION ENHANCEMENT; SINGULAR VALUE DECOMPOSITION; MULTIDIMENSIONAL NMR; LINEAR-PREDICTION; PROJECTION-RECONSTRUCTION; CROSS-SATURATION; GFT-NMR; SPECTROSCOPY	NMR is a unique methodology for obtaining information about the conformational dynamics of proteins in heterogeneous biomolecular systems. In various NMR methods, such as transferred cross-saturation, relaxation dispersion, and paramagnetic relaxation enhancement experiments, fast determination of the signal intensity ratios in the NMR spectra with high accuracy is required for analyses of targets with low yields and stabilities. However, conventional methods for the reconstruction of spectra from undersampled time-domain data, such as linear prediction, spectroscopy with integration of frequency and time domain, and analysis of Fourier, and compressed sensing were not effective for the accurate determination of the signal intensity ratios of the crowded two-dimensional spectra of proteins. Here, we developed an NMR spectra reconstruction method, "conservation of experimental data in analysis of Fourier" (Co-ANAFOR), to reconstruct the crowded spectra from the undersampled time-domain data. The number of sampling points required for the transferred cross-saturation experiments between membrane proteins, photosystem I and cytochrome b (6) f, and their ligand, plastocyanin, with Co-ANAFOR was half of that needed for linear prediction, and the peak height reduction ratios of the spectra reconstructed from truncated time-domain data by Co-ANAFOR were more accurate than those reconstructed from non-uniformly sampled data by compressed sensing.	[Ueda, Takumi; Yoshiura, Chie; Matsumoto, Masahiko; Kofuku, Yutaka; Okude, Junya; Kondo, Keita; Shiraishi, Yutaro; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ueda, Takumi; Takeuchi, Koh] Japan Sci & Technol Agcy, Chiyoda Ku, Precursory Res Embryon Sci & Technol, Tokyo 1020075, Japan; [Matsumoto, Masahiko] Japan Biol Informat Consortium, Koto Ku, Tokyo 1358073, Japan; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr, Koto Ku, Tokyo 1350064, Japan	Shimada, I (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	We are grateful to Drs. Masanori Osawa and Noritaka Nishida for their helpful advice, and to Ms. Tomomi Kimura for the preparation of HPr and EIN. This work was supported by a Grant from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry (METI).	Hyberts SG, 2007, J AM CHEM SOC, V129, P5108, DOI 10.1021/ja068541x; Schuyler AD, 2011, J BIOMOL NMR, V50, P247, DOI 10.1007/s10858-011-9512-6; Tal A, 2009, ANGEW CHEM INT EDIT, V48, P2732, DOI 10.1002/anie.200805612; Luan T, 2005, J BIOMOL NMR, V33, P1, DOI 10.1007/s10858-005-1363-6; Mobli M, 2008, CONCEPT MAGN RESON A, V32A, P436, DOI 10.1002/cmr.a.20126; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Hyberts SG, 2009, J BIOMOL NMR, V45, P283, DOI 10.1007/s10858-009-9368-1; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Hiller S, 2005, J BIOMOL NMR, V32, P61, DOI 10.1007/s10858-005-3070-8; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Bodart PR, 2002, SOLID STATE NUCL MAG, V21, P1, DOI 10.1006/snmr.2001.0040; Bostock MJ, 2012, J BIOMOL NMR, V54, P15, DOI 10.1007/s10858-012-9643-4; Mayzel M, 2014, J BIOMOL NMR, V58, P129, DOI 10.1007/s10858-013-9811-1; BARKHUIJSEN H, 1985, MAGNET RESON MED, V2, P86, DOI 10.1002/mrm.1910020111; Tolman JR, 2006, CHEM REV, V106, P1720, DOI 10.1021/cr040429z; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Ueda T, 2014, Q REV BIOPHYS, V47, P143, DOI 10.1017/S0033583514000043; Shrot Y, 2011, J MAGN RESON, V209, P352, DOI 10.1016/j.jmr.2011.01.017; Ban D, 2013, MOLECULES, V18, P11904, DOI 10.3390/molecules181011904; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Matsuki Y, 2009, J AM CHEM SOC, V131, P4648, DOI 10.1021/ja807893k; Hiller S, 2008, J AM CHEM SOC, V130, P12073, DOI 10.1021/ja803161d; MANASSEN Y, 1987, J MAGN RESON, V72, P551, DOI 10.1016/0022-2364(87)90161-2; Matsuki Y, 2011, J PHYS CHEM B, V115, P13740, DOI 10.1021/jp2081116; Freeman R, 2004, CONCEPT MAGN RESON A, V23A, P63, DOI 10.1002/cmr.a.20021; Qu XB, 2015, ANGEW CHEM INT EDIT, V54, P852, DOI 10.1002/anie.201409291; Mayzel M, 2014, CHEM COMMUN, V50, P8947, DOI 10.1039/c4cc03047h; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Stern AS, 2002, J AM CHEM SOC, V124, P1982, DOI 10.1021/ja011669o; Theillet FX, 2011, J BIOMOL NMR, V51, P487, DOI 10.1007/s10858-011-9577-2; Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Kupce E, 2006, J AM CHEM SOC, V128, P6020, DOI 10.1021/ja0609598; Rovnyak D, 2004, J BIOMOL NMR, V30, P1, DOI 10.1023/B:JNMR.0000042946.04002.19; Brucale M, 2014, CHEM REV, V114, P3281, DOI 10.1021/cr400297g; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI [10.1021/ja077282o, 10.1021/jao077282o]; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; BARNA JCJ, 1987, J MAGN RESON, V75, P384, DOI 10.1016/0022-2364(87)90047-3; BARKHUIJSEN H, 1985, J MAGN RESON, V61, P465, DOI 10.1016/0022-2364(85)90187-8; Chen JH, 2000, J MAGN RESON, V147, P129, DOI 10.1006/jmre.2000.2176; Clore GM, 2014, BIOPHYS CHEM, V186, P3, DOI 10.1016/j.bpc.2013.08.006; Kupce E, 2004, J AM CHEM SOC, V126, P6429, DOI 10.1021/ja049432q; HOCH JC, 1989, METHOD ENZYMOL, V176, P216; LED JJ, 1991, CHEM REV, V91, P1413, DOI 10.1021/cr00007a007; LEVITT MH, 1984, J MAGN RESON, V58, P462; Lippens G, 2003, J MAGN RESON, V161, P174, DOI 10.1016/S1090-7807(03)00005-3; McGeorge G, 1997, J MAGN RESON, V129, P134, DOI 10.1006/jmre.1997.1268; Mobli M, 2014, PROG NUCL MAG RES SP, V83, P21, DOI 10.1016/j.pnmrs.2014.09.002; Moriya J, 2009, BBA-GEN SUBJECTS, V1790, P1368, DOI 10.1016/j.bbagen.2009.06.001; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; SCHUSSHEIM AE, 1987, J MAGN RESON, V71, P371, DOI 10.1016/0022-2364(87)90072-2; Tychonoff A. N., 1977, SOLUTION ILL POSED P; Ueda T, 2012, Q REV BIOPHYS, V24, P4173	61	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	MAY	2015	62	1					31	41		10.1007/s10858-015-9908-9		11	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CI1FG	WOS:000354487600005		
J	Buchner, L; Guntert, P				Buchner, Lena; Guentert, Peter			Systematic evaluation of combined automated NOE assignment and structure calculation with CYANA	JOURNAL OF BIOMOLECULAR NMR			English	Article						Automated assignment; NOESY; Distance restraints; Structure calculation; CYANA	PROTEIN-STRUCTURE DETERMINATION; NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; SARCOMA ONCOGENE FES; ARABIDOPSIS-THALIANA; RESONANCE ASSIGNMENT; HOMOLOGY DOMAIN; CHEMICAL-SHIFT; SPECTRA; ALGORITHM	The automated assignment of NOESY cross peaks has become a fundamental technique for NMR protein structure analysis. A widely used algorithm for this purpose is implemented in the program CYANA. It has been used for a large number of structure determinations of proteins in solution but a systematic evaluation of its performance has not yet been reported. In this paper we systematically analyze the reliability of combined automated NOESY assignment and structure calculation with CYANA under a variety of conditions on the basis of the experimental NMR data sets of ten proteins. To evaluate the robustness of the algorithm, the original high-quality experimental data sets were modified in different ways to simulate the effect of data imperfections, i.e. incomplete or erroneous chemical shift assignments, missing NOESY cross peaks, inaccurate peak positions, inaccurate peak intensities, lower dimensionality NOESY spectra, and higher tolerances for the matching of chemical shifts and peak positions. The results show that the algorithm is remarkably robust with regard to imperfections of the NOESY peak lists and the chemical shift tolerances but susceptible to lacking or erroneous resonance assignments, in particular for nuclei that are involved in many NOESY cross peaks.	[Buchner, Lena; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Buchner, Lena; Guentert, Peter] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; [Guentert, Peter] ETH, Phys Chem Lab, Zurich, Switzerland; [Guentert, Peter] Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo, Japan	Guntert, P (reprint author), Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany.	guentert@em.uni-frankfurt.de	Fachbereich14, Dekanat/C-8553-2015		Lichtenberg program of the Volkswagen Foundation; Japan Society for the Promotion of Science (JSPS)	We gratefully acknowledge financial support by the Lichtenberg program of the Volkswagen Foundation and a Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS).	Altieri AS, 2004, CURR OPIN STRUC BIOL, V14, P547, DOI 10.1016/j.sbi.2004.09.003; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Guerry P, 2011, Q REV BIOPHYS, V44, P257, DOI 10.1017/S0033583510000326; Rosato A, 2012, STRUCTURE, V20, P227, DOI 10.1016/j.str.2012.01.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Zhang ZY, 2014, J BIOMOL NMR, V59, P135, DOI 10.1007/s10858-014-9832-4; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Rosato A, 2009, NAT METHODS, V6, P625, DOI 10.1038/nmeth0909-625; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Billeter M, 2008, J BIOMOL NMR, V42, P155, DOI 10.1007/s10858-008-9277-8; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; Williamson MP, 2009, J BIOMOL NMR, V43, P131, DOI 10.1007/s10858-008-9295-6; MUMENTHALER C, 1995, J MOL BIOL, V254, P465, DOI 10.1006/jmbi.1995.0631; Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Schmidt E, 2012, J AM CHEM SOC, V134, P12817, DOI 10.1021/ja305091n; Baran MC, 2004, CHEM REV, V104, P3541, DOI 10.1021/cr030408p; Vogeli B, 2012, NAT STRUCT MOL BIOL, V19, P1053, DOI 10.1038/nsmb.2355; Vogeli B, 2009, J AM CHEM SOC, V131, P17215, DOI 10.1021/ja905366h; Antuch W, 1996, NAT STRUCT BIOL, V3, P662, DOI 10.1038/nsb0896-662; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Gronwald W, 2004, PROG NUCL MAG RES SP, V44, P33, DOI 10.1016/j.pnmrs.2003.12.002; Gronwald W, 2002, J BIOMOL NMR, V23, P271, DOI 10.1023/A:1020279503261; Guntert P, 1998, Q REV BIOPHYS, V31, P145, DOI 10.1017/S0033583598003436; Güntert Peter, 2004, Methods Mol Biol, V278, P353; GUNTERT P, 1993, J BIOMOL NMR, V3, P601; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hung Ling-Hong, 2006, J Biomol NMR, V36, P189, DOI 10.1007/s10858-006-9082-1; Ikeya T, 2011, J BIOMOL NMR, V50, P137, DOI 10.1007/s10858-011-9502-8; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Kirchner DK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-170; Kuszewski J, 2004, J AM CHEM SOC, V126, P6258, DOI 10.1021/ja049786h; Lopez-Mendez B, 2004, J BIOMOL NMR, V29, P205, DOI 10.1023/B:JNMR.0000019239.44783.66; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; MEADOWS RP, 1994, J BIOMOL NMR, V4, P79; Moseley HNB, 1999, CURR OPIN STRUC BIOL, V9, P635, DOI 10.1016/S0959-440X(99)00019-6; Nabuurs SB, 2006, PLOS COMPUT BIOL, V2, P71, DOI 10.1371/journal.pcbi.0020009; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Paakkonen K, 2006, PROTEINS, V64, P665, DOI 10.1002/prot.21030; Pantoja-Uceda D, 2005, PROTEIN SCI, V14, P224, DOI 10.1110/ps.041138705; Pantoja-Uceda D, 2004, J BIOMOL NMR, V29, P207, DOI 10.1023/B:JNMR.0000019241.66789.c3; Schmidt E, 2013, J BIOMOL NMR, V57, P193, DOI 10.1007/s10858-013-9779-x; Scott A, 2005, J BIOMOL NMR, V31, P357, DOI 10.1007/s10858-005-0946-6; Scott A, 2004, J BIOMOL NMR, V30, P463, DOI 10.1007/s10858-004-5432-z; Wimmer R, 1999, J BIOL CHEM, V274, P22597, DOI 10.1074/jbc.274.32.22597	53	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-2738	1573-5001		J BIOMOL NMR	J. Biomol. NMR	MAY	2015	62	1					81	95		10.1007/s10858-015-9921-z		15	Biochemistry & Molecular Biology; Spectroscopy	Biochemistry & Molecular Biology; Spectroscopy	CI1FG	WOS:000354487600010		
J	Isogai, T; Yasunaga, H; Matsui, H; Tanaka, H; Horiguchi, H; Fushimi, K				Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki; Tanaka, Hiroyuki; Horiguchi, Hiromasa; Fushimi, Kiyohide			Effect of Intravenous Immunoglobulin for Fulminant Myocarditis on In-Hospital Mortality: Propensity Score Analyses	JOURNAL OF CARDIAC FAILURE			English	Article						Fulminant myocarditis; immunoglobulin; propensity score analysis; mortality	VENTRICULAR ENDOMYOCARDIAL BIOPSY; EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; AMERICAN-HEART-ASSOCIATION; GAMMA-GLOBULIN; SCIENTIFIC STATEMENT; COMPLICATION RATE; KAWASAKI SYNDROME; EUROPEAN-SOCIETY; IMMUNE GLOBULIN	Background: Fulminant myocarditis (FM) is a rare but life-threatening disease. Intravenous immunoglobulin (IVIG) is not recommended for acute or chronic myocarditis in Western nations owing to the lack of rigorous evidence, but it is widely used in other countries, including Japan. This nationwide retrospective cohort study focused on evaluating the effect of IVIG in FM patients. Methods and Results: Using the Diagnosis Procedure Combination database in Japan, we identified 603 FM patients aged a 16 years who received mechanical circulatory support within 7 days after admission. We performed propensity score analyses to compare the in-hospital mortality and total costs between IVIG users (n = 220; 36.5%) and nonusers (n = 383; 63.5%). Among propensity score matched patients (164 pairs), there was no significant difference in in-hospital mortality between IVIG users and nonusers (36.6% vs 37.2%; P = .909). A multivariable logistic regression analysis showed no significant association between IVIG use and in-hospital mortality (adjusted odds ratio 0.91; 95% confidence interval 0.52 to 1.58; P = .733). The median total costs were significantly higher for IVIG users than for nonusers (US $44,226 vs $33,280; P < .001). Conclusion: IVIG for FM was not significantly associated with a decrease in in-hospital mortality.	[Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Isogai, Toshiaki; Tanaka, Hiroyuki] Tokyo Metropolitan Tama Med Ctr, Dept Cardiol, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Isogai, T (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	toisogai-circ@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation) [H26-Policy-011]	Grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Kishimoto C, 2000, J AM COLL CARDIOL, V36, P1979, DOI 10.1016/S0735-1097(00)00978-5; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Acker MA, 2001, ANN THORAC SURG, V71, pS73, DOI 10.1016/S0003-4975(00)02628-X; Cheng R, 2014, J CARD FAIL, V20, P400, DOI 10.1016/j.cardfail.2014.03.005; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Aoyama N, 2002, CIRC J, V66, P133, DOI 10.1253/circj.66.133; McNamara DM, 2001, CIRCULATION, V103, P2254; Chimenti C, 2013, CIRCULATION, V128, P1531, DOI 10.1161/CIRCULATIONAHA.13.001414; Howlett JG, 2009, CAN J CARDIOL, V25, P85; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Asaumi Y, 2005, EUR HEART J, V26, P2185, DOI 10.1093/eurheartj/ehi411; Mirabel M, 2011, CRIT CARE MED, V39, P1029, DOI 10.1097/CCM.0b013e31820ead45; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; NEWBURGER JW, 1989, CIRCULATION, V79, P1237; LIEBERMAN EB, 1991, J AM COLL CARDIOL, V18, P1617; [Anonymous], 2011, CIRC J, V75, P734; Peura JL, 2012, CIRCULATION, V126, P2648, DOI 10.1161/CIR.0b013e3182769a54; Holzmann M, 2008, CIRCULATION, V118, P1722, DOI 10.1161/CIRCULATIONAHA.107.743427; DRUCKER NA, 1994, CIRCULATION, V89, P252; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Goland S, 2008, CAN J CARDIOL, V24, P571; Hsu KH, 2011, EUR J CARDIO-THORAC, V40, P682, DOI 10.1016/j.ejcts.2010.12.050; Kato S, 2007, HEART VESSELS, V22, P48, DOI 10.1007/s00380-006-0923-3; Kim HS, 2004, INT J CARDIOL, V96, P485, DOI 10.1016/j.ijcard.2003.05.037; Kishimoto C, 2014, HEART VESSELS, V29, P336, DOI 10.1007/s00380-013-0368-4; Maisch B, 2013, HEART FAIL REV, V18, P761, DOI 10.1007/s10741-012-9362-7; McNamara DM, 1997, CIRCULATION, V95, P2476; Nakatani Takeshi, 2009, Circ J, V73 Suppl A, pA55; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Robinson Joan L, 2005, BMC Cardiovasc Disord, V5, P12, DOI 10.1186/1471-2261-5-12; ROSEN FS, 1993, CLIN IMMUNOL IMMUNOP, V67, pS41, DOI 10.1006/clin.1993.1082; TAKADA H, 1995, CIRCULATION, V92, P1604; Yu DQ, 2014, EXP THER MED, V7, P97, DOI 10.3892/etm.2013.1372	39	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	MAY	2015	21	5					391	397		10.1016/j.cardfail.2015.01.004		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI0IP	WOS:000354420600005		
J	Miyazaki, S; Ichihara, N; Iesaka, Y				Miyazaki, Shinsuke; Ichihara, Noboru; Iesaka, Yoshito			Pulmonary Vein Stenosis After Cryoablation Using 28-mm Second-Generation Balloon	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						atrial fibrillation; catheter ablation; cryoablation; pulmonary vein stenosis			[Miyazaki, Shinsuke; Ichihara, Noboru; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, Tsuchiura, Ibaraki 3000053, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Ctr, Div Cardiol, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAY	2015	26	5					570	571		10.1111/jce.12596		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9YR	WOS:000354393100016		
J	Kaneko, Y; Nakajima, T; Ota, M; Kurabayashi, M				Kaneko, Yoshiaki; Nakajima, Tadashi; Ota, Masaki; Kurabayashi, Masahiko			His-Bundle Bigeminy Evidenced by Short His-Ventricular Interval	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material						catheter ablation; His arrhythmia; His-bundle ectopy			[Kaneko, Yoshiaki; Nakajima, Tadashi; Ota, Masaki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma 3718511, Japan	Kaneko, Y (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	kanekoy@gunma-u.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAY	2015	26	5					572	573		10.1111/jce.12613		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9YR	WOS:000354393100017		
J	Hirai, K; Fujimoto, H; Naito, M; Doi, N				Hirai, Kaeko; Fujimoto, Hajime; Naito, Masaki; Doi, Naofumi			Efficacy of Ethanol Infusion in the Vein of Marshall for Bidirectional Mitral Isthmus Block in Unsuccessful Cases with Conventional Ablation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Meeting Abstract	20th Annual Atrial Fibrillation (AF) Symposium on Mechanisms and New Directions in Therapy	JAN 08-10, 2015	Orlando, FL						[Hirai, Kaeko; Fujimoto, Hajime; Naito, Masaki; Doi, Naofumi] Nara Prefecture Western Med Ctr, Sango, Nara, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAY	2015	26	5				4	583	583				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9YR	WOS:000354393100024		
J	Ishihara, S; Fujimoto, H; Hirai, K; Naito, M; Doi, N				Ishihara, Satomi; Fujimoto, Hajime; Hirai, Kaeko; Naito, Masaki; Doi, Naofumi			Localization and Reproducibility of Rotational Activities in Patients with Atrial Fibrillation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Meeting Abstract	20th Annual Atrial Fibrillation (AF) Symposium on Mechanisms and New Directions in Therapy	JAN 08-10, 2015	Orlando, FL						[Ishihara, Satomi; Fujimoto, Hajime; Hirai, Kaeko; Naito, Masaki; Doi, Naofumi] Nara Prefectural Western Med Ctr, Sango, Nara 6360802, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAY	2015	26	5				6	583	584				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9YR	WOS:000354393100026		
J	Minami, K; Nakamura, K; Naito, S; Kumagai, K; Oshima, S				Minami, Kentaro; Nakamura, Kohki; Naito, Shigeto; Kumagai, Koji; Oshima, Shigeru			Esophageal Complications Following Radiofrequency Ablation of Atrial Fibrillation: A Prospective Comparative Study Between Low and High Contact Force Ablation	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Meeting Abstract	20th Annual Atrial Fibrillation (AF) Symposium on Mechanisms and New Directions in Therapy	JAN 08-10, 2015	Orlando, FL						[Minami, Kentaro; Nakamura, Kohki; Naito, Shigeto; Kumagai, Koji; Oshima, Shigeru] Gunma Prefecture Maebashi City, Gunma Cardiovasc Ctr, Maebashi, Gumma 379215411, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	MAY	2015	26	5				5	583	583				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9YR	WOS:000354393100025		
J	Morimoto, N; Takeuchi, H; Nishida, Y; Morisawa, M; Yoshikawa, T; Morita, T; Morimoto, M; Sugimoto, C; Matsumura, Y; Sugiura, T				Morimoto, Norihito; Takeuchi, Hiroaki; Nishida, Yoshie; Morisawa, Mie; Yoshikawa, Tomoe; Morita, Tamae; Morimoto, Miyuki; Sugimoto, Chizuko; Matsumura, Yoshihisa; Sugiura, Tetsuro			Clinical Application of the DiversiLab Microbial Typing System Using Repetitive Sequence-Based PCR for Characterization of Helicobacter pylori in Japan	JOURNAL OF CLINICAL LABORATORY ANALYSIS			English	Article						Helicobacter pylori; genotyping; rep-PCR; DiversiLab Microbial Typing System; gastric cancer; antibiotic resistant	INFECTION; ERADICATION; CHILDREN; THERAPY; ULCER; AGE	We evaluated the DiversiLab (DL) system with universal primers, a semiautomated repetitive extragenic palindromic sequence-based polymerase chain reaction (PCR) (rep-PCR) system, for the characterization of Helicobacter pylori in Japan. All 135 isolates from Japanese patients with gastric cancer (GC, n = 55) or non-GC (n = 80) were used and subjected to the drug susceptibility examinations (amoxicillin, AMPC; metronidazole, MNZ; and clarithromycin, CAM) by E-test. There were 28 MNZ-resistant (20.7%), 35 CAM-resistant (25.9%), and 16 MNZ/CAM-resistant (11.9%) isolates. DL rep-PCR fingerprinting analysis at the level of 95% similarity revealed five major groups (A-E) and the other including 45 isolates. The occupation rates of GC-derived isolates in groups B (54.2%) and E (58.8%) were higher than in the other groups: A (26.7%), C (28.6%), D (30.0%), and the other (40.0%). Relative higher occupation rates of drug resistants, such as MNZ-, CAM- and double MNZ/CAM-resistant isolates, were observed in groups B (45.8%), C (42.6%), and D (40%). Five of eight GC-derived isolates with MNZ/CAM resistance were significantly assigned to group B (P = 0.0312, (2)-test). These results suggest that the isolates classified in group B have a potential to contribute to the development of severe gastric disorders. The DL system, rapid and high sensitive technology, would be widely available in clinical laboratory for pathological and epidemiological analyses even in H. pylori.	[Morimoto, Norihito; Nishida, Yoshie; Morisawa, Mie; Yoshikawa, Tomoe; Morita, Tamae; Morimoto, Miyuki; Sugiura, Tetsuro] Kochi Univ, Kochi Med Sch, Dept Clin Lab, Nankoku, Kochi 7838505, Japan; [Takeuchi, Hiroaki; Nishida, Yoshie; Sugimoto, Chizuko; Matsumura, Yoshihisa; Sugiura, Tetsuro] Kochi Univ, Sch Med, Clin Lab Med, Nankoku, Kochi 7838505, Japan	Takeuchi, H (reprint author), Kochi Univ, Kochi Med Sch, Dept Clin Lab Med, Oko Cho, Nankoku, Kochi 7838505, Japan.	htake@kochi-u.ac.jp			MEXT/JSPS KAKENHI [23590677, 24590697]	Grant sponsor: MEXT/JSPS KAKENHI; Grant numbers: 23590677 and 24590697.	Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665; Dombek PE, 2000, APPL ENVIRON MICROB, V66, P2572, DOI 10.1128/AEM.66.6.2572-2577.2000; GO MF, 1995, SCAND J GASTROENTERO, V30, P640, DOI 10.3109/00365529509096306; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Malaty HM, 2002, LANCET, V359, P931, DOI 10.1016/S0140-6736(02)08025-X; Ben-Darif E, 2010, J MICROBIOL METH, V81, P11, DOI 10.1016/j.mimet.2010.01.013; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; ASHORN M, 1995, SCAND J GASTROENTERO, V30, P876, DOI 10.3109/00365529509101594; Burucoa C, 1999, J CLIN MICROBIOL, V37, P4071; Granstrom M, 1997, J CLIN MICROBIOL, V35, P468; Kawai T, 2006, ALIMENT PHARM THERAP, V24, P16, DOI 10.1111/j.1365-2036.2006.00021.x; Kidd M, 2001, J CLIN MICROBIOL, V39, P1833, DOI 10.1128/JCM.39.5.1833-1839.2001; Li L, 2002, DIGEST DIS SCI, V47, P2512, DOI 10.1023/A:1020564126960; Nada T, 2004, ALIMENT PHARM THERAP, V20, P39, DOI 10.1111/j.1365-2036.2004.01968.x; Shibayama K, 2011, MICROBIOL IMMUNOL, V55, P408, DOI 10.1111/j.1348-0421.2011.00333.x; Trang VT, 2009, J AGR FOOD CHEM, V57, P11343, DOI 10.1021/jf9026876	18	0	1	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-8013	1098-2825		J CLIN LAB ANAL	J. Clin. Lab. Anal.	MAY	2015	29	3					250	253		10.1002/jcla.21758		4	Medical Laboratory Technology	Medical Laboratory Technology	CI3LQ	WOS:000354649700013		
J	Miyagaki, T; Sugaya, M				Miyagaki, Tomomitsu; Sugaya, Makoto			Recent advances in atopic dermatitis and psoriasis: Genetic background, barrier function, and therapeutic targets	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review							GENERALIZED PUSTULAR PSORIASIS; ACTIVATION-REGULATED CHEMOKINE; OF-FUNCTION VARIANTS; JAPANESE POPULATION; HUMAN KERATINOCYTES; SKIN INFLAMMATION; T-CELLS; EPIDERMAL-KERATINOCYTES; SUSCEPTIBILITY LOCI; PREDISPOSING FACTOR	Atopic dermatitis (AD) and psoriasis are common inflammatory skin diseases. Although clinical pictures of these two diseases are quite different, they share some common pathological backgrounds such as barrier dysfunction and enhanced IL-22 expression. To explain the clinical differences of the diseases, it has been proposed that Th2/Th22-polarized immune status together with an attenuated Th17 axis may cause insufficient induction of antimicrobial peptides and more severe barrier dysfunction in AD. While skin barrier dysfunction is commonly seen in AD and psoriasis, a Th2-dominant cytokine milieu down-regulates immunity against infections, which are commonly seen in lesional skin of AD. In the era of biologics, increase in the understanding or new discoveries of molecules involved in the development of various diseases will instantly lead to a new therapeutic strategy. In this review, we give an overview of recent advances in AD and psoriasis, especially on genetic background, barrier function, and therapeutic targets. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Miyagaki, Tomomitsu; Sugaya, Makoto] Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Sugaya, M (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sugayam-der@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	The study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Andoh T, 2014, J DERMATOL SCI, V76, P206, DOI 10.1016/j.jdermsci.2014.10.005; Son ED, 2014, J DERMATOL SCI, V74, P64, DOI 10.1016/j.jdermsci.2013.12.004; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sugiura K, 2014, J DERMATOL SCI, V74, P187, DOI 10.1016/j.jdermsci.2014.02.006; Jung DL, 2014, J DERMATOL SCI, V74, P23, DOI 10.1016/j.jdermsci.2013.11.015; Sakai T, 2014, J DERMATOL SCI, V74, P222, DOI 10.1016/j.jdermsci.2014.01.012; Hou RX, 2013, J DERMATOL SCI, V72, P103, DOI 10.1016/j.jdermsci.2013.07.002; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Schaper K, 2013, J DERMATOL SCI, V71, P29, DOI 10.1016/j.jdermsci.2013.03.006; Chen JQ, 2013, CELL BIOCHEM BIOPHYS, V66, P523, DOI 10.1007/s12013-012-9499-y; Eiris N, 2014, J DERMATOL SCI, V75, P167, DOI 10.1016/j.jdermsci.2014.05.010; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Eyerich K, 2009, J ALLERGY CLIN IMMUN, V123, P59, DOI [10.1016/j.jaci.2008.10.031, 10.1016/j.jaci.2009.10.031]; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Tarutani M, 2013, J DERMATOL SCI, V72, P110, DOI 10.1016/j.jdermsci.2013.06.007; Peters JH, 2013, J DERMATOL SCI, V69, P44, DOI 10.1016/j.jdermsci.2012.10.004; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Gaspar K, 2013, J DERMATOL SCI, V71, P12, DOI 10.1016/j.jdermsci.2013.04.011; Saeki H, 2013, J DERMATOL SCI, V71, P148, DOI 10.1016/j.jdermsci.2013.04.002; Sugiyama H, 2005, J IMMUNOL, V174, P164; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Diaconu D, 2013, J DERMATOL SCI, V72, P322, DOI 10.1016/j.jdermsci.2013.08.005; Dugu Long, 2014, J Dermatol Sci, V73, P225, DOI 10.1016/j.jdermsci.2013.10.008; Egawa G, 2013, J DERMATOL SCI, V69, P262, DOI 10.1016/j.jdermsci.2012.11.007; Hau CS, 2013, J DERMATOL SCI, V71, P174, DOI 10.1016/j.jdermsci.2013.04.023; Hayashi M, 2014, J DERMATOL SCI, V73, P264, DOI 10.1016/j.jdermsci.2013.11.012; Hayashi M, 2014, J DERMATOL SCI, V76, P267, DOI 10.1016/j.jdermsci.2014.10.008; Hemmerle T, 2014, J DERMATOL SCI, V76, P96, DOI 10.1016/j.jdermsci.2014.07.012; Hoffmann JH, 2014, J DERMATOL SCI, V76, P180; Jung M, 2014, J DERMATOL SCI, V76, P231, DOI 10.1016/j.jdermsci.2014.09.004; Kato A, 2014, J DERMATOL SCI, V74, P229, DOI 10.1016/j.jdermsci.2014.02.009; Koga Y, 2014, J DERMATOL SCI, V74, P170, DOI 10.1016/j.jdermsci.2014.01.005; Li P, 2013, J DERMATOL SCI, V72, P64, DOI 10.1016/j.jdermsci.2013.05.011; Li XY, 2014, J DERMATOL SCI, V76, P132, DOI 10.1016/j.jdermsci.2014.08.007; Loiseau N, 2013, J DERMATOL SCI, V72, P296, DOI 10.1016/j.jdermsci.2013.08.003; Moniaga CS, 2013, J DERMATOL SCI, V71, P76, DOI 10.1016/j.jdermsci.2013.03.011; Mori T, 2013, J DERMATOL SCI, V71, P37, DOI 10.1016/j.jdermsci.2013.03.008; Osamu N, 2014, J DERMATOL SCI, V75, P201, DOI 10.1016/j.jdermsci.2014.05.007; Sasaki T, 2014, J DERMATOL SCI, V76, P10, DOI 10.1016/j.jdermsci.2014.06.004; Shoda T, 2014, J DERMATOL SCI, V76, P90, DOI 10.1016/j.jdermsci.2014.08.009; Suzuki T, 2014, J DERMATOL SCI, V74, P116, DOI 10.1016/j.jdermsci.2013.12.013; Takaishi M, 2014, J DERMATOL SCI, V73, P261, DOI 10.1016/j.jdermsci.2013.11.008; Tamari M, 2014, J DERMATOL SCI, V76, P156, DOI 10.1016/j.jdermsci.2014.08.005; Yin XY, 2013, J DERMATOL SCI, V70, P94, DOI 10.1016/j.jdermsci.2013.02.006; Zhao S, 2013, J DERMATOL SCI, V70, P182, DOI 10.1016/j.jdermsci.2013.02.005; Zhou X, 2014, J DERMATOL SCI, V73, P63, DOI 10.1016/j.jdermsci.2013.08.014	50	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					89	94		10.1016/j.jdermsci.2015.02.010		6	Dermatology	Dermatology	CI1KJ	WOS:000354502800001		
J	Otsuka, A; Levesque, MP; Dummer, R; Kabashima, K				Otsuka, Atsushi; Levesque, Mitchell P.; Dummer, Reinhard; Kabashima, Kenji			Hedgehog signaling in basal cell carcinoma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Basal cell carcinoma; Hedgehog; Acquired immune responses	RANDOMIZED CONTROLLED-TRIAL; NONMELANOMA SKIN-CANCER; CYTOTOXIC T-CELLS; HUMAN HOMOLOG; SMOOTHENED INHIBITOR; NEVUS SYNDROME; PATHWAY; ACTIVATION; DISCOVERY; MELANOMA	Basal cell carcinoma (BCC), the most common type of skin cancer, is occasionally aggressive with deep invasion, destruction of adjacent structures, recurrence and, on very rare occasions, regional and distant metastases. Mutations that occur in BCC in hedgehog (Hh) pathway genes primarily involve the genes encoding patched homolog (PTCH) and smoothened homolog (SMO). Several animal models have demonstrated the functional relevance of genetic alterations in the Hh pathway during tumorigenesis. Recently, targeted therapy has become available both commercially and in the context of human clinical trials. Interestingly, Hh pathway inhibitors not only suppress BCC progression but also promote acquired immune responses. Since immune responses are crucial for long-term tumor control, new clinical trials, such as those involving a combination of Hh inhibitors with immune modifiers, are needed to supplement standard methods of tumor control. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Otsuka, Atsushi; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Levesque, Mitchell P.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Otsuka, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan.	otsukamn@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labour and Welfare of Japan. No additional external funding was received for this study.	Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Campbell SB, 2012, AM J TRANSPLANT, V12, P1146, DOI 10.1111/j.1600-6143.2012.04004.x; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Munchhof MJ, 2012, ACS MED CHEM LETT, V3, P106, DOI 10.1021/ml2002423; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Arits AHMM, 2013, LANCET ONCOL, V14, P647, DOI 10.1016/S1470-2045(13)70143-8; Kato Y, 2014, J DERMATOL SCI, V75, P140, DOI 10.1016/j.jdermsci.2014.04.014; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Xie JW, 1998, NATURE, V391, P90; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Dreier J, 2014, EXPERT OPIN EMERG DR, V19, P353, DOI 10.1517/14728214.2014.914171; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Fujiyama T, 2014, J DERMATOL SCI, V75, P43, DOI 10.1016/j.jdermsci.2014.04.005; Walling HW, 2004, CANCER METAST REV, V23, P389, DOI 10.1023/B:CANC.0000031775.04618.30; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Gehrke S, 2014, J DERMATOL SCI, V74, P167, DOI 10.1016/j.jdermsci.2014.01.006; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Atwood SX, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013581; Boaventura P, 2014, J DERMATOL SCI, V73, P31, DOI 10.1016/j.jdermsci.2013.09.002; Dreier J, 2014, Br J Dermatol, V171, P1066, DOI 10.1111/bjd.13217; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Haniffa M, 2014, J DERMATOL SCI; KEELER RF, 1966, CAN J BIOCHEM CELL B, V44, P819; Laner-Plamberger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075317; Liang MR, 2014, J DERMATOL SCI, V76, P104, DOI 10.1016/j.jdermsci.2014.08.002; Nitzki F., 2012, J SKIN CANC, V2012, DOI [10.1155/2012/90754323024864, DOI 10.1155/2012/90754323024864]; Nomura T, 2014, J DERMATOL SCI, V76, P3, DOI 10.1016/j.jdermsci.2014.07.010; Ogawa Y, 2014, J DERMATOL SCI, V76, P67, DOI 10.1016/j.jdermsci.2014.07.004; Otsuka A, 2015, CLIN CANC RES; Rowbotham NJ, 2008, CELL CYCLE, V7, P904; Rowbotham NJ, 2007, BLOOD, V109, P3757, DOI 10.1182/blood-2006-07-037655; Rowbotham NJ, 2007, CELL CYCLE, V6, P2138; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Walter A, 2010, CLIN CANCER RES, V16, P3562, DOI 10.1158/1078-0432.CCR-09-3136	44	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					95	100		10.1016/j.jdermsci.2015.02.007		6	Dermatology	Dermatology	CI1KJ	WOS:000354502800002		
J	Yokota, K; Sawada, M; Matsumoto, T; Hasegawa, Y; Kono, M; Akiyama, M				Yokota, Kenji; Sawada, Masaki; Matsumoto, Takaaki; Hasegawa, Yoshie; Kono, Michihiro; Akiyama, Masashi			Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Adjuvant therapy; Interferon; Lymphatic flow; Malignant melanoma; Near-infrared; Sentinel lymph node	LOCAL/IN-TRANSIT RECURRENCE; SINGLE-INSTITUTION; INTERFERON-BETA; BREAST-CANCER; INCREASE; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; METASTASIS; DISSECTION; DRAINAGE	Background: Knowledge of changes in lymphatic flow after sentinel lymph node biopsy (SLNB) is important for the development of strategies for postoperative adjuvant therapy in malignant melanoma. Objectives: 41 patients (22 males and 19 females; average age: 67.0 +/- 24.0 years) with primary cutaneous malignant melanoma (PCMM) participated in the present study. The primary tumor sites were the upper extremities (9 patients), the lower extremities (20 patients), the trunk (11 patients) and the scalp (1 patient). The tumor thicknesses of the PCMM lesions were from 0.5 mm to 9.0 mm (average: 3.3 +/- 2.5 mm). All the participants underwent wide local excision and SLNB. Methods: We studied lymphatic flow before and after SLNB by near-infrared (NIR) imaging in all 41 cases. In addition, we performed NIR imaging of lymphatic flow after the lymph node dissection in one case with sentinel lymph node (SLN) metastasis. Results: Almost no changes in lymphatic flow were seen in 38 of the 41 patients (92.7%) after SLNB. Only in 3 patients (7.3%), one with SLN metastasis and the other two without SLN metastasis, was apparent alteration in the lymphatic flow observed after SLNB. Of the 16 patients without SLN metastasis, only 3 patients showed recurrence of the tumors. Interestingly, 1 of the 2 patients without SLN metastasis but with lymphatic flow alteration had recurrence (regional lymph node metastasis) of the melanoma, whereas only 2 of the 14 patients without SLN metastasis or lymphatic flow alteration had recurrence, 1 with regional lymph node metastasis and the other with distant lymph node metastasis. In 1 case, we reexamined the lymphatic flow after regional lymph node dissection and the lymphatic flow was found to be dramatically changed. Conclusion: We clearly demonstrated that SLNB has only a minimal effect on lymphatic flow. The present results suggest that SLNB does not increase the risk of local recurrence/in-transit metastasis and may support the efficacy of post-SLNB local adjuvant injection to prevent local recurrence and in-transit metastasis. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Yokota, Kenji; Sawada, Masaki; Matsumoto, Takaaki; Hasegawa, Yoshie; Kono, Michihiro; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4668550, Japan	Akiyama, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	makiyama@med.nagoya-u.ac.jp					Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; Moshiri M, 2002, AM J ROENTGENOL, V178, P405; Jung SY, 2014, ANN SURG ONCOL, V21, P1254, DOI 10.1245/s10434-013-3437-0; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Aoyagi S, 2012, ONCOLOGY-BASEL, V82, P139, DOI 10.1159/000336490; Kubo H, 2008, ARCH DERMATOL RES, V300, P297, DOI 10.1007/s00403-008-0841-6; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Celebioglu F, 2007, ACTA RADIOL, V48, P488, DOI 10.1080/02841850701305440; Kang JC, 2005, J CLIN ONCOL, V23, P4764, DOI 10.1200/JCO.2005.20.537; Mastumoto T, 2013, J EUR ACAD DERMATOL, V27, P1514; Matsumoto T, 2010, J DERMATOL, V37, P629, DOI 10.1111/j.1346-8138.2010.00856.x; Pawlik TM, 2005, EJSO, V31, P323, DOI 10.1016/j.ejso.2004.11.010; Sharma R, 2007, AM J PHYSIOL-HEART C, V292, pH3109, DOI 10.1152/ajpheart.01223.2006; Thomas JM, 2004, EJSO, V30, P686, DOI 10.1016/j.ejso.2004.04.004; van Poll D, 2005, ANN SURG ONCOL, V12, P597, DOI 10.1245/ASO.2005.08.012	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					101	107		10.1016/j.jdermsci.2015.02.011		7	Dermatology	Dermatology	CI1KJ	WOS:000354502800003		
J	Kawaguchi, M; Hozumi, Y; Suzuki, T				Kawaguchi, Masakazu; Hozumi, Yutaka; Suzuki, Tamio			ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Melanocyte; Melanosome; PMEL17; ADAM protease; Melanogenesis	ALZHEIMERS-DISEASE; TACE INHIBITORS; METALLOPROTEINASES; PIGMENTATION; PERSPECTIVE; BIOGENESIS; SECRETASE; PROTEINS; MELANOMA; CLEAVAGE	Background: ADAMs (a disintegrin and metalloprotease) are a family of proteases involved in ectodomain shedding that play a role in various biological processes such as cell adhesion and migration. ADAM10 and ADAM17 are suggested to be involved in pigmentary disorders. Objective: We examined the effect of ADAM protease inhibitors on the modulation of melanogenesis in normal human epidermal melanocytes (NHEM). Methods: NHEMs and B1 6F10 treated with ADAM protease inhibitors were analyzed. AlamarBlue cell proliferation assay, melanin content assay, tyrosinase activity assay, Western blotting analysis, electron microscopic analysis, and RNA interference were employed. Results: In NHEMs, melanin content was reduced by treatment with ADAM protease inhibitors. The inhibitors did not change the protein expression of tyrosinase, TRP-1, and MITF. In B1 6F10 cells, treatment of the cells with ADAM protease inhibitor diminished the alpha-MSH-induced increase in melanin content. Electron microscopy showed that the number of fibrillar and mature melanosomes was significantly reduced and that the vacuolar compartments were filled with dense unstructured aggregates after treatment with ADAM protease inhibitors. We therefore focused on the processing of PMEL17, a melanosomal glycoprotein that forms a fibrillar matrix on which melanin gets deposited. Proteolytic processing of PMEL17 is required to form functional fibrils during melanogenesis. Recently, gamma-secretase and beta-site amyloid precursor protein-cleaving enzyme 2 (BACE2) were found to cleave PMEL17. We found that ADAM protease inhibitors exerted effects on the processing of C-terminal and Nterminal fragments of PMEL17. Using BACE2 siRNA and gamma-secretase inhibitor, we showed that ADAM protease inhibitor affected PMEL17 processing in a gamma-secretase and BACE2-independent mechanism. Conclusion: Several proteases, including ADAM proteases, can contribute to the formation of fibrils and their assembly into sheets in melanosomes. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Kawaguchi, Masakazu; Hozumi, Yutaka; Suzuki, Tamio] Yamagata Univ, Dept Dermatol, Fac Med, Yamagata 9909585, Japan	Kawaguchi, M (reprint author), Yamagata Univ, Dept Dermatol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	kawaguch@med.id.yamagata-u.ac.jp			JSPS KAKENHI [JSPS KAKENHI grant number 24591641]; Ministry of Health, Welfare and Labor of Japan [H24-039, 24132701]	This work was supported by JSPS KAKENHI grant number 24591641, a grant-in-aid from Research for Incurable Disorders from the Ministry of Health, Welfare and Labor of Japan (H24-039, number 24132701: to MK).	Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; DasGupta S, 2009, BIOORGAN MED CHEM, V17, P444, DOI 10.1016/j.bmc.2008.11.067; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; Tsuboi T, 1998, PIGM CELL RES, V11, P275, DOI 10.1111/j.1600-0749.1998.tb00736.x; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Schlondorff J, 1999, J CELL SCI, V112, P3603; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; TOMITA Y, 1992, PIGM CELL RES, V5, P357, DOI 10.1111/j.1600-0749.1992.tb00562.x; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Buoso E, 2010, PHARMACOL RES, V62, P308, DOI 10.1016/j.phrs.2010.05.002; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Kamei N, 2004, BIOORG MED CHEM LETT, V14, P2897, DOI 10.1016/j.bmcl.2004.03.048; Kawaguchi M, 2012, J INVEST DERMATOL, V132, P2791, DOI 10.1038/jid.2012.261; Kono M, 2013, HUM MOL GENET, V22, P3524, DOI 10.1093/hmg/ddt207; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; Meierjohann S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-201; Papageorgiou N, 2008, NEUROREPORT, V19, P1787, DOI 10.1097/WNR.0b013e3283193e82; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					133	142		10.1016/j.jdermsci.2015.02.020		10	Dermatology	Dermatology	CI1KJ	WOS:000354502800007		
J	Nakamura, M; Fukunaga-Kalabis, M; Yamaguchi, Y; Furuhashi, T; Nishida, E; Kato, H; Mizuno, T; Sugiura, M; Morita, A				Nakamura, Motoki; Fukunaga-Kalabis, Mizuho; Yamaguchi, Yuji; Furuhashi, Takuya; Nishida, Emi; Kato, Hiroshi; Mizuno, Toshihiko; Sugiura, Mayumi; Morita, Akimichi			Site-specific migration of human fetal melanocytes in volar skin	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Human melanocytes; Melanoblasts; Stem cells; Palmoplantar; Volar skin; Sweat gland	HUMAN HAIR-FOLLICLES; STEM-CELLS; MELANOMA; LOCALIZATION; NICHE; DIFFERENTIATION; MECHANISMS; EXPRESSION; EPIDERMIS; DENSITY	Background: Melanocytes originate from the neural crest and migrate ventrally from the dorsal neural tube during embryogenesis. How human melanocytes locate at their suitable positions during embryogenesis, however, is unclear. Although a growing body of evidence indicates that melanocytes, melanoblasts, and melanocyte stem cells are closely related to hair follicles, little is known about volar skin. Objective: The aim of this study was to observe skin development during human fetal period and clarify the site-specific migration process of human fetal sole melanocytes. Methods: We obtained 4-mm punch biopsies from the scalp, back, abdomen, and right sole of 36 aborted fetuses (gestational age 12-21 weeks). We compared the migration process between hairly areas and volar areas by immunohistochemical staining. Results: Immunohistochemical examination revealed that gp100 (HMB-45) sensitively detects human melanocytes in embryogenesis. Melanocytes were present at the epidermal base, where hair placodes/buds form at 12-15 weeks gestation. Fetal melanocytes in hair follicles are supplied from the epidermis. In volar skin, melanocytes originally localize only in the acrosyringium, where they migrate deeper into with gland development at 16-18 weeks gestation. Palmoplantar melanocyte migration and maturation processes differ considerably from those of the other hairy skin sites. Conclusion: Eccrine sweat glands seem to have a central role in the palmoplantar melanocyte migration process, similar to the role of hair follicles in hairy sites. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Nakamura, Motoki; Yamaguchi, Yuji; Furuhashi, Takuya; Nishida, Emi; Kato, Hiroshi; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan; [Fukunaga-Kalabis, Mizuho] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Sugiura, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan; [Mizuno, Toshihiko] Gynecol Hosp Mizuno Clin, Nagoya, Aichi, Japan	Nakamura, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	qkswg204@yahoo.co.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25860963]	This work was supported by a Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grant-in-Aid for Young Scientists B, No. 25860963).	RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248; Chou WC, 2013, NAT MED, V19, P924, DOI 10.1038/nm.3194; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; Ishihara Y, 2006, AM J DERMATOPATH, V28, P21, DOI 10.1097/01.dad.0000187931.05030.a0; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Tadokoro T, 2005, J INVEST DERMATOL, V124, P1326, DOI 10.1111/j.0022-202X.2005.23760.x; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Berson JF, 2001, MOL BIOL CELL, V12, P3451; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; BECKER SW, 1955, J INVEST DERMATOL, V25, P103, DOI 10.1038/jid.1955.104; HOLBROOK KA, 1989, ANAT EMBRYOL, V180, P443, DOI 10.1007/BF00305119; Horikawa T, 1996, J INVEST DERMATOL, V106, P28, DOI 10.1111/1523-1747.ep12326989; KAPUR RP, 1992, J HISTOCHEM CYTOCHEM, V40, P207; Kikuchi A, 1996, BRIT J DERMATOL, V135, P400, DOI 10.1111/j.1365-2133.1996.tb01503.x; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; MISHIMA Y, 1966, J INVEST DERMATOL, V46, P263; Nakamura M, 2009, J INVEST DERMATOL, V129, P2077, DOI 10.1038/jid.2008.443; Narisawa Y, 1997, ACTA DERM-VENEREOL, V77, P97; Okamoto N, 2014, PIGM CELL MELANOMA R, V27, P1039, DOI [10.1111/pcmr.12297, 10.1111/pcmr.12298]; SILVER AF, 1969, EXPERIENTIA, V25, P299, DOI 10.1007/BF02034407; Whiteman DC, 1999, ARCH DERMATOL RES, V291, P511, DOI 10.1007/s004030050446; Yamaguchi Y, 2006, FASEB J, V20, P630	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					143	148		10.1016/j.jdermsci.2015.03.003		6	Dermatology	Dermatology	CI1KJ	WOS:000354502800008		
J	Sakai, T; Hatano, Y; Matsuda-Hirose, H; Nishiyori, R; Fujiwara, S				Sakai, Takashi; Hatano, Yutaka; Matsuda-Hirose, Haruna; Nishiyori, Ryo; Fujiwara, Sakuhei			Atopic dermatitis-like dermatitis emerges unevenly on different sites in flaky tail mice	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						HPGD; Primary hypertrophic; osteoarthropathy; Prostaglandin E2; Prostaglandin transporter; SLCO2A1	STRATUM-CORNEUM; GENE; MAINTENANCE; PREVENTS; MUTATION; BARRIER; MODEL		[Sakai, Takashi; Hatano, Yutaka; Matsuda-Hirose, Haruna; Nishiyori, Ryo; Fujiwara, Sakuhei] Oita Univ, Fac Med, Dept Dermatol, Yufu, Oita 8795593, Japan	Hatano, Y (reprint author), Oita Univ, Fac Med, Dept Dermatol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.	hatano@oita-u.ac.jp					Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Sakai T, 2014, J DERMATOL SCI, V74, P222, DOI 10.1016/j.jdermsci.2014.01.012; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Sasaki T, 2013, J ALLERGY CLIN IMMUN, V132, P1111, DOI 10.1016/j.jaci.2013.08.027; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; Hatano Y, 2009, J INVEST DERMATOL, V129, P1824, DOI 10.1038/jid.2008.444; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Lee HJ, 2014, EXP DERMATOL, V23, P736, DOI 10.1111/exd.12525; Saunders SP, 2013, J ALLERGY CLIN IMMUN, V132, P1121, DOI 10.1016/j.jaci.2013.08.046	10	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					151	153		10.1016/j.jdermsci.2015.01.008		3	Dermatology	Dermatology	CI1KJ	WOS:000354502800010		
J	Nakazawa, S; Niizeki, H; Matsuda, M; Nakabayashi, K; Seki, A; Mori, T; Tokura, Y				Nakazawa, Shinsuke; Niizeki, Hironori; Matsuda, Maiko; Nakabayashi, Kazuhiko; Seki, Atsuhito; Mori, Tatsuyoshi; Tokura, Yoshiki			Involvement of prostaglandin E2 in the first Japanese case of pachydermoperiostosis with HPGD mutation and recalcitrant leg ulcer	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						HPGD; Primary hypertrophic osteoarthropathy; Prostaglandin E2; Prostaglandin transporter; SLCO2A1	PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; GENE SLCO2A1; PHENOTYPE		[Nakazawa, Shinsuke; Mori, Tatsuyoshi; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Nakazawa, Shinsuke; Mori, Tatsuyoshi] Fujinomiya City Hosp, Div Dermatol, Fujinomiya, Japan; [Niizeki, Hironori; Matsuda, Maiko] Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, Tokyo, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Seki, Atsuhito] Natl Ctr Child Hlth & Dev, Dept Orthoped, Setagaya Ku, Tokyo, Japan	Niizeki, H (reprint author), Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, 2-10-1 Ohkura, Tokyo, Japan.	niizeki-h@ncchd.go.jp					Zhang ZL, 2012, AM J HUM GENET, V90, P125, DOI 10.1016/j.ajhg.2011.11.019; Seifert W, 2012, HUM MUTAT, V33, P660, DOI 10.1002/humu.22042; Uppal S, 2008, NAT GENET, V40, P789, DOI 10.1038/ng.153; FALUS A, 1992, SCAND J RHEUMATOL, V21, P116; Kabashima K, 2010, AM J PATHOL, V176, P721, DOI 10.2353/ajpath.2010.090454; Li L, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.75; Niizeki H, 2014, BRIT J DERMATOL, V170, P1187, DOI 10.1111/bjd.12790; Niizeki H, 2014, J DERMATOL SCI, V75, P193, DOI 10.1016/j.jdermsci.2014.05.008; Sasaki T, 2012, J DERMATOL SCI, V68, P36, DOI 10.1016/j.jdermsci.2012.07.008	9	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					153	155		10.1016/j.jdermsci.2015.02.002		3	Dermatology	Dermatology	CI1KJ	WOS:000354502800011		
J	Akasaka, E; Okawa, Y; Nakano, H; Takiyoshi, N; Rokunohe, D; Toyomaki, Y; Sawamura, D; Sueki, H				Akasaka, Eijiro; Okawa, Yuko; Nakano, Hajime; Takiyoshi, Noriko; Rokunohe, Daiki; Toyomaki, Yuka; Sawamura, Daisuke.; Sueki, Hirohiko			Two Japanese familial cases of punctate palmoplantar keratoderma caused by a novel AAGAB mutation, c.191_194delCAAA	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Palmoplantar keratoderma; Punctate; AAGAB; Etretinate; Bleomycin; Japanese			[Akasaka, Eijiro; Nakano, Hajime; Takiyoshi, Noriko; Rokunohe, Daiki; Toyomaki, Yuka; Sawamura, Daisuke.] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Okawa, Yuko] Showa Univ, Northern Yokohama Hosp, Div Dermatol, Yokohama, Kanagawa, Japan; [Sueki, Hirohiko] Showa Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan	Nakano, H (reprint author), Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan.	hnakano@cc.hirosaki-u.ac.jp					Cui HZ, 2013, J INVEST DERMATOL, V133, P2631, DOI 10.1038/jid.2013.198; Erkek E, 2006, ARCH DERMATOL, V142, P1076, DOI 10.1001/archderm.142.8.1076; Eytan O, 2014, CLIN EXP DERMATOL, V39, P182, DOI 10.1111/ced.12213; Furniss M, 2014, J INVEST DERMATOL, V134, P1749, DOI 10.1038/jid.2014.4; Giehl KA, 2012, AM J HUM GENET, V91, P754, DOI 10.1016/j.ajhg.2012.08.024; Lienemann AO, 2004, CUTIS, V73, P303; Nomura T, 2014, ACTA DERM VENEREOL; Pohler E, 2013, J INVEST DERMATOL, V113, P2805; Pohler E, 2014, BRIT J DERMATOL, V171, P433, DOI 10.1111/bjd.12927; Pohler E, 2012, NAT GENET, V44, P1272, DOI 10.1038/ng.2444	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2015	78	2					156	158		10.1016/j.jdermsci.2015.02.004		3	Dermatology	Dermatology	CI1KJ	WOS:000354502800012		
J	Kawakami, T; Ishinabe, T; Sasai, M; Kano, M; Nasu, S; Uchida, T; Ozawa, S; Mieda, S; Yao, Y; Date, M; Takada, H				Kawakami, Tohru; Ishinabe, Takahiro; Sasai, Mutsumi; Kano, Mitsuru; Nasu, Senshi; Uchida, Tatsuo; Ozawa, Shiro; Mieda, Satoshi; Yao, Yasuhiro; Date, Munekazu; Takada, Hideaki			Large High-Definition Multiview Display System Capable of Controlling Observation Area	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Displays; large screen displays	SCREEN	We developed a large high-definition multiview projection display configured from newly developed double-sided lenticular lens, a Fresnel lens, and multiple projectors. The system projects magnified images of each projector's iris side by side using a Fresnel lens, which minimizes the crosstalk between the images in adjacent areas and creates a broad observation area with highly uniform in-plane brightness. In addition, by using an inclined screen, we developed a method to evaluate the observation area of the multiview display. The characteristics of the proposed multiview display are the easily adjustable projector arrangement and the broad observation area without crosstalk between images in adjacent areas. The proposed multiview display is expected to be useful in future teleconference and digital signed systems.	[Kawakami, Tohru; Ishinabe, Takahiro; Sasai, Mutsumi; Kano, Mitsuru] Tohoku Univ, Sendai, Miyagi 9808579, Japan; [Nasu, Senshi; Uchida, Tatsuo] Sendai Natl Coll Technol, Sendai, Miyagi 9893128, Japan; [Ozawa, Shiro; Mieda, Satoshi; Yao, Yasuhiro; Date, Munekazu; Takada, Hideaki] NTT Corp, NTT Media Intelligence Labs, Yokosuka, Kanagawa 2390847, Japan	Kawakami, T (reprint author), Tohoku Univ, Sendai, Miyagi 9808579, Japan.	ishinabe@ecei.tohoku.ac.jp					Lee JH, 2013, OPT EXPRESS, V21, P26820, DOI 10.1364/OE.21.026820; Feldmann I., 2010, P 3DTV C TAMP FINL J, P1; Jones A, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531370; Kawakami T, 2012, J DISP TECHNOL, V8, P496, DOI 10.1109/JDT.2012.2190494; Kawakami T., 2010, P IDW2010, P1479; Lee J. - H., 2014, SID INT S, P520; Nasu S., 2012, SID INT S, P633; Ozawa S, 2014, J DISP TECHNOL, V10, P87, DOI 10.1109/JDT.2013.2284477; Ozawa S., 2012, P JOINT VIRT REAL C, P49; Ozawa S., 2012, SID INT S, P1009; Ozawa S., 2012, P SIGGRAPH AS 2012 P; Sharp Inc, SHARP TRIPL DIR VIEW; Takamine H., 2013, SID INT S, P81; Takaya T., 2007, SHARP TECHNICAL J, P21; Willemsen O., 2007, SOC INF DISPL 2007 I, P1154	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	MAY	2015	11	5					403	411		10.1109/JDT.2015.2402614		9	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CI1AJ	WOS:000354471700002		
J	Newton, J; Sawa, R				Newton, Jonathan; Sawa, Ryoji			A one-shot deviation principle for stability in matching problems	JOURNAL OF ECONOMIC THEORY			English	Article						Learning; Stochastic stability; Matching; Marriage; College admissions	STOCHASTIC STABILITY; RANDOM-PATHS; COLLEGE ADMISSIONS; EVOLUTION; MARKETS; GAMES; NETWORKS; MARRIAGE	This paper considers marriage problems, roommate problems with nonempty core, and college admissions problems with responsive preferences. All stochastically stable matchings are shown to be contained in the set of matchings which are most robust to one-shot deviation. (C) 2014 Elsevier Inc. All rights reserved.	[Newton, Jonathan] Univ Sydney, Sch Econ, Sydney, NSW 2006, Australia; [Sawa, Ryoji] Univ Aizu, Ctr Cultural Res & Studies, Aizu Wakamatsu, Fukushima, Japan	Sawa, R (reprint author), Ikki Machi, Aizu Wakamatsu, Fukushima 9658580, Japan.	jonathan.newton@sydney.edu.au; rsawa@u-aizu.ac.jp			Australian Research Council	This work was completed while the author was supported by a Discovery Early Career Researcher Award funded by the Australian Research Council.	Klaus B, 2010, J ECON THEORY, V145, P2218, DOI 10.1016/j.jet.2010.07.006; Kojima F, 2008, INT J GAME THEORY, V36, P473, DOI 10.1007/s00182-006-0037-2; ROTH AE, 1985, J ECON THEORY, V36, P277, DOI 10.1016/0022-0531(85)90106-1; Agastya M, 1997, REV ECON STUD, V64, P411, DOI 10.2307/2971721; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Diamantoudi E, 2004, GAME ECON BEHAV, V48, P18, DOI 10.1016/j.geb.2003.05.003; Jackson MO, 2002, J ECON THEORY, V106, P265, DOI 10.1006/jeth.2001.2903; Ellison G, 2000, REV ECON STUD, V67, P17, DOI 10.1111/1467-937X.00119; Bergin J, 1996, ECONOMETRICA, V64, P943, DOI 10.2307/2171851; Newton J, 2012, J ECON THEORY, V147, P364, DOI 10.1016/j.jet.2011.11.007; FELDMAN AM, 1974, ECONOMETRICA, V42, P35, DOI 10.2307/1913683; Abdulkadiroglu A, 2011, AM ECON REV, V101, P399, DOI 10.1257/aer.101.1.399; ROTH AE, 1986, ECONOMETRICA, V54, P425, DOI 10.2307/1913160; ROTH AE, 1990, ECONOMETRICA, V58, P1475, DOI 10.2307/2938326; Biro P, 2013, INT J GAME THEORY, V42, P1021, DOI 10.1007/s00182-012-0352-8; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Boudreau J., 2012, P MATCH UP 2012 2 IN, P39; Boudreau JW, 2011, OPER RES LETT, V39, P231, DOI 10.1016/j.orl.2011.04.010; Chen B., 2010, KIER WORKING PAPERS; Dokumaci E, 2011, J ECON THEORY, V146, P2151, DOI 10.1016/j.jet.2011.06.013; Echenique R, 2012, EXPT STUDY DEC UNPUB; FREDMAN ML, 1987, J ACM, V34, P596, DOI 10.1145/28869.28874; GREEN JR, 1974, ECONOMETRICA, V42, P21, DOI 10.2307/1913682; Gusfield D., 1989, STABLE MARRIAGE PROB; Klaus B., 2013, CAHIERS RECHERCHES E; Kwiatkowska M., 2011, LNCS, V6806, P585, DOI DOI 10.1007/978-3-642-22110-1_; Maschler M., 1979, Mathematics of Operations Research, V4, DOI 10.1287/moor.4.4.303; Myatt DP, 2003, J ECON THEORY, V113, P286, DOI 10.1016/S0022-0531(03)00069-3; Myerson R. B., 1978, International Journal of Game Theory, V7, DOI 10.1007/BF01753236; Nax H. H., 2013, WORKING PAPER; NOLDEKE G, 1993, GAME ECON BEHAV, V5, P425, DOI 10.1006/game.1993.1024; Pais J., 2012, WORKING PAPERS U LIS; Paulusma D., 2012, P WG 12 38 INT WORKS, V7551, P69; Roth A. E., 1992, 2 SIDED MATCHING STU; Sandholm W. H., 2010, POPULATION GAMES EV; Sawa R, 2014, GAME ECON BEHAV, V88, P90, DOI 10.1016/j.geb.2014.07.005; Selten R., 1975, International Journal of Game Theory, V4, DOI 10.1007/BF01766400; Shapley L. S., 1972, International Journal of Game Theory, V1; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778	40	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0531	1095-7235		J ECON THEORY	J. Econ. Theory	MAY	2015	157						1	27		10.1016/j.jet.2014.11.015		27	Economics	Business & Economics	CI2QV	WOS:000354593000001		
J	Oyama, D; Takahashi, S				Oyama, Daisuke; Takahashi, Satoru			Contagion and uninvadability in local interaction games: The bilingual game and general supermodular games	JOURNAL OF ECONOMIC THEORY			English	Article						Equilibrium selection; Strategic complementarity; Bilingual game; Network; Contagion; Uninvadability	NOISE-INDEPENDENT SELECTION; PERFECT FORESIGHT DYNAMICS; EQUILIBRIUM SELECTION; GLOBAL GAMES; RANDOM NETWORKS; STRATEGIC COMPLEMENTARITIES; INCOMPLETE INFORMATION; STATISTICAL-MECHANICS; SOCIAL NETWORKS; DIFFUSION	In a setting where an infinite population of players interact locally and repeatedly, we study the impacts of payoff structures and network structures on contagion of a convention beyond 2 x 2 coordination games. First, we consider the "bilingual game", where each player chooses one of two conventions or adopts both (i.e., chooses the "bilingual option") at an additional cost. For this game, we completely characterize when a convention spreads contagiously from a finite subset of players to the entire population in some network, and conversely, when a convention is never invaded by the other convention in any network. We show that the Pareto-dominant (risk-dominant, resp.) convention is contagious if the cost of bilingual option is low (high, resp.). Furthermore, if the cost is in a medium range, both conventions are each contagious in respective networks, and in particular, the Pareto-dominant convention is contagious only in some non-linear networks. Second, we consider general supermodular games, and compare networks in terms of their power of inducing contagion. We show that if there is a weight-preserving node identification from one network to another, then the latter is more contagion-inducing than the former in all supermodular games. (C) 2015 Elsevier Inc. All rights reserved.	[Oyama, Daisuke] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Satoru] Natl Univ Singapore, Dept Econ, Singapore 117570, Singapore	Oyama, D (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan.	oyama@e.u-tokyo.ac.jp; ecsst@nus.edu.sg			JSPS	Earlier versions of this paper were circulated under the title "Contagion and Uninvadability in Social Networks with Bilingual Option". We would like to thank Ryota Iijima, Atsushi Kajii, Takashi Kunimoto, Dunia Lopez-Pintado, Neng Qian, Alex Teytelboym, Takashi Ui, anonymous referees, and especially, Stephen Morris for helpful comments and discussions. D. Oyama acknowledges financial support by JSPS Grant-in-Aid for Scientific Research (S).	Acemoglu D, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P2329, DOI 10.1109/CDC.2011.6160999; Goyal S, 1997, J ECON THEORY, V77, P34, DOI 10.1006/jeth.1997.2315; Galeotti A, 2010, REV ECON STUD, V77, P218, DOI 10.1111/j.1467-937X.2009.00570.x; Wolitzky A, 2013, REV ECON STUD, V80, P395, DOI 10.1093/restud/rds016; Monderer D, 1996, GAME ECON BEHAV, V14, P124, DOI 10.1006/game.1996.0044; Lelarge M, 2012, GAME ECON BEHAV, V75, P752, DOI 10.1016/j.geb.2012.03.009; CARLSSON H, 1993, ECONOMETRICA, V61, P989, DOI 10.2307/2951491; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Frankel DM, 2003, J ECON THEORY, V108, P1, DOI 10.1016/S0022-0531(02)00018-2; MATSUI A, 1995, J ECON THEORY, V65, P415, DOI 10.1006/jeth.1995.1015; Lopez-Pintado D, 2008, GAME ECON BEHAV, V62, P573, DOI 10.1016/j.geb.2007.08.001; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Ellison G, 2000, REV ECON STUD, V67, P17, DOI 10.1111/1467-937X.00119; Montanari A, 2010, P NATL ACAD SCI USA, V107, P20196, DOI 10.1073/pnas.1004098107; Young HP, 2011, P NATL ACAD SCI USA, V108, P21285, DOI 10.1073/pnas.1100973108; Oury M, 2013, J ECON THEORY, V148, P2638, DOI 10.1016/j.jet.2013.04.021; Basteck C, 2011, J MATH ECON, V47, P749, DOI 10.1016/j.jmateco.2011.10.004; Berninghaus S., 2010, GAMES, V1, P262, DOI 10.3390/g1030262; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; BLUME LE, 1995, GAME ECON BEHAV, V11, P111, DOI 10.1006/game.1995.1046; Contagion S. Morris, 2000, REV ECON STUD, V67, P57; Easley D., 2010, NETWORKS CROWDS MARK; Ellison G, 1993, ECONOMETRICA, V61, P1047, DOI DOI 10.2307/2951493; Fudenberg D., 1998, THEORY LEARNING GAME; Galesloot BM, 1997, J MATH ECON, V28, P249, DOI 10.1016/S0304-4068(97)00810-0; Goyal S, 2007, CONNECTIONS: AN INTRODUCTION TO THE ECONOMICS OF NETWORKS, P1; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Honda J, 2011, J MATH ECON, V47, P663, DOI 10.1016/j.jmateco.2011.06.005; Immorlica N, 2007, EC'07: PROCEEDINGS OF THE EIGHTH ANNUAL CONFERENCE ON ELECTRONIC COMMERCE, P75; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kajii A, 1997, ECONOMETRICA, V65, P1283, DOI 10.2307/2171737; Kreindler G. E., 2012, RAPID INNOVATION DIF; Lee IH, 2000, REV ECON STUD, V67, P47, DOI 10.1111/1467-937X.00120; Lopez-Pintado D, 2006, INT J GAME THEORY, V34, P371, DOI 10.1007/s00182-006-0026-5; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; MATSUI A, 1991, J ECON THEORY, V54, P245, DOI 10.1016/0022-0531(91)90122-K; Morris S., 2005, EC EVOLVING COMPLEX; Morris S., 1997, 9702 CARESS U PENNS; Morris S, 2005, J ECON THEORY, V124, P45, DOI 10.1016/j.jet.2004.06.009; Morris S., 1999, POTENTIAL METH UNPUB; Oyama D, 2010, J ECON THEORY, V145, P752, DOI 10.1016/j.jet.2009.10.009; Oyama D., 2009, EC B, V29, P2132; Oyama D, 2011, J MATH ECON, V47, P683, DOI 10.1016/j.jmateco.2011.09.001; Oyama D, 2012, GAME ECON BEHAV, V74, P321, DOI 10.1016/j.geb.2011.06.003; Takahashi S, 2008, INT J GAME THEORY, V37, P15, DOI 10.1007/s00182-007-0101-6; Oyama D, 2008, THEOR ECON, V3, P155; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO; Wortman J., 2008, MSCIS0819 U PENNS; Young H. P., 1998, INDIVIDUAL STRATEGY; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899	50	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0531	1095-7235		J ECON THEORY	J. Econ. Theory	MAY	2015	157						100	127		10.1016/j.jet.2014.12.012		28	Economics	Business & Economics	CI2QV	WOS:000354593000005		
J	Dufourt, F; Nishimura, K; Venditti, A				Dufourt, Frederic; Nishimura, Kazuo; Venditti, Alain			Indeterminacy and sunspots in two-sector RBC models with generalized no-income-effect preferences	JOURNAL OF ECONOMIC THEORY			English	Article						Indeterminacy; Sunspots; Two-sector model; Sector-specific externalities; Real business cycles	BUSINESS CYCLES; EXTERNALITIES; RETURNS; SUBSTITUTION; INVESTMENT; SCALE; LABOR	We analyze sunspot-driven fluctuations in the standard two-sector RBC model with moderate increasing returns to scale and generalized no-income-effect preferences a la Greenwood, Hercovitz and Huffman [13]. We provide a detailed theoretical analysis enabling us to derive relevant bifurcation loci and to characterize the steady-state local stability properties as a function of various structural parameters. We show that local indeterminacy occurs through flip and Hopf bifurcations for a large set of values for the elasticity of intertemporal substitution in consumption, provided that the labor supply is sufficiently inelastic. Finally, we provide a detailed quantitative analysis of the model. Computing, on a quarterly basis, a new set of empirical moments related to two broadly defined consumption and investment sectors, we are able to identify, among the set of admissible calibrations consistent with sunspot equilibria, the ones that provide the best fit of the data. The model properly calibrated solves several empirical puzzles traditionally associated with two-sector RBC models. (c) 2015 Elsevier Inc. All rights reserved.	[Dufourt, Frederic; Venditti, Alain] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, EHESS, Marseille, France; [Dufourt, Frederic] Inst Univ France, Lyon, France; [Nishimura, Kazuo] Kobe Univ, RIEB, Kobe, Hyogo, Japan; [Nishimura, Kazuo] Kyoto Univ, KIER, Kyoto 6068501, Japan; [Venditti, Alain] EDHEC Business Sch, Roubaix, France	Venditti, A (reprint author), Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, EHESS, Marseille, France.	frederic.dufourt@univ-amu.fr; nishimura@kier.kyoto-u.ac.jp; alain.venditti@univ-amu.fr			French National Research Agency [ANR-08-BLAN-0245-01]; Japan Society for the Promotion of Science [23000001, (B)23330063]	This paper previously circulated under the title "Indeterminacy and sunspot fluctuations in two-sector RBC models: theory and calibration". This work was supported by French National Research Agency Grant (ANR-08-BLAN-0245-01) and by Japan Society for the Promotion of Science, Grant-in-Aid for Specially Promoted Research #23000001 and #(B)23330063. We are indebted to Jean-Michel Grandmont for many insightful comments and suggestions that helped us to greatly improve the successive versions of this paper. We also thank the Editor R. Lagos, an Associate Editor and three anonymous referees, together with H. d'Albis, S. Bosi, R. Boucelddne, R. Dos Santos Ferreira, C. Le Van, J.P. Drugeon, T. Lloyd-Braga, L. Modesto, C. Nourry, T. Seegmuller and Y. Vailalds for useful comments and suggestions. This paper also benefited from presentations at the International Conference on "New issues on macroeconomic regulation: financial crisis, stabilisation policies and sustainable development", GREQAM, June 2011, the "11th SAET Conference", Faro, Portugal, June 2011 and the "Workshop in honor of Cuong Le Van", Exeter, September 2011.	Benhabib J, 1998, J ECON THEORY, V81, P58, DOI 10.1006/jeth.1998.2414; Rogerson R, 2009, J ECON THEORY, V144, P2277, DOI 10.1016/j.jet.2008.05.011; Grandmont JM, 1998, J ECON THEORY, V80, P14, DOI 10.1006/jeth.1997.2383; Basu S, 1997, J POLIT ECON, V105, P249, DOI 10.1086/262073; Baxter M, 1996, REV ECON STAT, V78, P147, DOI 10.2307/2109854; Benhabib J., 1996, J MONETARY ECON, V37, P397; CASS D, 1983, J POLIT ECON, V91, P193, DOI 10.1086/261139; Dufourt F., 2014, SUNSPOT EQUILIBRIA E; FARMER REA, 1994, J ECON THEORY, V63, P42, DOI 10.1006/jeth.1994.1032; Garnier J. -P., 2007, INT J ECON THEORY, V3, P235; Grandmont J.-M., 1988, CEPREMAP STANFORD TE; Grandmont J.-M., 2008, RES EC, V62, P122, DOI 10.1016/j.rie.2008.06.003; GREENWOOD J, 1988, AM ECON REV, V78, P402; Gruber J., 2013, Q J FINANCE, V3, P1; Guo JT, 2010, J ECON THEORY, V145, P287, DOI 10.1016/j.jet.2009.07.003; Harrison SG, 2003, REV ECON DYNAM, V6, P963, DOI 10.1016/S1094-2025(03)00034-6; Harrison SG, 2001, J ECON DYN CONTROL, V25, P747, DOI 10.1016/S0165-1889(99)00040-8; Jaimovich N, 2008, J ECON THEORY, V143, P610, DOI 10.1016/j.jet.2008.03.007; BENHABIB J, 1994, J ECON THEORY, V63, P19, DOI 10.1006/jeth.1994.1031; Meng Q, 2008, J MACROECON, V30, P97, DOI 10.1016/j.jmacro.2007.02.003; Mulligan C., 2002, 9373 NBER; Nishimura K, 2010, MATH SOC SCI, V60, P46, DOI 10.1016/j.mathsocsci.2010.04.001; Nishimura K, 2009, J NONLINEAR CONVEX A, V10, P279; Nishimura K, 2007, J MATH ECON, V43, P446, DOI 10.1016/j.jmateco.2006.06.002; Prescott E., 2011, 457 FED RES BANK MIN; Vissing-Jorgensen A, 2003, AM ECON REV, V93, P383, DOI 10.1257/000282803321947399	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0531	1095-7235		J ECON THEORY	J. Econ. Theory	MAY	2015	157						1056	1080		10.1016/j.jet.2015.03.005		25	Economics	Business & Economics	CI2QV	WOS:000354593000041		
J	Nomura, K; Iwahashi, H; Iguchi, A; Shigematsu, T				Nomura, Kazuki; Iwahashi, Hitoshi; Iguchi, Akinori; Shigematsu, Toru			Barosensitivity in Saccharomyces cerevisiae is Closely Associated with a Deletion of the COX1 Gene	JOURNAL OF FOOD SCIENCE			English	Article						DNA microarray; high-pressure processing; mitochondria; pressure-regulated fermentation; Saccharomyces cerevisiae	HIGH-PRESSURE INACTIVATION; HIGH HYDROSTATIC-PRESSURE; UV MUTAGENESIS; YEAST; MICROORGANISMS; BAROTOLERANCE; TREHALOSE; ENZYMES; MUTANT	High hydrostatic pressure causes physical stress to microorganisms; therefore, this technology may be applied to food pasteurization without introducing the unfavorable effects of thermal denaturation. However, its application is limited to high-value foods because the treatment requires a robust steel vessel and expensive pressurization equipment. To reduce these costs, we studied the pasteurization of Saccharomyces cerevisiae using relatively moderate high-pressure levels. A mutant strain isolated by ultraviolet mutagenesis showed significant loss of viability under high-pressure conditions. Gene expression analysis of the mutant strain revealed that it incurred a deletion of the COX1 gene. Our results suggest that the pressure-sensitivity can readily be introduced into industrial/food microorganisms by complementing a COX1 deleted mitochondria.	[Nomura, Kazuki; Iwahashi, Hitoshi] Gifu Univ, United Grad Sch Agr Sci, Gifu, Gifu 5011193, Japan; [Iguchi, Akinori; Shigematsu, Toru] NUPALS, Fac Appl Life Sci, Dept Food Sci, Akiha Ku, Niigata, Niigata 9568603, Japan	Nomura, K (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.	K.nomura6103@gmail.com			Niigata Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) program of the Japan Science and Technology Agency (JST) [08001660]	This work was supported in part by the Niigata Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence (CREATE) program of the Japan Science and Technology Agency (JST) under Project 08001660.	Nishimura A, 2010, FEMS YEAST RES, V10, P687, DOI 10.1111/j.1567-1364.2010.00650.x; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Du XY, 2005, J BIOCHEM, V138, P391, DOI 10.1093/jb/mvi134; EPHRUSSI B, 1955, P NATL ACAD SCI USA, V41, P1065, DOI 10.1073/pnas.41.12.1065; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Fujii S, 1996, FEMS MICROBIOL LETT, V141, P97; Ganzle MG, 2001, J FOOD SCI, V66, P1174; HARA A, 1990, NIPPON NOGEIK KAISHI, V64, P1025; Hasegawa T, 2012, J BIOSCI BIOENG, V113, P788, DOI 10.1016/j.jbiosc.2012.02.001; HAYAKAWA K, 1995, NIPPON NOGEIK KAISHI, V69, P1021; HAYASHI R, 1987, J FOOD SCI, V52, P1107, DOI 10.1111/j.1365-2621.1987.tb14289.x; Iwahashi H, 2007, BMC GENOMICS, V8, P1; Iwahashi H, 2005, FEBS LETT, V579, P2847, DOI 10.1016/j.febslet.2005.03.100; Iwahashi H, 1997, FEBS LETT, V416, P1, DOI 10.1016/S0014-5793(97)01141-1; Iwahashi H, 2001, EXTREMOPHILES, V5, P417, DOI 10.1007/s007920100217; Iwahashi H, 2003, EXTREMOPHILES, V7, P291, DOI 10.1007/s00792-003-0322-y; Miura T, 2004, FEMS MICROBIOL LETT, V239, P171, DOI 10.1016/j.femsle.2004.08.035; NAGAI S, 1959, SCIENCE, V130, P1188, DOI 10.1126/science.130.3383.1188-a; Nomura K, 2014, REV AGR SCI, V2, P1; Shigematsu T, 2010, HIGH PRESSURE RES, V30, P524, DOI 10.1080/08957959.2010.539568; Shigematsu T, 2010, J FOOD SCI, V75, pM509, DOI 10.1111/j.1750-3841.2010.01789.x; YAYANOS AA, 1969, BIOPHYS J, V9, P1464	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	MAY	2015	80	5					M1051	M1059		10.1111/1750-3841.12873		9	Food Science & Technology	Food Science & Technology	CH8PG	WOS:000354297800018		
J	Mori, K; Ueno, H; Otani, N; Tomura, S; Wada, K; Tomiyama, A				Mori, Kentaro; Ueno, Hideaki; Otani, Naoki; Tomura, Satoshi; Wada, Kojiro; Tomiyama, Arata			Extradural Optic Canal Opening via Trans-superior Orbital Fissure Approach for Treatment of Traumatic Optic Nerve Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Meeting Abstract									[Mori, Kentaro; Ueno, Hideaki; Otani, Naoki; Tomura, Satoshi; Wada, Kojiro; Tomiyama, Arata] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 359, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3				0012	E66	E66				1	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100018		
J	Ohbuchi, H; Maegawa, T; Sasahara, A; Hagiwara, S; Kasuya, H				Ohbuchi, Hidenori; Maegawa, Tatsuya; Sasahara, Atsushi; Hagiwara, Shinji; Kasuya, Hidetoshi			Clinical Predictors for Brain Injuries in Infants With Minor Head Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Meeting Abstract									[Ohbuchi, Hidenori; Maegawa, Tatsuya; Sasahara, Atsushi; Hagiwara, Shinji; Kasuya, Hidetoshi] Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3				0029	E71	E72				2	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100031		
J	Boucher, C; Pinti, DL; Roy, M; Castro, MC; Cloutier, V; Blanchette, D; Larocque, M; Hall, CM; Wen, T; Sano, Y				Boucher, Christine; Pinti, Daniele L.; Roy, Martin; Castro, M. Clara; Cloutier, Vincent; Blanchette, Daniel; Larocque, Marie; Hall, Chris M.; Wen, Tao; Sano, Yuji			Groundwater age investigation of eskers in the Amos region, Quebec, Canada	JOURNAL OF HYDROLOGY			English	Article						Esker; Groundwater age; H-3/He-3; U-Th/He-4; Helium flux; Abitibi-Temiscamingue	MANTLE HELIUM FLUXES; NOBLE-GASES; ISOTOPIC FRACTIONATION; TRITIOGENIC HE-3; CRUSTAL HE-4; PARIS BASIN; INERT-GASES; ICE SHEETS; WATER AGES; FLOW	Noble gases, in particular He-3/He-4 (R) ratios, were measured together with tritium activity in groundwater from eskers and moraines of the Abitibi-Temiscamingue region of northwestern Quebec (eastern Canada). These high-latitude glaciofluvial landforms contain precious freshwater resources that need to be quantified. Here we provide estimates of residence time for groundwater in glaciofluvial sediments forming the Saint-Mathieu-Berry (SMB) and Barraute eskers, the Harricana moraine and in the underlying fractured bedrock aquifer. The He-3/He-4 ratios range from 0.224 +/- 0.012 to 1.849 +/- 0.036Ra, where Ra is the atmospheric He-3/He-4 ratio (1.386 x 10(-6)). These results suggest the occurrence of He-3 produced by decay of tritium and terrigenic He-4 produced by decay of U and Th. Calculated H-3/He-3 apparent ages of groundwater from the SMB esker and the Harricana moraine range from 6.6 +/- 1.1 a to 32 +/- 7.4 a. Terrigenic He-4 (He-4(terr)) was found in the deeper wells of the SMB esker and in the wells tapping water from the deeper fractured aquifer located below the eskers and moraines and confined by postglacial clays. The amount of He-4(terr) ranges from 3.4 x 10(-9) to 2.2 x 10(-6) cm(3)STP g(-1) and shows a clear gradient with depth, suggesting addition of a He-4(terr) flux entering the bottom of the eskers. Modeled He-4(terr) fluxes range from 2.0 x 10(-8) cm(3)STP cm(-2) yr(-1) at the Harricana moraine to 6.6 x 10(-7) cm(3)STP cm(-2) yr(-1) in the southern section of the SMB esker. Calculated fluxes are highly variable and 5-165 times lower than the helium continental crustal flux, suggesting local helium sources, with helium being driven upward through preferential pathways such as local faults. Maximum U-Th/He-4 ages obtained for the groundwater in the fractured bedrock range from 1473 +/- 300 a to 137 +/- 28 ka, suggesting the occurrence of several generations of fossil meltwater trapped under the clay plain after the last two glaciations. (C) 2015 Elsevier B.V. All rights reserved.	[Boucher, Christine; Pinti, Daniele L.; Roy, Martin; Larocque, Marie] Univ Quebec, Geotop, Montreal, PQ H3C 3P8, Canada; [Boucher, Christine; Pinti, Daniele L.; Roy, Martin; Larocque, Marie] Univ Quebec, Dept Sci Terre & Atmosphere, Montreal, PQ H3C 3P8, Canada; [Castro, M. Clara; Hall, Chris M.; Wen, Tao] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Cloutier, Vincent; Blanchette, Daniel] Univ Quebec Abitibi Temiscamingue, Inst Rech Mines & Envirornm, Grp Rech Souterraine, Amos, PQ, Canada; [Pinti, Daniele L.; Sano, Yuji] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Pinti, DL (reprint author), Univ Quebec, Geotop, CP8888 Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	pinti.daniele@uqam.ca		Wen, Tao/0000-0002-6113-7532	Fonds de Recherche Quebec Nature et Technologie (Programme de recherche en partenariat sur les eaux souterraines du Quebec) [136990]; NSERC [314496]; Ministry of Environment of Quebec	We wish to thank one anonymous reviewer and Andrew Hunt for their thorough comments and suggestions that deeply improved this manuscript. Funding support was obtained from Ministry of Environment of Quebec, Fonds de Recherche Quebec Nature et Technologie (contract no. 136990 of the Programme de recherche en partenariat sur les eaux souterraines du Quebec to DLP, MR and ML) and the NSERC Discovery Grant to DLP no. 314496. Local municipalities of Amos, Landrienne and Barraute and local individuals are thanked for their help and cooperation during sampling.	Aeschbach-Hertig W., 2001, INT C STUD ENV CHANG, P34; ANDREWS JN, 1985, EARTH PLANET SC LETT, V73, P317, DOI 10.1016/0012-821X(85)90080-9; Pinti DL, 2011, GEOCHIM COSMOCHIM AC, V75, P4228, DOI 10.1016/j.gca.2011.05.006; Roy M, 2011, QUATERNARY SCI REV, V30, P682, DOI 10.1016/j.quascirev.2010.12.008; Boulton G S, 2009, Quaternary Science Reviews, V28, DOI 10.1016/j.quascirev.2008.05.009; CLARK PU, 1994, GEOL SOC AM BULL, V106, P304, DOI 10.1130/0016-7606(1994)106<0304:SDEADB>2.3.CO;2; SOLOMON DK, 1993, WATER RESOUR RES, V29, P2951, DOI 10.1029/93WR00968; Dyke AS, 2004, DEV QUA SCI, V2, P373; SCHLOSSER P, 1989, EARTH PLANET SC LETT, V94, P245, DOI 10.1016/0012-821X(89)90144-1; Solomon DK, 1996, WATER RESOUR RES, V32, P1805, DOI 10.1029/96WR00600; BOULTON GS, 1995, QUATERNARY SCI REV, V14, P545, DOI 10.1016/0277-3791(95)00039-R; Castro MC, 1998, WATER RESOUR RES, V34, P2467, DOI 10.1029/98WR01957; Lucas LL, 2000, J RES NATL INST STAN, V105, P541, DOI 10.6028/jres.105.043; Torgersen T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002930; Kulongoski JT, 2005, GEOCHIM COSMOCHIM AC, V69, P3857, DOI 10.1016/j.gca.2005.03.001; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P481, DOI 10.2138/rmg.2002.47.12; STUTE M, 1992, GEOCHIM COSMOCHIM AC, V56, P2051, DOI 10.1016/0016-7037(92)90329-H; Aeschbach-Hertig W, 1998, GROUND WATER, V36, P661, DOI 10.1111/j.1745-6584.1998.tb02841.x; SMITH SP, 1983, GEOCHIM COSMOCHIM AC, V47, P503, DOI 10.1016/0016-7037(83)90273-9; Ballentine CJ, 1999, GEOCHIM COSMOCHIM AC, V63, P2315, DOI 10.1016/S0016-7037(99)00131-3; TORGERSEN T, 1985, GEOCHIM COSMOCHIM AC, V49, P2445, DOI 10.1016/0016-7037(85)90244-3; LUPTON JE, 1983, ANNU REV EARTH PL SC, V11, P371, DOI 10.1146/annurev.ea.11.050183.002103; Kulongoski JT, 2003, CHEM GEOL, V202, P95, DOI 10.1016/j.chemgeo.2003.07.002; TAKAOKA N, 1987, EARTH PLANET SC LETT, V85, P74, DOI 10.1016/0012-821X(87)90022-7; [Anonymous], 2012, THESIS ECOLE POLYTEC; MARTY B, 1993, WATER RESOUR RES, V29, P1025, DOI 10.1029/93WR00007; BENSON BB, 1980, J SOLUTION CHEM, V9, P895, DOI 10.1007/BF00646402; Ma L, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC001010; Castro MC, 2000, APPL GEOCHEM, V15, P1137, DOI 10.1016/S0883-2927(99)00113-4; Castro MC, 2005, GROUND WATER, V43, P368, DOI 10.1111/j.1745-6584.2005.0046.x; TORGERSEN T, 1985, GEOCHIM COSMOCHIM AC, V49, P1211, DOI 10.1016/0016-7037(85)90011-0; ONIONS RK, 1983, NATURE, V306, P429, DOI 10.1038/306429a0; ANDREWS JN, 1979, J HYDROL, V41, P233, DOI 10.1016/0022-1694(79)90064-7; HEATON THE, 1981, J HYDROL, V50, P201, DOI 10.1016/0022-1694(81)90070-6; Matsuda J, 2002, GEOCHEM J, V36, P191; Sano Y, 2008, ANAL SCI, V24, P521, DOI 10.2116/analsci.24.521; Banerjee I., 1975, SOC EC PALEONTOLOGIS, V23, P132; Castelli S., 2011, P GEOH 2011 JOINT IA; Castro MC, 2005, EARTH PLANET SC LETT, V237, P893, DOI 10.1016/j.epsl.2005.06.037; Cloutier V., 2013, P001 GRES IRME  U QU; Cloutier V., 2011, P GEOH 2011 JOINT IA; Cloutier V., 2007, P 60 CAN GEOT C 8 JO, P355; Freeze R. A., 1979, GROUNDWATER; Fritz P., 1997, ENV ISOTOPES HYDROGE; Heemskerk A.R., 1998, TRITIUM ANAL TECHNIC; IAEA/WMO (International Atomic Energy Agency/World Meteorological Organization), 2004, GLOB NETW IS PREC; Kinzelbach W, 2002, UNEPDEWAR5022; Lisiecki L., 2005, PALEOCEANOGRAPHY, V20; MARTY B, 1984, GEOCHEM J, V18, P157; Morrison P., 1955, ANN NY ACAD SCI, V62, P69; MULJA T, 1995, CAN MINERAL, V33, P793; Nadeau S, 2011, THESIS U QUEBEC MONT; Ozima M., 1983, NOBLE GAS GEOCHEMIST; Patriarche D, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003173; Riverin M.N., 2006, THESIS INRS ETE QUEB; Sano Y, 1998, CHEM GEOL, V150, P171, DOI 10.1016/S0009-2541(98)00055-2; Sano Y., 2013, ADV ISOTOPE GEOCHEMI, P17, DOI DOI 10.1007/978-3-642-28836-4_2; Shilts W.W., 1987, GEOMORPHIC SYSTEMS N, P119; Stute M., 1993, CLIMATE CHANGE CONTI, P89, DOI [10.1029/GM078p0089, DOI 10.1029/GM078P0089]; TOLSTIKH.IN, 1969, GEOCHEM INT, V6, P810; Veillette J.J., 2004, 57 CAN GEOT C 5 JOIN, P6; Veillette J.J, 1996, GEOL SURV CANADA B, V476, P269; VEILLETTE JJ, 1994, QUATERNARY SCI REV, V13, P945, DOI 10.1016/0277-3791(94)90010-8; Veillette J.J., 2003, 1523 GEOL SURV CAN, V1523; Veillette J.J., 2007, P 60 CAN GEOT C 8 JO, P347; Vogel J.C., 1967, 8324 IAEASM, p[355, 355]; Weber W.W., 1964, AMOS BARRAUTE AREA; Weise S., 1987, GROUNDWATER DATING H, P105	68	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	MAY	2015	524						1	14		10.1016/j.jhydrol.2015.01.072		14	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CI1KO	WOS:000354503300001		
J	Kashiwaya, K; Hasegawa, T; Nakata, K; Tomioka, Y; Mizuno, T				Kashiwaya, Koki; Hasegawa, Takuma; Nakata, Kotaro; Tomioka, Yuichi; Mizuno, Takashi			Multiple tracer study in Horonobe, northern Hokkaido, Japan: 2. Depletion of chlorofluorocarbons (CFCs) estimated using H-3/He-3 index and lumped parameter models	JOURNAL OF HYDROLOGY			English	Article						Chlorofluorocarbon; Tritium/helium-3; Lumped parameter model; Microbial degradation; Sorption; Gas stripping	KARSTIC LIMESTONE AQUIFER; UPPER FLORIDAN AQUIFER; GROUNDWATER MIXTURES; YOUNG FRACTION; RIVER WATER; DEGRADATION; CFC-11; SHALLOW; RATES; FLOW	The conservativeness of chlorofluorocarbons (CFC-12, CFC-11, and CFC-113) in an environment rich in organic carbon was evaluated using multiple tracer analyses and lumped parameter models (LPMs). Wells on a coastal plain in Horonobe, northern Hokkaido, Japan, were studied. The CFC concentrations in groundwater from 22 wells were measured, converted into atmospheric mixing ratios (CARs), and compared with estimated ratios (EARs) obtained from H-3/He-3 values and LPMs. The degree of CFC depletion was expressed as the percentage of the CAR relative to the EAR, and was less than 43% for CFC-12 and 28% for CFC-11 (but one well had unusual values). CFC-113 was depleted more than the other CFCs, and could not be detected in most wells. The CFC depletion mechanisms were different in each of the three well groups. Groundwater of northern Shimonuma wells (NSW) was oxic and oxidative, so CFC depletion in the NSW could be attributed to sorption by organic carbon in the lignite and peat in the aquifers. Groundwater of southern Shimonuma wells (SSW) was anoxic and reductive. The northerly SSW are supplied from the aquifer that supplies the most of the NSW, so CFC depletion in the SSW was caused by degradation under sulfate-reducing and methanogenic conditions, in addition to sorption by lignite in the northerly SSW. Gas stripping, contamination from a local source, and methane interfering with the CFC analysis were found in groundwater of Hamasato wells (HW). One well of HW was not affected by these problems, but the CFCs were depleted by microbial degradation. Assuming that the CFC depletion mechanisms follow first-order reaction kinetics, reaction rate constants of 2.7 y(-1) for CFC-12 and 2.8 y(-1) for CFC-11 were estimated. Microbial degradation, sorption, gas stripping of CFCs, and methane formation processes are enhanced in environments rich in organic carbon. Special attention is required when CFCs are used as transient tracers in such environments. The combination of multiple tracer analysis and LPMs allowed the degree of CFC depletion to be effectively quantified and the applicability of CFCs in groundwater flow systems to be evaluated. (C) 2015 Elsevier B.V. All rights reserved.	[Kashiwaya, Koki; Hasegawa, Takuma; Nakata, Kotaro; Tomioka, Yuichi] Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Nucl Fuel Cycle Backend Res Ctr, Chiba 2701194, Japan; [Mizuno, Takashi] Japan Atom Energy Agcy, Horonobe Underground Res Ctr, Horonobe, Hokkaido 0983224, Japan	Kashiwaya, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Urban Management, Nishikyo Ku, C1-2-214 Kyoto Daigaku Katsura, Kyoto 6158540, Japan.	kashiwaya.koki.8a@kyoto-u.ac.jp; t-hase@criepi.denken.or.jp; k-nakata@criepi.denken.or.jp; tomioka@criepi.denken.or.jp; mizuno.takashi@jaea.go.jp			Japanese Ministry of Economy, Trade and Industry	This research is a part of the "Development and research on groundwater movement evaluation technique" project, funded by the Japanese Ministry of Economy, Trade and Industry and implemented by the Central Research Institute of Electric Power Industry (CRIEPI) from 2008 to 2010. The field measurements and sample collections were performed jointly with the Japan Atomic Energy Agency and the National Institute of Advanced Industrial Science and Technology. The authors received valuable advices from professors Y. Mahara (Kyoto University), T. Nakamura (Nagoya University), J. Shimada (Kumamoto University), T. Tokunaga (University of Tokyo), and Dr. T. Moriya (NUMO). The manuscript was highly improved by helpful comments by anonymous reviewers and the editors. We are deeply grateful to all of the people involved.	Oster H, 1996, WATER RESOUR RES, V32, P2989, DOI 10.1029/96WR01775; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; COOK PG, 1995, WATER RESOUR RES, V31, P425, DOI 10.1029/94WR02528; LASHOF DA, 1990, NATURE, V344, P529, DOI 10.1038/344529a0; Szabo Z, 1996, WATER RESOUR RES, V32, P1023, DOI 10.1029/96WR00068; KATZ BG, 1995, WATER RESOUR RES, V31, P1565, DOI 10.1029/95WR00220; RAMANATHAN V, 1975, SCIENCE, V190, P50; CICERONE RJ, 1974, SCIENCE, V185, P1165, DOI 10.1126/science.185.4157.1165; LOVLEY DR, 1992, ENVIRON SCI TECHNOL, V26, P925, DOI 10.1021/es00029a009; Bohlke J.K., 2006, USE CHLOROFLUOROCARB, P239; Cook P.G., 2006, USE CHLOROFLUOROCARB, P31; Editorial Committee of Hokkaido, 1990, REG GEOL JAP 1, P211; Happell JD, 2003, J HYDROL, V279, P94, DOI 10.1016/S0022-1694(03)00169-0; Hinsby K, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005854; Hirota T., 1983, EXPLANATORY TEXT HYD; Horneman A, 2008, J CONTAM HYDROL, V97, P27, DOI 10.1016/j.jconhyd.2007.12.001; Horonobe Research Institute for the Subsurface Environment, 2007, H18 ANN REP SUBS ENV; Horonobe Research Institute for the Subsurface Environment, 2006, H17 ANN REP SUBS ENV; Ikawa R, 2014, HYDROGEOL J, V22, P987, DOI 10.1007/s10040-014-1106-4; Jurgens B.C., 2012, 4F3 US GEOL SURV, P4; Kameyama T., 2006, J GROUNDW HYDROL, V48, P3; Kashiwaya K, 2014, J HYDROL, V519, P532, DOI 10.1016/j.jhydrol.2014.07.025; LACIS A, 1981, GEOPHYS RES LETT, V8, P1035, DOI 10.1029/GL008i010p01035; LESAGE S, 1992, CHEMOSPHERE, V24, P1225, DOI 10.1016/0045-6535(92)90049-W; Mitani K., 1981, EXPLANATORY TEXT GEO; Miyamoto M., 2009, GEO STUD, V84, P111; Oka T., 1997, COMMEM, P341; Oka T., 2006, REP GEOL SURVEY HOKK, V77, P17; Oka T., 1985, ACTIVE FAULT RES, V1, P19; Plummer L. N., 2000, ENV TRACERS SUBSURFA, P441; Plummer LN, 1998, APPL GEOCHEM, V13, P1017, DOI 10.1016/S0883-2927(98)00032-8; Plummer LN, 1998, APPL GEOCHEM, V13, P995, DOI 10.1016/S0883-2927(98)00031-6; Plummer L.N., 2007, ISOTOPES WATER CYCLE, P193; Plummer L.N., 2006, USE CHLOROFLUOROCARB, P105; Sakaguchi Y., 1961, J FS U TOKYO, V1112, P421; Sakai T., 2011, J JPN SOC ENG GEOL, V52, P2, DOI DOI 10.5110/JJSEG.52.2; Sakai T, 2012, J JPN SOC ENG GEOL, V53, P172, DOI DOI 10.5110/JJSEG.53.172; Sebol LA, 2007, J HYDROL, V347, P1, DOI 10.1016/j.jhydrol.2007.08.009; Shapiro SD, 1997, MAR CHEM, V59, P141, DOI 10.1016/S0304-4203(97)00007-8; Siegemund G., 1988, ULLMANNS ENCY IND CH, P349; SONIER DN, 1994, APPL ENVIRON MICROB, V60, P4567; Zuber A., 2001, ENV ISOTOPES HYDROLO, VVI, P5	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	MAY	2015	524						111	122		10.1016/j.jhydrol.2015.02.016		12	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CI1KO	WOS:000354503300010		
J	Sugita, M; Yoshizawa, S; Byambakhuu, I				Sugita, Michiaki; Yoshizawa, Shintaroh; Byambakhuu, Ishgaldan			Limiting factors for nomadic pastoralism in Mongolian steppe: A hydrologic perspective	JOURNAL OF HYDROLOGY			English	Article						Water balance; Groundwater recharge; Nomadic pastoralism; Steppe; Mongolia	UNFROZEN WATER-CONTENT; ENERGY-BALANCE; MODEL; RANGELANDS; REGIONS; RUNOFF	In this study, limiting factors for continuing nomadic pastoralism in steppe areas were studied based on a hydrologic perspective. Two small watersheds in central Mongolia were selected for an assessment of water balance and hydrologic processes. We determined that the majority of annual precipitation, similar to 88-96 mm, was lost by evaporation (82%) while only a small proportion went to groundwater discharge, surface runoff, and groundwater consumption by nomadic activities. The soil column was found to absorb large fluctuations in precipitation although its connection to groundwater was very weak. Groundwater recharge was, therefore, very small and occurred only rarely during heavy rainfall events in valley bottoms. However, current water storage in shallow groundwater was determined to be quite sufficient for continuing nomadic pastoralism when compared to the drinking water requirements of livestock. The main limiting factors identified were a temporal lack of feed to animals due to a loss of aboveground biomass resulting from soil moisture shortages during drought conditions, and a decline in the number and maintenance level of the traditional well network that, due to access to shallow groundwater, has allowed herders to migrate to areas with better conditions in remote Mongolian steppe. (C) 2015 Elsevier B.V. All rights reserved.	[Sugita, Michiaki] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Yoshizawa, Shintaroh; Byambakhuu, Ishgaldan] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan	Sugita, M (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan.	sugita@geoenv.tsukuba.ac.jp	Sugita, Michiaki/L-2155-2013	Sugita, Michiaki/0000-0002-2241-9334	RIHN project "Collapse and Restoration of Ecosystem Networks with Human Activity"; Japan Society for the Promotion of Science [24241053]	We thank I. Kaihotsu (Hiroshima U.) and the Japan Aerospace Exploration Agency for providing wind speed data from their AWS, M. Tsujimura for the arrangement of the tritium concentration analysis, and G. Davaa and D. Oyunbaatar (Research and Information Institute of Meteorology, Hydrology, and Environment (IMH)) for facilitating local logistics and for arranging the maintenance of stations through the Meteorological Centers of IMH at Mandalgobi and Dalanzadgado. We are also grateful to T. Satoh and Y. Morinaga (U. Tsukuba) for participating in the field observations for this study, and to Y. Konagaya (National Museum of Ethnology of japan), S. Mori (IMG, Inc.), and G.U. Nachinshonhor (Okayama U.) for providing us with references on the history of well construction in Mongolia, and for an anonymous referee and associate editor for providing valuable comments to improve the quality of the manuscript. Finally, we also express appreciation to N. Fujita and N. Yamamura (Research Institute for Humanity and Nature (RIHN)). Without their initiatives and leadership the experiments for this study would not have been possible. Our research was supported and financed, in part, by the RIHN project "Collapse and Restoration of Ecosystem Networks with Human Activity" and by a Grant-In-Aid for Scientific Research (A, no. 24241053) from the Japan Society for the Promotion of Science.	Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Arora VK, 2002, J HYDROL, V265, P164, DOI 10.1016/S0022-1694(02)00101-4; Sternberg T, 2008, J ARID ENVIRON, V72, P1294, DOI 10.1016/j.jaridenv.2007.12.016; Watanabe K, 2009, COLD REG SCI TECHNOL, V59, P34, DOI 10.1016/j.coldregions.2009.05.011; Yoshikawa K, 2005, COLD REG SCI TECHNOL, V42, P250, DOI 10.1016/j.coldregions.2005.03.001; Onda Y, 2007, J HYDROL, V333, P124, DOI 10.1016/j.jhydrol.2006.07.030; Brutsaert W, 2008, HYDROLOG SCI J, V53, P1221, DOI 10.1623/hysj.53.6.1221; Scanlon BR, 2006, HYDROL PROCESS, V20, P3335, DOI 10.1002/hyp.6335; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Sato T, 2007, J HYDROL, V333, P144, DOI 10.1016/j.jhydrol.2006.07.023; [Anonymous], 1982, SECRET HIST MONGOLS, V2, P1; Brutsaert W, 2005, HYDROLOGY INTRO; Brutsaert W. H., 1982, EVAPORATION ATMOSPHE; Byambakhuu I, 2010, REMOTE SENS ENVIRON, V114, P2361, DOI 10.1016/j.rse.2010.05.013; CGIAR-CSI, 2008, SRTM 90 M DIG EV DAT; Chen YX, 2007, J HYDROL, V333, P155, DOI 10.1016/j.jhydrol.2006.07.019; Chuluun T., 2002, FUNDAMENTAL ISSUES A, P52; Cribb R, 1991, NOMADS ARCHAEOLOGY; Dorzhgotov D., 2003, SOILS OF MONGOLIA; Freeze R. A., 1979, GROUNDWATER; Healy RW, 2010, ESTIMATING GROUNDWAT; Higuchi S., 2005, THESIS KUMAMOTO U; Jacoby G, 1999, IAWA J, V20, P339; Kahimba F.C., 2007, CAN BIOSYS ENG, V49; Kruseman G.P., 1990, ANAL EVALUATION PUMP, V46; Matsubara M., 2005, MESSAGE EURASIAN GRA, P11; Minister of Nature and Environment, 1995, 153 MIN NAT ENV, V153; Miyawaki J., 2002, HIST OF MONGOLIA; National Statistical Office of Mongolia, 2005, NAT STAT OFF MONG YB; National Statistical Office of Mongolia, 2009, NAT STAT OFF MONG YB; National Statistical Office of Mongolia, 2007, NAT STAT OFF MONG YB; National Statistical Office of Mongolia, 1999, NAT STAT OFF MONG YB; Ozyurt NN, 2005, COMPUT GEOSCI-UK, V31, P329, DOI 10.1016/j.cageo.2004.09.024; Pederson N, 2001, J CLIMATE, V14, P872, DOI 10.1175/1520-0442(2001)014<0872:HRFNMD>2.0.CO;2; Pratt M., 2001, DETERMINING YOUR STO; RATHOD KS, 1991, GROUND WATER, V29, P499, DOI 10.1111/j.1745-6584.1991.tb00541.x; Satoh T., 2012, ECOLOGICAL RES MONOG, P43; Sharkhuu Ts., 1975, SITUATION LAND COMMU; Shiirevdamba Ts., 1998, BIOL DIVERSITY MONGO; Sugita M, 2007, J HYDROL, V333, P3, DOI 10.1016/j.jhydrol.2006.07.032; Toda M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002573; Tsogtbaatar J., 2009, FINAL REPORT PROJECT; Tsujimura M, 2007, B TERR ENV RES CTR U, V8, P82; Tuinhof A., 2009, 25012009 AC WAT; WMO, 2012, 1090 WMO; Yamanaka T, 2011, HYDROL PROCESS, V25, P2654, DOI 10.1002/hyp.8007; Yamanaka T., 2003, B TERR ENV RES CTR U, V16, P246; Yamanaka T, 2007, J ARID ENVIRON, V69, P65, DOI 10.1016/j.jaridenv.2006.09.003	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	MAY	2015	524						455	467		10.1016/j.jhydrol.2015.02.050		13	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CI1KO	WOS:000354503300036		
J	Suzuki, S				Suzuki, Seizi			Recognition of the Sex of the Parents by Young: Effects of Hunger and Biparental Care on the Begging Behavior of Nicrophorus quadripuncatus Larvae	JOURNAL OF INSECT BEHAVIOR			English	Article						Biparental care; begging; Nicrophorus; honest signal	BURYING BEETLES; DIFFERENTIAL RESPONSE; FEMALES; MALES; MATE; MANIPULATION; CONFLICT; DYNAMICS; INSECTS; SIGNALS	The behavior of offspring begging for food from their parents has received much attention because begging is regarded as an honest signal of young's need. Although the feeding frequency of young insects is often different toward the sexes in biparental care, few studies have examined the begging behavior in light of the sex of the parents. I conducted an experiment to investigate the relation between the degree of hunger in Nicrophorus quadripunctatus larvae and their selection of male or female parents as the target of their begging. I found that the N. quadripunctatus larvae that were not provisioned increased the intensity of their begging, and that the larvae showed more begging toward their mother regardless of their hunger status. The results indicate that Nicrophorus larvae increase the intensity of their begging when they are hungry, and that they can recognize the sex of their parents.	Hokkaido Univ, Grad Sch Agr, Dept Systemat & Ecol, Sapporo, Hokkaido 0608589, Japan	Suzuki, S (reprint author), Hokkaido Univ, Grad Sch Agr, Dept Systemat & Ecol, Kitaku Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	seizis@res.agr.hokudai.ac.jp			Japan Society for the Promotion of Science [24570013]	This study was supported in part by a Grant-in-Aid for Scientific Research (#24570013) from the Japan Society for the Promotion of Science.	Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Steiger S, 2008, P ROY SOC B-BIOL SCI, V275, P1831, DOI 10.1098/rspb.2008.0375; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; Eggert AK, 1998, ANIM BEHAV, V55, P97, DOI 10.1006/anbe.1997.0588; Suzuki S, 2009, ETHOLOGY, V115, P1, DOI 10.1111/j.1439-0310.2008.01598.x; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Royle NJ, 2004, POPUL ECOL, V46, P231, DOI 10.1007/s10144-004-0196-6; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; FETHERSTON IA, 1990, ETHOLOGY, V85, P177; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Smiseth PT, 2004, BEHAV ECOL, V15, P621, DOI 10.1093/beheco/arh053; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Smiseth PT, 2002, ANIM BEHAV, V63, P577, DOI 10.1006/anbe.2001.1944; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Dickens M, 2008, ANIM BEHAV, V75, P167, DOI 10.1016/j.anbehav.2007.04.024; Eggert Anne-Katrin, 1997, P216; Gowaty PA, 1991, P 20 INT ORN C, P932; Hall CL, 2015, J INSECT CONSERV, V19, P155, DOI 10.1007/s10841-015-9755-8; Kolliker M, 1998, ANIM BEHAV, V55, P215, DOI 10.1006/anbe.1997.0571; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; Maarit IM, 2014, ETHOLOGY, P395; Panaitof SC, 2004, J INSECT PHYSIOL, V50, P715, DOI 10.1016/j.jinsphys.2004.05.008; Smiseth PT, 2010, BEHAV ECOL, V21, P526, DOI 10.1093/beheco/arq019; Steiger S, 2009, ETHOLOGY, V115, P178, DOI 10.1111/j.1439-0310.2008.01600.x; Suzuki S, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13101; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916	28	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7553	1572-8889		J INSECT BEHAV	J. Insect Behav.	MAY	2015	28	3					338	344		10.1007/s10905-015-9506-4		7	Entomology	Entomology	CI3FW	WOS:000354634100011		
J	Bauer, M; Glenn, T; Alda, M; Andreassen, OA; Angelopoulos, E; Ardau, R; Baethge, C; Bauer, R; Baune, BT; Bellivier, F; Belmaker, RH; Berk, M; Bjella, TD; Bossini, L; Bersudsky, Y; Cheung, EYW; Conell, J; Del Zompo, M; Dodd, S; Etain, B; Fagiolini, A; Frye, MA; Fountoulakis, KN; Garneau-Fournier, J; Gonzalez-Pinto, A; Gottlieb, JF; Harima, H; Hassel, S; Henry, C; Iacovides, A; Isometsa, ET; Kapczinski, F; Kliwicki, S; Konig, B; Krogh, R; Kunz, M; Lafer, B; Larsen, ER; Lewitzka, U; Lopez-Jaramillo, C; MacQueen, G; Manchia, M; Marsh, W; Martinez-Cengotitabengo, M; Melle, I; Monteith, S; Morken, G; Munoz, R; Nery, FG; O'Donovan, C; Osher, Y; Pfennig, A; Quiroz, D; Ramesar, R; Rasgon, N; Reif, A; Ritter, P; Rybakowski, JK; Sagduyu, K; Miranda-Scippa, A; Severus, E; Simhandl, C; Stein, DJ; Strejilevich, S; Sulaiman, AH; Suominen, K; Tagata, H; Tatebayashi, Y; Torrent, C; Vieta, E; Viswanath, B; Wanchoo, MJ; Zetin, M; Whybrow, PC				Bauer, Michael; Glenn, Tasha; Alda, Martin; Andreassen, Ole A.; Angelopoulos, Elias; Ardau, Raffaella; Baethge, Christopher; Bauer, Rita; Baune, Bernhard T.; Bellivier, Frank; Belmaker, Robert H.; Berk, Michael; Bjella, Thomas D.; Bossini, Letizia; Bersudsky, Yuly; Cheung, Eric Yat Wo; Conell, Joern; Del Zompo, Maria; Dodd, Seetal; Etain, Bruno; Fagiolini, Andrea; Frye, Mark A.; Fountoulakis, Kostas N.; Garneau-Fournier, Jade; Gonzalez-Pinto, Ana; Gottlieb, John F.; Harima, Hirohiko; Hassel, Stefanie; Henry, Chantal; Iacovides, Apostolos; Isometsa, Erkki T.; Kapczinski, Flavio; Kliwicki, Sebastian; Koenig, Barbara; Krogh, Rikke; Kunz, Mauricio; Lafer, Beny; Larsen, Erik R.; Lewitzka, Ute; Lopez-Jaramillo, Carlos; MacQueen, Glenda; Manchia, Mirko; Marsh, Wendy; Martinez-Cengotitabengo, Monica; Melle, Ingrid; Monteith, Scott; Morken, Gunnar; Munoz, Rodrigo; Nery, Fabiano G.; O'Donovan, Claire; Osher, Yamima; Pfennig, Andrea; Quiroz, Danilo; Ramesar, Raj; Rasgon, Natalie; Reif, Andreas; Ritter, Philipp; Rybakowski, Janusz K.; Sagduyu, Kemal; Miranda-Scippa, Angela; Severus, Emanuel; Simhandl, Christian; Stein, Dan J.; Strejilevich, Sergio; Sulaiman, Ahmad Hatim; Suominen, Kirsi; Tagata, Hiromi; Tatebayashi, Yoshitaka; Torrent, Carla; Vieta, Eduard; Viswanath, Biju; Wanchoo, Mihir J.; Zetin, Mark; Whybrow, Peter C.			Influence of light exposure during early life on the age of onset of bipolar disorder	JOURNAL OF PSYCHIATRIC RESEARCH			English	Review						Bipolar disorder; Age of onset; Sunlight; Insolation; Hours of daylight	HAMSTERS PHODOPUS-SUNGORUS; MAJOR AFFECTIVE-DISORDER; CIRCADIAN-RHYTHMS; VITAMIN-D; PERINATAL PHOTOPERIOD; MOOD DISORDERS; FAMILY-HISTORY; BIRTH COHORT; BIOLOGICAL CLOCK; PRETERM INFANTS	Background: Environmental conditions early in life may imprint the circadian system and influence response to environmental signals later in life. We previously determined that a large springtime increase in solar insolation at the onset location was associated with a younger age of onset of bipolar disorder, especially with a family history of mood disorders. This study investigated whether the hours of daylight at the birth location affected this association. Methods: Data collected previously at 36 collection sites from 23 countries were available for 3896 patients with bipolar I disorder, born between latitudes of 1.4 N and 70.7 N, and 1.2 S and 413 S. Hours of daylight variables for the birth location were added to a base model to assess. the relation between the age of onset and solar insolation. Results: More hours of daylight at the birth location during early life was associated with an older age of onset, suggesting reduced vulnerability to the future circadian challenge of the springtime increase in solar insolation at the onset location. Addition of the minimum of the average monthly hours of daylight during the first 3 months of life improved the base model, with a significant positive relationship to age of onset. Coefficients for all other variables remained stable, significant and consistent with the base model. Conclusions: Light exposure during early life may have important consequences for those who are susceptible to bipolar disorder, especially at latitudes with little natural light in winter. This study indirectly supports the concept that early life exposure to light may affect the long term adaptability to respond to a circadian challenge later in life. (C) 2015 Elsevier Ltd. All rights reserved.	[Bauer, Michael; Bauer, Rita; Conell, Joern; Lewitzka, Ute; Pfennig, Andrea; Ritter, Philipp; Severus, Emanuel] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Dept Psychiat & Psychotherapy, D-01307 Dresden, Germany; [Glenn, Tasha] ChronoRecord Assoc, Fullerton, CA USA; [Alda, Martin; Manchia, Mirko; O'Donovan, Claire] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Andreassen, Ole A.; Bjella, Thomas D.; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Andreassen, Ole A.; Bjella, Thomas D.; Melle, Ingrid] Inst Clin Med, Oslo, Norway; [Angelopoulos, Elias] Univ Athens, Eginit Hosp, Sch Med, Dept Psychiat, GR-11528 Athens, Greece; [Ardau, Raffaella] Univ Hosp Cagliari, Clin Pharmacol Unit, Cagliari, Italy; [Baethge, Christopher] Univ Cologne, Sch Med, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Baune, Bernhard T.] Univ Adelaide, Sch Med, Discipline Psychiat, Adelaide, SA 5005, Australia; [Bellivier, Frank] Univ D Diderot, AP HP, INSERM,Psychiat, GH St Louis Lariboisiere F Widal,Fac Med,UMR S114, Paris, France; [Belmaker, Robert H.; Bersudsky, Yuly; Osher, Yamima] Ben Gurion Univ Negev, Beer Sheva Mental Hlth Ctr, Fac Hlth Sci, Dept Psychiat, IL-84105 Beer Sheva, Israel; [Berk, Michael; Dodd, Seetal] Deakin Univ, Sch Med, IMPACT Strateg Res Ctr, Geelong, Vic 3220, Australia; [Berk, Michael] Univ Melbourne, Ctr Youth Mental Hlth, ORYGEN Youth Hlth Res Ctr, Dept Psychiat, Parkville, Vic 3052, Australia; [Berk, Michael] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Bossini, Letizia; Fagiolini, Andrea] Univ Siena, Dept Mol Med, I-53100 Siena, Italy; [Bossini, Letizia; Fagiolini, Andrea] Univ Siena, Dept Mental Hlth DAI, I-53100 Siena, Italy; [Bossini, Letizia; Fagiolini, Andrea] Univ Siena, Med Ctr, I-53100 Siena, Italy; [Cheung, Eric Yat Wo] Castle Peak Hosp, Dept Gen Adult Psychiat, Hong Kong, Hong Kong, Peoples R China; [Del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Sardinia, Italy; [Dodd, Seetal] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia; [Etain, Bruno; Henry, Chantal] Univ Paris Est, INSERM, Hop Univ Henri Mondor, AP HP,U955,IMRB, Creteil, France; [Frye, Mark A.; Wanchoo, Mihir J.] Mayo Clin, Mayo Clin Depress Ctr, Dept Psychiat & Psychol, Rochester, MN USA; [Fountoulakis, Kostas N.; Iacovides, Apostolos] Aristotle Univ Thessaloniki, Sch Med, Div Neurosci, Dept Psychiat 3, GR-54006 Thessaloniki, Greece; [Garneau-Fournier, Jade; Rasgon, Natalie] Stanford Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA USA; [Gonzalez-Pinto, Ana] Univ Basque Country, CIBERSAM, Univ Hosp Alava, Dept Psychiat, Vitoria, Spain; [Gottlieb, John F.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Harima, Hirohiko; Tagata, Hiromi] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Tokyo, Japan; [Hassel, Stefanie; MacQueen, Glenda] Univ Calgary, Fac Med, Dept Psychiat, Calgary, AB, Canada; [Isometsa, Erkki T.] Univ Helsinki, Inst Clin Med, Dept Psychiat, FIN-00014 Helsinki, Finland; [Isometsa, Erkki T.] Natl Inst Hlth & Welf, Helsinki, Finland; [Kapczinski, Flavio; Kunz, Mauricio] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Mol Psychiat, Porto Alegre, RS, Brazil; [Kliwicki, Sebastian; Rybakowski, Janusz K.] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland; [Koenig, Barbara; Simhandl, Christian] BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria; [Krogh, Rikke; Larsen, Erik R.] Aarhus Univ Hosp, Mood Disorders Res Unit, Dept Affect Disorders, Aarhus, Denmark; [Lafer, Beny; Nery, Fabiano G.] Univ Sao Paulo, Sch Med, Dept Psychiat, Bipolar Disorder Res Program, Sao Paulo, Brazil; [Lopez-Jaramillo, Carlos] Univ Antioquia, Dept Psychiat, Mood Disorders Program, Fdn San Vicente Paul, Medellin, Colombia; [Marsh, Wendy] Univ Massachusetts, Dept Psychiat, Worcester, MA 01605 USA; [Monteith, Scott] Michigan State Univ, Coll Human Med, Traverse City, MI USA; [Morken, Gunnar] Norwegian Univ Sci & Technol NTNU, Dept Neurosci, Trondheim, Norway; [Munoz, Rodrigo] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Quiroz, Danilo] Diego Portales Univ, Dept Psychiat, Santiago, Chile; [Ramesar, Raj] Univ Cape Town, Inst Infect Dis & Mol Med, UCT MRC Human Genet Res Unit, ZA-7925 Cape Town, South Africa; [Reif, Andreas] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60054 Frankfurt, Germany; [Sagduyu, Kemal] Univ Missouri, Sch Med, Dept Psychiat, Kansas City, MO 64108 USA; [Miranda-Scippa, Angela] Univ Fed Bahia, Dept Neurosci & Mental Hlth, Salvador, BA, Brazil; [Stein, Dan J.] Univ Cape Town, Dept Psychiat, ZA-7925 Cape Town, South Africa; [Strejilevich, Sergio] Favaloro Univ, Inst Neurosci, Bipolar Disorder Program, Buenos Aires, DF, Argentina; [Sulaiman, Ahmad Hatim] Univ Malaya, Fac Med, Dept Psychol Med, Kuala Lumpur, Malaysia; [Suominen, Kirsi] Dept Social Serv & Hlth Care, Psychiat, Helsinki, Finland; [Tatebayashi, Yoshitaka] Tokyo Metropolitan Inst Med Sci, Schizophrenia & Affect Disorders Res Project, Seatagaya, Tokyo, Japan; [Torrent, Carla; Vieta, Eduard] Univ Barcelona, CIBERSAM, IDIBAPS, Bipolar Disorders Program,Hosp Clin, Barcelona, Catalonia, Spain; [Viswanath, Biju] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore 560029, Karnataka, India; [Zetin, Mark] Chapman Univ, Dept Psychol, Orange, CA USA; [Whybrow, Peter C.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Bellivier, Frank; Henry, Chantal] Fdn FondaMental, Creteil, France; [Morken, Gunnar] Univ Trondheim Hosp, St Olavs Hosp, Dept Res & Dev, Psychiat, Trondheim, Norway	Bauer, M (reprint author), Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Dept Psychiat & Psychotherapy, Germany Fetscherstr 74, D-01307 Dresden, Germany.	michael.bauer@uniklinikum-dresden.de	Ramesar, Raj/I-6941-2015; OSHER, YAMIMA/F-1359-2012; 	Ramesar, Raj/0000-0001-5688-1634; OSHER, YAMIMA/0000-0002-9635-7973; Lopez, Carlos/0000-0002-1875-1369; Torrent Font, Carla/0000-0003-0335-582X; Stein, Dan/0000-0001-7218-7810	European College of Neuropsychopharmacology (ECNP) Network Initiative	We thank the European College of Neuropsychopharmacology (ECNP) Network Initiative for supporting the European Network of Bipolar Research Expert Centres (ENBREC) involved in this research.	Allen KL, 2013, INT J EAT DISORDER, V46, P669, DOI 10.1002/eat.22147; Chepesiuk R, 2009, ENVIRON HEALTH PERSP, V117, pA20; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Machon RA, 1997, ARCH GEN PSYCHIAT, V54, P322; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Romero S, 2007, J CLIN PSYCHIAT, V68, P1517; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Smith L, 2009, J NEUROENDOCRINOL, V21, P946, DOI 10.1111/j.1365-2826.2009.01914.x; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Rutter M, 2005, J AM ACAD CHILD PSY, V44, P3, DOI 10.1097/01.chi.0000145374.45992.c9; Giglio LM, 2010, J PSYCHIATR RES, V44, P220, DOI 10.1016/j.jpsychires.2009.08.003; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; Jackson CR, 2014, J NEUROSCI, V34, P4627, DOI 10.1523/JNEUROSCI.4887-13.2014; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; Pyter LM, 2006, BEHAV NEUROSCI, V120, P125, DOI 10.1037/0735-7044.120.1.125; Gonzalez-Pinto A, 2008, J CLIN PSYCHIAT, V69, P1210; Baldessarini RJ, 2012, WORLD PSYCHIATRY, V11, P40; Bauer M, 2014, J AFFECT DISORDERS, V167, P104, DOI 10.1016/j.jad.2014.05.032; Brooks E, 2013, NEUROSCI BIOBEHAV R, V37, P551, DOI 10.1016/j.neubiorev.2013.02.012; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Shimada M, 1999, BRAIN DEV-JPN, V21, P468, DOI 10.1016/S0387-7604(99)00054-6; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Frank E, 2000, BIOL PSYCHIAT, V48, P593, DOI 10.1016/S0006-3223(00)00969-0; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Hardt J, 2007, EUR PSYCHIAT, V22, P49, DOI 10.1016/j.eurpsy.2006.10.003; Karasz A, 2005, SOC SCI MED, V60, P1625, DOI 10.1016/j.socscimed.2004.08.011; Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190; Bauer M, 2012, BIPOLAR DISORD, V14, P654, DOI 10.1111/j.1399-5618.2012.01025.x; Giglio LMF, 2009, J AFFECT DISORDERS, V118, P161, DOI 10.1016/j.jad.2009.01.018; Shen GH, 2008, BIPOLAR DISORD, V10, P520, DOI 10.1111/j.1399-5618.2008.00583.x; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; Morselli PL, 2003, BIPOLAR DISORD, V5, P265, DOI 10.1034/j.1399-5618.2003.00037.x; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Rivkees SA, 2003, PEDIATRICS, V112, P373, DOI 10.1542/peds.112.2.373; McGraw K, 1999, SLEEP, V22, P303; Sylvia LG, 2009, BEHAV THER, V40, P131, DOI 10.1016/j.beth.2008.04.003; Gluckman PD, 2005, EARLY HUM DEV, V81, P51, DOI 10.1016/j.earlhumdev.2004.10.003; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Bauer M, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.10.005; Brooks E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097160; Canal MM, 2009, CHRONOBIOL INT, V26, P1545, DOI 10.3109/07420520903398542; CHEN WJ, 1993, GENET EPIDEMIOL, V10, P43, DOI 10.1002/gepi.1370100106; Chengappa KNR, 2003, AM J PSYCHIAT, V160, P1636, DOI 10.1176/appi.ajp.160.9.1636; CIA, 2013, WORLD FACTB 2013 14; Daglas R, 2014, AUST NZ J PSYCHIAT, V48, P1017, DOI 10.1177/0004867414545672; DIN. Deutsches Institut fur Normung, 2011, OPT RAD, P5031; Erren TC, 2011, CHRONOBIOL INT, V28, P471, DOI 10.3109/07420528.2011.577542; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Fountoulakis KN, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-3; Gilman S. E., 2014, MOL PSYCHIAT; GLOTZBACH SF, 1994, PEDIATRICS, V94, P482; Hao HP, 1999, P NATL ACAD SCI USA, V96, P2426, DOI 10.1073/pnas.96.5.2426; Harrison Y, 2004, J SLEEP RES, V13, P345, DOI 10.1111/j.1365-2869.2004.00435.x; HEIMBUCH RC, 1980, AM J HUM GENET, V32, P564; IES. Illuminating Engineering Society of North America, 2008, TM1808 IES; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; MANN NP, 1986, BRIT MED J, V293, P1265; MCMILLEN IC, 1991, PEDIATR RES, V29, P381, DOI 10.1203/00006450-199104000-00010; MILLER CL, 1995, INFANT BEHAV DEV, V18, P87, DOI 10.1016/0163-6383(95)90010-1; NASA, 2012, SURF MET SOL EN SSE; Ng TH, 2015, SLEEP MED REV, V20, P46, DOI 10.1016/j.smrv.2014.06.006; Rivkees SA, 1997, P NATL ACAD SCI USA, V94, P292, DOI 10.1073/pnas.94.1.292; Rivkees SA., 2007, SLEEP MED CLIN, V2, P331, DOI 10.1016/j.jsmc.2007.05.010; Rivkees SA, 2004, PEDIATRICS, V113, P833, DOI 10.1542/peds.113.4.833; ROBINSON J, 1990, ARCH DIS CHILD, V65, P35; Tiwari GN, 2010, RSC ENERGY SER, P1; Watanabe Shimpei, 2013, Front Endocrinol (Lausanne), V4, P113, DOI 10.3389/fendo.2013.00113; Weil ZM, 2006, AM J PHYSIOL-REG I, V290, pR1714, DOI 10.1152/ajpregu.00869.2005; Westall CA, 1999, DOC OPHTHALMOL, V96, P355; Wirz-Justice A, 2006, INT CLIN PSYCHOPHARM, V21, pS11, DOI 10.1097/01.yic.0000195660.37267.cf; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	75	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	MAY	2015	64						1	8		10.1016/j.jpsychires.2015.03.013		8	Psychiatry	Psychiatry	CH9FS	WOS:000354342000001		
J	Nagaki, A				Nagaki, Aiichiro			Synthetic Chemistry in Flow Microreactors	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						flow chemistry; microreactor; new methodology; fast mixing; precise residence time control; precise temperature control	CONTROLLED ANIONIC-POLYMERIZATION; IN-SITU GENERATION; MICROFLOW-SYSTEM; ORGANIC-SYNTHESIS; BLOCK-COPOLYMERS; FLASH CHEMISTRY; ORGANOLITHIUM REACTIONS; TRANSFER HYDROGENATION; ALKOXYCARBONYL GROUPS; MULTISTEP SYNTHESIS	Flow microreactor, new methodology that can change the whole concept of conventional synthetic chemistry, has attracted a lot of attention from both academia and industry. This paper describes the progress and brief history of the flow microreactor research, and then discusses features of various flow reactors, reaction types suitable for flow microreactor, advantages over conventional batch reactors, and the future development in this field.	Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Nagaki, A (reprint author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	anagaki@sbchem.kyoto-u.ac.jp					Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; Yamada YMA, 2012, CHEMSUSCHEM, V5, P293, DOI 10.1002/cssc.201100418; McMullen JP, 2010, ANNU REV ANAL CHEM, V3, P19, DOI 10.1146/annurev.anchem.111808.073718; Serra CA, 2008, CHEM ENG TECHNOL, V31, P1099, DOI 10.1002/ceat.200800219; Knowles JP, 2012, BEILSTEIN J ORG CHEM, V8, P2025, DOI 10.3762/bjoc.8.229; Nagaki A, 2014, CHEM-EUR J, V20, P7931, DOI 10.1002/chem.201402520; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Nagaki A, 2010, CHEM-EUR J, V16, P11167, DOI 10.1002/chem.201000876; Fukuyama T, 2002, ORG LETT, V4, P1691, DOI 10.1021/ol0257732; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Usutani H, 2007, J AM CHEM SOC, V129, P3046, DOI 10.1021/ja068330s; Tonhauser C, 2012, MACROMOLECULES, V45, P9551, DOI 10.1021/ma301671x; Nagaki A, 2005, J AM CHEM SOC, V127, P11666, DOI 10.1021/ja0527424; Ehrich H, 2002, CHIMIA, V56, P647, DOI 10.2533/000942902777680063; Riva E, 2010, TETRAHEDRON, V66, P3242, DOI 10.1016/j.tet.2010.02.078; Nagaki A, 2009, ANGEW CHEM INT EDIT, V48, P8063, DOI 10.1002/anie.200904316; Wakami H, 2005, ORG PROCESS RES DEV, V9, P787, DOI 10.1021/op0501500; Sahoo HR, 2007, ANGEW CHEM INT EDIT, V46, P5704, DOI 10.1002/anie.200701434; Tanaka K, 2007, ORG LETT, V9, P299, DOI 10.1021/ol062777o; Ceylan S, 2011, CHEM-EUR J, V17, P1884, DOI 10.1002/chem.201002291; Nagaki A, 2004, J AM CHEM SOC, V126, P14702, DOI 10.1021/ja044879k; Hartung A, 2007, J ORG CHEM, V72, P10235, DOI 10.1021/jo701758p; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/nchem.1753, 10.1038/NCHEM.1753]; Nagaki A, 2012, CHEM COMMUN, V48, P11211, DOI 10.1039/c2cc36197c; CHEN LS, 1980, J ORGANOMET CHEM, V193, P283, DOI 10.1016/S0022-328X(00)90287-0; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Nagaki A, 2007, CHEM-ASIAN J, V2, P1513, DOI 10.1002/asia.200700231; Nagaki A, 2015, ANGEW CHEM INT EDIT, V54, P1914, DOI 10.1002/anie.201410717; Yoshida J, 2013, CHEM COMMUN, V49, P9896, DOI 10.1039/c3cc44709j; Nagaki A, 2008, MACROMOLECULES, V41, P6322, DOI 10.1021/ma800769n; Wurm F, 2008, MACROMOL CHEM PHYS, V209, P1106, DOI 10.1002/macp.200700613; Kobayashi J, 2006, CHEM-ASIAN J, V1, P22, DOI 10.1002/asia.200600058; Nagaki A, 2012, ANGEW CHEM INT EDIT, V51, P3245, DOI 10.1002/anie.201108932; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Kawaguchi T, 2005, ANGEW CHEM INT EDIT, V44, P2413, DOI 10.1002/anie.200462466; Cantillo D, 2012, ANGEW CHEM INT EDIT, V51, P10190, DOI 10.1002/anie.201205792; Nagaki A, 2014, J AM CHEM SOC, V136, P12245, DOI 10.1021/ja5071762; Nagaki A, 2008, CHEM-ASIAN J, V3, P1558, DOI 10.1002/asia.200800081; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Watts P, 2005, CHEM SOC REV, V34, P235, DOI 10.1039/b313866f; Geyer K, 2006, CHEM-EUR J, V12, P8434, DOI 10.1002/chem.200600596; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Fuse S, 2011, CHEM COMMUN, V47, P12661, DOI 10.1039/c1cc15662d; Hessel V, 2004, ORG PROCESS RES DEV, V8, P511, DOI 10.1021/op0341768; Nagaki A, 2008, ANGEW CHEM INT EDIT, V47, P7833, DOI 10.1002/anie.200803205; Fukuyama T, 2011, J FLOW CHEM, V1, P40, DOI 10.1556/jfchem.2011.00007; Hartman RL, 2009, LAB CHIP, V9, P2495, DOI 10.1039/b906343a; Basavaraju KC, 2013, ANGEW CHEM INT EDIT, V52, P6735, DOI 10.1002/anie.201301124; Ehrfeld W, 1999, IND ENG CHEM RES, V38, P1075, DOI 10.1021/ie980128d; Nguyen JD, 2013, CHEM COMMUN, V49, P4352, DOI 10.1039/c2cc37206a; Schwalbe T, 2004, ORG PROCESS RES DEV, V8, P440, DOI 10.1021/op049970n; Doku GN, 2005, TETRAHEDRON, V61, P2733, DOI 10.1016/j.tet.2005.01.028; Guetzoyan L, 2013, CHEM SCI, V4, P764, DOI 10.1039/c2sc21850j; Ahmed-Omer B, 2007, ORG BIOMOL CHEM, V5, P733, DOI 10.1039/b615072a; Amii H, 2013, BEILSTEIN J ORG CHEM, V9, P2793, DOI 10.3762/bjoc.9.314; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Lin WY, 2009, NANO TODAY, V4, P470, DOI 10.1016/j.nantod.2009.10.007; Nagaki A, 2011, RSC ADV, V1, P758, DOI 10.1039/c1ra00377a; Nagaki A, 2012, CHEM-EUR J, V18, P11871, DOI 10.1002/chem.201201579; Suga S, 2001, J AM CHEM SOC, V123, P7941, DOI 10.1021/ja015823i; Kozak JA, 2013, J AM CHEM SOC, V135, P18497, DOI 10.1021/ja4079094; Brancour C, 2013, ORG LETT, V15, P2794, DOI 10.1021/ol401092a; Pieber B, 2013, ANGEW CHEM INT EDIT, V52, P10241, DOI 10.1002/anie.201303528; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Nagaki A, 2013, CHEM COMMUN, V49, P3242, DOI 10.1039/c3cc40392k; Webb D, 2012, ORG LETT, V14, P568, DOI 10.1021/ol2031872; Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c; Iwasaki T, 2005, MACROMOLECULES, V38, P1159, DOI 10.1021/ma048369m; Fukuyama T, 2014, GREEN CHEM, V16, P2042, DOI 10.1039/c3gc41789a; Tomida Y, 2011, J AM CHEM SOC, V133, P3744, DOI 10.1021/ja110898s; Baxendale IR, 2009, ANGEW CHEM INT EDIT, V48, P4017, DOI 10.1002/anie.200900970; Horii D, 2007, J AM CHEM SOC, V129, P11692, DOI 10.1021/ja075180s; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Hopkin MD, 2011, CHIM OGGI, V29, P28; Nagaki A, 2009, MACROMOLECULES, V42, P4384, DOI 10.1021/ma900551a; Mason BP, 2007, CHEM REV, V107, P2300, DOI 10.1021/cr050944c; Uozumi Y, 2006, J AM CHEM SOC, V128, P15994, DOI 10.1021/ja066697r; Baumann M, 2008, SYNLETT, P2111, DOI 10.1055/s-2008-1078026; Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012; Baxendale I. R., 2012, AUST J CHEM, V66, P131, DOI 10.1071/CH12365; Chiba H, 2011, J SYN ORG CHEM JPN, V69, P600; Ducry L, 2005, ANGEW CHEM INT EDIT, V44, P7972, DOI 10.1002/anie.200502387; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Fukuyama T, 2009, BEILSTEIN J ORG CHEM, V5, DOI 10.3762/bjoc.5.34; Gutmann B., ANGEW CHEM IN PRESS, P54; Heinichen H., 2001, CHEM TECH, V30, P89; Hisamoto H, 2001, CHEM COMMUN, P2662, DOI 10.1039/b106494k; Katayama H, 2013, CHEM LETT, V42, P471, DOI 10.1246/cl.130061; Kim H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1264; Kirschning A, 2012, CHEM LETT, V41, P562, DOI 10.1246/cl.2012.562; Kurahashi K, 2012, CHEMSUSCHEM, V5, P270, DOI 10.1002/cssc.201100373; Ley SV, 2000, J CHEM SOC PERK T 1, P3815, DOI 10.1039/b006588i; Midorikawa K, 2006, CHEM COMMUN, P3794, DOI 10.1039/b607284d; Munoz JD, 2012, GREEN CHEM, V14, P1335, DOI 10.1039/c2gc35037h; Nagaki A, 2011, ORG BIOMOL CHEM, V9, P7559, DOI 10.1039/c1ob06350b; Nagaki A, 2008, ORG LETT, V10, P3937, DOI 10.1021/ol8015572; Nagaki A., 2010, KOBUNSHI, V59, P569; Nagaki A, 2013, J SYN ORG CHEM JPN, V71, P1002; Nagaki A, 2011, KOBUNSHI RONBUNSHU, V68, P521; Nagaki A, 2013, ADV POLYM SCI, V259, P1, DOI 10.1007/12_2012_179; Nagaki A, 2010, MACROMOLECULES, V43, P8424, DOI 10.1021/ma101663x; Nagaki A., 2012, J CHEM EDUC, V60, P190; Nagaki A, 2014, J FLOW CHEM, V4, P168, DOI 10.1556/JFC-D-14-00017; Nagaki A, 2012, MACROMOL REACT ENG, V6, P467, DOI 10.1002/mren.201200051; Nagaki A, 2010, CHEM-EUR J, V16, P14149, DOI 10.1002/chem.201000815; Polyzos A., 2011, ANGEW CHEM INT EDIT, V49, P1190; RYS P, 1976, ACCOUNTS CHEM RES, V9, P345, DOI 10.1021/ar50106a001; Schepper S. C. K. D., 2008, CHEM ENG J, V138, P349; Suga S, 2003, ORG LETT, V5, P945, DOI 10.1021/ol0341243; Suzuki T, 2012, CHEM LETT, V41, P541, DOI 10.1246/cl.2012.541; Takasuga M, 2006, J CHEM ENG JPN, V39, P772, DOI 10.1252/jcej.39.772; Yoshida J, 2005, CHEM COMMUN, P4509, DOI 10.1039/b508341a; Yoshida J., 2009, KAGAKU, V64, P22; Yoshida Jun-ichi, 2013, Drug Discov Today Technol, V10, pe53, DOI 10.1016/j.ddtec.2012.10.013; Yoshida J., 2011, SYNLETT, V9, P1189; Yoshida M, 2014, EUR J ORG CHEM, P6010, DOI 10.1002/ejoc.201402675	118	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					423	434				12	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000003		
J	Matsubara, S				Matsubara, Seijiro			Organozinc Reagents in a Flow-microreactor -From Methylenation to Asymmetric Autocatalysis-	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						integrated synthesis; flow-micro; flash chemistry; methylenation; oxy-Cope rearrangement; Soai reaction; autocatalysis	MICROFLOW SYSTEM; CYCLOHEPTANE RING; BIS(IODOZINCIO)METHANE; GENERATION; 1,2-DIKETONE; CHEMISTRY; CATALYST	A flow-micro reactor can integrate the simple reactions to complete the molecular transformation consisting from many steps. Especially, it can set the most preferable reaction conditions including the temperature and the period to each reaction; the sequence of steps is also able to be planned precisely either in linear or parallel configuration. The method had already shown the great success in the flash chemistry, which uses reactive, unstable, and short-lived intermediates to perform the multi-step organic synthesis efficiently in the flow. On the other hand, a flow-micro reactor shows the efficiency in the classical one-pot reaction, as it can exclude the sensitive product from the starting substrate and the reagent by a flow. We introduced our recent results of the selective methylenation of telephthaldehyde and [6+1] type cycloheptane-ring synthesis using a micro-flow reactor. In addition, we show the Soai asymmetric autocatalysis and amplification reaction by a micro-flow system. The system show the high performance of the Soai reaction clearly and efficiently; the amplification of enantiomeric excess was observed clearly.	Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Matsubara, S (reprint author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	matsubara.seijiro.2e@kyoto-u.ac.jp					Tanaka K, 2009, ORG PROCESS RES DEV, V13, P983, DOI 10.1021/op900084f; Yoshida J, 2013, CHEM COMMUN, V49, P9896, DOI 10.1039/c3cc44709j; Soai K, 2003, TETRAHEDRON-ASYMMETR, V14, P185, DOI 10.1016/S0957-4166(02)00791-7; Sada M, 2010, J AM CHEM SOC, V132, P17452, DOI 10.1021/ja104439w; Fuse S, 2011, CHEM COMMUN, V47, P12661, DOI 10.1039/c1cc15662d; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Minakawa M, 2013, ORG LETT, V15, P5798, DOI 10.1021/ol4028495; Amii H, 2013, BEILSTEIN J ORG CHEM, V9, P2793, DOI 10.3762/bjoc.9.314; Nagaki A, 2012, CHEM-EUR J, V18, P11871, DOI 10.1002/chem.201201579; Tomida Y, 2011, J AM CHEM SOC, V133, P3744, DOI 10.1021/ja110898s; Tsutsumi K, 2010, CHEM LETT, V39, P828, DOI 10.1246/cl.2010.828; Fukuyama T, 2012, SYNTHESIS-STUTTGART, V44, P2555, DOI 10.1055/s-0031-1290780; Haraguchi R, 2015, ORG BIOMOL CHEM, V13, P241, DOI 10.1039/c4ob01474j; Haraguchi R, 2012, CHEM LETT, V41, P628, DOI 10.1246/cl.2012.628; Ishigaki Y, 2011, MATERIALS, V4, P1906, DOI 10.3390/ma4111906; Katayama H, 2013, CHEM LETT, V42, P471, DOI 10.1246/cl.130061; Kawasaki T, 2014, ANGEW CHEM INT EDIT, V53, P11199, DOI 10.1002/anie.201405441; Kim H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1264; Matsubara S, 2007, J SYN ORG CHEM JPN, V65, P194; Mizota L, 2013, CHEM LETT, V42, P995; Nagaki A, 2013, J SYN ORG CHEM JPN, V71, P1002; Sada M., 2014, SYNLETT, P2831; Singleton DA, 2002, J AM CHEM SOC, V124, P10010, DOI 10.1021/ja027129o; Soai K, 2014, CHEM REC, V14, P70, DOI 10.1002/tcr.201300028; Soai K, 2002, J SYN ORG CHEM JPN, V60, P668; Takada Y, 2010, ORG LETT, V12, P5204, DOI 10.1021/ol102237b; Takada Y, 2011, CHEM LETT, V40, P364, DOI 10.1246/cl.2011.364; Ukai K, 2000, J AM CHEM SOC, V122, P12047, DOI 10.1021/ja003360v; Umezu S, 2014, TETRAHEDRON LETT, V55, P1822, DOI 10.1016/j.tetlet.2014.01.147; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946; Yoshida Jun-ichi, 2013, Drug Discov Today Technol, V10, pe53, DOI 10.1016/j.ddtec.2012.10.013	31	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					435	441				7	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000004		
J	Fuse, S; Takahashi, T				Fuse, Shinichiro; Takahashi, Takashi			Efficient Organic Synthesis based on Micro-flow Photo-reaction, Imidoylation, and Acylation	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						micro-flow; photo-reaction; thermal reaction; imidoylation; acylation; natural product; peptide; vitamin D; aurilide; diimine	AMIDE BOND FORMATION; HARE DOLABELLA-AURICULARIA; PEPTIDE COUPLING REAGENTS; D ENDOCRINE SYSTEM; VITAMIN-D; AUTOMATED SYNTHESIZER; AURILIDE ANALOGS; NATURAL-PRODUCTS; CHEMISTRY; PHOTOCHEMISTRY	Micro-flow synthesis has advantages over conventional batch synthesis such as precise control of the reaction time (<1 sec) and temperature by rapid mixing and high heat and mass transfer. In addition, light-penetration efficiency can be improved in photo-reactions due to the thinness of micro-flow reactors. Moreover, scale-up can be readily achieved with high reproducibility either by continuous running or by numbering up of micro-flow reactors. Increasing number of highly efficient reactions and syntheses have been reported based on micro-flow technology in recent years. We have also developed efficient micro-flow photo-reaction, imidoylation, and acylation by taking the advantages of micro-flow technology. Herein, we wish to report our synthesis of bioactive vitamin D-3, its analogues and alpha-aryl carbonyl compounds based on the micro-flow photo-reaction as well as the synthesis of diimine ligands for olefin polymerization catalysts and peptides based on the micro-flow imidoylation and acylation.	[Fuse, Shinichiro] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Yokohama Coll Pharm, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Fuse, S (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.		Fuse, Shinichiro/B-9396-2015	Fuse, Shinichiro/0000-0002-6836-4180			Ittel SD, 2000, CHEM REV, V100, P1169, DOI 10.1021/cr9804644; Wang SL, 2014, J ORGANOMET CHEM, V751, P717, DOI 10.1016/j.jorganchem.2013.08.021; Knowles JP, 2012, BEILSTEIN J ORG CHEM, V8, P2025, DOI 10.3762/bjoc.8.229; Fuse S, 2012, ORG BIOMOL CHEM, V10, P5205, DOI 10.1039/c2ob25511a; Willumstad TP, 2013, J ORG CHEM, V78, P11450, DOI 10.1021/jo402010b; El-Faham A, 2011, CHEM REV, V111, P6557, DOI 10.1021/cr100048w; Ramesh S, 2014, AMINO ACIDS, V46, P2091, DOI 10.1007/s00726-014-1776-1; Fuse S, 2013, BEILSTEIN J ORG CHEM, V9, P2336, DOI 10.3762/bjoc.9.268; ECKERT H, 1987, ANGEW CHEM INT EDIT, V26, P894, DOI 10.1002/anie.198708941; Doi T, 2006, CHEM-ASIAN J, V1, P370, DOI 10.1002/asia.200600156; Nakamura A, 2009, CHEM REV, V109, P5215, DOI 10.1021/cr900079r; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Garbarino S, 2014, J ORG CHEM, V79, P3615, DOI 10.1021/jo500535f; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Protasova LN, 2013, ORG PROCESS RES DEV, V17, P760, DOI 10.1021/op4000169; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Han SY, 2004, TETRAHEDRON, V60, P2447, DOI 10.1016/j.tet.2004.01.020; Fuse S, 2011, CHEM COMMUN, V47, P12661, DOI 10.1039/c1cc15662d; Franssen NMG, 2013, CHEM SOC REV, V42, P5809, DOI 10.1039/c3cs60032g; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Azoulay JD, 2009, ANGEW CHEM INT EDIT, V48, P1089, DOI 10.1002/anie.200804661; Oelgemoller M, 2011, MOLECULES, V16, P7522, DOI 10.3390/molecules16097522; Amii H, 2013, BEILSTEIN J ORG CHEM, V9, P2793, DOI 10.3762/bjoc.9.314; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Su YH, 2014, CHEM-EUR J, V20, P10562, DOI 10.1002/chem.201400283; Fuse S, 2014, ANGEW CHEM INT EDIT, V53, P851, DOI 10.1002/anie.201307987; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; Hessel V, 2013, CHEMSUSCHEM, V6, P746, DOI 10.1002/cssc.201200766; Chen EYX, 2009, CHEM REV, V109, P5157, DOI 10.1021/cr9000258; Baumann M, 2011, MOL DIVERS, V15, P613, DOI 10.1007/s11030-010-9282-1; Schuster EM, 2014, ISR J CHEM, V54, P361, DOI 10.1002/ijch.201400045; Hook BDA, 2005, J ORG CHEM, V70, P7558, DOI 10.1021/jo050705p; Sato S, 2011, CHEM BIOL, V18, P131, DOI 10.1016/j.chembiol.2010.10.017; Takeuchi D, 2011, MACROMOL CHEM PHYS, V212, P1545, DOI 10.1002/macp.201100182; ZHU GD, 1995, CHEM REV, V95, P1877, DOI 10.1021/cr00038a007; Myers RM, 2014, CHEM-EUR J, V20, P12348, DOI 10.1002/chem.201402801; Montalbetti CAGN, 2005, TETRAHEDRON, V61, P10827, DOI 10.1016/j.tet.2005.08.031; Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Baier MC, 2014, ANGEW CHEM INT EDIT, V53, P9722, DOI 10.1002/anie.201400799; Baxendale I. R., 2012, AUST J CHEM, V66, P131, DOI 10.1071/CH12365; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; COOPER FC, 1951, J CHEM SOC, P391, DOI 10.1039/jr9510000391; DAUBEN WG, 1982, J AM CHEM SOC, V104, P355, DOI 10.1021/ja00365a093; DAUBEN WG, 1982, J AM CHEM SOC, V104, P5780, DOI 10.1021/ja00385a037; Doi T, 1999, J AM CHEM SOC, V121, P6749, DOI 10.1021/ja990739c; Doi T, 2004, TETRAHEDRON LETT, V45, P5727, DOI 10.1016/j.tetlet.2004.05.125; ETTINGER RA, 1996, ADV DRUG RES, V28, P269, DOI 10.1016/S0065-2490(96)80007-4; Fuse S, 2012, J SYN ORG CHEM JPN, V70, P177; Fuse S, 2010, CHEM COMMUN, V46, P8722, DOI 10.1039/c0cc02239j; Fuse S, 2011, ORG BIOMOL CHEM, V9, P3825, DOI 10.1039/c0ob01169j; Kashiwagi T, 2014, J SYN ORG CHEM JPN, V72, P506; Machida K, 2010, CHEM PHARM BULL, V58, P87; Mifune Y, 2014, J FLOW CHEM, V4, P173, DOI 10.1556/JFC-D-14-00015; Mutou T., 1997, SYNLETT, V199; Nagaki A, 2013, J SYN ORG CHEM JPN, V71, P1002; Nishiyama Y, 2014, J FLOW CHEM, V4, P185, DOI 10.1556/JFC-D-14-00012; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; OKABE M, 1995, J ORG CHEM, V60, P767, DOI 10.1021/jo00108a055; Posner G. H., 2001, J AM CHEM SOC, V123, P3716; Rafael R., 2008, PCT Wo08/128782, Patent No. 08128782; SATO T, 1980, J NUTR SCI VITAMINOL, V26, P545; Suenaga K, 2004, TETRAHEDRON, V60, P8509, DOI 10.1016/j.tet.2004.06.125; Suenaga K, 2008, BIOORG MED CHEM LETT, V18, P3902, DOI 10.1016/j.bmcl.2008.06.035; Suenaga K, 1996, TETRAHEDRON LETT, V37, P6771, DOI 10.1016/S0040-4039(96)01464-5; Sumino Y, 2012, J SYN ORG CHEM JPN, V70, P896; Takahashi T, 2003, J COMB CHEM, V5, P414, DOI 10.1021/cc020091r; Takahashi T, 2012, NEW STRATEGIES CHEM, P33; Takahashi T, 2011, J SYN ORG CHEM JPN, V69, P379; Tanaka Y, 2009, ORG PROCESS RES DEV, V13, P1111, DOI 10.1021/op9002455; Terao K, 2014, J FLOW CHEM, V4, P35, DOI 10.1556/JFC-D-13-00035; Tsubogo T, 2014, J SYN ORG CHEM JPN, V72, P484; Vaske YSM, 2010, J AM CHEM SOC, V132, P11379, DOI 10.1021/ja1050023; Hutchings MJ, 2013, MICROREACTORS IN ORGANIC CHEMISTRY AND CATALYSIS, 2ND EDITION, P197; Yamamoto T, 2011, J SYN ORG CHEM JPN, V69, P526	77	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					442	451				10	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000005		
J	Fukase, K; Shimoyama, A; Manabe, Y				Fukase, Koichi; Shimoyama, Atsushi; Manabe, Yoshiyuki			Effective Synthesis of Oligosaccharide under Microfiuidic Conditions	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						alpha-sialylation; beta-mannosylation; N-glycosylation; alpha-Kdo glycosylation; dehydration; photo-bromination; aldol reaction; microreactor	STEREOSELECTIVE-SYNTHESIS; MICROFLUIDIC CONDITIONS; ALPHA-SIALYLATION; N-GLYCOSYLATION; SIALIC-ACID; MICROREACTOR; DONOR; KEY; MANNOSYLATION; SYSTEM	Continuous microflow synthesis is an innovative technology for chemical processes from small-scale synthesis to large-scale production. This technology enables fast and efficient mixing, rapid heating and cooling, strict temperature control, precise residence time control, and effective mass transfer. Moreover, once the reaction conditions are optimized for a small-scale operation, the same conditions are directly applicable to large-scale synthesis under the flow process. We successfully developed the alcohol dehydration process using microreactor and applied it to the large-scale production of saturated terpenoid pristane, which has been used as an adjuvant for monoclonal antibody production in mice. We then have been investigating to apply the advantageous features of the microfluidic systems to oligosaccharide synthesis. Our successful examples include alpha-sialylation, beta-mannosylation, N-glycosylation on asparagine, alpha-selective glycosylation of 3-deoxy-D-manno-2-octulosonic acid (Kdo), and photo-bromination of toluene derivatives.	[Fukase, Koichi; Shimoyama, Atsushi; Manabe, Yoshiyuki] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Fukase, K (reprint author), Osaka Univ, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	koichi@chem.sci.osaka-u.ac.jp; ashimo@chem.sci.osaka-u.ac.jp; manabey12@chem.sci.osaka-u.ac.jp					Tanaka K, 2007, ORG LETT, V9, P299, DOI 10.1021/ol062777o; Tanaka K, 2009, ORG PROCESS RES DEV, V13, P983, DOI 10.1021/op900084f; Tanaka H, 2006, J AM CHEM SOC, V128, P7124, DOI 10.1021/ja0613613; Flogel O, 2006, ANGEW CHEM INT EDIT, V45, P7000, DOI 10.1002/anie.200602167; Podvalnyy NM, 2014, J CARBOHYD CHEM, V33, P213, DOI 10.1080/07328303.2014.913058; Tanaka K, 2008, TETRAHEDRON LETT, V49, P2010, DOI 10.1016/j.tetlet.2008.01.057; Tanaka K, 2009, CHEM-ASIAN J, V4, P574, DOI 10.1002/asia.200800411; Ehrfeld W., 1999, MICROREACT TECHNOL I, V3rd, P14; Fukase K, 2005, SYNLETT, P2342, DOI 10.1055/s-2005-872269; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Fuse S, 2014, SYNLETT, V25, P2087, DOI 10.1055/s-0034-1378244; Kononov L. O., 2013, ADV CHEM RES, V18, P143; Kononov LO, 2009, EUR J ORG CHEM, P611, DOI 10.1002/ejoc.200801017; Kononov LO, 2008, EUR J ORG CHEM, P3251, DOI 10.1002/ejoc.200800324; Nokami T, 2012, CARBOHYD RES, V363, P1, DOI 10.1016/j.carres.2012.09.023; Ratner DM, 2005, CHEM COMMUN, P578, DOI 10.1039/b414503h; Shimoyama A, 2011, CHEM-EUR J, V17, P14464, DOI 10.1002/chem.201003581; Shimoyama A., 2011, SYNLETT, P2359; Tanaka H, 2005, J AM CHEM SOC, V127, P1630, DOI 10.1021/ja0450298; Tanaka K., 2011, MIRAI ZAIRYO, V11, P11; Tanaka K, 2009, SYNLETT, P1571, DOI 10.1055/s-0029-1217343; Tanaka K, 2009, J CARBOHYD CHEM, V28, P1, DOI 10.1080/07328300802571129; Tanaka K, 2007, SYNLETT, P164, DOI 10.1055/s-2006-958410; Tanaka S, 2005, SYNLETT, P2325, DOI 10.1055/s-2005-872678; Tanaka SI, 2007, J CARBOHYD CHEM, V26, P369, DOI 10.1080/07328300701634796; Uchinashi Y, 2011, ORG BIOMOL CHEM, V9, P7243, DOI 10.1039/c1ob06164j; Uchinashi Y, 2014, J CARBOHYD CHEM, V33, P55, DOI 10.1080/07328303.2014.880116; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946; Yoshida J.-i., 2014, FLOW CHEM, V59	29	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					452	459				8	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000006		
J	Nishiyama, Y; Mizuno, K				Nishiyama, Yasuhiro; Mizuno, Kazuhiko			Highly Efficient and Selective Diastereodifferentiating Organic Photoreactions Using Flow Microreactor	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						flow microreactor; asymmetric photoreaction; [2+2] photocycloaddition; Paterno-Buchi reaction; capillary flowreactor; slug flow; ethylene; chiral auxiliary; menthol	DIASTEREOSELECTIVE 2+2 PHOTOCYCLOADDITION; CYCLOHEXENONE CARBOXYLATES; PHOTOCHEMICAL-REACTIONS; MICROCAPILLARY REACTOR; CHIRAL CYCLOHEXENONE; LIGHT; ETHYLENE; PHOTOCYCLIZATION; CYCLOPENTENE; ENHANCEMENT	This article describes the highly efficient asymmetric photoreactions using flow microreactor. Organic photochemical reactions are highly effective methods forming complicated or distorted structures that cannot be obtained easily by conventional thermal reactions. On the other hand, photoreactions suffer from low reaction efficiency in common batch reactors owing to low light penetration. To solve this problem, microreactors have recently been fascinated. The asymmetric [2+2] photocycloadditions performed in both hand-made capillary reactors and purchased microreactors, and could be achieved higher diastereoselectivity and productivity than those in batch reactors. Additionally, the Paterno-Buchi type photoreactions in slug flow conditions with organic layer and unreactive layer (water or nitrogen gas) showed the unprecedented enhancement on reaction efficiency. These results demonstrate the good potential of micro flowreactor to achieve the efficient organic photoreactions not only in the lab scale chemistry but also in the process chemistry.	[Nishiyama, Yasuhiro] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Ikoma 6300192, Japan	Nishiyama, Y (reprint author), Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, 8916-5 Takayama, Ikoma 6300192, Japan.	y-west@ms.naist.jp; kmizuno@ms.naist.jp					Knowles JP, 2012, BEILSTEIN J ORG CHEM, V8, P2025, DOI 10.3762/bjoc.8.229; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Willumstad TP, 2013, J ORG CHEM, V78, P11450, DOI 10.1021/jo402010b; Namyslo JC, 2003, CHEM REV, V103, P1485, DOI 10.1021/cr010010y; Asano K, 2013, ORG LETT, V15, P2398, DOI 10.1021/ol4008519; Liao HH, 2013, CHEM COMMUN, V49, P7953, DOI 10.1039/c3cc43996h; Coyle EE, 2008, PHOTOCH PHOTOBIO SCI, V7, P1313, DOI 10.1039/b808778d; Cantillo D, 2014, ORG LETT, V16, P896, DOI 10.1021/ol403650y; Tsutsumi K, 2010, CHEM-EUR J, V16, P7448, DOI 10.1002/chem.201000429; Cantillo D, 2014, J ORG CHEM, V79, P223, DOI 10.1021/jo402409k; Yang C, 2014, CHEM SOC REV, V43, P4123, DOI 10.1039/c3cs60339c; Fukuyama T, 2011, J FLOW CHEM, V1, P40, DOI 10.1556/jfchem.2011.00007; Matsushita Y, 2007, PURE APPL CHEM, V79, P1959, DOI 10.1351/pac200779111959; Terao K, 2012, J PHOTOCH PHOTOBIO A, V242, P13, DOI 10.1016/j.jphotochem.2012.05.021; Lefebvre Q, 2013, BEILSTEIN J ORG CHEM, V9, P1883, DOI 10.3762/bjoc.9.221; Sakamoto M, 2006, J PHOTOCH PHOTOBIO C, V7, P183, DOI 10.1016/j.jphotochemrev.2006.11.002; Muller C, 2008, AUST J CHEM, V61, P557, DOI 10.1071/CH08195; Maeda H, 2005, CHEM LETT, V34, P66, DOI 10.1246/cl.2005.66; Hook BDA, 2005, J ORG CHEM, V70, P7558, DOI 10.1021/jo050705p; Shvydkiv O, 2011, PHOTOCH PHOTOBIO SCI, V10, P1399, DOI 10.1039/c1pp05024a; Tsutsumi K, 2010, CHEM LETT, V39, P828, DOI 10.1246/cl.2010.828; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Furutani A, 2004, TETRAHEDRON LETT, V45, P7621, DOI 10.1016/j.tetlet.2004.08.102; GOTTHARDT H, 1979, ANGEW CHEM INT EDIT, V18, P868, DOI 10.1002/anie.197908681; Inhulsen I, 2013, TETRAHEDRON, V69, P782, DOI 10.1016/j.tet.2012.10.074; Inoue Y., 2004, CHIRAL PHOTOCHEMISTR; Lide D, 2009, CRC HDB CHEM PHYS; Manabe Y, 2014, CHEM-EUR J, V20, P12750, DOI 10.1002/chem.201402303; Mifune Y., 2014, J FLOW CHEM, V4, P172; Nishiyama Y, 2013, J ORG CHEM, V78, P7186, DOI 10.1021/jo401126p; Nishiyama Y., 2014, J FLOW CHEM, V4, P184; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; Okamoto H, 2014, CHEM LETT, V43, P994, DOI 10.1246/cl.140182; Ouchi A., 2014, J FLOW CHEM, V4, P189; Ramamurthy V., 2011, SUPRAMOLECULAR PHOTO; Sakeda K, 2007, J PHOTOCH PHOTOBIO A, V192, P166, DOI 10.1016/j.jphotochem.2007.05.019; Terao K, 2012, J FLOW CHEM, V2, P73, DOI 10.1556/JFC-D-12-00005; Terao K, 2014, J FLOW CHEM, V4, P35, DOI 10.1556/JFC-D-13-00035; Tsutsumi K, 2004, J ORG CHEM, V69, P785, DOI 10.1021/jo0354746	39	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					460	468				9	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000007		
J	Nagasawa, Y; Yamaguchi, E; Tada, N; Itoh, A				Nagasawa, Yoshitomo; Yamaguchi, Eiji; Tada, Norihiro; Itoh, Akichika			Study of Aerobic-Photooxidation Reactions with Continuous Flow Micro Reactor	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						aerobic photo-oxidation; molecular oxygen; visible light irradiation; flow micro reactor; glass chip; slug flow; LED; internal circulation	VISIBLE-LIGHT IRRADIATION; PHOTOREDOX CATALYSIS; MERGING PHOTOREDOX; FLUORESCENT LAMP; SINGLET OXYGEN; OXIDATION; ARTEMISININ; ALDEHYDES; ALCOHOLS; IODINE	We studied catalytic photooxidation with molecular oxygen to improve the characteristics of the existing oxidation reactions and have found several oxidation methods using mild conditions. These oxidations are appealing in terms of green chemistry since they reduce waste, use molecular oxygen, and do not require heavy metals; however, longer reaction times were required to accomplish them in batch reactions. This is due to both a small specific interfacial area and a large decrease in the energy of light traveling through the reaction mixture. With these reaction characteristics in mind, we designed a glass continuous flow microreactor that can form a slug flow region on the chip and irradiate light effectively at a very close distance. In slug flow, internal circulation, accelerating the mixing of the gas and liquid phases and increasing the reaction rate, occurs within a slug. Furthermore, internal circulation flow prevents the liberation of precipitate on the channel walls and causing blockages in the channel. We examined the development of our aerobic photooxidation with our continuous flow microreactor that can form a slug flow region on the chip, and solved problems raised by using batch system as mentioned above. Although many reaction devices designed for photoreactions have been studied previously, the glass continuous flow microreactor, which had not been studied yet, is a very suitable reaction device for photoreactions. Here we report our detailed study of aerobic photooxidation with this microreactor.	[Nagasawa, Yoshitomo; Yamaguchi, Eiji; Tada, Norihiro; Itoh, Akichika] Gifu Pharmaceut Univ, Gifu 5011196, Japan	Nagasawa, Y (reprint author), Gifu Pharmaceut Univ, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ynagasawa.gpu@gmail.com; yamaguchi@gifu-pu.ac.jp; ntada@gifu-pu.ac.jp; itoha@gifu-pu.ac.jp					Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Nagaki A, 2014, CHEM-EUR J, V20, P7931, DOI 10.1002/chem.201402520; Kopetzki D, 2013, CHEM-EUR J, V19, P5450, DOI 10.1002/chem.201204558; Vanoye L, 2014, RSC ADV, V4, P57159, DOI 10.1039/c4ra12067a; Beatty JW, 2014, J AM CHEM SOC, V136, P10270, DOI 10.1021/ja506170g; Huo HH, 2014, NATURE, V515, P100, DOI 10.1038/nature13892; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Wootton RCR, 2002, ORG PROCESS RES DEV, V6, P187, DOI 10.1021/op0155155; Bourne RA, 2009, ANGEW CHEM INT EDIT, V48, P5322, DOI 10.1002/anie.200901731; [Anonymous], 1987, NIH CONSENS STATEMEN, V6, P1; Shidpour R, 2014, IND ENG CHEM RES, V53, P11973, DOI 10.1021/ie5021987; Nobuta T, 2013, RSC ADV, V3, P10189, DOI 10.1039/c3ra41850b; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525; Burns JR, 2001, LAB CHIP, V1, P10, DOI 10.1039/b102818a; Cui L., 2013, ADV SYNTH CATAL, V35, P2203; Echeverri LF, 2010, INT J HEAT MASS TRAN, V53, P2284, DOI 10.1016/j.ijheatmasstransfer.2009.11.020; Feynman R., 2005, FEYNMAN LECT PHYS DE; Hirashima S, 2007, GREEN CHEM, V9, P318, DOI 10.1039/b613931k; Hirashima S, 2007, PHOTOCH PHOTOBIO SCI, V6, P521, DOI 10.1039/b702703f; Kleemann A., 2008, PHARM SUBSTANCES, V5th; Larock R. C., 1999, COMPREHENSIVE ORGANI; Nakayama H, 2006, CHEM PHARM BULL, V54, P1620, DOI 10.1248/cpb.54.1620; Pollak P., 2011, FINE CHEM IND BUSINE; Taber DF, 2014, J ORG CHEM, V79, P3410, DOI 10.1021/jo500164x; Tada N, 2011, GREEN CHEM, V13, P1669, DOI 10.1039/c1gc15154a; Trost B. M., 1992, COMPREHENSIVE ORGANI; Wang X, 2014, MICROFLUID NANOFLUID, V16, P413, DOI 10.1007/s10404-013-1226-5; Yamashita A, 2007, IEEE INT CONF ROBOT, P4570, DOI 10.1109/ROBOT.2007.364183	29	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					469	474				6	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000008		
J	Kawanami, H				Kawanami, Hajime			The Development of New Organic Synthetic Method in High-Pressure and High-temperature Water by Using Microreactor System	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						high-pressure; high-temperature; supercritical; water; microreactor; Claisen rearrangement; nitration; C-C cross coupling; Sonogashira coupling	SUPERCRITICAL WATER	High-pressure and high-temperature water including supercritical water with its unique properties is considered as a green solvent; a suitable replacement of conventional organic solvents. Until to the date, there were little successful examples to conduct organic reactions using high-pressure and high-temperature (HPHT) water in batch-wise method. Recently, we developed a high-pressure and high-temperature water microreaction system, which can be successfully used to conduct various organic reactions, resulted high yield and high selectivity of desired products within a very short reaction time. For instance, Claisen rearrangement can be achieved with almost quantitative yields within a few minutes in the absence of catalysts as well as any organic solvents at the reaction temperature and pressure of 250 degrees C and 5 MPa, respectively. Furthermore, the microreaction system was also effective for palladium catalyzed cross coupling (Sonogashira coupling) and obtained almost 100% yields within the shortest reaction time of 0.1 s. The described system was advantageous in terms of the separation and purification of products due to the automatic separation of products from water. Successful application of the described microreaction system for various organic reactions without using any organic solvent make it a potential contender to the development of greener process not only in the small scale laboratory level but also will be extended to the industrial large scale production processes.	Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Organ Mat Synth Team, Miyagino Ku, Sendai, Miyagi 9838551, Japan	Kawanami, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Organ Mat Synth Team, Miyagino Ku, 4-2-1 Nigatake, Sendai, Miyagi 9838551, Japan.	h-kawanami@aist.go.jp					Kawanami H, 2011, CHEM ENG J, V167, P572, DOI 10.1016/j.cej.2010.09.084; Ohtomo Y, 2014, NAT GEOSCI, V7, P25, DOI [10.1038/ngeo2025, 10.1038/NGEO2025]; Javaid R, 2011, CHEM ENG J, V167, P431, DOI 10.1016/j.cej.2010.08.080; Sato M, 2009, GREEN CHEM, V11, P763, DOI 10.1039/b819106a; Borwieck H, 1998, J ORGANOMET CHEM, V570, P121, DOI 10.1016/S0022-328X(98)00844-4; Broll D., 1999, ANGEW CHEM INT EDIT, V38, P2998, DOI 10.1002/(SICI)1521-3773(19991018)38:20<2998::AID-ANIE2998>3.0.CO;2-L; Haar L, 1988, NBS NRC WASSERDAMPFT; Harvery A. H., 2004, AQUEOUS SYSTEM ELEVA; Kawanami H., 2007, ANGEW CHEM INT EDIT, V46, P5192; Korzenski MB, 1997, TETRAHEDRON LETT, V38, P5611, DOI 10.1016/S0040-4039(97)01274-4; Sato M, 2007, ANGEW CHEM INT EDIT, V46, P6284, DOI 10.1002/anie.200700180; Sato M, 2009, LAB CHIP, V9, P2877, DOI 10.1039/b913515d; Todheide K., 1972, WATER COMPREHENSIVE, V1; Wakashima Y, 2007, J CHEM ENG JPN, V40, P622, DOI 10.1252/jcej.40.622	14	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					475	482				8	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000009		
J	Akinaga, H				Akinaga, Hiromichi			Development of Heck Carbonylation Using Flow Reactor	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						flow reactor; Heck carbonylation; carbon monoxide; batch reactor; syringe pump; residence time; mass flow controller; mixer; scale up	CATALYZED CARBONYLATION; VINYLIC HALIDES; MICROFLOW SYSTEM; PALLADIUM; ARYL; AGENTS; INHIBITORS; ARYLATION; DESIGN; BENZYL	Heck carbonylation reaction is useful for obtaining various carbonyl-containing compounds. Since it usually requires a high pressure of toxic carbon monoxide and reaction is highly exothermic, it needs to take strict process management and safety planning. The use of a flow reactor in place of a large batch plant is expected to reduce not only the size of the apparatus, but the manufacturing costs. Furthermore, the easier control of the reaction under flow conditions could lead to a significant improvement of operational safety in manufacturing process. As a result of extensive studies of Heck carbonylation reaction with a flow reactor, we found that the reaction proceeded with a higher conversion rate under lower temperature and lower pressure conditions compared with the reaction using a batch autoclave reactor. These results would demonstrate that the flow Heck carbonylation reaction is favorable for environmental protection and safer manufacturing. In this paper, we introduce the applicability of a flow reactor to Heck carbonylation reaction and its mass production.	Nihon Nohyaku Co Ltd, Res Ctr, Proc Chem Unit, Div Res & Dev, Kawachi Nagano 5860094, Japan	Akinaga, H (reprint author), Nihon Nohyaku Co Ltd, Res Ctr, Proc Chem Unit, Div Res & Dev, 345 Oyamada, Kawachi Nagano 5860094, Japan.	akinaga-hiromichi@nichino.co.jp					Akinaga H., 2014, CHEM LETT, V43, P9; HECK RF, 1968, J AM CHEM SOC, V90, P5518, DOI 10.1021/ja01022a034; MacDonough MT, 2013, BIOORGAN MED CHEM, V21, P6831, DOI 10.1016/j.bmc.2013.07.028; Fukuyama T, 2002, ORG LETT, V4, P1691, DOI 10.1021/ol0257732; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; Rolland C, 2005, J MED CHEM, V48, P6563, DOI 10.1021/jm0500673; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Barnard CFJ, 2008, ORGANOMETALLICS, V27, P5402, DOI 10.1021/om800549q; Zhu ZB, 2012, EUR J MED CHEM, V57, P211, DOI 10.1016/j.ejmech.2012.08.041; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Papadopoulou MV, 2012, J MED CHEM, V55, P5554, DOI 10.1021/jm300508n; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; Fukuyama T, 2014, GREEN CHEM, V16, P2042, DOI 10.1039/c3gc41789a; Fukuyama T., 2014, COMPREHENSIVE ORGANI, V3, P1073; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Gerspacher M, 2005, PROGR MED CHEM, V43, P49, DOI 10.1016/S0079-6468(05)43003-9; Gilman H, 1931, ORG SYNTH, V11, P80; Gushin V. V., 1992, J CHEM SOC CHEM COMM, V8, P611; Hessel V., 2009, MICROPROCESS ENG; Kashid MN, 2005, IND ENG CHEM RES, V44, P5003, DOI 10.1021/ie0490536; Miller PW, 2006, CHEM COMMUN, P546, DOI 10.1039/b515710b; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; Rahman MT, 2006, CHEM COMMUN, P2236, DOI 10.1039/b600970k; SCHOENBE.A, 1974, J AM CHEM SOC, V96, P7761, DOI 10.1021/ja00832a024; SCHOENBE.A, 1974, J ORG CHEM, V39, P3318, DOI 10.1021/jo00937a003; SCHOENBE.A, 1974, J ORG CHEM, V39, P3327, DOI 10.1021/jo00937a004; Sotowa K., 2013, JAPANESE J MULTIPHAS, V27, P258; Wirth T., 2008, MICROREACTORS ORGANI	28	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					483	489				7	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000010		
J	Togashi, S; Asano, Y				Togashi, Shigenori; Asano, Yukako			Yield Improvement of Consecutive Reaction Using Microreactor and Simulation Technology	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						microreactor; Monte Carlo simulation; consecutive reaction; reaction rate constants; conventional batch method	MIXER; MICROMIXERS	To predict the conditions for improving chemical reaction yield in a microreactor, the relationship between chemical reaction and molecular mixing was analyzed by Monte Carlo simulation. The targeted chemical reaction in the microreactor is the consecutive reaction, where k(1) is the reaction-rate constant of the first stage, and k(2) is the reaction-rate constant of the second stage. The non-dimensional Damkohler number Da is defined as the ratio of a chemical reaction time to a molecular mixing time. It was found that the reaction yield of main product was improved by using a microreactor when the ratio of the reaction rate constants is k(1)/k(2)>1. To validate the Monte Carlo simulation results described above, the validation experiments of four kinds of consecutive reactions were conducted using both the microreactor and the conventional batch method. It was found that the experimental results were good agreement with the predicted results by Monte Carlo simulation.	[Togashi, Shigenori; Asano, Yukako] Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Mech Syst, Hitachinaka, Ibaraki 3120034, Japan	Togashi, S (reprint author), Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Mech Syst, Hitachinaka, Ibaraki 3120034, Japan.	shigenori.togashi.gf@hitachi.com; yukako.asano.dp@hitachi.com					BENSON RS, 1993, CHEM ENG RES DES, V71, P160; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Mengeaud V, 2002, ANAL CHEM, V74, P4279, DOI 10.1021/ac025642e; Hessel V, 2005, CHEM ENG SCI, V60, P2479, DOI 10.1016/j.ces.2004.11.033; Suzuki H, 2004, J MICROELECTROMECH S, V13, P779, DOI 10.1109/JMEMS.2004.835775; Ehrfeld W, 1999, IND ENG CHEM RES, V38, P1075, DOI 10.1021/ie980128d; Munson MS, 2004, ANAL CHIM ACTA, V507, P63, DOI 10.1016/j.aca.2003.11.064; Wong SH, 2003, SENSOR ACTUAT B-CHEM, V95, P414, DOI 10.1016/S0925-4005(03)00447-7; He B, 2001, ANAL CHEM, V73, P1942, DOI 10.1021/ac000850x; Asano Y, 2014, J CHEM ENG JPN, V47, P287, DOI 10.1252/jcej.13we080; Asano Y, 2013, J CHEM ENG JPN, V46, P307, DOI 10.1252/jcej.12we234; Asano Y, 2013, J CHEM ENG JPN, V46, P313, DOI 10.1252/jcej.12we280; Asano Y., 2010, PHARM ENG, V30, P32; Kawahara A, 2000, NUCL ENG DES, V202, P27, DOI 10.1016/S0029-5493(00)00300-9; Lee C. Y., 2011, INT J MOL SCI, V12, P1422; Moghadam S. A., 2001, ORG PROCESS R D, V5, P652; NAKAMURA I, 1987, J FLUID MECH, V178, P379, DOI 10.1017/S0022112087001277; Nguyen N. T., 2005, J MICROMECH MICROENG, V15, P960; Suga S, 2003, CHEM COMMUN, P354, DOI 10.1039/b211433j; Togashi S., 2009, J CHEM ENG JPN, V42, P12; Tojo C, 1998, J NON-CRYST SOLIDS, V235, P688, DOI 10.1016/S0022-3093(98)00572-9; van Duijn CJ, 2008, ADV CHEM ENG, V34, P1, DOI 10.1016/S0065-2377(08)00001-X; Yasuda K, 2000, SENSOR ACTUAT B-CHEM, V64, P128, DOI 10.1016/S0925-4005(99)00495-5; Zang Z., 2001, SENSOR ACTUAT A-PHYS, V93A, P266	24	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					490	497				8	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000011		
J	Matsukawa, K; Mitamura, K; Watase, S; Ishizuka, N				Matsukawa, Kimihiro; Mitamura, Koji; Watase, Seiji; Ishizuka, Norio			Present State of Flow Reactors and Development of Novel Column Reactor	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						flow reactor; micro reactor; catalyst-combined micro reactor; Pd-immobilized epoxy monolith; monolith column reactor	CYCLOADDITION REACTION; MONOLITHS; POLYMERIZATION; NANOPARTICLES; MICROREACTOR; CATALYST; HECK	Flow reactor is a powerful tool to synthesize functional compounds at high yield rapidly and continuously. Many types of flow reactors have been developed all over the world so far. Micro reactors using micro-channels or capillary tubes can provide specific selectivity and high yield of the product, due to rapid mixing and thermal exchange in the limited space of micrometers. In addition of such physical effects of the micro reactor, catalyst-combined micro reactors chemically enhance the reaction efficiency and selectivity. Especially, micro reactors with Pd catalysts are widely applied to Pd-mediated flow reactions like hydrogenation, Heck reaction, Suzuki-Miyaura coupling, and so on. In order to achieve high throughput of flow reactor, Pd-immobilized epoxy monolith have been successfully prepared as the column reactor with high surface area and cavity volume. We also demonstrate fabrication of the Pd-immobilized epoxy monolith and actual examples of flow Heck reaction and Suzuki-Miyaura coupling using this column reactor.	[Matsukawa, Kimihiro; Mitamura, Koji; Watase, Seiji; Ishizuka, Norio] Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, Osaka 5368553, Japan	Matsukawa, K (reprint author), Osaka Municipal Tech Res Inst, Elect Mat Res Div, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.	kmatsu@omtri.or.jp; mitamura@omtri.or.jp; watase@omtri.or.jp; norio@emaus-kyoto.com					Ali I., 2008, J CHROMATOGRAPHIC SC, V47, P432; Greenway GM, 2000, SENSOR ACTUAT B-CHEM, V63, P153, DOI 10.1016/S0925-4005(00)00352-X; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Gomann A, 2009, TETRAHEDRON, V65, P1450, DOI 10.1016/j.tet.2008.12.007; Odedra A, 2009, ANGEW CHEM INT EDIT, V48, P2699, DOI 10.1002/anie.200804407; Pestana CJ, 2014, CHEM ENG J, V235, P293, DOI 10.1016/j.cej.2013.09.041; Tsujioka N, 2005, MACROMOLECULES, V38, P9901, DOI 10.1021/ma051409h; Nikbin N, 2007, ORG PROCESS RES DEV, V11, P458, DOI 10.1021/op7000436; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1; Barlow KJ, 2014, POLYM CHEM-UK, V5, P722, DOI 10.1039/c3py01015e; Roper KA, 2011, BEILSTEIN J ORG CHEM, V7, P1648, DOI 10.3762/bjoc.7.194; Fukuyama T, 2004, CHEM LETT, V33, P1430, DOI 10.1246/cl.2004.1430; Uozumi Y, 2006, J AM CHEM SOC, V128, P15994, DOI 10.1021/ja066697r; Chiroli V, 2013, ORG LETT, V15, P3590, DOI 10.1021/ol401390z; Hostetler EB, 2014, MATER LETT, V128, P54, DOI 10.1016/j.matlet.2014.04.089; Jones RC, 2009, TETRAHEDRON, V65, P7474, DOI 10.1016/j.tet.2009.07.013; Laumann A, 2012, J ELECTROCHEM SOC, V159, pA166, DOI 10.1149/2.084202jes; Matsukawa K., UNPUB; Omer B. A., 2007, ORG BIOMOL CHEM, V5, P733; Oyamada H., 2006, CHEM COMMUN, V4, P4279; Rojo MV, 2015, ORG BIOMOL CHEM, V13, P1768, DOI 10.1039/c4ob02376e; Suga S, 2003, CHEM COMMUN, P354, DOI 10.1039/b211433j; Suga S, 2003, ORG LETT, V5, P945, DOI 10.1021/ol0341243; Tsujioka N, 2008, J POLYM SCI POL CHEM, V46, P3272, DOI 10.1002/pola.22665; Yoswathananont N., 2005, CHEM COMMUN, P40	27	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					498	503				6	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000012		
J	Takayama, M				Takayama, Masami			Application of Flow Micro Synthesis Technology for Medicinal Chemistry	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						medicinal chemistry; lab automation; library synthesis; click reaction; macrocyclization reaction; Lab-on-A chip; on line assay; microflow photochemistry; flow electrochemistry; drug metabolite	REACTOR TECHNOLOGY; PHOTOCHEMISTRY; MACROCYCLES; DERIVATIVES; LIBRARY	In recent years, the micro-flow synthesis technologies have been attracting attention as the new technologies alternative to a batch reaction. Mainly, these technologies are being utilized in the field of the CMC by taking advantage of easy scale-up reactions. On the other hand, each company is exploring how to use these technologies in the field of medicinal chemistry. Although I have experienced for 20 years as medicinal chemist, I felt it was difficult to apply these technologies in the work-flow of medicinal chemistry. But in these few years, many interesting articles by medicinal chemists have been reported for example, the application of library synthesis. In this review, I will present the recent information of using flow-micro synthesis technologies as the view point of Medicinal Chemist.	Shionogi & Co Ltd, Strateg Res Planning Off, Toyonaka, Osaka 5610825, Japan	Takayama, M (reprint author), Shionogi & Co Ltd, Strateg Res Planning Off, 3-1-1 Futaba Cho, Toyonaka, Osaka 5610825, Japan.	masami.takayama@shionogi.co.jp					Yavorskyy A, 2012, ORG LETT, V14, P4342, DOI 10.1021/ol301773r; Stalder R, 2013, ACS MED CHEM LETT, V4, P1119, DOI 10.1021/ml400316p; Bogdan AR, 2010, CHEM-EUR J, V16, P14506, DOI 10.1002/chem.201002215; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Bogdan AR, 2009, ADV SYNTH CATAL, V351, P849, DOI 10.1002/adsc.200800758; Bogdan AR, 2012, J AM CHEM SOC, V134, P2127, DOI 10.1021/ja208503y; Marsault E, 2011, J MED CHEM, V54, P1961, DOI 10.1021/jm1012374; Pagano N, 2011, J FLOW CHEM, V1, P28, DOI 10.1556/jfchem.2011.00001; Bogdan AR, 2011, ORG LETT, V13, P4060, DOI 10.1021/ol201567s; Su YH, 2014, CHEM-EUR J, V20, P10562, DOI 10.1002/chem.201400283; Herath A, 2010, ORG LETT, V12, P5182, DOI 10.1021/ol102216x; Venturoni F, 2010, ORG BIOMOL CHEM, V8, P1798, DOI 10.1039/b925327k; Kabeshov MA, 2014, ORG LETT, V16, P4618, DOI 10.1021/ol502201d; Bachollet S, 2013, BEILSTEIN J ORG CHEM, V9, P2015, DOI 10.3762/bjoc.9.237; Desai B, 2013, J MED CHEM, V56, P3033, DOI 10.1021/jm400099d; Goto S, 2008, SYNLETT, P1361, DOI 10.1055/s-2008-1072771; Pagano N, 2012, SYNTHESIS-STUTTGART, V44, P2537, DOI 10.1055/s-0031-1290953; Sugiono E, 2013, BEILSTEIN J ORG CHEM, V9, P2457, DOI 10.3762/bjoc.9.284; Wheeler RC, 2011, ORG PROCESS RES DEV, V15, P565, DOI 10.1021/op100288t	19	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					504	511				8	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000013		
J	Matsumoto, T				Matsumoto, Tsutomu			Technological Trends in Flow and Microreactor Synthesis: A Review as Viewed from Patent Survey and Scale-up Studies	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						microreactor; microchannel; flow chemistry; organic synthesis; continuous processing; patent survey	ORGANIC-SYNTHESIS; MICROFLOW SYSTEM; CHEMISTRY; REACTORS	Attention to microreactors and flow reaction technologies, in both academia and industry, has noticeably increased over the past decade. Although a large number of chemical reactions suitable for microstructured devices have been reported, there still exists a gap between laboratory and production scale. This review focuses on the use of microreactors in synthetic organic chemistry, aiming toward the production of chemical and pharmaceutical entities, through a survey of patents and other open information. The global movement of microreaction technologies is also discussed, from a viewpoint of the number of research articles and patent applications published worldwide. The goal of the present review is to provide an overview of the process development and scale-up studies in the fine chemical and pharmaceutical industries, and to illustrate an outlook for continuous-flow manufacturing as a cost effective, safe, green, and sustainable production method.	Sumitomo Chem Co Ltd, Organ Synth Res Lab, Osaka 5548558, Japan	Matsumoto, T (reprint author), Sumitomo Chem Co Ltd, Organ Synth Res Lab, 3-1-98 Kasugadenaka, Osaka 5548558, Japan.	matsumotot7@sc.sumitomo-chem.co.jp					Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; Jimenez-Gonzalez C, 2011, ORG PROCESS RES DEV, V15, P900, DOI 10.1021/op100327d; Wakami H, 2005, ORG PROCESS RES DEV, V9, P787, DOI 10.1021/op0501500; Mascia S, 2013, ANGEW CHEM INT EDIT, V52, P12359, DOI 10.1002/anie.201305429; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Braune S, 2009, CHIM OGGI, V27, P26; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Hartman RL, 2011, ANGEW CHEM INT EDIT, V50, P7502, DOI 10.1002/anie.201004637; Hessel V, 2004, ORG PROCESS RES DEV, V8, P511, DOI 10.1021/op0341768; Iwasaki T, 2006, ORG PROCESS RES DEV, V10, P1126, DOI 10.1021/op060127u; Bieringer T, 2013, CHEM ENG TECHNOL, V36, P900, DOI 10.1002/ceat.201200631; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; LaPorte TL, 2008, ORG PROCESS RES DEV, V12, P956, DOI 10.1021/op800079u; Heider PL, 2014, ORG PROCESS RES DEV, V18, P402, DOI 10.1021/op400294z; Poechlauer P, 2013, ORG PROCESS RES DEV, V17, P1472, DOI 10.1021/op400245s; Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Chiba H, 2011, J SYN ORG CHEM JPN, V69, P600; Ehrfeld W., 2004, MICROREACTORS NEW TE; Fujimoto K., 2001, J JPN ASS PET TECHNO, V66, P151; Ondrey G., 2011, CHEM ENG, V118, P17; Pieters B., 2006, 2006 SPRING M 2 GLOB, p23a; Segawa A., 2012, PETROTECH, V35, P13; Thayer AM, 2005, CHEM ENG NEWS, V83, P43; Thayer A. M., 2014, C EN, V92, P13; Wille Ch, 2002, P 6 INT C MICR TECHN, P7; Hutchings MJ, 2013, MICROREACTORS IN ORGANIC CHEMISTRY AND CATALYSIS, 2ND EDITION, P197	28	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					512	520				9	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000014		
J	Odajima, H				Odajima, Hiromichi			Development of a Highly Efficient High Temp. High Pressure, Continuous Flow Microwave System for Organic Synthesis	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article									Saida FDS Inc, Yaizu 4250054, Japan	Odajima, H (reprint author), Saida FDS Inc, 143-10 Isshiki, Yaizu 4250054, Japan.	h.odajima@saidagroup.jp					Yokozawa S, 2015, RSC ADV, V5, P10204, DOI 10.1039/c4ra12428f	1	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					526	531				6	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000016		
J	Kuroda, N; Kobayashi, M				Kuroda, Noritaka; Kobayashi, Masahide			Efficient and Economical Flow Organic Synthesis and Chromatography Using Recycling Technique	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article									[Kuroda, Noritaka] YMC Co Ltd, Chiral Technol Lab, Sakyo Ku, Kyoto 6060033, Japan	Kuroda, N (reprint author), YMC Co Ltd, Chiral Technol Lab, Sakyo Ku, 59 Yonnotubo Cho Iwakuraminami, Kyoto 6060033, Japan.	n-kuroda@ymc.co.jp; kobayashi@ymc.co.jp					Asano K, 2013, ORG LETT, V15, P2398, DOI 10.1021/ol4008519; Fukuyama T, 2011, J FLOW CHEM, V1, P40, DOI 10.1556/jfchem.2011.00007; Minakawa M, 2013, ORG LETT, V15, P5798, DOI 10.1021/ol4028495; Nagai T, 2011, J CHROMATOGR A, V1218, P2880, DOI 10.1016/j.chroma.2011.02.067; Esaki H, 2013, CHEMCATCHEM, V5, P3629, DOI 10.1002/cctc.201300639	5	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					532	536				5	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000017		
J	Inoue, M; Yoshitake, M; Izumi, Y; Mitsui, H				Inoue, Makoto; Yoshitake, Masato; Izumi, Yoshitada; Mitsui, Hitoshi			Microreactors for Organic Chemists	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article									[Inoue, Makoto; Yoshitake, Masato; Izumi, Yoshitada] Nakamura Choukou Co Ltd, Nishi Ku, Sakai, Osaka 5938323, Japan; [Mitsui, Hitoshi] MiChS Co Ltd, Yao 5810851, Japan	Inoue, M (reprint author), Nakamura Choukou Co Ltd, Nishi Ku, 27-27 Tsuruta Cho, Sakai, Osaka 5938323, Japan.	inoue@nakamura-gp.co.jp; yoshitake@nakamura-gp.co.jp; y-izumi@nakamura-gp.co.jp; hitoshi_mitsui321@nifty.com					Akinaga H, 2014, CHEM LETT, V43, P1456, DOI 10.1246/cl.140415; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Ehrfeld W, 1999, IND ENG CHEM RES, V38, P1075, DOI 10.1021/ie980128d; Kawamoto T, 2014, J ORG CHEM, V79, P3999, DOI 10.1021/jo500464q; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Fukuyama T, 2011, BEILSTEIN J ORG CHEM, V7, P1288, DOI 10.3762/bjoc.7.149; Fukuyama T, 2013, BEILSTEIN J ORG CHEM, V9, P1791, DOI 10.3762/bjoc.9.208; OUMINO Y, 2012, J SYNTH ORG CHEM JPN, V70, P896; Ryu Ilhyong, 2008, Org Lett, V10, P1005, DOI 10.1021/ol7031043	9	0	0	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	MAY	2015	73	5					537	541				5	Chemistry, Organic	Chemistry	CI2SJ	WOS:000354597000018		
J	Iwata, M; Nagahashi, R; Maeda, M; Ishibashi, Y				Iwata, Makoto; Nagahashi, Ryo; Maeda, Masaki; Ishibashi, Yoshihiro			Temperature-electric-field phase diagram for Pb(Zn1/3Nb2/3)O-3-PbTiO3 - concentration dependence of the critical endpoint	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						PZN; Relaxor; Ferroelectric; Dielectric Permittivity; Phase diagram; Critical endpoint	SOLID-SOLUTION SYSTEMS; SINGLE-CRYSTALS; OXIDE FERROELECTRICS; ELECTROMECHANICAL RESPONSE; BOUNDARY; PB(ZN1/3NB2/3)O-3-9-PERCENT-PBTIO3	The temperature and the DC biasing-field dependences of the dielectric permittivities along the [001] (c) , [011] (c) , and [111] (c) directions of the pseudocubic coordinates have been investigated in Pb(Zn1/3Nb2/3)O3-x PbTiO3 (x = 6%). The temperature-electric-field phase diagrams have been clarified in the field range below 8 kV/cm. The critical endpoint has been found at 1.3 kV/cm and 164A degrees C for an electric field applied along the [001] (c) direction. The concentration dependences of the critical temperature and the transition temperature are discussed. The expected transition temperature T (0) (x) at which the second-order phase transition would occur is shown to be determined by the transition temperature T (CT) (x) and the critical temperature T (CEP) (x).	[Iwata, Makoto; Nagahashi, Ryo; Maeda, Masaki] Nagoya Inst Technol, Dept Engn Phys Elect & Mech, Grad Sch Engn, Nagoya, Aichi 4668555, Japan; [Ishibashi, Yoshihiro] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan	Iwata, M (reprint author), Nagoya Inst Technol, Dept Engn Phys Elect & Mech, Grad Sch Engn, Nagoya, Aichi 4668555, Japan.	miwata@nitech.ac.jp			Japan Society for the Promotion of Science [25400323]	The authors would like to thank the NF Corporation for fabricating the DC bias probe for ZGA5900 to measure the dielectric permittivity. This work was supported in part by a Grant-in-Aid for Scientific Research C (No. 25400323) from the Japan Society for the Promotion of Science to MI.	Davis M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014115; Fu HX, 2000, NATURE, V403, P281; Lu Y, 2002, APPL PHYS LETT, V80, P1918, DOI 10.1063/1.1461902; La-Orauttapong D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144101; Ishibashi Y, 1998, JPN J APPL PHYS 2, V37, pL985, DOI 10.1143/JJAP.37.L985; Iwata M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.034703; Kutnjak Z, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.104102; Ishibashi Y, 1999, JPN J APPL PHYS 1, V38, P800, DOI 10.1143/JJAP.38.800; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; Iwata M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.038004; Cox DE, 2001, APPL PHYS LETT, V79, P400, DOI 10.1063/1.1384475; KUWATA J, 1982, JPN J APPL PHYS 1, V21, P1298, DOI 10.1143/JJAP.21.1298; Chang WS, 2010, J APPL PHYS, V108, DOI 10.1063/1.3460804; Ishibashi Y, 1999, JPN J APPL PHYS 1, V38, P1454, DOI 10.1143/JJAP.38.1454; Iwata M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PD05; Iwata M, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.044702; Iwata M, 2012, FERROELECTRICS, V440, P67, DOI 10.1080/00150193.2012.747413; Iwata M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09ME01; Iwata M, 2012, FERROELECTRICS, V428, P1, DOI 10.1080/00150193.2012.675251; Iwata M, 2011, CURR APPL PHYS, V11, pS42, DOI 10.1016/j.cap.2011.03.007; Liu SF, 2002, J APPL PHYS, V92, P461, DOI 10.1063/1.1486028; Ohwada K, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094111; Priya S, 2002, APPL PHYS LETT, V81, P2430, DOI 10.1063/1.1507831; Samara GA., 2001, ADV RES APPL, V56, P239; Shen MR, 2004, J APPL PHYS, V95, P8124, DOI 10.1063/1.1728315; Uesu Y, 2002, J PHYS SOC JPN, V71, P960, DOI 10.1143/JPSJ.71.960	26	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1327	1333		10.3938/jkps.66.1327		7	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100001		
J	Ishibashi, Y; Iwata, M				Ishibashi, Yoshihiro; Iwata, Makoto			Reconsideration of the morphotropic phase boundary - the order of the ferroelectric phase transition	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Morphotropic phase boundary; Ferroelectrics; Solid solution; Second-order transition; First-order transition	SOLID-SOLUTION SYSTEMS; COPOLYMER SINGLE-CRYSTALS; OXIDE FERROELECTRICS; ELASTIC PROPERTIES; MARTENSITE ALLOYS; HYSTERESIS LOOP; LANDAU THEORY; PHENOMENOLOGY	The morphtropic phase boundary existing in a perovskite-type solid solution like Pb(Zr,Ti)O-3 (PZT) is reconsidered in relation to the order of the ferroelectric phase transition. For the secondorder transition from the paraelectric cubic phase, at the triple point S where the cubic, tetragonal and rhombohedral phases meet, the free energy is isotropic in the order parameter space, and a vertical boundary guarantees dielectrically excellent properties, while for the first-order transition, at the triple point F, the free energy is usually anisotropic, and even a vertical boundary does not necessarily guarantee the best properties.	[Ishibashi, Yoshihiro] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan; [Iwata, Makoto] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Nagoya, Aichi 4668555, Japan	Ishibashi, Y (reprint author), Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan.	yishi@iris.ocn.ne.jp					Noheda B, 1999, APPL PHYS LETT, V74, P2059, DOI 10.1063/1.123756; Ishibashi Y, 1998, JPN J APPL PHYS 2, V37, pL985, DOI 10.1143/JJAP.37.L985; SAWAGUCHI E, 1953, J PHYS SOC JPN, V8, P615, DOI 10.1143/JPSJ.8.615; Ishibashi Y, 1999, JPN J APPL PHYS 1, V38, P800, DOI 10.1143/JJAP.38.800; KUWATA J, 1982, JPN J APPL PHYS 1, V21, P1298, DOI 10.1143/JJAP.21.1298; Fujita K, 1997, JPN J APPL PHYS 1, V36, P254, DOI 10.1143/JJAP.36.254; Ishibashi Y, 1999, J PHYS SOC JPN, V68, P1353, DOI 10.1143/JPSJ.68.1353; Ishibashi Y, 2003, J PHYS SOC JPN, V72, P1675, DOI 10.1143/JPSJ.72.1675; Ishibashi Y, 1999, JPN J APPL PHYS 1, V38, P1454, DOI 10.1143/JJAP.38.1454; Ishibashi Y, 2005, JPN J APPL PHYS 1, V44, P6624, DOI 10.1143/JJAP.44.6624; Iwata M, 2005, JPN J APPL PHYS 1, V44, P3095, DOI 10.1143/JJAP.44.3095; Iwata M, 2005, JPN J APPL PHYS 1, V44, P6667, DOI 10.1143/JJAP.44.6667; Iwata M, 2003, J PHYS SOC JPN, V72, P2843, DOI 10.1143/JPSJ.72.2843; Jaffe B, 1971, PIEZOELECTRIC CERAMI; JANOVEC V, 1975, CZECH J PHYS, V25, P1362, DOI 10.1007/BF01587561; Vanderbilt D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094108; Zhao J., 1995, JPN J APPL PHYS, V34, P5958	17	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1334	1338		10.3938/jkps.66.1334		5	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100002		
J	Yoneda, Y; Nagata, H; Takenaka, T				Yoneda, Yasuhiro; Nagata, Hajime; Takenaka, Tadashi			Local structure analysis of Bi0.5Na0.5TiO3	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Bi0.5Na0.5TiO3; Ferroelectrics; Perovskite; Pair-distribution function; Synchrotron radiation; Local structure analysis	POLARIZATION ROTATION; PHASE-TRANSITIONS; EXIT BENDER; NA0.5BI0.5TIO3; CERAMICS	The potential lead-free piezoelectric material bismuth sodium titanate, Bi0.5Na0.5TiO3 (BNT), was investigated by means of high-energy synchrotron X-ray diffraction. BNT has been assumed thus far to exhibit the rhombohedral space group R3c at room temperature. Recently, the average structure of BNT was described by the monoclinic space group C c. We performed a local structure analysis of BNT using atomic pair-distribution function method. The ground state of BNT was found to have a rhombohedral structure in which bismuth and sodium atoms were chemically ordered in the perovskite A-site.	[Yoneda, Yasuhiro] JAEA, React Dynam Res Div, Mikazuki, Hyogo 6795148, Japan; [Nagata, Hajime; Takenaka, Tadashi] Tokyo Univ Sci, Fac Sci & Technol, Dept Elect Engn, Noda, Chiba 2788510, Japan	Yoneda, Y (reprint author), JAEA, React Dynam Res Div, Mikazuki, Hyogo 6795148, Japan.	yoneda@spring8.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26400326]	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 26400326) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The synchrotron radiation experiments were performed at the BL04B2 and the BL14B1 in the SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI), (Proposal Nos. 2010A1068, 2009B1084, and 2008A3602).	Kodama K, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.124605; Hiruma Y, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903498; Yokota H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104109; Hiruma Y, 2008, J APPL PHYS, V104, DOI 10.1063/1.3043588; Viola G, 2014, J PHYS CHEM C, V118, P8564, DOI 10.1021/jp500609h; Levin I, 2012, ADV FUNCT MATER, V22, P3445, DOI 10.1002/adfm.201200282; Noheda B, 2001, PHYS REV LETT, V86, P3891, DOI 10.1103/PhysRevLett.86.3891; Proffen T, 1999, J APPL CRYSTALLOGR, V32, P572, DOI 10.1107/S0021889899003532; Izumi F, 2007, SOL ST PHEN, V130, P15; Ye ZG, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184114; Yoneda Y, 2001, J SYNCHROTRON RADIAT, V8, P18, DOI 10.1107/S0909049500014515; Aksel E, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573826; Keeble DS, 2013, ADV FUNCT MATER, V23, P185, DOI 10.1002/adfm.201201564; Shuvaeva VA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.174114; Gorfman S, 2010, J APPL CRYSTALLOGR, V43, P1409, DOI 10.1107/S002188981003342X; Jones GO, 2002, ACTA CRYSTALLOGR B, V58, P168, DOI 10.1107/S0108768101020845; Egami T., 2001, UNDERNEATH BRAGG PEA; Hiruma Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3115409; Kiat JM, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064106; Noheda B., 2001, Physical Review B (Condensed Matter), V63, DOI 10.1103/PhysRevB.63.014103; Parija B, 2013, J MATER SCI-MATER EL, V24, P402, DOI 10.1007/s10854-012-0764-z; Qiu X., 2004, J APPL CRYSTALLOGR, V37, P678, DOI DOI 10.1107/S0021889804011744; Ranjan R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.092101; Yamamoto K, 2008, JPN J APPL PHYS, V47, P7623, DOI 10.1143/JJAP.47.7623; Yoneda Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09ME09; Yoneda Y, 2001, NUCL INSTRUM METH A, V467, P370, DOI 10.1016/S0168-9002(01)00327-8	26	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1339	1343		10.3938/jkps.66.1339		5	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100003		
J	Tanaka, E; Ishii, Y; Tsukasaki, H; Mori, S; Osada, M; Taniguchi, H; Sato, Y; Kubota, Y				Tanaka, E.; Ishii, Y.; Tsukasaki, H.; Mori, S.; Osada, M.; Taniguchi, H.; Sato, Y.; Kubota, Y.			Structural changes and microstructures of Ba1-x Sr (x) Al2O4 for 0 < x < 0.4	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Trydimyte structure; BaAl2O4; Diffuse scattering	NEGATIVE THERMAL-EXPANSION; PHASE-TRANSITION; BAAL2O4; MODES; ZRW2O8	We have investigated the structural changes and the microstructures of Ba1-x Sr (x) Al2O4 for 0 < x < 0.4 by using transmission electron microscope (TEM) and synchrotron radiation powder X-ray diffraction experiments. The TEM experiments revealed the existence of a structural phase boundary at approximately x = 0.1, at which the superlattice reflection spots at the 1/2 0 0 -type positions change into diffuse streaks along three equivalent < 110 > directions in the hexagonal structure. In addition, real-space images of Ba1-x Sr (x) Al2O4 for 0 < x < 0.4 reveal that BaAl2O4 should be characterized as a modulated structure with triple-q modulation vectors along the < 110 > directions and on the other hand, Ba1-x Sr (x) Al2O4 for 0.1 < x < 0.4 be characterized as an intermediate (precursor) state with a rigid unit mode due to structural instability. These experimental results implied that the partial substitution of Sr2+ for Ba2+ should suppress a structural instability due to the AlO4 tetrahedral network and decrease the structural phase transition temperature.	[Tanaka, E.; Ishii, Y.; Tsukasaki, H.; Mori, S.] Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan; [Osada, M.] Natl Inst Mat Sci NIMS, Tsukuba, Ibaraki 3050044, Japan; [Taniguchi, H.] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648603, Japan; [Sato, Y.; Kubota, Y.] Osaka Prefecture Univ, Dept Phys Sci, Sakai, Osaka 5998531, Japan	Tanaka, E (reprint author), Osaka Prefecture Univ, Dept Mat Sci, Sakai, Osaka 5998531, Japan.	ishii@mtr.osakafu-u.ac.jp; mori@mtr.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	The work performed at Osaka Prefecture University was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Abakumov AM, 2000, PHASE TRANSIT, V71, P143, DOI 10.1080/01411590008224545; Lind C, 2012, MATERIALS, V5, P1125, DOI 10.3390/ma5061125; Evans JSO, 1998, J SOLID STATE CHEM, V137, P148, DOI 10.1006/jssc.1998.7744; Zhang LW, 2007, ADV FUNCT MATER, V17, P3781, DOI 10.1002/adfm.200700506; Mary TA, 1996, SCIENCE, V272, P90, DOI 10.1126/science.272.5258.90; Hammonds KD, 1996, AM MINERAL, V81, P1057; Liu Y, 2004, APPL PHYS LETT, V84, P5016, DOI 10.1063/1.1763223; Larsson AK, 2008, J SOLID STATE CHEM, V181, P1816, DOI 10.1016/j.jssc.2008.03.043; Wallez G, 2011, MATER RES BULL, V46, P1777, DOI 10.1016/j.materresbull.2011.08.003; Fukuda K, 2005, J SOLID STATE CHEM, V178, P3662, DOI 10.1016/j.jssc.2005.09.015; Bieniok A, 1998, MICROPOR MESOPOR MAT, V25, P193, DOI 10.1016/S1387-1811(98)00207-8; Perez-Mato JM, 2010, ACTA CRYSTALLOGR A, V66, P558, DOI 10.1107/S0108767310016247; Withers RL, 2003, SOLID STATE SCI, V5, P115, DOI 10.1016/S1293-2558(02)00085-7; Dove MT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/27/275209; Evans JSO, 1996, CHEM MATER, V8, P2809, DOI 10.1021/cm9602959; Gupta MK, 2011, CHINESE J PHYS, V49, P316; Ishii Y., UNPUB; Liu B, 2011, J ALLOY COMPD, V509, P4300, DOI 10.1016/j.jallcom.2011.01.046; Mothudi BM, 2012, PHYSICA B, V407, P1620, DOI 10.1016/j.physb.2011.09.100; Niyomwas S., 2011, MARER SCI ENG, V18; Petricek V., 2006, CRYSTALLOGRAPHIC COM; Rodehorst U., MINERALOGICAL MAG, V67; Ryu H, 2008, PHYSICA B, V403, P126, DOI 10.1016/j.physb.2007.08.088; Stokes HT, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064105; Tanaka E, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PB01; Wu QL, 2009, PHYSICA B, V404, P2499, DOI 10.1016/j.physb.2009.05.011; Xie C., PHYS LETT A IN PRESS; Yamada H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2896296	28	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1355	1358		10.3938/jkps.66.1355		4	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100006		
J	Ma, Q; Mimura, K; Kato, K				Ma, Qiang; Mimura, Ken-ichi; Kato, Kazumi			Size and morphology controlling of barium titanate nanocubes by using hydrothermal method	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Barium titanate; Nanocubes; Hydrothermal method; Size controlling	BATIO3; NANOCRYSTALS; GROWTH	Nano-sized barium titanate (BT) cubes were synthesized by using a hydrothermal method with an aqueous Ti compound. tert-Butylamine was used as an activation agent to expedite precursor hydrolysis. Oleic acid was employed as a surfactant. The concentrations of the raw materials were found to have a very important effect on tailoring the size and the morphology of the BT nanocubes. The size of the nanocubes varied from 15 nm to 30 nm, and the size distribution was relatively narrow. The surface condition and the size of the BT nanocubes were related to the molar ratios of oleic acid to tert-butylamine. High molar ratios resulted in BT nanocubes with rough surfaces.	[Ma, Qiang; Mimura, Ken-ichi; Kato, Kazumi] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Ma, Q (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	qiang-ma@aist.go.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST).	Adireddy S, 2010, CHEM MATER, V22, P1946, DOI 10.1021/cm9038768; HUYBRECHTS B, 1995, J MATER SCI, V30, P2463, DOI 10.1007/BF00362121; Adam J, 2013, J AM CERAM SOC, V96, P2987, DOI 10.1111/jace.12404; Nguyen TD, 2009, J PHYS CHEM C, V113, P11204, DOI 10.1021/jp900226m; Wang WW, 2013, CERAM INT, V39, P7127, DOI 10.1016/j.ceramint.2013.02.055; Xing XR, 2004, J ALLOY COMPD, V384, P312, DOI 10.1016/j.jallcom.2004.06.062; Zhou J, 2013, CRYSTENGCOMM, V15, P8912, DOI 10.1039/c3ce41549j; Mimura K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.061501; HENNINGS D, 1991, ADV MATER, V3, P334, DOI 10.1002/adma.19910030703; Zheng YH, 2009, COLLOID SURFACE A, V339, P178, DOI 10.1016/j.colsurfa.2009.02.018; Wada S, 2007, J KOREAN PHYS SOC, V51, P878, DOI 10.3938/jkps.51.878; Nguyen TD, 2011, INORG CHEM, V50, P1309, DOI 10.1021/ic101871v; Kato K, 2013, J MATER RES, V28, P2932, DOI 10.1557/jmr.2013.299; Dang F, 2012, NANOSCALE, V4, P1344, DOI 10.1039/c2nr11594h; Ma Q, 2014, CRYSTENGCOMM, V16, P8398, DOI 10.1039/c4ce01195c; Choi GJ, 1998, CHEM MATER, V10, P4104, DOI 10.1021/cm980520h; Moon S., 2012, J AM CERAM SOC, V7, P2248	17	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1364	1366		10.3938/jkps.66.1364		3	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100008		
J	Shibata, R; Muraki, R; Yamaguchi, T; Takashige, M				Shibata, Ryo; Muraki, Ryota; Yamaguchi, Toshihisa; Takashige, Masaaki			Dielectric and phase transitional properties of Rb2ZnI4 and its mixed systems at low temperatures	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Quantum ferroelectricity; Phase transition; Rb2ZnI4; K2ZnI4; Rb2CdI4	FERROELECTRICITY; CRYSTALS	The temperature dependence of the dielectric constant of Rb2ZnI4 shows two peak anomalies: one at 4 K and the other at 62 K. To study this, we prepared crystals of the mixed system Rb2Zn1-x Cd (x) I-4 from the melt by using the Czochralski method. Dielectric constant and spontaneous polarization measurements were performed on crystals from the mixed system. The phase diagram of Rb2Zn1-x Cd (x) I-4 was completed over a full range of concentrations x. The result was compared with the already-reported result for (Rb1-x K (x) )(2)ZnI4.	[Shibata, Ryo; Muraki, Ryota; Yamaguchi, Toshihisa; Takashige, Masaaki] Meisei Univ, Dept Phys, Hino, Tokyo 1918506, Japan	Shibata, R (reprint author), Meisei Univ, Dept Phys, 2-1-1 Hodokubo, Hino, Tokyo 1918506, Japan.	t-yamaguchi@phys.meisei-u.ac.jp					Takashige M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.045001; YAMADA Y, 1983, J PHYS SOC JPN, V52, P3466, DOI 10.1143/JPSJ.52.3466; SCHNEIDER T, 1976, PHYS REV B, V13, P1123, DOI 10.1103/PhysRevB.13.1123; MCMILLAN WL, 1976, PHYS REV B, V14, P1496, DOI 10.1103/PhysRevB.14.1496; GESHI K, 1984, J PHYS SOC JPN, V53, P3850, DOI 10.1143/JPSJ.53.3850; GESI K, 1985, J PHYS SOC JPN, V54, P3694, DOI 10.1143/JPSJ.54.3694; Mashiyama H., 2013, COMMUNICATION; Puragahn J., 1998, THESIS KARLSRUHE; RYTZ D, 1980, PHYS REV B, V22, P359, DOI 10.1103/PhysRevB.22.359; SAWADA S, 1977, J PHYS SOC JPN, V43, P2099, DOI 10.1143/JPSJ.43.2099; Shimizu F, 2003, FERROELECTRICS, V286, P29, DOI 10.1080/00150190390206202; Yamaguchi T, 2014, FERROELECTRICS, V462, P216, DOI 10.1080/00150193.2014.891403	12	1	1	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1367	1370		10.3938/jkps.66.1367		4	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100009		
J	Koda, S; Takayama, H; Shibata, T; Mori, T; Kojima, S; Park, IS; Shin, TG				Koda, Shota; Takayama, Haruki; Shibata, Tomohiko; Mori, Tatsuya; Kojima, Seiji; Park, In-Sung; Shin, Tae-Gyu			Small angle neutron scattering study on the structural variation of lysozyme in bioprotectants	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Small angle neutron scattering (SANS); Lysozyme; Denaturation; Trehalose; Choline acetate	EGG-WHITE LYSOZYME; X-RAY-SCATTERING; IONIC LIQUIDS; PREFERENTIAL INTERACTIONS; THERMAL TRANSITION; LIGHT-SCATTERING; PROTEIN DYNAMICS; AQUEOUS-SOLUTION; DENATURATION; TREHALOSE	The thermal denaturation and subsequent structural variation of lysozyme in various bioprotectant candidate solutions such as trehalose and choline acetate have been investigated by using small angle neutron scattering and differential scanning calorimetry. The gyration radius shows little change with the addition of additives in a native state at room temperature. On heating the lysozyme solution, a remarkable increase in the gyration radius is observed at temperatures above the denaturation temperature without any bioprotectants. Such an increase is suppressed by the additives owing to the intermolecular interactions between the lysozyme molecules and the bioprotectants of trehalose and choline acetate. The fractal dimension of lysozyme varies slightly with the addition of the bioprotectant solutions, and shows a remarkable drop in the vicinity of the denaturation temperature for all the solutions.	[Koda, Shota; Takayama, Haruki; Shibata, Tomohiko; Mori, Tatsuya; Kojima, Seiji] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Park, In-Sung] Hanyang Univ, Inst Nano Sci & Technol, Seoul 133791, South Korea; [Shin, Tae-Gyu] Korea Atom Energy Res Inst, Div Neutron Sci, Daejeon 305353, South Korea	Koda, S (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	s1420412@u.tsukuba.ac.jp; parkis77@hanyang.ac.kr			International Internship Program - University of Tsukuba; Sasakawa Scientific Research Grant from The Japan Science Society; JSPS [24740194]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A6A1029029]	This study was supported in part by the International Internship Program funded by the University of Tsukuba, by the Sasakawa Scientific Research Grant from The Japan Science Society, by a Grants-in-Aid for Young Scientists (B) (24740194) from JSPS, and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A6A1029029).	Sheldon RA, 2002, GREEN CHEM, V4, P147, DOI 10.1039/b110008b; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Sauer BB, 2000, POLYMER, V41, P1099, DOI 10.1016/S0032-3861(99)00258-X; Figueiredo AM, 2013, PHYS CHEM CHEM PHYS, V15, P19632, DOI 10.1039/c3cp53395f; Constatinescu D, 2010, PHYS CHEM CHEM PHYS, V12, P1756, DOI 10.1039/b921037g; Enright MB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011912; Winther LR, 2012, J PHYS CHEM B, V116, P9196, DOI 10.1021/jp304982c; Liu QX, 2006, SURF COAT TECH, V201, P1352, DOI 10.1016/j.surfcoat.2006.01.065; Tsai AM, 2001, BIOPHYS J, V81, P2339; Armand M, 2009, NAT MATER, V8, P621, DOI [10.1038/nmat2448, 10.1038/NMAT2448]; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Lins RD, 2004, PROTEINS, V55, P177, DOI 10.1002/prot.10632; Xue LY, 2013, COLLOID SURFACE B, V105, P81, DOI 10.1016/j.colsurfb.2012.12.050; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Voets IK, 2010, J PHYS CHEM B, V114, P11875, DOI 10.1021/jp103515b; Fujita K, 2007, BIOMACROMOLECULES, V8, P2080, DOI 10.1021/bm070041o; Carr JK, 2013, J PHYS CHEM B, V117, P13291, DOI 10.1021/jp4037217; Arai S, 1999, BIOPHYS J, V76, P2192; Guinier A., 1955, SMALL ANGLE SCATTERI, P126; Hedoux A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4882058; Hirai M, 1999, J PHYS CHEM B, V103, P549, DOI 10.1021/jp982315v; Imoto T., 2002, PHARM SOC JPN, V122, P537; LORBER B, 1993, J CRYST GROWTH, V128, P1203, DOI 10.1016/S0022-0248(07)80124-2; Lushnikov SG, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031913; Magazu S, 2007, J MOL STRUCT, V840, P114, DOI 10.1016/j.molstruc.2006.11.028; Miles AJ, 2008, J SYNCHROTRON RADIAT, V15, P420, DOI 10.1107/S0909049508009606; Miller W. R., 1997, KANSAS SCH NATURALIS, V43, P1; Svanidze AV, 2012, J RAMAN SPECTROSC, V43, P1510, DOI 10.1002/jrs.4059; Svanidze AV, 2009, JETP LETT+, V90, P80, DOI 10.1134/S0021364009130165	29	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1376	1380		10.3938/jkps.66.1376		5	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100011		
J	Temba, C; Kawakami, S; Nakajima, N; Ishimatsu, N; Maruyama, H				Temba, Chisato; Kawakami, Shuhei; Nakajima, Nobuo; Ishimatsu, Naoki; Maruyama, Hiroshi			X-ray absorption study of the local dipole moment in SrTiO3 under uniaxial pressure	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Uniaxial pressure; Phase transition; Strontium titanate	FERROELECTRICITY; SURFACE	X-ray absorption spectra under uniaxial pressure were measured at the Ti K-edge of a SrTiO3 single crystal in order to obtain direct evidence for the ferroelectric transition that is expected on the basis of second harmonic generation studies. A uniaxial pressure was applied perpendicular to the ab-plane. The pre-edge peak, which corresponds to Ti 3d e (g) -O 2p sigma bonding, shows little change across the transition temperature of 40 K at 1 GPa. This indicates that a local electric dipole moment is not induced under uniaxial pressure, as opposed to the macroscopic ferroelectric moments that are predicted to be induced along the ab-plane.	[Temba, Chisato; Kawakami, Shuhei; Nakajima, Nobuo; Ishimatsu, Naoki; Maruyama, Hiroshi] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan	Temba, C (reprint author), Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan.	tenba-chisato@hiroshima-u.ac.jp			JSPS KAKENHI [24540325]	The authors thank Dr. Naomi Kawamura for his excellent support with the XAS measurements. This work was performed under the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2013B1453) and was financially supported by a JSPS KAKENHI (Grant-in-Aid for Scientific Research (C)) Grant No. 24540325.	Santander-Syro AF, 2011, NATURE, V469, P189, DOI 10.1038/nature09720; Meevasana W, 2011, NAT MATER, V10, P114, DOI 10.1038/nmat2943; Nozawa S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.061501; UWE H, 1976, PHYS REV B, V13, P271, DOI 10.1103/PhysRevB.13.271; Kan D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202750; FUJII Y, 1987, J PHYS SOC JPN, V56, P1940, DOI 10.1143/JPSJ.56.1940; Nozawa S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.121101; Takesada M, 2003, J PHYS SOC JPN, V72, P37, DOI 10.1143/JPSJ.72.37; He FZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176101; Muller K.A., 1991, PHYS B, V84, P277; Nobuo N., 2013, JPN J APPL PHYS, V52; Syassen K., 2008, HIGH PRES RES, V28, P92; Tsujimi Y, 2012, FERROELECTRICS, V430, P50, DOI 10.1080/00150193.2012.677688	13	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1386	1388		10.3938/jkps.66.1386		3	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100013		
J	Nakashima, S; Uchida, T; Takayama, K; Fujisawa, H; Shimizu, M				Nakashima, Seiji; Uchida, Tomohisa; Takayama, Kouta; Fujisawa, Hironori; Shimizu, Masaru			Influence of the polarization direction of light on the anomalous photovoltaic effect in BiFeO3 thin films	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						Photovoltaic effect; BiFeO3; Thin film	DOMAIN-WALLS	Recently, an anomalous photovoltaic effect in a BiFeO3 (BFO) thin film has attracted much attention. In this research, Pt/BFO/Pt coplanar capacitors have been prepared using striped- and single-domain structured BFO thin films, and the influence of the polarization direction of incident violet laser light (lambda = 405 nm) on the photovoltage of these capacitors has been investigated. In a specific geometry, both coplanar capacitors, the one using a striped-domain and the other using a single-domain structured BFO thin film showed anomalous photovoltages above band gap of BFO, indicating that an anomalous photovoltage should be observed under randomly-polarized light illumination such as that by a halogen lamp.	[Nakashima, Seiji; Uchida, Tomohisa; Takayama, Kouta; Fujisawa, Hironori; Shimizu, Masaru] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6702201, Japan	Nakashima, S (reprint author), Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6702201, Japan.	nakashima@eng.u-hyogo.ac.jp			Japan Society for Promotion of Science [26820115]; University of Hyogo, Japan; KEIRIN RACE; CASIO Science Promotion Foundation	This work was supported in part by the Japan Society for Promotion of Science, a Grant-in-Aid for Young Scientists (B) 26820115, a research grant from the University of Hyogo, Japan, JKA and its promotion funds from KEIRIN RACE, and a grant from the CASIO Science Promotion Foundation.	Lebeugle D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753390; CHYNOWETH AG, 1956, PHYS REV, V102, P705, DOI 10.1103/PhysRev.102.705; Lebeugle D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024116; Chiu YP, 2011, ADV MATER, V23, P1530, DOI 10.1002/adma.201004143; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; KOCH WTH, 1975, SOLID STATE COMMUN, V17, P847, DOI 10.1016/0038-1098(75)90735-8; Yang SY, 2010, NAT NANOTECHNOL, V5, P143, DOI [10.1038/nnano.2009.451, 10.1038/NNANO.2009.451]; Jang HW, 2009, ADV MATER, V21, P817, DOI 10.1002/adma.200800823; Xiao Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247603; Meyer B, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104111; Maksymovych P, 2011, NANO LETT, V11, P1906, DOI 10.1021/nl104363x; GLASS AM, 1974, APPL PHYS LETT, V25, P233, DOI 10.1063/1.1655453; Bhatnagar A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3835; Nakashima S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LB02; Nakashima S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KB03; Nakashima S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.09PA16; Seidel J., 2011, PHYS REV LETT, V105; Zavaliche F, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149180	18	1	1	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1389	1393		10.3938/jkps.66.1389		5	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100014		
J	Jin, SB; Long, W; Sahu, BB; Han, JG; Hori, M				Jin, Su B.; Long, Wen; Sahu, B. B.; Han, Jeon G.; Hori, M.			Improving the gas barrier and mechanical properties of a-SiO (x) films synthesized at low temperature by using high energy and hydrogen flow rate control	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article						a-SiOx; Gas barrier property; Mechanical property; Low-temperature process	CHEMICAL-VAPOR-DEPOSITION; ION CURRENT-DENSITY	Silicon-oxide thin films were deposited on polyethylene-terephthalate (PET) and glass substrates for applications in transparent barrier packaging and replacement display cover glasses by using plasma-enhanced chemical vapor deposition (PECVD). The bias conditions and the input power in the radio-frequency plasma were changed to optimize the gas barrier and the mechanical properties of the silicon-oxide thin film. We made an advanced plasma source for large-area PECVD (370 x 470 mm(2) size). The dissociation of the octamethylycyclodisiloxane (OMCTS) precursor was controlled by using the plasma processing parameters. The gas barrier and the mechanical properties of the a-SiO (x) film were improved by controlling the plasma process parameters. The gas barrier and the mechanical properties of the coatings were examined using a Permatran (MOCON) system and a pencil hardness measurement. The chemical structure properties of the coatings were examined by using Fourier transform infrared spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS). The properties of the a-SiO (x) thin films were improved by the dissociation of OMCTS obtained by using various appropriate plasma processing parameters.	[Jin, Su B.; Long, Wen; Sahu, B. B.; Han, Jeon G.] Sungkyunkwan Univ, NU SKKU Joint Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, Suwon 440746, South Korea; [Hori, M.] Nagoya Univ, NU SKKU Joint Inst Plasma Nano Mat, Plasma Nanotechnol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Jin, SB (reprint author), Sungkyunkwan Univ, NU SKKU Joint Inst Plasma Nano Mat, Ctr Adv Plasma Surface Technol, Suwon 440746, South Korea.	hanjg@skku.edu			R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI); Global Research Development Center (GRDC), a program of the Ministry of Science, ICT and Future Planning (MSIP) [20120006672]; Korea Institute for Advancement of Technology (KIAT); Ministry of Trade, Industry Energy (MOTIE) [N0000590]	This study was supported by the R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) funded by the Government, by the Global Research Development Center (GRDC), a program of the Ministry of Science, ICT and Future Planning (MSIP, Grant No. 20120006672, 2nd stage, 1st year) and by the Korea Institute for Advancement of Technology (KIAT), which is funded by the Ministry of Trade, Industry & Energy (MOTIE, Grant No. N0000590).	Babayan SE, 2001, PLASMA SOURCES SCI T, V10, P573, DOI 10.1088/0963-0252/10/4/305; Jin SB, 2010, SURF COAT TECH, V205, pS139, DOI 10.1016/j.surfcoat.2010.06.061; Jin SB, 2010, THIN SOLID FILMS, V518, P6385, DOI 10.1016/j.tsf.2010.03.134; Jin SB, 2011, THIN SOLID FILMS, V519, P6763, DOI 10.1016/j.tsf.2011.01.214; Jin SB, 2011, THIN SOLID FILMS, V519, P6334, DOI 10.1016/j.tsf.2011.04.022; Wang CY, 2001, APPL SPECTROSC, V55, P1347, DOI 10.1366/0003702011953469; SAWADA Y, 1995, J PHYS D APPL PHYS, V28, P1661, DOI 10.1088/0022-3727/28/8/015; Han L. M., 2001, J ELECTROCHEM SOC, V148, P148; Jin SB, 2011, CURR APPL PHYS, V11, P1107, DOI 10.1016/j.cap.2011.02.005; Nowling G. R., 2005, PLASMA SOURCES SCI T, V447, P14; Socrates G, INFRARED CHARACTERIS; Teshima K, 2003, SURF COAT TECH, V169, P583, DOI 10.1016/S0257-8972(03)00111-7; Tomozeiu N, 2002, THIN SOLID FILMS, V420, P382, DOI 10.1016/S0040-6090(02)00842-8	13	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884	1976-8524		J KOREAN PHYS SOC	J. Korean Phys. Soc.	MAY	2015	66	9					1410	1415		10.3938/jkps.66.1410		6	Physics, Multidisciplinary	Physics	CI3JD	WOS:000354643100018		
J	Asai, T; Kinoshita, T; Suzuki, T; Shiraishi, S; Koike, M				Asai, Tohru; Kinoshita, Takeshi; Suzuki, Tomoaki; Shiraishi, Shoichiro; Koike, Masato			Early and follow-up results of butterfly resection of prolapsed posterior leaflet in 76 consecutive patients	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							SYSTOLIC ANTERIOR MOTION; MITRAL-VALVE REPAIR; MANAGEMENT; GUIDELINES	Objective: The present study aims to examine the medium-term results of butterfly resection. Methods: Of 587 consecutive patients who underwent surgery for mitral regurgitation between January 2002 and August 2012, 162 patients underwent valve reconstruction of a prolapsed posterior leaflet. Quadrangular resection (n = 50, Quadrangular group) was primarily used before November 2006 (when we innovated the concept of butterfly resection). After that, we mainly used butterfly resection (n = 76, Butterfly group). Results: Although there was no sign of systolic anterior motion in the Butterfly group, it occurred in 2 patients in the Quadrangular group. One patient in the Quadrangular group died of stroke at postoperative day 17. The mean follow-up period was 2.2 +/- 1.6 years for the Butterfly group and 6.1 +/- 2.5 years for the Quadrangular group. During those periods, 2 patients died of noncardiac causes in the Butterfly group and 1 patient died of an unknown cause in the Quadrangular group. One patient in the Quadrangular group required a reoperation for recurrent mitral regurgitation arising from a new lesion of the anterior leaflet. One patient in the Butterfly group required a reoperation for partial dehiscence of suture at the posterior leaflet. The 3-year estimated survivals free from overall death and reoperation for recurrent mitral regurgitation in the Butterfly group and the Quadrangular group were 97% +/- 2% versus 96% +/- 3% (P =.89) and 95% +/- 3% versus 96% +/- 3% (P =.75), respectively. Conclusions: Butterfly resection provides acceptable early and medium-term results.	[Asai, Tohru; Kinoshita, Takeshi; Suzuki, Tomoaki] Shiga Univ Med Sci, Div Cardiovasc Surg, Otsu, Shiga 5202192, Japan; [Shiraishi, Shoichiro; Koike, Masato] Oumikusatsu Tokusyukai Hosp, Div Cardiovasc Surg, Kusatsu, Shiga, Japan	Asai, T (reprint author), Shiga Univ Med Sci, Otsu, Shiga 5202192, Japan.	toruasai@belle.shiga-med.ac.jp					Abicht TO, 2014, J THORAC CARDIOV SUR, V148, P2780, DOI 10.1016/j.jtcvs.2014.06.075; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; Brown ML, 2007, J THORAC CARDIOV SUR, V133, P136, DOI 10.1016/j.jctvs.2006.09.024; Asai T, 2011, ANN THORAC SURG, V92, P2097, DOI 10.1016/j.athoracsur.2011.07.087; Crescenzi G, 2009, J THORAC CARDIOV SUR, V137, P320, DOI 10.1016/j.jtcvs.2008.08.018; Akins CW, 2008, J THORAC CARDIOV SUR, V135, P732, DOI 10.1016/j.jtcvs.2007.12.002; JEBARA VA, 1993, CIRCULATION, V88, P30; Asai Tohru, 2011, Innovations (Phila), V6, P54, DOI 10.1097/IMI.0b013e31820c0107; Calafiore AM, 2014, J THORAC CARDIOV SUR, V148, P1407, DOI 10.1016/j.jtcvs.2014.02.046; Carpentier A, 2010, CARPENTIERS RECONSTR, P30; Loulmet DF, 2014, J THORAC CARDIOV SUR, V148, P2787, DOI 10.1016/j.jtcvs.2014.07.076; Manabe S, 2012, J THORAC CARDIOVASC, V146, P291; Mohty D, 2001, CIRCULATION S1, V104, P1; Perier P, 1997, ANN THORAC SURG, V64, P445, DOI 10.1016/S0003-4975(97)00537-7; Sawazaki M, 2013, J THORAC CARDIOV SUR, V146, P275, DOI 10.1016/j.jtcvs.2012.06.054; Varghese R, 2012, J THORAC CARDIOV SUR, V143, pS2, DOI 10.1016/j.jtcvs.2012.01.063	17	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAY	2015	149	5					1296	1300		10.1016/j.jtcvs.2015.01.001		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CI2HP	WOS:000354567100019		
J	Asai, S; Sato, S; Okami, K; Takanashi, N; Umezawa, K; Damdinsuren, A; Matsushita, H; Nakamura, N; Suzuki, Y; Miyachi, H				Asai, Satomi; Sato, Shinji; Okami, Kenji; Takanashi, Noboru; Umezawa, Kazuo; Damdinsuren, Anar; Matsushita, Hiromichi; Nakamura, Naoya; Suzuki, Yasuo; Miyachi, Hayato			Sonographic Evaluation of the Treatment Response in Patients With Immunoglobulin G4-Related Disease of the Submandibular Glands	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						glucocorticoid; head and neck ultrasound; immunoglobulin G4-related disease; sonography; treatment response	IGG4-RELATED SYSTEMIC-DISEASE; LYMPHOID-TISSUE LYMPHOMA; INFILTRATION; APPEARANCE; CELL	Objectives-To evaluate the usefulness of sonography for monitoring the response to glucocorticoid treatment in patients with immunoglobulin G4 (IgG4)-related disease. Methods-We conducted a retrospective study using sonography in 12 patients with bilateral swollen submandibular glands who had a diagnosis of IgG4-related disease based on an elevated serum IgG4 level (>135 mg/dL) and histopathologic findings between January 2010 and December 2012. Among these patients, 6 were treated with prednisolone, and the other 6 were placed under observation. B-mode sonographic examinations of the submandibular glands were performed with or without color Doppler imaging at the initial examination and 6 months later. Findings were compared between the groups (treated and untreated), and their relationship with the treatment response of the primarily involved organs was investigated. Results-In the treated group, the submandibular glands of all 6 patients decreased in both size and volume after treatment (average volume +/- SD, 27,449.7 +/- 24,227.6 to 4609.7 +/- 1911.4 mm(3); P = .004). The internal echo texture, characterized by multiple hypoechoic foci scattered against a heterogeneous hyperechoic background of submandibular tissue with demarcated hyperechoic lines, with or without hypoechoic tumor formation, disappeared or was obscured in all cases. In addition, the blood flow signals were reduced in all 3 patients who underwent color Doppler sonography, and the response observed on sonography was found to correlate with the IgG4 level and recovery of specific organ involvement. In contrast, in the untreated group, the submandibular glands showed a tendency to increase in both size and volume (average volume, 9326.3 +/- 3054.8 to 12,217.4 +/- 4605.5 mm(3); P = .2) without a decrease in the blood flow signals. Conclusions-Sonography is considered useful for evaluating the response to glucocorticoid therapy in patients with IgG4-related disease of the submanclibular glands.	[Asai, Satomi; Damdinsuren, Anar; Matsushita, Hiromichi; Miyachi, Hayato] Tokai Univ Sch Med, Dept Lab Med, Isehara, Kanagawa 2591193, Japan; [Sato, Shinji; Suzuki, Yasuo] Tokai Univ Sch Med, Dept Rheumatol, Isehara, Kanagawa 2591193, Japan; [Okami, Kenji] Tokai Univ Sch Med, Dept Otolaryngol, Isehara, Kanagawa 2591193, Japan; [Umezawa, Kazuo] Tokai Univ Sch Med, Dept Crit Care & Emergency Med, Isehara, Kanagawa 2591193, Japan; [Nakamura, Naoya] Tokai Univ Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan; [Takanashi, Noboru] Tokai Univ Hosp, Clin Lab Ctr, Isehara, Kanagawa, Japan	Asai, S (reprint author), Tokai Univ Sch Med, Dept Lab Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	sa@is.icc.u-tokai.ac.jp					Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Guma M, 2012, BEST PRACT RES CL RH, V26, P425, DOI 10.1016/j.berh.2012.07.001; Ebbo M, 2014, ARTHRIT CARE RES, V66, P86, DOI 10.1002/acr.22058; Nakatani K, 2012, CLIN RADIOL, V67, P297, DOI 10.1016/j.crad.2011.10.011; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Asai S, 2010, J ULTRAS MED, V29, P111; Asai S, 2001, AM J HEMATOL, V67, P234, DOI 10.1002/ajh.1122; Asai S, 2008, J ULTRAS MED, V27, P969; Asai S, 2013, J ULTRAS MED, V32, P731, DOI 10.7863/ultra.32.5.731; Asai S, 2012, J ULTRAS MED, V31, P489; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Masaki Yasufumi, 2011, J Clin Exp Hematop, V51, P13; Yamamoto M, 2006, MOD RHEUMATOL, V16, P335	14	0	0	AMER INST ULTRASOUND MEDICINE	LAUREL	SUBSCRIPTION DEPT, 14750 SWEITZER LANE, STE 100, LAUREL, MD 20707-5906 USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	MAY	2015	34	5					783	788		10.7863/ultra.34.5.783		6	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CH4ON	WOS:000354012900005		
J	Ikui, Y; Nakamura, H; Sano, D; Hyakusoku, H; Kishida, H; Kudo, Y; Joki, H; Koyano, S; Yamauchi, A; Takano, S; Tayama, N; Hirose, H; Oridate, N; Tanaka, F				Ikui, Yukiko; Nakamura, Haruko; Sano, Daisuke; Hyakusoku, Hiroshi; Kishida, Hitaru; Kudo, Yosuke; Joki, Hideto; Koyano, Shigeru; Yamauchi, Akihito; Takano, Shingo; Tayama, Niro; Hirose, Hajime; Oridate, Nobuhiko; Tanaka, Fumiaki			An Aerodynamic Study of Phonations in Patients With Parkinson Disease (PD)	JOURNAL OF VOICE			English	Article						Parkinson disease; Fundamental frequency; Airflow rate; Intensity of voice; Laryngeal muscles; Aging voice	INTENSIVE VOICE TREATMENT; SPEAKING FUNDAMENTAL-FREQUENCY; SPEECH TREATMENT; LARYNGEAL ELECTROMYOGRAPHY; ACOUSTIC CHARACTERISTICS; TREATMENT LSVT; DISORDERS; AGE; INDIVIDUALS; DYSARTHRIA	Background. The precise comparison of the voice characteristics of Parkinson disease (PD) patients with age-matched normal subjects is still one of the important research projects. The present study aimed at comparing the voice characteristics in sustained phonations of PD patients with an age-matched control group. Methods. The subjects were 30 Japanese PD patients (15 males and 15 females). The control group consisted of 30 age-matched normal Japanese subjects (15 males and 15 females). Each subject was required to phonate into a mouthpiece attached to Vocal Function Analyzer (PS-77E; Nagashima Medical Instrumental Corporation, Tokyo, Japan) with the airway interruption system, and expiratory lung pressure, mean flow rate, fundamental frequency and intensity of voice, and pitch range were measured. Maximum phonation time was also assessed. Results. The highest pitch level was significantly lower in the PD group than that of the control group in both sexes, whereas the lowest pitch level was significantly higher in the PD group only in males. In both sexes, the pitch range was significantly narrower in the PD group than in the control group. There was no significant difference in intensity, mean flow rate, expiratory pressure, or maximum phonation time between the two groups, for both males and females. Conclusion. Only remarkable difference in the voice characteristics between PD patients and age-matched normal elderlies was limited to the narrowing of the pitch range in PD patients. The restriction in pitch regulation in PD patients was considered to be because of difficulty in reciprocal control of the laryngeal muscles secondary to latent rigidity.	[Ikui, Yukiko; Sano, Daisuke; Hyakusoku, Hiroshi; Hirose, Hajime; Oridate, Nobuhiko] Yokohama City Univ, Grad Sch Med, Dept Biol & Funct Head & Neck, Yokohama, Kanagawa 232, Japan; [Nakamura, Haruko; Kishida, Hitaru; Kudo, Yosuke; Joki, Hideto; Koyano, Shigeru; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Clin Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan; [Yamauchi, Akihito] Tokyo Univ Hosp, Dept Otolaryngol, Tokyo 113, Japan; [Takano, Shingo; Tayama, Niro] Natl Ctr Global Hlth & Med, Dept Otolaryngol & Tracheoesophagol, Tokyo, Japan	Ikui, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Biol & Funct Head & Neck, Yokohama, Kanagawa 232, Japan.	t116005b@yokohama-cu.ac.jp					ALLAN CM, 1966, BRIT J DISORD COMMUN, V1, P55; Skodda S, 2009, MOVEMENT DISORD, V24, P716, DOI 10.1002/mds.22430; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462; Sapir S, 2007, J SPEECH LANG HEAR R, V50, P899, DOI 10.1044/1092-4388(2007/064); Holmes RJ, 2000, INT J LANG COMM DIS, V35, P407; Ramig LO, 1996, J SPEECH HEAR RES, V39, P798; Sapir S, 2011, EXPERT REV NEUROTHER, V11, P815, DOI [10.1586/ern.11.43, 10.1586/ERN.11.43]; KAPLAN HA, 1954, J NERV MENT DIS, V119, P398, DOI 10.1097/00005053-195405000-00003; Sapir S, 2002, FOLIA PHONIATR LOGO, V54, P296, DOI 10.1159/000066148; De Letter M, 2007, CLIN LINGUIST PHONET, V21, P783, DOI 10.1080/02699200701538181; HONJO I, 1980, ARCH OTOLARYNGOL, V106, P149; Rusz J, 2011, J ACOUST SOC AM, V129, P350, DOI 10.1121/1.3514381; RAMIG LO, 1995, J SPEECH HEAR RES, V38, P1232; PLASSE HM, 1981, ARCH OTOLARYNGOL, V107, P252; Midi I, 2008, ACTA NEUROL SCAND, V117, P26, DOI 10.1111/j.1600-0404.2007.00965.x; Fox Cynthia M., 2006, Seminars in Speech and Language, V27, P283, DOI 10.1055/s-2006-955118; Ramig Lorraine Olson, 2004, Seminars in Speech and Language, V25, P169; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246; Awan SN, 1991, J SPEECH HEAR RES, V34, P1000; Azevedo Luciana Lemos de, 2013, Arq Neuropsiquiatr, V71, P835, DOI 10.1590/0004-282X20130141; Bauer V, 2011, COLLEGIUM ANTROPOL, V35, P209; BOHME G, 1970, FOLIA PHONIATR, V22, P176; BROWN W S JR, 1989, Journal of Voice, V3, P113, DOI 10.1016/S0892-1997(89)80137-7; CANTER GJ, 1963, J SPEECH HEAR DISORD, V28, P221; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217; CRITCHLEY EMR, 1981, J NEUROL NEUROSUR PS, V44, P751, DOI 10.1136/jnnp.44.9.751; Dohqan A, 2012, FOLIA PHONIATR LOGO, V64, P265; Duffy JR, 1987, MOTOR SPEECH DISORDE; Dumer AI, 2014, J INT NEUROPSYCH SOC, V29, P302; LINVILLE SE, 1985, J GERONTOL, V40, P324; Fox C, 1997, AM J SPEECH-LANG PAT, V2, P29; Fox CM, 2002, AM J SPEECH-LANG PAT, V11, P111, DOI 10.1044/1058-0360(2002/012); GREWEL F, 1957, ACTA PSYCH NEUROL, V32, P440, DOI 10.1111/j.1600-0447.1957.tb07555.x; HIROSE H, 1986, FOLIA PHONIATR, V38, P61; HIROSE H, 1981, FOLIA PHONIATR, V33, P204; HOLLIEN H, 1972, J SPEECH HEAR RES, V15, P155; Jiang J, 1999, J VOICE, V13, P583, DOI 10.1016/S0892-1997(99)80012-5; Logmann JA, 1978, J SPEECH HEAR DISORD, V18, P47; Mori H., 2007, JPN J LOGOP PHONIATR, V48, P237; ORLIKOFF RF, 1990, J SPEECH HEAR RES, V33, P450; Ramig LO, 2001, J NEUROL NEUROSUR PS, V71, P493, DOI 10.1136/jnnp.71.4.493; Ramig LO., 1995, CURRENT OPINION OTOL, V3, P174, DOI 10.1097/00020840-199506000-00005; Ramig LO, 1998, J SPEECH LANG HEAR S, V41, P101; Ramig LO, 1994, J MED SPEECH-LANG PA, V2, P191; Ramig LO, 1997, VOICE TREATMENT PARK; RIGRODSK.S, 1970, J AM GERIATR SOC, V18, P142; Ringel RL, 1987, J VOICE, V1, P31, DOI 10.1016/S0892-1997(87)80021-8; RUSSELL A, 1995, J SPEECH HEAR RES, V38, P101; SARNO MARTHA TAYLOR, 1968, ARCH PHYS MED REHABIL, V49, P269; Sawashima M, 1987, JPN J LOGOP PHONIATR, V28, P257; Spielman J, 2007, AM J SPEECH-LANG PAT, V16, P95, DOI 10.1044/1058-0360(2007/014); Trail M, 2005, NEUROREHABILITATION, V20, P205; Tykalova T, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.07.001; VAS CJ, 1965, J NEUROL NEUROSUR PS, V28, P401, DOI 10.1136/jnnp.28.5.401; WILCOX KA, 1980, J GERONTOL, V35, P194; Xue SA, 1995, J SPEECH HEAR RES, V38, P101; Zarzur AP, 2014, LARYNGOSCOPE, V124, P725, DOI 10.1002/lary.24379; Zarzur AP, 2007, LARYNGOSCOPE, V117, P831, DOI 10.1097/MLG.0b013e3180333145	58	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0892-1997	1873-4588		J VOICE	J. Voice	MAY	2015	29	3					273	280		10.1016/j.jvoice.2014.08.012		8	Otorhinolaryngology	Otorhinolaryngology	CI2AI	WOS:000354546200003		
J	Teramoto, H; Kojima, K				Teramoto, Hidetoshi; Kojima, Katsura			Incorporation of Methionine Analogues Into Bombyx mori Silk Fibroin for Click Modifications	MACROMOLECULAR BIOSCIENCE			English	Article						click chemistry; modification; proteins; silk fibroin; unnatural amino acids	UNNATURAL AMINO-ACIDS; TRANSFER-RNA; BACTERIAL-CELLS; IN-VIVO; PROTEINS; HEAVY; SITE; FUNCTIONALIZATION; GENERATION; CHEMISTRY	Bombyx mori silk fibroin incorporating three methionine (Met) analogueshomopropargylglycine (Hpg), azidohomoalanine (Aha), and homoallylglycine (Hag)can be produced simply by adding them to the diet of B. mori larvae. The Met analogues are recognized by methionyl-tRNA synthetase, bound to tRNA(Met), and used for the translation of adenine-uracil-guanine (AUG) codons competitively with Met. In the presence of the standard amount of Met in the diet, incorporation of these analogues remains low. Lowering the amount of Met in the diet drastically improves incorporation efficiencies. Alkyne and azide groups in Hpg and Aha incorporated into silk fibroin can be selectively modified with Cu-catalyzed azide-alkyne cycloaddition reactions (click chemistry). Since Met residues exist only at the N-terminal domain of the fibroin heavy chain and in the fibroin light chain, good access to the reactive sites is expected and domain-selective modifications are possible without perturbing other major domains, including repetitive domains.	[Teramoto, Hidetoshi; Kojima, Katsura] NIAS, Silk Mat Res Unit, Genetically Modified Organisms Res Ctr, Tsukuba, Ibaraki 3058634, Japan	Teramoto, H (reprint author), NIAS, Silk Mat Res Unit, Genetically Modified Organisms Res Ctr, Tsukuba, Ibaraki 3058634, Japan.	teramoto@affrc.go.jp			JSPS KAKENHI [24688008]	We acknowledge the Transgenic Silkworm Research Unit at NIAS for providing silkworm eggs. We thank Dr. Q. Zhang for her technical assistance. This work was supported by JSPS KAKENHI Grant Number 24688008.	Hinz FI, 2013, CURR OPIN CHEM BIOL, V17, P738, DOI 10.1016/j.cbpa.2013.07.021; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413; Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353; YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; van Hest JCM, 1998, FEBS LETT, V428, P68, DOI 10.1016/S0014-5793(98)00489-X; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a; Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6; Kambe Y, 2010, BIOMATERIALS, V31, P7503, DOI 10.1016/j.biomaterials.2010.06.045; Lin YYA, 2009, CHEMBIOCHEM, V10, P959, DOI 10.1002/cbic.200900002; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Link AJ, 2005, METHODS, V36, P291, DOI 10.1016/j.ymeth.2005.04.005; Teramoto H, 2014, BIOMACROMOLECULES, V15, P2682, DOI 10.1021/bm5005349; Li N, 2011, J AM CHEM SOC, V133, P15316, DOI 10.1021/ja2066913; Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Song W, 2008, J AM CHEM SOC, V130, P9654, DOI 10.1021/ja803598e; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Li YM, 2012, CHEM SCI, V3, P2766, DOI 10.1039/c2sc20433a; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; Arai N., 1964, J SERICULT SCI JPN, V33, P107; Hartman MCT, 2006, P NATL ACAD SCI USA, V103, P4356, DOI 10.1073/pnas.0509219103; Kuwana Y., 2014, PLOS ONE, V9; Nadarajan SP, 2013, J MOL GRAPH MODEL, V39, P79, DOI 10.1016/j.jmgm.2012.11.005; Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Sato M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04080; Teramoto H., 2013, Journal of Insect Biotechnology and Sericology, V82, P61; Teramoto Hidetoshi, 2010, Journal of Insect Biotechnology and Sericology, V79, P53; Watanabe K., 1980, J SERIC SCI JPN, V49, P177	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	MAY	2015	15	5					719	727		10.1002/mabi.201400482		9	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CI0AB	WOS:000354396800013		
J	Higaki, Y; Kabayama, H; Tao, D; Takahara, A				Higaki, Yuji; Kabayama, Hirofumi; Tao, Di; Takahara, Atsushi			Surface Functionalization of Electrospun Poly(butylene terephthalate) Fibers by Surface-Initiated Radical Polymerization	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						electrospun fibers; poly(butylene terephthalate); polymer brushes; polymerization; surface modification; surface-initiated atom transfer radical	MOLECULAR-ORIENTATION; NANOFIBERS; BRUSHES; POLYETHYLENE; WETTABILITY; RESISTANCE; BEHAVIOR; MATS	A facile surface modification procedure for electrospun poly(butylene terephthalate) (PBT) fibers by surface-initiated atom transfer radical polymerization (SI-ATRP) is reported. Initiators are introduced through aminolysis and chemical vapor adsorption. SI-ATRP is subsequently carried out to prepare a polymer-grafted layer at the PBT fiber surface without altering the fiber geometry. After modification with a zwitterionic poly(sulfobetaine), poly(3-(N-2-methacryloyloxyethyl-N,N-dimethyl) ammonatopropanesulfonate), the surface is superhydrophilic. The surface properties are thermally stable due to the high melting temperature of the PBT crystallites and are maintained for a prolonged period.	[Higaki, Yuji; Kabayama, Hirofumi; Tao, Di; Takahara, Atsushi] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Higaki, Yuji; Takahara, Atsushi] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Higaki, Yuji; Takahara, Atsushi] JST ERATO Takahara Soft Interfaces Project, Nishi Ku, Fukuoka 8190395, Japan; [Higaki, Yuji; Tao, Di; Takahara, Atsushi] Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Takahara, A (reprint author), Kyushu Univ, Grad Sch Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	takahara@cstf.kyushu-u.ac.jp	Higaki, Yuji/O-4179-2015				Kobayashi M, 2013, POLYM CHEM-UK, V4, P731, DOI 10.1039/c2py20712e; Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7; Richard-Lacroix M, 2013, MACROMOLECULES, V46, P9473, DOI 10.1021/ma401681m; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Hardman SJ, 2011, MACROMOLECULES, V44, P6461, DOI 10.1021/ma200852z; Catalani LH, 2007, MACROMOLECULES, V40, P1693, DOI 10.1021/ma061342d; Yano T, 2011, POLYM J, V43, P838, DOI 10.1038/pj.2011.80; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a; Kobayashi M, 2013, SOFT MATTER, V9, P5138, DOI 10.1039/c3sm27700c; Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j; Yao C, 2008, J MEMBRANE SCI, V320, P259, DOI 10.1016/j.memsci.2008.04.012; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Arinstein A, 2011, J POLYM SCI POL PHYS, V49, P691, DOI 10.1002/polb.22247; Therien-Aubin H, 2011, POLYMER, V52, P5419, DOI 10.1016/j.polymer.2011.09.017; TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302; Kobayashi M, 2012, LANGMUIR, V28, P7212, DOI 10.1021/la301033h; Terayama Y, 2011, MACROMOLECULES, V44, P104, DOI 10.1021/ma102223y; Kang ET, 2000, ADV MATER, V12, P1481, DOI 10.1002/1521-4095(200010)12:20<1481::AID-ADMA1481>3.0.CO;2-Z; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Desai SM, 2004, ADV POLYM SCI, V169, P231, DOI 10.1007/b13524; Fadeev AY, 1998, LANGMUIR, V14, P5586, DOI 10.1021/la980512f; Gerard E, 2011, J POLYM SCI POL CHEM, V49, P5087, DOI 10.1002/pola.24975; Kimura T, 2009, CHEM LETT, V38, P446, DOI 10.1246/cl.2009.446; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lancuski A, 2012, ACS APPL MATER INTER, V4, P6499, DOI 10.1021/am301458y; Lopez-Donaire ML, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40328, 10.1002/APP.40328]; Oezcam A. E., 2012, J MATER CHEM, V22, P5855; STEIN RS, 1980, J POLYM SCI POL PHYS, V18, P327, DOI 10.1002/pol.1980.180180215; Viswanathan P., 2014, BIOMACROMOLECULES, V16, P66; Wang ZF, 2014, ACS APPL MATER INTER, V6, P11640, DOI 10.1021/am502398u; Yoshikawa C, 2005, MACROMOLECULES, V38, P4604, DOI 10.1021/ma047556h	32	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	MAY	2015	216	10					1103	1108		10.1002/macp.201500066		6	Polymer Science	Polymer Science	CI2HF	WOS:000354565900008		
J	Oestreicher, Z; Taoka, A; Fukumori, Y				Oestreicher, Zachery; Taoka, Azuma; Fukumori, Yoshihiro			A comparison of the surface nanostructure from two different types of gram-negative cells: Escherichia coli and Rhodobacter sphaeroides	MICRON			English	Article						High-speed atomic force microscopy; Rhodobacter spheroides; Outer bacterial membrane; Porin	ATOMIC-FORCE MICROSCOPY; DYNAMIC BIOMOLECULAR PROCESSES; OUTER-MEMBRANE-PROTEIN; HIGH-SPEED AFM; ELECTRON-MICROSCOPY; NANO-VISUALIZATION; PORIN; RESOLUTION; PERMEABILITY; CAPSULATUS	Bacteria have been studied using different microscopy methods for many years. Recently, the developments of high-speed atomic force microscopy have opened the doors to study bacteria in new ways due to the fact that it uses much less force on the sample while imaging. This makes the high-speed atomic force microscope an indispensable technique for imaging the surface of living bacterial cells because it allows for the high-resolution visualization of surface proteins in their natural condition without disrupting the cell or the activity of the proteins. Previous work examining living cells of Magnetospirillum magneticum AMB-1 demonstrated that the surface of these bacteria was covered with a net-like structure that is mainly composed of porin molecules. However, it was unclear whether or not this feature was unique to other living bacteria. In this study we used the high-speed atomic force microscope to examine the surface of living cells of Escherichia coli and Rhodobacter sphaeroides to compare their structure with that of M. magneticum. Our research clearly demonstrated that both of these types of cells have an outer surface that is covered in a network of nanometer-sized holes similar to M. magneticum. The diameter of the holes was 8.0 +/- 1.5 nm for E. coli and 6.6 +/- 1.1 nm for R. sphaeroides. The results in this paper confirm that this type of outer surface structure exists in other types of bacteria and it is not unique to Magnetospirillum. (C) 2015 Elsevier Ltd. All rights reserved.	[Oestreicher, Zachery; Taoka, Azuma; Fukumori, Yoshihiro] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan; [Taoka, Azuma; Fukumori, Yoshihiro] Kanazawa Univ, Coll Sci & Engn, BioAFM Frontier Res Ctr, Kanazawa, Ishikawa, Japan	Fukumori, Y (reprint author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan.	fukumor@staff.kanazawa-u.ac.jp			MEXT KAKENHI Grant [24117007]	This work was supported by MEXT KAKENHI Grant Number 24117007. The authors would like to thank Dr. T. Ando (Kanazawa Univ.) for his support with the HS-AFM and Dr. N. Kodera (Kanazawa Univ.), Dr. H. Yamashita (Osaka Univ.), and Dr. T. Nakayama (Kanazawa Univ.) for their useful discussions.	Amako K, 1996, MICROBIOL IMMUNOL, V40, P749; Ando T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08KA02; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Ando T, 2014, CHEM REV, V114, P3120, DOI 10.1021/cr4003837; Ando T, 2013, MICROSCOPY-JPN, V62, P81, DOI 10.1093/jmicro/dfs093; Braga PC, 1998, ANTIMICROB AGENTS CH, V42, P18; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/nnano.2010.29, 10.1038/NNANO.2010.29]; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Jaroslawski S, 2009, MOL MICROBIOL, V74, P1211, DOI 10.1111/j.1365-2958.2009.06926.x; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Yamamoto D, 2010, METHOD ENZYMOL, V475, P541, DOI 10.1016/S0076-6879(10)75020-5; Beveridge TJ, 1999, J BACTERIOL, V181, P4725; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; KESSEL M, 1988, J MOL BIOL, V203, P275, DOI 10.1016/0022-2836(88)90108-8; BEVERIDGE TJ, 1991, MICROBIOL REV, V55, P684; CHALCROFT JP, 1987, FEBS LETT, V211, P53, DOI 10.1016/0014-5793(87)81273-5; DORSET DL, 1983, J MOL BIOL, V165, P701, DOI 10.1016/S0022-2836(83)80275-7; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595; KESSEL M, 1985, J MICROSC-OXFORD, V139, P63; KREUSCH A, 1994, J MOL BIOL, V243, P891, DOI 10.1006/jmbi.1994.1690; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X; ROSENBUS.JP, 1974, J BIOL CHEM, V249, P8019; Sambrook J., 2001, MOL CLONING LAB MANU, V1; SASS HJ, 1989, J MOL BIOL, V209, P171, DOI 10.1016/0022-2836(89)90180-0; SCHABERT FA, 1994, BIOPHYS J, V67, P2394; SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347; Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x; TAKEUCHI Y, 1981, BIOCHEMISTRY-US, V20, P523, DOI 10.1021/bi00506a013; Umeda A, 1998, MICROBIOL IMMUNOL, V42, P159; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-4328			MICRON	Micron	MAY	2015	72						8	14		10.1016/j.micron.2015.02.001		7	Microscopy	Microscopy	CI1ME	WOS:000354507500002		
J	Cretu, O; Lin, YC; Suenaga, K				Cretu, Ovidiu; Lin, Yung-Chang; Suenaga, Kazutomo			Inelastic electron irradiation damage in hexagonal boron nitride	MICRON			English	Article						Hexagonal boron-nitride; Inelastic irradiation damage; Low-voltage TEM	RADIATION-DAMAGE; GRAPHENE; MICROSCOPY; MEMBRANES	We present a study of the inelastic effects caused by electron irradiation in monolayer hexagonal boron nitride (h-BN). The data was obtained through in situ experiments performed inside a low-voltage aberration-corrected transmission electron microscope (TEM). By using various specialized sample holders, we study defect formation and evolution with sub-nanometer resolution over a wide range of temperatures, between -196 and 1200 degrees C, highlighting significant differences in the geometry of the structures that form. The data is then quantified, allowing insight into the defect formation mechanism, which is discussed in comparison with the potential candidate damage processes. We show that the defect shapes are determined by an interplay between electron damage, which we assign to charging, and thermal effects. We additionally show that this damage can be avoided altogether by overlapping the samples with a monolayer of graphene, confirming this for h-BN and providing a way to overcome the well-known fragility of h-BN under the electron beam. (C) 2015 Elsevier Ltd. All rights reserved.	[Cretu, Ovidiu; Lin, Yung-Chang; Suenaga, Kazutomo] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Cretu, O (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	ovidiu.cretu@aist.go.jp	Suenaga, Kazu/E-2339-2014; Lin, Yung-Chang/G-1545-2015; 	Suenaga, Kazu/0000-0002-6107-1123; Cretu, Ovidiu/0000-0002-1822-8172	JST Research Acceleration Program	This work is supported by the JST Research Acceleration Program.	Algara-Siller G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830036; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Ramasse QM, 2012, ACS NANO, V6, P4063, DOI 10.1021/nn300452y; Warner JH, 2010, ACS NANO, V4, P1299, DOI 10.1021/nn901648q; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; CAZAUX J, 1995, ULTRAMICROSCOPY, V60, P411, DOI 10.1016/0304-3991(95)00077-1; Meyer JC, 2009, NANO LETT, V9, P2683, DOI 10.1021/nl9011497; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Hu T, 2013, PHYSICA E, V54, P191, DOI 10.1016/j.physe.2013.06.028; Sasaki T, 2010, J ELECTRON MICROSC, V59, pS7, DOI 10.1093/jmicro/dfq027; Huang B, 2012, NANO RES, V5, P62, DOI 10.1007/s12274-011-0185-y; Lehtinen O, 2014, NANOSCALE, V6, P6569, DOI 10.1039/c4nr01918k; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Alem N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155425; Zan R, 2013, ACS NANO, V7, P10167, DOI 10.1021/nn4044035; Meyer JC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196102; Pacile D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903702; Mukherjee R, 2011, J CHEM THEORY COMPUT, V7, P720, DOI 10.1021/ct1006345; Cao XK, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829026; Lin YC, 2011, ACS NANO, V5, P2362, DOI 10.1021/nn200105j; Haider M, 1998, ULTRAMICROSCOPY, V75, P53, DOI 10.1016/S0304-3991(98)00048-5; Kotakoski J, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113404; Krivanek OL, 1999, ULTRAMICROSCOPY, V78, P1, DOI 10.1016/S0304-3991(99)00013-3; Cretu O, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.075502; Hobbs L. W, 1979, INTRO ANAL ELECT MIC; HOBBS LW, 1990, SCANNING MICROSCOPY, P171; Howitt D.G., 1986, PRINCIPLES ANAL ELEC, P375; Kim JS, 2011, ACS NANO, V5, P3977, DOI 10.1021/nn2005443; Kotakoski J., 2011, ACS NANO, V6, P671; Pierson H. O., 1996, HDB REFRACTORY CARBI; Suenaga K, 2012, J ELECTRON MICROSC, V61, P285, DOI 10.1093/jmicro/dfs054; Williams D.B., 2009, TRANSMISSION ELECT M	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-4328			MICRON	Micron	MAY	2015	72						21	27		10.1016/j.micron.2015.02.002		7	Microscopy	Microscopy	CI1ME	WOS:000354507500004		
J	Hajdu, P; Martin, GV; Chimote, AA; Szilagyi, O; Takimoto, K; Conforti, L				Hajdu, Peter; Martin, Geoffrey V.; Chimote, Ameet A.; Szilagyi, Orsolya; Takimoto, Koichi; Conforti, Laura			The C-terminus SH3-binding domain of Kv1.3 is required for the actin-mediated immobilization of the channel via cortactin	MOLECULAR BIOLOGY OF THE CELL			English	Article							BINDING PROTEIN CORTACTIN; HUMAN T-LYMPHOCYTES; POTASSIUM CHANNEL; IMMUNOLOGICAL SYNAPSE; SURFACE EXPRESSION; ION CHANNELS; SH3 DOMAIN; F-ACTIN; CELLS; POLYMERIZATION	Kv1.3 channels play a pivotal role in the activation and migration of T-lymphocytes. These functions are accompanied by the channels' polarization, which is essential for associated downstream events. However, the mechanisms that govern the membrane movement of Kv1.3 channels remain unclear. F-actin polymerization occurs concomitantly to channel polarization, implicating the actin cytoskeleton in this process. Here we show that cortactin, a factor initiating the actin network, controls the membrane mobilization of Kv1.3 channels. FRAP with EGFP-tagged Kv1.3 channels demonstrates that knocking down cortactin decreases the actin-based immobilization of the channels. Using various deletion and mutation constructs, we show that the SH3 motif of Kv1.3 mediates the channel immobilization. Proximity ligation assays indicate that deletion or mutation of the SH3 motif also disrupts interaction of the channel with cortactin. In T-lymphocytes, the interaction between HS1 (the cortactin homologue) and Kv1.3 occurs at the immune synapse and requires the channel's C-terminal domain. These results show that actin dynamics regulates the membrane motility of Kv1.3 channels. They also provide evidence that the SH3 motif of the channel and cortactin plays key roles in this process.	[Hajdu, Peter; Martin, Geoffrey V.; Chimote, Ameet A.; Szilagyi, Orsolya; Conforti, Laura] Univ Cincinnati, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45267 USA; [Hajdu, Peter; Szilagyi, Orsolya] Univ Debrecen, Dept Biophys & Cell Biol, H-4032 Debrecen, Hungary; [Takimoto, Koichi] Nagaoka Univ Technol, Dept Bioengn & Bioinformat, Nagaoka, Niigata 9402137, Japan	Conforti, L (reprint author), Univ Cincinnati, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45267 USA.	laura.conforti@uc.edu			American Heart Association [0855457D]; National Institutes of Health [R01CA095286]; European Union; state of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Hungarian Social Renewal Operational Program [TAMOP-4.2.2-A-11/1/KONV-2012-0025]	We greatly appreciate the technical assistance of Lisa Neumeier and Charles Ebersbacher. This project was funded in part by American Heart Association Grant-in-Aid 0855457D and National Institutes of Health Grant R01CA095286. O.S. was supported by the European Union and the state of Hungary, cofinanced by the European Social Fund in the framework of the TAMOP 4.2.4. A/2-11-1-2012-0001 National Excellence Program. This project was partly supported by the Hungarian Social Renewal Operational Program (TAMOP-4.2.2-A-11/1/KONV-2012-0025).	Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Kummerow C, 2009, IMMUNOL REV, V231, P132, DOI 10.1111/j.1600-065X.2009.00811.x; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Daly RJ, 2004, BIOCHEM J, V382, P13; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Herrmann S, 2012, J BIOL CHEM, V287, P44151, DOI 10.1074/jbc.M112.372540; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Hajdu P, 2013, BIOMATERIALS, V34, P10249, DOI 10.1016/j.biomaterials.2013.09.019; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1389; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Chimote AA, 2012, J BIOL CHEM, V287, P2055, DOI 10.1074/jbc.M111.274209; Doczi MA, 2011, EXP CELL RES, V317, P2333, DOI 10.1016/j.yexcr.2011.06.009; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; Favier B, 2001, INT IMMUNOL, V13, P1525, DOI 10.1093/intimm/13.12.1525; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; Hu LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054267; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; Nicolaou SA, 2007, J IMMUNOL, V179, P346; Nicolaou SA, 2010, CELL CALCIUM, V47, P19, DOI 10.1016/j.ceca.2009.11.001; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; Shin HW, 2000, J NEUROSCI, V20, P3580; Szigligeti P, 2006, J PHYSIOL-LONDON, V573, P357, DOI 10.1113/jphysiol.2006.109967; Szilagyi O, 2013, PFLUG ARCH EUR J PHY, V465, P1341, DOI 10.1007/s00424-013-1256-6; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Zhu J, 2007, MOL MEMBR BIOL, V24, P194, DOI 10.1080/09687860601066309; Zhu J, 2003, BIOCHEM J, V375, P761, DOI 10.1042/BJ20030885	40	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	MAY 1	2015	26	9					1640	1651		10.1091/mbc.E14-07-1195		12	Cell Biology	Cell Biology	CI0FQ	WOS:000354412500007		
J	Ono, K; Obinata, T; Yamashiro, S; Liu, ZM; Ono, S				Ono, Kanako; Obinata, Takashi; Yamashiro, Sawako; Liu, Zhongmei; Ono, Shoichiro			UNC-87 isoforms, Caenorhabditis elegans calponin-related proteins, interact with both actin and myosin and regulate actomyosin contractility	MOLECULAR BIOLOGY OF THE CELL			English	Article							BODY-WALL MUSCLE; DEPOLYMERIZING FACTOR/COFILIN PROTEINS; SMOOTH-MUSCLE; ATPASE ACTIVITY; FILAMENT DYNAMICS; STRIATED-MUSCLE; SOMATIC GONAD; HEAVY-CHAIN; F-ACTIN; C. ELEGANS	Calponin-related proteins are widely distributed among eukaryotes and involved in signaling and cytoskeletal regulation. Calponin-like (CLIK) repeat is an actin-binding motif found in the C-termini of vertebrate calponins. Although CLIK repeats stabilize actin filaments, other functions of these actin-binding motifs are unknown. The Caenorhabditis elegans unc-87 gene encodes actin-binding proteins with seven CLIK repeats. UNC-87 stabilizes actin filaments and is essential for maintenance of sarcomeric actin filaments in striated muscle. Here we show that two UNC-87 isoforms, UNC-87A and UNC-87B, are expressed in muscle and nonmuscle cells in a tissue-specific manner by two independent promoters and exhibit quantitatively different effects on both actin and myosin. Both UNC-87A and UNC-87B have seven CLIK repeats, but UNC-87A has an extra N-terminal extension of similar to 190 amino acids. Both UNC-87 isoforms bind to actin filaments and myosin to induce ATP-resistant actomyosin bundles and inhibit actomyosin motility. UNC-87A with an N-terminal extension binds to actin and myosin more strongly than UNC-87B. UNC-87B is associated with actin filaments in nonstriated muscle in the somatic gonad, and an unc-87 mutation causes its excessive contraction, which is dependent on myosin. These results strongly suggest that proteins with CLIK repeats function as a negative regulator of actomyosin contractility.	[Ono, Kanako; Yamashiro, Sawako; Liu, Zhongmei; Ono, Shoichiro] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Ono, Kanako; Yamashiro, Sawako; Liu, Zhongmei; Ono, Shoichiro] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Obinata, Takashi] Chiba Univ, Fac Sci, Dept Biol, Chiba 2638522, Japan	Ono, S (reprint author), Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.	sono@emory.edu	Ono, Shoichiro/A-6475-2015	Ono, Shoichiro/0000-0002-4763-0398	National Institute of Child Health and Human Development; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; National Institutes of Health [R01 AR48615]; Ministry of Education, Science, and Culture, Japan [23570097]	We thank Jung Hee Woo for technical assistance in sequencing the unc-87 mutation sites. Monoclonal antibody 5-6 (developed by Henry Epstein, University of Texas Medical Branch, Galveston, TX) and MH24 (developed by Robert Waterston, University of Washington, Seattle, WA) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa, Iowa City, IA. Monoclonal antibody MH44 was obtained from Robert Waterston. Some C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). This work was supported by grants from the National Institutes of Health (R01 AR48615) to S.O. and from the Ministry of Education, Science, and Culture, Japan (Grant 23570097) to T.O.	ABE M, 1990, J BIOCHEM-TOKYO, V108, P835; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Malmqvist U, 1997, P NATL ACAD SCI USA, V94, P7655, DOI 10.1073/pnas.94.14.7655; GOETINCK S, 1994, J CELL BIOL, V127, P71, DOI 10.1083/jcb.127.1.71; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; Ono K, 2014, CYTOSKELETON, V71, P36, DOI 10.1002/cm.21152; VELAZ L, 1989, J BIOL CHEM, V264, P9602; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Kranewitter WJ, 2001, J BIOL CHEM, V276, P6306, DOI 10.1074/jbc.M009561200; KAKE T, 1995, BIOCHEM J, V312, P587; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; GOETINCK S, 1994, J CELL BIOL, V127, P79, DOI 10.1083/jcb.127.1.79; Lener T, 2004, FEBS LETT, V556, P221, DOI 10.1016/S0014-5793(03)01401-7; Rozenblum GT, 2008, INT J BIOCHEM CELL B, V40, P1990, DOI 10.1016/j.biocel.2007.07.010; Ono S, 2011, MOL BIOL CELL, V22, P2258, DOI 10.1091/mbc.E10-12-0934; Kim S, 2013, ADV EXP MED BIOL, V757, P277, DOI 10.1007/978-1-4614-4015-4_10; TAKAHASHI K, 1988, HYPERTENSION, V11, P620; WINDER SJ, 1990, J BIOL CHEM, V265, P10148; Hobert O, 2002, BIOTECHNIQUES, V32, P728; Ono K, 2007, DEV DYNAM, V236, P1093, DOI 10.1002/dvdy.21091; Ono K, 2006, MOL BIOL CELL, V17, P2722, DOI 10.1091/mbc.E06-02-0114; Gimona M, 1998, J CELL SCI, V111, P1813; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; DIBB NJ, 1985, J MOL BIOL, V183, P543, DOI 10.1016/0022-2836(85)90170-6; EBASHI S, 1984, J MOL CELL CARDIOL, V16, P129, DOI 10.1016/S0022-2828(84)80701-4; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Galkin VE, 2006, J MOL BIOL, V359, P478, DOI 10.1016/j.jmb.2006.03.044; HARRIS HE, 1977, BIOCHEMISTRY-US, V16, P859, DOI 10.1021/bi00624a008; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; Hodgkinson JL, 2000, J MUSCLE RES CELL M, V21, P115, DOI 10.1023/A:1005697301043; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; MOERMAN DG, 1982, CELL, V29, P773, DOI 10.1016/0092-8674(82)90439-1; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1.016; Myers CD, 1996, J CELL BIOL, V132, P1061, DOI 10.1083/jcb.132.6.1061; Obinata T, 2012, METHODS, V56, P3, DOI 10.1016/j.ymeth.2011.09.026; Obinata T, 2010, J CELL SCI, V123, P1557, DOI 10.1242/jcs.065060; Ono K, 2004, MOL BIOL CELL, V15, P2782, DOI 10.1091/mbc.E04-03-0179; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Ono S, 2014, ANAT REC, V297, P1548, DOI 10.1002/ar.22965; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PEARLSTONE JR, 1987, J BIOL CHEM, V262, P5985; Schroeter MM, 2005, J MUSCLE RES CELL M, V26, P183, DOI 10.1007/s10974-005-9009-6; Sellers JR, 2001, CURR PROTOC CELL BIO; SHAPLAND C, 1993, J CELL BIOL, V121, P1065, DOI 10.1083/jcb.121.5.1065; Squire JM, 1997, CURR OPIN STRUC BIOL, V7, P247, DOI 10.1016/S0959-440X(97)80033-4; Squire JM, 1998, FASEB J, V12, P761; Stiernagle T, 2006, WORMBOOK, V11, P1, DOI DOI 10.1895/W0RMB00K.1.101.1; Takahashi K, 2000, BIOCHEM BIOPH RES CO, V279, P150, DOI 10.1006/bbrc.2000.3909; TANII I, 1985, J BIOCHEM-TOKYO, V98, P1201; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415; Yamashiro S, 2007, J CELL SCI, V120, P3022, DOI 10.1242/jcs.013516; Yamashiro S, 2005, BIOCHEMISTRY-US, V44, P14238, DOI 10.1021/bi050933d; Yoshimoto R, 2000, JPN J PHARMACOL, V84, P474, DOI 10.1254/jjp.84.474; Yu R, 2006, CELL MOTIL CYTOSKEL, V63, P659, DOI 10.1002/cm.20152	60	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	MAY 1	2015	26	9					1687	1698		10.1091/mbc.E14-10-1483		12	Cell Biology	Cell Biology	CI0FQ	WOS:000354412500011		
J	Hayashi, S; Okada, Y				Hayashi, Shinichi; Okada, Yasushi			Ultrafast superresolution fluorescence imaging with spinning disk confocal microscope optics	MOLECULAR BIOLOGY OF THE CELL			English	Article							STRUCTURED ILLUMINATION; LIVE CELLS; RESOLUTION; LIMIT	Most current superresolution (SR) microscope techniques surpass the diffraction limit at the expense of temporal resolution, compromising their applications to live-cell imaging. Here we describe a new SR fluorescence microscope based on confocal microscope optics, which we name the spinning disk superresolution microscope (SDSRM). Theoretically, the SDSRM is equivalent to a structured illumination microscope (SIM) and achieves a spatial resolution of 120 nm, double that of the diffraction limit of wide-field fluorescence microscopy. However, the SDSRM is 10 times faster than a conventional SIM because SR signals are recovered by optical demodulation through the stripe pattern of the disk. Therefore a single SR image requires only a single averaged image through the rotating disk. On the basis of this theory, we modified a commercial spinning disk confocal microscope. The improved resolution around 120 nm was confirmed with biological samples. The rapid dynamics of microtubules, mitochondria, lysosomes, and endosomes were observed with temporal resolutions of 30-100 frames/s. Because our method requires only small optical modifications, it will enable an easy upgrade from an existing spinning disk confocal to a SR microscope for live-cell imaging.	[Hayashi, Shinichi] Olympus Corp, R&D Div, Prod Dev Dept 6, Hachioji, Tokyo 1928507, Japan; [Okada, Yasushi] RIKEN, Quantitat Biol Ctr, Lab Cell Polar Regulat, Suita, Osaka 5650874, Japan	Okada, Y (reprint author), RIKEN, Quantitat Biol Ctr, Lab Cell Polar Regulat, Furuedai 6-2-3, Suita, Osaka 5650874, Japan.	y.okada@riken.jp	Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689	Ministry of Education, Science, Sports and Culture [24659092, 25113723, 25293046]; Uehara Memorial Foundation; Naito Foundation	We are grateful to S. Niwa and N. Hirokawa (University of Tokyo, Tokyo, Japan) for the plasmids (tubulin, Lamp1, and Rab11a); M. Davidson for the plasmid mEmerald-TOMM20-N-10 (#54282; Addgene); K. Abe (Olympus) for discussion and assistance; S. Xu, J. Asada, M. Komeno, and M. Kakiuchi (Quantitative Biology Center) for technical and secretarial assistance; and D. Priest (Quantitative Biology Center) for editing the manuscript. Part of this work was supported by Ministry of Education, Science, Sports and Culture Grants-in-Aid for Scientific Research (KAKENHI) 24659092, 25113723, and 25293046, the Uehara Memorial Foundation, and the Naito Foundation to Y.O.	Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI DOI 10.1007/BF02956173; Allen R D, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P85; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; SHEPPARD CJR, 1988, OPTIK, V80, P53; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/nmeth.1324, 10.1038/NMETH.1324]; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; York AG, 2013, NAT METHODS, V10, P1122, DOI [10.1038/nmeth.2687, 10.1038/NMETH.2687]	14	3	3	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	MAY 1	2015	26	9					1743	1751		10.1091/mbc.E14-08-1287		9	Cell Biology	Cell Biology	CI0FQ	WOS:000354412500015		
J	Murata, M; Narahara, S; Kawano, T; Hamano, N; Piao, JS; Kang, JH; Ohuchida, K; Murakami, T; Hashizume, M				Murata, Masaharu; Narahara, Sayoko; Kawano, Takahito; Hamano, Nobuhito; Piao, Jing Shu; Kang, Jeong-Hun; Ohuchida, Kenoki; Murakami, Takashi; Hashizume, Makoto			Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1	MOLECULAR PHARMACEUTICS			English	Article						drug delivery system; protein nanocages; pancreatic cancer; neuropilin-1	NANOPARTICLES; DOXORUBICIN; EXPRESSION; CELECOXIB; PEPTIDE; GROWTH; NANOCAPSULES; INHIBITORS; OSU-03012; DYNAMICS	We describe the development of neuropilin 1-binding peptide (iRGD)-nanocages that specifically target human pancreatic cancer cells in which an iRGD is joined to the surface of naturally occurring heat shock protein (HSP) cages. Using a genetic engineering approach, the iRGD domain was joined to the C-terminal region of the HSP cage using flexible linker moieties. The characteristics of the interdomain linkages between the nanocage and the iRGD domain play an important role in the specificity and affinity of the iRGD-nanocages for their target cells. An engineered L30-iRGD-nanocage with 30 amino acid linkers, (GGS)(10), showed greater binding affinity for pancreatic cancer cells relative to that of other linkers. Furthermore, a moderately hydrophobic anticancer drug, OSU03012, was successfully incorporated into the L30-iRGD nanocage by heating the mixture. The OSU03012-loaded L30-iRGD nanocage induced cell death of pancreatic cancer cells by activating the caspase cascade more effectively than the same concentrations of free OSU03012. The iRGD-nanocages show great potential as a novel nanocarrier for pancreatic cancer-targeted drug delivery.	[Murata, Masaharu; Narahara, Sayoko; Kawano, Takahito; Hamano, Nobuhito; Piao, Jing Shu; Ohuchida, Kenoki; Hashizume, Makoto] Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka 8128582, Japan; [Murata, Masaharu; Narahara, Sayoko; Kawano, Takahito; Hashizume, Makoto] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 8128582, Japan; [Ohuchida, Kenoki] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Kang, Jeong-Hun] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Osaka 5658565, Japan; [Murakami, Takashi] Takasaki Univ Hlth & Welf, Lab Tumor Biol, Takasaki, Gunma 3700033, Japan	Murata, M (reprint author), Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	m-murata@dem.med.kyushu-u.ac.jp			Health Labour Sciences Research Grant (Research on Publicly Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare of Japan; Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation"); Ministry of Education, Culture, Sports, Science and Technology of Japan [24300172]	This work was supported by a Health Labour Sciences Research Grant (Research on Publicly Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare of Japan; Special Coordination Funds for Promoting Science and Technology (SCF funding program "Innovation Center for Medical Redox Navigation"); and a Grant-in Aid for Scientific Research (No. 24300172) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Adair JH, 2010, ACS NANO, V4, P4967, DOI 10.1021/nn102324e; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063; Min J, 2014, MACROMOL BIOSCI, V14, P557, DOI 10.1002/mabi.201300401; Wang YC, 2008, CANCER RES, V68, P2820, DOI 10.1158/0008-5472.CAN-07-1336; Ruoslahti E, 2012, ADV MATER, V24, P3747, DOI 10.1002/adma.201200454; Murata M, 2012, INT J NANOMED, V7, P4353, DOI 10.2147/IJN.S31365; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Hansel DE, 2004, AM J SURG PATHOL, V28, P347, DOI 10.1097/00000478-200403000-00007; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031; Nakayama M, 2007, REACT FUNCT POLYM, V67, P1398, DOI 10.1016/j.reactfunctpolym.2007.07.056; Toita R, 2012, BIOCONJUGATE CHEM, V23, P1494, DOI 10.1021/bc300015f; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t; Shah NB, 2012, MOL PHARMACEUT, V9, P2146, DOI 10.1021/mp200626j; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Pang HB, 2014, J CONTROL RELEASE, V175, P48, DOI 10.1016/j.jconrel.2013.12.006; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; McCubrey JA, 2006, MOL PHARMACOL, V70, P437, DOI 10.1124/mol.106.026252; Brannon-Peppas L, 2012, ADV DRUG DELIVER REV, V64, P206, DOI 10.1016/j.addr.2012.09.033; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Toita R, 2013, INT J NANOMED, V8, P1989, DOI 10.2147/IJN.S40239; Hu CMJ, 2010, MOL PHARMACEUT, V7, P914, DOI 10.1021/mp900316a; Kawano T, 2015, INT J MOL SCI, V16, P148, DOI 10.3390/ijms16010148; Toita R, 2013, CHEM COMMUN, V49, P7442, DOI 10.1039/c3cc44508a; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; Holloway SE, 2006, ANN SURG ONCOL, V13, P1145, DOI 10.1245/ASO.2006.05.049; Kim DR, 2003, BIOCHEM BIOPH RES CO, V307, P991, DOI 10.1016/S0006-291X(03)01302-0; Li JN, 2006, J GASTROINTEST SURG, V10, P207, DOI 10.1016/j.gassur.2005.07.025; Sao K, 2009, BIOCHEM BIOPH RES CO, V383, P293, DOI 10.1016/j.bbrc.2009.03.129; Sao K, 2009, BIOORGAN MED CHEM, V17, P85, DOI 10.1016/j.bmc.2008.11.013; Schonthal AH, 2008, EXPERT OPIN INV DRUG, V17, P197, DOI 10.1517/13543784.17.2.197; Ye YP, 2011, BIOORG MED CHEM LETT, V21, P1146, DOI 10.1016/j.bmcl.2010.12.112; Yu XJ, 2010, BBA-REV CANCER, V1805, P97, DOI 10.1016/j.bbcan.2009.10.001	43	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	MAY	2015	12	5					1422	1430		10.1021/mp5007129		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CH5KY	WOS:000354075700009		
J	Yageta, S; Lauer, TM; Trout, BL; Honda, S				Yageta, Seiki; Lauer, Timothy M.; Trout, Bernhardt L.; Honda, Shinya			Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions	MOLECULAR PHARMACEUTICS			English	Article						antibody aggregation; antibody domain; acid denaturation; conformational and colloidal stabilities; empirical phase diagram	ALTERNATIVELY FOLDED STATE; PROTEIN AGGREGATION; MONOCLONAL-ANTIBODIES; PREDICTION; FAB; IGG1; PURIFICATION; FORMULATION; PROPENSITY; MECHANISM	Antibody therapeutics are now in widespread use and provide a new approach for treating serious diseases such as rheumatic diseases and cancer. Monoclonal antibodies used as therapeutic agents must be of high quality, and their safety must be guaranteed. Aggregated antibody is a degradation product that may be generated during the manufacturing process. To maintain the high quality and safety of antibody therapeutics, it is necessary to understand the mechanism of aggregation and to develop technologies to strictly control aggregate formation. Here, we extensively investigated the conformational and colloidal characteristics of isolated antibody constant domains, and provided insights into the molecular mechanism of antibody aggregation. Isolated domains (CH2, CH3, CL, and CH1-CL dimer) of human immunoglobulin G were synthesized, solubilized using 49 sets of solution conditions (pH 2-8 and 0-300 mM NaCl), and characterized using circular dichroism, intrinsic tryptophan fluorescence, and dynamic light scattering. Salt-induced conformational changes and oligomer formation were kinetically analyzed by NaCl-jump measurements (from 0 to 300 mM at pH 3). Phase diagrams revealed that the domains have different conformational and colloidal stabilities. The unfolded fractions of CH3 and CH2 at pH 3 were larger than that of CL and CH1-CL dimer. The secondary and tertiary structures and particle sizes of CH3 and CH2 showed that, in non-native states, these domains were sensitive to salt concentration. Kinetic analyses suggest that oligomer formation by CH3 and CH2 proceeds through partially refolded conformations. The colloidal stability of CH3 in non-native states is the lowest of the four domains under the conditions tested. We propose that the impact of IgG constant domains on aggregation follows the order CH3 > CH2 > CH1-CL dimer > CL; furthermore, we suggest that CH3 plays the most critical role in driving intact antibody aggregation under acidic conditions.	[Yageta, Seiki; Honda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Lauer, Timothy M.; Trout, Bernhardt L.] MIT, Dept Chem Engn, Cambridge, MA 02319 USA; [Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan	Honda, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	s.honda@aist.go.jp			Ministry of Economy, Trade and Industry, Japan	We thank Dr. Hideki Watanabe, Dr. Hisashi Takahashi, Dr. Hiroshi Imamura, Ayako Ooishi, and Dr. Feng Yan Wen in our research group for their technical support, discussions, and advice. This study was financially supported in part by a grant for the project focused on developing key technology of discovering and manufacturing drug for next-generation treatment and diagnosis from the Ministry of Economy, Trade and Industry, Japan.	Fesinmeyer RM, 2009, PHARM RES-DORD, V26, P903, DOI 10.1007/s11095-008-9792-z; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Latypov RF, 2012, J BIOL CHEM, V287, P1381, DOI 10.1074/jbc.M111.297697; Zheng K, 2011, MABS-AUSTIN, V3, P568, DOI 10.4161/mabs.3.6.17922; Chennamsetty N, 2009, J MOL BIOL, V391, P404, DOI 10.1016/j.jmb.2009.06.028; Chi EY, 2003, PHARMACEUT RES, V20, P1325, DOI 10.1023/A:1025771421906; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Phillips J, 2001, CYTOTHERAPY, V3, P233, DOI 10.1080/146532401753174061; Mueller M, 2013, APPL BIOCHEM BIOTECH, V169, P1431, DOI 10.1007/s12010-012-0084-z; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Moiani D, 2009, J PHYS CHEM B, V113, P16268, DOI 10.1021/jp909405b; Feige MJ, 2010, J MOL BIOL, V399, P719, DOI 10.1016/j.jmb.2010.04.032; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; Brorson K, 2003, BIOTECHNOL BIOENG, V82, P321, DOI 10.1002/bit.10574; [Anonymous], 1999, SPEC TEST PROC ACC C; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thies MJW, 2001, J MOL BIOL, V309, P1077, DOI 10.1006/jmbi.2001.4707; Saito S, 2013, PHARM RES-DORDR, V30, P1263, DOI 10.1007/s11095-012-0965-4; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Chennamsetty N, 2010, J PHYS CHEM B, V114, P6614, DOI 10.1021/jp911706q; Gagnon P, 2012, J CHROMATOGR A, V1221, P57, DOI 10.1016/j.chroma.2011.10.034; Kim N, 2013, BIOPHYS CHEM, V172, P26, DOI 10.1016/j.bpc.2012.12.004; Bhambhani A, 2012, J PHARM SCI-US, V101, P1120, DOI 10.1002/jps.23008; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Vazquez-Rey M, 2011, BIOTECHNOL BIOENG, V108, P1494, DOI 10.1002/bit.23155; Kameoka D, 2007, J BIOCHEM, V142, P383, DOI 10.1093/jb/mvm145; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Ayyar BV, 2012, METHODS, V56, P116, DOI 10.1016/j.ymeth.2011.10.007; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Fahrner R L, 2001, Biotechnol Genet Eng Rev, V18, P301; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; HENDLER RW, 1994, J BIOCHEM BIOPH METH, V28, P1, DOI 10.1016/0165-022X(94)90061-2; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Kim JH, 2012, PROTEIN SCI, V21, P1540, DOI 10.1002/pro.2144; LILIE H, 1995, FEBS LETT, V362, P43, DOI 10.1016/0014-5793(95)00203-L; Peng Y. W., 2012, J PHARM BIOMED ANAL, V57, P143; Ramsey JD, 2009, J PHARM SCI-US, V98, P2432, DOI 10.1002/jps.21619; Rosenberg Amy S, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Wang W, 2005, INT J PHARM, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Zhang-van Enk J., 2013, MOL PHARM, V10, P619	51	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	MAY	2015	12	5					1443	1455		10.1021/mp500759p		13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CH5KY	WOS:000354075700011		
J	Hasegawa, Y; Higashi, K; Yamamoto, K; Moribe, K				Hasegawa, Yuki; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu			Direct Evaluation of Molecular States of Piroxicam/Poloxamer Nanosuspension by Suspended-State NMR and Raman Spectroscopies	MOLECULAR PHARMACEUTICS			English	Article						suspended-state NMR; nanosuspension; wet milling; nanoparticle stabilization; Raman spectroscopy	AMORPHOUS DRUG NANOSUSPENSIONS; NUCLEAR-MAGNETIC-RESONANCE; CYCLODEXTRIN INCLUSION COMPOUND; POORLY SOLUBLE DRUGS; TRIBLOCK COPOLYMERS; SIZE-REDUCTION; FT-RAMAN; NANOPARTICLES; FORMULATION; PIROXICAM	A nanosuspension of piroxicam (PXC) and poloxamer 407 (poloxamer) prepared by the wet milling method was directly evaluated at the molecular level from the viewpoint of both solution and solid phases. C-13 solution-state NMR measurements revealed a reduction in the concentration of dissolved poloxamer in the nanosuspension. Furthermore, the fraction of dissolved poly(ethylene oxide) (PRO) chain, which is the hydrophilic part of poloxamer, was higher than that of dissolved poly(propylene oxide) (PPO) chain, the hydrophobic part. C-13 suspended-state NMR and Raman spectroscopies detected both solid-state PXC and poloxamer involved in the nanoparticles. Interestingly, the coexistence of crystalline and amorphous PXC in the nanoparticle was demonstrated. The yellow color of the nanosuspension strongly supported the existence of amorphous PXC. Changes in the peak intensity depending on the contact time in the suspended-state NMR spectrum revealed that the PEO chain of poloxamer in the nanoparticle had higher mobility compared with the PPO chain. The PRO chain should project into the water phase and form the outer layer of the nanoparticles, whereas the PPO chain should face the inner side of the nanoparticles. Amorphous PXC could be stabilized by intermolecular interaction with the PPO chain near the surface of the nanoparticles, whereas crystalline PXC could form the inner core.	[Hasegawa, Yuki; Higashi, Kenjirou; Yamamoto, Keiji; Moribe, Kunikazu] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Moribe, K (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	moribe@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology (Monbukagakusho) of Japan	We appreciate Dr. Katsuhide Terada in Toho University and Dr. Etsuo Yonemochi in Hoshi Pharmaceutical University for their kind help on Raman spectroscopy measurement. We would like to thank BASF Japan for their gift of poloxamer. This study was supported in part by a Grant-in Aid from the Ministry of Education, Culture, Sports, Science and Technology (Monbukagakusho) of Japan.	Gardiennet C, 2012, ANGEW CHEM INT EDIT, V51, P7855, DOI 10.1002/anie.201200779; Kojima T, 2012, PHARM RES-DORDR, V29, P2777, DOI 10.1007/s11095-011-0655-7; Sakai T, 2005, J PHYS CHEM B, V109, P7766, DOI 10.1021/jp046221z; Su YL, 2002, MACROMOLECULES, V35, P6426, DOI 10.1021/ma0105284; Bertini I, 2012, J BIOMOL NMR, V54, P123, DOI 10.1007/s10858-012-9657-y; Jinno J, 2006, J CONTROL RELEASE, V111, P56, DOI 10.1016/j.jconrel.2005.11.013; Shegokar R, 2010, INT J PHARMACEUT, V399, P129, DOI 10.1016/j.ijpharm.2010.07.044; Wu LB, 2011, ADV DRUG DELIVER REV, V63, P456, DOI 10.1016/j.addr.2011.02.001; Choi JY, 2005, CURR APPL PHYS, V5, P472, DOI 10.1016/j.cap.2005.01.012; Lubach JW, 2007, J PHARM SCI-US, V96, P777, DOI 10.1002/jps.20684; Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009; Sheth AR, 2005, J AM CHEM SOC, V127, P6641, DOI 10.1021/ja045823t; Basak R, 2013, LANGMUIR, V29, P4350, DOI 10.1021/la304836e; Lindfors L, 2006, LANGMUIR, V22, P906, DOI 10.1021/la0523661; Tyrrell ZL, 2010, PROG POLYM SCI, V35, P1128, DOI 10.1016/j.progpolymsci.2010.06.003; Bertini I, 2013, ACCOUNTS CHEM RES, V46, P2059, DOI 10.1021/ar300342f; Muller RH, 1998, INT J PHARMACEUT, V160, P229, DOI 10.1016/S0378-5173(97)00311-6; Paudel A, 2014, J PHARM SCI-US, V103, P2635, DOI 10.1002/jps.23966; Rabinow BE, 2004, NAT REV DRUG DISCOV, V3, P785, DOI 10.1038/nrd1494; Heald CR, 2002, LANGMUIR, V18, P3669, DOI 10.1021/la011393y; Moribe K, 2012, J PHARM SCI-US, V101, P3413, DOI 10.1002/jps.23141; Lindfors L, 2007, LANGMUIR, V23, P9866, DOI 10.1021/1a700811b; Alexandridis P, 1997, CURR OPIN COLLOID IN, V2, P478, DOI 10.1016/S1359-0294(97)80095-7; Hu JH, 2004, DRUG DEV IND PHARM, V30, P233, DOI 10.1081/DDC-120030422; Bertini I, 2011, P NATL ACAD SCI USA, V108, P10396, DOI 10.1073/pnas.1103854108; Van Eerdenbrugh B, 2008, INT J PHARMACEUT, V364, P64, DOI 10.1016/j.ijpharm.2008.07.023; Alexander S, 2011, LANGMUIR, V27, P8054, DOI 10.1021/la201124c; Yang W, 2010, EUR J PHARM BIOPHARM, V75, P33, DOI 10.1016/j.ejpb.2010.01.011; Flodstrom K, 2004, LANGMUIR, V20, P680, DOI 10.1021/la030173c; Liu P, 2011, INT J PHARMACEUT, V411, P215, DOI 10.1016/j.ijpharm.2011.03.050; Sheth AR, 2004, CRYST GROWTH DES, V4, P1091, DOI 10.1021/cg049876y; Bentley MVLB, 1999, INT J PHARM, V193, P49, DOI 10.1016/S0378-5173(99)00313-0; Bertoluzza A, 1999, J MOL STRUCT, V481, P535; Calucci L, 2011, MACROMOLECULES, V44, P7288, DOI 10.1021/ma201199a; Cheow WS, 2014, MOL PHARMACEUT, V11, P1611, DOI 10.1021/mp400788p; Crisp JL, 2010, SOLID STATE NUCL MAG, V37, P75, DOI 10.1016/j.ssnmr.2010.05.001; Doub WH, 2007, PHARM RES, V24, P934, DOI 10.1007/s11095-006-9211-2; Goppert TM, 2005, EUR J PHARM BIOPHARM, V60, P361, DOI 10.1016/j.ejpb.2005.02.006; Guo C, 1999, J COLLOID INTERF SCI, V209, P368, DOI 10.1006/jcis.1998.5897; Hoffmann D, 2000, J CHEM PHYS, V112, P4242, DOI 10.1063/1.480970; Lindfors L, 2006, LANGMUIR, V22, P911, DOI 10.1021/la052367t; Mayer C, 2005, ANNU REP NMR SPECTRO, V55, P205, DOI 10.1016/s0066-4103(04)55004-4; Mayer C, 2002, PROG NUCL MAG RES SP, V40, P307, DOI 10.1016/S0079-6565(02)00004-3; Mayer C, 2002, INT J PHARM, V242, P37, DOI 10.1016/S0378-5173(02)00184-9; Melosh NA, 1999, MACROMOLECULES, V32, P4332, DOI 10.1021/ma9817323; Merisko-Liversidge E, 2003, EUR J PHARM SCI, V18, P113, DOI 10.1016/S0928-0987(02)00251-8; Moribe K, 2008, CHEM PHARM BULL, V56, P878, DOI 10.1248/cpb.56.878; Nutan MTH, 2010, PHARMACEUTICAL SUSPENSIONS: FROM FORMULATION DEVELOPMENT TO MANUFACTURING, P39, DOI 10.1007/978-1-4419-1087-5_2; Park SC, 2007, ANAL CHIM ACTA, V593, P46, DOI 10.1016/j.aca.2007.04.056; Pongpeerapat A, 2006, PHARM RES, V23, P2566, DOI 10.1007/s11095-006-9089-z; Redenti E, 1999, BIOSPECTROSCOPY, V5, P243, DOI 10.1002/(SICI)1520-6343(1999)5:4<243::AID-BSPY5>3.0.CO;2-C; Shin S C, 1997, Pharm Dev Technol, V2, P403, DOI 10.3109/10837459709022639; Xinjuan Li, 2008, Polymer, V49, DOI 10.1016/j.polymer.2008.04.042; Zhang JY, 2012, INT J PHARMACEUT, V423, P571, DOI 10.1016/j.ijpharm.2011.11.028	54	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	MAY	2015	12	5					1564	1572		10.1021/mp500872g		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CH5KY	WOS:000354075700022		
J	Bennett, JL; de Seze, J; Lana-Peixoto, M; Palace, J; Waldman, A; Schippling, S; Tenembaum, S; Banwell, B; Greenberg, B; Levy, M; Fujihara, K; Chan, KH; Kim, HJ; Asgari, N; Sato, DK; Saiz, A; Wuerfel, J; Zimmermann, H; Green, A; Villoslada, P; Paul, F				Bennett, J. L.; de Seze, J.; Lana-Peixoto, M.; Palace, J.; Waldman, A.; Schippling, S.; Tenembaum, S.; Banwell, B.; Greenberg, B.; Levy, M.; Fujihara, K.; Chan, K. H.; Kim, H. J.; Asgari, N.; Sato, D. K.; Saiz, A.; Wuerfel, J.; Zimmermann, H.; Green, A.; Villoslada, P.; Paul, F.		GJCF-ICC BR	Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography	MULTIPLE SCLEROSIS JOURNAL			English	Review						Neuromyelitis optica; optical coherence tomography; multiple sclerosis; optic neuritis; retinal nerve fiber layer; ganglion cell layer	NERVE-FIBER LAYER; MICROCYSTIC MACULAR EDEMA; INTERFERON-BETA TREATMENT; INNER NUCLEAR LAYER; SPECTRUM DISORDERS; GANGLION-CELL; RETINAL DEGENERATION; AQUAPORIN 4; NEURITIS; THICKNESS	Neuromyelitis optica (NMO) is an inflammatory autoimmune disease of the central nervous system that preferentially targets the optic nerves and spinal cord. The clinical presentation may suggest multiple sclerosis (MS), but a highly specific serum autoantibody against the astrocytic water channel aquaporin-4 present in up to 80% of NMO patients enables distinction from MS. Optic neuritis may occur in either condition resulting in neuro-anatomical retinal changes. Optical coherence tomography (OCT) has become a useful tool for analyzing retinal damage both in MS and NMO. Numerous studies showed that optic neuritis in NMO typically results in more severe retinal nerve fiber layer (RNFL) and ganglion cell layer thinning and more frequent development of microcystic macular edema than in MS. Furthermore, while patients' RNFL thinning also occurs in the absence of optic neuritis in MS, subclinical damage seems to be rare in NMO. Thus, OCT might be useful in differentiating NMO from MS and serve as an outcome parameter in clinical studies.	[Bennett, J. L.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA; [Bennett, J. L.] Univ Colorado, Dept Ophthalmol, Denver, CO 80202 USA; [de Seze, J.] Univ Hosp Strasbourg, Neurol Serv, Strasbourg, France; [Lana-Peixoto, M.] Univ Fed Minas Gerais, Sch Med, CIEM MS Res Ctr, Belo Horizonte, MG, Brazil; [Palace, J.] Natl Hlth Serv Trust, Oxford Univ Hosp, Dept Neurol, Oxford, England; [Waldman, A.; Banwell, B.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Schippling, S.] Univ Zurich Hosp, Dept Neurol, Neuroimmunol & Multiple Sclerosis Res Sect, Zurich, Switzerland; [Tenembaum, S.] Natl Pediat Hosp Dr Juan P Garrahan, Dept Neurol, Buenos Aires, DF, Argentina; [Greenberg, B.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Greenberg, B.] Univ Texas SW Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA; [Levy, M.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Fujihara, K.] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Chan, K. H.] Univ Hong Kong, LKS Fac Med, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; [Kim, H. J.] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea; [Asgari, N.] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Asgari, N.] Vejle Hosp, Dept Neurol, Odense, Denmark; [Sato, D. K.] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Saiz, A.] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Saiz, A.] Inst Biomed Res August Pi Sunyer, Barcelona, Spain; [Wuerfel, J.; Zimmermann, H.; Paul, F.] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Wuerfel, J.] Univ Med Gottingen, Inst Intervent & Diagnost Neuroradiol, Gottingen, Germany; [Green, A.] UCSF Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA; [Green, A.] UCSF Dept Ophthalmol, Neuroophthalmol Serv, San Francisco, CA USA; [Paul, F.] Charite, NeuroCure Clin Res, D-13353 Berlin, Germany; [Paul, F.] Charite, Dept Neurol, D-13353 Berlin, Germany; [Paul, F.] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Paul, F.] Max Delbruck Ctr Mol Med, Berlin, Germany	Paul, F (reprint author), Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany.	friedemann.paul@charite.de	Sato, Douglas/F-2508-2013	Sato, Douglas/0000-0002-7695-6020			Albrecht P, 2007, J NEUROL, V254, P1595, DOI 10.1007/s00415-007-0538-3; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; von Glehn F, 2014, MULT SCLER J, V20, P1189, DOI 10.1177/1352458513519838; Lange AP, 2013, J NEURO-OPHTHALMOL, V33, P213, DOI 10.1097/WNO.0b013e31829c510e; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; McKeon A, 2008, NEUROLOGY, V71, P93, DOI 10.1212/01.wnl.0000314832.24682.c6; Merle H, 2012, ARCH OPHTHALMOL-CHIC, V130, P858, DOI 10.1001/archophthalmol.2012.1126; Young KL, 2013, EUR J NEUROL, V20, P803, DOI 10.1111/ene.12070; Zaveri MS, 2008, ARCH NEUROL-CHICAGO, V65, P924, DOI 10.1001/archneur.65.7.924; Toledo J, 2008, MULT SCLER, V14, P906, DOI 10.1177/1352458508090221; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Khatri BO, 2012, J CLIN APHERESIS, V27, P183, DOI 10.1002/jca.21215; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Levin MH, 2013, PROG RETIN EYE RES, V36, P159, DOI 10.1016/j.preteyeres.2013.03.001; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Mealy MA, 2014, JAMA NEUROL, V71, P324, DOI 10.1001/jamaneurol.2013.5699; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Grieve K, 2004, INVEST OPHTH VIS SCI, V45, P4126, DOI 10.1167/iovs.04-0584; Ringelstein M, 2014, MULT SCLER J, V20, P617, DOI 10.1177/1352458513503053; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Matiello M, 2013, JAMA NEUROL, V70, P1118, DOI 10.1001/jamaneurol.2013.3124; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Kim SH, 2012, MULT SCLER J, V18, P1480, DOI 10.1177/1352458512439439; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Merle H, 2007, OPHTHALMOLOGY, V114, P810, DOI 10.1016/j.ophtha.2006.06.060; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Asavapanumas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-16; Bertuzzi F, 2010, OPHTHALMOLOGY, V117, P1256, DOI 10.1016/j.ophtha.2010.02.024; Bouyon M, 2013, MULT SCLER J, V19, P1320, DOI 10.1177/1352458513476562; Brandt AU, 2014, NEUROLOGY, V83, P73, DOI 10.1212/WNL.0000000000000545; Chen Teresa C, 2008, Int Ophthalmol Clin, V48, P29, DOI 10.1097/IIO.0b013e318187e801; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Fernandes DB, 2012, J NEURO-OPHTHALMOL, V32, P102, DOI 10.1097/WNO.0b013e31823a9ebc; Frohman E, 2006, LANCET NEUROL, V5, P853, DOI 10.1016/S1474-4422(06)70573-7; GEORGE J, 2013, 29 C EUR COMM RES TR; Henderson APD, 2010, J NEUROL, V257, P1083, DOI 10.1007/s00415-010-5467-x; Hofman P, 2001, INVEST OPHTH VIS SCI, V42, P895; Horio N, 2001, ARCH OPHTHALMOL-CHIC, V119, P1329; Kallenbach K, 2007, EUR J NEUROL, V14, P841, DOI 10.1111/j.1468-1331.2007.01736.x; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; Khanna S, 2012, J NEURO-OPHTHALMOL, V32, P216, DOI 10.1097/WNO.0b013e318254c62d; Kitley JL, 2011, ARCH NEUROL-CHICAGO, V68, P1086, DOI 10.1001/archneurol.2011.170; Li QH, 2001, INVEST OPHTH VIS SCI, V42, P2981; Liu LY, 2008, NEUROSCI LETT, V434, P155, DOI 10.1016/j.neulet.2007.12.052; Merle Harold, 2013, Clin Ophthalmol, V7, P1145, DOI 10.2147/OPTH.S43894; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI DOI 10.1155/2012/530305; PFUELLER CF, 2011, MULT SCLER INT, V2011; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; SEPULCRE J, 2007, MS NEUROLOGY, V68, P1488; Storoni M, 2013, J NEURO-OPHTHALMOL, V33, P123, DOI 10.1097/WNO.0b013e318283c3ed; Tsoi VL, 2006, J NEURO-OPHTHALMOL, V26, P87, DOI 10.1097/01.wno.0000223266.48447.1b; Tzartos JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074773	80	5	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6					678	688		10.1177/1352458514567216		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600002		
J	Hyun, JW; Kim, SH; Huh, SY; Kim, W; Yun, J; Joung, A; Sato, DK; Fujihara, K; Kim, HJ				Hyun, Jae-Won; Kim, Su-Hyun; Huh, So-Young; Kim, Woojun; Yun, Junglim; Joung, AeRan; Sato, Douglas Kazutoshi; Fujihara, Kazuo; Kim, Ho Jin			Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis	MULTIPLE SCLEROSIS JOURNAL			English	Article						Longitudinally extensive transverse myelitis; aquaporin-4 antibody; neuromyelitis optica; idiopathic	NEUROMYELITIS-OPTICA-IGG; NMO SPECTRUM DISORDERS; OLIGODENDROCYTE GLYCOPROTEIN; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; ASSAY; MULTICENTER; DISTINCTION; PROGNOSIS; SERUM	Background: Longitudinally extensive transverse myelitis (LETM) is a characteristic manifestation of neuromyelitis optica (NMO). However, not all patients with LETM are positive for aquaporin-4 (AQP4) antibodies. We evaluated the characteristics of idiopathic isolated LETM negative for AQP4 antibodies. Methods: From the National Cancer Center registry of inflammatory diseases of the central nervous system, patients with LETM as an initial manifestation and follow-up for at least two years were enrolled. Their medical records and MRIs were reviewed retrospectively. AQP4 antibody was confirmed by three different validated methods at least three times. Cerebrospinal fluid (CSF) glial fibrillary acidic protein (GFAP) levels were measured to investigate astrocyte damage. Results: Among 108 patients with first-ever LETM, 55 were positive for AQP4 antibodies (P-LETM) and 53 were consistently negative. Of them, seven were later diagnosed with seronegative NMO, and four were positive for MOG antibodies. The remaining 42 patients (N-LETM) showed several features distinct from P-LETM: male predominance, older age of onset, milder clinical presentation, spinal cord confinement and absence of combined autoimmunity. CSF GFAP levels were not increased in N-LETM but were markedly elevated in P-LETM. Conclusions: Idiopathic isolated N-LETM is not that rare among first-ever LETM, and has many features distinct from P-LETM where astrocytic damage is evident.	[Hyun, Jae-Won; Kim, Su-Hyun; Yun, Junglim; Joung, AeRan; Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, Goyang, South Korea; [Huh, So-Young] Kosin Univ, Sch Med, Busan, South Korea; [Kim, Woojun] Catholic Univ, Sch Med, Seoul, South Korea; [Sato, Douglas Kazutoshi; Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Neurol & Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan	Kim, HJ (reprint author), Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea.	hojinkim@ncc.re.kr	Sato, Douglas/F-2508-2013	Sato, Douglas/0000-0002-7695-6020			Alvarenga MP, 2012, J SPINAL CORD MED, V35, P251, DOI [10.1179/2045772312Y.0000000019, 10.1179/2045772312Y.0025100000019]; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Trebst C, 2011, NAT REV NEUROL, V7, P688, DOI 10.1038/nrneurol.2011.176; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Chang KH, 2013, MULT SCLER J, V19, P299, DOI 10.1177/1352458512451659; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Sato DK, 2013, NEUROLOGY, V80, P2210, DOI 10.1212/WNL.0b013e318296ea08; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Kim W, 2012, MULT SCLER J, V18, P578, DOI 10.1177/1352458511424590; Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917; Iorio R, 2013, J NEUROL, V260, P2396, DOI 10.1007/s00415-013-6997-9; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Chan KH, 2009, EUR J NEUROL, V16, P310, DOI 10.1111/j.1468-1331.2008.02376.x; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jiao Y, 2013, JAMA NEUROL, V71, P48; Jiao YJ, 2013, NEUROLOGY, V81, P1197, DOI 10.1212/WNL.0b013e3182a6cb5c; Kim KK, 2003, ARCH NEUROL-CHICAGO, V60, P1290, DOI 10.1001/archneur.60.9.1290; Kim SH, 2010, J NEUROL, V257, P920, DOI 10.1007/s00415-009-5438-2; Kim SM, 2013, MULT SCLER J, V19, P1060, DOI 10.1177/1352458512472748; Kitley J, 2013, JAMA NEUROL, V70, P1375, DOI 10.1001/jamaneurol.2013.3890; Kitley JL, 2012, MULT SCLER J, V18, P271, DOI 10.1177/1352458511406165; Li R, 2011, J NEUROL, V258, P2206, DOI 10.1007/s00415-011-6093-y; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; McKeon A, 2011, NEUROLOGY, V76, P1108, DOI 10.1212/WNL.0b013e318211c379; Pawate S, 2009, SPINAL CORD, V47, P257, DOI 10.1038/sc.2008.99; Qiu W, 2010, J NEUROL NEUROSUR PS, V81, P209, DOI 10.1136/jnnp.2009.172973; Ravaglia S, 2009, SPINAL CORD, V47, P531, DOI 10.1038/sc.2008.157; Scott TF, 1998, NEUROLOGY, V50, P429	34	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6					710	717		10.1177/1352458514551454		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600008		
J	Misu, T				Misu, Tatsuro			NMO Immunopathology	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Misu, Tatsuro] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				L-10	802	802				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600032		
J	Nishiyama, S				Nishiyama, Shuhei			AQP4 Immunology in NMOSD	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Nishiyama, Shuhei] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				L-11	802	802				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600033		
J	Hayashida, S; Masaki, K; Yonekawa, T; Isobe, N; Watanabe, M; Matsushita, T; Kira, J				Hayashida, S.; Masaki, K.; Yonekawa, T.; Isobe, N.; Watanabe, M.; Matsushita, T.; Kira, J.			A Combined Neuroimaging and Neuropathological Study for Spinal Cord Lesions of Neuromyelitis Optica: with Special Reference to Lesion Distribution and Extension Patterns	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									Kyushu Univ, Inst Neurol, Grad Sch Med Sci, Dept Neurol, Fukuoka 812, Japan; Kyushu Univ, Inst Neurol, Grad Sch Med Sci, Dept Neurol Therapeut, Fukuoka 812, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-2	804	804				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600039		
J	Sato, DK; Callegaro, D; Lana-Peixoto, MA; Waters, PJ; Tanaka, S; Jorge, F; Takahashi, T; Misu, T; Apostolos-Pereira, SL; Talim, N; Simm, RF; Lino, AMM; Nakashima, I; Nomura, K; Aoki, M; Fujihara, K				Sato, D. K.; Callegaro, D.; Lana-Peixoto, M. A.; Waters, P. J.; Tanaka, S.; Jorge, F.; Takahashi, T.; Misu, T.; Apostolos-Pereira, S. L.; Talim, N.; Simm, R. F.; Lino, A. M. M.; Nakashima, I.; Nomura, K.; Aoki, M.; Fujihara, K.			Autoantibodies against MOG in Neuromyelitis Optica Spectrum Disorders	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Sato, D. K.; Nakashima, I.; Aoki, M.] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Callegaro, D.; Jorge, F.; Apostolos-Pereira, S. L.; Simm, R. F.; Lino, A. M. M.] Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, Brazil; [Lana-Peixoto, M. A.; Talim, N.] Univ Fed Minas Gerais, CIEM MS Res Ctr, Belo Horizonte, MG, Brazil; [Waters, P. J.] Nuffield Dept Clin Neurosci, Oxford, England; [Tanaka, S.; Nomura, K.] Saitama Med Univ, Dept Neurol, Saitama, Japan; [Takahashi, T.] Yonezawa Natl Hosp, Dept Neurol, Yonezawa, Yamagata, Japan; [Misu, T.; Fujihara, K.] Tohoku Univ, Dept Multiple Sclerosis Therapeut, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-3	804	805				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600040		
J	Shinoda, K; Sun, X; Oyamada, A; Yamada, H; Kira, J; Yoshikai, Y				Shinoda, K.; Sun, Xun; Oyamada, Akiko; Yamada, Hisakata; Kira, Jun-ichi; Yoshikai, Yasunobu			CD30 Ligand is a New Therapeutic Target for Central Nervous System Autoimmunity	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Shinoda, K.; Kira, Jun-ichi] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Shinoda, K.; Oyamada, Akiko; Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Div Host Def, Fukuoka 812, Japan; [Sun, Xun] China Med Univ, Dept Immunol, Shenyang 110001, Peoples R China								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-8	806	807				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600045		
J	Nakahara, J; Fujiyoshi, K; Hikishima, K; Hata, J; Momoshima, S; Takahashi, S; Okano, H; Nakamura, M; Suzuki, N				Nakahara, J.; Fujiyoshi, K.; Hikishima, K.; Hata, J.; Momoshima, S.; Takahashi, S.; Okano, H.; Nakamura, M.; Suzuki, N.			Visualization of Demyelination and Remyelination by A Novel "Myelin Map" MR I: A Longitudinal Pilot Study	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Nakahara, J.; Takahashi, S.; Suzuki, N.] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Fujiyoshi, K.] Natl Hosp Org, Murayama Med Ctr, Dept Orthopaed Surg, Tokyo, Japan; [Fujiyoshi, K.; Nakamura, M.] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Hikishima, K.; Hata, J.; Okano, H.] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Momoshima, S.] Keio Univ, Sch Med, Dept Diagnost Radiol, Tokyo, Japan			Okano, Hideyuki/J-5973-2013; Suzuki, Norihiro/J-5125-2013					0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-9	807	807				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600046		
J	Niino, M; Sato, S; Fukazawa, T; Masaki, K; Miyazaki, Y; Matsuse, D; Yonekawa, T; Takahashi, E; Kikuchi, S; Kira, J				Niino, M.; Sato, S.; Fukazawa, T.; Masaki, K.; Miyazaki, Y.; Matsuse, D.; Yonekawa, T.; Takahashi, E.; Kikuchi, S.; Kira, J.			Decreased Serum Vitamin D Levels in Japanese Patients with Multiple Sclerosis	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Niino, M.; Miyazaki, Y.; Takahashi, E.] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido, Japan; [Sato, S.; Masaki, K.; Matsuse, D.; Yonekawa, T.; Kira, J.] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Neurol, Fukuoka 812, Japan; [Fukazawa, T.] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan; [Miyazaki, Y.; Kikuchi, S.] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-16	809	810				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600053		
J	Nakamura, Y; Matsushita, T; Sato, S; Niino, M; Fukazawa, T; Yoshimura, S; Hisahara, S; Isobe, N; Shimohama, S; Yoshida, K; Houzen, H; Miyazaki, Y; Kikuchi, S; Kira, J				Nakamura, Y.; Matsushita, T.; Sato, S.; Niino, M.; Fukazawa, T.; Yoshimura, S.; Hisahara, S.; Isobe, N.; Shimohama, S.; Yoshida, K.; Houzen, H.; Miyazaki, Y.; Kikuchi, S.; Kira, J.		Japan Multiple Sclerosis Genetic C	Multiple Sclerosis Susceptibility/Resistance and Clinical Manifestations are Determined by HLA-DRB1 Alleles and Latitude in Japanese Patients.	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Nakamura, Y.; Sato, S.; Yoshimura, S.; Isobe, N.; Kira, J.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Matsushita, T.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol Therapeut, Fukuoka 812, Japan; [Niino, M.; Miyazaki, Y.] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido, Japan; [Fukazawa, T.] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan; [Hisahara, S.; Shimohama, S.] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Yoshida, K.] Asahikawa Red Cross Hosp, Dept Neurol, Asahikawa, Hokkaido, Japan; [Houzen, H.] Obihiro Kosei Gen Hosp, Dept Neurol, Obihiro, Hokkaido, Japan; [Miyazaki, Y.; Kikuchi, S.] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-17	810	810				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600054		
J	Matsushita, T; Sato, S; Yamamoto, K; Madireddy, L; Gourraud, P; Baranzini, S; Oksenberg, J; Kira, J				Matsushita, T.; Sato, S.; Yamamoto, K.; Madireddy, L.; Gourraud, P.; Baranzini, S.; Oksenberg, J.; Kira, J.		Japan MS Genetics Consortium	Genome-wide Association Study for Multiple Sclerosis and Neuromyelitis Optica in the Japanese Population	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Matsushita, T.] Kyushu Univ, Grad Sch Med Sci, Dept Neurol Therapeut, Fukuoka 812, Japan; [Sato, S.; Kira, J.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Yamamoto, K.] Kurume Univ, Sch Med, Dept Med Chem, Kurume, Fukuoka 830, Japan; [Madireddy, L.; Gourraud, P.; Baranzini, S.; Oksenberg, J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				O-19	811	811				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600056		
J	Nakashima, I; Harada, N; Nakaya, F				Nakashima, I.; Harada, N.; Nakaya, F.			Large-Scale Epidemiological Survey of Disability Progression in Japanese Patients with Multiple Sclerosis and Neuromyelitis Optica	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Nakashima, I.] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Harada, N.; Nakaya, F.] Biogen Idec Japan Ltd, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-39	824	824				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600095		
J	Sato, DK; Callegaro, D; Jorge, FMH; Nakashima, I; Nishiyama, S; Takahashi, T; Simm, RF; Apostolos-Pereira, SL; Misu, T; Steinman, L; Aoki, M; Fujihara, K				Sato, D. K.; Callegaro, D.; Jorge, F. M. H.; Nakashima, I.; Nishiyama, S.; Takahashi, T.; Simm, R. F.; Apostolos-Pereira, S. L.; Misu, T.; Steinman, L.; Aoki, M.; Fujihara, K.			Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Sato, D. K.; Nakashima, I.; Nishiyama, S.; Takahashi, T.; Aoki, M.] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Callegaro, D.; Jorge, F. M. H.; Simm, R. F.; Apostolos-Pereira, S. L.] Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, Brazil; [Misu, T.; Fujihara, K.] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Steinman, L.] Stanford Univ, Dept Pediat Neurol & Neurol Sci, Stanford, CA 94305 USA								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-48	827	827				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600104		
J	Song, ZY; Kawano, Y; Sato, S; Watanabe, M; Imamura, S; Yonekawa, T; Masaki, K; Matsushita, T; Yamasaki, R; Kira, J				Song, Z. Y.; Kawano, Y.; Sato, S.; Watanabe, M.; Imamura, S.; Yonekawa, T.; Masaki, K.; Matsushita, T.; Yamasaki, R.; Kira, J.			Peripheral Blood T Cell Alterations in Myelitis with Various Causes	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Song, Z. Y.; Kawano, Y.; Sato, S.; Watanabe, M.; Imamura, S.; Yonekawa, T.; Masaki, K.; Matsushita, T.; Yamasaki, R.; Kira, J.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-53	829	829				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600109		
J	Fujii, T; Yamasaki, R; Wang, B; Kido, M; Masaki, K; Kira, J				Fujii, T.; Yamasaki, R.; Wang, B.; Kido, M.; Masaki, K.; Kira, J.			Peripheral Atopic Diathesis Induces Neuropathic Pain and Activation of Astrocytes in The Posterior Horns of The Spinal Cord	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Fujii, T.; Wang, B.; Masaki, K.; Kira, J.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan; [Yamasaki, R.] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol Therapeut, Fukuoka 812, Japan; [Kido, M.] Kyushu Univ, Grad Sch Dent Sci, Dept Oral Anat & Cell Biol, Fukuoka 812, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-58	830	831				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600114		
J	Kurosawa, K; Misu, T; Takahashi, T; Sato, D; Nishiyama, S; Kuroda, H; Nakashima, I; Fujihara, K; Aoki, M				Kurosawa, K.; Misu, T.; Takahashi, T.; Sato, D.; Nishiyama, S.; Kuroda, H.; Nakashima, I.; Fujihara, K.; Aoki, M.			The Lesion Localization of Passive Transfer NMO-IgG Model in Lewis Rats	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Kurosawa, K.; Takahashi, T.; Sato, D.; Kuroda, H.; Nakashima, I.; Fujihara, K.] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Misu, T.; Aoki, M.] Tohoku Univ, Grad Sch Med, Neurol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-56	830	830				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600112		
J	Takai, Y				Takai, Yoshiki			Binding Properties of Anti-AQP4 Antibodies Influencing Endocytosis of AQP4 and Complement-Dependent Cytotoxicity	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Takai, Yoshiki] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-57	830	830				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600113		
J	Ozawa, T; Warabi, Y; Isozaki, E				Ozawa, T.; Warabi, Y.; Isozaki, E.			Efficacy of Fingolimod for Recurrent Spinal Cord Lesions in A Case of Multiple Sclerosis	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Ozawa, T.; Warabi, Y.; Isozaki, E.] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-64	832	833				2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600120		
J	Kaneko, K; Sato, DK; Misu, T; Kurosawa, K; Nakashima, I; Fujihara, K; Aoki, M				Kaneko, K.; Sato, D. K.; Misu, T.; Kurosawa, K.; Nakashima, I.; Fujihara, K.; Aoki, M.			Anti-NMDAR plus /anti-MOG plus recurrent ADEM	MULTIPLE SCLEROSIS JOURNAL			English	Meeting Abstract									[Kaneko, K.; Sato, D. K.; Misu, T.; Kurosawa, K.; Nakashima, I.; Fujihara, K.; Aoki, M.] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAY	2015	21	6				P-75	836	836				1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CH8AR	WOS:000354258600131		
J	Jo, CH; Cho, DH; Noh, HJ; Yashiro, H; Sun, YK; Myung, ST				Jo, Chang-Heum; Cho, Dae-Hyun; Noh, Hyung-Joo; Yashiro, Hithshi; Sun, Yang-Kook; Myung, Seung Taek			An effective method to reduce residual lithium compounds on Ni-rich Li[Ni0.6Co0.2Mn0.2]O-2 active material using a phosphoric acid derived Li3PO4 nanolayer	NANO RESEARCH			English	Article						Li3PO4; coating; positive electrode; lithium; batteries	LI-ION BATTERIES; POSITIVE ELECTRODE MATERIALS; ELECTROCHEMICAL PROPERTIES; CATHODE MATERIALS; LIPF6; BEHAVIOR; LICOO2; COPRECIPITATION; MICROSTRUCTURE; INTERCALATION	The Ni-rich Li[Ni0.6Co0.2Mn0.2]O-2 surface has been modified with H3PO4. After coating at 80 A degrees C, the products were heated further at a moderate temperature of 500 A degrees C in air, when the added H3PO4 transformed to Li3PO4 after reacting with residual LiOH and Li2CO3 on the surface. A thin and uniform smooth nanolayer (< 10 nm) was observed on the surface of Li[Ni0.6Co0.2Mn0.2]O-2 as confirmed by transmission electron microscopy (TEM). Time-of-flight secondary ion mass spectroscopic (ToF-SIMS) data exhibit the presence of LiP+, LiPO+, and Li2PO (2) (+) fragments, indicating the formation of the Li3PO4 coating layer on the surface of the Li[Ni0.6Co0.2Mn0.2]O-2. As a result, the amounts of residual lithium compounds, such as LiOH and Li2CO3, are significantly reduced. As a consequence, the Li3PO4-coated Li[Ni0.6Co0.2Mn0.2]O-2 exhibits noticeable improvement in capacity retention and rate capability due to the reduction of residual LiOH and Li2CO3. Further investigation of the extensively cycled electrodes by X-ray diffraction (XRD), TEM, and ToF-SIMS demonstrated that the Li3PO4 coating layers have multi-functions: Absorption of water in the electrolyte that lowers the HF level, HF scavenging, and protection of the active materials from deleterious side reactions with the electrolyte during extensive cycling, enabling high capacity retention over 1,000 cycles.	[Jo, Chang-Heum; Cho, Dae-Hyun; Myung, Seung Taek] Sejong Univ, Dept Nano Engn, Seoul 143747, South Korea; [Yashiro, Hithshi] Iwate Univ, Dept Chem Engn, Morioka, Iwate 0208551, Japan; [Noh, Hyung-Joo; Sun, Yang-Kook] Hanyang Univ, Dept Energy Engn, Seoul 133791, South Korea	Sun, YK (reprint author), Hanyang Univ, Dept Energy Engn, Seoul 133791, South Korea.	yksun@hanyang.ac.kr; smyung@sejong.ac.kr			MKE/KEIT [10041856, 10041094]	This work was partially supported by the IT R&D program of MKE/KEIT (No. 10041856 Technology development for life improvement of high-Ni-composition cathodes at high temperatures (>= 60 degrees C)) and the secondary battery R&D program for leading green industry of MKE/KEIT (No. 10041094 Development of Co-free, high-thermal-stability, and eco-friendly layered cathode materials for lithium ion batteries).	Eom J, 2008, J ELECTROCHEM SOC, V155, pA239, DOI 10.1149/1.2830946; Bettge M, 2013, J POWER SOURCES, V233, P346, DOI 10.1016/j.jpowsour.2013.01.082; Aurbach D, 1999, ELECTROCHIM ACTA, V45, P67, DOI 10.1016/S0013-4686(99)00194-2; Lux SF, 2012, ELECTROCHEM COMMUN, V14, P47, DOI 10.1016/j.elecom.2011.10.026; Myung ST, 2007, J PHYS CHEM C, V111, P4061, DOI 10.1021/jp0674367; Myung ST, 2010, J MATER CHEM, V20, P7074, DOI 10.1039/c0jm00508h; Chen CH, 2004, J POWER SOURCES, V128, P278, DOI 10.1016/j.jpowsour.2003.10.009; Chen ZH, 2004, ELECTROCHIM ACTA, V49, P1079, DOI 10.1016/j.electacta.2003.10.019; Kim GH, 2005, J ELECTROCHEM SOC, V152, pA1707, DOI 10.1149/1.1952747; Lee KS, 2009, J MATER CHEM, V19, P1995, DOI 10.1039/b819224c; Belharouak I, 2003, J POWER SOURCES, V123, P247, DOI 10.1016/S0378-7753(03)00529-9; Sun YK, 2009, NAT MATER, V8, P320, DOI 10.1038/nmat2418; Appapillai AT, 2007, CHEM MATER, V19, P5748, DOI 10.1021/cm0715390; Tasaki K, 2003, J ELECTROCHEM SOC, V150, pA1628, DOI 10.1149/1.1622406; Edstrom K, 2004, ELECTROCHIM ACTA, V50, P397, DOI 10.1016/j.electacta.2004.03.049; Kunduraci M, 2006, CHEM MATER, V18, P3585, DOI 10.1021/cm060729s; REIMERS JN, 1992, J ELECTROCHEM SOC, V139, P2091, DOI 10.1149/1.2221184; Rosina KJ, 2012, J MATER CHEM, V22, P20602, DOI 10.1039/c2jm34114j; Lu YC, 2009, CHEM MATER, V21, P4408, DOI 10.1021/cm900862v; Yu XH, 1997, J ELECTROCHEM SOC, V144, P524, DOI 10.1149/1.1837443; Amatucci GG, 1996, SOLID STATE IONICS, V83, P167, DOI 10.1016/0167-2738(95)00231-6; Myung ST, 2005, CHEM MATER, V17, P2427, DOI 10.1021/cm050033j; Lee MH, 2004, ELECTROCHIM ACTA, V50, P939, DOI 10.1016/j.electacta.2004.07.038; AURBACH D, 1989, J ELECTROCHEM SOC, V136, P906, DOI 10.1149/1.2096876; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Aurbach D, 1998, MATER RES SOC SYMP P, V496, P435; Cho DH, 2014, J ELECTROCHEM SOC, V161, pA920, DOI 10.1149/2.042406jes; Cho Y.M., 2013, APPL MECH MAT, V284, P342; COHN M, 1958, J BIOL CHEM, V230, P369; Jiang J, 2004, ELECTROCHEM COMMUN, V6, P724, DOI 10.1016/j.elecom.2004.05.004; Kim GH, 2004, ELECTROCHEM SOLID ST, V7, pA477, DOI 10.1149/1.1809554; Lee D.-J., 2011, J POWER SOURCES, V196, P7745; Lee KS, 2007, J ELECTROCHEM SOC, V154, pA971, DOI 10.1149/1.2769831; Liao PY, 2005, J ELECTROCHEM SOC, V152, pA1695, DOI 10.1149/1.1952687; Myung ST, 2010, J PHYS CHEM C, V114, P4710, DOI 10.1021/jp9082322; Noh H.-J., 2014, J POWER SOURCES, V233, P121; Sloop SE, 2001, ELECTROCHEM SOLID ST, V4, pA42, DOI 10.1149/1.1353158; Verdier S, 2007, J ELECTROCHEM SOC, V154, pA1088, DOI 10.1149/1.2789299; Woo S.-W., 2009, ELECTROCHIM ACTA, V54, pA163	39	3	3	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2015	8	5					1464	1479		10.1007/s12274-014-0631-8		16	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI3CQ	WOS:000354625600005		
J	Entani, S; Antipina, LY; Avramov, PV; Ohtomo, M; Matsumoto, Y; Hirao, N; Shimoyama, I; Naramoto, H; Baba, Y; Sorokin, PB; Sakai, S				Entani, Shiro; Antipina, Liubov Yu; Avramov, Pavel V.; Ohtomo, Manabu; Matsumoto, Yoshihiro; Hirao, Norie; Shimoyama, Iwao; Naramoto, Hiroshi; Baba, Yuji; Sorokin, Pavel B.; Sakai, Seiji			Contracted interlayer distance in graphene/sapphire heterostructure	NANO RESEARCH			English	Article						graphene; sapphire; chemical vapor deposition; graphene/insulator interface	CHEMICAL-VAPOR-DEPOSITION; INITIO MOLECULAR-DYNAMICS; ELECTRIC-FIELD; GRAPHENE FILMS; SAPPHIRE; CARBON; SPECTROSCOPY; ALPHA-AL2O3; SUBSTRATE; GRAPHITE	Direct growth of graphene on insulators is expected to yield significant improvements in performance of graphene-based electronic and spintronic devices. In this study, we successfully reveal the atomic arrangement and electronic properties of a coherent heterostructure of single-layer graphene and alpha-Al2O3(0001). The analysis of the atomic arrangement of single-layer graphene on alpha-Al2O3(0001) revealed an apparentcontradiction. The in-plane analysis shows that single-layer graphene grows not in a single-crystalline epitaxial manner, but rather in polycrystalline form, with two strongly pronounced preferred orientations. This suggests relatively weak interfacial interactions are operative. However, we demonstrate that unusually strong physical interactions between graphene and alpha-Al2O3(0001) exist, as evidenced by the small separation between the graphene and the alpha-Al2O3(0001) surface. The interfacial interaction is shown to be dominated by the electrostatic forces involved in the graphene pi-system and the unsaturated electrons of the topmost O layer of alpha-Al2O3(0001), rather than the van der Waals interactions. Such features causes graphene hole doping and enable the graphene to slide on the alpha-Al2O3(0001) surface with only a small energy barrier despite the strong interfacial interactions.	[Entani, Shiro; Avramov, Pavel V.; Ohtomo, Manabu; Matsumoto, Yoshihiro; Naramoto, Hiroshi; Sorokin, Pavel B.; Sakai, Seiji] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Antipina, Liubov Yu; Sorokin, Pavel B.] Technol Inst Superhard & Novel Carbon Mat, Moscow 142190, Russia; [Antipina, Liubov Yu] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow, Russia; [Avramov, Pavel V.] Siberian Fed Univ, Krasnoyarsk 660041, Russia; [Hirao, Norie; Shimoyama, Iwao; Baba, Yuji] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Sorokin, Pavel B.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia	Entani, S (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan.	entani.shiro@jaea.go.jp; PBSorokin@tisnum.ru	Sorokin, Pavel/C-9749-2011	Sorokin, Pavel/0000-0001-5248-1799	Japan Society for the Promotion of Science [22760033]; Photon Factory Program Advisory Committee (PF PAC) [2010G660, 2012G741]; Russian Science Foundation [14-13-00139]	We are grateful to the 'Chebishev' and 'Lomonosov' supercomputers of Moscow State University for providing the chance of using a cluster computer for quantum-chemical calculations. S.E. thanks Prof. H. Kondo (Keio University) and Prof. T. Shimada (Hirosaki University) for NIXSW measurements. This work was partly supported by Grants-in-Aid for Young Scientists B (Grant No. 22760033) from the Japan Society for the Promotion of Science. The present work has been performed under the approval of the Photon Factory Program Advisory Committee (PF PAC Nos. 2010G660 and 2012G741). P.V.A., P.B.S. and L.Y.A. acknowledge the support from the Russian Science Foundation (project No. 14-13-00139).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Song HJ, 2012, NANOSCALE, V4, P3050, DOI 10.1039/c2nr30330b; Preobrajenski AB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.073401; Casiraghi C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818692; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Eberlein T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.233406; Perevalov TV, 2007, JETP LETT+, V85, P165, DOI 10.1134/S0021364007030071; Du AJ, 2011, J PHYS CHEM LETT, V2, P894, DOI 10.1021/jz2002698; WAGNER CD, 1978, J VAC SCI TECHNOL, V15, P518, DOI 10.1116/1.569459; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; ARAKAWA ET, 1968, J PHYS CHEM SOLIDS, V29, P735, DOI 10.1016/0022-3697(68)90135-2; LESPADE P, 1984, CARBON, V22, P375, DOI 10.1016/0008-6223(84)90009-5; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Hwang J, 2013, ACS NANO, V7, P385, DOI 10.1021/nn305486x; BALZAROTTI A, 1976, PHYS STATUS SOLIDI B, V76, P689, DOI 10.1002/pssb.2220760230; LEWIS J, 1982, ACTA CRYSTALLOGR A, V38, P733, DOI 10.1107/S0567739482001478; NAGASHIMA A, 1994, PHYS REV B, V50, P17487, DOI 10.1103/PhysRevB.50.17487; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Chae SJ, 2009, ADV MATER, V21, P2328, DOI 10.1002/adma.200803016; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; Gong C, 2010, J APPL PHYS, V108, DOI 10.1063/1.3524232; Gamo Y, 1997, SURF SCI, V374, P61, DOI 10.1016/S0039-6028(96)00785-6; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; FRENCH RH, 1990, J AM CERAM SOC, V73, P477, DOI 10.1111/j.1151-2916.1990.tb06541.x; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Gass MH, 2008, NAT NANOTECHNOL, V3, P676, DOI 10.1038/nnano.2008.280; TRUCANO P, 1975, NATURE, V258, P136, DOI 10.1038/258136a0; Baba Yuji, 2012, e-Journal of Surface Science and Nanotechnology, V10, DOI 10.1380/ejssnt.2012.69; Busse C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036101; Chen K, 2012, J PHYS CHEM C, V116, P6259, DOI 10.1021/jp211255t; Entani S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194867; Entani S, 2010, J PHYS CHEM C, V114, P20042, DOI 10.1021/jp106188w; Entani S, 2012, J APPL PHYS, V111, DOI 10.1063/1.3694662; Fanton MA, 2011, ACS NANO, V5, P8062, DOI 10.1021/nn202643t; Giovannetti G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026803; Hamrin K., 1970, Physica Scripta, V1, DOI 10.1088/0031-8949/1/5-6/018; Hwang JH, 2010, J CRYST GROWTH, V312, P3219, DOI 10.1016/j.jcrysgro.2010.07.046; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kozlov S. M., 2012, J PHYS CHEM C, V116, P736; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Nakamura A, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DN03; Stradi D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245401; Vanin M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081408; WOODRUFF DP, 1987, PHYS REV LETT, V58, P1460, DOI 10.1103/PhysRevLett.58.1460	51	0	0	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2015	8	5					1535	1545		10.1007/s12274-014-0640-7		11	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI3CQ	WOS:000354625600010		
J	Cui, HW; Suganuma, K; Uchida, H				Cui, Hui-Wang; Suganuma, Katsuaki; Uchida, Hiroshi			Highly stretchable, electrically conductive textiles fabricated from silver nanowires and cupro fabrics using a simple dipping-drying method	NANO RESEARCH			English	Article						fabrics/textiles; metals; smart materials; electrical properties	TRANSPARENT; FIBERS; FILMS; POLYPYRROLE; ELECTRONICS; ARRAYS; HAZE	In this study, we combined silver nanowires with cupro fabrics using a dipping-drying method to prepare electrically conductive fabrics. The silver nanowires were first adhered to and then absorbed by microfibers to form electrically conductive fibers. They also filled the gaps and spaces between the microfibers, and were stacked or piled together to form networks with high electrical conductivity. The electrically conductive fabric had low resistance and good stretchability, e.g., 0.0047-0.0091 Omega in the strain range of 0-190%. They also exhibited stable electrical conductivity, as well as excellent flexibility, which remained even when the fabric was stretched, shrunk, or bent. The results show that the electrically conductive fabric can be used as a smart textile, especially in fields associated with weaving, clothing, food products, lifestyle products, medicine, biology, electronics, aviation, and military equipment and accessories.	[Cui, Hui-Wang; Suganuma, Katsuaki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Uchida, Hiroshi] Showa Denko Co Ltd, Inst Polymers, Ichihara, Chiba 2900067, Japan; [Uchida, Hiroshi] Showa Denko Co Ltd, Chem Business Dev Ctr, Ichihara, Chiba 2900067, Japan	Cui, HW (reprint author), Osaka Univ, Inst Sci & Ind Res, Mihogaoka 8-1, Osaka 5670047, Japan.	cuihuiwang@hotmail.com					Akerfeldt M, 2013, TEXT RES J, V83, P618, DOI 10.1177/0040517512444330; Anderson EB, 2012, J MATER CHEM, V22, P11851, DOI 10.1039/c2jm30186e; Lim ZH, 2010, SENSOR ACTUAT B-CHEM, V151, P121, DOI 10.1016/j.snb.2010.09.037; Castano LM, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/5/053001; Tokuno T, 2011, NANO RES, V4, P1215, DOI 10.1007/s12274-011-0172-3; Araki T, 2014, NANO RES, V7, P236, DOI 10.1007/s12274-013-0391-x; Maity S, 2014, J TEXT I, V105, P887, DOI 10.1080/00405000.2013.861149; Jiu J, 2012, J MATER CHEM, V22, P23561, DOI 10.1039/c2jm35545k; Xue CH, 2012, APPL SURF SCI, V258, P2468, DOI 10.1016/j.apsusc.2011.10.074; Lee HM, 2013, ANGEW CHEM INT EDIT, V52, P7718, DOI 10.1002/anie.201301941; Hu JL, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/5/053001; Wang YD, 2013, NANO RES, V6, P159, DOI 10.1007/s12274-013-0291-0; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Cui HW, 2013, POLYM INT, V62, P1644, DOI 10.1002/pi.4461; Preston C, 2013, NANO RES, V6, P461, DOI 10.1007/s12274-013-0323-9; Paul G, 2014, SENSOR ACTUAT A-PHYS, V206, P35, DOI 10.1016/j.sna.2013.11.026; Paul G, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/2/025006; Cui HW, 2014, RSC ADV, V4, P15914, DOI 10.1039/c4ra00292j; Bashir T., 2011, POLYM ADVAN TECHNOL, V22, P214; Khumpuang S, 2011, SENSOR ACTUAT A-PHYS, V169, P378, DOI 10.1016/j.sna.2011.01.006; Kim BC, 2013, PROG ORG COAT, V76, P1296, DOI 10.1016/j.porgcoat.2013.04.004; Ko YH, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-28; Nateghi MR, 2013, INT J POLYM MATER PO, V62, P648, DOI 10.1080/00914037.2013.769167; Nilsson E, 2013, J APPL POLYM SCI, V130, P2579, DOI 10.1002/app.39480; Perumalraj R, 2011, J REINF PLAST COMP, V30, P203, DOI 10.1177/0731684410391508; Ramachandran T, 2009, J IND TEXT, V39, P81, DOI 10.1177/1528083709103317; Yamashita T, 2014, ELECTR COMMUN JPN, V97, P48, DOI 10.1002/ecj.11485; Yang K, 2013, TEXT RES J, V83, P2023, DOI 10.1177/0040517513490063; Zhao YP, 2013, SYNTHETIC MET, V175, P1, DOI 10.1016/j.synthmet.2013.04.018	29	0	0	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2015	8	5					1604	1614		10.1007/s12274-014-0649-y		11	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI3CQ	WOS:000354625600016		
J	Escano, MCS				Escano, Mary Clare Sison			First-principles calculations of the dissolution and coalescence properties of Pt nanoparticle ORR catalysts: The effect of nanoparticle shape	NANO RESEARCH			English	Article						Pt nanoparticle ORR catalyst; density functional theory; shape; dissolution; coalescence; stability	OXYGEN-REDUCTION-REACTION; AUGMENTED-WAVE METHOD; AB-INITIO; ELECTROCHEMICAL STABILITY; PLATINUM NANOPARTICLES; METAL NANOCRYSTALS; DEPENDENCE; DESIGN	The degradation of Pt nanoparticles (NPs) in fuel cell cathodes leads to the loss of the precious metal catalyst. While the effect of NP size on Pt dissolution has been studied extensively, the influence of NP shape is largely unexplored. Because of the recent development of experimental methods to control the shape of metal NPs, rational guidelines/insights on the shape effects on NP stability are imperative. In this study, first-principles calculations based on density functional theory were conducted to determine the stability of 1-2 nm Pt NPs against Pt dissolution and coalescence with respect to NP shape. Toward dissolution, the stability of the Pt NPs increases in the following order: Hexagonal close-packed < icosahedral < cuboctahedral < truncated octahedral. This trend is attributed to the synergy of the oxygen adsorption strength and the local coordination of the Pt atoms. With respect to coalescence, the size of a NP is related to its propensity to coalesce or detach/migrate to form larger particles. The stability of the Pt NPs was found to increase in the following order: Hexagonal close-packed < truncated octahedral < cuboctahedral < icosahedral, and was correlated with the cohesive energies of the particles. By combining the characteristic stabilities of the shapes, new "metal-interfaced" Pt-based coreshell architectures were proposed that should be more stable than pure Pt nanoparticles with respect to both dissolution and coalescence.	Univ Fukui, Grad Sch Engn, Fukui 9108507, Japan	Escano, MCS (reprint author), Univ Fukui, Grad Sch Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	mcescano@u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Science and Technology Agency (JST); Tenure Track Program for Innovative Research	M. C. S. Escano extends gratitude to Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), Japan Science and Technology Agency (JST), and Tenure Track Program for Innovative Research for research funds. The calculations are done using the Kyoto University Supercomputer and the High-Performance Computing Cluster Fukui (HPCCF) of Escano Research Group, University of Fukui.	Peng ZM, 2009, NANO TODAY, V4, P143, DOI 10.1016/j.nantod.2008.10.010; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Wang C, 2011, NANO LETT, V11, P919, DOI 10.1021/nl102369k; Matsumoto M, 2011, J PHYS CHEM C, V115, P11163, DOI 10.1021/jp201959h; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Da Silva JLF, 2006, SURF SCI, V600, P703, DOI 10.1016/j.susc.2005.12.008; Escano MCS, 2014, J POWER SOURCES, V247, P562, DOI 10.1016/j.jpowsour.2013.09.013; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Zheng FL, 2014, NANO RES, V7, P410, DOI 10.1007/s12274-014-0407-1; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Beale AM, 2010, PHYS CHEM CHEM PHYS, V12, P5562, DOI 10.1039/b925206a; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Devivaraprasad R, 2014, LANGMUIR, V30, P8995, DOI 10.1021/la501109g; Niu WX, 2011, NANO TODAY, V6, P265, DOI 10.1016/j.nantod.2011.04.006; Gumeci C, 2014, J PHYS CHEM C, V118, P14433, DOI 10.1021/jp5037525; Qiao Y, 2011, J MATER CHEM, V21, P4027, DOI 10.1039/c0jm02871a; An W, 2013, J PHYS CHEM C, V117, P16144, DOI 10.1021/jp4057785; Seo JK, 2013, J POWER SOURCES, V238, P137, DOI 10.1016/j.jpowsour.2013.03.077; Teranishi T, 2000, J INORG ORGANOMET P, V10, P145, DOI 10.1023/A:1009476128466; Noh SH, 2013, NANOSCALE, V5, P8625, DOI 10.1039/c3nr02611f; Darling RM, 2003, J ELECTROCHEM SOC, V150, pA1523, DOI 10.1149/1.1613669; Wang LY, 2009, J PHYS CHEM C, V113, P17989, DOI 10.1021/jp900965q; Wu JB, 2011, NANO RES, V4, P72, DOI 10.1007/s12274-010-0049-x; TETER MP, 1989, PHYS REV B, V40, P12255, DOI 10.1103/PhysRevB.40.12255; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/nmat3458, 10.1038/NMAT3458]; Larsen AH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245429; Long NV, 2011, ACTA MATER, V59, P2901, DOI 10.1016/j.actamat.2011.01.033; Si WF, 2013, NANO RES, V6, P720, DOI 10.1007/s12274-013-0349-z; Frenkel A, 2007, Z KRISTALLOGR, V222, P605, DOI 10.1524/zkri.2007.222.11.605; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Fajin J. L. C., 2012, J CHEM PHYS, V137; Han BC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075410; Kikuchi H, 2010, ELECTROCHEM COMMUN, V12, P544, DOI 10.1016/j.elecom.2010.01.039; Kittel Ch, 1996, INTRO SOLID STATE PH; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Leong GJ, 2014, APPL ORGANOMET CHEM, V28, P1, DOI 10.1002/aoc.3048; Lou J., 2006, ELECTROCHIM ACTA, V51, P4821; Lou J., 2005, CHEM MATER, V17, P5282; Makino K, 2010, ECS TRANSACTIONS, V33, P105, DOI 10.1149/1.3484507; Meier JC, 2014, BEILSTEIN J NANOTECH, V5, P44, DOI 10.3762/bjnano.5.5; Okaya K, 2012, ACS APPL MATER INTER, V4, P6981, DOI 10.1021/am302224n; Ota K-i, 2006, ECS T, V3, P619, DOI 10.1149/1.2356182; Porter N. S., 2012, ACCOUNTS CHEM RES, V46, P1867; Takahashi H., 2012, US Pat, Patent No. [8,338, 051, 8338051]; Wachter A., 1996, ANN PHYS, V6, P215	47	3	3	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	MAY	2015	8	5					1689	1697		10.1007/s12274-014-0670-1		9	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CI3CQ	WOS:000354625600024		
J	Kaida, K; Niki, K; Born, J				Kaida, Kosuke; Niki, Kazuhisa; Born, Jan			Role of sleep for encoding of emotional memory	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Sleep; Emotion; Memory encoding	EYE-MOVEMENT SLEEP; REM-SLEEP; DEPRIVATION; HOMEOSTASIS; BRAIN; CONSOLIDATION; HIPPOCAMPUS; PERFORMANCE; PLASTICITY; PICTURES	Total sleep deprivation (TSD) has been consistently found to impair encoding of information during ensuing wakefulness, probably through suppressing NonREM (non-rapid eye movement) sleep. However, a possible contribution of missing REM sleep to this encoding impairment after TSD has so far not been systematically examined in humans, although such contribution might be suspected in particular for emotional information. Here, in two separate experiments in young healthy men, we compared effects of TSD and of selective REM sleep deprivation (REMD), relative to respective control conditions of undisturbed sleep, on the subsequent encoding of neutral and emotional pictures. The pictures were presented in conjunction with colored frames to also assess related source memory. REMD was achieved by tones presented contingently upon initial signs of REM sleep. Encoding capabilities were examined in the evening (18:00 h) after the experimental nights, by a picture recognition test right after encoding. TSD significantly decreased both the rate of correctly recognized pictures and of recalled frames associated with the pictures. The TSD effect was robust and translated into an impaired long term memory formation, as it was likewise observed on a second recognition testing one week after the encoding phase. Contrary to our expectation, REMD did not affect encoding in general, or particularly of emotional pictures. Also, REMD did not affect valence ratings of the encoded pictures. However, like TSD, REMD distinctly impaired vigilance at the time of encoding. Altogether, these findings indicate an importance of NonREM rather than REM sleep for the encoding of information that is independent of the emotionality of the materials. (C) 2015 Elsevier Inc. All rights reserved.	[Kaida, Kosuke; Niki, Kazuhisa] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Born, Jan] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany	Kaida, K (reprint author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Higashi Ku, Tsukuba Cent 6-11,1-1-1, Tsukuba, Ibaraki 3058566, Japan.	kaida-kosuke@umin.ac.jp			JSPS [25705022]; Deutsche Forschungsgemeinschaft [TR-SFB 654]	We want to thank Sabine Groch for technical assistance. This work was supported by JSPS KAKENHI Grant Number 25705022. J.B. is supported by a grant from the Deutsche Forschungsgemeinschaft (TR-SFB 654 "Plasticity and Sleep").	Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Drummond SPA, 2000, NATURE, V403, P655; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Groch S, 2013, NEUROBIOL LEARN MEM, V99, P1, DOI 10.1016/j.nlm.2012.10.006; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Antonenko D, 2013, EUR J NEUROSCI, V37, P1142, DOI 10.1111/ejn.12118; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-2005-867080; Kim EY, 2005, NEUROSCI LETT, V388, P163, DOI 10.1016/j.neulet.2005.06.057; Lara-Carrasco J, 2009, J SLEEP RES, V18, P178, DOI 10.1111/j.1365-2869.2008.00709.x; Lopez J, 2008, NEUROSCIENCE, V153, P44, DOI 10.1016/j.neuroscience.2008.01.072; Mander BA, 2011, CURR BIOL, V21, pR183, DOI 10.1016/j.cub.2011.01.019; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wagner U, 2002, PSYCHOSOM MED, V64, P627, DOI 10.1097/01.PSY.0000021940.35402.51; Dinges DF, 1997, SLEEP, V20, P267; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Iber C, 2007, AASM MANUAL SCORING; Payne JD, 2015, EMOTION, V15, P176, DOI 10.1037/a0038683; Payne Jessica D, 2012, Front Integr Neurosci, V6, P108, DOI 10.3389/fnint.2012.00108; POLZELLA DJ, 1975, J EXP PSYCHOL-HUM L, V104, P194; Ravassard P., 2015, CEREB CORTEX, V10; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Werner GG, 2015, PSYCHOPHYSIOLOGY	32	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	MAY	2015	121						72	79		10.1016/j.nlm.2015.04.002		8	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Behavioral Sciences; Neurosciences & Neurology; Psychology	CI3QP	WOS:000354662800008		
J	Sasa, H; Suzuki, A; Sei, K; Shimazaki, H; Sugita, M; Furuya, K				Sasa, Hidenori; Suzuki, Ayako; Sei, Kiguna; Shimazaki, Hideyuki; Sugita, Michio; Furuya, Kenichi			Immunohistochemical Expression of Serpin Peptidase Inhibitor B2 and Carboxypeptidase A4 in Uterine Cervical Lesions	OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	61st Annual Clinical Meeting of the American-College-of-Obstetricians-and-Gynecologists - Women's Health Care Physicians	MAY 07, 2013	New Orleans, LA	Amer Coll Obstetricians & Gynecologists					[Sasa, Hidenori] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	MAY	2015	125			1		200	66S	66S				1	Obstetrics & Gynecology	Obstetrics & Gynecology	CH6EI	WOS:000354128700220		
J	Takata, T; Enomoto, T; Matsuo, K; Tanaka, Y; Yagi, A; Kimura, T				Takata, Tomomi; Enomoto, Takayuki; Matsuo, Koji; Tanaka, Yusuke; Yagi, Asami; Kimura, Tadashi			Internet Survey Factors Affecting Human Papillomavirus Vaccination in Japan After Adverse Media Reports	OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	61st Annual Clinical Meeting of the American-College-of-Obstetricians-and-Gynecologists - Women's Health Care Physicians	MAY 07, 2013	New Orleans, LA	Amer Coll Obstetricians & Gynecologists					[Takata, Tomomi] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	MAY	2015	125			1		367	114S	115S				2	Obstetrics & Gynecology	Obstetrics & Gynecology	CH6EI	WOS:000354128700385		
J	Tanaka, Y; Enomoto, T; Kimura, T; Matsuo, K; Takata, T; Yagi, A				Tanaka, Yusuke; Enomoto, Takayuki; Kimura, Tadashi; Matsuo, Koji; Takata, Tomomi; Yagi, Asami			Effect of Adverse Media Reports and Abeyance of Governmental Recommendation of Human Papillomavirus Vaccine in Japan	OBSTETRICS AND GYNECOLOGY			English	Meeting Abstract	61st Annual Clinical Meeting of the American-College-of-Obstetricians-and-Gynecologists - Women's Health Care Physicians	MAY 07, 2013	New Orleans, LA	Amer Coll Obstetricians & Gynecologists					[Tanaka, Yusuke] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	MAY	2015	125			1		368	115S	115S				1	Obstetrics & Gynecology	Obstetrics & Gynecology	CH6EI	WOS:000354128700386		
J	Gaynor, JW; Stopp, C; Wypij, D; Andropoulos, DB; Atallah, J; Atz, AM; Beca, J; Donofrio, MT; Duncan, K; Ghanayem, NS; Goldberg, CS; Hovels-Gurich, H; Ichida, F; Jacobs, JP; Justo, R; Latal, B; Li, JS; Mahle, WT; McQuillen, PS; Menon, SC; Pemberton, VL; Pike, NA; Pizarro, C; Shekerdemian, LS; Synnes, A; Williams, I; Bellinger, DC; Newburger, JW				Gaynor, J. William; Stopp, Christian; Wypij, David b; Andropoulos, Dean B.; Atallah, Joseph; Atz, Andrew M.; Beca, John; Donofrio, Mary T. g; Duncan, Kim; Ghanayem, Nancy S.; Goldberg, Caren S.; Hovels-Gurich, Hedwig; Ichida, Fukiko; Jacobs, Jeffrey P.; Justo, Robert n; Latal, Beatrice; Li, Jennifer S.; Mahle, William T.; McQuillen, Patrick S.; Menon, Shaji C.; Pemberton, Victoria L.; Pike, Nancy A.; Pizarro, Christian; Shekerdemian, Lara S.; Synnes, Anne; Williams, Ismee; Bellinger, David C.; Newburger, Jane W.		ICCON Investigators	Neurodevelopmental Outcomes After Cardiac Surgery in Infancy	PEDIATRICS			English	Article							HYPOTHERMIC CARDIOPULMONARY BYPASS; CONGENITAL HEART-DISEASE; PARTICIPANT DATA METAANALYSIS; CIRCULATORY ARREST; SINGLE VENTRICLE; HEALTH OUTCOMES; D-TRANSPOSITION; GREAT-ARTERIES; CHILDREN; TRIAL	BACKGROUND: Neurodevelopmental disability is the most common complication for survivors of surgery for congenital heart disease (CHD). METHODS: We analyzed individual participant data from studies of children evaluated with the Bayley Scales of Infant Development, second edition, after cardiac surgery between 1996 and 2009. The primary outcome was Psychomotor Development Index (PDI), and the secondary outcome was Mental Development Index (MDI). RESULTS: Among 1770 subjects from 22 institutions, assessed at age 14.5 +/- 3.7 months, PDIs and MDIs (77.6 +/- 18.8 and 88.2 +/- 16.7, respectively) were lower than normative means (each P < .001). Later calendar year of birth was associated with an increased proportion of high-risk infants (complexity of CHD and prevalence of genetic/extracardiac anomalies). After adjustment for center and type of CHD, later year of birth was not significantly associated with better PDI or MDI. Risk factors for lower PDI were lower birth weight, white race, and presence of a genetic/extracardiac anomaly (all P <= .01). After adjustment for these factors, PDIs improved over time (0.39 points/year, 95% confidence interval 0.01 to 0.78; P = .045). Risk factors for lower MDI were lower birth weight, male gender, less maternal education, and presence of a genetic/extracardiac anomaly (all P < .001). After adjustment for these factors, MDIs improved over time (0.38 points/year, 95% confidence interval 0.05 to 0.71; P = .02). CONCLUSIONS: Early neurodevelopmental outcomes for survivors of cardiac surgery in infancy have improved modestly over time, but only after adjustment for innate patient risk factors. As more high-risk CHD infants undergo cardiac surgery and survive, a growing population will require significant societal resources.	[Gaynor, J. William] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Stopp, Christian; Wypij, David b; Bellinger, David C.; Newburger, Jane W.] Boston Childrens Hosp, Boston, MA USA; [Andropoulos, Dean B.] Texas Childrens Hosp, Houston, TX 77030 USA; [Atallah, Joseph] Stollery Childrens Hosp, Edmonton, AB, Canada; [Atallah, Joseph] Western Canadian Complex Pediat Therapies Follow, Edmonton, AB, Canada; [Atz, Andrew M.] Med Univ S Carolina, Div Pediat Cardiol, Charleston, SC 29425 USA; [Beca, John] Starship Childrens Hosp, Auckland, New Zealand; [Donofrio, Mary T. g] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Duncan, Kim] Childrens Hosp & Med Ctr, Omaha, NE USA; [Ghanayem, Nancy S.] Childrens Hosp Wisconsin, Med Coll Wisconsin, Milwaukee, WI 53201 USA; [Goldberg, Caren S.] Motts Childrens Hosp, Ann Arbor, MI USA; [Hovels-Gurich, Hedwig] Univ Hosp Aachen, Aachen, Germany; [Ichida, Fukiko] Toyama Univ Hosp, Toyama, Japan; [Jacobs, Jeffrey P.] Johns Hopkins All Childrens Heart Inst, St Petersburg, FL USA; [Justo, Robert n] Univ Queensland, Brisbane, Qld, Australia; [Latal, Beatrice] Univ Childrens Hosp Zurich, Zurich, Switzerland; [Li, Jennifer S.] Duke Univ, Med Ctr, Durham, NC USA; [Mahle, William T.] Childrens Healthcare Atlanta, Atlanta, GA USA; [McQuillen, Patrick S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Menon, Shaji C.] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Pemberton, Victoria L.] NHLBI, Bethesda, MD 20892 USA; [Pike, Nancy A.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Pizarro, Christian] Alfred I duPont Hosp Children, Wilmington, DE USA; [Shekerdemian, Lara S.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Synnes, Anne] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Williams, Ismee] New York Presbyterian Morgan Stanley Childrens Ho, New York, NY USA	Gaynor, JW (reprint author), Childrens Hosp Philadelphia, Div Cardiothorac Surg, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	gaynor@email.chop.edu	Justo, Robert/D-4708-2011; Colditz, Paul/F-6772-2010		Mend-a-Heart Foundation; Kostin Family Innovation Fund; American Heart Association [9950480N, 0365018Y]; Auckland Medical Research Fund, Australia; New Zealand Intensive Care Society; Canadian Institutes of Health Research [MOP93780]; CReFF (Clinical Research Feasibility Fund); Children's National Medical Center Board of Visitors Grant; Doris Duke Foundation; Ethel Brown Foerderer Fund for Excellence; Farb Family Fund; Food and Drug Administration's Office of Orphan Products Development; Green Lane Research and Education Fund; Heart Foundation of New Zealand; Internal Children's National Medical Center Grants; Larry L. Hillblom Foundation [2002/3E]; March of Dimes Foundation [5-FY2005-1231, 6-FY2009-303]; Mercator Foundation Switzerland; Murdoch Children's Research Institute; National Center for Research Resources [RR01271, RR02172]; National Heart Foundation of Australia; National Heart, Lung, and Blood Institute [HL41786, HL063411, HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, HL085057]; National Institute of Child Health and Development [HD18655, HD055501]; National Institute of Neurologic Disorders and Stroke [NS35902, NS40117, NS063876]; Prince Charles Hospital Foundation	This pooled data analysis project was funded by a grant from the Mend-a-Heart Foundation. The Kostin Family Innovation Fund supplied partial support for Mr Stopp. Individual studies that contributed data were funded by grants from the American Heart Association (9950480N, 0365018Y), Auckland Medical Research Fund, Australia and New Zealand Intensive Care Society, Canadian Institutes of Health Research (MOP93780), CReFF (Clinical Research Feasibility Fund) Grant, Children's National Medical Center Board of Visitors Grant, Doris Duke Foundation, Ethel Brown Foerderer Fund for Excellence, Farb Family Fund, Food and Drug Administration's Office of Orphan Products Development, Green Lane Research and Education Fund, Heart Foundation of New Zealand, Internal Children's National Medical Center Grants, Larry L. Hillblom Foundation (2002/3E), March of Dimes Foundation (5-FY2005-1231, 6-FY2009-303), Mercator Foundation Switzerland, Murdoch Children's Research Institute, National Center for Research Resources (RR01271, RR02172), National Heart Foundation of Australia, National Heart, Lung, and Blood Institute (HL41786, HL063411, HL068269, HL068270, HL068279, HL068281, HL068285, HL068288, HL068290, HL068292, HL085057), National Institute of Child Health and Development (HD18655, HD055501), National Institute of Neurologic Disorders and Stroke (NS35902, NS40117, NS063876), and Prince Charles Hospital Foundation.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Newburger JW, 2012, CIRCULATION, V125, P2081, DOI 10.1161/CIRCULATIONAHA.111.064113; Fuller S, 2009, EUR J CARDIO-THORAC, V36, P40, DOI 10.1016/j.ejcts.2009.02.047; Newburger JW, 2008, J THORAC CARDIOV SUR, V135, P347, DOI 10.1016/j.jtcvs.2007.01.051; Bellinger DC, 2009, CARDIOL YOUNG, V19, P86, DOI 10.1017/S1047951108003454; Licht DJ, 2009, J THORAC CARDIOV SUR, V137, P529, DOI 10.1016/j.jtcvs.2008.10.025; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037//0033-2909.95.1.29; von Rhein M, 2014, BRAIN, V137, P268, DOI 10.1093/brain/awt322; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Ravishankar C, 2013, J PEDIATR-US, V162, P250, DOI 10.1016/j.jpeds.2012.07.048; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Wypij D, 2008, J THORAC CARDIOV SUR, V135, P355, DOI 10.1016/j.jtcvs.2007.03.067; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Carey AS, 2013, CIRC-CARDIOVASC GENE, V6, P444, DOI 10.1161/CIRCGENETICS.113.000189; Clouchoux C, 2012, BRAIN STRUCT FUNCT, V217, P127, DOI 10.1007/s00429-011-0325-x; Bellinger DC, 2001, J THORAC CARDIOV SUR, V121, P374, DOI 10.1067/mtc.2001.111206; Beca J, 2013, CIRCULATION, V127, P971, DOI 10.1161/CIRCULATIONAHA.112.001089; Licht DJ, 2004, J THORAC CARDIOV SUR, V128, P841, DOI 10.1016/j.jtcvs.2004.07.022; Ortinau C, 2012, J THORAC CARDIOV SUR, V143, P1264, DOI 10.1016/j.jtcvs.2011.10.039; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Goldberg CS, 2007, J THORAC CARDIOV SUR, V133, P880, DOI 10.1016/j.jtcvs.2006.11.029; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Bellinger DC, 2011, CIRCULATION, V124, P1361, DOI 10.1161/CIRCULATIONAHA.111.026963; [Anonymous], 2013, J PEDIAT; Creighton DE, 2007, PEDIATRICS, V120, pE478, DOI 10.1542/peds.2006-3250; Atallah J, 2008, CIRCULATION, V118, P1410, DOI 10.1161/CIRCULATIONAHA.107.741579; Atallah J, 2007, J THORAC CARDIOV SUR, V134, P772, DOI 10.1016/j.jtcvs.2007.03.007; Bayley N., 1969, MANUAL BAYLEY SCALES; Bayley N, 2006, BAYLEY SCALES INFANT; Clancy RR, 2000, J THORAC CARDIOV SUR, V119, P347, DOI 10.1016/S0022-5223(00)70191-7; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1067/S0022-5223(03)01188-7; Gaynor JW, 2007, J THORAC CARDIOVASC, V133, pe1; Gaynor JW, 2007, J THORAC CARDIOV SUR, V133, P1344, DOI 10.1016/j.jtcvs.2006.10.087; Gaynor JW, 2009, PEDIATRICS, V124; Goldberg CS, 2014, J PEDIAT, V165, pe8; Goldberg CS, 2014, J PEDIATR-US, V165, P490, DOI 10.1016/j.jpeds.2014.05.019; Licht DJ, 2009, J THORAC CARDIOVASC, V137, P536; McGrath E, 2004, PEDIATRICS, V114, pE572, DOI 10.1542/peds.2003-0983-L; Neufeld RE, 2008, J THORAC CARDIOV SUR, V136, P1413, DOI 10.1016/j.jtcvs.2008.05.011; Oster ME, 2013, PEDIATRICS, V131; Robertson DR, 2004, CARDIOL YOUNG, V14, P389, DOI 10.1017/S104795110400407X	43	4	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAY	2015	135	5					816	825		10.1542/peds.2014-3825		10	Pediatrics	Pediatrics	CH0QX	WOS:000353728400043		
J	Takada, M; Sozu, T; Sato, T				Takada, Michihiro; Sozu, Takashi; Sato, Tosiya			Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended	PHARMACEUTICAL STATISTICS			English	Article						crossover designs; re-randomization designs; irreversible endpoints; the Mantel-Haenszel method; the logistic mixture model	INTRAUTERINE INSEMINATION; MALE SUBFERTILITY; GONADOTROPIN; ESTIMATOR	Crossover designs have some advantages over standard clinical trial designs and they are often used in trials evaluating the efficacy of treatments for infertility. However, clinical trials of infertility treatments violate a fundamental condition of crossover designs, because women who become pregnant in the first treatment period are not treated in the second period. In previous research, to deal with this problem, some new designs, such as re-randomization designs, and analysis methods including the logistic mixture model and the beta-binomial mixture model were proposed. Although the performance of these designs and methods has previously been evaluated in large-scale clinical trials with sample sizes of more than 1000 per group, the actual sample sizes of infertility treatment trials are usually around 100 per group. The most appropriate design and analysis for these moderate-scale clinical trials are currently unclear. In this study, we conducted simulation studies to determine the appropriate design and analysis method of moderate-scale clinical trials for irreversible endpoints by evaluating the statistical power and bias in the treatment effect estimates. The Mantel-Haenszel method had similar power and bias to the logistic mixture model. The crossover designs had the highest power and the smallest bias. We recommend using a combination of the crossover design and the Mantel-Haenszel method for two-period, two-treatment clinical trials with irreversible endpoints. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Takada, Michihiro] Ajinomoto Pharmaceut CO Ltd, Chuo Ku, Tokyo 1040042, Japan; [Sozu, Takashi; Sato, Tosiya] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto 6068501, Japan	Takada, M (reprint author), Ajinomoto Pharmaceut CO Ltd, Chuo Ku, 1-1,Irifune2 Chome, Tokyo 1040042, Japan.	michihiro_takada@ajinomoto.com					Makubate B, 2010, STAT MED, V29, P3203, DOI 10.1002/sim.3981; MANTEL N, 1959, J NATL CANCER I, V22, P719; HAUCK WW, 1991, J CLIN EPIDEMIOL, V44, P77, DOI 10.1016/0895-4356(91)90203-L; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Nason M, 2010, BIOMETRICS, V66, P958, DOI 10.1111/j.1541-0420.2009.01358.x; Cohlen BJ, 1998, HUM REPROD, V13, P1553, DOI 10.1093/humrep/13.6.1553; Cohlen BJ, 1998, FERTIL STERIL, V70, P40, DOI 10.1016/S0015-0282(98)00114-9; DUBEY S D, 1986, Clinical Research Practices and Drug Regulatory Affairs, V4, P127, DOI 10.3109/10601338609051233; Gregoriou O, 1996, EUR J OBSTET GYN R B, V64, P213, DOI 10.1016/0301-2115(95)02280-5; Guidance for Industry Clinical Investigators Institutional Review Boards and Food and Drug Administration Staff, 2013, GUID IND CLIN INV I; Norman GR, 2000, FERTIL STERIL, V74, P319, DOI 10.1016/S0015-0282(00)00597-5; NULSEN JC, 1993, OBSTET GYNECOL, V82, P780; SATO T, 1990, BIOMETRICS, V46, P71, DOI 10.2307/2531631; SATO T, 1989, BIOMETRICS, V45, P1323; Senns S, 2002, CROSS OVER TRIALS CL, VSecond; Walters WS, 2013, GEN LINEAR MIXED MOD	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-1604	1539-1612		PHARM STAT	Pharm. Stat.	MAY-JUN	2015	14	3					198	204		10.1002/pst.1674		7	Pharmacology & Pharmacy; Statistics & Probability	Pharmacology & Pharmacy; Mathematics	CI0HF	WOS:000354417000005		
J	Yamamoto, A; Hasan, TM; Kodama, K; Shigekawa, N; Kuzuhara, M				Yamamoto, A.; Hasan, T. Md.; Kodama, K.; Shigekawa, N.; Kuzuhara, M.			Thick (similar to 1 mu m) p-type InxGa1-xN (x similar to 0.36) grown by MOVPE at a low temperature (similar to 570 degrees C)	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						annealing; doping; InGaN; magnesium; MOVPE; phase separation	SOLAR-CELLS; INGAN; CHALLENGES	This paper reports the post-growth annealing effects of low-temperature grown Mg-doped InGaN. By using MOVPE, 1 mm-thick Mg-doped InxGa1-xN (x similar to 0.36) films are grown at 570 degrees C. In order to activate the Mg acceptors, grown samples are treated by the conventional furnace annealing (FA) or the rapid thermal annealing (RTA). In the case of the FA at 650 degrees C for 20 min, the InGaN film is phase-separated. On the other hand, the RTA at a temperature higher than 700 degrees C enables us to get p-type samples. By using the RTA at 850 for 20 s, p-type samples with a hole concentration 10(18) - 10(19) cm(-3) are successfully obtained without phase separation. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Yamamoto, A.; Hasan, T. Md.; Kodama, K.; Kuzuhara, M.] Univ Fukui, Fukui 9108507, Japan; [Yamamoto, A.; Hasan, T. Md.] Univ Fukui, Fukui 9108507, Japan; [Shigekawa, N.] Osaka City Univ, Osaka 5588585, Japan	Yamamoto, A (reprint author), Univ Fukui, 3-9-1 Bunkyo, Fukui 9108507, Japan.	ayamamot@u-fukui.ac.jp			"Creative research for clean energy generation using solar energy" project in Core Research for Evolutionary Science and Technology (CREST) programs of JST, Japan	This work was supported in part by "Creative research for clean energy generation using solar energy" project in Core Research for Evolutionary Science and Technology (CREST) programs of JST, Japan.	Chang CA, 2007, JPN J APPL PHYS 1, V46, P2840, DOI 10.1143/JJAP.46.2840; Kumakura K, 2003, J APPL PHYS, V93, P3370, DOI 10.1063/1.1545155; Bhuiyan AG, 2012, IEEE J PHOTOVOLT, V2, P276, DOI 10.1109/JPHOTOV.2012.2193384; Pantha BN, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3279149; NAKAMURA S, 1992, JPN J APPL PHYS 2, V31, pL139, DOI 10.1143/JJAP.31.L139; Billen K., 1997, SEMICOND SCI TECH, V12, P1271; Makimoto T, 2001, APPL PHYS LETT, V79, P380, DOI 10.1063/1.1387261; Tuna O, 2013, J CRYST GROWTH, V370, P2, DOI 10.1016/j.jcrysgro.2012.09.055; Wang H, 2009, CHINESE PHYS LETT, V26; Yamamoto A., 2013, Materials For Renewable and Sustainable Energy, V2, DOI 10.1007/s40243-013-0010-5; Yamamoto A, 2010, PHYS STATUS SOLIDI C, V7, P1309, DOI 10.1002/pssc.200983106; Yamamoto A, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.035502; Yamamoto A., 2014, 14 INT WORKSH NITR S	13	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		909	912		10.1002/pssb.201451736		4	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300008		
J	Kataoka, K; Kanechika, M; Narita, T; Kimoto, Y; Uedono, A				Kataoka, Keita; Kanechika, Masakazu; Narita, Tetsuo; Kimoto, Yasuji; Uedono, Akira			Positron annihilation and cathodoluminescence study on inductively coupled plasma etched GaN	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						cathodoluminescence; defects; GaN; plasma etching; positron annihilation	ETCHING-INDUCED DAMAGE; SPECTROSCOPY	Etching damage induced by inductively coupled plasma (ICP) with a mixture of Cl-2 and BCl3 gases and the effect of subsequent annealing in N-2 were studied through positron annihilation and cathodoluminescence (CL) for Mg-doped and Si-doped GaN. The changes in the concentration of nonradiative defects and in the shape of band bending caused by ICP etching or subsequent annealing were studied by comparing the CL intensities and the diffusion lengths of implanted positrons, respectively. For Mg-doped GaN, CL spectra revealed that etching inactivated the Mg acceptors at the near-surface region. After annealing at 900 degrees C, the Mg acceptors were reactivated. For Si-doped GaN, etching introduced neutral vacancy-type defects, and after annealing at 900 degrees C, the etching-induced defects almost disappeared. However, there were residual nonradiative defects on the top surface that were associated with a change in the surface's Fermi level position. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kataoka, Keita; Kanechika, Masakazu; Narita, Tetsuo; Kimoto, Yasuji] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 48011, Japan; [Uedono, Akira] Univ Tsukuba, Div Appl Phys, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan	Kataoka, K (reprint author), Toyota Cent Res & Dev Labs Inc, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	e1354@mosk.tytlabs.co.jp					Reshchikov MA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1868059; KHAN MA, 1993, APPL PHYS LETT, V63, P1214; Choi KJ, 2003, APPL PHYS LETT, V82, P1233, DOI 10.1063/1.1557316; Uedono A, 2001, J APPL PHYS, V90, P181, DOI 10.1063/1.1372163; Aoki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NH03; Cheung R, 2003, J VAC SCI TECHNOL B, V21, P1268, DOI 10.1116/1.1575249; Cho HK, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155314; Coleman P. G., 2000, POSITRON BEAMS THEIR; Han YJ, 2003, JPN J APPL PHYS 1, V42, P6409, DOI 10.1143/JJAP.42.6409; Kataoka K, 2012, SURF INTERFACE ANAL, V44, P709, DOI 10.1002/sia.3876; Kato M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2908227; Krause-Rehberg R., 1999, SOLID STATE SCI, V127; Narita T, 2011, PHYS STATUS SOLIDI A, V208, P1541, DOI 10.1002/pssa.201000952; Pearton S. J., 1998, SEMICONDUCTOR SEMIME, V50; Rawal DS, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4868616; Suzuki R, 1998, JPN J APPL PHYS 1, V37, P4636, DOI 10.1143/JJAP.37.4636; Uedono A, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675516; Watanabe H, 2007, JPN J APPL PHYS 1, V46, P35, DOI 10.1143/JJAP.46.35	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		913	916		10.1002/pssb.201451498		4	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300009		
J	Yoshida, H; Hikosaka, T; Nago, H; Nunoue, S				Yoshida, Hisashi; Hikosaka, Toshiki; Nago, Hajime; Nunoue, Shinya			Impact of dislocations and defects on the relaxation behavior of InGaN/GaN multiple quantum wells grown on Si and sapphire substrates	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						defects; dislocations; GaN; InGaN; lattice mismatch; multiple quantum wells	VAPOR-PHASE EPITAXY; GAN; THICKNESS; LAYER	We investigated the relaxation behavior of InGaN/GaN blue multiple quantum wells (MQWs) grown on Si (111) and sapphire (0001) substrates to determine how the threading dislocation density (TDD) in the underlying GaN layer, the thickness of the MQWs, and the growth substrate (Si or sapphire) affect the relaxation behavior of MQWs. The results demonstrate that the value of the in-plane lattice parameter difference between MQWs and GaN (IPLDMQWs-GaN) is strongly dependent on the TDD in the underlying GaN layer. The thickness of the InGaN well layer has the greatest effect on the IPLDMQWs-GaN value of the blue MQW structure: a thin InGaN well layer with high In content is more effective than a thick InGaN well layer with low In content for obtaining high-quality blue MQWs without misfit dislocations (MDs). Furthermore, MQWs grown on Si are likely to contain MDs and unlikely to form V-defects, whereas the opposite tendency is true of MQWs grown on sapphire. Using threading dislocations, MDs, and V-defects, we propose relaxation mechanisms for MQWs grown on Si (111) and sapphire (0001) substrates. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Yoshida, Hisashi; Hikosaka, Toshiki; Nago, Hajime; Nunoue, Shinya] Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, Kawasaki, Kanagawa 2128582, Japan	Yoshida, H (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, 1 Komukai Toshiba Cho, Kawasaki, Kanagawa 2128582, Japan.	hisashi8.yoshida@toshiba.co.jp					Feltin E, 2001, APPL PHYS LETT, V79, P3230, DOI 10.1063/1.1415043; PEOPLE R, 1985, APPL PHYS LETT, V47, P322, DOI 10.1063/1.96206; Tomiya S, 2010, P IEEE, V98, P1208, DOI 10.1109/JPROC.2009.2032306; Lee SR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1947367; Leyer M, 2008, J CRYST GROWTH, V310, P4913, DOI 10.1016/j.jcrysgro.2008.08.021; Wu XH, 1998, APPL PHYS LETT, V72, P692, DOI 10.1063/1.120844; Holec D, 2008, J APPL PHYS, V104, DOI 10.1063/1.3033553; MATTHEWS JW, 1974, J CRYST GROWTH, V27, P118, DOI 10.1016/S0022-0248(74)80055-2; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Dadgar A, 2000, JPN J APPL PHYS 2, V39, pL1183, DOI 10.1143/JJAP.39.L1183; Harada Y., 2012, P SOC PHOTO-OPT INS, V8278; Hikosaka T, 2014, PHYS STATUS SOLIDI C, V11, P617, DOI 10.1002/pssc.201300441; Ishikawa A., 1999, PHYS STATUS SOLIDI A, V176, P599; Kimura S., 2011, P SOC PHOTO-OPT INS, V7937	14	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		917	922		10.1002/pssb.201451585		6	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300010		
J	Kamata, N; Islam, AZMT; Julkarnain, M; Murakoshi, N; Fukuda, T; Hirayama, H				Kamata, N.; Islam, A. Z. M. Touhidul; Julkarnain, M.; Murakoshi, N.; Fukuda, T.; Hirayama, H.			Nonradiative centers in deep-UV AlGaN-based quantum wells revealed by two-wavelength excited photoluminescence	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						AlGaN; nonradiative recombination centers; photoluminescence; quantum wells; two-wavelength excitation	HIGH-QUALITY ALN; RECOMBINATION CENTERS; GAP; SPECTROSCOPY; SAPPHIRE; EMISSION; STATES	We have succeeded in detecting nonradiative recombination (NRR) centers in InAlGaN multiple quantum wells (MQWs) for the sterilization wavelength at around 265 nm by our scheme of two-wavelength excited photoluminescence (PL). Samples studied are InAlGaN multiple quantum well structures with InAlGaN electron blocking layer grown on sapphire (0001) substrates by metal-organic chemical vapor deposition (MOCVD) technique at the growth temperature of 880 degrees C (sample A) and 920 degrees C (sample B). The MQW consists of three InAlGaN wells of 2 nm sandwiched by 7 nm InAlGaN barrier layers. With the addition of the below-gap excitation (BGE) light of 1.17 eV, the PL intensity decreased for the sample A but increased for the sample B. Both change in the PL intensity implies the existence of NRR centers, which were activated by the BGE. We attribute both intensity change to two-levels model and one level model, respectively. Based on rate equation analysis, a set of NRR parameters of sample B was determined by utilizing a saturating tendency of the PL intensity change. Spectroscopic and quantitative advantages of the method enable us to clarify energy distribution of NRR centers without providing electrode. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kamata, N.; Julkarnain, M.; Murakoshi, N.; Fukuda, T.] Saitama Univ, Dept Funct Mat Sci, Sakura Ku, Saitama 3388570, Japan; [Islam, A. Z. M. Touhidul; Julkarnain, M.] Rajshahi Univ, Fac Engn, Rajshahi 6205, Bangladesh; [Hirayama, H.] RIKEN, Ctr Adv Photon, Wako, Saitama 3510198, Japan	Kamata, N (reprint author), Saitama Univ, Dept Funct Mat Sci, Sakura Ku, 255 Shimo Ohkubo, Saitama 3388570, Japan.	kamata@fms.saitama-u.ac.jp	Fukuda, Takeshi/G-8647-2011		JSPS KAKENHI [24360005]; MEXT Frontier Photonics Project in Saitama University	The work was supported by JSPS KAKENHI Grant Number 24360005 and MEXT Frontier Photonics Project in Saitama University.	Calleja E, 1997, PHYS REV B, V55, P4689, DOI 10.1103/PhysRevB.55.4689; HALL RN, 1952, PHYS REV, V87, P387, DOI 10.1103/PhysRev.87.387; Hirayama H, 2008, PHYS STATUS SOLIDI C, V5, P2283, DOI 10.1002/pssc.200778697; Hirayama H, 2009, PHYS STATUS SOLIDI A, V206, P1176, DOI 10.1002/pssa.200880961; Armstrong AM, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032101; KANOH E, 1995, J LUMIN, V63, P235, DOI 10.1016/0022-2313(94)00084-P; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Bebb H. B., 1972, SEMICONDUCT SEMIMET, V8; Chen IJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360221; EDMONDS HD, 1973, APPL PHYS LETT, V23, P382, DOI 10.1063/1.1654927; GRIMMEIS.HG, 1973, PHYS STATUS SOLIDI A, V19, P505, DOI 10.1002/pssa.2210190214; Hirayama H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2770662; Hoshino K, 1998, J LUMIN, V79, P39, DOI 10.1016/S0022-2313(98)00017-9; Islam A. Z. M. T., 2013, P INT C NITR SEM; Islam AZMT, 2014, PHYS STATUS SOLIDI C, V11, P832, DOI 10.1002/pssc.201300405; Kamata N., 1999, QUANTUM ELECTRON, V1, P123; Kim JW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200392; Ocampo JMZ, 2001, PHYS STATUS SOLIDI A, V183, P189, DOI 10.1002/1521-396X(200101)183:1<189::AID-PSSA189>3.0.CO;2-5; Ocampo JMZ, 2000, J LUMIN, V87-9, P363; Ogawa H, 2008, PHYS STATUS SOLIDI C, V5, P2929, DOI 10.1002/pssc.200779245; TAJIMA M, 1984, JPN J APPL PHYS 2, V23, pL690, DOI 10.1143/JJAP.23.L690	21	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		936	939		10.1002/pssb.201451582		4	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300013		
J	Murotani, H; Yamada, Y; Honda, Y; Amano, H				Murotani, Hideaki; Yamada, Yoichi; Honda, Yoshio; Amano, Hiroshi			Excitation density dependence of radiative and nonradiative recombination lifetimes in InGaN/GaN multiple quantum wells	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						charge carrier lifetimes; charge carrier recombination; InGaN; multiquantum wells; quantum efficiency; time-resolved photoluminescence	ELASTIC PROPERTIES; INN; GAN; ALN; POLARIZATION; CONSTANTS; NITRIDES; GALLIUM; ALLOYS	The optical properties of InGaN/GaN multiple quantum wells (MQWs) have been studied by means of photoluminescence (PL) and time-resolved photoluminescence (TRPL) spectroscopy. The radiative and nonradiative recombination lifetimes were evaluated as a function of the excitation energy density. The radiative recombination lifetime decreased and subsequently reached a nearly constant value with increasing excitation energy density, which was attributed to screening of internal electric fields by photoexcited carriers. On the other hand, the nonradiative recombination lifetime increased and subsequently decreased with increasing excitation energy density. The initial increase in the nonradiative recombination lifetime could be attributed to saturation of nonradiative recombination centers with photoexcited carriers. The nonradiative recombination lifetime was found to decrease to a considerably weaker extent than that expected for the Auger recombination process of free carriers. This indicated that the decrease in the internal quantum efficiency (IQE) at high carrier densities could not be explained only by the Auger recombination process of free carriers. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Murotani, Hideaki] Toyota Natl Coll Technol, Dept Elect & Elect Engn, Toyota, Aichi 4718525, Japan; [Yamada, Yoichi] Yamaguchi Univ, Dept Mat Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Honda, Yoshio; Amano, Hiroshi] Nagoya Univ, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Murotani, H (reprint author), Toyota Natl Coll Technol, Dept Elect & Elect Engn, 2-1 Eisei Cho, Toyota, Aichi 4718525, Japan.	murotani@toyota-ct.ac.jp					Xie JQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988324; Murotani H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4825124; Yeo YC, 1998, J APPL PHYS, V83, P1429, DOI 10.1063/1.366847; Kim MH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2800290; Verzellesi G, 2013, J APPL PHYS, V114, DOI 10.1063/1.4816434; Kohno T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.072102; Chow WW, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3490232; David A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3330870; Wei SH, 1996, APPL PHYS LETT, V69, P2719, DOI 10.1063/1.117689; Lin GB, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704366; BARKER AS, 1973, PHYS REV B, V7, P743, DOI 10.1103/PhysRevB.7.743; Murotani H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739431; Schubert MF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963029; Iveland J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177406; Hader J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446889; Langer T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4830366; Malyutenko VK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529470; Nanishi Y, 2003, JPN J APPL PHYS 1, V42, P2549, DOI 10.1143/JJAP.42.2549; Hader J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658031; CHIN VWL, 1994, J APPL PHYS, V75, P7365, DOI 10.1063/1.356650; Watanabe S, 2003, APPL PHYS LETT, V83, P4906, DOI 10.1063/1.1633672; Hammersley S, 2012, J APPL PHYS, V111, DOI 10.1063/1.3703062; Wright AF, 1997, J APPL PHYS, V82, P2833, DOI 10.1063/1.366114; Wang CH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507891; [Anonymous], 2001, J APPL PHYS; Kioupakis E, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3570656; Miyajima T, 2002, PHYS STATUS SOLIDI B, V234, P801, DOI 10.1002/1521-3951(200212)234:3<801::AID-PSSB801>3.0.CO;2-W; Delaney KT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133359; Shimada K, 1998, J APPL PHYS, V84, P4951, DOI 10.1063/1.368739; Wang JX, 2012, J APPL PHYS, V112, DOI 10.1063/1.4736591; Schubert MF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2822442; Monemar B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801704; Leroux M, 1998, PHYS REV B, V58, P13371; Shen YC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2785135; Kioupakis E, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241201; Kalliakos S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.205307; Bernardini F, 1997, PHYS REV B, V56, P10024; Cao XA, 2008, J APPL PHYS, V104, DOI 10.1063/1.3009967; Davies MJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4781398; Nakamura S, 2000, BLUE LASER DIODE; Ni X., 2008, APPL PHYS LETT, V93; Wu J, 2003, PHYS STATUS SOLIDI B, V240, P412, DOI [10.1002/pssb.200303475, 10.1002/pssb.2003030475]; Xu JR, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3058687; Yamaguchi M, 1997, J PHYS-CONDENS MAT, V9, P241, DOI 10.1088/0953-8984/9/1/025	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		940	945		10.1002/pssb.201451491		6	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300014		
J	Julkarnain, M; Murakoshi, N; Islam, AZMT; Fukuda, T; Kamata, N; Arakawa, Y				Julkarnain, M.; Murakoshi, N.; Islam, A. Z. M. Touhidul; Fukuda, T.; Kamata, N.; Arakawa, Y.			Dominant nonradiative centers in InGaN single quantum well by time-resolved and two-wavelength excited photoluminescence	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						InGaN; nonradiative recombination; photoluminescence; quantum wells	LIGHT-EMITTING-DIODES; LEVEL TRANSIENT SPECTROSCOPY; RECOMBINATION CENTERS; GAAS; GAP	The nonradiative recombination processes in undoped InGaN single quantum well (SQW) grown by MOCVD method have been studied by time-resolved and two-wavelength excited photoluminescence. External quantum efficiency and carrier recombination lifetime decreases with increasing the excitation density which can be explained by an enhanced nonradiative recombination rate. A dominant nonradiative center with an optical activation energy of around 1.17 eV has been detected inside and/or hetero-interface of SQW, which might be an important clue for determining their origin and eliminating them during growth process. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Julkarnain, M.; Murakoshi, N.; Fukuda, T.; Kamata, N.] Saitama Univ, Dept Funct Mat Sci, Sakura Ku, Saitama 3388570, Japan; [Julkarnain, M.; Islam, A. Z. M. Touhidul] Rajshahi Univ, Fac Engn, Rajshahi 6205, Bangladesh; [Arakawa, Y.] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Julkarnain, M (reprint author), Saitama Univ, Dept Funct Mat Sci, Sakura Ku, 255 Shimo Ohkubo, Saitama 3388570, Japan.	s13ds053@mail.saitama-u.ac.jp; kamata@fms.saitama-u.ac.jp	Fukuda, Takeshi/G-8647-2011		JSPS KAKENHI [24360005, 25600087]; MEXT Frontier Photonics Project in Saitama University	The work was supported by JSPS KAKENHI Grant Number 24360005, 25600087 and MEXT Frontier Photonics Project in Saitama University.	CHANTRE A, 1981, PHYS REV B, V23, P5335, DOI 10.1103/PhysRevB.23.5335; Crawford MH, 2009, IEEE J SEL TOP QUANT, V15, P1028, DOI 10.1109/JSTQE.2009.2013476; Armstrong AM, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032101; KANOH E, 1995, J LUMIN, V63, P235, DOI 10.1016/0022-2313(94)00084-P; Armstrong A, 2012, OPT EXPRESS, V20, pA812, DOI 10.1364/OE.20.00A812; Chen IJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360221; EDMONDS HD, 1973, APPL PHYS LETT, V23, P382, DOI 10.1063/1.1654927; Evans DL, 1997, P SOC PHOTO-OPT INS, V3002, P142, DOI 10.1117/12.271036; GRIMMEIS.HG, 1973, PHYS STATUS SOLIDI A, V19, P505, DOI 10.1002/pssa.2210190214; Hsueh H. H., 2014, INT J PHOTOENERGY, DOI [10.1155/2014/796253, DOI 10.1155/2014/796253.(2014)]; Islam AZMT, 2014, PHYS STATUS SOLIDI C, V11, P832, DOI 10.1002/pssc.201300405; Kamata N., 1999, QUANTUM ELECTRON, V1, P123; Kim EK, 2006, J KOREAN PHYS SOC, V49, P2132; Kim JW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200392; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Ocampo JMZ, 2001, PHYS STATUS SOLIDI A, V183, P189, DOI 10.1002/1521-396X(200101)183:1<189::AID-PSSA189>3.0.CO;2-5; Ocampo JMZ, 2000, J LUMIN, V87-9, P363; Ogawa H, 2008, PHYS STATUS SOLIDI C, V5, P2929, DOI 10.1002/pssc.200779245; Rivera C., 2006, PHYS STATUS SOLIDI C, V6, P1978; Shon JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05325; Sobolev MM, 2009, PHYSICA B, V404, P4907, DOI 10.1016/j.physb.2009.08.268; TAJIMA M, 1984, JPN J APPL PHYS 2, V23, pL690, DOI 10.1143/JJAP.23.L690	22	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		952	955		10.1002/pssb.201451499		4	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300016		
J	Ito, T; Nunoue, S				Ito, Toshihide; Nunoue, Shinya			Schottky barrier height modulation at metal/n-GaN interface by BCl3/Ar plasma treatment	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						BCl3; GaN; Fermi-level pinning; plasma treatment; Schottky barrier height; X-ray photoelectron spectroscopy	N-GAN; DIODES; HEMTS	When n-GaN surface is treated by BCl3/Ar plasma, the Schottky barrier height (SBH) of Pt, Ni, or Ag/n-GaN is decreased, whereas that of Al/n-GaN is increased. The slope parameter is decreased by the BCl3/Ar plasma treatment, indicating that the Fermi-level pinning is strengthened and the SBH is modulated. From the secondary ion mass spectrometry and X-ray photoelectron spectroscopy measurements, it is assumed that the strong Fermi-level pinning is due to the interface states related to oxidized B. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Ito, Toshihide; Nunoue, Shinya] Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, Kawasaki, Kanagawa 2128582, Japan	Ito, T (reprint author), Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, 1 Komukai Toshiba Cho, Kawasaki, Kanagawa 2128582, Japan.	toshihide1.ito@toshiba.co.jp					Fujishima T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819334; NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL797, DOI 10.1143/JJAP.34.L797; Teraji T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.035312; Laubsch A, 2010, IEEE T ELECTRON DEV, V57, P79, DOI 10.1109/TED.2009.2035538; Fan ZF, 1996, APPL PHYS LETT, V68, P1672, DOI 10.1063/1.115901; Cich MJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769228; Kikkawa T, 2009, PHYS STATUS SOLIDI A, V206, P1135, DOI 10.1002/pssa.200880983; Lin YJ, 2003, J APPL PHYS, V94, P1819, DOI 10.1063/1.1591417; Rhoderick E. H., 1988, METAL SEMICONDUCTOR, P99; SCHLUTER M, 1978, PHYS REV B, V17, P5044, DOI 10.1103/PhysRevB.17.5044; Sze S. M., 1981, PHYSICS SEMICONDUCTO, V2nd, P304; Tung RT, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4858400; Yu HJ, 2005, IEEE ELECTR DEVICE L, V26, P283, DOI 10.1109/LED.2005.846583	14	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1011	1016		10.1002/pssb.201451577		6	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300027		
J	Yamamoto, S; Kihara, Y; Shiojima, K				Yamamoto, Shingo; Kihara, Yuhei; Shiojima, Kenji			Mapping of inhomogeneity and thermal degradation of Au/Ni/n-GaN Schottky diodes using scanning internal photoemission microscopy	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						Schottky contacts; GaN; internal photoemission; gold; nickel	N-GAN; CONTACTS; STABILITY; VOLTAGE	We have developed a new mapping technique, termed scanning internal-photoemission microscopy, to characterize the electrical inhomogeneity of metal-semiconductor interfaces. We characterized the initial stage of thermal degradation of Au/Ni/n-GaN Schottky contacts. We found that, upon 400 degrees C annealing, a partial thermal degradation occurred from a scratch on the dot, where Au atoms diffused to the interface and reacted with GaN. When the top Au layer was partially missing, upon annealing, the Ni surface was oxidized and NiOx/n-GaN with a small Schottky barrier height was formed. In addition, a thin contamination layer at the interface was clearly observed as a pattern. It was confirmed that this method is a powerful tool to map metal contacts for the investigations of partial thermal degradation, formation of parallel contacts, and inhomogeneity of surface chemistry. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Yamamoto, Shingo; Kihara, Yuhei; Shiojima, Kenji] Univ Fukui, Grad Sch Elect & Elect Engn, Fukui 9108507, Japan	Shiojima, K (reprint author), Univ Fukui, Grad Sch Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	shiojima@u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology	Acknowledgements Apart of this work was supported by a Grant-in-Aid for Scientific Reserch C from the Ministry of Education, Culture, Sports, Science, and Technology.	Hatakeyama Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.028007; Makaram P, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3446869; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Liu QZ, 1998, J APPL PHYS, V84, P881, DOI 10.1063/1.368151; Sheu JK, 1999, APPL PHYS LETT, V74, P2340, DOI 10.1063/1.123844; Dobos L, 2006, APPL SURF SCI, V253, P655, DOI 10.1016/j.apsusc.2005.12.167; Kanechika M, 2007, JPN J APPL PHYS 2, V46, pL503, DOI 10.1143/JJAP.46.L503; del Alamo JA, 2009, MICROELECTRON RELIAB, V49, P1200, DOI 10.1016/j.microrel.2009.07.003; Yang HM, 2008, J ALLOY COMPD, V459, P98, DOI 10.1016/j.jallcom.2007.04.258; Guo JD, 1996, J APPL PHYS, V80, P1623, DOI 10.1063/1.363822; Ishikawa H, 1997, J APPL PHYS, V81, P1315, DOI 10.1063/1.363912; Saitoh Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.081001; Joh J, 2011, IEEE T ELECTRON DEV, V58, P132, DOI 10.1109/TED.2010.2087339; Bandic ZZ, 1999, APPL PHYS LETT, V74, P1266, DOI 10.1063/1.123520; NEWMAN R, 1959, PHYS REV, V114, P1507, DOI 10.1103/PhysRev.114.1507; Bell L. D., 1998, J VAC SCI TECHNOL B, V16, P4; Chen GL, 2002, APPL PHYS LETT, V80, P595, DOI 10.1063/1.1425455; Joh J, 2011, MICROELECTRON RELIAB, V51, P201, DOI 10.1016/j.microrel.2010.08.021; OKUMURA T, 1989, JPN J APPL PHYS 2, V28, pL1108; Shiojima K., 1989, J CRYST GROWTH, V103, P234; Shiojima K., 1991, P 29 ANN INT REL PHY, P234; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P245; Toshihiro O., 2012, MRS SPRING M; Venugopalan HS, 1997, J APPL PHYS, V82, P650, DOI 10.1063/1.365593	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1017	1023		10.1002/pssb.201451579		7	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300028		
J	Naganawa, M; Aoki, T; Son, JS; Amano, H; Shiojima, K				Naganawa, Moe; Aoki, Toshichika; Son, Ji-Su; Amano, Hiroshi; Shiojima, Kenji			Electrical characteristics of a-plane low-Mg-doped p-GaN Schottky contacts	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						doping; GaN; magnesium; Schottky contacts	LIGHT-EMITTING-DIODES; VAPOR-PHASE EPITAXY; OHMIC CONTACTS; QUANTUM-WELLS; SURFACE-TREATMENT; GALLIUM NITRIDE; LOW-RESISTANCE; LASER-DIODES; SAPPHIRE; SINGLE	Electrical characteristics of a variety of Schottky contacts formed with ten metal species on the a-plane of p-type low-Mg-doped GaN grown on r-plane sapphire substrates were studied. We found that while current-voltage characteristics obtained under voltage scanning show no memory effect in samples formed on a-plane samples on c-plane showed a substantial memory effects. We consider that the absence of memory effect in the a-plane p-GaN samples is originating from a smaller density of interfacial defect than that in the c-plane p-GaN samples. In internal photoemission spectra, we observed two linearly increasing portions suggesting two different Schottky barriers with different heights coexisting in a contact. A potential barrier corresponding to a linear increase locating at lower photon energy typically ranged between 1.6 and 2.5 eV; and that corresponding to another linear increase locating at higher energy ranged between 0.7 and 1.7. The barrier heights showed no relevance to metal work function. The a-plane GaN surface was found to reveal a lamellar structure with stripes along [0001] direction with a randomly oriented roughness. We thus speculate that contact barrier spatially varies according to the different crystal plane. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Naganawa, Moe; Aoki, Toshichika; Shiojima, Kenji] Univ Fukui, Grad Sch Elect & Elect Engn, Fukui 9018507, Japan; [Son, Ji-Su; Amano, Hiroshi] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shiojima, K (reprint author), Univ Fukui, Grad Sch Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9018507, Japan.	shiojima@u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology	A part of this work was supported by a Grant-in-Aid for Scientific Research C from the Ministry of Education, Culture, Sports, Science, and Technology.	AMANO H, 1991, MAT RES SOC EXT ABST, V21, P165; NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL797, DOI 10.1143/JJAP.34.L797; Sawada T, 2000, APPL SURF SCI, V159, P449, DOI 10.1016/S0169-4332(00)00060-X; Craven MD, 2002, APPL PHYS LETT, V81, P469, DOI 10.1063/1.1493220; Haskell BA, 2005, J ELECTRON MATER, V34, P357, DOI 10.1007/s11664-005-0110-9; Chichibu S, 1996, APPL PHYS LETT, V69, P4188, DOI 10.1063/1.116981; Schmidt MC, 2007, JPN J APPL PHYS 2, V46, pL126, DOI 10.1143/JJAP.46.L126; Jang JS, 1999, J VAC SCI TECHNOL B, V17, P2667, DOI 10.1116/1.591045; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Akasaki I, 1996, ELECTRON LETT, V32, P1105, DOI 10.1049/el:19960743; KHAN MA, 1992, APPL PHYS LETT, V60, P2917, DOI 10.1063/1.106819; Kim JK, 1998, APPL PHYS LETT, V73, P2953, DOI 10.1063/1.122641; AMANO H, 1990, J ELECTROCHEM SOC, V137, P1639, DOI 10.1149/1.2086742; Fichtenbaum NA, 2008, J CRYST GROWTH, V310, P1124, DOI 10.1016/j.jcrysgro.2007.12.051; Shiojima K, 1999, APPL PHYS LETT, V74, P1936, DOI 10.1063/1.123733; Haskell BA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866225; Schmidt MC, 2007, JPN J APPL PHYS 2, V46, pL190, DOI 10.1143/JJAP.46.L190; Okamoto K, 2007, JPN J APPL PHYS 2, V46, pL187, DOI 10.1143/JJAP.46.L187; Funato M, 2006, JPN J APPL PHYS 2, V45, pL659, DOI 10.1143/JJAP.45.L659; Song JO, 2010, IEEE T ELECTRON DEV, V57, P42, DOI 10.1109/TED.2009.2034506; Takeuchi T, 1997, JPN J APPL PHYS 2, V36, pL382, DOI 10.1143/JJAP.36.L382; Chitnis A, 2004, APPL PHYS LETT, V84, P3663, DOI 10.1063/1.1738938; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112; Tadatomo K, 2001, PHYS STATUS SOLIDI A, V188, P121, DOI 10.1002/1521-396X(200111)188:1<121::AID-PSSA121>3.0.CO;2-G; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; Shiojima K, 2000, APPL PHYS LETT, V77, P4353, DOI 10.1063/1.1332981; Chen CQ, 2003, JPN J APPL PHYS 2, V42, pL818, DOI 10.1143/JJAP.42.L818; Deguchi T, 1999, JPN J APPL PHYS 2, V38, pL914, DOI 10.1143/JJAP.38.L914; Edgar J. H., 1999, PROPERTIES PROCESSIN, P282; Fukushima Y, 2009, PHYS STATUS SOLIDI C, V6, pS856, DOI 10.1002/pssc.200880857; Iida D, 2009, J CRYST GROWTH, V311, P2887, DOI 10.1016/j.jcrysgro.2009.01.036; Koide Y, 1999, J ELECTRON MATER, V28, P341, DOI 10.1007/s11664-999-0037-7; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Okamoto K, 2006, JPN J APPL PHYS 2, V45, pL1197, DOI 10.1143/JJAP.45.L1197; POWELL RJ, 1969, J APPL PHYS, V40, P5093, DOI 10.1063/1.1657358; Schmitz AC, 1998, J ELECTRON MATER, V27, P255, DOI 10.1007/s11664-998-0396-5; Shin HY, 2009, J CRYST GROWTH, V311, P4167, DOI 10.1016/j.jcrysgro.2009.07.023; Shiojima K, 2002, APPL SURF SCI, V190, P318, DOI 10.1016/S0169-4332(01)00900-X; Son J.-S., 2013, JPN J APPL PHYS, V52; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P245; Takeuchi T, 2000, JPN J APPL PHYS 1, V39, P413, DOI 10.1143/JJAP.39.413; Tsuchiya Y, 2005, JPN J APPL PHYS 2, V44, pL1516, DOI 10.1143/JJAP.44.L1516; Zakharov DN, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235334	43	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1024	1030		10.1002/pssb.201451581		7	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300029		
J	Aoki, T; Tachibana, S; Shiojima, K				Aoki, Toshichika; Tachibana, Sachi; Shiojima, Kenji			Electrical characteristics of low-Mg-doped p-AlGaN and p-InGaN Schottky contacts	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						AlGaN; doping; electrical properties; InGaN; magnesium; Schottky contacts	CAPACITANCE TRANSIENT SPECTROSCOPY; OHMIC CONTACTS; LOW-RESISTANCE; GAN; SURFACE; TEMPERATURES; BARRIERS; DIODES	Electrical characteristics of low-Mg-doped p-Al0.02-0.07Ga0.98-0.93N and p-In0.02Ga0.98N Schottky contacts were investigated. A memory effect was revealed in the current-voltage (I-V) characteristics, which is found also in p-GaN contacts and may be due to charge and discharge of holes to acceptor-type interfacial defects. High-temperature isothermal transient spectroscopy revealed that the defect densities in the Al0.02Ga0.98N and In0.02Ga0.98N samples were nearly half that in the GaN samples. A large reverse current with a memory effect was observed in the In0.02Ga0.98N contacts. It was suggested that current can flow via relatively shallow acceptor-type interfacial defects. For the AlxGa1-xN with x = 0.04 and 0.07, I-V characteristics became leaky. The Schottky barrier heights estimated from the photoresponse experiment were higher than the values estimated from the bandgap by 0.19, 0.21, 0.20, and 0.21 eV for Al0.02Ga0.98N, Al0.04Ga0.96N, Al0.07Ga0.93N, and In0.02Ga0.98N samples, respectively. A probable explanation for such discrepancies may be due to the total charge amount of the interfacial states, which varied the electric field and the barrier lowering. It was found that even though the Al or In content was only as small as 2%, the electrical characteristics of the contacts changed significantly. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Aoki, Toshichika; Tachibana, Sachi; Shiojima, Kenji] Univ Fukui, Grad Sch Elect & Elect Engn, Fukui 9108507, Japan	Aoki, T (reprint author), Univ Fukui, Grad Sch Elect & Elect Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	aoki0529@u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology	A part of this work was supported by a Grant-in-Aid for Scientific Research C from the Ministry of Education, Culture, Sports, Science, and Technology.	Bermudez VM, 2004, SURF SCI, V565, P89, DOI 10.1016/j.susc.2004.06.209; Uedono A, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675270; Uedono A, 2014, ECS TRANSACTIONS, V61, P19, DOI 10.1149/06105.0019ecst; Yu LS, 1998, APPL PHYS LETT, V73, P238, DOI 10.1063/1.121767; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Jang JS, 1999, J VAC SCI TECHNOL B, V17, P2667, DOI 10.1116/1.591045; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Shiojima K, 1999, APPL PHYS LETT, V74, P1936, DOI 10.1063/1.123733; Bermudez VM, 1996, J APPL PHYS, V80, P1190, DOI 10.1063/1.362924; OKUSHI H, 1981, JPN J APPL PHYS, V20, P261; Shiojima K, 2000, APPL PHYS LETT, V77, P4353, DOI 10.1063/1.1332981; Jang JS, 2000, APPL PHYS LETT, V76, P2898, DOI 10.1063/1.126510; Koide Y, 1999, J ELECTRON MATER, V28, P341, DOI 10.1007/s11664-999-0037-7; Mochizuki K, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.024104; Padma R, 2013, SUPERLATTICE MICROST, V56, P64, DOI 10.1016/j.spmi.2012.12.016; Shiojima K, 2002, APPL SURF SCI, V190, P318, DOI 10.1016/S0169-4332(01)00900-X; Shiojima K, 2014, THIN SOLID FILMS, V557, P268, DOI 10.1016/j.tsf.2013.11.031; Shiojima K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JJ08; Sze S, 1981, PHYSICS SEMICONDUCTO, V2, P245; Zhou L, 2000, ELECTRON LETT, V36, P91, DOI 10.1049/el:20000028	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1031	1037		10.1002/pssb.201451590		7	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300030		
J	Scajev, P; Miasojedovas, S; Jarasiunas, K; Hiramatsu, K; Miyake, H; Gil, B				Scajev, Patrik; Miasojedovas, Saulius; Jarasiunas, Kestutis; Hiramatsu, Kazumasa; Miyake, Hideto; Gil, Bernard			Excitation-dependent carrier dynamics in Al-rich AlGaN layers and multiple quantum wells	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						carrier diffusion; carrier recombination; light-induced transient gratings; nitride semiconductors; photoluminescence	ELECTRICAL-PROPERTIES; ALLOYS; PHOTOLUMINESCENCE; EXCITONS; GAN	The combined temporally, spatially and spectrally-resolved optical techniques, namely the photoluminescence, light induced transient grating, and differential reflectivity were used for investigation of excitation-dependent PL efficiency, exciton lifetime, and diffusion coefficient in Si-doped Al-rich multiple quantum wells and epilayers at various temperatures. Novel features of carrier recombination and in-plane diffusion were observed. Low-excitation radiative lifetime of 1-2 ns was found temperature-independent in 80-150 K interval, while it sublinearly decreased with excitation at excess carrier densities above 10(18) cm(-3). The lifetime decrease correlated with the increase of diffusion coefficient, indicating excitation-enhanced delocalization of localized excitons and therefore enhanced capture to nonradiative centers. The droop of photoluminescence efficiency with excitation was the strongest at 80-150K due to strong delocalisation at low-temperatures, while at higher temperatures the thermal activation prevailed in photoluminescence excitation dependence. The photoluminescence efficiency quenching at T>200K provided rather high activation energies of similar to 100 and 160meV for Al-rich multiple quantum wells and epilayers, correspondingly. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Scajev, Patrik; Miasojedovas, Saulius; Jarasiunas, Kestutis] Vilnius Univ, Inst Appl Res, LT-10222 Vilnius, Lithuania; [Hiramatsu, Kazumasa; Miyake, Hideto] Mie Univ, Dept Elect & Elect Engn, Fac Engn, Tsu, Mie 5148507, Japan; [Gil, Bernard] CNRS, Lab Charles Coulomb, UMR 5221, Montpellier, France	Scajev, P (reprint author), Vilnius Univ, Inst Appl Res, Sauletekio Al 9-3, LT-10222 Vilnius, Lithuania.	patrik.scajev@ff.vu.lt			European Social Fund [VP1-3.1-SMM-07-K-02-006]	This work at Vilnius University was supported by the European Social Fund under Project VP1-3.1-SMM-07-K-02-006.	Aleksiejunas R, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862026; Jiang HX, 2002, OPTO-ELECTRON REV, V10, P271; Murotani H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739431; Suzuki T, 2000, JPN J APPL PHYS 2, V39, pL497, DOI 10.1143/JJAP.39.L497; Lefebvre P, 2014, PHYS STATUS SOLIDI A, V211, P765, DOI 10.1002/pssa.201300505; Nam KB, 2002, APPL PHYS LETT, V81, P1038, DOI 10.1063/1.1492316; Klein PB, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466745; Feng SW, 2004, J APPL PHYS, V95, P5388, DOI 10.1063/1.1703828; Fukuyo F, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AF03; Jarasiunas K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4793637; Kurai S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JL07; Levinshtein M.E., 2001, PROPERTIES ADV SEMIC; Li J, 2001, APPL PHYS LETT, V79, P3245, DOI 10.1063/1.1418255; Morkoc H, 2008, HDB NITRIDE SEMICOND; Murotani H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3543631; Murotani H, 2008, PHYS STATUS SOLIDI C, V5, P2274, DOI 10.1002/pssc.200778683; Nam KB, 2003, APPL PHYS LETT, V83, P2787, DOI 10.1063/1.1616199; Rezaei B, 2006, PHYSICA B, V371, P107, DOI 10.1016/j.physb.2005.10.003; Ridley B K, 1999, QUANTUM PROCESSES SE; Sabbah AJ, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.165217; Scajev P, 2013, PHYS STATUS SOLIDI-R, V7, P647, DOI 10.1002/pssr.201307217; Scajev P, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3591173; Shahmohammadi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6251; Trinh XT, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816266	24	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1043	1049		10.1002/pssb.201451479		7	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300032		
J	Shen, XQ; Takahashi, T; Ide, T; Shimizu, M				Shen, X. Q.; Takahashi, T.; Ide, T.; Shimizu, M.			High-quality GaN film and AlGaN/GaN HEMT grown on 4-inch Si(110) substrates by MOCVD using an ultra-thin AlN/GaN superlattice interlayer	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						AlGaN; GaN; high-electron mobility transistors; MOCVD; silicon; superlattices	MOLECULAR-BEAM EPITAXY; VAPOR-PHASE EPITAXY	We report the characterization results of GaN films and AlGaN/GaN heterostructure grown on 4-inch Si(110) substrates by MOCVD using an ultra-thin AlN/GaN superlattice interlayer (SL IL) structure. The structure optimization of the SL IL, characterizations of the GaN film quality and the strain state are carried out. The SL IL is found to play an important role in controlling the strain states in GaN films. A crack-free GaN film up to 2 mu m thick is achieved by inserting one SL IL. High-quality GaN is obtained with the FWHM values of (002) and (102) diffraction peaks from a 2 mu m-thick GaN film being as narrow as 427 arcsec and 665 arcsec, respectively. A flat surface morphology of GaN with monolayer steps is obtained. Based on the SL IL technique, AlGaN/GaN heterostructure is grown with 2DEG mobility and sheet carrier density being similar to 1500 cm(2)/Vs and 1.2 x 10(13) cm(-2). A high-electron-mobility transistor (HEMT) is fabricated and good DC characteristics are demonstrated. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Shen, X. Q.; Takahashi, T.; Ide, T.; Shimizu, M.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Shen, XQ (reprint author), Natl Inst Adv Ind Sci & Technol, Umezono 1-1-1,Cent 2, Tsukuba, Ibaraki 3058568, Japan.	xq-shen@aist.go.jp					Feltin E, 2001, APPL PHYS LETT, V79, P3230, DOI 10.1063/1.1415043; Able A, 2005, J CRYST GROWTH, V276, P415, DOI 10.1016/j.jcrysgro.2004.12.003; Shen XQ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737874; Cordier Y, 2010, J CRYST GROWTH, V312, P2683, DOI 10.1016/j.jcrysgro.2010.06.024; Selvaraj SL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602919; Liu W, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430396; Damilano B, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.121101; Blake AH, 2012, J APPL PHYS, V111, DOI 10.1063/1.3684557; Cordier Y, 2008, IEEE ELECTR DEVICE L, V29, P1187, DOI 10.1109/LED.2008.2005211; Reiher F, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055107; Lu L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3596592; Yamaguchi S, 2001, APPL PHYS LETT, V79, P3062, DOI 10.1063/1.1416169; Reiher F, 2010, J CRYST GROWTH, V312, P180, DOI 10.1016/j.jcrysgro.2009.10.032; Cheng K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928224; Dadgar A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/389; Shen XQ, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JB05; Strite S., 1992, J VAC SCI TECHNOL B, V10, P1238	17	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1075	1078		10.1002/pssb.201451478		4	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300036		
J	Kawamura, T; Imabayashi, H; Maruyama, M; Imade, M; Yoshimura, M; Mori, Y; Morikawa, Y				Kawamura, Takahiro; Imabayashi, Hiroki; Maruyama, Mihoko; Imade, Mamoru; Yoshimura, Masashi; Mori, Yusuke; Morikawa, Yoshitada			First-principles investigation of the GaN growth process in carbon-added Na-flux method	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						carbon; first-principles calculations; GaN; growth	SINGLE-CRYSTALS; DYNAMICS; SODIUM	We hypothesized that a nitrogen transportation process mediated by cyanide (CN) ions causes the observed increase in growth rate by carbon addition in the Na-flux growth of GaN. Using first-principles calculations, we investigated the probability of the nitrogen transportation process from the viewpoint of change of free energy. In addition, to verify whether the CN can separate into N and C atoms, we estimated the C-N bond energy on the GaN crystal surface by the blue-moon method using constrained molecular dynamics simulations. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Kawamura, Takahiro] Mie Univ, Grad Sch Engn, Tsu, Mie 5148507, Japan; [Kawamura, Takahiro; Imabayashi, Hiroki; Maruyama, Mihoko; Imade, Mamoru; Yoshimura, Masashi; Mori, Yusuke; Morikawa, Yoshitada] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kawamura, T (reprint author), Mie Univ, Grad Sch Engn, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	tkawamura@mach.mie-u.ac.jp	Mori, Yusuke/C-3302-2014; Yoshimura, Masashi/N-7222-2013; Maruyama, Mihoko/L-7671-2015; Morikawa, Yoshitada/B-8257-2012				Sprik M, 1998, J CHEM PHYS, V109, P7737, DOI 10.1063/1.477419; Imade M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.075501; Kokalj A, 2003, COMP MATER SCI, V28, P155, DOI 10.1016/S0927-0256(03)00104-6; MORIKAWA Y, 1995, PHYS REV B, V51, P14802, DOI 10.1103/PhysRevB.51.14802; Kawamura F, 2008, J CRYST GROWTH, V310, P3946, DOI 10.1016/j.jcrysgro.2008.06.008; PULHAM RJ, 1983, J NUCL MATER, V115, P239, DOI 10.1016/0022-3115(83)90315-X; CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2; GLOCKLER G, 1951, J CHEM PHYS, V19, P124, DOI 10.1063/1.1747958; Imabayashi H, 2013, SENSOR MATER, V25, P165; Kawahara M, 2007, J CRYST GROWTH, V303, P34, DOI [10.1016/j.jcrysgro.2006.10.211, 10.1016/j.jcryson.2006.10.211]; Kawahara M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2713945; Kawamura T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JA04; Kittel C., 1980, THERMAL PHYSICS, V2nd, P78; Mori Y, 2010, PHYS STATUS SOLIDI A, V207, P1283, DOI 10.1002/pssa.200983482; Morishita M., 2007, THESIS OSAKA U OSAKA; Morishita M, 2005, J CRYST GROWTH, V284, P91, DOI 10.1016/j.jcrysgro.2005.06.034; Yamane H, 1997, CHEM MATER, V9, P413, DOI 10.1021/cm960494s	17	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1084	1088		10.1002/pssb.201451546		5	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300038		
J	Wang, YX; Teramoto, T; Ohkawa, K				Wang, Yaxin; Teramoto, Takashi; Ohkawa, Kazuhiro			Effects of intentional oxygen and carbon doping in MOVPE-grown GaN layers on photoelectric properties	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						deep levels; donors; GaN; impurities; MOVPE; thin films	DEFECTS; HYDROGEN; FILMS; LUMINESCENCE; NITRIDES; EPITAXY; ORIGIN	In order to qualitatively and quantitatively analyze the effects of N source impurity species and concentrations on the properties of epitaxial GaN layers, we intentionally introduced the oxygen-containing species CO and CO2 into GaN layers during growth. Subsequently, we determined the impurities or elements that had a strong effect on the photoelectric properties of the GaN layers and investigated the doping mechanism. The results of this study show that changes in the carrier density are more sensitive to CO2 than to CO. Oxygen as the main donor was found to affect the carrier density and photoluminescence (PL) emission intensities of CO and CO2-doped GaN, and the carbon incorporation efficiency of these molecules was found to be lower than the oxygen incorporation efficiency. In order to obtain ideal epitaxial GaN layers with a reduced carrier density of 10(13) cm(-3), the CO and CO2 concentrations in the ammonia source should be less than 100 ppb (CO) and 10(-1) ppb (CO2). (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Wang, Yaxin; Ohkawa, Kazuhiro] Tokyo Univ Sci, Dept Appl Phys, Tokyo 1258585, Japan; [Teramoto, Takashi] Air Liquide Labs, Tsukuba, Ibaraki 3004247, Japan	Wang, YX (reprint author), Tokyo Univ Sci, Dept Appl Phys, 6-3-1 Niijuku, Tokyo 1258585, Japan.	yaxin.wang@rs.tus.ac.jp; ohkawa@rs.kagu.tus.ac.jp					Reshchikov MA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1868059; Funke HH, 2004, J ELECTRON MATER, V33, P873, DOI 10.1007/s11664-004-0214-7; Liu R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1852085; Xu XL, 2000, APPL PHYS LETT, V76, P152, DOI 10.1063/1.125686; Pearton SJ, 1999, J APPL PHYS, V86, P1, DOI 10.1063/1.371145; Limpijumnong S, 2001, PHYS STATUS SOLIDI B, V228, P303, DOI 10.1002/1521-3951(200111)228:1<303::AID-PSSB303>3.0.CO;2-A; CHUNG BC, 1992, J APPL PHYS, V72, P651, DOI 10.1063/1.351848; Wickenden AE, 2004, J CRYST GROWTH, V260, P54, DOI 10.1016/j.jcrysgro.2003.08.024; Ning XJ, 1996, J MATER RES, V11, P580, DOI 10.1557/JMR.1996.0071; Xu SR, 2010, J CRYST GROWTH, V312, P3521, DOI 10.1016/j.jcrysgro.2010.09.026; Fritze S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3695172; Chien FR, 1996, APPL PHYS LETT, V68, P2678, DOI 10.1063/1.116279; Chtchekine DG, 1999, PHYS REV B, V60, P15980, DOI 10.1103/PhysRevB.60.15980; Hattori AN, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.021001; Lee SG, 1998, J KOREAN PHYS SOC, V32, P188; Neugebauer J, 1996, APPL PHYS LETT, V68, P1829, DOI 10.1063/1.116027; OHKAWA K, 1987, J APPL PHYS, V62, P3216, DOI 10.1063/1.339323; Okada N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.081001; SEIFERT W, 1983, CRYST RES TECHNOL, V18, P383, DOI 10.1002/crat.2170180314; Sun XL, 2002, J APPL PHYS, V91, P6729, DOI 10.1063/1.1454187; Van de Walle CG, 1997, PHYS REV B, V56, P10020; Van de Walle CG, 1998, J CRYST GROWTH, V189, P505, DOI 10.1016/S0022-0248(98)00340-6; Xie JQ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647772	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1116	1120		10.1002/pssb.201451495		5	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300043		
J	Minamikawa, D; Ino, M; Kawai, S; Takeuchi, T; Kamiyama, S; Iwaya, M; Akasaki, I				Minamikawa, Daichi; Ino, Masataka; Kawai, Shunsuke; Takeuchi, Tetsuya; Kamiyama, Satoshi; Iwaya, Motoaki; Akasaki, Isamu			GaIn N-based tunnel junctions with high InN mole fractions grown by MOVPE	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						GaInN; InN; MOVPE; tunnel junctions; transmission line model	TANDEM SOLAR-CELL; VCSELS; APERTURES; DESIGN	We demonstrated low-resistive GaInN-based tunnel junctions with high In mole fractions (over 0.35) grown by metalorganic vapor phase epitaxy (MOVPE). A 2 nm heavily Mg-doped Ga0.6In0.4N/15 nm heavily Si-doped GaN tunnel junction was grown on a standard-sized (310 x 310 mu m(2)) LED. The tunnel junction showed 0.06 V drop at 20 mA (26 A/cm(2)), corresponding to 4 x 10(-3) Omega cm(2) as the resistivity. This result indicates that MOVPE-grown tunnel junctions showed an almost comparable resistivity as conventional p-contact. We also found that the tunnel junction resistivity is decreased to 4 x 10(-4) Omega cm(2) with an increase of current density up to 5 kA/cm(2). A tunneling through midgap states was suggested from forward-biased I-V characteristics of transmission line model test structures with the tunnel junctions. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Minamikawa, Daichi; Ino, Masataka; Kawai, Shunsuke; Takeuchi, Tetsuya; Kamiyama, Satoshi; Iwaya, Motoaki; Akasaki, Isamu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan; [Akasaki, Isamu] Nagoya Univ, Grad Sch Engn, Akasaki Res Ctr, Nagoya, Aichi 4648601, Japan	Takeuchi, T (reprint author), Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.	take@meijo-u.ac.jp			MEXT [25000011, 26286045]; Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities	This work was supported by MEXT-Grants-in-Aid for Scientific Research Specially Promoted Research (#25000011) and Grant-in-Aid for Scientific Research (B) (#26286045), and the Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016.	Ozden I, 2001, APPL PHYS LETT, V79, P2532, DOI 10.1063/1.1410345; SUGIURA H, 1988, JPN J APPL PHYS 1, V27, P269, DOI 10.1143/JJAP.27.269; Ran JX, 2006, MICROELECTRON J, V37, P583, DOI 10.1016/j.mejo.2005.10.001; Krishnamoorthy S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3666862; Krishnamoorthy S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4796041; ESAKI L, 1958, PHYS REV, V109, P603, DOI 10.1103/PhysRev.109.603; AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549; OLSON JM, 1990, APPL PHYS LETT, V56, P623, DOI 10.1063/1.102717; Zhang ZH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4806978; Takamoto T, 1997, APPL PHYS LETT, V70, P381, DOI 10.1063/1.118419; Feezell D, 2005, IEEE PHOTONIC TECH L, V17, P2017, DOI 10.1109/LPT.2005.854357; Feezell D, 2006, IEEE J QUANTUM ELECT, V42, P494, DOI 10.1109/JQE.2006.874007; Jeon S. R., 2001, APPL PHYS LETT, V78, pxxx; Kaga M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JH06; Krishnamoorthy S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3517481; Kuwano Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.08JK12; Kumakura K, 2000, J CRYST GROWTH, V221, P267, DOI 10.1016/S0022-0248(00)00697-7; Mehta M, 2006, IEEE J QUANTUM ELECT, V42, P675, DOI 10.1109/JQE.2006.876713; Minamikawa D., 2013, 6 AS PAC WORKSH WID, pTB4; Wang CS, 2005, J CRYST GROWTH, V277, P13, DOI 10.1016/j.jcrysgro.2004.12.139; Watanabe M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FL06	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1127	1131		10.1002/pssb.201451507		5	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300045		
J	Takeuchi, S; Uchiyama, T; Arauchi, T; Hashimoto, Y; Nakamura, Y; Yamane, K; Okada, N; Tadatomo, K; Sakai, A				Takeuchi, Shotaro; Uchiyama, Toshiro; Arauchi, Takuji; Hashimoto, Yasuhiro; Nakamura, Yoshiaki; Yamane, Keisuke; Okada, Narihito; Tadatomo, Kazuyuki; Sakai, Akira			Thickness and growth condition dependence of crystallinity in semipolar (20-21) GaN films grown on (22-43) patterned sapphire substrates	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						morphology; patterning; sapphire; semipolar GaN; substrates; X-ray diffraction	GALLIUM NITRIDE; X-RAY; TEMPLATE	We have investigated the crystalline morphology such as lattice plane curvature and lattice plane tilting in (20-21) GaN films on (22-43) patterned sapphire substrates (PSS) by using X-ray rocking curve (XRC) measurements. The results of the symmetric XRC for the GaN (20-21) plane showed anisotropic lattice plane curvature between the [-1014] and [-12-10] directions. This is due to the large difference of the thermal expansion coefficient in the [0001] direction between GaN and sapphire. From the results of asymmetric XRC for the GaN (20-22) and (12-31) diffractions, it is found that lattice plane tilting is highly dependent on the film thickness and the growth condition. The -c-plane-suppressed growth process with tuning the V/III ratio for the (20-21) GaN films on the (22-43) PSS is very effective to suppress the generation of basal plane stacking faults as confirmed by TEM analysis. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Takeuchi, Shotaro; Uchiyama, Toshiro; Arauchi, Takuji; Nakamura, Yoshiaki; Sakai, Akira] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Hashimoto, Yasuhiro; Yamane, Keisuke; Okada, Narihito; Tadatomo, Kazuyuki] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan	Takeuchi, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	takeuchi@ee.es.osaka-u.ac.jp	Takeuchi, Shotaro/F-2886-2014; Nakamura, Yoshiaki/H-6852-2013	Takeuchi, Shotaro/0000-0002-3919-9083; 			Zhao YJ, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.082104; LESZCZYNSKI M, 1994, J APPL PHYS, V76, P4909, DOI 10.1063/1.357273; Leung B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4886578; Meisch T, 2014, PHYS STATUS SOLIDI C, V11, P537, DOI 10.1002/pssc.201300396; Liu L, 2002, MAT SCI ENG R, V37, P61, DOI 10.1016/S0927-796X(02)00008-6; Zywietz T, 1998, APPL PHYS LETT, V73, P487, DOI 10.1063/1.121909; Arauchi T, 2014, PHYS STATUS SOLIDI A, V211, P731, DOI 10.1002/pssa.201300461; Arauchi T, 2015, PHYS STATUS SOLIDI B, V252, P1149, DOI 10.1002/pssb.201451564; Bai J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1914956; Enya Y, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.082101; Feng Z., 2012, ELECTROMAGNETIC ANAL, V1, P13; Iida D., 2005, PHYS STATUS SOLIDI A, V204; Imer BM, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172159; Khan DT, 2013, J CRYST GROWTH, V381, P37, DOI 10.1016/j.jcrysgro.2013.07.012; Kucheyev SO, 2000, APPL PHYS LETT, V77, P3373, DOI 10.1063/1.1328047; Miyajima T, 2003, PHYS STATUS SOLIDI B, V240, P285, DOI 10.1002/pssb.200303323; Okada N, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3670046; Yamane K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.035502; Yamane K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.095503; Yamane K, 2014, PHYS STATUS SOLIDI C, V11, P401, DOI 10.1002/pssc.201300484	20	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1142	1148		10.1002/pssb.201451562		7	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300048		
J	Arauchi, T; Takeuchi, S; Hashimoto, Y; Nakamura, Y; Yamane, K; Okada, N; Imai, Y; Kimura, S; Tadatomo, K; Sakai, A				Arauchi, Takuji; Takeuchi, Shotaro; Hashimoto, Yasuhiro; Nakamura, Yoshiaki; Yamane, Keisuke; Okada, Narihito; Imai, Yasuhiko; Kimura, Shigeru; Tadatomo, Kazuyuki; Sakai, Akira			Crystalline property analysis of semipolar (20-21) GaN on (22-43) patterned sapphire substrate by X-ray microdiffraction and transmission electron microscopy	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						semipolar GaN; patterned sapphire substrate; defects; X-ray microdiffraction; transmission electron microscopy	DIFFUSION	We have investigated the microscopic crystalline morphology such as lattice plane tilting and defects in semipolar (20-21) GaN films grown on (22-43) patterned sapphire substrates (PSS) by using position-dependent omega-2 theta map measurement of X-ray microdiffraction (XRMD) combined with transmission electron microscopy (TEM). The results of the position-dependent omega-2 theta map measurement for the GaN (20-21) plane showed periodic variation of the diffraction spot shapes depending on the patterning pitch of the PSS. Broadening of the diffraction spots in the terrace area and single diffraction spots in the grooved one were also observed. These results indicate that the lattice plane tilting of the GaN film depends on the PSS structure and the presence of the defective GaN film on the terrace area where basal plane stacking-fault generation occurred, as confirmed by TEM. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Arauchi, Takuji; Takeuchi, Shotaro; Nakamura, Yoshiaki; Sakai, Akira] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Hashimoto, Yasuhiro; Yamane, Keisuke; Okada, Narihito; Tadatomo, Kazuyuki] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Imai, Yasuhiko; Kimura, Shigeru] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Takeuchi, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	takeuchi@ee.es.osaka-u.ac.jp	Takeuchi, Shotaro/F-2886-2014; Nakamura, Yoshiaki/H-6852-2013; 	Takeuchi, Shotaro/0000-0002-3919-9083; Kimura, Shigeru/0000-0003-1064-7572			Zhao YJ, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.082104; Leung B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4886578; Meisch T, 2014, PHYS STATUS SOLIDI C, V11, P537, DOI 10.1002/pssc.201300396; Zywietz T, 1998, APPL PHYS LETT, V73, P487, DOI 10.1063/1.121909; Romanov AE, 2006, J APPL PHYS, V100, DOI 10.1063/1.2218385; Bai J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1914956; Ebihara K, 2011, SOLID STATE ELECTRON, V60, P26, DOI 10.1016/j.sse.2011.01.017; Enya Y, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.082101; Imai Y, 2010, AIP CONF PROC, V1221, P30, DOI 10.1063/1.3399252; Kato T, 2010, THIN SOLID FILMS, V518, pS147, DOI 10.1016/j.tsf.2009.10.075; Khan DT, 2013, J CRYST GROWTH, V381, P37, DOI 10.1016/j.jcrysgro.2013.07.012; Miyajima T, 2003, PHYS STATUS SOLIDI B, V240, P285, DOI 10.1002/pssb.200303323; Okada N, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3670046; Shen H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3153145; Takeda S, 2006, JPN J APPL PHYS 2, V45, pL1054, DOI 10.1143/JJAP.45.L1054; Yamane K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.035502; Yamane K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.095503; Yamane K, 2014, PHYS STATUS SOLIDI C, V11, P401, DOI 10.1002/pssc.201300484	18	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1149	1154		10.1002/pssb.201451564		6	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300049		
J	Takeuchi, H; Ohtsuka, M; Fukuyama, H				Takeuchi, Hiroto; Ohtsuka, Makoto; Fukuyama, Hiroyuki			Effect of sputtering power on surface characteristics and crystal quality of AlN films deposited by pulsed DC reactive sputtering	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						AlN; crystal structure; sputtering; stress; surfaces; thin films	ALUMINUM NITRIDE; THIN-FILMS; SAPPHIRE SUBSTRATE; GROWTH; LAYERS; AIN	Aluminum nitride (AlN) is a promising material for use as a substrate for AlGaN-based ultraviolet LEDs and piezoelectric devices. Among the sputtering methods, pulsed DC sputtering provides a superior growth rate and dense AlN films because of the promotion of two-dimensional growth. In this study, the effect of sputtering power on surface characteristics, crystal quality, and residual stress of AlN films deposited by pulsed DC reactive sputtering on a nitrided sapphire substrate was investigated. The homoepitaxial growth of AlN films on this substrate gives high crystal quality compared with the use of other substrates such as sapphire or Si for heteroepitaxial growth. Surface damage on the AlN films increased with an increase in sputtering power, leading to a rough surface. At all sputtering powers, c-axis oriented AlN films were obtained in this study. From the difference in lattice constant compared with the AlN bulk, the inplane compressive stress of the AlN sputtered films was confirmed as residual stress. Residual stress in the AlN films was mostly caused by a peening effect rather than a thermal expansion coefficient difference. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Takeuchi, Hiroto; Ohtsuka, Makoto; Fukuyama, Hiroyuki] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan	Fukuyama, H (reprint author), Tohoku Univ, IMRAM, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	fukuyama@tagen.tohoku.ac.jp			Cabinet Office, Government of Japan through Funding Program for Next Generation World-Leading Researchers	This research was funded by the Cabinet Office, the Government of Japan, through its Funding Program for Next Generation World-Leading Researchers.	GERLICH D, 1986, J PHYS CHEM SOLIDS, V47, P437, DOI 10.1016/0022-3697(86)90039-9; Venkataraj S, 2006, THIN SOLID FILMS, V502, P235, DOI 10.1016/j.tsf.2005.07.281; Wu JJ, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.111004; Dubois MA, 1999, APPL PHYS LETT, V74, P3032, DOI 10.1063/1.124055; Wang DY, 1996, J VAC SCI TECHNOL A, V14, P3092, DOI 10.1116/1.580177; Kroncke H, 2008, ACTA PHYS POL A, V114, P1193; THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732; Cheng H, 2003, J CRYST GROWTH, V254, P46, DOI 10.1016/S0022-0248(03)01176-X; SUN CJ, 1994, J APPL PHYS, V75, P3964, DOI 10.1063/1.356017; Cho S, 2011, J CRYST GROWTH, V326, P179, DOI 10.1016/j.jcrysgro.2011.01.092; Fukuyama H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3272692; Kumada T, 2012, PHYS STATUS SOLIDI C, V9, P515, DOI 10.1002/pssc.201100489; MORKOC H, 1994, J APPL PHYS, V76, P1363; Iriarte GF, 2010, MATER RES BULL, V45, P1039, DOI 10.1016/j.materresbull.2010.05.035; Okada N, 2007, J CRYST GROWTH, V298, P349, DOI 10.1016/j.jcrysgro.2006.10.123; Cherng J.S., 2010, VACUUM, V84, P653; Choudhary R. K., 2013, ISRN MAT SCI, V2013; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P462; Dobrovinskaya E. R., 2009, SAPPHIRE MAT MANUFAC, P109; Dobrovinskaya E. R., 2009, SAPPHIRE MAT MANUFAC, P158; Fitzpatrick M. E., 2005, MEASUREMENT GOOD PRA, V52, P14; Kelly P. J., 2000, J VAC SCI TECHNOL A, V18, P6; Martin P. M., 2010, HDB DEPOSITION TECHN, P278; Morkoc H., 2008, HDB NITRIDE SEMICOND, P67; Novak M., 2013, POWDER METALL PROG, V13, P132; Okamoto K, 2005, PHYS STATUS SOLIDI A, V202, pR149, DOI 10.1002/pssa.200521231; STRITE S, 1992, J VAC SCI TECHNOL B, V10, P1237, DOI 10.1116/1.585897	27	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	MAY	2015	252	5			SI		1163	1171		10.1002/pssb.201451599		9	Physics, Condensed Matter	Physics	CH8DV	WOS:000354267300051		
J	Yamamoto, K; Shichiri, H; Uda, A; Yamashita, K; Nishioka, T; Kume, M; Makimoto, H; Nakagawa, T; Hirano, T; Hirai, M				Yamamoto, Kazuhiro; Shichiri, Hiroaki; Uda, Atsushi; Yamashita, Kazuhiko; Nishioka, Tatsuya; Kume, Manabu; Makimoto, Hiroo; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori			Apoptotic Effects of the Extracts of Cordyceps militaris via Erk Phosphorylation in a Renal Cell Carcinoma Cell Line	PHYTOTHERAPY RESEARCH			English	Article						Cordyceps militaris; Erk; RCC; apoptosis	PROLIFERATION; POLYSACCHARIDE; NUCLEOSIDES; INHIBITION; ACTIVATION; PATHWAYS; ARREST	Cordyceps militaris (CM) is gaining attention as a traditional medicinal food, but its molecular biological mechanisms for anti-cancer activity are not identified or clarified. We aimed to elucidate the synthesizing apoptotic effects of CM extracts and to determine the biological effects of CM extract against cordycepin alone in a renal cell carcinoma (RCC) cell line. CM extract showed higher effects of growth inhibition, apoptotic effect, and cell cycle arrest than cordycepin alone. Moreover, CM extract activated extracellular signal-regulated kinase (Erk) highly more than cordycepin alone. We suggest that cordycepin and CM extract induced apoptosis via the activation of Erk dominantly and AMP-activated protein kinase slightly; CM extract has more potent effects on apoptotic effects associated with Erk activation than cordycepin alone. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Yamamoto, Kazuhiro; Uda, Atsushi; Yamashita, Kazuhiko; Nishioka, Tatsuya; Kume, Manabu; Makimoto, Hiroo; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ Hosp, Dept Pharm, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Shichiri, Hiroaki; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Pharmacokinet,Chuo Ku, Kobe, Hyogo 6500017, Japan	Yamamoto, K (reprint author), Kobe Univ Hosp, Dept Pharm, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yamakz@med.kobe-u.ac.jp					Noori S, 2012, FREE RADICAL BIO MED, V52, P1987, DOI 10.1016/j.freeradbiomed.2012.01.026; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Wong YY, 2010, J BIOL CHEM, V285, P2610, DOI 10.1074/jbc.M109.071159; Ikeda R, 2008, BIOMED CHROMATOGR, V22, P630, DOI 10.1002/bmc.980; Ueda Y, 2014, BIOCHEM BIOPH RES CO, V447, P341, DOI 10.1016/j.bbrc.2014.03.150; Tarutani M, 2013, J DERMATOL SCI, V72, P110, DOI 10.1016/j.jdermsci.2013.06.007; Jing YS, 2014, CARBOHYD POLYM, V102, P288, DOI 10.1016/j.carbpol.2013.11.061; Akiyama T, 2010, CLIN EXP METASTAS, V27, P207, DOI 10.1007/s10585-010-9319-y; Chen YH, 2013, ONCOTARGETS THER, V6, P983, DOI 10.2147/OTT.S45322; Dass SK, 2010, FITOTERAPIA, V81, P961; Dong JZ, 2013, FOOD CHEM, V137, P164, DOI 10.1016/j.foodchem.2012.10.021; Osaki LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066651; Guos C, 2009, AM J TRANSL RES, V1, P283; Jung SM, 2012, EUR J PHARMACOL, V681, P15, DOI 10.1016/j.ejphar.2012.02.003; Kim HS, 2010, INT IMMUNOPHARMACOL, V10, P1284, DOI 10.1016/j.intimp.2010.07.012; Lius H, 2014, EXP DERMATOL, V23, P896; Nohs EM, 2010, INT J MOL MED, V25, P255; Ous YC, 2014, LIFE SCI, V100, P110; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Raos YK, 2010, J ETHNOPHARMACOL, V131, P363; Romero-Ramirezs H, 2014, IMMUNOLOGY, V144, P271; Wang Y, 2014, MOL CELL ENDOCRINOL, V382, P979, DOI 10.1016/j.mce.2013.11.018; Wang ZL, 2010, CHEM BIOL DRUG DES, V76, P340, DOI 10.1111/j.1747-0285.2010.01019.x; Wus C, 2014, J CELL MOL MED, V18, P293; Wus WD, 2014, INT J MOL SCI, V15, P12778; Xins H, 2009, CANCER RES, V69, P2506; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102110; Yamamoto K, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-83; Yuan HQ, 2014, BIOMED PHARMACOTHER, V68, P751, DOI 10.1016/j.biopha.2014.07.002; Yuan JP, 2008, J AGR FOOD CHEM, V56, P809, DOI 10.1021/jf0719205; Yues K, 2013, J PHARM PHARMACOL, V65, P474	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	MAY	2015	29	5					707	713		10.1002/ptr.5305		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CI3KY	WOS:000354647800011		
J	Tatematsu, K; Toyokura, K; Miyashima, S; Nakajima, K; Okada, K				Tatematsu, Kiyoshi; Toyokura, Koichi; Miyashima, Shunsuke; Nakajima, Keiji; Okada, Kiyotaka			A molecular mechanism that confines the activity pattern of miR165 in Arabidopsis leaf primordia	PLANT JOURNAL			English	Article						miR165; MIR165A; leaf primordia; adaxial-abaxial polarity; Arabidopsis thaliana; HD-Zip III; YABBY	FILAMENTOUS-FLOWER; GENE FAMILY; TRANSCRIPTION FACTORS; ARTIFICIAL MICRORNAS; SIRNA BIOGENESIS; HOMEOBOX GENES; CELL FATE; POLARITY; MERISTEM; LEAVES	In Arabidopsis leaf primordia, the expression of HD-Zip III, which promotes tissue differentiation on the adaxial side of the leaf primordia, is repressed by miRNA165/166 (miR165/166). Small RNAs, including miRNAs, can move from cell to cell. In this study, HD-Zip III expression was strikingly repressed by miR165/166 in the epidermis and parenchyma cells on the abaxial side of the leaf primordia compared with those on the adaxial side. We also found that the MIR165A locus, which was expressed in the abaxial epidermis, was sufficient to establish the rigid repression pattern of HD-Zip III expression in the leaf primordia. Ectopic expression analyses of MIR165A showed that the abaxial-biased miR165 activity in the leaf primordia was formed neither by a polarized distribution of factors affecting miR165 activity nor by a physical boundary inhibiting the cell-to-cell movement of miRNA between the adaxial and abaxial sides. We revealed that cis-acting factors, including the promoter, backbone, and mature miRNA sequence of MIR165A, are necessary for the abaxial-biased activity of miR165 in the leaf primordia. We also found that the abaxial-determining genes YABBYs are trans-acting factors that are necessary for the miR165 activity pattern, resulting in the rigid determination of the adaxial-abaxial boundary in leaf primordia. Thus, we proposed a molecular mechanism in which the abaxial-biased patterning of miR165 activity is confined. Significance Statement In this paper, we propose a molecular mechanism for determination of activity pattern of miR165/166 in leaf primordia, which depends on both mature miRNA sequence and MIRNA backbone. We consider that our finding will provide an insight into the roles of MIRNA transcript sequences in the mechanisms for determination of miRNA distribution to confine small RNA-meditated gene expression in plants.	[Tatematsu, Kiyoshi; Toyokura, Koichi; Okada, Kiyotaka] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Toyokura, Koichi] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Miyashima, Shunsuke; Nakajima, Keiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Miyashima, Shunsuke] Univ Helsinki, Inst Biotechnol, Dept Bio & Environm Sci, FIN-00014 Helsinki, Finland; [Okada, Kiyotaka] Natl Inst Nat Sci, Tokyo 1050001, Japan; [Okada, Kiyotaka] Ryukoku Univ, Dept Agr, Otsu, Shiga 5202194, Japan	Tatematsu, K (reprint author), Natl Inst Nat Sci, Natl Inst Basic Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	ktatem@nibb.ac.jp	Tatematsu, Kiyoshi/E-9588-2013		Ministry for Education, Culture, Sports, Science, and Technology (MEXT) [19060004, 23012030]; Japan Society for the Promotion of Science (JSPS) [19GS0315]; JSPS [25440145]; Model Plant Research Facility, NIBB Bioresource Center; JSPS Fellowship [20-2221]	We thank the Arabidopsis Biological Resource Center for providing the mutant seeds; Dr. Keiro Watanabe (Kyoto University) for providing the 35S: miGFP-W and 35S: miGFP-M constructs; Dr. Toshiaki Tameshige (ITbM, Nagoya University) for providing the pGWB-NB1-CH and pGWB-NB1-ATML1p vectors; Drs. Masayoshi Kawaguchi (National Institute for Basic Biology), Momoko Ikeuchi (RIKEN CSRS), and Miyuki Nakata (Rikkyo University) for fruitful discussion; and Ms. Reiko Hara, Miwako Matsumoto, Chihiro Nakamori, Nagisa Sugimoto, Shiho Terada, and Yumiko Tsuzuki for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry for Education, Culture, Sports, Science, and Technology (MEXT) to K.O. (No. 19060004) and K.N. (No. 23012030), a Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (JSPS) to K.O. (No. 19GS0315), a Grant-in-Aid for Scientific Research (C) from the JSPS to K.Ta. (No. 25440145), and the Model Plant Research Facility, NIBB Bioresource Center. K. To. was supported by a JSPS Fellowship (No. 20-2221).	Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Li H, 2005, PLANT CELL, V17, P2157, DOI [10.1105/tpc.105.033449, 10.1105/tpc.105.030973]; Ueno Y, 2007, PLANT CELL, V19, P445, DOI 10.1105/tpc.106.042325; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Nakata M, 2012, PLANT CELL, V24, P519, DOI 10.1105/tpc.111.092858; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Miyashima S, 2013, PLANT CELL PHYSIOL, V54, P375, DOI 10.1093/pcp/pcs188; McConnell JR, 1998, DEVELOPMENT, V125, P2935; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Miyashima S, 2011, DEVELOPMENT, V138, P2303, DOI 10.1242/dev.060491; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Carbonell A, 2014, PLANT PHYSIOL, V165, P15, DOI 10.1104/pp.113.234989; Toyokura K, 2011, PLANT CELL PHYSIOL, V52, P1340, DOI 10.1093/pcp/pcr079; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Lynn K, 1999, DEVELOPMENT, V126, P469; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Vazquez F, 2004, CURR BIOL, V14, P346, DOI [10.1016/j.cub.2004.01.035, 10.1016/S0960-9822(04)00047-8]; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Grigg SP, 2005, NATURE, V437, P1022, DOI 10.1038/nature04052; Smith ZR, 2010, NATURE, V464, P423, DOI 10.1038/nature08843; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Bonaccorso O, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-176; Hyun TK, 2011, PROTOPLASMA, V248, P101, DOI 10.1007/s00709-010-0225-6; KOMAKI MK, 1988, DEVELOPMENT, V104, P195; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Nakata Miyuki, 2013, Plants-Basel, V2, P174, DOI 10.3390/plants2020174; Stahle MI, 2009, PLANT CELL, V21, P3105, DOI 10.1105/tpc.109.070458; Tameshige T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003655; Watanabe K, 2003, PLANT CELL, V15, P2592, DOI 10.1105/tpc.015214; Yao XZ, 2009, FEBS LETT, V583, P3711, DOI 10.1016/j.febslet.2009.10.076; Yu L, 2005, PLANTA, V221, P231, DOI 10.1007/s00425-004-1439-7	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	MAY	2015	82	4					596	608		10.1111/tpj.12834		13	Plant Sciences	Plant Sciences	CH8LS	WOS:000354288500005		
J	Zhao, P; Zheng, W; Watanabe, J; Meng, YD; Nagatsu, M				Zhao, Peng; Zheng, Wei; Watanabe, Jun; Meng, Yue Dong; Nagatsu, Masaaki			Highly Conductive Cu Thin Film Deposition on Polyimide by RF-Driven Atmospheric Pressure Plasma Jets under Nitrogen Atmosphere	PLASMA PROCESSES AND POLYMERS			English	Article						atmospheric pressure plasma jets (APPJ); conductivity; Cu thin films; film morphology; polyimide (PI) substrates	REDUCTION; ADHESIVE	The use of Ar/H-2 atmospheric pressure plasma jets driven by a 13.56 MHz RF wave source with a Cu inner conductor was investigated for the deposition of highly conductive Cu thin films on polyimide substrates. It was found that the intensities of the Cu atom emission line were significantly increased by the addition of H-2 gas to the Ar plasmas. Secondary emission microscopy analysis indicated that the Cu films exhibited agglomerated structures with grains of several microns, which were larger than those produced using Ar plasma jets. It was found that the conductivity of Cu thin films prepared in nitrogen was 10 6 times higher than that of films produced using Ar/H-2 plasma jets with 10 sccm H-2, and 4 times higher than that for films produced using identical Ar/H-2 plasma jets in air.	[Zhao, Peng; Nagatsu, Masaaki] Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Zhao, Peng; Meng, Yue Dong] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China; [Zheng, Wei; Watanabe, Jun] Yazaki Corp, Res & Technol Ctr, Susono 4101194, Japan	Nagatsu, M (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	tmnagat@ipc.shizuoka.ac.jp					Chen H, 2002, SURF COAT TECH, V150, P31, DOI 10.1016/S0257-8972(01)01525-0; Sands BL, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/28/282001; Noh JH, 2007, SURF COAT TECH, V201, P5097, DOI 10.1016/j.surfcoat.2006.07.223; Bussiahn R, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/16/165201; Eom JS, 2008, THIN SOLID FILMS, V516, P4530, DOI 10.1016/j.tsf.2008.01.022; Usami K, 2012, THIN SOLID FILMS, V521, P22, DOI 10.1016/j.tsf.2012.03.080; Chen HY, 2012, APPL SURF SCI, V258, P8775, DOI 10.1016/j.apsusc.2012.05.090; PANZNER G, 1985, SURF SCI, V151, P400, DOI 10.1016/0039-6028(85)90383-8; Baguer N, 2005, J APPL PHYS, V97, DOI 10.1063/1.1929857; Bogaerts A, 2002, J ANAL ATOM SPECTROM, V17, P768, DOI 10.1039/b200025c; FLYNN C, 1993, PHYS REV A, V48, P1239, DOI 10.1103/PhysRevA.48.1239; Kikuchi T., 2004, J PHYS D, V37, P11; Kim S. H., 2005, SURF COAT TECHNOL, P200; Lin Y. S., 2008, THIN SOLID FILMS, V516, P8; MITCHELL DF, 1990, SURF INTERFACE ANAL, V15, P487, DOI 10.1002/sia.740150808; Nakahiro H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.056201; Noh BI, 2009, J MATER SCI-MATER EL, V20, P885, DOI 10.1007/s10854-008-9811-1; Vogelsang A, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/48/485201; Zhao P, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795808	19	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	MAY	2015	12	5					431	438		10.1002/ppap.201400093		8	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CI3BO	WOS:000354622600004		
J	Baitukha, A; Mori, S; Suzuki, M				Baitukha, Alibi; Mori, Shinsuke; Suzuki, Masaaki			Liquid Crystal Alignment on Thin Organic Films Deposited in a Low Pressure Plasma Enhanced CVD Reactor	PLASMA PROCESSES AND POLYMERS			English	Article						alignment layer; ion bombardment; plasma enhanced chemical vapor deposition (PECVD); plasma treatment	ATOMIC-BEAM ALIGNMENT; C-H FILMS; ATMOSPHERIC-PRESSURE; ION-BEAM; POLYIMIDE FILMS; SURFACE; MICROSTRUCTURE; IRRADIATION; PLANAR; LIGHT	The application of a low pressure plasma enhanced chemical vapor deposition (PECVD) system is considered for the deposition of thin carbon films with alignment properties for liquid crystals (LC). The original electrode configuration induces directional planar alignment properties on deposited films, and makes possible to fabricate alignment layer in a one step process. To evaluate the LC alignment properties LC cells are assembled from substrates with deposited carbon films and observed in a polarizing optical microscope. Directional ion bombardment induced by the electrode configuration is considered to be the cause of the observed LC molecules alignment. The simultaneous deposition and ion bombardment processes induce a favorable condition for depositing carbon films with anisotropic properties.	[Baitukha, Alibi; Mori, Shinsuke; Suzuki, Masaaki] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan	Baitukha, A (reprint author), Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	sad.neva@gmail.com			Japanese Government MEXT	We would like to thank the Japanese Government MEXT Scholarship for its partial financial support and Dr O. Yaroshchuk for his valuable comments and advice. Also we would like to show our appreciation to Mrs. E. Robertson, for her essential help in the editing of this article.	Stohr J, 1999, J ELECTRON SPECTROSC, V98, P189, DOI 10.1016/S0368-2048(98)00286-2; SCHADT M, 1992, JPN J APPL PHYS 1, V31, P2155, DOI 10.1143/JJAP.31.2155; GIBBONS WM, 1991, NATURE, V351, P49, DOI 10.1038/351049a0; Yaroshchuk O, 2004, LIQ CRYST, V31, P859, DOI 10.1080/02678290410001703145; Funada Y, 1999, NUCL INSTRUM METH B, V148, P664, DOI 10.1016/S0168-583X(98)00789-7; Chaudhari P, 2001, NATURE, V411, P56, DOI 10.1038/35075021; ICHIMURA K, 1988, LANGMUIR, V4, P1214, DOI 10.1021/la00083a030; Yaroshchuk O, 2001, P SOC PHOTO-OPT INS, V4418, P49, DOI 10.1117/12.428331; Gwag JS, 2004, J APPL PHYS, V96, P257, DOI 10.1063/1.1759391; ARMITAGE D, 1980, J APPL PHYS, V51, P2552, DOI 10.1063/1.327978; Baitukha A, 2012, THIN SOLID FILMS, V523, P37, DOI 10.1016/j.tsf.2012.06.015; Bazhenov VY, 2013, PROBL ATOM SCI TECH, P177; BERREMAN DW, 1973, MOL CRYST LIQ CRYST, V23, P215, DOI 10.1080/15421407308083374; Chaudhari P, 1998, JPN J APPL PHYS 2, V37, pL55, DOI 10.1143/JJAP.37.L55; Dantsker D, 2001, J APPL PHYS, V89, P4318, DOI 10.1063/1.1353811; DYADYUSHA AG, 1991, UKR FIZ ZH+, V36, P1059; Ensinger W, 1996, SURF COAT TECH, V84, P363, DOI 10.1016/S0257-8972(95)02772-6; Jang E, 2006, JPN J APPL PHYS 2, V45, pL1238, DOI 10.1143/JJAP.45.L1238; Khakhlou A, 2006, J SOC INF DISPLAY, V14, P257, DOI 10.1889/1.2185274; Lee CY, 2008, JPN J APPL PHYS, V47, P226, DOI 10.1143/JJAP.47.226; Lien SCA, 1998, IBM J RES DEV, V42, P537; Lu XM, 2003, CHEM PHYS LETT, V377, P433, DOI 10.1016/S0009-2614(03)01153-9; Matsuda H, 1995, MOL CRYST LIQ CRYS A, V264, P23, DOI 10.1080/10587259508037298; Seo DS, 2001, LIQ CRYST, V28, P313; Wahl KJ, 2000, WEAR, V237, P1, DOI 10.1016/S0043-1648(99)00316-6; Wei HK, 2008, DIAM RELAT MATER, V17, P1639, DOI 10.1016/j.diamond.2008.01.038; Wu KY, 2005, J APPL PHYS, V98, DOI [10.1063/1.2115093, 10.1063/1.21125093]; Yaroshchuk O., 2002, ADV DISPL TECH, V186; Yaroshchuk O, 2005, MOL CRYST LIQ CRYST, V438, P1759, DOI [10.1080/15421400590958151, 10.1080/1542140059098151]; Yaroshchuk OV, 2011, APPL SURF SCI, V257, P2443, DOI 10.1016/j.apsusc.2010.09.115	30	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	MAY	2015	12	5					450	455		10.1002/ppap.201400079		6	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CI3BO	WOS:000354622600006		
J	Yoshimura, B; Yada, Y; Horigome, T; Kishi, Y				Yoshimura, Bunta; Yada, Yuji; Horigome, Toshirou; Kishi, Yoshiki			Anti N-Methyl-D-Aspartate Receptor Encephalitis Presenting With Intermittent Catatonia	PSYCHOSOMATICS			English	Letter									[Yoshimura, Bunta; Yada, Yuji; Horigome, Toshirou; Kishi, Yoshiki] Okayama Psychiat Med Ctr, Dept Psychiat, Okayama, Japan	Yoshimura, B (reprint author), Okayama Psychiat Med Ctr, Dept Psychiat, Okayama, Japan.						Kayser MS, 2013, JAMA NEUROL, V70, P1133, DOI 10.1001/jamaneurol.2013.3216; Lim JA, 2014, J CLIN NEUROL, V10, P157, DOI 10.3988/jcn.2014.10.2.157; Fink M, 2013, ACTA PSYCHIAT SCAND, V127, P1, DOI 10.1111/acps.12038; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1	4	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	MAY-JUN	2015	56	3					313	315				4	Psychiatry; Psychology	Psychiatry; Psychology	CI0DJ	WOS:000354405900015		
J	Matsukawa, Y				Matsukawa, Yoshihiro			Suicide in Systemic Lupus Erythematosus	PSYCHOSOMATICS			English	Letter							ANTIBODIES; RECEPTOR		Nihon Univ, Dept Med, Div Hematol & Rheumatol, Itabashi Ku, Tokyo, Japan	Matsukawa, Y (reprint author), Nihon Univ, Dept Med, Div Hematol & Rheumatol, Itabashi Ku, Oyaguchi Kamicho, Tokyo, Japan.						Diamond B, 2012, IMMUNOL REV, V248, P56, DOI 10.1111/j.1600-065X.2012.01137.x; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Hirohata S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4518; MATSUKAWA Y, 1994, LUPUS, V3, P31, DOI 10.1177/096120339400300107; Tang K, 2015, PSYCHOSOMAT IN PRESS	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	MAY-JUN	2015	56	3					317	318				3	Psychiatry; Psychology	Psychiatry; Psychology	CI0DJ	WOS:000354405900018		
J	Wang, YP; He, W; Yamada, T; Tanaka, I; Iye, M; Ji, T				Wang, Yi-Ping; He, Wei; Yamada, Toru; Tanaka, Ichi; Iye, Masanori; Ji, Tuo			High resolution deep imaging of a bright radio quiet QSO at z similar to 3	RESEARCH IN ASTRONOMY AND ASTROPHYSICS			English	Article						galaxies: active; galaxies: high redshift; quasars: general; instrumentation: adaptive optics	HIGH-REDSHIFT QUASARS; LYMAN LIMIT SYSTEMS; HOST GALAXIES; ADAPTIVE OPTICS; ABSORPTION; ABSORBERS; ALPHA; ACCRETION; COLORS; IMAGES	We have obtained deep J and Ks-band images centered on a bright radio quiet QSO UM402 (z(em) = 2.856) using the IRCS camera and adaptive optics systems that are part of the Subaru Telescope, as well as retrieved WFC3/F140W archive images of this object. A faint galaxy (m(k) = 23.32 +/- 0.05 in the Vega magnitude system) that lies similar to 2.4 '' north of the QSO sightline has been clearly resolved in all three deep high resolution datasets, and appears as an irregular galaxy with two close components in the Ks-band images (separation similar to 0.3 ''). Given the small impact parameter (b = 19.6 kpc, at z(lls) = 2.531), as well as the red color of (J - Ks)(Vega) similar to 1.6, it might be a candidate galaxy giving rise to the Lyman Limit system absorption at z(abs) = 2.531 seen in the QSO spectrum. After carefully subtracting the point spread function from the QSO images, the host galaxy of this bright radio quiet QSO at z similar to 3 was marginally revealed. We placed a lower limit on the host component of m(k) similar to 23.3 according to our analyses.	[Wang, Yi-Ping; He, Wei] Chinese Acad Sci, Key Lab Opt Astron, Natl Astron Observ, Beijing 100012, Peoples R China; [Yamada, Toru] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tanaka, Ichi] Natl Astron Obs Japan, Subaru Telescope, Hilo, HI 96720 USA; [Iye, Masanori] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Ji, Tuo] Polar Res Inst China, Shanghai 200136, Peoples R China	Wang, YP (reprint author), Chinese Acad Sci, Key Lab Opt Astron, Natl Astron Observ, Beijing 100012, Peoples R China.	ypwang@bao.ac.cn			John Templeton Foundation; National Astronomical Observatories, Chinese Academy of Sciences; National Natural Science Foundation of China [10173025, 10673013, 10778709, 11073031]; National Basic Research Program of China (973 Program) [TG 2000077602]; NASA [NAS5-26555]; NASA Office of Space Science [NNX13AC07G]	This project/publication was made possible through the support of a grant from the John Templeton Foundation and National Astronomical Observatories, Chinese Academy of Sciences. The opinions expressed in this publication are those of the author(s) and do not necessarily reflect the views of the John Templeton Foundation or National Astronomical Observatories, Chinese Academy of Sciences. The funds from the John Templeton Foundation were awarded in a grant to The University of Chicago, which also managed the program in conjunction with National Astronomical Observatories, Chinese Academy of Sciences. YPW would like to thank Dr. Chien Peng for support on the GALFIT fitting process. YPW acknowledges the Subaru team and Dr. Yosuke Minowa for the hospitality, the National Natural Science Foundation of China (Grant Nos. 10173025, 10673013, 10778709 and 11073031) and the National Basic Research Program of China (973 Program, TG 2000077602). We would like to thank our referee Dr. Michael Strauss for helpful comments. Some/all of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts.	Fumagalli M, 2011, MON NOT R ASTRON SOC, V418, P1796, DOI 10.1111/j.1365-2966.2011.19599.x; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Falomo R, 2008, ASTROPHYS J, V673, P694, DOI 10.1086/524839; SARGENT WLW, 1989, ASTROPHYS J SUPPL S, V69, P703, DOI 10.1086/191326; Sanchez SF, 2004, ASTROPHYS J, V614, P586, DOI 10.1086/423234; Chun MR, 2006, ASTRON J, V131, P686, DOI 10.1086/499299; Kohler K, 2007, ASTROPHYS J, V655, P685, DOI 10.1086/510443; Hawarden TG, 2001, MON NOT R ASTRON SOC, V325, P563, DOI 10.1046/j.1365-8711.2001.04460.x; Peng CY, 2006, ASTROPHYS J, V649, P616, DOI 10.1086/506266; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Guillemin P, 1997, ASTRON ASTROPHYS, V328, P499; LEBRUN V, 1993, ASTRON ASTROPHYS, V279, P33; Schramm M, 2008, ASTRON ASTROPHYS, V478, P311, DOI 10.1051/0004-6361:20077319; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Rahmati A, 2014, MON NOT R ASTRON SOC, V438, P529, DOI 10.1093/mnras/stt2235; Katz N, 1996, ASTROPHYS J, V457, pL57, DOI 10.1086/309900; Prochaska JX, 2010, ASTROPHYS J, V718, P392, DOI 10.1088/0004-637X/718/1/392; Stocke JT, 2010, PUBL ASTRON SOC AUST, V27, P256, DOI 10.1071/AS09074; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Erkal D., 2014, ARXIV14016705; Kamann N., 2008, THESIS U POTSDAM; Karhunen K., 1947, ANN ACAD SCI FENN A1, V37, P1; Kuhlbrodt B, 2005, ASTRON ASTROPHYS, V439, P497, DOI 10.1051/0004-6361:20041305; Kukula MJ, 2001, MON NOT R ASTRON SOC, V326, P1533, DOI 10.1111/j.1365-2966.2001.04692.x; Loeve M., 2006, PROCESSES STOCHASTIG; MACALPINE GM, 1978, ASTROPHYS J SUPPL S, V36, P587, DOI 10.1086/190512; Minowa Y., 2008, SUBARU DATA REDUCTIO; Moller P, 1998, MON NOT R ASTRON SOC, V299, P661, DOI 10.1046/j.1365-8711.1998.01749.x; Rajan A., 2011, HIGH CONTRAST IMAGIN; Ribaudo J, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/207; Ridgway SE, 2001, ASTROPHYS J, V550, P122, DOI 10.1086/319725; Soummer R, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L28; Takami H, 2004, PUBL ASTRON SOC JPN, V56, P225; Tanaka I., 2011, PASJ, V63, P415; Wang Y. P., 2013, IAU S, V292, P195	35	0	0	NATL ASTRONOMICAL OBSERVATORIES, CHIN ACAD SCIENCES	BEIJING	20A DATUN RD, CHAOYANG, BEIJING, 100012, PEOPLES R CHINA	1674-4527			RES ASTRON ASTROPHYS	Res. Astron. Astrophys.	MAY	2015	15	5					673	686		10.1088/1674-4527/15/5/006		14	Astronomy & Astrophysics	Astronomy & Astrophysics	CH1KP	WOS:000353780600006		
J	Takatsuka, H; Zeng, DZ; Zhao, LX				Takatsuka, Hajime; Zeng, Dao-Zhi; Zhao, Laixun			Resource-based cities and the Dutch disease	RESOURCE AND ENERGY ECONOMICS			English	Article						Resource-based cities; Dutch disease; Resource goods; Industrialization; Transport costs	ECONOMIC-GEOGRAPHY; SCALE ECONOMIES; BOOMING SECTOR; TRADE; AGGLOMERATION; GROWTH; MODEL	This paper examines the relationship between resource development and industrialization. When transport costs are high, the region with a more valuable natural resource enjoys a higher welfare than the other region. However, as transport costs decrease, firms begin to move out of the region, causing the Dutch disease to occur, initially in terms of industry share, and eventually in terms of welfare too when transport is sufficiently free. A resource boom in intermediate inputs may strengthen the tendency for manufacturing agglomeration in the same region, but a resource boom in consumption inputs will weaken this tendency. The model thus provides insight for cities to utilize their limited resources efficiently. (c) 2015 Elsevier B.V. All rights reserved.	[Takatsuka, Hajime] Kagawa Univ, Grad Sch Management, Takamatsu, Kagawa 7608523, Japan; [Zeng, Dao-Zhi] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Zhao, Laixun] Kobe Univ, Res Inst Econ & Business, Kobe, Hyogo 6578501, Japan	Zeng, DZ (reprint author), Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan.	takatsuka@gsm.kagawa-u.ac.jp; zeng@se.is.tohoku.ac.jp; zhao@rieb.kobe-u.ac.jp			JSPS KAKENHI of Japan [26380282, 24243036, 24330072, 24530303, 20730183]	This paper is a revised version of our RIETI Discussion Paper #13-E-001. We thank two anonymous referees and two editors for valuable comments and suggestions that have greatly improved the paper. We also thank Yuko Akune, Marcus Berliant, Masahisa Fujita, Nobuaki Hamaguchi, Keith Head, Minjun Shi, Takaaki Takahashi, Jacques-Francois Thisse and Kaizhong Yang for their helpful suggestions. This research was partially funded by JSPS KAKENHI Grant Numbers 26380282, 24243036, 24330072, 24530303, 20730183 of Japan.	Amiti M, 1998, J INT ECON, V44, P231, DOI 10.1016/S0022-1996(97)00030-5; Hanson GH, 2005, J INT ECON, V67, P1, DOI 10.1016/j.jinteco.2004.09.008; Sachs JD, 1999, J DEV ECON, V59, P43, DOI 10.1016/S0304-3878(99)00005-X; DIXIT AK, 1977, AM ECON REV, V67, P297; CORDEN WM, 1982, ECON J, V92, P825, DOI 10.2307/2232670; KRUGMAN P, 1980, AM ECON REV, V70, P950; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; Redding S, 2004, J INT ECON, V62, P53, DOI 10.1016/j.jinteco.2003.07.001; Crozet M, 2004, J ECON GEOGR, V4, P439, DOI 10.1093/jnlecg/lbh029; van der Ploeg F, 2011, J ECON LIT, V49, P366, DOI 10.1257/jel.49.2.366; Picard PM, 2005, J DEV ECON, V77, P75, DOI 10.1016/j.jdeveco.2004.03.002; VENABLES AJ, 1987, ECON J, V97, P700, DOI 10.2307/2232931; Auty R., 1993, THESIS ROUTLEDGE; Baldwin R., 2003, EC GEOGRAPHY PUBLIC; Barbier E. B., 2005, NATURAL RESOURCES EC; Beine M, 2012, RESOUR ENERGY ECON, V34, P468, DOI 10.1016/j.reseneeco.2012.05.002; Brakman S, 2006, REG SCI URBAN ECON, V36, P613, DOI 10.1016/j.regsciurbeco.2006.06.004; CORDEN WM, 1984, OXFORD ECON PAP, V36, P359; Fujita M., 1999, SPATIAL EC CITIES RE; Helpman E, 1985, MARKET STRUCTURE FOR; KRUGMAN P, 1987, J DEV ECON, V27, P41, DOI 10.1016/0304-3878(87)90005-8; Takatsuka H, 2012, J JPN INT ECON, V26, P308, DOI 10.1016/j.jjie.2012.05.003; Young A, 2000, Q J ECON, V115, P1091, DOI 10.1162/003355300555024	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-7655	1873-0221		RESOUR ENERGY ECON	Resour. Energy Econ.	MAY	2015	40						57	84		10.1016/j.reseneeco.2015.01.003		28	Economics; Energy & Fuels; Environmental Sciences; Environmental Studies	Business & Economics; Energy & Fuels; Environmental Sciences & Ecology	CI1JS	WOS:000354501100004		
J	Liu, FC; Liao, J; Gao, Y; Nakata, K				Liu, F. C.; Liao, J.; Gao, Y.; Nakata, K.			Effect of plasma electrolytic oxidation coating on joining metal to plastic	SCIENCE AND TECHNOLOGY OF WELDING AND JOINING			English	Article						Friction lap welding; Metal; Polymer; Plasma electrolytic oxidation; Chemical bond	MAGNESIUM ALLOY; CORROSION-RESISTANCE; MG ALLOY; AZ91D; MECHANISMS; POLYMERS; BEHAVIOR; GROWTH	Joining of magnesium alloy to polyethylene without adhesive using a newly developed friction lap welding technology was investigated. The polyethylene and magnesium alloy were hard to be joined together without surface premodification due to the lack of polar groups on polyethylene surfaces. Strong hybrid joints were achieved after the polyethylene was treated by corona discharge, and the magnesium alloy was subjected to plasma electrolytic oxidation treatment. Scanning electron microscope and high resolution transmission electron microscope observations demonstrated that the high joining strength was attributed to the development of both chemical bonds at the interface and micromechanical interlocking.	[Liu, F. C.; Gao, Y.; Nakata, K.] Osaka Univ, JWRI, Ibaraki, Osaka 5670047, Japan; [Liao, J.] Kurimoto Ltd, Osaka 5590021, Japan	Liu, FC (reprint author), Osaka Univ, JWRI, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	fchliu@alum.imr.ac.cn			JSPS	F. C. Liu wishes to acknowledge the support of FY 2014 JSPS Postdoctoral Fellowship for Foreign Researchers.	Amancio ST, 2009, POLYM ENG SCI, V49, P1461, DOI 10.1002/pen.21424; Jung KW, 2013, MATER DESIGN, V47, P179, DOI 10.1016/j.matdes.2012.12.015; Duan HP, 2007, ELECTROCHIM ACTA, V52, P5002, DOI 10.1016/j.electacta.2007.02.021; Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7; Cheng IC, 2008, J ELECTROCHEM SOC, V155, pC219, DOI 10.1149/1.2883739; Mori Y, 2014, CORROS SCI, V88, P254, DOI 10.1016/j.corsci.2014.07.038; Liu FC, 2014, MATER DESIGN, V54, P236, DOI 10.1016/j.matdes.2013.08.056; Guo HF, 2005, APPL SURF SCI, V246, P229, DOI 10.1016/j.apsusc.2004.11.031; Fink A, 2010, COMPOS SCI TECHNOL, V70, P305, DOI 10.1016/j.compscitech.2009.11.002; Liao JS, 2013, CORROS SCI, V71, P53, DOI 10.1016/j.corsci.2013.02.003; ESCAIG B, 1993, J PHYS IV, V3, P753, DOI 10.1051/jp4:19937120; Goushegir S. M., 2014, MATER DESIGN, V47, P176; Katayama S, 2008, SCRIPTA MATER, V59, P1247, DOI 10.1016/j.scriptamat.2008.08.026; Liu FC, 2014, SCI TECHNOL WELD JOI, V19, P578, DOI 10.1179/1362171814Y.0000000228; Nakata K., 2012, International Patent Application, Patent No. [PCT/JP2012/053839, 2012053839]; Pandiyaraj K. N., 2004, APPL SURF SCI, V307, P109; Ryu HS, 2011, J ELECTROCHEM SOC, V158, pC266, DOI 10.1149/1.3604947; Sundararajan G, 2003, SURF COAT TECH, V167, P269, DOI 10.1016/S0257-8972(02)00918-0; Wheeler JM, 2010, SURF COAT TECH, V204, P3399, DOI 10.1016/j.surfcoat.2010.04.006	19	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1362-1718			SCI TECHNOL WELD JOI	Sci. Technol. Weld. Join.	MAY	2015	20	4					291	296		10.1179/1362171815Y.0000000012		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH9XH	WOS:000354389400004		
J	Wakabayashi, K; Hemthavy, P; Saito, S; Takahashi, K				Wakabayashi, K.; Hemthavy, P.; Saito, S.; Takahashi, K.			Change in temperature distribution by constriction of electric current through contact area	SCIENCE AND TECHNOLOGY OF WELDING AND JOINING			English	Article						Change in temperature distribution; Constriction of electric current; Contact; Analytical derivation; Numerical calculation; Time to melting; Melting area	RESISTANCE; SURFACES; CONDUCTION; SOLIDS	The change in temperature distribution due to constriction of an electric current through a contact area is analytically and numerically investigated. The potential distribution, current density distribution and heat density distribution inside the body are analytically obtained. The heat density has the singular point at the periphery of the contact area. It is revealed that the temperature has a finite value at the periphery, whereas the temperature change rate with respect to time has an infinite value because of the singularity. The results show the change in the temperature distribution. The times to melting and melting area are determined from the change in the temperature distribution. The total heat generated until melting occurs is also obtained.	[Wakabayashi, K.; Hemthavy, P.; Takahashi, K.] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Int Dev Engn, Tokyo 152, Japan; [Saito, S.] Tokyo Inst Technol, Dept Mech & Aerosp Engn, Tokyo 152, Japan	Wakabayashi, K (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Int Dev Engn, Tokyo 152, Japan.	wakabayashi.k.af@m.titech.ac.jp					Chung DDL, 2001, SMART MATER STRUCT, V10, P624, DOI 10.1088/0964-1726/10/4/305; BOWDEN FP, 1958, PROC R SOC LON SER-A, V246, P1, DOI 10.1098/rspa.1958.0102; FORD IJ, 1993, J PHYS D APPL PHYS, V26, P2219, DOI 10.1088/0022-3727/26/12/020; Bansal D. G., 2010, ACTA MAT, V59, P726; GREENWOOD JA, 1958, PROC R SOC LON SER-A, V246, P13, DOI 10.1098/rspa.1958.0103; GREENWOO.JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Kahn J. A., 2000, NUMER HEAT TR A-APPL, V37, P425; Kogut L, 2003, J APPL PHYS, V94, P3153, DOI 10.1063/1.1592628; Kohler M., 1952, Abhandlungen der Braunschweigischen Wissenschaftlichen Gesellschaft, V4; Kohlrausch F, 1900, ANN PHYS-BERLIN, V1, P132; Kubono T., 1985, T I ELECT ENG JPN, V104A, P47; Nied H. A., 1984, WELD J, V63, P123; ROBERTSON SR, 1982, IEEE T COMPON HYBR, V5, P3, DOI 10.1109/TCHMT.1982.1135923; Tabor D., 1976, J COLLOID INTERF SCI, V58, P2, DOI DOI 10.1016/0021-9797(77)90366-6; Wang SC, 2001, J HEAT TRANS-T ASME, V123, P576, DOI 10.1115/1.1370502; Wei PS, 2010, SCI TECHNOL WELD JOI, V15, P448, DOI 10.1179/136217110X12693513264295; Yoshioka Y., 1967, J I ELECT ENG JPN, V87, P757	17	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1362-1718			SCI TECHNOL WELD JOI	Sci. Technol. Weld. Join.	MAY	2015	20	4					337	344		10.1179/1362171815Y.0000000014		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CH9XH	WOS:000354389400011		
J	Chen, B; Bottoms, B; Armstrong, D; Isobayashi, A				Chen, Bill; Bottoms, Bill; Armstrong, Dave; Isobayashi, Atsunobu			ITRS 2.0: Heterogeneous Integration	SOLID STATE TECHNOLOGY			English	Article								Interconnecting transistors and other components in the IC, in the package, on the printed circuit board and at the system and global network level, are where the future limitations in performance, power, latency and cost reside.	[Chen, Bill] ASE US, Sunnyvale, CA 94085 USA; [Bottoms, Bill] 3MT Solut, Santa Clara, CA USA; [Armstrong, Dave] Advantest, Business Dev, Ft Collins, CO USA; [Isobayashi, Atsunobu] Toshibas Ctr Semicond Res & Dev, Kanagawa, Japan	Chen, B (reprint author), ASE US, Sunnyvale, CA 94085 USA.							0	0	0	PENNWELL PUBL CO	NORTHBROOK	P O BOX 3284, NORTHBROOK, IL 60065-3284 USA	0038-111X			SOLID STATE TECHNOL	Solid State Technol.	MAY	2015	58	3					13	17				5	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CI0IZ	WOS:000354421600002		
J	Dibaji, SM; Ishii, H				Dibaji, Seyed Mehran; Ishii, Hideaki			Consensus of second-order multi-agent systems in the presence of locally bounded faults	SYSTEMS & CONTROL LETTERS			English	Article						Multi-agent systems; Cyber-security; Consensus		We propose an algorithm for consensus of second-order sampled-data multi-agent systems in the presence of misbehaving agents. Each normal agent updates its states following a predetermined control law based on local information while some malicious agents make updates arbitrarily. The normal agents do not know the global topology of the network, but have prior knowledge on the maximum number of malicious agents in their neighborhood. Under the assumption that the network has sufficient connectivity in terms of robustness, we develop a resilient algorithm where each agent ignores the neighbors which have large and small position values to avoid being influenced by malicious agents. (C) 2015 Elsevier B.V. All rights reserved.	[Dibaji, Seyed Mehran; Ishii, Hideaki] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Ishii, H (reprint author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Midori Ku, 4259-J2-54 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	dibaji@sc.dis.titech.ac.jp; ishii@dis.titech.ac.jp			Japan Science and Technology Agency under the EMS-CREST program	This work was supported by Japan Science and Technology Agency under the EMS-CREST program.	LeBlanc HJ, 2013, IEEE J SEL AREA COMM, V31, P766, DOI 10.1109/JSAC.2013.130413; Zhang Y, 2009, AUTOMATICA, V45, P1195, DOI 10.1016/j.automatica.2008.11.005; Pasqualetti F, 2012, IEEE T AUTOMAT CONTR, V57, P90, DOI 10.1109/TAC.2011.2158130; Cao YC, 2010, INT J CONTROL, V83, P506, DOI 10.1080/00207170903214338; Shames I, 2011, AUTOMATICA, V47, P2757, DOI 10.1016/j.automatica.2011.09.011; Bouzid Z, 2010, THEOR COMPUT SCI, V411, P3154, DOI 10.1016/j.tcs.2010.05.006; Suzuki I, 1999, SIAM J COMPUT, V28, P1347, DOI 10.1137/S009753979628292X; Sundaram S, 2011, IEEE T AUTOMAT CONTR, V56, P1495, DOI 10.1109/TAC.2010.2088690; Azadmanesh M. H., 2002, International Journal of Parallel and Distributed Systems & Networks, V5; Azevedo M.M., 1998, IEEE T PARALL DISTR, V9, P1195; Dibaji S.M., 2015, P AM CONTR IN PRESS; Dibaji SM, 2014, P AMER CONTR CONF, P5139, DOI 10.1109/ACC.2014.6859500; Ding S. X., 2008, P 17 IFAC WORLD C SE, P13569; Dolev D., 1983, Proceedings Third Symposium on Reliability in Distributed Software and Database Systems; Ichimura A, 2010, INFORM PROCESS LETT, V110, P514, DOI 10.1016/j.ipl.2010.04.003; Kieckhafar R.M., 1994, IEEE T PARALL DISTR, V15, P53; Kieckhafar R.M., 1993, J COMPUTING INFORM, V3, P53; LeBlanc H.J., 2012, THESIS VANDERBILT U; Lynch N. A., 1996, DISTRIBUTED ALGORITH; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Nishino H., 2014, P 19 WORLD C IFAC, P11932; Vaidya N.H., 2012, P ACM S PRINC DISTR, P356; Zhang H., 2015, IEEE T CONT IN PRESS	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6911	1872-7956		SYST CONTROL LETT	Syst. Control Lett.	MAY	2015	79						23	29		10.1016/j.sysconle.2015.02.005		7	Automation & Control Systems; Operations Research & Management Science	Automation & Control Systems; Operations Research & Management Science	CI1LD	WOS:000354504800004		
J	Onodera, A; Nakayama, T				Onodera, Atsushi; Nakayama, Toshinori			Epigenetics of T cells regulated by Polycomb/Trithorax molecules	TRENDS IN MOLECULAR MEDICINE			English	Review						Polycomb; Trithorax; epigenetics; T cell; memory	SYSTEMIC-LUPUS-ERYTHEMATOSUS; HISTONE METHYLTRANSFERASE EZH2; POLYCOMB GROUP PROTEINS; AIRWAY INFLAMMATION; GENE-EXPRESSION; TRITHORAX PROTEINS; RESPONSE ELEMENT; TYPE-2 CELLS; HUMAN GENOME; STEM-CELLS	Epigenetics provides a bridge between genetic and environmental factors, and can change the transcriptional outcome of a gene without changing the genomic sequence. Allergies and autoimmune diseases are caused by both of these factors, and dynamic changes in epigenetic marks have been reported in T cells, which are key players in the pathogenesis of immune-mediated diseases. Advances in technology, including gene knockout systems and high-throughput sequencing, have significantly enhanced the understanding of the lifespan of T cells, including maturation, differentiation and memory formation. In this review, we focus on Polycomb and Trithorax proteins, well-characterized epigenetic modulators, and discuss their role in the epigenetic regulation of T cell differentiation and function.	[Onodera, Atsushi; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, Chiba 2608670, Japan; [Nakayama, Toshinori] JST, CREST, Chuo Ku, Chiba 2608670, Japan	Nakayama, T (reprint author), Chiba Univ, Grad Sch Med, Dept Immunol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	tnakayama@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [26221305, 23790523, 25860351, 221S0002]	We thank Dr. Yutaka Suzuki for his excellent experimental support. We thank the ENCODE consortium for providing the available data [104]. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) (Grants-in-Aid: for Scientific Research S #26221305, Young Scientists (B) #23790523 and #25860351, and for Scientific Research on Innovative Areas 'Genome Science' #221S0002).	Tong Q, 2014, J IMMUNOL, V192, P5012, DOI 10.4049/jimmunol.1302943; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bennett CL, 2001, NAT GENET, V27, P20; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Handel Adam E, 2010, Trends Mol Med, V16, P7, DOI 10.1016/j.molmed.2009.11.003; Mohan M, 2012, CELL, V149, P498, DOI 10.1016/j.cell.2012.03.025; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Zhou Y, 2011, LUPUS, V20, P1365, DOI 10.1177/0961203311413412; Meda F, 2011, CELL MOL IMMUNOL, V8, P226, DOI 10.1038/cmi.2010.78; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Horiuchi S, 2011, J IMMUNOL, V186, P6378, DOI 10.4049/jimmunol.1100179; Liu A, 2014, AUTOIMMUNITY, V47, P215, DOI 10.3109/08916934.2013.844794; Ito K, 2008, AM J RESP CELL MOL, V39, P543, DOI 10.1165/rcmb.2008-0028OC; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Peschansky VJ, 2014, EPIGENETICS-US, V9, P3, DOI 10.4161/epi.27473; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Rothenberg EV, 2014, TRENDS IMMUNOL, V35, P195, DOI 10.1016/j.it.2014.03.001; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Lu QJ, 2005, J IMMUNOL, V174, P6212; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Tenbrock K, 2006, J IMMUNOL, V177, P6159; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Zouali M, 2011, ANN NY ACAD SCI, V1217, P154, DOI 10.1111/j.1749-6632.2010.05831.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kato K, 2010, BIOL BLOOD MARROW TR, V16, P751, DOI 10.1016/j.bbmt.2010.01.012; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; McKinley L, 2008, J IMMUNOL, V181, P4089; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Tripathi SK, 2014, IMMUNOL REV, V261, P62, DOI 10.1111/imr.12204; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Hosokawa H, 2006, J IMMUNOL, V177, P7656; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Northrop JK, 2006, J IMMUNOL, V177, P1062; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Wang AB, 2013, J IMMUNOL, V191, P4908, DOI 10.4049/jimmunol.1300433; Ellmeier W, 2013, CELL MOL LIFE SCI, V70, P4537, DOI 10.1007/s00018-013-1393-2; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Ma L, 2012, J CLIN IMMUNOL, V32, P505, DOI 10.1007/s10875-011-9643-2; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Cheng MH, 2012, ANNU REV IMMUNOL, V30, P393, DOI 10.1146/annurev-immunol-020711-074953; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Nadeau K, 2010, J ALLERGY CLIN IMMUN, V126, P845, DOI 10.1016/j.jaci.2010.08.008; Hu N, 2008, J RHEUMATOL, V35, P804; Onodera A, 2010, J EXP MED, V207, P2493, DOI 10.1084/jem.20100760; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.05.005, 10.1016/j.tibs.2013.0S.005]; Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Guo Y, 2011, EUR J IMMUNOL, V41, P1098, DOI 10.1002/eji.201040794; He S, 2013, BLOOD, V122, P4119, DOI 10.1182/blood-2013-05-505180; He S, 2013, IMMUNOTHERAPY-UK, V5, P989, DOI 10.2217/imt.13.101; Heffner M, 2007, P NATL ACAD SCI USA, V104, P13414, DOI 10.1073/pnas.0706040104; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Laky K., 2015, TRENDS MOL MED, V42, P80; Mirabella F, 2010, J IMMUNOL, V184, P3043, DOI [10.4049/jimmunol.0901364, 10.4049/jimmunol.0901304]; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Miyazaki M, 2005, J IMMUNOL, V174, P2507; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Raaphorst FM, 2001, J IMMUNOL, V166, P5925; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schaller MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012172; Shrikant PA, 2010, IMMUNOL RES, V46, P12, DOI 10.1007/s12026-009-8130-9; Suzuki A, 2010, J IMMUNOL, V184, P4510, DOI 10.4049/jimmunol.0903426; Tubo NJ, 2014, TRENDS IMMUNOL, V35, P591, DOI 10.1016/j.it.2014.09.008; Watanabe Y, 2014, P NATL ACAD SCI USA, V111, P12829, DOI 10.1073/pnas.1321245111; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Zediak VP, 2011, CURR OPIN GENET DEV, V21, P154, DOI 10.1016/j.gde.2011.01.016; Zhang YX, 2014, BLOOD, V124, P737, DOI 10.1182/blood-2013-12-544106	103	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	MAY	2015	21	5					330	340		10.1016/j.molmed.2015.03.001		11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CI2NE	WOS:000354583500008		
J	Nakao, R; Qiu, YJ; Salim, B; Hassan, SM; Sugimoto, C				Nakao, Ryo; Qiu, Yongjin; Salim, Bashir; Hassan, Shawgi Mohamed; Sugimoto, Chihiro			Molecular Detection of Rickettsia africae in Amblyomma variegatum Collected from Sudan	VECTOR-BORNE AND ZOONOTIC DISEASES			English	Article						Rickettsia africae; African tick-bite fever; Sudan; Real-time PCR; Size-based multispacer typing	FEVER GROUP RICKETTSIAE; TICK-BITE FEVER; SPOTTED-FEVER; HIGH PREVALENCE; PCR; IDENTIFICATION; DISEASES; CATTLE; UGANDA; ROMPA	Despite the increasing awareness of the importance of emerging vector-borne diseases, human tick-borne diseases, particularly rickettsial infections, are overlooked, especially in the countries such as Sudan with limited resources to perform molecular-based surveys. This study aimed at detection and genetic characterization of Rickettsia spp. in ticks collected from Sudan. The samples were first screened for the presence of rickettsial agents by gltA real-time PCR and subsequently characterized by gltA and ompA PCR and size-based multispacer typing. The results demonstrated the wide distribution of Rickettsia africae and/or closely related species across Sudan. The results of this report highlight the need for careful consideration of rickettsial infections in patients with nonmalarial febrile illness in this country. Nationwide surveillance on ticks associated with human rickettsial infections in Sudan is warranted.	[Nakao, Ryo] Hokkaido Univ, Res Ctr Zoonosis Control, Unit Risk Anal & Management, Sapporo, Hokkaido 0010020, Japan; [Qiu, Yongjin; Sugimoto, Chihiro] Hokkaido Univ, Div Collaborat & Educ, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Salim, Bashir; Hassan, Shawgi Mohamed] Univ Khartoum, Fac Vet Med, Dept Parasitol, Khartoum, Sudan; [Salim, Bashir] Agr Res Council, Onderstepoort Vet Inst, Parasites Vectors & Vector Borne Dis, Onderstepoort, South Africa	Sugimoto, C (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido 0010020, Japan.	sugimoto@czc.hokudai.ac.jp	Sugimoto, Chihiro/F-6583-2012	Sugimoto, Chihiro/0000-0002-8708-0140	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24880003, 25850195]	This work was supported by Grant-in-Aid for Research Activity Start-up (no. 24880003) and Grant-in-Aid for Young Scientists (B) (no. 25850195) from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Ishikura M, 2003, MICROBIOL IMMUNOL, V47, P823; Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739; Stenos J, 2005, AM J TROP MED HYG, V73, P1083; KELLY PJ, 1991, J CLIN MICROBIOL, V29, P256; Jensenius M, 2003, LANCET INFECT DIS, V3, P557, DOI 10.1016/S1473-3099(03)00739-4; Roux V, 1996, J CLIN MICROBIOL, V34, P2058; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2001, EMERG INFECT DIS, V7, P1014; Cazorla C, 2008, INFECT DIS CLIN N AM, V22, P531, DOI 10.1016/j.idc.2008.03.009; Maina AN, 2014, VECTOR-BORNE ZOONOT, V14, P693, DOI 10.1089/vbz.2014.1578; Morita C, 2004, JPN J INFECT DIS, V57, P107; Nakao R, 2013, TICKS TICK-BORNE DIS, V4, P506, DOI 10.1016/j.ttbdis.2013.07.001; Nakao R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-137; Salih DA, 2004, ONDERSTEPOORT J VET, V71, P319	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-3667	1557-7759		VECTOR-BORNE ZOONOT	Vector-Borne Zoonotic Dis.	MAY 1	2015	15	5					323	325		10.1089/vbz.2014.1748		3	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CI3XV	WOS:000354681600006		
J	Terazono, A; Oguchi, M; Iino, S; Mogi, S				Terazono, Atsushi; Oguchi, Masahiro; Iino, Shigenori; Mogi, Satoshi			Battery collection in municipal waste management in Japan: Challenges for hazardous substance control and safety	WASTE MANAGEMENT			English	Article						Battery; Small waste electric and electronic equipment; Collection rules; Hazardous substances; Safety	PERSPECTIVES	To clarify current collection rules of waste batteries in municipal waste management in Japan and to examine future challenges for hazardous substance control and safety, we reviewed collection rules of waste batteries in the Tokyo Metropolitan Area. We also conducted a field survey of waste batteries collected at various battery and small waste electric and electronic equipment (WEEE) collection sites in Tokyo. The different types of batteries are not collected in a uniform way in the Tokyo area, so consumers need to pay attention to the specific collection rules for each type of battery in each municipality. In areas where small WEEE recycling schemes are being operated after the enforcement of the Act on Promotion of Recycling of Small Waste Electrical and Electronic Equipment in Japan in 2013, consumers may be confused about the need for separating batteries from small WEEE (especially mobile phones). Our field survey of collected waste batteries indicated that 6-10% of zinc carbon and alkaline batteries discarded in Japan currently could be regarded as containing mercury. More than 26% of zinc carbon dry batteries currently being discarded may have a lead content above the labelling threshold of the EU Batteries Directive (2006/66/EC). In terms of safety, despite announcements by producers and municipalities about using insulation (tape) on waste batteries to prevent fires, only 2.0% of discarded cylindrical dry batteries were insulated. Our field study of small WEEE showed that batteries made up an average of 4.6% of the total collected small WEEE on a weight basis. Exchangeable batteries were used in almost all of mobile phones, digital cameras, radios, and remote controls, but the removal rate was as low as 22% for mobile phones. Given the safety issues and the rapid changes occurring with mobile phones or other types of small WEEE, discussion is needed among stakeholders to determine how to safely collect and recycle WEEE and waste batteries. (c) 2015 Elsevier Ltd. All rights reserved.	[Terazono, Atsushi; Oguchi, Masahiro] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Iino, Shigenori] Tokyo Metropolitan Res Inst Environm Protect, Koto Ku, Tokyo 1360075, Japan; [Mogi, Satoshi] Tokyo Metropolitan Govt, Bur Environm, Shinjuku Ku, Tokyo 1638001, Japan	Terazono, A (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	terazono@nies.go.jp			Global Environment Research Fund of the Ministry of the Environment, Japan [K113011, 3K143010]; Environmental Control Center Co., Ltd.	This research was supported by the Global Environment Research Fund (K113011, 3K143010) of the Ministry of the Environment, Japan. We thank Dr. H. Koseki (National Research Institute of Fire and Disaster), the Tokyo Metropolitan Government (Clean Association of Tokyo23, Tokyo Metropolitan Research Institute for Environmental Protection, and Bureau of Environment), the municipalities where we conducted field surveys, and Environmental Control Center Co., Ltd. for their cooperation and support.	Duan H, 2014, ENVIRON SCI TECHNOL, V48, P3263, DOI 10.1021/es404365z; Asari M, 2011, J MATER CYCLES WASTE, V13, P10, DOI 10.1007/s10163-010-0313-x; Li JH, 2013, WASTE MANAGE, V33, P923, DOI 10.1016/j.wasman.2012.11.011; Lisbona D, 2011, PROCESS SAF ENVIRON, V89, P434, DOI 10.1016/j.psep.2011.06.022; Almeida MF, 2006, WASTE MANAGE, V26, P466, DOI 10.1016/j.wasman.2005.04.005; Aizawa H, 2008, RESOUR CONSERV RECY, V52, P1399, DOI 10.1016/j.resconrec.2008.07.013; Asari M., 2012, MAT CYCLES WASTE MAN, V23, P268; Asari M., 2011, MAT CYCLES WASTE MAN, V22, P412; Barrett HA, 2012, J POWER SOURCES, V206, P414, DOI 10.1016/j.jpowsour.2012.01.008; European Commission SEC, 2003, EXTENDED IMPACT ASSE, V1343, P19; Koseki H., 2008, PROGR SAFETY SCI TEC, P1964; Murakami H., 2010, BATTERIES HDB, V187; Oguchi M., 2004, ENV SCI, V17, P419; Recknagel S., 2011, SURVEY MERCURY CADMI; Recknagel S, 2014, WASTE MANAGE, V34, P156, DOI 10.1016/j.wasman.2013.09.024; Terazono A., 2012, E WASTE MANAGEMENT, P137; Tokyo Fire Department, 2013, ATT STOR BATT; Tomita H., 2005, P 34 FIR EX WORKSH N, P69; U.S. EPA, CONS COMM PROD	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	MAY	2015	39						246	257		10.1016/j.wasman.2015.01.038		12	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH6NC	WOS:000354152300027		
J	Carvalho, P; Marques, RC; Dollery, B				Carvalho, Pedro; Marques, Rui Cunha; Dollery, Brian			Is bigger better? An empirical analysis of waste management in New South Wales	WASTE MANAGEMENT			English	Review						Economies of size; Economies of output density; Economies of scope; Waste management; Recycling; New South Wales	MUNICIPAL SOLID-WASTE; REFUSE COLLECTION; PANEL-DATA; ECONOMIES; SECTOR; SCALE; COST; GOVERNMENT; EFFICIENCY; DENSITY	Across the world, rising demand for municipal solid waste services has seen an ongoing increase in the costs of providing these services. Moreover, municipal waste services have typically been provided through natural or legal monopolies, where few incentives exist to reduce costs. It is thus vital to examine empirically the cost structure of these services in order to develop effective public policies which can make these services more cost efficient. Accordingly, this paper considers economies of size and economies of output density in the municipal waste collection sector in the New South Wales (NSW) local government system in an effort to identify the optimal size of utilities from the perspective of cost efficiency. Our results show that as presently constituted NSW municipal waste services are not efficient in terms of costs, thereby demonstrating that 'bigger is not better.' The optimal size of waste utilities is estimated to fall in the range 12,000-20,000 inhabitants. However, significant economies of output density for unsorted (residual) municipal waste collection and recycling waste collection were found, which means it is advantageous to increase the amount of waste collected, but maintaining constant the number of customers and the intervention area. (c) 2015 Elsevier Ltd. All rights reserved.	[Carvalho, Pedro] Univ Fed Rio de Janeiro, Dept Civil Engn, LAMEMO Lab, COPPE UFRJ, BR-21941596 Rio De Janeiro, Brazil; [Carvalho, Pedro; Marques, Rui Cunha] Univ Lisbon, Inst Super Tecn, CESUR Ctr Urban & Reg Syst, P-1049001 Lisbon, Portugal; [Dollery, Brian] Univ New England, CLG, Armidale, NSW, Australia; [Dollery, Brian] Yokohama Natl Univ, Fac Econ, Yokohama, Kanagawa 240, Japan	Marques, RC (reprint author), Univ Lisbon, Inst Super Tecn, CESUR Ctr Urban & Reg Syst, Av Rovisco Pais, P-1049001 Lisbon, Portugal.	pedrotcc@gmail.com; rui.marques@tecnico.ulisboa.pt; bdollery@une.edu.au	Cunha Marques, Rui/F-6646-2010	Cunha Marques, Rui/0000-0003-0344-5200			Abrate G., 2012, REG STUD, P1; Aigner D. J., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Simoes P, 2010, WASTE MANAGE, V30, P1130, DOI 10.1016/j.wasman.2009.12.015; Antonioli B, 2002, REV IND ORGAN, V20, P239, DOI 10.1023/A:1015043524679; Greene W, 2005, J PROD ANAL, V23, P7, DOI 10.1007/s11123-004-8545-1; Carvalho P, 2014, WASTE MANAGE, V34, P12, DOI 10.1016/j.wasman.2013.10.004; CAVES DW, 1984, RAND J ECON, V15, P471, DOI 10.2307/2555519; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Worthington AC, 2001, POLICY STUD J, V29, P232, DOI 10.1111/j.1541-0072.2001.tb02088.x; Callan SJ, 2001, LAND ECON, V77, P548, DOI 10.2307/3146940; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Bel G, 2010, RESOUR CONSERV RECY, V54, P187, DOI 10.1016/j.resconrec.2009.07.015; Broitman D., 2012, WASTE MANAGE, V32; Chambers R. G., 1988, APPL PRODUCTION ANAL; Coelli T. J., 1992, J PROD ANAL, V3, P153, DOI DOI 10.1007/BF00158774; Daraio C., 2007, ADV ROBUST NONPARAME; DECCW, 2010, REV WAST STRAT POL S; DLG, 2013, COMP INF NSW LOC GOV; Feo G., 2012, WASTE MANAGE, V32, P1760; Folz DH, 1999, PUBLIC ADMIN REV, V59, P336, DOI 10.2307/3110116; Greene W, 2005, J ECONOMETRICS, V126, P269, DOI 10.1016/j.jeconom.2004.05.003; Greene William H., 2008, MEASUREMENT PRODUCTI; Hall J. P., 1973, Southern Journal of Agricultural Economics, V5, P115; Henningsen A, 2009, J PROD ANAL, V32, P217, DOI 10.1007/s11123-009-0142-x; HIRSCH WZ, 1965, REV ECON STAT, V47, P87, DOI 10.2307/1924127; Hsiao C., 2003, ANAL PANEL DATA; Lovell C. A. K., 2000, STOCHASTIC FRONTIER; PITT MM, 1981, J DEV ECON, V9, P43, DOI 10.1016/0304-3878(81)90004-3; Santibanez-Aguilar JE, 2013, WASTE MANAGE, V33, P2607, DOI 10.1016/j.wasman.2013.08.010; Schmidt P., 1984, J BUS ECON STAT, V2, P367, DOI DOI 10.2307/1391278; STEVENS BJ, 1978, REV ECON STAT, V60, P438, DOI 10.2307/1924169; Woodbury K., 2003, PUBLIC PERFORM MANAG, V27, P77	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	MAY	2015	39						277	286		10.1016/j.wasman.2015.01.024		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH6NC	WOS:000354152300030		
J	Kim, S; Mori, A				Kim, Soyoung; Mori, Akihisa			Revisiting the extended producer responsibility program for metal packaging in South Korea	WASTE MANAGEMENT			English	Article						Cost-benefit incidence analysis; Recycling rate; Waste deposit recycling program; Extended producer responsibility program; Metal packaging	LIFE-CYCLE ASSESSMENT; COST-BENEFIT-ANALYSIS; WASTE MANAGEMENT; SYSTEMS	Recently, developed and emerging countries have increasingly adopted the principle of extended producer responsibility (EPR) to reduce waste. In 2003, South Korea replaced the waste deposit recycling (WDR) program with the EPR program. Previous comparative analyses between the WDR and EPR programs have been qualitative evaluations and have not yet quantitatively shown whether the change has increased benefits. The aim of this paper is to explore which program brings larger net benefits. Because of limited data availability, here we focus on metal packaging exclusively. We find that the recycling rate dropped from 59% in 2000 to 40% in 2011 and recycling volume dropped accordingly. Cost-benefit incidence analysis shows that net social benefits decreased by 2.8 billion won (2.5 million US dollars), while the net benefits to producers increased by 1.9 billion won (1.7 million US dollars) under the EPR program compared with the WDR program. The government of South Korea should set an ambitious recycling target and narrow the scope of the exemption from the mandatory recycling requirement. (c) 2015 Elsevier Ltd. All rights reserved.	[Kim, Soyoung; Mori, Akihisa] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto 6068501, Japan	Kim, S (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Yoshidahonmachi, Kyoto 6068501, Japan.	kim.soyoung.72@st.kyoto-u.ac.jp; mori.akihisa.2a@kyoto-u.ac.jp			Graduate School of Global Environmental Studies Research Grant	This study was supported by a FY2013 Graduate School of Global Environmental Studies Research Grant for Young Faculty and Doctoral Students. The funding source played no role in the design, execution, or reporting of this study.	Lavee D, 2010, WASTE MANAGE, V30, P338, DOI 10.1016/j.wasman.2009.09.026; Reich MC, 2005, J CLEAN PROD, V13, P253, DOI 10.1016/j.jclepro.2004.02.015; Manomaivibool P, 2014, RESOUR CONSERV RECY, V83, P202, DOI 10.1016/j.resconrec.2013.10.011; Eriksson O, 2005, J CLEAN PROD, V13, P241, DOI 10.1016/j.jclepro.2004.02.018; Begum RA, 2006, RESOUR CONSERV RECY, V48, P86, DOI 10.1016/j.resconrec.2006.01.004; Baek S.H., 2011, J ENVIRON SCI, V20, P1395; Bruvoll A., 1998, COSTS ALTERNATIVE PO; Chang K., 1999, PRODUCER PAID DEPOSI, P26; Choi S., 2007, COST ESTIMATION RECY; CLC (Corporation for Landfill Management of Capital Area), 2013, SUD LANDF STAT YB, V11, P25; Craighill AL, 1996, RESOUR CONSERV RECY, V17, P75, DOI 10.1016/0921-3449(96)01105-6; Gwak J.M., 1998, APPL CHEM, V2, P274; Hosoyamada K., 2003, MONTHLY WASTE, V29, P34; Ibenholt K., 2003, J CONSUMER POLICY, V26, P301, DOI 10.1023/A:1025628405865; KECO, 2011, EV ACH EPR OP 8 YEAR, P28; KECO (Korea Environment Corporation), 2010, LOR ENV Q EXT PROD R, P9; KEI (Korea Environment Institute), 2002, COST EST REC IT EPR, P1; Kim K., 2006, REFORMING RESOURCE C, P23; KMCRA, 2012, CAN NAT, V14, P30; KMCRA (Korea Metal Cans Resources Association), 2009, CAN NAT, V9, P10; KOSIS, 2013, MARK TREND REC RES D; KOSIS, 2013, EXCH RAT US DOLL DAT; KOSIS, 2013, GDP DEFL; Lee S., 2004, THEORY PRACTICE ENV, Vfirst; Lee S., 2010, ENV CHARGES E ASIA, P228; Leu HG, 1998, RESOUR CONSERV RECY, V23, P183, DOI 10.1016/S0921-3449(98)00020-2; Lindhqvist T., 2000, THESIS LUND U LUND; Manomaivibool P., 2011, THESIS LUND U LUND; MOE, 2003, ENV WHIT PAP, P176; MOE, 2013, CURR STAT REC PERF E; MOE, 2012, ENV STAT YB, P505; MOE, 2001, ENV WHIT PAP, P7; MOE (Ministry of Environment of South Korea), 1992, ENV WHIT PAP, P57; Mok J.H., 2005, IMPROVEMENT PLAN WAS, P103; Morris J, 2005, INT J LIFE CYCLE ASS, V10, P273, DOI 10.1065/lca2004.09.180.10; Nolan-ITU SKM Economics and Envirosris, 2001, IND ASS KERBS REC AU; OECD, 2001, EXT PROD RESP GUID M; OECD and MOEJ (Ministry of the Environment of Japan), 2014, GLOB FOR ENV PROM SU; Oh G.J., 2008, DEV DECISION SUPPORT; Oh Y., 2003, KOREAN ASS POLICY ST, V12, P211; Park J.W, 2006, P EPR 3 EV C CHEONGP, P23; Shin H.S., 1995, ELECT TIMES; Smith S., 2005, ANAL FRAMEWORK EVALU; Sturges M., 2003, P OECD SEM EXT PROD, P150; Vigso D, 2004, WASTE MANAGE RES, V22, P477, DOI 10.1177/0734242X0409252; Walls M., 2006, 0608 RFF DP	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	MAY	2015	39						314	320		10.1016/j.wasman.2015.02.006		7	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CH6NC	WOS:000354152300034		
J	Imai, H; Miyawaki, S; Ono, H; Nakatomi, H; Yoshimoto, Y; Saito, N				Imai, Hideaki; Miyawaki, Satoru; Ono, Hideaki; Nakatomi, Hirofumi; Yoshimoto, Yuhei; Saito, Nobuhito			The Importance of Encephalo-Myo-Synangiosis in Surgical Revascularization Strategies for Moyamoya Disease in Children and Adults	WORLD NEUROSURGERY			English	Editorial Material						Direct anastomosis; Encephalo-myo-synangiosis; Indirect anastomosis; Moyamoya disease; Revascularization	MAJOR ARTERY STENOSIS/OCCLUSION; EPIDEMIOLOGIC FEATURES; ANGIOGRAPHIC OUTCOMES; CLINICAL ARTICLE; STA-MCA; ARTERIOGENESIS; SURGERY; VARIANT; RNF213; C.14576G-GREATER-THAN-A	OBJECTIVE: The optimal surgical procedure (direct, indirect, or combined anastomosis) for management of moyamoya disease is still debated. We evaluated the outcome of our broad area revascularization protocol, the Tokyo Daigaku (The University of Tokyo) (TODAI) protocol, analyzing the relative importance of direct, indirect, and combination revascularization strategies to identify the optimal surgical protocol. METHODS: The TODAI protocol was used to treat 65 patients with moyamoya disease (91 hemispheres, including 48 in 29 childhood cases collected during 1996-2012). The TODAI protocol combined direct superficial temporal artery (STA)-middle cerebral artery (MCA) anastomosis with indirect revascularization using encephalo-myo-synangiosis (EMS) for patients >= 10 years old or indirect revascularization using encephalo-duro-arterio-synangiosis (EDAS) with EMS for patients <= 9 years old. Clinical outcome was evaluated retrospectively. Digital subtraction angiography was performed for postoperative evaluation of revascularization in 47 patients (62 hemispheres; 27 adults and 35 children). Based on the relative contribution of additional flow from each revascularization path, 4 revascularization patterns were established. RESULTS: The mean follow-up period was 90 months in children and 72 months in adults. Perioperative complications were seen in 4 of 48 operations in children and 1 of 43 operations in adults. Except for 1 child with recurrent transient ischemic attacks and 1 adult with intracerebral hemorrhage, the patients showed excellent clinical outcomes. Postoperative digital subtraction angiography evaluation showed that in STA-MCA anastomosis + EMS cases (34 hemispheres; 25 adults and 9 children), STA-MCA anastomosis provided greater revascularization than EMS (STA-MCA anastomosis > EMS) in 7 hemispheres, the opposite was true (STA-MCA anastomosis < EMS) in 14 hemispheres, an equivalent contribution to revascularization (STA-MCA anastomosis approximate to EMS) was present in 12 hemispheres, and no functioning anastomosis was present in 1 hemisphere. In cases of EDAS + EMS (28 hemispheres; 2 adults and 26 children), all hemispheres showed revascularization: EDAS was dominant to EMS (EDAS > EMS) in 1 hemisphere, the opposite (EMS > EDAS) was true in 14 hemispheres, and EDAS was equivalent to EMS (EDAS approximate to EMS) in 13 hemispheres. EMS plus direct or indirect anastomosis is an effective surgical procedure in adults and children. CONCLUSIONS: The TODAI protocol provided efficient revascularization and yielded excellent results in preventing strokes in patients with moyamoya disease with very few complications. EMS had a main role in revascularization in each of the combined techniques.	[Imai, Hideaki; Miyawaki, Satoru; Ono, Hideaki; Nakatomi, Hirofumi; Saito, Nobuhito] Univ Tokyo, Fac Med, Dept Neurosurg, Tokyo 113, Japan; [Yoshimoto, Yuhei] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma, Japan	Saito, N (reprint author), Univ Tokyo, Fac Med, Dept Neurosurg, Tokyo 113, Japan.	nsaito-tky@umin.net					SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Houkin K, 1997, CHILD NERV SYST, V13, P24, DOI 10.1007/s003810050034; Dusick JR, 2011, NEUROSURGERY, V68, P34, DOI 10.1227/NEU.0b013e3181fc5ec2; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Guzman R, 2009, J NEUROSURG, V111, P927, DOI 10.3171/2009.4.JNS081649; Han DH, 2000, ACTA NEUROCHIR, V142, P1263, DOI 10.1007/s007010070024; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Nakamura M, 2009, J NEUROS-PEDIATR, V3, P488, DOI 10.3171/2008.6.PEDS0834; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Golby AJ, 1999, NEUROSURGERY, V45, P50, DOI 10.1097/00006123-199907000-00013; Heil M, 2007, CURR PHARM BIOTECHNO, V8, P35, DOI 10.2174/138920107779941408; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Baaj AA, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.01.FOCUS08293; Burke GM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08310; Dusick JR, 2012, J NEUROSURG, V117, P94, DOI 10.3171/2012.4.JNS111103; GOLDSMITH HS, 1975, AM J SURG, V130, P317, DOI 10.1016/0002-9610(75)90393-1; Hanggi D, 2008, ACT NEUR S, V103, P119; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P73, DOI 10.3171/2010.4.PEDS09478; Im Sang Hyuk, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P75, DOI 10.7461/jcen.2012.14.2.75; Imai H, 2009, J CEREBR BLOOD F MET, V29, pS377; Ishikawa T, 1997, STROKE, V28, P1170; KARASAWA J, 1977, Neurologia Medico-Chirurgica, V17, P29, DOI 10.2176/nmc.17pt1.29; KARASAWA J, 1978, J NEUROSURG, V49, P679, DOI 10.3171/jns.1978.49.5.0679; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; MASUMORI Y, 1992, SURG NEUROL, V38, P411, DOI 10.1016/0090-3019(92)90108-Y; MATSUSHIMA T, 1990, ACTA NEUROCHIR, V104, P96, DOI 10.1007/BF01842826; Mesiwala AH, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E15; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Mizoi K, 1996, SURG NEUROL, V45, P541, DOI 10.1016/0090-3019(95)00475-0; Reis Cassius V C, 2006, Neurosurg Focus, V20, pE7; Sainte-Rose C, 2006, J NEUROSURG, V105, P437, DOI 10.3171/ped.2006.105.6.437; Saito N, 2011, WORLD NEUROSURG, V75, P204, DOI 10.1016/j.wneu.2010.10.004; Takeuchi K, 1957, NO TO SHINKEI, V9, P37; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0; Zipfel GJ, 2005, SKULL BASE-INTERD AP, V15, P27, DOI 10.1055/s-2005-868161	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2015	83	5					691	699		10.1016/j.wneu.2015.01.016		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI2FS	WOS:000354561500005		
J	Sano, H; Satoh, A; Murayama, Y; Kato, Y; Origasa, H; Inamasu, J; Nouri, M; Cherian, I; Saito, N				Sano, Hirotoshi; Satoh, Akira; Murayama, Yuichi; Kato, Yoko; Origasa, Hideki; Inamasu, Joji; Nouri, Mohsen; Cherian, Iype; Saito, Nobuto		38 Registered Inst; WFNS Cerebrovasc Dis & Treatment C	Modified World Federation of Neurosurgical Societies Subarachnoid Hemorrhage Grading System	WORLD NEUROSURGERY			English	Article						Glasgow Coma Scale; Modified Rankin Scale; Outcomes; Subarachnoid hemorrhage; World Federation of Neurosurgical Societies	GLASGOW COMA SCALE; INTRACRANIAL ANEURYSMS; PREDICTION; SURGERY	OBJECT: A modified World Federation of Neurosurgical Societies scale (m-WFNS scale) for aneurysmal subarachnoid hemorrhage (SAH) recently has been proposed, in which patients with Glasgow Coma Scale (GCS) scores of 14 are assigned to grade II and those with GCS scores of 13 are assigned to grade III regardless of the presence of neurologic deficits. The study objective was to evaluate outcome predictability of the m-WFNS scale in a large cohort. METHODS: This was a multicenter prospective observational study conducted in Japan. A total of 1656 patients with SAH were registered during the 2.5-year study period, and the outcome predictability, using the Glasgow Outcome Scale (GOS) and modified Rankin Scale (mRS) scores at discharge and at 90 days after onset, was evaluated by comparing the m-WFNS with the original WFNS scale. We focused on whether significant differences in these scores were present between the neighboring grades. RESULTS: In the m-WFNS scale, significant difference between any neighboring grades was observed both in the mean GOS and mRS scores at 90 days except between grades III/IV. However, differences were not significant between grades II/III and between grades III/IV in the original WFNS scale. CONCLUSIONS: SAH-induced brain injury may be substantially severer in patients with GCS 13 than those with GCS 14, which may explain why grade III patients faired significantly worse than grade II patients by the modified WFNS scale. Although further validation is necessary, the m-WFNS scale has a potential of providing neurosurgeons with simpler and more reliable prognostication of patients with SAH.	[Sano, Hirotoshi; Satoh, Akira; Murayama, Yuichi; Kato, Yoko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, IWFNS Cerebrovasc Dis & Therapy Comm, Toyama 930, Japan; [Origasa, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Biostat & Clin Epidemiol, Toyama 930, Japan; [Inamasu, Joji] Fujita Hlth Univ, Sch Med, Dept Neurosurg, Toyoake, Aichi 47011, Japan; [Nouri, Mohsen] Univ Tehran Med Sci, Dept Neurosurg, Tehran, Iran; [Cherian, Iype] COMS Bharatpur, Dept Neurosurg, Bharatpur, Nepal; [38 Registered Inst] Japan Neurosurg Soc, Sci Council, Tokyo, Japan	Sano, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, IWFNS Cerebrovasc Dis & Therapy Comm, Toyama 930, Japan.	hsano@white-jack.jp					Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; DRAKE CG, 1988, J NEUROSURG, V68, P985; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/Neurocrit.Care2005;2:110-118; van Heuven AW, 2008, STROKE, V39, P1347, DOI 10.1161/STROKEAHA.107.498345; Aulmann C, 1998, ZBL NEUROCHIR, V59, P171; BOTTERELL EH, 1956, J NEUROSURG, V13, P1, DOI 10.3171/jns.1956.13.1.0001; Cavanagh Stephen J, 2002, J Neurosci Nurs, V34, P288; Chaing VL, 2000, NEUROSURGERY, V46, P28; Gotoh O, 1996, NEUROSURGERY, V39, P19, DOI 10.1097/00006123-199607000-00005; Hirai S, 1996, NEUROSURGERY, V39, P441, DOI 10.1097/00006123-199609000-00002; Hunt W E, 1974, Clin Neurosurg, V21, P79	12	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2015	83	5					801	807		10.1016/j.wneu.2014.12.032		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI2FS	WOS:000354561500035		
J	Yokobori, S; Zhang, ZQ; Moghieb, A; Mondello, S; Gajavelli, S; Dietrich, WD; Bramlett, H; Hayes, RL; Wang, M; Wang, KKW; Bullock, MR				Yokobori, Shoji; Zhang, Zhiqun; Moghieb, Ahmed; Mondello, Stefania; Gajavelli, Shyam; Dietrich, W. Dalton; Bramlett, Helen; Hayes, Ronald L.; Wang, Michael; Wang, Kevin K. W.; Bullock, M. Ross			Acute Diagnostic Biomarkers for Spinal Cord Injury: Review of the Literature and Preliminary Research Report	WORLD NEUROSURGERY			English	Review						Biomarker; Pathophysiology; Spinal cord injury; Treatment	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; FIBRILLARY ACIDIC PROTEIN; ALPHA-II-SPECTRIN; C-TERMINAL HYDROLASE; CLEAVED-TAU-PROTEIN; NEUROFILAMENT NF-H; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; AXONAL INJURY	OBJECTIVE: Many efforts have been made to create new diagnostic technologies for use in the diagnosis of central nervous system injury. However, there is still no consensus for the use of biomarkers in clinical acute spinal cord injury (SCI). The aims of this review are (1) to evaluate the current status of neurochemical biomarkers and (2) to discuss their potential acute diagnostic role in SCI by reviewing the literature. METHODS: PubMed (http://www.ncbi.nlm.nih.gov/pubmed) was searched up to 2012 to identify publications concerning diagnostic biomarkers in SCI. To support more knowledge, we also checked secondary references in the primarily retrieved literature. RESULTS: Neurofilaments, cleaved-Tau, microtubule-associated protein 2, myelin basic protein, neuron-specific enolase, S100 beta, and glial fibrillary acidic protein were identified as structural protein biomarkers in SCI by this review process. We could not find reports relating ubiquitin C-terminal hydrolase-L1 and alpha-II spectrin breakdown products, which are widely researched in other central nervous systeminjuries. Therefore, wepresent our preliminary data relating to these two biomarkers. Some of biomarkers showed promising results for SCI diagnosis and outcome prediction; however, there were unresolved issues relating to accuracy and their accessibility. CONCLUSION: Currently, there still are not many reports focused on diagnostic biomarkers in SCI. This fact warranted the need for greater efforts to innovate sensitive and reliable biomarkers for SCI.	[Yokobori, Shoji; Gajavelli, Shyam; Dietrich, W. Dalton; Bramlett, Helen; Wang, Michael; Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Zhang, Zhiqun; Moghieb, Ahmed; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Zhang, Zhiqun; Moghieb, Ahmed; Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Mondello, Stefania; Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Yokobori, S (reprint author), Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA.	SYokobori@med.miami.edu	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614			Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322, DOI 10.1097/01.PCC.0000075323.47797.B8; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Berger RP, 2005, J NEUROSURG, V103, P61; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Ueno T, 2011, SPINAL CORD, V49, P333, DOI 10.1038/sc.2010.116; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI [10.1586/erm.10.104, 10.1586/ERM.10.104]; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Marquardt G, 2009, ACTA NEUROCHIR, V151, P1439, DOI 10.1007/s00701-009-0408-0; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Herrmann M, 2000, STROKE, V31, P2670; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Baydas G, 2003, EUR J PHARMACOL, V462, P67, DOI 10.1016/S0014-2999(03)01294-9; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Missler U, 1997, STROKE, V28, P1956; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.00001089998.48026.C3; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Brisby H, 1999, SPINE, V24, P742, DOI 10.1097/00007632-199904150-00003; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cengiz P, 2008, PEDIATR CRIT CARE ME, V9, P524, DOI 10.1097/PCC.0b013e3181849dc9; Chen AS, 2009, METHODS MOL BIOL, V566, P57, DOI 10.1007/978-1-59745-562-6_4; Coleman M. P., 2004, Current Drug Targets - CNS and Neurological Disorders, V3, P227, DOI 10.2174/1568007043337436; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dumont AS, 2002, CURR OPIN NEUROL, V15, P713, DOI 10.1097/01.wco.0000044768.39452.5b; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Iino M, 2003, INT J LEGAL MED, V117, P153, DOI 10.1007/s00414-003-0370-y; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Keller JN, 2000, J CEREBR BLOOD F MET, V20, P1467; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Lee SJ, 2010, EMERG MED J, V27, P209, DOI 10.1136/emj.2008.063743; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Ma JJ, 2001, SCAND J PLAST RECONS, V35, P355; Marquardt Gerhard, 2006, Neurosurgery, V58, pE590; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; MATUS A, 1988, TRENDS NEUROSCI, V11, P291, DOI 10.1016/0166-2236(88)90086-0; Mondello S, 2011, J NEUROTRAUM, V29, P1096; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shiiya N, 2004, ANN THORAC SURG, V77, P2034, DOI 10.1016/j.athoracsur.2003.12.057; Springer JE, 1997, J NEUROCHEM, V69, P1592; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; Winnerkvist A, 2007, EUR J CARDIO-THORAC, V31, P637, DOI 10.1016/j.ejcts.2007.01.007; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yamazaki Y, 1995, SURG NEUROL, V43, P270; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang B, 2011, J TRAUMA, V71, P1680, DOI 10.1097/TA.0b013e318231bce7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	122	5	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2015	83	5					867	878		10.1016/j.wneu.2013.03.012		12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI2FS	WOS:000354561500044		
J	Zhang, QS; Song, X; Shao, XW; Zhao, HJ; Shibasaki, R				Zhang, Quanshi; Song, Xuan; Shao, Xiaowei; Zhao, Huijing; Shibasaki, Ryosuke			From RGB-D Images to RGB Images: Single Labeling for Mining Visual Models	ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY			English	Article						Design; Algorithms; Performance; Theory; Data mining; computer vision; big visual data; visual mining; transfer learning; visual knowledge base; RGB-D sensor	JOINT OBJECT DETECTION; GRAPH; DISCOVERY; HOUGH; OPTIMIZATION; RECOGNITION	Mining object-level knowledge, that is, building a comprehensive category model base, from a large set of cluttered scenes presents a considerable challenge to the field of artificial intelligence. How to initiate model learning with the least human supervision (i.e., manual labeling) and how to encode the structural knowledge are two elements of this challenge, as they largely determine the scalability and applicability of any solution. In this article, we propose a model-learning method that starts from a single-labeled object for each category, and mines further model knowledge from a number of informally captured, cluttered scenes. However, in these scenes, target objects are relatively small and have large variations in texture, scale, and rotation. Thus, to reduce the model bias normally associated with less supervised learning methods, we use the robust 3D shape in RGB-D images to guide our model learning, then apply the properly trained category models to both object detection and recognition in more conventional RGB images. In addition to model training for their own categories, the knowledge extracted from the RGB-D images can also be transferred to guide model learning for a new category, in which only RGB images without depth information in the new category are provided for training. Preliminary testing shows that the proposed method performs as well as fully supervised learning methods.	[Zhang, Quanshi] Univ Calif Los Angeles, Los Angeles, CA 90089 USA; [Zhang, Quanshi; Shibasaki, Ryosuke] Univ Tokyo, Tokyo 1138654, Japan; [Song, Xuan; Shao, Xiaowei; Shibasaki, Ryosuke] Univ Tokyo, Ctr Spatial Informat Sci, Tokyo, Japan; [Zhao, Huijing] Peking Univ, Key Lab Machine Percept MoE, Beijing 100871, Peoples R China	Zhang, QS (reprint author), Univ Calif Los Angeles, Los Angeles, CA 90089 USA.	zhangqs@g.ucla.edu; songxuan@csis.u-tokyo.ac.jp; shaoxw@csis.u-tokyo.ac.jp; zhaohj@cis.pku.edu.cn; shiba@csis.u-tokyo.ac.jp			Microsoft Research; Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23700192]; Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT)	This work was supported by Microsoft Research. It was also supported by a Grant-in-Aid for Young Scientists (23700192) of Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT); and a grant from Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT).	Lai K, 2011, IEEE INT CONF ROBOT, P1817; Ren XF, 2012, PROC CVPR IEEE, P2759; Torresani L, 2008, LECT NOTES COMPUT SC, V5303, P596, DOI 10.1007/978-3-540-88688-4_44; Lai K, 2010, INT J ROBOT RES, V29, P1019, DOI 10.1177/0278364910369190; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Liao ZC, 2012, PROC CVPR IEEE, P3442; Liu CK, 2005, ACM T GRAPHIC, V24, P1071, DOI 10.1145/1073204.1073314; Aldoma A, 2012, LECT NOTES COMPUT SC, V7574, P511, DOI 10.1007/978-3-642-33712-3_37; Zhu JY, 2012, PROC CVPR IEEE, P3218; Caetano TS, 2009, IEEE T PATTERN ANAL, V31, P1048, DOI 10.1109/TPAMI.2009.28; Zhou F, 2013, PROC CVPR IEEE, P2922, DOI 10.1109/CVPR.2013.376; Li LJ, 2010, INT J COMPUT VISION, V88, P147, DOI 10.1007/s11263-009-0265-6; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Duchenne O, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1792, DOI 10.1109/ICCV.2011.6126445; Kolmogorov V, 2006, IEEE T PATTERN ANAL, V28, P1568, DOI 10.1109/TPAMI.2006.200; Tuytelaars T, 2010, INT J COMPUT VISION, V88, P284, DOI 10.1007/s11263-009-0271-8; Zhang QS, 2013, PROC CVPR IEEE, P193, DOI 10.1109/CVPR.2013.32; Leordeanu M, 2005, IEEE I CONF COMP VIS, P1482; Kim G, 2012, PROC CVPR IEEE, P837; Lee YJ, 2011, PROC CVPR IEEE, P1721; Hu N, 2013, PROC CVPR IEEE, P2906, DOI 10.1109/CVPR.2013.374; Kim G, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P169; Cho M, 2010, PROC CVPR IEEE, P1617, DOI 10.1109/CVPR.2010.5539777; Maji S, 2009, PROC CVPR IEEE, P1038; Hu WZ, 2012, PROC CVPR IEEE, P2336; Yuan JS, 2012, IEEE T IMAGE PROCESS, V21, P2207, DOI 10.1109/TIP.2011.2181952; Silberman N, 2012, LECT NOTES COMPUT SC, V7576, P746, DOI 10.1007/978-3-642-33715-4_54; Leordeanu M, 2012, INT J COMPUT VISION, V96, P28, DOI 10.1007/s11263-011-0442-2; Hong PY, 2004, DISCRETE APPL MATH, V139, P113, DOI 10.1016/j.dam.2002.11.007; Ferrari V, 2010, INT J COMPUT VISION, V87, P284, DOI 10.1007/s11263-009-0270-9; Dalal N, 2005, PROC CVPR IEEE, P886; Liu HR, 2010, PROC CVPR IEEE, P1609, DOI 10.1109/CVPR.2010.5539780; Tan HK, 2009, IMAGE VISION COMPUT, V27, P1470, DOI 10.1016/j.imavis.2009.01.002; Wang XG, 2012, PROC CVPR IEEE, P151; Cho M, 2012, PROC CVPR IEEE, P398; Hsiao E, 2010, PROC CVPR IEEE, P2653, DOI 10.1109/CVPR.2010.5539981; Bradski G., 2011, NIST WILLOW GARAGE S; Browatzki B., 2011, IEEE ICCV WORKSH, P1189; Chen HY, 2013, PROC CVPR IEEE, P2762, DOI 10.1109/CVPR.2013.356; Chiu WC, 2013, PROC CVPR IEEE, P321, DOI 10.1109/CVPR.2013.48; Cho M., 2013, INT C COMP VIS ICCV; Collet A., 2011, ICRA; Faktor A, 2012, LECT NOTES COMPUT SC, V7578, P474, DOI 10.1007/978-3-642-33786-4_35; Fouhey D. F., 2013, INT C COMP VIS ICCV; Helmer S., 2010, UBC ROBOT VISION SUR; Janoch A., 2012, THESIS U CALIFORNIA; Jiang H., 2003, INT C VIS INF SYST, P63; Joulin A, 2012, PROC CVPR IEEE, P542, DOI 10.1109/CVPR.2012.6247719; Kang HW, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P762; Kim GH, 2008, IEEE WORKSH APPL COM, P1; Kim K. I., 2012, 12 EUR C COMP VIS EC, P272; KOPPULA H. S., 2011, NIPS, P244; Le Q. V., 2012, ICML; Leordeanu M., 2007, IEEE COMPUTER VISION, P1; Leordeanu M., 2008, IEEE C COMP VIS PATT, P1; Li CC, 2012, PROC CVPR IEEE, P2735; Lin C., 2004, SIMPLE PROBABILISTIC; Liu HR, 2012, PROC CVPR IEEE, P574; Liu K, 2012, PROC CVPR IEEE, P917; Microsoft, 2011, INTR KIN XB 360; Mukherjee L., 2012, P ECCV, V7575, P128; Olsson C, 2012, PROC CVPR IEEE, P1576, DOI 10.1109/CVPR.2012.6247849; Pepik B., 2012, EUR C COMP VIS ECCV, V7577, P356; Razavi N., 2012, 12 EUR C COMP VIS EC, P312; Silberman N., 2011, ICCV WORKSH, P601; Sun M, 2010, LECT NOTES COMPUT SC, V6315, P658; Susanto W., 2012, LNCS, V7584, P93; Vijayanarasimhan S, 2011, PROC CVPR IEEE, P1449, DOI 10.1109/CVPR.2011.5995430; Wallraven C., 2003, COMP VIS 2003 P 9 IE, V1, P257; Wang T, 2013, PROC CVPR IEEE, P1790, DOI 10.1109/CVPR.2013.234; Wohlkinger W., 2012, ICRA, P5384; Xie H., 2012, ACM MULTIMEDIA, P1385; Xu Y, 2012, PROC CVPR IEEE, P3402; Zhang Q., 2013, P IEEE INT C ROB AUT; Zhang Q., 2014, INT C COMP VIS PATT; Zhang Q., 2014, P IEEE INT C ROB AUT; Zhang Q., 2013, IEEE INT C COMP VIS; Zhang Q., 2013, CATEGORY DATASET KIN; Zhao G., 2010, ACM P INT C MULT, P975	79	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	2157-6904	2157-6912		ACM T INTEL SYST TEC	ACM Trans. Intell. Syst. Technol.	MAY	2015	6	2							16	10.1145/2629701		29	Computer Science, Artificial Intelligence; Computer Science, Information Systems	Computer Science	CH5BR	WOS:000354049800006		
J	Mohri, S; Ohisa, S; Isozaki, K; Yonezawa, N; Okamoto, A				Mohri, Saki; Ohisa, Shinji; Isozaki, Katsuhiro; Yonezawa, Noriyuki; Okamoto, Akiko			Hydrogen bonding between aromatic H and F groups leading to a stripe structure with R- and S-columns: the crystal structure of (2,7-dimethoxynaphthalen-1-yl)(3-fluorophenyl)methanone and comparison with its 1-aroylnaphthalene analogues	ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY			English	Article						crystal structure; 1-aroylnaphthalene; C-H center dot center dot center dot F hydrogen bonds; axial chirality; C-H center dot center dot center dot O=C hydrogen bonds; stripe structure; column structure of enantiomeric isomers	ARSE AROYLATION; NAPHTHALENE; CRYSTALLIZATION	In the molecule of (2,7-dimethoxynaphthalen-1-yl)(3-fluorophenyl) methanone, C19H15FO3, (I), the dihedral angle between the plane of the naphthalene ring system and that of the benzene ring is 85.90 (5)degrees. The molecules exhibit axial chirality, with either an R-or an S-stereogenic axis. In the crystal structure, each enantiomer is stacked into a columnar structure and the columns are arranged alternately to form a stripe structure. A pair of (methoxy) C-H center dot center dot center dot F hydrogen bonds and pi-pi interactions between the benzene rings of the aroyl groups link an R-and an S-isomer to form a dimeric pair. These dimeric pairs are piled up in a columnar fashion through (benzene) C-H center dot center dot center dot O=C and (benzene) CH center dot center dot center dot OCH3 hydrogen bonds. The analogous 1-benzoylated compound, namely (2,7-dimethoxynaphthalen-1-yl)(phenyl) methanone [Kato et al. (2010). Acta Cryst. E66, o2659], (II), affords three independent molecules having slightly different dihedral angles between the benzene and naphthalene rings. The three independent molecules form separate columns and the three types of column are connected to each other via two C-H center dot center dot center dot OCH3 hydrogen bonds and one C-H center dot center dot center dot O=C hydrogen bond. Two of the three columns are formed by the same enantiomeric isomer, whereas the remaining column consists of the counterpart isomer. In the case of the fluorinated 1-benzoylated naphthalene analogue, namely (2,7-dimethoxynaphthalen-1-yl)(4-fluorophenyl) methanone [Watanabe et al. (2011). Acta Cryst. E67, o1466], (III), the molecular packing is similar to that of (I), i.e. it consists of stripes of R-and S-enantiomeric columns. A pair of C-H center dot center dot center dot F hydrogen bonds between R-and S-isomers, and CH center dot center dot center dot O=C hydrogen bonds between R(or S)-isomers, are also observed. Consequently, the stripe structure is apparently induced by the formation of R center dot center dot center dot S dimeric pairs stacked in a columnar fashion. The pair of C-H center dot center dot center dot F hydrogen bonds effectively stabilizes the dimeric pair of R- and S-enantiomers. In addition, the co-existence of C-H center dot center dot center dot F and C-H center dot center dot center dot O=C hydrogen bonds makes possible the formation of a structure with just one independent molecule.	[Mohri, Saki; Ohisa, Shinji; Yonezawa, Noriyuki; Okamoto, Akiko] TUAT, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan; [Isozaki, Katsuhiro] Kyoto Univ, Inst Chem Res, Int Res Ctr Elements Sci, Kyoto 6110011, Japan	Okamoto, A (reprint author), TUAT, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan.	aokamoto@cc.tuat.ac.jp			Institute for Chemical Research, Kyoto University [2014-97]	The authors express their gratitude to Associate Professor Hikaru Takaya and Professor Masaharu Nakamura, Institute for Chemical Research, Kyoto University, for their kind advice. This work was partially supported by the Collaborative Research Programme of the Institute for Chemical Research, Kyoto University (grant No. 2014-97).	KONDEPUDI DK, 1993, J AM CHEM SOC, V115, P10211, DOI 10.1021/ja00075a041; Domasevitch KV, 2012, CHEM COMMUN, V48, P5847, DOI 10.1039/c2cc31770b; Sakamoto M, 2008, J AM CHEM SOC, V130, P1132, DOI 10.1021/ja077912m; Burla MC, 2007, J APPL CRYSTALLOGR, V40, P609, DOI 10.1107/S0021889807010941; Armarego W.L.F., 1996, PURIFICATION LAB CHE; Burnett M.N., 1996, ORNL6895; Higashi T., 1999, NUMABS; Jacques J., 1994, ENANTIOMERS RACEMATE; Kato Y, 2010, ACTA CRYSTALLOGR E, V66, pO2659, DOI 10.1107/S1600536810038195; Nakaema K., 2008, ACTA CRYSTALLOGR E, VE64, po807; Okamoto A., 2014, EUR CHEM B, V3, P829; Okamoto A, 2009, CHEM LETT, V38, P914, DOI 10.1246/cl.2009.914; Okamoto A, 2011, CHEM LETT, V40, P1283, DOI 10.1246/cl.2011.1283; Rigaku, 2010, CRYSTALSTRUCTURE; Rigaku, 1998, PROCESS AUTO; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Watanabe S, 2011, ACTA CRYSTALLOGR E, V67, pO1466, DOI 10.1107/S1600536811018332; Watanabe S, 2010, ACTA CRYSTALLOGR E, V66, pO329, DOI 10.1107/S1600536810000486; Yoshiwaka S, 2014, ACTA CRYSTALLOGR C, V70, P1096, DOI 10.1107/S2053229614022967	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-2701	1600-5759		ACTA CRYSTALLOGR C	Acta Crystallogr. Sect. C-Struct. Chem.	MAY	2015	71		5				344	U209		10.1107/S2053229615005720		12	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CH4YI	WOS:000354039600001		
J	Akita, H; Seto, T; Ohshima, T; Sakuraba, H				Akita, Hironaga; Seto, Tomonari; Ohshima, Toshihisa; Sakuraba, Haruhiko			Structural insight into the thermostable NADP(+)-dependent meso-diaminopimelate dehydrogenase from Ureibacillus thermosphaericus	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						meso-diaminopimelate dehydrogenase; Ureibacillus thermosphaericus	AMINO-ACID DEHYDROGENASE; 1ST CRYSTAL-STRUCTURE; CORYNEBACTERIUM-GLUTAMICUM; SYMBIOBACTERIUM-THERMOPHILUM; GLUTAMATE-DEHYDROGENASE; 3-DIMENSIONAL STRUCTURE; SOFTWARE; MUTAGENESIS; VALIDATION; STABILITY	Crystal structures of the thermostable meso-diaminopimelate dehydrogenase (DAPDH) from Ureibacillus thermosphaericus were determined for the enzyme in the apo form and in complex with NADP(+) and N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid. The main-chain coordinates of the enzyme showed notable similarity to those of Symbiobacterium thermophilum DAPDH. However, the subunit arrangement of U. thermosphaericus DAPDH (a dimer) was totally different from that of the S. thermophilum enzyme (a hexamer). Structural comparison with the dimeric enzyme from the mesophile Corynebacterium glutamicum revealed that the presence of large numbers of intrasubunit and intersubunit hydrophobic interactions, as well as the extensive formation of intersubunit ion-pair networks, were likely to be the main factors contributing to the higher thermostability of U. thermosphaericus DAPDH. This differs from S. thermophilum DAPDH, within which the unique hexameric assembly is likely to be responsible for its high thermostability. Analysis of the active site of U. thermosphaericus DAPDH revealed the key factors responsible for the marked difference in substrate specificity between DAPDH and the D-amino acid dehydrogenase recently created from DAPDH by introducing five point mutations [Akita et al. (2012). Biotechnol. Lett.34, 1693-1699; 1701-1702].	[Akita, Hironaga] Kyushu Univ, Fac Agr, Appl Mol Microbiol & Biomass Chem, Biosci & Biotechnol,Higashi Ku, Fukuoka 8128581, Japan; [Akita, Hironaga] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan; [Seto, Tomonari] Kagawa Univ, Fac Agr, Div Rare Sugar Sci, Miki, Kagawa 7610795, Japan; [Ohshima, Toshihisa] Osaka Inst Technol, Fac Engn, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Sakuraba, H (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	sakuraba@ag.kagawa-u.ac.jp			KAKENHI [25.4653, 22248010]; Promotion of Basic Research Activities for Innovative Bioscience from the Bio-oriented Technology Research Advancement Institution (BRAIN)	We are grateful to all of the laboratory members at Kagawa University and Kyushu University for their technical assistance and valuable discussions. This work was supported by grants from KAKENHI (25.4653 to HA and 22248010 to TO). This work was also supported by a grant for the Promotion of Basic Research Activities for Innovative Bioscience from the Bio-oriented Technology Research Advancement Institution (BRAIN).	Akita H, 2014, BIOTECHNOL LETT, V36, P2245, DOI 10.1007/s10529-014-1597-z; Akita H., 2012, BIOTECHNOL LETT, V34, P1701; Akita H, 2012, BIOTECHNOL LETT, V34, P1693, DOI 10.1007/s10529-012-0952-1; Akita H, 2014, APPL MICROBIOL BIOT, V98, P1135, DOI 10.1007/s00253-013-4902-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Akita H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-43; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Vedha-Peters K, 2006, J AM CHEM SOC, V128, P10923, DOI 10.1021/ja0603960; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; MISONO H, 1979, J BACTERIOL, V137, P22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M202117200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Scapin G, 1996, BIOCHEMISTRY-US, V35, P13540, DOI 10.1021/bi961628i; Bhuiya MW, 2005, J MOL BIOL, V345, P325, DOI 10.1016/j.jmb.2004.10.063; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cirilli M, 2000, PROTEIN SCI, V9, P2034; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gao XZ, 2013, APPL ENVIRON MICROB, V79, P5078, DOI 10.1128/AEM.01049-13; Gao XZ, 2012, APPL ENVIRON MICROB, V78, P8595, DOI 10.1128/AEM.02234-12; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Liu WD, 2014, CHEMBIOCHEM, V15, P217, DOI 10.1002/cbic.201300691; MISONO H, 1986, AGR BIOL CHEM TOKYO, V50, P2729; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakuraba H, 2003, J BIOL CHEM, V278, P10799, DOI 10.1074/jbc.M212449200; Scapin G, 1998, BIOCHEMISTRY-US, V37, P3278, DOI 10.1021/bi9727949; MISONO H, 1980, J BIOL CHEM, V255, P599; Watanabe M, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0027-x	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	MAY	2015	71		5				1136	1146		10.1107/S1399004715003673		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CH9SN	WOS:000354376700012		
J	Kikuchi, Y				Kikuchi, Yoshiyuki			UCL Chemistry Department 1828-1974	AMBIX			English	Book Review									[Kikuchi, Yoshiyuki] Grad Univ Adv Studies, Hayama, Japan	Kikuchi, Y (reprint author), Grad Univ Adv Studies, Hayama, Japan.						DAVIES A, 2013, UCL CHEM DEP 1828 19	1	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0002-6980	1745-8234		AMBIX	Ambix	MAY	2015	62	2			SI		194	195				2	History & Philosophy Of Science	History & Philosophy of Science	CH4UW	WOS:000354029500008		
J	Takaya, Y; Kusano, KF; Nakamura, K; Ito, H				Takaya, Yoichi; Kusano, Kengo F.; Nakamura, Kazufumi; Ito, Hiroshi			Comparison of Outcomes in Patients With Probable Versus Definite Cardiac Sarcoidosis	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							ATRIOVENTRICULAR-BLOCK; DIAGNOSIS; THERAPY; DISEASE; HEART	Patients with probable cardiac sarcoidosis (CS) who satisfy only clinical cardiac findings for CS are not uncommon. The aim of this study was to compare outcomes between patients with probable CS and those with definite CS treated with steroids. The study population consisted of 101 consecutive patients who satisfied clinical cardiac findings for CS. Patients with definite CS were defined as having histologic or clinical confirmation of CS according to the guidelines and were treated with steroids. Patients with probable CS were defined as having only clinical cardiac findings but not definite CS because of no histologic confirmation or extracardiac sarcoidosis and were not treated with steroids. The end point was major adverse cardiac events. Forty-seven patients had definite CS, and the other 54 had probable CS. Except for serum angiotensin-converting enzyme levels and left ventricular dysfunction, clinical characteristics were similar between the 2 groups. Over a median follow-up period of 15 months, major adverse cardiac events occurred more frequently in patients with probable CS than in those with definite CS (74% vs 53%, p = 0.029). The event-free survival rate was worse in patients with probable CS than in those with definite CS (log-rank test, p = 0.006). Cox proportional-hazards analysis showed that probable CS was an independent predictor of major adverse cardiac events. In conclusion, outcomes were worse in patients with probable CS than in those with definite CS treated with steroids. The initiation of steroid treatment may be considered for patients who satisfy only clinical cardiac findings for CS. (C) 2015 Elsevier Inc. All rights reserved.	[Takaya, Yoichi; Kusano, Kengo F.; Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan	Takaya, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan.	takayayoichi@yahoo.co.jp					ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Tadamura E, 2006, CIRCULATION, V113, pE771, DOI 10.1161/CIRCULATIONAHA.105.594200; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; MATSUI Y, 1976, ANN NY ACAD SCI, V278, P455, DOI 10.1111/j.1749-6632.1976.tb47058.x; Banba K, 2007, HEART RHYTHM, V4, P1292, DOI 10.1016/j.hrthm.2007.06.006; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118; Youssef G, 2011, HEART, V97, P2078, DOI 10.1136/hrt.2011.226076; OKAYAMA K, 1995, CHEST, V107, P330, DOI 10.1378/chest.107.2.330; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Kato Y, 2003, SARCOIDOSIS VASC DIF, V20, P133; Mehta D, 2011, CIRC-ARRHYTHMIA ELEC, V4, P43, DOI 10.1161/CIRCEP.110.958322; Bussinguer Michelle, 2012, Curr Treat Options Cardiovasc Med, V14, P652, DOI 10.1007/s11936-012-0208-3; FLEMING HA, 1986, ANN NY ACAD SCI, V465, P543, DOI 10.1111/j.1749-6632.1986.tb18531.x; Hiraga H, 1993, JPN MINISTRY HLTH WE, P23; Japanese Ministry of Health and Welfare, 2007, JPN J SARCOIDOSIS GR, V27, P89; White J, 2010, CIRC-HEART FAIL, V3, pE28, DOI 10.1161/CIRCHEARTFAILURE.110.939686	22	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	MAY 1	2015	115	9					1293	1297		10.1016/j.amjcard.2015.01.562		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH3JK	WOS:000353926800020		
J	Saito, E; Inoue, M; Sawada, N; Shimazu, T; Yamaji, T; Iwasaki, M; Sasazuki, S; Noda, M; Iso, H; Tsugane, S				Saito, Eiko; Inoue, Manami; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Noda, Mitsuhiko; Iso, Hiroyasu; Tsugane, Shoichiro			Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center-based Prospective Study	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						cardiovascular diseases/mortality; coffee; follow-up studies; neoplasms/mortality; respiratory diseases/mortality	CARDIOVASCULAR-DISEASE; TEA CONSUMPTION; LIVER-CANCER; GREEN TEA; ALL-CAUSE; RISK; COHORT; WOMEN; METAANALYSIS; DRINKING	Background: Despite the rising consumption of coffee worldwide, few prospective cohort studies assessed the association of coffee intake with mortality including total and major causes of death. Objective: We aimed to investigate the association between habitual coffee drinking and mortality from all causes, cancer, heart disease, cerebrovascular disease, respiratory disease, injuries, and other causes of death in a large-scale, population-based cohort study in Japan. Design: We studied 90,914 Japanese persons aged between 40 and 69 y without a history of cancer, cerebrovascular disease, or ischemic heart disease at the time of the baseline study. Subjects were followed up for an average of 18.7 y, during which 12,874 total deaths were reported. The association between coffee intake and risk of total and cause-specific mortality was assessed by using a Cox proportional hazards regression model with adjustment for potential confounders. Results: We showed an inverse association between coffee intake and total mortality in both men and women. HRs (95% CIs) for total death in subjects who consumed coffee compared with those who never drank coffee were 0.91 (0.86-0.95) for <1 cup/d, 0.85 (0.81-0.90) for 1-2 cups/d, 0.76 (0.70-0.83) for 3-4 cups/d, and 0.85 (0.75-0.98) for >5 cups/d (P-trend < 0.001). Coffee was inversely associated with mortality from heart disease, cerebrovascular disease, and respiratory disease. Conclusion: With this prospective study, we suggest that the habitual intake of coffee is associated with lower risk of total mortality and 3 leading causes of death in Japan.	[Saito, Eiko; Inoue, Manami; Sawada, Norie; Shimazu, Taichi; Yamaji, Taiki; Iwasaki, Motoki; Sasazuki, Shizuka; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Saito, Eiko; Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Inoue, Manami] Natl Ctr Global Hlth & Med, Dept Diabet Res, Diabet Res Ctr, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Osaka Fu, Japan	Inoue, M (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mnminoue@m.u-tokyo.ac.jp			National Cancer Center Research and Development Fund [23-A-31(toku), 26-A-2]; Ministry of Health, Labour and Welfare of Japan	Supported by the National Cancer Center Research and Development Fund [23-A-31(toku) and 26-A-2; since 2011] and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010).	Harris HR, 2012, BRIT J CANCER, V107, P874, DOI 10.1038/bjc.2012.337; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Kurozawa Y, 2005, BRIT J CANCER, V93, P607, DOI 10.1038/sj.bjc.6602737; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039; Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Iso H, 2006, ANN INTERN MED, V144, P554; Michikawa T, 2011, CANCER CAUSE CONTROL, V22, P985, DOI 10.1007/s10552-011-9771-2; Kalaska B, 2014, J AGR FOOD CHEM, V62, P2853, DOI 10.1021/jf5008538; Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI [10.1158/1055-9965.EPI-08-0923, 10.1158/1055-9965-EPI-08-0923]; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; [Anonymous], 2009, VIT STAT JAPAN LAT T; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904; Lopez-Garcia E, 2011, AM J CLIN NUTR, V94, P218, DOI 10.3945/ajcn.110.010249; Johnston KL, 2003, AM J CLIN NUTR, V78, P728; Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7; Dong J, 2011, WORLD J GASTROENTERO, V17, P1204, DOI 10.3748/wjg.v17.i9.1204; Zhang WL, 2009, DIABETOLOGIA, V52, P810, DOI 10.1007/s00125-009-1311-1; Klatsky AL, 2008, AM J CARDIOL, V101, P825, DOI 10.1016/j.amjcard.2007.11.022; Bidel S, 2006, DIABETOLOGIA, V49, P2618, DOI 10.1007/s00125-006-0435-9; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Zucchi R, 1997, PHARMACOL REV, V49, P1; Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020; Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004; Botelho F., 2006, SAUDE PUBLICA, V22, P889, DOI [10.1590/S0102-311X2006000500002, DOI 10.1590/S0102-311X2006000500002]; FAO, 2003, MED TERM PROSP AGR C; Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035; Shimazu T, 2008, INT J CANCER, V123, P2406, DOI 10.1002/ijc.23760; Spyridopoulos I, 2008, ARTERIOSCL THROM VAS, V28, P1967, DOI 10.1161/ATVBAHA.108.174060; Tsugane S, 2001, J Epidemiol, V11, pS24; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Watanabe S, 2001, J Epidemiol, V11, pS3; Welsh EJ, 2010, COCHRANE DB SYST REV, VI; World Health Organization, 1992, INT STAT CLASS DIS R	38	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	MAY	2015	101	5					1029	1037		10.3945/ajcn.114.104273		9	Nutrition & Dietetics	Nutrition & Dietetics	CH5KS	WOS:000354075100018		
J	Ishida, Y; Yamasaki, C; Yanagi, A; Yoshizane, Y; Fujikawa, K; Watashi, K; Abe, H; Wakita, T; Hayes, CN; Chayama, K; Tateno, C				Ishida, Yuji; Yamasaki, Chihiro; Yanagi, Ami; Yoshizane, Yasumi; Fujikawa, Kazuyuki; Watashi, Koichi; Abe, Hiromi; Wakita, Takaji; Hayes, C. Nelson; Chayama, Kazuaki; Tateno, Chise			Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ADULT HUMAN HEPATOCYTES; HEPATOMA-CELL LINE; CLOSED CIRCULAR DNA; SURFACE PROTEIN; CHIMERIC MICE; VIRAL-DNA; EXPRESSION; LIVER; REPLICATION; TRANSFECTION	The molecular mechanisms underlying the hepatitis B virus (HBV) Life cycle are poorly understood because of the lack of appropriate in vitro infection models. Herein, we report a highly effective in vitro HBV infection system using fresh human hepatocytes (HHs) isolated from chimeric mice with humanized livers. After the inoculation of sera collected from HBV-infected chimeric mice or patients to HHs, we measured levels of HBV DNA, mRNA, covalently closed circular DNA, and viral protein expression in HHs. We investigated the neutralization activity of hepatitis B immune globulin and the effects of siRNA against sodium taurocholate cotransporting polypeptide and clathrin heavy chain on HBV infection. We confirmed the expression of viral antigens in HHs and the presence of extracellular HBV DNA and hepatitis B surface antigen. The maximum infection rate was approximately 80%. Lamivudine and hepatitis B immune globulin treatment reduced HBV DNA levels in a dose-dependent manner. Knockdown of sodium taurocholate cotransporting polypeptide and clathrin heavy chain significantly reduced the levels of hepatitis B surface antigen. Infection was successfully established using different donor HHs and inocula. Elevation of extracellular HBV DNA levels and the increase of HBV-positive HHs were blocked by continuous hepatitis B immune globulin treatment, indicating virus spread in this model. Chimeric mouse derived HHs provide a robust in vitro infection model that can completely support the HBV life cycle.	[Ishida, Yuji; Yamasaki, Chihiro; Yanagi, Ami; Yoshizane, Yasumi; Tateno, Chise] PhoenixBio Co Ltd, Dept Res & Dev, Higashihiroshima, Hiroshima 7390046, Japan; [Fujikawa, Kazuyuki; Abe, Hiromi; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan; [Watashi, Koichi; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Abe, Hiromi; Hayes, C. Nelson; Chayama, Kazuaki] RIKEN, Ctr Integrat Med Sci, Lab Digest Dis, Saitama, Japan	Tateno, C (reprint author), PhoenixBio Co Ltd, 3-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	chise.mukaidani@phoenixbio.co.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan	Supported by the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan, grants-in-aid for scientific research and development (HA., C.N.H., K.C.).	Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Yamasaki C, 2010, DRUG METAB PHARMACOK, V25, P539, DOI 10.2133/dmpk.DMPK-10-RG-047; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; TSURIMOTO T, 1987, P NATL ACAD SCI USA, V84, P444, DOI 10.1073/pnas.84.2.444; Abe A, 1999, J CLIN MICROBIOL, V37, P2899; Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; CHANG CM, 1987, EMBO J, V6, P675; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; GRIPON P, 1993, VIROLOGY, V192, P534, DOI 10.1006/viro.1993.1069; Lucifora J, 2010, HEPATOLOGY, V51, P63, DOI 10.1002/hep.23230; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Cooper A, 2006, J BIOL CHEM, V281, P16563, DOI 10.1074/jbc.M601418200; Tsuge M, 2010, J GEN VIROL, V91, P1854, DOI 10.1099/vir.0.019224-0; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1616-1622.2005; GRIPON P, 1995, VIROLOGY, V213, P292, DOI 10.1006/viro.1995.0002; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; GRIPON P, 1988, J VIROL, V62, P4136; Chayama K, 2011, J GASTROEN HEPATOL, V26, P13, DOI 10.1111/j.1440-1746.2010.06470.x; Committee for the Update of the Guide for the Care, 2011, GUID CAR US LAB AN; Fujita S, 2010, METHODS MOL BIOL, V623, P197, DOI 10.1007/978-1-60761-588-0_13; GALLE PR, 1994, GASTROENTEROLOGY, V106, P664; Masumoto N, 2007, J ENDOCRINOL, V194, P529, DOI 10.1677/JOE-07-0126; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P121, DOI 10.2133/dmpk.20.121; OCHIYA T, 1989, P NATL ACAD SCI USA, V86, P1875, DOI 10.1073/pnas.86.6.1875; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; SHIMIZU Y, 1986, J MED VIROL, V20, P313, DOI 10.1002/jmv.1890200404; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Takkenberg RB, 2009, J MED VIROL, V81, P988, DOI 10.1002/jmv.21477; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Watashi Koichi, 2013, J Biol Chem, V288, P31715, DOI 10.1074/jbc.M113.501122; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yoshitsugu H, 2006, DRUG METAB PHARMACOK, V21, P465, DOI 10.2133/dmpk.21.465	35	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAY	2015	185	5					1275	1285		10.1016/j.ajpath.2015.01.028		11	Pathology	Pathology	CH4OL	WOS:000354012700010		
J	Kawasaki, H; Kosugi, I; Sakao-Suzuki, M; Meguro, S; Arai, Y; Tsutsui, Y; Iwashita, T				Kawasaki, Hideya; Kosugi, Isao; Sakao-Suzuki, Makiko; Meguro, Shiori; Arai, Yoshifumi; Tsutsui, Yoshihiro; Iwashita, Toshihide			Cytomegalovirus Initiates Infection Selectively from High-Level beta 1 Integrin-Expressing Cells in the Brain	AMERICAN JOURNAL OF PATHOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; DISINTEGRIN-LIKE DOMAIN; GROWTH-FACTOR RECEPTOR; NECROSIS-FACTOR-ALPHA; MURINE CYTOMEGALOVIRUS; GENE-EXPRESSION; NEONATAL MICE; ANNEXIN-II; STEM-CELLS; IN-VITRO	Cytomegalovirus (CMV) is a prevalent pathogen in intrauterine infections that causes congenital anomalies such as CMV encephalitis, which is characterized by the focal areas of reactive gliosis, reactive mononuclear cells, microglial nodules, and ventriculoencephalitis. To elucidate the mechanisms of CMV susceptibility in the developing brain, cell tropism and the infectious dynamics of CMV infection were investigated. We evaluated intraventricular and intravascular infections from the perspective of the distribution of CMV and its receptor (beta 1 integrin) in the earliest phase of infection. Murine CMV (MCMV) immediate early 1-positive cells were colocalized mainly with meninges and choroid plexus (after intraventricular infection) or with endothelial cells and pericytes (after intravascular infection). Using green fluorescent protein-expressing recombinant MCMV particles and fluorescent microbeads (100 to 300 nm), we revealed that CMV particle size is the primary factor determining the initial CMV distribution. beta 1 Integrin inhibition using a shRNA and functional blocking antibody significantly reduced MCMV infection. IHC analysis, flow cytometric, and brain slice analyses strongly support that high-level beta 1 integrin-expressing cells (eg, endothelial cells, pericytes, meninges, choroid plexus, and neural stem progenitor cells) are the first targets of MCMV. Therefore, our data demonstrate that the initial distributions of MCMV particles and beta 1 integrin determine the distinct pattern of infection in the brain in the acute phase.	[Kawasaki, Hideya; Kosugi, Isao; Meguro, Shiori; Iwashita, Toshihide] Hamamatsu Univ, Sch Med, Dept Regenerat & Infect Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Sakao-Suzuki, Makiko] Hamamatsu Univ, Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Arai, Yoshifumi] Seirei Hamamatsu Gen Hosp, Dept Pathol, Shizuoka, Japan; [Tsutsui, Yoshihiro] Tokoha Univ, Fac Hlth Sci, Hamamatsu, Shizuoka, Japan	Kawasaki, H (reprint author), Hamamatsu Univ, Sch Med, Dept Regenerat & Infect Pathol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	gloria@hama-med.ac.jp			JSPS KAKENHI [23590445]	Supported by JSPS KAKENHI grant 23590445 (H.K.).	Aiba-Masago S, 1999, AM J PATHOL, V154, P735, DOI 10.1016/S0002-9440(10)65320-5; Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95; Ivey NS, 2009, J NEUROVIROL, V15, P111, DOI 10.1080/13550280902769764; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Kosugi I, 2000, LAB INVEST, V80, P1373; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Feire AL, 2010, J VIROL, V84, P10026, DOI 10.1128/JVI.00710-10; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Li RY, 2000, TERATOLOGY, V62, P79; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Vliegen I, 2004, MICROBES INFECT, V6, P17, DOI 10.1016/j.micinf.2003.09.024; Koontz T, 2008, J EXP MED, V205, P423, DOI 10.1084/jem.20071489; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70; Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08; PERLMAN JM, 1992, ANN NEUROL, V31, P64, DOI 10.1002/ana.410310112; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; SODERBERG C, 1993, J VIROL, V67, P6576; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; Becroft D M, 1981, Perspect Pediatr Pathol, V6, P203; BEERSMA MFC, 1992, CURR EYE RES, V11, P141, DOI 10.3109/02713689208999524; BEERSMA MFC, 1991, J GEN VIROL, V72, P2757, DOI 10.1099/0022-1317-72-11-2757; Alcendor DJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt379; Britt WJ, 2010, CURR PROTOC MICROBIO; Brown RC, 2004, BRAIN RES, V1014, P221, DOI 10.1016/j.brainres.2004.04.034; Chadwick DR, 2006, BR MED B, V75-76, P1, DOI 10.1093/bmb/ldh057; CONBOY TJ, 1986, PEDIATRICS, V77, P801; EBIHARA K, 1984, J VIROL, V51, P117; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; FRENKEL LD, 1980, PEDIATRICS, V66, P763; GEIST LJ, 1994, J CLIN INVEST, V93, P474, DOI 10.1172/JCI116995; Glascock JJ, 2011, JOVE-J VIS EXP, V56, P2968; Ho M, 1991, CYTOMEGALOVIRUS BIOL, P205; Hsu KM, 2009, J GEN VIROL, V90, P33, DOI [10.1099/vir.0.006668-0, 10.1099/vir.0.2008/006668-0]; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Kawasaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017492; Kawasaki H, 2002, LAB INVEST, V82, P1347, DOI 10.1097/01.LAB.0000032376.58688.D4; Kosugi I, 2002, AM J PATHOL, V161, P919, DOI 10.1016/S0002-9440(10)64252-6; Li L, 2008, LAB INVEST, V88, P722, DOI 10.1038/labinvest.2008.39; Louboutin JP, 2010, NAT METHODS, V7, P905, DOI 10.1038/nmeth.1518; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; SHEPRO D, 1993, FASEB J, V7, P1031; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Pietropaolo R, 1999, J GEN VIROL, V80, P1807; Sakao-Suzuki Makiko, 2014, Ann Clin Transl Neurol, V1, P570, DOI 10.1002/acn3.88; Saunders NR, 2009, NAT BIOTECHNOL, V27, P804, DOI 10.1038/nbt0909-804; Sellner J, 2006, BRAIN RES, V1125, P155, DOI 10.1016/j.brainres.2006.09.093; Speir E, 1996, CIRC RES, V79, P1143; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Tsutsui Y, 2005, REV MED VIROL, V15, P327, DOI 10.1002/rmv.475; Vanarsdall AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002905; van den Pol AN, 2009, J VIROL, V83, P420, DOI 10.1128/JVI.01728-08; van den Pol AN, 1999, J NEUROSCI, V19, P10948; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; WRIGHT JF, 1995, J VIROL, V69, P4784; WYKES MN, 1992, ARCH VIROL, V123, P59, DOI 10.1007/BF01317138; Zunkeler B, 1996, J NEUROSURG, V85, P1056, DOI 10.3171/jns.1996.85.6.1056	67	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAY	2015	185	5					1304	1323		10.1016/j.ajpath.2015.01.032		20	Pathology	Pathology	CH4OL	WOS:000354012700013		
J	Nishie, W; Natsuga, K; Iwata, H; Izumi, K; Ujiie, H; Toyonaga, E; Hata, H; Nakamura, H; Shimizu, H				Nishie, Wataru; Natsuga, Ken; Iwata, Hiroaki; Izumi, Kentaro; Ujiie, Hideyuki; Toyonaga, Ellen; Hata, Hiroo; Nakamura, Hideki; Shimizu, Hiroshi			Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin	AMERICAN JOURNAL OF PATHOLOGY			English	Article							BULLOUS-PEMPHIGOID ANTIGEN; EPIDERMOLYSIS-BULLOSA; BASEMENT-MEMBRANE; ALPHA-6 INTEGRIN; EPIDERMAL-CELLS; IN-VITRO; BP180; AUTOANTIBODIES; AUTOANTIGEN; ANTIBODIES	Pemphigoid is a common autoimmune blistering disorder in which autoantibodies target transmembrane collagen XVII (COL17), a component of hemidesmosomes in basal keratinocytes. The ectodomain of COL17 can be cleaved from the cell surface within the juxtamembranous extracellular NC16A domain, and, interestingly, certain autoantibodies of pemphigoid patients preferentially react with the shed ectodomain. These findings suggest that COL17 ectodomain shedding generates neoepitopes on the shed form; however, the regulatory mechanism of the shedding in in vivo skin and the pathogenicity of the neoepitope-targeting antibodies still are uncertain. To address these issues, we produced rabbit antibodies specifically reacting with N-terminal cleavage sites of the shed COL17 ectodomain. The antibodies showed that certain amounts of the human COL17 ectodomain are cleaved physiologically at Gln(525) in in vivo skin. In contrast, migrating human keratinocytes cleave COL17 at Leu(524) but not at Gln(525). The passive transfer of antibodies reacting with an N-terminal cleavage site of the mouse COL17 ectodomain into neonatal wild-type mice failed to induce blister formation, even though the antibodies bound to the dermal-epidermal junctions, indicating that cleavage site-specific antibodies have reduced or absent pathogenicity for blister formation. This study shows the ectodomain shedding of COL17 to be a physiological event in in vivo human skin that probably generates nonpathologic epitopes on the cleavage sites.	[Nishie, Wataru; Natsuga, Ken; Iwata, Hiroaki; Izumi, Kentaro; Ujiie, Hideyuki; Toyonaga, Ellen; Hata, Hiroo; Nakamura, Hideki; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Nishie, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	nishie@med.hokudai.ac.jp			Challenging Exploratory Research grant [20443955];  [24390274]	Supported by a Grant-in-Aid for Scientific Research (B) grant 24390274 (W.N.) and by a Challenging Exploratory Research grant 20443955 (W.N.).	LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu YD, 2011, J BIOL CHEM, V286, P11211, DOI 10.1074/jbc.M110.185041; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Natsuga K, 2012, J IMMUNOL, V188, P5792, DOI [10.4049/jimmunol.1003402, 10.4049/jimmunol.1103402]; ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; Schumann H, 2000, AM J PATHOL, V156, P685, DOI 10.1016/S0002-9440(10)64772-4; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Gatalica B, 1997, AM J HUM GENET, V60, P352; Hirako Y, 2003, J INVEST DERMATOL, V121, P1554, DOI 10.1046/j.1523-1747.2003.12607.x; Hirako Y, 1998, J BIOL CHEM, V273, P9711, DOI 10.1074/jbc.273.16.9711; Hofmann SC, 2009, J INVEST DERMATOL, V129, P1730, DOI 10.1038/jid.2008.424; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; LANGHOFER M, 1993, J CELL SCI, V105, P753; LI KH, 1993, J BIOL CHEM, V268, P8825; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Nakamura H, 2006, INT J MOL MED, V18, P333; Nie ZX, 2000, J INVEST DERMATOL, V115, P1164, DOI 10.1046/j.1523-1747.2000.0202a-7.x; Nishie W, 2011, AM J PATHOL, V179, P829, DOI 10.1016/j.ajpath.2011.04.019; Nishie W, 2009, J IMMUNOL, V183, P4088, DOI 10.4049/jimmunol.0800389; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; Nishie W, 2010, J IMMUNOL, V185, P4938, DOI 10.4049/jimmunol.1001524; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; SHIMIZU H, 1995, J INVEST DERMATOL, V104, P370, DOI 10.1111/1523-1747.ep12665840; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Ujiie H, 2014, J IMMUNOL, V193, P4415, DOI 10.4049/jimmunol.1400095; Xu W, 2013, ANAL BIOCHEM, V436, P10, DOI 10.1016/j.ab.2013.01.017; Zillikens D, 1999, J INVEST DERMATOL, V113, P947, DOI 10.1046/j.1523-1747.1999.00808.x; Zone JJ, 1998, J INVEST DERMATOL, V110, P207, DOI 10.1046/j.1523-1747.1998.00129.x	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAY	2015	185	5					1361	1371		10.1016/j.ajpath.2015.01.012		11	Pathology	Pathology	CH4OL	WOS:000354012700017		
J	Hoshino, Y; Nishida, J; Katsuno, Y; Koinuma, D; Aoki, T; Kokudo, N; Miyazono, K; Ehata, S				Hoshino, Yukari; Nishida, Jun; Katsuno, Yoko; Koinuma, Daizo; Aoki, Taku; Kokudo, Norihiro; Miyazono, Kohei; Ehata, Shogo			Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ALDEHYDE DEHYDROGENASE 1; GROWTH-FACTOR-BETA; HEMATOPOIETIC STEM-CELLS; TGF-BETA; BREAST-CANCER; MESENCHYMAL TRANSITION; GASTRIC-CARCINOMA; MOLECULAR JEKYLL; PROGENITOR CELLS; POOR-PROGNOSIS	Cancer progression involves a rare population of undifferentiated cancer-initiating cells that have stem cell-like properties for self-renewal capacity and high tumorigenicity. We investigated how maintenance of pancreatic cancer-initiating cells is influenced by Smad4, which is frequently deleted or mutated in pancreatic cancers cells. Smad4 silencing up-regulated the expression of aldehyde dehydrogenase 1A1 (ALDH1A1) mRNA, whereas forced expression of Smad4 in pancreatic cancer cells down-regulated it. Smad4 and ALDH1 expression inversely correlated in some human clinical pancreatic adenocarcinoma tissues, suggesting that ALDH1 in pancreatic cancer cells was associated with decreased Smad4 expression. We then examined whether ALDH1 served as a marker of pancreatic cancer-initiating cells. Pancreatic cancer cells contained ALDH1(hi) cells in 3% to 10% of total cells, with high tumorigenic potential. Because Smad4 is a major mediator of transforming growth factor (TGF)-beta family signaling, we investigated the regulatory mechanism of ALDH activity by TGF-beta and bone morphogenetic proteins. Treatment with TGF-beta attenuated ALDH1(hi) cells in several pancreatic cancer cells, whereas bone morphogenetic protein-4 was not as potent. Biochemical experiments revealed that TGF-beta regulated ALDH1A1 mRNA transcription through binding of Smad4 to its regulatory sequence. It appears that TGF-beta negatively regulates ALDH1 expression in pancreatic cancer cells in a Smad-dependent manner and in turn impairs the activity of pancreatic cancer initiating cells.	[Hoshino, Yukari; Nishida, Jun; Katsuno, Yoko; Koinuma, Daizo; Miyazono, Kohei; Ehata, Shogo] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Aoki, Taku; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo 1130033, Japan	Miyazono, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp			Integrative Research on Cancer Microenvironment Network [22112002]; Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Takeda Science Foundation; Japan Society for the Promotion of Science [22700967]; Japan Society for the Promotion of Science for Young Scientists [24-3881]	Supported by Grant-in-Aid for Scientific Research on Innovative Area (Integrative Research on Cancer Microenvironment Network) grant 22112002 (K.M.); the Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KM.); a specific research grant from the Takeda Science Foundation (KM.); Grant-in-Aid for Young Scientists (B) grant 22700967 from the Japan Society for the Promotion of Science (SE.); and Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists grant 24-3881 (Y.H.).	Carbone C, 2012, EXPERT OPIN THER TAR, V16, pS1, DOI 10.1517/14728222.2011.645806; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; RUSSO JE, 1988, CANCER RES, V48, P2963; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ehata S, 2013, PATHOL INT, V63, P287, DOI 10.1111/pin.12067; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Rasheed ZA, 2010, J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Woodford-Richens KL, 2001, AM J PATHOL, V159, P1293, DOI 10.1016/S0002-9440(10)62516-3; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2007.00357.x; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Ohi Y, 2011, HISTOPATHOLOGY, V59, P776, DOI 10.1111/j.1365-2559.2011.03884.x; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Takaku K, 1999, CANCER RES, V59, P6113; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004.0170; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Hess DA, 2008, STEM CELLS, V26, P611, DOI 10.1634/stemcells.2007-0429; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Kawabata KC, 2013, ONCOGENE, V32, P2096, DOI 10.1038/onc.2012.219; Kim SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078130; Moreb JS, 1995, LEUKEMIA LYMPHOMA, V20, P77, DOI 10.3109/10428199509054756; Mu Xiaodong, 2013, Front Oncol, V3, P143, DOI 10.3389/fonc.2013.00143; Muramoto GG, 2010, STEM CELLS, V28, P523, DOI 10.1002/stem.299; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shirai Y, 2011, AM J PATHOL, V179, P2920, DOI 10.1016/j.ajpath.2011.08.022; Wang XH, 2013, AM J CANCER RES, V3, P356; Xie W, 2003, ONCOL RES, V14, P61; Xu X, 2010, ONCOGENE, V29, P674, DOI 10.1038/onc.2009.375	60	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	MAY	2015	185	5					1457	1470		10.1016/j.ajpath.2015.01.011		14	Pathology	Pathology	CH4OL	WOS:000354012700025		
J	Sagawa, M; Machida, Y; Tanaka, M; Motono, N; Maeda, S; Sakuma, T; Usuda, K				Sagawa, Motoyasu; Machida, Yuichiro; Tanaka, Makoto; Motono, Nozomu; Maeda, Sumiko; Sakuma, Tsutomu; Usuda, Katsuo			Left Pulmonary Agenesis Showing Extraordinary Chest X-Ray Findings	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Editorial Material									[Sagawa, Motoyasu; Machida, Yuichiro; Tanaka, Makoto; Motono, Nozomu; Maeda, Sumiko; Usuda, Katsuo] Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa 92002, Japan; [Sakuma, Tsutomu] Ogaki Hosp, Ogaki, Japan	Sagawa, M (reprint author), Kanazawa Med Univ, Dept Thorac Surg, Uchinada, Ishikawa 92002, Japan.						MALTZ DL, 1968, PEDIATRICS, V42, P175; Boulton BJ, 2011, ANN THORAC SURG, V92, pE27, DOI 10.1016/j.athoracsur.2011.03.045; Gunbey Hediye Pinar, 2014, J Clin Diagn Res, V8, pRD01, DOI 10.7860/JCDR/2014/7968.4420; Kim K, 2011, AM J RESP CRIT CARE, V184, P742; Ueda T, 2011, INTERNAL MED, V50, P463, DOI 10.2169/internalmedicine.50.4470	5	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	MAY 1	2015	191	9					1083	1083		10.1164/rccm.201501-01221M		1	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH2FJ	WOS:000353840800020		
J	Tanaka, K; Toiyama, Y; Inoue, Y; Araki, T; Mohri, Y; Mizoguchi, A; Kusunoki, M				Tanaka, Koji; Toiyama, Yuji; Inoue, Yasuhiro; Araki, Toshimitsu; Mohri, Yasuhiko; Mizoguchi, Akira; Kusunoki, Masato			Imaging Neutrophil Extracellular Traps in the Alveolar Space and Pulmonary Capillaries of a Murine Sepsis Model by Multiphoton Microscopy	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Letter									[Tanaka, Koji; Toiyama, Yuji; Inoue, Yasuhiro; Araki, Toshimitsu; Mohri, Yasuhiko; Mizoguchi, Akira; Kusunoki, Masato] Mie Univ Grad Sch Med, Tsu, Mie, Japan	Tanaka, K (reprint author), Mie Univ Grad Sch Med, Tsu, Mie, Japan.						Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC; Tanaka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111888	2	0	0	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	MAY 1	2015	191	9					1088	1089				2	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CH2FJ	WOS:000353840800023		
J	Uchida, S; Utsunomiya, H; Taketa, T; Sakoda, S; Hatakeyama, A; Nakamura, T; Sakai, A				Uchida, Soshi; Utsunomiya, Hajime; Taketa, Tomonori; Sakoda, Shinsuke; Hatakeyama, Akihisa; Nakamura, Toshitaka; Sakai, Akinori			Arthroscopic Fragment Fixation Using Hydroxyapatite/Poly-L-Lactate Acid Thread Pins for Treating Elbow Osteochondritis Dissecans	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						osteochondritis dissecans (OCD); elbow arthroscopy; arthroscopic fragment fixation	HUMERAL CAPITELLUM; LONG-TERM; FOLLOW-UP; INTERNAL-FIXATION; COMPOSITE RODS; BONE-FRACTURES; TRANSPLANTATION; MOSAICPLASTY; CARTILAGE; INJURIES	Background: Various procedures, such as arthroscopic debridement, osteochondral transplantation, and bone plug fixation, have been described for the treatment of osteochondritis dissecans (OCD) of the humeral capitellum. However, the use of hydroxyapatite/poly-L-lactate acid (HA/PLLA) thread pins to fix the osteochondral fragment in an OCD lesion is a recent development. Hypothesis: Adolescent throwing athletes would return to preinjury levels of function after arthroscopic osteochondral fragment fixation using HA/PLLA thread pins. Study Design: Case series; Level of evidence, 4. Methods: Enrolled in this prospective cohort study were 18 adolescent baseball players (mean age, 14.2 years; range 12-16, years) with elbow OCD who underwent arthroscopic fragment fixation with HA/PLLA thread pins between 2006 and 2009. All patients were affected on their dominant side. Plain radiographs taken before surgery showed an open physis in 13 patients (72%) and a closed physis in 5 patients (28%). During surgery, the condition of the OCD lesion was evaluated by use of the International Cartilage Research Society (ICRS) classification system; there were 5 grade II, 11 grade III, and 2 grade IV cases. Outcomes were assessed after 3 years (mean, 39 months; range, 36-50 months). Elbow function was measured using the Timmerman and Andrews score and the Mayo Elbow Performance Index. Return to sports activity was assessed as higher than preinjury, same level, lower level, or no return to sports. Results: The mean Timmerman and Andrews score improved significantly from 126.6 6.5 to 197.5 +/- 1.5, and the mean Mayo Elbow Performance Index improved significantly from 68.0 +/- 2.1 to 98.06 +/- 0.9 (P = .0001 for both). Mean elbow extension improved significantly from -10 degrees +/- 10.4 degrees to -0.8 degrees +/- 5.2 degrees (P = .006), and mean flexion improved significantly from 123.1 degrees +/- 17.9 degrees to 138.6 degrees +/- 6.1 degrees (P = .001). Three patients had a loss of extension greater than 5 degrees. Five patients returned to a higher level of sports activity, 10 patients returned to the same level, and 2 patients returned to a lower level. A remaining patient did not return to baseball. In one patient, the lesion did not heal, resulting in fragmentation at 1 year after surgery. This patient consequently underwent revision arthroscopy to remove the lesion, and he eventually returned to sports at the same level of activity. Conclusion: Arthroscopic fragment fixation using HA/PLLA thread pins provides a beneficial clinical outcome to adolescent baseball players with humeral capitellar OCD.	[Uchida, Soshi; Utsunomiya, Hajime; Taketa, Tomonori; Sakoda, Shinsuke; Hatakeyama, Akihisa; Nakamura, Toshitaka; Sakai, Akinori] Univ Occupat & Environm Hlth, Wakamatsu Hosp, Kitakyushu, Fukuoka 807, Japan	Uchida, S (reprint author), Univ Occupat & Environm Hlth, Wakamatsu Hosp, Dept Orthopaed Surg, 1-17-1 Hamamachi, Kitakyushu, Fukuoka 807, Japan.	soushi@med.uoeh-u.ac.jp					Nobuta S, 2008, UPSALA J MED SCI, V113, P201; van den Ende KIM, 2011, ARTHROSCOPY, V27, P122, DOI 10.1016/j.arthro.2010.08.008; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58; Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166; Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717; TIMMERMAN LA, 1994, AM J SPORT MED, V22, P230, DOI 10.1177/036354659402200213; Takahara M, 2007, J BONE JOINT SURG AM, V89A, P1205, DOI 10.2106/JBJS.F.00622; Rahusen FTG, 2006, BRIT J SPORT MED, V40, P966, DOI 10.1136/bjsm.2006.030056; Baker CL, 2010, AM J SPORT MED, V38, P1917, DOI 10.1177/0363546509354969; Cain EL, 2010, AM J SPORT MED, V38, P2426, DOI 10.1177/0363546510378100; Zak L, 2014, KNEE SURG SPORT TR A, V22, P1288, DOI 10.1007/s00167-014-2834-7; Miyamoto W, 2009, KNEE SURG SPORT TR A, V17, P204, DOI 10.1007/s00167-008-0636-5; Kuwahata Y, 1998, ORTHOPEDICS, V21, P449; Takeda H, 2002, AM J SPORT MED, V30, P713; Harada M, 2002, J SHOULDER ELB SURG, V11, P368, DOI 10.1067/mse.2002.123900; Krijnen MR, 2003, ARTHROSCOPY, V19, P210, DOI 10.1053/jars.2003.50052; Ruch DS, 1998, ARTHROSCOPY, V14, P797, DOI 10.1016/S0749-8063(98)70013-1; Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2; Kobayashi K, 2004, J AM ACAD ORTHOP SUR, V12, P246; Brownlow HC, 2006, KNEE SURG SPORT TR A, V14, P198, DOI 10.1007/s00167-005-0623-z; Iwasaki N, 2009, J BONE JOINT SURG AM, V91A, P2359, DOI 10.2106/JBJS.H.01266; Takahara M, 1999, AM J SPORT MED, V27, P728; Iwasaki N, 2006, AM J SPORT MED, V34, P1233, DOI 10.1177/0363546506286343; Iwasaki N, 2007, AM J SPORT MED, V35, P2096, DOI 10.1177/0363546507306465; Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003; Takeba J, 2010, KNEE SURG SPORT TR A, V18, P831, DOI 10.1007/s00167-009-0945-3; Li LH, 2010, ACTA BIOMATER, V6, P2525, DOI 10.1016/j.actbio.2009.03.028; Axe MJ, 1996, AM J SPORTS MED, V24, P594; Bruce JR, 2014, J AM ACAD ORTHOP SUR, V22, P315, DOI 10.5435/JAAOS-22-05-315; Byrd J W, 2001, J South Orthop Assoc, V10, P12; De Smet L, 1996, Acta Orthop Belg, V62, P26; Inoue G, 1991, Br J Sports Med, V25, P142; Ishii S, 2003, J BIOMED MATER RES B, V66B, P539, DOI 10.1002/jbm.b.10027; King GJW, 1999, J SHOULDER ELB SURG, V8, P351; Kusumi T, 2006, PATHOL INT, V56, P604, DOI 10.1111/j.1440-1827.2006.02015.x; Lee KT, 2011, ORTHOPEDICS, V34, pe356; Marlovits S, 2006, EUR J RADIOL, V57, P1, DOI 10.1016/j.ejrad.2005.08.004; Morrey B, 1993, FUNCTIONAL EVALUATIO; Takahara Masatoshi, 2008, J Bone Joint Surg Am, V90 Suppl 2 Pt 1, P47, DOI 10.2106/JBJS.G.01135; Vogt S, 2011, AM J SPORT MED, V39, P2619, DOI 10.1177/0363546511420127	40	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1057	1065		10.1177/0363546515570871		9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000009		
J	Mori, D; Funakoshi, N; Yamashita, F; Wakabayashi, T				Mori, Daisuke; Funakoshi, Noboru; Yamashita, Fumiharu; Wakabayashi, Tsuguru			Effect of Fatty Degeneration of the Infraspinatus on the Efficacy of Arthroscopic Patch Autograft Procedure for Large to Massive Rotator Cuff Tears	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						massive rotator cuff tears; fatty degeneration; arthroscopic patch autograft procedure; infraspinatus	FULL-THICKNESS TEARS; 10-YEAR FOLLOW-UP; RADIOGRAPHIC OUTCOMES; STRUCTURAL OUTCOMES; SHOULDER FUNCTION; REPAIR INTEGRITY; DOUBLE-ROW; LONG-TERM; MUSCLE; RECONSTRUCTION	Background: In a 2013 study involving 24 patients whose shoulders had large or massive rotator cuff tears (RCTs) and low-grade fatty degeneration of the infraspinatus (Goutallier stage 1 or 2), we reported significantly improved clinical results after an arthroscopic fascia lata autograft patch procedure, with a 79.2% rate of intact repairs. Based on that study, we began applying the fascia lata autograft patch procedure to shoulders with stage 3 or 4 degeneration of the supraspinatus and stage 3 or 4 degeneration of the infraspinatus. Purpose: To investigate the effects of the fascia lata autograft patch procedure on massive RCTs in shoulders with high-grade degeneration of the infraspinatus by comparing the clinical outcomes and structural features with those in shoulders with low-grade degeneration of the infraspinatus. Study Design: Cohort study; Level of evidence, 3. Methods: A case series of 45 consecutive patients with large to massive RCTs with high-grade fatty degeneration of the supraspinatus and either low-grade (group L; n = 26 [the same patients as in our previous study plus 2 additional patients]) or high-grade (group H; n = 19) fatty degeneration of the infraspinatus were treated with the fascia lata autograft patch procedure. Clinical (Constant and American Shoulder and Elbow Surgeons [ASES]) scores, structural outcomes on MRI, and muscle strength were assessed at a minimum 2-year follow-up and compared between the 2 groups. Results: Patients in group L had a higher frequency of intact repairs than did those in group H (73.1% vs 10.6%; P < .001), as assessed by MRI. Clinical scores, range of motion, and muscle strength ratios were improved after surgery in both groups. However, at the final follow-up, the mean Constant (78.4 in group L vs 63.9 in group H; P < .0001) and ASES (91.3 in group L vs 73.6 in group H; P < .001) scores were significantly higher in group L than in group H. Moreover, there were significant between-group differences in the mean muscle strength ratio of the affected to healthy sides for both abduction (0.68 in group L vs 0.54 in group H) and external rotation (0.67 in group L vs 0.50 in group H) for abduction at the final follow-up (P < .0001 for both). Conclusion: The arthroscopic fascia lata autograft patch procedure was not as beneficial for massive RCTs with high-grade fatty degeneration of the supraspinatus and infraspinatus as other treatment options that produce similar functional results.	[Mori, Daisuke; Funakoshi, Noboru; Yamashita, Fumiharu; Wakabayashi, Tsuguru] Kyoto Shimogamo Hosp, Dept Orthopaed Surg, Kyoto 6060866, Japan	Mori, D (reprint author), Kyoto Shimogamo Hosp, Dept Orthopaed Surg, Sakyo Ku, 17 Shimogamo Higashimorigamaecho, Kyoto 6060866, Japan.	altair.0421@gmail.com					Sugaya H, 2007, J BONE JOINT SURG AM, V89A, P953, DOI 10.2106/JBJS.F.00512; Yoo JC, 2009, ARTHROSCOPY, V25, P573, DOI 10.1016/j.arthro.2008.12.015; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Pedowitz RA, 2011, J AM ACAD ORTHOP SUR, V19, P368; Jost B, 2006, J BONE JOINT SURG AM, V88A, P472, DOI 10.2106/JBJS.E.00003; Gerber C, 2006, J BONE JOINT SURG AM, V88A, P113, DOI 10.2106/JBJS.E.00282; Bond JL, 2008, ARTHROSCOPY, V24, P403, DOI 10.1016/j.arthro.2007.07.033; Russell RD, 2014, J BONE JOINT SURG AM, V96A, P265, DOI 10.2106/JBJS.M.00265; ROCKWOOD CA, 1995, J BONE JOINT SURG AM, V77A, P857; Mihata T, 2013, ARTHROSCOPY, V29, P459, DOI 10.1016/j.arthro.2012.10.022; Moore DR, 2006, AM J SPORT MED, V34, P392, DOI 10.1177/0363546505281237; Karas V, 2013, ARTHROSCOPY, V29, P1755, DOI 10.1016/j.arthro.2013.08.001; Goutallier D, 2003, J SHOULDER ELB SURG, V12, P550, DOI 10.1016/S1058-2746(03)00211-8; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; Gerber C, 2007, J SHOULDER ELB SURG, V16, P691, DOI 10.1016/j.jse.2007.02.122; Thomazeau H, 1997, CLIN ORTHOP RELAT R, P275; Gusmer PB, 1997, AM J ROENTGENOL, V168, P559; Galatz LM, 2001, J BONE JOINT SURG AM, V83A, P1052; Mellado JM, 2005, AM J ROENTGENOL, V184, P1456; Slabaugh MA, 2012, AM J SPORT MED, V40, P1728, DOI 10.1177/0363546512452714; BURKHART SS, 1994, ARTHROSCOPY, V10, P4, DOI 10.1016/S0749-8063(05)80288-9; Ito J, 2003, INT ORTHOP, V27, P228, DOI 10.1007/s00264-003-0459-4; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Burkhart SS, 2007, ARTHROSCOPY, V23, P347, DOI 10.1016/j.arthro.2006.12.012; Barber FA, 2012, ARTHROSCOPY, V28, P8, DOI 10.1016/j.arthro.2011.06.038; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219; Yoo JC, 2009, ARTHROSCOPY, V25, P1093, DOI 10.1016/j.arthro.2009.07.010; Arce G, 2013, ARTHROSCOPY, V29, P1840, DOI 10.1016/j.arthro.2013.07.265; Kirkley A, 2003, ARTHROSCOPY, V19, P1109, DOI 10.1016/j.arthro.2003.10.030; Mihata T, 2011, AM J SPORT MED, V39, P2091, DOI 10.1177/0363546511415660; Lippe J, 2012, ARTHROSCOPY, V28, P154, DOI 10.1016/j.arthro.2011.07.016; Zingg PO, 2007, J BONE JOINT SURG AM, V89A, P1928, DOI 10.2106/JBJS.F.01073; Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71; Derwin KA, 2008, J BIOMED MATER RES A, V84A, P500, DOI 10.1002/jbm.a.31455; Mochizuki T, 2008, J BONE JOINT SURG AM, V90A, P962, DOI 10.2106/JBJS.G.00427; Paxton ES, 2013, J BONE JOINT SURG AM, V95A, P627, DOI 10.2106/JBJS.L.00255; Jost B, 2000, J BONE JOINT SURG AM, V82A, P304; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1894, DOI 10.2106/JBJS.I.01531; Ciampi P, 2014, AM J SPORT MED, V42, P1169, DOI 10.1177/0363546514525592; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Gupta AK, 2012, AM J SPORT MED, V40, P141, DOI 10.1177/0363546511422795; Gupta AK, 2013, AM J SPORT MED, V41, P872, DOI 10.1177/0363546512475204; HOWELL SM, 1986, J BONE JOINT SURG AM, V68A, P398; Iannotti J P, 1996, J Shoulder Elbow Surg, V5, P449, DOI 10.1016/S1058-2746(96)80017-6; Mori D, 2013, ARTHROSCOPY, V29, P1911, DOI 10.1016/j.arthro.2013.08.032; Oh JH, 2008, ARTHROSCOPY, V24, P983, DOI 10.1016/j.arthro.2008.06.007; OWEN RS, 1993, RADIOLOGY, V186, P443; Slabaugh MA, 2010, ARTHROSCOPY, V26, P393, DOI 10.1016/j.arthro.2009.07.023	48	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1108	1117		10.1177/0363546515569680		10	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000016		
J	Koga, H; Muneta, T; Yagishita, K; Watanabe, T; Mochizuki, T; Horie, M; Nakamura, T; Otabe, K; Sekiya, I				Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Otabe, Koji; Sekiya, Ichiro			Effect of Posterolateral Bundle Graft Fixation Angles on Clinical Outcomes in Double-Bundle Anterior Cruciate Ligament Reconstruction A Randomized Controlled Trial	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						double bundle; anterior cruciate ligament reconstruction; graft fixation angle; randomized controlled trial	KNEE FLEXION ANGLES; INITIAL TENSION; LAXITY; INJURIES; ROTATION; CURVES; TENDON; LOADS	Background: In double-bundle (DB) anterior cruciate ligament (ACL) reconstruction, no consensus exists on an optimal setting for the posterolateral bundle (PLB) graft fixation angles. Hypothesis: Different PLB fixation angles would affect clinical outcomes in DB ACL reconstruction. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: This study prospectively included 90 patients who underwent primary DB ACL reconstruction with an autologous semitendinosus tendon. The PLB fixation angles were randomly set as follows: 0 degrees of flexion (P0; n = 30), 20 degrees (P20; n = 30), and 45 degrees (P45; n = 30). In all groups, the anteromedial bundle was fixed at 20 degrees of flexion. The following evaluation methods were used at the preoperative period and at 3, 6, and 9 months and 1 and 2 years after the surgery: clinical examination, KT-1000 arthrometer measurement, muscle strength, Tegner score, Lysholm score, and subjective rating scale regarding patient satisfaction and sports performance levels. Graft retear, contralateral ACL tear, and additional meniscus surgery were also recorded. Results: Seventy-five patients (P0, n = 25; P20, n = 26; P45, n = 24) who were followed for 2 years were evaluated. Preoperatively, there were no differences among the groups. Postoperatively, pivot-shift test results in the P0 and P20 groups were better than those in the P45 group (P0, n = 23 graded negative and 2 graded 1+; P20, n = 23 and 2; P45, n = 15 and 7, respectively; P0 vs P45: P = .038 and P20 vs P45: P = .038). Average KT-1000 arthrometer laxity measurements were better in the P20 group than in the P45 group (P0, 0.4 mm; P20, 0.3 mm; P45, 1.3 mm; P20 vs P45: P = .048), and there were more patients with graft failure (KT-1000 measurement, 4 mm) in the P45 group (n = 3) than the P0 and P20 groups (each, n = 0). There were no significant differences in range of motion, other laxity tests, muscle strength, Tegner score, Lysholm score, subjective rating scale, or additional surgery. Conclusion: In DB ACL reconstruction, when the anteromedial bundle was fixed at 20 degrees of flexion, fixation of the PLB at 45 degrees was worse than fixation at 0 degrees and 20 degrees with respect to anterior and rotational stability during the 2-year follow-up. KT-1000 arthrometer measurements and pivot-shift test results were significantly worse, and there were more patients with graft failure in the P45 group. There were no differences among groups in other findings.	[Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Otabe, Koji; Sekiya, Ichiro] Tokyo Med & Dent Univ Hosp Med, Tokyo 1138519, Japan	Koga, H (reprint author), Tokyo Med & Dent Univ Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	koga.orj@tmd.ac.jp					Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Mae T, 2010, ARTHROSCOPY, V26, P1289, DOI 10.1016/j.arthro.2010.02.017; Miura K, 2006, AM J SPORT MED, V34, P577, DOI 10.1177/0363546505281814; Yasuda K, 2008, ARTHROSCOPY, V24, P276, DOI 10.1016/j.arthro.2007.08.031; Hatayama K, 2013, ARTHROSCOPY, V29, P1072, DOI 10.1016/j.arthro.2013.02.003; Woo SLY, 2002, J BONE JOINT SURG AM, V84A, P907; Anderson CJ, 2010, AM J SPORT MED, V38, P1575, DOI 10.1177/0363546510364841; Koga H, 2012, AM J SPORT MED, V40, P615, DOI 10.1177/0363546511426696; Koga H, 2013, ARTHROSCOPY, V29, P529, DOI 10.1016/j.arthro.2012.10.018; Wu CF, 2009, J ORTHOP RES, V27, P879, DOI 10.1002/jor.20822; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Koga H, 2014, KNEE SURG SPORT TR A, V22, P2811, DOI 10.1007/s00167-013-2693-7; NAKAJIMA H, 1979, ARCH ORTHOP TRAUM SU, V95, P233, DOI 10.1007/BF00389691; Yagi M, 2002, AM J SPORT MED, V30, P660; Murray PJ, 2010, ARTHROSCOPY, V26, P202, DOI 10.1016/j.arthro.2009.07.014; Conner CS, 2008, ARTHROSCOPY, V24, P1323, DOI 10.1016/j.arthro.2008.07.006; Cuomo P, 2007, AM J SPORT MED, V35, P2083, DOI 10.1177/0363546507308548; Bach JM, 1997, J BIOMECH, V30, P281, DOI 10.1016/S0021-9290(96)00132-7; AMIS AA, 1991, J BONE JOINT SURG BR, V73, P260; Gabriel MT, 2004, J ORTHOPAED RES, V22, P85, DOI 10.1016/S0736-0266(03)00133-5; Zantop T, 2007, AM J SPORT MED, V35, P223, DOI 10.1177/0363546506294571; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; Muneta T, 1996, AM J SPORT MED, V24, P603, DOI 10.1177/036354659602400507; Sonnery-Cottet B, 2007, ARTHROSCOPY, V23, P1128; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Tiamklang T, 2012, COCHRANE DB SYST REV, V11; Vercillo F, 2007, AM J SPORT MED, V35, P1513, DOI 10.1177/0363546507300822	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2015	43	5					1157	1164		10.1177/0363546514567069		8	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CH4CV	WOS:000353980000022		
J	Preston, RA; Marbury, TC; Wajima, T; Graham, S				Preston, Richard A.; Marbury, Thomas C.; Wajima, Toshihiro; Graham, Shelli			The Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Ospemifene, a Tissue- Selective Estrogen Agonist/Antagonist	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						ospemifene; postmenopausal women; renal impairment; hepatic impairment	POSTMENOPAUSAL WOMEN; GENITAL-TRACT	Ospemifene is a nonestrogen tissue-selective estrogen agonist/antagonist approved to treat moderate to severe dyspareunia due to vulvar and vaginal atrophy in postmenopausal women. Three single-dose, open-label, parallel-group pharmacokinetic studies examined the pharmacokinetics of ospemifene in postmenopausal women with (1) mild hepatic impairment (n = 7), (2) moderate hepatic impairment (n = 8), and (3) severe renal impairment (n = 8) compared with a similar number of matched healthy controls. The study durations ranged from 8 to 12 days. Study participants received a single oral dose of ospemifene 60 mg on day 1 and blood samples were collected serially. The geometric mean ratios (hepatic or renal impairment/healthy) and 90% confidence intervals (CIs) for area under the concentration-time curve from time 0 extrapolated to infinity (AUC(0-infinity)) and maximum concentration (C-max), respectively, of ospemifene were 90.86% (90% CI, 65.95%-125.19%) and 79.48% (90% CI, 65.95%-95.79%) in the mild hepatic impairment study; 128.62% (90% CI, 87.13%-189.88%) and 101.12% (90% CI, 66.17%-154.52%) in the moderate hepatic impairment study, and 119.63% (90% CI, 81.37%-175.88%) and 79.30% (90% CI, 52.85%-118.99%) in the severe renal impairment study. Overall, there was no clinically important effect of hepatic or renal impairment on the pharmacokinetics of ospemifene, indicating that dosing does not need to be adjusted in postmenopausal women with mild or moderate hepatic impairment or in subjects with severe renal impairment.	[Preston, Richard A.] Univ Miami, Miller Sch Med, Dept Med, Div Clin Pharmacol, Miami, FL 33136 USA; [Preston, Richard A.] Jackson Mem Hosp, Miami, FL 33136 USA; [Preston, Richard A.] Florida Int Univ, Dept Cellular Biol & Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Marbury, Thomas C.] Orlando Clin Res Ctr, Orlando, FL USA; [Wajima, Toshihiro] Shionogi & Co Ltd, Clin Pharmacol & Pharmacokinet, Dept Clin Res, Osaka, Japan; [Graham, Shelli] Shionogi Inc, Florham Pk, NJ USA	Preston, RA (reprint author), Univ Miami, Miller Sch Med, Med Clin, 1500 NW 12th Ave 15 West, Miami, FL 33136 USA.	rpreston@med.miami.edu			Shionogi; Abb-Vie; ApoPharma; Celerion; Celgene; Cempra; Forest Research Institute; Merck Inc; Novartis; Pfizer; Takeda Global Research and Development; Shionogi Inc.	R. A. Preston has a consulting agreement with Ferring Inc, and has received research grants from Shionogi (for this study), Abb-Vie, ApoPharma, Celerion, Celgene, Cempra, Forest Research Institute, Merck Inc, Novartis, Pfizer, and Takeda Global Research and Development. T. Wajima is an employee of Shionogi & Co., Ltd. S. Graham is an employee of Shionogi Inc. Funded by Shionogi Inc. T. C. Marbury has no conflicts of interest to declare.	COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; [Anonymous], 2010, GUID IND PHARM PAT I; Simon JA, 2013, MENOPAUSE, V20, P418, DOI 10.1097/gme.0b013e31826d36ba; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Portman DJ, 2013, MENOPAUSE, V20, P623, DOI 10.1097/gme.0b013e318279ba64; Committee for Medicinal Products for Human Use, 2005, GUID EV PAHRM MED PR; Gennari Luigi, 2004, Curr Opin Investig Drugs, V5, P448; Komi J, 2005, MENOPAUSE, V12, P202, DOI 10.1097/01.GME.0000133239.36901.4B; Rutanen EM, 2003, MENOPAUSE, V10, P433, DOI 10.1097/01.GME.0000063609.62485.27; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2003, GUID IND PHARM PAT I, P181; Voipio SK, 2002, MATURITAS, V43, P207, DOI 10.1016/S0378-5122(02)00206-2	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	MAY-JUN	2015	22	3					171	181				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH5WG	WOS:000354105700008		
J	Hamaguchi, S; Cuong, NC; Tra, DT; Doan, YH; Shimizu, K; Tuan, NQ; Yoshida, LM; Mai, LQ; Dang, DA; Ando, S; Arikawa, J; Parry, CM; Ariyoshi, K; Thuy, PT				Hamaguchi, Sugihiro; Ngo Chi Cuong; Doan Thu Tra; Doan, Yen Hai; Shimizu, Kenta; Nguyen Quang Tuan; Yoshida, Lay-Myint; Le Quynh Mai; Dang Duc-Anh; Ando, Shuji; Arikawa, Jiro; Parry, Christopher M.; Ariyoshi, Koya; Pham Thanh Thuy			Clinical and Epidemiological Characteristics of Scrub Typhus and Murine Typhus among Hospitalized Patients with Acute Undifferentiated Fever in Northern Vietnam	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ORIENTIA-TSUTSUGAMUSHI; RICKETTSIA-TYPHI; SOUTH-VIETNAM; DIAGNOSIS; THAILAND; INFECTION; PREVALENCE; FEATURES	A descriptive study on rickettsiosis was conducted at the largest referral hospital in Hanoi, Vietnam, to identify epidemiological and clinical characteristics of specific rickettsiosis. Between March 2001 and February 2003, we enrolled 579 patients with acute undifferentiated fever (AUF), excluding patients with malaria, dengue fever, and typhoid fever, and serologically tested for Orientia tsutsugamushi and Rickettsia typhi. Of the patients, 237 (40.9%) and 193 (33.3%) had scrub and murine typhus, respectively, and 149 (25.7%) had neither of them (non scrub and murine typhus [non-ST/MT]). The proportion of murine typhus was highest among patients living in Hanoi whereas that of scrub typhus was highest in national or regional border areas. The presence of an eschar, dyspnea, hypotension, and lymphadenopathy was significantly associated with a diagnosis of scrub typhus (OR = 46.56, 10.90, 9.01, and 7.92, respectively). Patients with murine typhus were less likely to have these findings but more likely to have myalgia, rash, and relative bradycardia (OR = 1.60, 1.56, and 1.45, respectively). Scrub typhus and murine typhus were shown to be common causes of AUF in northern Vietnam although the occurrence of spotted fever group rickettsiae was not determined. Clinical and epidemiological information may help local clinicians make clinical diagnosis of specific rickettsioses in a resource-limited setting.	[Hamaguchi, Sugihiro; Ngo Chi Cuong; Yoshida, Lay-Myint; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Trop Med, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Doan Thu Tra; Nguyen Quang Tuan; Pham Thanh Thuy] Bach Mai Hosp, Dept Infect Dis, Hanoi 84, Vietnam; [Doan, Yen Hai; Ando, Shuji] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Shimizu, Kenta; Arikawa, Jiro] Hokkaido Univ, Dept Microbiol, Infect Dis Lab, Grad Sch Med, Sapporo, Hokkaido 060, Japan; Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Parry, Christopher M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Hamaguchi, Sugihiro; Ngo Chi Cuong; Yoshida, Lay-Myint; Ariyoshi, Koya] Nagasaki Univ, Pediat Infect Dis, Nagasaki 852, Japan; [Doan, Yen Hai; Ando, Shuji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Le Quynh Mai; Dang Duc-Anh] Natl Inst Hyg & Epidemiol, Dept Virol, Hanoi, Vietnam	Thuy, PT (reprint author), Bach Mai Hosp, Dept Infect Dis, 78 Giai Phong Rd, Hanoi 84, Vietnam.	dzf14275@nifty.com; dr_c_ngochi@yahoo.com; thutraart@yahoo.com; yendoan@nih.go.jp; kshimizu@med.hokudai.ac.jp; drtuantnbm@yahoo.com; lmyint09@gmail.com; lom9@hotmail.com; ducanhnihe@hn.vnn.vn; shuando@nih.go.jp; j_arika@med.hokudai.ac.jp; chris.parry@lshtm.ac.uk; koya.ariyoshi@gmail.com; phamthanhthuy714@gmail.com			National Center of Global Health and Medicine, Japan; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan)	The cost of original assays was supported by the National Center of Global Health and Medicine (former International Medical Center of Japan), Japan. This retrospective investigation was funded by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), the Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan).	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Tsai CC, 2011, J MICROBIOL IMMUNOL, V44, P33, DOI 10.1016/j.jmii.2011.01.007; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Suttinont C, 2006, ANN TROP MED PARASIT, V100, P363, DOI [10.1197/136485906X112158, 10.1179/136485906X112158]; WALKER DH, 1989, AM J CLIN PATHOL, V91, P720; Ellis RD, 2006, AM J TROP MED HYG, V74, P108; Thiebaut MM, 1997, NEW ENGL J MED, V336, P1613, DOI 10.1056/NEJM199705293362220; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Richards AL, 1997, AM J TROP MED HYG, V57, P91; FAN MY, 1987, AM J TROP MED HYG, V36, P615; Wang CC, 2007, AM J TROP MED HYG, V76, P1148; BERMAN SJ, 1973, ANN INTERN MED, V79, P26; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Palanivel S, 2012, INDIAN J PEDIATR, V79, P1459, DOI 10.1007/s12098-012-0721-0; Aronoff DM, 2003, AM J TROP MED HYG, V68, P477; Aung AK, 2014, AM J TROP MED HYG, V91, P451, DOI 10.4269/ajtmh.14-0191; BERMAN SJ, 1973, AM J TROP MED HYG, V22, P796; Chung JH, 2012, WORLD J GASTROENTERO, V18, P5138, DOI 10.3748/wjg.v18.i36.5138; Duong V, 2013, INFECT GENET EVOL, V15, P35, DOI 10.1016/j.meegid.2011.01.004; Frances S. P., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P666; GENTRY J W, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P217; Hu ML, 2005, AM J TROP MED HYG, V73, P667; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Koma T, 2013, EPIDEMIOL INFECT, V141, P1876, DOI 10.1017/S0950268812002385; Lee CS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-216; Liu YX, 2007, AM J TROP MED HYG, V76, P801; Maude RR, 2014, AM J TROP MED HYG, V91, P580, DOI 10.4269/ajtmh.13-0570; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Nadjm B, 2014, T ROY SOC TROP MED H, V108, P739, DOI 10.1093/trstmh/tru145; Paris DH, 2008, T ROY SOC TROP MED H, V102, P1239, DOI 10.1016/j.trstmh.2008.04.040; SILPAPOJAKUL K, 1993, Q J MED, V86, P43; Silpapojakul K, 1996, QJM-MON J ASSOC PHYS, V89, P623; Silpapojakul K, 2004, T ROY SOC TROP MED H, V98, P354, DOI 10.1016/j.trstmh.2003.10.011; STRICKMAN D, 1994, AM J TROP MED HYG, V51, P149; Vallee J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000909; Varghese GM, 2014, INT J INFECT DIS, V23, P39, DOI 10.1016/j.ijid.2014.02.009; Watt G, 1996, LANCET, V348, P86, DOI 10.1016/S0140-6736(96)02501-9; Watt G, 2005, AM J TROP MED HYG, V72, P10; Wu YW, 2007, INT J ENVIRON HEAL R, V17, P25, DOI 10.1080/09603120601124280	41	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2015	92	5					972	978		10.4269/ajtmh.14-0806		7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CH5KQ	WOS:000354074900018		
J	Thompson, CN; Phan, MVT; Hoang, NVM; Minh, PV; Vinh, NT; Thuy, CT; Nga, TTT; Rabaa, MA; Duy, PT; Dung, TTN; Phat, VV; Nga, TVT; Tu, LTP; Tuyen, HT; Yoshihara, K; Jenkins, C; Duong, VT; Phuc, HL; Tuyet, PTN; Ngoc, NM; Vinh, H; Chinh, NT; Thuong, TC; Tuan, HM; Hien, TT; Campbell, JI; Chau, NVV; Thwaites, G; Baker, S				Thompson, Corinne N.; Phan, My V. T.; Nguyen Van Minh Hoang; Pham Van Minh; Nguyen Thanh Vinh; Cao Thu Thuy; Tran Thi Thu Nga; Rabaa, Maia A.; Pham Thanh Duy; Tran Thi Ngoc Dung; Voong Vinh Phat; Tran Vu Thieu Nga; Le Thi Phuong Tu; Ha Thanh Tuyen; Yoshihara, Keisuke; Jenkins, Claire; Vu Thuy Duong; Hoang Le Phuc; Pham Thi Ngoc Tuyet; Nguyen Minh Ngoc; Ha Vinh; Nguyen Tran Chinh; Tang Chi Thuong; Ha Manh Tuan; Tran Tinh Hien; Campbell, James I.; Nguyen Van Vinh Chau; Thwaites, Guy; Baker, Stephen			A Prospective Multi-Center Observational Study of Children Hospitalized with Diarrhea in Ho Chi Minh City, Vietnam	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; MULTIPLEX PCR; ETIOLOGY; EPIDEMIOLOGY; DISEASE; DNA	We performed a prospective multicenter study to address the lack of data on the etiology, clinical and demographic features of hospitalized pediatric diarrhea in Ho Chi Minh City (HCMC), Vietnam. Over 2,000 (1,419 symptomatic and 609 non-diarrheal control) children were enrolled in three hospitals over a 1-year period in 2009-2010. Aiming to detect a panel of pathogens, we identified a known diarrheal pathogen in stool samples from 1,067/1,419 (75.2%) children with diarrhea and from 81/609 (13.3%) children without diarrhea. Rotavirus predominated in the symptomatic children (664/1,419; 46.8%), followed by norovirus (293/1,419; 20.6%). The bacterial pathogens Salmonella, Campylobacter, and Shigella were cumulatively isolated from 204/1,419(14.4%) diarrheal children and exhibited extensive antimicrobial resistance, most notably to fluoroquinolones and third-generation cephalosporins. We suggest renewed efforts in generation and implementation of policies to control the sale and prescription of antimicrobials to curb bacterial resistance and advise consideration of a subsidized rotavirus vaccination policy to limit the morbidity due to diarrheal disease in Vietnam.	[Thompson, Corinne N.; Nguyen Van Minh Hoang; Pham Van Minh; Nguyen Thanh Vinh; Cao Thu Thuy; Tran Thi Thu Nga; Rabaa, Maia A.; Pham Thanh Duy; Tran Thi Ngoc Dung; Voong Vinh Phat; Tran Vu Thieu Nga; Le Thi Phuong Tu; Ha Thanh Tuyen; Tran Tinh Hien; Campbell, James I.; Thwaites, Guy; Baker, Stephen] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Thompson, Corinne N.; Tran Tinh Hien; Campbell, James I.; Thwaites, Guy; Baker, Stephen] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX1 2JD, England; [Thompson, Corinne N.; Baker, Stephen] London Sch Hyg & Trop Med, London WC1, England; [Phan, My V. T.] Wellcome Trust Sanger Inst, Cambridge, England; [Rabaa, Maia A.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Yoshihara, Keisuke] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Jenkins, Claire] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; Childrens Hosp 1, Ho Chi Minh City, Vietnam; Childrens Hosp 2, Ho Chi Minh City, Vietnam; [Ha Vinh; Nguyen Tran Chinh; Nguyen Van Vinh Chau] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Vu Thuy Duong] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme,Childrens, Ho Chi Minh City, Vietnam; [Hoang Le Phuc; Tang Chi Thuong] Childrens Hosp 1, Ho Chi Minh City, Vietnam; [Pham Thi Ngoc Tuyet; Nguyen Minh Ngoc; Ha Manh Tuan] Childrens Hosp 2, Ho Chi Minh City, Vietnam	Baker, S (reprint author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 764 Vo Van Kiet,Dist 5, Ho Chi Minh City, Vietnam.	cthompson@oucru.org; mp21@sanger.ac.uk; hoangnvm@oucru.org; minhpv@oucru.org; vinhnt@oucru.org; caothanhthuy09@gmail.com; ngattt@oucru.org; mrabaa@oucru.org; duypt@oucru.org; dungttn@oucru.org; phatvv@oucru.org; ngatvt@oucru.org; tultp@oucru.org; tuyenht@oucru.org; pelopop7171new@outlook.com; Claire.Jenkins1@phe.gov.uk; duongvt@oucru.org; drphuc.ph1@gmail.com; tuyetpham57@yahoo.com; mngocnd2@yahoo.com; vinhh@oucru.org; chinhquan284@vnn.vn; drtcthuong@gmail.com; manhtuanzu@yahoo.com; hientt@oucru.org; jcampbell@oucru.org; chaunvv@oucru.org; gthwaites@oucru.org; sbaker@oucru.org		Rabaa, Maia/0000-0003-0529-2228; Thwaites, Guy/0000-0002-2858-2087	Wellcome Trust (United Kingdom) [WT1093724]; Li Ka Shing Foundation (People's Republic of China); Oak Foundation (United States); Wellcome Trust [100087/Z/12/Z]; Royal Society [100087/Z/12/Z]	This work was funded by the Wellcome Trust (United Kingdom) (WT1093724), the Li Ka Shing Foundation (the People's Republic of China), and the Oak Foundation (United States). Stephen Baker is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z).	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Howard SJ, 2013, LANCET INFECT DIS, V13, P1001, DOI [10.1016/S1473-3099(13)70195-6, 10.1016/51473-3099(13)70195-6]; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Jean SS, 2011, INT J ANTIMICROB AG, V37, P291, DOI 10.1016/j.ijantimicag.2011.01.009; Vinh H, 2009, J MED MICROBIOL, V58, P281, DOI 10.1099/jmm.0.002949-0; Chalmers RM, 2011, J MED MICROBIOL, V60, P1598, DOI 10.1099/jmm.0.034181-0; Le TMV, 2009, J MED MICROBIOL, V58, P1585, DOI 10.1099/jmm.0.010033-0; Jenkins C, 2012, J MED MICROBIOL, V61, P1082, DOI 10.1099/jmm.0.041517-0; [Anonymous], 2012, STAT YB HO CHI MINH; Jain D, 2005, T ROY SOC TROP MED H, V99, P207, DOI 10.1016/j.trstmh.2004.09.006; Zhang MJ, 2010, J MED MICROBIOL, V59, P1171, DOI 10.1099/jmm.0.022418-0; Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI [10.4269/ajtmh.2010.10-0367, 10.4269/ajtmh.2010.10.0367]; Carrique-Mas JJ, 2013, EPIDEMIOL INFECT, V142, P1; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT DISK; Dang DA, 2012, VACCINE S1, V30, P114; Davidson G, 2002, J PEDIATR GASTR NUTR, V35, pS143, DOI 10.1097/01.MPG.0000027003.95204.D7; Dewan N, 1998, ACTA PAEDIATR, V87, P627, DOI 10.1080/080352598750014012; Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001; Le LT, 2009, VACCINE, V27, pF130, DOI 10.1016/j.vaccine.2009.08.086; Meng CY, 2011, PEDIATR INFECT DIS J, V30, P331, DOI 10.1097/INF.0b013e3181fb6f82; My PVT, 2013, EMERG INFECT DIS, V19, P29; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Ochoa TJ, 2010, CLIN INFECT DIS, V49, P1694; OLIVE DM, 1989, J CLIN MICROBIOL, V27, P261; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Tra My PV, 2011, AM J TROP MED HYG, V85, P768, DOI DOI 10.4269/AJTMH.2011.11-0364; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; Vinh Ha, 2009, BMC Infect Dis, V9, P204, DOI 10.1186/1471-2334-9-204; Vu Nguyen Trung, 2006, Int J Infect Dis, V10, P298, DOI 10.1016/j.ijid.2005.05.009; Walker C.L., 2013, LANCET, V38, P1405, DOI DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2005, TREATM DIARRH MAN PH; World Health Organization (WHO), 2006, WHO CHILD GROWTH STA; World Health Organization (WHO), 2005, GUID CONTR SHIG INCL	41	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	MAY	2015	92	5					1045	1052		10.4269/ajtmh.14-0655		8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CH5KQ	WOS:000354074900030		
J	Kashiwagi, A; Hosokawa, S; Maeyama, Y; Ueki, R; Kaneki, M; Martyn, JAJ; Yasuhara, S				Kashiwagi, Aki; Hosokawa, Sachiko; Maeyama, Yoshihiro; Ueki, Ryusuke; Kaneki, Masao; Martyn, J. A. Jeevendra; Yasuhara, Shingo			Anesthesia with Disuse Leads to Autophagy Up-regulation in the Skeletal Muscle	ANESTHESIOLOGY			English	Article							DUCHENNES MUSCULAR-DYSTROPHY; MICE; MITOCHONDRIA; RHABDOMYOLYSIS; PROLIFERATION; ANTIOXIDANT; MECHANISMS; INHIBITOR; MITOPHAGY; PATHWAYS	Background: It has been known that skeletal muscles show atrophic changes after prolonged sedation or general anesthesia. Whether these effects are due to anesthesia itself or disuse during anesthesia has not been fully clarified. Autophagy dysregulation has been implicated in muscle-wasting conditions. This study tested the hypothesis that the magnitude of skeletal muscle autophagy is affected by both anesthesia and immobility. Methods: The extent of autophagy was analyzed chronologically during general anesthesia. In vivo microscopy was performed using green fluorescent protein-tagged LC3 for the detection of autophagy using sternomastoid muscles of live mice during pentobarbital anesthesia (n = 6 and 7). Western blotting and histological analyses were also conducted on tibialis anterior muscles (n = 3 to 5). To distinguish the effect of anesthesia from that due to disuse, autophagy was compared between animals anesthetized with pentobarbital and those immobilized by short-term denervation without continuation of anesthesia. Conversely, tibialis anterior and sternomastoid muscles were electrically stimulated during anesthesia. Results: Western blots and microscopy showed time-dependent autophagy up-regulation during pentobarbital anesthesia, peaking at 3 h (728.6 +/- 93.5% of basal level, mean +/- SE). Disuse by denervation without sustaining anesthesia did not lead to equivalent autophagy, suggesting that anesthesia is essential to cause autophagy. In contrast, contractile stimulation of the tibialis anterior and sternomastoid muscles significantly reduced the autophagy up-regulation during anesthesia (85% at 300 min). Ketamine, ketamine plus xylazine, isoflurane, and propofol also up-regulated autophagy. Conclusions: Short-term disuse without anesthesia does not lead to autophagy, but anesthesia with disuse leads to marked up-regulation of autophagy.	[Kashiwagi, Aki; Hosokawa, Sachiko; Ueki, Ryusuke; Kaneki, Masao; Martyn, J. A. Jeevendra; Yasuhara, Shingo] Shriners Hosp Children, Massachusetts Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02114 USA; [Kashiwagi, Aki; Hosokawa, Sachiko; Ueki, Ryusuke; Kaneki, Masao; Martyn, J. A. Jeevendra; Yasuhara, Shingo] Harvard Univ, Sch Med, Boston, MA USA; [Maeyama, Yoshihiro] Hyogo Coll Med, Dept Surg, Kobe, Hyogo, Japan	Yasuhara, S (reprint author), Shriners Hosp Children, 51 Blossom St, Boston, MA 02114 USA.	shingoyasuhara136@gmail.com			Shriners Hospital (Tampa, Florida); Massachusetts General Hospital, Department of Anesthesia, Critical Care and Pain Medicine Department Fund (Boston, Massachusetts); National Institutes of Health (Bethesda, Maryland) [P-50 GM2500]	Supported by a research grant funded by Shriners Hospital (Tampa, Florida; to Dr. Yasuhara), by Massachusetts General Hospital, Department of Anesthesia, Critical Care and Pain Medicine Department Fund (Boston, Massachusetts; to Dr. Yasuhara), and partly by National Institutes of Health P-50 GM2500: Project-I (Bethesda, Maryland; to Dr. Martyn).	Fanin M, 2014, MUSCLE NERVE, V50, P340, DOI 10.1002/mus.24167; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Hosokawa S, 2013, AM J PHYSIOL-ENDOC M, V304, pE922, DOI 10.1152/ajpendo.00078.2013; Arras M, 2001, COMPARATIVE MED, V51, P443; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Shiomi M, 2014, J ANESTH, V28, P593, DOI 10.1007/s00540-013-1755-9; Li Y, 2013, ACTA ANAESTH SCAND, V57, P380, DOI 10.1111/aas.12018; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Asai A, 2007, JOVE-J VIS EXP, pe210; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bains R, 2006, ACTA ANAESTH SCAND, V50, P572, DOI 10.1111/j.1399-6576.2006.00988.x; Culley Deborah J, 2007, Curr Opin Anaesthesiol, V20, P408; Fanin M, 2013, NEUROPATH APPL NEURO, V39, P762, DOI 10.1111/nan.12034; Fish RE, 2008, ANESTHESIA ANALGESIA, V2nd, P237; Flecknell P, 2009, LABORATORY ANIMAL ANAESTHESIA, 3RD EDITION, P19, DOI 10.1016/B978-0-12-369376-1.00002-2; Girshin M, 2006, PEDIATR ANESTH, V16, P170, DOI 10.1111/j.1460-9592.2005.01698.x; Goresky GV, 1999, CAN J ANAESTH, V46, P525; HERTSENS R, 1984, BIOCHIM BIOPHYS ACTA, V769, P411, DOI 10.1016/0005-2736(84)90325-0; Leitzke AS, 2013, STROKE, V44, P3587, DOI 10.1161/STROKEAHA.113.001988; Li JT, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/108928; Nagashima M, 2013, ANESTH ANALG, V116, P994, DOI 10.1213/ANE.0b013e31828841e3; O'Leary MFN, 2009, AUTOPHAGY, V5, P230; Phadke A, 2007, ANESTH ANALG, V105, P977, DOI 10.1213/01.ane.0000280935.90260.d0; Poole TC, 2010, BRIT J ANAESTH, V104, P487, DOI 10.1093/bja/aeq035; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Simpson RS, 2013, ANAESTH INTENS CARE, V41, P805; Spitali P., 2013, PLOS CURR, DOI [10.1371/currents.md.e1226cefa851a2f079bbc406c0a21e80, DOI 10.1371/CURRENTS.MD.E1226CEFA851A2F079BBC406C0A21E80]; Talbert EE, 2013, J APPL PHYSIOL, V115, P529, DOI 10.1152/japplphysiol.00471.2013; Volti GL, 2008, CLIN TER, V159, P463; Xie J, 2009, CANCER LETT, V282, P35, DOI 10.1016/j.canlet.2009.02.055; Zhang JH, 2013, REDOX BIOL, V1, P19, DOI 10.1016/j.redox.2012.11.008	39	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	MAY	2015	122	5					1075	1083		10.1097/ALN.0000000000000561		9	Anesthesiology	Anesthesiology	CH5PT	WOS:000354088500016		
J	Deguchi, T; Seiryu, M; Daimaruya, T; Garetto, LP; Takano-Yamamoto, T; Roberts, WE				Deguchi, Toru; Seiryu, Masahiro; Daimaruya, Takayoshi; Garetto, Lawrence P.; Takano-Yamamoto, Teruko; Roberts, W. Eugene			Decreased alveolar bone turnover is related to the occurrence of root resorption during experimental tooth movement in dogs	ANGLE ORTHODONTIST			English	Article						Root resorption; Alveolar bone turnover; Histomorphometric analysis; Tooth movement; Biomechanics	SKELETAL STRUCTURAL ADAPTATIONS; MECHANICAL USAGE SATMU; REDEFINING WOLFF LAW; ORTHODONTIC FORCES	Objective: To investigate the relationship between root resorption (RR) and bone turnover in two different types of tooth movement in dogs. Materials and Methods: A total of 16 dogs in two different groups were used. Tooth movement of dog premolars resulted from approximately 200 g of force. Histomorphometric analysis of premolar roots was assessed after 4 and 12 weeks of tooth movement by comparing nonresorptive to resorptive surfaces. Results: Histomorphometric analysis indicated a significant decrease in the bone formation rate in the root resorptive areas, which resulted in decreased bone volume after 12 weeks. The threshold to detect RR in periapical radiographs was about 1.0 mm(2). Conclusions: A sustained mechanical load, due to the prolonged stress and strain of continuous mechanics, induces elevated bone metabolic activity, such as the bone turnover (remodeling) and change in bone volume (modeling). Therefore, our data support the hypothesis that increased RR is related to decreased bone formation (turnover) in high stress areas exposed to prolonged orthodontic tooth movement.	[Deguchi, Toru] Ohio State Univ, Coll Dent, Div Orthodont, Columbus, OH 43210 USA; [Deguchi, Toru; Seiryu, Masahiro; Takano-Yamamoto, Teruko] Tohoku Univ, Div Orthodont, Grad Sch Dent, Sendai, Miyagi 980, Japan; [Daimaruya, Takayoshi] Tsutsujigaoka Orthodont Clin, Sendai, Miyagi, Japan; [Garetto, Lawrence P.] Indiana Univ Sch Med, Indiana Univ Sch Dent, Dept Cellular Integrat Physiol, Indianapolis, IN 46202 USA; [Roberts, W. Eugene] Indiana Univ Purdue Univ, Orthodont, Indianapolis, IN 46202 USA; [Roberts, W. Eugene] Indiana Univ Purdue Univ, Mech Engn, Indianapolis, IN 46202 USA	Deguchi, T (reprint author), Ohio State Univ, Coll Dent, Div Orthodont, Postle Hall Room 4088,305 W 12th Ave, Columbus, OH 43210 USA.	deguchi.4@osu.edu					FROST HM, 1990, ANAT REC, V226, P414, DOI 10.1002/ar.1092260403; Baumrind S, 1996, AM J ORTHOD DENTOFAC, V110, P311, DOI 10.1016/S0889-5406(96)80016-3; Konoo T, 2001, J DENT RES, V80, P457; Chan E, 2005, AM J ORTHOD DENTOFAC, V127, P186, DOI 10.1016/j.ajodo.2003.11.026; Al-Qawasmi RA, 2003, AM J ORTHOD DENTOFAC, V123, P242, DOI 10.1067/mod.2003.42; Hartsfield JK, 2004, CRIT REV ORAL BIOL M, V15, P115; MIRABELLA AD, 1995, AM J ORTHOD DENTOFAC, V108, P48, DOI 10.1016/S0889-5406(95)70065-X; BURSTONE CJ, 1980, AM J ORTHOD DENTOFAC, V77, P396, DOI 10.1016/0002-9416(80)90105-0; Fox Nigel, 2005, Evid Based Dent, V6, P21, DOI 10.1038/sj.ebd.6400304; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Han GL, 2005, ANGLE ORTHOD, V75, P912; Jeon PD, AM J ORTHOD DENTOFAC, V99, P267; Kimmel DB, 1983, BONE HISTOMORPHOMETR, P89; lino S, 2007, AM J ORTHOD DENTOFAC, V131; Maltha J C, 2004, Orthod Craniofac Res, V7, P115, DOI 10.1111/j.1601-6343.2004.00283.x; Oyama K, 2007, EUR J ORTHODONT, V29, P113, DOI 10.1093/ejo/cjl043; Parfitt AM, 1983, BONE HISTOMORPHOMETR, P53; Roberts WE, 2000, ORTHODONTICS CURRENT, P193; ENGSTROM C, 1988, AM J ORTHOD DENTOFAC, V93, P486, DOI 10.1016/0889-5406(88)90077-7	19	0	0	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	MAY	2015	85	3					386	393		10.2319/021714-117.1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH4KO	WOS:000354002600005		
J	Deguchi, T; Terao, F; Aonuma, T; Kataoka, T; Sugawara, Y; Yamashiro, T; Takano-Yamamoto, T				Deguchi, Toru; Terao, Fumie; Aonuma, Tomo; Kataoka, Tomoki; Sugawara, Yasuyo; Yamashiro, Takashi; Takano-Yamamoto, Teruko			Outcome assessment of lingual and labial appliances compared with cephalometric analysis, peer assessment rating, and objective grading system in Angle Class II extraction cases	ANGLE ORTHODONTIST			English	Article						Lingual appliance; Clinical outcome; Peer assessment rating; Objective grading system	APICAL ROOT RESORPTION; ORTHODONTIC TREATMENT; MAXILLARY INCISORS; TORQUE CONTROL; MALOCCLUSION; COMPLEXITY; PATIENT; INDEX	Objective: To validate our hypothesis that there would be significant differences in treatment outcomes, including cephalometric values, degree of root resorption, occlusal indices, and functional aspect, between cases treated with labial and lingual appliances. Materials and Methods: Twenty-four consecutively treated Class II cases with extractions and lingual appliance were compared with 25 matched cases treated with extraction and labial appliance. Orthodontic treatment outcomes were evaluated by cephalometric analysis, peer assessment rating, and an objective grading system (OGS). Additionally, functional analysis was also performed in both groups after orthodontic treatment. Statistical comparison was performed using the Wilcoxon signed rank test within the groups, and the Mann-Whitney U-test was used to compare between the labial and lingual groups. Results: The only significant difference between the groups was that the interincisal angle was larger in the lingual group than in the labial group. OGS evaluation showed that control over root angulation was significantly worse in the lingual group than in the labial group. There was no significant difference between groups in the amount of root resorption or in functional evaluation. Conclusions: Generally, lingual appliances offer comparable treatment results to those obtained with labial appliances. However, care should be taken with lingual appliances because they are more prone to produce uprighted incisors and root angulation.	[Deguchi, Toru] Ohio State Univ, Coll Dent, Div Orthodont, Columbus, OH 43210 USA; [Deguchi, Toru; Aonuma, Tomo; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Div Orthodont, Sendai, Miyagi 9808575, Japan; [Terao, Fumie] Tohoku Univ, Grad Sch Dent, Dept Orthodont, Sendai, Miyagi 9808575, Japan; [Kataoka, Tomoki; Sugawara, Yasuyo] Okayama Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yamashiro, Takashi] Okayama Univ, Dept Orthodont & Dentofacial Orthoped, Grad Sch Med Dent & Pharmaceut Sci, Div Orthodont, Okayama, Japan	Takano-Yamamoto, T (reprint author), Tohoku Univ, Div Orthodont & Dentofacial Orthoped, Grad Sch Dent, Aoba Ku, 4-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	t-yamamo@mail.tains.tohoku.ac.jp			Japan Society for the Promotion of Science	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Baumrind S, 1996, AM J ORTHOD DENTOFAC, V110, P311, DOI 10.1016/S0889-5406(96)80016-3; Cangialosi TJ, 2004, AM J ORTHOD DENTOFAC, V125, P270, DOI 10.1016/j.ajodo.2004.01.005; DEGUZMAN L, 1995, AM J ORTHOD DENTOFAC, V107, P172, DOI 10.1016/S0889-5406(95)70133-8; Hong RK, 2005, ANGLE ORTHOD, V75, P129; Taner T, 1999, EUR J ORTHODONT, V21, P491, DOI 10.1093/ejo/21.5.491; Parker RJ, 1998, AM J ORTHOD DENTOFAC, V114, P677, DOI 10.1016/S0889-5406(98)70200-8; Dahlberg G, 1940, STAT METHODS MED BIO, P122; DESHIELD.RW, 1969, ANGLE ORTHOD, V39, P231; Dianmond M., 1983, J CLIN ORTHOD, V17, P240; Fritz Ulrike, 2003, J Orofac Orthop, V64, P434, DOI 10.1007/s00056-003-0243-5; Fuck Lars-Michael, 2005, J Orofac Orthop, V66, P363, DOI 10.1007/s00056-005-0442-3; FULMER DT, 1989, AM J ORTHOD DENTOFAC, V95, P514, DOI 10.1016/0889-5406(89)90415-0; Geron S, 2004, ANGLE ORTHOD, V74, P195; GORMAN JC, 1991, AM J ORTHOD DENTOFAC, V99, P202, DOI 10.1016/0889-5406(91)70002-E; Kim TK, 2005, ANGLE ORTHOD, V75, P177; Kurz C, 1988, J AM LING ASS, V3, P10; Liang W, 2009, AM J ORTHOD DENTOFAC, V135, P316, DOI 10.1016/j.ajodo.2007.03.039; LINGE L, 1991, AM J ORTHOD DENTOFAC, V99, P35, DOI 10.1016/S0889-5406(05)81678-6; Miyawaki S, 2001, J DENT RES, V80, P437; MORAN KI, 1987, AM J ORTHOD DENTOFAC, V92, P24, DOI 10.1016/0889-5406(87)90292-7; Pulfer RM, 2009, ANGLE ORTHOD, V79, P468, DOI 10.2319/042308-227.1; Scuzzo Giuseppe, 2010, J Clin Orthod, V44, P114; Smith J R, 1986, J Clin Orthod, V20, P252; Sonnesen L, 2008, EUR J ORTHODONT, V30, P621, DOI 10.1093/ejo/cjn044; Takeshita N, 2013, AM J ORTHOD DENTOFAC, V144, P441, DOI 10.1016/j.ajodo.2012.09.024; Upadhyay M, 2008, AM J ORTHOD DENTOFAC, V134; Yang-Powers LC, 2002, AM J ORTHOD DENTOFAC, V122, P451, DOI 10.1067/mod.2002.128464	27	0	0	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	MAY	2015	85	3					400	407		10.2319/031014-173.1		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH4KO	WOS:000354002600007		
J	Kaku, M; Shimasue, H; Ohtani, J; Kojima, S; Sumi, H; Shikata, H; Kojima, S; Motokawa, M; Abonti, TR; Kawata, T; Tanne, K; Tanimoto, K				Kaku, Masato; Shimasue, Hiroshi; Ohtani, Junji; Kojima, Shunichi; Sumi, Hiromi; Shikata, Hanaka; Kojima, Shotoku; Motokawa, Masahide; Abonti, Tahsin Raquib; Kawata, Toshitsugu; Tanne, Kazuo; Tanimoto, Kotaro			A case of tooth autotransplantation after long-term cryopreservation using a programmed freezer with a magnetic field	ANGLE ORTHODONTIST			English	Article						Autotransplantation; Cryopreservation; Programmed freezer; Magnetic field	PERIODONTAL REGENERATION; TEETH; TRANSPLANTATION; SURVIVAL; MOLARS	This case report describes the treatment of a skeletal Class III malocclusion with autotransplantation of a cryopreserved tooth. To gain an esthetic facial profile and good occlusion, extraction of bimaxillary premolars and surgical therapy were chosen. The patient had chronic apical periodontitis on the lower left first molar. Although she did not feel any pain in that region, the tooth was considered to have a poor prognosis. Therefore, we cryopreserved the extracted premolars to prepare for autotransplantation in the lower first molar area because the tooth would probably need to be removed in the future. The teeth were frozen by a programmed freezer with a magnetic field (CAS freezer) that was developed for tissue cryopreservation and were cryopreserved in -150 degrees C deep freezer. After 1.5 years of presurgical orthodontic treatment, bilateral sagittal split ramus osteotomy was performed for mandible setback. Improvement of the facial profile and the occlusion were achieved in the retention phase. Six years after the initial visit, the patient had pain on the lower left first molar, and discharge of pus was observed, so we extracted the lower left first molar and autotransplanted the cryopreserved premolar. Three years later, healthy periodontium was observed at the autotransplanted tooth. This case report suggests that long-term cryopreservation of teeth by a CAS freezer is useful for later autotransplantation, and this can be a viable technique to replace missing teeth.	[Kaku, Masato; Kojima, Shunichi; Sumi, Hiromi; Shikata, Hanaka; Kojima, Shotoku; Motokawa, Masahide; Abonti, Tahsin Raquib; Tanne, Kazuo; Tanimoto, Kotaro] Hiroshima Univ, Dept Orthodont, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Shimasue, Hiroshi] Hiroshima Univ, Dept Oral & Maxillofacial Surg, Inst Biomed & Hlth Sci, Hiroshima 7348553, Japan; [Ohtani, Junji] Ohtani Orthodont Clin, Hiroshima, Japan; [Kawata, Toshitsugu] Kanagawa Dent Univ, Dept Orthodont, Yokosuka, Kanagawa, Japan	Kaku, M (reprint author), Hiroshima Univ, Dept Orthodont, Appl Life Sci, Inst Biomed & Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mkaku@hiroshima-u.ac.jp					Abedini S, 2011, CRYOBIOLOGY, V62, P181, DOI 10.1016/j.cryobiol.2011.03.001; ANDREASEN JO, 1990, EUR J ORTHODONT, V12, P14; Czochrowska EM, 2002, AM J ORTHOD DENTOFAC, V121, P110, DOI 10.1067/mod.2002.119979; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; Kaku M, 2010, CRYOBIOLOGY, V61, P73, DOI 10.1016/j.cryobiol.2010.05.003; Iwasaka M, 2011, J APPL PHYS, V109; Izumi N, 2007, INT J ORAL MAX SURG, V36, P838, DOI 10.1016/j.ijom.2007.06.003; Kamada H, 2011, AM J ORTHOD DENTOFAC, V140, P799, DOI 10.1016/j.ajodo.2011.04.024; Kawasaki N, 2004, ARCH ORAL BIOL, V49, P59, DOI 10.1016/j.archoralbio.2003.07.002; KRISTERSON L, 1991, J CLIN PERIODONTOL, V18, P521, DOI 10.1111/j.1600-051X.1991.tb00084.x; Kuhl S, 2012, OR SURG OR MED OR PA, V113, pE5, DOI 10.1016/j.tripleo.2011.06.020; Laureys W, 2001, AM J ORTHOD DENTOFAC, V119, P346, DOI 10.1067/mod.2001.113259; Lundberg T, 1996, BRIT J ORAL MAX SURG, V34, P181, DOI 10.1016/S0266-4356(96)90374-5; Oh YH, 2005, CRYOBIOLOGY, V51, P322, DOI 10.1016/j.cryobiol.2005.08.008; Paulsen Hans Ulrik, 2006, World J Orthod, V7, P27; SCHWARTZ O, 1986, AM J ORTHOD DENTOFAC, V90, P67, DOI 10.1016/0889-5406(86)90029-6; SCHWARTZ O, 1986, INT J ORAL MAX SURG, V15, P30; Temmerman L, 2006, AM J ORTHOD DENTOFAC, V129, P691, DOI 10.1016/j.ajodo.2004.12.021	18	0	0	E H ANGLE EDUCATION RESEARCH FOUNDATION, INC	NEWTON N	1615 BEACON ST, NEWTON N, MA 02468-1507 USA	0003-3219	1945-7103		ANGLE ORTHOD	Angle Orthod.	MAY	2015	85	3					518	524		10.2319/030314-148.1		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CH4KO	WOS:000354002600023		
J	Nguyen, BX; Kikuchi, K; Uoc, NT; Dang-Nguyen, TQ; Linh, NV; Men, NT; Nguyen, TT; Nagai, T				Bui Xuan Nguyen; Kikuchi, Kazuhiro; Nguyen Thi Uoc; Thanh Quang Dang-Nguyen; Nguyen Viet Linh; Nguyen Thi Men; Trung Thanh Nguyen; Nagai, Takashi			Production of Ban miniature pig embryos by in vitro fertilization: A comparative study with Landrace	ANIMAL SCIENCE JOURNAL			English	Article						Ban miniature pig; frozen semen; hormone-stimulated oocyte; in vitro fertilization	DEVELOPMENTAL COMPETENCE; BOAR SPERMATOZOA; PORCINE OOCYTES; INVITRO FERTILIZATION; FOLLICLE; BIRTH; SIZE	Ban is an endangered miniature pig breed in Vietnam. This study aimed to set up an in vitro embryo production (IVP) system for this breed. Ban's epididymal sperm concentration (1240 +/- 35x10(6)/mL) was lower (P<0.01) compared with Landrace (4160 +/- 42x10(6)/mL). However, sperm characteristics before and after freezing in Ban and Landrace were similar. The numbers of follicles with diameter larger than 2mm per ovary in Ban females treated with equine chorionic gonadotropin and human chorionic gonadotropin (27.1 +/- 1.3) were higher (P<0.05) than those in Landrace (12.9 +/- 2.0) and in non-hormone stimulated Ban (no >2mm follicles). After in vitro maturation, the percentages of oocytes with expanded cumulus cells and the first polar body (matured oocytes) were not different among Ban, hormone-stimulated Ban and Landrace. The percentages of two-cell embryos and morulae derived from oocytes collected from three sources did not differ. However, the rate of blastocysts derived from oocytes in non-stimulated Ban (4.0 +/- 3.8%) was lower (P<0.05) than that in Landrace (15.3 +/- 1.8%). In conclusion, an effective IVP system for good quality embryos in Ban, that is essential for genetic conservation of this breed, was established.	[Bui Xuan Nguyen; Nguyen Thi Uoc; Thanh Quang Dang-Nguyen; Nguyen Viet Linh; Nguyen Thi Men; Trung Thanh Nguyen] Vietnamese Acad Sci & Technol, Inst Biotechnol, Lab Embryo Biotechnol & Stem Cells, Hanoi, Vietnam; [Kikuchi, Kazuhiro; Nguyen Thi Men] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki 3058602, Japan; [Thanh Quang Dang-Nguyen] Vet Res Inst, CS-62132 Brno, Czech Republic; [Nguyen Thi Men] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei, Taiwan; [Nagai, Takashi] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea	Kikuchi, K (reprint author), Natl Inst Agrobiol Sci, Div Anim Sci, Anim Dev & Differentiat Res Unit Kannondai, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.	kiku@affrc.go.jp			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.16.141.09]	This study was supported by the Vietnam National Foundation for Science and Technology Development (NAFOSTED; grant number 106.16.141.09; Bui Xuan Nguyen).	Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; NAGAI T, 1988, J REPROD FERTIL, V84, P585; MATTIOLI M, 1989, THERIOGENOLOGY, V31, P1201, DOI 10.1016/0093-691X(89)90089-7; Kikuchi K, 1998, THERIOGENOLOGY, V50, P615, DOI 10.1016/S0093-691X(98)00166-6; Abeydeera LR, 1998, THERIOGENOLOGY, V50, P981, DOI 10.1016/S0093-691X(98)00201-5; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Suzuki K, 2002, INT J ANDROL, V25, P84, DOI 10.1046/j.1365-2605.2002.00330.x; Marchal R, 2002, THERIOGENOLOGY, V57, P1523, DOI 10.1016/S0093-691X(02)00655-6; Bagg MA, 2007, REPROD FERT DEVELOP, V19, P797, DOI 10.1071/RD07018; Mermillod P, 2008, REPROD DOMEST ANIM, V43, P393, DOI 10.1111/j.1439-0531.2008.01190.x; Funahashi H, 1996, BIOL REPROD, V54, P1412, DOI 10.1095/biolreprod54.6.1412; Dang-Nguyen TQ, 2010, J REPROD DEVELOP, V56, P31; Misumi K, 2014, ANIM SCI J, V85, P112, DOI 10.1111/asj.12097; Niwa T., 1989, MANUAL CRYOPRESERVAT, P19; Petters R M, 1993, J Reprod Fertil Suppl, V48, P61; YOSHIDA M, 1993, THERIOGENOLOGY, V39, P1303, DOI 10.1016/0093-691X(93)90232-T	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					487	493		10.1111/asj.12317		7	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300001		
J	Kitaji, H; Ookutsu, S; Sato, M; Miyoshi, K				Kitaji, Hideki; Ookutsu, Shoji; Sato, Masahiro; Miyoshi, Kazuchika			A new rolling culture-based in vitro fertilization system capable of reducing polyspermy in porcine oocytes	ANIMAL SCIENCE JOURNAL			English	Article						in vitro fertilization; oocytes; pig; polyspermy; rolling culture	EPIDERMAL-GROWTH-FACTOR; TRIS-BUFFERED MEDIUM; PIG OOCYTES; EJACULATED SPERMATOZOA; SPONTANEOUS MOTILITY; EMBRYO DEVELOPMENT; SPERM PENETRATION; OVIDUCT; MATURATION; INVITRO	The high incidence of polyspermy is one of the major obstacles during in vitro fertilization (IVF) in pigs. To overcome this, we developed a novel IVF method, which involves constant rotation. Oocytes matured in vitro were mixed with spermatozoa (0.2x10(5) sperm/mL) in an IVF medium (200L) using a 200L PCR tube. This tube was then rotated at 1rpm for 6h at 38.5 degrees C in a rotation mixer (experimental group). A second PCR tube was simultaneously cultured without rotation (control group). The rate of polyspermy was evaluated 12h after insemination and was significantly (P<0.05; 21.0% vs. 48.3%) lower in the experimental group than in the control group. Sperm penetration rate was similar in oocytes from the experimental and control groups (75.2% vs. 83.1%). However, monospermic fertilization rate of the oocytes was significantly (P<0.05; 44.8% vs. 21.2%) higher in the experimental group than in the control group. Furthermore, the rate of blastocyst formation (30.1% vs. 20.8%) increased in the experimental group, as compared to the control group. This present system will contribute to increase the efficacy of blastocyst production through reduction of polyspermic penetration.	[Kitaji, Hideki; Ookutsu, Shoji; Miyoshi, Kazuchika] Kagoshima Univ, Frontier Sci Res Ctr, Lab Anim Reprod, Fac Agr, Kagoshima 8908544, Japan; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima 8908544, Japan	Sato, M (reprint author), Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	masasato@ms.kagoshima-u.ac.jp					Abeydeera LR, 1998, MOL REPROD DEV, V51, P395, DOI 10.1002/(SICI)1098-2795(199812)51:4<395::AID-MRD6>3.0.CO;2-Y; Abeydeera LR, 2000, THERIOGENOLOGY, V54, P787, DOI 10.1016/S0093-691X(00)00390-3; Wang WH, 1998, MOL REPROD DEV, V49, P308, DOI 10.1002/(SICI)1098-2795(199803)49:3<308::AID-MRD11>3.0.CO;2-S; Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Funahashi H, 2000, BIOL REPROD, V63, P1157, DOI 10.1095/biolreprod63.4.1157; Han YM, 1999, BIOL REPROD, V60, P1110, DOI 10.1095/biolreprod60.5.1110; Yeste M, 2013, THERIOGENOLOGY, V79, P929, DOI 10.1016/j.theriogenology.2013.01.008; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; NAGAI T, 1990, MOL REPROD DEV, V26, P377, DOI 10.1002/mrd.1080260413; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; Kim NH, 1996, J REPROD FERTIL, V107, P79; BAVISTER BD, 1977, BIOL REPROD, V16, P228, DOI 10.1095/biolreprod16.2.228; Han YM, 1999, BIOL REPROD, V61, P1340, DOI 10.1095/biolreprod61.5.1340; Somfai T, 2008, ANIM REPROD SCI, V107, P131, DOI 10.1016/j.anireprosci.2007.06.025; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Abeydeera LR, 1997, THERIOGENOLOGY, V48, P537, DOI 10.1016/S0093-691X(97)00270-7; Wang WH, 2003, MICROSC RES TECHNIQ, V61, P335, DOI 10.1002/jemt.10346; CROXATTO HB, 1975, GYNECOL OBSTET INVES, V6, P215; FUNAHASHI H, 1993, J REPROD FERTIL, V99, P97; Gil MA, 2003, THERIOGENOLOGY, V60, P767, DOI 10.1016/S0093-691X(03)00051-7; HUNTER RHF, 1991, MOL REPROD DEV, V29, P385, DOI 10.1002/mrd.1080290411; Hunter R H, 1990, J Reprod Fertil Suppl, V40, P211; Li YH, 2003, BIOL REPROD, V69, P1580, DOI 10.1095/biolreprod.103.018937; Niwa K, 2001, REPROD BIOTECHNOLOGY, P27; RODRIGUEZMARTINEZ H, 1982, BIOL REPROD, V26, P98, DOI 10.1095/biolreprod26.1.98; RODRIGUEZMARTINEZ H, 1982, J REPROD FERTIL, V66, P615; RODRIGUEZMARTINEZ H, 1984, ZBL VET MED A, V31, P91; WANG WH, 1994, BIOL REPROD, V50, P510, DOI 10.1095/biolreprod50.3.510; WANG W-H, 1992, Journal of Reproduction and Development, V38, P125	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					494	498		10.1111/asj.12327		5	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300002		
J	Astuti, A; Obitsu, T; Sugino, T; Taniguchi, K; Okita, M; Kurokawa, Y				Astuti, Andriyani; Obitsu, Taketo; Sugino, Toshihisa; Taniguchi, Kohzo; Okita, Miki; Kurokawa, Yuzo			Milk production, plasma metabolite profiles and mammary arterial-venous differences of milk precursors in early lactation cows milked at different frequencies by an automatic milking system	ANIMAL SCIENCE JOURNAL			English	Article						automatic milking; mammary gland; milk production; milking frequency	TIMES DAILY MILKING; ONCE-DAILY MILKING; DAIRY-COWS; FEEDING FREQUENCY; ENERGY DENSITY; NITROGEN-UTILIZATION; BLOOD-METABOLITES; SODIUM CASEINATE; AMINO-ACIDS; YIELD	The objective of this study was to clarify the effect of different milking frequencies under an automatic milking system (AMS) on milk yield, plasma metabolite profiles and mammary arterial-venous (A-V) differences of milk precursors by mammary tissues in early lactation cows. Twelve Holstein cows were divided into two and four times milking frequency treatments by AMS after calving to 50 days postpartum. Cows were given a partial mixed ration ad libitum and a concentrate diet at every milking. Dry matter intake increased similarly in both treatments with advancing postpartum days. Milk yield was greater (P<0.001) by 25% with four times milking, but milk composition was not affected by milking frequency. Body weight change was also not affected by milking frequency. Arterial concentrations of glucose and glutamate were lower (P<0.05) for four times milking frequency. However, arterial concentration of nonesterified fatty acids did not differ between treatments. Although mammary A-V differences of plasma concentration for most milk precursors did not differ between treatments, estimated plasma flow was higher (P<0.05) for four times milking frequency. These results indicate that higher milking frequency may increase mammary uptake of milk precursors, whereas may not affect the extent of fat mobilization of early lactating cows from day 20 postpartum onward.	[Astuti, Andriyani; Obitsu, Taketo; Sugino, Toshihisa; Taniguchi, Kohzo; Okita, Miki; Kurokawa, Yuzo] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan	Obitsu, T (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima, Japan.	tobitsu@hiroshima-u.ac.jp			Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia under a BPPLN scholarship; JSPS KAKENHI [23580369]	This work was supported in part by the Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia under a BPPLN scholarship. This work was also supported by JSPS KAKENHI Grant Number 23580369. The authors are grateful to Dr. Rika Fukumori for the contribution of hormone analysis.	Andersen JB, 2004, J VET MED A, V51, P52, DOI 10.1111/j.1439-0442.2004.00605.x; DEPETERS EJ, 1985, J DAIRY SCI, V68, P123; BarPeled U, 1995, J DAIRY SCI, V78, P2726, DOI 10.3168/jds.S0022-0302(95)76903-X; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Hale SA, 2003, J DAIRY SCI, V86, P2061, DOI 10.3168/jds.S0022-0302(03)73795-3; Dahl GE, 2004, J DAIRY SCI, V87, P882; Andersen JB, 2003, LIVEST PROD SCI, V81, P119, DOI 10.1016/S0301-6226(02)00303-2; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Speroni M, 2006, J DAIRY SCI, V89, P4687; Eslamizad M, 2010, J DAIRY SCI, V93, P4054, DOI 10.3168/jds.2010-3104; Andersen JB, 2002, J VET MED A, V49, P177, DOI 10.1046/j.1439-0442.2002.00444.x; MILLER PS, 1991, J DAIRY SCI, V74, P3791; Hart KD, 2013, J DAIRY SCI, V96, P6973, DOI 10.3168/jds.2013-6764; AOAC, 1995, OFFICIAL METHODS ANA; Delamaire E, 2006, J DAIRY SCI, V89, P2007; DERRIG RG, 1974, J NUTR, V104, P151; Egan AR, 1969, J NUTR, V96, P450; FOLDAGER J, 1980, J DAIRY SCI, V63, P396; Guinard-Flament J, 2007, J DAIRY SCI, V90, P5062, DOI 10.3168/jds.2007-0250; Guinard-Flament J, 2006, REPROD NUTR DEV, V46, P589, DOI 10.1051/rnd:2006030; McNamara S, 2008, LIVEST SCI, V117, P70, DOI 10.1016/j.livsci.2007.11.013; MEIJER GAL, 1993, METABOLISM, V42, P358, DOI 10.1016/0026-0495(93)90087-5; MURASE M, 1995, J CHROMATOGR B, V664, P415, DOI 10.1016/0378-4347(94)00491-M; NARO (National Agriculture and Food Research Organization), 2006, JAP FEED STAND DAIR; National Agriculture and Food Research Organization (NARO), 2009, STAND TABL FEED COMP; Norgaard J, 2005, J DAIRY SCI, V88, P975; Patton J, 2006, J DAIRY SCI, V89, P1478; Plaizier JC, 2005, J DAIRY SCI, V88, P3595; [SAS] Statistical Analysis System, 2004, SAS STAT 9 1 US GUID; Shabi Z, 1999, J DAIRY SCI, V82, P1252; Shabi Z, 1998, J DAIRY SCI, V81, P1991; SPIRES HR, 1975, J NUTR, V105, P1111; Sugino T, 2004, ANIM REPROD SCI, V82-3, P183, DOI 10.1016/j.anireprosci.2004.05.001; SUTTON JD, 1988, BRIT J NUTR, V60, P265, DOI 10.1079/BJN19880098; Svennersten-Sjaunja KM, 2008, J ANIM SCI, V86, P37, DOI 10.2527/jas.2007-0527	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					499	507		10.1111/asj.12332		9	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300003		
J	Roh, SG; Carroll, JA; Kim, SW				Roh, Sang-Gun; Carroll, Jeffery A.; Kim, Sung Woo			Effects of fermented soybean meal on innate immunity-related gene expressions in nursery pigs acutely challenged with lipopolysaccharides	ANIMAL SCIENCE JOURNAL			English	Article						fermented soybean meal; lipopolysaccharides; pig; plasma protein	SPRAY-DRIED PLASMA; PITUITARY-ADRENAL AXIS; ACUTE-PHASE RESPONSE; GROWTH-PERFORMANCE; INTESTINAL MORPHOLOGY; WEANED PIGLETS; YOUNG-PIGS; INFLAMMATION; ACTIVATION; STRESS	This experiment was to determine if replacing soybean meal with fermented soybean meal (FSBM) would reduce the innate immune response after lipopolysaccharide challenge and the changes of gene expression profiles associated with this response. Forty-eight 21 day-old pigs were housed individually and fed three diets for 15 days: CON (a diet without FSBM or spray-dried plasma protein; SDPP), PP7 (a diet with 7% SDPP), and FS10 (a diet with 10% FSBM). Pigs were fitted with a jugular vein catheters receiving lipopolysaccharide challenge (25g/kg body weight (BW)) on day 15. Blood was collected for 5h at 30-min intervals to measure cortisol. Expressions of gene transcripts in total RNA from leukocytes were compared using an oligonucleotide microarray at 210min after lipopolysaccharides injection. Cortisol of FS10 was lower (P<0.05) than CON after lipopolysaccharides challenge. The expression levels of 17 transcripts, including cytosolic glutathione peroxidase and glutathione S-transferase A4-4 were increased (P<0.05), whereas 23 genes including adiponectin, neonatal Fc receptor and tumor necrosis factor ligand superfamily member 5 were decreased (P<0.05) in FS10. This study suggests that FSBM-fed pigs can modulate expression of genes related to inflammatory response and anti-oxidant activity which can be a potential reason for reduced serum cortisol.	[Roh, Sang-Gun; Kim, Sung Woo] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [Carroll, Jeffery A.] USDA ARS, Livestock Issue Res Unit, Lubbock, TX USA; [Roh, Sang-Gun] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Physiol, Sendai, Miyagi 980, Japan	Kim, SW (reprint author), N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA.	sungwoo_kim@ncsu.edu					Alberts GF, 2004, CELL CYCLE, V3, P678; Faucher K, 2003, BIOCHIMIE, V85, P611, DOI 10.1016/S0300-9084(03)00089-0; Carroll JA, 1999, LAB ANIM, V33, P129, DOI 10.1258/002367799780578345; Yi GF, 2005, J ANIM SCI, V83, P634; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; BERGELSON S, 1994, CANCER RES, V54, P36; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; LI DF, 1990, J ANIM SCI, V68, P1790; SCHRECK R, 1991, EMBO J, V10, P2247; Frias J, 2008, J AGR FOOD CHEM, V56, P99, DOI 10.1021/jf072177j; Liu XD, 2007, J IMMUNOL, V179, P2999; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Carroll JA, 2006, J ANIM SCI, V84, P1271; Carroll JA, 2002, J ANIM SCI, V80, P502; Daniel JA, 1999, J ANIM SCI, V77, P742; Eyster KM, 2007, VASC PHARMACOL, V47, P238, DOI 10.1016/j.vph.2007.06.007; Fannin RD, 2005, PHYSIOL GENOMICS, V21, P92, DOI 10.1152/physiolgenomics.00190.2004; Feng J, 2007, DIGEST DIS SCI, V52, P1845, DOI 10.1007/s10620-006-9705-0; Frank JW, 2003, J ANIM SCI, V81, P1166; Gebru E, 2010, J ANIM SCI, V88, P3880, DOI 10.2527/jas.2010-2939; Heesom KJ, 1998, FEBS LETT, V422, P43, DOI 10.1016/S0014-5793(97)01597-4; JACKSON R, 1970, NATURE, V227, P672, DOI 10.1038/227672a0; Jones CK, 2010, J ANIM SCI, V88, P1725, DOI 10.2527/jas.2009-2110; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Kiers JL, 2003, J APPL MICROBIOL, V95, P545, DOI 10.1046/j.1365-2672.2003.02011.x; Kim MH, 2010, ANIM SCI J, V81, P475, DOI 10.1111/j.1740-0929.2010.00760.x; Kim MH, 2012, J DAIRY SCI, V95, P5203, DOI 10.3168/jds.2012-5317; Kim SW, 2010, J ANIM SCI, V88, P214, DOI 10.2527/jas.2009-1993; Kojima CJ, 2009, J ANIM SCI, V87, P3218, DOI 10.2527/jas.2009-2033; Koopmans SJ, 2006, J ANIM SCI, V84, P963; Lenehan NA, 2007, J ANIM SCI, V85, P3013, DOI 10.2527/jas.2007-0071; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095; Victor VM, 2002, MOL CELL BIOCHEM, V229, P107, DOI 10.1023/A:1017976629018	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					508	516		10.1111/asj.12319		9	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300004		
J	Honda, K; Saneyasu, T; Aoki, K; Shimatani, T; Yamaguchi, T; Kamisoyama, H				Honda, Kazuhisa; Saneyasu, Takaoki; Aoki, Koji; Shimatani, Tomohiko; Yamaguchi, Takuya; Kamisoyama, Hiroshi			Correlation analysis of hypothalamic mRNA levels of appetite regulatory neuropeptides and several metabolic parameters in 28-day-old layer chickens	ANIMAL SCIENCE JOURNAL			English	Article						appetite; CRF; hypothalamus; NPY; POMC	CENTRAL-NERVOUS-SYSTEM; CORTICOTROPIN-RELEASING-FACTOR; FOOD-INTAKE; BROILER CHICKS; GENE-EXPRESSION; GALLUS-GALLUS; BODY-WEIGHT; INSULIN; PROOPIOMELANOCORTIN; MELANOCORTINS	Various lines of evidence suggest that appetite-related neuropeptides in the hypothalamus are regulated by adiposity signals such as leptin and insulin in mammals. In the present study, we examined age-dependent changes in the weight of abdominal fat and hypothalamic mRNA levels of neuropeptide Y (NPY, an orexigenic neuropeptide) and proopiomelanocortin (POMC, a precursor of anorexigenic neuropeptides) in growing chickens at 7, 14, 21 and 28 days of age. Hypothalamic NPY mRNA levels were significantly (P<0.05) decreased after 14 days of age, whereas hypothalamic POMC mRNA levels were significantly (P<0.05) increased at 28 days of age. The percentage of abdominal fat was significantly increased after 14 days of age in chickens. We next examined the correlation of hypothalamic NPY and POMC mRNA levels and several parameters at 28 days of age. There were no significant correlations between hypothalamic mRNA levels of NPY or POMC and the percentage of abdominal fat. These findings suggest that the gene expressions of NPY and POMC do not depend on adiposity in chickens, at least in 28-day-old layer chickens.	[Honda, Kazuhisa; Saneyasu, Takaoki; Aoki, Koji; Shimatani, Tomohiko; Yamaguchi, Takuya; Kamisoyama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Kobe, Hyogo 6578501, Japan	Honda, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	honda@tiger.kobe-u.ac.jp					Alkemade A, 2012, J CLIN ENDOCR METAB, V97, pE925, DOI 10.1210/jc.2011-3259; Christensen K, 2013, BRIT POULTRY SCI, V54, P199, DOI 10.1080/00071668.2013.772953; Hanada R, 2000, BIOCHEM BIOPH RES CO, V268, P88, DOI 10.1006/bbrc.1999.2081; Shiraishi JI, 2008, DOMEST ANIM ENDOCRIN, V34, P223, DOI 10.1016/j.domaniend.2007.05.002; Honda K, 2012, PEPTIDES, V37, P13, DOI 10.1016/j.peptides.2012.06.015; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; Gerets HHJ, 2000, J COMP NEUROL, V417, P250; Richard S, 2004, J COMP NEUROL, V469, P559, DOI 10.1002/cne.11023; Song ZG, 2012, GEN COMP ENDOCR, V178, P546, DOI 10.1016/j.ygcen.2012.06.026; Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117; Shiraishi J, 2011, NEUROSCI LETT, V491, P177, DOI 10.1016/j.neulet.2011.01.031; Pitel F, 2010, GEN COMP ENDOCR, V167, P1, DOI 10.1016/j.ygcen.2009.10.006; Tachibana T, 2007, COMP BIOCHEM PHYS A, V147, P173, DOI 10.1016/j.ebpa.2006.12.044; Benoit SC, 2002, J NEUROSCI, V22, P9048; Honda K, 2007, NEUROSCI LETT, V423, P153, DOI 10.1016/j.neulet.2007.07.004; Grove KL, 2001, ENDOCRINOLOGY, V142, P4771, DOI 10.1210/en.142.11.4771; Yuan LX, 2009, BRAIN RES, V1273, P18, DOI 10.1016/j.brainres.2009.03.052; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Saneyasu T, 2011, COMP BIOCHEM PHYS A, V159, P422, DOI 10.1016/j.cbpa.2011.04.008; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Schwartz MW, 2000, NATURE, V404, P661; Anukulkitch C, 2009, DOMEST ANIM ENDOCRIN, V36, P138, DOI 10.1016/j.domaniend.2008.12.002; Ellis C, 2008, AM J PHYSIOL-REG I, V294, pR1148, DOI 10.1152/ajpregu.00825.2007; Furuse M., 2002, Animal Science Journal, V73, P83, DOI 10.1046/j.1344-3941.2002.00014.x; Havenstein GB, 2003, POULTRY SCI, V82, P1509; Ibuki M, 2013, J POULT SCI, V50, P120, DOI 10.2141/jpsa.0120138; Kuenzel WJ, 1988, STEREOTAXIC ATLAS BR; KUENZEL WJ, 1994, J NUTR, V124, pS1355; Saneyasu T, 2013, J POULT SCI, V50, P364, DOI 10.2141/jpsa.0120188; SAS, 1998, STATVIEW VERS 5; Tachibana T, 2006, COMP BIOCHEM PHYS A, V143, P112, DOI 10.1016/j.cbpa.2005.11.007; Tokushima Y, 2003, BRIT POULTRY SCI, V44, P746, DOI 10.1080/00071660310001645758; Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					517	522		10.1111/asj.12320		6	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300005		
J	Yamauchi, K; Yamauchi, N; Yamagami, K; Nakamura, N; Yamashita, S; Islam, MR; Tabata, S; Yahiro, K; Tamura, T; Hashizume, K; Hattori, MA				Yamauchi, Keisuke; Yamauchi, Nobuhiko; Yamagami, Kazuki; Nakamura, Nobuhisa; Yamashita, Seiya; Islam, Md Rashedul; Tabata, Shoji; Yahiro, Kanji; Tamura, Tomoko; Hashizume, Kazuyoshi; Hattori, Masa-aki			Development of an in vitro model for the analysis of bovine endometrium using simple techniques	ANIMAL SCIENCE JOURNAL			English	Article						bovine; cell culture; endometrial explants; endometrium; hetero-spheroid	OXYTOCIN RECEPTOR CONCENTRATIONS; PROGESTERONE-RECEPTORS; PREGNANCY RECOGNITION; OVINE UTERUS; IMPLANTATION; CULTURE; EXPRESSION; CELLS; INTERFERONS; RUMINANTS	This study aimed to develop an in vitro model for the analysis of the bovine endometrium. Immunofluorescent staining revealed that the hetero-spheroids and the cultured explants showed almost similar structure in the localization of bovine endometrial epithelial cells and endometrial stromal cells, except the glandular-like structure of the epithelial cells inside the explants. Gelatin zymography revealed that the hetero-spheroids did not express matrix metalloproteinases (MMPs) after 4 days of culture, but strong MMP expressions were observed in the cultured explants until 7 days of culture. Additionally, expression of progesterone receptor (PR), estrogen receptor alpha (ER), type I interferon receptor 1 (IFNAR1) and 2 (IFNAR2) messenger RNA was observed both in the homo- and hetero-spheroids. The expression of oxytocin receptor (OTR) mRNA in E2 and E2+P4 (1,3,5(10)-Estratrien-3, 17-diol + 4-Pregnen-3, 20-dinone) treated groups were significantly (P<0.05) higher than that of the control group of spheroids. In case of cultured explants, the expression of PR and OTR mRNA were significantly (P<0.05) higher in E2 treated groups compared to the control groups. Hepatocyte growth factor (HGF) mRNA expression was also higher in P4 treated groups at 10 days in culture (P<0.05). In a nutshell, the in vitro model developed in this study for the analysis of the endometrium may provide a new platform for extensive research on bovine endometrial function.	[Yamauchi, Keisuke; Yamauchi, Nobuhiko; Yamagami, Kazuki; Nakamura, Nobuhisa; Yamashita, Seiya; Islam, Md Rashedul; Tabata, Shoji; Hattori, Masa-aki] Kyushu Univ, Grad Sch, Dept Anim & Marine Bioresource Sci, Fukuoka 8128581, Japan; [Yahiro, Kanji; Tamura, Tomoko] STEM Biomethod Corp, Kitakyushu, Fukuoka, Japan; [Hashizume, Kazuyoshi] Iwate Univ, Dept Vet Med, Morioka, Iwate 020, Japan	Yamauchi, N (reprint author), Kyushu Univ, Grad Sch, Dept Anim & Marine Bioresource Sci, Lab Reprod Physiol & Biotechnol, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ny0531@agr.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25660214, 26292141]	This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS; no. 25660214 and no. 26292141, to NY).	Lee KH, 2000, YONSEI MED J, V41, P774; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Yamauchi N, 2003, PLACENTA, V24, P258, DOI 10.1053/plac.2002.0901; HIXON JE, 1987, J REPROD FERTIL, V79, P457; L'Heureux N, 1998, FASEB J, V12, P47; GRUMMER R, 1994, PLACENTA, V15, P411, DOI 10.1016/0143-4004(94)90008-6; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; Salamonsen LA, 1999, REV REPROD, V4, P11; Kimmins S, 2001, PLACENTA, V22, P742, DOI 10.1053/plac.2001.0708; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Bazer FW, 2008, REPROD BIOL, V8, P179; Hashizume K, 2007, J REPROD DEVELOP, V53, P1, DOI 10.1262/jrd.18123; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Rosenfeld CS, 2002, BIOL REPROD, V67, P847, DOI 10.1095/biolreprod.102.004267; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Sharkey A, 1998, REV REPROD, V3, P52, DOI 10.1530/ror.0.0030052; Singh M, 2011, J ENDOCRINOL, V210, P5, DOI 10.1530/JOE-10-0461; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Bazer FW, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-23; BEARD AP, 1994, J REPROD FERTIL, V100, P469; Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X; Leung ST, 2000, J REPROD FERTIL, V119, P287, DOI 10.1530/reprod/119.2.287; Mann GE, 2001, DOMEST ANIM ENDOCRIN, V20, P217, DOI 10.1016/S0739-7240(01)00091-1; Matsumoto K, 2009, CELL TISSUE RES, V335, P575, DOI 10.1007/s00441-008-0734-1; Mishra B, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102152; Murakami S, 2001, MOL REPROD DEV, V60, P472, DOI 10.1002/mrd.1112; Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010; Satterfield MC, 2008, BIOL REPROD, V79, P1226, DOI 10.1095/biolreprod.108.071787; Xiao CW, 1999, J REPROD FERTIL, V115, P101; Yamamoto Y, 2014, J REPROD DEVELOP, V60, P73, DOI 10.1262/jrd.2013-061; Yamauchi Nobuhiko, 2001, Journal of Reproduction and Development, V47, P165, DOI 10.1262/jrd.47.165	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					523	531		10.1111/asj.12318		9	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300006		
J	Suzuki, T; Fukuoka, H; Ushikoshi, S; Sato, R; Morita, H; Takizawa, T				Suzuki, Takehito; Fukuoka, Hideo; Ushikoshi, Setsuo; Sato, Reiichiro; Morita, Hidetoshi; Takizawa, Tatsuya			Protective effect of aqueous extracts from Rhizopus oryzae on liver injury induced by carbon tetrachloride in rats	ANIMAL SCIENCE JOURNAL			English	Article						insulin-like growth factor 1 (IGF-1); liver injury; Rhizopus oryzae	HEPATOCYTE GROWTH-FACTOR; POSTPARTUM DAIRY-COWS; WATER EXTRACTS; SCATTER FACTOR; TREATED RATS; FACTOR-ALPHA; INSULIN; EXPRESSION; REGENERATION; PURIFICATION	Hepatoprotective effects of Rhizopusoryzae/U-1 aqueous extract (RU) were demonstrated in carbon tetrachloride (CCl4)-induced liver-injured rats. In order to investigate the RU effects, the rats were administered RU at a dose of 10 or 100mg/kg of body weight for 10 days before induction of the liver injury by oral administration of CCl4 (125mg/kg body weight). (i) Pretreatment with RU caused a significant decrease in serum lactate dehydrogenase (LDH), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities that were increased by the administration of CCl4. (ii) RU pretreatment (100mg/kg) increased 5-bromo-2-deoxyuridine incorporation at 48h after CCl4 treatment in hepatocytes. (iii) Histological hematoxylin and eosin staining of the liver showed that RU pretreatment reduced the damage induced by CCl4 administration. (iv) Reverse transcriptase PCR analysis showed RU retreatment caused a transient but significant increase in hepatocyte growth factor (HGF) and a sustained and significant increase in insulin-like growth factor-I (IGF-I) gene expression in hepatocytes injured by CCl4 treatment. From these results, we conclude that oral pre-administration of RU was effective to suppress liver injury induced by the subsequent oral CCl4 administration, and RU-induced increase in IGF-I and HGF gene expression may be, even in part, involved in biological actions of RU in rats.	[Suzuki, Takehito; Fukuoka, Hideo; Sato, Reiichiro; Morita, Hidetoshi; Takizawa, Tatsuya] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan; [Ushikoshi, Setsuo] Ushikoshi Res Inst Physiol Co Ltd, Sakura, Japan	Suzuki, T (reprint author), Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	suzuki-t@azabu-u.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan	This work was supported in part by a Grant-in-Aid for Matching Fund Subsidies for Private Universities from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Silva JRV, 2009, THERIOGENOLOGY, V71, P1193, DOI 10.1016/j.theriogenology.2008.12.015; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; Sugiyama A, 1996, INFECT IMMUN, V64, P1426; Kawashima C, 2007, REPRODUCTION, V133, P155, DOI 10.1530/REP-06-0046; Ahmed AF, 2011, ANN HEPATOL, V10, P207; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; Zhou J, 1997, MOL ENDOCRINOL, V11, P1924, DOI 10.1210/me.11.13.1924; Lucy MC, 2001, J DAIRY SCI, V84, P1277; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Matsumura A, 2013, INT J ONCOL, V42, P535, DOI 10.3892/ijo.2012.1728; ASAMI O, 1991, J BIOCHEM-TOKYO, V109, P8; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; Higuchi T, 1979, MED BIOL, V99, P145; Horiuchi C, 1985, MED BIOL, V110, P27; LUETTEKE NC, 1988, BIOCHEMISTRY-US, V27, P6487, DOI 10.1021/bi00417a043; MCGOWAN JA, 1981, J CELL PHYSIOL, V108, P353, DOI 10.1002/jcp.1041080309; Meussen BJ, 2012, APPL MICROBIOL BIOT, V94, P875, DOI 10.1007/s00253-012-4033-0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; RECKNAGE RO, 1967, PHARMACOL REV, V19, P145; Rhoads ML, 2008, J DAIRY SCI, V91, P1802, DOI 10.3168/jds.2007-0664; Rhoads ML, 2008, J DAIRY SCI, V91, P140, DOI 10.3168/jds.2007-0439; Saito H, 1980, MED BIOL, V100, P101; Scharf JG, 2004, ENDOCRINOLOGY, V145, P3463, DOI 10.1210/en.2003-1541; Suzuki T, 2007, FOOD SCI TECHNOL RES, V13, P235, DOI 10.3136/fstr.13.235; TAMURA M, 1993, J BIOL CHEM, V268, P8140; Umezu M, 1973, J ANIM REPROD, V19, P67; Yamada Y, 1998, AM J PATHOL, V152, P1577; Yemitan OK, 2006, PHYTOTHER RES, V20, P997, DOI 10.1002/ptr.1957; Zhang JY, 1999, CLIN CHIM ACTA, V282, P89, DOI 10.1016/S0009-8981(99)00013-3	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					532	540		10.1111/asj.12328		9	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300007		
J	Kai, S; Watanabe, G; Kubota, M; Kadowaki, M; Fujimura, S				Kai, Shinichi; Watanabe, Genya; Kubota, Masatoshi; Kadowaki, Motoni; Fujimura, Shinobu			Effect of dietary histidine on contents of carnosine and anserine in muscles of broilers	ANIMAL SCIENCE JOURNAL			English	Article						anserine; broiler chicken; carnosine; dietary histidine; meat	HUMAN-SERUM CARNOSINASE; ALANINE ENHANCES BRAIN; BETA-ALANINE; CHICKS; DIPEPTIDES; HOMOCARNOSINE; CONSTITUENTS; PURIFICATION; COMPONENTS; PEPTIDES	Carnosine (-alanyl-L-histidine) and anserine (-alanyl-1-methyl-L-histidine) are dipeptides mainly found in skeletal muscle and brain of many vertebrates, and particularly high concentrations are observed in chicken pectoral muscles. It was reported that these peptides have many functions, such as antioxidant activity. In this study, we examined the effect of different levels of dietary histidine on carnosine and anserine contents in broiler muscles. The 14-days-old female Chunky strain broilers were given feeds containing three different levels of histidine; 67% (Low-His), 100% (Control) and 200% (High-His) of histidine requirement according to the NRC (1994). Chicks were fed experimental diets for 10 days. Both dipeptides in muscle were significantly decreased. In particular, carnosine was not detected at all in the Low-His group and was significantly increased in the High-His group. Both dipeptides were not detected in plasma. These results indicated the possibility to produce chicken meat with enhanced amount of these dipeptides by high histidine feeding.	[Kai, Shinichi; Watanabe, Genya; Kadowaki, Motoni; Fujimura, Shinobu] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Kubota, Masatoshi; Kadowaki, Motoni; Fujimura, Shinobu] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9502181, Japan	Fujimura, S (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	fujimura@agr.niigata-u.ac.jp					AMEND JF, 1979, J NUTR, V109, P1779; Aristoy MC, 2004, MEAT SCI, V67, P211, DOI 10.1016/j.meatsci.2003.10.008; Tomonaga S, 2006, ANIM SCI J, V77, P79, DOI 10.1111/j.1740-0929.2006.00323.x; LENNEY JF, 1982, CLIN CHIM ACTA, V123, P221, DOI 10.1016/0009-8981(82)90166-8; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; JACKSON MC, 1991, CLIN CHIM ACTA, V196, P193, DOI 10.1016/0009-8981(91)90073-L; Haug A, 2008, ACTA AGR SCAND A-AN, V58, P71, DOI 10.1080/09064700802213545; Niijima A, 2002, AUTON NEUROSCI-BASIC, V97, P99, DOI 10.1016/S1566-0702(02)00048-6; Tomonaga S, 2004, BRAIN RES BULL, V63, P75, DOI 10.1016/j.brainresbull.2004.01.002; Yanai N, 2008, BIOSCI BIOTECH BIOCH, V72, P3100, DOI 10.1271/bbb.80159; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; NISHIMURA T, 1988, AGR BIOL CHEM TOKYO, V52, P2323; Preston JE, 1998, NEUROSCI LETT, V242, P105, DOI 10.1016/S0304-3940(98)00058-5; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; BAUER K, 1994, EUR J BIOCHEM, V219, P43, DOI 10.1111/j.1432-1033.1994.tb19912.x; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; Drozak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064805; Dunnett M, 1999, EQUINE VET J S, V30, P499, DOI DOI 10.1111/J.2042-3306.1999.TB05273.X; Imanari M, 2007, BRIT POULTRY SCI, V48, P167, DOI 10.1080/00071660701244738; Kobayashi H, 2011, ANIM SCI J, V82, P86, DOI 10.1111/j.1740-0929.2010.00811.x; LENNEY JF, 1976, BIOCHIM BIOPHYS ACTA, V429, P214, DOI 10.1016/0005-2744(76)90044-9; LENNEY JF, 1985, BIOCHEM J, V228, P653; LENNEY JF, 1990, BIOL CHEM H-S, V371, P167, DOI 10.1515/bchm3.1990.371.1.167; McManus R, 1962, J BIOL CHEM, V237, P1207; National Research Council (NRC), 1994, NUTR REQ POULTR; SAS (Statistical Analysis System), 1999, SAS US GUID VERS 8; TAMAKI N, 1977, J NUTR SCI VITAMINOL, V23, P331; Tomonaga S, 2005, EUR J PHARMACOL, V524, P84, DOI 10.1016/j.ejphar.2005.09.008; Tomonaga S, 2012, J POULT SCI, V49, P308, DOI 10.2141/jpsa.0110165; Yamano T, 2001, NEUROSCI LETT, V313, P78, DOI 10.1016/S0304-3940(01)02231-5; Yeum KJ, 2010, AMINO ACIDS, V38, P847, DOI 10.1007/s00726-009-0291-2	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					541	546		10.1111/asj.12322		6	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300008		
J	Wakamatsu, JI; Murakami, N; Nishimura, T				Wakamatsu, Jun-ichi; Murakami, Naoko; Nishimura, Takanori			A comparative study of zinc protoporphyrin IX-forming properties of animal by-products as sources for improving the color of meat products	ANIMAL SCIENCE JOURNAL			English	Article						animal by-product; color; internal organs; meat product; zinc protoporphyrin IX	DRY-CURED HAM; ZN-PROTOPORPHYRIN; PARMA HAM; FERROCHELATASE CATALYZES; HEME; IRON; BIOSYNTHESIS; CONVERSION; MYOGLOBIN; REMOVAL	The objective of this study was to obtain fundamental data for improving the color of meat products by using animal by-products. We investigated zinc protoporphyrin IX (ZnPP)-forming properties of various internal organs from pigs and chickens. ZnPP was formed in the liver, heart and kidney, whereas the porcine spleen and bile, which are involved in the metabolism of heme, did not have ZnPP-forming properties. The optimum pH values were different among the internal organs and the ZnPP-forming properties of porcine organs were better than those of chicken organs. The porcine liver showed the greatest ZnPP-forming properties among all of the internal organs investigated in this study. The optimum pH value for ZnPP formation in the liver was lower than that of skeletal muscle. Oxygen did not inhibit the formation of ZnPP in the liver, unlike in skeletal muscle. Animal by-products such as the liver have good ability for the formation of ZnPP and might be useful for improving the color of meat products.	[Wakamatsu, Jun-ichi; Nishimura, Takanori] Hokkaido Univ, Res Fac Agr, Div Bioresources & Prod Sci, Meat Sci Lab, Sapporo, Hokkaido 0608589, Japan; [Murakami, Naoko] Hokkaido Univ, Sch Agr, Sapporo, Hokkaido 0608589, Japan	Wakamatsu, JI (reprint author), Hokkaido Univ, Res Fac Agr, Div Bioresources & Prod Sci, Meat Sci Lab,Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	jwaka@anim.agr.hokudai.ac.jp	Nishimura, Takanori/H-4158-2015	Nishimura, Takanori/0000-0002-1021-1763	JSPS KAKENHI [23580362]	This work was supported by JSPS KAKENHI Grant Number 23580362.	Adamsen CE, 2004, EUR FOOD RES TECHNOL, V218, P403, DOI 10.1007/s00217-004-0891-8; Wakamatsu JI, 2007, MEAT SCI, V77, P580, DOI 10.1016/j.meatsci.2007.05.008; Wakamatsu J, 2004, MEAT SCI, V67, P95, DOI 10.1016/j.meatsci.2003.09.012; Morita H, 1996, J FOOD SCI, V61, P1021, DOI 10.1111/j.1365-2621.1996.tb10924.x; Taketani S, 2007, BIOCHEMISTRY-US, V46, P15054, DOI 10.1021/bi701460x; Wakamatsu J, 2004, MEAT SCI, V68, P313, DOI 10.1016/j.meatsci.2004.03.014; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Chau TT, 2011, J AGR FOOD CHEM, V59, P12238, DOI 10.1021/jf203145p; BLOOMER JR, 1983, GASTROENTEROLOGY, V85, P663; Chau TT, 2010, BIOSCI BIOTECH BIOCH, V74, P1415, DOI 10.1271/bbb.100078; Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7; Ishikawa H, 2006, FOOD SCI TECHNOL RES, V12, P125, DOI 10.3136/fstr.12.125; Ishikawa H, 2007, FOOD SCI TECHNOL RES, V13, P85, DOI 10.3136/fstr.13.85; Jacobs JM, 1998, TOXICOLOGY, V125, P95, DOI 10.1016/S0300-483X(97)00164-9; PORRA RJ, 1963, BIOCHEM J, V87, P186; Wakamatsu J, 2006, MEAT SCI, V74, P594, DOI 10.1016/j.meatsci.2006.05.011; Wakamatsu J, 2009, MEAT SCI, V82, P139, DOI 10.1016/j.meatsci.2008.12.011	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAY	2015	86	5					547	552		10.1111/asj.12326		6	Agriculture, Dairy & Animal Science	Agriculture	CH4VC	WOS:000354030300009		
J	Sugawara, S; Oizumi, S; Minato, K; Harada, T; Inoue, A; Fujita, Y; Maemondo, M; Yoshizawa, H; Ito, K; Gemma, A; Nishitsuji, M; Harada, M; Isobe, H; Kinoshita, I; Morita, S; Kobayashi, K; Hagiwara, K; Kurihara, M; Nukiwa, T				Sugawara, S.; Oizumi, S.; Minato, K.; Harada, T.; Inoue, A.; Fujita, Y.; Maemondo, M.; Yoshizawa, H.; Ito, K.; Gemma, A.; Nishitsuji, M.; Harada, M.; Isobe, H.; Kinoshita, I.; Morita, S.; Kobayashi, K.; Hagiwara, K.; Kurihara, M.; Nukiwa, T.		North East Japan Study Grp; Tokyo Cooperative Oncology Grp	Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902	ANNALS OF ONCOLOGY			English	Article						non-small cell lung cancer; first-line; EGFR-TKI; chemotherapy; combination; EGFR mutation	OPEN-LABEL; CARBOPLATIN-PACLITAXEL; MAINTENANCE THERAPY; 1ST-LINE TREATMENT; JAPANESE PATIENTS; DOUBLE-BLIND; ERLOTINIB; TRIAL; COMBINATION; CISPLATIN	Background: The first-line combination of an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) and platinum-based doublet chemotherapy has not been sufficiently evaluated for patients with EGFR-mutant non-small cell lung cancer (NSCLC). This randomized phase II study was designed to select a combination regimen for phase III evaluation. Patients and methods: Chemotherapy-naive patients with advanced non-squamous, EGFR-mutant NSCLC were randomly assigned to receive either a concurrent or a sequential alternating regimen with gefitinib (250 mg) and carboplatin/pemetrexed [area under the curve (AUC) = 6 and 500 mg/m(2); 3-weekly]. The primary end point was progression-free survival (PFS). Secondary end points were overall survival (OS), response, and safety. Results: All 80 patients enrolled were eligible and assessable for efficacy (41 and 39 patients in the concurrent and sequential alternating regimen groups, respectively). Median PFS was 18.3 months for the concurrent regimen and 15.3 months for the sequential alternating regimen [hazard ratio (HR) 0.71 (0.42-1.20), P = 0.20]. Although OS data are immature (16 and 24 death events), median survival times were 41.9 and 30.7 months in the concurrent and sequential alternating regimen groups, respectively [HR 0.51 (0.26-0.99); P = 0.042]. Response rates were similar in both groups (87.8% and 84.6%). Hematological and non-hematological adverse events were common and reversible; interstitial lung disease was neither frequent nor fatal (two cases in each group; 5% of all patients). Conclusion: This is the first randomized study to investigate the efficacy of combinational EGFR-TKI and chemotherapy in the EGFR-mutated setting. Both regimens had promising efficacy with predictable toxicities, although concurrent regimens might provide better OS. The concurrent regimen was chosen to compare with gefitinib monotherapy in our ongoing phase III study.	[Sugawara, S.] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Oizumi, S.] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 0608638, Japan; [Minato, K.] Gunma Prefectural Canc Ctr, Dept Resp Med, Gunma, Japan; [Harada, T.] JCHO Hokkaido Hosp, Ctr Resp Dis, Sapporo, Hokkaido, Japan; [Inoue, A.] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan; [Fujita, Y.] Asahikawa Med Ctr, Dept Resp Med, Natl Hosp Org, Asahikawa, Hokkaido, Japan; [Maemondo, M.] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Yoshizawa, H.] Niigata Univ, Biosci Med Res Ctr, Med & Dent Hosp, Niigata, Japan; [Ito, K.] Niigata City Gen Hosp, Dept Resp Med, Niigata, Japan; [Gemma, A.] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan; [Nishitsuji, M.] Ishikawa Prefectural Cent Hosp, Dept Resp Med, Kanazawa, Ishikawa, Japan; [Harada, M.] Hokkaido Canc Ctr, Natl Hosp Org, Dept Resp Med, Sapporo, Hokkaido, Japan; [Isobe, H.] KKR Sapporo Med Ctr, Dept Med Oncol, Sapporo, Hokkaido, Japan; [Kinoshita, I.] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Morita, S.] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Kobayashi, K.] Saitama Med Univ, Int Med Ctr, Dept Resp Med, Hidaka, Japan; [Hagiwara, K.] Saitama Med Univ, Dept Resp Med, Saitama, Japan; [Kurihara, M.] Tokyo Cooperat Oncol Grp, Tokyo, Japan; [Nukiwa, T.] Japan AntiTB Assoc, Tokyo, Japan	Oizumi, S (reprint author), Hokkaido Univ, Sch Med, Dept Med 1, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	soizumi@med.hokudai.ac.jp			North East Japan Study Group (NEJ); Tokyo Cooperative Oncology Group (TCOG)	This study was supported by the North East Japan Study Group (NEJ) and the Tokyo Cooperative Oncology Group (TCOG), non-profit organizations (no grant number apply).	Akamatsu H, 2013, JPN J CLIN ONCOL, V43, P664, DOI 10.1093/jjco/hyt049; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Oizumi S, 2012, ONCOLOGIST, V17, P863, DOI 10.1634/theoncologist.2011-0426; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Kanda S, 2013, J CLIN ONCOL, V31; Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933; Magne N, 2003, CLIN CANCER RES, V9, P4735; Mahaffey CM, 2007, CLIN LUNG CANCER, V8, P548, DOI 10.3816/CLC.2007.n.041; Okamoto I, 2010, LUNG CANCER, V70, P168, DOI 10.1016/j.lungcan.2010.02.007; Okamoto I, 2013, INVEST NEW DRUG, V31, P1275, DOI 10.1007/s10637-013-9941-z	27	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					888	894		10.1093/annonc/mdv063		7	Oncology	Oncology	CH2BS	WOS:000353830000009		
J	Fuchs, CS; Azevedo, S; Okusaka, T; Van Laethem, JL; Lipton, LR; Riess, H; Szczylik, C; Moore, MJ; Peeters, M; Bodoky, G; Ikeda, M; Melichar, B; Nemecek, R; Ohkawa, S; Swieboda-Sadlej, A; Tjulandin, SA; Cutsem, E; Loberg, R; Haddad, V; Gansert, JL; Bach, BA; Carrato, A				Fuchs, C. S.; Azevedo, S.; Okusaka, T.; Van Laethem, J. -L.; Lipton, L. R.; Riess, H.; Szczylik, C.; Moore, M. J.; Peeters, M.; Bodoky, G.; Ikeda, M.; Melichar, B.; Nemecek, R.; Ohkawa, S.; Swieboda-Sadlej, A.; Tjulandin, S. A.; Van Cutsem, E.; Loberg, R.; Haddad, V.; Gansert, J. L.; Bach, B. A.; Carrato, A.			A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial	ANNALS OF ONCOLOGY			English	Article						ganitumab; gemcitabine; pancreatic cancer; IGF-1 receptor; biomarker	DUCTAL ADENOCARCINOMA; MONOCLONAL-ANTIBODY; SOLID TUMORS; AMG 479; CANCER; GROWTH; SURVIVAL; CONATUMUMAB; BEVACIZUMAB; BIOMARKERS	Background: This double-blind, phase 3 study assessed the efficacy and safety of ganitumab combined with gemcitabine as first-line treatment of metastatic pancreatic cancer. Patients and methods: Patients with previously untreated metastatic pancreatic adenocarcinoma were randomly assigned 2 : 2 : 1 to receive intravenous gemcitabine 1000 mg/m(2) (days 1, 8, and 15 of each 28-day cycle) plus placebo, ganitumab 12 mg/kg, or ganitumab 20 mg/kg (days 1 and 15 of each cycle). The primary end point was overall survival (OS). Secondary end points included progression-free survival (PFS), safety, and efficacy by levels of circulating biomarkers. Results: Overall, 322 patients were randomly assigned to placebo, 318 to ganitumab 12 mg/kg, and 160 to ganitumab 20 mg/kg. The study was stopped based on results from a preplanned futility analysis; the final results are reported. Median OS was 7.2 months [95% confidence interval (CI), 6.3-8.2] in the placebo arm, 7.0 months (95% CI, 6.2-8.5) in the ganitumab 12-mg/kg arm [hazard ratio (HR), 1.00; 95% CI, 0.82-1.21; P = 0.494], and 7.1 months (95% CI, 6.4-8.5) in the ganitumab 20-mg/kg arm (HR, 0.97; 95% CI, 0.76-1.23; P = 0.397). Median PFS was 3.7, 3.6 (HR, 1.00; 95% CI, 0.84-1.20; P = 0.520), and 3.7 months (HR, 0.97; 95% CI, 0.77-1.22; P = 0.403), respectively. No unexpected toxicity was observed with ganitumab plus gemcitabine. The circulating biomarkers assessed [insulin-like growth factor-1 (IGF-1), IGF-binding protein-2, and -3] were not associated with a treatment effect on OS or PFS by ganitumab. Conclusion: Ganitumab combined with gemcitabine had manageable toxicity but did not improve OS, compared with gemcitabine alone in unselected patients with metastatic pancreatic cancer.	[Fuchs, C. S.] Dana Farber Canc Inst, Dept Med Oncol Solid Tumor Oncol, Boston, MA 02215 USA; [Azevedo, S.] Hosp Clin Porto Alegre, Oncol Serv, Porto Alegre, RS, Brazil; [Okusaka, T.] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Van Laethem, J. -L.] Erasme Univ Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium; [Lipton, L. R.] Royal Melbourne Hosp, Med Oncol, Parkville, Vic 3050, Australia; [Riess, H.] Charite, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany; [Szczylik, C.] Mil Inst Hlth Serv, Dept Oncol, Warsaw, Poland; [Moore, M. J.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Peeters, M.] Univ Antwerp Hosp, Dept Oncol, Edegum, Belgium; [Bodoky, G.] St Laszlo Hosp, Dept Oncol, Budapest, Hungary; [Ikeda, M.] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan; [Melichar, B.] Palacky Univ, Sch Med, Dept Oncol, CR-77147 Olomouc, Czech Republic; [Melichar, B.] Teaching Hosp, Olomouc, Czech Republic; [Nemecek, R.] Masaryk Univ, Sch Med, Dept Oncol, Brno, Czech Republic; [Nemecek, R.] Masaryk Mem Canc Inst, Brno, Czech Republic; [Ohkawa, S.] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Kanagawa 2410815, Japan; [Swieboda-Sadlej, A.] Med Univ Warsaw, Dept Haematol Oncol & Internal Med, Warsaw, Poland; [Tjulandin, S. A.] Russian Canc Res Ctr, Dept Clin Pharmacol & Chemotherapy, Moscow, Russia; [Van Cutsem, E.] Univ Hosp Gasthuisberg Leuven, Digest Oncol, Leuven, Belgium; [Van Cutsem, E.] Katholieke Univ Leuven, Leuven, Belgium; [Loberg, R.] Amgen Inc, Med Sci, Thousand Oaks, CA 91320 USA; [Haddad, V.] Amgen Ltd, Global Biostat Sci, Cambridge, England; [Gansert, J. L.] Global Dev, Thousand Oaks, CA USA; [Bach, B. A.] Amgen Inc, Dev Oncol Therapeut, Thousand Oaks, CA 91320 USA; [Carrato, A.] Univ Hosp Ramon y Cajal, Dept Med Oncol, Madrid, Spain	Fuchs, CS (reprint author), Dana Farber Canc Inst, Dept Med Oncol Solid Tumor Oncol, Mailstop Dana 1220,450 Brookline Ave, Boston, MA 02215 USA.	charles_fuchs@dfci.harvard.edu	Peeters, Marc/C-5525-2013	Peeters, Marc/0000-0003-4969-2303	Amgen Inc.; Takeda Global Research & Development Center, Inc.	This study was supported by Amgen Inc. in collaboration with Takeda Global Research & Development Center, Inc. There were no grants or applicable grant numbers for this study.	McCaffery I, 2013, CLIN CANCER RES, V19, P4282, DOI 10.1158/1078-0432.CCR-12-1840; Hakam A, 2003, DIGEST DIS SCI, V48, P1972, DOI 10.1023/A:1026122421369; Appleman VA, 2012, MOL CANCER RES, V10, P1228, DOI 10.1158/1541-7786.MCR-12-0340-T; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; [Anonymous], 2013, ABR NAB PACL FULL PR; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Cohn AL, 2013, ANN ONCOL, V24, P1777, DOI 10.1093/annonc/mdt057; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Atzori F, 2011, CLIN CANCER RES, V17, P6304, DOI 10.1158/1078-0432.CCR-10-3336; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Beltran PJ, 2009, MOL CANCER THER, V8, P1095, DOI 10.1158/1535-7163.MCT-08-1171; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; BERGMANN U, 1995, CANCER RES, V55, P2007; Yee D, 2012, J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Arnaldez FI, 2012, HEMATOL ONCOL CLIN N, V26, P527, DOI 10.1016/j.hoc.2012.01.004; Furuse J, 2013, CLIN PRACT, V10, P695; Hixon ML, 2009, J CLIN ONCOL, V27; Lu J, 2011, J CLIN ONCOL, V29; National Cancer Institute, SEER STAT FACT SHEET; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID	28	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					921	927		10.1093/annonc/mdv027		7	Oncology	Oncology	CH2BS	WOS:000353830000014		
J	Takahashi, Y; Sheridan, P; Niida, A; Sawada, G; Uchi, R; Mizuno, H; Kurashige, J; Sugimachi, K; Sasaki, S; Shimada, Y; Hase, K; Kusunoki, M; Kudo, S; Watanabe, M; Yamada, K; Sugihara, K; Yamamoto, H; Suzuki, A; Doki, Y; Miyano, S; Mori, M; Mimori, K				Takahashi, Y.; Sheridan, P.; Niida, A.; Sawada, G.; Uchi, R.; Mizuno, H.; Kurashige, J.; Sugimachi, K.; Sasaki, S.; Shimada, Y.; Hase, K.; Kusunoki, M.; Kudo, S.; Watanabe, M.; Yamada, K.; Sugihara, K.; Yamamoto, H.; Suzuki, A.; Doki, Y.; Miyano, S.; Mori, M.; Mimori, K.			The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC	ANNALS OF ONCOLOGY			English	Article						MYC; AURKA; TPX2; synthetic lethality; co-amplification	C-MYC; COLORECTAL-CANCER; BREAST-CANCER; AURORA-A; KINASE; AMPLIFICATION; INHIBITION; ONCOGENE; SPINDLE; TPX2	Background: The MYC oncogene has long been established as a central driver in many types of human cancers including colorectal cancer. However, the realization of MYC-targeting therapies remains elusive; as a result, synthetic lethal therapeutic approaches are alternatively being explored. A synthetic lethal therapeutic approach aims to kill MYC-driven tumors by targeting a certain co-regulator on the MYC pathway. Patients and methods: We analyzed copy number and expression profiles from 130 colorectal cancer tumors together with publicly available datasets to identify co-regulators on the MYC pathway. Candidates were functionally tested by in vitro assays using colorectal cancer and normal fibroblast cell lines. Additionally, survival analyses were carried out on another 159 colorectal cancer patients and public datasets. Results: Our in silico screening identified two MYC co-regulator candidates, AURKA and TPX2, which are interacting mitotic regulators located on chromosome 20q. We found the two candidates showed frequent co-amplification with the MYC locus while expression levels of MYC and the two genes were positively correlated with those of MYC downstream target genes across multiple cancer types. In vitro, the aberrant expression of MYC, AURKA and TPX2 resulted in more aggressive anchorage-independent growth in normal fibroblast cells. Furthermore, knockdown of AURKA or TPX2, or treatment with an AURKA-specific inhibitor effectively suppressed the proliferation of MYC-expressing colorectal cancer cells. Additionally, combined high expression of MYC, AURKA and TPX2 proved to be a poor prognostic indicator of colorectal cancer patient survival. Conclusions: Through bioinformatic analyses and experiments, we proposed TPX2 and AURKA as novel co-regulators on the MYC pathway. Inhibiting the AURKA/TPX2 axis would be a novel synthetic lethal therapeutic approach for MYC-driven cancers.	[Takahashi, Y.; Sawada, G.; Uchi, R.; Kurashige, J.; Sugimachi, K.; Mimori, K.] Kyushu Univ, Dept Surg, Beppu Hosp, Beppu, Oita 8740838, Japan; [Takahashi, Y.; Sasaki, S.; Yamamoto, H.; Doki, Y.; Mori, M.] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan; [Sheridan, P.; Niida, A.; Miyano, S.] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Mizuno, H.] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Dept Discovery Res, Kamakura, Kanagawa, Japan; [Sasaki, S.] Omori Red Cross Hosp, Dept Surg, Tokyo, Japan; [Shimada, Y.] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan; [Hase, K.] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Kusunoki, M.] Mie Univ, Dept Surg, Tsu, Mie 514, Japan; [Kudo, S.] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa, Japan; [Watanabe, M.] Kitasato Univ, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Yamada, K.] Takano Hosp, Dept Surg, Kumamoto, Japan; [Sugihara, K.] Tokyo Med & Dent Univ, Dept Surg, Tokyo, Japan; [Suzuki, A.] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan	Mimori, K (reprint author), Kyushu Univ, Dept Surg, Beppu Hosp, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp			CREST, Japan Science and Technology Agency (JST); Funding Program for Next Generation World-Leading Researchers [LS094]; Japan Society for the Promotion of Science (JSPS) [25861199]; MEXT 'Systems Cancer Research' [4201]; MEXT Strategic Programs on Innovative Research 'Supercomputational Life Science'; Osaka Cancer Society	The present study was supported in part by the following grants and foundation; CREST, Japan Science and Technology Agency (JST), the Funding Program for Next Generation World-Leading Researchers (LS094), Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research, grant number 25861199, Grants-in-Aid for Scientific Research on Innovative Areas of MEXT 'Systems Cancer Research' (4201), and the MEXT Strategic Programs on Innovative Research 'Supercomputational Life Science', and Osaka Cancer Society.	Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blancato J, 2004, BRIT J CANCER, V90, P1612, DOI 10.1038/sj.bjc.6601703; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; [Anonymous], 2012, NATURE, V487, P330, DOI DOI 10.1038/NATURE11252; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; De Luca M, 2006, CELL CYCLE, V5, P296; KOZMA L, 1994, CANCER LETT, V81, P165, DOI 10.1016/0304-3835(94)90198-8; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Niida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010910; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x	21	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					935	942		10.1093/annonc/mdv034		9	Oncology	Oncology	CH2BS	WOS:000353830000016		
J	Chihara, D; Asano, N; Ohmachi, K; Nishikori, M; Okamoto, M; Sawa, M; Sakai, R; Okoshi, Y; Tsukamoto, N; Yakushijin, Y; Nakamura, S; Kinoshita, T; Ogura, M; Suzuki, R				Chihara, D.; Asano, N.; Ohmachi, K.; Nishikori, M.; Okamoto, M.; Sawa, M.; Sakai, R.; Okoshi, Y.; Tsukamoto, N.; Yakushijin, Y.; Nakamura, S.; Kinoshita, T.; Ogura, M.; Suzuki, R.			Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)	ANNALS OF ONCOLOGY			English	Article						mantle cell lymphoma; CNS relapse; risk factors; Ki-67	HIGH-DOSE METHOTREXATE; CEREBROSPINAL-FLUID; PROGNOSTIC-FACTORS; PHASE-II; LENALIDOMIDE; RITUXIMAB; INVOLVEMENT; RISK; MULTICENTER; CYTARABINE	Background: Central nervous system (CNS) relapse is an uncommon but challenging complication in patients with mantle cell lymphoma (MCL). Survival after CNS relapse is extremely poor. Identification of high-risk populations is therefore critical in determining patients who might be candidates for a prophylactic approach. Patients and methods: A total of 608 patients (median age, 67 years; range 22-92) with MCL newly diagnosed between 1994 and 2012 were evaluated. Pretreatment characteristics and treatment regimens were evaluated for their association with CNS relapse by competing risk regression analysis. Results: None of the patients received intrathecal prophylaxis. Overall, 33 patients (5.4%) experienced CNS relapse during a median follow-up of 42.7 months. Median time from diagnosis to CNS relapse was 20.3 months (range: 2.2-141.3 months). Three-year cumulative incidence of CNS relapse was 5.6% [95% confidence interval (95% CI) 3.7% to 8.0%]. Univariate analysis revealed several risk factors including blastoid variant, leukemic presentation, high-risk MCL International Prognostic Index and high Ki-67 (proliferation marker). Multivariate analyses revealed that Ki-67 >= 30 was the only significant risk factor for CNS relapse (hazard ratio: 6.0, 95% CI 1.9-19.4, P = 0.003). Two-year cumulative incidence of CNS relapse in patients with Ki-67 = 30 was 25.4% (95% CI 13.5-39.1), while that in the patients with Ki-67 < 30 was 1.6% (95% CI 0.4-4.2). None of the treatment modalities, including rituximab, high-dose cytarabine, high-dose methotrexate or consolidative autologous stem-cell transplant, were associated with a lower incidence of CNS relapse. Survival after CNS relapse was poor, with median survival time of 8.3 months. There was no significant difference in the survival by the site of CNS involvement.	[Chihara, D.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Chihara, D.] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Asano, N.; Nakamura, S.] Nagoya Univ, Grad Sch Med, Dept Pathol & Clin Labs, Nagoya, Aichi 4648601, Japan; [Ohmachi, K.] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Nishikori, M.] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Okamoto, M.] Fujita Hlth Univ, Sch Med, Dept Hematol & Med Oncol, Toyoake, Aichi 47011, Japan; [Sawa, M.] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan; [Sakai, R.] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Okoshi, Y.] Univ Tsukuba, Fac Med, Dept Hematol, Tsukuba, Ibaraki, Japan; [Tsukamoto, N.] Gunma Univ, Grad Sch Med, Dept Med & Clin Sci, Gunma, Japan; [Yakushijin, Y.] Ehime Univ, Grad Sch Med, Dept Clin Oncol, Matsuyama, Ehime 790, Japan; [Kinoshita, T.] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Ogura, M.] Suzuka Natl Hosp, Dept Hematol & Lab Med, Suzuka, Japan; [Suzuki, R.] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management & Biostat, Nagoya, Aichi 4648601, Japan	Chihara, D (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dchihara-kob@umin.ac.jp	Nakamura, Shigeo/I-1571-2012				Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Zucca E, 2003, J CLIN ONCOL, V21, P20, DOI 10.1200/JCO.2003.11.141; Conconi A, 2013, LEUKEMIA LYMPHOMA, V54, P1908, DOI 10.3109/10428194.2013.767454; de Jong D, 2007, J CLIN ONCOL, V25, P805, DOI 10.1200/JCO.2006.09.4490; Romaguera JE, 2005, J CLIN ONCOL, V23, P7013, DOI 10.1200/JCO.2005.01.1825; Wang M, 2012, LANCET ONCOL, V13, P716, DOI 10.1016/S1470-2045(12)70200-0; Ferrer A, 2008, ANN ONCOL, V19, P135, DOI 10.1093/annonc/mdm447; Goy A, 2013, J CLIN ONCOL, V31, P3688, DOI 10.1200/JCO.2013.49.2835; Kasamon YL, 2005, BIOL BLOOD MARROW TR, V11, P93, DOI 10.1016/j.bbmt.2004.09.009; Tiemann M, 2005, BRIT J HAEMATOL, V131, P29, DOI 10.1111/j.1365-2141.2005.05716.x; Cheah CY, 2013, ANN ONCOL, V24, P2119, DOI 10.1093/annonc/mdt139; Rubenstein JL, 2011, J CLIN ONCOL, V29, pE595, DOI 10.1200/JCO.2011.34.7252; Dreyling M, 2013, ANN ONCOL, V24, P857, DOI 10.1093/annonc/mds643; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; LIPPENS RJJ, 1988, PEDIATR HEMAT ONCOL, V5, P115, DOI 10.3109/08880018809031261; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Cheah CY, 2014, BRIT J CANCER, V111, P1072, DOI 10.1038/bjc.2014.405; Fine J.P., 2001, BIOSTATISTICS, V2, P85, DOI 10.1093/biostatistics/2.1.85; Hosein PJ, 2014, BRIT J HAEMATOL, V165, P358, DOI 10.1111/bjh.12753; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Katzenberger T, 2006, BLOOD, V107, P3407, DOI 10.1182/blood-2005-10-4079; Muscal JA, 2012, CANCER CHEMOTH PHARM, V69, P943, DOI 10.1007/s00280-011-1781-y; Oki Y, 2008, CANCER SCI, V99, P179, DOI 10.1111/j.1349-7006.2007.00662.x; Swerdlow S, 2008, WHO CLASSIFICATION T; Vose Julie M, 2013, Am J Hematol, V88, P1082, DOI 10.1002/ajh.23615; Warren KE, 2011, J CLIN ONCOL, V29, P324, DOI 10.1200/JCO.2010.31.3601	26	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					966	973		10.1093/annonc/mdv074		9	Oncology	Oncology	CH2BS	WOS:000353830000020		
J	Chu, QSC; Nielsen, TO; Alcindor, T; Gupta, A; Endo, M; Goytain, A; Xu, H; Verma, S; Tozer, R; Knowling, M; Bramwell, VB; Powers, J; Seymour, LK; Eisenhauer, EA				Chu, Q. S. -C.; Nielsen, T. O.; Alcindor, T.; Gupta, A.; Endo, M.; Goytain, A.; Xu, H.; Verma, S.; Tozer, R.; Knowling, M.; Bramwell, V. B.; Powers, J.; Seymour, L. K.; Eisenhauer, E. A.			A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200	ANNALS OF ONCOLOGY			English	Article						translocation-associated sarcoma; histone deacetylase inhibitor; phase II	SOFT-TISSUE SARCOMA; SYNOVIAL-SARCOMA; SOLID TUMORS; CELL-DEATH; TRANSCRIPTIONAL REPRESSION; EWINGS-SARCOMA; HDAC INHIBITOR; CANCER CELLS; COMPLEX; TRIAL	Background: A subgroup of sarcomas is characterized by defining chromosomal translocations, creating fusion transcription factor oncogenes. Resultant fusion oncoproteins associate with chromatin-modifying complexes containing histone deacetylases (HDAC), and lead to epigenetic transcriptional dysregulation. HDAC inhibitors were shown to be effective in vitro, reversing gene repression by these complexes, restoring PTEN expression and apoptosis via the PI3K/Akt/mTOR pathway. Patients and methods: SB939 is an oral inhibitor of classes 1 and 2 HDAC. Eligible patients with recurrent or metastatic translocation-associated sarcoma (TAS) by local pathology were treated with 60 mg/day every other day for 3 of 4 weeks. Central pathology review was conducted with fusion oncogenes characterized, and HDAC2 expression correlated with efficacy in pre-specified methods. Results: Twenty-two patients were treated with a median of 2 cycles. Fourteen patients were assessable for response with confirmed specific chromosomal translocations; 8 had a best response of stable disease (SD) (median duration 5.4 months) with no confirmed objective responses. The 3-month progression-free survival (PFS) rate was 49%. Among those with HDAC2 score >= 5, 7/10 had SD, versus 0/3 with HDAC2 score <5. SB939 was considered as well tolerated with <10% patients experienced >= grade 3 toxicity. Conclusion: This study was stopped prematurely due to prolonged unavailability of SB939. No objective responses were seen. Although the observed SD in HDAC2 high patients was interesting, due to the small sample size, no definitive conclusion can be drawn about the efficacy of SB939 in this patient population.	[Chu, Q. S. -C.] Cross Canc Inst, Div Med Oncol, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Nielsen, T. O.; Goytain, A.; Knowling, M.] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Alcindor, T.] McGill Univ, Dept Oncol, Div Med Oncol, Montreal, PQ, Canada; [Gupta, A.] Univ Toronto, Mt Sinai Hosp, Princess Margaret Hosp, Div Med Oncol,Dept Oncol, Toronto, ON M5G 1X5, Canada; [Endo, M.] Kyushu Univ, Dept Orthoped Surg, Fukuoka 812, Japan; [Xu, H.; Powers, J.; Seymour, L. K.; Eisenhauer, E. A.] NCIC Clin Trials Grp, Invest New Drug Program, Kingston, ON, Canada; [Verma, S.] Univ Ottawa, Ottawa Canc Ctr, Dept Med Oncol, Ottawa, ON, Canada; [Tozer, R.] McMaster Univ, Jurvinski Canc Ctr, Dept Oncol, Div Med Oncol, Hamilton, ON L8S 4L8, Canada; [Bramwell, V. B.] Univ Calgary, Tom Baker Canc Ctr, Dept Oncol, Div Med Oncol, Calgary, AB, Canada	Chu, QSC (reprint author), Cross Canc Inst, Div Med Oncol, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	quincy.chu@albertahealthservices.ca			Canadian Cancer Society Research Institute [021039, 701582]	This study was supported by the Canadian Cancer Society Research Institute (grant #021039 and #701582) and drug kindly supplied by S<SUP>star</SUP>BIO.	Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Marchion DC, 2009, MOL CANCER THER, V8, P794, DOI 10.1158/1535-7163.MCT-08-0985; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439; Strahl BD, 2000, NATURE, V403, P41; Razak ARA, 2011, BRIT J CANCER, V104, P756, DOI 10.1038/bjc.2011.13; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Yong WP, 2011, ANN ONCOL, V22, P2516, DOI 10.1093/annonc/mdq784; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Lagarde P, 2013, J CLIN ONCOL, V31, P608, DOI 10.1200/JCO.2012.46.0147; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; O'Sullivan B, 2002, LANCET, V359, P2235, DOI 10.1016/S0140-6736(02)09292-9; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Munster PN, 2009, BRIT J CANCER, V101, P1044, DOI 10.1038/sj.bjc.6605293; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Cassier PA, 2013, BRIT J CANCER, V109, P909, DOI 10.1038/bjc.2013.442; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Bramwell Vivien H. C., 2003, Sarcoma, V7, P43, DOI 10.1080/13577140310001607266; DeVita VT, 2008, DEVITA HELLMAN ROSEN; Figueredo Alvaro, 2002, Sarcoma, V6, P5, DOI 10.1080/13577140220127512; Furuyama T, 2004, CURR BIOL, V14, P1812, DOI 10.1016/j.cub.2004.09.060; Hrzenjak A, 2008, J PATHOL, V216, P495, DOI 10.1002/path.2434; Ito T, 2005, CANCER LETT, V224, P311, DOI 10.1016/j.canlet.2004.10.030; Liu SZ, 2008, MOL CANCER THER, V7, P1751, DOI 10.1158/1535-7163.MCT-07-0560; Novotny-Diermayr V, 2011, MOL CANCER THER, V10, P1207, DOI 10.1158/1535-7163.MCT-11-0044; Osuna Daniel, 2009, Rev Recent Clin Trials, V4, P12; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Pacheco M, 2012, MODERN PATHOL, V25, P222, DOI 10.1038/modpathol.2011.157; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Todd R, 2008, EXPERT REV ANTICANC, V8, P939, DOI 10.1586/14737140.8.6.939; van der Vlag J, 1999, NAT GENET, V23, P474; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	43	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					973	981		10.1093/annonc/mdv033		10	Oncology	Oncology	CH2BS	WOS:000353830000021		
J	Wong, AL; Soo, RA; Tan, DS; Lee, SC; Lim, JS; Marban, PC; Kong, LR; Lee, YJ; Wang, LZ; Thuya, WL; Soong, R; Yee, MQ; Chin, TM; Cordero, MT; Asuncion, BR; Pang, B; Pervaiz, S; Hirpara, JL; Sinha, A; Xu, WW; Yuasa, M; Tsunoda, T; Motoyama, M; Yamauchi, T; Goh, BC				Wong, A. L.; Soo, R. A.; Tan, D. S.; Lee, S. C.; Lim, J. S.; Marban, P. C.; Kong, L. R.; Lee, Y. J.; Wang, L. Z.; Thuya, W. L.; Soong, R.; Yee, M. Q.; Chin, T. M.; Cordero, M. T.; Asuncion, B. R.; Pang, B.; Pervaiz, S.; Hirpara, J. L.; Sinha, A.; Xu, W. W.; Yuasa, M.; Tsunoda, T.; Motoyama, M.; Yamauchi, T.; Goh, B. C.			Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies	ANNALS OF ONCOLOGY			English	Article						phase I; biomarker; STAT3 inhibitor; refractory solid malignancies	CANCER; MUTATIONS; CELLS	Background: The aim of this study was to determine the maximum-tolerated dose (MTD), safety, pharmacokinetics, and pharmacodynamics of OPB-51602, an oral, direct signal transduction activator of transcription 3 (STAT3) inhibitor, in patients with refractory solid tumors. Patients and methods: Three cohorts were studied: cohort A, a sequential dose escalation of OPB-51602 administered intermittently (days 1-14 every 21 days); cohort B, an expansion cohort evaluating the dose lower than the MTD; cohort C, evaluating continuous daily dosing. Results: Fifty-one patients were studied at 2, 4, and 5 mg per day dosing. The MTD was 5 mg; first-cycle dose-limiting toxicities (DLTs) were grade 3 hyponatremia in one patient, and grade 3 dehydration in another. Intermittent dosing of both 2 and 4 mg doses were tolerable, and the recommended phase II dose was 4 mg. Cohort B investigated 4 mg intermittently, whereas cohort C investigated 4 mg continuously. Common toxicities included fatigue, nausea/vomiting, diarrhea, anorexia, and early-onset peripheral neuropathy. Drug-induced pneumonitis occurred in two patients in cohort C. Continuous dosing was associated with a higher incidence of peripheral neuropathy and a lower mean relative dose intensity, compared with intermittent dosing. Steady-state pharmacokinetics was characterized by high oral clearance, mean elimination half-life ranging from 44 to 61 h, and a large terminal-phase volume of distribution. An active metabolite, OPB-51822, accumulated to a greater extent than OPB-51602. Flow cytometry of peripheral blood mononuclear cells demonstrated pSTAT3 (Tyr(705)) inhibition following exposure. Two patients achieved partial responses at 5 mg intermittently and 4 mg continuously; both had epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC) with prior EGFR tyrosine kinase inhibitor exposure. Conclusion: OPB-51602 demonstrates promising antitumor activity, particularly in NSCLC. Its long half-life and poorer tolerability of continuous dosing, compared with intermittent dosing, suggest that less frequent dosing should be explored.	[Wong, A. L.; Soo, R. A.; Lee, S. C.; Lim, J. S.; Chin, T. M.; Goh, B. C.] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore 119228, Singapore; [Wong, A. L.; Soo, R. A.; Lee, S. C.; Lim, J. S.; Marban, P. C.; Chin, T. M.; Cordero, M. T.; Goh, B. C.] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Haematol Oncol Res Grp, Singapore 119228, Singapore; [Wong, A. L.; Soo, R. A.; Lee, S. C.; Kong, L. R.; Lee, Y. J.; Wang, L. Z.; Thuya, W. L.; Soong, R.; Yee, M. Q.; Chin, T. M.; Asuncion, B. R.; Pang, B.; Hirpara, J. L.; Goh, B. C.] Natl Univ Hlth Syst, Canc Sci Inst, Singapore 119228, Singapore; [Tan, D. S.] Natl Univ Hlth Syst, Natl Canc Ctr, Dept Med Oncol, Singapore 119228, Singapore; [Wang, L. Z.; Goh, B. C.] Natl Univ Hlth Syst, Dept Pharmacol, Singapore 119228, Singapore; [Pervaiz, S.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Physiol, Singapore 119228, Singapore; [Sinha, A.] Natl Univ Hlth Syst, Dept Diagnost Imaging, Singapore 119228, Singapore; [Xu, W. W.] Otsuka Beijing Res Inst, Beijing, Peoples R China; [Yuasa, M.; Tsunoda, T.; Motoyama, M.] Otsuka Pharmaceut Co Ltd, Chiyoda Ku, Tokyo, Japan; [Yamauchi, T.] Otsuka Pharmaceut Co Ltd, Fuji Mem Res Inst, Chiyoda Ku, Tokyo, Japan	Goh, BC (reprint author), Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Level 7,NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore.	phcgbc@nus.edu.sg	Pervaiz, Shazib/C-4188-2015		National Medical Research Council of Singapore [NMRC/CSA/021/2010]; NUHS Clinician Scientist Program Clinician Scientist Unit; Yong Loo Lin School of Medicine; National University of Singapore	This work was supported by the National Medical Research Council of Singapore (NMRC/CSA/021/2010) and NUHS Clinician Scientist Program Clinician Scientist Unit, Yong Loo Lin School of Medicine, and National University of Singapore.	Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Bendell JC, 2014, CANCER CHEMOTH PHARM, V74, P125, DOI 10.1007/s00280-014-2480-2; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Genini D, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-953; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	12	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	MAY	2015	26	5					998	1005		10.1093/annonc/mdv026		8	Oncology	Oncology	CH2BS	WOS:000353830000025		
J	Mitsukane, M; Sekiya, N; Himei, S; Oyama, K				Mitsukane, Masahiro; Sekiya, Noboru; Himei, Sayaka; Oyama, Koji			Immediate Effects of Repetitive Wrist Extension on Grip Strength in Patients With Distal Radial Fracture	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Hand strength; Radius fractures; Rehabilitation; Wrist joint	REDISLOCATED COLLES FRACTURE; SKELETAL-MUSCLE; BONE-CEMENT; NORIAN SRS; FIXATION; POSITION; PAIN	Objective: To evaluate the immediate effect of repetitive wrist extension on grip strength in patients with distal radial fracture. Design: Interventional study. S etting: Patients who were admitted to a hospital department of occupational therapy. Participants: Consecutive patients with a unilateral distal radial fracture (N=28). Intervention: Each patient was randomly allocated to either the experimental group (n=14) or the control group (n=14). The experimental group performed 30 repetitive wrist extensions with maximal isometric contraction of the extensors of their affected hands during a 6-minute intervention period, whereas the control group did not perform the exercise. Main Outcome Measures: Grip strength was measured just before and after the intervention period. Pain during grip strength measurements was also quantified using the visual analog scale. Wrist extension strength was measured 10 minutes after the grip strength measurement. Results: Grip strength increased immediately after repetitive wrist extension in the experimental group, but it remained the same in the control group. Visual analog scale scores indicated that pain was relieved only in the experimental group. However, pain was unrelated to strength production. Conclusions: The intervention used in this study might be useful during physical examination to reveal the potential grip strength of patients. The intervention may also be an effective warm-up training procedure in preparation for conventional grip-strengthening exercises. 2015 by the American Congress of Rehabilitation Medicine	[Mitsukane, Masahiro] Tokyo Univ Technol, Sch Hlth Sci, Dept Occupat Therapy, Tokyo 1448535, Japan; [Sekiya, Noboru] Showa Univ, Sch Nursing & Rehabil Sci, Dept Phys Therapy, Yokohama, Kanagawa, Japan; [Himei, Sayaka] Fujisawa Shounandai Hosp, Dept Rehabil Med, Fujisawa, Kanagawa, Japan; [Oyama, Koji] Fujisawa Shounandai Hosp, Dept Orthoped Surg, Fujisawa, Kanagawa, Japan	Mitsukane, M (reprint author), Tokyo Univ Technol, Sch Hlth Sci, Dept Occupat Therapy, Ohta Ku, 5-23-22 Nishikamata, Tokyo 1448535, Japan.	mitsukane@sff.teu.ac.jp					Agee JM, 1993, CLIN MECH HAND, V2nd, P371; ALTISSIMI M, 1986, CLIN ORTHOP RELAT R, P202; Girard O, 2009, EUR J APPL PHYSIOL, V106, P573, DOI 10.1007/s00421-009-1047-0; PRYCE JC, 1980, J BIOMECH, V13, P505, DOI 10.1016/0021-9290(80)90343-7; De Ruiter CJ, 2000, PFLUG ARCH EUR J PHY, V440, P163, DOI 10.1007/s004240000284; TRUMBLE TE, 1994, J HAND SURG-AM, V19A, P325, DOI 10.1016/0363-5023(94)90028-0; Galer BS, 1999, J PAIN SYMPTOM MANAG, V18, P213, DOI 10.1016/S0885-3924(99)00076-7; Li ZM, 2002, J HAND SURG-AM, V27A, P886, DOI 10.1053/jhsu.2002.35078; Chou R, 2007, ANN INTERN MED, V147, P478; COONEY WP, 1979, J BONE JOINT SURG AM, V61, P840; Farthing JP, 2005, MED SCI SPORT EXER, V37, P1594, DOI 10.1249/mss.0000177588.74448.75; Sanchez-Sotelo J, 2000, J BONE JOINT SURG BR, V82B, P856, DOI 10.1302/0301-620X.82B6.10317; SOLGAARD S, 1988, ACTA ORTHOP SCAND, V59, P39, DOI 10.3109/17453678809149341; ARO HT, 1991, J HAND SURG-AM, V16A, P392, DOI 10.1016/0363-5023(91)90003-T; Asano A, 2008, SEIKEIGEKAREHABILITA, V11, P48; Berg HE, 1997, J APPL PHYSIOL, V82, P182; DIAS JJ, 1987, J BONE JOINT SURG BR, V69, P463; DUCHATEAU J, 1987, J APPL PHYSIOL, V62, P2168; Kamezis IA, 2002, J BONE JOINT SURG BR, V84-B, P967; Kasapinova K, 2001, PRILOZI, V32, P231; Klopstegt P, 1968, HUMAN LIMBS THEIR SU, P178; Kopylov P, 1999, ACTA ORTHOP SCAND, V70, P1, DOI 10.3109/17453679909000946; McQhueen M, 1988, J BONE JOINT SURG BR, V70-B, P649; McQhueen MM, 1998, J BONE JOINT SURG BR, V80-B, P665; McQhueen MM, 1992, CLIN ORTHOP RELAT R, V285, P200; McQhueen MM, 1996, J BONE JOINT SURG BR, V78-B, P404; MELONE CP, 1984, ORTHOP CLIN N AM, V15, P217; Mitsukane M, 2005, GEN REHABIL, V33, P378; ODRISCOLL SW, 1992, J HAND SURG-AM, V17A, P169, DOI 10.1016/0363-5023(92)90136-D; RANATUNGA KW, 1987, J PHYSIOL-LONDON, V390, P383; SCHMALHOLZ A, 1990, CLIN ORTHOP RELAT R, P236; SCHMALHOLZ A, 1989, ACTA ORTHOP SCAND, V60, P212, DOI 10.3109/17453678909149258; Siegel S, 1988, NONPARAMETRIC STAT B; Ushida T, 2001, J Orthop Sci, V6, P46, DOI 10.1007/s007760170024; VANDERLINDEN W, 1981, J BONE JOINT SURG AM, V63, P1285; Voltz RG, 1980, CLIN ORTHOP RELAT R, V149, P112; YEN ST, 1991, CLIN ORTHOP RELAT R, P154	37	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2015	96	5					862	868		10.1016/j.apmr.2014.09.024		7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CH6JL	WOS:000354142800013		
J	Nitta, K; Ishikawa, N; Kawaguchi, M; Ooi, A; Watanabe, G				Nitta, Kanae; Ishikawa, Norihiko; Kawaguchi, Masahiko; Ooi, Akishi; Watanabe, Go			Thyroidectomy Using Pure Natural Orifice Transluminal Endoscopic Surgery in a Porcine Model	ARTIFICIAL ORGANS			English	Article						Natural orifice transluminal endoscopic surgery; Thyroidectomy; Endoscopic surgery; Oral approach	PERITONEOSCOPY	Surgical procedures for thyroid disease that provide cosmetically acceptable results are in demand. Natural orifice transluminal endoscopic surgery (NOTES) is performed through natural orifices and thus avoids incision of the body wall. This study aimed to develop an incision-free surgical procedure for thyroid lobectomy using pure NOTES with an oral approach. In six pig carcasses, an incision was made between the mandible and subcutaneous tissue under direct vision. After subcutaneous dissection and identification of the hyoid bone, the operative field was developed under endoscopic view. After the thyrohyoid membrane was identified, dissection was continued along the thyroid cartilage until the cricoid cartilage was identified and the thyroid isthmus was reached. An original retractor was inserted between dissected tissues to lift and fix the carcass. The thyroid gland was successfully removed through the incision. Similar macroscopic and histological findings were observed on the normal and treated sides, with no damage to the recurrent laryngeal nerves. The times required for securing the operative field and thyroidectomy improved with each operation. This study suggests the feasibility and safety of using pure NOTES for thyroidectomy through a subcutaneous route with an original retractor.	[Nitta, Kanae; Ishikawa, Norihiko; Kawaguchi, Masahiko; Watanabe, Go] Kanazawa Univ, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan; [Ooi, Akishi] Kanazawa Univ, Dept Cellular Transplantat Biol, Kanazawa, Ishikawa 9208641, Japan	Nitta, K (reprint author), Kanazawa Univ, Dept Gen & Cardiothorac Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	attin7nitta@gmail.com					Jeong JJ, 2009, J SURG ONCOL, V100, P477, DOI 10.1002/jso.21367; Kang SW, 2009, ENDOCR J, V56, P361; Rattner D, 2006, SURG ENDOSC, V20, P329, DOI 10.1007/s00464-005-3006-0; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Bergstrom M, 2008, GASTROINTEST ENDOSC, V67, P528, DOI 10.1016/j.gie.2007.09.049; BOWMAN DE, 2006, GASTROINTEST ENDOSC, V63, P199, DOI 10.1016/j.gie.2005.12.007; Chen DW, 2012, JSLS-J SOC LAPAROEND, V16, P60, DOI 10.4293/108680812X13291597715989; Hazey JW, 2008, SURG ENDOSC, V22, P16, DOI 10.1007/s00464-007-9548-6; Huscher CSG, 1997, SURG ENDOSC-ULTRAS, V11, P877, DOI 10.1007/s004649900476; Ishimaru T, 2012, J LAPAROENDOSC ADV S, V22, P724, DOI 10.1089/lap.2012.0017; Marescaux J, 2007, ARCH SURG-CHICAGO, V142, P823, DOI 10.1001/archsurg.142.9.823; Shimizu K, 2002, SURG TODAY, V32, P862; Shimizu Kazuo, 2002, J Nippon Med Sch, V69, P2, DOI 10.1272/jnms.69.2; Shin S, 2012, WORLD J SURG, V36, P2831, DOI 10.1007/s00268-012-1780-0; Ujiki MB, 2006, ANN SURG ONCOL, V13, P182, DOI 10.1245/ASO.2006.03.057	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	MAY	2015	39	5					441	445		10.1111/aor.12398		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CH7ZT	WOS:000354256100010		
J	Izumi, S; Azuma, S; Sugie, T				Izumi, Shinsaku; Azuma, Shun-ichi; Sugie, Toshiharu			Distributed Hybrid Controllers for Multi-Agent Mass Games By A Variable Number of Player Agents	ASIAN JOURNAL OF CONTROL			English	Article						Multi-agent system; distributed control; halftone image processing	COLLECTIVE CIRCULAR MOTION; GEOMETRIC PATTERNS; MOBILE ROBOTS; SYSTEMS; ALGORITHMS; CONSENSUS; NETWORKS	This paper considers a problem of finding distributed controllers for the multi-agent mass games, that is, to let agents organize themselves into a formation displaying a given grayscale image. As a solution to this problem, we propose distributed hybrid controllers. The key idea is to combine a coverage control method and halftone image processing, i.e., to combine techniques from the control theory and the image processing. The performance of the proposed controllers is demonstrated by numerical experiments with standard images.(c) 2014 Chinese Automatic Control Society and Wiley Publishing Asia Pty Ltd	[Izumi, Shinsaku; Azuma, Shun-ichi; Sugie, Toshiharu] Kyoto Univ, Grad Sch Informat, Uji, Kyoto 6110011, Japan	Izumi, S (reprint author), Kyoto Univ, Grad Sch Informat, Uji, Kyoto 6110011, Japan.	izumi@robot.kuass.kyoto-u.ac.jp			Aihara Innovative Mathematical Modelling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP); JSPS KAKENHI [25249058]	This research is partly supported by the Aihara Innovative Mathematical Modelling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP), and by JSPS KAKENHI Grant Number 25249058.	Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Fax JA, 2004, IEEE T AUTOMAT CONTR, V49, P1465, DOI 10.1109/TAC.2004.834433; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Sugihara K, 1996, J ROBOTIC SYST, V13, P127, DOI 10.1002/(SICI)1097-4563(199603)13:3<127::AID-ROB1>3.0.CO;2-U; Du HB, 2013, ASIAN J CONTROL, V15, P282, DOI 10.1002/asjc.533; Chen ZY, 2013, AUTOMATICA, V49, P1236, DOI 10.1016/j.automatica.2013.01.017; Zhang HT, 2013, IEEE T CONTR SYST T, V21, P1416, DOI 10.1109/TCST.2012.2200679; Dunbar WB, 2006, AUTOMATICA, V42, P549, DOI 10.1016/j.automatica.2005.12.008; Chen ZY, 2011, AUTOMATICA, V47, P1929, DOI 10.1016/j.automatica.2011.03.012; Cortes J, 2004, IEEE T ROBOTIC AUTOM, V20, P243, DOI 10.1109/TRA.2004.824698; Gu DB, 2008, IEEE T CONTR SYST T, V16, P85, DOI 10.1109/TCST.2007.899732; Suzuki I, 1999, SIAM J COMPUT, V28, P1347, DOI 10.1137/S009753979628292X; Azuma Shun-ichi, 2012, Transactions of the Institute of Systems, Control and Information Engineers, V25, DOI 10.5687/iscie.25.94; Bullo F, 2009, PRINC SER APPL MATH, P1; Howard A., 2002, P 6 INT S DISTR AUT, V5, P299; Izumi S., 2012, P 4 IFAC C AN DES HY, P339; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Mista T., 1993, P IEEE INF C AC SPEE, V5, P301; Olfati-Saber R., 2002, P 15 IFAC WORLD C BA; Ren W, 2008, COMMUN CONTROL ENG, P3; Ren W, 2008, ROBOT AUTON SYST, V56, P324, DOI 10.1016/j.robot.2007.08.005; Ulicheney R., 1987, DIGITAL HALFTONING; Yu WW, 2010, SYST CONTROL LETT, V59, P543, DOI 10.1016/j.sysconle.2010.06.014	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1561-8625	1934-6093		ASIAN J CONTROL	Asian J. Control	MAY	2015	17	3					762	774		10.1002/asjc.930		13	Automation & Control Systems	Automation & Control Systems	CH8DO	WOS:000354266500003		
J	Zhu, HZ; Sugie, T; Fujimoto, H				Zhu, Hongzhong; Sugie, Toshiharu; Fujimoto, Hiroshi			Smooth Output Reconstruction for Linear Systems with Quantized Measurements	ASIAN JOURNAL OF CONTROL			English	Article						Quantization; polynomial fitting approach; convex optimization; state observer	STABILIZATION; SIGNALS; FILTER; DESIGN	This paper presents a novel approach to reconstruct the output of linear systems in the case where the measured output is uniformly quantized. By fitting the quantized measurements with polynomials in a moving horizon manner, a smooth signal is reconstructed by solving a convex optimization problem with (1)-norm regularization. The quantization feature and the system models are taken into account in the optimization. A numerical example is given to show the excellent reconstruction performance of the proposed method. In addition, the proposed method is implemented in a high-precision linear stage through DSP, and its effectiveness is verified through experiments using a real positioning system.	[Zhu, Hongzhong; Fujimoto, Hiroshi] Univ Tokyo, Dept Elect Engn, Kashiwa, Chiba 2778561, Japan; [Sugie, Toshiharu] Kyoto Univ, Dept Syst Sci, Uji, Kyoto 6110011, Japan	Zhu, HZ (reprint author), Univ Tokyo, Dept Elect Engn, Kashiwa, Chiba 2778561, Japan.	zhu@hflab.k.u-tokyo.ac.jp; sugie@i.kyoto-u.ac.jp; fujimoto@k.u-tokyo.ac.jp					Xia YQ, 2012, CONTROL ENG PRACT, V20, P954, DOI 10.1016/j.conengprac.2012.04.009; Devasia S, 2007, IEEE T CONTR SYST T, V15, P802, DOI 10.1109/TCST.2007.903345; Merry RJE, 2010, MECHATRONICS, V20, P20, DOI 10.1016/j.mechatronics.2009.06.010; Che WW, 2013, INT J SYST SCI, V44, P265, DOI 10.1080/00207721.2011.600473; GAUTSCHI W, 1975, NUMER MATH, V24, P1, DOI 10.1007/BF01437212; Fujimoto H, 2001, IEEE T IND ELECTRON, V48, P636, DOI 10.1109/41.925591; Goodwin GC, 2010, ASIAN J CONTROL, V12, P443, DOI 10.1002/asjc.201; Brockett RW, 2000, IEEE T AUTOMAT CONTR, V45, P1279, DOI 10.1109/9.867021; Widrow B, 1996, IEEE T INSTRUM MEAS, V45, P353, DOI 10.1109/19.492748; Azuma SI, 2008, AUTOMATICA, V44, P396, DOI 10.1016/j.automatica.2007.06.012; Boyd S, 2004, CONVEX OPTIMIZATION; Fu MY, 2009, IEEE T AUTOMAT CONTR, V54, P1165, DOI 10.1109/TAC.2009.2017815; Hirata M, 2009, IEEE T IND ELECTRON, V56, P3817, DOI 10.1109/TIE.2009.2015751; Jian W., 2014, ASIAN J CONTROL, V16, P233, DOI [10.1002/.asjc.630, DOI 10.1002/.ASJC.630]; Laakso TI, 2000, SIGNAL PROCESS, V80, P567, DOI 10.1016/S0165-1684(99)00154-1; Ling Q, 2012, ASIAN J CONTROL, V14, P538, DOI 10.1002/asjc.363; LUONGVAN D, 2004, P 43 IEEE C DEC CONT, P2680; Mattingley J., 2010, P IEEE MULT SYST CON, P985; Tian E., 2008, INFORM SCI, V178; Zhang J., 2008, P 17 IFAC WORLD C SE, P9254; ZHU SY, 2013, HYPERFINE INTERACT, V220, P1, DOI DOI 10.1007/s10751-012-0749-6	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1561-8625	1934-6093		ASIAN J CONTROL	Asian J. Control	MAY	2015	17	3					1039	1049		10.1002/asjc.950		11	Automation & Control Systems	Automation & Control Systems	CH8DO	WOS:000354266500025		
J	Chen, N; Zhai, GS; Guo, YQ; Gui, WH; Shen, XY				Chen, Ning; Zhai, Guisheng; Guo, Yuqian; Gui, Weihua; Shen, Xiaoyu			Parametric Stabilization of Quantized Interconnected Systems with Application to Coupled Inverted Pendulums	ASIAN JOURNAL OF CONTROL			English	Article						Interconnected systems; quantization; parametric stability; coupled inverted pendulums	NONLINEAR-SYSTEMS; FEEDBACK-CONTROL; LINEAR-SYSTEMS; ABSOLUTE STABILITY; LURE SYSTEMS; UNCERTAINTY	This paper studies the analysis of parametric stability and decentralized state feedback control of a kind of quantized interconnected systems. The output of each controller is quantized logarithmically before it is input to the subsystem, and the quantized density would affect the stability of the systems. First, a decentralized state feedback controller is designed for interconnected systems without quantization and the corresponding stable region is obtained. Second, for a given controller, the lower bound of the quantization density is evaluated from parameters of local controllers. Finally, the proposed method is applied to coupled inverted pendulums systems which can be viewed as quantized interconnected systems. The simulation results show that by using the proposed quantized controllers, the interconnected inverted pendulum systems are parametrically stabilized.	[Chen, Ning; Guo, Yuqian; Gui, Weihua; Shen, Xiaoyu] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Peoples R China; [Zhai, Guisheng] Shibaura Inst Technol, Dept Math Sci, Saitama 3378570, Japan	Guo, YQ (reprint author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Peoples R China.	gyuqian@amss.ac.cn	Chen, Ning/N-6120-2015		National Natural Science Foundation of China [61074001]; Fundamental Research Funds for the Central Universities [2010QZZD016]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [61321003]	This work was supported in part by the National Natural Science Foundation of China (61074001), in part by the Fundamental Research Funds for the Central Universities (2010QZZD016), and in part by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (61321003).	Wada T, 2000, AUTOMATICA, V36, P1365, DOI 10.1016/S0005-1098(00)00052-2; Fu MY, 2005, IEEE T AUTOMAT CONTR, V50, P1698, DOI 10.1109/TAC.2005.858689; Wada T, 1998, IEEE T AUTOMAT CONTR, V43, P1649, DOI 10.1109/9.728889; GAVEL DT, 1989, IEEE T AUTOMAT CONTR, V34, P413, DOI 10.1109/9.28016; Elia N, 2001, IEEE T AUTOMAT CONTR, V46, P1384, DOI 10.1109/9.948466; Sundarapandian V, 2006, MATH COMPUT MODEL, V43, P9, DOI 10.1016/j.mcm.2005.04.010; Bakule L, 2008, ANNU REV CONTROL, V32, P87, DOI 10.1016/j.arcontrol.2008.03.004; Brockett RW, 2000, IEEE T AUTOMAT CONTR, V45, P1279, DOI 10.1109/9.867021; Gao H, 2008, AUTOMATICA, V44, P534, DOI 10.1016/j.automatica.2007.06.015; Chen Ning, 2007, Acta Automatica Sinica, V33; Chen N, 2014, ASIAN J CONTROL, V16, P225, DOI 10.1002/asjc.661; Fu MY, 2009, IEEE T AUTOMAT CONTR, V54, P1165, DOI 10.1109/TAC.2009.2017815; Gong ZM, 1996, IEEE T AUTOMAT CONTR, V41, P850, DOI 10.1109/9.506237; Ikeda M., 1991, PARAMETRIC STABILITY; IKEDA M, 1980, J MATH BIOL, V9, P65, DOI 10.1007/BF00276036; Ishii H., 2002, LTD DATA RATE CONTRO; Jamshidi M., 1983, LARGE SCALE SYSTEMS; Kalman R. E., 1956, P S NONL CIRC AN, VVI, P273; KWATNY HG, 1986, IEEE T CIRCUITS SYST, V33, P981, DOI 10.1109/TCS.1986.1085856; Liu T., 2012, AUTOMATICA, V46, P145; OHTA Y, 1994, SYST CONTROL LETT, V22, P437, DOI 10.1016/0167-6911(94)90087-6; Siljak D., 1978, LARGE SCALE DYNAMIC; Song Z., 2003, P 2003 IEEE INT S CO, V3, P1457; Yan HC, 2013, ASIAN J CONTROL, V15, P1468, DOI 10.1002/asjc.762; Zecevic AI, 2010, COMMUN CONTROL ENG, P1, DOI 10.1007/978-1-4419-1216-9; Zecevic AI, 2003, IEEE T AUTOMAT CONTR, V48, P1036, DOI 10.1109/TAC.2003.812791	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1561-8625	1934-6093		ASIAN J CONTROL	Asian J. Control	MAY	2015	17	3					1061	1069		10.1002/asjc.955		9	Automation & Control Systems	Automation & Control Systems	CH8DO	WOS:000354266500027		
J	Itami, K; Tanaka, S; Sunahara, K; Tatsuta, G; Mori, A				Itami, Kazuki; Tanaka, Shota; Sunahara, Kazuhiro; Tatsuta, Go; Mori, Atsunori			Addition-Elimination of Aryldimethylaluminum Reagents to Vinylarenes Promoted by the Addition of a Ketone	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						addition-elimination; aluminum; cross-coupling; nickel; rhodium	HECK-TYPE REACTION; HETEROCYCLIC CARBENE LIGANDS; COUPLING REACTIONS; AROMATIC KETONES; BOND-CLEAVAGE; PALLADIUM; ARYLATION; COMPLEXES; ARYL; DERIVATIVES	Addition-elimination reactions of an arylaluminum reagent with vinylarenes is achieved mediated by a rhodium catalyst. The reaction of dimethyl(phenyl)aluminum with a rhodium(I) catalyst takes place to afford (E)-stilbene. The reaction is promoted by the addition of ketone as an additive to give (E)-stilbene in a quantitative yield. A nickel complex bearing cyclopentadienyl (Cp) and N-heterocyclic carbene (NHC) ligands also catalyzes the reaction to afford 1,2-diarylethenes accompanied by a small amount of the saturated byproduct, 1,2-diarylethanes.	[Itami, Kazuki; Tanaka, Shota; Sunahara, Kazuhiro; Tatsuta, Go; Mori, Atsunori] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Mori, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	amori@kobe-u.ac.jp	Mori, Atsunori/C-2476-2011	Mori, Atsunori/0000-0002-1163-264X	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22350042, 25288049]; Kakenhi by MEXT [22350042, 25288049]; JSPS	This work was partially supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) and Kakenhi by MEXT (grant numbers 22350042 and 25288049). S.T. thanks the JSPS for a Research Fellowship for Young Scientists.	Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; [Anonymous], 2003, ANGEW CHEM, V115, P93; Fagnou K, 2002, ANGEW CHEM INT EDIT, V41, P26, DOI 10.1002/1521-3773(20020104)41:1<26::AID-ANIE26>3.0.CO;2-9; Iwasaki T, 2014, J AM CHEM SOC, V136, P9260, DOI 10.1021/ja5043534; Westermann J, 1998, EUR J INORG CHEM, P295; Malyshev DA, 2006, ORGANOMETALLICS, V25, P4462, DOI 10.1021/om060302v; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; Koike T, 2003, ANGEW CHEM INT EDIT, V42, P89, DOI 10.1002/anie.200390061; BUMAGIN NA, 1985, TETRAHEDRON LETT, V26, P4819, DOI 10.1016/S0040-4039(00)94960-8; [Anonymous], 2011, ANGEW CHEM, V123, P12691; Kakiuchi F, 2003, J AM CHEM SOC, V125, P1698, DOI 10.1021/ja029273f; Lautens M, 2001, J AM CHEM SOC, V123, P5358, DOI 10.1021/ja010402m; Kelly RA, 2005, ORGANOMETALLICS, V24, P3442, DOI 10.1021/om0501879; An BK, 2004, J AM CHEM SOC, V126, P10232, DOI 10.1021/ja046215g; Kakiuchi F, 2005, J AM CHEM SOC, V127, P5936, DOI 10.1021/ja043334n; Matsubara K, 2006, ORGANOMETALLICS, V25, P3422, DOI 10.1021/om0602658; [Anonymous], 2014, ANGEW CHEM, V126, P4475; [Anonymous], 2002, ANGEW CHEM, V114, P26; Mori A, 2001, J AM CHEM SOC, V123, P10774, DOI 10.1021/ja0159281; Ritleng V, 2008, ORGANOMETALLICS, V27, P4223, DOI 10.1021/om800376q; Hirabayashi K, 1998, TETRAHEDRON LETT, V39, P7893, DOI 10.1016/S0040-4039(98)01750-X; Du XL, 2001, ORG LETT, V3, P3313, DOI 10.1021/ol016529y; Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; Yan DP, 2011, ANGEW CHEM INT EDIT, V50, P12483, DOI 10.1002/anie.201106391; Henrion M, 2014, CHEM COMMUN, V50, P4624, DOI 10.1039/c4cc00959b; Tamba S, 2013, CHEM LETT, V42, P281, DOI 10.1246/cl.2013.281; CHO CS, 1994, J ORGANOMET CHEM, V465, P85, DOI 10.1016/0022-328X(94)87040-3; Cornella J, 2013, ORG LETT, V15, P6298, DOI 10.1021/ol4031815; Fischer C, 2004, SYNTHESIS-STUTTGART, P1497, DOI 10.1055/s-2004-822403; Fugami K, 1998, SYNLETT, P477; Hartwig J. F., 2010, ORGANOTRANSITION MET; Hirabayashi K, 2000, B CHEM SOC JPN, V73, P1409, DOI 10.1246/bcsj.73.1409; Hirabayashi K, 1999, SYNLETT, P99; Martinez R, 2007, ORG LETT, V9, P3213, DOI 10.1021/ol071098q; McCann LC, 2014, ANGEW CHEM INT EDIT, V53, P4386, DOI 10.1002/anie.201400459; Tanaka S, 2015, CHEM COMMUN, V51, P1949, DOI 10.1039/c4cc09306b; Tanaka S, 2014, EUR J ORG CHEM, V2014, P1167, DOI 10.1002/ejoc.201301757	40	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	MAY	2015	4	5					477	481		10.1002/ajoc.201500048		5	Chemistry, Organic	Chemistry	CH7KG	WOS:000354214500010		
J	Rubin, D; Aldering, G; Amanullah, R; Barbary, K; Dawson, KS; Deustua, S; Faccioli, L; Fadeyev, V; Fakhouri, HK; Fruchter, AS; Gladders, MD; de Jong, RS; Koekemoer, A; Krechmer, E; Lidman, C; Meyers, J; Nordin, J; Perlmutter, S; Ripoche, P; Schlegel, DJ; Spadafora, A; Suzuki, N				Rubin, D.; Aldering, G.; Amanullah, R.; Barbary, K.; Dawson, K. S.; Deustua, S.; Faccioli, L.; Fadeyev, V.; Fakhouri, H. K.; Fruchter, A. S.; Gladders, M. D.; de Jong, R. S.; Koekemoer, A.; Krechmer, E.; Lidman, C.; Meyers, J.; Nordin, J.; Perlmutter, S.; Ripoche, P.; Schlegel, D. J.; Spadafora, A.; Suzuki, N.			A CALIBRATION OF NICMOS CAMERA 2 FOR LOW COUNT RATES	ASTRONOMICAL JOURNAL			English	Article						supernovae: general; techniques: photometric	HUBBLE-SPACE-TELESCOPE; EXTRAGALACTIC LEGACY SURVEY; ORIGINS DEEP SURVEY; GOODS-SOUTH FIELD; IA SUPERNOVAE; GALAXY CLUSTER; DARK-ENERGY; SPECTROSCOPIC SURVEY; MASSIVE CLUSTER; REDSHIFT SURVEY	NICMOS 2 observations are crucial for constraining distances to most of the existing sample of z > 1 SNe Ia. Unlike conventional calibration programs, these observations involve long exposure times and low count rates. Reciprocity failure is known to exist in HgCdTe devices and a correction for this effect has already been implemented for high and medium count rates. However, observations at faint count rates rely on extrapolations. Here instead, we provide a new zero-point calibration directly applicable to faint sources. This is obtained via inter-calibration of NIC2 F110W/F160W with the Wide Field Camera 3 (WFC3) in the low count-rate regime using z similar to 1 elliptical galaxies as tertiary calibrators. These objects have relatively simple near-IR spectral energy distributions, uniform colors, and their extended nature gives a superior signal-to-noise ratio at the same count rate than would stars. The use of extended objects also allows greater tolerances on point-spread function profiles. We find space telescope magnitude zero points (after the installation of the NICMOS cooling system, NCS) of 25.296 +/- 0.022 for F110W and 25.803 +/- 0.023 for F160W, both in agreement with the calibration extrapolated from count rates greater than or similar to 1000 times larger (25.262 and 25.799). Before the installation of the NCS, we find 24.843 +/- 0.025 for F110W and 25.498 +/- 0.021 for F160W, also in agreement with the high-count-rate calibration (24.815 and 25.470). We also check the standard bandpasses of WFC3 and NICMOS 2 using a range of stars and galaxies at different colors and find mild tension for WFC3, limiting the accuracy of the zero points. To avoid human bias, our cross-calibration was "blinded" in that the fitted zero-point differences were hidden until the analysis was finalized.	[Rubin, D.] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Aldering, G.; Barbary, K.; Fakhouri, H. K.; Nordin, J.; Perlmutter, S.; Schlegel, D. J.; Spadafora, A.] EO Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Amanullah, R.] Univ Stockholm, AlbaNova, Dept Phys, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Dawson, K. S.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Deustua, S.; Fruchter, A. S.; Koekemoer, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Faccioli, L.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Faccioli, L.] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Fadeyev, V.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Fakhouri, H. K.; Krechmer, E.; Perlmutter, S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Gladders, M. D.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Gladders, M. D.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [de Jong, R. S.] Leibniz Inst Astrophys Potsdam AIP, D-14482 Potsdam, Germany; [Lidman, C.] Australian Astron Observ, Epping, NSW 1710, Australia; [Meyers, J.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Nordin, J.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Ripoche, P.] Google, Pittsburgh, PA USA; [Suzuki, N.] Univ Tokyo, Kavli Inst Phys & Math Universe, Kashiwa, Chiba 2778583, Japan	Rubin, D (reprint author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.				NASA from the Space Telescope Science Institute [GO/DD-11799, GO/DD-12051]; Office of Science, Department of Energy [DE-AC02-05CH11231]; NASA [NAS 5-26555]	Financial support for this work was provided by NASA through programs GO/DD-11799 and GO/DD-12051 from the Space Telescope Science Institute, which is operated by AURA, Inc., under NASA contract NAS 5-26555. This work was also partially supported by the Director, Office of Science, Department of Energy, under grant DE-AC02-05CH11231. This research has made use of the NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. We thank the anonymous referee for feedback that improved this work.	Abell G. O., 1958, ASTROPHYS J        S, V3, P211, DOI 10.1086/190036; Szokoly GP, 2004, ASTROPHYS J SUPPL S, V155, P271, DOI 10.1086/424707; Le Fevre O, 2004, ASTRON ASTROPHYS, V428, P1043, DOI 10.1051/0004-6361:20048072; Vanzella E, 2008, ASTRON ASTROPHYS, V478, P83, DOI 10.1051/0004-6361:20078332; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; [Anonymous], 2003, PHYS REV LETT; Barger AJ, 2008, ASTROPHYS J, V689, P687, DOI 10.1086/592735; Dawson KS, 2009, ASTRON J, V138, P1271, DOI 10.1088/0004-6256/138/5/1271; Tonry JL, 2003, ASTROPHYS J, V594, P1, DOI 10.1086/376865; Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Riess AG, 2001, ASTROPHYS J, V560, P49, DOI 10.1086/322348; Kneib JP, 2000, ASTROPHYS J, V544, pL35, DOI 10.1086/317285; Amanullah R, 2010, ASTROPHYS J, V716, P712, DOI 10.1088/0004-637X/716/1/712; Chevallier M, 2001, INT J MOD PHYS D, V10, P213, DOI 10.1142/S0218271801000822; Nordin J, 2014, MON NOT R ASTRON SOC, V440, P2742, DOI 10.1093/mnras/stu376; Sirianni M, 2005, PUBL ASTRON SOC PAC, V117, P1049, DOI 10.1086/444553; Riess AG, 2004, ASTROPHYS J, V607, P665, DOI 10.1086/383612; Santos JS, 2009, ASTRON ASTROPHYS, V501, P49, DOI 10.1051/0004-6361/200811546; Brodwin M, 2006, ASTROPHYS J, V651, P791, DOI 10.1086/507838; Riess AG, 2007, ASTROPHYS J, V659, P98, DOI 10.1086/510378; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Wirth GD, 2004, ASTRON J, V127, P3121, DOI 10.1086/420999; Rosati P, 2004, ASTRON J, V127, P230, DOI 10.1086/379857; Mullis CR, 2005, ASTROPHYS J, V623, pL85, DOI 10.1086/429801; ABELL GO, 1989, ASTROPHYS J SUPPL S, V70, P1, DOI 10.1086/191333; Balestra I, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913626; Bohlin R. C., 2005, TECHNICAL REPORT; Bohlin R. C., 2006, TECHNICAL REPORT; Brown MJI, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/2/18; Bushouse H, 2000, ASTR SOC P, V216, P531; Cohen JG, 2000, ASTROPHYS J, V538, P29, DOI 10.1086/309096; Dahlen T., 2008, TECHNICAL REPORT; de Jong R. S., 2006, TECHNICAL REPORT; Fisher D, 1998, ASTROPHYS J, V498, P195, DOI 10.1086/305553; Fruchter A. S., 2010, 2010 SPAC TEL SCI I, P382; Graur O, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/28; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Hartig G. F., 2009, TECHNICAL REPORT; Hsiao E. Y., 2010, HUBBLE SM4 PREPARING; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Koornneef J., 1986, HIGHLIGHTS ASTRON, V7, P833; KRIST J, 1993, ASTR SOC P, V52, P536; Krist J. E., 2011, P SPIE, V8127; Meyers J, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/1; Mobasher B., 2005, TECHNICAL REPORT; Nobili S, 2009, ASTROPHYS J, V700, P1415, DOI 10.1088/0004-637X/700/2/1415; Pickles AJ, 1998, PUBL ASTRON SOC PAC, V110, P863, DOI 10.1086/316197; Postman M, 2012, ASTROPHYS J SUPPL S, V199, DOI 10.1088/0067-0049/199/2/25; Regan M., 2012, P SOC PHOTO-OPT INS, V8442, P4; Riess A., 2010, HUBBLE SM4 PREPARING; Riess A. G., 2011, TECHNICAL REPORT; Riess A. G., 2010, TECHNICAL REPORT; Rodney SA, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/1/13; Rubin D, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/35; Sirianni M, 1998, P SOC PHOTO-OPT INS, V3355, P608, DOI 10.1117/12.316832; Stephens AW, 2000, ASTRON J, V119, P419, DOI 10.1086/301189; Suzuki N, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/85; THOMPSON R, 1992, SPACE SCI REV, V61, P69, DOI 10.1007/BF00212476; van Dokkum PG, 2001, PUBL ASTRON SOC PAC, V113, P1420, DOI 10.1086/323894; Viana A., 2009, NICMOS INSTRUMENT HD, V11.0	60	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	MAY	2015	149	5							159	10.1088/0004-6256/149/5/159		15	Astronomy & Astrophysics	Astronomy & Astrophysics	CH5HC	WOS:000354065200010		
J	Arav, N; Chamberlain, C; Kriss, GA; Kaastra, JS; Cappi, M; Mehdipour, M; Petrucci, PO; Steenbrugge, KC; Behar, E; Bianchi, S; Boissay, R; Branduardi-Raymont, G; Costantini, E; Ely, JC; Ebrero, J; di Gesu, L; Harrison, FA; Kaspi, S; Malzac, J; De Marco, B; Matt, G; Nandra, KP; Paltani, S; Peterson, BM; Pinto, C; Ponti, G; Nunez, FP; De Rosa, A; Seta, H; Ursini, F; de Vries, CP; Walton, DJ; Whewell, M				Arav, N.; Chamberlain, C.; Kriss, G. A.; Kaastra, J. S.; Cappi, M.; Mehdipour, M.; Petrucci, P. -O.; Steenbrugge, K. C.; Behar, E.; Bianchi, S.; Boissay, R.; Branduardi-Raymont, G.; Costantini, E.; Ely, J. C.; Ebrero, J.; di Gesu, L.; Harrison, F. A.; Kaspi, S.; Malzac, J.; De Marco, B.; Matt, G.; Nandra, K. P.; Paltani, S.; Peterson, B. M.; Pinto, C.; Ponti, G.; Nunez, F. Pozo; De Rosa, A.; Seta, H.; Ursini, F.; de Vries, C. P.; Walton, D. J.; Whewell, M.			Anatomy of the AGN in NGC 5548 II. The spatial, temporal, and physical nature of the outflow from HST/COS Observations	ASTRONOMY & ASTROPHYSICS			English	Article						galaxies: Seyfert	ABSORPTION-LINE VARIABILITY; X-RAY ABSORBER; QUASAR OUTFLOWS; MULTIWAVELENGTH CAMPAIGN; ORIGINS SPECTROGRAPH; SHOOTER OBSERVATIONS; CHEMICAL ABUNDANCES; NUCLEAR ENVIRONMENT; COLUMN DENSITIES; ATOMIC DATABASE	Context. AGN outflows are thought to influence the evolution of their host galaxies and of super massive black holes. Our deep multiwavelength campaign on NGC 5548 has revealed a new, unusually strong X-ray obscuration, accompanied by broad UV absorption troughs observed for the first time in this object. The X-ray obscuration caused a dramatic decrease in the incident ionizing flux on the outflow that produces the long-studied narrow UV absorption lines in this AGN. The resulting data allowed us to construct a comprehensive physical, spatial, and temporal picture for this enduring AGN wind. Aims. We aim to determine the distance of the narrow UV outflow components from the central source, their total column-density, and the mechanism responsible for their observed absorption variability. Methods. We study the UV spectra acquired during the campaign, as well as from four previous epochs (1998-2011). Our main analysis tools are ionic column-density extraction techniques, photoionization models based on the code CLOUDY, and collisional excitation simulations. Results. A simple model based on a fixed total column-density absorber, reacting to changes in ionizing illumination, matches the very different ionization states seen in five spectroscopic epochs spanning 16 years. The main component of the enduring outflow is situated at 3.5 +/- 1.1 pc from the central source, and its distance and number density are similar to those of the narrow-emitting-line region in this object. Three other components are situated between 5-70 pc and two are farther than 100 pc. The wealth of observational constraints and the anti-correlation between the observed X-ray and UV flux in the 2002 and 2013 epochs make our physical model a leading contender for interpreting trough variability data of quasar outflows. Conclusions. This campaign, in combination with prior UV and X-ray data, yields the first simple model that can explain the physical characteristics and the substantial variability observed in an AGN outflow.	[Arav, N.; Chamberlain, C.] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Kriss, G. A.; Ely, J. C.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kriss, G. A.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Kaastra, J. S.; Mehdipour, M.; Costantini, E.; Ebrero, J.; di Gesu, L.; de Vries, C. P.] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Kaastra, J. S.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Cappi, M.] INAF IASF Bologna, I-40129 Bologna, Italy; [Mehdipour, M.; Branduardi-Raymont, G.; Whewell, M.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Petrucci, P. -O.; Ursini, F.] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Petrucci, P. -O.; Ursini, F.] CNRS, IPAG, F-38000 Grenoble, France; [Steenbrugge, K. C.] Univ Catolica Norte, Inst Astron, Antofagasta, Chile; [Steenbrugge, K. C.] Univ Oxford, Dept Phys, Oxford OX1 3RH, England; [Behar, E.; Kaspi, S.] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Bianchi, S.; Matt, G.] Univ Rome Tre, Dipartimento Matemat & Fis, I-00146 Rome, Italy; [Boissay, R.; Paltani, S.] Univ Geneva, Dept Astron, CH-1290 Versoix, Switzerland; [Harrison, F. A.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Malzac, J.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse, France; [Malzac, J.] CNRS, IRAP, F-31028 Toulouse 4, France; [De Marco, B.; Nandra, K. P.; Ponti, G.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Peterson, B. M.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Peterson, B. M.] Ohio State Univ, Ctr Cosmol & AstroParticle Phys, Columbus, OH 43210 USA; [Pinto, C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Nunez, F. Pozo] Ruhr Univ Bochum, Astron Inst, D-44801 Bochum, Germany; [De Rosa, A.] INAF IAPS, I-00133 Rome, Italy; [Seta, H.] Rikkyo Univ, Res Ctr Measurement Adv Sci, Fac Sci, Toshima Ku, Tokyo 171, Japan	Arav, N (reprint author), Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA.	arav@vt.edu	Bianchi, Stefano/B-4804-2010; 	Bianchi, Stefano/0000-0002-4622-4240; Cappi, Massimo/0000-0001-6966-8920; De Rosa, Alessandra/0000-0001-5668-6863	NASA [13184, NAS5-26555]; NWO, the Netherlands Organization for Scientific Research; Studentship Enhancement Programme, UK Science & Technology Facilities Council (STFC); CNES; CNRS/PICS; VINCI program of the French-Italian University; Fondo Fortalecimiento de la Productividad Cientfica VRIDT; Israel's MoST; ISF [1163/10]; I-CORE program [1937/12]; CNRS/PNHE in France; CNRS/PICS in France; Italian Space Agency [ASI/INAF I/037/12/0-011/13]; US NSF [AST-1008882]; INAF/PICS; EU Marie Curie Intra-European fellowship [FP-PEOPLE-2012-IEF-331095]; Ph.D. studentship, UK Science & Technology Facilities Council (STFC); International Space Science Institute (ISSI) in Bern; ESA Member States; USA (NASA)	This work was supported by NASA through grants for HST program number 13184 from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, under NASA contract NAS5-26555. SRON is supported financially by NWO, the Netherlands Organization for Scientific Research. M.M. acknowledges the support of a Studentship Enhancement Programme awarded by the UK Science & Technology Facilities Council (STFC). P.-O.P. and F.U. thank financial support from the CNES and from the CNRS/PICS. F.U. acknowledges Ph.D. funding from the VINCI program of the French-Italian University. K.C.S. wants to acknowledge financial support from the Fondo Fortalecimiento de la Productividad Cientfica VRIDT 2013. E.B. is supported by grants from Israel's MoST, ISF (1163/10), and I-CORE program (1937/12). J.M. acknowledges funding from CNRS/PNHE and CNRS/PICS in France. G.M. and F.U. acknowledge financial support from the Italian Space Agency under grant ASI/INAF I/037/12/0-011/13. B.M.P. acknowledges support from the US NSF through grant AST-1008882. M.C., S.B., G.M. and A.D.R. acknowledge INAF/PICS support. G.P. acknowledges support via an EU Marie Curie Intra-European fellowship under contract no. FP-PEOPLE-2012-IEF-331095. M.W. acknowledges the support of a Ph.D. studentship awarded by the UK Science & Technology Facilities Council (STFC). The data used in this research are stored in the public archives of the satellites that are involved. We thank the International Space Science Institute (ISSI) in Bern for support. This work is based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and the USA (NASA). It is also based on observations with INTEGRAL, an ESA project with instrument and science data center funded by ESA member states (especially the PI countries: Denmark, France, Germany, Italy, Switzerland, Spain), Czech Republic, and Poland and with the participation of Russia and the USA. This work made use of data supplied by the UK Swift Science Data Centre at the University if Leicester. This research made use of the Chandra Transmission Grating Catalog and archive (http://tgcat.mit.edu). This research has made use of data obtained with the NuSTAR mission, a project led by the California Institute of Technology (Caltech), managed by the Jet Propulsion Laboratory (JPL) and funded by NASA, and has utilized the NuSTAR Data Analysis Software (NUSTARDAS) jointly developed by the ASI Science Data Center (ASDC, Italy) and Caltech (USA). Figure 6 was created by Ann Feild from STScI.	Capellupo DM, 2012, MON NOT R ASTRON SOC, V422, P3249, DOI 10.1111/j.1365-2966.2012.20846.x; Arav N, 2005, ASTROPHYS J, V620, P665, DOI 10.1086/425560; Dere KP, 1997, ASTRON ASTROPHYS SUP, V125, P149, DOI 10.1051/aas:1997368; Ciotti L, 2010, ASTROPHYS J, V717, P708, DOI 10.1088/0004-637X/717/2/708; Arav N, 2013, MON NOT R ASTRON SOC, V436, P3286, DOI 10.1093/mnras/stt1812; Arav N, 2001, ASTROPHYS J, V561, P118, DOI 10.1086/323369; HAMANN F, 1993, ASTROPHYS J, V418, P11, DOI 10.1086/173366; Faucher-Giguere CA, 2012, MON NOT R ASTRON SOC, V420, P1347, DOI 10.1111/j.1365-2966.2011.20120.x; Ferland GJ, 2013, REV MEX ASTRON ASTR, V49, P137; de Kool M, 2002, ASTROPHYS J, V580, P54, DOI 10.1086/343107; Ostriker JP, 2010, ASTROPHYS J, V722, P642, DOI 10.1088/0004-637X/722/1/642; Costantini E, 2007, ASTRON ASTROPHYS, V461, P121, DOI 10.1051/0004-6361:20065390; Kaastra JS, 2014, SCIENCE, V345, P64, DOI 10.1126/science.1253787; Gabel JR, 2005, ASTROPHYS J, V631, P741, DOI 10.1086/432682; Steenbrugge KC, 2005, ASTRON ASTROPHYS, V434, P569, DOI 10.1051/0004-6361:20047138; Hopkins PF, 2010, MON NOT R ASTRON SOC, V401, P7, DOI 10.1111/j.1365-2966.2009.15643.x; Arav N, 1999, ASTROPHYS J, V524, P566, DOI 10.1086/307841; Arav N, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201118501; Arav N, 2007, ASTROPHYS J, V658, P829, DOI 10.1086/511666; Arav N, 2002, ASTROPHYS J, V566, P699, DOI 10.1086/338113; Arav N, 2008, ASTROPHYS J, V681, P954, DOI 10.1086/588651; Ballero SK, 2008, ASTRON ASTROPHYS, V478, P335, DOI 10.1051/0004-6361:20078663; BARLOW TA, 1992, ASTROPHYS J, V397, P81, DOI 10.1086/171768; Borguet BCJ, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/49; Borguet BCJ, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/69; Borguet BCJ, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/107; Crenshaw DM, 1999, ASTROPHYS J, V516, P750, DOI 10.1086/307144; Crenshaw DM, 2003, ASTROPHYS J, V594, P116, DOI 10.1086/376792; Crenshaw DM, 2009, ASTROPHYS J, V698, P281, DOI 10.1088/0004-637X/698/1/281; Edmonds D, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/7; Ak NF, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/168; Gabel JR, 2003, ASTROPHYS J, V583, P178, DOI 10.1086/345096; Gabel JR, 2006, ASTROPHYS J, V646, P742, DOI 10.1086/505070; Green JC, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/60; Hamann F, 1997, ASTROPHYS J, V478, P80, DOI 10.1086/303781; Kaastra JS, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118161; KORISTA KT, 1995, ASTROPHYS J SUPPL S, V97, P285, DOI 10.1086/192144; Landi E, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/86; Lodders K., 2009, LANDOLT BORNSTEIN B, V4B, P44; Mehdipour M. M., 2014, XRAY UNIVERSE 2014, P34; Pancoast A, 2014, MON NOT R ASTRON SOC, V445, P3073, DOI 10.1093/mnras/stu1419; Peterson BM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/109; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Soker N, 2011, MON NOT R ASTRON SOC, V411, P1803, DOI 10.1111/j.1365-2966.2010.17810.x	44	5	5	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAY	2015	577								A37	10.1051/0004-6361/201425302		27	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8RT	WOS:000353579600037		
J	Benic, S; Blaschke, D; Alvarez-Castillo, DE; Fischer, T; Typel, S				Benic, Sanjin; Blaschke, David; Alvarez-Castillo, David E.; Fischer, Tobias; Typel, Stefan			A new quark-hadron hybrid equation of state for astrophysics I. High-mass twin compact stars	ASTRONOMY & ASTROPHYSICS			English	Article						stars: neutron; stars: interiors; dense matter; equation of state	NEUTRON-STARS; MULTIQUARK INTERACTIONS; VECTOR INTERACTION; DENSE MATTER; 3RD FAMILY; QCD; QUIESCENT	Aims. We present a new microscopic hadron-quark hybrid equation of state model for astrophysical applications, from which compact hybrid star configurations are constructed. These are composed of a quark core and a hadronic shell with a first-order phase transition at their interface. The resulting mass-radius relations are in accordance with the latest astrophysical constraints. Methods. The quark matter description is based on a quantum chromodynamics (QCD) motivated chiral approach with higher-order quark interactions in the Dirac scalar and vector coupling channels. For hadronic matter we select a relativistic mean-field equation of state with density-dependent couplings. Since the nucleons are treated in the quasi-particle framework, an excluded volume correction has been included for the nuclear equation of state at suprasaturation density which takes into account the finite size of the nucleons. Results. These novel aspects, excluded volume in the hadronic phase and the higher-order repulsive interactions in the quark phase, lead to a strong first-order phase transition with large latent heat, i.e. the energy-density jump at the phase transition, which fulfils a criterion for a disconnected third-family branch of compact stars in the mass-radius relationship. These twin stars appear at high masses (similar to 2 M-circle dot) that are relevant for current observations of high-mass pulsars. Conclusions. This analysis offers a unique possibility by radius observations of compact stars to probe the QCD phase diagram at zero temperature and large chemical potential and even to support the existence of a critical point in the QCD phase diagram.	[Benic, Sanjin] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10000, Croatia; [Benic, Sanjin] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Blaschke, David; Fischer, Tobias] Univ Wroclaw, Inst Theoret Phys, PL-50204 Wroclaw, Poland; [Blaschke, David; Alvarez-Castillo, David E.] Joint Inst Nucl Res, Bogoliubov Lab Theoret Phys, Dubna 141980, Russia; [Alvarez-Castillo, David E.] Univ Autonoma San Luis Potosi, Inst Fis, Mexico City 78290, DF, Mexico; [Typel, Stefan] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany	Benic, S (reprint author), Univ Zagreb, Fac Sci, Dept Phys, Bijenicka C 32, Zagreb 10000, Croatia.	sanjinb@phy.hr			Narodowe Centrum Nauki (NCN) within the "Maestro" programme [DEC-2011/02/A/ST2/00306]; COST Action "NewCompStar" within the STSM programme [MP1304]; Croatian Science Foundation [8799]; Polish Ministry for Science and Higher Education [1009/S/IFT/14]; Heisenberg-Landau programme; NCN within the "Sonata" programme [UMO-2013/11/D/ST2/02645]; Helmholtz Association (HGF) through the Nuclear Astrophysics Virtual Institute [VH-VI-417]	We gratefully acknowledge numerous discussions and collaboration work on the topic addressed in this contribution with our colleagues, in particular with A. Ayriyan, G.A. Contrera, H. Grigorian, O. Kaczmarek, T. Klahn, E. Laermann, R. Lastowiecki, M.C. Miller, G. Poghosyan, S.B. Popov, M. Sokolowski, J. Trumper, D.N. Voskresensky and F. Weber. This research has been supported by Narodowe Centrum Nauki (NCN) within the "Maestro" programme under contract number DEC-2011/02/A/ST2/00306. The visits of S.B. and D.E.A.-C. at the University of Wroclaw were supported by the COST Action MP1304 "NewCompStar" within the STSM programme. S. B. acknowledges partial support by the Croatian Science Foundation under Project No. 8799. D.B. acknowledges support by the Polish Ministry for Science and Higher Education under grant number 1009/S/IFT/14. D.E.A.-C. is grateful for support by the Heisenberg-Landau programme for collaboration between JINR Dubna and German Universities and Institutes. T.F. is supported by the NCN within the "Sonata" programme under contract number UMO-2013/11/D/ST2/02645. S.T. acknowledges support by the Helmholtz Association (HGF) through the Nuclear Astrophysics Virtual Institute (VH-VI-417), and by the Heisenberg-Landau programme.	Agrawal BK, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.103006; Alvarez-Castillo D., 2013, P 17 C YOUNG SCI SPE; Alvarez-Castillo D., 2014, ARXIV14084449; Servillat M, 2012, MON NOT R ASTRON SOC, V423, P1556, DOI 10.1111/j.1365-2966.2012.20976.x; Klahn T, 2007, PHYS LETT B, V654, P170, DOI 10.1016/j.physletb.2007.08.048; Alford MG, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.083013; Alford M, 2005, ASTROPHYS J, V629, P969, DOI 10.1086/430902; Steinheimer J, 2014, PHYS LETT B, V736, P241, DOI 10.1016/j.physletb.2014.07.018; Sagert I, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.081101; Sugano J, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.037901; Orsaria M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.023001; Fukushima K, 2013, PROG PART NUCL PHYS, V72, P99, DOI 10.1016/j.ppnp.2013.05.003; Yasutake N, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.065803; Typel S, 1999, NUCL PHYS A, V656, P331, DOI 10.1016/S0375-9474(99)00310-3; Di Toro M, 2006, NUCL PHYS A, V775, P102, DOI 10.1016/j.nuclphysa.2006.04.007; Gendreau KC, 2012, PROC SPIE, V8443, DOI 10.1117/12.926396; Bratovic N, 2013, PHYS LETT B, V719, P131, DOI 10.1016/j.physletb.2013.01.003; Fuchs C, 2006, PROG PART NUCL PHYS, V56, P1, DOI 10.1016/j.ppnp.2005.07.004; Yamamoto Y, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.045805; Demorest PB, 2010, NATURE, V467, P1081, DOI 10.1038/nature09466; Hambaryan V, 2014, J PHYS CONF SER, V496, DOI 10.1088/1742-6596/496/1/012015; Klahn T, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.085001; Buballa M, 2014, J PHYS G NUCL PARTIC, V41, DOI 10.1088/0954-3899/41/12/123001; Read JS, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.124032; Pons JA, 2001, PHYS REV LETT, V86, P5223, DOI 10.1103/PhysRevLett.86.5223; Typel S, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.015803; Banik S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.123003; RISCHKE DH, 1991, Z PHYS C PART FIELDS, V51, P485, DOI 10.1007/BF01548574; Haensel P, 2007, ASTROPHYS SPACE SC L, V326, P1, DOI 10.1007/978-0-387-47301-7; Steiner AW, 2010, ASTROPHYS J, V722, P33, DOI 10.1088/0004-637X/722/1/33; Agrawal BK, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.023009; Schertler K, 2000, NUCL PHYS A, V677, P463, DOI 10.1016/S0375-9474(00)00305-5; Akmal A, 1998, PHYS REV C, V58, P1804, DOI 10.1103/PhysRevC.58.1804; Antoniadis J, 2013, SCIENCE, V340, P6131, DOI DOI 10.1126/SCIENCE.1233232; Banik S, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.055805; Benic S, 2014, EUR PHYS J A, V50, DOI 10.1140/epja/i2014-14111-1; BLASCHKE D, 1990, SOV J NUCL PHYS+, V52, P675; Blaschke D, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.065805; Blaschke D., 1988, JINRE28877; Blaschke D., 2013, POS CPOD; Bogdanov S, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/96; Contrera G.A., 2014, PHYS PART NUCL LETT, V11, P342; Fischer T., 2011, ASTROPHYS J SUPPL SE, V194, P28; Fraga ES, 2014, ASTROPHYS J LETT, V781, DOI 10.1088/2041-8205/781/2/L25; Fraga E S, 2002, NUCL PHYS A, V702, P217, DOI 10.1016/S0375-9474(02)00709-1; Fukushima K, 2014, NUCL PHYS A, V931, P257, DOI 10.1016/j.nuclphysa.2014.10.011; GERLACH UH, 1968, PHYS REV, V172, P1325, DOI 10.1103/PhysRev.172.1325; Glendenning N. K., 2000, ASTRON ASTROPHYS, V353, P795; Guillot S, 2014, ASTROPHYS J LETT, V796, DOI 10.1088/2041-8205/796/1/L3; Hebeler K, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/11; Hell Thomas, 2013, J MOD PHYS, V4, P644; Inoue T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.112503; KAMPFER B, 1981, J PHYS A-MATH GEN, V14, pL471, DOI 10.1088/0305-4470/14/11/009; Kashiwa K, 2007, PHYS LETT B, V647, P446, DOI 10.1016/j.physletb.2007.01.061; Lattimer J. M., 2010, ARXIV10123208; Masuda K, 2013, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptt045; Mignani RP, 2012, IAU SYMP P SERIES, V285, P372, DOI 10.1017/S1743921312001111; Miller M. C., 2013, ARXIV13120029; Nakazato K., 2014, ASTRON ASTROPHYS, V558, pA5; Ohnishi A, 2011, PHYS LETT B, V704, P284, DOI 10.1016/j.physletb.2011.09.018; Popov SB, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.025803; Schaffner-Bielich J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.171101; Steiner AW, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/1/L5; Trumper JE, 2011, PROG PART NUCL PHYS, V66, P674, DOI 10.1016/j.ppnp.2011.01.018; Zdunik JL, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220697	65	7	7	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAY	2015	577								A40	10.1051/0004-6361/201425318		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8RT	WOS:000353579600040		
J	Pilleri, P; Joblin, C; Boulanger, F; Onaka, T				Pilleri, P.; Joblin, C.; Boulanger, F.; Onaka, T.			Mixed aliphatic and aromatic composition of evaporating very small grains in NGC 7023 revealed by the 3.4/3.3 mu m ratio	ASTRONOMY & ASTROPHYSICS			English	Article						photon-dominated region (PDR); ISM: individual objects: NGC 7023; ISM: molecules	INFRARED-EMISSION FEATURES; PHOTODISSOCIATION REGIONS; HYDROCARBON CLUSTERS; INTERSTELLAR-MEDIUM; PHOTOCHEMICAL EVOLUTION; PROTOPLANETARY NEBULAE; MICRON SPECTROSCOPY; MILKY-WAY; BANDS; DUST	Context. A chemical scenario was proposed for photon-dominated regions (PDRs) according to which UV photons from nearby stars lead to the evaporation of very small grains (VSGs) and the production of gas-phase polycyclic aromatic hydrocarbons (PAHs). Aims. Our goal is to achieve better insight into the composition and evolution of evaporating very small grains (eVSGs) and PAHs through analyzing the infrared (IR) aliphatic and aromatic emission bands. Methods. We combined spectro-imagery in the near-and mid-IR to study the spatial evolution of the emission bands in the prototypical PDR NGC 7023. We used near-IR spectra obtained with the IRC instrument onboard AKARI to trace the evolution of the 3.3 mu m and 3.4 mu m bands, which are associated with aromatic and aliphatic C-H bonds on PAHs. The spectral fitting involved an additional broad feature centered at 3.45 mu m that is often referred to as the plateau. Mid-IR observations obtained with the IRS instrument onboard the Spitzer Space Telescope were used to distinguish the signatures of eVSGs and neutral and cationic PAHs. We correlated the spatial evolution of all these bands with the intensity of the UV field given in units of the Habing field G(0) to explore how their carriers are processed. Results. The intensity of the 3.45 mu m plateau shows an excellent correlation with that of the 3.3 mu m aromatic band (correlation coefficient R = 0.95) and a relatively poor correlation with the aliphatic 3.4 mu m band (R = 0.77). This indicates that the 3.45 mu m feature is dominated by the emission from aromatic bonds. We show that the ratio of the 3.4 mu m and 3.3 mu m band intensity (I-3.4/I-3.3) decreases by a factor of 4 at the PDR interface from the more UV-shielded layers (G(0) > 150, I-3.4/I-3.3 = 0.13) to the more exposed layers (G(0) > 1 x 10(4); I-3.4/I-3.3 = 0.03). The intensity of the 3.3 mu m band relative to the total neutral PAH intensity shows an overall increase with G(0), associated with an increase of both the hardness of the UV field and the H abundance. In contrast, the intensity of the 3.4 mu m band relative to the total neutral PAH intensity decreases with G(0), showing that their carriers are actively destroyed by UV irradiation and are not e ffi ciently regenerated. The transition region between the aliphatic and aromatic material is found to correspond spatially with the transition zone between neutral PAHs and eVSGs. Conclusions. We conclude that the photo-processing of eVSGs leads to the production of PAHs with attached aliphatic sidegroups that are revealed by the 3.4 mu m emission band. Our analysis provides evidence for the presence of very small grains of mixed aromatic and aliphatic composition in PDRs.	[Pilleri, P.; Joblin, C.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse, France; [Pilleri, P.; Joblin, C.] CNRS, IRAP, F-31028 Toulouse 4, France; [Boulanger, F.] Inst Astrophys Spatiale, F-91405 Orsay, France; [Onaka, T.] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan	Pilleri, P (reprint author), Univ Toulouse, UPS OMP, IRAP, BP 44346, F-31028 Toulouse, France.	paolo.pilleri@irap.omp.eu			French National Program, Physique et Chimie du Milieu Interstellaire; Centre National d'Erudes Spatiales (CNES); European Research Council under the European Union's Seventh Framework Programme (FP) ERC-SyG [610256]	We thank the anonymous referee for useful comments. This work was supported by the French National Program, Physique et Chimie du Milieu Interstellaire, which is gratefully acknowledged. P. Pilleri acknowledges financial support from the Centre National d'Erudes Spatiales (CNES). The research leading to these results has also received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) ERC-2013-SyG, Grant Agreement No. 610256 NANOCOSMOS.	ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; Berne O, 2007, ASTRON ASTROPHYS, V469, P575, DOI 10.1051/0004-6361:20066282; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; Bernstein MP, 1996, ASTROPHYS J, V472, pL127, DOI 10.1086/310376; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Pech C, 2002, ASTRON ASTROPHYS, V388, P639, DOI 10.1051/0004-6361:20020416; Peeters E, 2002, ASTRON ASTROPHYS, V390, P1089, DOI 10.1051/0004-6361:20020773; Rapacioli M, 2006, ASTRON ASTROPHYS, V460, P519, DOI 10.1051/0004-6361:20065412; Rapacioli M, 2005, ASTRON ASTROPHYS, V429, P193, DOI 10.1051/0004-6361:20041247; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; Alecian E, 2008, MON NOT R ASTRON SOC, V385, P391, DOI 10.1111/j.1365-2966.2008.12842.x; Jones AP, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117623; BARKER JR, 1987, ASTROPHYS J, V315, pL61, DOI 10.1086/184861; Benisty M, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201219893; Malloci G, 2007, CHEM PHYS, V332, P353, DOI 10.1016/j.chemphys.2007.01.001; GEBALLE TR, 1989, ASTROPHYS J, V341, P278, DOI 10.1086/167491; JOBLIN C, 1992, ASTROPHYS J, V393, pL79, DOI 10.1086/186456; FUENTE A, 1993, ASTRON ASTROPHYS, V276, P473; Sloan GC, 1997, ASTROPHYS J, V474, P735, DOI 10.1086/303484; Joblin C, 1996, ASTROPHYS J, V458, P610, DOI 10.1086/176843; Sloan GC, 2007, ASTROPHYS J, V664, P1144, DOI 10.1086/519236; Berne O, 2012, P NATL ACAD SCI USA, V109, P401, DOI 10.1073/pnas.1114207108; Boersma C, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/8; Dartois E, 2004, ASTRON ASTROPHYS, V423, pL33, DOI 10.1051/0004-6361:200400032; FINKENZELLER U, 1985, ASTRON ASTROPHYS, V151, P340; Fuente A, 1996, ASTRON ASTROPHYS, V310, P286; Gerin M, 1998, ASTROPHYS J, V500, P329, DOI 10.1086/305726; Goto M, 2003, ASTROPHYS J, V589, P419, DOI 10.1086/368018; HABING HJ, 1968, B ASTRON I NETH, V19, P421; DEMUIZON MJ, 1990, ASTRON ASTROPHYS, V235, P367; Kwok S, 2001, ASTROPHYS J, V554, pL87, DOI 10.1086/320913; Lemaire JL, 1996, ASTRON ASTROPHYS, V308, P895; Li AG, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L35; Martini P, 1997, ASTROPHYS J, V484, P296, DOI 10.1086/304322; Montillaud J, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201323141; Montillaud J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220757; Mori TI, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/53; Mulas G, 2006, ASTRON ASTROPHYS, V460, P93, DOI 10.1051/0004-6361:20054276; Murakami H., 2007, PASJ, V59, P369; Onaka T., 2007, PASJ, V59, P401; Pauzat F, 2011, EAS PUBLICATIONS, V46, P75, DOI 10.1051/eas/1146008; Pilleri P, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201015915; Simon A, 2009, J PHYS CHEM A, V113, P4878, DOI 10.1021/jp8099785; Steglich M, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/26; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P309, DOI 10.1086/422413; Witt AN, 2006, ASTROPHYS J, V636, P303, DOI 10.1086/498052	47	2	2	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAY	2015	577								A16	10.1051/0004-6361/201425590		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8RT	WOS:000353579600016		
J	Schodel, R; Feldmeier, A; Kunneriath, D; Stolovy, S; Neumayer, N; Amaro-Seoane, P; Nishiyama, S				Schoedel, R.; Feldmeier, A.; Kunneriath, D.; Stolovy, S.; Neumayer, N.; Amaro-Seoane, P.; Nishiyama, S.			Surface brightness profile of the Milky Way's nuclear star cluster (vol 566, A47, 2014)	ASTRONOMY & ASTROPHYSICS			English	Correction						dust, extinction; Galaxy: center; Galaxy: nucleus; Galaxy: structure; galaxies: nuclei; errata, addenda			[Schoedel, R.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Feldmeier, A.; Neumayer, N.] European So Observ, D-85748 Garching, Germany; [Kunneriath, D.] Acad Sci Czech Republic, Inst Astron, Prague 14100, Czech Republic; [Stolovy, S.] El Camino Coll, Torrance, CA 90506 USA; [Amaro-Seoane, P.] Albert Einstein Inst, Max Planck Inst Gravitat Phys, D-14476 Potsdam, Germany; [Nishiyama, S.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Schodel, R (reprint author), CSIC, Inst Astrofis Andalucia, Glorieta Astron S-N, E-18008 Granada, Spain.	rainer@iaa.es					Schodel R, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423481	1	0	0	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361	1432-0746		ASTRON ASTROPHYS	Astron. Astrophys.	MAY	2015	577								C1	10.1051/0004-6361/201423481e		1	Astronomy & Astrophysics	Astronomy & Astrophysics	CG8RT	WOS:000353579600049		
J	Yoshida, T; Yamaguchi, A; Tsutsui, H; Wake, T				Yoshida, Takako; Yamaguchi, Ayumi; Tsutsui, Hideomi; Wake, Tenji			Tactile search for change has less memory than visual search for change	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Active touch; Visual search; Change detection; Working memory	SHORT-TERM-MEMORY; EYE-MOVEMENTS; WORKING-MEMORY; PATTERN PERCEPTION; CHANGE BLINDNESS; RECOGNITION; CAPACITY; SIMILARITY; INTEGRATION; INFORMATION	Haptic perception of a 2D image is thought to make heavy demands on working memory. During active exploration, humans need to store the latest local sensory information and integrate it with kinesthetic information from hand and finger locations in order to generate a coherent perception. This tactile integration has not been studied as extensively as visual shape integration. In the current study, we compared working-memory capacity for tactile exploration to that of visual exploration as measured in change-detection tasks. We found smaller memory capacity during tactile exploration (approximately 1 item) compared with visual exploration (2-10 items). These differences generalized to position memory and could not be attributed to insufficient stimulus-exposure durations, acuity differences between modalities, or uncertainty over the position of items. This low capacity for tactile memory suggests that the haptic system is almost amnesic when outside the fingertips and that there is little or no cross-position integration.	[Yoshida, Takako] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528552, Japan; [Yamaguchi, Ayumi; Tsutsui, Hideomi] Chukyo Univ, Dept Psychol, Nagoya, Aichi, Japan; [Wake, Tenji] Kanagawa Univ, Inst Visual Sci, Yokohama, Kanagawa, Japan	Yoshida, T (reprint author), Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, 2-12-1 OOkayama, Tokyo 1528552, Japan.	yoshida.t.bb@m.titech.ac.jp			Japan Society for the Promotion of Sciences; Nissan Science Foundation; Strategic Information and Communications R&D Promotion Programme Ministry of Internal Affairs and Communications of Japan	This work was supported by grants from the Japan Society for the Promotion of Sciences, Nissan Science Foundation, and Strategic Information and Communications R&D Promotion Programme Ministry of Internal Affairs and Communications of Japan. The authors thank Amelia Hunt and Patrick Cavanagh for their comments.	Gallace A, 2006, PSYCHON B REV, V13, P300, DOI 10.3758/BF03193847; GILSON EQ, 1969, Q J EXP PSYCHOL, V21, P180, DOI 10.1080/14640746908400211; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; HELLER MA, 1989, PERCEPTION, V18, P379, DOI 10.1068/p180379; Lederman SJ, 1997, J EXP PSYCHOL HUMAN, V23, P1680, DOI 10.1037//0096-1523.23.6.1680; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037//0033-295X.96.3.433; Gallace A, 2009, PSYCHOL BULL, V135, P380, DOI 10.1037/a0015325; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Saiki J, 2003, VISION RES, V43, P2107, DOI 10.1016/S0042-6989(03)00331-6; LOOMIS JM, 1991, PERCEPTION, V20, P167, DOI 10.1068/p200167; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Rensink RA, 2000, VIS COGN, V7, P345, DOI 10.1080/135062800394847; Irwin DE, 1998, VIS COGN, V5, P127; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Lakatos S, 1999, PERCEPT PSYCHOPHYS, V61, P895, DOI 10.3758/BF03206904; LOOMIS JM, 1990, J EXP PSYCHOL HUMAN, V16, P106, DOI 10.1037/0096-1523.16.1.1066; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233; BALAKRISHNAN JD, 1989, PERCEPT PSYCHOPHYS, V46, P387, DOI 10.3758/BF03204993; Bliss I, 2005, SCAND J PSYCHOL, V46, P247, DOI 10.1111/j.1467-9450.2005.00454.x; Gibson J. J., 1966, SENSES CONSIDERED PE; HILL JW, 1968, PERCEPT PSYCHOPHYS, V4, P91, DOI 10.3758/BF03209516; Hochberg Julian, 1986, HDB PERCEPTION HUMAN, V1, P1; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; IRWIN DE, 1992, J EXP PSYCHOL LEARN, V18, P307, DOI 10.1037/0278-7393.18.2.307; Irwin D. E., 1992, ATTENTION PERFORM, P121; Kennedy J. M., 1977, ARTS COGNITION, P118; Kennedy JM, 2000, DEBATES PSYCHOL, P67; KLATZKY RL, 1987, PSYCHOL LEARN MOTIV, V21, P121; Lederman S. J., 1986, HDB PERCEPTION HUMAN; LOOMIS JM, 1982, PERCEPT PSYCHOPHYS, V31, P41, DOI 10.3758/BF03206199; LOOMIS JM, 1981, PERCEPTION, V10, P5, DOI 10.1068/p100005; MAGEE LE, 1980, NATURE, V283, P287, DOI 10.1038/283287a0; Mahrer P, 2002, MEMORY, V10, P7; MILLER GA, 1994, PSYCHOL REV, V101, P343; RICHARDSON BL, 1981, NATURE, V292, P90, DOI 10.1038/292090a0; Wolfe JM, 1999, MIT BRAD COGN PSYCH, P71	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	MAY	2015	77	4					1200	1211		10.3758/s13414-014-0829-6		12	Psychology; Psychology, Experimental	Psychology	CH1YL	WOS:000353819500015		
J	Koizumi, A; Maniscalco, B; Lau, H				Koizumi, Ai; Maniscalco, Brian; Lau, Hakwan			Does perceptual confidence facilitate cognitive control?	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Perceptual confidence; Visual perception; Confidence; Cognitive control; Signal detection theory	PREFRONTAL CORTEX; UNCONSCIOUS ACTIVATION; CONSCIOUS PERCEPTION; FRONTAL-CORTEX; DISSOCIATION; BLINDSIGHT; AWARENESS	Our visual perception is typically accompanied by a sense of subjective confidence. Since perceptual confidence is related to prefrontal activity, higher perceptual confidence may enhance cognitive control functions. To examine this interaction, we developed a novel method to selectively manipulate perceptual confidence while keeping stimulus discrimination accuracy constant. In a behavioral experiment, grating stimuli with different orientations were presented as go/no-go signals. Surprisingly, the results showed that confidence in visual discrimination of the signals on its own did not facilitate response inhibition, since when participants were presented with stimuli that yielded higher confidence, they were no better at performing a go/no-go task. These results were replicated with different (dot motion) stimuli, ruling out alternative explanations based on stimulus idiosyncrasy. In a different experiment, when the grating stimuli were presented as cues for task set preparation, we found that higher perceptual confidence also did not enhance task set preparation efficiency. This result was again replicated with dot motion stimuli. Since confidence may relate to perceptual awareness (Peirce & Jastrow, 1885), our findings may put current dominant theories in question, since these theories often suppose the critical involvement of consciousness in cognitive control. As a proof of concept, our method may also provide a new and powerful way to examine other functions of consciousness in future studies.	[Koizumi, Ai; Maniscalco, Brian; Lau, Hakwan] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Koizumi, Ai] Univ Tokyo, Dept Psychol, Tokyo, Japan; [Koizumi, Ai] US Japan Brain Res Cooperat Program, Okazaki, Aichi, Japan; [Maniscalco, Brian] NINDS, NIH, Bethesda, MD 20892 USA; [Lau, Hakwan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA	Koizumi, A (reprint author), Columbia Univ, Dept Psychol, 406 Schermerhorn Hall,1190 Amsterdam Ave MC 5501, New York, NY 10027 USA.	bellkoizumi@gmail.com			Templeton Foundation [21569]	This work was supported by a grant from the Templeton Foundation (No. 21569). We thank Aaron Apple, Xiaoyu Yan, and Guy Gerard Graney for helping with the data collection. We thank Ka Yuet Liu for advice on the data analysis.	Del Cul A, 2009, BRAIN, V132, P2531, DOI 10.1093/brain/awp111; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Mattler U, 2003, PERCEPT PSYCHOPHYS, V65, P167, DOI 10.3758/BF03194793; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Desender K, 2014, PSYCHOL SCI, V25, P675, DOI 10.1177/0956797613511468; Jack AI, 2001, COGNITION, V79, P161, DOI 10.1016/S0010-0277(00)00128-1; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Schmidt T, 2006, PERCEPT PSYCHOPHYS, V68, P489, DOI 10.3758/BF03193692; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; McCurdy LY, 2013, J NEUROSCI, V33, P1897, DOI 10.1523/JNEUROSCI.1890-12.2013; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Hughes G, 2009, PSYCHOPHYSIOLOGY, V46, P1258, DOI 10.1111/j.1469-8986.2009.00873.x; Ko Y, 2012, PHILOS T R SOC B, V367, P1401, DOI 10.1098/rstb.2011.0380; Lau H., 2009, COGNITIVE NEUROSCIEN, P1191; Macmillan N. A., 2005, DETECTION THEORY USE; Michelson A., 1927, STUDIES OPTICS; Norman D., 1986, CONSCIOUSNESS SELF R, V4, P1; Passingham R.E., 2012, NEUROBIOLOGY PREFRON; Peirce C. S., 1884, MEMOIRS NATIONAL ACA, V3, P73; Rounis E, 2010, COGN NEUROSCI, V1, P165, DOI 10.1080/17588921003632529; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Weiskrantz L., 2009, BLINDSIGHT CASE STUD; Wokke ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025729; Zylberberg Ariel, 2012, Front Integr Neurosci, V6, P79, DOI 10.3389/fnint.2012.00079	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	MAY	2015	77	4					1295	1306		10.3758/s13414-015-0843-3		12	Psychology; Psychology, Experimental	Psychology	CH1YL	WOS:000353819500022		
J	Mitsudo, H				Mitsudo, Hiroyuki			Inferring the depth of 3-D objects from tactile spatial information	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Cutaneous input; Somatotopic information; Depth; Haptic working memory; Speeded discrimination	HAPTIC PERCEPTION; DISCRIMINATION; DISTANCE; RECOGNITION; FORCE; SPACE; TOUCH; SKIN; HAND	Four psychophysical experiments were conducted to examine the relation between tactile spatial information and the estimated depth of partially touched 3-D objects. Human participants touched unseen, tactile grating patterns with their hand while keeping the hand shape flat. Experiment 1, by means of a production task, showed that the estimated depth of the concave part below the touched grating was well correlated with the separation between the elements of the grating, but not with the overall size of the grating, nor with the local structure of the touched parts. Experiments 2 and 3, by means of a haptic working memory task, showed that the remembered depth of a target surface was biased toward the estimated bottom position of a tactile grating distractor. Experiment 4, by means of a discrimination task, revealed that tactile grating patterns influenced speeded judgments about visual 3-D shapes. These results suggest that the haptic system uses heuristics based on spatial information to infer the depth of an untouched part of a 3-D object.	[Mitsudo, Hiroyuki] Kyushu Univ, Fac Human Environm Studies, Fukuoka 8128581, Japan; [Mitsudo, Hiroyuki] Kyushu Univ, Dept Human Sci, Fac Human Environm Studies, Higashi Ku, Fukuoka 8128581, Japan	Mitsudo, H (reprint author), Kyushu Univ, Dept Human Sci, Fac Human Environm Studies, Higashi Ku, 6-19-1 Hakozaki, Fukuoka 8128581, Japan.	hmitsudo@lit.kyushu-u.ac.jp					Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; KLATZKY RL, 1993, PERCEPT PSYCHOPHYS, V54, P170, DOI 10.3758/BF03211752; Baud-Bovy G, 1998, J NEUROSCI, V18, P1528; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Levy M, 2007, EXP BRAIN RES, V178, P240, DOI 10.1007/s00221-006-0728-8; GREEN BG, 1982, PERCEPT PSYCHOPHYS, V31, P315, DOI 10.3758/BF03202654; Shore DI, 2006, NEUROSCI LETT, V392, P96, DOI 10.1016/j.neulet.2005.09.001; Miyazaki M, 2010, J NEUROSCI, V30, P1856, DOI 10.1523/JNEUROSCI.3887-09.2010; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Bancroft T, 2011, EXP BRAIN RES, V208, P529, DOI 10.1007/s00221-010-2501-2; BARACCIKOJA D, 1993, J EXP PSYCHOL GEN, V122, P347; Brainard D., 1997, SPATIAL VISION, V10, P443, DOI [10.1163/156856897X00357, DOI 10.1163/156856897X00357]; Cabe PA, 2012, J EXP PSYCHOL HUMAN, V38, P1328, DOI 10.1037/a0027738; DEGROOT AMB, 1986, ACTA PSYCHOL, V61, P17, DOI 10.1016/0001-6918(86)90019-3; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Frisoli A, 2011, BRAIN RES BULL, V85, P260, DOI 10.1016/j.brainresbull.2010.11.011; GOODWIN AW, 1991, EXP BRAIN RES, V86, P663; GREENSPAN JD, 1984, SOMATOSENS RES, V2, P33; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hatwell Y., 2003, TOUCHING KNOWING, P123; Kaas A. L., 2008, HUMAN HAPTIC PERCEPT, P113, DOI 10.1007/978-3-7643-7612-3_9; Kennedy J. M., 1991, PSYCHOL TOUCH, P263; KLATZKY RL, 1985, PERCEPT PSYCHOPHYS, V37, P299, DOI 10.3758/BF03211351; Kleiner M, 2007, PERCEPT S, p[36, 21], DOI DOI 10.1068/V070821; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Loomis J. M., 1992, PRESENCE-TELEOP VIRT, V1, P113; Loomis J. M., 1986, HDB PERCEPTION HUMAN, V2, P311; Mercer T, 2010, ATTEN PERCEPT PSYCHO, V72, P2289, DOI 10.3758/APP.72.8.2289; Neely J. H., 1991, BASIC PROCESSES READ, P264; Rensink RA, 1998, VISION RES, V38, P2489, DOI 10.1016/S0042-6989(98)00051-0; VONBEKESY G, 1959, J ACOUST SOC AM, V31, P1236	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	MAY	2015	77	4					1411	1422		10.3758/s13414-015-0878-5		12	Psychology; Psychology, Experimental	Psychology	CH1YL	WOS:000353819500031		
J	Hayashi, N; Takai, S				Hayashi, Naoki; Takai, Shigemasa			GTS-based communication task scheduling for quantized output consensus over IEEE 802.15.4 wireless networks	AUTOMATICA			English	Article						Cooperative control; Quantized output consensus; IEEE 802.15.4 wireless networks	CONTROL-SYSTEMS; AGENTS	This paper presents an output consensus problem for low-rate wireless networks under the IEEE 802.15.4 protocol. We consider a multi-agent system with quantized output consensus dynamics in which each agent updates its state according to quantized relative differences of outputs among its neighbor agents. Information exchanges of quantized relative outputs are done by a PAN coordinator through a static and undirected wireless network. We propose a multiple superfranie structure and a non-preemptive GTS scheduling algorithm for an output consensus under the IEEE 802.15.4 protocol. (C) 2015 Elsevier Ltd. All rights reserved.	[Hayashi, Naoki; Takai, Shigemasa] Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan	Hayashi, N (reprint author), Osaka Univ, Div Elect Elect & Informat Engn, Suita, Osaka 5650871, Japan.	n.hayashi@eei.eng.osaka-u.ac.jp; takai@eei.eng.osaka-u.ac.jp			JSPS [25820180]; Mitutoyo Association for Science and Technology	This research is supported in part by the JSPS Grant-in-Aid for Young Scientists (B) No. 25820180 and Mitutoyo Association for Science and Technology. The material in this paper was partially presented at the 12th European Control Conference, July 17-19,2013, Zurich, Switzerland. This paper was recommended for publication in revised form by Associate Editor Denis Dochain under the direction of Editor Frank Allgower.	Tiberi U, 2013, AUTOMATICA, V49, P712, DOI 10.1016/j.automatica.2012.11.046; Guo M, 2013, AUTOMATICA, V49, P2531, DOI 10.1016/j.automatica.2013.05.001; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Xiao L, 2004, SYST CONTROL LETT, V53, P65, DOI 10.1016/j.sysconle.2004.02.022; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Araujo J, 2014, IEEE T IND INFORM, V10, P175, DOI 10.1109/TII.2013.2262281; Buttazzo G.C., 2005, HARD REAL TIME COMPU; Godsil C. D., 2001, ALGEBRAIC GRAPH THEO; Guo M, 2013, INT J CONTROL, V86, P567, DOI 10.1080/00207179.2012.747735; HAYASHI N, 2013, P 12 EUR CONTR C, P1764; TIBERI U, 2010, P 49 IEEE C DEC CONT, P2099; Li T, 2011, IEEE T AUTOMAT CONTR, V56, P279, DOI 10.1109/TAC.2010.2052384	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	MAY	2015	55						6	11		10.1016/j.automatica.2015.02.028		6	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CH9FA	WOS:000354340200002		
J	Tanno, T; Silberberg, A; Sakagami, T				Tanno, Takayuki; Silberberg, Alan; Sakagami, Takayuki			The copyist model and the shaping view of reinforcement	BEHAVIOURAL PROCESSES			English	Article						Strengthening view; Shaping view; Variable ratio; Variable interval; Concurrent schedule; Copyist model	VARIABLE-INTERVAL SCHEDULES; INTERRESPONSE-TIME REINFORCEMENT; RESPONSE RATES; MATCHING LAW; BEHAVIOR; CHOICE; RATIO; PERFORMANCE; PRIMACY; SENSITIVITY	The strengthening view of reinforcement attributes behavior change to changes in the response strength or the value of the reinforcer. In contrast, the shaping view explains behavior change as shaping different response units through differential reinforcement. In this paper, we evaluate how well these two views explain: (1) the response-rate difference between variable-ratio and variable-interval schedules that provide the same reinforcement rate; and (2) the phenomenon of matching in choice. The copyist model (Tanno and Silberberg, 2012) - a shaping-view account - can provided accurate predictions of these phenomena without a strengthening mechanism; however, the model has limitations. It cannot explain the relation between behavior change and stimulus control, reinforcer amount, and reinforcer quality. These relations seem easily explained by a strengthening view. Future work should be directed at a model which combine the strengths of these two types of accounts. (C) 2015 Elsevier B.V. All rights reserved.	[Tanno, Takayuki] Bunkyo Gakuin Univ, Dept Psychol, Fujimino Shi, Saitama 3568533, Japan; [Silberberg, Alan] Amer Univ, Dept Psychol, Washington, DC 20016 USA; [Sakagami, Takayuki] Keio Univ, Dept Psychol, Minato Ku, Tokyo 1088345, Japan	Tanno, T (reprint author), Meisei Univ, Dept Psychol, Hodokubo 2-1-1, Hino, Tokyo 1918506, Japan.	tantantan01@gmail.com; asilber@american.edu; gami@flet.keio.ac.jp			JSPS KAKENHI [00237309, 26995075]	This work was supported by JSPS KAKENHI#00237309 and #26995075. The authors thank Dr. Kyoichi Hiraoka for his suggestions on the stay/switch idea of the copyist model.	Cleaveland JM, 1999, J EXP ANAL BEHAV, V72, P317, DOI 10.1901/jeab.1999.72-317; MacDonall JS, 1999, J EXP ANAL BEHAV, V71, P57, DOI 10.1901/jeab.1999.71-57; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Shimp CP, 2013, BEHAV ANALYST, V36, P295; Tanno T, 2012, PSYCHON B REV, V19, P759, DOI 10.3758/s13423-012-0267-1; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; BAUM WM, 1969, J EXP ANAL BEHAV, V12, P861, DOI 10.1901/jeab.1969.12-861; Sakai Y, 2008, NEURAL COMPUT, V20, P227, DOI 10.1162/neco.2008.20.1.227; MacDonall JS, 2009, J EXP ANAL BEHAV, V91, P21, DOI 10.1901/jeab.2009.91-21; PEELE DB, 1984, J EXP PSYCHOL ANIM B, V10, P149; Reed P, 2000, J EXP PSYCHOL ANIM B, V26, P416, DOI 10.1037//0097-7403.26.4.416; SKINNER BF, 1950, PSYCHOL REV, V57, P193, DOI 10.1037/h0054367; Tanno T, 2008, J EXP ANAL BEHAV, V89, P5, DOI 10.1901/jeab.2008.89-5; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Tolman EC, 1938, PSYCHOL REV, V45, P1, DOI 10.1037/h0062733; STUBBS DA, 1969, J EXP ANAL BEHAV, V12, P887, DOI 10.1901/jeab.1969.12-887; BAUM WM, 1993, J EXP ANAL BEHAV, V59, P245, DOI 10.1901/jeab.1993.59-245; BAUM WM, 1973, J EXP ANAL BEHAV, V20, P137, DOI 10.1901/jeab.1973.20-137; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; CATANIA AC, 1963, J EXP ANAL BEHAV, V6, P299, DOI 10.1901/jeab.1963.6-299; Cole M.R., 1994, J EXP ANAL BEHAV, V61, P319; Ferster C. B., 1957, SCHEDULES REINFORCEM; Hermstein R.J., 1979, J EXP ANAL BEHAV, V31, P209; Keller F. S., 1950, PRINCIPLES PSYCHOL; MATTHEWS BA, 1977, J EXP ANAL BEHAV, V27, P453, DOI 10.1901/jeab.1977.27-453; McDowell JJ, 2013, PSYCHOL REV, V120, P731, DOI 10.1037/a0034244; MILLER HL, 1976, J EXP ANAL BEHAV, V26, P335, DOI 10.1901/jeab.1976.26-335; Morse W. H., 1966, OPERANT BEHAV AREAS, P52; Niv Y., 2007, THESIS HEBREW U JERU; RACHLIN H, 1981, BEHAV BRAIN SCI, V4, P371; SHIMP CP, 1966, J EXP ANAL BEHAV, V9, P443, DOI 10.1901/jeab.1966.9-443; SHIMP CP, 1969, PSYCHOL REV, V76, P97, DOI 10.1037/h0027311; SHIMP CP, 1976, J EXP ANAL BEHAV, V26, P113, DOI 10.1901/jeab.1976.26-113; SILBERBERG A, 1988, J EXP ANAL BEHAV, V49, P331, DOI 10.1901/jeab.1988.49-331; SKINNER BF, 1986, J EXP ANAL BEHAV, V45, P229, DOI 10.1901/jeab.1986.45-229; Tanno T, 2010, LEARN BEHAV, V38, P382, DOI 10.3758/LB.38.4.382; Tanno T, 2015, LEARN BEHAV, V43, P54, DOI 10.3758/s13420-014-0161-y; TEMPLE W, 1995, J EXP ANAL BEHAV, V63, P71, DOI 10.1901/jeab.1995.63-71; WEARDEN JH, 1988, J EXP PSYCHOL ANIM B, V14, P200, DOI 10.1037/0097-7403.14.2.200	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-6357	1872-8308		BEHAV PROCESS	Behav. Processes	MAY	2015	114				SI		72	77		10.1016/j.beproc.2015.02.009		6	Psychology, Biological; Behavioral Sciences; Zoology	Psychology; Behavioral Sciences; Zoology	CH9GQ	WOS:000354344400009		
J	Kato, H; Gomez, EA; Fujita, M; Ishimaru, Y; Uezato, H; Mimori, T; Iwata, H; Hashiguchi, Y				Kato, Hirotomo; Gomez, Eduardo A.; Fujita, Megumi; Ishimaru, Yuka; Uezato, Hiroshi; Mimori, Tatsuyuki; Iwata, Hiroyuki; Hashiguchi, Yoshihisa			Ayadualin, a novel RGD peptide with dual antihemostatic activities from the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis	BIOCHIMIE			English	Article						RDG peptide; Sand fly; Saliva; Anticoagulant; Antiplatelet	PLATELET-AGGREGATION INHIBITOR; PROTECTIVE SALIVARY PROTEIN; BLOOD-FEEDING ARTHROPODS; IIB-IIIA ANTAGONIST; VISCERAL LEISHMANIASIS; PHLEBOTOMUS-DUBOSCQI; GLAND; IDENTIFICATION; LONGIPALPIS; EXPRESSION	Sequence analysis of the Lutzomyia (Lu.) ayacuchensis salivary gland cDNA library identified a short peptide containing an RGD (Arg-Gly-Asp) sequence flanked by two cysteine residues in the C-terminal end as the most abundant transcript. In the present study, a recombinant protein of the RGD-containing peptide, designated ayadualin, was expressed in Escherichia colt and its activity was characterized. Ayadualin inhibited both collagen and ADP-induced platelet aggregations by interfering with the binding of integrin alpha(IIb)beta(3) to fibrinogen. The RGD sequence and cysteine residues located on both sides of the RGD sequence were essential for the inhibitory action. Moreover, ayadualin efficiently inhibited the intrinsic blood coagulation pathway irrespective of the RGD sequence. Measuring the enzymatic activity of coagulation factors using chromogenic substrates revealed that ayadualin efficiently inhibited factor XIIa (FXIIa) activity in a dose-dependent manner. In addition, pre-incubation of ayadualin with FXII inhibited FXIIa activity, while activated FXIIa was not affected by ayadualin, indicating that ayadualin inhibits the activation of FXII, but not enzymatic activity of FXIIa. These results indicated that ayadualin plays an important role in the blood feeding of Lu. ayacuchensis by inhibiting host hemostasis via dual mechanisms. (C) 2015 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.	[Kato, Hirotomo] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Parasitol Lab, Sapporo, Hokkaido, Japan; [Gomez, Eduardo A.] Univ Catolica Guayaquil, Fac Med, Dept Trop Med, Quito, Ecuador; [Fujita, Megumi; Ishimaru, Yuka; Iwata, Hiroyuki] Yamaguchi Univ, Fac Agr, Lab Vet Hyg, Yamaguchi 753, Japan; [Uezato, Hiroshi] Univ Ryukyus, Fac Med, Dept Dermatol, Okinawa, Japan; [Mimori, Tatsuyuki] Kumamoto Univ, Fac Life Sci, Grad Sch Hlth Sci, Dept Microbiol, Kumamoto, Japan; [Hashiguchi, Yoshihisa] Kochi Univ, Kochi Med Sch, Dept Parasitol, Kochi 780, Japan; [Hashiguchi, Yoshihisa] Univ Cent Ecuador, Ctr Biomed, Quito, Ecuador; [Hashiguchi, Yoshihisa] Secretaria Nacl Educ Super Ciencia Tecnol & Innov, Quito, Ecuador	Kato, H (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Parasitol Lab, Sapporo, Hokkaido, Japan.	hkato@vetmed.hokudai.ac.jp	Kato, Hirotomo/A-4820-2012	Kato, Hirotomo/0000-0001-5429-9536	Japan Science and Technology Agency (JST) [AS242Z00081Q]; Ministry of Education, Science, Culture and Sports of Japan [23580424]	This study was supported in part by Grants-in-aid for Scientific Research from Japan Science and Technology Agency (JST), A-STEP feasibility study program (No. AS242Z00081Q), and the Ministry of Education, Science, Culture and Sports of Japan (No. 23580424).	Andersen JF, 2005, ARCH INSECT BIOCHEM, V58, P97, DOI 10.1002/arch.20032; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Kato H, 2010, INT J ENV RES PUB HE, V7, P814, DOI 10.3390/ijerph7030814; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Assumpcao TCF, 2012, TOXINS, V4, P296, DOI 10.3390/toxins4050296; Kato H, 2008, AM J TROP MED HYG, V79, P719; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; THEODOS CM, 1991, INFECT IMMUN, V59, P1592; Decrem Y, 2009, J EXP MED, V206, P2381, DOI 10.1084/jem.20091007; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Kato H, 2013, INFECT GENET EVOL, V13, P56, DOI 10.1016/j.meegid.2012.08.024; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HUANG TF, 1987, J BIOL CHEM, V262, P16157; Lima HC, 1996, INFECT IMMUN, V64, P5442; Ishimaru Y, 2012, J EXP BIOL, V215, P3597, DOI 10.1242/jeb.074211; Kato H, 2007, J EXP BIOL, V210, P733, DOI 10.1242/jeb.001289; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Ma DY, 2009, MOL CELL PROTEOMICS, V8, P2071, DOI 10.1074/mcp.M900186-MCP200; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; LERNER EA, 1992, J BIOL CHEM, V267, P1062; Collin N, 2012, ARTERIOSCL THROM VAS, V32, P2185, DOI 10.1161/ATVBAHA.112.253906; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; Caceres AG, 2004, AM J TROP MED HYG, V70, P607; Champagne DE, 2005, PATHOPHYSIOL HAEMO T, V34, P221, DOI 10.1158/000092428; Charlab R., 2001, GENE, V267, P13; de Moura TR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002242; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Hamasaki R., 2009, J INSECT PHYSL, V55, P1044; Hayashi Y, 1998, BIOORGAN MED CHEM, V6, P355, DOI 10.1016/S0968-0896(97)10050-5; Hostomska J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-282; Katada J, 1997, J BIOL CHEM, V272, P7720; Kato H, 2005, AM J TROP MED HYG, V72, P87; Kato H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-226; Kato N, 2005, THROMB HAEMOSTASIS, V93, P359, DOI 10.1160/TH04-05-0319; LU XJ, 1993, BIOCHEM J, V296, P21; MAZUR P, 1993, PROTEIN EXPRES PURIF, V4, P282, DOI 10.1006/prep.1993.1036; MUNSTERMANN L.E., 2004, BIOL DIS VECTORS, P141; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; SEYMOUR JL, 1990, J BIOL CHEM, V265, P10143; Shan JX, 2003, PROTEIN EXPRES PURIF, V27, P143, DOI 10.1016/S1046-5928(02)00608-3; TAKAOKA H, 1990, J MED ENTOMOL, V27, P701; Valenzuela J. G., 2004, BIOL DIS VECTORS, Vsecond, pp377; Vlkova M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002709	49	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0300-9084	1638-6183		BIOCHIMIE	Biochimie	MAY	2015	112						49	56		10.1016/j.biochi.2015.02.011		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH4NC	WOS:000354009200006		
J	Takehara, H; Ohta, Y; Motoyama, M; Haruta, M; Nagasaki, M; Takehara, H; Noda, T; Sasagawa, K; Tokuda, T; Ohta, J				Takehara, Hiroaki; Ohta, Yasumi; Motoyama, Mayumi; Haruta, Makito; Nagasaki, Mizuki; Takehara, Hironari; Noda, Toshihiko; Sasagawa, Kiyotaka; Tokuda, Takashi; Ohta, Jun			Intravital fluorescence imaging of mouse brain using implantable semiconductor devices and epi- illumination of biological tissue	BIOMEDICAL OPTICS EXPRESS			English	Article							MONTE-CARLO SIMULATIONS; FREELY MOVING MICE; IN-VIVO; QUANTUM DOTS; FABRICATION; CORTEX; TECHNOLOGY; MICROSCOPY; DIFFUSER; SYSTEMS	The application of the fluorescence imaging method to living animals, together with the use of genetically engineered animals and synthesized photo-responsive compounds, is a powerful method for investigating brain functions. Here, we report a fluorescence imaging method for the brain surface and deep brain tissue that uses compact and mass-producible semiconductor imaging devices based on complementary metal-oxide semiconductor (CMOS) technology. An image sensor chip was designed to be inserted into brain tissue, and its size was 1500 x 450 mu m. Sample illumination is also a key issue for intravital fluorescence imaging. Hence, for the uniform illumination of the imaging area, we propose a new method involving the epi-illumination of living biological tissues, and we performed investigations using optical simulations and experimental evaluation. (C) 2015 Optical Society of America	[Takehara, Hiroaki; Ohta, Jun] Nara Inst Sci & Technol, Inst Res Initiat, Ikoma, Nara 6300192, Japan; [Takehara, Hiroaki; Ohta, Yasumi; Motoyama, Mayumi; Haruta, Makito; Nagasaki, Mizuki; Takehara, Hironari; Noda, Toshihiko; Sasagawa, Kiyotaka; Tokuda, Takashi; Ohta, Jun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan	Takehara, H (reprint author), Nara Inst Sci & Technol, Inst Res Initiat, 8916-5 Takayama Cho, Ikoma, Nara 6300192, Japan.	takehara@ms.naist.ac.jp	Takehara, Hiroaki/M-3341-2013	Takehara, Hiroaki/0000-0003-3222-8483	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26249051]; VLSI Design and Education Center (VDEC), The University of Tokyo; Cadence Corporation; Mentor Graphics Corporation; Project for Promotion of Researches	The authors would like to thank S. Shiosaka (NAIST) for valuable discussions. This research was supported by Project for Promotion of Researches toward Creation of Humanophilic Science and Technology and Grants-in-Aid for Scientific Research (A) (#26249051) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and VLSI Design and Education Center (VDEC), The University of Tokyo, in collaboration with Cadence Corporation and Mentor Graphics Corporation.	Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/nmeth.1694, 10.1038/NMETH.1694]; Mayes PA, 2008, BIOTECHNIQUES, V45, P459, DOI 10.2144/000112946; Choi M, 2013, NAT PHOTONICS, V7, P987, DOI 10.1038/NPHOTON.2013.278; Tamura H, 2008, J NEUROSCI METH, V173, P114, DOI 10.1016/j.jneumeth.2008.06.002; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI [10.1038/nmeth.1242, 10.1038/NMETH.1242]; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Mank M, 2008, NAT METHODS, V5, P805, DOI [10.1038/nmeth.1243, 10.1038/NMETH.1243]; Ohta J, 2009, SENSORS-BASEL, V9, P9073, DOI 10.3390/s91109073; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/rme.13.16, 10.2217/RME.13.16]; Aswathy RG, 2010, ANAL BIOANAL CHEM, V397, P1417, DOI 10.1007/s00216-010-3643-6; Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Ng DC, 2006, SENSOR ACTUAT B-CHEM, V119, P262, DOI 10.1016/j.snb.2005.12.020; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Kim G, 2005, EUR POLYM J, V41, P1729, DOI 10.1016/j.europolymj.2005.02.029; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/nmeth.1440, 10.1038/NMETH.1440]; Wu CY, 2008, OPT EXPRESS, V16, P19978, DOI 10.1364/OE.16.019978; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Barajas O, 1997, PHYS MED BIOL, V42, P1675, DOI 10.1088/0031-9155/42/9/001; Bernstein JG, 2008, P SOC PHOTO-OPT INS, V6854, pH8540, DOI 10.1117/12.768798; Binzoni T, 2006, PHYS MED BIOL, V51, pN313, DOI 10.1088/0031-9155/51/17/N04; Hall G, 2012, BIOMED OPT EXPRESS, V3, P2707, DOI 10.1364/BOE.3.002707; Haruta M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EL05; Koehler A., 1894, J ROYAL MICROSCOPICA, V14, P261; Le QT, 2005, ELECTROPHORESIS, V26, P1038, DOI 10.1002/elps.200306142; Ruffieux P, 2008, OPT EXPRESS, V16, P19541, DOI 10.1364/OE.16.019541; Sakai D, 2005, OPT REV, V12, P383, DOI 10.1007/s10043-005-0383-5; Tagawa A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DL02; Tagawa A, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.01AG02; Takehara H., 2013, P IEEE C INT M FUT E, P32; Takehara H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06721; Valentine RM, 2012, PHYS MED BIOL, V57, P6327, DOI 10.1088/0031-9155/57/20/6327; Wang JH, 2009, OPT MATER, V32, P374, DOI 10.1016/j.optmat.2009.09.005; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	44	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAY 1	2015	6	5					1553	1564		10.1364/BOE.6.001553		12	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CH3JN	WOS:000353927100002		
J	Kurata, T; Li, ZG; Oda, S; Kawahira, H; Haneishi, H				Kurata, Tomohiro; Li, Zhenguang; Oda, Shigeto; Kawahira, Hiroshi; Haneishi, Hideaki			Impact of vessel diameter and bandwidth of illumination in sidestream dark-field oximetry	BIOMEDICAL OPTICS EXPRESS			English	Article							OXYGEN-SATURATION; PHOTON MIGRATION; FUNDUS IMAGES; BLOOD; MICROCIRCULATION	We investigate the possibility of oxygen saturation estimation from images obtained by the sidestream dark-field (SDF) technique. The SDF technique is a method for microvascular imaging. In SDF imaging, light enters a tissue directly from illumination sources configured around a camera and then the camera captures the light scattered by the tissue. To advance the capability of the SDF imaging system, we develop a SDF oximetry method with LED illumination sources. In this paper, we evaluate some SDF oximetry methods from virtual SDF images obtained by the Monte Carlo photon propagation simulation. As a result, we verify that SDF imaging allows the estimation of oxygen saturation of the individual vessels from virtual images using the average extinction coefficients considering the bandwidth of the illumination and the effect of the integration of the camera. (C) 2015 Optical Society of America	[Kurata, Tomohiro] Takano Co Ltd, Nagano 3994301, Japan; [Kurata, Tomohiro; Li, Zhenguang] Chiba Univ, Grad Sch Engn, Chiba 2638522, Japan; [Oda, Shigeto] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan; [Kawahira, Hiroshi; Haneishi, Hideaki] Chiba Univ, Ctr Frontier Med Engn, Chiba 2638522, Japan	Kurata, T (reprint author), Takano Co Ltd, Nagano 3994301, Japan.	tomohirok@takano-net.co.jp			Technology Foundation, Kakenhi [B25282151]	This research was supported by Technology Foundation, Kakenhi, the Grant-in-Aid for Scientific Research B25282151.	Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Fang QQ, 2010, BIOMED OPT EXPRESS, V1, P165, DOI 10.1364/BOE.1.000165; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Hammer M, 2001, IEEE T BIO-MED ENG, V48, P592, DOI 10.1109/10.918598; Maikala RV, 2010, INT J IND ERGONOM, V40, P125, DOI 10.1016/j.ergon.2009.02.011; Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178; Roggan A, 1999, J BIOMED OPT, V4, P36, DOI 10.1117/1.429919; HICKAM JB, 1963, CIRCULATION, V27, P375; Pedersen L, 2000, PATTERN RECOGN LETT, V21, P1215, DOI 10.1016/S0167-8655(00)00084-2; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; Akbari H, 2010, IEEE T BIO-MED ENG, V57, P2011, DOI 10.1109/TBME.2010.2049110; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Fang QQ, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P1142; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; Styp-Rekowska B, 2007, MICROCIRCULATION, V14, P207, DOI 10.1080/10739680601139302; Bashkatov N. A., 2005, J PHYS D, V38, P2543; COHEN AJ, 1976, IEEE T BIO-MED ENG, V23, P391, DOI 10.1109/TBME.1976.324650; Fang Q., MESH BASED MONTE CAR; Fang Q., ISO2MESH; Hidovic-Rowe D, 2005, PHYS MED BIOL, V50, P1071, DOI 10.1088/0031-9155/50/6/003; PITTMAN RN, 1975, J APPL PHYSIOL, V38, P321; Prahl S., 1998, OPTICAL ABSORPTION H; Pries A. R., 1983, AM J PHYSIOL, V245, P167; Smith MH, 1999, APPL OPTICS, V38, P258, DOI 10.1364/AO.38.000258; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; WEISS GH, 1989, J MOD OPTIC, V36, P349, DOI 10.1080/09500348914550381	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAY 1	2015	6	5					1616	1631		10.1364/BOE.6.001616		16	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CH3JN	WOS:000353927100006		
J	Teussink, MM; Cense, B; van Grinsven, MJJP; Klevering, BJ; Hoyng, CB; Theelen, T				Teussink, Michel M.; Cense, Barry; van Grinsven, Mark J. J. P.; Klevering, B. Jeroen; Hoyng, Carel B.; Theelen, Thomas			Impact of motion-associated noise on intrinsic optical signal imaging in humans with optical coherence tomography	BIOMEDICAL OPTICS EXPRESS			English	Article							HUMAN CONE PHOTORECEPTORS; FIXATIONAL EYE-MOVEMENTS; ADAPTIVE-OPTICS; SCATTERING CHANGES; HIGH-RESOLUTION; MACULAR DEGENERATION; OCT ANGIOGRAPHY; LIGHT RESPONSE; VISUAL PIGMENT; HUMAN RETINA	A growing body of evidence suggests that phototransduction can be studied in the human eye in vivo by imaging of fast intrinsic optical signals (IOS). There is consensus concerning the limiting influence of motion-associated imaging noise on the reproducibility of IOS-measurements, especially in those employing spectral-domain optical coherence tomography (SD-OCT). However, no study to date has conducted a comprehensive analysis of this noise in the context of IOS-imaging. In this study, we discuss biophysical correlates of IOS, and we address motion-associated imaging noise by providing correctional post-processing methods. In order to avoid cross-talk of adjacent IOS of opposite signal polarity, cellular resolution and stability of imaging to the level of individual cones is likely needed. The optical Stiles-Crawford effect can be a source of significant IOS-imaging noise if alignment with the peak of the Stiles-Crawford function cannot be maintained. Therefore, complete head stabilization by implementation of a bite-bar may be critical to maintain a constant pupil entry position of the OCT beam. Due to depth-dependent sensitivity fall-off, heartbeat and breathing associated axial movements can cause tissue reflectivity to vary by 29% over time, although known methods can be implemented to null these effects. Substantial variations in reflectivity can be caused by variable illumination due to changes in the beam pupil entry position and angle, which can be reduced by an adaptive algorithm based on slope-fitting of optical attenuation in the choriocapillary lamina. (C) 2015 Optical Society of America	[Teussink, Michel M.; Klevering, B. Jeroen; Hoyng, Carel B.; Theelen, Thomas] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; [Cense, Barry] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [van Grinsven, Mark J. J. P.] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, Dept Radiol & Nucl Med, NL-6500 HB Nijmegen, Netherlands	Teussink, MM (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands.	thomas.theelen@radboudumc.nl	Hoyng, C.B./H-8050-2014; Klevering, B.J./L-4434-2015; Teussink, Michel/P-6247-2015		Foundation Fighting Blindness USA Center Grant, Baltimore, Maryland, USA [C-CL-0811-0549-RAD05]; Gelderse Blindenstichting, Velp, the Netherlands	This research was funded by Foundation Fighting Blindness USA Center Grant (www.blindness.org), Baltimore, Maryland, USA, grant nr. C-CL-0811-0549-RAD05 and by the Gelderse Blindenstichting (www.gelderseblinden.nl), Velp, the Netherlands. The authors gratefully acknowledge Ramon A.C. van Huet, Radboud University Medical Center, Nijmegen, the Netherlands and Yiheng Lim, Center for Optical Research and Education, Utsunomiya University, Tochigi, Japan for valuable assistance with the acquisition of fOCT recordings.	Nassif NA, 2004, OPT EXPRESS, V12, P367, DOI 10.1364/OPEX.12.000367; Podoleanu A, 2004, PHYS MED BIOL, V49, P1277, DOI 10.1088/0031-9155/49/7/015; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Delint PJ, 1997, VISION RES, V37, P243, DOI 10.1016/S0042-6989(96)00118-6; de Kinkelder R, 2011, INVEST OPHTH VIS SCI, V52, P3908, DOI 10.1167/iovs.10-6738; BURNS SA, 1995, J OPT SOC AM A, V12, P2329, DOI 10.1364/JOSAA.12.002329; LATIES AM, 1971, INVEST OPHTH VISUAL, V10, P69; Yao XC, 2005, APPL OPTICS, V44, P2019, DOI 10.1364/AO.44.002019; HARARY HH, 1978, SCIENCE, V202, P1083, DOI 10.1126/science.102035; Shih YYI, 2011, INVEST OPHTH VIS SCI, V52, P5303, DOI 10.1167/iovs.10-6438; Srinivasan VJ, 2009, OPT EXPRESS, V17, P3861, DOI 10.1364/OE.17.003861; Grulkowski I, 2012, BIOMED OPT EXPRESS, V3, P2733, DOI 10.1364/BOE.3.002733; Kocaoglu OP, 2014, BIOMED OPT EXPRESS, V5, P2262, DOI 10.1364/BOE.5.002262; vandeKraats J, 1996, VISION RES, V36, P2229, DOI 10.1016/0042-6989(96)00001-6; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Yao XC, 2009, JPN J OPHTHALMOL, V53, P327, DOI 10.1007/s10384-009-0685-4; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977; ELSNER AE, 1993, J OPT SOC AM A, V10, P52, DOI 10.1364/JOSAA.10.000052; Stiles WS, 1933, P R SOC LOND B-CONTA, V112, P428, DOI 10.1098/rspb.1933.0020; Zawadzki RJ, 2005, OPT EXPRESS, V13, P8532, DOI 10.1364/OPEX.13.008532; Potsaid B, 2008, OPT EXPRESS, V16, P15149, DOI 10.1364/OE.16.015149; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Moayed AA, 2011, OPT LETT, V36, P4575, DOI 10.1364/OL.36.004575; Yun SH, 2003, OPT EXPRESS, V11, P3598, DOI 10.1364/OE.11.003598; Grieve K, 2008, INVEST OPHTH VIS SCI, V49, P713, DOI 10.1167/iovs.07-0837; Radhakrishnan H, 2013, BIOMED OPT EXPRESS, V4, P1255, DOI 10.1364/BOE.4.001255; Thaler L, 2013, VISION RES, V76, P31, DOI 10.1016/j.visres.2012.10.012; Nagy D, 2008, INVEST OPHTH VIS SCI, V49, P4664, DOI 10.1167/iovs.07-1360; Miller DT, 1996, VISION RES, V36, P1067, DOI 10.1016/0042-6989(95)00225-1; Ts'o D, 2009, JPN J OPHTHALMOL, V53, P334, DOI 10.1007/s10384-009-0687-2; YOSHIZAWA T, 1994, BIOPHYS CHEM, V50, P17, DOI 10.1016/0301-4622(94)85016-X; Braaf B, 2013, BIOMED OPT EXPRESS, V4, P51, DOI 10.1364/BOE.4.000051; Faber DJ, 2004, OPT EXPRESS, V12, P4353, DOI 10.1364/OPEX.12.004353; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Klein T, 2013, BIOMED OPT EXPRESS, V4, P1890, DOI 10.1364/BOE.4.001890; Yao XC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2393155; Bedggood P, 2012, INVEST OPHTH VIS SCI, V53, P3673, DOI 10.1167/iovs.11-8796; Bizheva K, 2006, P NATL ACAD SCI USA, V103, P5066, DOI 10.1073/pnas.0506997103; Gao WH, 2008, OPT EXPRESS, V16, P6486, DOI 10.1364/OE.16.006486; Wang BQ, 2013, OPT LETT, V38, P4526, DOI 10.1364/OL.38.004526; Jonnal RS, 2012, BIOMED OPT EXPRESS, V3, P104, DOI 10.1364/BOE.3.000104; Zagers NPA, 2003, J OPT SOC AM A, V20, P18, DOI 10.1364/JOSAA.20.000018; Rha J, 2009, OPT LETT, V34, P3782, DOI 10.1364/OL.34.003782; Bedggood P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907211; Bedggood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079251; Bizheva K., 2005, INVEST OPHTH VIS SCI, V46, P5066; Brown RL, 2003, J GEN PHYSIOL, V122, P749, DOI 10.1085/jgp.200308823; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; DeLint PJ, 2000, INVEST OPHTH VIS SCI, V41, P282; Friedburg C, 2004, J PHYSIOL-LONDON, V556, P819, DOI 10.1113/jphysiol.2004.061523; GORRAND J-M, 1990, Investigative Ophthalmology and Visual Science, V31, P425; Grinvald A., 2001, MODERN TECHNIQUES NE; Heck M, 2000, METHOD ENZYMOL, V315, P329; HILL BC, 1977, SCIENCE, V196, P426, DOI 10.1126/science.850785; HODGKIN AL, 1977, J PHYSIOL-LONDON, V267, P737; HOOD DC, 1995, VISION RES, V35, P2801, DOI 10.1016/0042-6989(95)00034-W; IMAI H, 1995, BIOCHEMISTRY-US, V34, P10525, DOI 10.1021/bi00033a026; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; Jonnal R. S., 2014, ARVO 2014 ORL FL MAY; Kocaoglu OP, 2011, BIOMED OPT EXPRESS, V2, P748, DOI 10.1364/BOE.2.000748; KUHN H, 1981, P NATL ACAD SCI-BIOL, V78, P6873, DOI 10.1073/pnas.78.11.6873; Kusnetzow A, 2001, BIOCHEMISTRY-US, V40, P7832, DOI 10.1021/bi010387y; Lim Y., 2013, OPTICS PHOTONICS JAP; Mayer M., OPTICAL COHERENCE TO; Moller F, 1996, ACTA OPHTHALMOL SCAN, V74, P578; Ricco S, 2009, LECT NOTES COMPUT SC, V5761, P100; Sardar DK, 2004, J BIOMED OPT, V9, P624, DOI 10.1117/1.1688813; Schmoll T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463008; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; SUNNESS JS, 1989, OPHTHALMOLOGY, V96, P375; TASAKI I, 1984, SCIENCE, V223, P411, DOI 10.1126/science.6691153; TASAKI I, 1987, BIOCHEM BIOPH RES CO, V143, P93, DOI 10.1016/0006-291X(87)90634-6; Theelen T., 2011, PROGR BIOMEDICAL OPT, V12; Tumlinson AR, 2009, JPN J OPHTHALMOL, V53, P315, DOI 10.1007/s10384-009-0684-5; Vermeer K A, 2013, Biomed Opt Express, V5, P322, DOI 10.1364/BOE.5.000322; Vought BW, 1999, BIOCHEMISTRY-US, V38, P11287, DOI 10.1021/bi990968b; WESTHEIM.G, 1967, J PHYSIOL-LONDON, V192, P309; Zhang QQ, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5235	81	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAY 1	2015	6	5					1632	1647		10.1364/BOE.6.001632		16	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CH3JN	WOS:000353927100007		
J	Makita, S; Yasuno, Y				Makita, Shuichi; Yasuno, Yoshiaki			In vivo photothermal optical coherence tomography for non-invasive imaging of endogenous absorption agents	BIOMEDICAL OPTICS EXPRESS			English	Article							DEPTH-RESOLVED DETECTION; GOLD NANOPARTICLES; HUMAN SKIN; HIGH-SPEED; TISSUE; OCT; ANGIOGRAPHY; RESONANCE; RANGE; NOISE	In vivo photothermal optical coherence tomography (OCT) is demonstrated for cross-sectional imaging of endogenous absorption agents. In order to compromise the sensitivity, imaging speed, and sample motion immunity, a new photothermal detection scheme and phase processing method are developed. Phase-resolved swept-source OCT and fiber-pigtailed laser diode (providing excitation at 406 nm) are combined to construct a high-sensitivity photothermal OCT system. OCT probe and excitation beam coaxially illuminate and are focused on tissues. The photothermal excitation and detection procedure is designed to obtain high efficiency of photothermal effect measurement. The principle and method of depth-resolved cross-sectional imaging of absorption agents with photothermal OCT has been derived. The phase-resolved thermal expansion detection algorithm without motion artifact enables in vivo detection of photothermal effect. Phantom imaging with a blood phantom and in vivo human skin imaging are conducted. A phantom with guinea-pig blood as absorber has been scanned by the photothermal OCT system to prove the concept of cross-sectional absorption agent imaging. An in vivo human skin measurement is also performed with endogenous absorption agents. (C) 2015 Optical Society of America	[Makita, Shuichi; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki 3058573, Japan	Makita, S (reprint author), Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki 3058573, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Makita, Shuichi/G-3806-2011; Yasuno, Yoshiaki/F-2586-2011	Makita, Shuichi/0000-0002-6614-3640; Yasuno, Yoshiaki/0000-0003-1645-7948			Akkin T, 2003, LASER SURG MED, V33, P219, DOI 10.1002/lsm.10221; Boyer D, 2002, SCIENCE, V297, P1160, DOI 10.1126/science.1073765; An L, 2010, OPT EXPRESS, V18, P8220, DOI 10.1364/OE.18.008220; Blatter C, 2012, BIOMED OPT EXPRESS, V3, P2636, DOI 10.1364/BOE.3.002636; Lee J, 2012, OPT EXPRESS, V20, P22262, DOI 10.1364/OE.20.022262; Skala MC, 2008, NANO LETT, V8, P3461, DOI 10.1021/nl802351p; Xiao P, 2013, OPT LETT, V38, P4429, DOI 10.1364/OL.38.004429; Guan GY, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3659211; Makita S, 2008, OPT EXPRESS, V16, P8406, DOI 10.1364/OE.16.008406; Adler DC, 2008, OPT EXPRESS, V16, P4376, DOI 10.1364/OE.16.004376; Kurokawa K, 2012, OPT EXPRESS, V20, P22796, DOI 10.1364/OE.20.022796; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; Pache C, 2012, OPT EXPRESS, V20, P21385, DOI 10.1364/OE.20.021385; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Tucker-Schwartz JM, 2012, BIOMED OPT EXPRESS, V3, P2881, DOI 10.1364/BOE.3.002881; Fleming CP, 2013, BIOMED OPT EXPRESS, V4, P1269, DOI 10.1364/BOE.4.001269; Jung Y, 2011, NANO LETT, V11, P2938, DOI 10.1021/nl2014394; Zhou C, 2010, OPT LETT, V35, P700, DOI 10.1364/OL.35.000700; Park BH, 2005, OPT EXPRESS, V13, P3931, DOI 10.1364/OPEX.13.003931; Yi J, 2013, OPT LETT, V38, P1796, DOI 10.1364/OL.38.001796; Weiss N, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042312; Oh JW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2985762; Chi TT, 2014, OPT EXPRESS, V22, P11754, DOI 10.1364/OE.22.011754; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Bialkowski S. E., 1996, PHOTOTHERMAL SPECTRO; Carslaw H. S., 1986, CONDUCTION HEAT SOLI; Gemert M. J. C. v., 1996, PHYS MED BIOL, V41, P1381; Hong YJ, 2012, OPT EXPRESS, V20, P2740, DOI 10.1364/OE.20.002740; International Electrotechnical Commission, 2007, SAF LAS PROD 1, V2nd; Jacob D, 2010, OPT EXPRESS, V18, P12399, DOI 10.1364/OE.18.012399; JAIN N.C., 1993, ESSENTIALS VET HEMAT; Kernick DP, 1999, PFLUG ARCH EUR J PHY, V437, P624, DOI 10.1007/s004240050826; Kim J, 2008, LASER SURG MED, V40, P415, DOI 10.1002/lsm.20650; Kim Jihoon, 2006, J Biomed Opt, V11, P041122, DOI 10.1117/1.2236289; Kupradze V., 1979, 3 DIMENSIONAL PROBLE; Kuranov RV, 2011, OPT EXPRESS, V19, P23831, DOI 10.1364/OE.19.023831; Makita S, 2014, OPT EXPRESS, V22, P4830, DOI 10.1364/OE.22.004830; Paranjape AS, 2010, BIOMED OPT EXPRESS, V1, P2; Prahl S. A., 1999, OPTICAL ABSORPTION H; Roider J., 1995, OPTICAL THERMAL RESP, V1st, P385; Song SZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121505; Subhash HM, 2012, OPT LETT, V37, P981; Telenkov SA, 2004, PHYS MED BIOL, V49, P111, DOI 10.1088/0031-9155/49/1/008; Tucker-Schwartz JM, 2012, OPT LETT, V37, P872, DOI 10.1364/OL.37.000872; Vakoc BJ, 2009, IEEE T MED IMAGING, V28, P814, DOI 10.1109/TMI.2009.2012891; Walther J, 2009, OPT EXPRESS, V17, P19698, DOI 10.1364/OE.17.019698	46	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAY 1	2015	6	5					1707	1725		10.1364/BOE.6.001707		19	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CH3JN	WOS:000353927100012		
J	Fukushima, S; Shimizu, M; Miura, J; Matsuda, Y; Kubo, M; Hashimoto, M; Aoki, T; Takeshige, F; Araki, T				Fukushima, Shuichiro; Shimizu, Masato; Miura, Jiro; Matsuda, Yusuke; Kubo, Mizuho; Hashimoto, Mamoru; Aoki, Takuya; Takeshige, Fumio; Araki, Tsutomu			Decrease in fluorescence lifetime by glycation of collagen and its application in determining advanced glycation end-products in human dentin	BIOMEDICAL OPTICS EXPRESS			English	Article							IN-VITRO; QUANTIFICATION; HYDROXYPROLINE; ACCUMULATION; MICROSCOPY; PROTEINS; GLUCOSE; TISSUES; MATRIX	Advanced Glycation End-products (AGEs) are produced by the Maillard reaction, which causes cross-linking of collagen and results in changes in the mechanical properties of collagen tissues. Several types of AGE fluoresce, and measurement of this fluorescence is effective for determining the presence of AGEs. Because fluorescence intensity by steady-state fluorometry is affected by sample surface condition and light source, we focused on fluorescence lifetime measurement (FLM). We found that fluorescence lifetime of collagen gel decreased with glycation progress. In vivo application of FLM for determination of AGEs was confirmed in human dentin. (C) 2015 Optical Society of America	[Fukushima, Shuichiro; Hashimoto, Mamoru; Aoki, Takuya; Araki, Tsutomu] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Suita, Osaka 565, Japan; [Shimizu, Masato; Miura, Jiro; Matsuda, Yusuke; Kubo, Mizuho; Takeshige, Fumio] Osaka Univ, Grad Sch Dent, Div Interdisciplinary Dent, Suita, Osaka 565, Japan	Fukushima, S (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Suita, Osaka 565, Japan.	miura_j@dent.osaka-u.ac.jp			JSPS (Japan Society for the Promotion of Science) [25560196, 25462957, 25462956]	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grants (numbers 25560196, 25462957 and 25462956). The authors would also like to thank Kantaro Nishikawa (present address, Olympus Co., Ltd.) and Keita Kondo of Osaka University for their technical support in fluorometric measurements.	Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; EBLE AS, 1983, J BIOL CHEM, V258, P9406; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Ortwerth BJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P666, DOI 10.1111/j.1751-1097.1997.tb01909.x; Kleter GA, 1998, J DENT RES, V77, P488; Dysli C, 2014, INVEST OPHTH VIS SCI, V55, P2106, DOI 10.1167/iovs.13-13627; Panayotov I, 2013, CLIN ORAL INVEST, V17, P757, DOI 10.1007/s00784-012-0770-9; BAILEY AJ, 1995, BIOCHEM J, V305, P385; Hofman K, 2011, ANAL BIOCHEM, V417, P289, DOI 10.1016/j.ab.2011.06.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; ARAKI T, 1990, APPL SPECTROSC, V44, P627, DOI 10.1366/0003702904087505; Blackwell J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830658; Fang QY, 2004, REV SCI INSTRUM, V75, P151, DOI 10.1063/1.1634354; Glanzmann T, 1999, REV SCI INSTRUM, V70, P4067, DOI 10.1063/1.1150038; Kleter GA, 1997, EUR J ORAL SCI, V105, P278, DOI 10.1111/j.1600-0722.1997.tb00212.x; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P142; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Matsumoto H, 1999, ARCH ORAL BIOL, V44, P309, DOI 10.1016/S0003-9969(98)00126-5; Meng J, 2001, NEPHRON, V88, P30, DOI 10.1159/000045955; Miura J, 2014, ARCH ORAL BIOL, V59, P119, DOI 10.1016/j.archoralbio.2013.10.012; Nomoto K., 2013, ANTIAGING MED, V10, P92; SELL DR, 1989, J BIOL CHEM, V264, P21597; Tseng JY, 2011, BIOMED OPT EXPRESS, V2, P218, DOI 10.1364/BOE.2.000218	25	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	MAY 1	2015	6	5					1844	1856		10.1364/BOE.6.001844		13	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CH3JN	WOS:000353927100022		
J	Saito, M; Watanabe-Nakayama, T; Machida, S; Osada, T; Afrin, R; Ikai, A				Saito, Masakazu; Watanabe-Nakayama, Takahiro; Machida, Shinichi; Osada, Toshiya; Afrin, Rehana; Ikai, Atsushi			Spectrin-ankyrin interaction mechanics: A key force balance factor in the red blood cell membrane skeleton	BIOPHYSICAL CHEMISTRY			English	Article						Dynamic force microscopy; Protein-protein interaction; Spectrin; Ankyrin; Membrane skeleton	ERYTHROCYTE-MEMBRANE; ADHESION FORCES; MICROSCOPY; REPEATS; SPECTROSCOPY; CYTOSKELETON; INTERFACES; TETRAMER; INSIGHTS; REVEALS	As major components of red blood cell (RBC) cytoskeleton, spectrin and F-actin form a network that covers the entire cytoplasmic surface of the plasma membrane. The cross-linked two layered structure, called the membrane skeleton, keeps the structural integrity of RBC under drastically changing mechanical environment during circulation. We performed force spectroscopy experiments on the atomic force microscope (AFM) as a means to clarify the mechanical characteristics of spectrin-ankyrin interaction, a key factor in the force balance of the RBC cytoskeletal structure. An AFM tip was functionalized with ANK1-62k and used to probe spectrin crosslinked to mica surface. A force spectroscopy study gave a mean unbinding force of similar to 30 pN under our experimental conditions. Two energy barriers were identified in the unbinding process. The result was related to the well-known flexibility of spectrin tetramer and participation of ankyrin 1-spectrin interaction in the overall balance of membrane skeleton dynamics. (C) 2015 Elsevier B.V. All rights reserved.	[Saito, Masakazu; Watanabe-Nakayama, Takahiro; Machida, Shinichi; Afrin, Rehana; Ikai, Atsushi] Tokyo Inst Technol, Innovat Lab, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Afrin, Rehana] Tokyo Inst Technol, Biofrontier Ctr, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Osada, Toshiya] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Saito, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	saito_m@bio.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [19GS0418]	This work was supported by Grants-in-Aid for Creative Scientific Research (19GS0418) to A. I. from the Japan Society for the Promotion of Science (JSPS).	Agre P., 1989, RED BLOOD CELL MEMBR; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Mizuno T, 2002, ASAIO J, V48, P668, DOI 10.1097/01.MAT.0000033867.03197.BA; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Peng ZL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031904; Girasole M, 2012, MICRON, V43, P1273, DOI 10.1016/j.micron.2012.03.019; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Evans E, 1997, BIOPHYS J, V72, P1541; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; PINDER JC, 1989, BIOCHEM J, V264, P423; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Yan C, 2009, BIOPHYS CHEM, V144, P72, DOI 10.1016/j.bpc.2009.06.009; Yersin A, 2008, BIOPHYS J, V94, P230, DOI 10.1529/biophysj.107.114637; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Yuan CB, 2000, BIOCHEMISTRY-US, V39, P10219, DOI 10.1021/bi992715o; Lee W, 2012, BIOPHYS J, V102, P1118, DOI 10.1016/j.bpj.2012.01.046; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Ohta Y, 2002, ARTIF ORGANS, V26, P10, DOI 10.1046/j.1525-1594.2002.06702.x; Gad M, 1997, CELL BIOL INT, V21, P697, DOI 10.1006/cbir.1997.0214; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Evans E, 1998, FARADAY DISCUSS, V111, P1; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; Afrin R, 2012, CYTOSKELETON, V69, P101, DOI 10.1002/cm.21001; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Anong WA, 2006, J BIOL CHEM, V281, P22360, DOI 10.1074/jbc.M513839200; Ipsaro JJ, 2008, BIOCHEMISTRY-US, V47, P7452, DOI 10.1021/bi702525z; Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108; Stroh C, 2004, P NATL ACAD SCI USA, V101, P12503, DOI 10.1073/pnas.0403538101; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Boal D. H., 2002, MECH CELL; CIANCI CD, 1988, J CELL BIOCHEM, V37, P301, DOI 10.1002/jcb.240370305; Discher DE, 2000, CURR OPIN HEMATOL, V7, P117, DOI 10.1097/00062752-200003000-00008; EVANS EA, 1989, METHOD ENZYMOL, V173, P3; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Kim S, 2011, J BIOL CHEM, V286, P20746, DOI 10.1074/jbc.M111.230326; Mirijanian DT, 2008, P NATL ACAD SCI USA, V105, P1204, DOI 10.1073/pnas.0707500105; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Palek J, 1980, Prog Clin Biol Res, V43, P21; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-4622	1873-4200		BIOPHYS CHEM	Biophys. Chem.	MAY-JUN	2015	200						1	8		10.1016/j.bpc.2015.03.007		8	Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical	Biochemistry & Molecular Biology; Biophysics; Chemistry	CH9FB	WOS:000354340300001		
J	Tatsumi, K; Nishimura, O; Itomi, K; Tanegashima, C; Kuraku, S				Tatsumi, Kaori; Nishimura, Osamu; Itomi, Kazu; Tanegashima, Chiharu; Kuraku, Shigehiro			Optimization and cost-saving in tagmentation-based mate-pair library preparation and sequencing	BIOTECHNIQUES			English	Article						mate pair library; genome assembly; genome scaffolding; CEGMA; tagmentation		In de novo genome sequencing, mate-pair reads are crucial for scaffolding assembled contigs. However, preparation of matepair libraries is not a trivial task, even when using one of the latest approaches, the Nextera Mate Pair Sample Prep Kit from Illumina. To reduce cost and enhance library yield and fidelity when using this kit, we have modified the manufacturer's protocol based on (i) variable tagmentation conditions, (ii) intensive DNA shearing to decrease library insert length, and (iii) sequencing on an Illumina HiSeq with >150 cycles. Finally, we provide additional suggestions for further improvement in the application of this kit.	[Tatsumi, Kaori; Nishimura, Osamu; Itomi, Kazu; Tanegashima, Chiharu; Kuraku, Shigehiro] RIKEN, Ctr Life Sci Technol, Phyloinformat Unit, Kobe, Hyogo, Japan	Kuraku, S (reprint author), RIKEN, Ctr Life Sci Technol, Phyloinformat Unit, Kobe, Hyogo, Japan.	shigehiro.kuraku@riken.jp					Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Leggett RM, 2014, BIOINFORMATICS, V30, P566, DOI 10.1093/bioinformatics/btt702; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Park N., 2013, METHODS NEXT GENER S, V1, P10; Peng Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029437; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Van Nieuwerburgh F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1000; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118	10	1	1	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	MAY	2015	58	5					253	257		10.2144/000114288		4	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CI0SM	WOS:000354448200008		
J	Katayama, M; Kishimoto-Yamada, K; Tanaka, HO; Endo, T; Hashimoto, Y; Yamane, S; Itioka, T				Katayama, Motoki; Kishimoto-Yamada, Keiko; Tanaka, Hiroshi O.; Endo, Tomoji; Hashimoto, Yoshiaki; Yamane, Seiki; Itioka, Takao			Negative Correlation between Ant and Spider Abundances in the Canopy of a Bornean Tropical Rain Forest	BIOTROPICA			English	Article						Araneidae; Borneo; Formicidae; generalist predators; interference competition; intra-guild interactions; Southeast Asian tropics; spatial distribution	ARTHROPOD FAUNA; ARBOREAL ANTS; INTRAGUILD PREDATION; WANDERING SPIDERS; JUMPING SPIDERS; ARGENTINE ANT; TREES; NECTAR; COMMUNITIES; DIVERSITY	In tropical rain forests, high canopy trees have diverse and abundant populations of ants and spiders. However, accessing high trees and their fauna remains difficult; thus, how ants and spiders interact in the canopy remains unclear. To better understand the interspecific interactions between these two dominant arthropod groups, we investigated their spatial distributions at the canopy surface in a tropical rain forest in Borneo. We sampled ants and spiders six times between 2009 and 2011 by sweeping with an insect net at the tree crown surfaces of 190 emergent or tall (20m in height) trees. We collected 438 ant individuals belonging to 94 species and 1850 spider individuals (1630 juveniles and 220 adults) belonging to 142 morphospecies (adults only) from a total of 976 samples. The fact that we collected four times more spider individuals than ant individuals suggests that fewer ants forage at the tree crown surface than previously thought. The number of spider individuals negatively correlated with the number of ant individuals and the number of ant species, indicating significant exclusivity between ant and spider spatial distributions at the tree crown surface. Niche-overlap between the two taxa confirmed this observation. Although our data do not address the causes of these spatial distributions, antagonistic interspecific interactions such as interference behaviors and intra-guild predation are ecological mechanisms that give rise to exclusive spatial distributions.	[Katayama, Motoki; Kishimoto-Yamada, Keiko; Tanaka, Hiroshi O.; Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Kishimoto-Yamada, Keiko] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Endo, Tomoji] Kobe Coll, Sch Human Sci, Nishinomiya, Hyogo, Japan; [Hashimoto, Yoshiaki] Univ Hyogo, Div Phylogenet, Inst Nat & Environm Sci, Museum Nat & Human Act, Sanda, Hyogo, Japan; [Yamane, Seiki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 890, Japan	Itioka, T (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan.	ichioka.takao.5m@kyoto-u.ac.jp			Research Institute for Humanity and Nature [D-04]; Japanese Ministry of Education, Science and Culture [24570109]	Our study was conducted in accordance with the Memorandums of Understanding signed between the Sarawak Forestry Corporation (SFC, Kuching, Malaysia) and the Japan Research Consortium for Tropical Forests in Sarawak (JRCTS, Sendai, Japan) in November 2005, and between the Sarawak Forest Department (SFD, Kuching, Malaysia) and JRCTS in December 2012. We are grateful to Joseph Kendawang, Mohd. Shahbudin Sabki, Engkamat Anak Lading, and Mohamad bin Kohdi of SFD and to Lucy Chong and Het Kaliang of SFC for help in obtaining permission to conduct this study. We thank Tohru Nakashizuka (Tohoku University, Sendai, Japan) and Shoko Sakai (Research Institute for Humanity and Nature, Kyoto, Japan) for their support of our field study. Anonymous reviewers provided valuable comments on our drafts. This study was financially supported by the Research Institute for Humanity and Nature (project number D-04) and Grants-in-Aid (no. 21255004 to T.I. and no. 24570109 to Y. H.) from the Japanese Ministry of Education, Science and Culture.	Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Taylor RM, 2009, ENVIRON ENTOMOL, V38, P1379, DOI 10.1603/022.038.0505; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Wardhaugh CW, 2014, AUSTRAL ECOL, V39, P367, DOI 10.1111/aec.12085; Klimes P, 2012, J ANIM ECOL, V81, P1103, DOI 10.1111/j.1365-2656.2012.02002.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Taylor RM, 2008, ENVIRON ENTOMOL, V37, P996, DOI 10.1603/0046-225X(2008)37[996:NFBWSO]2.0.CO;2; Vandermeer J, 2002, AGROFOREST SYST, V56, P271, DOI 10.1023/A:1021328820123; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Cushing PE, 1997, FLA ENTOMOL, V80, P165, DOI 10.2307/3495552; Halaj J, 1997, OECOLOGIA, V109, P313, DOI 10.1007/s004420050089; Wielgoss A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2144; ASHTON PS, 1992, J ECOL, V80, P459, DOI 10.2307/2260691; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x; Taylor RM, 2009, J ARACHNOL, V37, P232; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; STORK NE, 1987, ECOL ENTOMOL, V12, P69, DOI 10.1111/j.1365-2311.1987.tb00986.x; Marin L, 2013, ENVIRON ENTOMOL, V42, P204, DOI 10.1603/EN11223; Kumagai T, 2005, AGR FOREST METEOROL, V128, P81, DOI 10.1016/j.agrformet.2004.08.006; BASSET Y, 1991, AUST J ZOOL, V39, P171, DOI 10.1071/ZO9910171; CHASE J. M., 2003, ECOLOGICAL NICHES LI; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 1996, NEOTROPICAL BIODIVER, P127; Elgar Mark A., 1993, Memoirs of the Queensland Museum, V33, P411; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Eubanks MD, 2002, ENVIRON ENTOMOL, V31, P1168, DOI 10.1603/0046-225X-31.6.1168; Fisher RA, 1915, BIOMETRIKA, V10, P507, DOI 10.2307/2331838; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Floren A, 2005, ECOSYSTEMS, V8, P559, DOI 10.1007/s10021-002-0272-8; Floren A, 2001, ECOGRAPHY, V24, P547, DOI 10.1034/j.1600-0587.2001.d01-210.x; Gotelli N. J., 2013, ECOSIMR 1 00; Harrison RD, 2005, ECOL STU AN, V174, P51; Hölldobler B., 1990, The ants.; Jackson R. R., 2012, MYRMECOL NEWS, V17, P34; Jackson RR, 2001, J ZOOL, V255, P25, DOI 10.1017/S095283690100108X; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Lowman M. S., 2012, METHODS FOREST CANOP, P221; Mestre K., 2012, BASIC APPL ECOL, V13, P355; Nelson XJ, 2006, BEHAV ECOL, V17, P676, DOI 10.1093/beheco/ark017; Nelson XJ, 2012, J EXP BIOL, V215, P2255, DOI 10.1242/jeb.069609; Pfeiffer William J., 1996, P247; R Core Team, 2013, R LANG ENV STAT COMP; RUSSELLSMITH A, 1995, J TROP ECOL, V11, P223; Sakai S., 2002, GLOBAL CANOPY HDB, P77; Sanders D, 2007, OECOLOGIA, V150, P611, DOI 10.1007/s00442-006-0538-5; Schuldt A, 2012, BIOTROPICA, V44, P793, DOI 10.1111/j.1744-7429.2012.00876.x; Sokal R. R., 2011, BIOMETRY, P937; Stork N. E., 1997, P3; STORK NE, 1991, J TROP ECOL, V7, P161; Tanaka HO, 2009, ECOL RES, V24, P1393, DOI 10.1007/s11284-009-0622-5; Tanaka HO, 2010, POPUL ECOL, V52, P147, DOI 10.1007/s10144-009-0172-2; Taylor Robin M., 1996, American Entomologist, V42, P82; Wilson E. O., 1992, DIVERSITY LIFE, P440	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3606	1744-7429		BIOTROPICA	Biotropica	MAY	2015	47	3					363	368		10.1111/btp.12208		6	Ecology	Environmental Sciences & Ecology	CH4GZ	WOS:000353993300013		
J	Nim, HT; Furtado, MB; Costa, MW; Rosenthal, NA; Kitano, H; Boyd, SE				Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Rosenthal, Nadia A.; Kitano, Hiroaki; Boyd, Sarah E.			VISIONET: intuitive visualisation of overlapping transcription factor networks, with applications in cardiogenic gene discovery	BMC BIOINFORMATICS			English	Article						Visualisation; Human-readable; Gene expression; Transcription factor; Network overlap	HEART DEVELOPMENT; SYSTEMS BIOLOGY; MOUSE; GATA4; CHALLENGES; REPRESSOR; SOFTWARE; DELETION; PLATFORM; DISEASE	Background: Existing de novo software platforms have largely overlooked a valuable resource, the expertise of the intended biologist users. Typical data representations such as long gene lists, or highly dense and overlapping transcription factor networks often hinder biologists from relating these results to their expertise. Results: VISIONET, a streamlined visualisation tool built from experimental needs, enables biologists to transform large and dense overlapping transcription factor networks into sparse human-readable graphs via numerically filtering. The VISIONET interface allows users without a computing background to interactively explore and filter their data, and empowers them to apply their specialist knowledge on far more complex and substantial data sets than is currently possible. Applying VISIONET to the Tbx20-Gata4 transcription factor network led to the discovery and validation of Aldh1a2, an essential developmental gene associated with various important cardiac disorders, as a healthy adult cardiac fibroblast gene co-regulated by cardiogenic transcription factors Gata4 and Tbx20. Conclusions: We demonstrate with experimental validations the utility of VISIONET for expertise-driven gene discovery that opens new experimental directions that would not otherwise have been identified.	[Nim, Hieu T.; Rosenthal, Nadia A.; Kitano, Hiroaki; Boyd, Sarah E.] Monash Univ, Syst Biol Inst SBI Australia, Clayton, Vic 3800, Australia; [Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Rosenthal, Nadia A.; Kitano, Hiroaki; Boyd, Sarah E.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Rosenthal, Nadia A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Kitano, Hiroaki] Sony Comp Sci Labs Inc, Shinagawa Ku, Tokyo, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Kunigami, Okinawa, Japan	Nim, HT (reprint author), Monash Univ, Syst Biol Inst SBI Australia, Clayton, Vic 3800, Australia.	hieu.nim@monash.edu; sarah.boyd@monash.edu		Boyd, Sarah/0000-0002-7264-8602	ARC Discovery Grant [DP130104792]; NH&MRC Australia Fellowship; State Government of Victoria; Australian Government	ARC Discovery Grant DP130104792 to SEB and HK, and an NH&MRC Australia Fellowship to NR. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government.	Alworth SV, 2010, J BIOMOL SCREEN, V15, P968, DOI 10.1177/1087057110373546; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Brandes U, 2002, LECT NOTES COMPUT SC, V2265, P501; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/nmeth.1436, 10.1038/NMETH.1436]; SUGIYAMA K, 1981, IEEE T SYST MAN CYB, V11, P109, DOI 10.1109/TSMC.1981.4308636; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Lusis AJ, 2010, CIRCULATION, V121, P157, DOI 10.1161/CIRCULATIONAHA.108.847699; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Matsuoka Y, 2010, BIOINFORMATICS, V26, P1381, DOI 10.1093/bioinformatics/btq143; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; von Landesberger T, 2011, COMPUT GRAPH FORUM, V30, P1719, DOI 10.1111/j.1467-8659.2011.01898.x; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Castillo HA, 2010, DEVELOPMENT, V137, P507, DOI 10.1242/dev.043257; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Furtado Milena B, 2014, Genom Data, V2, P345, DOI 10.1016/j.gdata.2014.10.006; Hansen D, 2010, ANAL SOCIAL MEDIA NE; Harel D., 2001, LNCS, V1984, P183; Hu ZJ, 2013, NUCLEIC ACIDS RES, V41, pW225, DOI 10.1093/nar/gkt401; Hurley D, 2012, NUCLEIC ACIDS RES, V40, P2377, DOI 10.1093/nar/gkr902; leda M, 2010, CELL, V142, P375; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Nim HT, 2014, PROGR BIOPHYS MOL BI, DOI [10.1016/j.pbiomolbio.2014.1011.1006, DOI 10.1016/J.PBIOMOLBIO.2014.1011.1006]; Pavan M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-113; Pico AR, 2008, PLOS BIOL, V6, P184; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Smoot M, 2010, BIOINFORMATICS, V27, P431, DOI DOI 10.1093/BI0INF0RMATICS/BTQ675; Steiner MB, 2014, J MED CASE REP, V7, P287	41	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	MAY 1	2015	16								141	10.1186/s12859-015-0578-0		7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	CH5OS	WOS:000354085800001		
J	Tanaka, M; Kanamori, H; Matsumoto, K; Tachibana, T; Numata, A; Ohashi, K; Kobayashi, T; Nakaseko, C; Kanda, Y; Yamazaki, E; Fujisawa, S; Ooi, J; Sakura, T; Aotsuka, N; Onoda, M; Machida, S; Kato, J; Usuki, K; Watanabe, R; Taguchi, J; Yano, S; Saito, T; Takahashi, S; Sakamaki, H; Okamoto, S				Tanaka, M.; Kanamori, H.; Matsumoto, K.; Tachibana, T.; Numata, A.; Ohashi, K.; Kobayashi, T.; Nakaseko, C.; Kanda, Y.; Yamazaki, E.; Fujisawa, S.; Ooi, J.; Sakura, T.; Aotsuka, N.; Onoda, M.; Machida, S.; Kato, J.; Usuki, K.; Watanabe, R.; Taguchi, J.; Yano, S.; Saito, T.; Takahashi, S.; Sakamaki, H.; Okamoto, S.		Kanto Study Grp Cell Therapy	Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy	BONE MARROW TRANSPLANTATION			English	Article							VERSUS-HOST-DISEASE; C-REACTIVE PROTEIN; IRON OVERLOAD; MYELODYSPLASTIC SYNDROME; PROGNOSTIC IMPACT; COMPETING RISK; TRANSPLANTATION; INFECTION	This prospective study aimed to investigate the influence of pretransplant serum ferritin levels on the outcomes of allogeneic hematopoietic SCT (HSCT). In total, 190 patients with acute leukemia or myelodysplastic syndrome were consecutively enrolled. The patients were divided into two groups: low-ferritin group (<1000 ng/mL) and high-ferritin group (>= 1000 ng/mL). The primary end point was the cumulative incidence of infection within 100 days after HSCT, which was similar between the two groups: bloodstream infection, 35 vs 38%, P = 0.65; bacterial infection, 44 vs 41%, P = 0.68; and fungal infection, 6 vs 8%, P = 0.71. The 1-year adjusted probability of OS of the high-ferritin group was significantly lower than that of the low-ferritin group (76 vs 63%, P = 0.017). Using receiver operating characteristic curve, the threshold of pretransplant serum ferritin levels for bloodstream infection was 1400 ng/mL; the threshold for OS, EFS and non-relapse mortality was 1349 ng/mL. In conclusion, pretransplant serum ferritin levels of. 1000 ng/mL did not influence the incidence of infection but adversely affected OS after HSCT. A higher threshold of pretransplant serum ferritin levels may predict HSCT outcomes.	[Tanaka, M.; Kanamori, H.; Matsumoto, K.; Tachibana, T.; Numata, A.] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2418515, Japan; [Tachibana, T.; Yamazaki, E.] Yokohama City Univ, Grad Sch Med, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Numata, A.; Fujisawa, S.; Sakamaki, H.] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan; [Ohashi, K.; Kobayashi, T.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Nakaseko, C.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Div Hematol, Chiba, Japan; [Kanda, Y.] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan; [Ooi, J.; Takahashi, S.] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Mol Therapy, Tokyo, Japan; [Sakura, T.] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Maebashi, Gumma, Japan; [Aotsuka, N.] Narita Red Cross Hosp, Dept Hematol, Narita, Japan; [Onoda, M.] Chiba Aoba Municipal Hosp, Dept Internal Med, Chiba, Japan; [Machida, S.] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kato, J.; Okamoto, S.] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Usuki, K.] NTT Med Ctr Tokyo, Div Hematol, Tokyo, Japan; [Watanabe, R.] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Saitama, Japan; [Taguchi, J.] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan; [Yano, S.] Jikei Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Hematol, Tokyo, Japan; [Saito, T.] Gunma Univ, Sch Med, Dept Med & Clin Sci, Maebashi, Gumma 371, Japan	Tanaka, M (reprint author), Kanagawa Canc Ctr, Dept Hematol, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	tanakam@kcch.jp					Alessandrino EP, 2010, HAEMATOL-HEMATOL J, V95, P476, DOI 10.3324/haematol.2009.011429; Kanda J, 2011, BONE MARROW TRANSPL, V46, P208, DOI 10.1038/bmt.2010.108; Lim ZY, 2010, LEUKEMIA RES, V34, P723, DOI 10.1016/j.leukres.2009.10.028; Armand P, 2007, BLOOD, V109, P4586, DOI 10.1182/blood-2006-10-054924; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Altes A, 2004, BONE MARROW TRANSPL, V34, P505, DOI 10.1038/sj.bmt.1704628; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; Sakamoto S, 2013, INT J HEMATOL, V97, P109, DOI 10.1007/s12185-012-1229-0; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Grossekatthofer M, 2013, ANN HEMATOL, V92, P1121, DOI 10.1007/s00277-013-1737-x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kataoka K, 2009, BIOL BLOOD MARROW TR, V15, P195, DOI 10.1016/j.bbmt.2008.11.012; Mahindra A, 2009, BRIT J HAEMATOL, V146, P310, DOI 10.1111/j.1365-2141.2009.07774.x; Pullarkat V, 2008, BONE MARROW TRANSPL, V42, P799, DOI 10.1038/bmt.2008.262; Sahlstedt L, 2001, BRIT J HAEMATOL, V113, P836, DOI 10.1046/j.1365-2141.2001.02820.x; Tachibana T, 2011, INT J HEMATOL, V93, P368, DOI 10.1007/s12185-011-0784-0; Tachibana T, 2011, BONE MARROW TRANSPL, V46, P150, DOI 10.1038/bmt.2010.62; Tachibana T, 2011, BONE MARROW TRANSPL, V46, P1268, DOI 10.1038/bmt.2010.271; Tanaka M, 2012, BONE MARROW TRANSPL, V47, P596, DOI 10.1038/bmt.2011.122; VANASBECK BS, 1984, J IMMUNOL, V132, P851	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAY	2015	50	5					727	733		10.1038/bmt.2015.17		7	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CH4ZI	WOS:000354042900018		
J	Ito, T; Matsuda, T; Shimojo, S				Ito, Takehito; Matsuda, Tetsuya; Shimojo, Shinsuke			Functional connectivity of the striatum in experts of stenography	BRAIN AND BEHAVIOR			English	Article						Long-term neural plasticity; putamen; stenography	MOVEMENT-RELATED ACTIVITY; BASAL GANGLIA; CAUDATE-NUCLEUS; BIMANUAL COORDINATION; MOTOR-SKILLS; HUMAN BRAIN; RESONANCE; NETWORKS; CORTEX; REORGANIZATION	Introduction: Stenography, or shorthand, is a unique set of skills that involves intensive training which is nearly life-long and orchestrating various brain functional modules, including auditory, linguistic, cognitive, mnemonic, and motor. Stenography provides cognitive neuroscientists with a unique opportunity to investigate the neural mechanisms underlying the neural plasticity that enables such a high degree of expertise. However, shorthand is quickly being replaced with voice recognition technology. We took this nearly final opportunity to scan the brains of the last alive shorthand experts of the Japanese language. Methods: Thirteen right-handed stenographers and fourteen right-handed controls participated in the functional magnetic resonance imaging (fMRI) study. Results: The fMRI data revealed plastic reorganization of the neural circuits around the putamen. The acquisition of expert skills was accompanied by structural and functional changes in the area. The posterior putamen is known as the execution center of acquired sensorimotor skills. Compared to nonexperts, the posterior putamen in stenographers had high covariation with the cerebellum and midbrain. The stenographers' brain developed different neural circuits from those of the nonexpert brain. Conclusions: The current data illustrate the vigorous plasticity in the putamen and in its connectivity to other relevant areas in the expert brain. This is a case of vigorous neural plastic reorganization in response to massive overtraining, which is rare especially considering that it occurred in adulthood.	[Ito, Takehito; Matsuda, Tetsuya] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan; [Ito, Takehito] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Inage Ku, Chiba 2638555, Japan; [Shimojo, Shinsuke] CALTECH, Div Biol & Biol Engn Computat & Neural Syst, Pasadena, CA 91125 USA	Shimojo, S (reprint author), CALTECH, Div Biol & Biol Engn Computat & Neural Syst, 139-74, Pasadena, CA 91125 USA.	tetsuya@lab.tamagawa.ac.jp; sshimojo@its.caltech.edu			Ministry of Education, Culture, Sports, Science and Technology of Japan [23118003]; Japanese Agency of Technology; CREST program	This work was funded by the Tamagawa University Global Center of Excellence (GCOE) program of the Japanese Ministry of Education, Culture, Sports and Technology and a Grant-in-Aid for Scientific Research on Innovative Areas (23118003; Adolescent Mind & Self-Regulation) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. SS was supported by the Japanese Agency of Technology, CREST program (Implicit Interpersonal Communication). We thank all of the stenographers and control participants who cooperated in this study.	ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Kraft E, 2007, BRAIN RES, V1151, P62, DOI 10.1016/j.brainres.2007.01.142; Chang YM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00035; Mosier K, 2011, J NEUROPHYSIOL, V105, P1295, DOI 10.1152/jn.00757.2010; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Numminen J, 2004, NEUROIMAGE, V22, P815, DOI 10.1016/j.neuroimage.2004.02.011; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Wu T, 2008, J PHYSIOL-LONDON, V586, P4295, DOI 10.1113/jphysiol.2008.153445; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; ALLEN GI, 1974, PHYSIOL REV, V54, P957; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; Shah C, 2013, HUM BRAIN MAPP, V34, P1088, DOI 10.1002/hbm.21493; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.neuro.13.1.25; SCHOLZ JP, 1990, J MOTOR BEHAV, V22, P98; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3&lt;206::AID-HBM5&gt;3.0.CO;2-7; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Houk JC, 2005, BIOL CYBERN, V92, P427, DOI 10.1007/s00422-005-0569-8; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; ROMO R, 1992, EXP BRAIN RES, V91, P385, DOI 10.1007/BF00227835; Butler AJ, 2011, J COGNITIVE NEUROSCI, V23, P3515, DOI 10.1162/jocn_a_00015; Gaser C, 2003, J NEUROSCI, V23, P9240; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Aramaki Y, 2010, EXP BRAIN RES, V203, P407, DOI 10.1007/s00221-010-2244-0; Campitelli G, 2005, SPAN J PSYCHOL, V8, P238; Choudhury M, 2009, MODEL SIMUL SCI ENG, P145, DOI 10.1007/978-0-8176-4751-3_9; DesLuca C., 2010, J NEUROSCI, V30, P3167; Dick F, 2011, CEREB CORTEX, V21, P938, DOI 10.1093/cercor/bhq166; DisPaola M., 2013, HUM BRAIN MAPP, V34, P2707; Gauthier I., 2010, PRECEPTUAL EXPERTISE; Gazzaniga M, 2009, COGNITIVE NEUROSCIEN, V3rd, P395; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Kim J, 2008, NEUROSCI LETT, V445, P236, DOI 10.1016/j.neulet.2008.09.018; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lotze M., 2014, FRONT HUM NEUROSCI, V15, P516; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Park IS, 2011, HUM MOVEMENT SCI, V30, P56, DOI 10.1016/j.humov.2010.09.001; Petroni A, 2010, J NEUROPHYSIOL, V104, P1867, DOI 10.1152/jn.00386.2010; Reithler J, 2010, NEUROIMAGE, V52, P263, DOI 10.1016/j.neuroimage.2010.03.073; Voss JL, 2011, NEUROPSYCHOLOGIA, V49, P3956, DOI 10.1016/j.neuropsychologia.2011.10.012; Wan XH, 2011, SCIENCE, V331, P341, DOI 10.1126/science.1194732; Woods DL, 2009, CURR OPIN OTOLARYNGO, V17, P407, DOI 10.1097/MOO.0b013e3283303330	58	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2015	5	5							e00333	10.1002/brb3.333		12	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CH8FA	WOS:000354270500005		
J	Shimada-Sugimoto, M; Otowa, T; Miyagawa, T; Khor, SS; Kashiwase, K; Sugaya, N; Kawamura, Y; Umekage, T; Kojima, H; Saji, H; Miyashita, A; Kuwano, R; Kaiya, H; Kasai, K; Tanii, H; Okazaki, Y; Tokunaga, K; Sasaki, T				Shimada-Sugimoto, Mihoko; Otowa, Takeshi; Miyagawa, Taku; Khor, Seik-Soon; Kashiwase, Koichi; Sugaya, Nagisa; Kawamura, Yoshiya; Umekage, Tadashi; Kojima, Hiroto; Saji, Hiroh; Miyashita, Akinori; Kuwano, Ryozo; Kaiya, Hisanobu; Kasai, Kiyoto; Tanii, Hisashi; Okazaki, Yuji; Tokunaga, Katsushi; Sasaki, Tsukasa			Immune-related pathways including HLA-DRB1*13:02 are associated with panic disorder	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Panic disorder; Genome-wide association study; Human Leukocyte Antigen; HLA-B; HLA-DRB1; Pathway analysis; Immunity	GENOME-WIDE ASSOCIATION; METHYLTRANSFERASE GENETIC-POLYMORPHISM; HEALTH-SERVICE USE; QUALITY-OF-LIFE; BIPOLAR DISORDER; RECEPTOR GENE; JAPANESE POPULATION; ANXIETY DISORDERS; COMMON VARIANTS; ASTHMA CONTROL	Panic disorder (PD) is an anxiety disorder characterized by panic attacks and anticipatory anxiety. Both genetic and environmental factors are thought to trigger PD onset. Previously, we performed a genome-wide association study (GWAS) for PD and focused on candidate SNPs with the lowest P values. However, there seemed to be a number of polymorphisms which did not reach genome-wide significance threshold due to their low allele frequencies and odds ratios, even though they were truly involved in pathogenesis. Therefore we performed pathway analyses in order to overcome the limitations of conventional single-marker analysis and identify associated SNPs with modest effects. Each pathway analysis indicated that pathways related to immunity showed the strongest association with PD (DAVID, P = 2.08 x 10(-6); i-GSEA4GWAS, P < 10(-3); ICSNPathway, P < 10(-3)). Based on the results of pathway analyses and the previously performed GWAS for PD, we focused on and investigated HIA-B and HLA-DRB1 as candidate susceptibility genes for PD. We typed HLA-B and HLA-DRB1 in 744 subjects with PD and 1418 control subjects. Patients with PD were significantly more likely to carry HLA-DRB1*13:02 (P = 2.50 x 10(-4), odds ratio = 1.54). Our study provided initial evidence that HLA-DRB1*13:02 and genes involved in immune-related pathways are associated with PD. Future studies are necessary to confirm these results and clarify the underlying mechanisms causing PD. (C) 2015 Elsevier Inc. All rights reserved.	[Shimada-Sugimoto, Mihoko; Miyagawa, Taku; Khor, Seik-Soon; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Otowa, Takeshi; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo 1130033, Japan; [Kashiwase, Koichi] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan; [Sugaya, Nagisa] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa, Japan; [Kawamura, Yoshiya] Sakae Seijinkai Hosp, Dept Psychiat, Yokosuka, Kanagawa, Japan; [Umekage, Tadashi] Univ Tokyo, Div Environm Hlth & Safety, Tokyo 1130033, Japan; [Kojima, Hiroto; Saji, Hiroh] HLA Fdn Lab, Kyoto, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Dept Mol Genet, Ctr Bioresources, Niigata, Japan; [Kaiya, Hisanobu] Warakukai Med Corp, Pan Disorder Res Ctr, Tokyo, Japan; [Tanii, Hisashi] Mie Univ, Grad Sch Med, Inst Med Life Sci, Dept Psychiat, Tsu, Mie, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Dept Phys & Hlth Educ, Tokyo 1130033, Japan	Otowa, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	totowa-psy@umin.org	Khor, Seik-Soon/C-4700-2015	Khor, Seik-Soon/0000-0002-6809-4731	JSPS KAKENHI [25461723]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17019029, 21300242, 22133008]	We thank all participants in this study. This study was supported by JSPS KAKENHI (No. 25461723) and Grants-in-Aid for Scientific Research on Priority Areas 'Comprehensive Genomics' and 'Applied Genomics' (Nos. 17019029; 21300242), Innovative Areas (No. 22133008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Johnson WG, 2009, ARCH PEDIAT ADOL MED, V163, P542, DOI 10.1001/archpediatrics.2009.74; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; WARREN RP, 1992, IMMUNOGENETICS, V36, P203, DOI 10.1007/BF00215048; Goodwin RD, 2010, J PSYCHOSOM RES, V68, P165, DOI 10.1016/j.jpsychores.2009.06.005; Favreau H, 2014, PSYCHOSOM MED, V76, P147, DOI 10.1097/PSY.0000000000000032; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; MARAZZITI D, 1992, NEUROPSYCHOBIOLOGY, V26, P23, DOI 10.1159/000118891; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Otowa T, 2010, J HUM GENET, V55, P91, DOI 10.1038/jhg.2009.127; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Perna G, 1997, BIOL PSYCHIAT, V42, P625, DOI 10.1016/S0006-3223(96)00436-2; Otowa T, 2009, J HUM GENET, V54, P122, DOI 10.1038/jhg.2008.17; Perini GI, 1995, HUM PSYCHOPHARM CLIN, V10, P461, DOI 10.1002/hup.470100605; Bachen EA, 2009, ARTHRIT RHEUM-ARTHR, V61, P822, DOI 10.1002/art.24519; MacKinnon DF, 2002, AM J PSYCHIAT, V159, P30, DOI 10.1176/appi.ajp.159.1.30; Young S, 2013, PSYCHOPATHOLOGY, V46, P176, DOI 10.1159/000339556; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Lavoie KL, 2005, RESP MED, V99, P1249, DOI 10.1016/j.rmed.2005.03.003; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Rothe C, 2006, NEUROPSYCHOPHARMACOL, V31, P2237, DOI 10.1038/sj.npp.1301048; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Zhang KL, 2011, NUCLEIC ACIDS RES, V39, pW437, DOI 10.1093/nar/gkr391; Freeman MP, 2002, J AFFECT DISORDERS, V68, P1, DOI 10.1016/S0165-0327(00)00299-8; EATON WW, 1994, AM J PSYCHIAT, V151, P413; Bergmann CC, 2003, J IMMUNOL, V170, P3204; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; Debnath M, 2013, HUM IMMUNOL, V74, P593, DOI 10.1016/j.humimm.2012.11.032; Deckert J, 1998, MOL PSYCHIATR, V3, P81, DOI 10.1038/sj.mp.4000345; Domschke K, 2004, INT J NEUROPSYCHOPH, V7, P183, DOI 10.1017/s146114570400416X; Ebihara M, 2003, AM J MED GENET B, V118B, P32, DOI 10.1002/ajmg.b.10058; Erhardt A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.85; Figueiredo TC, 2012, J MOL NEUROSCI, V47, P26, DOI 10.1007/s12031-011-9656-6; Goldstein RB, 1997, ARCH GEN PSYCHIAT, V54, P271; Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311; Hamilton SP, 2002, BIOL PSYCHIAT, V51, P591, DOI 10.1016/S0006-3223(01)01322-1; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Hattori E, 2001, AM J MED GENET, V105, P779, DOI 10.1002/ajmg.10043; Holoshitz J, 2013, DISCOV MED, V87, P93; Inada Y, 2003, PSYCHIAT RES, V118, P25, DOI 10.1016/S0165-1781(03)00064-7; Khor S.S., PHARMACOGENOMICS J; MacKinnon DF, 1997, BIOL PSYCHIAT, V42, P90, DOI 10.1016/S0006-3223(96)00299-5; Manfro GG, 2000, DEPRESS ANXIETY, V11, P31, DOI 10.1002/(SICI)1520-6394(2000)11:1<31::AID-DA5>3.0.CO;2-O; Maron E, 2005, INT J NEUROPSYCHOPH, V8, P261, DOI 10.1017/S1461154704004985; Na HR, 2011, J KOREAN MED SCI, V26, P701, DOI 10.3346/jkms.2011.26.6.701; Nahar Z, 2012, PAK J PHARM SCI, V25, P149; Navarrete CV, 2000, BEST PRACT RES CL HA, V13, P511, DOI 10.1053/beha.2000.0097; Otowa T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.89; Park JE, 2005, J KOREAN MED SCI, V20, P215; Purcell SM, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; Rapaport MH, 1998, BIOL PSYCHIAT, V43, P458, DOI 10.1016/S0006-3223(97)00263-1; Rothe C, 2004, NEUROSCI LETT, V363, P276, DOI 10.1016/j.neulet.2004.04.010; Rothe C, 2004, INT J NEUROPSYCHOPH, V7, P189, DOI 10.1017/S1461145703004061; Schizophrenia Working Group of the Psychiatric Genomics C, 2014, NATURE, V511, P421, DOI DOI 10.1038/NATURE13595; Schleifer SJ, 2002, BRAIN BEHAV IMMUN, V16, P698, DOI 10.1016/S0889-1591(02)00022-3; TOKUNAGA K, 1985, IMMUNOGENETICS, V22, P359, DOI 10.1007/BF00430919; Torres AR, 2002, HUM IMMUNOL, V63, P311, DOI 10.1016/S0198-8859(02)00374-9; Wang ZW, 1998, AM J MED GENET, V81, P228, DOI 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S; Woo JM, 2002, AM J PSYCHIAT, V159, P1785, DOI 10.1176/appi.ajp.159.10.1785	65	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAY	2015	46						96	103		10.1016/j.bbi.2015.01.002		8	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CH0ZO	WOS:000353751100013		
J	Zhao, XC; Wu, T; Chang, CF; Wu, H; Han, XN; Li, Q; Gao, YF; Li, Q; Hou, ZP; Maruyama, T; Zhang, JY; Wang, J				Zhao, Xiaochun; Wu, Tao; Chang, Che-Feng; Wu, He; Han, Xiaoning; Li, Qian; Gao, Yufeng; Li, Qiang; Hou, Zhipeng; Maruyama, Takayuki; Zhang, Jiangyang; Wang, Jian			Toxic role of prostaglandin E-2 receptor EP1 after intracerebral hemorrhage in mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Diffusion tensor imaging; Hemoglobin; Inflammation; Intracerebral hemorrhage; Magnetic resonance imaging; Matrix metalloproteinase; Prostaglandin EP1 receptor; Src-kinase	THROMBIN-INDUCED INJURY; TUFTSIN FRAGMENT 1-3; EARLY BRAIN-INJURY; CEREBRAL-ISCHEMIA; MOUSE MODEL; MATRIX METALLOPROTEINASES; CELL-DEATH; AGED RATS; SRC; NEUROTOXICITY	Inflammatory mechanisms mediated by prostaglandins may contribute to the progression of intracerebral hemorrhage (ICH)-induced brain injury, but they are not fully understood. In this study, we examined the effect of prostaglandin E-2 receptor EP1 (EP1R) activation and inhibition on brain injury in mouse models of ICH and investigated the underlying mechanism of action. ICH was induced by injecting collagenase, autologous blood, or thrombin into the striatum of middle-aged male and female mice and aged male mice. Effects of selective EP1R agonist ONO-DI-004, antagonist SC51089, and nonspecific Src family kinase inhibitor PP2 were evaluated by a combination of histologic, magnetic resonance imaging (MRI), immunofluorescence, molecular, cellular, and behavioral assessments. EP1R was expressed primarily in neurons and axons but not in astrocytes or microglia after ICH induced by collagenase. In middle-aged male mice subjected to collagenase-induced ICH, EP1R inhibition mitigated brain injury, brain edema, cell death, neuronal degeneration, neuroinflammation, and neurobehavioral deficits, whereas its activation exacerbated these outcomes. EP1R inhibition also was protective in middle-aged female mice and aged male mice after collagenase-induced ICH and in middle-aged male mice after blood- or thrombin-induced ICH. EP1R inhibition also reduced oxidative stress, white matter injury, and brain atrophy and improved functional outcomes. Histologic results were confirmed by MRI. Src kinase phosphorylation and matrix metalloproteinase-9 activity were increased by EP1R activation and decreased by EP1R inhibition. EP1R regulated matrix metalloproteinase-9 activity through Src kinase signaling, which mediated EP1R toxicity after collagenase-induced ICH. We conclude that prostaglandin E-2 EP1R activation plays a toxic role after ICH through mechanisms that involve the Src kinases and the matrix metalloproteinase-9 signaling pathway. EP1R inhibition could be a novel therapeutic strategy to improve outcomes after ICH. (C) 2015 Elsevier Inc. All rights reserved.	[Zhao, Xiaochun; Chang, Che-Feng; Han, Xiaoning; Li, Qian; Gao, Yufeng; Li, Qiang; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Wu, Tao] Second Mil Med Univ, Changhai Hosp, Dept Neurol, Stroke Ctr,Stroke Screening & Intervent Base, Shanghai 200433, Peoples R China; [Wu, He] Harbin Med Univ, Clin Hosp 1, Dept Pathol, Harbin 150001, Peoples R China; [Hou, Zhipeng; Zhang, Jiangyang] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Maruyama, Takayuki] Ono Pharmaceut Co Ltd, Project Management Discovery & Res, Osaka 6188585, Japan	Wu, T (reprint author), Changhai Hosp, Dept Neurol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	twu163@163.com; jwang79@jhmi.edu			AHA [13GRNT15730001]; NIH [K01AG031926, R01NS078026, R01AT007317]	This work was supported by AHA 13GRNT15730001, NIH K01AG031926, R01NS078026, and R01AT007317 (JW). We thank Suzy Cho, Lingshu Liu, Joy Ziyi Zhou, Weizhu Tang, and Jieru Wan for blind analysis of histology and immunofluorescence and for neuronal culture. We thank Claire Levine, MS, ELS, for assistance with manuscript preparation and Dr. Raymond Koehler, Dr. Zengjin Yang, and the Wang lab team members for insightful input.	Andreasson K, 2010, BRIT J PHARMACOL, V160, P844, DOI 10.1111/j.1476-5381.2010.00715.x; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zan LK, 2011, NEUROCHEM INT, V58, P872, DOI 10.1016/j.neuint.2011.02.014; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Strbian D, 2007, J CEREBR BLOOD F MET, V27, P795, DOI 10.1038/sj.jcbfm.9600387; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Ardizzone TD, 2007, STROKE, V38, P1621, DOI 10.1161/STROKEAHA.106.478966; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Kalia LV, 2004, ONCOGENE, V23, P8007, DOI 10.1038/sj.onc.1208158; Fukumoto K, 2010, EUR J PHARMACOL, V640, P82, DOI 10.1016/j.ejphar.2010.05.001; Leys D, 1999, EUR NEUROL, V42, P67, DOI 10.1159/000069414; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; DelBigio MR, 1996, STROKE, V27, P2312; Xue MZ, 2009, BRAIN, V132, P26, DOI 10.1093/brain/awn215; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Tober KL, 2006, J INVEST DERMATOL, V126, P205, DOI 10.1038/sj.jid.5700014; Andreasson K, 2010, PROSTAG OTH LIPID M, V91, P104, DOI 10.1016/j.prostaglandins.2009.04.003; Wang J, 2008, BRAIN RES, V1222, P214, DOI 10.1016/j.brainres.2008.05.058; Wasserman JK, 2008, EXP NEUROL, V214, P266, DOI 10.1016/j.expneurol.2008.08.010; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Tang JP, 2005, J NEUROCHEM, V94, P1342, DOI 10.1111/j.1471-4159.2005.03292.x; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Brown M S, 1995, J Neuroimaging, V5, P23; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI DOI 10.1002/ACN3.54; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Liu DZ, 2011, ACTA NEUROCHIR SUPPL, V111, P77, DOI 10.1007/978-3-7091-0693-8_13; Mohan S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00031; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Singh N, 2013, NEUROTOX RES, V24, P549, DOI 10.1007/s12640-013-9410-7; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang YX, 2011, J CLIN NEUROSCI, V18, P1392, DOI 10.1016/j.jocn.2010.11.039; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Wu T., 2011, J NEUROINFLAMM, V8, P22; Xue MZ, 2009, STROKE, V40, P2199, DOI 10.1161/STROKEAHA.108.540393; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423	63	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAY	2015	46						293	310		10.1016/j.bbi.2015.02.011		18	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CH0ZO	WOS:000353751100033		
J	Tsujimoto, M				Tsujimoto, Masahiko			Recent advances in sentinel node biopsy in breast surgery	BREAST CANCER			English	Editorial Material									Osaka Police Hosp, Dept Diagnost Pathol, Osaka, Japan	Tsujimoto, M (reprint author), Osaka Police Hosp, Dept Diagnost Pathol, Osaka, Japan.	m-tsujimo@oph.gr.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					211	211		10.1007/s12282-015-0601-3		1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400001		
J	Motomura, K				Motomura, Kazuyoshi			Sentinel node biopsy for breast cancer: past, present, and future	BREAST CANCER			English	Article						Sentinel node; Sentinel node biopsy; Axillary lymph node dissection; Breast cancer; Staging	COMPUTED-TOMOGRAPHY-LYMPHOGRAPHY; COMPLETION AXILLARY DISSECTION; ISOLATED TUMOR-CELLS; LYMPH-NODE; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; OCCULT METASTASES; REGIONAL RECURRENCE; LYMPHADENECTOMY; MICROMETASTASES	Sentinel node biopsy has replaced axillary lymph node dissection as the standard of care in early breast cancers. Sentinel node biopsy represents a highly accurate and less-morbid axillary staging, which allows most patients to avoid unnecessary axillary lymph node dissection and its morbidity. This review provides information including several issues which are still under debate, such as clinical significance of micrometastases, avoidance of axillary lymph node dissection for patients with positive sentinel nodes, accuracy and timing of sentinel node biopsy in patients undergoing neoadjuvant chemotherapy, and how many sentinel nodes are sufficient for removal. Finally, a new topic is introduced: superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for the detection of metastases in sentinel nodes localized by computed tomography (CT)-lymphography (CT-LG) in patients with breast cancer. SPIO-enhanced MR imaging is a useful method of detecting metastases in sentinel nodes localized by CT-LG in patients with breast cancer. Patients with clinically negative nodes may be spared even sentinel node biopsy when the sentinel node is diagnosed as disease free using SPIO-enhanced MR imaging.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Osaka 5378511, Japan	Motomura, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	motomurak@hotmail.com			National Cancer Center Research and Development Fund [22-38]	This work was supported in part by the National Cancer Center Research and Development Fund (22-38).	Guenther JM, 2003, ARCH SURG-CHICAGO, V138, P52; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; van Deurzen CHM, 2009, EUR J CANCER, V45, P3124, DOI 10.1016/j.ejca.2009.08.001; Jeruss JS, 2005, ANN SURG ONCOL, V12, P34, DOI 10.1245/ASO.2005.04.020; Cox CE, 1998, ANN SURG, V227, P645, DOI 10.1097/00000658-199805000-00005; Naik AM, 2004, ANN SURG, V240, P462, DOI 10.1097/01.sla.0000137130.23530.19; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V306, P385, DOI 10.1001/jama.2011.1034; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108; Papa MZ, 2008, J SURG ONCOL, V98, P403, DOI 10.1002/jso.21128; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Pepels MJ, 2012, ANN SURG, V255, P116, DOI 10.1097/SLA.0b013e31823dc616; Hunt KK, 2012, ANN SURG, V256, P428, DOI 10.1097/SLA.0b013e3182654494; Albertini JJ, 1996, JAMA-J AM MED ASSOC, V276, P1818, DOI 10.1001/jama.276.22.1818; GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Motomura K, 2011, ANN SURG ONCOL, V18, P3422, DOI 10.1245/s10434-011-1710-7; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; Kelly AM, 2009, ACAD RADIOL, V16, P551, DOI 10.1016/j.acra.2009.01.026; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; HAINSWORTH PJ, 1993, BRIT J SURG, V80, P459, DOI 10.1002/bjs.1800800417; Chung MH, 2001, ANN SURG ONCOL, V8, P688, DOI 10.1245/aso.2001.8.9.688; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Mamounas EP, 2005, J CLIN ONCOL, V23, P2694, DOI 10.1200/JCO.2005.05.188; Giuliano AE, 1997, J CLIN ONCOL, V15, P2345; Hunt KK, 2009, ANN SURG, V250, P558, DOI 10.1097/SLA.0b013e3181b8fd5e; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Straver ME, 2009, EUR J CANCER, V45, P2284, DOI 10.1016/j.ejca.2009.04.029; Hwang RF, 2007, CANCER, V110, P723, DOI 10.1002/cncr.22847; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; McMasters KM, 2000, J CLIN ONCOL, V18, P2560; Tafra L, 2001, ANN SURG, V233, P51, DOI 10.1097/00000658-200101000-00009; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Bilimoria KY, 2009, J CLIN ONCOL, V27, P2946, DOI 10.1200/JCO.2008.19.5750; Giuliano AE, 2000, J CLIN ONCOL, V18, P2553; Bedrosian I, 2000, CANCER, V88, P2540, DOI 10.1002/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO;2-A; Cox CE, 2006, ANN SURG ONCOL, V13, P483, DOI 10.1245/ASO.2006.03.592; Dowlatshahi K, 1999, CANCER, V86, P990, DOI 10.1002/(SICI)1097-0142(19990915)86:6<990::AID-CNCR14>3.0.CO;2-D; Galimberti V, 2012, CANCER RES, V71, pS3; Gimbergues P, 2008, ANN SURG ONCOL, V15, P1316, DOI 10.1245/s10434-007-9759-z; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Grube BJ, 2008, ARCH SURG-CHICAGO, V143, P692, DOI 10.1001/archsurg.143.7.692; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Kinoshita Takayuki, 2007, Breast Cancer, V14, P10, DOI 10.2325/jbcs.14.10; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6; Lang JE, 2004, J AM COLL SURGEONS, V199, P856, DOI 10.1016/j.jamcollsurg.2004.08.023; Lee S, 2007, BREAST CANC RES TREA, V102, P238; Martin RCG, 2001, ANN SURG ONCOL, V8, P592, DOI 10.1245/aso.2001.8.7.592; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Motomura K, 2011, CANCER RES, V70; Motomura K, 2001, J SURG ONCOL, V76, P95, DOI 10.1002/1096-9098(200102)76:2<95::AID-JSO1018>3.0.CO;2-D; Motomura K, 2002, BRIT J SURG, V89, P1032, DOI 10.1046/j.1365-2168.2002.02177.x; Motomura K, 1999, BREAST CANC, V6, P259, DOI 10.1007/BF02967180; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID, P1; Ollila DW, 2005, AM J SURG, V190, P371, DOI 10.1016/j.amjsurg.2005.01.044; Park J, 2007, ANN SURG, V245, P462, DOI 10.1097/01.sla.0000250439.86020.85; Schrenk P, 2008, AM J SURG, V196, P176, DOI 10.1016/j.amjsurg.2007.08.068; Shimazu K, 2004, CANCER, V100, P2555, DOI 10.1002/cncr.20242; Spiguel L, 2011, J AM COLL SURGEONS, V213, P122, DOI 10.1016/j.jamcollsurg.2011.03.034; Swenson KK, 2005, CANCER, V104, P1834, DOI 10.1002/cncr.21357; Tangoku A, 2004, SURGERY, V135, P258, DOI 10.1016/j.surg.2003.07.003; Tausch C, 2008, ANN SURG ONCOL, V15, P3378, DOI 10.1245/ASO.2006.08.010; van der Ploeg IMC, 2008, EJSO-EUR J SURG ONC, V34, P1277, DOI 10.1016/j.ejso.2008.01.034; Wasif N, 2010, ARCH SURG-CHICAGO, V145, P161, DOI 10.1001/archsurg.2009.269; Wong SL, 2001, J AM COLL SURGEONS, V192, P684, DOI 10.1016/S1072-7515(01)00858-4; Yi M, 2010, ANN SURG ONCOL, V17, pS343, DOI 10.1245/s10434-010-1253-3; Zakaria S, 2007, J SURG ONCOL, V96, P554, DOI 10.1002/jso.20878; Zervos EE, 2001, AM J SURG, V182, P372, DOI 10.1016/S0002-9610(01)00740-1; Zervos E E, 2000, Breast Cancer, V7, P195, DOI 10.1007/BF02967460	74	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					212	220		10.1007/s12282-012-0421-7		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400002		
J	Tsuda, H				Tsuda, Hitoshi			Histological examination of sentinel lymph nodes: significance of macrometastasis, micrometastasis, and isolated tumor cells	BREAST CANCER			English	Article						Sentinel lymph node; Micrometastasis; Histopathology; Isolated tumor cells; NSABP B-32 study; MIRROR study; IBCSG 23-01 study; ACOSOG Z0011 study; AMAROS study	BREAST-CANCER PATIENTS; NUCLEIC-ACID AMPLIFICATION; EORTC 10981-22023 AMAROS; NO AXILLARY DISSECTION; MULTICENTER TRIAL; AMERICAN-SOCIETY; METASTASES; BIOPSY; CARCINOMA; ONCOLOGY	Sentinel lymph node biopsy has been started in 1990 s and has become one of the standard diagnostic procedures used to treat patients with early breast cancer in this century. In Japan, for the microscopic diagnosis of metastasis to sentinel lymph nodes, intraoperative frozen section diagnosis is widely used in combination with subsequent permanent section diagnosis of the residual specimens. Metastatic foci to sentinel lymph nodes have been classified into macrometastasis, micrometastasis, and isolated tumor cells in 2002, and the definition of isolated tumor cells was modified in 2010. Clinical significance of occult sentinel lymph node metastases, being mostly composed of micrometastasis and isolated tumor cells, has been clarified in terms of predictive factors for non-sentinel lymph node metastasis and patient prognosis by large-scale retrospective studies and prospective randomized clinical trials. In the present review, clinical implications of micrometastases and isolated tumor cells in sentinel lymph nodes and the methods for pathological examination of SLN metastases employed in these studies were overviewed.	Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 3598513, Japan	Tsuda, H (reprint author), Natl Def Med Coll, Dept Basic Pathol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	hstsuda@gmail.com			National Cancer Center Research and Development Fund; Ministry of Health, Labor, and Welfare, Japan	This work was supported in part by the National Cancer Center Research and Development Fund and from the Grand-in-Aid of the Ministry of Health, Labor, and Welfare, Japan.	Aihara T, 2004, ANN SURG ONCOL, V11, P419; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Gatzemeier W, 2013, BREAST, V22, P211, DOI 10.1016/j.breast.2013.02.001; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108; Donker M, 2014, LANCET ONCOL, V15, P1303, DOI 10.1016/S1470-2045(14)70460-7; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Veronesi U, 1999, J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Viale G, 2001, CANCER, V92, P1378, DOI 10.1002/1097-0142(20010915)92:6<1378::AID-CNCR1460>3.0.CO;2-Y; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; van Deurzen CHM, 2008, J NATL CANCER I, V100, P1574, DOI 10.1093/jnci/djn343; Gradishar WJ, 2014, J NATL COMPR CANC NE, V12, P542; Cserni G, 2004, BRIT J SURG, V91, P1245, DOI 10.1002/bjs.4725; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Jimbo K, 2013, BREAST, V22, P1194, DOI 10.1016/j.breast.2013.08.003; Apple SK, 2010, BREAST, V19, P360, DOI 10.1016/j.breast.2010.02.010; Bolster MJ, 2013, EJSO-EUR J SURG ONC, V39, P437, DOI 10.1016/j.ejso.2013.02.013; Cavanas R., 1977, CANCER, V39, P456; Chao C, 2001, AM J SURG, V182, P609, DOI 10.1016/S0002-9610(01)00794-2; Edge SB, 2010, AJCC CANC STAGING MA; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Hieken Tina J, 2013, Gland Surg, V2, P128, DOI 10.3978/j.issn.2227-684X.2013.07.04; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Motomura K, 1999, BREAST CANC, V6, P259, DOI 10.1007/BF02967180; Noguchi M, 1999, BREAST CANCER RES TR, V53, P97, DOI 10.1023/A:1006118827167; Sato K, 1998, BREAST CANC, V5, P389, DOI 10.1007/BF02967436; Sobin LH, 2010, TNM CLASSIFICATION M; Sobin LH, 2002, TNM CLASSIFICATION M; Taras AR, 2009, AM J SURG, V197, P643, DOI 10.1016/j.amjsurg.2008.12.019; Turner RR, 2008, J CLIN ONCOL, V26, P258, DOI 10.1200/JCO.2007.13.0179; Vestjens JHMJ, 2012, ANN ONCOL, V23, P2561, DOI 10.1093/annonc/mds072; Weaver DL, 2009, AM J SURG PATHOL, V33, P1583, DOI 10.1097/PAS.0b013e3181b274e7	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					221	229		10.1007/s12282-015-0588-9		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400003		
J	Tamaki, Y				Tamaki, Yasuhiro			One-step nucleic acid amplification assay (OSNA) for sentinel lymph node biopsy	BREAST CANCER			English	Article						Breast; Cancer; Sentinel; OSNA	BREAST-CANCER PATIENTS; ISOLATED TUMOR-CELLS; AXILLARY DISSECTION; MOLECULAR METHOD; METASTASES; MICROMETASTASES; EXPRESSION; WOMEN; RECURRENCE; DIAGNOSIS	The one-step nucleic acid amplification assay (OSNA) has been developed for the intraoperative rapid detection of sentinel lymph node metastasis. Pooled analysis of recent studies comparing OSNA with pathology indicated that OSNA is as accurate as pathology (96.3 % concordance rate) and is useful for making the decision to omit axillary dissection for OSNA-negative patients (97.4 % negative predictive value). The advantage of OSNA over pathology is that the former allows the semiquantitative evaluation of total tumor volume in the node when a whole node is examined. OSNA is expected to be a powerful tool for the estimation of risk of non-sentinel lymph node metastasis and also patient prognosis, though further studies about this issue with larger numbers of patients is needed.	Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Higashinari Ku, Osaka 5378511, Japan	Tamaki, Y (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	tamaki-ya@mc.pref.osaka.jp					Feldman S, 2011, CANCER-AM CANCER SOC, V117, P2599, DOI 10.1002/cncr.25822; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Bernet L, 2011, HISTOPATHOLOGY, V58, P863, DOI 10.1111/j.1365-2559.2011.03836.x; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V306, P385, DOI 10.1001/jama.2011.1034; Osako T, 2011, CANCER-AM CANCER SOC, V117, P4365, DOI 10.1002/cncr.26060; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108; Pepels MJ, 2012, ANN SURG, V255, P116, DOI 10.1097/SLA.0b013e31823dc616; Visser M, 2008, INT J CANCER, V122, P2562, DOI 10.1002/ijc.23451; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Parikh RR, 2008, INT J RADIAT ONCOL, V70, P35, DOI 10.1016/j.ijrobp.2007.05.066; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Reed J, 2009, J AM COLL SURGEONS, V208, P333, DOI 10.1016/j.jamcollsurg.2008.10.036; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Castellano I, 2012, ANN SURG, V255, P334, DOI 10.1097/SLA.0b013e31823000ed; Gobardhan PD, 2011, ANN SURG ONCOL, V18, P1657, DOI 10.1245/s10434-010-1451-z; Khaddage A, 2011, ANTICANCER RES, V31, P585; Christiansen P, 2008, ACTA ONCOL, V47, P561, DOI 10.1080/02841860802023206; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Viale G, 2005, ANN SURG, V241, P319, DOI 10.1097/01.sla.0000150255.30665.52; Godey F, 2012, BREAST CANCER RES TR, V131, P509, DOI 10.1007/s10549-011-1808-4; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Le Frere-Belda MA, 2011, INT J CANCER, V130, P2377; Rebollo-Aguirre AC, 2012, REV ESP MED NUCL IMA, V31, P117, DOI 10.1016/j.remn.2011.04.007; Sagara Y, 2012, BREAST CANC IN PRESS; Tamaki Y, 2012, CANCER IN PRESS; Viardell F, 2012, VIRCHOWS AR IN PRESS; Vogue LB, 2012, DIAGN MOL PATHOL, V21, P69	31	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					230	234		10.1007/s12282-012-0390-x		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400004		
J	Kurebayashi, J; Miyoshi, Y; Ishikawa, T; Saji, S; Sugie, T; Suzuki, T; Takahashi, S; Nozaki, M; Yamashita, H; Tokuda, Y; Nakamura, S				Kurebayashi, Junichi; Miyoshi, Yasuo; Ishikawa, Takashi; Saji, Shigehira; Sugie, Tomoharu; Suzuki, Takashi; Takahashi, Shunji; Nozaki, Miwako; Yamashita, Hiroko; Tokuda, Yutaka; Nakamura, Seigo			Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011	BREAST CANCER			English	Article						Clinicopathological characteristics; Trends in the management of breast cancer patients; Japanese Breast Cancer Society; Registry; Japan	POSTMENOPAUSAL WOMEN; DUCTAL CARCINOMA; DATABASE; PROGNOSIS; RECEPTOR; OUTCOMES; DISEASE; COHORT; RISK	We conducted a study to analyze the clinicopathological characteristics of breast cancer in Japan registered to the Japanese Breast Cancer Registry of the Japanese Breast Cancer Society (JBCS). Trends in the management of breast cancer patients in Japan were also analyzed. More than 250,000 breast cancer patients were registered to the JBCS registry between 2004 and 2011. Demographic and clinicopathological factors in newly diagnosed primary breast cancer patients were registered to the JBCS through the Web-based system from affiliated institutes nationwide. Two distinct peaks were observed, in patients in their late 40s and early 60s, in the population-adjusted age distribution of breast cancer patients. An increased rate of screen-detected breast cancer may contribute to an earlier detection of breast cancer and increased rate of non-invasive ductal carcinoma. The positive rate of either ER or PgR appears to have increased in recent years. The annual rates of patients treated with breast-conserving surgery increased until 2006, but these increases stopped in 2007 and thereafter plateaued at approximately 60 %. The annual rates of patients treated with sentinel lymph node dissection alone have steadily increased. The annual rates of patients treated with preoperative trastuzumab plus chemotherapy have also increased, as well as those treated with postoperative aromatase inhibitors. The annual rates of patients treated with postoperative anthracycline-containing regimens have decreased, whereas those treated with postoperative taxane-containing regimens have increased. The postoperative use of trastuzumab has markedly increased since 2007. Although this study was based on the registry database, several unique clinicopathological characteristics of breast cancer in Japan have been unveiled. Our results suggest that recent trends in the management of breast cancer patients in Japan were strongly followed by clinical evidence that originated from a number of clinical trials worldwide.	[Kurebayashi, Junichi] Kawasaki Med Univ, Dept Breast & Thyroid Surg, Kurashiki, Okayama 7010192, Japan; [Kurebayashi, Junichi] Japanese Breast Canc Soc, Comm Acad Affairs, Tokyo, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo 6638501, Japan; [Ishikawa, Takashi] Tokyo Med Univ, Dept Breast Oncol, Tokyo 1608402, Japan; [Saji, Shigehira] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan; [Sugie, Tomoharu] Kansai Med Univ, Dept Surg, Hirakata, Osaka, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol & Histotechnol, Sendai, Miyagi 980, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan; [Nozaki, Miwako] Dokkyo Med Univ, Koshigaya Hosp, Dept Radiol, Saitama, Japan; [Yamashita, Hiroko] Hokkaido Univ Hosp, Dept Breast Surg, Sapporo, Hokkaido 060, Japan; [Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Breast & Endocrine Surg, Isehara, Kanagawa 25911, Japan; [Tokuda, Yutaka] Japanese Breast Canc Soc, Comm Breast Canc Registrat, Tokyo, Japan; [Nakamura, Seigo] Showa Univ, Dept Surg, Div Breast Surg Oncol, Tokyo, Japan; [Nakamura, Seigo] Japanese Breast Canc Soc, Board Directors, Tokyo, Japan	Kurebayashi, J (reprint author), Kawasaki Med Univ, Dept Breast & Thyroid Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kure@med.kawasaki-m.ac.jp			Eisai Co.; Chugai Pharmaceutical Co., Ltd	J. Kurebayashi and S. Saji received research funding from Eisai Co. and Chugai Pharmaceutical Co., Ltd, respectively. The other authors declare that they have no competing interests.	Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Heron DE, 2000, CANCER, V88, P2739, DOI 10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.0.CO;2-J; Baum M, 2002, LANCET, V359, P2131; Brouckaert O, 2012, ANN ONCOL, V23, P2578, DOI 10.1093/annonc/mds062; Kim Z, 2014, J BREAST CANCER, V17, P99, DOI 10.4048/jbc.2014.17.2.99; Yamashita H, 2011, ANN ONCOL, V22, P1318, DOI 10.1093/annonc/mdq596; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Jagsi R, 2010, J CLIN ONCOL, V28, P2396, DOI 10.1200/JCO.2009.26.8433; Clarke CA, 2012, J NATL CANCER I, V104, P1094, DOI 10.1093/jnci/djs264; Hosoda M, 2014, BREAST CANCER RES TR, V144, P249, DOI 10.1007/s10549-014-2867-0; Rescigno J, 2009, ANN SURG ONCOL, V16, P687, DOI 10.1245/s10434-008-0195-5; Hartman M, 2007, J CLIN ONCOL, V25, P4210, DOI 10.1200/JCO.2006.10.5056; Ko BS, 2012, J BREAST CANCER, V15, P393, DOI 10.4048/jbc.2012.15.4.393; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Chen AC, 2014, BRIT J CANCER, V111, P619, DOI 10.1038/bjc.2014.301; Ellis IO, 2003, WHO CLASSIFICATION T, P13; Greene FL., 2002, TNM CLASSIFICATION M, P131; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Pant K, 2008, MED ONCOL, V25, P294, DOI 10.1007/s12032-007-9034-y; Tokuda Yutaka, 2014, Nihon Geka Gakkai Zasshi, V115, P17; World Health Organization, 2003, TUMOURS BREAST FEMAL	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					235	244		10.1007/s12282-015-0599-6		10	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400005		
J	Machida, Y; Tozaki, M; Shimauchi, A; Yoshida, T				Machida, Youichi; Tozaki, Mitsuhiro; Shimauchi, Akiko; Yoshida, Tamiko			Breast density: the trend in breast cancer screening	BREAST CANCER			English	Review						Breast cancer; Breast density; Mammography; Screening	HORMONE REPLACEMENT THERAPY; DUAL-ENERGY MAMMOGRAPHY; QUANTITATIVE CLASSIFICATION; PARENCHYMAL PATTERNS; JAPANESE WOMEN; RISK-FACTORS; FOLLOW-UP; MORTALITY; AGE; TRIAL	The primary modality for breast cancer screening is mammography. Recent investigations, however, have indicated that an insufficient number of life-threatening cases have been detected by mammography while mammography can often results in a large number of overdiagnoses. To make breast cancer screening more effective, potential factors that influence screening efficacy need to be elucidated. Breast density is one of limiting factors for breast cancer detection using mammography. In this article, influence of breast density on breast screening is explained. Current topics related to breast density, objective assessment of breast density using applications, revision of breast composition classification in Breast Imaging-Reporting and Data System Mammography fifth edition, and legislative movement regarding breast density in the United States, are also mentioned in this review article.	[Machida, Youichi; Tozaki, Mitsuhiro; Shimauchi, Akiko; Yoshida, Tamiko] Kameda Kyobashi Clin, Dept Radiol, Chuo Ku, Tokyo 1040031, Japan; [Tozaki, Mitsuhiro] Kameda Med Ctr, Breast Ctr, Kamogawa City, Chiba 2968602, Japan; [Shimauchi, Akiko] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, Sendai, Miyagi 9808574, Japan	Machida, Y (reprint author), Kameda Kyobashi Clin, Dept Radiol, Chuo Ku, Tokyo Sq Garden 4F,3-1-1 Kyobashi, Tokyo 1040031, Japan.	mcdmrad@tmd.ac.jp					Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Redondo A, 2012, BRIT J RADIOL, V85, P1465, DOI 10.1259/bjr/21256379; TABAR L, 1985, LANCET, V1, P829; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965-EPI-06-0034; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; Carney PA, 2003, ANN INTERN MED, V138, P168; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Nagata C, 2005, BRIT J CANCER, V92, P2102, DOI 10.1038/sj.bjc.6602643; Le-Petross HT, 2011, CANCER-AM CANCER SOC, V117, P3900, DOI 10.1002/cncr.25971; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Kriege M, 2006, BREAST CANCER RES TR, V100, P109, DOI 10.1007/s10549-006-9230-z; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Ooms EA, 2007, BREAST, V16, P568, DOI 10.1016/j.breast.2007.04.007; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Wong CS, 2011, BRIT J CANCER, V104, P871, DOI 10.1038/sj.bjc.6606085; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Buist DSM, 2004, J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; Bernardi D, 2012, RADIOL MED, V117, P519, DOI 10.1007/s11547-011-0777-3; ANDERSSON I, 1988, BRIT MED J, V297, P943; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Cook AJ, 2010, J CLIN EPIDEMIOL, V63, P441, DOI 10.1016/j.jclinepi.2009.06.008; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Rosenberg RD, 1998, RADIOLOGY, V209, P511; Ducote JL, 2010, MED PHYS, V37, P793, DOI 10.1118/1.3284975; Helvie MA, 2014, CANCER-AM CANCER SOC, V120, P2649, DOI 10.1002/cncr.28784; FRISELL J, 1991, BREAST CANCER RES TR, V18, P49, DOI 10.1007/BF01975443; ROBERTS MM, 1990, LANCET, V335, P241; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Brand JS, 2014, CANCER EPIDEM BIOMAR, V23, P1764, DOI 10.1158/1055-9965.EPI-13-1219; Brem RF, 2015, RADIOLOGY, V274, P663, DOI 10.1148/radiol.14132832; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Ducote JL, 2008, MED PHYS, V35, P5411, DOI 10.1118/1.3002308; Eng A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0439-1; Evans D Gareth, 2014, Breast Cancer Res Treat, V145, P663, DOI 10.1007/s10549-014-2931-9; Hammann-Kloss JS, 2014, EUR J RADIOL, V83, P1092, DOI 10.1016/j.ejrad.2014.03.028; Ho JM, 2014, AM J ROENTGENOL, V203, P449, DOI 10.2214/AJR.13.11969; Kotsuma Y, 2008, BREAST, V17, P27, DOI 10.1016/j.breast.2007.06.002; Machida Y, 2014, JPN J RADIOL, V32, P561, DOI 10.1007/s11604-014-0333-x; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Osako Tomo, 2007, Breast Cancer, V14, P229, DOI 10.2325/jbcs.891; Sickles EA, 2014, ACR BI RADS ATLAS BR, V5th, P123; Sivaramakrishna R, 2001, ACAD RADIOL, V8, P250, DOI 10.1016/S1076-6332(03)80534-2; Skippage P, 2013, BREAST J, V19, P79, DOI 10.1111/tbj.12046; VanDijck JAAM, 1996, INT J CANCER, V66, P727, DOI 10.1002/(SICI)1097-0215(19960611)66:6<727::AID-IJC3>3.0.CO;2-1; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; WOLFE JN, 1987, AM J ROENTGENOL, V148, P1087	54	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					253	261		10.1007/s12282-015-0602-2		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400007		
J	Sakuma, T; Mimura, A; Tanigawa, N; Takamizu, R; Morishima, H; Matsunami, N				Sakuma, Takahiko; Mimura, Akihiro; Tanigawa, Naoto; Takamizu, Ryuichi; Morishima, Hirotaka; Matsunami, Nobuki			Rapid on-site cytologic examination of 1500 breast lesions using the modified Shorr's stain	BREAST CANCER			English	Article						Core-needle biopsy; Fine-needle aspiration; Papanicolaou stain; Rapid on-site evaluation; Shorr stain	FINE-NEEDLE-ASPIRATION; BIOPSY SPECIMENS; IMPRINT CYTOLOGY; FROZEN-SECTION; CORE-BIOPSY; DIAGNOSIS; CANCER; ACCURACY	Rapid on-site evaluation (ROSE) cytology enables sample quality assessment in the procedure room and facilitates the process of examination. While its use for mammary lesions in one-stop breast clinics has been reported, its usefulness as a cytologic diagnostic tool has not been fully explored. A total of 1500 examinations of core-needle biopsy imprint/fine-needle aspiration cytology were performed for outpatients with breast lesions. The slides were immediately processed with modified Shorr's stain, which can be completed within a few minutes yet produces specimens of similar staining quality as the Papanicolaou (Pap) stain. The adequacy of sampling was evaluated on site, and a cytologic diagnosis was also made. ROSE cytologic findings were classified into five grades: class 1, inadequate; class 2, benign; class 3, indeterminate; class 4, suspicious for malignancy; class 5, malignant. If enough epithelial cells could not be obtained despite repeated examinations, the sample was scored as ineligible. These scores were utilized for patient management. Final cytologic diagnoses were made with conventional Pap stains. Reproducibility of scores between both staining methods was excellent (weighted kappa statistic = 0.985). When compared class by class, concordance of cytologic diagnoses was particularly high in class 2 and 5 Shorr scores, in which the agreement with Pap diagnoses was 92.8 and 93.6 %, respectively. Our modified Shorr's staining protocol was useful to reduce the time for the diagnosis and treatment planning of breast lesions suspected of being breast cancer. It is beneficial for both the patients and clinicians.	[Sakuma, Takahiko; Mimura, Akihiro; Tanigawa, Naoto; Takamizu, Ryuichi] Osaka Rosai Hosp, Dept Diagnost Pathol, Kita Ku, Sakai, Osaka 5918025, Japan; [Morishima, Hirotaka; Matsunami, Nobuki] Osaka Rosai Hosp, Dept Surg, Kita Ku, Sakai, Osaka 5918025, Japan	Sakuma, T (reprint author), Atsumi Hosp, Dept Lab Med, 1-1 Akaishi, Tahara, Aichi 4413415, Japan.	thsakuma@atsumi.jaaikosei.or.jp			Japan Labor Health and Welfare Organization	This project was supported by a research fund to promote the hospital functions of the Japan Labor Health and Welfare Organization.	Albert US, 2000, ACTA CYTOL, V44, P57, DOI 10.1159/000326226; GONZALEZ E, 1985, ANN SURG, V202, P696, DOI 10.1097/00000658-198512000-00006; SILVERMAN JF, 1989, ACTA CYTOL, V33, P791; YANG GCH, 1995, ACTA CYTOL, V39, P55; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; BAUERMEISTER DE, 1980, CANCER, V46, P947, DOI 10.1002/1097-0142(19800815)46:4+<947::AID-CNCR2820461316>3.0.CO;2-N; Brunner AH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-341; Farshid G, 2003, CANCER CYTOPATHOL, V99, P357, DOI 10.1002/cncr.11785; GODWIN JT, 1976, ACTA CYTOL, V20, P111; Jones L, 2004, CLIN RADIOL, V59, P903, DOI 10.1016/j.crad.2004.02.016; Klevesath MB, 2005, EJSO, V31, P490, DOI 10.1016/j.ejso.2005.01.004; Kurita T, 2012, BREAST CANCER-TOKYO, V19, P23, DOI 10.1007/s12282-010-0251-4; LAMB J, 1987, J CLIN PATHOL, V40, P705, DOI 10.1136/jcp.40.7.705; MAVEC P, 1967, ACTA CYTOL, V11, P229; MILLER DA, 1986, AM J ROENTGENOL, V147, P155; Mueller-Holzner E, 2007, BREAST CANCER RES TR, V106, P399, DOI 10.1007/s10549-007-9508-9; Nasuti JF, 2002, DIAGN CYTOPATHOL, V27, P1, DOI 10.1002/dc.10065; Qureshi NA, 2007, BREAST, V16, P81, DOI 10.1016/j.breast.2006.07.002; Sakuma T, 2012, J FR OPHTALMOL, V35, DOI 10.1016/j.jfo.2011.08.009; SHORR EPHRAIM, 1941, SCIENCE, V94, P545, DOI 10.1126/science.94.2449.545-a; SNEIGE N, 1994, ACTA CYTOL, V38, P971; Sneige N, 2000, DIAGN CYTOPATHOL, V23, P29, DOI 10.1002/1097-0339(200007)23:1<29::AID-DC7>3.0.CO;2-8; The Japanese Breast Cancer Society, 2012, HIST CLASS BREAST TU, V17th, P70	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					280	286		10.1007/s12282-013-0479-x		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400010		
J	Hamahata, A; Kubo, K; Takei, H; Saitou, T; Hayashi, Y; Matsumoto, H; Nagai, S; Inoue, K; Kurosumi, M; Yamaki, T; Sakurai, H				Hamahata, Atsumori; Kubo, Kazuyuki; Takei, Hiroyuki; Saitou, Takashi; Hayashi, Yuji; Matsumoto, Hiroshi; Nagai, Shigenori; Inoue, Kenichi; Kurosumi, Masafumi; Yamaki, Takashi; Sakurai, Hiroyuki			Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study	BREAST CANCER			English	Article						Breast reconstruction; Adjuvant chemotherapy; Complications	WOUND COMPLICATIONS; MASTECTOMY; CANCER; SURVIVAL; TIME	Various studies have indicated a worldwide increase in the number of immediate breast reconstruction surgeries. However, breast reconstruction should not delay or prevent postoperative cancer therapeutics such as adjuvant chemotherapy and radiotherapy. In response to these developments, our team researched the impact of immediate breast reconstruction on postoperative adjuvant chemotherapy. From April 2006 to March 2011, 116 patients at Saitama Cancer Center underwent postoperative adjuvant chemotherapy following mastectomy with or without immediate breast reconstruction. Fifty patients received postoperative adjuvant chemotherapy following mastectomy with immediate breast reconstruction (IBR group), and 66 patients received the same treatment but without immediate breast reconstruction (non-IBR group). The outcomes were studied retrospectively by chart review. Patients' average age, body mass index, postoperative complication rate, and days to adjuvant chemotherapy were calculated. Mean age and body mass index of patients were 47.0 +/- A 9.0 years, 22.2 +/- A 3.0 kg/m(2) and 55.5 +/- A 10.1 years, 23.0 +/- A 3.6 kg/m(2) in IBR group and non-IBR group, respectively. Postoperative complication rate was 10.0 % in IBR group and 6.1 % in non-IBR group. Days to adjuvant chemotherapy was 61.0 +/- A 10.5 days in IBR group and 58.0 +/- A 12.3 days in non-IBR group. Although complication rate and days to adjuvant chemotherapy were slightly increased in IBR group, the delay was not critical to the initiation of adjuvant chemotherapy in these patient groups.	[Hamahata, Atsumori; Saitou, Takashi] Saitama Canc Ctr, Div Plast & Reconstruct Surg, Kitaadachigunn, Saitama, Japan; [Kubo, Kazuyuki; Takei, Hiroyuki; Hayashi, Yuji; Matsumoto, Hiroshi] Saitama Canc Ctr, Div Breast Surg, Saitama, Japan; [Nagai, Shigenori; Inoue, Kenichi] Saitama Canc Ctr, Div Breast Oncol, Saitama, Japan; [Yamaki, Takashi; Sakurai, Hiroyuki] Tokyo Womens Med Univ, Dept Plast & Reconstruct Surg, Tokyo, Japan	Hamahata, A (reprint author), Saitama Canc Ctr, Div Plast & Reconstruct Surg, 818 Komuro,Inamachi, Kitaadachigunn, Saitama, Japan.	a.hamahata@gmail.com					Alderman AK, 2010, CANCER-AM CANCER SOC, V116, P1791, DOI 10.1002/cncr.24891; Allweis TM, 2002, AM J SURG, V183, P218, DOI 10.1016/S0002-9610(02)00793-6; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Woerdeman LAE, 2007, PLAST RECONSTR SURG, V119, P455, DOI 10.1097/01.prs.0000246379.99318.74; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Gouy S, 2005, ANN SURG ONCOL, V12, P161, DOI 10.1245/ASO.2005.04.003; Mortenson MM, 2004, ARCH SURG-CHICAGO, V139, P988, DOI 10.1001/archsurg.139.9.988; OBRIEN W, 1993, AM J SURG, V166, P1, DOI 10.1016/S0002-9610(05)80572-0; Taylor CW, 2005, BREAST, V14, P18, DOI 10.1016/j.breast.2004.07.004; Zhong T, 2011, ANN SURG ONCOL, V19, P560	10	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					287	291		10.1007/s12282-013-0480-4		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400011		
J	Kurebayashi, J; Kanomata, N; Yamashita, T; Shimo, T; Mizutoh, A; Moriya, T; Sonoo, H				Kurebayashi, Junichi; Kanomata, Naoki; Yamashita, Tetsumasa; Shimo, Toshiro; Mizutoh, Akiko; Moriya, Takuya; Sonoo, Hiroshi			Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab	BREAST CANCER			English	Article						Trastuzumab; Adjuvant therapy; Prognostic factor; pHER2; p53	FOLLOW-UP; CHEMOTHERAPY; RESISTANCE; PTEN; ACTIVATION; THERAPY; EXPRESSION; PATHWAY; TRIAL; CARCINOMAS	Adjuvant trastuzumab has been routinely used in HER2-positive operable breast cancer patients. Prognostic factors remain to be well characterized in these patients and might correlate with primary and/or acquired resistance to trastuzumab. The study subjects were 78 HER2-positive operable breast cancer patients treated with adjuvant chemotherapy followed by 1-year trastuzumab between 2005 and 2010 in our institute. All breast tumors showed a HercepTest score of 3+ or that of 2+ and positive fluorescence in situ hybridization. Expression levels of HER1, phosphorylated HER2 (pY1248), HER3, HER4, and p53 were assessed by immunohistochemistry. Prognostic factors were investigated with univariate and multivariate analyses using the Kaplan-Meier/log-rank test and Cox proportional hazards model, respectively. The median age and follow-up period of the patients were 54 years and 39 months, respectively. The mean tumor size was 2.1 cm and the node-positive rate was 42 %. Eight patients had recurrent diseases but no patient died of cancer. Univariate analysis revealed that pHER2 positivity was only a significantly worse prognostic factor for relapse-free survival (RFS) (P = 0.049). A HercepTest score of 2+ and high expression level of p53 showed a trend. Multivariate analysis revealed three biological markers: pHER2 positivity [hazard ratio (HR) = 11.6, 95 % confidence interval (CI) 1.3-111.1, P = 0.031], p53 positivity (HR = 6.4, 95 % CI 1.0-40.0, P = 0.047) and a HercepTest score of 2+ (HR = 8.6, 95 % CI 1.6-45.2, P = 0.011) to be worse prognostic factors for RFS. Notably, three out of five patients with breast tumors expressing HER2 at a score of 2+ and pHER2 had recurrent diseases. Interestingly, the expression level of pHER2 significantly correlated with the expression levels of HER2 and HER3 in HER2-positive breast tumors. This retrospective cohort study suggests that a lower expression level of HER2 and high expression levels of pHER2 and p53 may indicate a worse prognosis in HER2-positive breast cancer patients treated with trastuzumab and chemotherapy. Further studies are needed to evaluate pHER2 expression in HER2-positive breast cancer as a prognostic and/or predictive marker.	[Kurebayashi, Junichi; Yamashita, Tetsumasa; Shimo, Toshiro; Mizutoh, Akiko; Sonoo, Hiroshi] Kawasaki Med Univ, Dept Breast & Thyroid Surg, Kurashiki, Okayama 7010192, Japan; [Kanomata, Naoki; Moriya, Takuya] Kawasaki Med Univ, Dept Pathol 2, Kurashiki, Okayama 7010192, Japan	Kurebayashi, J (reprint author), Kawasaki Med Univ, Dept Breast & Thyroid Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kure@med.kawasaki-m.ac.jp			Kawasaki Medical School [23-18, 24-5]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23591911]	We thank Mrs. Kaoru Tsuboi and Ms. Megumi Ogo for their technical assistance. This work was supported by research project grants (23-18 and 24-5) from Kawasaki Medical School and by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23591911).	Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Patani N, 2013, INT J CANCER, V133, P1, DOI 10.1002/ijc.27997; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Yonemori K, 2009, MED ONCOL, V26, P344, DOI 10.1007/s12032-008-9127-2; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Hofmann M, 2008, J CLIN PATHOL, V61, P89, DOI 10.1136/jcp.2006.043562; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Wulfkuhle JD, 2012, CLIN CANCER RES, V18, P6426, DOI 10.1158/1078-0432.CCR-12-0452; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Gluck S, 2012, BREAST CANCER RES TR, V132, P781, DOI 10.1007/s10549-011-1412-7; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Montemurro F, 2006, ONCOLOGIST, V11, P318, DOI 10.1634/theoncologist.11-4-318; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Barbareschi M, 2012, VIRCHOWS ARCH, V461, P129, DOI 10.1007/s00428-012-1267-2; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Dowsett M, 2009, J CLIN ONCOL, V27, P2962, DOI 10.1200/JCO.2008.19.7939; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Barros FFT, 2010, HISTOPATHOLOGY, V56, P560, DOI 10.1111/j.1365-2559.2010.03494.x; Cicenas J, 2006, EUR J CANCER, V42, P636, DOI 10.1016/j.ejca.2005.11.012; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Kostler WJ, 2005, J CANCER RES CLIN, V131, P420, DOI 10.1007/s00432-005-0670-3; Kurebayashi J, 2012, BREAST CANC; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P57, DOI 10.1007/s12282-007-0014-z; Taniyama K, 2008, BREAST CANCER-TOKYO, V15, P231, DOI 10.1007/s12282-007-0026-8; Thor AD, 2000, J CLIN ONCOL, V18, P3230; Vu Thuy, 2012, Front Oncol, V2, P62, DOI 10.3389/fonc.2012.00062	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					292	299		10.1007/s12282-013-0478-y		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400012		
J	Kawase, M; Toyama, T; Takahashi, S; Sato, S; Yoshimoto, N; Endo, Y; Asano, T; Kobayashi, S; Fujii, Y; Yamashita, H				Kawase, Mai; Toyama, Tatsuya; Takahashi, Satoru; Sato, Shinya; Yoshimoto, Nobuyasu; Endo, Yumi; Asano, Tomoko; Kobayashi, Shunzo; Fujii, Yoshitaka; Yamashita, Hiroko			FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer	BREAST CANCER			English	Article						Breast cancer; Neoadjuvant chemotherapy; Estrogen receptor; FOXA1	PATHOLOGICAL COMPLETE RESPONSE; PROTEIN-TAU; SYSTEMIC THERAPY; PREDICTIVE-VALUE; KI67 EXPRESSION; SUBTYPES; METAANALYSIS; DOCETAXEL; CONSENSUS; TRIAL	Recent studies have indicated that the response to chemotherapy and the prognostic impact of a pathological complete response (pCR) after neoadjuvant chemotherapy differ among breast cancer subtypes. Predictors of response to chemotherapy and prognostic factors for survival might be different in estrogen receptor (ER)-positive breast cancer. Women with Stage II to III ER-positive HER2-negative breast cancer treated with anthracycline and taxane-containing neoadjuvant chemotherapy between 2003 and 2011 were retrospectively analyzed. Expression of forkhead box A1 (FOXA1), B cell lymphoma 2 (BCL2) and microtubule-associated protein tau (MAPT) as well as ER, progesterone receptor, HER2 and Ki67 was examined by immunohistochemistry in pre- and post-treatment specimens. Factors predictive of response to neoadjuvant chemotherapy and distant disease-free survival were analyzed. Tumor grade was positively correlated with Ki67 expression. Expression levels of ER were positively correlated with expression levels of HER2, BCL2, FOXA1 and MAPT in pre-treatment tumors. The Ki67 labeling index was the only factor that was significantly associated with clinical response measured by the reduction of tumor volume and pCR. Lymph node status, expression of ER before neoadjuvant chemotherapy and expression of FOXA1 after neoadjuvant chemotherapy were significantly associated with distant disease-free survival, both by univariate and multivariate analyses. Patients with ER-positive HER2-negative breast cancer should be selected for neoadjuvant chemotherapy. FOXA1 expression could be a prognostic marker in ER-positive breast cancer.	[Kawase, Mai; Toyama, Tatsuya; Yoshimoto, Nobuyasu; Endo, Yumi; Asano, Tomoko; Kobayashi, Shunzo; Fujii, Yoshitaka; Yamashita, Hiroko] Nagoya City Univ, Grad Sch Med Sci, Oncol Immunol & Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Takahashi, Satoru; Sato, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan; [Yamashita, Hiroko] Hokkaido Univ Hosp, Breast & Endocrine Surg, Kita Ku, Sapporo, Hokkaido 0608648, Japan	Yamashita, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Oncol Immunol & Surg, Mizuho Ku, Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hirokoy@huhp.hokudai.ac.jp					Houssami N, 2012, EUR J CANCER, V48, P3342, DOI 10.1016/j.ejca.2012.05.023; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI [10.1038/sj.bjc.6605736, 10.1038/sj.bjc6605736]; Pusztai L, 2009, J CLIN ONCOL, V27, P4287, DOI 10.1200/JCO.2008.21.6887; Lips EH, 2012, BREAST CANCER RES TR, V131, P827, DOI 10.1007/s10549-011-1488-0; Viale G, 2008, J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Endo Y, 2013, ENDOCR-RELAT CANCER, V20, P91, DOI 10.1530/ERC-12-0207; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; Jones RL, 2010, BREAST CANCER RES TR, V119, P315, DOI 10.1007/s10549-009-0329-x; Allred DC, 1998, MODERN PATHOL, V11, P155; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Montagna E, 2010, BREAST CANCER RES TR, V124, P689, DOI 10.1007/s10549-010-1027-4; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Yamashita H, 2009, CANCER SCI, V100, P2028, DOI 10.1111/j.1349-7006.2009.01274.x; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Baquero MT, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2937; Burcombe R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1508; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; Endo Y, 2011, INT J CLIN ONCOL, V16, P512, DOI 10.1007/s10147-011-0215-5; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Matsubara N, 2013, BREAST CANCER RES TR, V137, P203, DOI 10.1007/s10549-012-2344-6; Piccart-Gebhart MJ, 2010, ONCOLOGIST, V15, P18, DOI 10.1634/theoncologist.2010-S5-18; von Minckwitz G, 2012, BREAST CANCER-TOKYO, V19, P282, DOI 10.1007/s12282-012-0393-7	32	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					308	316		10.1007/s12282-013-0482-2		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400014		
J	Akahane, K; Kato, K; Ogiso, S; Sakaguchi, K; Hashimoto, M; Ishikawa, A; Kato, T; Fuwa, Y; Takahashi, A; Kobayashi, K				Akahane, Kazuhisa; Kato, Kazuo; Ogiso, Seiji; Sakaguchi, Kenji; Hashimoto, Mizuo; Ishikawa, Akira; Kato, Takehiro; Fuwa, Yoshitaka; Takahashi, Ayako; Kobayashi, Kenji			Malignant granular cell tumor of the breast: case report and literature review	BREAST CANCER			English	Review						Malignant granular cell tumor; Breast; Ki67	BENIGN	Granular cell tumors (GCTs) are uncommon soft tissue tumors that mostly occur in patients between 40 and 60 years of age and can occur at various body sites. Malignant granular cell tumors (MGCTs) comprise less than 2 % of GCTs and are mostly found on the lower extremities, especially the thighs. These tumors grow more rapidly than benign GCTs, and most importantly, they can metastasize. We describe an MGCT that presented as a right breast mass in a 79-year-old Japanese woman. Local excision was performed for the primary tumor, which was diagnosed as an atypical GCT, but 15 months later, the tumor recurred at the same site. Thereafter, right mastectomy with axillary lymph node dissection was performed. Metastatic disease was identified in 2 of 12 lymph nodes. The pathological examination revealed that the tumor had progressed to an MGCT after recurrence. Multiple liver, lung and bone metastases were revealed 4 months after the second surgery, and the patient died 34 months after the primary surgery. Our findings highlighted the difficulty in diagnosing MGCTs using histological features alone and suggested the usefulness of Ki67 values. A tumor with a high level of Ki67 should be treated as malignant, even if the tumor has few pathological features of malignancy.	[Akahane, Kazuhisa; Ogiso, Seiji; Sakaguchi, Kenji; Hashimoto, Mizuo; Ishikawa, Akira; Kato, Takehiro; Fuwa, Yoshitaka; Kobayashi, Kenji] Chubu Rosai Hosp, Dept Surg, Nagoya, Aichi, Japan; [Akahane, Kazuhisa] Aichi Hosp, Aichi Canc Ctr, Dept Breast Oncol, Okazaki, Aichi 4440011, Japan; [Kato, Kazuo; Takahashi, Ayako] Chubu Rosai Hosp, Dept Pathol, Nagoya, Aichi, Japan	Akahane, K (reprint author), Aichi Hosp, Aichi Canc Ctr, Dept Breast Oncol, 18 Kuriyado,Kakemachi, Okazaki, Aichi 4440011, Japan.	kazwing2005@yahoo.co.jp					Adeniran Adebowale, 2004, Breast J, V10, P528, DOI 10.1111/j.1075-122X.2004.21525.x; Thacker MM, 2007, CLIN ORTHOP RELAT R, P267, DOI 10.1097/01.blo.0000238786.06231.17; Abrikossoff A, 1926, VIRCHOWS ARCH A, V260, P215, DOI 10.1007/BF02078314; Fanburg-Smith JC, 1998, AM J SURG PATHOL, V22, P779, DOI 10.1097/00000478-199807000-00001; Mahoney A, 2010, AM J DERMATOPATH, V32, P370, DOI 10.1097/DAD.0b013e3181be99e3; Yoshizawa A, 2004, VIRCHOWS ARCH, V444, P304, DOI 10.1007/s00428-003-0957-1; KHANSUR T, 1987, CANCER, V60, P220, DOI 10.1002/1097-0142(19870715)60:2<220::AID-CNCR2820600217>3.0.CO;2-V; Nasser H, 2011, PATHOL RES PRACT, V207, P164, DOI 10.1016/j.prp.2010.12.007; Argenyi ZB, 2006, WHO CLASSIFICATION T, P274; Brown AC, 2011, SURG ONCOL, V20, P97, DOI 10.1016/j.suronc.2009.12.001; Callejo SA, 2000, OPHTHALMOLOGY, V107, P550, DOI 10.1016/S0161-6420(99)00135-9; CHETTY R, 1992, J SURG ONCOL, V49, P135, DOI 10.1002/jso.2930490216; CRAWFORD ES, 1953, CANCER, V6, P786; Cruz-Mojarrieta J, 2001, INT J SURG PATHOL, V9, P255, DOI 10.1177/106689690100900315; Curtis BV, 1997, HEAD NECK-J SCI SPEC, V19, P634, DOI 10.1002/(SICI)1097-0347(199710)19:7<634::AID-HED12>3.0.CO;2-2; Irshad A, 2008, J ULTRAS MED, V27, P467; KRAGEL PJ, 1995, SOUTHERN MED J, V88, P1146; MAZUR MT, 1990, ARCH PATHOL LAB MED, V114, P692; NAKAZATO Y, 1982, Cancer, V49, P1624, DOI 10.1002/1097-0142(19820415)49:8<1624::AID-CNCR2820490816>3.0.CO;2-H; Papalas JA, 2011, ARCH PATHOL LAB MED, V135, P890, DOI 10.1043/2010-0430-OAR.1; Qureshi N A, 2006, Int Semin Surg Oncol, V3, P21, DOI 10.1186/1477-7800-3-21; RAVICH A, 1945, ANN SURG, V121, P361, DOI 10.1097/00000658-194503000-00010; Simsir A, 1996, HUM PATHOL, V27, P853, DOI 10.1016/S0046-8177(96)90462-1; Strong E W, 1970, Cancer, V25, P415, DOI 10.1002/1097-0142(197002)25:2<415::AID-CNCR2820250221>3.0.CO;2-T; UZOARU I, 1992, ARCH PATHOL LAB MED, V116, P206; Yang WT, 2006, J CLIN ULTRASOUND, V34, P153, DOI 10.1002/jcu.20227	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					317	323		10.1007/s12282-012-0362-1		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400015		
J	Tanaka, Y; Bando, H; Hara, H; Ito, Y; Okamoto, Y				Tanaka, Yuko; Bando, Hiroko; Hara, Hisato; Ito, Yasuaki; Okamoto, Yoshifumi			Cystoid macular edema induced by nab-paclitaxel	BREAST CANCER			English	Article						Nab-paclitaxel; Breast cancer; Cystoid macular edema	CYSTIC MACULOPATHY; SECONDARY; THERAPY	Cystoid macular edema (CME) is a rare complication of taxane-based chemotherapy. We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. Early detection of this disease enables continuation of appropriate treatment without reducing the quality of life for patients with end-stage disease. Physicians should be aware of this potential adverse effect, and should make changes to the treatment of patients as soon as possible.	[Tanaka, Yuko; Bando, Hiroko; Hara, Hisato] Univ Tsukuba, Dept Breast Thyroid & Endocrine Surg, Tsukuba, Ibaraki 3058575, Japan; [Ito, Yasuaki; Okamoto, Yoshifumi] Univ Tsukuba, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan	Tanaka, Y (reprint author), Univ Tsukuba, Dept Breast Thyroid & Endocrine Surg, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	choshi_sai_yuu@k6.dion.ne.jp					Yamamoto Y, 2011, ONCOTARGETS THER, V4, P123, DOI 10.2147/OTT.S13836; Ito Sei, 2010, Nippon Ganka Gakkai Zasshi, V114, P23; Joshi MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P709, DOI 10.1001/archopht.125.5.709; Murphy CG, 2010, J CLIN ONCOL, V28, pE684, DOI 10.1200/JCO.2010.30.3750; Smith SV, 2008, ARCH OPHTHALMOL-CHIC, V126, P1605, DOI 10.1001/archopht.126.11.1605; Teitelbaum BA, 2003, OPTOMETRY VISION SCI, V80, P277, DOI 10.1097/00006324-200304000-00004; Telander David G, 2007, Semin Ophthalmol, V22, P151, DOI 10.1080/08820530701457373	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	MAY	2015	22	3					324	326		10.1007/s12282-012-0373-y		3	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH3TO	WOS:000353953400016		
J	Takeuchi, S				Takeuchi, Shingo			A melt viscosity scale for preeruptive magmas	BULLETIN OF VOLCANOLOGY			English	Article						Magma viscosity; Silicate melt; Preeruptive condition; Phase equilibrium; Petrological analysis	CALC-ALKALINE DIFFERENTIATION; HYDROUS PHASE-EQUILIBRIA; SATSUMA-IWOJIMA VOLCANO; PRE-ERUPTIVE CONDITIONS; LESSER-ANTILLES ARC; STORAGE-CONDITIONS; EXPERIMENTAL CONSTRAINTS; BASALTIC ANDESITE; CRYSTAL-BEARING; EXPERIMENTAL CRYSTALLIZATION	A simplified method to estimate preeruptive melt viscosity by using only melt SiO2 content (groundmass SiO2 content) is proposed for sub-alkaline magmas. Melt viscosity is controlled by many magmatic properties (e.g., melt composition, melt water content, and temperature); however, these properties are linked by phase equilibrium in preeruptive magmas. In this study, the magmatic properties were investigated by compiling data of phase equilibria experiments performed under preeruptive conditions. Negative correlations are found between melt SiO2 contents and liquidus temperatures, and between liquidus temperatures and melt water contents. Both increasing melt SiO2 content and decreasing liquidus temperature have the effect of increasing the melt viscosity, producing a linear positive correlation between logarithmic values of melt viscosity and linear values of melt SiO2 content. For a specific melt SiO2 content, an increase in liquidus temperature causes a decrease in melt viscosity, whereas a decrease in water content causes an increase in melt viscosity. As a result of this opposing effect, the melt viscosity is strongly correlated with the melt SiO2 content (the correlation coefficient of similar to 1). Based on this relationship, an empirical equation predicting logarithmic values of preeruptive melt viscosity is proposed as a linear function of melt SiO2 content, referred to as the melt viscosity scale. The equation reproduces melt viscosities for compiled experimental melts and natural melts with root-mean-square deviation of similar to 0.4 and similar to 0.5 log units, respectively. This method provides order-of-magnitude estimates for preeruptive melt viscosity. Its strength is in being applicable to examples for which a full dataset of preeruptive magmatic properties is lacking or has large uncertainties (e.g., slowly cooled lavas). The simplicity of this method enables us to easily and promptly estimate preeruptive melt viscosity. Combined with rheological models for multiphase magmas, the present method can be applied widely and thus greatly increase the number of case studies which include evidence-based estimates of preeruptive magma viscosity.	Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Geosphere Sci, Abiko, Chiba 2701194, Japan	Takeuchi, S (reprint author), Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Geosphere Sci, 1646 Abiko, Abiko, Chiba 2701194, Japan.	takeshin@criepi.denken.or.jp					BEARD JS, 1991, J PETROL, V32, P365; Di Carlo I, 2006, J PETROL, V47, P1317, DOI 10.1093/petrology/egl011; Melekhova E, 2013, NAT GEOSCI, V6, P385, DOI [10.1038/ngeo1781, 10.1038/NGEO1781]; Couch S, 2003, J PETROL, V44, P1455, DOI 10.1093/petrology/44.8.1455; Pertermann M, 2006, J VOLCANOL GEOTH RES, V157, P222, DOI 10.1016/j.jvolgeores.2006.03.043; Kent AJR, 2010, NAT GEOSCI, V3, P631, DOI 10.1038/NGEO924; Hamada M, 2008, CONTRIB MINERAL PETR, V155, P767, DOI 10.1007/s00410-007-0269-6; Feig ST, 2006, CONTRIB MINERAL PETR, V152, P611, DOI 10.1007/s00410-006-0123-2; IMAI N, 1995, GEOSTANDARD NEWSLETT, V19, P135, DOI 10.1111/j.1751-908X.1995.tb00158.x; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Zhang YX, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000216; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; LEBAS MJ, 1986, J PETROL, V27, P745; Bogaerts M, 2006, J PETROL, V47, P2405, DOI 10.1093/petrology/egl049; Jellinek AM, 2003, B VOLCANOL, V65, P363, DOI 10.1007/s00445-003-0277-y; BAGDASSAROV NS, 1994, PHYS EARTH PLANET IN, V83, P83, DOI 10.1016/0031-9201(94)90066-3; Witter JB, 2004, J VOLCANOL GEOTH RES, V134, P303, DOI 10.1016/j.jvolgeores.2004.03.002; SCAILLET B, 1995, J PETROL, V36, P663; Andujar J, 2012, LITHOS, V152, P122, DOI 10.1016/j.lithos.2012.05.009; Moore G, 1998, CONTRIB MINERAL PETR, V130, P304, DOI 10.1007/s004100050367; Hui HJ, 2007, GEOCHIM COSMOCHIM AC, V71, P403, DOI 10.1016/j.gca.2006.09.003; Botcharnikov RE, 2008, J VOLCANOL GEOTH RES, V175, P168, DOI 10.1016/j.jvolgeores.2008.03.026; Pistone M, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008986; Pichavant M, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000315; Parman SW, 2011, J PETROL, V52, P257, DOI 10.1093/petrology/egq079; LEJEUNE AM, 1995, J GEOPHYS RES-SOL EA, V100, P4215, DOI 10.1029/94JB02985; Pichavant M, 2009, J PETROL, V50, P601, DOI 10.1093/petrology/egp014; Szramek L, 2006, J VOLCANOL GEOTH RES, V157, P182, DOI 10.1016/j.volgeores.2006.03.039; Plank T, 2013, EARTH PLANET SC LETT, V364, P168, DOI 10.1016/j.epsl.2012.11.044; Botcharnikov RE, 2008, J PETROL, V49, P1687, DOI 10.1093/petrology/egn043; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Martel C, 1998, EARTH PLANET SC LETT, V156, P89, DOI 10.1016/S0012-821X(98)00003-X; Lejeune AM, 1999, EARTH PLANET SC LETT, V166, P71, DOI 10.1016/S0012-821X(98)00278-7; Scaillet B, 1999, J PETROL, V40, P381, DOI 10.1093/petrology/40.3.381; Grove TL, 1997, CONTRIB MINERAL PETR, V127, P205, DOI 10.1007/s004100050276; Hammer JE, 2002, CONTRIB MINERAL PETR, V144, P144, DOI 10.1007/s00410-002-0393-2; RUBIN AM, 1995, J GEOPHYS RES-SOL EA, V100, P5911, DOI 10.1029/94JB02942; Blundy J, 2008, REV MINERAL GEOCHEM, V69, P179, DOI 10.2138/rmg.2008.69.6; Martel C, 1999, J GEOPHYS RES-SOL EA, V104, P29453, DOI 10.1029/1999JB900191; Sato H, 2013, EARTH PLANETS SPACE, V65, P623, DOI 10.5047/eps.2013.05.018; Caricchi L, 2007, EARTH PLANET SC LETT, V264, P402, DOI 10.1016/j.epsl.2007.09.032; Berndt J, 2005, J PETROL, V46, P135, DOI 10.1093/petrology/egh066; Blatter DL, 2001, GEOCHIM COSMOCHIM AC, V65, P4043, DOI 10.1016/S0016-7037(01)00708-6; Costa F, 2004, J PETROL, V45, P855, DOI 10.1093/petrology/egg114; Ishibashi H, 2009, J VOLCANOL GEOTH RES, V181, P78, DOI 10.1016/j.jvolgeores.2009.01.004; RUTHERFORD MJ, 1985, J GEOPHYS RES-SOLID, V90, P2929, DOI 10.1029/JB090iB04p02929; Grove TL, 2003, CONTRIB MINERAL PETR, V145, P515, DOI 10.1007/s00410-003-0448-z; Takagi D, 2005, CONTRIB MINERAL PETR, V149, P527, DOI 10.1007/s00410-005-0666-7; DEVINE JD, 1995, AM MINERAL, V80, P319; Pichavant M, 2007, CONTRIB MINERAL PETR, V154, P535, DOI 10.1007/s00410-007-0208-6; JOHNSON MC, 1994, REV MINERAL, V30, P281; PINKERTON H, 1992, J VOLCANOL GEOTH RES, V53, P47, DOI 10.1016/0377-0273(92)90073-M; Moune S, 2009, CONTRIB MINERAL PETR, V157, P691, DOI 10.1007/s00410-008-0359-0; SHAW HR, 1972, AM J SCI, V272, P870; Arce JL, 2013, J VOLCANOL GEOTH RES, V249, P49, DOI 10.1016/j.jvolgeores.2012.09.012; Browne B, 2010, INT GEOL REV, V52, P95, DOI 10.1080/00206810903332413; Castro JM, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0702-9; Cottrell E, 1999, CONTRIB MINERAL PETR, V135, P315, DOI 10.1007/s004100050514; Holtz F, 2005, J PETROL, V46, P319, DOI 10.1093/petrology/egh077; Izbekov P, 2004, J VOLCANOL GEOTH RES, V131, P1, DOI 10.1016/S0377-0273(03)00312-3; Larsen JF, 2006, CONTRIB MINERAL PETR, V152, P523, DOI 10.1007/s00410-006-0121-4; Manga M, 2001, J VOLCANOL GEOTH RES, V105, P19, DOI 10.1016/S0377-0273(00)00239-0; MARSH BD, 1988, GEOL SOC AM BULL, V100, P1720, DOI 10.1130/0016-7606(1988)100<1720:CCSARI>2.3.CO;2; Saito G, 2001, J VOLCANOL GEOTH RES, V108, P11, DOI 10.1016/S0377-0273(00)00276-6; Saito G, 2002, EARTH PLANETS SPACE, V54, P303; Scaillet B, 1998, J GEOPHYS RES-SOL EA, V103, P27257, DOI 10.1029/98JB02469; Schmitt AK, 2001, J GEOPHYS RES-SOL EA, V106, P30561, DOI 10.1029/2000JB000089; Shcherbakov VD, 2013, J VOLCANOL GEOTH RES, V263, P132, DOI 10.1016/j.jvolgeores.2013.02.010; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; Stein DJ, 2002, J VOLCANOL GEOTH RES, V113, P243, DOI 10.1016/S0377-0273(01)00260-8; Takeuchi S, 2004, GEOLOGY, V32, P1001, DOI 10.1130/G20792.1; Takeuchi S, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008243; Takeuchi S, 2001, B VOLCANOL, V63, P365; Tomiya A, 2010, J PETROL, V51, P1333, DOI 10.1093/petrology/egq021	74	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0258-8900	1432-0819		B VOLCANOL	Bull. Volcanol.	MAY	2015	77	5							41	10.1007/s00445-015-0929-8		11	Geosciences, Multidisciplinary	Geology	CH7BZ	WOS:000354191900008		
J	Kunii, E; Oguri, T; Kasai, D; Ozasa, H; Uemura, T; Takakuwa, O; Ohkubo, H; Takemura, M; Maeno, K; Niimi, A				Kunii, Eiji; Oguri, Tetsuya; Kasai, Daishi; Ozasa, Hiroaki; Uemura, Takehiro; Takakuwa, Osamu; Ohkubo, Hirotsugu; Takemura, Masaya; Maeno, Ken; Niimi, Akio			Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Organic cation transporter; Cisplatin; Oxaliplatin; Drug resistance; Lung cancer	PLATINUM DRUGS; EXPRESSION; EXPOSURE; GENE; IDENTIFICATION; CHEMOTHERAPY; OXALIPLATIN; MULTIDRUG; SLC22A16; REPAIR	The purposes of this study were to determine whether organic cation transporters (OCTs) can mediate platinum uptake, and whether OCT down-regulation confers resistance against cisplatin (CDDP) in cancer cells. Two lung cancer cell lines, PC-6 and PC-14, and their CDDP-resistant derivatives, PC-6/CDDP and PC-14/CDDP, were analyzed. OCT expression levels were assayed using quantitative RT-PCR and Western blotting. Additionally, the effect of OCT6 overexpression, induced by transfection of the OCT6 gene SLC22A16 using a forced expression vector, on cellular sensitivity to CDDP and on intracellular platinum accumulation was measured using PC-14/CDDP cells. Both gene and protein expression of OCT6 were decreased in both CDDP-resistant cell lines compared with their expression in their respective parental cells. Intracellular accumulation of platinum was decreased in PC-14/CDDP cells compared with the parental cells after CDDP treatment. Furthermore, OCT6 overexpression induced by transfection of the OCT6 gene (SLC22A16) forced expression vector-sensitized PC-14/CDDP cells to CDDP and oxaliplatin (L-OHP) concomitant with increased intracellular concentration of platinum. OCT6 is a mediator of platinum uptake in cancer cells, and down-regulation of OCT6 is possibly one of the mechanisms of resistance against cisplatin in lung cancer.	[Kunii, Eiji; Oguri, Tetsuya; Kasai, Daishi; Uemura, Takehiro; Takakuwa, Osamu; Ohkubo, Hirotsugu; Takemura, Masaya; Maeno, Ken; Niimi, Akio] Nagoya City Univ, Dept Resp Med Allergy & Clin Immunol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Ozasa, Hiroaki] Kyoto Univ, Grad Sch Med, Dept Multidisciplinary Canc Treatment, Sakyo Ku, Kyoto 6068507, Japan	Oguri, T (reprint author), Nagoya City Univ, Dept Resp Med Allergy & Clin Immunol, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	t-oguri@med.nagoya-cu.ac.jp			Kidani Memorial Trust	This study was supported by a Grant-in-Aid from the Kidani Memorial Trust.	Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Enomoto A, 2002, J BIOL CHEM, V277, P36262, DOI 10.1074/jbc.M203883200; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Lal S, 2007, PHARMACOGENOMICS, V8, P567, DOI 10.2217/14622416.8.6.567; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Ishii M, 2000, ANTI-CANCER DRUG, V11, P353, DOI 10.1097/00001813-200006000-00005; Oguri T, 2000, INT J CANCER, V86, P95, DOI 10.1002/(SICI)1097-0215(20000401)86:1<95::AID-IJC15>3.0.CO;2-G; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Kim ES, 2012, J CLIN ONCOL, V30, P3345, DOI 10.1200/JCO.2011.40.8120; Grinfeld J, 2013, BRIT J HAEMATOL, V163, P631, DOI 10.1111/bjh.12591; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769; Koepsell H, 2007, PHARM RES, V24, P1227, DOI 10.1007/s11095-9254-z; Gong SM, 2002, EXP HEMATOL, V30, P1162, DOI 10.1016/S0301-472X(02)00901-3; MORIKAGE T, 1993, CANCER RES, V53, P3302; Oguri T, 2001, INT J CANCER, V93, P584, DOI 10.1002/ijc.1369; Oguri T, 1998, BRIT J CANCER, V77, P1089, DOI 10.1038/bjc.1998.181; Oguri T, 1999, ANN ONCOL, V10, P455, DOI 10.1023/A:1008317502977	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	MAY	2015	75	5					985	991		10.1007/s00280-015-2723-x		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CH5DU	WOS:000354055800013		
J	Kimura, T; Nojiri, T; Hosoda, H; Ishikane, S; Shintani, Y; Inoue, M; Miyazato, M; Okumura, M; Kangawa, K				Kimura, Toru; Nojiri, Takashi; Hosoda, Hiroshi; Ishikane, Shin; Shintani, Yasushi; Inoue, Masayoshi; Miyazato, Mikiya; Okumura, Meinoshin; Kangawa, Kenji			Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in Mice	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						C-type natriuretic peptide; Cisplatin; Nephrotoxicity; Anti-inflammatory	ACUTE KIDNEY INJURY; MESANGIAL CELL-PROLIFERATION; URINARY BIOMARKER; RENAL INJURY; B-RECEPTOR; SYSTEM; INHIBITION; MECHANISMS; RATS; CNP	Cisplatin is a highly effective chemotherapeutic agent used to treat various malignancies, but its utility is compromised by its nephrotoxicity. C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, exhibits anti-inflammatory effects by activating its specific receptor, guanylyl cyclase (GC)-B. CNP and GC-B receptor are known to be expressed in both the vascular endothelium and the kidney. The objective of this study was to investigate the renoprotective effects of CNP in a mouse model of cisplatin-induced nephrotoxicity. C57BL/6 mice were divided into three groups: normal control mice; cisplatin (20 mg/kg, intraperitoneal) mice treated with vehicle; and cisplatin mice treated with CNP (2.5 A mu g/kg/min, subcutaneous). At 72 h after cisplatin injection, urine, blood and kidney samples were collected. Urine and blood samples were examined biochemically. Histological findings and gene expression in kidney tissue were evaluated. CNP reduced histological renal tubular damage and apoptosis induced by cisplatin and suppressed plasma blood urea nitrogen and creatinine levels, which were elevated by cisplatin administration. CNP treatment decreased the expression of kidney injury molecule-1 and monocyte chemoattractant protein-1, which were elevated in the kidney by cisplatin administration. CNP treatment attenuated the decrease in GC-B expression in cisplatin-induced kidney injury. The present study is the first to show that CNP inhibits nephrotoxicity and kidney cell damage induced by cisplatin. The mechanism of action may involve down-regulation of inflammatory cytokine expression in cisplatin-induced kidney injury and attenuation of apoptosis in renal tubular cells.	[Kimura, Toru; Nojiri, Takashi; Ishikane, Shin; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Kimura, Toru; Nojiri, Takashi; Shintani, Yasushi; Inoue, Masayoshi; Okumura, Meinoshin] Osaka Univ Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka, Japan; [Hosoda, Hiroshi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan	Kimura, T (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kimura@thoracic.med.osaka-u.ac.jp			JSPS KAKENHI [26861135]; Takeda Science Foundation	This work was supported in part by a Grant-in-Aid for Young Scientists (JSPS KAKENHI Grant Number 26861135) and a Grant from the Takeda Science Foundation.	SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; Sangaralingham SJ, 2011, AM J PHYSIOL-RENAL, V301, pF943, DOI 10.1152/ajprenal.00170.2011; Dean AD, 1996, AM J PHYSIOL-RENAL, V270, pF311; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Launay-Vacher V, 2008, CANCER CHEMOTH PHARM, V61, P903, DOI 10.1007/s00280-008-0711-0; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Lau AH, 1999, KIDNEY INT, V56, P1295, DOI 10.1046/j.1523-1755.1999.00687.x; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; Whitaker RM, 2013, J PHARMACOL EXP THER, V347, P626, DOI 10.1124/jpet.113.208017; McIlroy DR, 2010, ANESTHESIOLOGY, V112, P998, DOI 10.1097/ALN.0b013e3181cded3f; Lewko B, 2004, KIDNEY INT, V66, P1001, DOI 10.1111/j.1523-1755.2004.00848.x; Mangiafico S, 2013, EUR HEART J, V34, P886, DOI 10.1093/eurheartj/ehs262; Taguchi T, 2005, CONTRIB NEPHROL, V148, P107; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Kim CS, 2012, REGUL PEPTIDES, V174, P65, DOI 10.1016/j.regpep.2011.12.001; CANAANKUHL S, 1992, ENDOCRINOLOGY, V130, P550, DOI 10.1210/en.130.1.550; Canaan-Kuhl S, 1998, KIDNEY INT, V53, P1143, DOI 10.1046/j.1523-1755.1998.00895.x; Del Ry S, 2013, PEPTIDES, V40, P93, DOI 10.1016/j.peptides.2012.12.010; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Igaki T, 1996, Kidney Int Suppl, V55, pS144; Itoh T, 2004, AM J RESP CRIT CARE, V170, P1204, DOI 10.1164/rccm.200404-455OC; Kiemer AK, 2002, ENDOCRINOLOGY, V143, P846, DOI 10.1210/en.143.3.846; Kimura T, 2015, J SURG RES, V194, P631, DOI 10.1016/j.jss.2014.11.023; Lee KW, 2009, TOXICOLOGY, V257, P137, DOI 10.1016/j.tox.2008.12.017; Lohe A, 1995, J AM SOC NEPHROL, V6, P1552; Nojiri T, 2015, CANCER CHEMOTH PHARM, V75, P123, DOI 10.1007/s00280-014-2624-4; Obata H, 2007, BIOCHEM BIOPH RES CO, V356, P60, DOI 10.1016/j.bbrc.2007.02.085; Pham I, 1997, AM J PHYSIOL-REG I, V273, pR1457; Schachner T, 2004, EUR J CARDIO-THORAC, V25, P585, DOI 10.1016/j.ejcts.2003.07.013; Segawa K, 1998, N-S ARCH PHARMACOL, V357, P70	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	MAY	2015	75	5					1057	1063		10.1007/s00280-015-2734-7		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CH5DU	WOS:000354055800020		
J	Hata, Y; Kinoshita, K; Kudo, K; Ikeda, N; Nishida, N				Hata, Yukiko; Kinoshita, Koshi; Kudo, Keiko; Ikeda, Noriaki; Nishida, Naoki			Anomalous origin of the right coronary artery from the left coronary sinus with an intramural course: comparison between sudden-death and non-sudden-death cases	CARDIOVASCULAR PATHOLOGY			English	Article						Coronary artery anomaly; Right coronary artery; Sudden death; Methamphetamine	MANAGEMENT; SEPTUM; AORTA	Background: The prognosis of patients in whom the right coronary artery (RCA) arises from the left coronary sinus (LCS) is unequal. An initial intramural course of the coronary artery within the aortic media is considered to cause myocardial ischemia in cases of coronary anomalies. Methods: Clinicopathological findings in five autopsy cases where the RCA arose from the LCS with an intramural course were examined. Comparison between sudden cardiac death and noncardiac death was also performed. Results: Two of five cases were sudden cardiac death, and the other three cases were noncardiac death. In one case of sudden death, the person collapsed during light exercise, and in the other case, the person was under the effect of methamphetamine. Both of the cases of sudden death showed an RCA-dominant pattern in distribution of the coronary artery, atherosclerotic narrowing of the RCA, and acute ischemic necrosis in the posterior basilar ventricular septum around the atrioventricular conduction system, which is considered to be the territory of the RCA. Conclusions: An intramural course within the aortic media may be an accelerating factor of decreased blood flow in cases with an origin of the RCA arising from the LCS because of compression from the aortic lumen. However, this finding may not be an independent predictor of pathological ischemia. Additional factors that diminish blood flow in the intramural segment may be required to cause significant myocardial ischemia. Additionally, inciting factors, which can increase blood pressure, may also play a role in causing symptomatic myocardial ischemia by initiating mechanical compression from the aorta to the intramural segment of the RCA. (C) 2014 Elsevier Inc. All rights reserved.	[Hata, Yukiko; Kinoshita, Koshi; Nishida, Naoki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Legal Med, Toyama 9300194, Japan; [Kudo, Keiko; Ikeda, Noriaki] Kyushu Univ, Grad Sch Med Sci, Dept Forens Sci, Fukuoka 812, Japan	Nishida, N (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Legal Med, 2630 Sugitani, Toyama 9300194, Japan.	nishida@med.u-toyama.ac.jp		Nishida, Naoki/0000-0002-6921-1768	KAKENHI grant from the Japan Society for the Promotion of Science [24590852]	This work was supported in part by a KAKENHI grant from the Japan Society for the Promotion of Science to Y.H. (24590852).	ANGELINI P, 1989, AM HEART J, V117, P418, DOI 10.1016/0002-8703(89)90789-8; Gulati R, 2007, J THORAC CARDIOV SUR, V134, P1171, DOI 10.1016/j.jtcvs.2007.02.051; TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; VIRMANI R, 1984, J AM COLL CARDIOL, V3, P766; Mallory GK, 1939, AM HEART J, V18, P647; Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0; ROBERTS WC, 1982, AM J CARDIOL, V49, P863, DOI 10.1016/0002-9149(82)91970-1; Erol C, 2011, J COMPUT ASSIST TOMO, V35, P618, DOI 10.1097/RCT.0b013e31822aef59; Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57; KRAGEL AH, 1988, AM J CARDIOL, V62, P771, DOI 10.1016/0002-9149(88)91220-9; Winek CL, 2001, FORENSIC SCI INT, V122, P107, DOI 10.1016/S0379-0738(01)00483-2; Peacock J, 2013, PROG CARDIOVASC DIS, V55, P582, DOI 10.1016/j.pcad.2013.03.001; Kosar P, 2009, DIAGN INTERV RADIOL, V15, P275, DOI 10.4261/1305-3825.DIR.2550-09.1; BURKE AP, 1993, J AM COLL CARDIOL, V21, P117; Frecsura C, 1988, HUM PATHOL, V29, P689; He SY, 1996, JPN J LEGALMED, V50, P63; JAMES TN, 1958, CIRCULATION, V17, P391; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; LIBERTHSON RR, 1979, CIRCULATION, V59, P748; LODGEPATCH I, 1951, BRIT HEART J, V13, P37; Nishida N, 2003, FORENSIC SCI INT, V138, P62, DOI 10.1016/j.forsciint.2003.08.006; Nishida N, 2006, CRIT CARE MED, V34, P363, DOI 10.1097/01.CCM.0000195015.73154.3D; Nishida N, 2005, VIRCHOWS ARCH, V447, P742, DOI 10.1007/s00428-005-0017-0; WHITE NK, 1948, ARCH PATHOL, V45, P766	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	MAY-JUN	2015	24	3					154	159		10.1016/j.carpath.2014.11.004		6	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CH6HB	WOS:000354136100004		
J	Shimizu, S; Funakoshi, Y; Yoon, HE; Okuma, T; Utsumi, T; Ito, N; Sakaguchi, M; Taniguchi, K; Eimoto, T; Matsumura, A				Shimizu, Shigeki; Funakoshi, Yasunobu; Yoon, Hyung-Eun; Okuma, Tomohisa; Utsumi, Tomoki; Ito, Norimasa; Sakaguchi, Masahiro; Taniguchi, Kazuhiro; Eimoto, Tadaaki; Matsumura, Akihide			Small calcifying fibrous pseudotumor of the heart confined to the epicardium	CARDIOVASCULAR PATHOLOGY			English	Article						Calcifying fibrous pseudotumor; Epicardium; Pericardial cavity		A calcifying fibrous pseudotumor (CFPT) is a rare benign lesion that often presents in the upper and lower extremities of children and young adults. In the present report, we describe a case of a small CFPT arising from the epicardium (visceral pericardium) in a 32-year-old woman. The tumor presented as a 25-mm polypoid mass protruding into the pericardial cavity, without extending into the myocardium. A complete resection was performed, and the patient has not experienced any relapse for more than 2 years. On histological examination, the lesion contained densely hyalinized collagen with psammomatous and dystrophic calcifications, as well as patchy chronic inflammatory infiltrate. The localization in the epicardium with no involvement of the myocardium was confirmed by the elastic stain. Amyloid was negative by the Congo red stain. On immunohistochemical analysis, the lesional cells indicated diffuse positive staining for vimentin and factor XIIIa and focal positive staining for CD34, but did not indicate positive staining for other pertinent antigens such as cytokeratins, calretinin, desmin, a-smooth muscle actin, ALK, and estrogen and progesterone receptors as well as IgG4 in plasma cells. To our knowledge, only three cases of CFPT in the heart have been reported in the literature, all of which developed in young females as a large mass involving the epicardium; the lesion also extended to the parietal pericardium in two cases. Moreover, all cases presented with few symptoms, despite the large lesion. In the present case, the CFPT developed also in a young woman, but the lesion was much smaller than those previously published and was localized in the visceral serous membrane of the heart. The findings of this case suggest a potential preferable site of origin of CFPTs of the heart. (C) 2014 Elsevier Inc. All rights reserved.	[Shimizu, Shigeki] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Lab Med & Pathol, Osaka, Japan; [Funakoshi, Yasunobu; Yoon, Hyung-Eun; Utsumi, Tomoki; Ito, Norimasa; Sakaguchi, Masahiro; Matsumura, Akihide] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Surg, Osaka, Japan; [Okuma, Tomohisa] Natl Hosp Org Kinki Chuo Chest Med Ctr, Dept Radiol, Osaka, Japan; [Taniguchi, Kazuhiro] Osaka Rosai Hosp, Japan Labor Hlth & Welf Org, Dept Cardiovasc Surg, Osaka, Japan; [Eimoto, Tadaaki] Okazaki City Med Assoc Publ Hlth Ctr, Pathol Lab, Okazaki, Aichi, Japan; [Shimizu, Shigeki] Hyogo Coll Med, Dept Mol Pathol, Nishinomiya, Hyogo 6638501, Japan	Shimizu, S (reprint author), Hyogo Coll Med, Dept Mol Pathol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	sh-shimizu@hyo-med.ac.jp					Kirby PA, 2006, PEDIATR DEVEL PATHOL, V9, P384, DOI 10.2350/06-01-0022.1; Pinkard NB, 1996, AM J CLIN PATHOL, V105, P189; Goldblum JR, 2013, ENZINGER WEISSS SOFT, V6th, P280; Rudez I, 2011, ANN THORAC SURG, V91, P291, DOI 10.1016/j.athoracsur.2010.06.123; Shigematsu Hisayuki, 2006, J Thorac Cardiovasc Surg, V132, pe21, DOI 10.1016/j.jtcvs.2006.04.042	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	MAY-JUN	2015	24	3					191	193		10.1016/j.carpath.2014.11.003		3	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CH6HB	WOS:000354136100010		
J	Takashima, A; Shimabukuro, M; Tabata, M; Fukuda, D; Uematsu, E; Ishibashi-Ueda, H; Takanashi, S; Sata, M				Takashima, Akira; Shimabukuro, Michio; Tabata, Minoru; Fukuda, Daiju; Uematsu, Etsuko; Ishibashi-Ueda, Hatsue; Takanashi, Shuichiro; Sata, Masataka			Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens	CARDIOVASCULAR PATHOLOGY			English	Article						Coronary endarterectomy; Coronary artery bypass; Percutaneous coronary intervention; In-stent restenosis	BARE-METAL STENTS; DRUG	Here, we histopathologically compare four patients undergoing coronary artery bypass with coronary endarterectomy and onlay patch grafting for in-stent restenosis (ISR) after the implantation of a bare-metal stent (BMS), sirolimus-eluting stent (SES), or paclitaxel-eluting stent (PES) in an everolimus-eluting stent (EES). Heterogeneity of ISR was noted histopathologically. In ISR for BMS, restenosis is likely caused by so-called neoatherosclerosis that occurred which altered the healing process of BMS implantation. Two ISR cases for SES showed a histopathological heterogeneity: one showed nodular calcified thrombus around stent strut protruding into the lumen, and the other showed concentric neointima composed of CD68-positive foam cell proliferation. In the ISR lesion for PES in EES, infiltrations with foam cells macrophages, particularly numerous eosinophilic cell infiltrations, suggest a peristent strut hypersensitivity reaction. We found a remarkable histopathological heterogeneity of ISR. The study using coronary endarterectomy specimens can give us pivotal information about the histopathological heterogeneity of ISR. (C) 2014 Elsevier Inc. All rights reserved.	[Takashima, Akira; Shimabukuro, Michio; Fukuda, Daiju; Uematsu, Etsuko; Sata, Masataka] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Shimabukuro, Michio; Fukuda, Daiju] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiodiabet Med, Tokushima 7708503, Japan; [Tabata, Minoru; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Tokyo, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan	Shimabukuro, M (reprint author), Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiodiabet Med, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	mshimabukuro-ur@umin.ac.jp					Steinberg DH, 2009, AM J CARDIOL, V103, P491, DOI 10.1016/j.amjcard.2008.09.107; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Hao H, 2011, CIRC J, V75, P1548, DOI 10.1253/circj.CJ-11-0393; Takanashi S, 2003, ANN THORAC SURG, V76, P635, DOI 10.1016/S0003-4975(02)05024-5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-8807	1879-1336		CARDIOVASC PATHOL	Cardiovasc. Pathol.	MAY-JUN	2015	24	3					194	197		10.1016/j.carpath.2014.11.002		4	Cardiac & Cardiovascular Systems; Pathology	Cardiovascular System & Cardiology; Pathology	CH6HB	WOS:000354136100011		
J	Takeuchi, H; Taki, Y; Hashizume, H; Asano, K; Asano, M; Sassa, Y; Yokota, S; Kotozaki, Y; Nouchi, R; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Asano, Kohei; Asano, Michiko; Sassa, Yuko; Yokota, Susumu; Kotozaki, Yuka; Nouchi, Rui; Kawashima, Ryuta			The Impact of Television Viewing on Brain Structures: Cross-Sectional and Longitudinal Analyses	CEREBRAL CORTEX			English	Article						children; gray matter volume; television; verbal; white matter volume	VOXEL-BASED MORPHOMETRY; GRAY-MATTER DENSITY; GENERAL INTELLIGENCE; INTERINDIVIDUAL DIFFERENCES; PREFRONTAL CORTEX; PHYSICAL-ACTIVITY; TALAIRACH ATLAS; HEALTHY-ADULTS; YOUNG-ADULTS; BROCAS AREA	Television (TV) viewing is known to affect children's verbal abilities and other physical, cognitive, and emotional development in psychological studies. However, the brain structural development associated with TV viewing has never been investigated. Here we examined cross-sectional correlations between the duration of TV viewing and regional gray/white matter volume (rGMV/rWMV) among 133 boys and 143 girls as well as correlations between the duration of TV viewing and longitudinal changes that occurred a few years later among 111 boys and 105 girls. After correcting for confounding factors, we found positive effects of TV viewing on rGMV of the frontopolar and medial prefrontal areas in cross-sectional and longitudinal analyses, positive effects of TV viewing on rGMV/rWMV of areas of the visual cortex in cross-sectional analyses, and positive effects of TV viewing on rGMV of the hypothalamus/septum and sensorimotor areas in longitudinal analyses. We also confirmed negative effects of TV viewing on verbal intelligence quotient (IQ) in crosssectional and longitudinal analyses. These anatomical correlates may be linked to previously known effects of TV viewing on verbal competence, aggression, and physical activity. In particular, the present results showed effects of TV viewing on the frontopolar area of the brain, which has been associated with intellectual abilities.	[Takeuchi, Hikaru; Taki, Yasuyuki; Hashizume, Hiroshi; Asano, Kohei; Asano, Michiko; Sassa, Yuko] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki; Kawashima, Ryuta] Tohoku Univ, Div Med Neuroimaging Anal, Dept Community Med Supports, Tohoku Med Megabank Org, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Yokota, Susumu; Kawashima, Ryuta] Tohoku Univ, Grad Sch Educ, Sendai, Miyagi 9808575, Japan; [Kotozaki, Yuka] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Nouchi, Rui] Tohoku Univ, Human & Social Response Res Div, Int Res Inst Disaster Sci, Sendai, Miyagi 9808575, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 9808575, Japan	Takeuchi, H (reprint author), Tohoku Univ, Div Dev Cognit Neurosci, IDAC, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	takehi@idac.tohoku.ac.jp			JST/RISTEX; JST/CREST; (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology [23700306]	This study was supported by JST/RISTEX and JST/CREST. This study was supported by a grant-in-aid for Young Scientists (B) (KAKENHI 23700306) from the Ministry of Education, Culture, Sports, Science, and Technology.	Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Lu LH, 2007, CEREB CORTEX, V17, P1092, DOI 10.1093/cercor/bhl019; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Takeuchi H, 2013, NEUROIMAGE, V77, P222, DOI 10.1016/j.neuroimage.2013.04.004; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Modinos G, 2010, PSYCHOL MED, V40, P1423, DOI 10.1017/S0033291709991875; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Colom R, 2006, INTELLIGENCE, V34, P561, DOI 10.1016/j.intell.2006.03.006; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Ramsden S, 2011, NATURE, V479, P113, DOI 10.1038/nature10514; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Takeuchi H, 2011, J NEUROSCI, V31, P12139, DOI 10.1523/JNEUROSCI.2948-11.2011; Johnson JG, 2007, ARCH PEDIAT ADOL MED, V161, P480, DOI 10.1001/archpedi.161.5.480; Andersen RE, 1998, JAMA-J AM MED ASSOC, V279, P938, DOI 10.1001/jama.279.12.938; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Karama S, 2011, NEUROIMAGE, V55, P1443, DOI 10.1016/j.neuroimage.2011.01.016; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Houwen S, 2009, MED SCI SPORT EXER, V41, P103, DOI 10.1249/MSS.0b013e318183389d; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Menary K, 2013, INTELLIGENCE, V41, P597, DOI 10.1016/j.intell.2013.07.010; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Landhuis CE, 2007, PEDIATRICS, V120, P532, DOI 10.1542/peds.2007-0978; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Takeuchi H, 2013, BRAIN STRUCT FUNCT, V218, P1017, DOI 10.1007/s00429-012-0444-z; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hu XC, 2011, NEUROIMAGE, V54, P1994, DOI 10.1016/j.neuroimage.2010.10.024; Konrad A, 2012, J COGNITIVE NEUROSCI, V24, P888, DOI 10.1162/jocn_a_00187; Anderson CA, 2002, SCIENCE, V295, P2377, DOI 10.1126/science.1070765; Latalova K, 2010, PSYCHIAT QUART, V81, P239, DOI 10.1007/s11126-010-9133-3; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Azuma H, 1998, JAPANESE WECHSLER IN; Zimmerman FJ, 2005, ARCH PEDIAT ADOL MED, V159, P619, DOI 10.1001/archpedi.159.7.619; Fujita K., 2006, JAPANESE WECHSLER AD; GADBERRY S, 1980, Journal of Applied Developmental Psychology, V1, P45, DOI 10.1016/0193-3973(80)90061-1; Gentzkow M, 2008, Q J ECON, V123, P279, DOI 10.1162/qjec.2008.123.1.279; GORTMAKER SL, 1990, PUBLIC OPIN QUART, V54, P594, DOI 10.1086/269230; Greenstein B., 2000, COLOR ATLAS NEUROSCI; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Hanggi J, 2010, J COGNITIVE NEUROSCI, V22, P139, DOI 10.1162/jocn.2008.21175; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Johnson JG, 2002, SCIENCE, V295, P2468, DOI 10.1126/science.1062929; OKADA N, 1971, J ANTHROPOL SOC NIP, V79, P139; PAIK H, 1994, COMMUN RES, V21, P516, DOI 10.1177/009365094021004004; POTTS R, 1994, J BROADCAST ELECTRON, V38, P79; Ridley-Johnson R, 1983, J EDUC RES, P294; Silver M., 2010, NEUROIMAGE, V54, P992, DOI DOI 10.1016/J.NEUR0IMAGE.2010.08.049; Takeuchi H, HUM BRAIN MAPP; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Turner R., 2012, PSYCHIAT RES-NEUROIM, V201, P1; Wechsler D., 1997, WAIS 3 ADM SCORING M	64	4	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2015	25	5					1188	1197		10.1093/cercor/bht315		10	Neurosciences	Neurosciences & Neurology	CH2EW	WOS:000353839500006		
J	Murayama, K; Matsumoto, M; Izuma, K; Sugiura, A; Ryan, RM; Deci, EL; Matsumoto, K				Murayama, Kou; Matsumoto, Madoka; Izuma, Keise; Sugiura, Ayaka; Ryan, Richard M.; Deci, Edward L.; Matsumoto, Kenji			How Self-Determined Choice Facilitates Performance: A Key Role of the Ventromedial Prefrontal Cortex	CEREBRAL CORTEX			English	Article						autonomy; intrinsic motivation; orbitofrontal cortex; striatum; value representation	INTRINSIC MOTIVATION; ORBITOFRONTAL CORTEX; DECISION-MAKING; PREDICTION ERRORS; MONETARY REWARD; FRONTAL-CORTEX; HUMAN STRIATUM; NEURAL BASIS; BEHAVIOR; VALUATION	Recent studies have documented that self-determined choice does indeed enhance performance. However, the precise neural mechanisms underlying this effect are not well understood. We examined the neural correlates of the facilitative effects of self-determined choice using functional magnetic resonance imaging (fMRI). Participants played a game-like task involving a stopwatch with either a stopwatch they selected (self-determined-choice condition) or one they were assigned without choice (forced-choice condition). Our results showed that self-determined choice enhanced performance on the stopwatch task, despite the fact that the choices were clearly irrelevant to task difficulty. Neuroimaging results showed that failure feedback, compared with success feedback, elicited a drop in the vmPFC activation in the forced-choice condition, but not in the self-determined-choice condition, indicating that negative reward value associated with the failure feedback vanished in the self-determined-choice condition. Moreover, the vmPFC resilience to failure in the self-determined-choice condition was significantly correlated with the increased performance. Striatal responses to failure and success feedback were not modulated by the choice condition, indicating the dissociation between the vmPFC and striatal activation pattern. These findings suggest that the vmPFC plays a unique and critical role in the facilitative effects of self-determined choice on performance.	[Murayama, Kou] Univ Reading, Sch Psychol & Clin Language Sci, Reading RG6 6AL, Berks, England; [Matsumoto, Madoka; Matsumoto, Kenji] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan; [Izuma, Keise] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Izuma, Keise] Japan Soc Promot Sci, Tokyo 1028471, Japan; [Sugiura, Ayaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Ryan, Richard M.; Deci, Edward L.] Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA	Matsumoto, K (reprint author), Tamagawa Univ, Brain Sci Inst, 6-1-1 Tamagawa Gakuen, Machida, Tokyo 1948610, Japan.	matsumot@lab.tamagawa.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24240061, 4103, 24120717]; Tamagawa University Global Center of Excellence grant from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare, Japan [H24-seishin-ippan-002]	This study was supported by a Grant-in-Aid for Scientific Research (A#24240061; to K.Matsumoto), a Grand-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (#24120717; to K.Matsumoto), and Tamagawa University Global Center of Excellence grant from the Ministry of Education, Culture, Sports, Science, and Technology, and a Grant from the Ministry of Health, Labour, and Welfare (H24-seishin-ippan-002; to K.Matsumoto) Japan.	Amabile KM, 1996, CREATIVITY CONTEXT U; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Weber B, 2009, P NATL ACAD SCI USA, V106, P5025, DOI 10.1073/pnas.0901490106; Huys QJM, 2009, COGNITION, V113, P314, DOI 10.1016/j.cognition.2009.01.008; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moller AC, 2006, PERS SOC PSYCHOL B, V32, P1024, DOI 10.1177/0146167206288008; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Shohamy D, 2011, CURR OPIN NEUROBIOL, V21, P408, DOI 10.1016/j.conb.2011.05.009; Legault L, 2013, J PERS SOC PSYCHOL, V105, P123, DOI 10.1037/a0030426; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Mobbs D, 2009, PSYCHOL SCI, V20, P955, DOI 10.1111/j.1467-9280.2009.02399.x; Murayama K, 2010, P NATL ACAD SCI USA, V107, P20911, DOI 10.1073/pnas.1013305107; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; PEELE DB, 1984, J EXP PSYCHOL ANIM B, V10, P149; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Cordova DI, 1996, J EDUC PSYCHOL, V88, P715, DOI 10.1037/0022-0663.88.4.715; Lee W, 2013, SOC COGN AFFECT NEUR, V8, P538, DOI 10.1093/scan/nss029; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Leotti LA, 2011, PSYCHOL SCI, V22, P1310, DOI 10.1177/0956797611417005; Patall EA, 2008, PSYCHOL BULL, V134, P270, DOI 10.1037/0033-2909.134.2.270; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Van den Broeck A, 2008, WORK STRESS, V22, P277, DOI 10.1080/02678370802393672; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sellitto M, 2010, J NEUROSCI, V30, P16429, DOI 10.1523/JNEUROSCI.2516-10.2010; Kluger AN, 1996, PSYCHOL BULL, V119, P254, DOI 10.1037/0033-2909.119.2.254; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Daniel R, 2010, J NEUROSCI, V30, P47, DOI 10.1523/JNEUROSCI.2205-09.2010; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Cacioppo J. T., 1985, PSYCHOL PROCESSES AD, P91; Carver C. S., 1998, SELF REGULATION BEHA; Deci E. L., 1985, INTRINSIC MOTIVATION; Glascher I, 2010, NEURON, V66, P585; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Kim H, 2007, P NATL ACAD SCI USA, V104, P18253, DOI 10.1073/pnas.0703101104; Kool W, 2013, J COGNITIVE NEUROSCI, V25, P852, DOI 10.1162/jocn_a_00369; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037//0022-3514.32.2.311; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; McArdle JJ, 1990, HDB PSYCHOL AGING, P21; MIKULINCER M, 1988, J SOC CLIN PSYCHOL, V7, P203, DOI 10.1521/jscp.1988.7.2-3.203; O'Doherty JP, 2012, EUR J NEUROSCI, V35, P987, DOI 10.1111/j.1460-9568.2012.08074.x; Passingham RE, 2010, TRENDS COGN SCI, V14, P16, DOI 10.1016/j.tics.2009.11.001; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037//0022-3514.43.3.450; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; SELIGMAN M. E., 1975, HELPLESSNESS DEPRESS	68	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2015	25	5					1241	1251		10.1093/cercor/bht317		11	Neurosciences	Neurosciences & Neurology	CH2EW	WOS:000353839500010		
J	Matsuo, T; Kawasaki, K; Kawai, K; Majima, K; Masuda, H; Murakami, H; Kunii, N; Kamitani, Y; Kameyama, S; Saito, N; Hasegawa, I				Matsuo, Takeshi; Kawasaki, Keisuke; Kawai, Kensuke; Majima, Kei; Masuda, Hiroshi; Murakami, Hiroatsu; Kunii, Naoto; Kamitani, Yukiyasu; Kameyama, Shigeki; Saito, Nobuhito; Hasegawa, Isao			Alternating Zones Selective to Faces and Written Words in the Human Ventral Occipitotemporal Cortex	CEREBRAL CORTEX			English	Article						ECoG; electrocorticography; visual recognition; category selectivity	HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-CORTEX; HUMAN OBJECT AREAS; TEMPORAL-LOBE; FORM AREA; HUMAN BRAIN; INTRACRANIAL RECORDINGS; FUSIFORM GYRUS; PERCEPTION; POTENTIALS	Recognition of faces and written words is associated with category-specific brain activation in the ventral occipitotemporal cortex (vOT). However, topological and functional relationships between face-selective and word-selective vOT regions remain unclear. In this study, we collected data from patients with intractable epilepsy who underwent high-density recording of surface field potentials in the vOT. "Faces" and "letterstrings" induced outstanding category-selective responses among the 24 visual categories tested, particularly in high-gamma band powers. Strikingly, within-hemispheric analysis revealed alternation of face-selective and letterstring-selective zones within the vOT. Two distinct face-selective zones located anterior and posterior portions of the mid-fusiform sulcus whereas letterstring-selective zones alternated between and outside of these 2 face-selective zones. Further, a classification analysis indicated that activity patterns of these zones mostly represent dedicated categories. Functional connectivity analysis using Granger causality indicated asymmetrically directed causal influences from face-selective to letterstring-selective regions. These results challenge the prevailing view that different categories are represented in distinct contiguous regions in the vOT.	[Matsuo, Takeshi; Kawasaki, Keisuke; Hasegawa, Isao] Niigata Univ, Sch Med, Dept Physiol, Niigata 9518510, Japan; [Matsuo, Takeshi; Kawai, Kensuke; Kunii, Naoto; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1138655, Japan; [Majima, Kei; Kamitani, Yukiyasu] ATR Computat Neurosci Labs, Kyoto 6190288, Japan; [Majima, Kei; Kamitani, Yukiyasu] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan; [Masuda, Hiroshi; Murakami, Hiroatsu; Kameyama, Shigeki] Nishi Niigata Chuo Natl Hosp, Dept Neurosurg, Niigata 9502085, Japan; [Hasegawa, Isao] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9518510, Japan	Hasegawa, I (reprint author), Niigata Univ, Sch Med, Dept Physiol, Chuo Ku, 1-757 Asahimachi St, Niigata 9518510, Japan.	ihasegawa-nsu@umin.ac.jp			MEXT of Japan; Takeda Science Foundation; Hayao Nakayama Foundation for Science and Technology and Culture; Niigata University [20A010, 23B008, 23H081]; MHLW of Japan [H23-Nervous and Muscular-General-003]; JSPS KAKENHI [11J08024]	This work was supported by Strategic Research Program for Brain Science from the MEXT of Japan to I.H. and Y.K., 2008 Specified Research grant from Takeda Science Foundation, Grant (A) from Hayao Nakayama Foundation for Science and Technology and Culture to I.H. Grant for Promotion of Niigata University Research Project (20A010, 23B008, 23H081) to I.H., Grant for Comprehensive Research on Disability, Health and Welfare (H23-Nervous and Muscular-General-003) from MHLW of Japan to K.Kawai. and JSPS KAKENHI (11J08024) to K.M.	Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Toda H, 2011, NEUROIMAGE, V54, P203, DOI 10.1016/j.neuroimage.2010.08.003; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Klopp J, 1999, CLIN NEUROPHYSIOL, V110, P676, DOI 10.1016/S1388-2457(98)00039-X; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Weiner KS, 2012, TRENDS COGN SCI, V16, P251, DOI 10.1016/j.tics.2012.03.003; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Chan AM, 2011, J NEUROSCI, V31, P18119, DOI 10.1523/JNEUROSCI.3122-11.2011; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Puce A, 1996, J NEUROSCI, V16, P5205; Allison T, 2002, J NEUROPHYSIOL, V88, P2864, DOI 10.1152/jn.00202.2002; ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Crone NE, 2011, INT J PSYCHOPHYSIOL, V79, P9, DOI 10.1016/j.ijpsycho.2010.10.013; Levy I, 2001, NAT NEUROSCI, V4, P533; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Linden H, 2010, J COMPUT NEUROSCI, V29, P423, DOI 10.1007/s10827-010-0245-4; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Engell AD, 2011, CEREB CORTEX, V21, P1213, DOI 10.1093/cercor/bhq206; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Baker CI, 2007, NAT NEUROSCI, V10, P3, DOI 10.1038/nn0107-3; Barton JJS, 2009, J COGNITIVE NEUROSCI, V22, P1649; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Engell AD, 2012, NEUROIMAGE, V59, P2600, DOI 10.1016/j.neuroimage.2011.08.079; Granger C.W.J., 1969, ECONOMETRICA, V37, P424, DOI DOI 10.2307/1912791; Green DM, 1966, SIGNAL DETECTION THE; Haist F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00181; John K, 2000, HUM BRAIN MAPP, V11, P286; Matsuo Takeshi, 2011, Front Syst Neurosci, V5, P34, DOI 10.3389/fnsys.2011.00034; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Op de Beeck HP, 2008, J NEUROSCI, V28, P11796, DOI 10.1523/JNEUROSCI.3799-08.2008; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; Rolls ET, 2010, OXFORD HDB FACE PERC, P51; Seth Anil, 2007, SCHOLARPEDIA, V2, P1667, DOI [10.4249/scholarpedia.1667, DOI 10.4249/SCHOLARPEDIA.1667]; Talairach J., 1988, COPLANAR STEREOTAXIC; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Vapnik V., 1998, STAT LEARNING THEORY; Vidal JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00195; Vindiola M, 2011, NEUROIMAGE, V54, P2822, DOI 10.1016/j.neuroimage.2010.09.091; Wandell Brian A, 2011, Ann N Y Acad Sci, V1224, P63, DOI 10.1111/j.1749-6632.2010.05954.x; Weiner K, 2013, NEUROIMAGE, V84C, P453; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	72	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2015	25	5					1265	1277		10.1093/cercor/bht319		13	Neurosciences	Neurosciences & Neurology	CH2EW	WOS:000353839500012		
J	Blot, K; Kimura, S; Bai, J; Kemp, A; Manahan-Vaughan, D; Giros, B; Tzavara, E; Otani, S				Blot, Kevin; Kimura, Shin-ichi; Bai, Jing; Kemp, Anne; Manahan-Vaughan, Denise; Giros, Bruno; Tzavara, Eleni; Otani, Satoru			Modulation of Hippocampus-Prefrontal Cortex Synaptic Transmission and Disruption of Executive Cognitive Functions by MK-801	CEREBRAL CORTEX			English	Article						long-term potentiation; MK-801; NMDA receptor hypofunction; prefrontal cortex; schizophrenia	LONG-TERM POTENTIATION; SPATIAL WORKING-MEMORY; NMDA RECEPTOR HYPOFUNCTION; SET-SHIFTING ABILITY; GLUTAMATE RECEPTORS; DOPAMINE RELEASE; MOTOR BEHAVIORS; D1 RECEPTORS; IN-VIVO; SCHIZOPHRENIA	Noncompetitive N-methyl-D-aspartate receptor antagonists such as phencyclidine and MK-801 are known to impair cognitive function in rodents and humans, and serve as a useful tool to study the cellular basis for pathogenesis of schizophrenia cognitive symptoms. In the present study, we tested in rats the effect of MK-801 on ventral hippocampus (HPC)-medial prefrontal cortex (mPFC) synaptic transmission and the performance in 2 cognitive tasks. We found that single injection of MK-801 (0.1 mg/kg) induced gradual and long-lasting increases of the HPC-mPFC response, which shares the common expression mechanisms with long-term potentiation (LTP). But unlike LTP, its induction required no enhanced or synchronized synaptic inputs, suggesting aberrant characteristics. In parallel, rats injected with MK-801 showed impairments of mPFC-dependent cognitive flexibility and HPC-mPFC pathway-dependent spatial working memory. The effects of MK-801 on HPC-mPFC responses and spatial working memory decayed in parallel within 24 h. Moreover, the therapeutically important subtype 2/3 metabotropic glutamate receptor agonist LY379268, which blocked MK-801-induced potentiation, ameliorated the MK-801-induced impairment of spatial working memory. Our results show a novel form of use-independent long-lasting potentiation in HPC-mPFC pathway induced by MK-801, which is associated with impairment of HPC-mPFC projection-dependent cognitive function.	[Blot, Kevin; Kimura, Shin-ichi; Bai, Jing; Giros, Bruno; Tzavara, Eleni; Otani, Satoru] INSERM, UMRS 952, Paris, France; [Blot, Kevin; Kimura, Shin-ichi; Bai, Jing; Giros, Bruno; Tzavara, Eleni; Otani, Satoru] CNRS, UMR 7224, Paris, France; [Blot, Kevin] Univ Paris 05, Paris, France; [Kimura, Shin-ichi; Bai, Jing; Giros, Bruno; Tzavara, Eleni; Otani, Satoru] Univ Paris 06, Paris, France; [Kemp, Anne; Manahan-Vaughan, Denise] Ruhr Univ Bochum, Dept Expt Neurophysiol, Bochum, Germany; [Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp, Montreal, PQ, Canada	Otani, S (reprint author), Ryotokuji Univ, Ctr Med Educ, Akemi 5 Chome,8-1 Urayasu, Chiba 2798567, Japan.	otani@ryotokuji-u.ac.jp			INSERM; CNRS; UPMC; French Ministry of Higher Education and Research	This work was supported by the INSERM, CNRS, UPMC and the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367; Zahrt J, 1997, J NEUROSCI, V17, P8528; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Kargieman L, 2007, P NATL ACAD SCI USA, V104, P14843, DOI 10.1073/pnas.0704848104; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Xi D, 2009, INT J NEUROPSYCHOPH, V12, P1395, DOI 10.1017/S146114570900042X; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Driesen NR, 2008, BIOL PSYCHIAT, V64, P1026, DOI 10.1016/j.biopsych.2008.07.029; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Kos T, 2011, PSYCHOPHARMACOLOGY, V214, P911, DOI 10.1007/s00213-010-2102-6; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Kamiyama H, 2011, NEUROSCIENCE, V177, P159, DOI 10.1016/j.neuroscience.2010.12.012; Hu NW, 2012, PHARMACOL BIOCHEM BE, V100, P855, DOI 10.1016/j.pbb.2011.04.013; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Roenker NL, 2012, NEUROPHARMACOLOGY, V63, P575, DOI 10.1016/j.neuropharm.2012.04.032; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Del Arco A, 2011, PSYCHOPHARMACOLOGY, V214, P525, DOI 10.1007/s00213-010-2055-9; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; WEDZONY K, 1993, BRAIN RES, V622, P325, DOI 10.1016/0006-8993(93)90839-F; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Churchwell JC, 2011, BEHAV BRAIN RES, V225, P389, DOI 10.1016/j.bbr.2011.07.045; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Birrell JM, 2000, J NEUROSCI, V20, P4320; Jodo E, 2005, CEREB CORTEX, V15, P663, DOI 10.1093/cercor/bhh168; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Floresco SB, 1997, J NEUROSCI, V17, P1880; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Egerton A, 2005, PSYCHOPHARMACOLOGY, V179, P77, DOI 10.1007/s00213-004-2109-y; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; Lopez-Gil X, 2007, NEUROPSYCHOPHARMACOL, V32, P2087, DOI 10.1038/sj.npp.1301356; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Bai J, 2014, CEREB CORTEX, V24, P945, DOI 10.1093/cercor/bhs376; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Stefani MR, 2003, BEHAV NEUROSCI, V117, P728, DOI 10.1037/0735-7044.117.4.728; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; Verma A, 1996, J NEUROSCI, V16, P373; Tyson PJ, 2004, PSYCHIAT RES, V129, P229, DOI 10.1016/j.psychres.2004.09.007; Ceaser AE, 2008, BIOL PSYCHIAT, V64, P782, DOI 10.1016/j.biopsych.2008.05.009; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Suzuki Y, 2002, NEUROSCIENCE, V114, P769, DOI 10.1016/S0306-4522(02)00298-1; Gurden H, 1999, NEUROSCIENCE, V94, P1019, DOI 10.1016/S0306-4522(99)00395-4; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Gurden H, 2000, J NEUROSCI, V20, part. no.; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Hasan A, 2012, BRAIN STIMUL, V5, P475, DOI 10.1016/j.brs.2011.08.004; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Everett J, 2001, J PSYCHIATR NEUROSCI, V26, P123; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hasan A, 2012, BEHAV BRAIN RES, V224, P15; Homayoun Houman, 2005, Journal of Neurophysiology (Bethesda), V93, P1989; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Marquis JP, 2008, NEUROBIOL LEARN MEM, V90, P339, DOI 10.1016/j.nlm.2008.04.005; Pinkerton AB, 2004, J MED CHEM, V47, P4595, DOI 10.1021/jm040088h; Stefani MR, 2005, BEHAV NEUROSCI, V119, P420, DOI 10.1037/0735-7044.119.2.420; WEINBERGER DR, 1994, J NEUROPSYCH CLIN N, V6, P419	69	3	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2015	25	5					1348	1361		10.1093/cercor/bht329		14	Neurosciences	Neurosciences & Neurology	CH2EW	WOS:000353839500019		
J	Ito, T; Nakamura, T; Kusaka, E; Kurihara, R; Tanabe, K				Ito, Takeo; Nakamura, Takuma; Kusaka, Eriko; Kurihara, Ryohsuke; Tanabe, Kazuhito			Controlling Localization and Excretion of Nanoparticles by Click Modification of the Surface Chemical Structures inside Living Cells	CHEMPLUSCHEM			English	Article						click chemistry; intracellular behavior; nanoparticles; phospholipids; silicon	GOLD NANOPARTICLES; COPPER-FREE; IN-VIVO; EXOCYTOSIS; CHEMISTRY; SIZE; DELIVERY; INTERNALIZATION; PHOSPHOLIPIDS; ENDOCYTOSIS	Surface modification of silica nanoparticles (SiNPs) inside living cells was conducted by using the copper-free bioorthogonal click reaction to evaluate the effects of surface chemical structures on dynamic behavior and excretion of SiNPs. The results demonstrated the spatial translocation of intracellular SiNPs to the plasma membrane upon surface modification insitu with phospholipids. Moreover, the extent and kinetics of excretion of the SiNPs from inside the cell were enhanced by modification.	[Ito, Takeo; Nakamura, Takuma; Kusaka, Eriko; Kurihara, Ryohsuke; Tanabe, Kazuhito] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	Ito, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan.	takeoito.kyoto@gmail.com; tanabeka@scl.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This study was supported by a Grant-in-Aid for Challenging Exploratory Research and the Program for Fostering Regional Innovation "Kyoto Environmental Nanotechnology Cluster" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Tang L, 2012, ACS NANO, V6, P3954, DOI 10.1021/nn300149c; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; [Anonymous], 2001, ANGEW CHEM, V113, P4254; Mukhopadhyay A, 2012, APPL BIOCHEM BIOTECH, V167, P327, DOI 10.1007/s12010-012-9666-z; Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; [Anonymous], 2008, ANGEW CHEM, V120, P2285; [Anonymous], 2011, ANGEW CHEM, V123, P1294; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/nnano.2010.58, 10.1038/NNANO.2010.58]; Sakhtianchi R, 2013, ADV COLLOID INTERFAC, V201, P18, DOI 10.1016/j.cis.2013.10.013; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Yanes RE, 2013, SMALL, V9, P697, DOI 10.1002/smll.201201811; Mackowiak SA, 2013, NANO LETT, V13, P2576, DOI 10.1021/nl400681f; Teow Y, 2011, CHEM COMMUN, V47, P7025, DOI 10.1039/c0cc05271j; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; Wang YL, 2013, NANOSCALE, V5, P4737, DOI 10.1039/c3nr00796k; Panyam J, 2003, PHARMACEUT RES, V20, P212, DOI 10.1023/A:1022219003551; [Anonymous], 2004, ANGEW CHEM, V116, P6166; Koo H, 2012, ANGEW CHEM INT EDIT, V51, P11836, DOI 10.1002/anie.201206703; Krug HF, 2011, ANGEW CHEM INT EDIT, V50, P1260, DOI 10.1002/anie.201001037; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; [Anonymous], 2012, ANGEW CHEM, V124, P12006; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Somers RC, 2007, CHEM SOC REV, V36, P579, DOI 10.1039/b517613c; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; [Anonymous], 2011, ANGEW CHEM, V123, P9524; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Wu CF, 2010, ANGEW CHEM INT EDIT, V49, P9436, DOI 10.1002/anie.201004260; Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651; [Anonymous], 2010, ANGEW CHEM, V122, P9626; Kim C, 2010, NAT CHEM, V2, P962, DOI [10.1038/nchem.858, 10.1038/NCHEM.858]; Yoon TJ, 2006, SMALL, V2, P209, DOI 10.1002/smll.200500360; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Debets MF, 2011, ACCOUNTS CHEM RES, V44, P805, DOI 10.1021/ar200059z; Chen Y, 2011, ANAL BIOANAL CHEM, V399, P2503, DOI 10.1007/s00216-010-4622-7; Dippe M, 2008, CHEM PHYS LIPIDS, V152, P71, DOI 10.1016/j.chemphyslip.2008.01.005; Dombu CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355102; Goodman G. M., 2004, BIOCONJUGATE CHEM, V15, P897; Goonewardena SN, 2013, CHEMPLUSCHEM, V78, P430, DOI 10.1002/cplu.201300007; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Lie D., 2011, ANGEW CHEM INT EDIT, V50, P9352; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Ryman-Rasmussen JP, 2007, NANO LETT, V7, P1344, DOI 10.1021/nl070375j	46	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	MAY	2015	80	5					796	799		10.1002/cplu.201402436		4	Chemistry, Multidisciplinary	Chemistry	CH3WO	WOS:000353961800002		
J	Fang, YL; Kai, Y; Yanagimoto, T; Song, N; Gao, TX				Fang Yalu; Kai, Yoshiaki; Yanagimoto, Takashi; Song Na; Gao Tianxiang			A new record of Sebastes koreanus from China based on morphological characters and DNA barcoding	CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY			English	Article						Sebastes koreanus; coastal waters of northern China; new record; morphological characters; cytochrome oxidase subunit I (COI)	MITOCHONDRIAL LINEAGES; GENETIC-DIFFERENCES; BLACK ROCKFISH; NORTH-ATLANTIC; SCORPAENIFORMES; PACIFIC; PLATYCEPHALIDAE; TELEOSTEI; MENTELLA; REDFISH	A new record of Sebastes koreanus (Kim and Lee, 1994) was documented based on morphological characters and DNA barcoding. Fifty-six Sebastes specimens were collected from the coastal waters of northern China. Samples were identified as S. koreanus based on morphological characters. The coloration and morphometric measurements were consistent with those described from specimens collected in South Korea. In this study, specimens had the following morphological characteristics: light brown body with dark stripes and tiny dark spots, 4-5 wide indistinct vertical patterns on the side, 2 radial stripes behind and below the eyes, 1 large dark blotch on the opercle. Additionally, the following meristic characters were recorded: dorsal fin XIV-13, pectoral fin 16, anal fin III-6-7, pelvic fin I-5, lateral line scales 29-30, and vertebrae 26. The fragment of cytochrome oxidase subunit I (COI) gene of mitochondrial DNA was sequenced for phylogenetic analysis. The mean genetic distance within the species was 0.3%. Net genetic distances between S. koreanus and other Sebastes species ranged from 3.1% to 7.6%, which was greater than the threshold for species delimitation. The phylogenetic analysis strongly supports the validity of S. koreanus in China at the genetic level. The origion, evolution, patterns of speciation and unique features in genome divergence among primate lineages of this species still need future directions of research.	[Fang Yalu; Song Na] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Kai, Yoshiaki] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Kyoto 6250086, Japan; [Yanagimoto, Takashi] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Gao Tianxiang] Zhejiang Ocean Univ, Fishery Coll, Zhoushan 316000, Peoples R China	Gao, TX (reprint author), Zhejiang Ocean Univ, Fishery Coll, Zhoushan 316000, Peoples R China.	gaotianxiang0611@163.com			National Natural Science Foundation of China [41176117]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120132110009]	Supported by the National Natural Science Foundation of China (No. 41176117) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20120132110009)	Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Kai Y, 2002, MOL ECOL, V11, P2591, DOI 10.1046/j.1365-294X.2002.01628.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kai Y, 2003, ICHTHYOL RES, V50, P239, DOI 10.1007/s10228-003-0163-9; Johansen T, 2000, FISH RES, V49, P179, DOI 10.1016/S0165-7836(00)00193-4; Hyde JR, 2007, MOL PHYLOGENET EVOL, V44, P790, DOI 10.1016/j.ympev.2006.12.026; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Orr JW, 2004, FISH B-NOAA, V102, P328; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; Rocha-Olivares A, 1999, J HERED, V90, P404, DOI 10.1093/jhered/90.3.404; NEDREAAS K, 1994, ICES J MAR SCI, V51, P461, DOI 10.1006/jmsc.1994.1047; Johansen T, 2002, J APPL ICHTHYOL, V18, P177, DOI 10.1046/j.1439-0426.2002.00320.x; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; [卞晓东 BIAN Xiaodong], 2008, [水产学报, Journal of Fisheries of China], V32, P342; Domingues RR, 2013, J APPL ICHTHYOL, V29, P738, DOI 10.1111/jai.12154; Eitner B, 1999, COPEIA, P85, DOI 10.2307/1447388; Gao TX, 2011, ZOOL STUD, V50, P254; Gross M, 2012, CURR BIOL, V22, pR73; He Wen-Ping, 2011, Acta Hydrobiologica Sinica, V35, P565; Jin X B, 2006, FAUNA SINICA CHINA O, P154; Kai Yoshiaki, 2002, Species Diversity, V7, P371; Kai Y, 2012, J FISH BIOL, V81, P954, DOI 10.1111/j.1095-8649.2012.03326.x; Kim Ik-Soo, 1994, Korean Journal of Zoology, V37, P409; Kim IS, 2005, ILLUSTRATED BOOK KOR; Liu C X, 1987, FAUNA LIAONINGICA PI, P381; Love MS, 2002, ROCKFISHES NE PACIFI; Nakabo T., 2000, FISHES JAPAN PICTORI, V2nd; Nelson JS, 2006, FISHES WORLD; Qin Y, 2013, CHIN J OCEANOL LIMN, V31, P617, DOI 10.1007/s00343-013-2186-z; TAMURA K., 2011, MOL BIOL EVOL, V28, P731; Wang Y J, 2011, PERIODIC OCEAN U CHI, V41, P46; Yoon JM, 2007, KOREAN J GENETIC, V29, P437; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zheng J S, 1997, PERIODIC OCEAN U CHI, V27, P333	35	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, 100717, PEOPLES R CHINA	0254-4059	1993-5005		CHIN J OCEANOL LIMN	Chin. J. Oceanol. Limnol.	MAY	2015	33	3					590	596		10.1007/s00343-015-4166-y		7	Limnology; Oceanography	Marine & Freshwater Biology; Oceanography	CH2YL	WOS:000353891400005		
J	Tomita, H; Okumura, K				Tomita, Hirofumi; Okumura, Ken			Is Low Body Weight a Novel Risk Factor for Thromboembolic Events in Patients With Non-Valvular Atrial Fibrillation?	CIRCULATION JOURNAL			English	Editorial Material							J-RHYTHM REGISTRY; JAPANESE PATIENTS; OUTCOMES; GUIDELINES; OBESITY		[Tomita, Hirofumi; Okumura, Ken] Hirosaki Univ, Dept Cardiol, Grad Sch Med, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Dept Cardiol, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@hirosaki-u.ac.jp					Hamatani Y, 2015, CIRC J, V79, P1009, DOI 10.1253/circj.CJ-14-1245; Verma A, 2014, CAN J CARDIOL, V30, P1114, DOI 10.1016/j.cjca.2014.08.001; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Wang J, 2014, CLIN RES CARDIOL, V103, P533, DOI 10.1007/s00392-014-0681-7; Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Suzuki S, 2015, CIRC J, V79, P432, DOI 10.1253/circj.CJ-14-1131	11	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					960	961		10.1253/circj.CJ-15-0307		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700008		
J	Kokubo, Y				Kokubo, Yoshihiro			New Oral Anticoagulants (NOAC) Studies in the Ideal and the Real World - Needs of Prospective Observational Studies	CIRCULATION JOURNAL			English	Editorial Material							NONVALVULAR ATRIAL-FIBRILLATION; WARFARIN		Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan	Kokubo, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	ykokubo@hsp.ncvc.go.jp					Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Saji N, 2015, CIRC J, V79, P1018, DOI 10.1253/circj.CJ-14-1209; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Gomez-Outes A, 2013, THROMBOSIS, V2013, DOI DOI 10.1155/2013/640723; Hobbs FR, 2015, EUR J PREV CARD 0220, DOI [10.1177/2047487315571890, DOI 10.1177/2047487315571890]; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; JCS Joint Working Group, 2013, CIRC J, V78, P1997; Kokubo Y, 2015, AM J HYPERTENS, DOI [10.1093/ajh/hpv038, DOI 10.1093/AJH/HPV038]; National Clinical Guideline Centre (UK), 2014, ATRIAL FIBRILLATION; O'Brien EC, 2015, JAMA INTERN MED 0302, DOI [10.1001/jamainternmed.2015.13, DOI 10.1001/JAMAINTERNMED.2015.13]; Patel AD, 2015, AM J CARDIOL, V115, P641, DOI 10.1016/j.amjcard.2014.12.022; Toyoda K, 2015, INT J STROKE, DOI [10.1111/ijs.12452, DOI 10.1111/IJS.12452]	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					962	963		10.1253/circj.CJ-15-0326		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700009		
J	Hase, M				Hase, Mamoru			Quality of Bystander Cardiopulmonary Resuscitation - Can a Smartphone Bring About a Revolution?	CIRCULATION JOURNAL			English	Editorial Material							SUPPORT		[Hase, Mamoru] Sapporo Med Univ, Sch Med, Dept Emergency Med, Sapporo, Hokkaido 0608543, Japan	Hase, M (reprint author), Sapporo Med Univ, Sch Med, Dept Emergency Med, Chuo Ku, South 1 West 16, Sapporo, Hokkaido 0608543, Japan.	hase@sapmed.ac.jp					Nagao K, 2013, CIRC J, V77, P2742, DOI 10.1253/circj.CJ-13-0457; Paal P, 2012, J EMERG MED, V43, P472, DOI 10.1016/j.jemermed.2011.09.011; [Anonymous], 2010, CIRCULATION, V122, pS250; Kern KB, 2010, RESUSCITATION, V81, P206, DOI 10.1016/j.resuscitation.2009.10.015; Merchant RM, 2010, ANN EMERG MED, V55, P538, DOI 10.1016/j.annemergmed.2010.01.020; Kalz M, 2014, J MED INTERNET RES, V16, P177, DOI 10.2196/jmir.2951; Sakai T, 2015, CIRC J, V79, P1052, DOI 10.1253/circj.CJ-14-1258	7	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					964	965		10.1253/circj.CJ-15-0281		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700010		
J	Morimoto, T				Morimoto, Takeshi			Investigating the Quality of Care in Cardiovascular Medicine	CIRCULATION JOURNAL			English	Editorial Material							OUTCOMES		Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo 6638501, Japan	Morimoto, T (reprint author), Hyogo Coll Med, Dept Clin Epidemiol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	tm@hyo-med.ac.jp					Amalberti R, 2005, ANN INTERN MED, V142, P756; Kawaji T, 2014, CIRC J, V78, P1628, DOI 10.1253/circj.CJ-13-1388; LOHR KN, 1990, NEW ENGL J MED, V322, P707, DOI 10.1056/NEJM199003083221031; GRIFFIN N, 1986, JAMA-J AM MED ASSOC, V256, P1032; HAMMERMEISTER KE, 1995, MED CARE, V33, pOS5, DOI 10.1097/00005650-199510001-00002; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Moskowitz CS, 2008, STAT MED, V27, P3191, DOI 10.1002/sim.3151; The World Bank, GIN IND; Tomoike H, 2015, CIRC J, V79, P1058, DOI 10.1253/circj.CJ-14-1214	9	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					966	968		10.1253/circj.CJ-15-0371		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700011		
J	Motoyama, S; Ito, H; Ozaki, Y				Motoyama, Sadako; Ito, Hajime; Ozaki, Yukio			Can Lipid Tissues Including Epicardial Adipose Tissue (EAT), Visceral Adipose Tissue (VAT) and Coronary Plaque Be Moving in the Same Direction?	CIRCULATION JOURNAL			English	Editorial Material							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ARTERY CALCIFICATION; CALCIUM SCORE; CARDIAC EVENTS; FAT VOLUME; ASSOCIATION; DISEASE; RISK; PROGRESSION; CT		[Motoyama, Sadako; Ito, Hajime; Ozaki, Yukio] Fujita Hlth Univ, Dept Cardiol, Toyoake, Aichi 4701192, Japan; [Motoyama, Sadako] Mt Sinai Hosp, Div Cariol, New York, NY 10029 USA	Ozaki, Y (reprint author), Fujita Hlth Univ, Dept Cardiol, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	ozakiyuk@fujita-hu.ac.jp					Choi EK, 2008, J AM COLL CARDIOL, V52, P357, DOI 10.1016/j.jacc.2008.02.086; Oka T, 2012, INT J CARDIOL, V161, P45, DOI 10.1016/j.ijcard.2011.04.021; Nakanishi R, 2011, ATHEROSCLEROSIS, V218, P363, DOI 10.1016/j.atherosclerosis.2011.07.093; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Tsushima H, 2015, CIRC J, V79, P1084, DOI 10.1253/circj.CJ-14-1169; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Yamamoto H, 2011, CIRC J, V75, P2424, DOI 10.1253/circj.CJ-11-0087; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI [10.1016/j.jcmg.2009.03.009, 10.1016/j.jcmg.2009.03.0]; Gottlieb I, 2010, COLL CARDIOL, V55, P627; Ito T, 2013, INT J CARDIOL, V167, P2852, DOI 10.1016/j.ijcard.2012.07.026; Kawai H, 2014, CIRC J, V78, P2735, DOI 10.1253/circj.CJ-14-0743; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Pursnani A, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002225	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					969	971		10.1253/circj.CJ-15-0329		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700012		
J	Natsuaki, M; Node, K				Natsuaki, Masahiro; Node, Koichi			Glycemic Variability and Cardiac Remodeling in Patients With Acute Myocardial Infarction	CIRCULATION JOURNAL			English	Editorial Material							OXIDATIVE STRESS; GLUCOSE; HYPERGLYCEMIA; MORTALITY; SALVAGE; RISK		[Natsuaki, Masahiro] Saiseikai Fukuoka Gen Hosp, Div Cardiol, Fukuoka 8100001, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan	Natsuaki, M (reprint author), Saiseikai Fukuoka Gen Hosp, Div Cardiol, Chuo Ku, 1-3-46 Tenjin, Fukuoka 8100001, Japan.	natsuaki@kuhp.kyoto-u.ac.jp					Patel A, 2008, NEW ENGL J MED, V358, P2560; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Teraguchi I, 2014, CIRC J, V78, P170, DOI 10.1253/circj.CJ-13-0723; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Gohbara M, 2015, CIRC J, V79, P1092, DOI 10.1253/circj.CJ-14-1226; CHAREONTHAITAWEE P, 1995, J AM COLL CARDIOL, V25, P567, DOI 10.1016/0735-1097(94)00431-O; Fujii H, 2002, JPN HEART J, V43, P203, DOI 10.1536/jhj.43.203; HOCHMAN JS, 1987, CIRCULATION, V75, P299; Yang SW, 2010, HEART, V96, P1444, DOI 10.1136/hrt.2009.189316	14	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					972	973		10.1253/circj.CJ-15-0339		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700013		
J	Inuzuka, R; Abe, J				Inuzuka, Ryo; Abe, Jun			Red Blood Cell Distribution Width as a Link Between Ineffective Erythropoiesis and Chronic Inflammation in Heart Failure	CIRCULATION JOURNAL			English	Editorial Material							IRON-DEFICIENCY; PROGNOSTIC MARKER; DISEASE; ANEMIA; ADULTS; RESISTANCE; MECHANISMS; MORTALITY		[Inuzuka, Ryo] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Abe, Jun] Natl Ctr Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan	Inuzuka, R (reprint author), Univ Tokyo, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inuzukar-tky@umin.ac.jp					Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Tay ELW, 2011, INT J CARDIOL, V151, P307, DOI 10.1016/j.ijcard.2010.05.066; Van der Putten K, 2008, NAT CLIN PRACT NEPHR, V4, P47, DOI 10.1038/ncpneph0655; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Inuzuka R, 2012, CIRCULATION, V125, P250, DOI 10.1161/CIRCULATIONAHA.111.058719; Dimopoulos K, 2009, J AM COLL CARDIOL, V54, P2093, DOI 10.1016/j.jacc.2009.06.050; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Arora NP, 2014, HEART FAIL CLIN, V10, P281, DOI 10.1016/j.hfc.2013.11.002; Emans ME, 2011, J CARD FAIL, V17, P626, DOI 10.1016/j.cardfail.2011.04.009; Martinez-Quintana E, 2013, CONGENIT HEART DIS, V8, P117, DOI 10.1111/j.1747-0803.2012.00708.x; Masutani S, 2013, CIRC J, V77, P2375, DOI 10.1253/circj.CJ-12-1271; Miyamoto K, 2015, CIRC J, V79, P1100, DOI 10.1253/circj.CJ-14-1296; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	15	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					974	975		10.1253/circj.CJ-15-0254		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700014		
J	Nicholls, SJ; Kataoka, Y				Nicholls, Stephen J.; Kataoka, Yu			Lipid Lowering in Patients With Kidney Disease - Is It Really That Hard?	CIRCULATION JOURNAL			English	Editorial Material							LDL CHOLESTEROL; HEART; ROSUVASTATIN; ATORVASTATIN; HEMODIALYSIS; TRIAL		[Nicholls, Stephen J.] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Kataoka, Yu] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Nicholls, SJ (reprint author), South Australian Hlth & Med Res Inst, POB 11060, Adelaide, SA 5001, Australia.	stephen.nicholls@sahmri.com					Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ishii M, 2015, CIRC J, V79, P1115, DOI 10.1253/circj.CJ-14-0789; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Oh J, 2014, CIRC J, V78, P2447, DOI 10.1253/circj.CJ-14-0670	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					976	977		10.1253/circj.CJ-15-0384		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700015		
J	Iso, T; Kurabayashi, M				Iso, Tatsuya; Kurabayashi, Masahiko			Extremely Low Levels of Serum Uric Acid Are Associated With Endothelial Dysfunction in Humans	CIRCULATION JOURNAL			English	Editorial Material							RISK; HYPERTENSION; DISEASE		[Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Iso, Tatsuya] Gunma Univ, Educ & Res Support Ctr, Grad Sch Med, Maebashi, Gumma 3718511, Japan	Iso, T (reprint author), Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	isot@gunma-u.ac.jp					Numa S, 2014, CIRC J, V78, P1600, DOI 10.1253/circj.CJ-13-1385; Waring WS, 2006, DIABETES, V55, P3127, DOI 10.2337/db06-0283; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Morelli M, 2010, PROG BRAIN RES, V183, P183, DOI 10.1016/S0079-6123(10)83010-9; Sugihara S, 2015, CIRC J, V79, P1125, DOI 10.1253/circj.CJ-14-1267; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Verdecchia P, 2000, HYPERTENSION, V36, P1072; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Bobulescu Ion Alexandru, 2012, Adv Chronic Kidney Dis, V19, P358, DOI 10.1053/j.ackd.2012.07.009; De Leeuw PW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027871.86296.92; Ohta T, 2004, NEPHROL DIAL TRANSPL, V19, P1447, DOI 10.1093/ndt/gfh094; Sperling O, 2006, MOL GENET METAB, V89, P14, DOI 10.1016/j.ymgme.2006.03.015	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					978	980		10.1253/circj.CJ-15-0232		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700016		
J	Momomura, S; Seino, Y; Kihara, Y; Adachi, H; Yasumura, Y; Yokoyama, H; Wada, H; Ise, T; Tanaka, K				Momomura, Shin-ichi; Seino, Yoshihiko; Kihara, Yasuki; Adachi, Hitoshi; Yasumura, Yoshio; Yokoyama, Hiroyuki; Wada, Hiroshi; Ise, Takayuki; Tanaka, Koichi		SAVIOR-C Investigators	Adaptive Servo-Ventilation Therapy for Patients With Chronic Heart Failure in a Confirmatory, Multicenter, Randomized, Controlled Study	CIRCULATION JOURNAL			English	Article						Adaptive servo-ventilation; Cardiac function; Chronic heart failure; Noninvasive positive pressure ventilation; Nonpharmacotherapy	SYMPATHETIC-NERVE ACTIVITY; POSITIVE AIRWAY PRESSURE; NONINVASIVE VENTILATION; SLEEP-APNEA; SERVOVENTILATION; RECOMMENDATIONS; EFFICACY; DEVICES; ADULTS	Background: Adaptive servo-ventilation (ASV) therapy is expected to be novel nonpharmacotherapy with hemodynamic effects on patients with chronic heart failure (CHF), but sufficient evidence has not been obtained. Methods and Results: A 24-week, open-label, randomized, controlled study was performed to confirm the cardiac function-improving effect of ASV therapy on CHF patients. At 39 institutions, 213 outpatients with CHF, whose left ventricular ejection fraction (LVEF) was <40% and who had mild to severe symptoms [New York Heart Association (NYHA) class: >= II], were enrolled. After excluding 8 patients, 102 and 103 underwent ASV plus guideline-directed medical therapy (GDMT) [ASV group] and GDMT only [control group], respectively. The primary endpoint was LVEF, and the secondary endpoints were HF deterioration, B-type natriuretic peptide (BNP), and clinical composite response (CCR: NYHA class+HF deterioration). LVEF and BNP improved significantly at completion against the baseline values in the 2 groups. However, no significant difference was found between these groups. HF deterioration tended to be suppressed. The ASV group showed a significant improvement in CCR corroborated by significant improvements in NYHA class and ADL against the control group. Conclusions: Under the present study's conditions, ASV therapy was not superior to GDMT in the cardiac function-improving effect but showed a clinical status-improving effect, thus indicating a given level of clinical benefit.	[Momomura, Shin-ichi; Wada, Hiroshi] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama 3308503, Japan; [Seino, Yoshihiko] Chiba Hokusoh Hosp, Nippon Med Sch, Cardiovasc Ctr, Dept Cardiol, Inzai, Japan; [Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan; [Adachi, Hitoshi] Gunma Prefectural Cardiovasc Ctr, Div Cardiol, Maebashi, Gumma, Japan; [Yasumura, Yoshio] Osaka Natl Hosp, Cardiovasc Div, Osaka, Japan; [Yokoyama, Hiroyuki] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Ise, Takayuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 770, Japan; [Tanaka, Koichi] Miyoshi Cent Hosp, Div Cardiovasc Dis, Miyoshi, Japan	Momomura, S (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	momoshin@omiya.jichi.ac.jp	Murohara, Toyoaki/M-4958-2014		Teijin Pharma Limited	The research fund for SAVIOR-C was provided to the Comprehensive Support Project for Clinical Research of Lifestyle-Related Disease of the Public Health Research Foundation by Teijin Pharma Limited.	Flemons WW, 1999, SLEEP, V22, P667; Rector TS, 2005, J CARD FAIL, V11, P173, DOI 10.1016/j.cardfail.2004.09.002; TAKANO T, 1986, JPN CIRC J, V50, P359; Harada D, 2011, AUTON NEUROSCI-BASIC, V161, P95, DOI 10.1016/j.autneu.2010.12.001; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Philippe C, 2006, HEART, V92, P337, DOI 10.1136/hrt.2005.060038; Haruki N, 2011, EUR J HEART FAIL, V13, P1140, DOI 10.1093/eurjhf/hfr103; Takama N, 2011, CIRC J, V75, P1164, DOI 10.1253/circj.CJ-10-0831; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; NAUGHTON MT, 1995, CIRCULATION, V91, P1725; Koyama T, 2011, CIRC J, V75, P710, DOI 10.1253/circj.CJ-10-0956; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; Ushijima R, 2014, CIRC J, V78, P1387, DOI 10.1253/circj.CJ-13-1468; Yamada S, 2013, CIRC J, V77, P1214, DOI 10.1253/circj.CJ-12-1088; Merlo M, 2011, J AM COLL CARDIOL, V57, P1468, DOI 10.1016/j.jacc.2010.11.030; Chesson AL, 2003, SLEEP, V26, P907; Koyama T, 2013, EUR J HEART FAIL, V15, P902, DOI 10.1093/eurjhf/hft049; Joho S, 2012, J CARD FAIL, V18, P769, DOI 10.1016/j.cardfail.2012.08.360; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540; JCS Joint Working Group, 2013, CIRC J, V77, P2157; JOHNS MW, 1991, SLEEP, V14, P540; KATZ AM, 1989, J AM COLL CARDIOL, V13, P513; Matsuzaki M, GUIDELINES TREATMENT; Momomura S, 2015, HEART VESSELS, V30, P805, DOI 10.1007/s00380-014-0558-8; PACKER M, 1992, LANCET, V340, P92; Sasayama S, 1992, NEW ASPECTS TREATMEN, P113; Seino Y, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0530-z; Takama N, 2014, J CARDIOL, V63, P302, DOI 10.1016/j.jjcc.2013.09.008; Tamura Y, 2014, J CARDIOL	31	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					981	990		10.1253/circj.CJ-15-0221		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700017		
J	Sawa, Y; Yoshikawa, Y; Toda, K; Fukushima, S; Yamazaki, K; Ono, M; Sakata, Y; Hagiwara, N; Kinugawa, K; Miyagawa, S				Sawa, Yoshiki; Yoshikawa, Yasushi; Toda, Koichi; Fukushima, Satsuki; Yamazaki, Kenji; Ono, Minoru; Sakata, Yasushi; Hagiwara, Nobuhisa; Kinugawa, Koichiro; Miyagawa, Shigeru			Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease	CIRCULATION JOURNAL			English	Article						Heart failure; Multicenter study; Myoblast sheets; Regenerative therapy	IMPAIRED MYOCARDIUM; CELL THERAPY; TRANSPLANTATION; IMPLANTATION; TRIAL; CARDIOMYOPATHY; DEVICE	Background: Poor survival outcomes for patients with severe heart failure (HF) and the donor shortage for heart transplantation warrant the development of myocardial regenerative therapy. We performed a multicenter, phase II study to evaluate the safety and efficacy of autologous skeletal myoblast sheets (TCD-51073). Methods and Results: In 3 study sites, we enrolled 7 patients with severe chronic HF due to ischemic heart disease despite maximal therapy, all of whom underwent transplantation of TCD-51073. No serious arrhythmia was reported, and no changes were noted in the frequency of ventricular extrasystole frequency. The primary efficacy endpoint of the change in left ventricular ejection fraction (LVEF) on gated blood-pool scintigraphy at 26 weeks after transplantation showed that 5 subjects were responders (classified as "improved" or "unchanged"). In addition, LVEF on echocardiography improved over time, with a change in LVEF of 7.1 +/- 2.8% at 26 weeks posttransplantation. Among the 7 subjects, 6 showed improvement in New York Heart Association functional class by at least 1 class. The 6-min walk distance was 410.1 +/- 136.1 m before transplantation and 455.4 +/- 103.7 m at 26 weeks after transplantation. Conclusions: This study demonstrated the feasibility and safety of the transplantation of TCD-51073 in the patients with severe chronic HF due to ischemic heart disease, suggesting that TCD-51073 might maintain or improve cardiac function, symptoms, and physical function.	[Sawa, Yoshiki; Yoshikawa, Yasushi; Toda, Koichi; Fukushima, Satsuki; Miyagawa, Shigeru] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yamazaki, Kenji] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo, Japan; [Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan	Sawa, Y (reprint author), Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sawa@surg1.med.osaka-u.ac.jp			Terumo Corporation	UMIN study Identifier: UMIN000008013. Sponsor/Name of Grant: Terumo Corporation.	Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Hare JM, 2013, CIRCULATION, V127, P1630, DOI 10.1161/CIRCULATIONAHA.112.000779; Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Hata H, 2006, J THORAC CARDIOV SUR, V132, P918, DOI 10.1016/j.jtcvs.2006.01.024; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Duckers HJ, 2011, EUROINTERVENTION, V6, P805, DOI 10.4244/EIJV6I7A139; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miyagawa S, 2010, TRANSPLANTATION, V90, P364, DOI 10.1097/TP.0b013e3181e6f201; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005; Shudo Y, 2013, CIRC J, V77, P1063, DOI 10.1253/circj.CJ-12-0615; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sakaguchi T, 2013, CIRC J, V77, P1736, DOI 10.1253/circj.CJ-12-1410; Dib N, 2005, CELL TRANSPLANT, V14, P11, DOI 10.3727/000000005783983296; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; US Food and Drug Administration, 2010, GUID IND CELL THER C	18	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					991	+		10.1253/circj.CJ-15-0243		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700018		
J	Takegami, M; Miyamoto, Y; Yasuda, S; Nakai, M; Nishimura, K; Ogawa, H; Hirata, K; Toh, R; Morino, Y; Nakamura, M; Takeishi, Y; Shimokawa, H; Naito, H				Takegami, Misa; Miyamoto, Yoshihiro; Yasuda, Satoshi; Nakai, Michikazu; Nishimura, Kunihiro; Ogawa, Hisao; Hirata, Ken-ichi; Toh, Ryuji; Morino, Yoshihiro; Nakamura, Motoyuki; Takeishi, Yasuchika; Shimokawa, Hiroaki; Naito, Hiroaki			Comparison of Cardiovascular Mortality in the Great East Japan and the Great Hanshin-Awaji Earthquakes - A Large-Scale Data Analysis of Death Certificates	CIRCULATION JOURNAL			English	Article						Acute myocardial infarction; Great East Japan Earthquake; Hanshin-Awaji Earthquake; Stroke	HEART-DISEASE; CARDIAC DEATH; RISK-FACTORS; DISASTER; FAILURE	Background: Large earthquakes have been associated with cardiovascular disease (CVD) mortality. In Japan, the 1995 Great Hanshin-Awaji (H-A) Earthquake was an urban-underground-type earthquake, whereas the 2011 Great East Japan (GEJ) Earthquake was an ocean-trench type. In the present study, we examined how these different earthquake types affected CVD mortality. Methods and Results: We examined death certificate data from 2008 to 2012 for 131 municipalities in Iwate, Miyagi, and Fukushima prefectures (n=320,348) and from 1992 to 1996 for 220 municipalities in Hyogo, Osaka, and Kyoto prefectures (n=592,670). A Poisson regression model showed significant increases in the monthly numbers of acute myocardial infarction (AMI)-related deaths (incident rate ratio [IRR] GEJ=1.34, P=0.001; IRR of H-A=1.57, P<0.001) and stroke-related deaths (IRR of GEJ=1.42, P<0.001; IRR of H-A=1.33, P<0.001) after the earthquakes. Two months after the earthquakes, AMI deaths remained significant only for H-A (IRR=1.13, P=0.029). When analyzing the standardized mortality ratio (SMR) after the earthquakes using the Cochran-Armitage trend test, seismic intensity was significantly associated with AMI mortality for 2 weeks after both the GEJ (P for trend=0.089) and H-A earthquakes (P for trend=0.005). Conclusions: Following the GEJ and H-A earthquakes, there was a sharp increase in CVD mortality. The effect of the disaster was sustained for months after the H-A earthquake, but was diminished after the GEJ Earthquake.	[Takegami, Misa; Miyamoto, Yoshihiro; Nakai, Michikazu; Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka 5658656, Japan; [Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658656, Japan; [Ogawa, Hisao; Naito, Hiroaki] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka 5658656, Japan; [Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Toh, Ryuji] Kobe Univ, Grad Sch Med, Div Evidence Based Lab Med, Kobe, Hyogo 657, Japan; [Morino, Yoshihiro; Nakamura, Motoyuki] Iwate Med Univ, Sch Med, Div Cardiol, Dept Internal Med, Morioka, Iwate 020, Japan; [Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Takegami, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, 5-7-1 Fujishiro Dai, Suita, Osaka 5658656, Japan.	takegami-kyt@umin.ac.jp			Ministry of Health, Labour and Welfare, Japan	This study was supported by grants from the Ministry of Health, Labour and Welfare, Japan.	Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; Satoh M, 2011, HYPERTENSION, V58, pE193, DOI 10.1161/HYPERTENSIONAHA.111.184077; [Anonymous], WHIT PAP DIS MAN 201; [Anonymous], 2000, REP DEATH GREAT HANS; [Anonymous], 1995, ANN REP POP EST; Aoki T, 2013, CIRC J, V77, P490, DOI 10.1253/circj.CJ-12-1594; [Anonymous], DAT SEISM INT; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; Fuse Akira, 2010, Journal of Nippon Medical School, V77, P318, DOI 10.1272/jnms.77.318; Fuse A, 2011, J NIPPON MED SCH, V78, P401; FUSTER V, 1992, NEW ENGL J MED, V326, P242; Hao K, 2014, CIRC J, V78, P634, DOI 10.1253/circj.CJ-13-1286; Ishii H, 2014, CIRC J, V78, P586, DOI 10.1253/circj.CJ-14-0020; Kario K, 1997, J AM COLL CARDIOL, V29, P926; Kloner RA, 1997, J AM COLL CARDIOL, V30, P1174, DOI 10.1016/S0735-1097(97)00281-7; Leor J, 1996, NEW ENGL J MED, V334, P413, DOI 10.1056/NEJM199602153340701; Nakagawa I, 2009, HEART, V95, P2009, DOI 10.1136/hrt.2009.174201; Nakamura M, 2012, AM J CARDIOL, V110, P1856, DOI 10.1016/j.amjcard.2012.08.020; Niiyama M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000798; Ogawa K, 2000, INT J EPIDEMIOL, V29, P449, DOI 10.1093/ije/29.3.449; Sokejima S, 2004, PREHOSP DISASTER MED, V19, P297; The Report on Damage from the East Japan Earthquake, 2014, 150 FIR DIS MAN AG; The Report on Damage from the Great Hanshin-Awaji Earthquake, 2006, DIN REP FIR DIS MAN; TREVISAN M, 1986, ARTERIOSCLEROSIS, V6, P491; TRICHOPOULOS D, 1983, LANCET, V1, P441; Tsuchida M, 2009, CIRC J, V73, P1243	27	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1000	+		10.1253/circj.CJ-15-0223		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700019		
J	Hamatani, Y; Ogawa, H; Uozumi, R; Iguchi, M; Yamashita, Y; Esato, M; Chun, YH; Tsuji, H; Wada, H; Hasegawa, K; Abe, M; Morita, S; Akao, M				Hamatani, Yasuhiro; Ogawa, Hisashi; Uozumi, Ryuji; Iguchi, Moritake; Yamashita, Yugo; Esato, Masahiro; Chun, Yeong-Hwa; Tsuji, Hikari; Wada, Hiromichi; Hasegawa, Koji; Abe, Mitsuru; Morita, Satoshi; Akao, Masaharu			Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Low body weight; Stroke	RISK-FACTOR; MASS INDEX; PREDICTING STROKE; IMPROVED SURVIVAL; ROCKET AF; WARFARIN; OUTCOMES; RIVAROXABAN; OBESITY; TRIAL	Background: Japanese patients with atrial fibrillation (AF) are generally small and lean, but knowledge of the clinical characteristics of those with low body weight (LBW: <= 50 kg) is limited. Methods and Results: The Fushimi AF Registry is a community-based prospective survey of AF patients who visited the participating medical institutions in Fushmi-ku, Japan. The BW and follow-up data were available for 2,945 patients. We compared the background and the incidence of clinical events during a median follow-up of 746 days between a LBW and non-LBW group. Patients in the LBW group accounted for 26.8% (788 patients) of the total. The LBW group was more often female, older, and had higher CHADS(2) score. The incidence of stroke/systemic embolism (SE) during follow-up was higher in the LBW group (hazard ratio (HR): 2.19, 95% confidence interval (CI): 1.57-3.04; P<0.01), whereas that of major bleeding was comparable (HR: 1.05, 95% CI: 0.64-1.68; P=0.84). This trend was consistently observed in the subgroups stratified by age, sex, and oral anticoagulant prescription at baseline. Multivariate analysis as well as propensity-score matching analysis further supported the significance of LBW as a risk of stroke/SE. Conclusions: Patients in the LBW group had high risk profiles and showed a higher incidence of stroke/SE, but the incidence of major bleeding was not particularly high.	[Hamatani, Yasuhiro; Ogawa, Hisashi; Iguchi, Moritake; Yamashita, Yugo; Abe, Mitsuru; Akao, Masaharu] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto 6128555, Japan; [Uozumi, Ryuji; Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Esato, Masahiro; Chun, Yeong-Hwa] Ijinkai Takeda Gen Hosp, Dept Arrhythmia, Kyoto, Japan; [Tsuji, Hikari] Tsuji Clin, Kyoto, Japan; [Wada, Hiromichi; Hasegawa, Koji] Natl Hosp Org Kyoto Med Ctr, Div Translat Res, Kyoto 6128555, Japan	Akao, M (reprint author), Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	akao@kuhp.kyoto-u.ac.jp			Boehringer Ingelheim; Bayer Healthcare; Pfizer; Bristol-Myers Squibb; Astellas Pharma; AstraZeneca; Daiichi-Sankyo; Novartis Pharma; MSD; Sanofi-Aventis; Takeda Pharmaceutical	The Fushimi AF Registry is supported by research funding from Boehringer Ingelheim, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Astellas Pharma, AstraZeneca, Daiichi-Sankyo, Novartis Pharma, MSD, Sanofi-Aventis and Takeda Pharmaceutical. Dr Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare.	Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Novo G, 2008, BRIT J CLIN PHARMACO, V66, P345, DOI 10.1111/j.1365-2125.2008.03234.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Park DW, 2013, CIRC-CARDIOVASC INTE, V6, P146, DOI 10.1161/CIRCINTERVENTIONS.112.000062; Mak KH, 2009, EUR HEART J, V30, P857, DOI 10.1093/eurheartj/ehp037; Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wang J, 2014, CLIN RES CARDIOL, V103, P533, DOI 10.1007/s00392-014-0681-7; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Weber MA, 2001, J AM COLL CARDIOL, V37, P169, DOI 10.1016/S0735-1097(00)01103-7; Ardestani A, 2010, AM J CARDIOL, V106, P369, DOI 10.1016/j.amjcard.2010.03.036; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; WOLF PA, 1991, STROKE, V22, P983; Conway DSG, 2004, J AM COLL CARDIOL, V43, P2075, DOI 10.1016/j.jacc.2003.11.062; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Higashi Y, 2003, J AM COLL CARDIOL, V42, P256, DOI 10.1016/S0735-1097(03)00630-2; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Kelly Robert V, 2006, J Invasive Cardiol, V18, P115; Lipinski S, 2011, HAMOSTASEOLOGIE, V31, P94, DOI 10.5482/ha-1134; Nakajima K, 2009, OBESITY, V17, P803, DOI 10.1038/oby.2008.596; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; SIMOONS ML, 1993, LANCET, V342, P1523, DOI 10.1016/S0140-6736(05)80089-3; Wassertheil-Smoller S, 2000, ARCH INTERN MED, V160, P494, DOI 10.1001/archinte.160.4.494	33	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1009	1017		10.1253/circj.CJ-14-1245		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700020		
J	Saji, N; Kimura, K; Aoki, J; Uemura, J; Sakamoto, Y				Saji, Naoki; Kimura, Kazumi; Aoki, Junya; Uemura, Junichi; Sakamoto, Yuki			Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) - Multicenter Retrospective Cohort Study in Japan -	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Cerebral hemorrhage; Intracranial hemorrhage; Non-vitamin K antagonist oral anticoagulants	NONVALVULAR ATRIAL-FIBRILLATION; J-RHYTHM REGISTRY; J-ROCKET AF; INTRACEREBRAL HEMORRHAGE; WARFARIN; DABIGATRAN; RIVAROXABAN; STROKE; PREVENTION; MORTALITY	Background: We conducted a multicenter retrospective cohort study to elucidate the characteristics of intracranial hemorrhage (ICH) in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs). Methods and Results: We sent a questionnaire to the directors of 241 stroke centers in Japan to establish the clinical characteristics of NOAC-associated cerebral hemorrhage (CH), including hematoma size, hematoma enlargement (HE) and in-hospital mortality of patients treated in their institutions. We undertook a literature review to establish the clinical characteristics of warfarin-associated CH and compared these with our data. We received 174 responses (72.2%), of which 67 (38.5%) gave anonymous details of 130 eligible patients (male, 67.7%; mean age, 77.3 +/- 8.3 years, in-hospital mortality rate, 11.5%). We judged that 87 of the 130 patients had presented with CH: one-fifth had taken antiplatelet drugs. We found that the incidences of HE and mortality in the 87 patients presenting with NOAC-associated CH were lower than would have been expected in those with warfarin-associated CH (17% vs. 26%, and 16% vs. 35%, respectively). Conclusions: More than half the stroke center directors who responded to our questionnaire had not experienced cases of NOAC-associated ICH. Compared with warfarin, NOACs appear to present a lower risk of HE and death in patients with atrial fibrillation who develop CH.	[Saji, Naoki; Uemura, Junichi] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama 7010192, Japan; [Kimura, Kazumi; Aoki, Junya; Sakamoto, Yuki] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Tokyo 113, Japan	Saji, N (reprint author), Kawasaki Med Univ, Dept Stroke Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	sajink@nifty.com			Japan Society for the Promotion of Science [26870765]	Dr Saji received a research grant from the Grant-in-Aid for Scientific Research program (No. 26870765) of the Japan Society for the Promotion of Science.	Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882; Hori M, 2014, CIRC J, V78, P1349, DOI 10.1253/circj.CJ-13-1324; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Simonsen CZ, 2014, J STROKE CEREBROVASC, V23, pE133, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.011; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI 10.1093/eurheartj/ehq278; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Okumura K, 2014, CIRC J, V78, P1593, DOI 10.1253/circj.CJ-14-0144; Toyoda K, 2009, CEREBROVASC DIS, V27, P151, DOI 10.1159/000177924; Alonso A, 2014, STROKE, V45, P2286, DOI 10.1161/STROKEAHA.114.006016; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Witt DM, 2013, THROMB RES, V132, P770, DOI 10.1016/j.thromres.2013.10.024; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Singer DE, 2009, ANN INTERN MED, V151, P297; Laliberte F, 2014, CURR MED RES OPIN, V30, P1317, DOI 10.1185/03007995.2014.907140; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Cameron C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004301; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Chen YW, 2013, EUR J NEUROL, V20, P1128, DOI 10.1111/j.1468-1331.2012.03847.x; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Horstmann S, 2013, J NEUROL, V260, P2046, DOI 10.1007/s00415-013-6939-6; Inoue H, 2014, CIRC J, V78, P2388, DOI 10.1253/circj.CJ-14-0507; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kono S, 2014, STROKE, V45, P2404, DOI 10.1161/STROKEAHA.114.005316; Kosiuk J, 2014, CIRC J, V78, P2402, DOI 10.1253/circj.CJ-14-0665; Kothari Rashmi U., 1996, Stroke, V27, P1304; Kuwashiro T, 2010, CEREBROVASC DIS, V29, P446, DOI 10.1159/000289348; Liotta EM, 2012, STROKE, V43, P2503, DOI 10.1161/STROKEAHA.112.664540; Sabir I, 2014, NAT REV CARDIOL, V11, P290, DOI 10.1038/nrcardio.2014.22; Saji Naoki, 2014, Cerebrovasc Dis Extra, V4, P174, DOI 10.1159/000365565; Tanahashi N, 2013, J STROKE CEREBROVASC, V22, P1317, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.010	40	4	4	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1018	+		10.1253/circj.CJ-14-1209		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700021		
J	Maeda, K; Kuratani, T; Torikai, K; Mizote, I; Ichibori, Y; Onishi, T; Nakatani, S; Sakata, Y; Toda, K; Sawa, Y				Maeda, Koichi; Kuratani, Toru; Torikai, Kei; Mizote, Isamu; Ichibori, Yasuhiro; Onishi, Toshinari; Nakatani, Satoshi; Sakata, Yasushi; Toda, Koichi; Sawa, Yoshiki			New Self-Expanding Transcatheter Aortic Valve Device for Transfemoral Implantation - Early Results of the First-in-Asia Implantation of the ACURATE Neo/TF (TM) System -	CIRCULATION JOURNAL			English	Article						Aortic stenosis; Japanese; Valvular disease	HIGH-RISK PATIENTS; REPLACEMENT; STENOSIS; PROSTHESIS; COREVALVE; REGISTRY; JAPAN	Background: Feasibility and early results of transfemoral aortic valve implantation using the ACURATE neo/TF (TM) self-expanding stent are reported. Methods and Results: The study group of 15 patients (mean age 83.3 +/- 6.0) was enrolled with a mean EuroSCORE and STS score of 21.9 +/- 11.6% and 7.5 +/- 3.1%, respectively. Clinical and echocardiographic evaluations were performed at baseline, discharge, 30 days and 6 months. The primary endpoint was all-cause mortality at 30 days. Transcatheter aortic valve implantation (TAVI) using the ACURATE neo/TF device was successful in 14 patients; 1 patient underwent valve-in-valve implantation because the prosthetic valve embolized during withdrawal of the delivery system. Conversion to surgery, coronary obstruction, peri-operative stroke, and pacemaker implantation did not occur at 30 days. Mean transvalvular gradients at discharge significantly decreased from 44.2 +/- 10.5 mmHg (preprocedural) to 7.7 +/- 3.1 mmHg (P<0.0001) and effective orifice area significantly increased from 0.77 +/- 0.12 to 1.69 +/- 0.25 cm(2) (P<0.0001). None or trace paravalvular leak was revealed in 50.0%, and no patient exhibited moderate or higher paravalvular leak. The overall mortality at 30 days and 6 months was 0% and 6.7%, respectively. Conclusions: A new self-expanding TF TAVI device, ACURATE neo/TF, is safe and effective in the treatment of severe aortic stenosis in elderly patients at high risk for surgery.	[Maeda, Koichi; Kuratani, Toru; Torikai, Kei; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Mizote, Isamu; Ichibori, Yasuhiro; Onishi, Toshinari; Nakatani, Satoshi; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiol, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sawa@surg1.med.osaka-u.ac.jp			Symetis S.A.	The study was supported by Symetis S.A. (device donation and training/proctoring provision only).	Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Maeda K, 2013, CIRC J, V77, P359, DOI 10.1253/circj.CJ-12-0650; Kempfert J, 2013, EUR J CARDIO-THORAC, V43, P52, DOI 10.1093/ejcts/ezs139; Buellesfeld L, 2011, J AM COLL CARDIOL, V57, P1650, DOI 10.1016/j.jacc.2010.11.044; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Grube E, 2014, EUR HEART J, V35, P490, DOI 10.1093/eurheartj/eht558; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI 10.1016/j.jacc.2012.09.001; Bates MGD, 2011, INTERACT CARDIOV TH, V12, P243, DOI 10.1510/icvts.2010.256578; Chiam PTL, 2009, AM HEART J, V157, P229, DOI 10.1016/j.ahj.2008.10.003; De Jaegere Peter P Th, 2008, EuroIntervention, V4, P351, DOI 10.4244/EIJV4I3A63; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Singh IM, 2008, CLEV CLIN J MED, V75, P805; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Treede H, 2012, EUR J CARDIO-THORAC, V41, pe131, DOI 10.1093/ejcts/ezs129	20	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1037	+		10.1253/circj.CJ-14-1110		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700024		
J	Matsumoto, Y; Fujita, T; Hata, H; Shimahara, Y; Sato, S; Kobayashi, J				Matsumoto, Yorihiko; Fujita, Tomoyuki; Hata, Hiroki; Shimahara, Yusuke; Sato, Shunsuke; Kobayashi, Junjiro			Hemodynamic Performance and Durability of Mosaic Bioprostheses for Aortic Valve Replacement, up to 13 Years	CIRCULATION JOURNAL			English	Article						Aortic valve replacement; Bioprosthesis; Small valve	PROSTHESIS-PATIENT MISMATCH; EDWARDS PERICARDIAL VALVE; LEFT-VENTRICULAR MASS; CLINICAL IMPACT; FOLLOW-UP; POSITION; PORCINE; PREVENTION; STENOSIS; BOVINE	Background: This study evaluated the mid to long-term durability and hemodynamics of the small-size Mosaic bioprosthesis, a third-generation stented porcine bioprosthesis, for aortic valve replacement (AVR). Methods and Results: From 2000 to 2012, 207 patients (117 women; age, 74 +/- 8 years; body surface area, 1.48 +/- 0.25m(2)) underwent AVR with a Mosaic bioprosthesis. The mean follow-up period was 3.5 +/- 2.7 years (maximum, 12.4 years) and the follow-up rate was 93.7%. A 19-, 21-, 23-, 25-, and 27-mm prosthesis was used in 103, 53, 35, 13, and 3 patients, respectively. The measured effective orifice area was 1.17 +/- 0.25, 1.29 +/- 0.19, 1.39 +/- 0.24, and 1.69 cm(2) for the 19-25 mm prostheses, and the mean transvalvular pressure gradient was 19.4 +/- 6.0, 18.5 +/- 5.8, 16.5 +/- 7.3, and 13.2 +/- 2.9 mmHg, respectively. The left ventricular mass regression was significant (P<0.05) with rates of 74.6 +/- 18.8%, 75.5 +/- 30.2%, 68.1 +/- 30.5%, 55.9 +/- 12.9%, and 49.2%, respectively. The 30-day mortality rate was 1.9% and the 5- and 10-year actuarial survival rates were 86.0% and 73.7%, respectively. Valve-related comorbidities occurred in 3 patients (structural valve deterioration [SVD] in 1 after 7.2 years, and prosthetic valve endocarditis in 2). Freedom from SVD at 10-year was 96.7%. Conclusions: The mid to long-term performance of the small Mosaic bioprosthesis was satisfactory, with excellent hemodynamics and few valve-related adverse events.	[Matsumoto, Yorihiko; Fujita, Tomoyuki; Hata, Hiroki; Shimahara, Yusuke; Sato, Shunsuke; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan	Fujita, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	tfujita@ncvc.go.jp	Kobayashi, Junjiro/J-8547-2015				Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Minakata K, 2014, CIRC J, V78, P882, DOI 10.1253/circj.CJ-13-1068; Jamieson WRE, 2011, J THORAC CARDIOV SUR, V142, P302, DOI 10.1016/j.jtcvs.2010.08.090; Riess FC, 2010, EUR J CARDIO-THORAC, V37, P145, DOI 10.1016/j.ejcts.2009.04.073; McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046; Pibarot P, 2000, J AM COLL CARDIOL, V36, P1131, DOI 10.1016/S0735-1097(00)00859-7; DEVEREUX RB, 1977, CIRCULATION, V55, P613; Forcillo J, 2013, ANN THORAC SURG, V96, P486, DOI 10.1016/j.athoracsur.2013.03.032; Dalmau MJ, 2011, EUR J CARDIO-THORAC, V39, P844, DOI 10.1016/j.ejcts.2010.11.015; Glaser N, 2014, ANN THORAC SURG, V97, P1314, DOI 10.1016/j.athoracsur.2013.10.078; Pibarot P, 2006, HEART, V92, P1022, DOI 10.1136/hrt.2005.067363; Kobayashi J, 2013, CIRC J, V77, P309, DOI 10.1253/circj.CJ-12-1546; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Seitelberger R, 2004, EUR J CARDIO-THORAC, V25, P358, DOI 10.1016/j.ejcts.2003.12.011; Bach DS, 2012, J THORAC CARDIOV SUR, V144, P453, DOI 10.1016/j.jtcvs.2011.12.036; Celiento M, 2012, ANN THORAC SURG, V93, P510, DOI 10.1016/j.athoracsur.2011.10.062; Duarte IG, 2001, ANN THORAC SURG, V71, P92, DOI 10.1016/S0003-4975(00)01989-5; Dzemali O, 2008, J HEART VALVE DIS, V17, P317; Ito Toshiaki, 2012, Gen Thorac Cardiovasc Surg, V60, P818, DOI 10.1007/s11748-012-0089-0; Kuehnel RU, 2006, THORAC CARDIOV SURG, V54, P85, DOI 10.1055/s-2005-872854; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098; Ruzicka DJ, 2009, CIRCULATION, V120, pS139, DOI 10.1161/CIRCULATIONAHA.109.844332; Sato S, 2014, CIRC J, V78, P1908, DOI 10.1253/circj.CJ-14-0431; Suri RM, 2009, ANN THORAC SURG, V88, P1232, DOI 10.1016/j.athoracsur.2009.04.128; Yoganathan A P, 1988, J Biomater Appl, V2, P579	26	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1044	1051		10.1253/circj.CJ-14-0990		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700025		
J	Sakai, T; Kitamura, T; Nishiyama, C; Murakami, Y; Ando, M; Kawamura, T; Tasaki, O; Kuwagata, Y; Shimazu, T; Iwami, T				Sakai, Tomohiko; Kitamura, Tetsuhisa; Nishiyama, Chika; Murakami, Yukiko; Ando, Masahiko; Kawamura, Takashi; Tasaki, Osamu; Kuwagata, Yasuyuki; Shimazu, Takeshi; Iwami, Taku			Cardiopulmonary Resuscitation Support Application on a Smartphone - Randomized Controlled Trial -	CIRCULATION JOURNAL			English	Article						Automated external defibrillator; Cardiopulmonary resuscitation; Randomized controlled trial; Smartphones	MOBILE PHONE; SURVIVAL; CPR; RETENTION; ARREST; SKILLS; BLS	Background: This simulation trial aimed to compare the quality of cardiopulmonary resuscitation (CPR) with and without the newly-developed CPR support application on smartphones. Methods and Results: In this trial, participants were randomly assigned to either the CPR support application group or the control group, stratified by sex and previous CPR training. Participants' CPR skills were evaluated by a 2-min case-based scenario test using the Leardal Resusci Anne PC Skillreporting Manikin System (R). The outcome measures were the proportion of chest compressions performed in each group and the number of total chest compressions and appropriate chest compressions performed during the 2-min test period. A total of 84 participants were enrolled and completed the protocol. All participants in the CPR support application group performed chest compressions, compared with only 31 (75.6%) in the control group (P<0.001). Among participants who performed chest compressions during the 2-min test period, the number of total chest compressions was significantly higher in the CPR support application group than in the control group (211.6 +/- 29.5 vs. 77.0 +/- 43.3, P<0.001). The number of appropriate chest compressions tended to be greater in the CPR support application group than in the control group, although it was statistically insignificant (30.3 +/- 57.3 vs. 17.2 +/- 28.7, P=0.246). Conclusions: In this cohort of laypersons, the newly-developed CPR support application for smartphones contributed to increasing the implementation rate and the number of total chest compressions performed and may assist in improving the survival rate for out-of-hospital cardiac arrests (UMIN000004740).	[Sakai, Tomohiko; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Div Environm Med & Populat Sci, Suita, Osaka, Japan; [Nishiyama, Chika] Kyoto Univ, Grad Sch Med, Dept Crit Care Nursing, Kyoto, Japan; [Nishiyama, Chika] Kyoto Univ, Sch Hlth Sci, Kyoto, Japan; [Murakami, Yukiko; Kawamura, Takashi; Iwami, Taku] Kyoto Univ Hlth Serv, Kyoto 6068501, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Tasaki, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Unit Clin Med, Dept Emergency Med, Nagasaki 852, Japan; [Kuwagata, Yasuyuki] Kansai Med Univ, Hirakata Hosp, Dept Emergency & Crit Care Med, Hirakata, Osaka, Japan	Iwami, T (reprint author), Kyoto Univ Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	iwamit@e-mail.jp			JR Anhin Foundation	This study was supported by a grant from the JR Anhin Foundation. None of the authors has a relationship with industry that requires disclosure or financial associations that might pose a conflict of interest in connection with the submitted article.	Ambulance Service Planning Office of Fire and Disaster Management Agency of Japan, EFF 1 CARD AR; Nishiyama C, 2008, RESUSCITATION, V79, P90, DOI 10.1016/j.resuscitation.2008.05.009; [Anonymous], 2007, JAPANESE GUIDELINES, V3rd; Semeraro F, 2011, RESUSCITATION, V82, P436, DOI 10.1016/j.resuscitation.2010.11.023; Ahn JY, 2011, RESUSCITATION, V82, P1543, DOI 10.1016/j.resuscitation.2011.08.029; Nagao K, 2013, CIRC J, V77, P2742, DOI 10.1253/circj.CJ-13-0457; [Anonymous], 2010, CIRCULATION, V122, pS639; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Sakai T, 2011, RESUSCITATION, V82, P69, DOI 10.1016/j.resuscitation.2010.09.466; [Anonymous], 2010, CIRCULATION, V122, pS250; Nishiyama C, 2009, RESUSCITATION, V80, P1164, DOI 10.1016/j.resuscitation.2009.06.019; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; [Anonymous], 2010, RESUSCITATION, V81, P1219; Nishiyama C, 2014, ACAD EMERG MED, V21, P47, DOI 10.1111/acem.12293; Kern KB, 2010, RESUSCITATION, V81, P206, DOI 10.1016/j.resuscitation.2009.10.015; Merchant RM, 2010, ANN EMERG MED, V55, P538, DOI 10.1016/j.annemergmed.2010.01.020; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Iserbyt P, 2014, RESUSCITATION, V85, P809, DOI 10.1016/j.resuscitation.2014.01.018; Kalz M, 2014, J MED INTERNET RES, V16, P177, DOI 10.2196/jmir.2951; Kovic I, 2011, RESUSCITATION, V82, P776, DOI 10.1016/j.resuscitation.2011.02.014; Lamhaut L, 2013, CIRC J, V77, P2696, DOI 10.1253/circj.CJ-13-0995; Lee JS, 2011, RESUSCITATION, V82, P64, DOI 10.1016/j.resuscitation.2010.09.467; The Ministry of Internal Affairs and Communications of Japan, PRES COND SUBJ SMART; Zapletal B, 2014, RESUSCITATION, V85, P560, DOI 10.1016/j.resuscitation.2013.10.028	24	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1052	1057		10.1253/circj.CJ-14-1258		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700026		
J	Tomoike, H; Yokoyama, H; Sumita, Y; Hanai, S; Kada, A; Okamura, T; Yoshikawa, J; Doi, Y; Hori, M; Tei, C				Tomoike, Hitonobu; Yokoyama, Hiroyuki; Sumita, Yoko; Hanai, Sotaro; Kada, Akiko; Okamura, Tomonori; Yoshikawa, Junichi; Doi, Yoshinori; Hori, Masatsugu; Tei, Chuwa		Sci Comm JCS	Nationwide Distribution of Cardiovascular Practice in Japan - Results of Japanese Circulation Society 2010 Annual Survey -	CIRCULATION JOURNAL			English	Article						Cardiovascular disease; Gini coefficient; Lorenz curve; Prefectural disparity in cardiovascular practice	UNIVERSAL HEALTH-CARE; GEOGRAPHIC-DISTRIBUTION; HEART-DISEASE; PHYSICIANS; ASSOCIATION; STROKE; INCOME	Background: The geographic distribution of cardiovascular (CV) health-care services has not been assessed systematically. Methods and Results: Data of the Japanese Circulation Society (JCS) annual survey were provided to the JCS working group with the permission of the JCS Scientific Committee. The status of CV practice in 2010 was then assessed in 47 prefectures retrospectively, along with national census and gross domestic product (GDP) data. The surveyed indices included resources (hospitals, beds and cardiologists), burden (number of inpatients), and outcome (CV mortality and autopsy) in each prefecture, which correlated well with respective populations or GDP. Inequality of geographic distribution was evident for pediatrics among the 47 prefectures, according to Lorenz curve, Gini coefficient or the maximum/ minimum ratio for each index. According to the Gini coefficients, only the number of inpatients (medical or acute myocardial infarction) and beds for the total number of general hospitals or the hospitals surveyed in the present JCS study were lower than expected with regard to GDP. Conclusions: Geographic disparity of CV resources or burden was larger in pediatrics than in CV medicine or surgery. Improvement of equality in CV practice with regard to appropriateness and quality are the coming challenges for the JCS.	[Tomoike, Hitonobu] Sakakibara Heart Inst, Fuchu, Tokyo 1830003, Japan; [Yokoyama, Hiroyuki; Sumita, Yoko; Hanai, Sotaro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Kada, Akiko] NHO Nagoya Med Ctr, Nagoya, Aichi, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Heart Ctr, Nishinomiya, Hyogo, Japan; [Doi, Yoshinori] Chikamori Hosp Grp, Kochi, Japan; [Hori, Masatsugu] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Tei, Chuwa] Waon Therapy Res Inst, Tokyo, Japan	Tomoike, H (reprint author), Sakakibara Heart Inst, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	htomoike@shi.heart.or.jp	Okamura, Tomonori/L-1693-2013		Japanese Circulation Society (JCS)	This work was totally funded by the Japanese Circulation Society (JCS). The authors would like to thank all individuals nationwide who have contributed to the JCS survey over the past 10 years. We are also proud of the contribution by staff in the surveyed institutions for CV practice despite the limited number of cardiologists and of available general beds.	Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; SCHWARTZ WB, 1980, NEW ENGL J MED, V303, P1032, DOI 10.1056/NEJM198010303031803; Hilbert M, 2011, SCIENCE, V332, P60, DOI 10.1126/science.1200970; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Matsumoto M, 2010, HEALTH POLICY, V96, P255, DOI 10.1016/j.healthpol.2010.02.012; Okamoto Y, 2013, CIRC J, V77, P2596, DOI 10.1253/circj.CJ-12-1604; Karlsson M, 2010, SOC SCI MED, V70, P875, DOI 10.1016/j.socscimed.2009.10.056; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; [Anonymous], 2008, CIRC J S4, V72, P1347; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Smith SC, 2012, J AM COLL CARDIOL, V60, P2343, DOI 10.1016/j.jacc.2012.08.962; Cabinet Office Government of Japan, 2013, ANN REP AG SOC; Cabinet Office Government of Japan, KENM; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Japanese Society of Pathology, ANN PATH AUT CAS JAP; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P489, DOI 10.1161/CIRCOUTCOMES.111.963058; Lee WC, 1997, STAT MED, V16, P729, DOI 10.1002/(SICI)1097-0258(19970415)16:7<729::AID-SIM491>3.0.CO;2-A; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ministry of Health Labour and Welfare, 2011, PAT SURV 2008; Ministry of Health Labour and Welfare, HOSP REP; Ministry of Health Labour and Welfare, 2011, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare, HLTH STAT JAP 2010; Ministry of Internal Affairs and Communications, DOU SHYU SEI; Nakaya T, 2005, SOC SCI MED, V60, P2865, DOI 10.1016/j.socscimed.2004.11.007; OECD, GROW UN INC DISTR PO; Schofield DJ, 2014, CIRC J, V78, P644, DOI 10.1253/circj.CJ-13-0937; Shihara M, 2001, JPN CIRC J, V65, P1005, DOI 10.1253/jcj.65.1005; Tanihara S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-260; The Japanese Circulation Society, JAP REG ALL CARD VAS; WHO, UN HIGH LEV M NONC D	30	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1058	1067		10.1253/circj.CJ-14-1214		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700027		
J	Imamura, T; Kinugawa, K; Nitta, D; Inaba, T; Maki, H; Hatano, M; Komuro, I				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru; Komuro, Issei			Novel Scoring System Using Cardiopulmonary Exercise Testing Predicts Prognosis in Heart Failure Patients Receiving Guideline-Directed Medical Therapy	CIRCULATION JOURNAL			English	Article						Cardiopulmonary exercise testing; Heart transplantation; Peak oxygen consumption; Ventilation	BETA-BLOCKER THERAPY; CHRONOTROPIC INCOMPETENCE; CARDIAC TRANSPLANTATION; OXYGEN-CONSUMPTION; POOR-PROGNOSIS; VENTILATORY EFFICIENCY; FUNCTIONAL-CAPACITY; CONTINUOUS-FLOW; CRITERIA; PROFESSIONALS	Background: Among variables obtained from cardiopulmonary exercise testing (CPXT), peak oxygen consumption (P(V) over dotO(2)) and the minute ventilation vs. carbon dioxide output ((V) over dotE vs. (V) over dotCO(2)) slope were established as predictors of death of patients with heart failure (HF) at the cutoff points of 14 ml.min(-1).kg(-1) and 34, respectively. However, a recent update of guideline-directed medical treatment (GDMT) might alter the implication of these variables. Methods and Results: We enrolled 77 HF patients receiving GDMT who had undergone symptom-limited CPXT between 2006 and 2014. Among them, 29 patients were re-hospitalized for HF and there were 13 cardiac deaths during the 4-year study period. Cox regression analyses demonstrated that the (V) over dotE vs. (V) over dotCO(2) slope, peak heart rate, peak systolic blood pressure, and P(V) over dotO(2) were significant predictors of both re-admission and cardiac death at each cutoff point calculated by receiver-operating characteristic analyses. A new scoring system was constructed using the following criteria: 1 point was assigned to a variable meeting the cutoff point for re-admission; 2 points were assigned to that for cardiac death. The total scores calculated as the summation of each point (range, 0-8 points) had significantly highest area under the curves compared with each CPXT variable (P<0.05), and significantly stratified both event-free rate into 3 groups (P<0.05). Conclusions: A novel scoring system using 4 CPXT variables simultaneously predicted re-admission and cardiac death even in patients with HF receiving GDMT.	[Imamura, Teruhiko; Kinugawa, Koichiro] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Ponikowski P, 2001, CIRCULATION, V103, P967; Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Arena R, 2007, CIRCULATION, V115, P2410, DOI 10.1161/CIRCULATIONAHA.107.686576; O'Neill JO, 2005, CIRCULATION, V111, P2313, DOI 10.1161/01.CIR.0000164270.72123.18; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P1024, DOI 10.1016/j.healun.2006.06.008; Roche F, 2001, CLIN PHYSIOL, V21, P335, DOI 10.1046/j.1365-2281.2001.00328.x; MANCINI DM, 1991, CIRCULATION, V83, P778; Myers J, 2008, AM HEART J, V156, P1177, DOI 10.1016/j.ahj.2008.07.010; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Magri D, 2014, EUR J HEART FAIL, V16, P201, DOI 10.1002/ejhf.36; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Jorde UP, 2008, EUR J HEART FAIL, V10, P96, DOI 10.1016/j.ejheart.2007.11.006; Agostoni P, 2002, CHEST, V122, P2062, DOI 10.1378/chest.122.6.2062; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585; McKelvie RS, 1999, CIRCULATION, V100, P1056; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; WEBER KT, 1982, CIRCULATION, V65, P1213; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONHA.105.167586; Myers J, 1998, ANN INTERN MED, V129, P286; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; COSTANZO MR, 1995, CIRCULATION, V92, P3593; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577; Arena RA, 2007, MED SCI SPORT EXER, V39, P213, DOI 10.1249/01.mss.0000241655.45500.c7; Fukushima N, 2014, TRANSPL P, V46, P2050, DOI 10.1016/j.transproceed.2014.06.023; Hori M, 2014, HEART VESSELS, V29, P238, DOI 10.1007/s00380-013-0340-3; Ingle L, 2007, HEART FAIL REV, V12, P12, DOI 10.1007/s10741-007-9000-y; Kato TS, 2013, CIRC-HEART FAIL, V6, P6, DOI 10.1161/CIRCHEARTFAILURE.112.968123; Pohwani AL, 2003, J HEART LUNG TRANSPL, V22, P78, DOI 10.1016/S1053-2498(02)00480-1; Saito S, 2014, J HEART LUNG TRANSPL, V33, P599, DOI 10.1016/j.healun.2014.02.015; Tsurugaya H, 2006, CIRC J, V70, P1332, DOI 10.1253/circj.70.1332	33	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1068	1075		10.1253/circj.CJ-14-1249		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700028		
J	Tsushima, H; Yamamoto, H; Kitagawa, T; Urabe, Y; Tatsugami, F; Awai, K; Kihara, Y				Tsushima, Hiroshi; Yamamoto, Hideya; Kitagawa, Toshiro; Urabe, Yoji; Tatsugami, Fuminari; Awai, Kazuo; Kihara, Yasuki			Association of Epicardial and Abdominal Visceral Adipose Tissue With Coronary Atherosclerosis in Patients With a Coronary Artery Calcium Score of Zero	CIRCULATION JOURNAL			English	Article						Atherosclerosis; Metabolic syndrome; Multidetector computed tomography (MDCT); Obesity; Plaque	MULTISLICE COMPUTED-TOMOGRAPHY; ALL-CAUSE MORTALITY; CT ANGIOGRAPHY; CARDIOVASCULAR-DISEASE; NONOBESE PATIENTS; FAT ACCUMULATION; PROGNOSTIC VALUE; PERICARDIAL FAT; CALCIFICATION; VOLUME	Background: We sought to examine whether epicardial and abdominal visceral adipose tissue distribution is associated with coronary atherosclerosis in patients with a coronary artery calcium (CAC) score of zero, assessed by coronary computed tomography angiography (CCTA). Methods and Results: We studied 352 patients with suspected coronary artery disease (mean age 61 +/- 11 years, 57% male) with a CAC score of zero who had undergone CCTA. Non-calcified coronary plaques (NCPs) were detected in 102 patients (29%); those causing >= 50% stenosis were found in 15 patients (4%). Patients were divided into 4 groups on the basis of CT-based epicardial adipose tissue (EAT) volume and abdominal visceral adipose tissue (VAT) area using the sex-specific median value. Multivariate analysis showed that the adjusted odds ratios for the presence of NCPs in the high VAT area/low EAT volume group, and the high VAT area/high EAT volume group were 2.80 (95% confidence interval [95% CI]: 1.25-6.35, P=0.01) and 2.68 (95% CI: 1.36-5.45, P=0.004), respectively. Interestingly, the low VAT area/high EAT volume group showed an equivalent adjusted odds ratio of 3.02 (95% CI: 1.33-6.90, P=0.008). Conclusions: EAT volume is eligible as a marker to be evaluated in addition to VAT area in patients with a CAC score of zero.	[Tsushima, Hiroshi; Yamamoto, Hideya; Kitagawa, Toshiro; Urabe, Yoji; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima 7348551, Japan; [Tatsugami, Fuminari; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Diagnost Radiol, Hiroshima 7348551, Japan	Yamamoto, H (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hideyayama@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (Tokyo, Japan) [23591044]	H.Y. received a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Tokyo, Japan, No. 23591044).	Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Okada K, 2014, J CARDIOVASC MED, V15, P384, DOI 10.2459/JCM.0b013e32836094da; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Sarin S, 2008, AM J CARDIOL, V102, P767, DOI 10.1016/j.amjcard.2008.04.058; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Gottlieb I, 2010, J AM COLL CARDIOL, V55, P627, DOI 10.1016/j.jacc.2009.07.072; Oka T, 2012, INT J CARDIOL, V161, P45, DOI 10.1016/j.ijcard.2011.04.021; Ohashi N, 2009, ATHEROSCLEROSIS, V202, P192, DOI 10.1016/j.atherosclerosis.2008.04.019; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Kunita E, 2012, CIRC J, V76, P1687, DOI 10.1253/circj.CJ-11-1442; Kunita E, 2014, ATHEROSCLEROSIS, V233, P447, DOI 10.1016/j.atherosclerosis.2014.01.038; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Ohashi N, 2010, JACC-CARDIOVASC IMAG, V3, P908, DOI 10.1016/j.jcmg.2010.06.014; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Urabe Y, 2013, CIRC J, V77, P2578, DOI 10.1253/circj.CJ-13-0257; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Tajima M, 2014, CIRC J, V78, P1152, DOI 10.1253/circj.CJ-13-1082; Yamamoto H, 2011, CIRC J, V75, P2424, DOI 10.1253/circj.CJ-11-0087; Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012; Nicklas BJ, 2004, AM J EPIDEMIOL, V160, P741, DOI 10.1093/aje/kwh281; Tardif JC, 2010, CIRC-CARDIOVASC IMAG, V3, P298, DOI 10.1161/CIRCIMAGING.110.937169; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI [10.1016/j.jcmg.2009.03.009, 10.1016/j.jcmg.2009.03.0]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ito T, 2013, INT J CARDIOL, V167, P2852, DOI 10.1016/j.ijcard.2012.07.026; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Morita H, 2012, INT J CARDIOL, V158, P272, DOI 10.1016/j.ijcard.2011.02.052; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; The International Expert Committe, 2009, DIABETES CARE, V32, P1327; Uretsky S, 2011, INT J CARDIOVAS IMAG, V27, P805, DOI 10.1007/s10554-010-9730-0; Yatsuya H, 2014, CIRC J, V78, P2807, DOI 10.1253/circj.CJ-14-0850; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041; Yong HS, 2010, INT J CARDIOVAS IMAG, V26, P53, DOI 10.1007/s10554-009-9542-2	34	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1084	1091		10.1253/circj.CJ-14-1169		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700030		
J	Gohbara, M; Iwahashi, N; Kataoka, S; Hayakawa, Y; Sakamaki, K; Akiyama, E; Maejima, N; Tsukahara, K; Hibi, K; Kosuge, M; Ebina, T; Umemura, S; Kimura, K				Gohbara, Masaomi; Iwahashi, Noriaki; Kataoka, Shunsuke; Hayakawa, Yoshikazu; Sakamaki, Kentaro; Akiyama, Eiichi; Maejima, Nobuhiko; Tsukahara, Kengo; Hibi, Kiyoshi; Kosuge, Masami; Ebina, Toshiaki; Umemura, Satoshi; Kimura, Kazuo			Glycemic Variability Determined by Continuous Glucose Monitoring System Predicts Left Ventricular Remodeling in Patients With a First ST-Segment Elevation Myocardial Infarction	CIRCULATION JOURNAL			English	Article						Acute myocardial infarction; Continuous glucose monitoring system; Glucose; Glycemic variability; Remodeling	PERCUTANEOUS CORONARY INTERVENTION; TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; MORTALITY; HYPERGLYCEMIA; COMPLICATIONS; FLUCTUATIONS; INFLAMMATION; ASSOCIATION; ACTIVATION	Background: Impaired glucose metabolism plays an important role in patients with acute myocardial infarction, but the clinical significance of glycemic variability (GV) early after the onset of ST-segment elevation myocardial infarction (STEMI) remains to be fully elucidated. Methods and Results: We prospectively investigated the clinical impact of GV, as determined by a continuous glucose monitoring system (CGMS), on left ventricular remodeling (LVR) assessed by cardiac magnetic resonance imaging (CMR) in 69 patients (63 +/- 13 years, 59 men) with a first reperfused STEMI within 12 h of onset. All patients were equipped with a CGMS when in a stable phase after admission and underwent repeat CMR at baseline and 7 months follow-up. Patients were divided into 2 groups according to the mean amplitude of glycemic excursions (MAGE). Patients in the upper tertile of MAGE were categorized as group High (H) and the other two-thirds as group Low (L). LVR was defined as an absolute increase in left ventricular end-diastolic volume index of >= 20%. LVR more frequently occurred in group H than in group L (56% vs. 11%, P<0.001). Multivariate analysis showed the higher MAGE group was an independent predictor of LVR in the chronic phase (odds ratio, 13.999; 95% confidence interval, 3.059 to 64.056; P=0.001). Conclusions: MAGE early after the onset of STEMI identified patients with LVR in the chronic phase.	[Gohbara, Masaomi; Iwahashi, Noriaki; Kataoka, Shunsuke; Akiyama, Eiichi; Maejima, Nobuhiko; Tsukahara, Kengo; Hibi, Kiyoshi; Kosuge, Masami; Ebina, Toshiaki; Kimura, Kazuo] Yokohama City Univ, Div Cardiol, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Hayakawa, Yoshikazu] Yokohama City Univ, Div Radiol, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Dept Biostat & Epidemiol, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2320024, Japan	Iwahashi, N (reprint author), Yokohama City Univ, Div Cardiol, Med Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	iwahashi@ra2.so-net.ne.jp					American Diabetes Association, 2013, DIABETES CARE S1, V36, pS67, DOI DOI 10.2337/DC13-S067; Ishihara M, 2001, J AM COLL CARDIOL, V38, P1007, DOI 10.1016/S0735-1097(01)01477-2; Aletras AH, 2006, CIRCULATION, V113, P1865, DOI 10.1161/CIRCULATIONAHA.105.576025; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Lund GK, 2007, RADIOLOGY, V245, P95, DOI 10.1148/radiol.2451061219; Ozasa N, 2010, AM J CARDIOL, V106, P1225, DOI 10.1016/j.amjcard.2010.06.048; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; Choi KM, 2005, J CLIN ENDOCR METAB, V90, P175, DOI 10.1210/jc.2004-1795; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Bando YK, 2014, CIRC J, V78, P576, DOI 10.1253/circj.CJ-13-1564; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414; ZUANETTI G, 1993, J AM COLL CARDIOL, V22, P1788; Kim RJ, 1999, CIRCULATION, V100, P1992; Carrabba N, 2004, CIRCULATION, V110, P1974, DOI 10.1161/01.CIR.0000143376.64970.4A; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Timmer JR, 2011, CIRCULATION, V124, P704, DOI 10.1161/CIRCULATIONAHA.110.985911; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; SERVICE FJ, 1970, DIABETES, V19, P644; Ogawa H, 2013, CIRC J, V77, P231, DOI 10.1253/circj.CJ-66-0053; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; D'Archangelo Melissa J, 2008, J Diabetes Sci Technol, V2, P332; Kitabata H, 2013, JACC-CARDIOVASC INTE, V6, P1046, DOI 10.1016/j.jcin.2013.05.014; Sampaio CR, 2012, DIABETES TECHNOL THE, V14, P117, DOI 10.1089/dia.2011.0157; Springeling T, 2013, CIRC J, V77, P81, DOI 10.1253/circj.CJ-12-0043; Takahashi T, 2003, INT J CARDIOL, V88, P257, DOI 10.1016/S0167-5273(02)00416-3; Teraguchi I, 2013, CIRC J, V78, P170; Wang XF, 2014, INT J CARDIOL, V172, P498, DOI 10.1016/j.ijcard.2014.01.015; Werner GS, 2003, EUR HEART J, V24, P1134, DOI 10.1016/S0195-668X(03)00187-8; Yang SW, 2010, HEART, V96, P1444, DOI 10.1136/hrt.2009.189316	33	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1092	1099		10.1253/circj.CJ-14-1226		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700031		
J	Miyamoto, K; Inai, K; Takeuchi, D; Shinohara, T; Nakanishi, T				Miyamoto, Kenji; Inai, Kei; Takeuchi, Daiji; Shinohara, Tokuko; Nakanishi, Toshio			Relationships Among Red Cell Distribution Width, Anemia, and Interleukin-6 in Adult Congenital Heart Disease	CIRCULATION JOURNAL			English	Article						Congenital heart disease; Interleukin-6; Microcytic anemia; Red cell distribution width	IRON-DEFICIENCY; PROGNOSTIC MARKER; FAILURE PATIENTS; MORTALITY; PARAMETERS; BIOMARKERS; CHILDREN; SURGERY	Background: Red cell distribution width (RDW) is known to be associated with anemia and mortality in cardiovascular diseases, while anemia itself is related to increased mortality. RDW may also be related to cytokine activation. We investigated the potential of RDW to predict anemia-adjusted mortality in patients with adult congenital heart disease (ACHD) and we evaluated the relationships among RDW, anemia, and interleukin-6 (IL-6). Methods and Results: This was a single-center, retrospective cohort study. Blood RDW and IL-6 levels were measured in 144 patients with ACHD (median age [interquartile range (IQR)], 28 [22-36] years), 84% in New York Heart Association class I/II. During a mean 4.8-year follow-up, 21 (15%) patients died of cardiovascular causes. Elevated RDW (>15.0%) correlated significantly with mortality risk in a univariate analysis (RDW hazard ratio [HR]: 1.570; 95% confidence interval [CI]: 1.208-2.040 per 1 standard deviation increase; P=0.001). Elevated RDW levels correlated significantly with increased anemia-adjusted mortality (adjusted RDW HR: 1.912; 95% CI: 1.369-2.670; P<0.001). The high RDW group had significantly elevated serum IL-6 levels (RDW >15%, median [IQR], 3.7 [0.9-13.9] pg/ml vs. RDW <= 15%, 1.4 [0.8-2.5 pg/ml]; P=0.001), as did patients with anemia (anemia, 1.9 [0.9-5.2] pg/ml vs. no anemia, 1.4 [0.8-2.5 pg/ml]; P=0.021). Conclusions: Elevation of RDW may be related with increased IL-6 and anemia-adjusted cardiovascular mortality in patients with ACHD.	[Miyamoto, Kenji; Inai, Kei; Takeuchi, Daiji; Shinohara, Tokuko; Nakanishi, Toshio] Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo 1628666, Japan	Miyamoto, K (reprint author), Tokyo Womens Med Univ, Dept Pediat Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kenmimi@dokkyomed.ac.jp					Aung N, 2013, INT J CARDIOL, V168, P1997, DOI 10.1016/j.ijcard.2012.12.091; Makhoul BF, 2013, INT J CARDIOL, V167, P1412, DOI 10.1016/j.ijcard.2012.04.065; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Hunziker S, 2012, AM J MED, V125, P283, DOI 10.1016/j.amjmed.2011.08.021; Ohuchi H, 2014, HEART FAIL CLIN, V10, P43, DOI 10.1016/j.hfc.2013.09.020; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Aung N, 2013, HEART, V99, P1261, DOI 10.1136/heartjnl-2013-303910; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Tsuboi S, 2013, CIRC J, V77, P456, DOI 10.1253/circj.CJ-12-0730; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Oh J, 2012, CIRC J, V76, P109, DOI 10.1253/circj.CJ-11-0664; Nunez J, 2014, CIRC J, V78, P410, DOI 10.1253/circj.CJ-13-0630; Bolger AP, 2003, EUR HEART J, V24, P970, DOI 10.1016/S0195-668X(03)00005-8; Pascual-Figal DA, 2012, INT J CARDIOL, V160, P196, DOI 10.1016/j.ijcard.2011.04.018; BESSMAN JD, 1983, AM J CLIN PATHOL, V80, P322; Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Broberg CS, 2011, AM J CARDIOL, V107, P595, DOI 10.1016/j.amjcard.2010.10.019; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Broberg CS, 2006, J AM COLL CARDIOL, V48, P356, DOI 10.1016/j.jacc.2006.03.040; Dopsaj V, 2012, INT J LAB HEMATOL, V34, P461, DOI 10.1111/j.1751-553X.2012.01417.x; Kaemmerer H, 2004, AM J CARDIOL, V94, P825, DOI 10.1016/j.amjcard.2004.06.014; Martinez-Quintana E, 2013, CONGENIT HEART DIS, V8, P117, DOI 10.1111/j.1747-0803.2012.00708.x; Massin MM, 2012, PEDIATR CARDIOL, V33, P1021, DOI 10.1007/s00246-012-0220-0; Mitchell RMS, 2002, INT J CLIN PRACT, V56, P249; Olcay L, 1996, PEDIATR CARDIOL, V17, P150, DOI 10.1007/BF02505204; Onur Cemile Banu, 2003, Indian Journal of Pediatrics, V70, P29; Tomkiewicz-Pajak L, 2014, J CARDIOL, V64, P384, DOI 10.1016/j.jjcc.2014.02.021; Warwick R, 2013, EUR J CARDIO-THORAC, V43, P1165, DOI 10.1093/ejcts/ezs609; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	31	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1100	1106		10.1253/circj.CJ-14-1296		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700032		
J	Ishii, M; Hokimoto, S; Akasaka, T; Fujimoto, K; Miyao, Y; Kaikita, K; Oshima, S; Nakao, K; Shimomura, H; Tsunoda, R; Hirose, T; Kajiwara, I; Matsumura, T; Nakamura, N; Yamamoto, N; Koide, S; Oka, H; Morikami, Y; Sakaino, N; Matsui, K; Ogawa, H				Ishii, Masanobu; Hokimoto, Seiji; Akasaka, Tomonori; Fujimoto, Kazuteru; Miyao, Yuji; Kaikita, Koichi; Oshima, Shuichi; Nakao, Koichi; Shimomura, Hideki; Tsunoda, Ryusuke; Hirose, Toyoki; Kajiwara, Ichiro; Matsumura, Toshiyuki; Nakamura, Natsuki; Yamamoto, Nobuyasu; Koide, Shunichi; Oka, Hideki; Morikami, Yasuhiro; Sakaino, Naritsugu; Matsui, Kunihiko; Ogawa, Hisao		Kumamoto Intervention Conference	Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation - The Kumamoto Intervention Conference Study (KICS) Registry -	CIRCULATION JOURNAL			English	Article						Cardiovascular events; Chronic kidney disease; Statins; Stents	RANDOMIZED CONTROLLED-TRIAL; LIPID-LOWERING THERAPY; CARDIOVASCULAR-DISEASE; JAPANESE PATIENTS; MYOCARDIAL-INFARCTION; ATORVASTATIN; PREVENTION; ATHEROSCLEROSIS; CHOLESTEROL; EVENTS	Background: The aim of this study was to examine the effects of different statins on the clinical outcomes of Japanese patients with coronary stent implants. Methods and Results: This study included 5,801 consecutive patients (males, 4,160; age, 69.7 +/- 11.1 years, mean +/- SD) who underwent stent implantation between April 2008 and March 2011. They were treated with a strong statin (n=3,042, 52%, atorvastatin, pitavastatin, or rosuvastatin), a regular statin (n=1,082, 19%, pravastatin, simvastatin, or fluvastatin) or no statin (n=1,677, 29%). The patients with chronic kidney disease (CKD) were divided into mildto- moderate CKD (30 <= eGFR<60, n=1,956) and severe CKD (eGFR <30, n=559). Primary endpoints included cardiovascular death and nonfatal myocardial infarction, including stent thrombosis and ischemic stroke. The clinical outcome for the primary endpoint in mild-to-moderate CKD patients treated with a strong statin (hazard ratio 0.50, 95% confidence interval 0.31-0.81; P=0.005) was significantly lower than in those on no statins, but that in the patients treated with a regular statin was not (P=0.160). The clinical outcome for the primary endpoint in severe CKD patients treated with a strong or regular statin was no different than not being on statin therapy (P=0.446, P=0.194, respectively). Conclusions: In patients with mild-to-moderate CKD, only strong statins were associated with lower risk compared with no statin, but regular statins were not. It is possible that taking a strong statin from the early stage of CKD is useful for suppression of cardiovascular events.	[Ishii, Masanobu; Hokimoto, Seiji; Akasaka, Tomonori; Kaikita, Koichi; Matsui, Kunihiko; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Oshima, Shuichi] Kumamoto City Hosp, Div Cardiol, Kumamoto, Japan; [Nakao, Koichi] Kumamoto Saiseikai Hosp, Cardiovasc Ctr, Kumamoto, Japan; [Fujimoto, Kazuteru] Natl Hosp Org Kumamoto Med Ctr, Kumamoto, Japan; [Shimomura, Hideki] Fukuoka Tokushukai Hosp, Div Cardiol, Fukuoka, Japan; [Tsunoda, Ryusuke] Kumamoto Red Cross Hosp, Kumamoto, Japan; [Hirose, Toyoki] Minamata City Hosp & Med Ctr, Div Cardiol, Minamata, Japan; Div Kumamoto City Hosp, Kumamoto, Japan; [Sakaino, Naritsugu] Div Amakusa Reg Med Ctr, Amakusa, Japan; [Kajiwara, Ichiro] Div Arao City Hosp, Arao, Japan; [Matsumura, Toshiyuki] Div Kumamoto Rosai Hosp, Yatsushiro, Japan; [Nakamura, Natsuki] Div Shinbeppu Hosp, Beppu, Oita, Japan; [Yamamoto, Nobuyasu] Miyazaki Prefectural Nobeoka Hosp, Nobeoka, Japan; [Koide, Shunichi] Yatsushiro Gen Hosp, Div Hlth Insurance, Yatsushiro, Japan; [Oka, Hideki] Hitoyoshi Gen Hosp, Div Hlth Insurance, Hitoyoshi, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Heart Foundation, Tokyo; Japan Vascular Disease Research Foundation, Kyoto, Japan	This study was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Japan Heart Foundation, Tokyo, and the Japan Vascular Disease Research Foundation, Kyoto, Japan.	Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Natsuaki M, 2012, AM J CARDIOL, V110, P1568, DOI 10.1016/j.amjcard.2012.07.021; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Annema W, 2013, CIRC J, V77, P2432, DOI 10.1253/circj.CJ-13-1025; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Kono K, 2012, KIDNEY INT, V82, P344, DOI 10.1038/ki.2012.118; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Hou WY, 2013, EUR HEART J, V34, P1807, DOI 10.1093/eurheartj/eht065; Reinecke H, 2003, KIDNEY INT, V63, P696, DOI 10.1046/j.1523-1755.2003.00784.x; Dan K, 2012, CIRC J, V76, P2266, DOI 10.1253/circj.CJ-11-1455; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P603; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ridker PM, 2010, J AM COLL CARDIOL, V55, P1266, DOI 10.1016/j.jacc.2010.01.020; Shepherd J, 2008, J AM COLL CARDIOL, V51, P1448, DOI 10.1016/j.jacc.2007.11.072; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Levey AS, 2003, ANN INTERN MED, V139, P137; Chitose T, 2012, CIRC J, V76, P71, DOI 10.1253/circj.CJ-11-0699; Dasari TW, 2014, AM J CARDIOL, V113, P621, DOI 10.1016/j.amjcard.2013.11.006; Kato K, 2013, CIRC-CARDIOVASC IMAG, V6, P448, DOI 10.1161/CIRCIMAGING.112.000165; Murphy SA, 2007, AM J CARDIOL, V100, P1047, DOI 10.1016/j.amjcard.2007.04.053; Nguyen SV, 2014, CIRC J, V78, P2492, DOI 10.1253/circj.CJ-14-0380; Sipahi I, 2006, CLEV CLIN J MED, V73, P937	29	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1115	1124		10.1253/circj.CJ-14-0789		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700034		
J	Sugihara, S; Hisatome, I; Kuwabara, M; Niwa, K; Maharani, N; Kato, M; Ogino, K; Hamada, T; Ninomiya, H; Higashi, Y; Ichida, K; Yamamoto, K				Sugihara, Shinobu; Hisatome, Ichiro; Kuwabara, Masanari; Niwa, Koichiro; Maharani, Nani; Kato, Masahiko; Ogino, Kazuhide; Hamada, Toshihiro; Ninomiya, Haruaki; Higashi, Yukihito; Ichida, Kimiyoshi; Yamamoto, Kazuhiro			Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia	CIRCULATION JOURNAL			English	Article						Hypouricemia; Uric acid; Uric acid transporter 1; Vascular function	RENAL HYPOURICEMIA; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; ALLOPURINOL; JAPANESE; HUMANS; TYPE-1; HYPERTENSION; TRANSPORTER	Background: Uric acid (UA) serves as an antioxidant in vascular endothelial cells. UA transporter 1 (URAT1) encoded by SLC22A12 is expressed in the kidney and vessels and its loss of function causes hypouricemia. The purpose of this study was to examine whether there is any endothelial dysfunction in patients with hypouricemia. Methods and Results: Twenty-six patients with hypouricemia (<2.5 mg/dl) and 13 healthy control subjects were enrolled. Endothelial function was evaluated using flow-mediated dilation (FMD). mRNA of UA transporters expressed in cultured human umbilical endothelial cells (HUVEC) was detected on RT-PCR. There was a positive correlation between FMD and serum UA in the hypouricemia group. URAT1 loss-of-function mutations were found in the genome of 21 of 26 patients with hypouricemia, and not in the other 5. In the hypouricemia groups, serum UA in homozygous and compound heterozygous patients was significantly lower than in other groups, suggesting that severity of URAT1 dysfunction may influence the severity of hypouricemia. Thirteen of 16 hypouricemia subjects with homozygous and compound heterozygote mutations had SUA <0.8 mg/dl and their FMD was lower than in other groups. HUVEC do not express mRNA of URAT1, suggesting the null role of URAT1 in endothelial function. Conclusions: Depletion of UA due to SLC22A12/URAT1 loss-of-function mutations causes endothelial dysfunction in hypouricemia patients.	[Sugihara, Shinobu; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Div Cardiovasc Med, Dept Mol Med & Therapeut, Fac Med, Yonago, Tottori 6838504, Japan; [Hisatome, Ichiro; Maharani, Nani] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Genet Med & Regenerat Therapeut, Yonago, Tottori 6838504, Japan; [Kuwabara, Masanari; Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan; [Ogino, Kazuhide] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori, Japan; [Hamada, Toshihiro] Tottori Univ, Fac Med, Dept Reg Med, Yonago, Tottori 6838504, Japan; [Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838504, Japan; [Higashi, Yukihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Res Ctr Radiat Genome Med, Dept Regenerat & Med, Hiroshima, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo, Japan	Sugihara, S (reprint author), Tottori Univ, Div Cardiovasc Med, Dept Mol Med & Therapeut, Fac Med, 36-1 Nishimachi, Yonago, Tottori 6838504, Japan.	shinobutozuito@gmail.com					DAS DK, 1987, BIOCHEM BIOPH RES CO, V148, P314, DOI 10.1016/0006-291X(87)91112-0; Enomoto A, 2002, NATURE, V417, P447; Lin GM, 2013, J CARDIOL, V61, P122, DOI 10.1016/j.jjcc.2012.09.004; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Poredos P, 2002, INT ANGIOL, V21, P109; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Matsuzawa Y, 2013, CIRC J, V77, P2807, DOI 10.1253/circj.CJ-13-0549; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Waring WS, 2006, DIABETES, V55, P3127, DOI 10.2337/db06-0283; Dinour D, 2011, NEPHROL DIAL TRANSPL, V26, P2175, DOI 10.1093/ndt/gfq722; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Kato M, 2005, AM J CARDIOL, V96, P1576, DOI 10.1016/j.amjcard.2005.07.068; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Ichida K, 2008, CLIN GENET, V74, P243, DOI 10.1111/j.1399-0004.2008.01021.x; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRUCLATIONAHA.106.651117; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; Verdecchia P, 2000, HYPERTENSION, V36, P1072; Cheong HI, 2005, PEDIATR NEPHROL, V20, P886, DOI 10.1007/s00467-005-1863-3; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Price KL, 2006, J AM SOC NEPHROL, V17, P1791, DOI 10.1681/ASN.2006030264; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; De Leeuw PW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027871.86296.92; George Jacob, 2009, Vasc Health Risk Manag, V5, P265; HISATOME I, 1989, NEPHRON, V51, P13, DOI 10.1159/000185233; Komoda F, 2004, PEDIATR NEPHROL, V19, P728, DOI 10.1007/s00467-004-1424-1; KUO L, 1992, CIRC RES, V70, P465; Lee SH, 2013, EUR NEUROL, V71, P132; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Niizeki Takeshi, 2006, J Cardiol, V47, P219; Pitocco D, 2008, DIABETES-METAB RES, V24, P318, DOI 10.1002/dmrr.814; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129; Sperling O, 2006, MOL GENET METAB, V89, P14, DOI 10.1016/j.ymgme.2006.03.015; VANPEENE.HJ, 1973, ANN INTERN MED, V78, P977; YANASE M, 1988, NEPHRON, V48, P80, DOI 10.1159/000184876	41	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1125	+		10.1253/circj.CJ-14-1267		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700035		
J	Naganuma, T; Takagi, K; Fujino, Y; Kobayashi, T; Mitomo, S; Akita, M; Nakao, T; Nakamura, S				Naganuma, Toru; Takagi, Kensuke; Fujino, Yusuke; Kobayashi, Tsuyoshi; Mitomo, Satoru; Akita, Masafumi; Nakao, Tatsuya; Nakamura, Sunao			Valsalva Sinus Perforation Into the Right Atrium Due to Infective Endocarditis of Transcatheter Heart Valve	CIRCULATION JOURNAL			English	Editorial Material							SEVERE AORTIC-STENOSIS; IMPLANTATION; REPLACEMENT; OUTCOMES; COHORT		[Naganuma, Toru; Takagi, Kensuke; Fujino, Yusuke; Kobayashi, Tsuyoshi; Mitomo, Satoru; Nakamura, Sunao] New Tokyo Hosp, Dept Cardiol, Matsudo, Chiba 2702232, Japan; [Akita, Masafumi; Nakao, Tatsuya] New Tokyo Hosp, Dept Cardiovasc Surg, Matsudo, Chiba 2702232, Japan	Nakamura, S (reprint author), New Tokyo Hosp, Dept Cardiol, 1271 Wanagaya, Matsudo, Chiba 2702232, Japan.	boss0606@pluto.plala.or.jp					Gurvitch R, 2010, CIRCULATION, V122, P1319, DOI 10.1161/CIRCULATIONAHA.110.948877; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Puls M, 2013, EUROINTERVENTION, V8, P1407, DOI 10.4244/EIJV8I12A214; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Fuku Y, 2014, CIRC J, V78, P1357, DOI 10.1253/circj.CJ-13-1220; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1133	1135		10.1253/circj.CJ-14-1339		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700036		
J	Takemoto, K; Hirata, K; Tanimoto, T; Matsuo, Y; Ino, Y; Kubo, T; Tanaka, A; Akasaka, T				Takemoto, Kazushi; Hirata, Kumiko; Tanimoto, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi			Combined Non-Invasive Doppler Echocardiography and Coronary Computed Tomography Lead to Diagnosis of Anomalous Left Coronary Artery From the Pulmonary Artery (ALCAPA) Syndrome	CIRCULATION JOURNAL			English	Editorial Material							FLOW RESERVE; ORIGIN		[Takemoto, Kazushi; Hirata, Kumiko; Tanimoto, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Div Cardiol, Dept Med, Wakayama 6418509, Japan	Hirata, K (reprint author), Wakayama Med Univ, Div Cardiol, Dept Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	hirata8080@gmail.com					Pena E, 2009, RADIOGRAPHICS, V29, P553, DOI 10.1148/rg.292085059; Hozumi T, 1998, CIRCULATION, V97, P1557; MENAHEM S, 1987, BRIT HEART J, V58, P378; Nakanishi K, 2012, CIRC J, V76, P1958, DOI 10.1253/circj.CJ-12-0245; ARCINIEGAS E, 1980, CIRCULATION, V62, P180; Hirata K, 2004, J AM SOC ECHOCARDIOG, V17, P108, DOI 10.1067/j.echo.2003.09.019; Hoashi T, 2013, CIRC J, V77, P1202, DOI 10.1253/circj.CJ-12-1321; Kataoka Y, 2007, CIRC J, V71, P891, DOI 10.1253/circj.71.891; Kudumula V, 2014, ANN THORAC SURG, V97, P938, DOI 10.1016/j.athoracsur.2013.11.042; Schmitt B, 2014, ANN THORAC SURG, V98, P1425, DOI 10.1016/j.athoracsur.2014.05.031; Tian Z, 2013, INTERNAL MED, V52, P233, DOI 10.2169/internalmedicine.52.7643; Watanabe N, 2001, J AM COLL CARDIOL, V38, P1328, DOI 10.1016/S0735-1097(01)01556-X	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAY	2015	79	5					1136	1138		10.1253/circj.CJ-14-1374		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG8PP	WOS:000353571700037		
J	Sato, A; Kamei, A; Kamihigashi, E; Dohi, M; Akama, T; Kawahara, T				Sato, Akiko; Kamei, Akiko; Kamihigashi, Etsuko; Dohi, Michiko; Akama, Takao; Kawahara, Takashi			Use of Supplements by Japanese Elite Athletes for the 2012 Olympic Games in London	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports; athletes; Olympic Games; supplements; doping	DIETARY SUPPLEMENTATION; NUTRITIONAL SUPPLEMENTS; PERFORMANCE; SINGAPORE; SPORT	Objective: To investigate supplement use among Japanese elite athletes. Design: We conducted a cross-sectional survey study using individual interviews during athletes' medical evaluations. Setting: One to 5 months before the Olympic Games in 2012, London, United Kingdom. Participants: Five hundred fifty-two Japanese athletes for the London Games, including candidates. Independent Variables: Sex, sports, supplement category, and participation. Main Outcome Measures: Whether athletes used supplements, what products were used, the frequency and purposes of use, and from what sources athletes received information on supplements. Results: All 552 athletes were interviewed by pharmacists regarding supplement use and agreed to the survey. Of them, 452 (81.9%) used 1 or more supplement products in the year before the study; a total of 952 different products (mean = 1.7, SD = 1.4) were used. The most commonly used supplement was amino acids (310 athletes; 56.2%), and 358 (38.7%) of the total products were amino acids. Of the athletes, 241 (43.7%) took at least 1 supplement daily, and of the supplements, 457 (49.4%) were taken daily. The most common purpose for supplement use was recovery from fatigue-327 (59.2%) athletes chose this answer, and 486 (52.5%) products were used for this purpose. Finally, regarding athletes' information sources on supplements, coaches, managers, and trainers were the most frequent advisors (275 athletes, 49.8%; 466 products, 50.4%). Conclusions: The results revealed widespread supplement use among Japanese elite athletes for the London Olympic Games. Education system was required not only for athletes but also for athletes' entourage, such as coaches, managers, trainers, and supplement companies.	[Sato, Akiko] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Niigata 9503198, Japan; [Kamei, Akiko] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Kamihigashi, Etsuko; Dohi, Michiko; Kawahara, Takashi] Japan Inst Sports Sci, Dept Sports Med, Tokyo, Japan; [Akama, Takao] Waseda Univ, Fac Sport Sci, Saitama, Japan	Sato, A (reprint author), Niigata Univ Hlth & Welf, Dept Hlth & Sports, Kita Ku, 1398 Shimami Cho, Niigata, Niigata 9503198, Japan.	satotsuka1298@mbr.nifty.com					AIS Supplement Group Classification, 2011, AIS SUPPL GROUP CLAS; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Huang SH, 2006, CLIN J SPORT MED, V16, P27, DOI 10.1097/01.jsm.0000194766.35443.9c; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Molinero O, 2009, NUTR HOSP, V24, P128; Geyer H, 2008, J MASS SPECTROM, V43, P892, DOI 10.1002/jms.1452; Erdman KA, 2007, CLIN J SPORT MED, V17, P458; Lun V, 2012, INT J SPORT NUTR EXE, V22, P31; Braun H, 2009, INT J SPORT NUTR EXE, V19, P97; McDowall JA, 2007, J SPORT SCI MED, V6, P337; Geyer H, 2004, INT J SPORTS MED, V25, P124; Slater G, 2003, INT J SPORT NUTR EXE, V13, P320; Tian HH, 2009, SINGAP MED J, V50, P165; Bishop D, 2010, SPORTS MED, V40, P995, DOI 10.2165/11536870-000000000-00000; Diehl K, 2012, INT J SPORT NUTR EXE, V22, P165; Maughan RJ, 2011, J SPORT SCI, V29, pS57, DOI 10.1080/02640414.2011.587446; Maughan RJ, 2005, J SPORT SCI, V23, P883, DOI 10.1080/02640410400023258; SOBAL J, 1994, INT J SPORT NUTR, V4, P320; Tsitsimpikou C, 2009, CLIN J SPORT MED, V19, P33, DOI 10.1097/JSM.0b013e31818f169e; Erdman KA, 2006, MED SCI SPORT EXER, V38, P349, DOI 10.1249/01.mss.0000487332.92169.e0; Calfee R, 2006, PEDIATRICS, V117, pE577, DOI 10.1542/peds.2005-1429; Heikkinen A, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-1; Heikkinen A, 2011, INT J SPORT NUTR EXE, V21, P271; International Olympic Committee Web site, IOC CONS STAT SPORTS; Japan Institute of Sports Sciences Web site, SUPPL AT JISS; Judkins C, 2007, INVESTIGATION SUPPLE; Kamei A, 2008, JPN J NUTR DIET, V66, p274S; Kim J, 2011, INT J SPORT NUTR EXE, V21, P166; Sato A, 2012, CLIN J SPORT MED, V22, P418, DOI 10.1097/JSM.0b013e318266830a; World Anti-Doping Agency Web site, AB WADA	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					260	269				10	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700011		
J	Yaguchi, H; Tsuzaka, K; Shirai, S; Niino, M; Takahashi, T; Tanaka, K; Yabe, I; Sasaki, H				Yaguchi, Hiroaki; Tsuzaka, Kazufumi; Shirai, Shinichi; Niino, Masaaki; Takahashi, Tatsuro; Tanaka, Keiko; Yabe, Ichiro; Sasaki, Hidenao			Importance of T1-MRI enhanced pyramidal tracts in differential diagnosis as to paraneoplastic encephalomyelitis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Paraneoplastic neurological syndromes; Encephalomyelitis; T1-gadolinium enhancement; MRI; Pyramidal tract			[Yaguchi, Hiroaki; Shirai, Shinichi; Yabe, Ichiro; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido 0608638, Japan; [Yaguchi, Hiroaki; Tsuzaka, Kazufumi; Shirai, Shinichi; Niino, Masaaki] Kushiro Rosai Hosp, Dept Neurol, Kushiro, Hokkaido, Japan; [Yaguchi, Hiroaki] Sapporo City Gen Hosp, Brain Sci Ctr, Dept Neurol, Sapporo, Hokkaido, Japan; [Niino, Masaaki] Hokkaido Med Ctr, Dept Clin Res, Sapporo, Hokkaido, Japan; [Takahashi, Tatsuro] Kushiro Rosai Hosp, Dept Pathol, Kushiro, Hokkaido, Japan; [Tanaka, Keiko] Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa 92002, Japan	Yaguchi, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	yaguchi@xa2.so-net.ne.jp			JSPS KAKENHI [25893006]	We are grateful to Dr. Toshiyuki Takahashi for measurement of anti-AQP antibodies and to Dr. Satoshi Terae for important suggestions about MR findings. This work was supported by JSPS KAKENHI Grant Number 25893006.	Pittock SJ, 2005, ANN NEUROL, V58, P96, DOI 10.1002/ana.20529; Tackley G, 2014, MULT SCLER J, V20, P1153, DOI 10.1177/1352458514531087; Flanagan EP, 2011, NEUROLOGY, V76, P2089, DOI 10.1212/WNL.0b013e31821f468f; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Graber JJ, 2010, ARCH NEUROL-CHICAGO, V67, P298, DOI 10.1001/archneurol.2010.20; Leypoldt F, 2006, J NEUROL NEUROSUR PS, V77, P1199, DOI 10.1136/jnnp.2005.086140	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2015	132						9	11		10.1016/j.clineuro.2015.02.005		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CH0XI	WOS:000353745300002		
J	Koike, Y; Kanazawa, M; Terajima, K; Watanabe, K; Ohashi, M; Endo, N; Shimohata, T; Nishizawa, M				Koike, Yuka; Kanazawa, Masato; Terajima, Kenshi; Watanabe, Kei; Ohashi, Masayuki; Endo, Naoto; Shimohata, Takayoshi; Nishizawa, Masatoyo			Apparent diffusion coefficients distinguish amyotrophic lateral sclerosis from cervical spondylotic myelopathy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Amyotrophic lateral sclerosis (ALS); Apparent diffusion coefficient (ADC); 3T brain magnetic resonance imaging (MRI); Intracranial corticospinal tracts; Cervical spondylotic myelopathy (CSM)	CORTICOSPINAL TRACT; ALS; TENSOR	Objective: Fifty percent of patients with amyotrophic lateral sclerosis (ALS) have cervical spondylotic myelopathy (CSM) as a complication. Because patients with ALS do not develop bulbar signs and symptoms at onset, differentiating them from patients with CSM is sometimes difficult. We aimed to determine whether the apparent diffusion coefficients (ADCs) of intracranial corticospinal tracts can be used to distinguish between patients with ALS and those with CSM. Methods: We evaluated 19 consecutive patients with ALS who did not have CSM by cervical MRI, 16 patients with CSM, and 11 healthy controls. We examined the mean ADCs in the precentral gyrus, the corona radiata, the posterior limbs of the internal capsule (PLIC), and the cerebral peduncle by 3T magnetic resonance imaging (MRI). The mean ADCs in the intracranial corticospinal tracts in patients with ALS were compared with those in patients with CSM. Results: The mean ADCs in the intracranial corticospinal tracts in patients with ALS were compared with those in patients with CSM (p<0.05). Additionally, the mean ADCs in the precentral gyrus, the PLIC, and the cerebral peduncle in the patients with ALS, including the patients who were initially diagnosed as having clinically possible ALS on the basis of the revised El Escorial criteria and did not develop bulbar symptoms at onset, were also higher than those in patients with CSM (p<0.05). Conclusions: Elevated ADCs in the intracranial corticospinal tracts might be useful for distinguishing ALS from CSM in the early stage of the disease. (C) 2015 Elsevier B.V. All rights reserved.	[Koike, Yuka; Kanazawa, Masato; Terajima, Kenshi; Shimohata, Takayoshi; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Chuo Ku, Niigata, Niigata 9518585, Japan; [Terajima, Kenshi] Niigata Univ, Div Informat Sci & Biostat, Med & Dent Hosp, Chuo Ku, Niigata, Niigata 9518585, Japan; [Watanabe, Kei; Ohashi, Masayuki; Endo, Naoto] Niigata Univ, Div Orthopaed Surg, Dept Regenerat & Transplant Med, Grad Sch Med & Dent Sci,Chuo Ku, Niigata, Niigata 9518585, Japan	Nishizawa, M (reprint author), Niigata Univ, Brain Res Inst, Dept Neurol, Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518585, Japan.	nishi@bri.niigata-u.ac.jp					LEBIHAN D, 1986, RADIOLOGY, V161, P401; Wang SM, 2006, RADIOLOGY, V239, P831, DOI 10.1148/radiol.2393050573; Ding XQ, 2011, AMYOTROPH LATERAL SC, V12, P406, DOI 10.3109/17482968.2011.597402; [Anonymous], 2000, CLIN NEUROPHYSIOL, V111, P1031; Ellis CM, 1999, NEUROLOGY, V53, P1051; Hecht MJ, 2002, J NEUROL SCI, V199, P59, DOI 10.1016/S0022-510X(02)00104-1; Kanazawa M, 2004, J NEUROL, V251, P1121, DOI 10.1007/s00415-004-0494-0; Kang D X, 1995, Electromyogr Clin Neurophysiol, V35, P231; Karlsborg M, 2004, AMYOTROPH LATERAL SC, V5, P136, DOI 10.1080/14660820410018982; Subcommittee on Motor Neuron Disease Amyotrophic lateral Sclerosis of World Federation of Neurology Research Group on Neuromuscular Diseases and El Escorial Clinical Limits of Amyotrophic Lateral Sclerosis Workshop Collaborators, 1994, J NEUROL SCI S, V124, P96; Tauchi R, 2013, EUR SPINE J, V22, P156, DOI 10.1007/s00586-012-2506-6; Williams JR, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-160; Yamada Masahito, 2003, J Orthop Sci, V8, P878, DOI 10.1007/s00776-003-0712-0	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2015	132						33	36		10.1016/j.clineuro.2015.02.009		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CH0XI	WOS:000353745300008		
J	Suzuki, N; Ogiso, S; Yachiguchi, K; Kawabe, K; Maldno, F; Toriba, A; Kiyomoto, M; Sekiguchi, T; Tabuchi, Y; Kondo, T; Kitamura, KI; Hong, CS; Srivastav, AK; Oshima, Y; Hattori, A; Hayakawa, K				Suzuki, Nobuo; Ogiso, Shouzo; Yachiguchi, Koji; Kawabe, Kimi; Maldno, Fumiya; Toriba, Akira; Kiyomoto, Masato; Sekiguchi, Toshio; Tabuchi, Yoshiaki; Kondo, Takashi; Kitamura, Kei-ichiro; Hong, Chun-Sang; Srivastav, Ajai K.; Oshima, Yuji; Hattori, Atsuhiko; Hayakawa, Kazuichi			Monohydroxylated polycyclic aromatic hydrocarbons influence spicule formation in the early development of sea urchins (Hemicentrotus pulcherrimus)	COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY			English	Article						OHPAHs; PAHs; Spicule formation; Sea urchin; Embryogenesis	MAJOR MATRIX PROTEIN; VALDEZ OIL-SPILL; EMBRYO SPICULE; GENE; BIOACCUMULATION; TOXICITY; EXPOSURE; PATHWAY; DAMAGE; RAT	We previously demonstrated that monohydroxylated polycyclic aromatic hydrocarbons (OHPAHs), which are metabolites of polycyclic aromatic hydrocarbons (PAHs), act on calcified tissue and suppress osteoblastic and osteoclastic activity in the scales of teleost fish. The compounds may possibly influence other calcified tissues. Thus, the present study noted the calcified spicules in sea urchins and examined the effect of both PAHs and OHPAHs on spicule formation during the embryogenesis of sea urchins. After fertilization, benz[a]anthracene (BaA) and 4-hydroxybenz[a]anthracene (4-OHBaA) were added to seawater at concentrations of 10(-8) and 10(-7) M and kept at 18 degrees C. The influence of the compound was given at the time of the pluteus larva. At this stage, the length of the spicule was significantly suppressed by 4-OHBaA (10(-8) and 10(-7) M). BaA (10(-7) M) decreased the length of the spicule significantly, while the length did not change with BaA (10(-8) M).The expression of mRNAs (spicule matrix protein and transcription factors) in the 4-OHBaA (10(-7) M)-treated embryos was more strongly inhibited than were those in the BaA (10(-7) M)-treated embryos. This is the first study to demonstrate that OHPAHs suppress spicule formation in sea urchins. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Nobuo; Ogiso, Shouzo; Yachiguchi, Koji; Sekiguchi, Toshio] Kanazawa Univ, Inst Nat & Environm Technol, Noto Marine Lab, Noto, Ishikawa 9270553, Japan; [Kawabe, Kimi; Maldno, Fumiya; Toriba, Akira; Hayakawa, Kazuichi] Kanazawa Univ, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kakuma, Ishikawa 9201192, Japan; [Kiyomoto, Masato] Ochanomizu Univ, Marine & Coastal Res Ctr, Tateyama, Chiba 2940301, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 9300194, Japan; [Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Kitamura, Kei-ichiro] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Hong, Chun-Sang] Hankuk Univ Foreign Studies, Res & Business Fdn, Yongin 449791, Gyeonggi Do, South Korea; [Srivastav, Ajai K.] DDU Gorakhpur Univ, Dept Zool, Gorakhpur 273009, Uttar Pradesh, India; [Oshima, Yuji] Kyushu Univ, Fac Agr, Hakozaki, Fukuoka 8128581, Japan; [Hattori, Atsuhiko] Tokyo Med Dent Univ, Coll Liberal Arts & Sci, Dept Biol, Ichikawa, Chiba 2720827, Japan	Suzuki, N (reprint author), Kanazawa Univ, Inst Nat & Environm Technol, Noto Marine Lab, Noto, Ishikawa 9270553, Japan.	nobuos@staff.kanazaw-u.ac.jp	SUZUKI, Nobuo/J-8420-2015	SUZUKI, Nobuo/0000-0003-0283-9910	JSPS [24620004, 40378568, 24310046, 24500848, 24570068, 24651044]	We are grateful to Dr. Takuya Minokawa (Research Center for Marine Biology, Graduate School of Life Sciences, Tohoku University) for information regarding PCR primers in the mRNA expression analysis. This study was supported in part by grants to N.S. (Grant-in-Aid for Scientific Research [C] No. 24620004 by JSPS), to T.S. (Grant-in-Aid for Young Scientists [B] No. 40378568 by JSPS), to Y.T. (Grant-in-Aid for Scientific Research [B] No. 24310046 by JSPS), to K.K. (Grant-in-Aid for Scientific Research [C] No. 24500848 by JSPS), to A.H. (Grant-in-Aid for Scientific Research [C] No. 24570068 by JSPS), and to K.H. (Grant-in-Aid for Exploratory Research No. 24651044 by JSPS). This study was performed under the cooperative research program of the Institute of Nature and Environmental Technology, Kanazawa University (Accept No. 1).	Andreasen EA, 2007, TOXICOL SCI, V95, P215, DOI 10.1093/toxsci/kfl119; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Bue BG, 1998, T AM FISH SOC, V127, P35, DOI 10.1577/1548-8659(1998)127<0035:EODTPS>2.0.CO;2; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Suzuki N, 2011, BONE, V48, P1186, DOI 10.1016/j.bone.2011.02.004; Pillai MC, 2003, TOXICOLOGY, V186, P93, DOI 10.1016/S0300-483X(02)00695-9; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; Goldstone JV, 2007, MOL BIOL EVOL, V24, P2619, DOI 10.1093/molbev/msm200; Barron MG, 2004, TOXICOL SCI, V78, P60, DOI 10.1093/toxsci/kfh051; Lima ALC, 2003, ENVIRON SCI TECHNOL, V37, P53, DOI 10.1021/es025895p; BENSON S, 1987, DEV BIOL, V120, P499, DOI 10.1016/0012-1606(87)90253-3; Brandhorst BP, 2002, INT REV CYTOL, V213, P183; BREGER RK, 1981, DRUG METAB DISPOS, V9, P88; Chetiyanukornkul T, 2006, ANAL BIOANAL CHEM, V386, P712, DOI 10.1007/s00216-006-0628-6; Danion M, 2011, ECOTOX ENVIRON SAFE, V74, P1888, DOI 10.1016/j.ecoenv.2011.07.027; de Soysa TY, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-40; Hayakawa K, 2006, WATER RES, V40, P981, DOI 10.1016/j.watres.2005.12.035; Kurokawa D, 1999, MECH DEVELOP, V80, P41, DOI 10.1016/S0925-4773(98)00192-0; Lee LL, 2002, BONE, V30, P917, DOI 10.1016/S8756-3282(02)00726-3; Li DJ, 2004, AMBIO, V33, P107; Olsvik PA, 2011, CHEMOSPHERE, V83, P552, DOI 10.1016/j.chemosphere.2010.12.019; SUCOV HM, 1987, DEV BIOL, V120, P507, DOI 10.1016/0012-1606(87)90254-5; Suzuki N, 2009, LIFE SCI, V84, P482, DOI 10.1016/j.lfs.2009.01.008; Yakan SD, 2011, MAR POLLUT BULL, V63, P471, DOI 10.1016/j.marpolbul.2011.02.055	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1532-0456	1878-1659		COMP BIOCHEM PHYS C	Comp. Biochem. Physiol. C-Toxicol. Pharmacol.	MAY	2015	171						55	60		10.1016/j.cbpc.2015.02.004		6	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Toxicology; Zoology	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Toxicology; Zoology	CH9GG	WOS:000354343400008		
J	Yamada, S				Yamada, Shoko			The Constituent Elements of Comparative Education in Japan: A Comparison with North America	COMPARATIVE EDUCATION REVIEW			English	Article							IDENTITIES; TRENDS	This article, with the aim of identifying elements that constitute the characteristics of an academic space within comparative education, analyzes how comparative education has been discussed and practiced in Japan, based on a questionnaire completed by 264 members of the Japan Comparative Education Society and classification of articles published in its journal from 1975 to 2011. Reference to the discourse and practice in North America are made, using data provided by the scholars who looked into research trends among Comparative and International Education Society members and in Comparative Education Review. The natures of both spaces are influenced by the institutional contexts; research demands; and social, political, and economic environments in which they are situated. Researchers develop their academic identities by participating in research practices and discourse. The interrelated but separate dynamics between two sites show the factors that make them align with or diverge from each other.	Nagoya Univ, Comparat Educ & Educ Policy Studies, Grad Sch Int Dev, Nagoya, Aichi 4648601, Japan	Yamada, S (reprint author), Nagoya Univ, Comparat Educ & Educ Policy Studies, Grad Sch Int Dev, Nagoya, Aichi 4648601, Japan.	syamada@gsid.nagoya-u.ac.jp			Japan Society for Promotion of Science	This research is part of a larger research project, "Reconstructing Educational Research on/in Developing Countries: A Fusion between Area Studies and Development Studies," which was enabled by a grant-in-aid from the Japan Society for Promotion of Science. The criteria for article categorization were discussed among all researchers involved in the project, although the analysis presented here is strictly by the author.	Acosta Felicitas, 2011, INT REV EDUC, V57, P477; Little A, 2000, COMP EDUC, V36, P279, DOI 10.1080/713656612; Foster J, 2012, INT J EDUC DEV, V32, P711, DOI 10.1016/j.ijedudev.2011.12.003; Turner BL, 2002, ANN ASSOC AM GEOGR, V92, P52, DOI 10.1111/1467-8306.00279; Rust VD, 1999, COMP EDUC REV, V43, P86, DOI 10.1086/447546; Cook BJ, 2004, COMP EDUC REV, V48, P123, DOI 10.1086/382619; Gill A, 2012, CAN GEOGR-GEOGR CAN, V56, P3, DOI 10.1111/j.1541-0064.2011.00400.x; Bray M, 2001, COMP EDUC, V37, P451; Buller H., 2008, AREA, V41, P395, DOI DOI 10.1111/J.1475-4762.2008.00856.X; CHEN SC, 1994, COMP EDUC REV, V38, P233, DOI 10.1086/447243; Coser Lewis A., 1965, MEN IDEAS SOCIOLOGIS; Drake Timothy A., 2011, PEABODY J EDUC, V86, P189; Driscoll M., 2010, ED COLLABORATIVE, V1, P1; Ehara Takekazu, 2001, HIKAKU KYOIKUGAKU KE, V27, P4; Fairbrother GP, 2005, COMP EDUC, V41, P5, DOI 10.1080/03050060500073215; Gerholm Tomas, 1982, ETHNOS, V47, P5; Graham Loren, 1983, FUNCTIONS USES DISCI; Halls W. D., 1990, COMP ED CONT ISSUES; Hawkins JN, 2001, COMP EDUC, V37, P501; HOLMES B, 1972, BRIT J EDUC STUD, V20, P205, DOI 10.2307/3120220; Ichikawa Shogo, 1990, HIKAKU KYOIKUGAKU KE, V16, P5; Ikeda Susumu, 1975, HIKAKU KYOIKUGAKU KE, V1, P7; Jawitz J, 2009, TEACH HIGH EDUC, V14, P241, DOI 10.1080/13562510902898817; Jessop Bob, 2001, NEW POLIT ECON, V6, P89; Kitamura Yuto, 2005, HIKAKU KYOIKUGAKU KE, V31, P241; Klein Julie Thompson, 2005, HUMANITIES CULTURE I; Kobayashi Tetsuya, 1990, COMP ED CONT ISSUES; Koehl Robert, 1977, COMP EDUC REV, V21, P177; Kondo Takahiro, 2013, HIKAKU KYOIKUGAKU NO; Manzon M., 2011, COMP ED CONSTRUCTION; Masemann V., 2007, COMMON INTERESTS UNC; Nielsen K., 2003, RES PAPERS NETWORK I, V11, P1; Niibori Michiya, 1975, HIKAKU KYOIKUGAKU KE, V1, P17; Ninomiya Akira, 2007, COMMON INTERESTS UNC; Noah H. J., 1969, SCI COMP ED; Ogawa Yoshikazu, 2013, HIKAKU KYOIKUGAKU NO; Okihara Yutaka, 1991, HIKAKU KYOIKUGAKU KE, V17, P155; Otsuka Yutaka, 2009, ED STUDIES JAPAN, V4, P37; Paulston Rolland, 2000, COMPARE, V30, P353, DOI 10.1080/713657467; Paulston Rolland, 1993, COMPARE, V23, P101, DOI 10.1080/0305792930230202; Post R, 2009, CRIT INQUIRY, V35, P749; Raby Rosalind Latiner, 2008, COMP EDUC REV, V52, P461; Raby Rosalind Latiner, 2003, COMP EDUC REV, V48, P470; Raby Rosalind Latiner, 2010, COMP EDUC REV, V54, P415; Raby Rosalind Latiner, 2006, COMP EDUC REV, V50, P695; Rembold Elfie, 2011, NATL IDENTITIES, V13, P361; Ross Heidi, 1992, COMPARE, V22, P113; Rust Val, 2003, THEORY COMP ED UNPUB; SHU H, 1990, PROSPECTS, V20, P65, DOI 10.1007/BF02195429; Stambach Amy, 2011, COMP EDUC REV, V55, P457, DOI DOI 10.1086/660296; Thomas Murray, 1990, INT COMP ED PRACTICE; Umakoshi Toru, 1999, HIKAKU KYOIKUGAKU KE, V25, P4; Umakoshi Toru, 2007, HIKAKU KYOIKUGAKU EK; Wenger E., 1998, COMMUNITIES PRACTICE; Wiseman Alexander W., 2013, ANN REV COMP INT ED; Wolhuter C. C., 2008, RES COMP INT ED, V3, P323, DOI DOI 10.2304/RCIE.2008.3.4.323; Yamada S. (, 2014, INT J COMP ED DEV, V16, P31	57	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0010-4086	1545-701X		COMP EDUC REV	Comp. Educ. Rev.	MAY	2015	59	2					234	260		10.1086/680172		27	Education & Educational Research	Education & Educational Research	CH6AL	WOS:000354117500002		
J	Rappleye, J				Rappleye, Jeremy			Imagining Japan in Post-war East Asia: Identity Politics, Schooling and Popular Culture	COMPARATIVE EDUCATION REVIEW			English	Book Review									[Rappleye, Jeremy] Kyoto Univ, Kyoto 6068501, Japan	Rappleye, J (reprint author), Kyoto Univ, Kyoto 6068501, Japan.						Andersen N. A., 2003, DISCURSIVE ANAL STRA; Morris P., 2013, IMAGINING JAPAN POST	2	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0010-4086	1545-701X		COMP EDUC REV	Comp. Educ. Rev.	MAY	2015	59	2					373	376		10.1086/680393		6	Education & Educational Research	Education & Educational Research	CH6AL	WOS:000354117500015		
J	Bradley, WS				Bradley, William S.			Higher Education and the State: Changing Relationships in Europe and East Asia	COMPARATIVE EDUCATION REVIEW			English	Book Review									[Bradley, William S.] Ryukoku Univ, Kyoto, Japan	Bradley, WS (reprint author), Ryukoku Univ, Kyoto, Japan.						DECOKER G, 2013, JAPANESE ED ERA GLOB; Goodman R., 2013, HIGHER ED STATE CHAN; Goodman Roger, 2003, CAN JAPANESE CHANGE; Rappleye Jeremy, 2011, REIMAGINING JAPANESE	4	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0010-4086	1545-701X		COMP EDUC REV	Comp. Educ. Rev.	MAY	2015	59	2					378	380		10.1086/680365		5	Education & Educational Research	Education & Educational Research	CH6AL	WOS:000354117500017		
J	Sokol, J; Nunokawa, M				Sokol, Janusz; Nunokawa, Mamoru			On some class of convex functions	COMPTES RENDUS MATHEMATIQUE			English	Article								In this paper, we consider the order of starlikeness and strong starlikeness in the class of functions f (z)= z + a(2)z(2) + ... analytic in \z\ < 1 in the complex plane and satisfying [GRAPHICS] . (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.	[Sokol, Janusz] Rzeszow Univ Technol, Dept Math, PL-35959 Rzeszow, Poland; [Nunokawa, Mamoru] Gunma Univ, Chuou Ward, Chiba 2600808, Japan	Sokol, J (reprint author), Rzeszow Univ Technol, Dept Math, Al Powstancow Warszawy 12, PL-35959 Rzeszow, Poland.	jsokol@prz.edu.pl; mamoru_nuno@doctor.nifty.jp					Sokol J, 2011, COMPUT MATH APPL, V62, P4733, DOI 10.1016/j.camwa.2011.10.064; Banning F., 1993, P AM MATH SOC, V118, P189; Banning F., 1991, ANN U M CURIESKLOD A, V45, P117; Banning F., 1994, COMPLEX VAR, V24, P233; BRANNAN DA, 1969, J LONDON MATH SOC, V1, P431; Goodman A. W., 1991, ANN POL MATH, V56, P87; Ma W., 1993, ANN POL MATH, V3, P275; Ma W., 1992, ANN POL MATH, V2, P165; Miller S. S., 2000, MONOGRAPHS TXB PURE, V225; NUNOKAWA M, 1993, P JPN ACAD A-MATH, V69, P234; NUNOKAWA M, 1992, P JPN ACAD A-MATH, V68, P152; Sokol J., 1993, FOLIA SCI U TECH RES, V121, P35; Stankiewicz J, 1966, ANN U M CURIE SKLO A, V20, P59	13	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	1631-073X	1778-3569		CR MATH	C. R. Math.	MAY	2015	353	5					427	431		10.1016/j.crma.2015.03.002		5	Mathematics	Mathematics	CH6PV	WOS:000354159400009		
J	Neviarouskaya, A; Prendinger, H; Ishizuka, M				Neviarouskaya, Alena; Prendinger, Helmut; Ishizuka, Mitsuru			ATTITUDE SENSING IN TEXT BASED ON A COMPOSITIONAL LINGUISTIC APPROACH	COMPUTATIONAL INTELLIGENCE			English	Article						affective computing; attitude analysis in text; compositional linguistic approach; intelligent analytical interface	SENTIMENT	In this article, we introduce a compositional linguistic approach for attitude recognition in text. There are several aspects that distinguish our attitude analysis model (@AM) from other systems. First, our method classifies sentences using fine-grained attitude labels (nine for affective states, two for positive and negative judgment, and two for positive and negative appreciation), as compared against other methods that mainly focus on two sentiment categories (positive and negative) or basic emotions. Next, our @AM is based on the analysis of syntactic and dependence relations between words in a sentence, the compositionality principle, a novel linguistic approach based on the rules elaborated for semantically distinct verb classes, and a method considering the hierarchy of concepts. As distinct from the state-of-the-art approaches, the proposed method extensively deals with the semantics of terms, processes sentences of different complexity, handles not only correctly written text but also informal messages, and encodes the strength and the level of confidence of attitude through numerical values. The performance of our @AM was evaluated on data sets represented by sentences from different domains. @AM achieved a high level of accuracy on sentences from personal stories about life experiences, fairy tales, and news headlines, outperforming other methods on several measures.	[Neviarouskaya, Alena] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan; [Prendinger, Helmut] Natl Inst Informat, Digital Content & Media Sci Res Div, Tokyo, Japan; [Ishizuka, Mitsuru] Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan	Neviarouskaya, A (reprint author), Toyohashi Univ Technol, Dept Comp Sci & Engn, Tempaku Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	a.neviarouskaya@gmail.com					Alm C.O., 2005, P HUM LANG TECHN C C, P579, DOI DOI 10.3115/1220575.1220648; Alm C.O., 2008, THESIS U ILLINOIS UR; Aman S., 2008, P 3 INT JOINT C NAT, P296; Andreevskaia A., 2006, P 11 C EUR CHAPT ASS, P209; Subasic P, 2001, IEEE T FUZZY SYST, V9, P483, DOI 10.1109/91.940962; Subrahmanian VS, 2008, IEEE INTELL SYST, V23, P43, DOI 10.1109/MIS.2008.57; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037//0003-066X.48.4.384; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Boucouvalas A. C., 2003, BEING THERE CONCEPTS, P306; Chaumartin F.R., 2007, P 4 INT WORKSH SEM E, P422, DOI 10.3115/1621474.1621568; Choi Y., 2008, P C EMP METH NAT LAN, DOI 10.3115/1613715.1613816; Chuang Z-J, 2004, COMPUTATIONAL LINGUI, V9, P45; Derks D., 2007, THESIS OPEN U NETHER; Esuli A., 2006, P 5 C LANG RES EV LR, P417; Finkel Jenny Rose, 2005, P 43 ANN M ASS COMP, P363, DOI 10.3115/1219840.1219885; Ghazi D., 2010, P NAACL HLT 2010 WOR, P140; Hoye L., 1997, ADVERBS MODALITY ENG; Izard C. E., 1971, FACE EMOTION; Jarmasz Mario, 2001, P 14 BIENN C CAN SOC, P325; Kamps J., 2002, P BELG DUTCH C ART I, P449; Katz P., 2007, P 4 INT WORKSH SEM E, P308, DOI 10.3115/1621474.1621541; Keshtkar F., 2009, P INT C NAT LANG PRO, P1; Kim S, 2006, P HUM LANG TECHN C N, DOI 10.3115/1220835.1220861; Kipper K., 2007, LANG RESOUR EVAL, V42, P21; Kozareva Z., 2007, P 4 INT WORKSH SEM E, P334, DOI 10.3115/1621474.1621546; Leshed G., 2006, INT C COMP HUM INT, P1019; Liu H., 2003, P 8 INT C INT US INT, P125; Martin James R., 2005, LANGUAGE EVALUATION; Mihalcea R., 2006, P AAAI SPRING S COMP, P139; Miller G. A., 1999, WORDNET ELECT LEXICA, P23; Mishne G, 2005, P 1 WORKSH STYL AN T; Moilanen Karo, 2007, P REC ADV NAT LANG P, P378; MULDER M, 2004, P 7 INT C TEXT SPEEC, V3206, P171; Nadeau D., 2006, P WORKSH COMP AESTH; Nakagawa T., 2010, P HUM LANG TECHN 11, P786; Nasukawa T., 2003, P 2 INT C KNOWL CAPT, P70, DOI DOI 10.1145/945645.945658; Neviarouskaya A, 2010, P 23 INT C COMP LING, P806; NEVIAROUSKAYA A, 2011, INT J NATURAL LANGUA, V17, P95, DOI DOI 10.1017/S1351324910000239; Neviarouskaya A, 2011, IEEE T AFFECT COMPUT, V2, P22, DOI 10.1109/T-AFFC.2011.1; Olveres J., 1998, P 1 WORKSH EMB CONV, P47; Ortony A., 1988, COGNITIVE STRUCTURE; Palmer Frank R., 1986, MOOD MODALITY; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79; Planalp S, 2002, VERBAL COMMUNICATION OF EMOTIONS: INTERDISCIPLINARY PERSPECTIVES, P55; Polanyi L., 2004, AAAI SPRING S EXPL A, P1; Read J, 2005, P ACL STUD RES WORKS, P43, DOI 10.3115/1628960.1628969; Read J., 2004, THESIS U SUSSEX BRIG; Rib E., 2003, P 7 C NAT LANG LEARN, P25; Shaikh MA, 2009, AFFECTIVE INFORMATION PROCESSING, P45, DOI 10.1007/978-1-84800-306-4_4; Shaikh MAM, 2007, LECT NOTES COMPUT SC, V4738, P191; Soo-Min Kim, 2005, LECT NOTES COMPUTER, V3651, P61; STRAPPARAVA C, 2007, P INT JOINT C ART IN, P1719; STRAPPARAVA C, 2008, P 2008 ACM S APPL CO, P1556, DOI 10.1145/1363686.1364052; Strapparava C., 2004, P 4 INT C LANG RES E, P1083; Strapparava C., 2007, SEMEVAL 2007 TASK 14, P70; Taboada M., 2004, P AAAI SPRING S EXPL, P158; Turney PD, 2003, ACM T INFORM SYST, V21, P315, DOI 10.1145/944012.944013; Turney P. D., 2002, P 40 ANN M ASS COMP, P417, DOI DOI 10.3115/1073083.1073153; Vegnaduzzo S., 2004, P 7 GERM C NAT LANG, P613; Whitelaw C, 2005, P 14 ACM INT C INF K, P625, DOI [10.1145/1099554.1099714, DOI 10.1145/1099554.1099714]; Wiebe J., 2006, P JOINT C INT COMM C, P1065; Wilson TS, 2005, PHIL EDUC, P347, DOI 10.3115/1220575.1220619; Yu H., 2003, P C EMP METH NAT LAN, P129	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-7935	1467-8640		COMPUT INTELL-US	Comput. Intell.	MAY	2015	31	2					256	300		10.1111/coin.12020		45	Computer Science, Artificial Intelligence	Computer Science	CH6HF	WOS:000354136500003		
J	Sugita, M; Takahashi, T				Sugita, Masaki; Takahashi, Takuya			Influence of Corporate Culture on Environmental Management Performance: An Empirical Study of Japanese Firms	CORPORATE SOCIAL RESPONSIBILITY AND ENVIRONMENTAL MANAGEMENT			English	Article						organization culture; corporate culture; environmental performance; environmental policy; sustainability management	ORGANIZATIONAL CULTURE; ISSUES	This paper investigates the relationships between the scores of 109 Japanese corporations found in the NIKKEI environmental management ranking survey and the corporate culture of each firm. Corporate culture is measured with the instrument developed by Cameron and Quinn (2006). The instrument measures corporate culture in terms of four categories: clan culture, adhocracy culture, hierarchy culture, and market culture. The results indicate that adhocracy culture has statistically significant positive relationships with the management system, product development, and climate change mitigation aspects of environmental management or sustainability management. Excessive hierarchy culture has a negative relationship with the overall score of environmental management. An appropriate combination of hierarchy culture and adhocracy culture enhances the overall score. Copyright (c) 2013 John Wiley & Sons, Ltd and ERP Environment	[Sugita, Masaki] Meidensha Corp, Tokyo, Japan; [Takahashi, Takuya] Univ Shiga Prefecture, Sch Environm Sci, Hikone, Shiga 5228533, Japan	Takahashi, T (reprint author), Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka, Hikone, Shiga 5228533, Japan.	tak@ses.usp.ac.jp					Abetts L, 2010, THESIS U MICHIGAN AN; Howard-Grenville JA, 2006, ORGAN ENVIRON, V19, P46, DOI 10.1177/1086026605285739; Nakamura M, 2001, J ENVIRON ECON MANAG, V42, P23, DOI 10.1006/jeem.2000.1148; Baumgartner RJ, 2009, SUSTAIN DEV, V17, P102, DOI 10.1002/sd.405; Branzeis O, 2001, CROSS CULTURAL MANAG, V1, P287; Camerons KS, 2006, DIAGNOSING CHANGING; DENISON DR, 1995, ORGAN SCI, V6, P204, DOI 10.1287/orsc.6.2.204; DESHPANDE R, 1993, J MARKETING, V57, P23, DOI 10.2307/1252055; Hans JK, 1998, J MARKETING, V62, P30; Hicksons DJ, 2001, MANAGEMENT WORLDWIDE; Hoffmans AJ., 1993, BUSINESS STRATEGY EN, V2, P10, DOI 10.1002/bse.3280020402; International Organization for Standardization, 2012, ISO SERV CERT 2011; ISO World, 2011, CERT NUMB COUNTR WOR; Linnenluecke MK, 2009, BUS STRATEG ENVIRON, V18, P432, DOI 10.1002/bse.609; Mengucs B, 2009, J BUS ETHICS, V94, P279; Nihon Keizai Shinbunsya (Nikkei Inc), 2008, DAI 12 KAI KANKYOUKE; OECD, 1994, OECD ENV PERF REV JA; Packalen S, 2010, CORP SOC RESP ENV MA, V17, P118, DOI 10.1002/csr.236; Petts J., 1999, BUSINESS STRATEGY EN, V8, P14, DOI 10.1002/(SICI)1099-0836(199901/02)8:1<14::AID-BSE175>3.0.CO;2-4; Rondeau K V, 1998, Hosp Top, V76, P14; Scheins EH, 1999, CORPORATE CULTURE SU; Takahashi T., 2005, Corporate Social Responsibility and Environmental Management, V12, DOI 10.1002/csr.086; Wagner M, 2009, BUS STRATEG ENVIRON, V18, P122, DOI 10.1002/bse.641; Wehrmeyers W, 1995, BUSINESS STRATEGY EN, V4, P145, DOI 10.1002/bse.3280040306; Welfords R, 1997, CORPORATE ENV MANAGE; Zollo M., 2007, CORPORATE GOVERNANCE, V7, P476, DOI [10.1108/14720700710820551, DOI 10.1108/14720700710820551]	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1535-3958	1535-3966		CORP SOC RESP ENV MA	Corp. Soc. Responsib. Environ. Manag.	MAY-JUN	2015	22	3					182	192		10.1002/csr.1346		11	Business; Environmental Studies; Management	Business & Economics; Environmental Sciences & Ecology	CH3JA	WOS:000353925800005		
J	Yamao, Y; Matsumoto, R; Kunieda, T; Shibata, S; Shimotake, A; Kikuchi, T; Satow, T; Mikuni, N; Fukuyama, H; Ikeda, A; Miyamoto, S				Yamao, Yukihiro; Matsumoto, Riki; Kunieda, Takeharu; Shibata, Sumiya; Shimotake, Akihiro; Kikuchi, Takayuki; Satow, Takeshi; Mikuni, Nobuhiro; Fukuyama, Hidenao; Ikeda, Akio; Miyamoto, Susumu			Neural correlates of mirth and laughter: A direct electrical cortical stimulation study	CORTEX			English	Article						Mirth; Laughter; Electrical cortical stimulation; Mesial temporal structure; Basal temporal language area	DISTORTION-CORRECTED FMRI; SUPPLEMENTARY MOTOR AREA; SEMANTIC MEMORY; TEMPORAL-LOBE; HUMOR; CORTEX; APPRECIATION; INNERVATION; VOLUNTARY; NUCLEUS	Laughter consists of both motor and emotional aspects. The emotional component, known as mirth, is usually associated with the motor component, namely, bilateral facial movements. Previous electrical cortical stimulation (ES) studies revealed that mirth was associated with the basal temporal cortex, inferior frontal cortex, and medial frontal cortex. Functional neuroimaging implicated a role for the left inferior frontal and bilateral temporal cortices in humor processing. However, the neural origins and pathways linking mirth with facial movements are still unclear. We hereby report two cases with temporal lobe epilepsy undergoing subdural electrode implantation in whom ES of the left basal temporal cortex elicited both mirth and laughter-related facial muscle movements. In one case with normal hippocampus, high-frequency ES consistently caused contralateral facial movement, followed by bilateral facial movements with mirth. In contrast, in another case with hippocampal sclerosis (HS), ES elicited only mirth at low intensity and short duration, and eventually laughter at higher intensity and longer duration. In both cases, the basal temporal language area (BTLA) was located within or adjacent to the cortex where ES produced mirth. In conclusion, the present direct ES study demonstrated that 1) mirth had a close relationship with language function, 2) intact mesial temporal structures were actively engaged in the beginning of facial movements associated with mirth, and 3) these emotion-related facial movements had contralateral dominance. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamao, Yukihiro; Kunieda, Takeharu; Shibata, Sumiya; Kikuchi, Takayuki; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Matsumoto, Riki; Ikeda, Akio] Kyoto Univ, Grad Sch Med, Dept Epilepsy Movement Disorders & Physiol, Kyoto 6068507, Japan; [Shimotake, Akihiro] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Satow, Takeshi] Nagahama City Hosp, Dept Neurosurg, Nagahama, Shiga, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sch Med, Sapporo, Hokkaido, Japan; [Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068507, Japan	Matsumoto, R (reprint author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	matsumot@kuhp.kyoto-u.ac.jp; kuny@kuhp.kyoto-u.ac.jp		Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	Ministry of Education, Culture, Sports, Science and Technology of Japan [26282218, 24592159, 25861273, 26560465]; GlaxoSmithKline K.K.; NIHON KOHDEN CORPORATION; Otsuka Pharmaceutical Co.; UCB Japan Co., Ltd.	We are indebted to Dr. Keiko Usui for providing the patient data. This work was partly supported by Grants-in-Aid for Scientific Research (B) 26282218 (RM), (C) 24592159 (TK), Grant-in-aid for Young Scientists (B) 25861273 (TK) and Exploratory Research 26560465 (EM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine is an endowment department, supported with grants by GlaxoSmithKline K.K., NIHON KOHDEN CORPORATION, Otsuka Pharmaceutical Co., and UCB Japan Co., Ltd.	Amir O., 2013, CEREBRAL CORTEX; Sperli F, 2006, EPILEPSIA, V47, P440, DOI 10.1111/j.1528-1167.2006.00442.x; Babiloni C, 2003, CORTEX, V39, P293, DOI 10.1016/S0010-9452(08)70110-2; Krolak-Salmon P, 2006, ANN NEUROL, V59, P196, DOI 10.1002/ana.20706; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Krack P, 2001, MOVEMENT DISORD, V16, P867, DOI 10.1002/mds.1174; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; Usui K, 2003, BRAIN, V126, P632, DOI 10.1093/brain/awg057; ARROYO S, 1993, BRAIN, V116, P757, DOI 10.1093/brain/116.4.757; Kikuchi T, 2012, CLIN NEUROPHYSIOL, V123, P324, DOI 10.1016/j.clinph.2011.06.011; HOPF HC, 1992, NEUROLOGY, V42, P1918; Watson KK, 2007, CEREB CORTEX, V17, P314, DOI 10.1093/cercor/bhj149; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; Matsumoto R, 2011, NEUROPSYCHOLOGIA, V49, P1350, DOI 10.1016/j.neuropsychologia.2011.01.023; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Ikeda A, 2000, BRAIN, V123, P1710, DOI 10.1093/brain/123.8.1710; Satow T, 2003, J NEUROL NEUROSUR PS, V74, P1004, DOI 10.1136/jnnp.74.7.1004; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Mikuni N, 2006, EPILEPSIA, V47, P1347, DOI 10.1111/j.1528-1167.2006.00610.x; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; Okun MS, 2004, NEUROCASE, V10, P271, DOI 10.1080/13554790490507632; Visser M, 2010, NEUROPSYCHOLOGIA, V48, P1689, DOI 10.1016/j.neuropsychologia.2010.02.016; Schmitt JJ, 2006, EPILEPSY BEHAV, V8, P773, DOI 10.1016/j.yebeh.2006.03.003; Takayama M, 2004, NEUROLOGY, V63, P510; Fernandez-Baca V. G., 2011, EPILEPTIC DISORD, V13, P435; Kappos L, 2010, NEW ENGL J MED, V363, pE25, DOI 10.1056/NEJMicm0900573; Mima T, 1997, J NEUROL NEUROSUR PS, V63, P501, DOI 10.1136/jnnp.63.4.501; Schmahmann J. D., 2006, FIBER PATHWAYS BRAIN; Shimotake A., 2014, CEREBRAL CORTEX, V9; Suls J., 1972, PSYCHOL HUMOR THEORE; Wieser Heinz-Gregor, 2004, Epilepsia, V45, P695; Wild B, 2003, BRAIN, V126, P2121, DOI 10.1093/brain/awg226	35	1	1	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	MAY	2015	66						134	140		10.1016/j.cortex.2014.11.008		7	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CH6OS	WOS:000354156500011		
J	Taimatsu, K; Takubo, K; Maruyama, K; Suda, T; Kudo, A				Taimatsu, Kiyohito; Takubo, Keiyo; Maruyama, Kouichi; Suda, Toshio; Kudo, Akira			Proliferation Following Tetraploidization Regulates the Size and Number of Erythrocytes in the Blood Flow During Medaka Development, as Revealed by the Abnormal Karyotype of Erythrocytes in the Medaka TFDP1 Mutant	DEVELOPMENTAL DYNAMICS			English	Article						Medaka mutant; erythropoiesis; cell size; TFDP1; tetraploidization; cell cycle	E2F TARGET GENES; MOUSE YOLK-SAC; ORYZIAS-LATIPES; CELL-CYCLE; EMBRYONIC-DEVELOPMENT; FISH; DNA; DIFFERENTIATION; ERYTHROPOIESIS; HEMATOPOIESIS	Background: For the delivery of oxygen, the correct size/number of erythrocytes is required for proper blood flow. Results: By combined analyses of wild-type (WT) medaka and the kyoho (kyo) mutant, we found proliferation-mediated adaptation for size/number of erythrocytes in the blood flow during medaka development. Before the start of heart beating in the WT medaka, the karyotype of erythrocytes was 2N-4N. After the start of blood flow, the karyotype changed to 4N-8N with tetraploidization, and the cell size became larger. After the start of intersegmental and pharyngeal blood flow, the erythrocytes became smaller. The medaka mutant kyo showed erythrocytes of large size, and positional cloning of kyo demonstrated the candidate gene TFDP1, indicating higher polyploidization due to arrest in S-phase in erythrocytes of the kyo mutant. Conclusions: From our findings, we uncovered a previously unrecognized system for the regulation of the size/number in the blood flow:proliferation of erythrocytes following tetraploidization during embryonic development. Developmental Dynamics 244:651-668, 2015. (c) 2015 Wiley Periodicals, Inc.	[Taimatsu, Kiyohito; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; [Takubo, Keiyo; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Tokyo, Japan; [Maruyama, Kouichi] Natl Inst Radiol Sci, Chiba 260, Japan; [Takubo, Keiyo] Natl Ctr Global Hlth & Med, Dept Stem Cell Biol, Res Inst, Tokyo, Japan	Kudo, A (reprint author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, 4259-B-33 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	akuo@bio.titech.ac.jp			Japan Ministry of Education, Culture, Sports, and Technology of Japan	Grant sponsor: Japan Ministry of Education, Culture, Sports, and Technology of Japan.	Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; Fujita M, 2006, DEV DYNAM, V235, P734, DOI 10.1002/dvdy.20696; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Dirlam A, 2007, MOL CELL BIOL, V27, P8713, DOI 10.1128/MCB.01118-07; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; MURAD A, 1993, CAN J ZOOL, V71, P2190, DOI 10.1139/z93-308; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Barni S, 2007, AQUAT TOXICOL, V81, P45, DOI 10.1016/j.aquatox.2006.10.012; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Chen C, 2014, EXP HEMATOL, V42, P464, DOI 10.1016/j.exphem.2014.03.001; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; BORISY GG, 1967, J CELL BIOL, V34, P525, DOI 10.1083/jcb.34.2.525; Cianciarullo AM, 2000, GENET MOL BIOL, V23, P357, DOI 10.1590/S1415-47572000000200020; DELACHAP.A, 1969, P NATL ACAD SCI USA, V63, P812; Demiroglu H, 1997, BLOOD, V89, P4236; HAO XF, 1995, J CELL SCI, V108, P2945; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Inohaya K, 1999, DEV GROWTH DIFFER, V41, P557; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kohn MJ, 2004, MOL CELL BIOL, V24, P7197, DOI 10.1128/MCB.24.16.7197-7205.2004; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Lavia P, 1999, BIOESSAYS, V21, P221; Maruyama K, 2007, ZOOL SCI, V24, P997, DOI 10.2108/zsj.24.997; Moriyama A, 2010, DEV BIOL, V345, P133, DOI 10.1016/j.ydbio.2010.06.031; Naruse K, 2000, GENETICS, V154, P1773; SANGIORGI F, 1990, DEVELOPMENT, V110, P85; Tamplin OJ, 2010, CURR BIOL, V20, pR561, DOI 10.1016/j.cub.2010.05.014; Tanaka K, 2004, MECH DEVELOP, V121, P739, DOI 10.1016/j.mod.2004.04.011; Tefferi A, 2003, MAYO CLIN PROC, V78, P174; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Yoshinari N, 2012, DEV GROWTH DIFFER, V54, P818, DOI 10.1111/dgd.12013	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	MAY	2015	244	5					651	668		10.1002/dvdy.24259		18	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CH3TQ	WOS:000353953600003		
J	Prasitsak, T; Nandar, M; Okuhara, S; Ichinose, S; Ota, MS; Iseki, S				Prasitsak, Thanit; Nandar, Mya; Okuhara, Shigeru; Ichinose, Shizuko; Ota, Masato S.; Iseki, Sachiko			Foxc1 is Required for Early Stage Telencephalic Vascular Development	DEVELOPMENTAL DYNAMICS			English	Article						Foxc1; telencephalon; angiogenesis; subventricular vascular plexus; basement membrane	FORKHEAD TRANSCRIPTION FACTORS; CENTRAL-NERVOUS-SYSTEM; CONGENITAL-HYDROCEPHALUS; ENDOTHELIAL-CELLS; MOUSE EMBRYOS; ANGIOGENESIS; MORPHOGENESIS; PERICYTES; DIFFERENTIATION; EXPRESSION	Background: The brain vascular system arises from the perineural vascular plexus (PNVP) which sprouts radially into the neuroepithelium and subsequently branches off laterally to form a secondary plexus in the subventricular zone (SVZ), the subventricular vascular plexus (SVP). The process of SVP formation remains to be fully elucidated. We investigated the role of Foxc1 in early stage vascular formation in the ventral telencephalon. Results: The Foxc1 loss of function mutant mouse, Foxc1(ch/ch), showed enlarged telencephalon and hemorrhaging in the ventral telencephalon by embryonic day 11.0. The mutant demonstrated blood vessel dilation and aggregation of endothelial cells in the SVZ after the invasion of endothelial cells through the radial path, which lead to failure of SVP formation. During this early stage of vascular development, Foxc1 was expressed in endothelial cells and pericytes, as well as in cranial mesenchyme surrounding the neural tube. Correspondingly, abnormal deposition pattern of basement membrane proteins around the vessels and increased strong Vegfr2 staining dots were found in the aggregation sites. Conclusions: These observations reveal an essential role for Foxc1 in the early stage of vascular formation in the telencephalon. Developmental Dynamics 244:703-711, 2015. (c) 2015 Wiley Periodicals, Inc.	[Prasitsak, Thanit; Nandar, Mya; Okuhara, Shigeru; Ota, Masato S.; Iseki, Sachiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Tokyo 1138549, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Res Ctr Med & Dent Sci, Tokyo 1138549, Japan; [Ota, Masato S.] Japan Womens Univ, Fac Human Sci & Design, Dept Food & Nutr, Lab Biochem & Food Biol Sci, Tokyo 112, Japan	Iseki, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Craniofacial Embryol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	s.iseki.emb@tmd.ac.jp			Ministry of Education, Science and Culture [22592061, 22592254]	Grant sponsor: the Ministry of Education, Science and Culture; Grant number: 22592061; Grant number: 22592254.	Sizemore ST, 2012, J BIOL CHEM, V287, P24631, DOI 10.1074/jbc.M112.375865; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104; Seo S, 2012, P NATL ACAD SCI USA, V109, P2015, DOI 10.1073/pnas.1109540109; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Skarie JM, 2009, INVEST OPHTH VIS SCI, V50, P5026, DOI 10.1167/iovs.09-3447; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Daneman R, 2010, PLOS ONE, V10; Edgar LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085178; Gruneberg H, 1943, J GENET, V45, P1, DOI 10.1007/BF02982770; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; Siegenthaler JA, 2013, BIOL OPEN, V2, P647, DOI 10.1242/bio.20135009; Vasudevan A, 2008, CELL ADHES MIGR, V2, P167, DOI 10.4161/cam.2.3.6485; Vivatbutsiri P, 2008, J ANAT, V212, P603, DOI 10.1111/j.1469-7580.2008.00893.x; Yamanishi E, 2012, DEV GROWTH DIFFER, V54, P785, DOI 10.1111/dgd.12007	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	MAY	2015	244	5					703	711		10.1002/dvdy.24269		9	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CH3TQ	WOS:000353953600007		
J	Nakai, M; Ikoma, A; Sato, H; Sato, M; Nishimura, Y; Okamura, Y				Nakai, Motoki; Ikoma, Akira; Sato, Hirotatsu; Sato, Morio; Nishimura, Yoshiharu; Okamura, Yoshitaka			Risk factors associated with late aneurysmal sac expansion after endovascular abdominal aortic aneurysm repair	DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY			English	Article							INFERIOR MESENTERIC-ARTERY; COMPUTED-TOMOGRAPHY; II ENDOLEAKS; FOLLOW-UP; THROMBIN INJECTION; EMBOLIZATION; ENDOTENSION; ENLARGEMENT; PREDICTORS; REGRESSION	PURPOSE We aimed to identify the risk factors associated with late aneurysmal sac expansion after endovascular abdominal aortic aneurysm repair (EVAR). METHODS We retrospectively reviewed contrast-enhanced computed tomography (CT) images of 143 patients who were followed for >= 6 months after EVAR. Sac expansion was defined as an increase in sac diameter of 5 mm relative to the preoperative diameter. Univariate and multivariate analyses were performed to identify associated risk factors for late sac expansion after EVAR from the following variables: age, gender, device, endoleak, antiplatelet therapy, internal iliac artery embolization, and preprocedural variables (aneurysm diameter, proximal neck diameter, proximal neck length, suprarenal neck angulation, and infrarenal neck angulation). RESULTS Univariate analysis revealed female gender, endoleak, aneurysm diameter >= 60 mm, suprarenal neck angulation >45 degrees, and infrarenal neck angulation >60 degrees as factors associated with sac expansion. Multivariate analysis revealed endoleak, aneurysm diameter >= 60 mm, and infrarenal neck angulation >60 degrees as independent predictors of sac expansion (P < 0.05, for all). CONCLUSION Our results suggest that patients with small abdominal aortic aneurysms (<60 mm) and infrarenal neck angulation <= 60 degrees are more favorable candidates for EVAR. Intraprocedural treatments, such as prophylactic embolization of aortic branches or intrasac embolization, may reduce the risk of sac expansion in patients with larger abdominal aortic aneurysms or greater infrarenal neck angulation.	[Nakai, Motoki; Ikoma, Akira; Sato, Hirotatsu; Sato, Morio] Wakayama Med Univ, Dept Radiol, Wakayama, Japan; [Nishimura, Yoshiharu; Okamura, Yoshitaka] Wakayama Med Univ, Dept Cardiovasc Surg, Wakayama, Japan	Nakai, M (reprint author), Wakayama Med Univ, Dept Radiol, Wakayama, Japan.	momonga@wakayama-med.ac.jp					Lee JT, 2003, J VASC SURG, V38, P1254, DOI 10.1016/S0741-5214(03)00924-8; Habets J, 2013, EUR J VASC ENDOVASC, V45, P340, DOI 10.1016/j.ejvs.2012.12.014; Aoki A, 2011, J VASC SURG, V54, P947, DOI 10.1016/j.jvs.2011.03.269; Farner MC, 2003, J VASC INTERV RADIOL, V14, P205, DOI 10.1097/01.RVI.0000058322.82956.ad; Ward TJ, 2013, J VASC INTERV RADIOL, V24, P49, DOI 10.1016/j.jvir.2012.09.022; Muthu C, 2007, J ENDOVASC THER, V14, P661, DOI 10.1583/1545-1550(2007)14[661:STRTRO]2.0.CO;2; Yeung JJ, 2009, J ENDOVASC THER, V16, P380, DOI 10.1583/09-2732.1; Nevala T, 2010, CARDIOVASC INTER RAD, V33, P278, DOI 10.1007/s00270-009-9685-5; Greenberg RK, 2004, J VASC SURG, V39, P1209, DOI 10.1016/j.jvs.2004.02.032; Nevala T, 2010, J VASC INTERV RADIOL, V21, P181, DOI 10.1016/j.jvir.2009.10.014; Zanchetta M, 2007, J ENDOVASC THER, V14, P176, DOI 10.1583/1545-1550(2007)14[176:IITITP]2.0.CO;2; Schanzer A, 2011, CIRCULATION, V123, P2848, DOI 10.1161/CIRCULATIONAHA.110.014902; Mirza TA, 2010, EUR J VASC ENDOVASC, V39, P418, DOI 10.1016/j.ejvs.2010.01.001; Verhoeven ELG, 2011, J CARDIOVASC SURG, V52, P193; Makaroun M, 1999, EUR J VASC ENDOVASC, V18, P185, DOI 10.1053/ejvs.1998.0807; Marchiori A, 2011, J ENDOVASC THER, V18, P299, DOI 10.1583/10-3116.1; Veith FJ, 2002, J VASC SURG, V35, P1029, DOI 10.1067/mva.2002.123095; Boult M, 2006, EUR J VASC ENDOVASC, V31, P123, DOI 10.1016/j.ejvs.2005.08.013; Dubenec SR, 2003, J CARDIOVASC SURG, V44, P553; Golzarian J, 1997, RADIOLOGY, V202, P731; Hiatt Mark D, 2004, Semin Vasc Surg, V17, P268, DOI 10.1053/j.semvascsurg.2004.09.003; Ichihashi S, 2013, J VASC SURG, V58, P66, DOI 10.1016/j.jvs.2012.12.061; Ishibashi H, 2011, SURG TODAY, V41, P1605, DOI 10.1007/s00595-011-4531-1; Nakai M, 2013, JPN J RADIOL, V31, P585, DOI 10.1007/s11604-013-0223-7; Nakai M, 2014, J VASC INTERV RADIOL, V25, P405, DOI 10.1016/j.jvir.2013.12.004; Stavropoulos SW, 2005, J VASC INTERV RADIOL, V16, P857, DOI 10.1097/01.RVI.0000156495.660262.62; Stavropoulos SW, 2009, J VASC INTERV RADIOL, V20, P1299, DOI 10.1016/j.jvir.2009.07.003; Uthoff H, 2012, J VASC SURG, V56, P965, DOI 10.1016/j.jvs.2012.03.269; van Sambeek Marc R H M, 2004, Semin Vasc Surg, V17, P284, DOI 10.1053/j.semvascsurg.2004.09.004	29	0	0	TURKISH SOC RADIOLOGY	ANKARA	HOSDERE CAD, GUZELKENT SOK, CANKAYA EVLERI, F-2, ANKARA, 06540, TURKEY	1305-3825	1305-3612		DIAGN INTERV RADIOL	Diagn. Interv. Radiol.	MAY-JUN	2015	21	3					195	201		10.5152/dir.2014.14308		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH4BN	WOS:000353976100002		
J	Ikeya, K; Sugimoto, K; Kawasaki, S; Iida, T; Maruyama, Y; Watanabe, F; Hanai, H				Ikeya, Kentaro; Sugimoto, Ken; Kawasaki, Shinsuke; Iida, Takayuki; Maruyama, Yasuhiko; Watanabe, Fumitoshi; Hanai, Hiroyuki			Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis	DIGESTIVE AND LIVER DISEASE			English	Article						Mayo endoscopic subscore; Mucosal healing; Response to tacrolimus; Ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; ORAL TACROLIMUS; REFRACTORY COLITIS; FOLLOW-UP; THERAPY; FK506; EFFICACY; EXPERIENCE; CHILDREN; COHORT	Background: Tacrolimus has shown efficacy in patients with ulcerative colitis. Aims: To evaluate the efficacy of tacrolimus as remission induction therapy and assess medium to long-term outcomes in patients who achieve remission. Methods: Forty-four ulcerative colitis patients who were treated with tacrolimus in three institutes during 2009-2013 were retrospectively reviewed. Short-term efficacy was based on the clinical activity index and the Mayo endoscopic subscores. Clinical activity index <= 4 meant clinical remission, while Mayo endoscopic subscore 0 or 1 meant mucosal healing. Medium to long-term prognosis was based on relapse free survival in relation to the Mayo endoscopic subscore and duration of tacrolimus therapy in patients who achieved remission. Results: At 12 weeks, clinical remission was achieved in 29 of 44 patients (65.9%). Thirty-two patients received endoscopic evaluations, and mucosal healing rate was 43.8%. Among patients with clinical remission, mucosal healing rate was 60.9%. Relapse-free survival at 6, 12, and 24 months were 66%, 56%, and 50%, respectively, and was higher in patients on long-term tacrolimus (over 4 months, P = 0.03), and patients with better endoscopic subscore (P = 0.009). Conclusions: Mucosal healing observed within 12 weeks or after a longer duration of tacrolimus therapy was associated with significantly better remission maintenance time. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Ikeya, Kentaro; Kawasaki, Shinsuke; Iida, Takayuki; Watanabe, Fumitoshi; Hanai, Hiroyuki] Hamamatsu South Hosp, Ctr Gastroenterol & Inflammatory Bowel Dis Res, Hamamatsu, Shizuoka 4300846, Japan; [Sugimoto, Ken] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Maruyama, Yasuhiko] Fujieda Municipal Gen Hosp, Dept Gastroenterol, Fujieda, Shizuoka, Japan	Hanai, H (reprint author), Hamamatsu South Hosp, Ctr Gastroenterol & Inflammatory Bowel Dis Res, Minami Ku, 26 Shirowacho, Hamamatsu, Shizuoka 4300846, Japan.	hanai@hamamatsu-minami.com					Ogata H, 2006, GUT, V55, P1255, DOI 10.1136/gut.2005.081794; Hanai H, 2003, CLIN GASTROENTEROL H, V1, P28, DOI 10.1053/jcgh.2003.50005; Benson A, 2008, INFLAMM BOWEL DIS, V14, P7, DOI 10.1002/ibd.20263; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Baars JE, 2012, INFLAMM BOWEL DIS, V18, P1634, DOI 10.1002/ibd.21925; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Moskovitz DN, 2006, CLIN GASTROENTEROL H, V4, P760, DOI 10.1016/j.cgh.2006.01.001; Bamba S, 2012, EXP THER MED, V4, P99, DOI 10.3892/etm.2012.545; Baumgart DC, 2006, AM J GASTROENTEROL, V101, P1048, DOI 10.1111/j.1542-0241.2006.00524.x; Baumgart DC, 2003, ALIMENT PHARM THERAP, V17, P1273, DOI 10.1046/j.0269-2813.2003.01534.x; Fellermann K, 2002, INFLAMM BOWEL DIS, V8, P317, DOI 10.1097/00054725-200209000-00002; Fellermann K, 1998, AM J GASTROENTEROL, V93, P1860; Hogenauer C, 2003, ALIMENT PHARM THERAP, V18, P415, DOI 10.1046/j.0269-2813.2003.01662.x; Miyoshi J, 2013, J CROHNS COLITIS, V7, P609; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; Ogata H, 2012, INFLAMM BOWEL DIS, V18, P803, DOI 10.1002/ibd.21853; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Sacco Rodolfo, 2013, J Crohns Colitis, V7, pe692, DOI 10.1016/j.crohns.2013.06.012; Sacco R, 2014, EXPERT REV GASTROENT, V27, P1; Saniabadi AR, 2014, WORLD J GASTROENTERO, V20, P9699, DOI 10.3748/wjg.v20.i29.9699; Schmidt KJ, 2013, ALIMENT PHARM THER, V37, P129, DOI 10.1111/apt.12118; Schuuring J, 2003, AM J NEURORADIOL, V24, P2085; Tanaka T, 2008, DIGEST LIVER DIS, V40, P731, DOI 10.1016/j.dld.2008.02.012; Watson S, 2011, INFLAMM BOWEL DIS, V17, P22, DOI 10.1002/ibd.21418; Yamamoto S, 2011, J CLIN GASTROENTEROL, V45, P526, DOI 10.1097/MCG.0b013e318209cdc4; Yamamoto S, 2008, ALIMENT PHARM THER, V28, P589, DOI 10.1111/j.1365-2036.2008.03764.x; Yamamoto T, 2010, INFLAMM BOWEL DIS, V16, P1905, DOI 10.1002/ibd.21260; Ziring DA, 2007, J PEDIATR GASTR NUTR, V45, P306	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	MAY	2015	47	5					365	371		10.1016/j.dld.2015.01.149		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH5DX	WOS:000354056200004		
J	Oana, S; Shibata, S; Matsuda, N; Matsumoto, T				Oana, Shuhei; Shibata, Sho; Matsuda, Nozomi; Matsumoto, Takayuki			Efficacy and safety of double-balloon endoscopy-assisted endoscopic papillary large-balloon dilatation for common bile duct stone removal	DIGESTIVE AND LIVER DISEASE			English	Article						Double-balloon endoscopy; Endoscopic papillary large-balloon dilatation; Endoscopic retrograde cholangiopancreatography; Roux-en-Y reconstruction	EN-Y ANASTOMOSIS; DILATION; SPHINCTEROTOMY; ENTEROSCOPY; EXPERIENCE; DIFFICULT	Background: Endoscopic retrograde cholangiopancreatography is difficult to perform in patients with gastrointestinal tract reconstruction. Aims: To evaluate the efficacy and safety of double-balloon endoscopy-assisted endoscopic papillary large-balloon dilatation for common bile duct stones in patients with gastrointestinal tract reconstruction. Methods: We conducted a retrospective case series with a comparison to historical controls. During the period 2009-2013, 11 postoperative patients underwent endoscopic papillary large-balloon dilatation (Group A). Procedure efficacy and safety were compared with patients who underwent endoscopic sphincterotomy without endoscopic papillary large-balloon dilatation, who served as historical controls (Group B). Results: Group A consisted of 11 patients (63.6% males, mean age 78 + 10 years), and Group B consisted of 32 patients (78.1% males, mean age 75 +/- 7 years). The stone clearance rate was significantly higher in Group A than in Group B (100% vs. 65.6%, respectively; p < 0.05). Median procedure time was significantly shorter in Group A than in Group B (54 min vs. 102 min, respectively; p < 0.05), and the complication rate was not significantly different between groups (18% vs. 15.6%, respectively; p = 0.586). Conclusion: Endoscopic papillary large-balloon dilatation may be an effective and safe treatment procedure in patients with gastrointestinal tract reconstruction. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Oana, Shuhei; Shibata, Sho; Matsuda, Nozomi; Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 0208505, Japan	Oana, S (reprint author), Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.	shuoana@iwate-med.ac.jp					Shimatani M, 2009, ENDOSCOPY, V41, P849, DOI 10.1055/s-0029-1215108; Kim JH, 2013, WORLD J GASTROENTERO, V19, P8580, DOI 10.3748/wjg.v19.i46.8580; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Aabakken L, 2007, ENDOSCOPY, V39, P1068, DOI 10.1055/s-2007-966841; Maaser C, 2008, AM J GASTROENTEROL, V103, P894, DOI 10.1111/j.1572-0241.2007.01745.x; Stefanidis G, 2011, AM J GASTROENTEROL, V106, P278, DOI 10.1038/ajg.2010.421; Ersoz G, 2003, GASTROINTEST ENDOSC, V57, P156, DOI 10.1067/mge.2003.52; Yang XM, 2013, J DIGEST DIS, V14, P125, DOI 10.1111/1751-2980.12013; Itoi T, 2009, AM J GASTROENTEROL, V104, P560, DOI 10.1038/ajg.2008.67; Cho S, 2011, CAN J GASTROENTEROL, V25, P615; Itoi T, 2010, DIG ENDOSC S1, V22, P98; Itoi T, 2011, DIGEST LIVER DIS, V43, P237, DOI 10.1016/j.dld.2010.09.002; Jang HW, 2013, DIGEST DIS SCI, V58, P1737, DOI 10.1007/s10620-013-2580-6; Lee DK, 2007, DIGEST ENDOSC, V19, P52; Masser C, 2008, AM J GASTROENTEROL, V103, P894; Monkemuller K, 2008, GASTROINTEST ENDOSC, V67, P992, DOI 10.1016/j.gie.2007.10.023; Shimatani M, 2014, J HEPATOBILIARY PANC, V21, P22	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	MAY	2015	47	5					401	404		10.1016/j.dld.2015.02.006		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH5DX	WOS:000354056200010		
J	Kawasaki, K; Kurahara, K; Matsumoto, T				Kawasaki, Keisuke; Kurahara, Koichi; Matsumoto, Takayuki			Pyogenic granuloma of the ileum depicted by small-bowel radiography, capsule endoscopy and double balloon endoscopy	DIGESTIVE AND LIVER DISEASE			English	Editorial Material									[Kawasaki, Keisuke; Matsumoto, Takayuki] Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Morioka, Iwate 0208505, Japan; [Kurahara, Koichi] Matsuyama Red Cross Hosp, Div Gastroenterol, Matsuyama, Ehime, Japan	Kawasaki, K (reprint author), Iwate Med Univ, Dept Internal Med, Div Gastroenterol, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.	kkeisuke@iwate-med.ac.jp					Chou JW, 2009, CLIN GASTROENTEROL H, V7, pXXVI, DOI 10.1016/j.cgh.2008.10.030	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	MAY	2015	47	5					436	436		10.1016/j.dld.2014.11.014		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH5DX	WOS:000354056200017		
J	Kadoya, EZ; Ishii, HS				Kadoya, Eri Z.; Ishii, Hiroshi S.			Host manipulation of bumble bee queens by Sphaerularia nematodes indirectly affects foraging of non-host workers	ECOLOGY			English	Article						Bombus terrestris; Hokkaido, Japan; host modification; indirect interaction; parasite; pollinator; resource competition; Sphaerularia bombi	APIDAE; HYMENOPTERA; PARASITES; MORPHOLOGY; BEHAVIOR; BOMBI	Sphaerularia bombi Dufour is a major parasite of bumble bee queens that manipulates its host's behavior: parasitized queens do not breed and found nests but continue to fly into the early summer months. We examined the indirect consequences of this host manipulation on non-host workers in central Hokkaido Island, Japan. In this area, parasitism of Bombus terrestris by S. bombi is common but does not affect every queen; therefore, as summer begins, B. terrestris queens continue to dominate some flower patches and disappear from others. At sites dominated by parasitized queens, we found that the nectar standing crop of red clover was smaller, B. terrestris workers carried out fewer legitimate visits to red clover and more nectar robberies, and the workers were smaller than at other sites. Removing queens from a site increased the nectar standing crop of red clover, the frequency of worker visits to red clover, and the size of the workers. These results suggest that host manipulation by S. bombi increased competition for flower resources among host queens and non-host workers and altered the interaction between plants and non-host flower visitors.	[Kadoya, Eri Z.; Ishii, Hiroshi S.] Toyama Univ, Grad Sch Sci & Engn, Dept Environm Biol & Chem, Toyama 9308555, Japan	Ishii, HS (reprint author), Toyama Univ, Grad Sch Sci & Engn, Dept Environm Biol & Chem, 3190 Gofuku, Toyama 9308555, Japan.	hishii@sci.u-toyama.ac.jp			Japan Society for the Promotion of Science [20770013]	We are grateful to A. Yanagisawa, Y. Hirabayashi, H. Masuda, H. Suzuki, and K. Y. Shinjo for their assistance in the fieldwork; to L. D. Harder for his useful advice in the early stage of this study; and to T. Osawa for his assistance in drawing the map. This study was partly supported by a grant-in-aid for young scientists from the Japan Society for the Promotion of Science to H. S. Ishii (no. 20770013).	Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Thomas F, 1998, P ROY SOC B-BIOL SCI, V265, P1091, DOI 10.1098/rspb.1998.0403; POINAR GO, 1972, NEMATOLOGICA, V18, P239; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; Sato T, 2011, ECOLOGY, V92, P201, DOI 10.1890/09-1565.1; Hingston AB, 2002, AUSTRAL ECOL, V27, P162, DOI 10.1046/j.1442-9993.2002.01179.x; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Sato T, 2012, ECOL LETT, V15, P786, DOI 10.1111/j.1461-0248.2012.01798.x; Biodiversity Center of Japan, 2012, JAP INT BIOD INF SYS; BOWERS MA, 1985, OECOLOGIA, V67, P224, DOI 10.1007/BF00384289; Brostrom G., 2011, GLMMML GEN LINEAR MO; Ishii HS, 2008, BIOL CONSERV, V141, P2597, DOI 10.1016/j.biocon.2008.07.029; Ishii HS, 2013, ECOL RES, V28, P603, DOI 10.1007/s11284-013-1051-z; Kosaka H., 2008, JAPANESE J NEMATOLOG, V38, P115; MACFARLANE RP, 1990, NEW ZEAL J ZOOL, V17, P191; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; McCorquodale DB, 1998, CAN ENTOMOL, V130, P877; Mitsuhata M., 1995, P 39 ANN M JAP SOC A, V39, P91; Paxton RJ, 2001, MOL ECOL, V10, P2489, DOI 10.1046/j.0962-1083 .2001.01377.x; Pinheiro J, 2012, NLME LINEAR NONLINEA; Plischuk S, 2012, PARASITOL RES, V111, P947, DOI 10.1007/s00436-012-2853-6; R Development Core Team, 2012, R LANG ENV STAT COMP; RICHARDS KW, 1978, CAN ENTOMOL, V110, P301	27	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9658	1939-9170		ECOLOGY	Ecology	MAY	2015	96	5					1361	1370		10.1890/14-0036.1		10	Ecology	Environmental Sciences & Ecology	CH6BB	WOS:000354119300020		
J	Yamazaki, N; Wada, N; Yamauchi, C; Yoneyama, K				Yamazaki, N.; Wada, N.; Yamauchi, C.; Yoneyama, K.			High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy	EJSO			English	Article						Breast cancer; Breast conserving therapy; Ki-67; Neoadjuvant chemotherapy	INTERNATIONAL EXPERT CONSENSUS; MONOCLONAL-ANTIBODY KI-67; SURGICAL ADJUVANT BREAST; CANCER PATIENTS; RANDOMIZED-TRIAL; PROGNOSTIC-SIGNIFICANCE; SYSTEMIC TREATMENT; NUCLEAR ANTIGEN; PRIMARY THERAPY; MASTECTOMY	Introduction: During the past decade, neoadjuvant chemotherapy (NAC) has been increasingly used in patients to reduce large tumors to a size eligible for breast-conserving therapy (BCT). However, the association between NAC and Ki-67 has not yet been fully elucidated. The aim of this study was to evaluate the prognostic significance of Ki-67, specifically after NAC followed by BCT, particularly in terms of locoregional recurrence (LRR). Methods: A total 217 patients who received BCT after NAC were retrospectively analyzed. In these patients, immunohistochemistry analyses defined four tumor subtypes, Luminal A, Luminal B, Triple negative, and HER2 type. Ki-67 was examined by immunohistochemistry in both pretreatment core needle samples and post-treatment surgical excision specimens. High Ki-67 expression was defined as >20%. The prognostic factors LRR, locoregional relapse-free survival (LRRFS), and overall survival (OS) were analyzed. Results: In total, LRR developed in 14 patients, and the 5 year-LRRFS was 94.2%. Post-treatment high Ki-67 expression, triple negative, the presence of lymphovascular invasion, and histological grade 3 were significantly high in LRR for prognostic factors (P < 0.05). There were significant differences in Kaplan-Meier method for LRRFS curves according to these three factors for patients receiving BCT following NAC (P < 0.05). There was a significant difference in the 5 year-OS for patients with and without LRR (41.7% vs. 93.9%, P < 0.001). Conclusion: Post-treatment high Ki-67 expression could be one of the important prognostic factors of LRR, and require careful follow-up on LRR at the time of surveillance. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamazaki, N.; Wada, N.; Yamauchi, C.; Yoneyama, K.] Natl Canc Ctr Hosp East, Dept Breast Surg, Kashiwa, Chiba 2778577, Japan	Wada, N (reprint author), Natl Canc Ctr Hosp East, Dept Breast Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	nowada@east.ncc.go.jp					Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Mamounas EP, 2012, J CLIN ONCOL, V30, P3960, DOI 10.1200/JCO.2011.40.8369; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; van Dongen JA, 2000, J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Mauri D, 2005, J NATL CANCER I, V97, P188; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Rouzier R, 2001, J CLIN ONCOL, V19, P3828; Chen AM, 2004, J CLIN ONCOL, V22, P2303, DOI 10.1200/JCO.2004.09.062; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Arriagada R, 1996, J CLIN ONCOL, V14, P1558; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Hafeez F, 2013, INT J RADIAT ONCOL, V87, P344, DOI 10.1016/j.ijrobp.2013.05.052; GERDES J, 1984, J IMMUNOL, V133, P1710; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; GERDES J, 1991, AM J PATHOL, V138, P867; Cleator SJ, 2005, ANN ONCOL, V16, P267, DOI 10.1093/annonc/mdi049; Broet P, 1999, BREAST CANCER RES TR, V58, P151, DOI 10.1023/A:1006339918798; Cebrecos I, 2010, EJSO-EUR J SURG ONC, V36, P528, DOI 10.1016/j.ejso.2010.04.004; Matsubara N, 2013, BREAST CANCER RES TR, V137, P203, DOI 10.1007/s10549-012-2344-6; Matsuda N, 2014, J SURG ONCOL, V109, P764, DOI 10.1002/jso.23586; Pathmanathan N, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201793; Shin HC, 2013, ANN SURG ONCOL, V20, P2582, DOI 10.1245/s10434-013-2909-6; Tiezzi DG, 2008, EJSO-EUR J SURG ONC, V34, P863, DOI 10.1016/j.ejso.2008.01.015; Touboul E, 1997, RADIOTHER ONCOL, V42, P219, DOI 10.1016/S0167-8140(97)01923-3	29	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	MAY	2015	41	5					617	624		10.1016/j.ejso.2015.01.036		8	Oncology; Surgery	Oncology; Surgery	CH6OB	WOS:000354154800004		
J	Lee, YS; Park, JS; Jung, SM; Kim, SD; Kim, JH; Lee, JY; Jung, KC; Mamura, M; Lee, S; Kim, SJ; Bae, YS; Park, SH				Lee, Youn Sook; Park, Jin Seok; Jung, Su Myung; Kim, Sang-Doo; Kim, Jun Hwan; Lee, Jae Young; Jung, Kyeong Cheon; Mamura, Mizuko; Lee, Sangho; Kim, Seong-Jin; Bae, Yoe-Sik; Park, Seok Hee			Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide	EMBO MOLECULAR MEDICINE			English	Article						inflammation; Pellino-1; sepsis; Smad6; TLR4	PROTEIN-PROTEIN INTERACTIONS; E3 UBIQUITIN LIGASES; GROWTH-FACTOR-BETA; PELLINO PROTEINS; SEVERE SEPSIS; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; I INTERFERONS; CELL-DEATH; T-CELLS	We have previously reported that Smad6, one of the inhibitory Smads of transforming growth factor- (TGF-)/bone morphogenetic protein (BMP) signaling, inhibits Toll-like receptor (TLR) 4 signaling by disrupting the Pellino-1-mediated TLR4 signaling complex. Here, we developed Smaducin-6, a novel membrane-tetheredpalmitic acid-conjugated Smad6-derived peptide composed of amino acids 422-441 of Smad6. Smaducin-6 interacted with Pellino-1, located in the inner membrane, thereby disrupting the formation of IRAK1-, RIP1-, IKK epsilon-mediated TLR4 signaling complexes. Systemic administration of Smaducin-6 showed a significant therapeutic effect on mouse TLR4-mediated inflammatory disease models, cecal-ligation-puncture (CLP)-induced sepsis, andlipopolysaccharide-induced endotoxemia, by inhibiting pro-inflammatory cytokine production and apoptosis while enhancing neutrophil migration and bacterial clearance. Our findings provide clues to develop new peptide-based drugs to target Pellino-1 protein in TLR4 signaling pathway for the treatment of sepsis.	[Lee, Youn Sook; Park, Jin Seok; Jung, Su Myung; Kim, Sang-Doo; Kim, Jun Hwan; Lee, Jae Young; Lee, Sangho; Bae, Yoe-Sik; Park, Seok Hee] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Jung, Kyeong Cheon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Mamura, Mizuko] Tokyo Med Univ, Dept Mol Pathol, Tokyo 1608402, Japan; [Mamura, Mizuko] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kim, Seong-Jin] CHA Univ, CHA Canc Inst, Seoul, South Korea; [Bae, Yoe-Sik; Park, Seok Hee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea	Park, SH (reprint author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	parks@skku.edu			National Research Foundation of Korea - Korean Government [2009-0081756, 2012M3A9C1057306, 2012R1A6A3A04040738]	We thank Dr. Min Sung Choi for critical reading of the manuscript. This work was supported by National Research Foundation grants of Korea (2009-0081756, 2012M3A9C1057306 to SHP) funded by the Korean Government. YSL is a recipient of a National Research Foundation grant of Korea (2012R1A6A3A04040738) funded by the Korean Government.	Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Dejager L, 2014, J INFECT DIS, V209, P960, DOI 10.1093/infdis/jit600; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/SHK.0b013e318157ee55, 10.1097/shk.0b013e318157ee55]; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Kaiser WJ, 2005, J IMMUNOL, V174, P4942; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Imamura T, 1997, NATURE, V389, P622; Corazza N, 2009, ANN NY ACAD SCI, V1171, P50, DOI 10.1111/j.1749-6632.2009.04905.x; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Kirikae T, 1997, MICROBIOL IMMUNOL, V41, P285; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Kim SD, 2010, J IMMUNOL, V185, P4302, DOI 10.4049/jimmunol.1001310; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Yang S, 2013, NAT IMMUNOL, V14, P927, DOI 10.1038/ni.2669; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Diehl GE, 2004, IMMUNITY, V21, P877, DOI 10.1016/j.immuni.2004.11.008; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Siednienko J, 2012, NAT IMMUNOL, V13, P1055, DOI 10.1038/ni.2429; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Moynagh PN, 2014, NAT REV IMMUNOL, V14, P122, DOI 10.1038/nri3599; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Cummings CJ, 1999, J IMMUNOL, V162, P2341; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; Covic L, 2007, HDB CELL PENETRATING, P245; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Lin CC, 2008, STRUCTURE, V16, P1806, DOI 10.1016/j.str.2008.09.011; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Wittebole X, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/568396; Yang S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3583	63	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	MAY	2015	7	5					577	592				16	Medicine, Research & Experimental	Research & Experimental Medicine	CH6GV	WOS:000354135500006		
J	Nakatani, T; Yamagata, K; Kimura, T; Oda, M; Nakashima, H; Hori, M; Sekita, Y; Arakawa, T; Nakamura, T; Nakano, T				Nakatani, Tsunetoshi; Yamagata, Kazuo; Kimura, Tohru; Oda, Masaaki; Nakashima, Hiroyuki; Hori, Mayuko; Sekita, Yoichi; Arakawa, Tatsuhiko; Nakamura, Toshinobu; Nakano, Toru			Stella preserves maternal chromosome integrity by inhibiting 5hmC-induced gamma H2AX accumulation	EMBO REPORTS			English	Article						5-hydroxymethylcytosine; gammaH2AX; Stella; Tet3; zygote	MOUSE PREIMPLANTATION DEVELOPMENT; DNA DEMETHYLATION; PATERNAL GENOME; SELF-RENEWAL; STEM-CELLS; REPLICATION; H2AX; EMBRYOS; ZYGOTE; 5-HYDROXYMETHYLCYTOSINE	In the mouse zygote, Stella/PGC7 protects 5-methylcytosine (5mC) of the maternal genome from Tet3-mediated oxidation to 5-hydroxymethylcytosine (5hmC). Although ablation of Stella causes early embryonic lethality, the underlying molecular mechanisms remain unknown. In this study, we report impaired DNA replication and abnormal chromosome segregation (ACS) of maternal chromosomes in Stella-null embryos. In addition, phosphorylation of H2AX (H2AX), which has been reported to inhibit DNA replication, accumulates in the maternal chromatin of Stella-null zygotes in a Tet3-dependent manner. Cell culture assays verified that ectopic appearance of 5hmC induces abnormal accumulation of H2AX and subsequent growth retardation. Thus, Stella protects maternal chromosomes from aberrant epigenetic modifications to ensure early embryogenesis.	[Nakatani, Tsunetoshi; Kimura, Tohru; Oda, Masaaki; Sekita, Yoichi; Nakano, Toru] Osaka Univ, Sch Med, Dept Pathol, Osaka 530, Japan; [Yamagata, Kazuo; Hori, Mayuko] Osaka Univ, Microbial Dis Res Inst, Osaka 530, Japan; [Kimura, Tohru; Oda, Masaaki; Nakashima, Hiroyuki; Arakawa, Tatsuhiko; Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Osaka 530, Japan; [Kimura, Tohru; Sekita, Yoichi] Kitasato Univ, Sch Sci, Kanagawa, Japan; [Nakamura, Toshinobu] Nagahama Inst Biosci & Technol, Shiga, Japan; [Nakamura, Toshinobu; Nakano, Toru] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Nakano, T (reprint author), Osaka Univ, Sch Med, Dept Pathol, Osaka 530, Japan.	tnakano@patho.med.osaka-u.ac.jp			JST CREST; Ministry of Education, Science, Sports, Culture, and Technology of Japan	We thank Guo-Liang Xu (Institute of Biochemistry And Cell Biology, Shanghai, China) for providing the rabbit anti-Tet3 antibody and Hiroyuki Miyoshi (RIKEN BRC, Tsukuba, Japan) for providing the pCAG-HIVgp, pCMV-VSV-G-RSV-Rev, and CSII-EF-MCS-IRES2-Venus plasmid. The work was funded by JST CREST, Ministry of Education, Science, Sports, Culture, and Technology of Japan.	An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/nchembio.1042, 10.1038/NCHEMBIO.1042]; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ziegler-Birling C, 2009, INT J DEV BIOL, V53, P1003, DOI 10.1387/ijdb.082707cz; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/nchembio.573, 10.1038/NCHEMBIO.573]; Brown EJ, 2000, GENE DEV, V14, P397; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Arney KL, 2002, INT J DEV BIOL, V46, P317; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gu TP, 2012, NATURE, V477, P606; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAY	2015	16	5					582	589		10.15252/embr.201439427		8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CH6FK	WOS:000354131600010		
J	Nitta, T; Muro, R; Shimizu, Y; Nitta, S; Oda, H; Ohte, Y; Goto, M; Yanobu-Takanashi, R; Narita, T; Takayanagi, H; Yasuda, H; Okamura, T; Murata, S; Suzuki, H				Nitta, Takeshi; Muro, Ryunosuke; Shimizu, Yukiko; Nitta, Sachiko; Oda, Hiroyo; Ohte, Yuki; Goto, Motohito; Yanobu-Takanashi, Rieko; Narita, Tomoya; Takayanagi, Hiroshi; Yasuda, Hisataka; Okamura, Tadashi; Murata, Shigeo; Suzuki, Harumi			The thymic cortical epithelium determines the TCR repertoire of IL-17-producing gamma delta T cells	EMBO REPORTS			English	Article						IL-17; thymic epithelial cell; thymus; beta 5t; gamma delta T	POSITIVE SELECTION; INTERFERON-GAMMA; MICE LACKING; NKT CELLS; THYMOCYTES; MEDULLA; INFLAMMATION; LYMPHOCYTES; MOUSE; REQUIREMENT	The thymus provides a specialized microenvironment in which distinct subsets of thymic epithelial cells (TECs) support T-cell development. Here, we describe the significance of cortical TECs (cTECs) in T-cell development, using a newly established mouse model of cTEC deficiency. The deficiency of mature cTECs caused a massive loss of thymic cellularity and impaired the development of gamma delta T cells and invariant natural killer T cells. Unexpectedly, the differentiation of certain gamma delta T-cell subpopulationsinterleukin-17-producing V gamma 4 and V gamma 6 cellswas strongly dysregulated, resulting in the perturbation of gamma delta T-mediated inflammatory responses in peripheral tissues. These findings show that cTECs contribute to the shaping of the TCR repertoire, not only of "conventional" T cells but also of inflammatory "innate" alpha beta T cells.	[Nitta, Takeshi; Muro, Ryunosuke; Nitta, Sachiko; Oda, Hiroyo; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan; [Shimizu, Yukiko; Goto, Motohito; Yanobu-Takanashi, Rieko; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Tokyo, Japan; [Ohte, Yuki; Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo, Japan; [Narita, Tomoya; Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Narita, Tomoya; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Tokyo, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Sect Anim Models, Tokyo, Japan	Suzuki, H (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan.	hsuzuki@ri.ncgm.go.jp			Ministry of Education, Culture, Sports, and Technology in Japan [25111516]; National Center for Global Health and Medicine [24-112]; Astellas Foundation; Inamori Foundation; Kanae Foundation	We thank Dr. Robert E. Tigelaar for providing 17D1 antibody; Drs. Kensuke Shibata and Yasunobu Yoshikai for helpful discussion; and Dr. Michael S. Patrick for reading the manuscript. This study was supported by Grants-in-Aid for Research from the Ministry of Education, Culture, Sports, and Technology in Japan (25111516), the grant for National Center for Global Health and Medicine (24-112), Astellas Foundation, Inamori Foundation, and Kanae Foundation.	Akiyama T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00249; Ohigashi I, 2013, P NATL ACAD SCI USA, V110, P9885, DOI 10.1073/pnas.1301799110; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; White AJ, 2014, J IMMUNOL, V192, P2659, DOI 10.4049/jimmunol.1303057; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shakib S, 2009, J IMMUNOL, V182, P130; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri.797; Rode I, 2012, P NATL ACAD SCI USA, V109, P3463, DOI 10.1073/pnas.1118823109; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Xing Y, 2013, P NATL ACAD SCI USA, V110, P6979, DOI 10.1073/pnas.1222244110; PEREZ RL, 1994, AM J RESP CRIT CARE, V149, P510; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Shitara S, 2013, J IMMUNOL, V190, P6173, DOI 10.4049/jimmunol.1202573; Gommeaux J, 2009, EUR J IMMUNOL, V39, P956, DOI 10.1002/eji.200839175; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Alves NL, 2014, EUR J IMMUNOL, V44, P16, DOI 10.1002/eji.201344110; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Shibata K, 2008, J IMMUNOL, V181, P5940; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Reinhardt A, 2014, EUR J IMMUNOL, V44, P1320, DOI 10.1002/eji.201344330; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Assarsson E, 2007, J IMMUNOL, V178, P5018; Cai YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4986; Cai YH, 2011, IMMUNITY, V35, P649, DOI 10.1016/j.immuni.2011.10.002; Chien Y-h, 2013, TRENDS IMMUNOL, V34, P151; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Nitta Takeshi, 2013, Methods Mol Biol, V946, P85, DOI 10.1007/978-1-62703-128-8_6; Oda H, 2013, IMMUNOL LETT, V151, P1, DOI 10.1016/j.imlet.2013.02.007; Ohigashi I, 2011, EUR J IMMUNOL, V41, P1822, DOI 10.1002/eji.201141480; Plotkin J, 2003, J IMMUNOL, V171, P4521; Saitoh T, 2012, IMMUNOPHARM IMMUNOT, V34, P815, DOI 10.3109/08923973.2012.658922; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Takeo T, 2009, CRYOBIOLOGY, V58, P196, DOI 10.1016/j.cryobiol.2008.12.011; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	MAY	2015	16	5					638	653		10.15252/embr.201540096		16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CH6FK	WOS:000354131600016		
J	Nemoto, M; Bannai, H; Tsujimura, K; Kobayashi, M; Kikuchi, T; Yamanaka, T; Kondo, T				Nemoto, Manabu; Bannai, Hiroshi; Tsujimura, Koji; Kobayashi, Minoru; Kikuchi, Takuya; Yamanaka, Takashi; Kondo, Takashi			Getah Virus Infection among Racehorses, Japan, 2014	EMERGING INFECTIOUS DISEASES			English	Article							AMPLIFICATION; ASSAY	An outbreak of Getah virus infection occurred among racehorses in Japan during September and October 2014. Of 49 febrile horses tested by reverse transcription PCR, 25 were positive for Getah virus. Viruses detected in 2014 were phylogenetically different from the virus isolated in Japan in 1978.	[Nemoto, Manabu; Bannai, Hiroshi; Tsujimura, Koji; Yamanaka, Takashi; Kondo, Takashi] Japan Racing Assoc, Shimotsuke, Tochigi 3290412, Japan; [Kobayashi, Minoru; Kikuchi, Takuya] Japan Racing Assoc, Miho, Japan	Nemoto, M (reprint author), Japan Racing Assoc, Epizoot Res Ctr, Equine Res Inst, 1400-4 Shiba, Shimotsuke, Tochigi 3290412, Japan.	nemoto_manabu@epizoo.equinst.go.jp			Japan Racing Association	This study was supported financially by the Japan Racing Association.	Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Balasuriya UBR, 2002, J VIROL METHODS, V101, P21, DOI 10.1016/S0166-0934(01)00416-5; Brown CM, 1998, TROP ANIM HEALTH PRO, V30, P241, DOI 10.1023/A:1005079229232; Fukunaga Y, 2000, VET CLIN N AM-EQUINE, V16, P605; Griffin D.E., 2013, FIELDS VIROLOGY, P651; KAMADA M, 1980, AM J TROP MED HYG, V29, P984; LAWRENCE GL, 1994, J VIROL METHODS, V47, P59, DOI 10.1016/0166-0934(94)90066-3; Li Xue-Dong, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P730; lmagawa H, 1981, NIPPON JUIGAKU ZASSH, V43, P797; lzumida A, 1988, NIPPON JUIGAKU ZASSH, V50, P679; Nemoto M, 2011, J VIROL METHODS, V178, P239, DOI 10.1016/j.jviromet.2011.07.015; Tajima S, 2014, ARCH VIROL, V159, P2969, DOI 10.1007/s00705-014-2152-x; Wekesa SN, 2001, VET MICROBIOL, V83, P137, DOI 10.1016/S0378-1135(01)00417-5; YAGO K, 1987, JPN J VET SCI, V49, P989	14	1	1	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	MAY	2015	21	5					883	885		10.3201/eid2105.141975		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CG9BW	WOS:000353610400024		
J	Clark, CW; Yoshimura, J				Clark, Colin W.; Yoshimura, Jin			The Economic Incentives Underlying Resource and Environmental Depletion	ENVIRONMENTAL & RESOURCE ECONOMICS			English	Article						Over-harvesting; Future discounting; Short-term economic incentives		We discuss the current global economic crisis as an analog of short-term harvesting of a biological resource, in which motives of short-term profit over-ride sustainability considerations.	[Clark, Colin W.] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada; [Yoshimura, Jin] Shizuoku Univ, Dept Math Syst Engn, Hamamatsu, Shizuoka 4328561, Japan	Clark, CW (reprint author), Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada.	colin_clark@shaw.ca					HARDIN G, 1968, SCIENCE, V162, P1243; Clark CW, 1975, J ENVIRON ECON MANAG, V2, P93; Clark CW, 2010, MATH BIOECONOMICS MA, V3rd; Ostrom E., 1990, GOVERNING COMMONS EV	4	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0924-6460	1573-1502		ENVIRON RESOUR ECON	Environ. Resour. Econ.	MAY	2015	61	1			SI		87	90		10.1007/s10640-014-9763-2		4	Economics; Environmental Studies	Business & Economics; Environmental Sciences & Ecology	CH9SJ	WOS:000354376300005		
J	Chiba, H				Chiba, Hayato			A proof of the Kuramoto conjecture for a bifurcation structure of the infinite-dimensional Kuramoto model	ERGODIC THEORY AND DYNAMICAL SYSTEMS			English	Article							GLOBALLY-COUPLED OSCILLATORS; PHASE OSCILLATORS; SYNCHRONIZATION; POPULATIONS; STABILITY; SINGULARITIES; INCOHERENCE; SPACES; LIMIT	The Kuramoto model is a system of ordinary differential equations for describing synchronization phenomena defined as coupled phase oscillators. In this paper, a bifurcation structure of the infinite-dimensional Kuramoto model is investigated. A purpose here is to prove the bifurcation diagram of the model conjectured by Kuramoto in 1984; if the coupling strength K between oscillators, which is a parameter of the system, is smaller than some threshold K-C, the de-synchronous state (trivial steady state) is asymptotically stable, while if K exceeds K-C, a non-trivial stable solution, which corresponds to the synchronization, bifurcates from the de-synchronous state. One of the difficulties in proving the conjecture is that a certain non-selfadjoint linear operator, which defines a linear part of the Kuramoto model, has the continuous spectrum on the imaginary axis. Hence, the standard spectral theory is not applicable to prove a bifurcation as well as the asymptotic stability of the steady state. In this paper, the spectral theory on a space of generalized functions is developed with the aid of a rigged Hilbert space to avoid the continuous spectrum on the imaginary axis. Although the linear operator has an unbounded continuous spectrum on a Hilbert space, it is shown that it admits a spectral decomposition consisting of a countable number of eigenfunctions on a space of generalized functions. The semigroup generated by the linear operator will be estimated with the aid of the spectral theory on a rigged Hilbert space to prove the linear stability of the steady state of the system. The center manifold theory is also developed on a space of generalized functions. It is proved that there exists a finite-dimensional center manifold on a space of generalized functions, while a center manifold on a Hilbert space is of infinite dimension because of the continuous spectrum on the imaginary axis. These results are applied to the stability and bifurcation theory of the Kuramoto model to obtain a bifurcation diagram conjectured by Kuramoto.	Kyushu Univ, Inst Math, Fukuoka 8190395, Japan	Chiba, H (reprint author), Kyushu Univ, Inst Math, Fukuoka 8190395, Japan.	chiba@imi.kyushu-u.ac.jp			MEXT Japan [22740069]	This work was supported by a Grant-in-Aid for Young Scientists (B), No. 22740069 from MEXT Japan.	Acebron JA, 1998, PHYSICA D, V114, P296, DOI 10.1016/S0167-2789(97)00197-8; Ahlfors L., 1978, COMPLEX ANAL INTRO T; Chiba H, 2009, PHYSICA D, V238, P1068, DOI 10.1016/j.physd.2009.03.005; KOMATSU H, 1967, J MATH SOC JPN, V19, P366; Balmforth NJ, 2000, PHYSICA D, V143, P21, DOI 10.1016/S0167-2789(00)00095-6; Mirollo R, 2007, J NONLINEAR SCI, V17, P309, DOI 10.1007/s00332-006-0806-x; CRAWFORD JD, 1995, PHYS REV LETT, V74, P4341, DOI 10.1103/PhysRevLett.74.4341; STROGATZ SH, 1991, J STAT PHYS, V63, P613, DOI 10.1007/BF01029202; CRAWFORD JD, 1994, J STAT PHYS, V74, P1047, DOI 10.1007/BF02188217; STROGATZ SH, 1992, PHYS REV LETT, V68, P2730, DOI 10.1103/PhysRevLett.68.2730; Chen XY, 1997, J DIFFER EQUATIONS, V139, P283, DOI 10.1006/jdeq.1997.3255; MIROLLO RE, 1990, J STAT PHYS, V60, P245, DOI 10.1007/BF01013676; BONILLA LL, 1992, J STAT PHYS, V67, P313, DOI 10.1007/BF01049037; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Bates P. W., 1989, DYNAMICS REPORTED, V2, P1; Bonilla LL, 1998, PHYSICA D, V113, P79, DOI 10.1016/S0167-2789(97)00187-5; Chiba H, 2013, DISCRETE CONT DYN-A, V33, P1891, DOI 10.3034/dcds.2013.33.1891; Chiba H., 2011, CHAOS, V21; Crawford JD, 1999, PHYSICA D, V125, P1, DOI 10.1016/S0167-2789(98)00235-8; Gel'fand I. M., 1964, APPL HARMONIC ANAL, V4; Gelfand I. M., 1968, SPACES FUNDAMENTAL G, V2; Grothendieck A., 1973, TOPOLOGICAL VECTOR S; Kato Tosio, 1995, PERTURBATION THEORY; Krisztin T, 2004, SIAM J MATH ANAL, V36, P717, DOI 10.1137/S0036141003419170; Kuramoto Y., 1975, LECTURE NOTES PHYSIC, V39, P420, DOI DOI 10.1007/BFB0013365; Kuramoto Y, 1984, SPRINGER SERIES SYNE, V19; Maistrenko Y., 2004, PHYS REV LETT, V93; Maistrenko YL, 2005, INT J BIFURCAT CHAOS, V15, P3457, DOI 10.1142/S0218127405014155; Martens E. A., 2009, PHYS REV E, V79; Marvel S. A., 2009, CHAOS, V19; Maurin K, 1968, GEN EIGENFUNCTION EX; Ott E., 2009, CHAOS, V19; Ott E., 2008, CHAOS, V18; Phillips R. S., 1957, FUNCTIONAL ANAL SEMI; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Reed M., 1978, METHODS MODERN MATH; Sanders J, 1985, AVERAGING METHODS NO; Shohat J. A., 1943, PROBLEM MOMENTS; Stein E.M., 1971, INTRO FOURIER ANAL E; Titchmarsh EC, 1986, INTRO THEORY FOURIER; Treves F., 1967, TOPOLOGICAL VECTOR S; Vanderbauwhede A., 1992, DYNAMICS REPORTED EX, V1; Vilenkin N., 1968, SPECIAL FUNCTIONS TH; Yosida K., 1995, FUNCTIONAL ANAL	45	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0143-3857	1469-4417		ERGOD THEOR DYN SYST	Ergod. Theory Dyn. Syst.	MAY	2015	35		3				762	834		10.1017/etds.2013.68		73	Mathematics, Applied; Mathematics	Mathematics	CH9BK	WOS:000354330800006		
J	Yoshida, M; Muro, K; Tsuji, A; Hamamoto, Y; Yoshino, T; Yoshida, K; Shirao, K; Miyata, Y; Takahari, D; Takahashi, T; Ohtsu, A				Yoshida, M.; Muro, K.; Tsuji, A.; Hamamoto, Y.; Yoshino, T.; Yoshida, K.; Shirao, K.; Miyata, Y.; Takahari, D.; Takahashi, T.; Ohtsu, A.			Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)	EUROPEAN JOURNAL OF CANCER			English	Article						Bevacizumab; Colorectal cancer; Elderly; S-1	RANDOMIZED CONTROLLED-TRIAL; PHASE-3 TRIAL; OPEN-LABEL; 1ST-LINE TREATMENT; PLUS BEVACIZUMAB; NON-INFERIORITY; OXALIPLATIN; CAPECITABINE; FLUOROURACIL; LEUCOVORIN	Background: Chemotherapeutic regimens for elderly patients with metastatic colorectal cancer (mCRC), such as bevacizumab combined with 5-fluorouracil (5-FU) and leucovorin, often exclude oxaliplatin and irinotecan owing to the risk of toxicity. However, treatment with infusional 5-fluorouracil and leucovorin requires percutaneous port-catheter placement and other precautions, causing unnecessary stress for patients as well as healthcare workers. Methods: We conducted a phase II study to evaluate the efficacy and safety of bevacizumab plus S-1 in elderly patients with previously untreated mCRC. Bevacizumab was given intravenously every two weeks, and S-1 was administered orally on days 1-28 of a 42-day cycle. The primary end-point was progression-free survival (PFS). The secondary end-points were time to treatment failure, response rate (RR), overall survival (OS), treatment completion status and safety. Results: From October 2007 through March 2010, 56 patients were enroled. The median PFS was 9.9 months, the median OS was 25.0 months, and the RR was 57%. The main adverse events of grade 3 or higher were hypertension (11%), diarrhoea (9%) and neutropenia (7%). Conclusion: Our results suggest that combination chemotherapy with S-1 and bevacizumab can be administered safely and continuously on an outpatient basis and is therapeutically effective in elderly patients with mCRC. (C) 2015 The Authors. Published by Elsevier Ltd.	[Yoshida, M.] Osaka Med Coll Hosp, Canc Chemotherapy Ctr, Takatsuki, Osaka 5698686, Japan; [Muro, K.; Takahari, D.] Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Tsuji, A.] Kochi Hlth Sci Hosp, Dept Med Oncol, Kochi 7818555, Japan; [Hamamoto, Y.] Tochigi Canc Ctr, Dept Med Oncol, Utsunomiya, Tochigi 3200834, Japan; [Yoshino, T.; Ohtsu, A.] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol Gastroenterol, Kashiwa, Chiba 2778577, Japan; [Yoshida, K.; Takahashi, T.] Gifu Univ, Dept Surg Oncol, Grad Sch Med, Gifu, Gifu 5011194, Japan; [Shirao, K.] Oita Univ, Fac Med, Dept Med Oncol, Oita 8795543, Japan; [Miyata, Y.] Saku Cent Hosp, Dept Gastroenterol, Nagano 3840393, Japan	Yoshida, M (reprint author), Osaka Med Coll Hosp, Div Canc Chemotherapy Ctr, ESMO ID 42465, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ctc004@poh.osaka-med.ac.jp			Taiho Pharmaceutical Co., Ltd., Tokyo, Japan	This work was supported by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan.	Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Shirao K, 2004, CANCER, V100, P2355, DOI 10.1002/cncr.20277; Figer A, 2007, CANCER, V110, P2666, DOI 10.1002/cncr.23091; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; [Anonymous], 2004, INT J CLIN ONCOL S3, V9, P1; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Jackson NA, 2009, CANCER, V115, P2617, DOI 10.1002/cncr.24305; Ducreux M, 2011, LANCET ONCOL, V12, P1032, DOI 10.1016/S1470-2045(11)70199-1; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3706, DOI 10.1200/JCO.2005.00.232; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Seymour MT, 2007, LANCET, V370, P143, DOI 10.1016/S0140-6736(07)61087-3; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.3.CO;2-N; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Hong YS, 2012, LANCET ONCOL, V13, P1125, DOI 10.1016/S1470-2045(12)70363-7; Ohtsu A, 2000, BRIT J CANCER, V83, P141; ClinicalTrials.gov, COMB CHEM PLUS BEV O; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	MAY	2015	51	8					935	941		10.1016/j.ejca.2015.03.007		7	Oncology	Oncology	CH2UR	WOS:000353880700006		
J	Tanabe, K; Wada, J; Ohkubo, J; Nitta, A; Ikezaki, T; Takeuchi, M; Handa, A; Tanaka, M; Murakami, N; Kashii, T; Kitazawa, H				Tanabe, Kouichi; Wada, Junko; Ohkubo, Jun; Nitta, Atsumi; Ikezaki, Tomoaki; Takeuchi, Miyako; Handa, Aya; Tanaka, Mai; Murakami, Nozomu; Kashii, Tatsuhiko; Kitazawa, Hidenori			Stability of octreotide acetate decreases in a sodium bisulfate concentration-dependent manner: compatibility study with morphine and metoclopramide injections	EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE			English	Article						sodium bisulfate; morphine; metoclopramide; compatibility; PALLIATIVE CARE	MALIGNANT BOWEL OBSTRUCTION; POLYPROPYLENE SYRINGES; EFFICACY; CANCER; SAFETY; DRUGS	Purpose Sodium bisulfate is known to affect the stability of octreotide. However, the critical concentration of sodium bisulfate is not known. Therefore, we assessed the critical concentration of sodium bisulfate needed to preserve the stability of octreotide using actual drugs containing sodium bisulfate. Methods Although morphine and metoclopramide preparations are considered to be compatible with octreotide, some of their products are known to contain sodium bisulfate. Thus, octreotide was mixed with preparations of sodium bisulfate solutions at serial concentrations and morphine and metoclopramide preparations containing sodium bisulfate, and octreotide stability was then evaluated using high performance liquid chromatography. Results Octreotide concentrations decreased significantly at a sodium bisulfate concentration of 0.1mg/mL or higher after 10days when octreotide was mixed with sodium bisulfate solutions at various concentrations. A significant decrease in octreotide concentrations also occurred when it was mixed with morphine and metoclopramide preparations containing sodium bisulfate and stored for 10days; however, slight decreases were observed in the mixture with both preparations and were within the clinically acceptable range for morphine preparations. Conclusions These results indicate that the residual rate of octreotide decreases with time in a sodium bisulfate concentration-dependent manner when octreotide was mixed with morphine or metoclopramide. However, this incompatibility may be clinically acceptable when the final sodium bisulfate concentration is lower than 0.1mg/mL and the mixed solution is used within 7days.	[Tanabe, Kouichi; Wada, Junko; Nitta, Atsumi] Toyama Univ, Dept Pharmaceut Therapy & Neuropharmacol, Fac Pharmaceut Sci, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Tanabe, Kouichi; Kashii, Tatsuhiko] Toyama Univ Hosp, Dept Med Oncol, Toyama, Japan; [Ohkubo, Jun; Ikezaki, Tomoaki; Takeuchi, Miyako; Handa, Aya; Tanaka, Mai; Kitazawa, Hidenori] Saiseikai Takaoka Hosp, Dept Pharm, Takaoka, Toyama, Japan; [Murakami, Nozomu] Kanazawa Med Univ, Dept Gen & Digest Surg, Himi Municipal Hosp, Kanazawa, Ishikawa, Japan	Tanabe, K (reprint author), Toyama Univ Hosp, Dept Med Oncol, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	tanabe@po2.nsknet.or.jp					Hisanaga T, 2010, JPN J CLIN ONCOL, V40, P739, DOI 10.1093/jjco/hyq048; Ripamonti C, 2001, SUPPORT CARE CANCER, V9, P223, DOI 10.1007/s005200000198; Mercadante S, 2004, J PAIN SYMPTOM MANAG, V28, P412, DOI 10.1016/j.jpainsymman.2004.01.007; CECIL R, 1962, BIOCHEM J, V82, P401; CECIL R, 1960, BIOCHEM J, V76, P146; Fielding H, 2000, PALLIATIVE MED, V14, P205, DOI 10.1191/026921600666997498; Horioka M, 1995, PRINCIPLES PRACTICE, P323; Mercadante S, 1995, J PALLIATIVE CARE, V11, P14; Murakami N, 2009, PALLIAT CARE RES, V4, P321, DOI [10.2512/jspm.4.321, DOI 10.2512/JSPM.4.321]; Novartis Pharma Co. Ltd, 2009, DRUG INT FORM SAND S, P48; Pless J, 2005, J Endocrinol Invest, V28, P1; PLESS J, 1992, METABOLISM, V41, P5, DOI 10.1016/0026-0495(92)90023-4; Pless J, 1986, Scand J Gastroenterol Suppl, V119, P54; Ripamonti C, 2010, OXFORD TXB PALLIATIV, P850; Shima Y, 2008, JPN J CLIN ONCOL, V38, P354, DOI 10.1093/jjco/hyn035; Steger PJK, 1996, J CLIN PHARM THER, V21, P73, DOI 10.1111/j.1365-2710.1996.tb00003.x; STILES ML, 1993, AM J HOSP PHARM, V50, P2356; Tanabe K, 2010, JPN J PHARM PALLIAT, V3, P53; Tanabe K, 2013, PALLIATIVE CARE RES, V8, P177, DOI 10.2512/jspm.8.177; Twycross R, 2007, PALLIATIVE CARE FORM, V3rd, P583; Vermeire A, 2002, PALLIATIVE MED, V16, P417, DOI 10.1191/0269216302pm542oa; Yin D, 2011, CHIN GERMAN J CLIN O, V10, P31, DOI [10.1007/s10330-011-0720-z, DOI 10.1007/S10330-011-0720-Z]	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2047-9956	2047-9964		EUR J HOSP PHARM-S P	Eur. J. Hosp. Pharm.-Sci. Pract.	MAY	2015	22	3					171	175		10.1136/ejhpharm-2014-000555		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH9QI	WOS:000354370500010		
J	Takeuchi, O				Takeuchi, Osamu			HuR keeps interferon-beta mRNA stable	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Editorial Material						Antiviral response; ELAVL1; HuR; Gene regulation; innate immunity; mRNA stability; Mass spectrometry; Type I interferon	TRISTETRAPROLIN; INFLAMMATION; RECOGNITION; DECAY; INITIATION; RESOLUTION; RECEPTORS; INDUCTION; STABILITY; RESPONSES	The expression of interferon (IFN) is highly induced in immune and nonimmune cells in response to virus infection. This upregulation is mediated at both transcriptional and posttranscriptional levels. Whereas the signaling pathways triggered by innate virus receptors leading to transcription factor activation have been extensively studied, the mechanisms by which IFN- mRNA stability is posttranscriptionally controlled are not fully understood. In this issue of the European Journal of Immunology, Herdy etal. [Eur. J. Immunol. 2015 45:1500-1511] show that a human RNA-binding protein, embryonic lethal, abnormal vision, drosophila-like 1 (ELAVL1)/Hu antigen R (HuR), strongly associates with IFN- mRNA via AU-rich sequences present in its 3 untranslated region in various human cell lines. The authors show that ELAVL1/HuR is required for the stabilization of IFN- mRNA, and suppression of ELAVL1/HuR by its inhibitor MS-444 leads to impaired expression of IFN- in response to viral dsRNA treatment. Thus, this study uncovers a novel mechanism of posttranscriptional IFN- mRNA regulation in response to virus infection, through IFN- stabilization by ELAVL1/HuR. Future studies are expected to identify further regulatory mechanisms of IFN- stabilization and destabilization in the course of antiviral responses.	[Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 6068507, Japan; [Takeuchi, Osamu] JST, CREST, Kyoto, Japan	Takeuchi, O (reprint author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	otake@virus.kyoto-u.ac.jp					Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Herdy B, 2015, EUR J IMMUNOL, V45, P1500, DOI 10.1002/eji.201444979; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Mino T, 2013, BIOTECHNOL GENET ENG, V29, P49, DOI 10.1080/02648725.2013.801236; vonsRoretz C., 2011, WILEY INTERDISCIP RE, V2, P336	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	MAY	2015	45	5					1296	1299		10.1002/eji.201545616		4	Immunology	Immunology	CH6YK	WOS:000354182300003		
J	Yokota, T; Oritani, K; Sudo, T; Ishibashi, T; Doi, Y; Habuchi, Y; Ichii, M; Fukushima, K; Okuzaki, D; Tomizuka, K; Yamawaki, K; Kakitani, M; Shimono, A; Morii, E; Kincade, PW; Kanakura, Y				Yokota, Takafumi; Oritani, Kenji; Sudo, Takao; Ishibashi, Tomohiko; Doi, Yukiko; Habuchi, Yoko; Ichii, Michiko; Fukushima, Kentaro; Okuzaki, Daisuke; Tomizuka, Kazuma; Yamawaki, Kengo; Kakitani, Makoto; Shimono, Akihiko; Morii, Eiichi; Kincade, Paul W.; Kanakura, Yuzuru			Estrogen-inducible sFRP5 inhibits early B-lymphopoiesis in vivo, but not during pregnancy	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						B-lymphopoiesis; Bone marrow; Estrogen; Hematopoietic stem cells; Immune tolerance; Lymphoid progenitors; Pregnancy; Soluble Frizzled-related proteins	FRIZZLED-RELATED PROTEIN-2; WNT/BETA-CATENIN; BONE-MARROW; MYOCARDIAL-INFARCTION; SIGNALING PATHWAY; SPEMANN ORGANIZER; SELF-RENEWAL; RAG1 LOCUS; STEM-CELLS; WNT	Mammals have evolved to protect their offspring during early fetal development. Elaborated mechanisms induce tolerance in the maternal immune system for the fetus. Female hormones, mainly estrogen, play a role in suppressing maternal lymphopoiesis. However, the molecular mechanisms involved in the maternal immune tolerance are largely unknown. Here, we show that estrogen-induced soluble Frizzled-related proteins (sFRPs), and particularly sFRP5, suppress B-lymphopoiesis in vivo in transgenic mice. Mice overexpressing sFRP5 had fewer B-lymphocytes in the peripheral blood and spleen. High levels of sFRP5 inhibited early B-cell differentiation in the bone marrow (BM), resulting in the accumulation of cells with a common lymphoid progenitor (CLP) phenotype. Conversely, sFRP5 deficiency reduced the number of hematopoietic stem cells (HSCs) and primitive lymphoid progenitors in the BM, particularly when estrogen was administered. Furthermore, a significant reduction in CLPs and B-lineage-committed progenitors was observed in the BM of sfrp5-null pregnant females. We concluded that, although high sFRP5 expression inhibits B-lymphopoiesis in vivo, physiologically, it contributes to the preservation of very primitive lymphopoietic progenitors, including HSCs, under high estrogen levels. Thus, sFRP5 regulates early lympho-hematopoiesis in the maternal BM, but the maternal-fetal immune tolerance still involves other molecular mechanisms that remain to be uncovered.	[Yokota, Takafumi; Oritani, Kenji; Sudo, Takao; Ishibashi, Tomohiko; Doi, Yukiko; Habuchi, Yoko; Ichii, Michiko; Fukushima, Kentaro; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Tomizuka, Kazuma] Kyowa Hakko Kirin Calif Inc, Div Res, La Jolla, CA USA; [Yamawaki, Kengo] Kyowa Hakko Kirin Co Ltd, Biol Res Labs, Div Res, Machida, Tokyo, Japan; [Kakitani, Makoto] Kyowa Hakko Kirin Co Ltd, Bio Proc Res & Dev Labs, Takasaki, Gunma, Japan; [Shimono, Akihiko] TransGenic Inc, Kobe, Hyogo, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka, Japan; [Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Yokota, T (reprint author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, C9,2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	yokotat@bldon.med.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); JSPS KAKENHI [21591241, 25461450]	Phylogenetic analyses were performed with the computing system at Genome Information Research Center, Osaka University. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) (funding recipients; K.T., K.Y., and M.K), JSPS KAKENHI Grant Number 21591241 (funding recipients; T.Y., K.O., and Y.K.) and JSPS KAKENHI Grant Number 25461450 (funding recipients; K.F., T.Y., K.O., and Y.K.). Author contributions; T.Y. conducted experiments and analyzed results; T.Y., K.O., P.W.K., and Y.K. designed the research plan and wrote the manuscript; T.S., T.I., Y.D., and Y.H. prepared mouse cells and performed the flow cytometry; M.I., K.F., and D.O. performed gene expression analyses; K.T., K.Y., and M.K. established sFRP transgenic mice; A.S. established sFRP5-deficient mice; E.M. prepared murine tissue sections and performed histological assessment. We thank Dr. Ouchi (Nagoya University) and Dr. Kamada (Osaka University) for transferring the sFRP5-deficient mice.	Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kincade PW, 2000, IMMUNOL REV, V175, P128, DOI 10.1034/j.1600-065X.2000.017502.x; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Yokota T, 2008, J IMMUNOL, V181, P6061; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Medina KL, 2000, BLOOD, V95, P2059; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P65, DOI 10.1016/j.bbrc.2009.09.067; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794; Kakitani M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni083; Kincade PW, 2002, SEMIN IMMUNOL, V14, P385, DOI 10.1016/S1044-5323(02)00073-8; Kuwata N, 1999, J IMMUNOL, V163, P6355; MEDINA KL, 1993, J EXP MED, V178, P1507, DOI 10.1084/jem.178.5.1507; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V35, P523; SMITHSON G, 1995, J IMMUNOL, V155, P3409; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	MAY	2015	45	5					1390	1401		10.1002/eji.201444939		12	Immunology	Immunology	CH6YK	WOS:000354182300012		
J	Saito, S; Kawamura, T; Higuchi, M; Kobayashi, T; Yoshita-Takahashi, M; Yamazaki, M; Abe, M; Sakimura, K; Kanda, Y; Kawamura, H; Jiang, SY; Naito, M; Yoshizaki, T; Takahashi, M; Fujii, M				Saito, Suguru; Kawamura, Toshihiko; Higuchi, Masaya; Kobayashi, Takahiro; Yoshita-Takahashi, Manami; Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji; Kanda, Yasuhiro; Kawamura, Hiroki; Jiang, Shuying; Naito, Makoto; Yoshizaki, Takumi; Takahashi, Masahiko; Fujii, Masahiro			RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						-GalCer; IL-4; Liver injury; NKT cell; Ras; RasGAP	KILLER T-CELLS; GTPASE-ACTIVATING PROTEINS; ALPHA-GALACTOSYLCERAMIDE; RECEPTOR; LIVER; TUMOR; ACCUMULATION; LYMPHOCYTES; METASTASIS; SUPPRESSOR	Ras GTPase-activating proteins negatively regulate the Ras/Erk signaling pathway, thereby playing crucial roles in the proliferation, function, and development of various types of cells. In this study, we identified a novel Ras GTPase-activating proteins protein, RASAL3, which is predominantly expressed in cells of hematopoietic lineages, including NKT, B, and Tcells. We established systemic RASAL3-deficient mice, and the mice exhibited a severe decrease in NKT cells in the liver at 8 weeks of age. The treatment of RASAL3-deficient mice with -GalCer, a specific agonist for NKT cells, induced liver damage, but the level was less severe than that in RASAL3-competent mice, and the attenuated liver damage was accompanied by a reduced production of interleukin-4 and interferon- from NKT cells. RASAL3-deficient NKT cells treated with -GalCer in vitro presented augmented Erk phosphorylation, suggesting that there is dysregulated Ras signaling in the NKT cells of RASAL3-deficient mice. Taken together, these results suggest that RASAL3 plays an important role in the expansion and functions of NKT cells in the liver by negatively regulating Ras/Erk signaling, and might be a therapeutic target for NKT-associated diseases.	[Saito, Suguru; Higuchi, Masaya; Yoshita-Takahashi, Manami; Yoshizaki, Takumi; Takahashi, Masahiko; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata 9518510, Japan; [Kawamura, Toshihiko; Kobayashi, Takahiro; Kanda, Yasuhiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Immunol, Niigata 9518510, Japan; [Yoshita-Takahashi, Manami] Niigata Univ, Ctr Fostering Innovat Leadership, Niigata 9518510, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Ctr, Div Neurocellular Biol, Niigata 9518510, Japan; [Kawamura, Hiroki] Niigata Univ Hlth & Welf, Fac Med Technol, Dept Clin Engn & Med Technol, Niigata, Japan; [Jiang, Shuying; Naito, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Pathol, Niigata 9518510, Japan; [Jiang, Shuying] Niigata Coll Med Technol, Niigata, Japan	Fujii, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, 1-757 Asahimachi Dori Niigata, Niigata 9518510, Japan.	fujiimas@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; grant for the Promotion of Niigata University Research Project	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant for the Promotion of Niigata University Research Project (to M.F., M.H., T.K., M.Y.). We thank Yoshitaka Maeda, Yoshitaka Yamamoto, and Kanako Oda for their support and technical advice regarding the animal experiments, and Masayoshi Mishina and Yasuaki Yamada for providing the TLCN-Cre mice and T-cell lines. We also thank Yasue Honma, Minoru Tanaka, and Misako Tobimatsu for the technical assistance.	Meier F, 2005, FRONT BIOSCI, V10, P2986, DOI 10.2741/1755; Genot E, 1996, EMBO J, V15, P3923; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Takahashi M, 2013, BLOOD, V122, P715, DOI 10.1182/blood-2013-03-493718; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Qiao Y, 2012, P NATL ACAD SCI USA, V109, P16264, DOI 10.1073/pnas.1207528109; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Oliver JA, 2013, MOL IMMUNOL, V55, P292, DOI 10.1016/j.molimm.2013.03.005; Dower NA, 2000, NAT IMMUNOL, V1, P317; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Hasegawa H, 2011, LEUKEMIA, V25, P575, DOI 10.1038/leu.2010.315; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Cox AD, 2010, SMALL GTPASES, V1, P2, DOI DOI 10.4161/SGTP.1.1.12178.PMID:21686117; Dennert G, 2006, CRIT REV IMMUNOL, V26, P453; Diez D, 2011, NUCLEIC ACIDS RES, V39, P5526, DOI 10.1093/nar/gkr154; Emoto M, 1999, J IMMUNOL, V162, P5094; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Kobayashi T, 2012, IMMUNOLOGY, V136, P86, DOI 10.1111/j.1365-2567.2012.03562.x; Lapinski PE, 2012, AM J EXP IMMUNOL, V1, P147; Matsumoto H, 2011, IMMUNOLOGY, V133, P21, DOI 10.1111/j.1365-2567.2011.03405.x; Miyazaki T, 2012, J NEUROSCI, V32, P1311, DOI 10.1523/JNEUROSCI.2755-11.2012; Pamonsinlapatham P, 2009, BIOCHIMIE, V3, P320, DOI DOI 10.1016/J.BIOCHI.2008.10.010; PASTOR MI, 1995, CANCER SURV, V22, P75; Wu L, 2009, TISSUE ANTIGENS, V73, P535, DOI 10.1111/j.1399-0039.2009.01256.x; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	MAY	2015	45	5					1512	1523		10.1002/eji.201444977		12	Immunology	Immunology	CH6YK	WOS:000354182300023		
J	Kamii, H; Kurosawa, R; Taoka, N; Shinohara, F; Minami, M; Kaneda, K				Kamii, Hironori; Kurosawa, Ryo; Taoka, Naofumi; Shinohara, Fumiya; Minami, Masabumi; Kaneda, Katsuyuki			Intrinsic membrane plasticity via increased persistent sodium conductance of cholinergic neurons in the rat laterodorsal tegmental nucleus contributes to cocaine-induced addictive behavior	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						addiction; conditioned place preference; mesocorticolimbic circuitry; neuroplasticity; persistent sodium channel	HIPPOCAMPAL PYRAMIDAL CELLS; SYNAPTIC PLASTICITY; DOPAMINE NEURONS; PLACE PREFERENCE; K+ CHANNELS; IN-VITRO; ACCUMBENS NEURONS; EVOKED PLASTICITY; AREA; GLUTAMATE	The laterodorsal tegmental nucleus (LDT) is a brainstem nucleus implicated in reward processing and is one of the main sources of cholinergic afferents to the ventral tegmental area (VTA). Neuroplasticity in this structure may affect the excitability of VTA dopamine neurons and mesocorticolimbic circuitry. Here, we provide evidence that cocaine-induced intrinsic membrane plasticity in LDT cholinergic neurons is involved in addictive behaviors. After repeated experimenter-delivered cocaine exposure, ex vivo whole-cell recordings obtained from LDT cholinergic neurons revealed an induction of intrinsic membrane plasticity in regular- but not burst-type neurons, resulting in increased firing activity. Pharmacological examinations showed that increased riluzole-sensitive persistent sodium currents, but not changes in Ca2+-activated BK, SK or voltage-dependent A-type potassium conductance, mediated this plasticity. In addition, bilateral microinjection of riluzole into the LDT immediately before the test session in a cocaine-induced conditioned place preference (CPP) paradigm inhibited the expression of cocaine-induced CPP. These findings suggest that intrinsic membrane plasticity in LDT cholinergic neurons is causally involved in the development of cocaine-induced addictive behaviors.	[Kamii, Hironori; Kurosawa, Ryo; Taoka, Naofumi; Shinohara, Fumiya; Minami, Masabumi; Kaneda, Katsuyuki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan	Kaneda, K (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan.	kkaneda@pharm.hokudai.ac.jp	Minami, Masabumi/A-3883-2012; Kaneda, Katsuyuki/A-8443-2012		Ministry of Education, Culture, Sports, Science, and Technology of Japan [24500432, 26120702]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Akiyama Life Science Foundation	This study was supported by a Grant-in-Aid for Scientific Research 24500432, 26120702 (K.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, The Mochida Memorial Foundation for Medical and Pharmaceutical Research (K.K.) and The Akiyama Life Science Foundation (K.K.).	Hassanzadeh K, 2010, PHARMACOL REP, V62, P664; Arencibia-Albite F, 2012, J NEUROPHYSIOL, V107, P2271, DOI 10.1152/jn.00818.2011; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Duprat F, 2000, MOL PHARMACOL, V57, P906; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Zhang L, 2005, J PHYSIOL-LONDON, V568, P469, DOI 10.1113/jphysiol.2005094722; LEONARD CS, 1994, NEUROSCIENCE, V59, P309, DOI 10.1016/0306-4522(94)90599-1; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Cao YJ, 2002, EUR J PHARMACOL, V449, P47, DOI 10.1016/S0014-2999(02)01987-8; Schmidt HD, 2010, ANN NY ACAD SCI, V1187, P35, DOI 10.1111/j.1749-6632.2009.05144.x; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Solecki W, 2013, NEUROPHARMACOLOGY, V75, P9, DOI 10.1016/j.neuropharm.2013.07.001; Kaneko Y, 2007, NEUROPSYCHOPHARMACOL, V32, P658, DOI 10.1038/sj.npp.1301111; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Gipson CD, 2013, P NATL ACAD SCI USA, V110, P9124, DOI 10.1073/pnas.1220591110; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Moussawi K, 2011, P NATL ACAD SCI USA, V108, P385, DOI 10.1073/pnas.1011265108; Sartor GC, 2012, EUR J NEUROSCI, V36, P3549, DOI 10.1111/j.1460-9568.2012.08277.x; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; KAMONDI A, 1992, J NEUROPHYSIOL, V68, P1359; Liang LL, 2013, J PAIN, V14, P638, DOI 10.1016/j.jpain.2013.01.778; Wolf ME, 2010, NEUROSCI BIOBEHAV R, V35, P185, DOI 10.1016/j.neubiorev.2010.01.013; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Gronier B, 1998, BRIT J PHARMACOL, V124, P455, DOI 10.1038/sj.bjp.0701850; Hargus NJ, 2013, J NEUROPHYSIOL, V110, P1144, DOI 10.1152/jn.00383.2013; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kitanaka N, 2006, NEUROCHEM RES, V31, P805, DOI 10.1007/s11064-006-9081-3; Kurosawa R, 2013, EUR J NEUROSCI, V38, P3027, DOI 10.1111/ejn.12296; Leonard CS, 1990, BRAIN CHOLINERGIC SY, P205; Lester DB, 2010, SYNAPSE, V64, P216, DOI 10.1002/syn.20717; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu XJ, 2014, NEUROPSYCHOPHARMACOL, V39, P989, DOI 10.1038/npp.2013.299; LUEBKE JI, 1992, P NATL ACAD SCI USA, V89, P743, DOI 10.1073/pnas.89.2.743; MANTZ J, 1992, ANESTHESIOLOGY, V76, P844, DOI 10.1097/00000542-199205000-00023; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; Nasif FJ, 2005, J NEUROSCI, V25, P3674, DOI 10.1523/JNEUROSCI.0010-05.2005; Nelson CL, 2007, NEUROSCIENCE, V146, P41, DOI 10.1016/j.neuroscience.2007.01.027; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Omelchenko N, 2006, J COMP NEUROL, V494, P863, DOI 10.1002/cne.20852; Schmidt HD, 2009, EUR J NEUROSCI, V30, P1358, DOI 10.1111/j.1460-9568.2009.06904.x; Shinohara F, 2014, NEUROPHARMACOLOGY, V79, P573, DOI 10.1016/j.neuropharm.2014.01.019; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733; SUGAYA K, 1994, MOL BRAIN RES, V23, P111, DOI 10.1016/0169-328X(94)90217-8; Watson C, 2007, RAT BRAIN STEREOTAXI; Zhang XF, 1998, J NEUROSCI, V18, P488	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2015	41	9					1126	1138		10.1111/ejn.12855		13	Neurosciences	Neurosciences & Neurology	CH6ZX	WOS:000354186400003		
J	Ogura, T; Taniguchi, H; Azuma, A; Inoue, Y; Kondoh, Y; Hasegawa, Y; Bando, M; Abe, S; Mochizuki, Y; Chida, K; Kluglich, M; Fujimoto, T; Okazaki, K; Tadayasu, Y; Sakamoto, W; Sugiyama, Y				Ogura, Takashi; Taniguchi, Hiroyuki; Azuma, Arata; Inoue, Yoshikazu; Kondoh, Yasuhiro; Hasegawa, Yoshinori; Bando, Masashi; Abe, Shinji; Mochizuki, Yoshiro; Chida, Kingo; Klueglich, Matthias; Fujimoto, Tsuyoshi; Okazaki, Kotaro; Tadayasu, Yusuke; Sakamoto, Wataru; Sugiyama, Yukihiko			Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis	EUROPEAN RESPIRATORY JOURNAL			English	Article							TYROSINE KINASE INHIBITOR; TRIPLE ANGIOKINASE INHIBITOR; ADVANCED SOLID TUMORS; BIBF 1120; PHASE-II; EFFICACY	A randomised, double-blind, phase II, dose escalation trial was conducted to assess the safety, tolerability and pharmacokinetics of the tyrosine kinase inhibitor nintedanib, alone and when added to ongoing pirfenidone therapy, in Japanese patients with idiopathic pulmonary fibrosis. 50 Japanese patients were randomised to receive nintedanib or placebo in one of three cohorts (nintedanib 50 mg twice daily or 100 mg twice daily for 14 days, or 150 mg twice daily for 28 days). Patients receiving pirfenidone at inclusion were stratified to every nintedanib dose group and placebo. Adverse events were reported in nine out of 17 patients receiving nintedanib alone and 10 out of 21 patients receiving nintedanib added to pirfenidone. All adverse events were mild or moderate in intensity. Gastrointestinal disorders were the most common adverse event Maximum plasma concentration and area under the curve at steady state for nintedanib and its metabolites tended to be lower when nintedanib was added to pirfenidone. Nintedanib had no effect on the pharmacokinetics of pirfenidone. In conclusion, further study is needed to evaluate the safety and tolerability profile of nintedanib when added to pirfenidone in patients with idiopathic pulmonary fibrosis. There was a trend toward lower exposure of nintedanib when it was added to pirfenidone.	[Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Taniguchi, Hiroyuki; Kondoh, Yasuhiro] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi 4898642, Japan; [Azuma, Arata; Abe, Shinji] Nippon Med Sch, Grad Sch Med, Tokyo 113, Japan; [Inoue, Yoshikazu] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Dept Diffuse Lung Dis & Resp Failure, Osaka, Japan; [Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi, Japan; [Mochizuki, Yoshiro] Himeji Med Ctr, Resp Med, Himeji, Hyogo, Japan; [Chida, Kingo] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Klueglich, Matthias] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Fujimoto, Tsuyoshi; Okazaki, Kotaro; Tadayasu, Yusuke; Sakamoto, Wataru] Nippon Boehringer Ingelheim Co Ltd, Tokyo, Japan	Taniguchi, H (reprint author), Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan.	hiro-tosei-lung@kkd.biglobe.ne.jp					[American Thoracic Society International Consensus Statement American Thoracic Society (ATS) and the European Respiratory Society (ERS)], 2000, AM J RESP CRIT CARE, V161, P646; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Okamoto I, 2010, MOL CANCER THER, V9, P2825, DOI 10.1158/1535-7163.MCT-10-0379; Stopfer P, 2011, XENOBIOTICA, V41, P297, DOI 10.3109/00498254.2010.545452; Reck M, 2011, ANN ONCOL, V22, P1374, DOI 10.1093/annonc/mdq618; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Mross K, 2010, CLIN CANCER RES, V16, P311, DOI 10.1158/1078-0432.CCR-09-0694; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Wollin L, 2014, J PHARMACOL EXP THER, V349, P209, DOI 10.1124/jpet.113.208223; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061; Valeyre D, 2014, RESPIROLOGY, V19, P740, DOI 10.1111/resp.12297; European Medicines Agency, CHMP ASS REP ESBR; Japanese Respiratory Society, 2004, ID INT PNEUM DIAGN T, P36; Pulmonary Physiology Specialist Committee of the Japanese Respiratory Society, 2001, J JPN RESP SOC, V39, P1; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL	19	11	11	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	MAY	2015	45	5					1382	1392		10.1183/09031936.00198013		11	Respiratory System	Respiratory System	CH6KI	WOS:000354145100023		
J	Chae, Y; Yokoyama, N; Ito, K; Fukuda, T; Arakawa, R; Zhang, YX; Saito, Y				Chae, Younghae; Yokoyama, Nanako; Ito, Katsura; Fukuda, Tatsuya; Arakawa, Ryo; Zhang, Yan-Xuan; Saito, Yutaka			Reproductive isolation between Stigmaeopsis celarius and its sibling species sympatrically inhabiting bamboo (Pleioblastus spp.) plants	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Article						Cryptic species; Mechanical isolation; Reinforcement; Reproductive interference; Secondary contact zone; Tetranychidae	SOCIAL SPIDER-MITE; MISCANTHI SAITO ACARI; BODY-SIZE DIFFERENCES; NATURAL-SELECTION; NEST SANITATION; TETRANYCHIDAE; INTERFERENCE; BEHAVIOR; GENUS; AGGRESSION	Stigmaeopsis celarius Banks (hereafter Sc) is a spider mite living and feeding on the leaves of various bamboo species such as Moso bamboo [Phyllostachys edulis (=P. pubescens)] and Pleioblastus spp. (Poaceae). A previous phylogenetic study revealed a cryptic, phylogenetic sister species to Sc (hereafter Ss). Although its life type appears to be similar to that of Sc, individuals of Ss make much smaller nests compared with Sc, and the nests have been found mostly on Nezasa bamboo (Pleioblastus argenteostriatus). To investigate whether Sc and Ss are reproductively isolated, we explored their populations in southwestern Japan, and crossed them to examine mating behaviors and fertilization success. Field surveys revealed that the nests of these two species occur on the same leaves and, thus, the individuals of these species may make frequent contact. Reciprocal crosses suggested that the two species are reproductively isolated. Though Sc males have tried to mate with Ss females, copulation seldom occurred because of their long opisthosoma (hind body), which prevented the insertion of the aedeagus into the genitalia of Ss females. In contrast, most Ss males ignored Sc females, and eggs were not fertilized even in the few cases where copulation appeared to occur. These results suggest that strong selection pressure is imposed on body length to prevent interspecific hybridization in the contact area of these species.	[Chae, Younghae; Yokoyama, Nanako; Ito, Katsura; Fukuda, Tatsuya; Arakawa, Ryo; Zhang, Yan-Xuan; Saito, Yutaka] Kochi Univ, Fac Agr, Lab Insect Ecol, Nanko Ku, Kochi 7838502, Japan	Ito, K (reprint author), Kochi Univ, Fac Agr, Lab Insect Ecol, Nanko Ku, 200 Monobeotsu, Kochi 7838502, Japan.	ktr@kochi-u.ac.jp			JSPS-KAKENHI [24570014]; China Recruitment Program of Global Experts (Foreign Experts) [2012-323]; State Administration of Foreign Experts Affairs Key Project for Introduction of Foreign Experts [SZ2013003]	We thank Drs. Kotaro Mori, Takane Sakagami, Ken Sahara for their valuable suggestions. We are indebted to Mr. Y. Kumekawa and Ms. K. Tamura, Drs. H. Hayakawa and Y. Minamiya for providing sampling material. This study was supported by JSPS-KAKENHI 24570014, China Recruitment Program of Global Experts (Foreign Experts) (2012-323) and State Administration of Foreign Experts Affairs Key Project for Introduction of Foreign Experts (SZ2013003).	Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; BULL CM, 1991, ANNU REV ECOL SYST, V22, P19; RYAN TA, 1960, PSYCHOL BULL, V57, P318, DOI 10.1037/h0044320; Hochkirch A, 2007, J ANIM ECOL, V76, P633, DOI 10.1111/j.1365-2656.2007.01241.x; Okuzaki Y, 2010, J ANIM ECOL, V79, P383, DOI 10.1111/j.1365-2656.2009.01645.x; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.2307/2410936; Uesugi R, 2009, EXP APPL ACAROL, V49, P281, DOI 10.1007/s10493-009-9267-x; Uesugi R, 2009, EXP APPL ACAROL, V47, P99, DOI 10.1007/s10493-008-9201-7; KUNO E, 1992, RES POPUL ECOL, V34, P275, DOI 10.1007/BF02514797; Tanabe T, 2008, AM NAT, V171, P692, DOI 10.1086/587075; Ben-David T, 2009, EXP APPL ACAROL, V48, P213, DOI 10.1007/s10493-008-9228-9; Cone W.W., 1985, P243; Coyne J. A., 2004, SPECIATION; Fujimoto H, 1996, APPL ENTOMOL ZOOL, V31, P59; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Ito K, 2009, APPL ENTOMOL ZOOL, V44, P343, DOI 10.1303/aez.2009.343; Ito K, 2011, B YAMAGATA U NAT SCI, V17, P19; Kishi S, 2009, J ANIM ECOL, V78, P1043, DOI 10.1111/j.1365-2656.2009.01560.x; Kyogoku D, 2013, POPUL ECOL, V55, P87, DOI 10.1007/s10144-012-0344-3; Kyogoku D, 2012, POPUL ECOL, V54, P391, DOI 10.1007/s10144-012-0313-x; Lindquist EE, 1985, SPIDER MITES THEIR A, V1A, P3; Mori K, 2006, ETHOLOGY, V112, P134, DOI 10.1111/j.1439-0310.2006.01130.x; Mori K, 2005, BEHAV ECOL, V16, P232, DOI 10.1093/beheco/arh157; Mori K, 2000, THESIS HOKKAIDO U SA; Oku K, 2014, J ETHOL, V32, P1, DOI 10.1007/s10164-013-0386-9; Oku K, 2014, APPL ENTOMOL ZOOL, V49, P1, DOI 10.1007/s13355-013-0238-7; Saito Y, 1999, APPL ENTOMOL ZOOL, V34, P383; Saito Yutaka, 1997, P443; Saito Y, 2004, ANN ENTOMOL SOC AM, V97, P635, DOI 10.1603/0013-8746(2004)097[0635:ROTGSB]2.0.CO;2; Saito Y, 2010, PLANT MITES AND SOCIALITY: DIVERSITY AND EVOLUTION, P1, DOI 10.1007/978-4-431-99456-5; SAITO Y, 1987, RES POPUL ECOL, V29, P57, DOI 10.1007/BF02515425; Saito Y., 1985, P253; SAITO Y, 1982, Japanese Journal of Ecology, V32, P69; SAITO Y, 1990, APPL ENTOMOL ZOOL, V25, P389; SAITO Y, 1983, ACAROLOGIA, V24, P377; Sato Y, 2008, EXP APPL ACAROL, V44, P265, DOI 10.1007/s10493-008-9147-9; Sato Y, 2003, ETHOLOGY, V109, P713, DOI 10.1046/j.1439-0310.2003.00905.x; Sato Y, 2006, ETHOLOGY, V112, P664, DOI 10.1111/j.1439-0310.2005.01184.x; Sato Y, 2000, APPL ENTOMOL ZOOL, V35, P605, DOI 10.1303/aez.2000.605; Sato Y, 2000, APPL ENTOMOL ZOOL, V35, P611, DOI 10.1303/aez.2000.611; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D, 1998, ENDLESS FORMS, P114; Shimizu N, 2001, BIOSCI BIOTECH BIOCH, V65, P1724, DOI 10.1271/bbb.65.1724; Suzuki S, 1996, ILLUSTRATIONS JAPANE; Takafuji A, 1997, EXP APPL ACAROL, V21, P379, DOI 10.1023/A:1018423711166; Uchimura E, 2005, BAMBOO BAMBOO GRASS	46	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	MAY	2015	66	1					11	23		10.1007/s10493-014-9865-0		13	Entomology	Entomology	CH7CT	WOS:000354193900002		
J	Chae, Y; Yokoyama, N; Ito, K; Fukuda, T; Arakawa, R; Zhang, YX; Saito, Y				Chae, Younghae; Yokoyama, Nanako; Ito, Katsura; Fukuda, Tatsuya; Arakawa, Ryo; Zhang, Yan-Xuan; Saito, Yutaka			Reproductive isolation between Stigmaeopsis celarius and its sibling species sympatrically inhabiting bamboo (Pleioblastus spp.) plants (vol 66, pg 11, 2015)	EXPERIMENTAL AND APPLIED ACAROLOGY			English	Correction									[Chae, Younghae; Yokoyama, Nanako; Ito, Katsura; Fukuda, Tatsuya; Arakawa, Ryo; Zhang, Yan-Xuan; Saito, Yutaka] Kochi Univ, Fac Agr, Lab Insect Ecol, Nanko Ku, Kochi 7838502, Japan	Ito, K (reprint author), Kochi Univ, Fac Agr, Lab Insect Ecol, Nanko Ku, 200 Monobeotsu, Kochi 7838502, Japan.	ktr@kochi-u.ac.jp					Chae Y, 2015, EXP APPL ACAROL, V66, P11, DOI 10.1007/s10493-014-9865-0	1	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0168-8162	1572-9702		EXP APPL ACAROL	Exp. Appl. Acarol.	MAY	2015	66	1					25	27		10.1007/s10493-015-9885-4		3	Entomology	Entomology	CH7CT	WOS:000354193900003		
J	Ishikawa, T; Abe, S; Kojima, Y; Sano, T; Iwanaga, A; Seki, KI; Honma, T; Yoshida, T; Yamazaki, M; Sakai, T; Tasaki, K; Suzuki, Y				Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Sano, Tomoe; Iwanaga, Akito; Seki, Kei-Ichi; Honma, Terasu; Yoshida, Toshiaki; Yamazaki, Mihoko; Sakai, Takehito; Tasaki, Kazuyuki; Suzuki, Yasushi			Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-beta/ribavirin	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						double filtration plasmapheresis; hepatitis C virus; interferon-beta	GENOTYPE 1B; BETA; RIBAVIRIN; MANAGEMENT; HCV; PEGINTERFERON; COMBINATION; DYNAMICS; EFFICACY; TRIAL	The aim of the present study was to determine predictors of a sustained virological response (SVR) with a regimen of double filtration plasmapheresis (DFPP) combined with interferon-beta plus ribavirin (IFN-beta/RBV) induction therapy prior to pegylated (PEG-IFN/RBV) standard of care (SOC) therapy for patients with chronic hepatitis C who had experienced SOC treatment failure. Predictors of a SVR were analyzed in chronic hepatitis C patients with genotype 1b hepatitis C virus (HCV), who had a high viral load. The patients had been unresponsive to previous IFN therapy and underwent induction therapy with IFN-beta/RBV plus DFPP, which was performed five times during the same period, followed by PEG-IFN/RBV. In total, 10 patients received the combination DFPP plus IFN-beta/RBV induction therapy prior to PEG-IFN/RBV therapy for the treatment of chronic hepatitis C. Two weeks after treatment initiation, a decrease in the HCV RNA levels of >= 2 log IU/ml occurred in 9/10 patients (90%), while a decrease of >= 4 log IU/ml was observed in 4/10 patients (40%). The HCV RNA levels at week 2 after treatment initiation in the SVR and non-SVR patients decreased by 5.0 +/- 0.8 and 2.9 +/- 1.1 log IU/ml, respectively. Despite no response to previous IFN therapy, three of the 10 patients (30%) experienced a SVR. The results indicated that a rapid virological response ensued following IFN-beta/RBV induction and DFPP supplementary therapy. Although the level of interleukin-28B is an important predictor of a SVR, a decrease in the HCV RNA volume of >= 4 log IU/ml at week 2 after the initial treatment is also an important predictor. Therefore, rapid virological reduction using DFPP, in addition to IFN-beta/RBV induction therapy, is an important predictor of a SVR.	[Ishikawa, Toru; Abe, Satoshi; Kojima, Yuichi; Sano, Tomoe; Iwanaga, Akito; Seki, Kei-Ichi; Honma, Terasu; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan; [Yamazaki, Mihoko; Sakai, Takehito; Tasaki, Kazuyuki; Suzuki, Yasushi] Saiseikai Niigata Daini Hosp, Dept Nephrol, Niigata 9501104, Japan	Ishikawa, T (reprint author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, 280-7 Teraji, Niigata 9501104, Japan.	toruishi@ngt.saiseikai.or.jp					Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Cacoub P, 2012, J HEPATOL, V56, P455, DOI 10.1016/j.jhep.2011.08.006; Chopra A, 2013, LIVER INT, V33, P30, DOI 10.1111/liv.12080; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Asahina Y, 2001, HEPATOLOGY, V34, P377, DOI 10.1053/jhep.2001.26086; Fujiwara K, 1998, HEPATOL RES, V12, P240, DOI 10.1016/S1386-6346(98)00072-2; HILFENHAUS J, 1981, J INTERFERON RES, V1, P427, DOI 10.1089/jir.1981.1.427; Ishikawa T, 2012, HEPATOL RES, V42, P864, DOI 10.1111/j.1872-034X.2012.00995.x; Ishikawa T, 2011, THER APHER DIAL, V15, P400, DOI 10.1111/j.1744-9987.2011.00965.x; Izumi N, 2001, DIGEST DIS SCI, V46, P516, DOI 10.1023/A:1005686829416; Okushin H, 1997, KANZO, V38, P11; Schettler V, 2001, EUR J CLIN INVEST, V31, P154, DOI 10.1046/j.1365-2362.2001.00758.x; Taniguchi M, 2006, TRANSPLANTATION, V81, P1747, DOI 10.1097/01.tp.0000226075.04938.43; Yamashita T, 2006, HEPATOL RES, V36, P167, DOI 10.1016/j.hepres.2006.07.013	17	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2015	9	5					1646	1650		10.3892/etm.2015.2340		5	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IU	WOS:000353849700015		
J	Tatematsu, T; Sasaki, H; Shimizu, S; Hikosaka, Y; Okuda, K; Haneda, H; Moriyama, S; Yano, M; Fujii, Y				Tatematsu, Tsutomu; Sasaki, Hidefumi; Shimizu, Shigeki; Hikosaka, Yu; Okuda, Katsuhiro; Haneda, Hiroshi; Moriyama, Satoru; Yano, Motoki; Fujii, Yoshitaka			Intra-tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						BRAF mutation; lung cancer; heterogeneity; V600E; competitive allele-specific polymerase chain reaction	HARBORING BRAF MUTATIONS; GEFITINIB THERAPY; CANCER PATIENTS; V600E MUTATION; FUSION GENE; MELANOMA; VEMURAFENIB; EGFR; SURVIVAL; PATHWAY	BRAF mutations exist in numerous types of cancer, including melanomas, colorectal cancers and lung cancers. The V600E-specific inhibitor vemurafenib has marked clinical activity in patients with BRAF V600E-mutated melanoma. However, there are many cases of resistance to vemurafenib. This may be due to the reported intra-tumor heterogeneity of the BRAF V600E mutation in primary melanomas. BRAF mutations are found in 1-5% of non-small cell carcinomas (NSCLCs), almost exclusively in adenocarcinoma. A few cases have been reported in which vemurafenib was effective against BRAF V600E-mutated lung cancers. In a previous study, five lung adenocarcinomas with BRAF V600E mutation were detected by direct sequencing. The present study analyzed these tumors for the percentage of mutation (%mutation) by competitive allele-specific polymerase chain reaction (CAST-PCR) assay. In addition, sections of all components of the adenocarcinomas were obtained by laser microdissection and analyzed. The %mutations of BRAF V600E within the macrodissected tumors (cases 1-5) were: Case 1, 10.0%; case 2, 8.0%; case 3, 8.9%; case 4, 21.5%; and case 5, 14.9%. In four cases (cases 2-5), the %mutations of each adenocarcinoma component were as follows: Case 2, lepidic growth 6.5-24.5%, papillary 1.3-11.2% and acinar 9.8%; case 3, solid 2.5-69.9%, acinar 12.4-27.1% and papillary 3.7-17.4%; case 4, acinar 10.0-45.0% and papillary 44.0%; and case 5, papillary 3.7-93.4%. Sensitive BRAF mutation detection methods were used and evidence for heterogeneity of the BRAF V600E mutation in these lung adenocarcinoma cases was observed. Targeted therapy with a BRAF V600E inhibitor such as vemurafenib may have potential in the treatment of lung cancer with this mutation; however, it is necessary to consider how the treatment effect of and drug resistance to BRAF V600E inhibitors are affected by the presence of heterogeneity in future studies.	[Tatematsu, Tsutomu; Sasaki, Hidefumi; Hikosaka, Yu; Okuda, Katsuhiro; Haneda, Hiroshi; Moriyama, Satoru; Yano, Motoki; Fujii, Yoshitaka] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi 4678601, Japan; [Shimizu, Shigeki] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Sasaki, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Mizuho Ku, Kawasumi 1,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hisasaki@hotmail.com			Japan Society for the Promotion of Science (JSPS) [26861125, 25293303, 24592097]	The authors would like to thank Miss Yuika Muto and Ito Yamamoto for their excellent technical assistance. This study was supported by Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS; Nos. 26861125, 25293303 and 24592097).	Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Sasaki H, 2007, ONCOL REP, V18, P623; Cardarella S, 2012, J THORAC ONCOL, V7, P1767, DOI 10.1097/JTO.0b013e3182745bcb; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Peters S, 2013, J CLIN ONCOL, V31, pE341, DOI 10.1200/JCO.2012.47.6143; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Shimizu S, 2000, CLIN CANCER RES, V6, P3994; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Sasaki H, 2013, LUNG CANCER, V82, P51, DOI 10.1016/j.lungcan.2013.06.014; Yokota K, 2012, ONCOL REP, V28, P1187, DOI 10.3892/or.2012.1908; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; TRAVIS WD, 1995, CANCER, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Endo K, 2006, ONCOL REP, V16, P533; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gautschi O, 2012, J THORAC ONCOL, V7, pE23, DOI 10.1097/JTO.0b013e3182629903; Ginsberg RJ, 1993, CANC PRINCIPLES PRAC, V4th, P673; Katona TM, 2007, AM J SURG PATHOL, V31, P1029, DOI 10.1097/PAS.0b013e31802b3488; Ligel B, 2008, J PATHOL, V216, P64; Sasaki H, 2012, EXP THER MED, V3, P771, DOI 10.3892/etm.2012.500; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336	29	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2015	9	5					1719	1722		10.3892/etm.2015.2298		4	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IU	WOS:000353849700025		
J	Imai, K; Fukuda, T; Wada, T; Kawanishi, M; Yamauchi, M; Hashiguchi, Y; Ichimura, T; Yasui, T; Sumi, T				Imai, Kenji; Fukuda, Takeshi; Wada, Takuma; Kawanishi, Masaru; Yamauchi, Makoto; Hashiguchi, Yasunori; Ichimura, Tomoyuki; Yasui, Tomoyo; Sumi, Toshiyuki			Complete recovery from paraneoplastic anti-NMDAR encephalitis associated with a small ovarian teratoma following a laparoscopic salpingo-oophorectomy: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						anti-N-methyl-D-aspartate receptor encephalitis; ovarian teratoma; laparoscopic salpingo-oophorectomy	RECEPTOR ENCEPHALITIS; ANTIBODIES	Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a severe but treatment-responsive disorder, initially identified in young women with an ovarian teratoma. Symptoms include mood, behavior and personality irregularities that resemble acute psychosis. The present study reports the rare case of a patient with anti-NMDAR encephalitis and severe neurological symptoms, that exhibited a rapid recovery following a laparoscopic salpingo-oophorectomy. The 39-year-old woman was admitted to the Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine (Osaka, Japan) with a 5-day history of fever and stomach ache. One week later, the patient developed hallucinations and emotional lability. Initially, a diagnosis of limbic or herpes encephalitis was considered; thus, the patient was administered acyclovir and received steroid pulse therapy. However, the patient subsequently developed apnea, and in response, a tracheal intubation, mechanical ventilation and plasmapheresis were performed. Anti-NMDAR encephalitis was subsequently considered as a diagnosis and mediastinal and pelvic computed tomography (CT) examinations were conducted to detect for the presence of a teratoma. A 24x24-mm cystic lesion was identified in the pelvis from an abdominal CT scan and the lesion appeared to be an ovarian teratoma. In addition, serum and cerebrospinal fluid samples were collected, and were found to test positive for anti-NMDAR antibodies. A laparoscopic salpingo-oophorectomy was performed, which resulted in rapid improvement of the patient's mental symptoms, followed by a complete recovery.	[Imai, Kenji; Fukuda, Takeshi; Wada, Takuma; Kawanishi, Masaru; Yamauchi, Makoto; Hashiguchi, Yasunori; Ichimura, Tomoyuki; Yasui, Tomoyo; Sumi, Toshiyuki] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 5458585, Japan	Fukuda, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	takeshif@med.osaka-cu.ac.jp					Ishiura H, 2008, NEUROLOGY, V71, P1921, DOI 10.1212/01.wnl.0000336648.43562.59; Seki M, 2008, J NEUROL NEUROSUR PS, V79, P324, DOI 10.1136/jnnp.2007.136473; Florance NR, 2009, ANN NEUROL, V66, P11, DOI 10.1002/ana.21756; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; Nokura K, 1997, ACTA NEUROL SCAND, V95, P367; Okamura H, 1997, LANCET, V350, P488, DOI 10.1016/S0140-6736(97)06208-9; Sansing LH, 2007, NAT CLIN PRACT NEURO, V3, P291, DOI 10.1038/ncpneuro0493	10	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2015	9	5					1723	1726		10.3892/etm.2015.2344		4	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IU	WOS:000353849700026		
J	Taguchi, S; Furuta, J; Ohara, G; Kagohashi, K; Satoh, H				Taguchi, Shijima; Furuta, Junichi; Ohara, Gen; Kagohashi, Katsunori; Satoh, Hiroaki			Severe airflow obstruction in a patient with ulcerative colitis and toxic epidermal necrolysis: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						airflow obstruction; ulcerative colitis; mesalazine; toxic epidermal necrolysis; obstructive bronchiolitis	STEVENS-JOHNSON-SYNDROME; VERSUS-HOST-DISEASE; BRONCHIOLITIS OBLITERANS; PULMONARY COMPLICATIONS; EMPHYSEMA	Bronchiolitis is a rare condition mainly affecting the intralobular conducting and transitional small airways. The present study describes a case of severe airflow limitation in a patient with ulcerative colitis who developed toxic epidermal necrolysis following mesalazine therapy. Forced expiratory volume in one second was decreased and a flow-volume curve showed airflow limitation, but the single-breath diffusing capacity of the lung for carbon monoxide (DLCO) and DLCO divided by alveolar volume (DLCO/VA) were not decreased. This rare clinical condition should be considered as a differential diagnosis for subjects presenting with sub-acutely developed airflow obstruction if the findings in chest computed tomography scans demonstrate hyperinflation but few low-attenuation areas. Relatively well-preserved DLCO and DLCO/VA provide a clue to establishing the correct diagnosis.	[Taguchi, Shijima] Univ Tsukuba, Mito Med Ctr, Div Dermatol, Mito, Ibaraki 3100015, Japan; [Furuta, Junichi] Univ Tsukuba, Dept Dermatol, Fac Med, Tsukuba, Ibaraki, Japan; [Ohara, Gen; Kagohashi, Katsunori; Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Ryu JH, 2003, AM J RESP CRIT CARE, V168, P1277, DOI 10.1164/rccm.200301.053SO; Haralambou G, 2001, MT SINAI J MED, V68, P384; Allen TC, 2010, ARCH PATHOL LAB MED, V134, P702, DOI 10.1043/1543-2165-134.5.702; Basker M, 1997, Indian Pediatr, V34, P831; BIERNACKI W, 1989, AM REV RESPIR DIS, V139, P1509; Burgel Pierre-Régis, 2013, Eur Respir Rev, V22, P131, DOI 10.1183/09059180.00001313; DELAROCHA SR, 1985, J ADOLESCENT HEALTH, V6, P220, DOI 10.1016/S0197-0070(85)80022-X; EPLER GR, 1988, CLIN CHEST MED, V9, P551; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Ishida T, 2004, NISHI NIHON HIFUKA, V66, P236, DOI 10.2336/nishinihonhifu.66.236; Kamada N, 2006, J DERMATOL, V33, P616, DOI 10.1111/j.1346-8138.2006.00142.x; Karadag F, 2001, Respirology, V6, P341, DOI 10.1046/j.1440-1843.2001.00347.x; Kim Jung Hyun, 2013, Asia Pac Allergy, V3, P136, DOI 10.5415/apallergy.2013.3.2.136; Letko E, 2005, ANN ALLERG ASTHMA IM, V94, P419; Mawson AR, 2015, MED SCI MONITOR, V21, P133, DOI 10.12659/MSM.891043; MORRISON NJ, 1989, AM REV RESPIR DIS, V139, P1179; Nanayakkara PW, 2004, EUR J INTERN MED, V15, P470, DOI 10.1016/j.ejim.2004.08.007; Oshikawa K, 1995, Nihon Kyobu Shikkan Gakkai Zasshi, V33, P1019; RALPH DD, 1984, AM REV RESPIR DIS, V129, P641; Sakamoto N, 2014, INTERNAL MED, V53, P875, DOI 10.2169/internalmedicine.53.1826; Shah AP, 2006, EUR RESPIR J, V28, P1276, DOI 10.1183/09031936.00036006; Tsujino I, 2000, Respirology, V5, P305, DOI 10.1046/j.1440-1843.2000.00266.x; TSUNODA N, 1990, CHEST, V98, P243, DOI 10.1378/chest.98.1.243; VIRANT FS, 1984, CLIN PEDIATR, V23, P412, DOI 10.1177/000992288402300711; WYATT SE, 1984, THORAX, V39, P887, DOI 10.1136/thx.39.12.887; YATSUNAMI J, 1995, INTERNAL MED, V34, P772, DOI 10.2169/internalmedicine.34.772	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2015	9	5					1944	1946		10.3892/etm.2015.2307		3	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IU	WOS:000353849700062		
J	Satoh, H; Takayashiki, N; Shiozawa, T; Miyazaki, K; Ohara, G; Kagohashi, K; Kurishima, K; Sugita, S; Aoyama, T; Hasegawa, T; Hizawa, N				Satoh, Hiroaki; Takayashiki, Norio; Shiozawa, Toshihiro; Miyazaki, Kunihiko; Ohara, Gen; Kagohashi, Katsunori; Kurishima, Koichi; Sugita, Shintaro; Aoyama, Tomoyuki; Hasegawa, Tadashi; Hizawa, Nobuyuki			Recurrent pulmonary synovial sarcoma effectively treated with amrubicin: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						pulmonary synovial sarcoma; chemotherapy; amrubicin	CELL LUNG-CANCER; ANTHRACYCLINE DERIVATIVE SM-5887; PHASE-II; DOXORUBICIN; CHEMOTHERAPY; FEATURES; TRIAL	Pulmonary synovial sarcoma is a rare but aggressive disease. The present study describes the case of a 68-year-old female with pulmonary synovial sarcoma. The patient was mistakenly treated for small cell lung cancer due to false-positive staining for synaptophysin and cluster of differentiation 56. Despite severe myelotoxicity, platinum-containing chemotherapies (cisplatin plus irinotecan and carboplatin plus etoposide) were not effective. As a third-line therapy, the patient received amrubicin (AMR) monotherapy. A partial response was achieved, and the patient was able to undertake ordinary daily life at home for 13 months from the initiation of AMR chemotherapy. Due to the atypical clinical condition and unusual response to chemotherapy in this patient, the pathological examination was repeated. The SS18 split-signal was detected in fluorescence in situ hybridization analysis. From these results, the tumor was diagnosed as a monophasic synovial sarcoma. To the best of our knowledge, this is the first case of a patient with pulmonary synovial sarcoma who underwent successful treatment with AMR. The present case could demonstrate a specific chemosensitivdty of such a rare tumor.	[Satoh, Hiroaki; Ohara, Gen; Kagohashi, Katsunori; Kurishima, Koichi] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 2100015, Japan; [Takayashiki, Norio] Univ Tsukuba, Mito Med Ctr, Div Pathol, Mito, Ibaraki 2100015, Japan; [Shiozawa, Toshihiro; Miyazaki, Kunihiko; Hizawa, Nobuyuki] Univ Tsukuba, Div Resp Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Sugita, Shintaro; Aoyama, Tomoyuki; Hasegawa, Tadashi] Sapporo Med Univ, Dept Pathol, Sapporo, Hokkaido 0608556, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 2100015, Japan.	hirosato@md.tsukuba.ac.jp					Miura Y, 2012, PATHOL INT, V62, P16, DOI 10.1111/j.1440-1827.2011.02739.x; Noda T, 1998, INVEST NEW DRUG, V16, P121, DOI 10.1023/A:1006088907271; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Suzuki T, 1997, INVEST NEW DRUG, V15, P219, DOI 10.1023/A:1005862730941; ZEREN H, 1995, HUM PATHOL, V26, P474, DOI 10.1016/0046-8177(95)90242-2; WEISS RB, 1992, SEMIN ONCOL, V19, P670; Onoda S, 2006, J CLIN ONCOL, V24, P5448, DOI 10.1200/JCO.2006.08.4145; Hartel PH, 2007, MODERN PATHOL, V20, P760, DOI 10.1038/modpathol.3800795; Frazier AA, 2006, RADIOGRAPHICS, V26, P923, DOI 10.1148/rg.263055211; Bacha EA, 1999, EUR J CARDIO-THORAC, V15, P456, DOI 10.1016/S1010-7940(99)00045-7; Cuffe S, 2011, J THORAC ONCOL, V6, P818, DOI 10.1097/JTO.0b013e31820c2f2e; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Fulbright JM, 2010, CURR ONCOL REP, V12, P411, DOI 10.1007/s11912-010-0129-9; Harada T, 2013, ONCOLOGIST, V18, P439, DOI 10.1634/theoncologist.2012-0308; Kitagawa C, 2012, CANCER CHEMOTH PHARM, V69, P1379, DOI 10.1007/s00280-011-1812-8; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Morrison B. A., 2003, BAYLOR U MED CTR P, V16, P285; Ogawara Daiki, 2010, Cancer Manag Res, V2, P191; Shah CM, 2009, RECENT PAT ANTI-CANC, V4, P241; Siegel HJ, 2007, ORTHOPEDICS, V30, P1020; Walczak BE, 2013, J AM ACAD ORTHOP SUR, V21, P480, DOI 10.5435/JAAOS-21-08-480; Watzka Stefan B, 2009, Interact Cardiovasc Thorac Surg, V9, P1026, DOI 10.1510/icvts.2009.213934	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2015	9	5					1947	1949		10.3892/etm.2015.2308		3	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IU	WOS:000353849700063		
J	Wang, LL; Clavaud, C; Bar-Hen, A; Cui, M; Gao, J; Liu, YY; Liu, C; Shibagaki, N; Gueniche, A; Jourdain, R; Lan, K; Zhang, CY; Altmeyer, R; Breton, L				Wang, Lili; Clavaud, Cecile; Bar-Hen, Avner; Cui, Meng; Gao, Jun; Liu, Yuanyuan; Liu, Chen; Shibagaki, Nakako; Gueniche, Audrey; Jourdain, Roland; Lan, Ke; Zhang, Chiyu; Altmeyer, Ralf; Breton, Lionel			Characterization of the major bacterial-fungal populations colonizing dandruff scalps in Shanghai, China, shows microbial disequilibrium	EXPERIMENTAL DERMATOLOGY			English	Letter						Chinese population; dandruff; disequilibrium; microflora profiling; skin physiology		Dandruff is a scalp disorder characterized by the formation of flaky white-yellowish scales due to an altered proliferation and differentiation status; a disrupted barrier function; a decrease in the level of hydration and of natural moisturizing factors (NMF) in the scalp, with a persistent and relapsing inflammatory condition. It was recently reported that an imbalance between bacterial and fungal species colonizing the scalp of French volunteers was associated with dandruff condition. The purpose of the present study was to analyze the major bacterial and fungal species present on the scalp surface of Chinese volunteers and to investigate possible region-related variation in the microbiota linked to dandruff condition. The data obtained from the Chinese populations were highly similar to those obtained in France, confirming that dandruff scalps are associated with a higher incidence of Malassezia restricta and Staphylococcal sp. The ratios of Malassezia to Propionibacterium and Propionibacterium to Staphylococcus were also significantly higher in the dandruff volunteers as compared to normal volunteers, suggesting that equilibrium between the major bacterial and fungal taxa found on the normal scalps is perturbed in the dandruff scalps. The main difference between the French and Shanghai subjects was in their Staphylococcal biota. The results obtained in China and in France suggest that targeting one particular Malassezia sp. by antifungals instead of using large spectrum antifungals and rebalancing the dandruff scalp microbiota could be common approach to improve dandruff condition in the two countries.	[Wang, Lili; Cui, Meng; Lan, Ke; Zhang, Chiyu; Altmeyer, Ralf] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Clavaud, Cecile; Gueniche, Audrey; Jourdain, Roland; Breton, Lionel] LOreal Res & Innovat, F-93601 Aulnay Sous Bois, France; [Bar-Hen, Avner] Univ Paris 05, MAP5, UFR Math & Informat, Paris, France; [Gao, Jun; Liu, Yuanyuan; Liu, Chen] LOreal Res & Innovat, Pudong, Peoples R China; [Shibagaki, Nakako] Nihon LOreal Res & Innovat, Kanagawa, Japan	Clavaud, C (reprint author), LOreal Res & Innovat, 1 Ave Eugene Schueller, F-93601 Aulnay Sous Bois, France.	cclavaud@rd.loreal.com; zhangcy1999@ips.ac.cn					Kerr K, 2011, INT J DERMATOL, V50, P102, DOI 10.1111/j.1365-4632.2010.04629.x; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Bonnist EYM, 2014, INT J COSMETIC SCI, V36, P347, DOI 10.1111/ics.12132; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Kistowska M, 2014, EXP DERMATOL, V23, P884, DOI 10.1111/exd.12552; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Stalhberger T, 2014, J BIOL CHEM, V289, P12647, DOI 10.1074/jbc.M113.547034; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017; Zhang H, 2013, MYCOPATHOLOGIA, V175, P83, DOI 10.1007/s11046-012-9606-z	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	MAY	2015	24	5					398	400		10.1111/exd.12684		3	Dermatology	Dermatology	CH4EP	WOS:000353985900022		
J	Ouchi, M; Kinoshita, S				Ouchi, M.; Kinoshita, S.			Implantation of refractive multifocal intraocular lens with a surface-embedded near section for cataract eyes complicated with a coexisting ocular pathology	EYE			English	Article							CONTRAST SENSITIVITY; VISUAL PERFORMANCE; RESTOR; IOL; EXCHANGE; QUALITY; REZOOM; ACUITY; SIZE	Purpose To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a surfaceembedded near section. Methods LENTIS MPlus (Oculentis GmbH) refractive MIOLs were implanted in 15 eyes with ocular pathologies other than cataract (ie, six high-myopia eyes with an axial length longer than 28 mm, two fundus albipunctatus eyes, two branch retinal-vein occlusion eyes, four glaucoma eyes (one with high myopia), and two keratoconus eyes). Uncorrected or corrected distance and near visual acuity (VA) (UDVA, UNVA, CDVA, and CNVA), contrast sensitivity, and defocus curve were measured at 1 day and 6 months postoperatively, and each patient completed a 6-month postoperative questionnaire regarding vision quality and eyeglass use. Results Thirteen eyes (87%) registered 0 or better in CDVA and 12 eyes (73%) registered better than 0 in CNVA. Contrast sensitivity in the eyes of all patients was comparable to that of normal healthy subjects. No patient required eyeglasses for distance vision, but three patients (20%) required them for near vision. No patient reported poor or very poor vision quality. Conclusion With careful case selection, sectorial refractive MIOL implantation is effective for treating cataract eyes complicated with ocular pathologies.	[Ouchi, M.] Ouchi Eye Clin, Kyoto 6018453, Japan; [Ouchi, M.; Kinoshita, S.] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Ouchi, M (reprint author), Ouchi Eye Clin, Minami Ku, 47-1 Karahashi Rajomon Cho, Kyoto 6018453, Japan.	mouchi@skyblue.ocn.ne.jp					Alio JL, 2011, J CATARACT REFR SURG, P37241; Pepose JS, 2007, AM J OPHTHALMOL, V144, P347, DOI 10.1016/j.ajo.2007.05.036; Munoz G, 2011, J CATARACT REFR SURG, V37, P2043, DOI 10.1016/j.jcrs.2011.05.045; Vingolo EM, 2007, J CATARACT REFR SURG, V33, P1244, DOI 10.1016/j.jcrs.2007.03.052; Alio JL, 2012, J REFRACT SURG, V28, P100, DOI 10.3928/1081597X-20120110-01; Artigas JM, 2007, J CATARACT REFR SURG, V33, P2111, DOI 10.1016/j.jcrs.2007.07.035; Alio JL, 2012, OPHTHALMOLOGY, V119, P555, DOI 10.1016/j.ophtha.2011.08.036; Chang DF, 2008, J CATARACT REFR SURG, V34, P934, DOI 10.1016/j.jcrs.2007.12.053; de Wit DW, 2012, J CATARACT REFR SURG, V38, P1796, DOI 10.1016/j.jcrs.2012.06.046; Blaylock JF, 2008, J REFRACT SURG, V24, P265; Braga-Mele R, 2014, J CATARACT REFR SURG, V40, P313, DOI 10.1016/j.jcrs.2013.12.011; Pieh S, 2001, BRIT J OPHTHALMOL, V85, P816, DOI 10.1136/bjo.85.7.816; Rocha KM, 2005, J REFRACT SURG, V21, P808; Souza CE, 2006, AM J OPHTHALMOL, V141, P827, DOI 10.1016/j.ajo.2005.12.031; Souza CE, 2006, J REFRACT SURG, V22, P303	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	MAY	2015	29	5					649	655		10.1038/eye.2015.12		7	Ophthalmology	Ophthalmology	CH5JC	WOS:000354070900009		
J	Yoshitake, S; Murakami, T; Uji, A; Unoki, N; Dodo, Y; Horii, T; Yoshimura, N				Yoshitake, S.; Murakami, T.; Uji, A.; Unoki, N.; Dodo, Y.; Horii, T.; Yoshimura, N.			Clinical relevance of quantified fundus autofluorescence in diabetic macular oedema	EYE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINAL-PIGMENT EPITHELIUM; VISUAL-ACUITY; RETINOPATHY; EYES; ANGIOGRAPHY; AREAS	Purpose To quantify the signal intensity of fundus autofluorescence (FAF) and evaluate its association with visual function and optical coherence tomography (OCT) findings in diabetic macular oedema (DMO). Methods We reviewed 103 eyes of 78 patients with DMO and 30 eyes of 22 patients without DMO. FAF images were acquired using Heidelberg Retina Angiograph 2, and the signal levels of FAF in the individual subfields of the Early Treatment Diabetic Retinopathy Study grid were measured. We evaluated the association between quantified FAF and the logMAR VA and OCT findings. Results One hundred and three eyes with DMO had lower FAF signal intensity levels in the parafoveal subfields compared with 30 eyes without DMO. The autofluorescence intensity in the parafoveal subfields was associated negatively with logMAR VA and the retinal thickness in the corresponding subfields. The autofluorescence levels in the parafoveal subfield, except the nasal subfield, were lower in eyes with autofluorescent cystoid spaces in the corresponding subfield than in those without autofluorescent cystoid spaces. The autofluorescence level in the central subfield was related to foveal cystoid spaces but not logMAR VA or retinal thickness in the corresponding area. Conclusions Quantified FAF in the parafovea has diagnostic significance and is clinically relevant in DMO.	[Yoshitake, S.; Murakami, T.; Uji, A.; Unoki, N.; Dodo, Y.; Horii, T.; Yoshimura, N.] Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Kyoto 6068507, Japan	Murakami, T (reprint author), Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	mutomo@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807			Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Otani T, 1999, AM J OPHTHALMOL, V127, P688, DOI 10.1016/S0002-9394(99)00033-1; Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051; Spaide RF, 2005, OPHTHALMOLOGY, V112, P825, DOI 10.1016/j.ophtha.2005.01.003; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Maheshwary AS, 2010, AM J OPHTHALMOL, V150, P63, DOI 10.1016/j.ajo.2010.01.039; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Bolz M, 2009, OPHTHALMOLOGY, V116, P66, DOI 10.1016/j.ophtha.2008.09.042; Otani T, 2007, OPHTHALMOLOGY, V114, P104, DOI 10.1016/j.ophtha.2006.06.044; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Pece A, 2010, OPHTHALMOLOGICA, V224, P230, DOI 10.1159/000260229; Provis JM, 1998, PROG NEUROBIOL, V54, P549, DOI 10.1016/S0301-0082(97)00079-8; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Chung H, 2012, OPHTHALMOLOGY, V119, P1056, DOI 10.1016/j.ophtha.2011.11.018; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Murakami T, 2008, AM J OPHTHALMOL, V145, P687, DOI 10.1016/j.ajo.2007.11.018; Otani T, 2010, RETINA-J RET VIT DIS, V30, P774, DOI 10.1097/IAE.0b013e3181c2e0d6; Unoki N, 2007, AM J OPHTHALMOL, V144, P755, DOI 10.1016/j.ajo.2007.07.011; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Waldstein SM, 2012, EYE, V26, P1078, DOI 10.1038/eye.2012.100; Vujosevic S, 2011, INVEST OPHTH VIS SCI, V52, P442, DOI 10.1167/iovs.10-5588; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; BEK T, 1994, ACTA OPHTHALMOL, V72, P409; Bessho K, 2009, GRAEF ARCH CLIN EXP, V247, P729, DOI 10.1007/s00417-008-1033-y; Sharuk GS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1701; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; Helve J, 1976, Am J Ophthalmol, V81, P493; Kessel L, 2003, CURR EYE RES, V26, P307, DOI 10.1076/ceyr.26.4.307.15433; Muqit MMK, 2010, AM J OPHTHALMOL, V149, P979, DOI 10.1016/j.ajo.2010.01.032; Murakami T, 2011, OPHTHALMOLOGY, V118, P359, DOI 10.1016/j.ophtha.2010.03.035; Reznicek L, 2013, INT J OPHTHALMOL-CHI, V6, P75, DOI 10.3980/j.issn.2222-3959.2013.01.16; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-222X	1476-5454		EYE	Eye	MAY	2015	29	5					662	669		10.1038/eye.2015.25		8	Ophthalmology	Ophthalmology	CH5JC	WOS:000354070900011		
J	Shiozaki, K; Takahashi, K; Hosono, M; Yamaguchi, K; Hata, K; Shiozaki, M; Bassi, R; Prinetti, A; Sonnino, S; Nitta, K; Miyagi, T				Shiozaki, Kazuhiro; Takahashi, Kohta; Hosono, Masahiro; Yamaguchi, Kazunori; Hata, Keiko; Shiozaki, Momo; Bassi, Rosaria; Prinetti, Alessandro; Sonnino, Sandro; Nitta, Kazuo; Miyagi, Taeko			Phosphatidic acid-mediated activation and translocation to the cell surface of sialidase NEU3, promoting signaling for cell migration	FASEB JOURNAL			English	Article						sialic acid; phospholipids; gangliosides; PLD1; cancer	MEMBRANE-ASSOCIATED SIALIDASE; SITE-DIRECTED MUTAGENESIS; GANGLIOSIDE SIALIDASE; PHOSPHOLIPASE D1; APOPTOSIS SUPPRESSION; MOLECULAR-CLONING; TYROSINE KINASE; GROWTH; EXPRESSION; BINDING	The plasma membrane-associated sialidase NEU3 plays crucial roles in regulation of transmembrane signaling, and its aberrant up-regulation in various cancers contributes to malignancy. However, it remains uncertain how NEU3 is naturally activated and locates to plasma membranes, because of its Triton X-100 requirement for the sialidase activity in vitro and its often changing subcellular location. Among phospholipids examined, we demonstrate that phosphatidic acid (PA) elevates its sialidase activity 4 to 5 times at 50 M in vitro at neutral pH and promotes translocation to the cell surface and cell migration through Ras-signaling in HeLa and COS-1 cells. NEU3 was found to interact selectively with PA as assessed by phospholipid array, liposome coprecipitation, and ELISA assays and to colocalize with phospholipase D (PLD) 1 in response to epidermal growth factor (EGF) or serum stimulation. Studies using tagged NEU3 fragments with point mutations identified PA- and calmodulin (CaM)-binding sites around the N terminus and confirmed its participation in translocation and catalytic activity. EGF induced PLD1 activation concomitantly with enhanced NEU3 translocation to the cell surface, as assessed by confocal microscopy. These results suggest that interactions of NEU3 with PA produced by PLD1 are important for regulation of transmembrane signaling, this aberrant acceleration probably promoting malignancy in cancers.	[Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Takahashi, Kohta; Hata, Keiko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Div Canc Glycosylat Res, Sendai, Miyagi 9818558, Japan; [Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Div Cell Recognit Study, Sendai, Miyagi 9818558, Japan; [Yamaguchi, Kazunori; Shiozaki, Momo] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Bassi, Rosaria; Prinetti, Alessandro; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	Miyagi, T (reprint author), Tohoku Pharmaceut Univ, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23110002]	The authors are grateful to Dr. M. A. Frohman, Stony Brook University, for a kind gift of PLD1 expression vector, pCGN-hPLD1b, and also to Mr. T. Wada and Ms. S. Moriya, Tohoku Pharmaceutical University, for their valuable technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Nomura H, 2006, ONCOL RES, V16, P289; Rodriguez JA, 2001, J NEUROSCI, V21, P8387; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Albohy A, 2010, GLYCOBIOLOGY, V20, P1127, DOI 10.1093/glycob/cwq077; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhang Y, 2014, J BIOL CHEM, V289, P22567, DOI 10.1074/jbc.R114.576876; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; KASZKIN M, 1992, BIOCHEM J, V287, P51; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Magesh S, 2006, J MOL GRAPH MODEL, V25, P196, DOI 10.1016/j.jmgm.2005.12.006; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Sonnino S, 1996, GLYCOBIOLOGY, V6, P479, DOI 10.1093/glycob/6.5.479-e; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132	39	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2099	2111		10.1096/fj.14-262543		13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	WOS:000354114600041		
J	Nakanishi, K; Kakiguchi, K; Yonemura, S; Nakano, A; Morishima, N				Nakanishi, Keiko; Kakiguchi, Kisa; Yonemura, Shigenobu; Nakano, Akihiko; Morishima, Nobuhiro			Transient Ca2+ depletion from the endoplasmic reticulum is critical for skeletal myoblast differentiation	FASEB JOURNAL			English	Article						ER deformation; ER stress; myoblast fusion; STIM1	UNFOLDED PROTEIN RESPONSE; PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM; CYCLOPIAZONIC ACID; MUSCLE; STRESS; FUSION; CELL; ER; CHANNELS	Endoplasmic reticulum (ER) stress is a cellular condition in which unfolded proteins accumulate in the ER because of various but specific causes. Physiologic ER stress occurs transiently during myoblast differentiation, and although its cause remains unknown, it plays a critical role in myofiber formation. To examine the mechanism underlying ER stress, we monitored ER morphology during differentiation of murine myoblasts. Novel ER-derived structures transiently appeared prior to myoblast fusion both in vitro and in vivo. Electron microscopy studies revealed that these structures consisted of pseudoconcentric ER cisternae with narrow lumens. Similar structures specifically formed by pharmacologically induced ER Ca2+ depletion, and inhibition of ER Ca2+ efflux channels in differentiating myoblasts considerably suppressed ER-specific deformation and ER stress signaling. Thus, we named the novel structures stress-activated response to Ca2+ depletion (SARC) bodies. Prior to SARC body formation, stromal interaction molecule 1 (STIM1), an ER Ca2+ sensor protein, formed ER Ca2+ depletion-specific clusters. Furthermore, myoblast differentiation manifested by myoblast fusion did not proceed under the same conditions as inhibition of ER Ca2+ depletion. Altogether, these observations suggest that ER Ca2+ depletion is a prerequisite for myoblast fusion, causing both physiologic ER stress signaling and SARC body formation.Nakanishi, K., Kakiguchi, K., Yonemura, S., Nakano, A., Morishima, N. Transient Ca2+ depletion from the endoplasmic reticulum is critical for skeletal myoblast differentiation.	[Nakanishi, Keiko; Nakano, Akihiko; Morishima, Nobuhiro] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; [Kakiguchi, Kisa; Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan; [Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 113, Japan	Morishima, N (reprint author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	morishim@riken.jp			RIKEN Bioarchitect Research Project; RIKEN Cellular System Program; RIKEN Incentive Research Grant; Japan Society for the Promotion of Science	The authors thank Tetsuya Tajima and Kaori Higuchi (RIKEN BSI-Olympus Collaboration Center) for technical support with fluorescent microscopy, Takashi Yoshiura (Yokogawa Electric Group) for support with 3-dimensional image reconstruction, and Yasue Ichikawa and Rie Nakazawa for DNA sequencing. K.N. was a Research Fellow of the Japan Society for the Promotion of Science. This work was supported in part by grants from the RIKEN Bioarchitect Research Project (to N.M.), RIKEN Cellular System Program (to N.M.), RIKEN Incentive Research Grant (to N.M.), and Japan Society for the Promotion of Science (to N.M. and K.N.). The authors declare no conflicts of interest.	Constantin B, 1996, CELL CALCIUM, V19, P365, DOI 10.1016/S0143-4160(96)90109-8; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; LI WWF, 1993, J BIOL CHEM, V268, P12003; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Caridha D, 2008, ANTIMICROB AGENTS CH, V52, P684, DOI 10.1128/AAC.00874-07; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Shin KS, 1996, DEV BIOL, V175, P14, DOI 10.1006/dbio.1996.0091; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JC126373; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143-4160(02)00192-6; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Bennett DL, 1996, J BIOL CHEM, V271, P6356; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; DEMAUREX N, 1992, J BIOL CHEM, V267, P2318; EZERMAN EB, 1967, J CELL BIOL, V35, P405, DOI 10.1083/jcb.35.2.405; Finger F., 2014, SCI SIGNAL, V7, P1; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Martonosi A. N., 2000, DEV SARCOPLASMIC RET; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; ORCI L, 1993, P NATL ACAD SCI USA, V90, P11089, DOI 10.1073/pnas.90.23.11089; Palnitkar SS, 1997, BIOCHEM J, V326, P847; Parys J. B., 2014, SCI SIGNAL, V7, P1; PRZYBYLSKI RJ, 1989, IN VITRO CELL DEV B, V25, P830; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Vandecaetsbeek I., 2011, COLD SPRING HARB PER, V3	53	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2137	2149		10.1096/fj.14-261529		13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	WOS:000354114600044		
J	Miura, K; Higashijima, A; Mishima, H; Miura, S; Kitajima, M; Kaneuchi, M; Yoshiura, K; Masuzaki, H				Miura, Kiyonori; Higashijima, Ai; Mishima, Hiroyuki; Miura, Shoko; Kitajima, Michio; Kaneuchi, Masanori; Yoshiura, Koh-ichiro; Masuzaki, Hideaki			Pregnancy-associated microRNAs in plasma as potential molecular markers of ectopic pregnancy	FERTILITY AND STERILITY			English	Article						Biomarker; ectopic pregnancy; pregnancy-associated microRNA; plasma	MATERNAL PLASMA; MESSENGER-RNA; FETAL; PLACENTA; IDENTIFICATION; C19MC; BLOOD	Objective: To investigate cell-free pregnancy-associated microRNAs as molecular markers for the diagnosis of ectopic pregnancy. Design: Laboratory study using human plasma samples. Setting: Research unit in a university hospital. Patient(s): Plasma samples from 18 women with ectopic pregnancies (EP group), 12 women with spontaneous abortion (SA group), and 26 normal women with singleton pregnancies (NP group). Intervention(s): Total RNAs containing small RNA molecules extracted from 1.2 mL of plasma. Main Outcome Measure(s): Plasma concentrations of cell-free microRNAs measured by quantitative real-time reverse-transcriptase polymerase chain reaction. Result(s): Plasma concentrations of cell-free pregnancy-associated microRNAs (miR-323-3p, miR-515-3p, miR-517a, miR-517c, and miR-518b) and serum concentration of human chorionic gonadotropin (hCG) were confirmed to have statistically significantly different plasma or serum concentrations in women with EP, SA, or NP. There was no statistically significant difference in the plasma concentrations of cell-free miR-21 between the three groups. By correlation coefficient analysis, no relationship was detected between serum hCG levels and plasma cell-free miR-517c, miR-515-3p, miR-517a, miR-518b, miR-323-3p, or miR-21 levels. Plasma concentrations of cell-free miR-517a could distinguish EP/SA from NP, yielding an area under the curve of 0.9654 (95% confidence interval, 0.9172-1.0). Plasma concentrations of cell-free miR-323-3p could distinguish EP from SA, yielding an area under the curve of 0.7454 (95% confidence interval, 0.5558-0.9349). Conclusion(s): Cell-free pregnancy-associated microRNAs have potential as molecular markers of ectopic pregnancy. (C) 2015 by American Society for Reproductive Medicine.	[Miura, Kiyonori; Higashijima, Ai; Mishima, Hiroyuki; Miura, Shoko; Kitajima, Michio; Kaneuchi, Masanori; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan; [Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528501, Japan	Miura, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	kiyonori@nagasaki-u.ac.jp			JSPS KAKENHI [26462495, 24791712, 25462563]	Supported by JSPS KAKENHI, grant numbers 26462495, 24791712, and 25462563 (to K. Miura, S. Miura, and H. Masuzaki, respectively).	American College of Obstetricians and Gynecologists, 2008, OBSTET GYNECOL, V111, P1479; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Galliano D, 2014, FERTIL STERIL, V101, P1531, DOI 10.1016/j.fertnstert.2014.04.023; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283; Mendell JT, 2005, CELL CYCLE, V4, P1179; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Ng EKO, 2002, CLIN CHEM, V48, P1212; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Hasegawa Y, 2013, CLIN CHEM, V59, P1410, DOI 10.1373/clinchem.2013.206391; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chiu RWK, 2010, CLIN CHEM, V56, P1656, DOI 10.1373/clinchem.2010.153684; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lozoya T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087698; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77	23	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	MAY	2015	103	5					1202	+		10.1016/j.fertnstert.2015.01.041		8	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CH2GM	WOS:000353843700022		
J	Mori, T; Ito, F; Matsushima, H; Takaoka, O; Tanaka, Y; Koshiba, A; Kusuki, I; Kitawaki, J				Mori, Taisuke; Ito, Fumitake; Matsushima, Hiroshi; Takaoka, Osamu; Tanaka, Yukiko; Koshiba, Akemi; Kusuki, Izumi; Kitawaki, Jo			G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis	FERTILITY AND STERILITY			English	Article						GPER; G-1; endometriosis; cell cycle arrest; apoptosis	DRUG-INDUCED APOPTOSIS; BREAST-CANCER CELLS; STROMAL CELLS; SUPPRESSES PROLIFERATION; INHIBITS PROLIFERATION; GPER EXPRESSION; OVARIAN-CANCER; IN-VITRO; GPR30; GROWTH	Objective: To demonstrate the effects of the selective G protein-coupled estrogen receptor 1 (GPER) agonist G-1 in human ovarian endometriotic stromal cells (ESCs). Design: Experimental in vitro study. Setting: University hospital. Patient(s): A total of 33 patients with ovarian endometrioma. Intervention(s): Endometriotic stromal cells from ovarian chocolate cysts were treated with the GPER agonist G-1. Main Outcome Measure(s): The primary outcomes were cell proliferation, measured using the WST-8 assay; cell cycle, as analyzed using flow cytometry, fluorescent immunocytochemistry, and cytotoxicity; caspase activity, as measured by fluorescent and luminescent enzyme assays; and protein expression levels, as determined by Western blot analysis. Result(s): G-1 suppressed ESC proliferation in a concentration-dependent manner. The inhibitory effect was not blocked when GPER signaling pathways, including the GPER itself, were inhibited. G-1 induced cell cycle arrest and accumulation in the sub-G1 phase in ESCs. Immunofluorescence analysis demonstrated that G-1 interrupted microtubule assembly at the mitotic phase. G-1 also induced caspase-3-dependent apoptosis without significant cytotoxicity. Conclusion(s): G-1 suppressed proliferation and induced apoptosis in ESCs, suggesting the potential use of this compound as a therapeutic drug for the treatment of endometriosis. (C) 2015 by American Society for Reproductive Medicine.	[Mori, Taisuke; Ito, Fumitake; Matsushima, Hiroshi; Takaoka, Osamu; Tanaka, Yukiko; Koshiba, Akemi; Kusuki, Izumi; Kitawaki, Jo] Kyoto Prefectural Univ Med, Dept Obstet & Gynecol, Grad Sch Med Sci, Kyoto 6028566, Japan	Mori, T (reprint author), Kyoto Prefectural Univ Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	moriman@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (Japan) [24592480, 23197849]	Supported in part by Grants-in-Aid for Scientific Research (nos. 24592480 and 23197849) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan).	Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Ngo C, 2010, J PATHOL, V222, P148, DOI 10.1002/path.2756; Yin XQ, 2012, J CLIN ENDOCR METAB, V97, pE35, DOI 10.1210/jc.2011-1527; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Minami T, 2013, EUR J OBSTET GYN R B, V166, P76, DOI 10.1016/j.ejogrb.2012.08.023; Tian RJ, 2013, FERTIL STERIL, V99, P256, DOI 10.1016/j.fertnstert.2012.09.011; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Nishida M, 2005, MOL HUM REPROD, V11, P29, DOI 10.1093/molehr/gah133; Plante BJ, 2012, REPROD SCI, V19, P684, DOI 10.1177/1933719111431000; Yamanaka K, 2012, FERTIL STERIL, V97, P477, DOI 10.1016/j.fertnstert.2011.11.005; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Li FZ, 1998, NATURE, V396, P580; Eaton JL, 2013, J CLIN ENDOCR METAB, V98, pE1871, DOI 10.1210/jc.2013-1661; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Dmowski WP, 2001, HUM REPROD, V16, P1802, DOI 10.1093/humrep/16.9.1802; Imesch P, 2013, FERTIL STERIL, V100, P770, DOI 10.1016/j.fertnstert.2013.05.008; Wang C, 2012, AM J TRANSL RES, V4, P390; Holm A, 2011, J VASC RES, V48, P327, DOI 10.1159/000322578; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Cheng W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045529; Chevalier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034672; Ignatov T, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-51; Ignatov T, 2013, CANCER INVEST, V31, P309, DOI 10.3109/07357907.2013.789901; Long L, 2012, INT J GYNECOL CANCER, V22, P539, DOI 10.1097/IGC.0b013e318247323d; Lubig J, 2012, CANCER INVEST, V30, P372, DOI 10.3109/07357907.2012.666690; Samartzis N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-30; Skrzypczak M, 2013, STEROIDS, V78, P1087, DOI 10.1016/j.steroids.2013.07.007; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Watanabe A, 2009, HUM REPROD, V24, P3172, DOI 10.1093/humrep/dep305	39	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	MAY	2015	103	5					1228	+		10.1016/j.fertnstert.2015.01.026		9	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CH2GM	WOS:000353843700026		
J	Bodri, D; Kato, R; Kondo, M; Hosomi, N; Katsumata, Y; Kawachiya, S; Matsumoto, T				Bodri, Daniel; Kato, Ryutaro; Kondo, Masae; Hosomi, Naoko; Katsumata, Yoshinari; Kawachiya, Satoshi; Matsumoto, Tsunekazu			Time-lapse monitoring of zona pellucida-free embryos obtained through in vitro fertilization: a retrospective case series	FERTILITY AND STERILITY			English	Editorial Material						Time-lapse monitoring; zona pellucida; blastocyst culture; minimal ovarian stimulation; in vitro fertilization	FREE OOCYTES; PREGNANCY	Objective: To report time-lapse monitoring of human oocytes in which the damaged zona pellucida was removed, producing zona-free (ZF) oocytes that were cultured until the blastocyst stage in time-lapse incubators. Design: Retrospective case series. Setting: Private infertility clinic. Patient(s): Infertile patients (n = 32) undergoing minimal ovarian stimulation or natural cycle IVF treatment between October 2012 and June 2014. Intervention(s): Intracytoplasmic sperm injection (ICSI) fertilization of ZF oocytes, prolonged embryo culture in time-lapse incubators, elective vitrification, and subsequent single vitrified-thawed blastocyst transfer (SVBT). Main Outcome Measure(s): Rate of fertilization, cleavage and blastocyst development, live-birth rate per SVBT cycle. Result(s): In spite of advanced maternal age (39 +/- 4.2; range, 30-46 years), good fertilization (94%), cleavage (94%), and blastocyst development rates (38%) were reached after fertilization and culturing of ZF oocytes/embryos. All thawed ZF blastocysts survived, and up to this date seven SVBT transfers were performed, yielding three (43%) term live births with healthy newborns. Conclusion(s): Time-lapse imagery gives a unique insight into the dynamics of embryo development in ZF embryos. Moreover, our case series demonstrate that an oocyte with a damaged zona pellucida that has been removed could be successfully fertilized with ICSI, cultured until blastocyst stage in a time-lapse incubator and vitrified electively for subsequent use. (C) 2015 by American Society for Reproductive Medicine.	[Bodri, Daniel; Kato, Ryutaro; Kondo, Masae; Hosomi, Naoko; Katsumata, Yoshinari; Kawachiya, Satoshi; Matsumoto, Tsunekazu] Kobe Motomachi Yume Clin, Kobe, Hyogo 6500037, Japan	Bodri, D (reprint author), Kobe Motomachi Yume Clin, Chuo Ku, 3F Miyuki Bldg,Akashimachi 44, Kobe, Hyogo 6500037, Japan.	bodridaniel@gmail.com					Ding J, 1999, HUM REPROD, V14, P476, DOI 10.1093/humrep/14.2.476; Hsieh Y Y, 2001, Chang Gung Med J, V24, P599; Kaser DJ, 2014, HUM REPROD UPDATE, V20, P617, DOI 10.1093/humupd/dmu023; Shu YM, 2010, REPROD BIOMED ONLINE, V21, P527, DOI 10.1016/j.rbmo.2010.04.033; Stanger JD, 2001, HUM REPROD, V16, P164, DOI 10.1093/humrep/16.1.164; Takahashi K, 1999, HUM REPROD, V14, P2677, DOI 10.1093/humrep/14.10.2677; Ueno S, 2014, FERTIL STERIL, V102, P1602, DOI 10.1016/j.fertnstert.2014.08.025; Vajta G, 2010, REPROD BIOMED ONLINE, V21, P17, DOI 10.1016/j.rbmo.2010.03.014	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	MAY	2015	103	5					E35	E35		10.1016/j.fertnstert.2015.02.016		1	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CH2GM	WOS:000353843700001		
J	Phetrungnapha, A; Kondo, H; Hirono, I; Panyim, S; Ongvarrasopone, C				Phetrungnapha, Amnat; Kondo, Hidehiro; Hirono, Ikuo; Panyim, Sakol; Ongvarrasopone, Chalermporn			Molecular cloning and characterization of Mj-mov-10, a putative RNA helicase involved in RNAi of kuruma shrimp	FISH & SHELLFISH IMMUNOLOGY			English	Article						RISC; White spot syndrome virus; Double stranded RNA; RNAi; Shrimp	SPOT SYNDROME VIRUS; DOUBLE-STRANDED-RNA; YHV-PROTEASE DSRNA; BLACK TIGER SHRIMP; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; FUNCTIONAL-CHARACTERIZATION; INTERFERENCE PATHWAY; WHITE SHRIMP; GENE	Identification and characterization of the RNAi-related genes is the key to understanding RNAi mechanism in shrimp. In this study, we have identified and characterized a novel putative RNA helicase gene, Mj-mov-10 from the kuruma shrimp, Marsupenaeus japonicus and its implication in shrimp RNAi was demonstrated. The full-length Mj-mov-10 gene contained 3536 bp, including 239 bp of 5'UTR, 2895 bp of the open reading frame (ORF) and 402 bp of 3'UTR, respectively. An ORF of Mj-mov-10 could be translated to a 109-kDa protein which consists of a single helicase core domain containing seven signature motifs of the RNA helicase superfamily-1. Mj-MOV-10 protein shared 47% and 40% identity with mammalian MOV-10 and plant SDE3, respectively. Expression of Mj-mov-10 gene was significantly up-regulated upon dsRNA and white spot syndrome virus (WSSV) challenge. In vivo gene knockdown of Mj-mov-10 resulted in an increase of a susceptibility of shrimp to WSSV infection. Our results implied the functional significance of Mj-MOV-10 in dsRNA-mediated gene silencing and antiviral defense mechanism in shrimp. (C) 2015 Elsevier Ltd. All rights reserved.	[Phetrungnapha, Amnat] Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok 65000, Thailand; [Kondo, Hidehiro; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Grad Sch, Minato Ku, Tokyo, Japan; [Panyim, Sakol; Ongvarrasopone, Chalermporn] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand; [Panyim, Sakol] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand	Ongvarrasopone, C (reprint author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phutthamonthon 4 Rd, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand.	chalermporn.ong@mahidol.ac.th	KONDO, Hidehiro/O-1954-2014; HIRONO, Ikuo/O-1940-2014	KONDO, Hidehiro/0000-0001-5102-6831; 	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund [RSA5480002, BRG5780006, DPG5680001]	This project is supported by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative and grants from the Thailand Research Fund (RSA5480002 and BRG5780006 to C.O. and DPG5680001 to S.P.).	Ambrus AM, 2009, CELL CYCLE, V8, P3500, DOI 10.4161/cc.8.21.9887; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Tirasophon W, 2007, ANTIVIR RES, V74, P150, DOI 10.1016/j.antiviral.2006.11.002; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Ongvarrasopone C, 2008, MAR BIOTECHNOL, V10, P374, DOI 10.1007/s10126-007-9073-6; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Yang L, 2014, FISH SHELLFISH IMMUN, V40, P146, DOI 10.1016/j.fsi.2014.06.019; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Rijiravanich A, 2008, FISH SHELLFISH IMMUN, V24, P308, DOI 10.1016/j.fsi.2007.11.017; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107; Shockey JE, 2009, DEV COMP IMMUNOL, V33, P668, DOI 10.1016/j.dci.2008.11.010; Hui JHL, 2008, PEPTIDES, V29, P252, DOI 10.1016/j.peptides.2007.08.033; Labreuche Y, 2010, DEV COMP IMMUNOL, V34, P1209, DOI 10.1016/j.dci.2010.06.017; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Carleton M, 2007, CELL CYCLE, V6, P2127; Phetrungnapha A, 2013, FISH SHELLFISH IMMUN, V35, P874, DOI 10.1016/j.fsi.2013.06.025; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Hipolito SG, 2014, DEV COMP IMMUNOL, V46, P461, DOI 10.1016/j.dci.2014.06.001; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Huang TZ, 2012, J VIROL, V86, P12997, DOI 10.1128/JVI.01702-12; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.2.186; Amparyup P, 2010, DEV COMP IMMUNOL, V34, P168, DOI 10.1016/j.dci.2009.09.004; Attasart P, 2010, ARCH VIROL, V155, P825, DOI 10.1007/s00705-010-0649-5; Chen YH, 2012, FISH SHELLFISH IMMUN, V32, P373, DOI 10.1016/j.fsi.2011.11.032; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Garcia D, 2012, MOL CELL, V48, P109, DOI 10.1016/j.molcel.2012.07.028; Lee JH, 2014, COMP BIOCH PHYSL B, V179, P9; lzumi T, 2013, J VIROL, V87, P11047; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886; Ongvarrasopone C, 2007, SCIENCEASIA, V33, P35, DOI 10.2306/scienceasia1513-1874.2007.33.035; Serquina AKP, 2013, J VIROL, V87, P8853, DOI 10.1128/JVI.00925-13; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Unajak S, 2006, COMP BIOCHEM PHYS B, V145, P179, DOI 10.1016/j.cbpb.2006.07.002; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030057; Yang LS, 2014, FISH SHELLFISH IMMUN, V36, P261, DOI 10.1016/j.fsi.2013.11.010	49	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	MAY	2015	44	1					241	247		10.1016/j.fsi.2015.02.028		7	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CH0WU	WOS:000353743900028		
J	Tasumi, S; Norshida, I; Boxshall, GA; Kikuchi, K; Suzuki, Y; Ohtsuka, S				Tasumi, Satoshi; Norshida, Ismail; Boxshall, Geoffrey A.; Kikuchi, Kiyoshi; Suzuki, Yuzuru; Ohtsuka, Susumu			Screening of candidate genes encoding proteins expressed in pectoral fins of fugu Takifugu rubripes, in relation to habitat site of parasitic copepod Caligus fugu, using suppression subtractive hybridization	FISH & SHELLFISH IMMUNOLOGY			English	Article						Settlement site specificity; Chemical cue; Caligus fugu; Takifugu rubripes; Suppression subtractive hybridization PCR	LEPEOPHTHEIRUS-SALMONIS COPEPODIDS; NEOBENEDENIA-GIRELLAE MONOGENEA; ATLANTIC SALMON; HOST LOCATION; SEA LOUSE; LICE; SIPHONOSTOMATOIDA; SEMIOCHEMICALS; ATTACHMENT; EVOLUTION	Caligus fugu is a parasitic copepod specific to the tetraodontid genus Takifugu including the commercially important Takifugu rubripes. Despite the rapid accumulation of knowledge on other aspects of its biology, the host and settlement-site recognition mechanisms of this parasite are not yet well understood. Since the infective copepodid stage shows preferential site selection in attaching to the fins, we considered it likely that the copepodid recognizes chemical cues released or leaking from the fins, and/or transmembrane protein present on the fins. To isolate molecules potentially related to attachment site specificity, we applied suppression subtractive hybridization (SSH) PCR by identifying genes expressed more highly in pectoral fins of T. rubripes than in the body surface skin. We sequenced plasmid DNA from 392 clones in a SSH library. The number of non-redundant sequences was 276, which included 135 sequences located on 117 annotated genes and 141 located in positions where no genes had been annotated. We characterized those annotated genes on the basis of gene ontology terms, and found that 46 of the identified genes encode secreted proteins, enzymes or membrane proteins. Among them nine showed higher expression in the pectoral fins than in the skin. These could be candidate genes for involvement in behavioral mechanisms related to the site specificity shown by the infective copepodids of C. fugu. (C) 2015 Elsevier Ltd. All rights reserved.	[Tasumi, Satoshi; Kikuchi, Kiyoshi; Suzuki, Yuzuru] Univ Tokyo, Fisheries Lab, Hamamatsu, Shizuoka 4310214, Japan; [Norshida, Ismail; Ohtsuka, Susumu] Hiroshima Univ, Grad Sch Biosphere Sci, Takehara, Hiroshima 7250024, Japan; [Boxshall, Geoffrey A.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Tasumi, S (reprint author), Univ Tokyo, Fisheries Lab, Nishi Ku, 2971-4 Bentenjima,Maisaka Cho, Hamamatsu, Shizuoka 4310214, Japan.	atasumi@mail.ecc.u-tokyo.ac.jp; ohtsuka@hiroshima-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [22780171, 23658162, 20228003]; Lotte Shigemitsu Prize; Japan Society of Promotion of Science [23658162]	We thank N. Mizuno, Y. Jo and M. Fujita from the University of Tokyo for assistance in fish purchase and rearing. S.T. was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan 22780171 and 23658162, and by the Lotte Shigemitsu Prize, Y.S. by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan 20228003 and 23658162, and S.O., Y.S. and S.T. by Grants-in-Aid for Scientific Research from the Japan Society of Promotion of Science 23658162.	Adolph KW, 2002, DNA SEQUENCE, V13, P277, DOI 10.1080/1042517021000019278; Bailey RJE, 2006, CAN J FISH AQUAT SCI, V63, P448, DOI 10.1139/F05-231; Ohtsuka S, 2009, J NAT HIST, V43, P1779, DOI 10.1080/00222930902993757; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Nagasawa Kazuya, 2010, Bulletin of the Biogeographical Society of Japan, V65, P103; Buchmann K, 2002, INT J PARASITOL, V32, P309, DOI 10.1016/S0020-7519(01)00332-0; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; Ingvarsdottir A, 2002, PEST MANAG SCI, V58, P537, DOI 10.1002/ps.510; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Costello MJ, 2009, P R SOC B, V276, P3385, DOI 10.1098/rspb.2009.0771; Gurskaya NG, 1996, ANAL BIOCHEM, V240, P90, DOI 10.1006/abio.1996.0334; REGNIER FE, 1971, BIOL REPROD, V4, P309; Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041; Tasumi S, 2007, J IMMUNOL, V179, P3086; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Boxshall G.A., 2004, RAY SOC LONDON, V166, P1; Bron JE, 1993, PATHOGENS WILD FARME, V1st, P125; Chaisson KE, 2012, TRENDS PARASITOL, V28, P427, DOI 10.1016/j.pt.2012.07.004; Cui J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085505; Devine GJ, 2000, J CHEM ECOL, V26, P1833, DOI 10.1023/A:1005592606682; Dojiri M, 2013, CRUSTACEANA MONOGR, V18, P1, DOI 10.1163/9789004204256; Heuch PA, 1997, J PLANKTON RES, V19, P735, DOI 10.1093/plankt/19.6.735; HEUCH PA, 1995, CAN J FISH AQUAT SCI, V52, P681; Ismail N, 2013, PARASITE, V20, DOI 10.1051/parasite/2013041; Karplus I, 2014, SYMBIOSIS IN FISHES: THE BIOLOGY OF INTERSPECIFIC PARTNERSHIPS, P1, DOI 10.1002/9781118759769; Kato K, 2013, BIOCHEM BIOPH RES CO, V436, P252, DOI 10.1016/j.bbrc.2013.05.085; Kawasaki K, 2011, EUR J ORAL SCI, V119, P247, DOI 10.1111/j.1600-0722.2011.00898.x; Krasnov A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-130; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Ohashi H, 2007, INT J PARASITOL, V37, P1483, DOI 10.1016/j.ijpara.2007.04.024; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Takashima F, 1995, ATLAS FISH HISTOLOGY; Yamaguti S., 1936, PARASITIC COPEPODS F, P22; Yoshinaga T, 2000, J PARASITOL, V86, P214, DOI 10.1645/0022-3395(2000)086[0214:AICOFT]2.0.CO;2; Zhi-Liang H, 2008, ONLINE J BIOINFORMAT, V9, P108	42	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	MAY	2015	44	1					356	364		10.1016/j.fsi.2015.02.031		9	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CH0WU	WOS:000353743900042		
J	Shen, XL; Hu, FX; Kumazawa, T; Shiode, D; Tokai, T				Shen, Xiaoli; Hu, Fuxiang; Kumazawa, Taisei; Shiode, Daisuke; Tokai, Tadashi			Hydrodynamic characteristics of a hyper-lift otter board with wing-end plates	FISHERIES SCIENCE			English	Article						Otter board; HLTD; Wing-end plate; Lift coefficient; Heel angle; Flume experiment	CAMBERED PLATES; FLOW VISUALIZATION	The paper investigates the hydrodynamic characteristics of a hyper-lift trawl door (HLTD), which consists of a cambered plate with two wing-end plates with the leading edge modified into an airfoil shape. Flume experiments were carried out in a circulating water tank using models having a wing area of 625 cm(2) and an aspect ratio of 1.0 at camber ratios of 15, 20, and 25 %. To determine the effect of the wing-end plates, models with different size of wing-end plates were tested. Moreover, the effect of heel angle on the hydrodynamic characteristics of the HLTD was also investigated. We concluded that the size of the wing-end plate was significant for h/c = 0.10 (h width of the wing-end plate, c chord length of cambered plate), and the maximum lift coefficients of HLTDs with camber ratios of 15, 20 and 25 % were 2.19, 2.38, and 2.48, respectively, at an attack of angle of 38A degrees. In addition, our findings showed that the effect of the heel angle was very small on the lift, drag and moment coefficients of a HLTD when it slants at heel angles from -20A degrees to 20A degrees during trawling.	[Shen, Xiaoli; Hu, Fuxiang; Shiode, Daisuke; Tokai, Tadashi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Kumazawa, Taisei] Nichimo Co Ltd, Dept Res & Dev, Shimonoseki, Yamaguchi 7501136, Japan	Hu, FX (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo 1088477, Japan.	fuxiang@kaiyodai.ac.jp	TOKAI, Tadashi/O-1882-2014; SHIODE, Daisuke/O-1957-2014	TOKAI, Tadashi/0000-0003-2681-9527; 			FAO, 1974, OTT BOARD DES PERF, P1; Fukuda K, 1999, NIPPON SUISAN GAKK, V65, P860; Fukuda K, 1997, NIPPON SUISAN GAKK, V63, P207; Fukuda K, 2000, NIPPON SUISAN GAKK, V66, P97; Goldstein S, 1965, MODERN DEV FLUID DYN, P42; Kwidzinski Z, 1988, P WORLD S FISH GEAR, P297; Makino M, 1989, BASIS AERODYNAMIC, VSecond, P79; Matuda K, 1999, NIPPON SUISAN GAKK, V65, P921; MATUDA K, 1990, NIPPON SUISAN GAKK, V56, P1815; Nishiyama T, 1992, NIKKAN KOGYO SHINBUN, P1; PARK CD, 1994, NIPPON SUISAN GAKK, V60, P485; PARK CD, 1994, NIPPON SUISAN GAKK, V60, P193; PARK CD, 1993, NIPPON SUISAN GAKK, V59, P627; Rinoie K, 1993, J VIS, V13, P18; Suberkrub F, 1959, FISHING NEWS, P359; Yang WJ, 1989, HDB FLOW VISUALIZATI, P41	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					433	442		10.1007/s12562-015-0873-8		10	Fisheries	Fisheries	CH7CV	WOS:000354194100003		
J	Houki, S; Kawamura, T; Irie, T; Won, NI; Watanabe, Y				Houki, Shouji; Kawamura, Tomohiko; Irie, Takahiro; Won, Nam-Il; Watanabe, Yoshiro			The daily cycle of siphon extension behavior in the Manila clam controlled by endogenous rhythm	FISHERIES SCIENCE			English	Article						Manila clam; Ruditapes philippinarum; Siphon extension behavior; Daily cycle; Endogenous rhythm	RUDITAPES-PHILIPPINARUM BIVALVIA; INCREMENT FORMATION; CIRCADIAN-RHYTHMS; FOOD AVAILABILITY; VALVE MOVEMENTS; TIDAL RHYTHM; VENERIDAE; DIGESTION; CRICKET; GROWTH	Periodicities in siphon extension behavior, which is considered an index of feeding behavior, of the Manila clam Ruditapes philippinarum were investigated by sequential visual observations in water tanks under laboratory conditions. Most clams actively extended their siphons in the dark period and closed their shells in the light period under the 12L:12D condition, and this diel cycle of the siphon extension behavior was maintained even under constant light and dark conditions, indicating that Manila clams had an endogenous rhythm with a 24-h cycle. Although the Manila clam has been considered to have a circatidal rhythm in previous studies, a 24.8-h circatidal cycle of the siphon extension behavior was not observed in any of the experimental trials in this study. Although the diel cycle of the siphon extension behavior was temporally collapsed by supplying food after starvation for 10 days, the diel cycle recovered thereafter. This phenomenon indicates that the endogenous rhythm remains even if the cycle of the behavior is lost due to changes in physiological conditions like starvation or in external environments such as food availability.	[Houki, Shouji; Kawamura, Tomohiko; Irie, Takahiro; Watanabe, Yoshiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Won, Nam-Il] KWI Korea Water Resources Corp, Taejon 305730, South Korea	Houki, S (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	houki@aori.u-tokyo.ac.jp					Garcia-March JR, 2008, MAR BIOL, V153, P689, DOI 10.1007/s00227-007-0842-6; BROWN FA, 1954, AM J PHYSIOL, V178, P510; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159; Abe Y, 1997, ZOOL SCI, V14, P719; Williams BG, 1997, J BIOL RHYTHM, V12, P173, DOI 10.1177/074873049701200208; Ortmann C, 2003, J EXP BIOL, V206, P4167, DOI 10.1242/jeb.00656; Satoh A, 2008, BIOL LETTERS, V4, P233, DOI 10.1098/rsbl.2008.0036; Kim WS, 2001, MAR BIOL, V138, P157, DOI 10.1007/s002270000430; BENNETT MF, 1957, BIOL BULL, V112, P267, DOI 10.2307/1539119; Broom DM, 1981, BIOL BEHAV MECH FUNC; Chatfield C., 1996, ANAL TIME SERIES INT; ENGLUND V, 1994, ANN ZOOL FENN, V31, P257; Gnyubkin VF, 2010, RUSS J MAR BIOL+, V36, P419, DOI 10.1134/S1063074010060039; Hamaguchi Masami, 2011, Bulletin of Fisheries Research Agency, P33; Hamaguchi Masami, 2002, Japanese Journal of Benthology, V57, P168; HIGGINS PJ, 1980, J EXP MAR BIOL ECOL, V45, P229, DOI 10.1016/0022-0981(80)90060-X; Isono R, 2000, J JPN SOC WATER ENV, V23, P683, DOI 10.2965/jswe.23.683; Isono RS, 1998, NIPPON SUISAN GAKK, V64, P373; JORGENSEN EG, 1962, PHYSIOL PLANTARUM, V15, P530, DOI 10.1111/j.1399-3054.1962.tb08056.x; Kim WS, 1999, MAR BIOL, V134, P107, DOI 10.1007/s002270050529; LANGTON RW, 1974, MAR BIOL, V24, P181, DOI 10.1007/BF00389353; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Masu T, 2008, FISHERIES SCI, V74, P41, DOI 10.1111/j.1444-2906.2007.01493.x; MORTON B, 1971, Biological Journal of the Linnean Society, V3, P329, DOI 10.1111/j.1095-8312.1971.tb00526.x; MORTON B, 1970, J MAR BIOL ASSOC UK, V50, P499; Okoshi K, 2007, NIPPON SUISAN GAKK, V73, P1129, DOI 10.2331/suisan.73.1129; Poulain C, 2011, J EXP MAR BIOL ECOL, V397, P58, DOI 10.1016/j.jembe.2010.11.001; RAO KP, 1954, BIOL BULL, V106, P353, DOI 10.2307/1538769; Shigeta T, 2012, J FISH TECH, V5, P1; Toba M., 1989, Suisan Zoshoku, V37, P63	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					453	461		10.1007/s12562-015-0859-6		9	Fisheries	Fisheries	CH7CV	WOS:000354194100005		
J	Kobayashi, Y; Takatsu, T; Yamaguchi, H; Joh, M				Kobayashi, Yuki; Takatsu, Tetsuya; Yamaguchi, Hiroshi; Joh, Mikimasa			Comparisons of diet and nutritional conditions in Pseudopleuronectes herzensteini juveniles between two nursery grounds off northern Hokkaido, Japan	FISHERIES SCIENCE			English	Article						Flatfish; Harpacticoid copepods; Condition factor K; Prey diversity; Sea of Japan; Sea of Okhotsk	FLOUNDERS LIMANDA-HERZENSTEINI; RIGHTEYE FLOUNDERS; MUTSU BAY; YOKOHAMAE; GROWTH; HABITS; SOLE	To characterise food-habit differences in Pseudopleuronectes herzensteini juveniles we compared diets, prey diversity and nutritional states between two groups, i.e., one in the Sea of Japan and the other in the Sea of Okhotsk around northern Hokkaido, Japan. Juveniles were collected with a sledge net along the sea bottom at depths of 8-50 m in August 2010 and 2011. In the Sea of Japan, 63 were analysed (23 in 2010 and 40 in 2011). In the Sea of Okhotsk, 88 were analysed (55 in 2010 and 33 in 2011). There were no differences in standard lengths of juveniles (the Sea of Japan: 27.0 mm in 2010 in median; 28.8 mm in 2011; the Sea of Okhotsk: 28.3 mm in 2010; 29.2 mm in 2011) or in bottom water temperatures at the study sites. However, stomach content volume and Fulton's condition factor K were higher in the Sea of Okhotsk than in the Sea of Japan. High feeding intensities in the Sea of Okhotsk may have led to a higher nutritional status in fish collected from this sea. In both seas, the diet comprised mainly harpacticoid copepods, gammarids and polychaetes, with some additional bivalves being observed in the Sea of Japan. The value of the prey-diversity index (Delta*) was lower when the K value of juveniles was higher.	[Kobayashi, Yuki; Takatsu, Tetsuya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Kobayashi, Yuki; Takatsu, Tetsuya] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Yamaguchi, Hiroshi] Hokkaido Res Org, Wakkanai Fisheries Res Inst, Wakkanai, Hokkaido 0970001, Japan; [Joh, Mikimasa] Hokkaido Res Org, Abashiri Fisheries Res Inst, Abashiri, Hokkaido 0993119, Japan	Takatsu, T (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.	takatsu@fish.hokudai.ac.jp					Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; TYLER AV, 1976, J FISH RES BOARD CAN, V33, P63; Yamashita Y, 2001, J SEA RES, V45, P205, DOI 10.1016/S1385-1101(01)00049-1; Aota M, 1976, LOW TEMP SCI A, V33, P151; ARITAKI M, 1994, NIPPON SUISAN GAKK, V60, P29; Funamoto K, 2012, MARINE FISHERIES STO, P1565; Hurst TP, 2006, J FISH BIOL, V68, P905, DOI 10.1111/j.1095-8649.2006.00985.x; Kaga Y, 1965, HOKUSUISHI GEPPOU, V22, P1; Komoto R, 2011, AQUAC SCI, V59, P615; Maruyama S, 1980, ABASHIRI SUISHI JIGY, P1; NISHIYAMA T, 1983, Bulletin of Plankton Society of Japan, V30, P159; OMORI M, 1975, Nippon Suisan Gakkaishi, V41, P615; PEARRE S, 1980, CAN J ZOOL, V58, P1884; Pinkas A, 1971, CALIF DEP FISH GAME, V152, P1; Shimoda K, 2006, HOKUSUISHI KENPOU, V71, P55; Suga K, 2007, HOKKAIDOSRITSU CHISH, P7; TAKAHASHI T, 1987, NIPPON SUISAN GAKK, V53, P1905; Takahashi T., 1987, Bulletin of the Japanese Society of Scientific Fisheries, V53, P177; TAKAHASHI T, 1982, B JPN SOC SCI FISH, V48, P1257; Takatsu T, 2007, FISHERIES SCI, V73, P142, DOI 10.1111/j.1444-2906.2007.01312.x; Tominaga O, 1990, THESIS HOKKAIDO U FI; Uchida Y, 2003, KOKKAIDORSITSU CHISH, P16; VANDERVEER HW, 1993, MAR ECOL PROG SER, V101, P81, DOI 10.3354/meps101081; Watanobe M, 2005, KITANO SAKANATACHI, V2nd, P272; Watanobe M, 1994, WAKKANAI SUISHI JIGY, P147; Watanobe M, 2000, HOKUSUISHI DAYORI, V48, P6; Yamanobe A, 2007, B FUKUSHIMA PREF FIS, V14, P1; Yamashita Y, 2010, GYORUI SEITAIGAKU KI, V1st, P172; Yoshimura K, 1996, WAKKANAI SUISHI JIGY, P154; Yoshimura K, 1997, WAKKANAI SUISHI JIGY, P190	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					463	472		10.1007/s12562-015-0860-0		10	Fisheries	Fisheries	CH7CV	WOS:000354194100006		
J	Kuniya, N; Jimbo, M; Tanimoto, F; Yamashita, H; Koike, K; Harii, S; Nakano, Y; Iwao, K; Yasumoto, K; Watabe, S				Kuniya, Nami; Jimbo, Mitsuru; Tanimoto, Fumika; Yamashita, Hiroshi; Koike, Kazuhiko; Harii, Saki; Nakano, Yoshikatsu; Iwao, Kenji; Yasumoto, Ko; Watabe, Shugo			Possible involvement of Tachylectin-2-like lectin from Acropora tenuis in the process of Symbiodinium acquisition	FISHERIES SCIENCE			English	Article						N-acetyl-D-galactosamine; Acropora tenuis; Coral; Lectin; Symbiodinium; Symbiosis	HORSESHOE-CRAB; GENUS SYMBIODINIUM; BINDING LECTIN; CLIMATE-CHANGE; CORAL-REEFS; PROTEIN IDENTIFICATION; SCLERACTINIAN CORALS; MOLECULAR PHYLOGENY; INNATE IMMUNITY; SYMBIOSIS	Most reef-building corals in tropical and subtropical areas symbiose with microalgae from the genus Symbiodinium (dinoflagellate) and depend on the photosynthate produced by the microalgae. The majority of corals acquire Symbiodinium from the surrounding environment through horizontal transfer, but the molecular mechanisms involved in the acquisition of Symbiodinium remain unknown. It has been hypothesized that carbohydrate-binding proteins, or lectins, of the host coral recognize cell surface carbohydrates of Symbiodinium in the process of acquiring symbionts. Thus, we examined the molecular mechanisms involving lectins and carbohydrates using model organism Acropora tenuis, a common reef-building coral, and Symbiodinium culture strains. Juvenile polyps acquire more cells of Symbiodinium strain NBRC102920 at 72-96 h of metamorphosis induction than in any other period. Glycosidase treatment of Symbiodinium inhibited the acquisition of Symbiodinium by juvenile coral polyps. The presence of carbohydrates D-galactose, N-acetyl-D-galactosamine, and N-acetyl-D-glucosamine at 10 mM also tended to decrease Symbiodinium acquisition. We isolated two N-acetyl-D-galactosamine binding lectins with apparent molecular masses of 14.6 and 29.0 kDa from A. tenuis, and de novo sequencing and cDNA cloning showed that the 29.0 kDa protein is Tachylectin-2-like lectin (AtTL-2). The anti-Tachylectin-2 antibody is suggested to bind specifically to AtTL-2. The antibody also inhibited binding of AtTL-2 to N-acetyl-D-galactosamine-resin and the acquisition of Symbiodinium by juvenile A. tenuis polyps. Based on these results, AtTL-2 is likely involved in the process of Symbiodinium acquisition.	[Kuniya, Nami; Jimbo, Mitsuru; Tanimoto, Fumika; Yasumoto, Ko; Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Yamashita, Hiroshi] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Ishigaki, Okinawa 9070451, Japan; [Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima 7398528, Japan; [Harii, Saki; Nakano, Yoshikatsu] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Okinawa 9050227, Japan; [Iwao, Kenji] Akajima Marine Sci Lab, Okinawa 9803311, Japan	Jimbo, M (reprint author), Kitasato Univ, Sch Marine Biosci, Minami Ku, I-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	mjinbo@kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [10009069]	We are grateful to Dr. Shun-ichiro Kawabata, Department of Sciences, the University of Kyushu, for providing anti-Tachylectin-2 antibodies. We thank Dr. Go Suzuki, Seikai National Fisheries Research Institute, Fisheries Research Agency for collecting A. tenuis. This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to MJ [10009069].	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Logan DDK, 2010, J PHYCOL, V46, P525, DOI 10.1111/j.1529-8817.2010.00819.x; Harii S, 2007, MAR ECOL PROG SER, V346, P89, DOI 10.3354/meps07114; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; DAVIES PS, 1984, CORAL REEFS, V2, P181; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Berkelmans R, 2006, P R SOC B, V273, P2305, DOI 10.1098/rspb.2006.3567; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Beardsley RL, 2002, ANAL CHEM, V74, P1884, DOI 10.1021/ac015613o; Kawabata S, 1999, DEV COMP IMMUNOL, V23, P391, DOI 10.1016/S0145-305X(99)00019-1; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Bulgheresi S, 2006, APPL ENVIRON MICROB, V72, P2950, DOI 10.1128/AEM.72.4.2950-2956.2006; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Gross R, 2009, MOL MICROBIOL, V73, P751, DOI 10.1111/j.1365-2958.2009.06820.x; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Hirsch AM, 1999, CURR OPIN PLANT BIOL, V2, P320, DOI 10.1016/S1369-5266(99)80056-9; Pochon X, 2006, MOL PHYLOGENET EVOL, V38, P20, DOI 10.1016/j.ympev.2005.04.028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Hayashibara T, 2004, CORAL REEFS, V23, P406, DOI 10.1007/s00338-004-0406-x; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; Lin KL, 2000, ZOOL STUD, V39, P172; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Jimbo M, 2013, J EXP MAR BIOL ECOL, V439, P129, DOI 10.1016/j.jembe.2012.10.022; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Chen P, 2004, RAPID COMMUN MASS SP, V18, P191, DOI 10.1002/rcm.1280; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; FERNANDEZPATRON C, 1992, BIOTECHNIQUES, V12, P564; FITT WK, 1981, B MAR SCI, V31, P436; GOTO R, 1992, DEV COMP IMMUNOL, V16, P9, DOI 10.1016/0145-305X(92)90047-G; GotoNance R, 1996, FISHERIES SCI, V62, P297; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Jimbo M, 2010, FISHERIES SCI, V76, P355, DOI 10.1007/s12562-009-0204-z; KLJAJIC Z, 1987, EUR J BIOCHEM, V169, P97, DOI 10.1111/j.1432-1033.1987.tb13585.x; KOCH OM, 1982, IMMUNOBIOLOGY, V163, P53; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; MULLER WEG, 1983, MAR BIOL, V76, P1, DOI 10.1007/BF00393049; MULLER WEG, 1981, J BACTERIOL, V145, P548; Okino N, 1995, J BIOL CHEM, V270, P31008; Rodriguez-Lanetty M, 2001, MAR BIOL, V138, P1175; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174	60	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					473	483		10.1007/s12562-015-0862-y		11	Fisheries	Fisheries	CH7CV	WOS:000354194100007		
J	Katamachi, D; Ikeda, M; Uno, K				Katamachi, Daisuke; Ikeda, Minoru; Uno, Katsutoshi			Identification of spawning sites of the tiger puffer Takifugu rubripes in Nanao Bay, Japan, using DNA analysis	FISHERIES SCIENCE			English	Article						Takifugu rubripes; Spawning site; Species identification; Genetic analysis; Genetic variability; Population structure	TAGGING EXPERIMENTS; MITOCHONDRIAL-DNA; HOMING BEHAVIOR; MIGRATION; POPULATIONS; PREFECTURE; CHINENSIS; SEQUENCES; FISHERIES; ATLANTIC	There are two possible spawning sites of the tiger puffer Takifugu rubripes near Nanao Bay in the Sea of Japan: one near Hachiro Lagoon, approximately 390 km northeast of Nanao Bay, and another in Wakasa Bay, approximately 170 km west of Nanao Bay. Tagging research suggests that these two spawning sites represent different subpopulations. In the present study, Nanao Bay spawning sites were identified by mitochondrial DNA control region sequencing of eggs collected using a sledge net in May and June of 2009. The spawning sites were distributed in a small region with a sandy bottom at a depth of 17.5-20.5 m (water temperature 13.07-16.56 A degrees C, salinity 33.95-34.12). The population structure of T. rubripes around Nanao Bay was also investigated using DNA analysis of mature adult samples from three locations. Genetic differentiation was not significant among the adults, suggesting the presence of gene flow resulting from broad dispersal of individuals from the three locations.	[Katamachi, Daisuke] Fisheries Res Agcy, Stock Enhancement & Aquaculture Div, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 7390452, Japan; [Ikeda, Minoru] Tohoku Univ, Grad Sch Agr Sci, Lab Integrat Aquat Biol, Sendai, Miyagi 9818555, Japan; [Uno, Katsutoshi] Ishikawa Prefectural Inland Fisheries Stn, Kaga, Ishikawa 9220134, Japan	Katamachi, D (reprint author), Fisheries Res Agcy, Stock Enhancement & Aquaculture Div, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 7390452, Japan.	kata79@fra.affrc.go.jp			Ishikawa Prefecture, Japan; Fisheries Research Agency of Japan	We thank Dr. Fujii for constructive comments regarding the manuscript. This study was supported by grants from the Ishikawa Prefecture, Japan, and the Fisheries Research Agency of Japan.	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Smedbol RK, 2001, J FISH BIOL, V59, P109, DOI 10.1006/jfbi.2001.1765; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Frank KT, 2001, J SEA RES, V45, P173, DOI 10.1016/S1385-1101(01)00056-9; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Watanabe S, 2004, MAR BIOTECHNOL, V6, P566, DOI 10.1007/s10126-004-1000-5; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bui AOV, 2011, ICES J MAR SCI, V68, P911, DOI 10.1093/icesjms/fsr016; Fujita S, 1988, JAPANESE FISHERIES R; Fujita S, 1962, SPEC REP NAGASAKI PR, V2, P1; Harden Jones F. R., 1968, FISH MIGRATION; Hidaka T, 1988, B FUKUOKA FISH EXP S, V14, P1; Ito M, 1998, NIPPON SUISAN GAKK, V64, P645; Ito M, 1998, NIPPON SUISAN GAKK, V64, P435; Ito M, 1999, NIPPON SUISAN GAKK, V65, P175; Ito M, 1997, FISHERIES STOCK MANA, P28; Kamiya N, 1992, SAIBAI GIKEN, V20, P109; Katamachi D, 2013, MARINE FISHERIES STO, P1589; Kawakami T, 2010, ENVIRON BIOL FISH, V87, P221, DOI 10.1007/s10641-010-9592-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KUSAKABE DAIJIRO, 1962, JOUR FAC FISH AND ANIMAL HUSBANDRY HIROSHIMA UNIV, V4, P47; Matsubara K, 1955, FISH MORPHOLOGY HIER; Matsumura Y, 2006, NIPPON SUISAN GAKK, V72, P1029, DOI 10.2331/suisan.72.1029; Ahlstrom E.H., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P121; Nakabo T, 2002, FISHES JAPAN PICTORI, P1425; Nakajima H, 2005, NIPPON SUISAN GAKK, V71, P736, DOI 10.2331/suisan.71.736; Nakajima H, 2001, B MIE PREF FISH RES, V9, P1; Nei M., 1987, MOL EVOLUTIONARY GEN; Reza MS, 2008, FISHERIES SCI, V74, P743, DOI 10.1111/j.1444-2906.2008.01585.x; Reza MS, 2011, FISHERIES SCI, V77, P59, DOI 10.1007/s12562-010-0310-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sato R, 1999, NIPPON SUISAN GAKK, V65, P689; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.2307/2409495; Suzuki N, 2001, CLARIFICATION FACTOR, V369, P44; TAJIMA F, 1983, GENETICS, V105, P437	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					485	494		10.1007/s12562-015-0867-6		10	Fisheries	Fisheries	CH7CV	WOS:000354194100008		
J	Kamimura, Y; Takahashi, M; Yamashita, N; Watanabe, C; Kawabata, A				Kamimura, Yasuhiro; Takahashi, Masanori; Yamashita, Norio; Watanabe, Chikako; Kawabata, Atsushi			Larval and juvenile growth of chub mackerel Scomber japonicus in relation to recruitment in the western North Pacific	FISHERIES SCIENCE			English	Article						Chub mackerel; Growth; Larval stage duration; Otolith; Recruitment; Temperature	SEA-SURFACE TEMPERATURE; EGG-PRODUCTION METHOD; COPEPOD PRODUCTION; CLASS STRENGTH; FISH LARVAE; MARINE FISH; FLUCTUATIONS; MORTALITY; PREDATION; DYNAMICS	To detect indices of recruitment intensity of the Pacific stock of chub mackerel Scomber japonicus, the relationship between the growth rate during early life and recruitment variability and the effects of temperature on annual change of the growth rate were examined. Growth-trajectories in larval and juvenile stages were back-calculated by otolith microstructure analysis using juveniles collected in the Kuroshio-Oyashio transition region of the western North Pacific in May and June from 2002 to 2011. A total of 532 otoliths were analysed. Hatch dates were distributed from mid-March to mid-May and most chub mackerel hatched in April. Mean daily growth rates +/- A standard deviation (SD) of the April cohort in larval and juvenile stages ranged between 1.03 +/- 0.10 (2006) and 1.52 +/- 0.23 mm day(-1) (2009). The mean daily growth rate and larval stage duration were significantly related to recruitment which had been estimated by virtual population analysis. The results indicated the growth rate of the April cohort was an important index of year-class strength. There was a significant correlation between sea surface temperature experienced by each fish and the mean daily growth rate during the larval period. Higher water temperature led to faster growth and shorter larval stage duration of the April cohort of the Pacific stock of chub mackerel.	[Kamimura, Yasuhiro; Watanabe, Chikako; Kawabata, Atsushi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Takahashi, Masanori] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 7390452, Japan; [Yamashita, Norio] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido 0850802, Japan	Kamimura, Y (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	yasukami@affrc.go.jp			Fisheries Agency; FRA of Japan	We thank K. Mori and H. Nishida of the Fisheries Agency, S. Honda and H. Kubota of the Fisheries Research Agency of Japan (FRA), T. Kaga of the Hokkaido National Fisheries Research Institute, FRA, and members of the National Research Institute of Fisheries Science, FRA, for their help with fish sampling and otolith analyses. We are grateful to the captain, officers and crews of the training vessel Hokuho-Maru and the research vessel Soyo-Maru for helping with collection and measurement. We thank Japan Scientific Texts for English proofreading. Three anonymous reviewers provided valuable comments on the manuscript. This research was financially supported by the Fisheries Agency and FRA of Japan.	Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; HUNTER JR, 1980, FISH B-NOAA, V78, P89; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Kawai H, 2002, FISHERIES SCI, V68, P963, DOI 10.1046/j.1444-2906.2002.00520.x; Robert D, 2009, MAR ECOL PROG SER, V377, P227, DOI 10.3354/meps07833; Yatsu A, 2005, FISH OCEANOGR, V14, P263, DOI 10.1111/j.1365-2419.2005.00335.x; Watanabe C, 2004, FISH B-NOAA, V102, P196; Campana SE, 1996, MAR ECOL PROG SER, V135, P21, DOI 10.3354/meps135021; Sogard SM, 2011, B MAR SCI, V87, P857, DOI 10.5343/bms.2010.1045; Robert D, 2007, MAR ECOL PROG SER, V337, P209, DOI 10.3354/meps337209; CHAMBERS RC, 1987, CAN J FISH AQUAT SCI, V44, P1936, DOI 10.1139/f87-238; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; Fortier L, 1996, OCEANOGR LIT REV, V43, P1155; Gluyas-Millan MG, 1998, SCI MAR, V62, P225; Houde E.D., 1987, AM FISH SOC S, V2, P17; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Hwang SD, 2005, FISHERIES SCI, V71, P1185, DOI 10.1111/j.1444-2906.2005.01081.x; IIZUKA K, 1974, Bulletin of Tohoku National Fisheries Research Institute, V33, P37; Iizuka K, 1987, B TOHOKU REGIONAL FI, V49, P35; Iizuka K., 1974, Bulletin Tohoku reg Fish Res Lab, VNo. 34,1974, P1; Kawabata A., 2013, MARINE FISHERIES STO, P133; Kawasaki T., 1968, Bulletin of the Tokai Regional Fisheries Research Laboratory, VNo. 55, P59; Masuda R, 2002, FISHERIES SCI, V68, P320, DOI 10.1046/j.1444-2906.2002.00428.x; Mendiola D, 2009, AQUAC SCI, V57, P291; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Murayama Tsukasa, 1995, Bulletin of the Japanese Society of Fisheries Oceanography, V59, P11; Nakabo T., 2013, FISHES JAPAN PICTORI; Okabe Kyu, 2009, Bulletin of the Japanese Society of Fisheries Oceanography, V73, P1; Ringuette M, 2002, CAN J FISH AQUAT SCI, V59, P646, DOI 10.1139/F02-039; Robert D, 2010, FISHERIES SCI, V76, P183, DOI 10.1007/s12562-009-0205-y; Sanchez-Velasco Laura, 2000, Pacific Science, V54, P127; Sassa C, 2014, B JPN SOC FISH OCEAN, V78, P36; Shoji J, 2001, UJNR TECH REP, V30, P93; Shoji JI, 2005, J MAR BIOL ASSOC UK, V85, P1255, DOI 10.1017/S0025315405012403; Takahashi M, 2012, FISH BIOL OCEANOGR K, V13, P93; Takahashi M, 2014, FISHERIES SCI, V80, P293, DOI 10.1007/s12562-013-0698-2; Takasuka A, 2007, MAR ECOL PROG SER, V350, P99, DOI 10.3354/meps07158; Usami S., 1973, Bulletin Tolkai reg Fish Res Lab, VNo. 76, P71; Watanabe C, 1999, NIPPON SUISAN GAKK, V65, P695; Watanabe Chikako, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P46; Watanabe C, 2002, FISHERIES SCI, V68, P97; Watanabe T., 1970, Bull. Tokai reg. Fish. Res. Lab., VNo. 62, P1	43	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					505	513		10.1007/s12562-015-0869-4		9	Fisheries	Fisheries	CH7CV	WOS:000354194100010		
J	Aoki, K; Onitsuka, G; Shimizu, M; Kuroda, H; Matsuo, H; Kitadai, Y				Aoki, Kazuhiro; Onitsuka, Goh; Shimizu, Manabu; Kuroda, Hiroshi; Matsuo, Hitoshi; Kitadai, Yuuki			Interregional differences in mortality of aquacultured yellowtail Seriola quinqueradiata in relation to a Chattonella bloom in the Yatsushiro Sea, Japan, in 2010	FISHERIES SCIENCE			English	Article						Chattonella bloom; Seriola quinqueradiata; Mass mortality; Wind induced current; River plume; Yatsushiro Sea	DIEL VERTICAL MIGRATION; ANTIQUA BLOOM; SPATIOTEMPORAL DISTRIBUTION; RIVER PLUME; BAY; MODEL; TRANSPORT; SALINITY; DYNAMICS; BEHAVIOR	Mass mortality of Seriola quinqueradiata was caused by a Chattonella bloom in summer 2010 in the southern area of the Yatsushiro Sea. We analyzed the diurnal records of the mortality occurrence and cell density of C. marina to examine the short-term mortality dynamics. In addition, a hydrodynamic model and Lagrangian particle tracking method were used to examine interregional differences in the mortalities. Mortalities were concentrated along the southern coast of Shishi Island and western coast of Nagashima Island in early July. In late July, mortalities occurred along the southern coast of Shishi Island and eastern coast of Nagashima Island. Severe mortalities occurred where the bloom (> 100 cells ml(-1) of Chattonella marina) appeared in both early and late July. Model results show that interregional difference of the bloom was controlled by the advection system in the Yatsushiro Sea. The consistent spatio-temporal pattern between fish mortalities and bloom dynamics indicates the potential benefits of real-time monitoring of harmful algae and assessing factors controlling hydrographic conditions to mitigate mortalities.	[Aoki, Kazuhiro; Shimizu, Manabu] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Onitsuka, Goh] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima 2368648, Japan; [Kuroda, Hiroshi] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Kushiro, Hokkaido 0850802, Japan; [Matsuo, Hitoshi; Kitadai, Yuuki] Azuma Cho Fishery Cooperat Assoc, Nagashima, Kagoshima 8991401, Japan	Aoki, K (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	kazuaoki@affrc.go.jp			Fisheries Research Agency	The authors thank two anonymous reviewers for their useful comments on the manuscript. This study was partly supported by grants from Fisheries Research Agency. We used the supercomputer of Agriculture, Forestry and Fisheries Research Information Technology Center, Japan.	Agency Fisheries, 2011, RED TID KYUSH AR 201; Angles S, 2008, HARMFUL ALGAE, V7, P808, DOI 10.1016/j.hal.2008.04.004; Aoki K, 2012, ESTUAR COAST SHELF S, V114, P148, DOI 10.1016/j.ecss.2012.08.028; Watanabe M, 1995, LIMNOL OCEANOGR, V40, P1447; Onitsuka G, 2015, FISHERIES SCI, V81, P123, DOI 10.1007/s12562-014-0812-0; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; He RY, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004602; Katano T, 2014, MAR BIOL RES, V10, P1007, DOI 10.1080/17451000.2013.879987; Katano T, 2012, J OCEANOGR, V68, P497, DOI 10.1007/s10872-012-0112-1; Yannicelli B, 2006, J PLANKTON RES, V28, P19, DOI 10.1093/plankt/fbi098; Fauchot J, 2008, HARMFUL ALGAE, V7, P214, DOI 10.1016/j.hal.2007.08.002; Imai I, 2012, HARMFUL ALGAE, V14, P46, DOI 10.1016/j.hal.2011.10.014; Saito K, 2006, MON WEATHER REV, V134, P1266, DOI 10.1175/MWR3120.1; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; Onitsuka Goh, 2011, Bulletin of the Japanese Society of Fisheries Oceanography, V75, P143; Aoki K, 2014, MAR POLLUT BULL, V81, P131, DOI 10.1016/j.marpolbul.2014.02.005; Aoki Kazuhiro, 2012, Bulletin of the Japanese Society of Fisheries Oceanography, V76, P9; Govoni John J., 1994, Fisheries Oceanography, V3, P120, DOI 10.1111/j.1365-2419.1994.tb00054.x; Kuroki Y, 2004, B KUMAMOTO PREF FISH, V6, P69; Matsumoto K., 2000, J OCEANOGR, V56, P567, DOI DOI 10.1023/A:1011157212596; McGillicuddy D.J. Jr, 2008, P599; NAKAMURA Y, 1989, Journal of the Oceanographical Society of Japan, V45, P116, DOI 10.1007/BF02108885; Nishi H, 2012, B KAGOSHIMA PREFECTU, V4, P34; Okaichi T., 1997, SUSTAINABLE DEV SETO, P251; Onitsuka G, 2010, HARMFUL ALGAE, V9, P390, DOI 10.1016/j.hal.2010.01.006; Roegner GC, 2002, LIMNOL OCEANOGR, V47, P1033; Shikata T, 2013, J PLANKTON RES, V35, P542, DOI 10.1093/plankt/fbt006; Shikata Tomoyuki, 2014, Plankton & Benthos Research, V9, P42; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Takayama H, 1974, FISH PATHOL, V8, P119; Velo-Suarez L, 2010, J MARINE SYST, V83, P242; WATANABE M, 1991, LIMNOL OCEANOGR, V36, P593; Yanagi T, 1997, AKASHIO NO KAGAKU, P181	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					525	532		10.1007/s12562-015-0876-5		8	Fisheries	Fisheries	CH7CV	WOS:000354194100012		
J	Dao, HV; Phan, VB; Teng, ST; Uchida, H; Leaw, CP; Lim, PT; Suzuki, T; Pham, KX				Ha Viet Dao; Vy Bao Phan; Teng, Sing Tung; Uchida, Hajime; Leaw, Chui Pin; Lim, Po Teen; Suzuki, Toshiyuki; Ky Xuan Pham			Pseudo-nitzschia fukuyoi (Bacillariophyceae), a domoic acid-producing species from Nha Phu Bay, Khanh Hoa Province, Vietnam	FISHERIES SCIENCE			English	Article						Domoic acid; Amnesic shellfish toxin; Pseudo-nitzschia fukuyoi; Vietnam	SP-NOV BACILLARIOPHYCEAE; PSEUDODELICATISSIMA COMPLEX; MORPHOLOGY; PHYLOGENY; MALAYSIA; DIVERSITY; TOXICITY; MALACCA; STRAIT	Two strains of Pseudo-nitzschia fukuyoi isolated from Vietnamese waters produce domoic acid, a toxin responsible for amnesic shellfish poisoning. Species identification was based on detailed morphological observation using a transmission electron microscope and also molecular data on large subunit (LSU) and the second internal transcribed spacer (ITS2) with NCBI nucleotide Blast (blastn). Toxin productivity of the two strains was confirmed and their range were 3.85-4.54 pg/cell by analyses using LC-MS/MS. This is the first report of occurrence of P. fukuyoi in Vietnamese waters, and the first confirmation of productivity of domoic acid of the species.	[Ha Viet Dao; Vy Bao Phan; Ky Xuan Pham] Vietnam Acad Sci & Technol, Inst Oceanog, Nhatrang, Vietnam; [Teng, Sing Tung] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan 94300, Sarawak, Malaysia; [Uchida, Hajime; Suzuki, Toshiyuki] Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi 9850001, Japan; [Leaw, Chui Pin; Lim, Po Teen] Univ Malaya, Bachok Marine Res Stn, Inst Ocean & Earth Sci, Bachok 16310, Kelantan, Malaysia	Dao, HV (reprint author), Vietnam Acad Sci & Technol, Inst Oceanog, 01 Cau Da, Nhatrang, Vietnam.	daovietha69@gmail.com	Lim, Po Teen/C-9758-2013	Lim, Po Teen/0000-0003-2823-0564	 [106.99-2010.22-NAFOSTED]	This study was funded by project 106.99-2010.22-NAFOSTED, Vietnam. The authors wish to express the deep thank to Dr. Stephen S. Bates (Fisheries and Oceans Canada, Gulf Fisheries Centre, Canada) for the help to improve the manuscript, both in scientific ideas and English correction.	Amato A, 2008, PHYCOLOGIA, V47, P487, DOI 10.2216/07-92.1; Orive E, 2013, J PHYCOL, V49, P1192, DOI 10.1111/jpy.12130; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; BATES SS, 1991, CAN J FISH AQUAT SCI, V48, P1136; Teng ST, 2014, HARMFUL ALGAE, V34, P17, DOI 10.1016/j.hal.2014.02.005; Teng ST, 2013, BOT MAR, V56, P375, DOI 10.1515/bot-2012-0194; Fernandes LF, 2014, DEEP-SEA RES PT II, V103, P139, DOI 10.1016/j.dsr2.2013.06.022; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Bargu S, 2002, J FISHERIES AQUATIC, V19, P479; Dao VH, 2009, FISHERIES SCI, V75, P507; Dao VH, 2014, ASIAN FISH SCI, V27, P16; Doan NH, 2013, P INT C BIEN DONG 20, P159; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26; Lim HC, 2013, J PHYCOL, V49, P902, DOI 10.1111/jpy.12101; Lim HC, 2012, J PHYCOL, V48, P1232, DOI 10.1111/j.1529-8817.2012.01213.x; Lim H.C., 2010, J SCI TECHNOL TROPIC, V6, pS116; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; Skov J, 2004, OPERA BOT, V140, P23; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					533	539		10.1007/s12562-015-0864-9		7	Fisheries	Fisheries	CH7CV	WOS:000354194100013		
J	Funabara, D; Watabe, S; Kanoh, S				Funabara, Daisuke; Watabe, Shugo; Kanoh, Satoshi			Phosphorylation properties of twitchin from Yesso scallop catch and striated muscles	FISHERIES SCIENCE			English	Article						cAMP-dependent protein kinase; Catch contraction; Catch muscle; Phosphorylation; Striated muscle; Twitchin; Yesso scallop	CAENORHABDITIS-ELEGANS; SMOOTH-MUSCLE; PROTEIN; MYOSIN; SEQUENCE; COMPLEX; ACTIN	Molluscan smooth muscle exhibits a unique muscle contraction, called catch, where the tension is maintained for long periods with little energy consumption. Catch contraction is regulated by twitchin, also called mini-titin, a member of the titin/connectin family. Twitchin is also found in molluscan non-catch striated muscle. We isolated twitchins from catch and striated muscles in the Yesso scallop Mizuhopecten yessoensis. Both twitchins are -500 kDa in size. Western blotting using the anti-twitchin kinase domain antibody revealed that both twitchins have a kinase domain. Both twitchins were phosphorylated by the catalytic subunit of cAMP-dependent protein kinase in vitro. Stoichiometric analysis revealed that 0.6 and 1.7 mol Pi were incorporated into catch and striated muscle twitchins, respectively. Phosphopeptide mapping revealed that catch muscle twitchin has one phosphorylation site, whereas striated muscle twitchin has two. cDNA cloning gave partial sequences of two Yesso scallop twitchin isoforms. One had two putative phosphorylation sites and the other had one.	[Funabara, Daisuke; Kanoh, Satoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520313, Japan	Funabara, D (reprint author), Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan.	funabara@bio.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BENIAN GM, 1993, GENETICS, V134, P1097; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Funabara D, 2005, J MUSCLE RES CELL M, V26, P455, DOI 10.1007/s10974-005-9029-2; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2009, J BIOL CHEM, V284, P18015, DOI 10.1074/jbc.M109.016485; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; Kusaka M, 2008, FISHERIES SCI, V74, P677, DOI 10.1111/j.1444-2906.2008.01574.x; PROBST WC, 1994, P NATL ACAD SCI USA, V91, P8487, DOI 10.1073/pnas.91.18.8487; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Tsutsui Y, 2007, J MOL BIOL, V365, P325, DOI 10.1016/j.jmb.2006.10.006; VIBERT P, 1993, J MUSCLE RES CELL M, V14, P598, DOI 10.1007/BF00141557	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					541	550		10.1007/s12562-015-0866-7		10	Fisheries	Fisheries	CH7CV	WOS:000354194100014		
J	Sato, T; Ohgami, S; Kaneniwa, M				Sato, Taku; Ohgami, Shin-ichi; Kaneniwa, Masaki			Differences in compositions of free amino acids, nucleotide-related compounds, and fatty acids between sexes of the coconut crab Birgus latro in Okinawa, Southwest Japan	FISHERIES SCIENCE			English	Article						Birgus latro; Free amino acid; Nucleotide-related compound; Fatty acid; Taste active value; Equivalent umami concentration; Atherogenic index; Thrombogenic index	CHINESE MITTEN CRAB; TASTE-ACTIVE COMPONENTS; CORONARY-HEART-DISEASE; ERIOCHEIR-SINENSIS; SOUTHERN JAPAN; HATOMA ISLAND; EGG EXTRUSION; PREVENTION; SPERM; SIZE	Despite the dietary utilization of the coconut crab Birgus latro throughout history, little is known about its nutritional composition and quality. This study assessed the differences between male and female coconut crabs caught in Okinawa, southwest Japan, in meat yield and compositions of free amino acids (FAA), nucleotide-related compounds (NRC), and fatty acids in muscle and hepatopancreas. The ratios of edible muscle and hepatopancreas to whole body weight were similar in males and females. Although concentrations of histidine and tryptophan in muscle and AMP in hepatopancreas differed in males and females, these differences were small, as were taste activities and equivalent umami concentrations, suggesting that the tastes of these tissues in males and females would be nearly identical. Fatty acid composition in muscle differed lightly between the sexes, with amounts of the 20:5n-3 and 22:6n-3 being significantly greater in males. However, the ratio of n-3 to n-6 polyunsaturated fatty acids and atherogenic and thrombogenic indices suggested that all lipids from both males and females are healthy for humans. There were no noticeable differences between the sexes in meat yield; FAA, NRC and fatty acid compositions; or nutritional qualities.	[Sato, Taku] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Ishigaki, Okinawa 8991401, Japan; [Ohgami, Shin-ichi] Fisheries Res Agcy, Nishi Ku, Yokohama, Kanagawa 2206115, Japan; [Kaneniwa, Masaki] Natl Res Inst Fisheries Sci, Res Ctr Biochem & Food Technol, Yokohama, Kanagawa 2368648, Japan	Sato, T (reprint author), Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, 148-446 Fukaiota, Ishigaki, Okinawa 8991401, Japan.	takusato@affrc.go.jp; ohgami@fra.affrc.go.jp; mskknnw@affrc.go.jp			Department of Fisheries of Ishigaki City government	This work was financed by Department of Fisheries of Ishigaki City government, and was possible thanks to the generous hospitality and cooperation of the residents of Hatoma Island. We thank the anonymous reviewers and members of the Research Center for Subtropical Fisheries, Seikai National Fisheries Research Institute, for their helpful comments and discussion. We also thank the staff of Japan Food Research Laboratories who helped us with the nutritional analyses.	Ackman R.G., 1989, P103; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Cherif S, 2008, FOOD CHEM, V111, P930, DOI 10.1016/j.foodchem.2008.05.007; KATO H, 1989, ACS SYM SER, V388, P158; Fuke S, 1996, TRENDS FOOD SCI TECH, V7, P407, DOI 10.1016/S0924-2244(96)10042-X; Zimmermann F, 2013, ICES J MAR SCI, V70, P1389, DOI 10.1093/icesjms/fst121; Sato T, 2008, FISHERIES SCI, V74, P1277, DOI 10.1111/j.1444-2906.2008.01652.x; Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; KING I, 1990, J AM DIET ASSOC, V90, P677; Chen DW, 2007, FOOD CHEM, V104, P1200, DOI 10.1016/j.foodchem.2007.01.042; FUKE S, 1991, PHYSIOL BEHAV, V49, P863, DOI 10.1016/0031-9384(91)90195-T; DYERBERG J, 1986, NUTR REV, V44, P125; Harper CR, 2005, AM J CARDIOL, V96, P1521, DOI 10.1016/j.amjcard.2005.07.071; Celik M, 2004, FOOD CHEM, V88, P271, DOI 10.1016/j.foodchem.2004.01.038; Guo YR, 2014, FISHERIES SCI, V80, P621, DOI 10.1007/s12562-014-0738-6; Sato T, 2013, AQUAT BIOL, V19, P143, DOI 10.3354/ab00517; Barrento S, 2009, J AGR FOOD CHEM, V57, P10814, DOI 10.1021/jf9025597; Brown I.W., 1991, ACIAR MONOGRAPH, V8, P1; Buckup L, 2008, COMP BIOCHEM PHYS A, V149, P59, DOI 10.1016/j.cbpa.2007.10.008; CHAPELLE S, 1977, BIOCHEM SYST ECOL, V5, P241, DOI 10.1016/0305-1978(77)90010-2; FAO/WHO, 1994, 57 FAOWHO, P168; Fletcher WJ, 1993, NEARSHORE MARINE RES, P643; FUNATSU Y, 2004, MORE EFFICIENT UTILI, V42, P193, DOI 10.1016/S0167-4501(04)80021-9; HENRY RP, 1981, J EXP ZOOL, V218, P83, DOI 10.1002/jez.1402180110; Huggins A. K., 1968, Advances in Comparative Physiology and Biochemistry, V3, P271; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; KOMATA Y, 1990, Food Reviews International, V6, P457; KONOSU S, 1978, B JPN SOC SCI FISH, V44, P505; LAWRENCE J M, 1970, Crustaceana (Leiden), V19, P264, DOI 10.1163/156854070X00347; Mello LGS, 2005, ICES J MAR SCI, V62, P1006, DOI 10.1016/j.icesjms.2005.03.008; Roynette CE, 2004, CLIN NUTR, V23, P139, DOI 10.1016/j.clnu.2003.07.005; Sato T, 2010, AQUAT BIOL, V10, P23, DOI 10.3354/ab00263; Sato T, 2010, MAR ECOL PROG SER, V402, P171, DOI 10.3354/meps08369; Sato T, 2010, J CRUSTACEAN BIOL, V30, P624, DOI 10.1651/10-3279.1; Sato Taku, 2009, Marine Biodiversity Records, V2, pe37, DOI 10.1017/S1755267209000426; Sato T, 2008, J CRUSTACEAN BIOL, V28, P663, DOI 10.1651/07-2966.1; Sato Taku, 2013, Plankton & Benthos Research, V8, P49; Sato T, 2011, AQUAT BIOL, V13, P11, DOI 10.3354/ab00350; Sato T, 2009, FISHERIES SCI, V75, P641, DOI 10.1007/s12562-009-0093-1; Sikorski ZE, 2004, RESOURCES NUTR COMPO, P30; Suzuki T, 1996, SHIN SYOKUHIN BUNSEK, P493; Valfre F, 2008, VET RES COMMUN, V32, pS3, DOI 10.1007/s11259-008-9082-6; WATANABE K, 1990, J JPN SOC FOOD SCI, V37, P439; Wu XG, 2010, J FOOD COMPOS ANAL, V23, P154, DOI 10.1016/j.jfca.2009.08.007; YAMAGUCH.S, 1971, J FOOD SCI, V36, P846, DOI 10.1111/j.1365-2621.1971.tb15541.x	45	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					569	579		10.1007/s12562-015-0861-z		11	Fisheries	Fisheries	CH7CV	WOS:000354194100017		
J	Zhong, C; Nakanishi, M; Geng, JT; Okazaki, E; Cao, MJ; Weng, WY; Osako, K				Zhong, Chan; Nakanishi, Masayo; Geng, Jie-Ting; Okazaki, Emiko; Cao, Min-Jie; Weng, Wu-Yin; Osako, Kazufumi			Comparison of non-volatile taste-active components in fish sauce produced from lizardfish Saurida wanieso viscera under different conditions	FISHERIES SCIENCE			English	Article						Fish sauce; Lizardfish viscera; Endogenous proteases; Non-volatile taste components; Sensory evaluation	BY-PRODUCTS; MAILLARD REACTION; AMINO-ACID; FERMENTATION; PROTEINS; KINETICS; QUALITY; CAPELIN; SURIMI; FOOD	Lizardfish is a major ingredient for the manufacture of surimi in Japan, and its viscera are considered a novel source of protease to enhance protein autolysis. We investigated the non-volatile taste components of fish sauce produced from the lizardfish Saurida wanieso viscera in order to clarify the effects of fermentation conditions on the quality of fish sauce. Samples were fermented for 40 days under three sets of conditions: group 1, pH 7.0 and 60 A degrees C; group 2, pH 11.0 and 40 A degrees C; and group 3, uncontrolled pH and ambient temperature. Group 2 showed the highest concentration of umami amino acids (1,195.29 mg/100 ml) and sweet amino acids (2,033.60 mg/100 ml). High levels of lactic acid (1,219.65 mg/100 ml), acetic acid (367.08 mg/100 ml), and pyroglutamic acid (261.66 mg/100 ml) were also found in group 2. In addition, investigation of nucleic acid-related compounds revealed differences in the degree of nucleotide hydrolysis among the three groups during fermentation. Sensory evaluation showed that group 2 had the highest umami and the lowest bitterness, indicating that this group had the most preferable taste. These results reveal that fermentation under conditions optimal for endogenous proteases is beneficial for producing a product with optimal taste qualities.	[Zhong, Chan; Geng, Jie-Ting; Okazaki, Emiko; Osako, Kazufumi] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Cao, Min-Jie; Weng, Wu-Yin] Jimei Univ, Coll Biol Engn, Xiamen 361021, Peoples R China; [Nakanishi, Masayo] Miyazaki Prefectural Inst Fisheries, Miyazaki 8892162, Japan	Osako, K (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	osako@kaiyodai.ac.jp	OSAKO, Kazufumi/O-1978-2014				Akerberg C, 1998, APPL MICROBIOL BIOT, V49, P682, DOI 10.1007/s002530051232; Osako K, 2005, FISHERIES SCI, V71, P1347, DOI 10.1111/j.1444-2906.2005.01101.x; Hjalmarsson GH, 2007, FOOD CHEM, V103, P495, DOI 10.1016/j.foodchem.2006.08.029; Park JN, 2001, J FOOD COMPOS ANAL, V14, P113, DOI 10.1006/jfca.2000.0963; Klomklao S, 2006, FOOD CHEM, V98, P440, DOI 10.1016/j.foodchem.2005.06.013; PETRIELLA C, 1985, J FOOD SCI, V50, P622, DOI 10.1111/j.1365-2621.1985.tb13759.x; Shimoda M, 1996, J AGR FOOD CHEM, V44, P3601, DOI 10.1021/jf960345u; Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X; Jiang JJ, 2007, FOOD CHEM, V104, P1629, DOI 10.1016/j.foodchem.2007.03.024; Kwak EJ, 2004, AMINO ACIDS, V27, P85, DOI 10.1007/s00726-004-0067-7; MORRISSEY MT, 1993, J FOOD SCI, V58, P1050, DOI 10.1111/j.1365-2621.1993.tb06109.x; Lopetcharat K, 2002, J FOOD SCI, V67, P511, DOI 10.1111/j.1365-2621.2002.tb10628.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Kawai M, 2002, CHEM SENSES, V27, P739, DOI 10.1093/chemse/27.8.739; Liu Y, 2013, FOOD SCI TECHNOL RES, V19, P417; Gehring CK, 2011, FOOD CHEM, V124, P422, DOI 10.1016/j.foodchem.2010.06.078; Beddows C. G., 1979, J SCI FOOD AGR, V11, P379; Chaveesuk R, 1993, J AQUAT FOOD PROD T, V2, P59; Funatsu Y, 2001, J JAP SOC FOOD SCI, V49, P21; Gildberg A., 2004, Journal of Food Product Technology, V13, P3, DOI 10.1300/J030v13n02_02; Gildberg A, 2001, BIORESOURCE TECHNOL, V76, P119, DOI 10.1016/S0960-8524(00)00095-X; Gildberg A, 2001, J AQUAT FOOD PROD T, V10, P77; Ijong Frans Gruber, 1995, Lebensmittel-Wissenschaft and Technologie, V28, P236, DOI 10.1016/S0023-6438(95)91606-7; Je JY, 2005, FOOD CHEM, V91, P15, DOI 10.1016/j.foodchem.2004.05.061; Klomklao S, 2008, FOOD CHEM, V107, P213, DOI 10.1016/j.foodchem.2007.08.007; Thuy LTM, 2014, FOOD CHEM, V149, P264, DOI 10.1016/j.foodchem.2013.10.094; NISHIMURA T, 1988, Food Reviews International, V4, P175; NOGUCHI M, 1975, J AGR FOOD CHEM, V23, P49, DOI 10.1021/jf60197a003; OREJANA FM, 1982, J FOOD SCI, V47, P198, DOI 10.1111/j.1365-2621.1982.tb11058.x; Park JN, 2002, FISHERIES SCI, V68, P913, DOI 10.1046/j.1444-2906.2002.00510.x; RAKSAKULTHAI N, 1992, ASEAN Food Journal, V7, P86; Sun LC, 2013, FISHERIES SCI, V79, P537, DOI 10.1007/s12562-013-0625-6; Taira W, 2007, FISHERIES SCI, V73, P913, DOI 10.1111/j.1444-2906.2007.01414.x; Tungkawachara S, 2003, J FOOD SCI, V68, P855, DOI 10.1111/j.1365-2621.2003.tb08255.x; Uchida M, 2005, FISHERIES SCI, V71, P422, DOI 10.1111/j.1444-2906.2005.00980.x; Visessanguan W, 2004, MEAT SCI, V66, P579, DOI 10.1016/S0309-1740(03)00172-4; Xu W, 2008, FOOD CHEM, V107, P1597, DOI 10.1016/j.foodchem.2007.10.030; YAMASAKI Y, 1980, AGR BIOL CHEM TOKYO, V44, P93; Yasuhiro F, 2000, NIPPON SUISAN GAKK, V66, P1026; Zarei M, 2012, FOOD CONTROL, V23, P511, DOI 10.1016/j.foodcont.2011.08.023	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0919-9268	1444-2906		FISHERIES SCI	Fish. Sci.	MAY	2015	81	3					581	590		10.1007/s12562-015-0865-8		10	Fisheries	Fisheries	CH7CV	WOS:000354194100018		
J	Miyamoto, W; Takao, M; Matsui, K; Matsushita, T				Miyamoto, Wataru; Takao, Masato; Matsui, Kentaro; Matsushita, Takashi			Fixation for Avulsion Fracture of the Calcaneal Tuberosity Using a Side-Locking Loop Suture Technique and Anti-Slip Knot	FOOT & ANKLE INTERNATIONAL			English	Editorial Material						avulsion; calcaneal tuberosity; fracture; reef knot	TENDON; SURGERY; REPAIR		[Miyamoto, Wataru; Takao, Masato; Matsui, Kentaro; Matsushita, Takashi] Teikyo Univ, Dept Orthopaed Surg, Sch Med, Tokyo 1738605, Japan	Miyamoto, W (reprint author), Teikyo Univ, Dept Orthopaed Surg, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	miyamoto@med.teikyo-u.ac.jp					Greenhagen RM, 2012, J FOOT ANKLE SURG, V51, P123, DOI 10.1053/j.jfas.2011.09.006; Schepers T, 2008, ARCH ORTHOP TRAUM SU, V128, P1099, DOI 10.1007/s00402-007-0517-2; Beavis RC, 2008, FOOT ANKLE INT, V29, P863, DOI 10.3113/FAI.2008.0000; Gardner MJ, 2008, J ORTHOP TRAUMA, V22, P439, DOI 10.1097/BOT.0b013e31817ace7e; BIEHL WC, 1993, CLIN ORTHOP RELAT R, P8; Komatsu F, 2007, CLIN BIOMECH, V22, P112, DOI 10.1016/j.clinbiomech.2006.06.006; Squires B, 2001, J BONE JOINT SURG BR, V83B, P55, DOI 10.1302/0301-620X.83B1.11184; Banerjee R, 2011, J ORTHOP TRAUMA, V25, P685, DOI 10.1097/BOT.0b013e3181ffe61e; GREGOR RJ, 1987, INT J SPORTS MED, V8, P9; Hazen GE, 2007, FOOT ANKLE INT, V28, P1183; Imade S, 2013, J FOOT ANKLE SURG, V52, P553, DOI 10.1053/j.jfas.2013.03.036; Imade S, 2011, FOOT ANKLE INT, V32, P1012, DOI 10.3113/FAI.2011.1012; Lowery RBW, 1996, FOOT ANKLE INT, V17, P360; Nishimura K, 2009, CLIN BIOMECH, V24, P403, DOI 10.1016/j.clinbiomech.2009.01.013; Robb C. A., 2003, FOOT ANKLE SURG, V9, P221, DOI 10.1016/S1268-7731(03)00089-4; Yotsumoto T, 2010, AM J SPORT MED, V38, P287, DOI 10.1177/0363546509351557; Yotsumoto T, 2005, J ORTHOP SCI, V10, P515, DOI 10.1007/s00776-005-0929-1	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	MAY	2015	36	5					603	607		10.1177/1071100714565179		5	Orthopedics	Orthopedics	CH4BD	WOS:000353975000017		
J	Fang, YW; Yang, SS; Chau, T; Nakamura, M; Yamazaki, O; Seki, G; Yamada, H; Hsu, HM; Cheng, CJ; Lin, SH				Fang, Y-W; Yang, S-S; Chau, T.; Nakamura, M.; Yamazaki, O.; Seki, G.; Yamada, H.; Hsu, H-M; Cheng, C-J; Lin, S-H			Therapeutic effect of prenatal alkalization and PTC124 in Na+/ HCO3- cotransporter 1 p.W516*knock-in mice	GENE THERAPY			English	Article							RENAL TUBULAR-ACIDOSIS; NA+-HCO3-COTRANSPORTER; OCULAR ABNORMALITIES; FUNCTIONAL-ANALYSIS; METABOLIC-ACIDOSIS; NONSENSE MUTATION; MISSENSE MUTATION; MOLECULAR-BASIS; PRETERM LABOR; GENE SLC4A4	We created Na+/HCO3- cotransporter 1 (NBCe1) p.W516* knock-in mice as a model of isolated proximal renal tubular acidosis showing early lethality associated with severe metabolic acidosis to investigate the therapeutic effects of prenatal alkalization or posttranscriptional control 124 (PTC124). NBCe1(W516*/W516*) mice were treated with non-alkalization (control, n = 12), prenatal alkalization postcoitus (prenatal group, n = 7) and postnatal alkalization from postnatal day 6 (postnatal group, n = 12). Mutationspecific therapy, PTC124 (60 mg kg(-1)) or gentamicin (30 mg kg(-1)), was administered intraperitoneally from postnatal day 6. Blood and urine biochemistry, acid-base analysis, survival rate and renal histology were examined. NBCe1 protein, mRNA abundance and activity ex vivo were assessed after PTC124 and gentamicin treatment. Prenatal group mice had similar initial body weight to wildtype mice and achieved significant weight gain thereafter compared with controls. They had higher serum bicarbonate level (15.5 +/- 1.4 vs 5.5 +/- 0.1 mmol l(-1), P < 0.05) on postnatal day 14 and better renal function, histology and survival rates (60.8 +/- 23.5 vs 41.1 +/- 15.8 days, Po0.05) than the postnatal group. Compared with the control and gentamicin therapies, PTC124 therapy significantly increased NBCe1 protein abundance despite unchanged mRNA transcription. Only PTC124 therapy significantly increased survival rate and partially rescued NBCe1 activity ex vivo. In NBCe1(W516*/W516*) mice, prenatal alkali therapy achieved higher survival rates and ameliorated organ dysfunction. PTC124 therapy for this nonsense mutation was partially effective in increasing NBCe1 expression and activity.	[Fang, Y-W; Hsu, H-M] Shin Kong Wu Ho Mem Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Fang, Y-W; Yang, S-S; Cheng, C-J; Lin, S-H] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Yang, S-S; Cheng, C-J; Lin, S-H] Triserv Gen Hosp, Dept Med, Div Nephrol, Taipei 111, Taiwan; [Chau, T.] Providence St Vincent Med Ctr, Dept Med, Portland, OR USA; [Nakamura, M.; Yamazaki, O.; Seki, G.; Yamada, H.] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 113, Japan	Lin, SH (reprint author), Triserv Gen Hosp, Dept Med, Div Nephrol, 325 Cheng Kung Rd Sect 2,Neihu 114, Taipei 111, Taiwan.	l521116@ndmctsgh.edu.tw			Shin Kong Wu Ho-Su Memorial Hospital [SKH-8302-99-DR-07]; Tri-Service General Hospital, Taiwan, Republic of China [TSGH-C104-113]	We thank the Transgenic Mouse Model Core Facility of the National Research Program for Genomic Medicine, NSC for the technical services provided. This study was supported by grants from the Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-99-DR-07) and Tri-Service General Hospital, Taiwan, Republic of China (TSGH-C104-113).	Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009; Pedoto A, 1999, AM J RESP CRIT CARE, V159, P397; Bonnici B, 2004, PFLUG ARCH EUR J PHY, V448, P16, DOI 10.1007/s00424-003-1227-4; Baum M, 2003, CURR OPIN NEPHROL HY, V12, P521, DOI 10.1097/01.mnh.0000088731.87142.98; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; Schultheis PJ, 1998, NAT GENET, V19, P282; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Katzir Z, 2008, NEPHROL DIAL TRANSPL, V23, P1211, DOI 10.1093/ndt/gfm583; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Amlal H, 2001, KIDNEY INT, V60, P1824, DOI 10.1046/j.1523-1755.2001.00995.x; BAUM M, 1990, J CLIN INVEST, V85, P499, DOI 10.1172/JCI114465; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI [10.1164/rccm.201001-0137OC, 10.1164/rccm.201001.0137OC]; Demirci FYK, 2006, MOL VIS, V12, P324; Bailey JL, 2005, KIDNEY INT, V68, pS15; Bhat YR, 2011, ANN TROP PAEDIATR, V31, P153, DOI 10.1179/1465328111Y.0000000006; BLECHNER JN, 1975, AM J OBSTET GYNECOL, V121, P789; Bobrow CS, 1990, ARCH DIS CHILD-FETAL, V80, pF246; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347; DORR HG, 1993, J CLIN ENDOCR METAB, V76, P117, DOI 10.1210/jc.76.1.117; Gonzalez PK, 1997, SHOCK, V8, P108, DOI 10.1097/00024382-199708000-00008; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713; Kunimi M, 2000, KIDNEY INT, V57, P534, DOI 10.1046/j.1523-1755.2000.00873.x; Laing CM, 2005, INT J BIOCHEM CELL B, V37, P1151, DOI 10.1016/j.biocel.2005.01.002; Li Y, 2008, J AM SOC NEPHROL, V19, P252, DOI 10.1681/ASN.2007030289; Lo YF, 2011, KIDNEY INT, V79, P730, DOI 10.1038/ki.2010.523; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Suri Vanita, 2009, Indian J Med Sci, V63, P411, DOI 10.4103/0019-5359.56117; Suzuki M, 2008, PFLUG ARCH EUR J PHY, V455, P583, DOI 10.1007/s00424-007-0319-y; Usui T, 2001, J CLIN INVEST, V108, P107, DOI 10.1172/JCI11869; Usui T, 1999, PFLUG ARCH EUR J PHY, V438, P458, DOI 10.1007/s004240051062; Wen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097318	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAY	2015	22	5					374	381		10.1038/gt.2015.7		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CH5WK	WOS:000354106200003		
J	Zhen, S; Hua, L; Liu, YH; Gao, LC; Fu, J; Wan, DY; Dong, LH; Song, HF; Gao, X				Zhen, S.; Hua, L.; Liu, Y-H; Gao, L-C; Fu, J.; Wan, D-Y; Dong, L-H; Song, H-F; Gao, X.			Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus	GENE THERAPY			English	Article							CIRCULAR VIRAL-DNA; HEPATOCELLULAR-CARCINOMA; PLASMID DNA; X PROTEIN; GENOME; RNA; INFECTION; MICE; EFFICIENT; ENDONUCLEASE	The current therapies to treat hepatitis B virus (HBV) infection are limited. Recently, clustered regularly interspaced short palindromic repeat (CRISPR) systems, originally identified in bacteria and archaea, have been found to consist of an RNA-based adaptive immune system that degrades complimentary sequences of invading plasmids and viruses. Here, we studied the effects of the CRISPR/CRISPR-associated Cas9 system that was targeted to the surface antigen (HBsAg)-encoding region of HBV, both in a cell culture system and in vivo. The HBsAg levels in the media of the cells and in the sera of mice were analyzed by a quantitative enzyme-linked immunosorbent assay. The HBV DNA levels were assessed by quantitative PCR and HBsAg expression in mouse livers was assessed by an immunohistochemical assay. The amount of HBsAg secreted in the cell culture and mouse serum was reduced by CRISPR/Cas9 treatment. Immunohistochemistry analyses showed almost no HBsAg-positive cells in the liver tissue of CRISPR/Cas9-S1+X3-treated mice. The CRISPR/Cas9 system efficiently produced mutations in HBV DNA. Thus, CRISPR/Cas9 inhibits HBV replication and expression in vitro and in vivo and may constitute a new therapeutic strategy for HBV infection.	[Zhen, S.; Hua, L.; Liu, Y-H; Gao, L-C; Fu, J.; Wan, D-Y; Dong, L-H; Song, H-F; Gao, X.] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Zhen, S.] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China; [Zhen, S.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Hua, L.] Huazhong Agr Univ, Coll Vet Med, Lab Pharmacol & Toxicol, Wuhan, Peoples R China	Song, HF (reprint author), Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, 27 Taiping Rd, Beijing 100850, Peoples R China.	songhf259@163.com; gaox_amms@126.com			National Natural Science Foundation of China [81272701]	We thank Professor Linsheng Zhan and Professor Yusen Zhou for providing the plasmids; Professor Hui Zhong for help with the modification of the article; Ling-Zhen Li, Shao-Ming Guo and Cui-Li Zhu for their excellent technical assistance. This study was supported by grants from the National Natural Science Foundation of China (grant no. 81272701).	Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Dienstag JL, 2003, HEPATOLOGY, V37, P748, DOI 10.1053/jhep.2003.50117; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Tremblay JP, 2013, MOL THER, V21, P266, DOI 10.1038/mt.2013.4; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; ZOULIM F, 1994, J VIROL, V68, P2026; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Ying RS, 2007, ANTIVIR RES, V73, P24, DOI 10.1016/j.antiviral.2006.05.022; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Chen XC, 2004, VACCINE, V22, P439, DOI 10.1016/j.vaccine.2003.07.014; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Aiba Y, 2011, CHEM SOC REV, V40, P5657, DOI 10.1039/c1cs15039a; Yang WG, 1996, J VIROL, V70, P4567; Bloom K, 2013, AM SOC GENE CELL THE, V10, P1038; BRECHOT C, 1982, NEW ENGL J MED, V306, P1384, DOI 10.1056/NEJM198206103062302; Buti M, 2005, J CLIN VIROL, V34, pS79, DOI 10.1016/S1386-6532(05)80015-0; Cain C, 2013, SCIBX, P1; DEJEAN A, 1982, VIROLOGY, V121, P195, DOI 10.1016/0042-6822(82)90129-5; DELIUS H, 1983, J VIROL, V47, P337; Dolgin E, 2010, NAT MED, V16, P254, DOI 10.1038/nm0310-254; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ebina H, 2013, SCI REP, V10, P1038; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fujji W, 2013, PLOS ONE, V8; Gao LF, 2004, WORLD J GASTROENTERO, V10, P841; Hu W, 2014, P NATL ACAD SCI US, V21; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; LAU JYN, 1993, LANCET, V342, P1335; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P681; Li D, 2005, J MED VIROL, V76, P2003; Lin OS, 2001, ANNU REV MED, V52, P29, DOI 10.1146/annurev.med.52.1.29; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Schiffer JT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003131; Tillmann HL, 2007, WORLD J GASTROENTERO, V13, P125; Wain-Hobson S, 1981, Dev Biol Stand, V50, P293; WANDS JR, 1991, NEW ENGL J MED, V325, P729, DOI 10.1056/NEJM199109053251010; Wang H, 2013, CELL, V10, P1016; Xie HY, 2011, HEPATOB PANCREAT DIS, V10, P295	67	12	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAY	2015	22	5					404	412		10.1038/gt.2015.2		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CH5WK	WOS:000354106200006		
J	Suzuki, M; Kondo, S; Pei, Z; Maekawa, A; Saito, I; Kanegae, Y				Suzuki, M.; Kondo, S.; Pei, Z.; Maekawa, A.; Saito, I.; Kanegae, Y.			Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position	GENE THERAPY			English	Article							GENE-EXPRESSION; REPORTER GENE; VIRAL GENOME; EFFICIENT; PROMOTER; CONSTRUCTION; GENERATION; SYSTEM; CASSETTES; CLONING	The adenovirus vector (AdV) can carry two transgenes in its genome, the therapeutic gene and a reporter gene, for example. The E3 insertion site has often been used for the expression of the second transgene. A transgene can be inserted at six different sites/orientations: E1, E3 and E4 sites, and right and left orientations. However, the best combination of the insertion sites and orientations as for the titers and the expression levels has not sufficiently been studied. We attempted to construct 18 AdVs producing GFP or LacZ gene driven by the EF1a promoter and Cre gene driven by the a-fetoprotein promoter. The AdV containing GFP gene at E3 in the rightward orientation (GFP-E3R) was not available. The LacZ-E3R AdV showed 20-fold lower titer and 50-fold lower level of fiber mRNA than the control E1L AdV. Notably, we found four aberrantly spliced mRNAs in the LacZ-E3L/R AdVs, probably explaining their very low titers. Although the transgene expression levels in the E4R AdVs were about threefold lower than those in the E1L AdVs, their titers are comparable with that of E1L AdVs. We concluded that E1L and E4R sites/orientations are preferable for expressing the main target gene and a second gene, respectively.	[Suzuki, M.; Kondo, S.; Pei, Z.; Maekawa, A.; Saito, I.; Kanegae, Y.] Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo 1088639, Japan	Kanegae, Y (reprint author), Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kanegae@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Program for Intractable Disease Research utilizing Disease-specific iPS Cells from JST; Practical Research on Hepatitis B from Ministry of Health, Labour and Welfare of Japan [009]	We thank N Goda for research assistance and Ms T Shino for her secretarial assistance. This study was supported in part by Grants-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology to YK and SK; The Program for Intractable Disease Research utilizing Disease-specific iPS Cells from JST to YK; a grant for Practical Research on Hepatitis B (009) from the Ministry of Health, Labour and Welfare of Japan to IS.	WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cb.06.110190.003335; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Wold WSM, 2013, CURR GENE THER, V13, P421; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Shin SP, 2013, MOL THER, V21, P688, DOI 10.1038/mt.2012.252; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466; Danthinne X, 2000, GENE THER, V7, P1707, DOI 10.1038/sj.gt.3301301; Zhang GP, 2012, NUCL MED BIOL, V39, P1243, DOI 10.1016/j.nucmedbio.2012.06.010; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Fukuda H, 2006, MICROBIOL IMMUNOL, V50, P643; Gil JS, 2013, MOL IMAGING BIOL, V15, P273, DOI 10.1007/s11307-012-0596-5; Kanegae Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq966; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Maekawa A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01136; Mailly L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-73; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mizuguchi H, 2001, BIOTECHNIQUES, V30, P1112; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Nakai M, 2007, HUM GENE THER, V18, P925, DOI 10.1089/hum.2007.085; Nakano M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni074; Pei Z, 2012, BIOCHEM BIOPH RES CO, V417, P945, DOI 10.1016/j.bbrc.2011.12.016; Pei Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03575; Pham L, 2009, J GENE MED, V11, P197, DOI 10.1002/jgm.1289; Qin CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061911; SAITO I, 1985, J VIROL, V54, P711; Sambrook J, 2001, MOL CLONING LAB MANU; Sato Y, 1998, BIOCHEM BIOPH RES CO, V244, P455, DOI 10.1006/bbrc.1997.8087; Small JC, 2014, HUM GENE THER, V25, P328, DOI 10.1089/hum.2013.216; Suzuki T, 2011, VIRUS RES, V158, P154, DOI 10.1016/j.virusres.2011.03.026; Trujillo MA, 2010, GENE THER, V17, P1325, DOI 10.1038/gt.2010.63; Watanabe M, 2014, ONCOL LETT, V7, P595, DOI 10.3892/ol.2013.1777; Yankulov K, 2013, BIOCHEM CELL BIOL, V91, P6, DOI 10.1139/bcb-2012-0048	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	MAY	2015	22	5					421	429		10.1038/gt.2014.124		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CH5WK	WOS:000354106200008		
J	Bloom, T				Bloom, Tendayi			The Business of Migration Control: Delegating Migration Control Functions to Private Actors	GLOBAL POLICY			English	Article								Private companies are explicitly and implicitly, directly and indirectly, involved at all stages of the migration process. This delegation of migration control functions to private actors is largely unregulated and the multi-layered policy implications are not well understood. The lines of responsibility and accountability, but also liability, for decisions being made and for force used are not always clear and this most seriously affects vulnerable migrants and potential migrants. This delegation is occurring in some form in all global regions. International agreements relating to migration do not take this privatisation into account and international discussions about the obligations of private companies do not consider the Migration Business directly. This survey article presents the situation and argues that informed international policy debate is needed in this area.	United Nations Univ, Inst Globalizat Culture & Mobil UNU GCM, Tokyo, Japan	Bloom, T (reprint author), United Nations Univ, Inst Globalizat Culture & Mobil UNU GCM, Tokyo, Japan.						Amnesty International, 1997, NO FLIGHTS TO SAF; Bedford R, 2012, FOUNDATIONS OF INTERNATIONAL MIGRATION LAW, P17; Bloom T., 2013, 0204 UN U I GLOB CUL; Burke G., 2012, TIMES PICAYUNE  0802; Crepeau F., 2013, HIGH LEV DIAL PREP R; Crepeau F., 2013, AHRC2346 UNGS; CSC, 2009, BORD IMM SOL; Dummett A, 1990, SUBJECTS CITIZENS AL; Duvell F., 2011, EUROPEAN SECURITY CH; Flynn Michael, 2009, PRIVATIZATION IMMIGR; Gammeltoft-Hansen T., 2010, FORGOTTEN GENOCIDES, P55; Gammeltoft-Hansen T., 2011, ACCESS TO ASYLUM; Gammeltoft-Hansen T., 2013, MIGRATION IND COMMER, P128; White A, 2010, CRIME PREV SECUR MAN, P1, DOI 10.1057/9780230299290; Global Policy Interview, 2014, COMMUNICATION; Kell G., 1999, GOV PUBL DOM ER WASH; Kritzman-Amir T., 2011, LAW ETHICS HUMAN RIG, V5, P193; Lahav G., 2003, MIGRATION SECURITY; Lahav Gallya, 2000, IMMIGRATION RES NEW, P215; Lemberg-Pedersen M., 2013, MIGRATION IND COMMER, P152; Lipton Eric, 2013, NEW YORK TIMES  0524, pa1; MCDONALD DC, 1994, BRIT J CRIMINOL, V34, P29; Menz G., 2013, MIGRATION IND COMMER, P108; Menz G., 2009, POLITICAL EC MANAGED; Nyberg Sorensen N., 2013, MIGRATION IND COMMER, P1; Perruchoud R, 2012, FOUNDATIONS OF INTERNATIONAL MIGRATION LAW, P123; Pham H., 2007, PRIVATIZATION IMMIGR; Prosegur, 2012, PROS ANN REP 2012; Rodier Claire, 2006, ANAL EXTERNAL DIMENS; Salt J., 2001, INT MIGRATION 21 CEN, P86; Zolberg A, 1999, HDB INT MIGRATION AM, P71	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-5880	1758-5899		GLOB POLICY	Glob. Policy	MAY	2015	6	2					151	157		10.1111/1758-5899.12188		7	International Relations; Political Science	International Relations; Government & Law	CH4AH	WOS:000353972200007		
J	Takedani, H; Shima, M; Horikoshi, Y; Koyama, T; Fukutake, K; Kuwahara, M; Ishiguro, N				Takedani, H.; Shima, M.; Horikoshi, Y.; Koyama, T.; Fukutake, K.; Kuwahara, M.; Ishiguro, N.			Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan	HAEMOPHILIA			English	Article						continuous infusion; haemophilia with inhibitors; Japan; postmarketing surveillance; recombinant factor VIIa; surgery	CONTINUOUS-INFUSION; SURGERY; EFFICACY; RFVIIA; TRIAL	Patients with congenital haemophilia with inhibitors or acquired haemophilia are at risk of bleeding complications during surgery. In these patients, replacement therapy for the missing coagulation factor is ineffective, and a bypassing agent such as recombinant activated factor VII (rFVIIa) is required to manage bleeding. To evaluate the safety and haemostatic efficacy of rFVIIa treatment in Japanese patients with congenital haemophilia with inhibitors to FVIII/FIX or acquired haemophilia undergoing surgery. Postmarketing surveillance data from May 2000 to March 2010 were analysed to assess the haemostatic efficacy of 38 procedures in 22 patients with congenital haemophilia A, 13 procedures in seven patients with congenital haemophilia B, and five procedures in five patients with acquired haemophilia. Postoperative bleeding control was judged to be effective (bleeding was stopped completely or reduced considerably) for 34/38 procedures (89%) in patients with congenital haemophilia A, 10/13 procedures (77%) in patients with congenital haemophilia B, and 4/5 procedures (80%) in patients with acquired haemophilia. Tranexamic acid was used concomitantly for 36/56 procedures (64%). Safety was analysed for 66 procedures in 37 patients. Adverse effects potentially related to rFVIIa treatment included mild superficial thrombophlebitis, mild decrease in platelet count, and mild elevation of the serum alanine transaminase level in one patient each. All adverse effects resolved without treatment. Administration of rFVIIa provided adequate haemostasis without serious adverse effects in the majority of cases. The efficacy and safety data in Japanese patients were similar to previously published data from other countries.	[Takedani, H.] Univ Tokyo IMSUT, Hosp Inst Med Sci, Tokyo, Japan; [Shima, M.] Nara Med Univ, Kashihara, Nara 6348522, Japan; [Horikoshi, Y.] Shizuoka Childrens Hosp, Shizuoka, Japan; [Koyama, T.] Tokyo Med & Dent Univ, Tokyo, Japan; [Fukutake, K.] Tokyo Med Univ, Tokyo 1608402, Japan; [Kuwahara, M.] Novo Nordisk Pharma Ltd, Tokyo, Japan; [Ishiguro, N.] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan	Shima, M (reprint author), Nara Med Univ, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	mshima@naramed-u.ac.jp			Novo Nordisk Pharma Ltd.	This study was sponsored by Novo Nordisk Pharma Ltd. Medical writing and editorial support were provided by Dr. Marguerite Elgin and ELM-COM (TM), and was funded by Novo Nordisk Pharma Ltd. MK is an employee of Novo Nordisk Pharma Ltd., and HT, MS, YH and NI received consulting fees for an expert panel meeting for surgery sponsored by Novo Nordisk Pharma Ltd.	Ludlam CA, 2003, BRIT J HAEMATOL, V120, P808, DOI 10.1046/j.1365-2141.2003.04173.x; Valentino LA, 2011, HAEMOPHILIA, V17, P579, DOI 10.1111/j.1365-2516.2010.02460.x; HEDNER U, 1988, LANCET, V2, P1193; Berntorp E, 2006, HAEMOPHILIA, V12, P1, DOI 10.1111/j.1365-2516.2006.01359.x; Shapiro AD, 1998, THROMB HAEMOSTASIS, V80, P773; Lak M, 2010, CLIN APPL THROMB-HEM, V16, P294, DOI 10.1177/1076029608331227; Morfini M, 2007, HAEMOPHILIA, V13, P606, DOI 10.1111/j.1365-2516.2007.01518.x; Hedner U, 2008, THROMB HAEMOSTASIS, V100, P557, DOI 10.1160/TH08-07-0434; Hoffman M, 1998, BLOOD COAGUL FIBRIN, V9, pS61; Mauser-Bunschoten EP, 2002, HAEMOPHILIA, V8, P649, DOI 10.1046/j.1365-2516.2002.00667.x; Ministry of Health Labour and Welfare Japan, 2004, ORD STAND COND POSTM; Monroe DM, 2010, THROMB RES, V125, pS74, DOI 10.1016/j.thromres.2010.01.043; Nakamura Masanori, 2002, Rinsho Ketsueki, V43, P183; Notarnicola A, 2011, BLOOD COAGUL FIBRIN, V22, P436, DOI 10.1097/MBC.0b013e32834689fa; Pruthi RK, 2007, THROMB HAEMOSTASIS, V98, P726, DOI 10.1160/TH07-03-0198; Schulman S, 1998, BLOOD COAGUL FIBRI S, V9, P97; Smith MP, 2001, THROMB HAEMOSTASIS, V86, P949; Takedani H, 2010, HAEMOPHILIA, V16, P290, DOI 10.1111/j.1365-2516.2009.02149.x; Takedani H, 2004, HAEMOPHILIA, V10, P179, DOI 10.1111/j.1365-2516.2004.00784.x	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-8216	1365-2516		HAEMOPHILIA	Haemophilia	MAY	2015	21	3					374	379		10.1111/hae.12611		6	Hematology	Hematology	CH4TN	WOS:000354025900079		
J	Shimada, C; Akaishi, R; Cho, K; Morikawa, M; Kaneshi, Y; Yamda, T; Minakami, H				Shimada, Chisa; Akaishi, Rina; Cho, Kazutoshi; Morikawa, Mamoru; Kaneshi, Yosuke; Yamda, Takahiro; Minakami, Hisanori			Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review	HYPERTENSION RESEARCH			English	Review						adverse effect; angiotensin receptor antagonists; hypertension; pregnancy; sartan family	FETAL RENAL-FAILURE; CONVERTING ENZYME-INHIBITORS; VENA-CAVA THROMBOSIS; ANTAGONISTS; PREGNANCY; TOXICITY; LOSARTAN; TERATOGENICITY; CANDESARTAN; VALSARTAN	This literature review was conducted to provide better counsel to pregnant women who erroneously took angiotensin receptor blockers (ARBs) during the second and/or third trimesters regarding infant outcomes. Information was available on 83 fetuses in 34 literature reports, including one that we encountered recently. Fourteen pregnancies were terminated, and six were unknown regarding status of amniotic fluid volume (AFV). Fifty-eight and five fetuses did and did not show oligohydramnios, respectively, after being exposed to ARBs. Of the 58 fetuses that presented with oligohydramnios, 57 were exposed to ARBs at gestational week (GW). 20, and 19 exhibited resolution of oligohydramnios 1-6 weeks after cessation of ARBs. The 24 mothers without oligohydramnios at delivery ceased taking ARBs earlier (GW of 26.8 +/- 5.1 vs. 31.8 +/- 4.0, respectively, P=0.000) and had longer duration of gestation after cessation of ARBs (8.4 +/- 5.2 vs. 0.7 +/- 2.3 weeks, respectively, P=0.000). The mothers without oligohydramnios also had better outcomes in terms of favorable infant outcomes (63% (15/24) vs. 15% (6/39), respectively, P=0.000) and infant mortality rates (13% (3/24) vs. 56% (22/39), respectively, P=0.001) than the 39 with oligohydramnios. Thus, a favorable outcome may be feasible if the fetuses are not indicated for prompt delivery at presentation and exhibit normal AFV or resolution of oligohydramnios after cessation of ARBs. Although the prevalence rate of oligohydramnios was high in this study, it may have been due to publication bias. A prospective study suggested a lower prevalence rate than that reported in the present study.	[Shimada, Chisa; Akaishi, Rina; Cho, Kazutoshi; Morikawa, Mamoru; Kaneshi, Yosuke; Yamda, Takahiro; Minakami, Hisanori] Hokkaido Univ Hosp, Ctr Perinatal Med, Sapporo, Hokkaido 060, Japan	Cho, K (reprint author), Hokkaido Univ Hosp, Ctr Perinatal Med, Sapporo, Hokkaido 060, Japan.	chotarou@med.hokudai.ac.jp					Alwan S, 2005, BIRTH DEFECTS RES A, V73, P123, DOI 10.1002/bdra.20102; Bullo M, 2012, HYPERTENSION, V60, P444, DOI 10.1161/HYPERTENSIONAHA.112.196352; Oppermann M, 2013, BRIT J CLIN PHARMACO, V75, P822, DOI 10.1111/j.1365-2125.2012.04388.x; Karthikeyan VJ, 2011, J HYPERTENS, V29, P396, DOI 10.1097/HJH.0b013e328341885d; Schaefer C, 2003, BIRTH DEFECTS RES A, V67, P591, DOI 10.1002/bdra.10081; Miura K, 2009, PEDIATR NEPHROL, V24, P1235, DOI 10.1007/s00467-008-1091-8; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Diav-Citrin O, 2011, REPROD TOXICOL, V31, P540, DOI 10.1016/j.reprotox.2011.02.008; Bakkum JN, 2006, OBSTET GYNECOL, V108, P739, DOI 10.1097/01.AOG.0000187942.09107.08; Bald M, 2005, PEDIATR NEPHROL, V20, P1664, DOI 10.1007/s00467-005-1937-2; Bass JK, 2006, AM J PERINAT, V23, P313, DOI 10.1055/s-2006-947162; Berkane N, 2004, BIRTH DEFECTS RES A, V70, P547, DOI 10.1002/bdra.20047; Biswas PN, 2002, J HUM HYPERTENS, V16, P795, DOI 10.1038/sj.jhh.1001490; Boix E, 2005, J ENDOCRINOL INVEST, V28, P1029; Bos-Thompson MA, 2005, ANN PHARMACOTHER, V39, P157, DOI 10.1345/aph.1E250; Briggs GG, 2001, ANN PHARMACOTHER, V35, P859; Celentano C, 2008, PEDIATR NEPHROL, V23, P333, DOI 10.1007/s00467-007-0618-8; Chung NA, 2001, LANCET, V357, P1620, DOI 10.1016/S0140-6736(00)04759-0; Cox RM, 2003, BJOG-INT J OBSTET GY, V110, P1038, DOI 10.1111/j.1471-0528.2003.02139.x; Daikha-Dahmane F, 2006, PEDIATR NEPHROL, V21, P729, DOI 10.1007/s00467-006-0070-1; Esposito F, 2011, ARCH GYNECOL OBSTET, V284, P1321, DOI 10.1007/s00404-011-2027-2; Forhead AJ, 1996, BRIT J PHARMACOL, V119, P393; Georgaki-Angelaki Eleni, 2009, NDT Plus, V2, P295, DOI 10.1093/ndtplus/sfp045; Gersak K, 2009, REPROD TOXICOL, V28, P109, DOI 10.1016/j.reprotox.2009.02.004; GRONE HJ, 1992, AM J PHYSIOL, V262, pF326; Haaland K, 2010, J HEADACHE PAIN, V11, P167, DOI 10.1007/s10194-009-0182-7; Hasbun HJ, 2008, REV MED CHILE, V136, P624; Hinsberger A, 2001, LANCET, V357, P1620, DOI 10.1016/S0140-6736(00)04758-9; Hunseler C, 2011, KLIN PADIATR, V223, P10, DOI 10.1055/s-0030-1269895; Kato K, 2008, J OBSTET GYNAECOL RE, V34, P242, DOI 10.1111/j.1447-0756.2008.00762.x; Lambot MA, 2001, LANCET, V357, P1619, DOI 10.1016/S0140-6736(00)04757-7; Mann RD, 1999, J HUM HYPERTENS, V13, P551, DOI 10.1038/sj.jhh.1000880; Markfeld-Erol F, 2012, DEUT MED WOCHENSCHR, V137, P1297, DOI 10.1055/s-0032-1305063; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; Morgan M, 2011, J NURS MANAGE, V19, P305, DOI 10.1111/j.1365-2834.2011.01250.x; Munk PS, 2010, REPROD TOXICOL, V29, P381, DOI 10.1016/j.reprotox.2010.01.010; Nayar Bonilla, 2003, Indian Journal of Pediatrics, V70, P923, DOI 10.1007/BF02730601; Pietrement Christine, 2003, J Perinatol, V23, P254, DOI 10.1038/sj.jp.7210871; Porta M, 2011, DIABETOLOGIA, V54, P1298, DOI 10.1007/s00125-010-2040-1; Roger N, 2007, GYNECOL OBSTET FERTI, V35, P556, DOI 10.1016/j.gyobfe.2007.03.015; Sahay AS, 2014, HYPERTENS RES, V37, P753, DOI 10.1038/hr.2014.71; Saji H, 2001, LANCET, V357, P363, DOI 10.1016/S0140-6736(00)03648-5; Serreau R, 2005, BJOG-INT J OBSTET GY, V112, P710, DOI 10.1111/j.1471-0528.2004.00525.x; Simonetti GD, 2006, PEDIATR NEPHROL, V21, P1329, DOI 10.1007/s00467-006-0162-y; Sinelli M T, 2008, Pediatr Med Chir, V30, P306; Spaggiari E, 2012, PRENATAL DIAG, V32, P1071, DOI 10.1002/pd.3960; Velazquez-Armenta EY, 2007, HYPERTENS PREGNANCY, V26, P51, DOI 10.1080/10641950601147937; Vendemmia M, 2005, J MATERN-FETAL NEO M, V18, P137, DOI 10.1080/14767050500217244	48	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAY	2015	38	5					308	313		10.1038/hr.2015.12		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5IY	WOS:000354070200002		
J	Sawada, H; Naito, Y; Oboshi, M; Iwasaku, T; Okuhara, Y; Morisawa, D; Eguchi, A; Hirotani, S; Masuyama, T				Sawada, Hisashi; Naito, Yoshiro; Oboshi, Makiko; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Hirotani, Shinichi; Masuyama, Tohru			Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice	HYPERTENSION RESEARCH			English	Article						aldosterone; iron; renal injury; salt; transferrin receptor 1	CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; DEFICIENCY PROTECTS; RAT MODEL; FIBROSIS; DAMAGE; INFLAMMATION; EXPRESSION	Excess iron is associated with the pathogenesis of several renal diseases. Aldosterone is reported to have deleterious effects on the kidney, but there have been no reports of the role of iron in aldosterone/salt-induced renal injury. Therefore, we investigated the effects of dietary iron restriction on the development of hypertension and renal injury in aldosterone/salt-induced hypertensive mice. Ten-week-old male C57BL/6J mice were uninephrectomized and infused with aldosterone for four weeks. These were divided into two groups: one fed a high-salt diet (Aldo) and the other fed a high-salt with iron-restricted diet (Aldo-IR). Vehicle-infused mice without a uninephrectomy were also divided into two groups: one fed a normal diet (control) and the other fed an iron-restricted diet (IR) for 4 weeks. As compared with control and IR mice, Aldo mice showed an increase in both systolic blood pressure and urinary albumin/creatinine ratio, but these increases were reduced in the Aldo-IR group. In addition, renal histology revealed that Aldo mice exhibited glomerulosclerosis and tubulointerstitial fibrosis, whereas these changes were attenuated in Aldo-IR mice. Expression of intracellular iron transport protein transferrin receptor 1 was increased in the renal tubules of Aldo mice compared with control mice. Dietary iron restriction attenuated the development of hypertension and renal injury in aldosterone/salt-induced hypertensive mice.	[Sawada, Hisashi; Naito, Yoshiro; Oboshi, Makiko; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Hirotani, Shinichi; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan	Naito, Y (reprint author), Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			JSPS [25460919]; Takeda Science Foundation; Hyogo Science and Technology Association	We thank Noriko Kumon and Sachi Ito for their excellent technical support. This study was supported by a Grant-in-Aid for Graduate Students, Hyogo College of Medicine (to H Sawada). This study was also supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919) and grants from Takeda Science Foundation and Hyogo Science and Technology Association (to Y Naito).	QUAN ZY, 1992, KIDNEY INT, V41, P326, DOI 10.1038/ki.1992.45; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448; Lee TS, 1999, CIRCULATION, V99, P1222; Ribstein J, 2005, J AM SOC NEPHROL, V16, P1320, DOI 10.1681/ASN.2004100878; Bochud M, 2006, HYPERTENSION, V48, P239, DOI 10.1161/01.HYP.0000231338.41548.fc; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Chrysostomou A, 2001, NEW ENGL J MED, V345, P925, DOI 10.1056/NEJM200109203451215; Halimi JM, 1995, J HYPERTENS, V13, P1801; Nishiyama A, 2004, HYPERTENSION, V43, P841, DOI 10.1161/01.HYP.0000118519.66430.22; Doi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093513; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Ma J, 2006, KIDNEY INT, V69, P1064, DOI 10.1038/sj.ki.5000201; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580; Schreier B, 2011, HYPERTENS RES, V34, P623, DOI 10.1038/hr.2011.16; Suzuki J, 2012, HYPERTENS RES, V35, P312, DOI 10.1038/hr.2011.186; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x	25	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAY	2015	38	5					317	322		10.1038/hr.2015.13		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5IY	WOS:000354070200004		
J	Saji, N; Kimura, K; Yagita, Y; Kawarai, T; Shimizu, H; Kita, Y				Saji, Naoki; Kimura, Kazumi; Yagita, Yoshiki; Kawarai, Toshitaka; Shimizu, Hirotaka; Kita, Yasushi			Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle-brachial index, brachial-ankle pulse wave velocity and cardio-ankle vascular index	HYPERTENSION RESEARCH			English	Article						ankle-brachial index; arterial stiffness; cardio-ankle vascular index; pulse wave velocity; stroke	SMALL VESSEL DISEASE; INTIMA-MEDIA THICKNESS; SILENT BRAIN INFARCT; ARTERIAL STIFFNESS; CAROTID ATHEROSCLEROSIS; HYPERTENSIVE PATIENTS; ASSOCIATION; MORTALITY; METAANALYSIS; POPULATION	The ankle-brachial index (ABI), brachial-ankle pulse wave velocity (baPWV) and cardio-ankle vascular index (CAVI) are surrogate markers of arteriosclerosis. However, their roles in patients with acute ischemic stroke remain unclear. From October 2003 to September 2011, we enrolled patients with arteriosclerotic ischemic stroke (AIS) exhibiting large infarcts attributed to large-artery atherosclerosis (LAA) or deep subcortical infarcts (mainly lacunar infarcts) attributed to small-artery disease (SAD). Outpatients without a history of stroke served as controls (CTL). We divided the study period into two terms and assessed patients using two different oscillometric devices (Form PWV/ABI, Omron Colin; and VaSera VS-1500, Fukuda Denshi) in each term. One-way analysis of variance and age-and sex-adjusted analysis of covariance were used to compare the three groups. We analyzed 842 patients. The ABI was significantly lower in the LAA (n=102) group than in the SAD (n=280) and CTL (n=460) groups. The baPWV was significantly higher in the LAA and SAD groups than in the CTL group. The CAVI gradually increased in the order of CTL, SAD and LAA. The cutoff values of baPWV and CAVI for detection of AIS were 18.3ms -1 (odds ratio (OR): 6.09, 95% confidence interval (CI): 3.97-9.62, P<0.01) and 9.5 (OR: 1.44, 95% CI: 1.24-1.70, Po0.001), respectively. Among the three indicators, a lower ABI indicated advanced atherosclerosis associated with LAA, and an increased baPWV more closely indicated AIS. An increased CAVI may indicate the degree of vessel stiffness due to arteriosclerosis.		Saji, N (reprint author), Kawasaki Med Univ, Dept Stroke Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	sajink@nifty.com			Kawasaki Foundation for Medical Science and Medical Welfare; Japan Society for the Promotion of Science [26870765]	This study was partially funded by The Kawasaki Foundation for Medical Science and Medical Welfare. Dr Saji has received research grants from The Kawasaki Foundation for Medical Science and Medical Welfare and Grants-in-Aid for Scientific Research (No. 26870765) from the Japan Society for the Promotion of Science.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Saji N, 2012, STROKE, V43, P3088, DOI 10.1161/STROKEAHA.112.670737; Kim J, 2014, HYPERTENSION, V64, P240, DOI 10.1161/HYPERTENSIONAHA.114.03304; Zhang J, 2011, AM J HYPERTENS, V24, P304, DOI 10.1038/ajh.2010.246; Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599; Gronewold J, 2014, ATHEROSCLEROSIS, V233, P545, DOI 10.1016/j.atherosclerosis.2014.01.044; Suzuki J, 2013, J STROKE CEREBROVASC, V22, P171, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.010; Takaki A, 2008, HYPERTENS RES, V31, P1347, DOI 10.1291/hypres.31.1347; Horinaka S, 2009, ANGIOLOGY, V60, P468, DOI 10.1177/0003319708325443; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Wardlaw JM, 2010, J NEUROL SCI, V299, P66, DOI 10.1016/j.jns.2010.08.042; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Choi SY, 2013, J ATHEROSCLER THROMB, V20, P178; Saji N, 2011, J STROKE CEREBROVASC, V20, P231, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.005; Saji N, 2012, HYPERTENS RES, V35, P756, DOI 10.1038/hr.2012.20; HANDA N, 1995, STROKE, V26, P1781; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V211, P187, DOI 10.1016/j.atherosclerosis.2010.02.010; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Saji N, 2011, NEUROEPIDEMIOLOGY, V36, P252, DOI 10.1159/000328260; Saji N, 2012, INTERNAL MED, V51, P1003, DOI 10.2169/internalmedicine.51.6852; Kim DH, 2008, CLIN NEUROL NEUROSUR, V110, P599, DOI 10.1016/j.clineuro.2008.03.009; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; De Silva DA, 2009, J HYPERTENS, V27, P1453, DOI 10.1097/HJH.0b013e32832a8dc5; Hu HQ, 2013, HYPERTENS RES, V36, P334, DOI 10.1038/hr.2012.192; Isa K, 2013, HYPERTENS RES, V36, P980, DOI 10.1038/hr.2013.72; Kawai T, 2013, HYPERTENS RES, V36, P902, DOI 10.1038/hr.2013.61; Kim J, 2011, ATHEROSCLEROSIS, V219, P887, DOI 10.1016/j.atherosclerosis.2011.09.013; Kubota Y, 2011, ARTERY RES, V5, P91; Meves SH, 2010, CEREBROVASC DIS, V29, P546, DOI 10.1159/000306640; Ochi N, 2009, HYPERTENS RES, V32, P255, DOI 10.1038/hr.2009.13; Ohmine T, 2008, HYPERTENS RES, V31, P75, DOI 10.1291/hypres.31.75; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI 10.1016/j.atherosclerosis.2012.05.007; Sen S, 2009, STROKE, V40, P3472, DOI 10.1161/STROKEAHA.109.559278; Xie W, 2014, HYPERTENS RES, V37, P960, DOI 10.1038/hr.2014.93; Yamashina A, 2013, CIRC J IN PRESS	37	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAY	2015	38	5					323	328		10.1038/hr.2015.8		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5IY	WOS:000354070200005		
J	Rakugi, H; Tsuchihashi, T; Shimada, K; Numaguchi, H; Nishida, C; Yamaguchi, H; Shirakawa, M; Azuma, K; Fujita, KP				Rakugi, Hiromi; Tsuchihashi, Takuya; Shimada, Kazuyuki; Numaguchi, Hirotaka; Nishida, Chisato; Yamaguchi, Hiroya; Shirakawa, Masayoshi; Azuma, Kyoichi; Fujita, Kenji P.			Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg	HYPERTENSION RESEARCH			English	Article						amlodipine; hydrochlorothiazide; Japan; losartan	BLOOD-PRESSURE CONTROL; COMBINATION THERAPY; INFERENCE; SAFETY; RATES	This study assessed the antihypertensive efficacy of a triple combination, fixed-dose therapy of losartan 50 mg (L50)/hydrochlorothiazide 12.5 mg (H12.5)/amlodipine 5mg (A5) versus co-administration of L50 plus A5 (L50+A5) in Japanese subjects with uncontrolled essential hypertension. Initially, all subjects received single-blind treatment with L50+A5 for 8 weeks. Subjects whose blood pressure (BP) remained stable within pre-specified limits during the last 4 weeks of L50+A5 administration were randomized (n=327) to double-blind treatment with L50/H12.5/A5 or L50+A5 for 8 weeks. Primary and secondary efficacy endpoints were mean change from baseline to Week 8 in trough diastolic BP (DBP) and trough systolic BP (SBP), respectively. Safety was assessed throughout the study. The treatment difference for L50/H12.5/A5 versus L50+A5 in mean change from baseline in DBP at Week 8 was -1.1mmHg (95% confidence interval (CI) -2.7, 0.6; P=0.205). However, the treatment difference in mean change from baseline in SBP at Week 8 was -3.2 mmHg (95% CI: -5.7, -0.8; P=0.011). A chance imbalance in the change in DBP before randomization between groups was identified in a post-hoc analysis as a major reason for the smaller-than-expected difference in DBP between groups. The overall safety profile was generally similar between groups. In conclusion, treatment with L50/H12.5/A5 for 8 weeks did not demonstrate a significant difference in DBP reduction, but demonstrated a nominally significant difference in SBP reduction, compared with L50+A5. L50/H12.5/A5 was well tolerated.	[Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Tsuchihashi, Takuya] Steel Mem Yawata Hosp, Hypertens Ctr, Kitakyushu, Fukuoka, Japan; [Shimada, Kazuyuki] Shin Oyama City Hosp, Dept Internal Med & Cardiol, Oyama, Japan; [Numaguchi, Hirotaka; Nishida, Chisato; Yamaguchi, Hiroya; Shirakawa, Masayoshi; Azuma, Kyoichi] MSD KK, Tokyo, Japan; [Fujita, Kenji P.] Merck & Co Inc, Kenilworth, NJ USA	Rakugi, H (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka,B6, Suita, Osaka 5650871, Japan.	rakugi@geriat.med.osaka-u.ac.jp			Merck Sharp & Dohme K.K., Tokyo, Japan	P357 study investigators: S. Morikawa (Clinic Horikawa), Y. Ohashi (Medical Corporation Kouhoukai Tokyo Ekimae-building Clinic), M W Hwang (Koh Internal Medicine Clinic), S. Inoue (Heishinkai Medical Group Incorporated OCROMClinic), R. Yuyama (Rakusai Newtown Hospital), H. Oda (Oda Clinic), H. Konishi (Yamamoto Hospital), T. Shiraiwa (Shiraiwa medical clinic), S. Yano (Maebashi Hirosegawa Clinic), T. Hoshina (Hoshina Clinic Medical Corporation Keneikai), O. Matsuoka (Heishinkai Medical Group Incorporated ToCROM Clinic), T. Ogasawara (Medical Corporation Sai Tadayoshi Kai SAIKATSU CLINIC), Y. Noguchi (Noguchi Naika Clinic), K. Mizuyama (Doujin Memorial Foundation Meiwa Hospital), M. Saito (Kaijo Bldg. Clinic), T. Doi (Medical Corporation Sanshukai Doi Internal Medicine Clinic), H. Beppu (Medical Corporation Beppunaika Clinic), Y. Shimizu (Sapporo Higashi Tokushukai Hospital), Y. Tatsuoka (Tatsuoka Neurology Clinic), Y. Hayakawa (Medical Corporation Meiwa Hospital), M. Ozaki (Social Medical Corporation Reimei-Kai Kitade Hospital), M. Irahara (Irahara Clinic), N. Kusunose (Kusunose Surgery Clinic), T. Nakamura (Nakamuratadashi Naikajunkankika Clinic), T. Eguchi (Eguchi Clinic), Y. Nishi (NAGATA HOSPITAL), M. Tsujimoto (The Veritas Hospital), S. Kouno (Asunaro Naika Clinic), A. Yamauchi (Medical Care Law person corporation Rikeikai Suruga Clinic), S. Morizono (Morizono Medical Clinic). Medical writing and editorial assistance was provided by Melanie Jones of Prime Healthcare, Knutsford, Cheshire, UK. This assistance was funded by Merck & Co. Inc., Kenilworth, NJ, USA. We thank Mary E Hanson, PhD, of Merck & Co. Inc., Kenilworth, NJ, USA, for scientific input and assistance with writing and editorial support. Analysis of the study data and opinions, conclusions and interpretation of the data are the responsibility of the authors. We also thank William Malbecq, Kristel Vandormael and Rachid Massaad of MSD Belgium for providing statistical expertise; Emanuela Santoro of Merck & Co. Inc., Kenilworth, NJ, USA, for assistance with study conduct; Yoichi Inoue, MD, and Hiromi Iwata of MSD K.K. for assistance with conduct of the study; Sachiko Yoshimoto, MD, of MSD K.K. for assistance with study design and conduct; and the Primary Investigators for conduct of the study. The study was funded by Merck Sharp & Dohme K.K., Tokyo, Japan.	Ohta Y, 2005, HYPERTENS RES, V28, P953, DOI 10.1291/hypres.28.953; Mori H, 2006, HYPERTENS RES, V29, P143, DOI 10.1291/hypres.29.143; Panjabi S, 2013, J AM SOC HYPERTENS, V7, P46, DOI 10.1016/j.jash.2012.11.001; Neutel JM, 2013, CARDIOVASC THER, V31, P251, DOI 10.1111/1755-5922.12015; Erdine S, 2012, AM J CARDIOVASC DRUG, V12, P295, DOI 10.2165/11635450-000000000-00000; Robins JM, 2000, BIOMETRIKA, V87, P113, DOI 10.1093/biomet/87.1.113; Lu KF, 2009, STAT MED, V28, P679, DOI 10.1002/sim.3507; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; He J, 1999, J HYPERTENS, V17, pS7; Kita T, 2012, CLIN EXP HYPERTENS, V34, P498, DOI 10.3109/10641963.2012.666606; Liang KY, 2000, SANKHYA INDIAN J S B, V62, P134; Maeda K, 2012, INTERNAL MED, V51, P1167, DOI 10.2169/internalmedicine.51.6297; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Ohta Y, 2011, INTERNAL MED, V50, P2107, DOI 10.2169/internalmedicine.50.5321; Oshikawa J, 2013, CLIN EXP HYPERTENS, V36, P244; Oshikawa J, 2014, CLIN EXP HYPERTENS, V36, P244, DOI 10.3109/10641963.2013.810227; Rakugi H, 2014, CLIN EXP HYPERTENS, DOI [10.3109/10641963.2014.954712, DOI 10.3109/10641963.2014.954712).]; Sakima A, 2011, CLIN EXP HYPERTENS, V33, P309, DOI 10.3109/10641963.2010.549260; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Taylor AA, 2012, PATIENT PREFER ADHER, V6, P555, DOI 10.2147/PPA.S14764	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAY	2015	38	5					329	335		10.1038/hr.2015.3		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5IY	WOS:000354070200006		
J	Sugawara, R; Horinaka, S; Yagi, H; Ishimura, K; Honda, T				Sugawara, Rie; Horinaka, Shigeo; Yagi, Hiroshi; Ishimura, Kimihiko; Honda, Takeharu			Central blood pressure estimation by using N-point moving average method in the brachial pulse wave	HYPERTENSION RESEARCH			English	Article						brachial artery pressure waveform; central systolic blood pressure; cuff-based brachial blood pressure; N-point moving average method; pulse volume plethysmography	CENTRAL AORTIC PRESSURE; GENERALIZED TRANSFER-FUNCTION; SYSTOLIC PRESSURE; ARTERY TONOMETRY; FORM; VALIDATION; IMPEDANCE; HYPERTENSION; EXERCISE	Recently, a method of estimating the central systolic blood pressure (C-SBP) using an N-point moving average method in the radial or brachial artery waveform has been reported. Then, we investigated the relationship between the C-SBP estimated from the brachial artery pressure waveform using the N-point moving average method and the C-SBP measured invasively using a catheter. C-SBP using a N/6 moving average method from the scaled right brachial artery pressure waveforms using VaSera VS-1500 was calculated. This estimated C-SBP was compared with the invasively measured C-SBP within a few minutes. In 41 patients who underwent cardiac catheterization (mean age: 65 years), invasively measured C-SBP was significantly lower than right cuff-based brachial BP (138.2 +/- 26.3 vs 141.0 +/- 24.9 mm Hg, difference -2.78 +/- 1.36 mm Hg, P=0.048). The cuff-based SBP was significantly higher than invasive measured C-SBP in subjects with younger than 60 years old. However, the estimated C-SBP using a N/6 moving average method from the scaled right brachial artery pressure waveforms and the invasively measured C-SBP did not significantly differ (137.8 +/- 24.2 vs 138.2 +/- 26.3 mm Hg, difference -0.49 +/- 1.39, P=0.73). N/6-point moving average method using the non-invasively acquired brachial artery waveform calibrated by the cuff-based brachial SBP was an accurate, convenient and useful method for estimating C-SBP. Thus, C-SBP can be estimated simply by applying a regular arm cuff, which is greatly feasible in the practical medicine.	[Sugawara, Rie; Horinaka, Shigeo; Yagi, Hiroshi; Ishimura, Kimihiko; Honda, Takeharu] Dokkyo Med Univ, Dept Cardiol & Nephrol, Mibu, Tochigi 3210293, Japan	Horinaka, S (reprint author), Dokkyo Med Univ, Dept Cardiol & Nephrol, Mibu, Tochigi 3210293, Japan.	horinaka@dokkyomed.ac.jp					ALEXANDER J, 1989, AM J PHYSIOL, V257, pH969; Adji A, 2012, J HYPERTENS, V30, P1540, DOI 10.1097/HJH.0b013e328354e859; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; OBRIEN E, 1993, J HYPERTENS, V11, P677, DOI 10.1097/00004872-199306000-00013; Williams B, 2011, J AM COLL CARDIOL, V57, P951, DOI 10.1016/j.jacc.2010.09.054; COX RH, 1975, AM J PHYSIOL, V229, P1371; KELLY R, 1992, J AM COLL CARDIOL, V20, P952; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Chen CH, 1996, HYPERTENSION, V27, P168; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90; Hope SA, 2007, J HYPERTENS, V25, P1812, DOI 10.1097/HJH.0b013e328277595d; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; KROEKER EJ, 1956, J APPL PHYSIOL, V8, P483; TING CT, 1993, HYPERTENSION, V22, P839; KROEKER EJ, 1955, CIRC RES, V3, P623; Gallagher D, 2004, AM J HYPERTENS, V17, P1059, DOI 10.1016/j.amjhyper.2004.05.027; Sharman JE, 2006, HYPERTENSION, V47, P1203, DOI 10.1161/01.HYP.0000223013.60612.72; GARDNER RM, 1981, ANESTHESIOLOGY, V54, P227, DOI 10.1097/00000542-198103000-00010; NICHOLS WW, 1974, BIOMED ENG, V9, P58; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Chen CH, 1997, CIRCULATION, V95, P1827; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Verbeke F, 2005, HYPERTENSION, V46, P244, DOI 10.1161/01.HYP.0000166723.07809.7e; Shih YT, 2014, HYPERTENSION, V63, P865, DOI 10.1161/HYPERTENSIONAHA.113.02229; Hope SA, 2004, CLIN SCI, V107, P205; Association for the Advancement of Medical Instrumentation, 2009, AM NAT STAND EL AUT; FALSETTI HL, 1974, CIRCULATION, V49, P165; LATSON TW, 1988, CIRC RES, V62, P884; NICHOLS WW, 1974, CIRCULATION, V50, P198; Ochiai H, 1997, JPN HEART J, V38, P393; Weber T, 2014, HYPERTENSION, V63, P665, DOI 10.1161/HYPERTENSIONAHA.113.02885; Wohlfahrt P, 2014, AM J HYPERTENS, V27, P162, DOI 10.1093/ajh/hpt166	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	MAY	2015	38	5					336	341		10.1038/hr.2015.5		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CH5IY	WOS:000354070200007		
J	Hu, S; Kousai, S; Park, JS; Chlieh, OL; Wang, H				Hu, Song; Kousai, Shouhei; Park, Jong Seok; Chlieh, Outmane Lemtiri; Wang, Hua			Design of A Transformer-Based Reconfigurable Digital Polar Doherty Power Amplifier Fully Integrated in Bulk CMOS	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Antenna mismatch; CMOS integrated circuits; digital; Doherty power amplifier; efficiency; linearity; polar modulation; reconfigurable	ADAPTIVE BIAS CONTROL; 90 NM CMOS; BACK-OFF; EFFICIENCY ENHANCEMENT; ENVELOPE ELIMINATION; CONTROL-CIRCUIT; PREDISTORTION; RESTORATION; TECHNOLOGY; ARRAY	This paper presents a digital polar Doherty power amplifier (PA) fully integrated in a 65 nm bulk CMOS process. It achieves + 27.3 dBm peak output power and 32.5% peak PA drain efficiency at 3.82 GHz and 3.60 GHz, respectively. The proposed digital Doherty PA architecture optimizes the cooperation of the main and auxiliary amplifiers and achieves superior back-off efficiency enhancement (a maximum 47.9% improvement versus the corresponding Class-B operation). This digital intensive architecture also allows in-field PA reconfigurability which both provides robust PA operation against antenna mismatches and allows flexible trade-off optimization on PA efficiency and linearity. Transformer-based passives are employed as the Doherty input and output networks. The input 90 signal splitter is realized by a 6-port folded differential transformer structure. The active Doherty load modulation and power combining at the PA output are achieved by two transformers in a parallel configuration. These transformer-based passives ensure an ultra-compact PA design (2.1 mm) and broad bandwidth (24.9% for 1 dB P bandwidth). Measurement with 1 MSym/s QPSK signal shows 3.5% rms EVM with + 23.5 dBm average output power and 26.8% PA drain efficiency. Measurement with 16-QAM signal exhibits the PA's flexibility on optimizing efficiency and linearity.	[Hu, Song; Park, Jong Seok; Chlieh, Outmane Lemtiri; Wang, Hua] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30308 USA; [Kousai, Shouhei] Toshiba Co Ltd, Ctr Semicond R&D, Saiwai Ku, Kawasaki, Kanagawa 2128520, Japan	Hu, S (reprint author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30308 USA.	husong@gatech.edu; shouhei.kousai@toshiba.co.jp; hua.wang@ece.gatech.edu					Nam J, 2007, IEEE T MICROW THEORY, V55, P633, DOI 10.1109/TMTT.2007.892800; Staszewski RB, 2005, IEEE J SOLID-ST CIRC, V40, P2469, DOI 10.1109/JSSC.2005.857417; Haldi P, 2008, IEEE J SOLID-ST CIRC, V43, P1054, DOI 10.1109/JSSC.2008.920347; Doherty WH, 1936, P IRE, V24, P1163, DOI 10.1109/JRPROC.1936.228468; Kavousian A, 2008, IEEE J SOLID-ST CIRC, V43, P2251, DOI 10.1109/JSSC.2008.2004338; Long JR, 2000, IEEE J SOLID-ST CIRC, V35, P1368, DOI 10.1109/4.868049; Presti CD, 2009, IEEE J SOLID-ST CIRC, V44, P1883, DOI 10.1109/JSSC.2009.2020226; Kim J, 2011, IEEE T MICROW THEORY, V59, P425, DOI 10.1109/TMTT.2010.2086466; Kim J, 2005, IEEE T MICROW THEORY, V53, P1802, DOI 10.1109/TMTT.2005.847073; Chowdhury D, 2011, IEEE J SOLID-ST CIRC, V46, P1796, DOI 10.1109/JSSC.2011.2155790; Chowdhury D, 2012, IEEE J SOLID-ST CIRC, V47, P1113, DOI 10.1109/JSSC.2012.2185555; Ryu N, 2014, IEEE J SOLID-ST CIRC, V49, P1356, DOI 10.1109/JSSC.2014.2313561; Moloudi S, 2013, IEEE J SOLID-ST CIRC, V48, P1357, DOI 10.1109/JSSC.2013.2252522; Frye RC, 2003, IEEE J SOLID-ST CIRC, V38, P550, DOI 10.1109/JSSC.2002.808287; [Anonymous], 2007, P IEEE RF INT CIRC S; Grebennikov A, 2012, P IEEE, V100, P3190, DOI 10.1109/JPROC.2012.2211091; Zhu AD, 2008, IEEE T MICROW THEORY, V56, P2237, DOI 10.1109/TMTT.2008.2003529; [Anonymous], 2014, P IEEE RF INT CIRC S; Kaymaksut E, 2012, IEEE J SOLID-ST CIRC, V47, P1659, DOI 10.1109/JSSC.2012.2191334; Kang D, 2013, IEEE T MICROW THEORY, V61, P3763, DOI 10.1109/TMTT.2013.2280186; Wang H, 2010, IEEE J SOLID-ST CIRC, V45, P2709, DOI 10.1109/JSSC.2010.2077171; Liu G, 2008, IEEE J SOLID-ST CIRC, V43, P600, DOI 10.1109/JSSC.2007.916585; Walling JS, 2009, IEEE J SOLID-ST CIRC, V44, P2339, DOI 10.1109/JSSC.2009.2023191; Wu RL, 2013, IEEE J SOLID-ST CIRC, V48, P2030, DOI 10.1109/JSSC.2013.2265501; Kousai S, 2009, IEEE J SOLID-ST CIRC, V44, P3376, DOI 10.1109/JSSC.2009.2032271; Afsahi A, 2010, IEEE J SOLID-ST CIRC, V45, P955, DOI 10.1109/JSSC.2010.2041401; Reynaert P, 2005, IEEE J SOLID-ST CIRC, V40, P2598, DOI 10.1109/JSSC.2005.857425; Noh YS, 2004, IEEE J SOLID-ST CIRC, V39, P967, DOI 10.1109/JSSC.2004.827804; Aoki I, 2002, IEEE T MICROW THEORY, V50, P316, DOI 10.1109/22.981284; Xu HT, 2011, IEEE J SOLID-ST CIRC, V46, P1596, DOI 10.1109/JSSC.2011.2143930; KAHN LR, 1952, P IRE, V40, P803, DOI 10.1109/JRPROC.1952.273844; Chireix H, 1935, P IRE, V23, P1370, DOI 10.1109/JRPROC.1935.227299; Arno P., 2014, IEEE INT SOL STAT CI, P296; Cripps S., 2006, RF POWER AMPLIFIERS; Ding L., 2014, P IEEE RF INT CIRC S, P231; Elmala M, 2006, IEEE J SOLID-ST CIRC, V41, P1323, DOI [10.1109/JSSC.2006.874284, 10.1109/JSSC.2006.874294]; Gaber W. M., 2012, P ESSCIRC, P341; Golcuk F, 2013, IEEE T MICROW THEORY, V61, P3099, DOI 10.1109/TMTT.2013.2269293; Hassan M., 2013, ISSCC, P366; Hu S, 2015, IEEE T MICROW THEORY, V63, P580, DOI 10.1109/TMTT.2014.2385860; Kaymaksut E, 2013, IEEE T CIRCUITS-I, V60, P825, DOI 10.1109/TCSI.2012.2221223; Kaymaksut E., 2014, P RFIC JUN, P167; Kobayashi H, 2001, IEEE T MICROW THEORY, V49, P2480, DOI 10.1109/22.971639; Koo B., 2012, IEEE ISSCC, P82; Oishi K, 2014, IEEE J SOLID-ST CIRC, V49, P2915, DOI 10.1109/JSSC.2014.2358554; Onizuka K., 2012, IEEE S VLSI CIRC, P78; Onizuka Kohei, 2012, Proceedings of the 2012 IEEE Asian Solid State Circuits Conference (A-SSCC); Park J. S., 2013, P IEEE CUST INT CIRC; Razavi B., 2011, RF MICROELECTRONICS; SALEH AAM, 1983, IEEE T MICROW THEORY, V31, P51; Shi QX, 2013, IEEE ASIAN SOLID STA, P325; Su DK, 1998, IEEE J SOLID-ST CIRC, V33, P2252, DOI 10.1109/4.735710; Wang YJ, 2012, IEEE J SOLID-ST CIRC, V47, P1810, DOI 10.1109/JSSC.2012.2196314; Wongkomet N, 2006, IEEE J SOLID-ST CIRC, V41, P2852, DOI 10.1109/JSSC.2006.884832; Yoon YC, 2010, IEEE MICROW WIREL CO, V20, P619, DOI 10.1109/LMWC.2010.2068282; Zhao C, 2014, IET MICROW ANTENNA P, V8, P131, DOI 10.1049/iet-map.2013.0241	56	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	MAY	2015	50	5					1094	1106		10.1109/JSSC.2015.2415494		13	Engineering, Electrical & Electronic	Engineering	CH6ZW	WOS:000354186300003		
J	Ogiwara, R; Takashima, D; Doumae, S; Shiratake, S; Takizawa, R; Shiga, H				Ogiwara, Ryu; Takashima, Daisaburo; Doumae, Sumiko; Shiratake, Shinichiro; Takizawa, Ryousuke; Shiga, Hidehiro			Highly Reliable Reference Bitline Bias Designs for 64 Mb and 128 Mb Chain FeRAMs	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						BGR; ferroelectric memory; FeRAM; hysteresis; reference voltage; temperature	FRAM	This paper presents highly reliable reference bitline bias designs for 64 Mb and 128 Mb chain FeRAM (TM). The hysteresis shape deformation of ferroelectric capacitor due to temperature variation causes cell signal level shifts of both "1" and "0" data. The reference bitline bias of 64 Mb chip is designed to keep intermediate value of "1" and "0" data at any operating temperatures from -40 degrees C to 85 degrees C by introducing a modified band-gap reference circuit with 3 bit temperature coefficient trimmers and 6 bit digital-to-analog converter (DAC) using laser fuses. The measured result shows the improvement of tail-to-tail cell signal windows by +/- 22 mV. Moreover, a new reference bias circuit called the "elevator circuit" with 3 bit temperature coefficient trimmers using ferroelectric fuses installed in a 128 Mb chip compensates array operating voltage VAA fluctuation as well as temperature variation. The elevator circuit enables the temperature dependency control at low external VDD of 1.8 V. This improves cell signal window by +/- 40 mV. The elevator circuit also varies reference bitline bias with array operating voltage VAA variation, resulting in improvement of cell signal windows by +/- 44 mV in the range of 1.5 V +/- 0.2 V VAA.	[Ogiwara, Ryu; Takashima, Daisaburo; Doumae, Sumiko; Shiratake, Shinichiro; Takizawa, Ryousuke; Shiga, Hidehiro] Toshiba Co Ltd, Ctr Semicond R&D, Yokohama, Kanagawa, Japan	Ogiwara, R (reprint author), Toshiba Co Ltd, Ctr Semicond R&D, Yokohama, Kanagawa, Japan.						Hoya K, 2010, IEEE T VLSI SYST, V18, P1745, DOI 10.1109/TVLSI.2009.2034380; Banba H, 1999, IEEE J SOLID-ST CIRC, V34, P670, DOI 10.1109/4.760378; Hidaka O., 2006, S VLSI TECHN, P126; Kraus W., 1998, S VLSI CIRC, P242; Ogiwara R, 2000, IEEE J SOLID-ST CIRC, V35, P545, DOI 10.1109/4.839914; Ogiwara R., 2010, IEEE AS SOL STTA CIR, P377; Shiga Hidehiro, 2009, 2009 IEEE International Solid-State Circuits Conference (ISSCC 2009), DOI 10.1109/ISSCC.2009.4977509; Takashima D, 1998, IEEE J SOLID-ST CIRC, V33, P787, DOI 10.1109/4.668994; Takashima D, 2001, IEEE J SOLID-ST CIRC, V36, P1713, DOI 10.1109/4.962293; Takashima D, 2011, IEEE J SOLID-ST CIRC, V46, P530, DOI 10.1109/JSSC.2010.2091324; Takashima D., 2010, ISSC FEB, P262; Takashima D., 2009, FOR SSD MEM SUBSY IN	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	MAY	2015	50	5					1324	1331		10.1109/JSSC.2015.2405932		8	Engineering, Electrical & Electronic	Engineering	CH6ZW	WOS:000354186300022		
J	Shimizu, Y; Kittaka, Y; Nezu, A; Matsuura, H; Akatsuka, H				Shimizu, Yoshihiro; Kittaka, Yuusuke; Nezu, Atsushi; Matsuura, Haruaki; Akatsuka, Hiroshi			Excited State Distributions of Hydrogen Atoms in the Microwave Discharge Hydrogen Plasma and the Effect of Electron Energy Probabilistic Function	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Collisional-radiative (CR) model; electron energy probabilistic function (EEPF); low-pressure hydrogen plasma; number density of excited H atoms; plasma spectroscopy; the Boltzmann equation for EEPF	POPULATION-INVERSION; HELIUM PLASMA; RANGE	To understand the essentiality of the electron energy distribution function in a low-pressure discharge plasma, an experimental study is carried out on the diagnostics of microwave discharge hydrogen plasma with its discharge pressure similar to 1 torr in a cylindrical quartz tube. The electron kinetic temperature and density are measured by a Langmuir double probe. Number densities of electronically excited states of hydrogen atoms are experimentally examined by an optical emission spectroscopic (OES) measurement of line intensities of the Balmer series. The rotational and vibrational temperatures are observed for the Fulcher-alpha band spectrum of hydrogen molecule to understand the approximate value to the neutral gas temperature. The number density of the ground state of hydrogen atom is also experimentally estimated from the actinometry measurement. The electron energy probabilistic function (EEPF) is numerically calculated as a solution to the Boltzmann equation. Number densities of excited hydrogen atoms are calculated with the collisional-radiative (CR) model with experimentally measured data as input parameters. It is found that the population densities of excited states of hydrogen atoms become about one order or much larger than those determined by OES measurement if we assume Maxwellian EEPF. The CR model with the EEPF as a solution to the Boltzmann equation theoretically reproduce the experimentally measured values very well.	[Shimizu, Yoshihiro] Kobe Steel Ltd, Kobe, Hyogo 6518585, Japan; [Kittaka, Yuusuke] Cent Japan Railway Co, Nagoya, Aichi 4506101, Japan; [Nezu, Atsushi; Akatsuka, Hiroshi] Tokyo Inst Technol, Nucl Reactors Res Lab, Tokyo 1528550, Japan; [Matsuura, Haruaki] Tokyo City Univ, Dept Nucl Safety Engn, Tokyo 1588557, Japan	Shimizu, Y (reprint author), Kobe Steel Ltd, Kobe, Hyogo 6518585, Japan.	shimuzu.yoshihiro@kobelco.com; kitty0903@softbank.ne.jp; nezu.a.aa@m.titech.ac.jp; hmatuura@tcu.ac.jp; hakatsuk@nr.titech.ac.jp	Akatsuka, Hiroshi/G-3776-2014	Akatsuka, Hiroshi/0000-0002-3567-3833			AKATSUKA H, 1994, CONTRIB PLASM PHYS, V34, P539, DOI 10.1002/ctpp.2150340403; AKATSUKA H, 1995, PLASMA SOURCES SCI T, V4, P125, DOI 10.1088/0963-0252/4/1/013; VLCEK J, 1989, J PHYS D APPL PHYS, V22, P623, DOI 10.1088/0022-3727/22/5/009; JOHNSON LC, 1972, ASTROPHYS J, V174, P227, DOI 10.1086/151486; Lavrov BP, 2003, PLASMA SOURCES SCI T, V12, P576, DOI 10.1088/0963-0252/12/4/309; Ichikawa Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106101; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Sakamoto T, 2007, J APPL PHYS, V101, DOI 10.1063/1.2426975; CHANG RSF, 1978, J CHEM PHYS, V69, P3885, DOI 10.1063/1.437126; Fujimoto T. J., 2004, PLASMA SPECTROSCOPY; Hishikawa A., 2004, J PLASMA FUSION RES, V80, P742, DOI 10.1585/jspf.80.742; Kado S., 2004, J PLASMA FUSION RES, V80, P749, DOI 10.1585/jspf.80.749; Kado S., 2004, J PLASMA FUSION RES, V80, P783, DOI 10.1585/jspf.80.783; Kashiwazaki R, 2002, JPN J APPL PHYS 1, V41, P5432, DOI 10.1143/JJAP.41.5432; Koike S, 2004, JPN J APPL PHYS 1, V43, P5550, DOI 10.1143/JJAP.43.5550; KROGH O, 1986, J VAC SCI TECHNOL A, V4, P1796, DOI 10.1116/1.573941; Lieberman MA, 2005, PRINCIPLES OF PLASMA DISCHARGES AND MATERIALS PROCESSING, 2ND EDITION, P1; Lunk A., 2008, LOW TEMPERATURE PLAS, V2, P757; Meler U, 1986, CHEM PHYS LETT, V126, P567, DOI 10.1016/S0009-2614(86)80175-0; Mizuochi J, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.036001; Ochkin V. N., 2009, SPECTROSCOPY LOW TEM; Okada K, 1999, J VAC SCI TECHNOL A, V17, P721, DOI 10.1116/1.581691; Pospieszczyk A, 1999, J NUCL MATER, V266, P138, DOI 10.1016/S0022-3115(98)00660-6; RICARD A, 1988, CAN J PHYS, V66, P740; ROUSSEAU A, 1994, J PHYS D APPL PHYS, V27, P1412, DOI 10.1088/0022-3727/27/7/012; Sakamoto T, 2006, JPN J APPL PHYS 1, V45, P7905, DOI 10.1143/JJAP.45.7905; SAWADA K, 1993, J APPL PHYS, V73, P8122, DOI 10.1063/1.353930; SAWADA K, 1994, PHYS REV E, V49, P5565, DOI 10.1103/PhysRevE.49.5565; WAGNER F, 1982, PHYS REV LETT, V49, P1408, DOI 10.1103/PhysRevLett.49.1408; Wiese W. L., 1966, ATOMIC TRANSITION PR, V1	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	MAY	2015	43	5	2				1758	1768		10.1109/TPS.2015.2419224		11	Physics, Fluids & Plasmas	Physics	CH9RT	WOS:000354374600013		
J	Hirai, T; Kano, M				Hirai, Toshiya; Kano, Manabu			Adaptive Virtual Metrology Design for Semiconductor Dry Etching Process Through Locally Weighted Partial Least Squares	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Equipment engineering system (EES); just-in-time (JIT) modeling; locally weighted regression (LWR); semiconductor process; virtual metrology (VM)	REGRESSION; SELECTION; MODEL; PERFORMANCE; ALGORITHM; PLS	In semiconductor manufacturing processes, virtual metrology (VM) has been investigated as a promising tool to predict important characteristics of products. Although partial least squares (PLS) is a well-known modeling technique that can cope with collinearity and therefore applied to construction of VM, its prediction performance deteriorates due to changes in process characteristics. In particular, maintenance of equipment strongly affects the process characteristics and the prediction performance. In this paper, VM was developed by using locally weighted PLS (LW-PLS), which is a type of just-in-time modeling technique, and it was used to predict the etching conversion differential of an actual dry etching process. The industrial application results have shown that the developed VM based on LW-PLS is superior to the conventional VM based on the sequential update model and artificial neural network model. In particular, it has been confirmed that the LW-PLS-based VM can keep its high prediction performance even after the maintenance, i.e., replacement of parts.	[Hirai, Toshiya] Sony Semicond Corp, Kikuchi 8691102, Japan; [Kano, Manabu] Kyoto Univ, Dept Syst Sci, Kyoto 6068501, Japan	Hirai, T (reprint author), Sony Semicond Corp, Kikuchi 8691102, Japan.	toshiya.hirai@jp.sony.com		Kano, Manabu/0000-0002-2325-1043	Japan Society for the Promotion of Science [24560940]	This work was supported by the Japan Society for the Promotion of Science through Grant-in-Aid for Scientific Research (C) 24560940.	Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Cheng C, 2004, CHEM ENG SCI, V59, P2801, DOI 10.1016/j.ces.2004.04.020; Yao Y, 2009, ANNU REV CONTROL, V33, P172, DOI 10.1016/j.arcontrol.2009.08.001; Moyne J, 2004, SOLID STATE TECHNOL, V47, P47; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Atkeson CG, 1997, ARTIF INTELL REV, V11, P11, DOI 10.1023/A:1006559212014; Ge ZQ, 2008, CONTROL ENG PRACT, V16, P1427, DOI 10.1016/j.conengprac.2008.04.004; Kim S, 2013, IND ENG CHEM RES, V52, P12346, DOI 10.1021/ie303488m; Kim S, 2013, CHEMOMETR INTELL LAB, V124, P43, DOI 10.1016/j.chemolab.2013.03.008; Zeng DK, 2009, IEEE T SEMICONDUCT M, V22, P419, DOI 10.1109/TSM.2009.2031750; Fujiwara K, 2009, AICHE J, V55, P1754, DOI 10.1002/aic.11791; Maron O, 1997, ARTIF INTELL REV, V11, P193, DOI 10.1023/A:1006556606079; Khan AA, 2007, IEEE T SEMICONDUCT M, V20, P364, DOI 10.1109/TSM.2007.907609; Wu MF, 2008, IEEE T SEMICONDUCT M, V21, P413, DOI 10.1109/TSM.2008.2001218; Qin SJ, 2006, J PROCESS CONTR, V16, P179, DOI 10.1016/j.jprocont.2005.06.002; Kano M, 2010, J PROCESS CONTR, V20, P969, DOI 10.1016/j.jprocont.2010.06.013; [Anonymous], 2002, EQ ENG FUNCT GUID VE; Shigemori H, 2011, J PROCESS CONTR, V21, P293, DOI 10.1016/j.jprocont.2010.06.022; Lynn SA, 2012, IEEE T SEMICONDUCT M, V25, P94, DOI 10.1109/TSM.2011.2176759; Ringwood JV, 2010, IEEE T SEMICONDUCT M, V23, P87, DOI 10.1109/TSM.2009.2039250; Kim S, 2011, INT J PHARMACEUT, V421, P269, DOI 10.1016/j.ijpharm.2011.10.007; Kano M, 2013, J CHEM ENG JPN, V46, P1, DOI 10.1252/jcej.12we167; Nakagawa H, 2012, ANAL CHEM, V84, P3820, DOI 10.1021/ac202443a; Fujiwara K, 2010, CHEMOMETR INTELL LAB, V101, P130, DOI 10.1016/j.chemolab.2010.02.006; Birattari M, 1999, ADV NEUR IN, V11, P375; Bontempi G, 1999, INT J CONTROL, V72, P643, DOI 10.1080/002071799220830; Chang SY, 2001, APPL SPECTROSC, V55, P1199, DOI 10.1366/0003702011953207; Chen P., 2005, P 2005 IEEE INT S SE, P155; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Fukasawa M., 2008, P INT S DRY PROC DPS, P247; Kano M, 2008, COMPUT CHEM ENG, V32, P12, DOI 10.1016/j.compchemeng.2007.07.005; Kibler D., 1989, Computational Intelligence, V5, DOI 10.1111/j.1467-8640.1989.tb00315.x; Pan TH, 2011, IEEE T IND INFORM, V7, P187, DOI 10.1109/TII.2010.2098416; WANG ZY, 1994, ANAL CHEM, V66, P249, DOI 10.1021/ac00074a012; Wold S., 1993, 3D QSAR DRUG DESIGN, P523	36	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	MAY	2015	28	2					137	144		10.1109/TSM.2015.2409299		8	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CH7BA	WOS:000354189400002		
J	Kiuchi, H; Okada, T; Karatsu, K; Sekimoto, Y				Kiuchi, Hitoshi; Okada, Takashi; Karatsu, Kenichi; Sekimoto, Yutaro			A Frequency Sweeping Readout System for Kinetic Inductance Detectors Based on Submillimeter Radio Astronomy	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Digital signal processing (DSP); frequency modulation; radio astronomy; submillimeter-wave measurement; superconducting device	LARGE ARRAYS	We have been developing a superconductive detector array for terahertz astronomical observation using Microwave Kinetic Inductance Detector (MKID) technology. MKID is accomplished by making a strip of superconductor part of a microwave resonant circuit, and monitoring the phase and amplitude of a probe signal transmitted through the resonator. Frequency-domain multiplexing will allow up to thousands of resonators to be read out through a single line. We developed a 600-pixel 220 GHz detector array and a 102-pixel 440-GHz detector array. We have developed a new scheme readout system for the detector arrays, and which uses a frequency-sweeping probe signal instead of a fixed-frequency probe signal. This scheme enables us a direct measurement of the changed resonance frequency after optical loading.	[Kiuchi, Hitoshi; Okada, Takashi; Karatsu, Kenichi; Sekimoto, Yutaro] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Okada, Takashi; Sekimoto, Yutaro] Univ Tokyo, Dept Astron, Tokyo 113, Japan	Kiuchi, H (reprint author), Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan.	hitoshi.kiuchi@nao.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan, KAKENHI [21244023, 24111712, 25247022]	This work was supported in part by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science, and Technology, Japan, KAKENHI, under Grant 21244023, 24111712, and Grant 25247022. (Corresponding author: Hitoshi Kiuchi.)	Hazumi M, 2012, PROC SPIE, V8442, DOI 10.1117/12.926743; McHugh S, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3700812; Nitta T, 2013, IEEE T THZ SCI TECHN, V3, P56, DOI 10.1109/TTHZ.2012.2235123; Day PK, 2003, NATURE, V425, P817, DOI 10.1038/nature02037; de Visser PJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047004; Barends R., 2009, THESIS U DELFT DELFT; Baselmans J., 2011, IEEE CSC EUR SUP NEW; Bourrion O, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/07/P07014; Calvo M, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201219854; Duan R., 2014, THESIS CALTECH PASAD; Gao J., 2006, THESIS CALTECH PASAD; Janssen RMJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829657; Karatsu K, 2014, J LOW TEMP PHYS, V176, P459, DOI 10.1007/s10909-014-1115-7; Karatsu K., 2014, IEICE T C, VE98C, P207; Mazin BA, 2006, NUCL INSTRUM METH A, V559, P799, DOI 10.1016/j.nima.2005.12.208; Yates S. J. C., 2009, APPL PHYS LETT, V95; Yates SJC, 2009, AIP CONF PROC, V1185, P249, DOI 10.1063/1.3292325	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	MAY	2015	5	3			SI		456	463		10.1109/TTHZ.2015.2413751		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CH3AE	WOS:000353897000020		
J	Delfanazari, K; Asai, H; Tsujimoto, M; Kashiwagi, T; Kitamura, T; Yamamoto, T; Wilson, W; Klemm, RA; Hattori, T; Kadowaki, K				Delfanazari, Kaveh; Asai, Hidehiro; Tsujimoto, Manabu; Kashiwagi, Takanari; Kitamura, Takeo; Yamamoto, Takashi; Wilson, Wade; Klemm, Richard A.; Hattori, Toshiaki; Kadowaki, Kazuo			Effect of Bias Electrode Position on Terahertz Radiation From Pentagonal Mesas of Superconducting Bi2Sr2CaCu2O8+delta	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						AC-Josephson effect; cavity resonance; intrinsic Josephson junctions (IJJs); superconductor; terahertz (THz) emitter devices	INTRINSIC JOSEPHSON-JUNCTIONS; SINGLE-CRYSTALS; THZ RADIATION; EMISSION; COHERENT; POWER	We examined the effect of the bias current position on the radiation of intense and coherent terahertz electromagnetic waves from the intrinsic Josephson junctions (IJJs) in regular pentagonal mesas of single crystalline high-T-c superconducting Bi2Sr2CaCu2O8+delta. The emission from Sample 1, a mesa with a current bias feed on its middle, is strong and sharply peaked at 0.47 THz, whereas that from Sample 2, a mesa with its feed along an edge, shows a comparably strong, sharp peak at 0.43 THz. The common backbending in the current-voltage characteristics due to Joule heating was seen for Sample 1 but almost not for Sample 2. The experimental results are in good agreement with numerical simulations and calculations, both for the cavity resonances and the angular emission patterns. The resonance peaks obtained from these pentagonal mesas are both stronger and narrower than those found previously from differently shaped mesas fabricated by focused ion beam milling. The overall devices are small enough to be cooled to their operational temperatures by Stirling refrigerators, so that properly designed devices could be held in one hand as for laser pointers. Therefore, our IJJ-based emitter devices are promising candidates to fill the THz gap with compact, continuous-wave quantum solid-state sources.	[Delfanazari, Kaveh] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England; [Delfanazari, Kaveh] Univ Southampton, Ctr Photon Metamat, Southampton SO17 1BJ, Hants, England; [Asai, Hidehiro] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Tsujimoto, Manabu] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 615851, Japan; [Kashiwagi, Takanari; Kitamura, Takeo; Hattori, Toshiaki; Kadowaki, Kazuo] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Yamamoto, Takashi] Natl Inst Mat Sci, Wide Bandgap Mat Grp, Tsukuba, Ibaraki 3050044, Japan; [Wilson, Wade] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	Delfanazari, K (reprint author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	kd2n12@orc.soton.ac.uk					JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; MOCHIKU T, 1994, PHYSICA C, V235, P523, DOI 10.1016/0921-4534(94)91485-0; Kashiwagi T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.010113; Bras L, 2012, IEEE T ANTENN PROPAG, V60, P1634, DOI 10.1109/TAP.2011.2180339; Koshelev AE, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014530; An DY, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794072; Guenon S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214506; Sekimoto S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827094; Asai H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064521; Kitamura T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4902336; Tsujimoto M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037005; Klemm RA, 2010, J SUPERCOND NOV MAGN, V23, P613, DOI 10.1007/s10948-010-0719-7; Wang HB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.057002; Delfanazari K, 2013, OPT EXPRESS, V21, P2171, DOI 10.1364/OE.21.002171; Ji M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896684; Krasnov VM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174517; Savel'ev S, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/2/026501; KLEINER R, 1992, PHYS REV LETT, V68, P2394, DOI 10.1103/PhysRevLett.68.2394; Kadowaki K, 2013, PHYSICA C, V491, P2, DOI 10.1016/j.physc.2013.04.011; Tsujimoto M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107006; Kadowaki K, 2008, PHYSICA C, V468, P634, DOI 10.1016/j.physc.2007.11.090; Kashiwagi T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.094709; Benseman TM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064523; Kashiwagi T, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4914083; Lin SZ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247006; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Welp U, 2013, NAT PHOTONICS, V7, P702, DOI [10.1038/nphoton.2013.216, 10.1038/NPHOTON.2013.216]; Koshelev AE, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174509; Benseman TM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813536; CAO JL, 1986, IEEE T ANTENN PROPAG, V34, P103, DOI 10.1109/TAP.1986.1143734; Chen RS, 2000, MICROW OPT TECHN LET, V27, P125, DOI 10.1002/1098-2760(20001020)27:2<125::AID-MOP13>3.3.CO;2-U; Chen RS, 2001, MICROW OPT TECHN LET, V31, P115, DOI 10.1002/mop.1374; Delfanazari K, 2013, PHYSICA C, V491, P16, DOI 10.1016/j.physc.2012.12.009; Delfanazari K, 2014, J INFRARED MILLIM TE, V35, P131, DOI 10.1007/s10762-013-0027-y; Gross B, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094524; Hu X., 2009, PHYS REV B, V80; KENNEY CS, 1992, IEEE T ELECTROMAGN C, V34, P214, DOI 10.1109/15.155832; Klemm R. A., 2010, J PHYS CONDENS MATT, V22; Klemm R. A., DUAL SOURCE MO UNPUB; Klemm RA, 2013, PHYSICA C, V491, P30, DOI 10.1016/j.physc.2012.11.006; Li MY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060505; Minami H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054503; Morales M., MODELLING ANGU UNPUB; Ravelo B, 2010, Progress In Electromagnetics Research M, V12, DOI 10.2528/PIERM10030306; Shukrinov YM, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/12/124007; Tsujimoto M, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.044016; Turkoglu F, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/12/125004; Wang HB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017006; Watanabe C, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/17/172201; Watanabe C, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906768; Zheng Q., 2011, 2 INT C MECH AUT CON, P1076	51	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	MAY	2015	5	3			SI		505	511		10.1109/TTHZ.2015.2409552		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CH3AE	WOS:000353897000026		
J	Wang, P; He, M; Wu, H; Ji, M; Zhou, XJ; Zhao, XJ; Hatano, T; Wang, HB				Wang, Pei; He, Ming; Wu, Hao; Ji, Min; Zhou, Xianjing; Zhao, XinJie; Hatano, Takeshi; Wang, Huabing			Terahertz Waves Emission From Two Bi2Sr2CaCu2O8 Mesas in Series	IEEE TRANSACTIONS ON TERAHERTZ SCIENCE AND TECHNOLOGY			English	Article						Bi2Sr2CaCu2O8 mesas; intrinsic Josephson junction; self-heating; terahertz emission	INTRINSIC JOSEPHSON-JUNCTIONS; THZ RADIATION	The dependence of terahertz (THz) emission power on the thickness of series Bi2Sr2CaCu2O8 (BSCCO) mesas is studied in this letter. An intrinsic Josephson junction (IJJ) array with two BSCCO mesas in series is proposed. The current-voltage characteristics of the IJJs, the powers, and Fourier spectra of the THz emission are measured for different thicknesses of the mesas, which is gradually mounted by the argon ion beam milling. Experiment results indicate that the THz emission power grows as the thickness of the mesas is increasing. The power reaches a maximum value of about 0.502 mu W at a frequency of 0.708 THz when the thickness is 1200 nm. However, the THz emission power decreases while the thickness of the mesas keeps increasing. This nonlinearity between the THz emission power and the thickness of the mesas is due to the cavity resonance of the mesas and the self-heating generated by the IJJs in the mesas. The structure of connecting two mesas in series can be extended to form an IJJ array of multiple series mesas, which could further improve the THz emission power.	[Wang, Pei; He, Ming; Zhao, XinJie] Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin 300071, Peoples R China; [Wang, Pei] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Wang, Pei] Beijing Inst Radio Measurement, Beijing 100854, Peoples R China; [Wu, Hao] Wuhan Univ, Sch Phys & Technol, Wuhan 430072, Peoples R China; [Wu, Hao; Ji, Min; Zhou, Xianjing; Hatano, Takeshi; Wang, Huabing] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Ji, Min; Zhou, Xianjing; Hatano, Takeshi; Wang, Huabing] Nanjing Univ, Res Inst Supercond Elect, Nanjing 210093, Jiangsu, Peoples R China	He, M (reprint author), Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin 300071, Peoples R China.	nkpeiwang@hotmail.com; heming@nankai.edu.cn; h.wu@whu.edu.cn; min.ji.rise.nju@gmail.com; zhouxj136@gmail.com; zhaoxj@nankai.edu; hatano.takeshi@nims.go.jp; wang.huabing@nims.go.jp	Wu, Hao/H-2103-2012		NIMS Internship Program, National Natural Science Foundation of China [51002081, 61176119, 61171028, 61101018, 61471208, 11234006]; JSPS [25289108]	This work was supported by NIMS Internship Program, National Natural Science Foundation of China under Grants 51002081, 61176119, 61171028, 61101018, 61471208, and 11234006 and the Grants-in-Aid for scientific research from JSPS under Grant 25289108.	JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; An DY, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794072; Sekimoto S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4827094; Yurgens A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.184501; Kurter C, 2009, IEEE T APPL SUPERCON, V19, P428, DOI 10.1109/TASC.2009.2019235; Tsujimoto M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.037005; Asai H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868219; Savel'ev S, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/2/026501; KLEINER R, 1992, PHYS REV LETT, V68, P2394, DOI 10.1103/PhysRevLett.68.2394; Gross B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014524; Tsujimoto M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107006; Benseman TM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064523; Lin SZ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247006; Ozyuzer L, 2007, SCIENCE, V318, P1291, DOI 10.1126/science.1149802; Welp U, 2013, NAT PHOTONICS, V7, P702, DOI [10.1038/nphoton.2013.216, 10.1038/NPHOTON.2013.216]; Asai H, 2013, PHYSICA C, V494, P121, DOI 10.1016/j.physc.2013.04.058; Benseman TM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813536; Benseman TM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795591; Li MY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060505; Likharev K. K., 1986, DYNAMICS JOSEPHSON J; Minami H, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269996; Wang HB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017006; Wang H. B., 2010, PHYS REV LETT, V105; Wang HB, 2003, SUPERCOND SCI TECH, V16, P1375, DOI 10.1088/0953-2048/16/12/011; Wang HB, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.107002; Yuan J, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/7/075015; Yurgens A, 2010, PHYSICA C, V470, P818, DOI 10.1016/j.physc.2010.02.086	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-342X			IEEE T THZ SCI TECHN	IEEE Trans. Terahertz Sci. Technol.	MAY	2015	5	3			SI		512	517		10.1109/TTHZ.2015.2402571		6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CH3AE	WOS:000353897000027		
J	Tamura, K; Ikutani, M; Yoshida, T; Tanaka-Hayashi, A; Yanagibashi, T; Inoue, R; Nagai, Y; Adachi, Y; Miyawaki, T; Takatsu, K; Mori, H				Tamura, Kentaro; Ikutani, Masashi; Yoshida, Taketoshi; Tanaka-Hayashi, Ayumi; Yanagibashi, Tsutomu; Inoue, Ran; Nagai, Yoshinori; Adachi, Yuichi; Miyawaki, Toshio; Takatsu, Kiyoshi; Mori, Hisashi			Increased production of intestinal immunoglobulins in Syntenin-1-deficient mice	IMMUNOBIOLOGY			English	Article						Antibodies; B cells; Knockout mice; Mucosal immunity; Syntenin-1	INFLAMMATORY-BOWEL-DISEASE; HUMAN-MELANOMA CELLS; PROTEIN SYNTENIN-1; NEGATIVE REGULATOR; B-1 CELLS; B-CELLS; MDA-9/SYNTENIN; GENE; METASTASIS; ANTIBODIES	Syntenin-1 is an intracellular PDZ protein that binds multiple proteins and regulates protein trafficking, cancer metastasis, exosome production, synaptic formation, and IL-5 signaling. However, the functions of Syntenin-1 have not yet been clearly characterized in detail, especially in vivo. In this study, we generated a Synteriin-1 knock out (KO) mouse strain and analyzed the role(s) of Syntenin-1 in IL-5 signaling, because the direct interaction of Syntenin-1 with the cytoplasmic domain of the IL-5 receptor alpha subunit and the regulation of IL-5 signaling by Syntenin-1 have been reported. Unexpectedly, the number of IL-5-responding cells was normal and the levels of fecal immunoglobulins were rather higher in the Syntenin-1 KO mice. We also found that IgA and IgM production of splenic B cells stimulated in vitro was increased in Syntenin-1 KO mice. In addition, we showed that a distribution of intestinal microbial flora was influenced in Syntenin-1 KO mice. Our data indicate that Syntenin-1 negatively regulates the intestinal immunoglobulin production and has a function to maintain the intestinal homeostasis in vivo. The analysis of Syntenin-1 KO mice may provide novel information on not only mucosal immunity but also other functions of Syntenin-1 such as cancer metastasis and neural development. (C) 2014 The Authors. Published by Elsevier GmbH.	[Tamura, Kentaro; Yoshida, Taketoshi; Adachi, Yuichi; Miyawaki, Toshio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 9300152, Japan; [Tamura, Kentaro; Tanaka-Hayashi, Ayumi; Inoue, Ran; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300152, Japan; [Ikutani, Masashi; Yanagibashi, Tsutomu; Nagai, Yoshinori; Takatsu, Kiyoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Immunobiol & Pharmacol Genet, Toyama 9300152, Japan	Mori, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, 2630 Sugitani, Toyama 9300152, Japan.	mikutani@med.u-toyama.ac.jp; hmori@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22150003]	This work was supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 22150003). We thank the members of the Departments of Molecular Neuroscience, Immunobiology and Pharmacological Genetics, and Pediatrics of the University of Toyama for their cooperation and for their constructive comments on this study. We also thank Kanako Konno for technical assistance.	Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Sala-Valdes M, 2012, J CELL SCI, V125, P1235, DOI 10.1242/jcs.094912; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Sun BH, 2013, J IMMUNOL, V190, P2080, DOI 10.4049/jimmunol.1202736; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Moon BG, 2004, J IMMUNOL, V172, P6020; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hirbec H, 2005, MOL CELL NEUROSCI, V28, P737, DOI 10.1016/j.mcn.2004.12.005; Beekman JM, 2009, BLOOD, V114, P3917, DOI 10.1182/blood-2009-03-208850; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Estrach S, 2007, J CELL SCI, V120, P2944, DOI 10.1242/jcs.016253; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Chen F, 2008, CELL SIGNAL, V20, P666, DOI 10.1016/j.cellsig.2007.12.002; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Chimura T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-300; Das SK, 2012, FRONT BIOSCI-LANDMRK, V17, P1, DOI 10.2741/3911; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Gupta S, 2012, CIRC RES, V111, P1410, DOI 10.1161/CIRCRESAHA.112.264754; HELGELAND L, 1992, GUT, V33, P1358, DOI 10.1136/gut.33.10.1358; Hiroi T, 1999, J IMMUNOL, V162, P821; Horton RE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00200; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Jeon HY, 2013, J MOL HISTOL, V44, P159, DOI 10.1007/s10735-012-9468-1; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311; Saeland E, 2003, J IMMUNOL, V170, P6158; Sira MM, 2009, INT IMMUNOL, V21, P1013, DOI 10.1093/intimm/dxp067; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Thoree VC, 2002, GUT, V51, P44, DOI 10.1136/gut.51.1.44; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429	48	2	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	MAY	2015	220	5					597	604		10.1016/j.imbio.2014.12.003		8	Immunology	Immunology	CH7QA	WOS:000354230500007		
J	Kamiyama, T; Watanabe, H; Sueki, H				Kamiyama, Taisuke; Watanabe, Hideaki; Sueki, Hirohiko			Bullous eosinophilic cellulitis with subcorneal pustules	INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY			English	Letter									[Kamiyama, Taisuke; Watanabe, Hideaki; Sueki, Hirohiko] Showa Univ, Sch Med, Dept Dermatol, Tokyo 1428555, Japan	Watanabe, H (reprint author), Showa Univ, Sch Med, Dept Dermatol, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	hwatanabe@med.showa-u.ac.jp					Chao Sheau-Chiou, 2010, Dermatitis, V21, pE11; Takata T, 2009, J DERMATOL, V36, P551, DOI 10.1111/j.1346-8138.2009.00700.x; Yin G, 2012, RHEUMATOL INT, V32, P1087, DOI 10.1007/s00296-011-1809-y; YOUSEFI S, 1995, J IMMUNOL, V154, P5481; Zhu LB, 2011, INT J DERMATOL, V50, P1535, DOI 10.1111/j.1365-4632.2011.04898.x	5	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0378-6323	0973-3922		INDIAN J DERMATOL VE	Indian J. Dermatol. Venereol. Leprol.	MAY-JUN	2015	81	3					301	+		10.4103/0378-6323.154791		3	Dermatology	Dermatology	CH9TP	WOS:000354379600019		
J	Hayashi, H; Murakami, H; Demura, S; Kato, S; Kawahara, N; Tsuchiya, H				Hayashi, Hiroyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Kawahara, Norio; Tsuchiya, Hiroyuki			Outcome of posterior lumbar interbody fusion for L4-L5 degenerative spondylolisthesis	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						Degenerative spondylolisthesis; posterior lumbar interbody fusion; adjacent segment degeneration; spinal instrumentation	ADJACENT SEGMENT DEGENERATION; POSTEROLATERAL FUSION; PEDICLE SCREW; RISK-FACTORS; FIXATION; BALANCE; SPINE; BONE; PLIF	Background: Posterior lumbar interbody fusion (PLIF) has become the standard in the treatment for degenerative spondylolisthesis since improvement of spinal instrumentation However, few published studies have reported long term outcomes of PLIF using a same surgical procedure. The purpose of this study is to evaluate a long term outcome of PLIF using a same surgical procedure for L4-L5 degenerative spondylolisthesis. Materials and Methods: Out of 45 patients who underwent L4-L5 PLIF for degenerative spondylolisthesis between 1995 and 2003, 37 patients (16 males and 21 females) were evaluated in this study. Mean age was 61.8 years. The average followup period was 121 months. We evaluated % slip, lordosis at L4/L5, lumbar lordosis, Japanese Orthopedic Association's (JOA) score and adjacent segment degeneration. Results: The % slip significantly improved from an average of 17.0% before surgery to 9.7% at the last followup. Lordosis at L4/L5 averaged 3.6 degrees before surgery, 8.2 degrees after surgery and 6.9 degrees at the last followup. Although patients experienced some loss of correction at last followup, their lordosis at L4/L5 at last followup still was significantly different from their lordosis at L4/L5 before surgery. Lumbar lordosis did not significantly change. Mean JOA score was 13.4 before surgery and 24.5 at the last followup; mean recovery ratio was 71.2%. Adjacent segment degeneration occurred in 40.5% of patients, almost all of which occurred in the cranial adjacent segment. Three patients (8.1%) required reoperation due to adjacent segment degeneration, at an average of 76 months after their initial surgery. Conclusions: With more than 10-year followup after L4-L5 PLIF for degenerative spondylolisthesis, the adjacent segment degeneration occurred in 40.5% and reoperation was required in 8.1%.	[Hayashi, Hiroyuki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Kawahara, Norio] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan	Hayashi, H (reprint author), Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	snoopeanuts27@hotmail.com					Akamaru T, 2003, SPINE, V28, P1560, DOI 10.1097/00007632-200307150-00016; Greiner-Perth R, 2004, SPINE, V29, P2516, DOI 10.1097/01.brs.0000144833.63581.c1; Cheng L, 2009, INT ORTHOP, V33, P1043, DOI 10.1007/s00264-008-0588-x; Okuda S, 2004, SPINE, V29, P1535, DOI 10.1097/01.BRS.0000131417.93637.9D; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Cho KS, 2009, J KOREAN NEUROSURG S, V46, P425, DOI 10.3340/jkns.2009.46.5.425; Okuyama K, 2007, J SPINAL DISORD TECH, V20, P53, DOI 10.1097/01.bsd.0000211243.44706.2b; Kawakami M, 2002, SPINE, V27, P59, DOI 10.1097/00007632-200201010-00014; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; CLOWARD RB, 1953, J NEUROSURG, V10, P154, DOI 10.3171/jns.1953.10.2.0154; Cobb JR, 1948, INSTR COURSE LECT, V5, P261; Miwa T, 2013, EUR SPINE J, V22, P2864, DOI 10.1007/s00586-013-2863-9; Ohwada T, 2008, SPINAL CORD, V21, P461; Patil SS, 2011, INDIAN J ORTHOP, V45, P500, DOI 10.4103/0019-5413.87117; ROYCAMILLE R, 1986, CLIN ORTHOP RELAT R, P7; Sakaura Hironobu, 2013, Global Spine J, V3, P219, DOI 10.1055/s-0033-1348088; Steffee A D, 1988, Clin Orthop Relat Res, V227, P99; TAILLARD WF, 1976, CLIN ORTHOP RELAT R, P30; Van Horn J R, 1992, Acta Orthop Belg, V58, P280; Wang YT, 2014, J CLIN NEUROSCI, V21, P287, DOI 10.1016/j.jocn.2013.04.039; Ye YP, 2013, ARCH ORTHOP TRAUM SU, V133, P1649, DOI 10.1007/s00402-013-1868-5	21	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	MAY-JUN	2015	49	3					284	288		10.4103/0019-5413.156188		5	Orthopedics	Orthopedics	CH9WA	WOS:000354385900004		
J	Huang, EY; Inoue, T; Leone, VA; Dalal, S; Touw, K; Wang, YW; Musch, MW; Theriault, B; Higuchi, K; Donovan, S; Gilbert, J; Chang, EB				Huang, Edmond Y.; Inoue, Takuya; Leone, Vanessa A.; Dalal, Sushila; Touw, Ketrija; Wang, Yunwei; Musch, Mark W.; Theriault, Betty; Higuchi, Kazuhide; Donovan, Sharon; Gilbert, Jack; Chang, Eugene B.			Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases	INFLAMMATORY BOWEL DISEASES			English	Article						animal models of IBD; inflammation in IBD; microbiology of IBD; steroids in IBD	NF-KAPPA-B; ULCERATIVE-COLITIS; IMMUNE-SYSTEM; MICE; MUCIN; BACTERIA; COLON; OBESITY; GLUCOCORTICOIDS; DEXAMETHASONE	Background:Commensal gut microbiota play an important role in regulating metabolic and inflammatory conditions. Reshaping intestinal microbiota through pharmacologic means may be a viable treatment option. We sought to delineate the functional characteristics of glucocorticoid-mediated alterations on gut microbiota and their subsequent repercussions on host mucin regulation and colonic inflammation.Methods:Adult male C57Bl/6 mice, germ-free, Muc2-heterozygote (), or Muc2-knockout (-/-) were injected with dexamethasone, a synthetic glucocorticoid, for 4 weeks. Fecal samples were collected for gut microbiota analysis through 16S rRNA terminal restriction fragment length polymorphism and amplicon sequencing. Intestinal mucosa was collected for mucin gene expression studies. Germ-free mice were conventionalized with gut microbes from treated and nontreated groups to determine their functional capacities in recipient hosts.Results:Exposure to dexamethasone in wild-type mice led to substantial shifts in gut microbiota over a 4-week period. Furthermore, a significant downregulation of colonic Muc2 gene expression was observed after treatment. Muc2-knockout mice harbored a proinflammatory environment of gut microbes, characterized by the increase or decrease in prevalence of specific microbiota populations such as Clostridiales and Lactobacillaceae, respectively. This colitogenic phenotype was transmissible to IL10-knockout mice, a genetically susceptible model of colonic inflammatory disorders. Microbiota from donors pretreated with dexamethasone, however, ameliorated symptoms of inflammation.Conclusions:Commensal gut bacteria may be a key mediator of the anti-inflammatory effects observed in the large intestine after glucocorticoid exposure. These findings underscore the notion that intestinal microbes comprise a microbial organ essential for host physiology that can be targeted by therapeutic approaches to restore intestinal homeostasis.	[Huang, Edmond Y.; Leone, Vanessa A.; Dalal, Sushila; Touw, Ketrija; Wang, Yunwei; Musch, Mark W.; Chang, Eugene B.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 569, Japan; [Theriault, Betty] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Donovan, Sharon] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Gilbert, Jack] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gilbert, Jack] Marine Biol Lab, Woods Hole, MA 02543 USA; [Gilbert, Jack] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Chang, EB (reprint author), Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, 5841 S Maryland Ave, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu			NIDDK Digestive Disease Research Center [DK-42086]; NIH [DK097268, T32 DK07074, DK47722]; Gastrointestinal Research Foundation; NIDDK [UH3DK083993]; Harry and Leone Helmsley Charitable Trust	Supported by NIDDK Digestive Disease Research Center DK-42086 (EBC), NIH grants DK097268, T32 DK07074, and DK47722 (EBC), the Gastrointestinal Research Foundation, NIDDK UH3DK083993 (EBC), and the Harry and Leone Helmsley Charitable Trust.	Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Crinelli R, 2000, BLOOD CELL MOL DIS, V26, P211, DOI 10.1006/bcmd.2000.0298; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Sellon RK, 1998, INFECT IMMUN, V66, P5224; HEIMDAL K, 1992, J NEURO-ONCOL, V12, P141; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; BLANK M, 1994, INT J CANCER, V59, P301, DOI 10.1002/ijc.2910590302; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Barnes PJ, 1998, CLIN SCI, V94, P557; Huang EY, 2013, JPEN-PARENTER ENTER, V37, P746, DOI 10.1177/0148607113486931; Hanski C, 1997, J PATHOL, V182, P385, DOI 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; van der Sluis M, 2008, LAB INVEST, V88, P634, DOI 10.1038/labinvest.2008.28; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Forsythe P, 2012, CURR OPIN GASTROEN, V28, P557, DOI 10.1097/MOG.0b013e3283572ffa; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ohkusa T, 2010, AM J GASTROENTEROL, V105, P1820, DOI 10.1038/ajg.2010.84; Friend DR, 1998, ALIMENT PHARM THERAP, V12, P591; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Furrie E, 2005, GUT, V54, P242, DOI 10.1136/gut.2004.044834; Meslin JC, 1999, COMP BIOCHEM PHYS A, V123, P235, DOI 10.1016/S1095-6433(99)00056-2; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Riedel CU, 2006, WORLD J GASTROENTERO, V12, P3729; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Deplancke B., 2001, AM J CLIN NUTR, V73, p1131S; Forstner JF, 1994, PHYSL GASTROINTESTIN, V2, P1255; GALLANT C, 1986, J AM ACAD DERMATOL, V14, P161, DOI 10.1016/S0190-9622(86)70018-2; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; HOSKINS LC, 1993, EUR J GASTROEN HEPAT, V5, P205, DOI 10.1097/00042737-199304000-00004; KIM YS, 1984, GASTROENTEROLOGY, V87, P1193; Liu Jian-bo, 2006, Zhonghua Yi Xue Za Zhi, V86, P2491; Loh G, 2012, GUT MICROBES, V3, P503; Lutgendorff F, 2008, CURR MOL MED, V8, P282, DOI 10.2174/156652408784533779; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Ramer-Tait A, 2012, INFLAMM BOWEL DIS, V18, pS92; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; Sudo N., 2006, INT C SER, V1287, P350, DOI 10.1016/j.ics.2005.12.019; TYTGAT KMAJ, 1995, BIOCHEM J, V309, P221; TYTGAT KMAJ, 1994, GASTROENTEROLOGY, V107, P1352; Unsal H, 2008, DIGEST DIS SCI, V53, P1842, DOI 10.1007/s10620-007-0089-6	64	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	MAY	2015	21	5					963	972		10.1097/MIB.0000000000000332		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CH5FU	WOS:000354061500003		
J	Nagano, K; Takeuchi, H; Gao, J; Mori, Y; Otani, T; Wang, D; Hirata, M				Nagano, Koki; Takeuchi, Hiroshi; Gao, Jing; Mori, Yoshihide; Otani, Takahito; Wang, DaGuang; Hirata, Masato			Tomosyn is a novel Akt substrate mediating insulin-dependent GLUT4 exocytosis	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Akt; Phosphorylation; GLUT4; Exocytosis; SNARE	PROTEIN-KINASE-B; GTPASE-ACTIVATING-PROTEIN; SNARE COMPLEX-FORMATION; MEMBRANE-FUSION; GLUT4-CONTAINING VESICLES; GLUCOSE-UPTAKE; NEUROTRANSMITTER RELEASE; MUSCLE-CELLS; TRANSLOCATION; TRAFFICKING	Insulin triggers glucose uptake into skeletal muscle and adipose tissues by gaining the available number of glucose transporter 4 (GLUT4) on the cell surface. GLUT4-loaded vesicles are targeted to plasma membrane from the intracellular reservoir through multiple trafficking and fusion processes that are mainly regulated by Akt. However, it is still largely unknown how GLUT4 expression in the cell surface is promoted by insulin. In the present study, we identified tomosyn at Ser-783 as a possible Akt-substrate motif and examined whether the phosphorylation at Ser-783 is involved in the regulation of GLUT4 expression. Both Akt1 and Akt2 phosphorylated the wild-type tomosyn, but not the mutant tomosyn in which Ser-783 was replaced with Ala. Phosphorylation of tomosyn at Ser-783 was also observed in the intact cells by insulin stimulation, which was blocked by PI3K inhibitor, LY294002. In vitro pull-down assay showed that phosphorylation of tomosyn at Ser-783 by Akt inhibited the interaction with syntaxin 4. Insulin stimulation increased GLUT4 in the cell surface of CHO-K1 cells to promote glucose uptake, however exogenous expression of the mutant tomosyn attenuated the increase by insulin. These results suggest that Ser-783 of tomosyn is a target of Akt and is implicated in the interaction with syntaxin 4. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagano, Koki; Gao, Jing; Otani, Takahito; Wang, DaGuang; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Mori, Yoshihide] Kyushu Univ, Fac Dent Sci, Sect Oral & Maxillofacial Surg, Fukuoka 8128582, Japan; [Takeuchi, Hiroshi] Kyushu Dent Univ, Div Appl Pharmacol, Kitakyushu, Fukuoka 8038580, Japan	Takeuchi, H (reprint author), Kyushu Dent Univ, Div Appl Pharmacol, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r12takeuchi@fa.kyu-dent.ac.jp			JSPS KAKENHI [24592805, 25861758, 24229009]; Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Takeda Science Foundation; Hirose International Scholarship	This work was supported by JSPS KAKENHI (Grant Nos. 24592805 to HT, 25861758 to JG and 24229009 to MH), The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care and Takeda Science Foundation to HT. DW is a foreign graduate student supported by the Hirose International Scholarship. We appreciate the Research Support Center, Graduate School of Medical Sciences, Kyushu University for technical support. We thank Profs. Tom Martin (University of Wisconsin at Madison) and Sun Sik Bae (Pusan National University, Korea) for providing us with SNARE constructs and human GLUT4 cDNA containing a HA epitope tag in the first exofacial loop, respectively.	Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Sutton RB, 1998, NATURE, V395, P347; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Welsh GL, 2005, BIOCHEM SOC T, V33, P346; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Ijuin T, 2012, J BIOL CHEM, V287, P6991, DOI 10.1074/jbc.M111.335539; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Park CE, 2007, EXP MOL MED, V39, P222; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Kim SH, 2013, BIOCHEM BIOPH RES CO, V439, P66, DOI 10.1016/j.bbrc.2013.08.027; HAYASHI T, 1994, EMBO J, V13, P5051; Wasik U, 2013, NEUROCHEM RES, V38, P2427, DOI 10.1007/s11064-013-1155-4; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.E04-04-0333; McNew JA, 2000, NATURE, V407, P153; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bhatnagar S, 2014, J BIOL CHEM, V289, P25276, DOI 10.1074/jbc.M114.575985; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Geerts CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091697; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Hey N, 2011, TRENDS ENDOCRIN MET, V22, P66; Joost HG, 2014, MAMM GENOME, V25, P401, DOI 10.1007/s00335-014-9514-2; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Linial M, 1997, J NEUROCHEM, V69, P1781; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Okada S, 2007, BIOCHEM BIOPH RES CO, V356, P102, DOI 10.1016/j.bbrc.2007.02.095; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Ramm G, 2005, CELL METAB, V2, P150, DOI 10.1016/j.cmet.2005.05.008; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Takeuchi H, 2010, MOL CELL BIOL, V30, P1689, DOI 10.1128/MCB.01105-09; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300	65	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	MAY	2015	62						62	71		10.1016/j.biocel.2015.02.013		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CH6OJ	WOS:000354155600007		
J	Miyazaki, T; Ruparelia, N; Kawamoto, H; Sato, K; Latib, A; Colombo, A				Miyazaki, Tadashi; Ruparelia, Neil; Kawamoto, Hiroyoshi; Sato, Katsumasa; Latib, Azeem; Colombo, Antonio			Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Bioresorbable scaffold (BRS); Late-acquired scaffold malapposition; Discontinuity; Optical coherence tomography (OCT)			[Miyazaki, Tadashi; Ruparelia, Neil; Kawamoto, Hiroyoshi; Sato, Katsumasa; Latib, Azeem; Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy; [Miyazaki, Tadashi] Juntendo Univ, Dept Cardiovasc Med, Tokyo, Japan; [Ruparelia, Neil] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Colombo, A (reprint author), EMO GVM Ctr Cuore Columbus, 48 Via Michelangelo Buonarroti, I-20145 Milan, Italy.	info@emocolumbus.it					Onuma Y, 2011, CIRCULATION, V123, P779, DOI 10.1161/CIRCULATIONAHA.110.971606; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P390, DOI 10.1016/j.jacc.2010.05.066	2	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						136	138		10.1016/j.ijcard.2015.03.235		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200041		
J	Nozato, T; Sato, A; Oumi, T; Hirose, S; Kato, R; Takahashi, Y; Hikita, H; Takahashi, A; Ashikaga, T; Satoh, Y; Isobe, M				Nozato, Toshihiro; Sato, Akira; Oumi, Tetsuo; Hirose, Shunsuke; Kato, Ryuichi; Takahashi, Yoshihide; Hikita, Hiroyuki; Takahashi, Atsushi; Ashikaga, Takashi; Satoh, Yasuhiro; Isobe, Mitsuaki			Endovascular treatment of peripheral artery disease reduces blood pressure and improves long-term prognosis	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Endovascular treatment; Hypertension; Peripheral artery disease; Prognosis			[Nozato, Toshihiro; Sato, Akira; Hirose, Shunsuke; Kato, Ryuichi; Satoh, Yasuhiro] Natl Hosp Org, Disaster Med Ctr, Dept Cardiol, Tokyo, Japan; [Sato, Akira] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan; [Hikita, Hiroyuki; Takahashi, Atsushi] Yokosuka Kyosai Hosp, Ctr Cardiovasc, Yokosuka, Kanagawa, Japan; [Hirose, Shunsuke; Ashikaga, Takashi; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiol, Tokyo, Japan	Sato, A (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	asato@md.tsukuba.ac.jp					Giugliano G, 2013, INT J CARDIOL, V167, P2566, DOI 10.1016/j.ijcard.2012.06.055; Lewington S, 2002, LANCET, V360, P1903; Biscetti F, 2013, INT J CARDIOL, V167, P910, DOI 10.1016/j.ijcard.2012.03.103; Eguchi K, 2014, J HUM HYPERTENS, V28, P51, DOI 10.1038/jhh.2013.37; FIELD FP, 1985, HYPERTENSION, V7, P228; Hansson L, 2000, Blood Press Suppl, V2, P17	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						161	163		10.1016/j.ijcard.2015.03.246		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200051		
J	Sueta, D; Hokimoto, S; Enomoto, K; Ono, T; Tabata, T; Kajiwara, I; Kaikita, K; Saruwatari, J; Oniki, K; Nakagawa, K; Ogawa, H				Sueta, Daisuke; Hokimoto, Seiji; Enomoto, Koji; Ono, Takamichi; Tabata, Terumi; Kajiwara, Ichiro; Kaikita, Koichi; Saruwatari, Junji; Oniki, Kentaro; Nakagawa, Kazuko; Ogawa, Hisao			A case of repetitive and simultaneous stent thromboses	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Stent thrombosis; Cytochrome P450 enzyme polymorphism; Clopidogrel resistivity	PERCUTANEOUS CORONARY INTERVENTION; POLYMORPHISM; IMPACT; CLOPIDOGREL; JAPANESE; DISEASE		[Sueta, Daisuke; Hokimoto, Seiji; Kaikita, Koichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Enomoto, Koji; Ono, Takamichi; Tabata, Terumi; Kajiwara, Ichiro] Arao City Hosp, Dept Cardiovasc Med, Arao, Japan; [Saruwatari, Junji; Oniki, Kentaro; Nakagawa, Kazuko] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Grad Sch Med & Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto 8608556, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp					Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060044; Kaikita K, 2014, J ATHEROSCLER THROMB, V21, P64; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; Hokimoto S, 2014, EUR J CLIN PHARMACOL, V70, P667, DOI 10.1007/s00228-014-1672-3; Hokimoto S, 2014, INT J CARDIOL, V177, P723, DOI 10.1016/j.ijcard.2014.10.023	5	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						210	212		10.1016/j.ijcard.2015.03.217		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200063		
J	Okada, S; Azuma, Y; Kaneyasu, H; Mizutani, M; Korenaga, Y; Kittaka, S; Suzuki, Y; Ohnishi, Y; Furuta, T; Ohga, S				Okada, Seigo; Azuma, Yoshihiro; Kaneyasu, Hidenobu; Mizutani, Makoto; Korenaga, Yuno; Kittaka, Setsuaki; Suzuki, Yasuo; Ohnishi, Yuji; Furuta, Takashi; Ohga, Shouichi			Takotsubo (stress) cardiomyopathy and obstructive renal stones in an infant with norovirus gastroenteritis	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Heart failure; Norovirus; Gastroenteritis; Urolithiasis; Renal failure			[Okada, Seigo; Azuma, Yoshihiro; Kaneyasu, Hidenobu; Mizutani, Makoto; Korenaga, Yuno; Kittaka, Setsuaki; Suzuki, Yasuo; Ohnishi, Yuji; Furuta, Takashi; Ohga, Shouichi] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Ube, Yamaguchi 7558505, Japan	Okada, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pediat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	p002um@yamaguchi-u.ac.jp					Allen HD, 2013, MOSS ADAMS HEART DIS; Ashida A, 2012, CLIN NEPHROL, V77, P49, DOI 10.5414/CN107098; Aksoy N, 2009, RENAL FAILURE, V31, P272, DOI 10.1080/08860220902780119; Bastug F, 2012, NAT REV UROL, V9, P138, DOI 10.1038/nrurol.2012.4; Ashida A, 2010, PEDIATR NEPHROL, V25, P2377, DOI 10.1007/s00467-010-1607-x; Bianchi Daniele, 2014, World J Nephrol, V3, P182, DOI 10.5527/wjn.v3.i4.182; Finsterer J, 2015, INT J CARDIOL, V179, P345, DOI 10.1016/j.ijcard.2014.11.080; Hernandez LE, 2014, CARDIOL YOUNG, V24, P580, DOI 10.1017/S1047951114000080	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						233	235		10.1016/j.ijcard.2015.03.199		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200069		
J	Fujino, Y; Attizzani, GF; Tahara, S; Takagi, K; Naganuma, T; Nakamura, S; Nakamura, S				Fujino, Yusuke; Attizzani, Guilherme F.; Tahara, Satoko; Takagi, Kensuke; Naganuma, Toru; Nakamura, Shotaro; Nakamura, Sunao			A honeycomb-like structure in chronic total occlusion demonstrated by frequency-domain optical coherence tomography	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Chronic total occlusion; FD-OCT; Honeycomb-like structure			[Fujino, Yusuke; Tahara, Satoko; Takagi, Kensuke; Naganuma, Toru; Nakamura, Shotaro; Nakamura, Sunao] New Tokyo Hosp, Chiba, Japan; [Attizzani, Guilherme F.] Univ Hosp, Case Med Ctr, Cleveland, OH USA	Fujino, Y (reprint author), New Tokyo Hosp, Dept Cardiol, 1270 Wanagaya, Matsudo, Chiba 2702232, Japan.	yusuke.fujino1979@gmail.com					Guo J, 2013, CATHETER CARDIO INTE, V81, P464, DOI 10.1002/ccd.24356; Toutouzas K, 2012, JACC-CARDIOVASC INTE, V5, P688, DOI 10.1016/j.jcin.2012.01.024	2	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						239	240		10.1016/j.ijcard.2015.03.251		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200071		
J	Kopec, G; Waligora, M; Stepniewski, J; Zmudka, K; Podolec, P; Matsubara, H				Kopec, Grzegorz; Waligora, Marcin; Stepniewski, Jakub; Zmudka, Krzysztof; Podolec, Piotr; Matsubara, Hiromi			In vivo characterization of changes in composition of organized thrombus in patient with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Balloon pulmonary angioplasty; Virtual histology; Intravascular ultrasound; Organized thrombus			[Kopec, Grzegorz; Waligora, Marcin; Stepniewski, Jakub; Podolec, Piotr] Jagiellonian Univ, John Paul II Hosp Krakow, Coll Med, Dept Cardiac & Vasc Dis, PL-31202 Krakow, Poland; [Zmudka, Krzysztof] Jagiellonian Univ, John Paul II Hosp Krakow, Coll Med, Dept Intervent Cardiol, PL-31202 Krakow, Poland; [Matsubara, Hiromi] Natl Hosp Org, Okayama Med Ctr, Dept Clin Sci, Okayama, Japan	Kopec, G (reprint author), Jagiellonian Univ, John Paul II Hosp Krakow, Coll Med, Dept Cardiac & Vasc Dis, Pradnicka 80, PL-31202 Krakow, Poland.	grzegorzkrakow1@gmail.com					Yanagisawa R, 2014, INT J CARDIOL, V175, P285, DOI 10.1016/j.ijcard.2014.05.011; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Kantake M, 2013, INT J CARDIOL, V165, P474, DOI 10.1016/j.ijcard.2011.08.851; Kitani M, 2014, CIRC-CARDIOVASC INTE, V7, P857, DOI 10.1161/CIRCINTERVENTIONS.114.001533; Nair Anuja, 2007, EuroIntervention, V3, P113; Ogawa A, 2014, INTERNAL MED, V53, P729, DOI 10.2169/internalmedicine.53.1343; Roik M, 2014, INT J CARDIOL, V177, pE139, DOI 10.1016/j.ijcard.2014.09.051; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						279	281		10.1016/j.ijcard.2015.03.203		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200081		
J	Minami, Y; Nakajima, T; Ikutomi, M; Morita, T; Komuro, I; Sata, M; Sahara, M				Minami, Yoshiyasu; Nakajima, Toshiaki; Ikutomi, Masayasu; Morita, Toshihiro; Komuro, Issei; Sata, Masataka; Sahara, Makoto			Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Angiogenesis; Endothelial progenitor cell; Ischemic vascular disease; Regenerative medicine	CARDIOVASCULAR DISORDERS; MYOCARDIAL-INFARCTION; STEM-CELLS; GROWTH; BLOOD; NEOVASCULARIZATION; TRANSPLANTATION; SUBPOPULATIONS; PRECURSORS; CONTRIBUTE	Background: Recent studies have suggested that late-outgrowth endothelial progenitor cells (EPCs) derived from human peripheral blood mononuclear cells (hPBMNCs) might have higher angiogenic potential than classically-defined early-outgrowth EPCs (EOCs). However, it still remains unclear which of "so-called" EPC subpopulations defined in a variety of ways has the highest angiogenic potential. Methods and results: We classified hPBMNC-derived EPC subpopulations by the time of their emergence in culture. EOCs were defined as attached cells on culture days 3-7. Late-outgrowth EPCs, defined as the cell forming colonies with cobblestone appearance since day 10, were further classified as follows: "moderate"-outgrowth EPCs (MOCs) emerging on days 10-16, "late"-outgrowth EPCs (LOCs) on days 17-23, and "very late"-outgrowth EPCs (VOCs) on days 24-30. Flow cytometry analyses showed the clear differences of hematopoietic/endothelial markers between EOC (CD31(+)VE-cadherin-CD34(-)CD14(+)CD45(+))and LOC (CD31(+)VE-cadherin(+)CD34(+)CD14(-)CD45(-)). We found that LOCs had the highest proliferation and tube formation capabilities in vitro along with the highest expression of angiogenic genes including KDR and eNOS. To investigate the in vivo therapeutic efficacies, each EPC subpopulation was intravenously transplanted into immunocompromised mice (total 4 x 10(5) cells) after unilateral hindlimb ischemia surgery. The LOC-treatedmice exhibited significantly-enhanced blood flow recovery (flow ratios of ischemic/non-ischemic leg: 0.99 +/- 0.02 [LOC group] versus 0.67 +/- 0.07 to 0.78 +/- 0.09 [other groups]; P < 0.05) and augmented capillary collateral formation in ischemic leg, which were attributable to their direct engraftment into host angiogenic vessels (approximately 10%) and paracrine effects. Conclusion: hPBMNC-derived late-outgrowth EPCs emerging on culture days 17-23 are superior to other EPC subpopulations with regard to therapeutic angiogenic potential. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Minami, Yoshiyasu; Nakajima, Toshiaki; Ikutomi, Masayasu; Morita, Toshihiro; Komuro, Issei; Sahara, Makoto] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Minami, Yoshiyasu; Nakajima, Toshiaki; Morita, Toshihiro] Tokyo Univ Hosp, 22nd Century Med & Res Ctr, Dept Ischem Circulatory Physiol, Bunkyo Ku, Tokyo 1138655, Japan; [Ikutomi, Masayasu] Teikyo Univ, Chiba Med Ctr, Dept Cardiovasc Med, Ichihara, Chiba 2990111, Japan; [Sata, Masataka] Univ Tokushima, Grad Sch Med, Inst Hlth Biosci, Dept Cardiovasc Med, Tokushima 7708503, Japan; [Sahara, Makoto] Karolinska Inst, Dept Med Cardiol Cell & Mol Biol, SE-17177 Stockholm, Sweden	Sahara, M (reprint author), Karolinska Inst, Dept Med Cardiol Cell & Mol Biol, SE-17177 Stockholm, Sweden.	makoto.sahara@ki.se			Ministry of Education, Culture, Sports, Science and Technology of Japan [19390207]; Japan Heart Foundation; Japan Research Promotion Society for Cardiovascular Disease; Public Trust Cardiovascular Research Fund; Cardiovascular Research Fund (Tokyo, Japan)	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [#19390207 to M. Sata] and by a research fellowship from Japan Heart Foundation, Japan Research Promotion Society for Cardiovascular Disease, and Public Trust Cardiovascular Research Fund to M. Sahara. This work was also supported by a grant-in-aid of the Cardiovascular Research Fund (Tokyo, Japan) to Y. Minami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Yang NN, 2011, CYTOTECHNOLOGY, V63, P217, DOI 10.1007/s10616-010-9329-2; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; CORY AH, 1991, CANCER COMMUN, V3, P207; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Peichev M, 2000, BLOOD, V95, P952; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Stroncek JD, 2009, TISSUE ENG PT A, V15, P3473, DOI 10.1089/ten.TEA.2008.0673; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Shantsila E, 2008, J AM COLL CARDIOL, V51, P669, DOI [10.1016/j.jacc.2007.09.057, 10.1016/j.jacc.2007.09.OS7]; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Sahara M, 2010, ARTERIOSCL THROM VAS, V30, P1315, DOI 10.1161/ATVBAHA.109.201327; Hagensen MK, 2010, CIRCULATION, V121, P898, DOI 10.1161/CIRCULATIONAHA.109.885459; Ben-Shoshan J, 2007, PHARMACOL THERAPEUT, V115, P25, DOI 10.1016/j.pharmthera.2007.03.012; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Kong D, 2004, CIRCULATION, V109, P1769, DOI 10.1161/01.CIR.0000121732.85572.6F; Sun CK, 2012, INT J CARDIOL, V162, P45, DOI 10.1016/j.ijcard.2011.05.002; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW	34	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAY 1	2015	186						305	314		10.1016/j.ijcard.2015.03.166		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CH9DW	WOS:000354337200091		
J	Ueda, H; Kibe, A; Saitoh, M; Inoue, T				Ueda, Hiroaki; Kibe, Ayumi; Saitoh, Mika; Inoue, Tomoshige			Snowfall variations in Japan and its linkage with tropical forcing	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						heavy snow; East Asia; La Nina	ASIAN WINTER MONSOON; TIBETAN PLATEAU; NORTHERN-HEMISPHERE; ARCTIC OSCILLATION; MOISTURE BUDGETS; SUMMER MONSOON; PACIFIC; CLIMATE; HEAT; CIRCULATION	In this study, the causes of inter-annual variability of wintertime snowfall in the coastal plain facing the Sea of Japan over the past 33 years (1980-2012) are investigated. The observational evidence showed that intensified cold air intrusion from the Eurasian continent towards Japan in combination with anomalous cyclonic circulation favours in situ heavy snowfall. The composite analysis of the tropical convection during the heavy snow winters indicates that enhancement of convection in the vicinity of the Philippines, including the eastern Indian Ocean, is responsible for the emergence of anti-cyclonic circulation over the Asian continent and subsequent anomalous cyclonic circulation around Japan. Idealized experiments by use of the linear baroclinic model (LBM) were conducted to elucidate the origin of the teleconnection. We put idealized diabatic heating in the LBM under the wintertime atmospheric circulation and examined the heat-induced response. The experimental results clearly indicated that the intensified convection over the maritime continents and the neighbouring oceans is primarily responsible for the pair of the anti-cyclonic and cyclonic circulation. Thus, a study of the predictability of the tropical forcing may shed light on the predictable dynamics of snowy winters in Japan.	[Ueda, Hiroaki; Kibe, Ayumi; Saitoh, Mika] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Inoue, Tomoshige] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan	Ueda, H (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	ueda.hiroaki.gm@u.tsukuba.ac.jp			SOUSEI Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of the Environment [A1201]	This work was supported by the Global Environment Research Fund (A1201) of the Ministry of the Environment. We also acknowledge Development of Basic Technology for Risk Information on Climate Change supported by the SOUSEI Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank to M. Watanabe for providing the LBM. The authors would like to thank A. Kumai and S. Watanabe for their technical assistance about the computation of atmospheric heating.	Hori ME, 2011, SOLA, V7, DOI 10.2151/sola.2011-007; Yasunaka S, 2003, J METEOROL SOC JPN, V81, P415, DOI 10.2151/jmsj.81.415; CHANG CP, 1980, MON WEATHER REV, V108, P298, DOI 10.1175/1520-0493(1980)108<0298:NCSANE>2.0.CO;2; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Zhou XJ, 2009, SCI CHINA SER D, V52, P1679, DOI 10.1007/s11430-009-0194-9; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Watanabe M, 1999, J CLIMATE, V12, P494, DOI 10.1175/1520-0442(1999)012<0494:DCITAC>2.0.CO;2; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; Kawamura R, 1998, J METEOROL SOC JPN, V76, P1009; Zhao P, 2001, ADV ATMOS SCI, V18, P106; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; MATSUMOTO J, 1992, J METEOROL SOC JPN, V70, P257; Watanabe M, 2000, Q J ROY METEOR SOC, V126, P3343, DOI 10.1256/smsqj.57016; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Hong CC, 2009, J CLIMATE, V22, P3786, DOI 10.1175/2009JCLI2864.1; Wang B, 2010, J CLIMATE, V23, P1495, DOI 10.1175/2009JCLI3243.1; Fujita T., 1966, TENKI, V13, P359; Fukaishi K., 1961, TENKI, V8, P395; Kawamura R, 2007, J JPN SOC SNOW ICE S, V69, P21, DOI 10.5331/seppyo.69.21; Manabe S., 1957, J METEOR SOC JAPAN, V35, P311; Manabe S., 1958, J METEOR SOC JAPAN, V26, P123; Matsumura S, 1998, TENKI, V45, P781; Matsuno T., 1966, J METEOR SOC JAPAN, V44, P25; Nakamura T, 1998, REPORT NAT RES I EAR, V58, P1; Nan SL, 2012, INT J CLIMATOL, V32, P888, DOI 10.1002/joc.2318; Ninomiya K., 1968, J METEOR SOC JAPAN, V46, P343; NITTA T, 1983, J METEOROL SOC JPN, V61, P590; Sakai K, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010824; Suzuki H., 2006, TENKI, V53, P185; TACHIBANA Y, 1995, J METEOROL SOC JPN, V73, P697; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Ueda H, 2003, J CLIMATE, V16, P2309, DOI 10.1175/2757.1; YANAI M, 1994, MON WEATHER REV, V122, P305, DOI 10.1175/1520-0493(1994)122<0305:MOHATB>2.0.CO;2; Yeh TC, 1979, METEOROLOGY QINGHAI	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	MAY	2015	35	6					991	998		10.1002/joc.4032		8	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CH4FE	WOS:000353987800015		
J	Itamochi, H; Oumi, N; Oishi, T; Taniguchi, F; Shoji, T; Fujiwara, H; Sugiyama, T; Suzuki, M; Kigawa, J; Harada, T				Itamochi, Hiroaki; Oumi, Nao; Oishi, Tetsuro; Taniguchi, Fuminori; Shoji, Tadahiro; Fujiwara, Hiroyuki; Sugiyama, Toru; Suzuki, Mitsuaki; Kigawa, Junzo; Harada, Tasuku			Fibroblast Growth Factor Receptor 2 Is Associated With Poor Overall Survival in Clear Cell Carcinoma of the Ovary and May Be a Novel Therapeutic Approach	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Clear cell; Ovarian carcinoma; FGFR2; Biomarker; Molecular target therapy	ENDOMETRIAL CANCER-CELLS; PANCREATIC-CANCER; GASTRIC-CANCER; BREAST-CANCER; LUNG-CANCER; EXPRESSION; FGFR2; MUTATIONS; PROGNOSIS; TUMORS	Objective We previously found that gene and protein expression of fibroblast growth factor receptor (FGFR) 2 were increased in ovarian clear cell carcinoma (CCC); here, we examined FGFR2 expression in CCC tumor tissues and its correlation with clinical parameters. We also analyzed the effect of an FGFR inhibitor on the growth of CCC cells to investigate whether FGFR2 could be a therapeutic target for this disease. Methods We analyze the protein expression of FGFR2 by immunohistochemical staining in CCC from 112 patients and evaluated the association of these molecular parameters with clinical outcome. We treated the 11 CCC cell lines with an FGFR inhibitor, and then assessed cell viability, the expression of protein in FGFR2 signaling pathway, and cell cycle distribution. Results The expressions of FGFR2 were found in 96% of CCC. The 5-year survival rate for patients with a moderate or strong expression of FGFR2 was significantly lower than that for those with an absent or poor expression of FGFR2 (54% vs 79%). Multivariable analysis revealed that FGFR2 expression and disease stage were independent prognostic factors. The FGFR inhibitor effectively suppressed the growth of CCC cells with induction of G1 cell cycle arrest and down-regulated the expression of phosphorylated Akt and phosphorylated ERK. Conclusions FGFR2 is an important biomarker predictive of patient outcome and is a potential target for CCC. Further study is warranted for FGFR inhibitor to treat CCC.	[Itamochi, Hiroaki; Oumi, Nao; Oishi, Tetsuro; Taniguchi, Fuminori; Harada, Tasuku] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 6838504, Japan; [Shoji, Tadahiro; Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan; [Fujiwara, Hiroyuki; Suzuki, Mitsuaki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Kigawa, Junzo] Matsue City Hosp, Matsue, Shimane, Japan	Itamochi, H (reprint author), Tottori Univ, Sch Med, Dept Obstet & Gynecol, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	itamochi@hotmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [17244120]	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17244120 to H. Itamochi).	Nomura S, 2008, BRIT J CANCER, V99, P305, DOI 10.1038/sj.bjc.6604473; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; Bernard-Pierrot I, 2006, CARCINOGENESIS, V27, P740, DOI 10.1093/carcin/bgi290; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Jang JH, 2001, CANCER RES, V61, P3541; Zhang H, 2014, BRIT J CANCER, V110, P320, DOI 10.1038/bjc.2013.754; Matsuda Y, 2011, CANCER LETT, V309, P209, DOI 10.1016/j.canlet.2011.06.009; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Munstedt K, 2000, CANCER, V89, P1783, DOI 10.1002/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Prat J, 2014, INT J GYNECOL OBSTET, V124, P1, DOI 10.1016/j.ijgo.2013.10.001; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Ogawa S, 2000, GYNECOL ONCOL, V77, P298, DOI 10.1006/gyno.2000.5765; Corn PG, 2013, CLIN CANCER RES, V19, P5856, DOI 10.1158/1078-0432.CCR-13-1550; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; Konecny GE, 2013, MOL CANCER THER, V12, P632, DOI 10.1158/1535-7163.MCT-12-0999; Sun SS, 2012, J SURG ONCOL, V105, P773, DOI 10.1002/jso.22120; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; AURE JC, 1971, OBSTET GYNECOL, V37, P860; Bane AL, 2009, BREAST CANCER RES TR, V117, P183, DOI 10.1007/s10549-008-0087-1; Heiskanen M, 2001, ANAL CELL PATHOL, V22, P229; Itamochi H, 2013, HUM CELL, V26, P121, DOI 10.1007/s13577-013-0062-y; REMMELE W, 1987, PATHOLOGE, V8, P138; Scully R E, 1975, Natl Cancer Inst Monogr, V42, P5; Taniguchi F, 2013, INT J GYNECOL CANCER, V23, P791, DOI 10.1097/IGC.0b013e31828f38c4	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	MAY	2015	25	4					570	576		10.1097/IGC.0000000000000414		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH5VH	WOS:000354103000006		
J	Sakurai, M; Satoh, T; Matsumoto, K; Michikami, H; Nakamura, Y; Nakao, S; Ochi, H; Onuki, M; Minaguchi, T; Yoshikawa, H				Sakurai, Manabu; Satoh, Toyomi; Matsumoto, Koji; Michikami, Hiroo; Nakamura, Yuko; Nakao, Sari; Ochi, Hiroyuki; Onuki, Mamiko; Minaguchi, Takeo; Yoshikawa, Hiroyuki			High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Plasma D-dimer; Epithelial ovarian cancer; Prognosis	SUSPECTED PULMONARY-EMBOLISM; COLORECTAL-CANCER; BREAST-CANCER; SURVIVAL; PROGRESSION; CA-125; STAGE	Objective Elevated plasma D-dimer (DD) is associated with decreased survival among patients with breast, lung, and colon cancers. The present study clarifies the prognostic significance of pretreatment plasma DD levels in patients with epithelial ovarian cancer (EOC). Methods We investigated pretreatment DD levels and other variables for overall survival using univariate and multivariate analyses in 134 consecutive patients with EOC stages II to IV who were initially treated between November 2004 and December 2010. Results The median follow-up period was 53 (7-106) months. Univariate analysis significantly associated elevated pretreatment DD (2.0 g/mL) levels to poor 5-year overall survival rates irrespective of previously treated venous thromboembolism (72.2% vs 52.6%, P = 0.039). Cancer antigen 125 levels of 200 U/mL or higher (P = 0.011), distant metastases (P = 0.0004), residual tumors (P < 0.0001), and International Federation of Gynecology and Obstetrics stage III/IV (P = 0.0033) were also poor prognostic factors. Multivariate analysis independently associated DD levels of 2.0 g/mL or higher (P = 0.041), distant metastases (P = 0.013), and residual tumors (P < 0.0001) with poor overall survival. Conclusions High pretreatment DD levels are associated with poor overall survival in patients with EOC independently of venous thromboembolism and tumor extension and might comprise a promising prognostic biomarker for patients with EOC.	Univ Tsukuba, Fac Med, Dept Obstet, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Fac Med, Dept Gynecol, Tsukuba, Ibaraki 3058575, Japan	Sakurai, M (reprint author), Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	m-sakurai@md.tsukuba.ac.jp			Ministry of Education, Science, and Culture, Japan [26861310, 26462513]	This research was supported, in part, by a Grant-in-Aid for Scientific Research (No. 26861310 and No. 26462513) from the Ministry of Education, Science, and Culture, Japan.	Chew HK, 2006, ARCH INTERN MED, V166, P458; Chew HK, 2007, J CLIN ONCOL, V25, P70, DOI 10.1200/JCO.2006.07.4393; Uno K, 2007, BRIT J CANCER, V96, P290, DOI 10.1038/sj.bjc.6603552; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI [10.3324/haematol.2011.054718, 10.3324/haemato1.2011.054718]; Satoh T, 2008, BRIT J CANCER, V99, P1034, DOI 10.1038/sj.bjc.6604658; Falanga A, 2009, BEST PRACT RES CL HA, V22, P49, DOI 10.1016/j.beha.2008.12.009; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj/bjc/6600069; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Pabinger I, 2009, ARTERIOSCL THROM VAS, V29, P332, DOI 10.1161/ATVBAHA.108.182188; Alcalay A, 2006, J CLIN ONCOL, V24, P1112, DOI 10.1200/JCO.2005.04.2150; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; HARRISON KA, 1993, J NUCL MED, V34, P896; Kakkar Ajay K, 2005, Cancer Control, V12 Suppl 1, P22; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Onda T, 2008, JPN J CLIN ONCOL, V38, P74, DOI 10.1093/jjco/hym145; RELLA C, 1993, TUMORI, V79, P347; Righini M, 2006, THROMB HAEMOSTASIS, V95, P715, DOI 10.1160/TH05-12-0791; ROSE PG, 1994, J SURG ONCOL, V56, P168, DOI 10.1002/jso.2930560309; Satoh T, 2013, THROMB RES, V131, P127; Satoh T, 2007, BRIT J CANCER, V97, P1053, DOI 10.1038/sj.bjc.6603989; Trousseau A, 1865, CLIN MED HOTEL DIEU, P654	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	MAY	2015	25	4					593	598		10.1097/IGC.0000000000000415		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH5VH	WOS:000354103000009		
J	Hareyama, H; Hada, K; Goto, K; Watanabe, S; Hakoyama, M; Oku, K; Hayakashi, Y; Hirayama, E; Okuyama, K				Hareyama, Hitoshi; Hada, Kenichi; Goto, Kumiko; Watanabe, Sawako; Hakoyama, Minako; Oku, Kikuo; Hayakashi, Yukitoki; Hirayama, Emi; Okuyama, Kazuhiko			Prevalence, Classification, and Risk Factors for Postoperative Lower Extremity Lymphedema in Women With Gynecologic Malignancies A Retrospective Study	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Lymphedema; Cellulitis; Pelvic node; Para-aortic node	LOWER-LIMB LYMPHEDEMA; EARLY CERVICAL-CANCER; ACUTE LEG CELLULITIS; PELVIC LYMPHADENECTOMY; RADICAL HYSTERECTOMY; NODE METASTASIS; BREAST-CANCER; ADJUVANT RADIOTHERAPY; DISTRIBUTION PATTERN; CARCINOMA	Objective Lower extremity lymphedema (LEL) is a major long-term complication of radical surgery. We aimed to estimate the incidence and grading of LEL in women who underwent lymphadenectomy and to evaluate risk factors associated with LEL. Materials and Methods We retrospectively reviewed 358 patients with cervical, endometrial, and ovarian cancer who underwent transabdominal complete systematic pelvic and para-aortic lymphadenectomy between 1997 and 2011. Lower extremity lymphedema was graded according to criteria of the International Society of Lymphology. Incidence of LEL and its correlation with various clinical characteristics were investigated using Kaplan-Meier survival and Cox proportional hazards methods. Results Overall incidence of LEL was 21.8% (stage 1, 60%; stage 2, 32%; and stage 3, 8%). Cumulative incidence increased with observation period: 12.9% at 1 year, 20.3% at 5 years, and 25.4% at 10 years. Age, cancer type, stage (International Federation of Gynecology and Obstetrics), body mass index, hysterectomy type, lymphocyst formation, lymph node metastasis, and chemotherapy were not associated with LEL. Multivariate analysis confirmed that removal of circumflex iliac lymph nodes (hazard ratio [HR], 4.28; 95% confidence interval [CI], 2.09-8.77; P < 0.0001), cellulitis (HR, 3.48; 95% CI, 2.03-5.98; P < 0.0001), and number of removed lymph nodes (HR, 0.99; 95% CI, 0.98-0.99; P = 0.038) were independent risk factors for LEL. Conclusions Postoperative LEL incidence increased over time. The results of the present study showed a significant correlation with removal of circumflex iliac lymph nodes and cellulitis with the incidence of LEL. Multicenter or prospective studies are required to clarify treatment efficacies.	[Hareyama, Hitoshi; Hada, Kenichi; Goto, Kumiko; Watanabe, Sawako; Hakoyama, Minako; Oku, Kikuo; Hayakashi, Yukitoki; Hirayama, Emi; Okuyama, Kazuhiko] Sapporo City Gen Hosp, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608604, Japan	Hareyama, H (reprint author), Sapporo City Gen Hosp, Dept Obstet & Gynecol, Tyuuou Ku, North 11,West 13, Sapporo, Hokkaido 0608604, Japan.	hitoshi.hareyama@doc.city.sapporo.jp					Fuller J, 2008, STRAHLENTHER ONKOL, V184, P206, DOI 10.1007/s00066-008-1728-3; Hareyama H, 2012, ANN SURG ONCOL, V19, P268, DOI 10.1245/s10434-011-1863-4; Bergmark K, 2006, INT J GYNECOL CANCER, V16, P1130, DOI 10.1111/j.1525-1438.2006.00601.x; Goldberg JI, 2010, ANN SURG ONCOL, V17, P3278, DOI 10.1245/s10434-010-1155-4; Chan JK, 2007, BRIT J CANCER, V97, P605, DOI 10.1038/sj.bjc.6603898; Tanaka T, 2007, INT J GYNECOL CANCER, V17, P460, DOI 10.1111/j.1525-1438.2007.00869.x; Ryan M, 2003, AUST NZ J OBSTET GYN, V43, P148, DOI 10.1046/j.0004-8666.2003.00040.x; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Abu-Rustum NR, 2006, GYNECOL ONCOL, V103, P714, DOI 10.1016/j.ygyno.2006.03.055; Helyer LK, 2010, BREAST J, V16, P48, DOI 10.1111/j.1524-4741.2009.00855.x; Abu-Rustum NR, 2007, GYNECOL ONCOL, V106, P4, DOI 10.1016/j.ygyno.2007.03.026; Tsumura N, 1998, INT J CANCER, V79, P526, DOI 10.1002/(SICI)1097-0215(19981023)79:5<526::AID-IJC14>3.0.CO;2-#; Brennan MJ, 1998, CANCER, V83, P2821, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2821::AID-CNCR33>3.0.CO;2-G; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Yuan ZB, 2006, ANN NUCL MED, V20, P341, DOI 10.1007/BF02987244; Beesley V, 2007, CANCER, V109, P2607, DOI 10.1002/cncr.22684; Hoffman MS, 1999, OBSTET GYNECOL, V94, P391, DOI 10.1016/S0029-7844(99)00310-5; Chan JK, 2007, CANCER, V109, P2454, DOI 10.1002/cncr.22727; DUEWELL S, 1992, RADIOLOGY, V184, P227; Todo Y, 2010, GYNECOL ONCOL, V119, P60, DOI 10.1016/j.ygyno.2010.06.018; BOUMA J, 1988, GYNECOL ONCOL, V29, P50, DOI 10.1016/0090-8258(88)90146-1; DANKERT J, 1987, BRIT J OBSTET GYNAEC, V94, P788, DOI 10.1111/j.1471-0528.1987.tb03728.x; Edwards TL, 2000, AUST NZ J SURG, V70, P412, DOI 10.1046/j.1440-1622.2000.01839.x; Hareyama H, 2012, INT J GYNECOL CANCER, V22, P1577, DOI 10.1097/IGC.0b013e31826fd644; Hirahatake K, 1997, J SURG ONCOL, V65, P82, DOI 10.1002/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.0.CO;2-J; International Society of Lymphology, 2003, LYMPHOLOGY, V36, P84; Japan Society of Gynecologic Oncology, 2012, NISSANNPUSI, V64, P1029; Kim JH, 2012, INT J GYNECOL CANCER, V22, P686, DOI 10.1097/IGC.0b013e3182466950; Mahdi H, 2011, J SURG ONCOL, V103, P724, DOI 10.1002/jso.21869; SOISSON AP, 1990, GYNECOL ONCOL, V37, P390, DOI 10.1016/0090-8258(90)90374-T; Tada H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-47; Takeishi M, 2006, ANN PLAS SURG, V57, P300, DOI 10.1097/01.sap.0000222727.05869.04	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	MAY	2015	25	4					751	757		10.1097/IGC.0000000000000405		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CH5VH	WOS:000354103000032		
J	Yamamoto, K; Yakushijin, K; Kurata, K; Sanada, Y; Kawamoto, S; Matsuoka, H; Minami, H				Yamamoto, Katsuya; Yakushijin, Kimikazu; Kurata, Keiji; Sanada, Yukinari; Kawamoto, Shinichiro; Matsuoka, Hiroshi; Minami, Hironobu			Disappearance of double minute chromosomes with MYC amplification in relapsed acute myeloid leukemia after stem cell transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material							TUMOR-CELLS; GENES		[Yamamoto, Katsuya; Yakushijin, Kimikazu; Kurata, Keiji; Sanada, Yukinari; Kawamoto, Shinichiro; Matsuoka, Hiroshi; Minami, Hironobu] Kobe Univ, Grad Sch Med, Dept Med, Div Med Oncol Hematol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Yamamoto, K (reprint author), Kobe Univ, Grad Sch Med, Dept Med, Div Med Oncol Hematol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kyamamo@med.kobe-u.ac.jp					VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165; Chinen Y, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0068-2; Raymond E, 2001, CLIN CANCER RES, V7, P1171; Schoenlein PV, 2003, INT J RADIAT ONCOL, V55, P1051, DOI 10.1016/S0360-3016(02)04473-5; Yamamoto K, 2013, AM J HEMATOL, V88, P717, DOI 10.1002/ajh.23431; Yu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071988	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAY	2015	101	5					423	425		10.1007/s12185-015-1757-5		3	Hematology	Hematology	CH7KB	WOS:000354213800001		
J	Murata, M				Murata, Makoto			Recent topics in graft-versus-host disease: from the perspectives of pathogenesis and treatment	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article									Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan	Murata, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	mmurata@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [H25-Immunology-104, H26-Immunology-106]	This work was supported in part by a Health and Labour Sciences Research Grant (H25-Immunology-104 and H26-Immunology-106) from the Ministry of Health, Labour and Welfare, Japan.	Jamil MO, 2015, INT J HEMATOL, DOI [10.1007/s12185-015-1785-1, DOI 10.1007/S12185-015-1785-1]; Murata M., 2015, INT J HEMATOL, DOI [10.1007/s12185-015-1784-2, DOI 10.1007/S12185-015-1784-2]; Nakasone H, 2015, INT J HEMATOL, DOI [10.1007/s12185-015-1782-4, DOI 10.1007/S12185-015-1782-4]; Shono Y, 2015, INT J HEMATOL, DOI [10.1007/s12185-015-1781-5, DOI 10.1007/S12185-015-1781-5]	4	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAY	2015	101	5					426	427		10.1007/s12185-015-1789-x		2	Hematology	Hematology	CH7KB	WOS:000354213800002		
J	Murata, M				Murata, Makoto			Prophylactic and therapeutic treatment of graft-versus-host disease in Japan	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Graft-versus-host disease; Prophylaxis; Therapy; Calcineurin inhibitor; Steroid	STEM-CELL-TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CORD-BLOOD TRANSPLANTATION; SEVERE APLASTIC-ANEMIA; LOBAR LUNG TRANSPLANTATION; SHORT-TERM METHOTREXATE; INTESTINAL THROMBOTIC MICROANGIOPATHY; MYELOABLATIVE CONDITIONING REGIMEN; ORAL BECLOMETHASONE DIPROPIONATE; TRIAL COMPARING CYCLOSPORINE	Allogeneic hematopoietic stem cell transplantation in Japan is very different from that in Western countries in terms of the homogeneous genetic background, the preference for bone marrow to peripheral blood stem cells, use of a single unit in cord blood transplantation, and frequent use of non-myeloablative preconditioning due to a large number of elderly patients. Therefore, conclusions obtained from well-designed prospective and/or comparative studies of treatment of graft-versus-host disease (GVHD) performed in the United States or Europe may not fit Japanese transplant patients. This article reviews the studies of prophylactic and therapeutic treatment of acute and chronic GVHD that have been conducted in Japan. A randomized study demonstrated a lower incidence of acute GVHD in tacrolimus-based prophylaxis than in cyclosporine A-based prophylaxis. Retrospective and non-randomized prospective studies suggest that cyclosporine A-based and tacrolimus-based GVHD prophylaxis regimens are well researched and nearly optimized for Japanese patients, including infusion methods and target blood concentration. However, most other studies were performed in a single institute including a small number of patients, resulting in biased conclusions. There is no conclusive report on steroid-refractory acute and chronic GVHD. This review provides a baseline for starting prospective studies to create new evidence for GVHD treatment from Japan.	Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, Nagoya, Aichi 4668550, Japan	Murata, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	mmurata@med.nagoya-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [H25-Immunology-104, H26-Immunology-106]	The author would like to thank the data managers at the Japan Data Center for Hematopoietic Cell Transplantation, the members of the GVHD working group of JSHCT, and all the physicians at each transplant center in Japan. This work was supported in part by a Health and Labour Sciences Research Grant (H25-Immunology-104 and H26-Immunology-106) from the Ministry of Health, Labour and Welfare, Japan.	Oshima K, 2008, AM J HEMATOL, V83, P226, DOI 10.1002/ajh.21087; Muroi K, 2013, INT J HEMATOL, V98, P206, DOI 10.1007/s12185-013-1399-4; Kurtzberg J, 2008, BLOOD, V112, P4318, DOI 10.1182/blood-2007-06-098020; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Gilman AL, 2012, BIOL BLOOD MARROW TR, V18, P84, DOI 10.1016/j.bbmt.2011.05.016; Fujino M, 2007, BONE MARROW TRANSPL, V39, P367, DOI 10.1038/sj.bmt.1705588; Nash RA, 2000, BLOOD, V96, P2062; Teshima T, 2009, INT J HEMATOL, V90, P253, DOI 10.1007/s12185-009-0370-x; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Kanda J, 2014, BONE MARROW TRANSPL, V49, P228, DOI 10.1038/bmt.2013.151; Bolwell B, 2004, BONE MARROW TRANSPL, V34, P621, DOI 10.1038/sj.bmt.1704647; CAHN JY, 1995, TRANSPLANTATION, V60, P939, DOI 10.1097/00007890-199511150-00010; Nawa Y, 2006, INT J HEMATOL, V83, P159, DOI 10.1532/IJH97.05006; Cutler C, 2011, BONE MARROW TRANSPL, V46, P659, DOI 10.1038/bmt.2010.192; Ozawa S, 2007, BRIT J HAEMATOL, V137, P142, DOI 10.1111/j.1365-2141.2007.06543.x; Murata M, 2013, BIOL BLOOD MARROW TR, V19, P1183, DOI 10.1016/j.bbmt.2013.05.003; Hiraoka A, 2001, BONE MARROW TRANSPL, V28, P181, DOI 10.1038/sj.bmt.1703097; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Ichinohe T, 2004, BLOOD, V104, P3821, DOI 10.1182/blood-2004-03-1212; Kanda Y, 2004, LEUKEMIA, V18, P1013, DOI 10.1038/sj.leu.2403343; Ogawa Y, 2010, BONE MARROW TRANSPL, V45, P565, DOI 10.1038/bmt.2009.173; Perkins J, 2010, BIOL BLOOD MARROW TR, V16, P937, DOI 10.1016/j.bbmt.2010.01.010; SULLIVAN KM, 1988, BLOOD, V72, P546; Kasamon YL, 2010, BIOL BLOOD MARROW TR, V16, P482, DOI 10.1016/j.bbmt.2009.11.011; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; Sato A, 2011, BONE MARROW TRANSPL, V46, P257, DOI 10.1038/bmt.2010.91; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; Ruggeri A, 2014, LEUKEMIA, V28, P779, DOI 10.1038/leu.2013.259; Maeda Y, 2013, INT J HEMATOL, V98, P293, DOI 10.1007/s12185-013-1421-x; Machishima T, 2013, CLIN TRANSPLANT, V27, P749, DOI 10.1111/ctr.12213; Nishida T, 2004, BONE MARROW TRANSPL, V33, P1143, DOI 10.1038/sj.bmt.1704512; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Huang XJ, 2012, BLOOD, V119, P5584, DOI 10.1182/blood-2011-11-389809; Ooi J, 2008, BIOL BLOOD MARROW TR, V14, P1341, DOI 10.1016/j.bbmt.2008.09.007; Oh H, 2005, BLOOD, V105, P1408, DOI 10.1182/blood-2004-06-2385; Furukawa T, 2010, INT J HEMATOL, V92, P144, DOI 10.1007/s12185-010-0610-0; Yanada M, 2004, BONE MARROW TRANSPL, V34, P331, DOI 10.1038/sj.bmt.1704596; Kojima S, 2002, BLOOD, V100, P799, DOI 10.1182/blood.V100.3.799; MARTIN PJ, 1990, BLOOD, V76, P1464; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Nagamura F, 2003, BONE MARROW TRANSPL, V32, P1051, DOI 10.1038/sj.bmt.1704259; Kanekiyo T, 2005, INT J HEMATOL, V81, P264, DOI 10.1532/IJH97.04162; Koc S, 2002, BLOOD, V100, P48, DOI 10.1182/blood.V100.1.48; Onizuka M, 2011, BONE MARROW TRANSPL, V46, P1113, DOI 10.1038/bmt.2010.273; Van Lint MT, 1998, BLOOD, V92, P2288; Paczesny S, 2013, INT J HEMATOL, V98, P275, DOI 10.1007/s12185-013-1406-9; Hockenbery DM, 2007, BLOOD, V109, P4557, DOI 10.1182/blood-2006-05-021139; Kanda Y, 2005, TRANSPLANTATION, V79, P1351, DOI 10.1097/01.TP.0000158718.49276.14; Koc S, 2000, BLOOD, V96, P3995; Kanda Y, 2013, AM J HEMATOL, V88, P294, DOI 10.1002/ajh.23392; Kanda Y, 2006, AM J HEMATOL, V81, P838, DOI 10.1002/ajh.20710; Inagaki J, 2008, BONE MARROW TRANSPL, V41, P571, DOI 10.1038/sj.bmt.1705922; Onishi C, 2010, INT J HEMATOL, V91, P464, DOI 10.1007/s12185-010-0516-x; Couriel DR, 2009, BIOL BLOOD MARROW TR, V15, P1555, DOI 10.1016/j.bbmt.2009.08.003; Ogawa N, 2004, BONE MARROW TRANSPL, V33, P549, DOI 10.1038/sj.bmt.1704374; Socie G, 2011, BLOOD, V117, P6375, DOI 10.1182/blood-2011-01-329821; Kishi Y, 2005, TRANSPLANTATION, V80, P34, DOI 10.1097/01.TP.0000163289.20406.86; Terasako K, 2010, HEMATOLOGY, V15, P165, DOI 10.1179/102453309X12583347113852; Ogawa H, 2006, BIOL BLOOD MARROW TR, V12, P1073, DOI 10.1016/j.bbmt.2006.06.007; Yaguchi S, 2012, BONE MARROW TRANSPL, V47, P1465, DOI 10.1038/bmt.2012.50; STORB R, 1986, BLOOD, V68, P119; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Bacigalupo A, 2006, BIOL BLOOD MARROW TR, V12, P560, DOI 10.1016/j.bbmt.2005.12.034; Martin PJ, 2009, BLOOD, V113, P5074, DOI 10.1182/blood-2009-02-202937; Nasu R, 2014, ANN HEMATOL, V93, P1215, DOI 10.1007/s00277-014-2027-y; Aversa F, 2005, J CLIN ONCOL, V23, P3447, DOI 10.1200/JCO.2005.09.117; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Yagasaki H, 2009, BIOL BLOOD MARROW TR, V15, P1603, DOI 10.1016/j.bbmt.2009.08.012; Inamoto Y, 2009, BONE MARROW TRANSPL, V44, P43, DOI 10.1038/bmt.2008.419; Arora M, 2001, BIOL BLOOD MARROW TR, V7, P265, DOI 10.1053/bbmt.2001.v7.pm11400948; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; Ogawa H, 2008, EXP HEMATOL, V36, P1, DOI 10.1016/j.exphem.2007.08.013; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; MacMillan ML, 2010, BLOOD, V115, P5412, DOI 10.1182/blood-2009-12-258442; Okamoto M, 2006, LEUKEMIA, V20, P172, DOI 10.1038/sj.leu.2403996; Alousi AM, 2009, BLOOD, V114, P511, DOI 10.1182/blood-2009-03-212290; Arai Y, 2015, BONE MARROW TRANSPL, V50, P312, DOI 10.1038/bmt.2014.258; Azuma E, 1997, BONE MARROW TRANSPL, V19, P1085, DOI 10.1038/sj.bmt.1700795; Chien Jason W, 2010, Biol Blood Marrow Transplant, V16, pS106, DOI 10.1016/j.bbmt.2009.11.002; Cragg L, 2000, BIOL BLOOD MARROW TR, V6, P441, DOI 10.1016/S1083-8791(00)70036-X; Date H, 2011, CURR OPIN ORGAN TRAN, V16, P453, DOI 10.1097/MOT.0b013e32834a9997; Fuji S, 2013, INT J HEMATOL, V98, P608, DOI 10.1007/s12185-013-1449-y; GONDO H, 1993, BONE MARROW TRANSPL, V12, P437; Hatanaka K, 2012, INT J HEMATOL, V96, P773, DOI 10.1007/s12185-012-1209-4; Hidaka M, 2010, BONE MARROW TRANSPL, V45, P912, DOI 10.1038/bmt.2009.251; Iida M, 2014, CLIN TRANSPLANT, V28, P980, DOI 10.1111/ctr.12405; Iida M, 2011, INT J HEMATOL, V93, P523, DOI 10.1007/s12185-011-0817-8; Ikegame K, 2012, INT J HEMATOL, V96, P101, DOI 10.1007/s12185-012-1097-7; Inagaki J, 2014, ANN HEMATOL, V93, P645, DOI 10.1007/s00277-013-1923-x; Inoue M, 1998, BONE MARROW TRANSPL, V22, P402, DOI 10.1038/sj.bmt.1701369; Iyama S, 2014, INT J HEMATOL, V99, P471, DOI 10.1007/s12185-014-1530-1; Izumi N, 2007, BONE MARROW TRANSPL, V40, P875, DOI 10.1038/sj.bmt.1705834; Kaida K, 2014, INT J HEMATOL, V99, P463, DOI 10.1007/s12185-014-1542-x; KANAMARU A, 1995, BONE MARROW TRANSPL, V15, P885; Kanda J, 2013, INT J HEMATOL, V98, P300, DOI 10.1007/s12185-013-1405-x; Kanda J, 2013, BIOL BLOOD MARROW TR, V19, P247, DOI 10.1016/j.bbmt.2012.09.017; Kato K, 2011, BIOL BLOOD MARROW TR, V17, P1814, DOI 10.1016/j.bbmt.2011.05.013; Kawano Y, 1998, BLOOD, V92, P3123; Kodama Y, 2015, INT J HEMATOL, V101, P92, DOI 10.1007/s12185-014-1712-x; Koga Y, 2003, BONE MARROW TRANSPL, V32, P171, DOI 10.1038/sj.bmt.1704051; Kohno A, 2006, INT J HEMATOL, V84, P83, DOI 10.1532/IJH97.05171; Kojima S, 2001, BRIT J HAEMATOL, V114, P706, DOI 10.1046/j.1365-2141.2001.02992.x; Konuma T, 2009, ANN HEMATOL, V88, P581, DOI 10.1007/s00277-008-0641-2; Kurokawa T, 2010, INT J HEMATOL, V91, P661, DOI 10.1007/s12185-010-0561-5; Kuwatsuka Y, 2014, BIOL BLOOD MARROW TR, V20, P662, DOI 10.1016/j.bbmt.2014.01.020; Lee SJ, 2004, BLOOD, V104, P1559, DOI 10.1182/blood-2004-03-0854; Martin PJ, 2004, INT J HEMATOL, V79, P221, DOI 10.1532/IJH97.03176; Matsuda Y, 1998, BONE MARROW TRANSPL, V21, P355, DOI 10.1038/sj.bmt.1701095; Miyakoshi S, 2007, TRANSPLANTATION, V84, P316, DOI 10.1097/01.tp.0000269796.23593.16; Miyakoshi S, 2004, CLIN CANCER RES, V10, P3586, DOI 10.1158/1078-0432.CCR-03-0754; Mizumoto C, 2009, INT J HEMATOL, V89, P538, DOI 10.1007/s12185-009-0306-5; Mochizuki K, 2011, CLIN TRANSPLANT, V25, P892, DOI 10.1111/j.1399-0012.2010.01352.x; Mori T, 2007, TRANSPL P, V39, P1615, DOI 10.1016/j.transproceed.2006.12.042; Mori T, 2012, BIOL BLOOD MARROW TR, V18, P229, DOI 10.1016/j.bbmt.2011.06.008; MORISHIMA Y, 1995, BONE MARROW TRANSPL, V15, P235; Morishima Y, 2013, BIOL BLOOD MARROW TR, V19, P1197, DOI 10.1016/j.bbmt.2013.05.020; MORISHIMA Y, 1989, BLOOD, V74, P2252; Nakai K, 2003, TRANSPLANTATION, V75, P2135, DOI 10.1097/01.TP.0000066453.32263.F7; Nakane T, 2015, LEUK LYMPHOMA; Nakaseko C, 2011, INT J HEMATOL, V93, P375, DOI 10.1007/s12185-011-0809-8; Nakasone H, 2013, TRANSPL INT, V26, P631, DOI 10.1111/tri.12093; Nakasone H, 2015, BONE MARROW TRANSPL, V50, P559, DOI 10.1038/bmt.2014.293; Narimatsu H, 2007, BONE MARROW TRANSPL, V39, P31, DOI 10.1038/sj.bmt.1705539; Nishida T, 2009, INT J HEMATOL, V89, P98, DOI 10.1007/s12185-008-0219-8; Nishikawa S, 2009, TRANSPL P, V41, P3873, DOI 10.1016/j.transproceed.2009.06.231; Nishimoto M, 2015, EXP HEMATOL, V43, P177, DOI 10.1016/j.exphem.2014.11.008; Obama K, 2004, BONE MARROW TRANSPL, V34, P897, DOI 10.1038/sj.bmt.1704692; Ogawa H, 2002, TRANSPLANTATION, V74, P236, DOI 10.1097/00007890-200207270-00015; Ohashi K, 2003, INT J HEMATOL, V77, P99, DOI 10.1007/BF02982612; Okumura H, 2007, INT J HEMATOL, V86, P369, DOI 10.1532/IJH97.07045; Ooi J, 2004, BLOOD, V103, P489, DOI 10.1182/blood-2003-07-2420; Ratanatharathorn V, 1998, BLOOD, V92, P2303; Sao H, 1999, INT J HEMATOL, V69, P27; Sawada A, 2014, PEDIATR HEMAT ONCOL, V31, P754, DOI 10.3109/08880018.2014.961214; Shimazaki C, 2003, BLOOD, V101, P3334, DOI 10.1182/blood-2002-09-2883; Sugita J, 2012, BONE MARROW TRANSPL, V47, P258, DOI 10.1038/bmt.2011.53; Takami A, 2006, INT J HEMATOL, V83, P80, DOI 10.1532/IJH97.05111; Takami A, 2013, INT J HEMATOL, V98, P309, DOI 10.1007/s12185-013-1416-7; Takashima S, 2014, INTERNAL MED, V53, P1315, DOI 10.2169/internalmedicine.53.1858; Tanosaki R, 2008, BIOL BLOOD MARROW TR, V14, P702, DOI 10.1016/j.bbmt.2008.03.010; Teshima T, 2005, BRIT J HAEMATOL, V130, P575, DOI 10.1111/j.1365-2141.2005.05632.x; Theurich S, 2012, COCHRANE DB SYST REV, V9; Uchida N, 2011, TRANSPLANTATION, V92, P366, DOI 10.1097/TP.0b013e318223d7ac; Uchida Naoyuki, 2008, Biol Blood Marrow Transplant, V14, P583, DOI 10.1016/j.bbmt.2008.03.003; Umeda K, 2015, PEDIATR BLOOD CANCER, V62, P291, DOI 10.1002/pbc.25243; Wada H, 2001, TRANSPLANTATION, V72, P1451, DOI 10.1097/00007890-200110270-00020; Wakahashi K, 2011, INT J HEMATOL, V94, P193, DOI 10.1007/s12185-011-0888-6; Wakatabe K, 2014, 56 ASH ANN M EXP DEC; Watanabe N, 2008, INT J HEMATOL, V88, P575, DOI 10.1007/s12185-008-0211-3; Watanabe N, 2010, BONE MARROW TRANSPL, V45, P1161, DOI 10.1038/bmt.2009.327; Yabe H, 2004, INT J HEMATOL, V80, P78, DOI 10.1532/ijh97.04004; Yabe H, 1996, BONE MARROW TRANSPL, V17, P985; Yamada MF, 2008, TRANSPL P, V40, P3637, DOI 10.1016/j.transproceed.2008.06.102; Yamane M, 2008, TRANSPLANTATION, V86, P1767, DOI 10.1097/TP.0b013e318190b0be; Yamane T, 2003, LEUKEMIA LYMPHOMA, V44, P2095, DOI 10.1080/1042819031000123483; Yano S, 2015, ANN HEMATOL, V94, P491, DOI 10.1007/s00277-014-2233-7; Yoshihara T, 2007, INT J HEMATOL, V85, P246, DOI 10.1532/IJH97.06185	161	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAY	2015	101	5					467	486		10.1007/s12185-015-1784-2		20	Hematology	Hematology	CH7KB	WOS:000354213800006		
J	Sato, M; Kako, S; Matsumoto, K; Oshima, K; Akahoshi, Y; Nakano, H; Ugai, T; Yamasaki, R; Wada, H; Ishihara, Y; Sakamoto, K; Kawamura, K; Ashizawa, M; Terasako-Saito, K; Kimura, S; Nakasone, H; Kikuchi, M; Tanihara, A; Yamazaki, R; Tanaka, Y; Kanda, J; Nishida, J; Morita, K; Kanda, Y				Sato, Miki; Kako, Shinichi; Matsumoto, Kana; Oshima, Kumi; Akahoshi, Yu; Nakano, Hirofumi; Ugai, Tomotaka; Yamasaki, Ryoko; Wada, Hidenori; Ishihara, Yuko; Sakamoto, Kana; Kawamura, Koji; Ashizawa, Masahiro; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Nakasone, Hideki; Kikuchi, Misato; Tanihara, Aki; Yamazaki, Rie; Tanaka, Yukie; Kanda, Junya; Nishida, Junji; Morita, Kunihiko; Kanda, Yoshinobu			Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Once-daily intravenous busulfan; Hematopoietic stem cell transplantation; Conditioning regimen; Pharmacokinetics; Area under the plasma concentration versus time curve	BONE-MARROW-TRANSPLANTATION; TOTAL-BODY IRRADIATION; HIGH-DOSE BUSULFAN; DAILY IV BUSULFAN; VENOOCCLUSIVE DISEASE; TARGETED BUSULFAN; FLUDARABINE; MORTALITY; EXPOSURE; FAILURE	In Japan, intravenous busulfan (ivBu) is usually given four times per day as an infusion at 0.8 mg/kg over 2 h. However, as this requires a midnight administration, a once-daily infusion of ivBu at 3.2 mg/kg over 3 h has been investigated as a more convenient and safer method. In this study, 20 Japanese patients received once-daily ivBu in conditioning regimens before allogeneic hematopoietic stem cell transplantation (HSCT), and blood samples were obtained just before, and 3, 3.5, 5, 7, 10, and 24 h after the initiation of ivBu infusion. The outcomes of HSCT were evaluated prospectively. The median area under the plasma concentration versus time curve (AUC) of Bu was 5272 mu mol x min/L (range 3491-6284 mu mol x min/L), and was similar to those in previous once-daily ivBu studies and to the estimated daily AUC in previous 4-times-daily ivBu studies. All of the patients but two, who died early due to infection, achieved neutrophil engraftment at a median of 25 days after transplantation. No patient was diagnosed with veno-occlusive disease according to the criteria established by Jones. No regimen-related toxicity was significantly associated with AUC. In conclusion, once-daily administration of ivBu has a stable pharmacokinetic profile, and was safely performed in Japanese patients.	[Sato, Miki; Kako, Shinichi; Oshima, Kumi; Akahoshi, Yu; Nakano, Hirofumi; Ugai, Tomotaka; Yamasaki, Ryoko; Wada, Hidenori; Ishihara, Yuko; Sakamoto, Kana; Kawamura, Koji; Ashizawa, Masahiro; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Nakasone, Hideki; Kikuchi, Misato; Tanihara, Aki; Yamazaki, Rie; Tanaka, Yukie; Kanda, Junya; Nishida, Junji; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, Saitama 3308503, Japan; [Matsumoto, Kana; Morita, Kunihiko] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Kyoto, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp			Otsuka Pharmaceutical Company	Y. Kanda received research funding and honorarium from the Otsuka Pharmaceutical Company.	Deeg HJ, 2002, BLOOD, V100, P1201, DOI 10.1182/blood-2002-02-0527; Madden T, 2007, BIOL BLOOD MARROW TR, V13, P56, DOI 10.1016/j.bbmt.2006.08.037; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Hartman AR, 1998, BONE MARROW TRANSPL, V22, P439, DOI 10.1038/sj.bmt.1701334; JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011; Gibbs JP, 1999, BLOOD, V93, P4436; HASSAN M, 1991, CANCER CHEMOTH PHARM, V28, P130, DOI 10.1007/BF00689702; Buggia I, 1996, ANTICANCER RES, V16, P2083; Choe S, 2012, KOREAN J PHYSIOL PHA, V16, P273, DOI 10.4196/kjpp.2012.16.4.273; Kangarloo SB, 2012, BIOL BLOOD MARROW TR, V18, P295, DOI 10.1016/j.bbmt.2011.07.015; Russell JA, 2002, BIOL BLOOD MARROW TR, V8, P468, DOI 10.1053/bbmt.2002.v8.pm12374451; MCDONALD GB, 1993, ANN INTERN MED, V118, P255; Slattery JT, 1997, BLOOD, V89, P3055; Bornhauser M, 2003, BLOOD, V102, P820, DOI 10.1182/blood-2002-11-3567; Sandstrom M, 2001, BONE MARROW TRANSPL, V28, P657, DOI 10.1038/sj.bmt.1703229; Dix SP, 1996, BONE MARROW TRANSPL, V17, P225; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562; Bredeson C, 2013, BLOOD, V122, P3871, DOI 10.1182/blood-2013-08-519009; Copelan EA, 2001, BONE MARROW TRANSPL, V27, P1121, DOI 10.1038/sj.bmt.1703047; Fuji S, 2013, INT J HEMATOL, V98, P608, DOI 10.1007/s12185-013-1449-y; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GROCHOW LB, 1993, SEMIN ONCOL, V20, P18; Grochow LB, 1993, SEMIN ONCOL S4, V20, P26; HASSAN M, 1989, EUR J CLIN PHARMACOL, V36, P525, DOI 10.1007/BF00558081; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim SW, 2009, BONE MARROW TRANSPL, V43, P611, DOI 10.1038/bmt.2008.372; Russell JA, 2013, BIOL BLOOD MARROW TR, V19, P1381, DOI 10.1016/j.bbmt.2013.07.002; Ryu SG, 2007, BIOL BLOOD MARROW TR, V13, P1095, DOI 10.1016/j.bbmt.2007.06.005	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAY	2015	101	5					497	504		10.1007/s12185-015-1756-6		8	Hematology	Hematology	CH7KB	WOS:000354213800008		
J	Kojima, M; Nakamura, N; Yabe, M; Tokunaka, M; Kikuti, YY; Kikuchi, T; Murayama, H; Moriuchi, M; Tsuboi, K; Ogawa, Y; Ando, K				Kojima, Minoru; Nakamura, Naoya; Yabe, Miharu; Tokunaka, Mami; Kikuti, Yara Yukie; Kikuchi, Tomoki; Murayama, Hiromichi; Moriuchi, Makiko; Tsuboi, Kosuke; Ogawa, Yoshiaki; Ando, Kiyoshi			A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Immunoglobulin heavy chain; VDJ rearrangement; Burkitt lymphoma	NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMA; THERAPY; ADULTS; REARRANGEMENT; RECURRENCE; LEUKEMIA; CHILDREN	We report a case of HIV-negative Burkitt lymphoma (BL) that relapsed 9 years after complete remission. We performed a polymerase chain reaction analysis of three regions of the VDJ junction of the immunoglobulin heavy chain (IGH) gene and compared the clonality of the first and second BL lesions, which were found to be clonally distinct. The patient received the R-Hyper CVAD/R-MA regimen; however, leukoencephalopathy subsequently developed due to the effect of cytarabine, and the regimen was changed to R-IVAM. The patient achieved complete remission and received high-dose chemotherapy following autologous stem cell transplantation. He maintained the complete remission for 72 months after transplantation. Given this outcome, we suggest that clonally distinct relapse of HIV-negative BL may exhibit a good prognosis.	[Kojima, Minoru; Murayama, Hiromichi; Moriuchi, Makiko; Ogawa, Yoshiaki; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Isehara, Kanagawa 2591143, Japan; [Nakamura, Naoya; Tokunaka, Mami; Kikuti, Yara Yukie; Kikuchi, Tomoki] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591143, Japan; [Yabe, Miharu] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 2591143, Japan; [Tsuboi, Kosuke] Nagaoka Chuo Gen Hosp, Dept Internal Med, Niigata, Japan	Kojima, M (reprint author), Tokai Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	kojima@tokai-u.jp					Wasterlid T, 2013, ANN ONCOL, V24, P1879, DOI 10.1093/annonc/mdt058; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Nguyen JT, 2014, J PEDIAT HEMATOL ONC, V36, pE125, DOI 10.1097/MPH.0b013e318290b9e6; Libra M, 2004, LEUKEMIA LYMPHOMA, V45, P1539, DOI 10.1080/10428190310001657308; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Dunleavy K, 2013, NEW ENGL J MED, V369, P1915, DOI 10.1056/NEJMoa1308392; Nishiuchi R, 1996, CANCER, V77, P757, DOI 10.1002/(SICI)1097-0142(19960215)77:4<757::AID-CNCR23>3.3.CO;2-9; BURKITT DP, 1969, J NATL CANCER I, V42, P19; Kikuchi A, 2008, LEUKEMIA LYMPHOMA, V49, P757, DOI 10.1080/10428190701843239; Lister J, 1996, BLOOD, V88, P1407; MAGRATH IT, 1984, BLOOD, V63, P1102; Nakamura N, 2001, LEUKEMIA, V15, P452, DOI 10.1038/sj.leu.2402031; SOUSSAIN C, 1995, BLOOD, V85, P664; Sweetenham JW, 1996, J CLIN ONCOL, V14, P2465; ZIEGLER JL, 1972, CANCER RES, V32, P1267	15	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	MAY	2015	101	5					520	524		10.1007/s12185-014-1729-1		5	Hematology	Hematology	CH7KB	WOS:000354213800011		
J	Okazaki, K				Okazaki, Kenta			An elementary proof of a non-triviality of the E-8 subfactor planar algebra	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Subfactor; planar algebra; Kuperberg program; planar graph	CLASSIFICATION; FLATNESS; INDEX; SKEIN	In this paper, we show in a combinatorial way that the 0-box space of the E-8 subfactor planar algebra is 1-dimensional. In the proof, we improve on Bigelow's relations for the E-8 subfactor planar algebra and give an efficient algorithm to reduce any planar diagram to the empty diagram.	Kyoto Univ, Math Sci Res Inst, Kyoto, Japan	Okazaki, K (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto, Japan.	junes@kurims.kyoto-u.ac.jp					KAWAHIGASHI Y, 1995, J FUNCT ANAL, V127, P63, DOI 10.1006/jfan.1995.1003; JONES VFR, 1983, INVENT MATH, V72, P1, DOI 10.1007/BF01389127; Bigelow S, 2010, J PURE APPL ALGEBRA, V214, P658, DOI 10.1016/j.jpaa.2009.07.010; POPA S, 1990, INVENT MATH, V101, P19, DOI 10.1007/BF01231494; BIONNADAL J, 1991, CURRENT TOPICS IN OPERATOR ALGEBRAS, P104; Goldman M., 1960, MICH MATH J, V7, P167; Goodman F. M., 1989, MATH SCI RES I PUBLI, V14; IZUMI M, 1991, PUBL RES I MATH SCI, V27, P953, DOI 10.2977/prims/1195169007; IZUMI M, 1994, PAC J MATH, V166, P305; Jones V., 1999, ARXIVMATH9909027V1MA, VI; Jones V. F. R., 2001, ESSAYS GEOMETRY RELA, V38, P401; Lickorish W.B.R., 1997, GRADUATE TEXTS MATH, V175; Morrison S, 2010, J PURE APPL ALGEBRA, V214, P117, DOI 10.1016/j.jpaa.2009.04.010; Morrison S., FORMULA JONES WENZL; Ocneanu A., 1991, U TOKYO SEMINARY NOT; Ocneanu Adrian, 1988, LONDON MATH SOC LECT, V2, P119; Okazaki K, 2013, ALGEBR GEOM TOPOL, V13, P3469, DOI 10.2140/agt.2013.13.3469; POPA S, 1990, CR ACAD SCI I-MATH, V311, P95; Suzuki N., 1962, TOHOKU MATH J, V14, P217, DOI 10.2748/tmj/1178244177	19	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAY	2015	26	5							1550037	10.1142/S0129167X15500378		31	Mathematics	Mathematics	CI0FK	WOS:000354411800009		
J	Someya, H; Fujiwara, H; Nagata, K; Wada, H; Hasegawa, K; Mikami, Y; Jinno, A; Sakai, H; Koyano, K; Kiyoshimai, T				Someya, Hirotaka; Fujiwara, Hiroaki; Nagata, Kengo; Wada, Hiroko; Hasegawa, Kana; Mikami, Yurie; Jinno, Akiko; Sakai, Hidetaka; Koyano, Kiyoshi; Kiyoshimai, Tamotsu			Thymosin beta 4 is associated with RUNX2 expression through the Smad and Akt signaling pathways in mouse dental epithelial cells	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						thymosin beta 4; RUNX2; calcification; odontogenesis; knockdown assay; Smad; Akt	TOOTH GERM DEVELOPMENT; ACTIN-SEQUESTERING PEPTIDE; LOWER 1ST MOLAR; FUNCTIONAL INVOLVEMENT; LOWER 1ST-MOLAR; DIFFERENTIATION; MORPHOGENESIS; PROMOTES; ACTIVATION; TRANSCRIPTION	In previous studies by our group, we reported that thymosin beta 4 (Tb4) is closely associated with the initiation and development of the tooth germ, and can induce the expression of runt-related transcription factor 2 (RUNX2) during the development of the tooth germ. RUNX2 regulates the expression of odontogenesis-related genes, such as amelogenin, X-linked (Amelx), ameloblastin (Ambn) and enamelin (Enam), as well as the differentiation of osteoblasts during bone formation. However, the mechanisms through which Tb4 induces the expression of RUNX2 remain unknown. In the present study, we employed a mouse dental epithelial cell line, mDE6, with the aim to elucidate these mechanisms. The mDE6 cells expressed odontogenesis-related genes, such as Runx2, Amelx, Ambn and Enam, and formed calcified matrices upon the induction of calcification, thus showing characteristics of odontogenic epithelial cells. The expression of odontogenesis-related genes, and the calcification of the mDE6 cells were reduced by the inhibition of phosphorylated Smad1/5 (p-Smad1/5) and phosphorylated Akt (p-Akt) proteins. Furthermore, we used siRNA against TM to determine whether RUNX2 expression and calcification are associated with TM expression in the mDE6 cells. The protein expression of p-Smad1/5 and p-Akt in the mDE6 cells was reduced by treatment with Tb4-siRNA. These results suggest that TM is associated with RUNX2 expression through the Smad and PI3K-Akt signaling pathways, and with calcification through RUNX2 expression in the mDE6 cells. This study provides putative information concerning the signaling pathway through which Tb4 induces RUNX2 expression, which may help to understand the regulation of tooth development and tooth regeneration.	[Someya, Hirotaka; Fujiwara, Hiroaki; Nagata, Kengo; Wada, Hiroko; Hasegawa, Kana; Mikami, Yurie; Jinno, Akiko; Sakai, Hidetaka; Kiyoshimai, Tamotsu] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 8128582, Japan; [Someya, Hirotaka; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Sect Implant & Rehabilitat Dent, Fukuoka 8128582, Japan; [Hasegawa, Kana] Kyushu Univ, Fac Dent Sci, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fukuoka 8128582, Japan; [Mikami, Yurie; Jinno, Akiko] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Sect Oral & Maxillofacial Oncol, Fukuoka 8128582, Japan	Fujiwara, H (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tank@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20390466, 23659859, 25861747]	The authors wish to acknowledge support by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, no. 20390466 (to Hidetaka Sakai), no. 23659859 (to Tamotsu Kiyoshima) and no. 25861747 (to Hiroaki Fujiwara).	Akhter M, 2010, J MOL HISTOL, V41, P185, DOI 10.1007/s10735-010-9277-3; Hu Y, 2014, INT J CLIN EXP PATHO, V7, P5369; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; Zhang YQ, 2008, CANCER BIOL THER, V7, P419; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Camilleri S, 2006, EUR J ORAL SCI, V114, P361, DOI 10.1111/j.1600-0722.2006.00399.x; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Martin J. W., 2011, Sarcoma, P282745, DOI 10.1155/2011/282745; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Ookuma YF, 2013, HISTOCHEM CELL BIOL, V139, P355, DOI 10.1007/s00418-012-1033-1; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Lee HK, 2010, J CELL BIOCHEM, V111, P755, DOI 10.1002/jcb.22766; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; Akhter M, 2005, HISTOCHEM CELL BIOL, V124, P207, DOI 10.1007/s00418-005-0040-x; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; SAFER D, 1991, J BIOL CHEM, V266, P4029; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Kiyoshima T, 2014, STEM CELL RES, V12, P309, DOI 10.1016/j.scr.2013.11.006; Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Oh SY, 2006, EXP CELL RES, V312, P1651, DOI 10.1016/j.yexcr.2006.01.030; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Cho KW, 2009, J EXP ZOOL PART B, V312B, P901, DOI 10.1002/jez.b.21309; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0; Honda J, 2011, J MOL HISTOL, V42, P83, DOI 10.1007/s10735-010-9309-z; Honda JY, 2008, HISTOL HISTOPATHOL, V23, P423; Hou X, 2012, INT J MOL SCI, V13, P7902, DOI 10.3390/ijms13077902; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Kihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103928; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Kumamoto H, 2007, ORAL DIS, V13, P461, DOI 10.1111/j.1601-0825.2006.01321.x; Lee SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061960; Ma P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112243; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4; Shiotsuka M, 2013, INT J DEV BIOL, V57, P873, DOI 10.1387/ijdb.120240hs; Stock M, 2005, J CELL BIOCHEM, V95, P506, DOI 10.1002/jcb.20471; Takahashi KF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-115; Takayama T, 2005, J PERIODONTOL, V76, P244, DOI 10.1902/jop.2005.76.2.244; Wada H, 2002, HISTOCHEM J, V34, P105, DOI 10.1023/A:1020930228303; Xie M, 2009, J MOL HISTOL, V40, P361, DOI 10.1007/s10735-009-9249-7; Xie M, 2007, J BIOL CHEM, V282, P23275, DOI 10.1074/jbc.M610779200; Xu L, 2007, OPEN BIOTECHNOL J, V1, P18; Yamaza H, 2001, INT J DEV BIOL, V45, P675; Yang GB, 2014, J BIOL CHEM, V289, P31492, DOI 10.1074/jbc.M114.600064	51	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2015	35	5					1169	1178		10.3892/ijmm.2015.2118		10	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IQ	WOS:000353849300003		
J	Yamada, Y; Matsui, K; Takeuchi, I; Oguri, M; Fujimaki, T				Yamada, Yoshiji; Matsui, Kota; Takeuchi, Ichiro; Oguri, Mitsutoshi; Fujimaki, Tetsuo			Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						hypertension; genetics; polymorphism; genetic epidemiology; longitudinal study	GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; JAPANESE INDIVIDUALS; RISK-FACTORS; FOLLOW-UP; LOCI; SUSCEPTIBILITY; BTN2A1; IDENTIFICATION	We previously identified 9 genes and chromosomal region 3q28 as susceptibility loci for Japanese patients with myocardial infarction, ischemic stroke, or chronic kidney disease by genome-wide or candidate gene association studies. In the present study, we investigated the possible association of 13 single nucleotide polymorphisms (SNPs) at these 10 loci with the prevalence of hypertension or their association with blood pressure (BP) in community-dwelling individuals in Japan. The study subjects comprised 6,027 individuals (2,250 subjects with essential hypertension, 3,777 controls) who were recruited into the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study on atherosclerotic, cardiovascular and metabolic diseases. The subjects were recruited from individuals who visited the Health Care Center of Inabe General Hospital for an annual health checkup, and they are followed up each year (mean follow-up period, 5 years). Longitudinal analysis with a generalized estimating equation and with adjustment for age, gender, body mass index and smoking status revealed that rs2116519 of family with sequence similarity 78, member B (FAM78B; P=0.0266), rs6929846 of butyrophilin, subfamily 2, member A1 (BTN2A1; P=0.0013), rs146021107 of pancreatic and duodenal homeobox 1 (PDX1; P=0.0031) and rs1671021 of lethal giant larvae homolog 2 (Drosophila) (LLGL2; P=0.0372) were significantly (P<0.05) associated with the prevalence of hypertension. Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for age, gender, body mass index and smoking status among individuals not taking anti-hypertensive medication revealed that rs6929846 of BTN2A1 was significantly associated with systolic (P=0.0017), diastolic (P=0.0008) and mean (P=0.0005) BP, and that rs2116519 of FAM78B, rs146021107 of PDX1 and rs1671021 of LLGL2 were significantly associated with diastolic (P=0.0495), systolic (P=0.0132), and both diastolic (P=0.0468) and mean (0.0471) BP, respectively. BTN2A1 may thus be a susceptibility gene for hypertension.	[Yamada, Yoshiji] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 5148507, Japan; [Yamada, Yoshiji; Matsui, Kota; Takeuchi, Ichiro] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Matsui, Kota; Takeuchi, Ichiro] Nagoya Inst Technol, Grad Sch Engn, Dept Sci & Engn Simulat, Nagoya, Aichi 4668555, Japan; [Oguri, Mitsutoshi] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi 4538511, Japan; [Fujimaki, Tetsuo] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe, Mie 5110428, Japan	Yamada, Y (reprint author), Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	yamada@gene.mie-u.ac.jp			CREST, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [24590746]	This study was supported by the CREST, Japan Science and Technology Agency (to Y.Y. and I.T.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 24590746 to Y.Y.).	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Chae CU, 2001, HYPERTENSION, V38, P399; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Fujimaki T, 2009, THROMB HAEMOSTASIS, V101, P963, DOI 10.1160/TH08-11-0761; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152; STAMLER J, 1989, HYPERTENSION, V14, P570; Oguri M, 2009, ATHEROSCLEROSIS, V206, P486, DOI 10.1016/j.atherosclerosis.2009.02.037; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Androulakis ES, 2009, CARDIOL REV, V17, P216, DOI 10.1097/CRD.0b013e3181b18e03; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Schillaci G, 2003, J HYPERTENS, V21, P1841, DOI 10.1097/01.hjh.0000084764.37215.60; Kupper N, 2005, HYPERTENSION, V45, P80, DOI 10.1161/01.HYP.0000149952.84391.54; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; Yamada Y, 2009, ATHEROSCLEROSIS, V207, P144, DOI 10.1016/j.atherosclerosis.2009.03.038; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Kannel WB, 2000, AM J CARDIOL, V85, P251, DOI 10.1016/S0002-9149(99)00635-9; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Sacco RL, 1997, STROKE, V28, P1507; PERLOFF D, 1993, CIRCULATION, V88, P2460; Yamada Y, 2013, J MED GENET, V50, P410, DOI 10.1136/jmedgenet-2013-101518; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Fujimaki T, 2014, BIOMED REP, V2, P127; Horibe H, 2011, AM J HYPERTENS, V24, P924, DOI 10.1038/ajh.2011.74; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Murakata Y, 2014, BIOMED REP, V2, P818; Oguri M, 2011, J MED GENET, V48, P787, DOI 10.1136/jmg.2010.088138; Oguri M, 2013, BIOMED REP, V1, P868; Shimokata S, 2013, BIOMED REP, V1, P940, DOI DOI 10.3892/BR.2013.173; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Ueyama C, 2013, BIOMED REP, V1, P840; Horibe H, 2014, MOL MED REP, V9, P808, DOI 10.3892/mmr.2014.1902; Yamada Y, 2006, THROMB HAEMOSTASIS, V96, P220, DOI 10.1160/TH06-02-0117; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200	45	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2015	35	5					1189	1198		10.3892/ijmm.2015.2151		10	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IQ	WOS:000353849300005		
J	Ishikawa, T; Takizawa, T; Iwaki, J; Mishima, T; Ui-Tei, K; Takeshita, T; Matsubara, S; Takizawa, T				Ishikawa, Tomoko; Takizawa, Takami; Iwaki, Jun; Mishima, Takuya; Ui-Tei, Kumiko; Takeshita, Toshiyuki; Matsubara, Shigeki; Takizawa, Toshihiro			Fc gamma receptor IIb participates in maternal IgG trafficking of human placental endothelial cells	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						Fc gamma region receptor IIb; maternal IgG; human placenta; placental endothelial cells; RAS-related protein Rab-3D	COATED PIT LOCALIZATION; TRANSCYTOTIC PATHWAY; REGULATED SECRETION; CRYSTAL-STRUCTURE; IMMUNOGLOBULIN-G; TRANSPORT; EXPRESSION; RAB3D; RIIB; FC-GAMMA-RIIB2	The human placental transfer of maternal IgG is crucial for fetal and newborn immunity. Low-affinity immunoglobulin gamma Fc region receptor IIb2 (FCGR2B2 or Fc gamma RIIb2) is exclusively expressed in an IgG-containing, vesicle-like organelle (the FCGR2B2 compartment) in human placental endothelial cells; thus, we hypothesized that the FCGR2B2 compartment functions as an IgG transporter. In this study, to examine this hypothesis, we performed in vitro bio-imaging analysis of IgG trafficking by FCGR2B2 compartments using human umbilical vein endothelial cells transfected with a plasmid vector containing enhanced GFP-tagged FCGR2B2 (pFCGR2B2-EGFP). FCGR2B2-EGFP signals were detected as intracellular vesicular structures similar to FCGR2B2 compartments in vivo. The internalization and transcytosis of IgG was significantly higher in the pFCGR2B2-EGFP-transfected cells than in the mock-transfected cells, and the majority of the internalized IgG was co-localized with the FCGR2B2-EGFP signals. Furthermore, we isolated FCGR2B2 compartments from the human placenta and found that the Rab family of proteins [RAS-related protein Rab family (RABs)] were associated with FCGR2B2 compartments. Among the RABs, RAB3D was expressed predominantly in placental endothelial cells. The downregulation of RAB3D by small interfering RNA (siRNA) resulted in a marked reduction in the FCGR2B2-EGFP signals at the cell periphery. Taken together, these findings suggest that FCGR2B2 compartments participate in the transcytosis of maternal IgG across the human placental endothelium and that RAB3D plays a role in regulating the intracellular dynamics of FCGR2B2 compartments.	[Ishikawa, Tomoko; Takizawa, Takami; Iwaki, Jun; Mishima, Takuya; Takizawa, Toshihiro] Nippon Med Sch, Dept Mol Med & Anat, Tokyo 1138602, Japan; [Ui-Tei, Kumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo 1138602, Japan; [Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan	Takizawa, T (reprint author), Nippon Med Sch, Dept Mol Med & Anat, 1-1-5 Sendagi, Tokyo 1138602, Japan.	t-takizawa@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (MEXT), Japan; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	We would like to thank Akira Katayama for assisting in LC-MS/MS and Takuji Kosuge for providing technical assistance. This study was supported in part by Grants-in-Aid for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science (MEXT), Japan and by a grant from the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2013-2017).	Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Mohanty S, 2010, J REPROD IMMUNOL, V84, P133, DOI 10.1016/j.jri.2009.10.008; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; PULFORD K, 1986, IMMUNOLOGY, V57, P71; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Takizawa T, 2005, J IMMUNOL, V175, P2331; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Roopenian DC, 2003, J IMMUNOL, V170, P3528; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Dickinson BL, 2008, MOL BIOL CELL, V19, P414, DOI 10.1091/mbc.E07-07-0658; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; SEDMAK DD, 1991, AM J PATHOL, V138, P175; Jung ST, 2010, P NATL ACAD SCI USA, V107, P604, DOI 10.1073/pnas.0908590107; Lyden TW, 2001, J IMMUNOL, V166, P3882; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Mukhopadhyay A, 2011, J CELL SCI, V124, P765, DOI 10.1242/jcs.079020; Callanan MB, 2000, P NATL ACAD SCI USA, V97, P309, DOI 10.1073/pnas.97.1.309; DANCIS J, 1961, AM J OBSTET GYNECOL, V82, P167; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Larkin JM, 2000, HEPATOLOGY, V32, P348, DOI 10.1053/jhep.2000.9110; LEACH L, 1994, PLACENTA, V15, P355, DOI 10.1016/0143-4004(94)90003-5; McPherson PS, 2010, PROTEOMICS, V10, P4025, DOI 10.1002/pmic.201000253; Medgyesi David, 2004, European Journal of Immunology, V34, P1127, DOI 10.1002/eji.200324733; Millar AL, 2002, HISTOL HISTOPATHOL, V17, P929; Mishima T, 2007, PLACENTA, V28, P170, DOI 10.1016/j.placenta.2006.01.024; Mohanty S, 2010, PLACENTA, V31, P144, DOI 10.1016/j.placenta.2009.11.007; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202	53	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2015	35	5					1273	1289		10.3892/ijmm.2015.2141		17	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IQ	WOS:000353849300014		
J	Yamada, Y; Matsui, K; Takeuchi, I; Fujimaki, T				Yamada, Yoshiji; Matsui, Kota; Takeuchi, Ichiro; Fujimaki, Tetsuo			Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						dyslipidemia; chronic kidney disease; genetics; polymorphism; longitudinal study	EAST-ASIAN POPULATIONS; METABOLIC SYNDROME; HEART-DISEASE; RISK-FACTORS; LIPID-LEVELS; ALL-CAUSE; LOCI; INFLAMMATION; BTN2A1; POLYMORPHISM	We previously identified 9 genes and chromosomal region 3q28 as susceptibility loci for myocardial infarction, ischemic stroke, or chronic kidney disease (CKD) in Japanese individuals by genome-wide or candidate gene association studies. In the present study, we examined the association of 13 polymorphisms at these 10 loci with the prevalence of hypertriglyceridemia, hyper-low-density lipoprotein (LDL) cholesterolemia, hypo-high-density lipoprotein (HDL) cholesterolemia, or CKD in community-dwelling Japanese individuals. The study subjects comprised 6,027 individuals who were recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular and metabolic diseases. The subjects were recruited from individuals who visited the Health Care Center at Inabe General Hospital for an annual health checkup, and they were followed up each year (mean follow-up period, 5 years). Longitudinal analysis with a generalized estimating equation and with adjustment for covariates revealed that rs6929846 of butyrophilin, subfamily 2, member Al gene (BTN2A1) was significantly associated with the prevalence of hypertriglyceridemia (P=0.0001), hyper-LDL cholesterolemia (P=0.0004), and CKD (P=0.0007); rs2569512 of interleukin enhancer binding factor 3 (ILF3) was associated with hyper-LDL cholesterolemia (P=0.0029); and rs2074379 (P=0.0019) and rs2074388 (P=0.0029) of alpha-kinase 1 (ALPK1) were associated with CKD. Longitudinal analysis with a generalized linear mixed-effect model and with adjustment for covariates among all individuals revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=0.0011), LDL cholesterol (P=3.3x10(-5)), and creatinine (P=0.0006), as well as with the estimated glomerular filtration rate (eGFR) (P=0.0004); rs2569512 of ILF3 was shown to be associated with the serum concentration of LDL cholesterol (P=0.0221); and rs2074379 (P=0.0302) and rs2074388 (P=0.0336) of ALPKI were shown to be associated with the serum concentration of creatinine. Similar analysis among individuals not taking any anti-dyslipidemic medication revealed that rs6929846 of BTN2A1 was significantly associated with the serum concentrations of triglycerides (P=8.3x10(-5)) and LDL cholesterol (P=0.0004), and that rs2569512 of ILF3 was associated with the serum concentration of LDL cholesterol (P=0.0010). BTN2A1 may thus be a susceptibility gene for hypertriglyceridemia, hyper-LDL cholesterolemia and CKD in Japanese individuals.	[Yamada, Yoshiji] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 5148507, Japan; [Yamada, Yoshiji; Matsui, Kota; Takeuchi, Ichiro] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Matsui, Kota; Takeuchi, Ichiro] Nagoya Inst Technol, Grad Sch Engn, Dept Sci & Engn Simulat, Nagoya, Aichi 4668555, Japan; [Fujimaki, Tetsuo] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe, Mie 5110428, Japan	Yamada, Y (reprint author), Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	yamada@gene.mie-u.ac.jp			CREST of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590746]	This study was supported by CREST of the Japan Science and Technology Agency (to Y.Y. and I.T.) and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24590746 to Y.Y.).	Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Schnaper HW, 2006, J AM SOC NEPHROL, V17, P1777, DOI 10.1681/ASN.2006030267; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Yamada Y, 2011, ATHEROSCLEROSIS, V215, P145, DOI 10.1016/j.atherosclerosis.2010.12.005; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Fujimaki T, 2009, THROMB HAEMOSTASIS, V101, P963, DOI 10.1160/TH08-11-0761; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Oguri M, 2009, ATHEROSCLEROSIS, V206, P486, DOI 10.1016/j.atherosclerosis.2009.02.037; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Yamada Y, 2007, GENOMICS, V90, P551, DOI 10.1016/j.ygeuo.2007.08.001; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamada Y, 2015, INT J MOL MED, V35, P1189, DOI 10.3892/ijmm.2015.2151; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Yamada Y, 2009, ATHEROSCLEROSIS, V207, P144, DOI 10.1016/j.atherosclerosis.2009.03.038; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Wang SJ, 2011, J MOL MED, V89, P1241, DOI 10.1007/s00109-011-0796-5; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Fujimaki T, 2011, EXP THER MED, V2, P745, DOI 10.3892/etm.2011.266; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Friedman DJ, 2011, J CLIN INVEST, V121, P3367, DOI 10.1172/JCI46263; Yamada Y, 2008, J MED GENET, V45, P22, DOI 10.1136/jmg.2007.052415; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Yamada Y, 2013, J MED GENET, V50, P410, DOI 10.1136/jmedgenet-2013-101518; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Arnett HA, 2009, CYTOKINE, V46, P370, DOI 10.1016/j.cyto.2009.03.009; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Fujimaki T, 2014, BIOMED REP, V2, P127; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Kawakami T., 2014, J AM SOC NEPHROL, V4, P107; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Murakata Y, 2014, BIOMED REP, V2, P818; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS1, DOI DOI 10.1053/AJKD.2002.30571.PUBMED:11904577; Oguri M, 2011, J MED GENET, V48, P787, DOI 10.1136/jmg.2010.088138; Oguri M, 2013, BIOMED REP, V1, P868; Ordovas JM, 2006, J AM DIET ASSOC, V106, P1074, DOI 10.1016/j.jada.2006.04.016; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Reiss Allison B, 2009, Curr Rheumatol Rep, V11, P255; Shimokata S, 2013, BIOMED REP, V1, P940, DOI DOI 10.3892/BR.2013.173; Takamatsu N, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-34; Ueyama C, 2013, BIOMED REP, V1, P840; Horibe H, 2014, MOL MED REP, V9, P808, DOI 10.3892/mmr.2014.1902; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yamada Y, 2006, THROMB HAEMOSTASIS, V96, P220, DOI 10.1160/TH06-02-0117; Yoshida T, 2011, NEPHROLOGY, V16, P642, DOI 10.1111/j.1440-1797.2011.01470.x	58	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2015	35	5					1290	1300		10.3892/ijmm.2015.2152		11	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IQ	WOS:000353849300015		
J	Matsuoka, R; Abe, S; Tokoro, F; Arai, M; Noda, T; Watanabe, S; Horibe, H; Fujimaki, T; Oguri, M; Kato, K; Minatoguchi, S; Yamada, Y				Matsuoka, Reiko; Abe, Shintaro; Tokoro, Fumitaka; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro; Horibe, Hideki; Fujimaki, Tetsuo; Oguri, Mitsutoshi; Kato, Kimihiko; Minatoguchi, Shinya; Yamada, Yoshiji			Association of six genetic variants with myocardial infarction	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						myocardial infarction; coronary artery disease; acute coronary syndrome; genetics; polymorphism	CORONARY-ARTERY-DISEASE; LIPOPROTEIN-LIPASE; GROWTH-FACTOR; CHROMOSOME 9P21.3; RISK; RECEPTOR; SUSCEPTIBILITY; POLYMORPHISMS; PLAQUES; STROKE	Although various genes that confer susceptibility to myocardial infarction (MI) have been identified for Caucasian populations in genome-wide association studies (GWAS), genetic variants related to this condition in Japanese individuals have not been identified definitively. The aim of the present study was to examine an association of MI in Japanese individuals with 29 polymorphisms identified as susceptibility loci for MI or coronary artery disease in Caucasian populations by meta-analyses of GWAS. The study subjects comprised 1,824 subjects with MI and 2,329 controls. Genotypes of the polymorphisms were determined by Luminex bead-based multiplex assay. To compensate for multiple comparisons, we adopted the criterion of a false discovery rate (FDR) of <0.05 for statistical significance for association. Comparisons of allele frequencies by the chi(2) test revealed that rs9369640 of the phosphatase and actin regulator 1 gene (PHACTRI, FDR=0.0007), rs4977574 of the CDKN2B antisense RNA 1 gene (CDKN2B-AS1,FDR=0.0038), rs264 of the lipoprotein lipase gene (LPL, FDR=0.0061), rs599839 of the proline/serine-rich coiled-coil 1 gene (PSRC1, FDR=0.0118), rs9319428 of the fms-related tyrosine kinase 1 gene (FLTI, FDR=0.0118) and rs12413409 of the cyclin and CBS domain divalent metal cation transport mediator 2 gene (CNNM2, FDR=0.0300) were significantly associated with MI. Multivariate logistic regression analysis with adjustment for covariates revealed that rs9369640 (P=0.0005; odds ratio, 0.89), rs4977574 (P=0.0001; odds ratio, 1.50), rs264 (P=0.0405; odds ratio, 0.85), rs599839 (P=0.0003; odds ratio, 0.68), rs9319428 (P=0.0155; odds ratio, 1.20) and rs12413409 (P=0.0076; odds ratio, 0.66) were significantly (P<0.05) associated with MI. PHACTRI, CDKN2B-AS1, LPL, PSRC1, FLTI and CNNM2 may thus be susceptibility loci for MI in Japanese individuals.	[Matsuoka, Reiko; Abe, Shintaro; Tokoro, Fumitaka; Arai, Masazumi; Noda, Toshiyuki; Watanabe, Sachiro] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu 5008717, Japan; [Horibe, Hideki] Gifu Prefectural Tajimi Hosp, Dept Cardiovasc Med, Tajimi 5078522, Japan; [Fujimaki, Tetsuo] Inabe Gen Hosp, Dept Cardiovasc Med, Inabe 5110428, Japan; [Oguri, Mitsutoshi] Japanese Red Cross Nagoya First Hosp, Dept Cardiol, Nagoya, Aichi 4538511, Japan; [Kato, Kimihiko] Meitoh Hosp, Dept Internal Med, Nagoya, Aichi 4650025, Japan; [Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu 5011194, Japan; [Yamada, Yoshiji] Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, Tsu, Mie 5148507, Japan	Yamada, Y (reprint author), Mie Univ, Life Sci Res Ctr, Dept Human Funct Genom, 1577 Kurima Machiya, Tsu, Mie 5148507, Japan.	yamada@gene.mie-u.ac.jp			Gifu Prefectural General Medical Center [H24-26]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24590746]	The present study was supported by a Collaborative Research Grant from the Gifu Prefectural General Medical Center (H24-26 to Y.Y.) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 24590746 to Y.Y.).	Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Eriksson JW, 2003, ATHEROSCLEROSIS, V166, P359, DOI 10.1016/S0021-9150(02)00366-0; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Patel RS, 2012, AM J HYPERTENS, V25, P797, DOI 10.1038/ajh.2012.41; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Pilarczyk K, 2008, ATHEROSCLEROSIS, V196, P333, DOI 10.1016/j.atherosclerosis.2006.10.038; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEMJoa072366; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; Roncal C, 2010, CARDIOVASC RES, V86, P29, DOI 10.1093/cvr/cvp380; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Khurana R, 2005, CIRCULATION, V111, P2828, DOI 10.1161/CIRCULATIONAHA.104.495887; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Fisher RM, 1997, ATHEROSCLEROSIS, V135, P145, DOI 10.1016/S0021-9150(97)00199-8; Consortium C. A. D., 2013, NAT GENET, V45, P25; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P445, DOI 10.1161/CIRCGENETICS.109.923508; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Peli W, 2013, FEBS J, V280, P596; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005	33	4	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2015	35	5					1451	1459		10.3892/ijmm.2015.2115		9	Medicine, Research & Experimental	Research & Experimental Medicine	CH2IQ	WOS:000353849300036		
J	Parisi, A; Nguyen, NT; Reim, D; Zhang, S; Jiang, ZW; Brower, ST; Azagra, JS; Facy, O; Alimoglu, O; Jackson, PG; Tsujimoto, H; Kurokawa, Y; Zang, L; Coburn, NG; Yu, PW; Zhang, B; Qi, F; Coratti, A; Annecchiarico, M; Novotny, A; Goergen, M; Lequeu, JB; Eren, T; Leblebici, M; Al-Refaie, W; Takiguchi, S; Ma, JJ; Zhao, YL; Liu, T; Desiderio, J				Parisi, Amilcare; Nguyen, Ninh T.; Reim, Daniel; Zhang, Shu; Jiang, Zhi-Wei; Brower, Steven T.; Azagra, Juan-Santiago; Facy, Olivier; Alimoglu, Orhan; Jackson, Patrick G.; Tsujimoto, Hironori; Kurokawa, Yukinori; Zang, Lu; Coburn, Natalie G.; Yu, Pei-Wu; Zhang, Ben; Qi, Feng; Coratti, Andrea; Annecchiarico, Mario; Novotny, Alexander; Goergen, Martine; Lequeu, Jean-Baptiste; Eren, Tunc; Leblebici, Metin; Al-Refaie, Waddah; Takiguchi, Shuji; Ma, Junjun; Zhao, Yong-Liang; Liu, Tong; Desiderio, Jacopo			Current status of minimally invasive surgery for gastric cancer: A literature review to highlight studies limits	INTERNATIONAL JOURNAL OF SURGERY			English	Review						Gastric cancer; Gastrectomy; Minimally invasive surgery; Robotic surgery; Laparoscopic surgery	ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; RANDOMIZED-CONTROLLED-TRIALS; LAPAROSCOPIC GASTRECTOMY; SURGICAL PERFORMANCE; SUBTOTAL GASTRECTOMY; ROBOTIC GASTRECTOMY; INTERIM-REPORT; MULTICENTER; ADENOCARCINOMA	Background: Gastric cancer represents a great challenge for health care providers and requires a multidisciplinary approach in which surgery plays the main role. Minimally invasive surgery has been progressively developed, first with the advent of laparoscopy and more recently with the spread of robotic surgery, but a number of issues are currently being investigate, including the limitations in performing effective extended lymph node dissections and, in this context, the real advantages of using robotic systems, the possible role for advanced Gastric Cancer, the reproducibility of completely intracorporeal techniques and the oncological results achievable during follow-up. Method: Searches of MEDLINE, Embase and Cochrane Central Register of Controlled Trials were performed to identify articles published until April 2014 which reported outcomes of surgical treatment for gastric cancer and that used minimally invasive surgical technology. Articles that deal with endoscopic technology were excluded. Results: A total of 362 articles were evaluated. After the review process, data in 115 articles were analyzed. Conclusion: A multicenter study with a large number of patients is now needed to further investigate the safety and efficacy as well as long-term outcomes of robotic surgery, traditional laparoscopy and the open approach. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Parisi, Amilcare; Desiderio, Jacopo] Univ Perugia, St Marys Hosp, Dept Digest Surg, Terni, Italy; [Nguyen, Ninh T.] Univ Calif Irvine, Irvine Med Ctr, Dept Surg, Div Gastrointestinal Surg, Orange, CA 92668 USA; [Reim, Daniel; Novotny, Alexander] Tech Univ Munich, Klinikum Rechts Isar, Chirurg Klin & Poliklin, D-80290 Munich, Germany; [Zhang, Shu; Jiang, Zhi-Wei] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China; [Brower, Steven T.] Mt Sinai Beth Israel Med Ctr, Dept Surg, New York, NY USA; [Azagra, Juan-Santiago; Goergen, Martine] Ctr Hosp Luxembourg, Unite Malad Appareil Digestif & Endocrine, Luxembourg, Luxembourg; [Facy, Olivier; Lequeu, Jean-Baptiste] CHU Bocage, Serv Chirurg Digest & Cancerol, Dijon, France; [Alimoglu, Orhan; Eren, Tunc; Leblebici, Metin] Istanbul Medeniyet Univ, Sch Med, Dept Gen Surg, Istanbul, Turkey; [Jackson, Patrick G.] Medstar Georgetown Univ Hosp, Div Gen Surg, Washington, DC USA; [Tsujimoto, Hironori] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Kurokawa, Yukinori] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Zang, Lu; Ma, Junjun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Coburn, Natalie G.] Sunnybrook Hlth Sci Ctr, Div Gen Surg, Toronto, ON M4N 3M5, Canada; [Yu, Pei-Wu; Zhang, Ben] Third Mil Med Univ, Dept Gen Surg, Southwest Hosp, Chongqing, Peoples R China; [Qi, Feng] Tianjin Med Univ Gen Hosp, Dept Gastrointestinal Surg, Tianjin, Peoples R China; [Coratti, Andrea; Annecchiarico, Mario] Careggi Univ Hosp, Dept Oncol, Div Oncol & Robot Surg, Florence, Italy; [Al-Refaie, Waddah] Medstar Georgetown Univ Hosp, Div Surg Oncol, Washington, DC USA	Desiderio, J (reprint author), Univ Perugia, St Marys Hosp, Dept Digest Surg, Terni, Italy.	djdesi85@hotmail.it	Reim, Daniel/J-3115-2013	Reim, Daniel/0000-0001-9736-3307	CARIT foundation (Fondazione Cassa di Risparmio di Terni e Narni)	CARIT foundation (Fondazione Cassa di Risparmio di Terni e Narni) for no profit financial support of IMIGASTRIC. LOGIX S.r.l. provided IT study solutions for IMIGASTRIC.	Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Jayaraman S, 2010, SURG ENDOSC, V24, P584, DOI 10.1007/s00464-009-0621-1; Huscher CGS, 2007, AM J SURG, V194, P839, DOI 10.1016/j.amjsurg.2007.08.037; Kim MC, 2008, ANN SURG ONCOL, V15, P2692, DOI 10.1245/s10434-008-0075-z; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Memon MA, 2008, SURG ENDOSC, V22, P1781, DOI 10.1007/s00464-008-9925-9; Hyun MH, 2013, ANN SURG ONCOL, V20, P1258, DOI 10.1245/s10434-012-2679-6; Woo Y, 2011, ARCH SURG-CHICAGO, V146, P1086, DOI 10.1001/archsurg.2011.114; Lee SI, 2006, J AM COLL SURGEONS, V202, P874, DOI 10.1016/j.jamcollsurg.2006.02.028; Park JY, 2012, BRIT J SURG, V99, P1554, DOI 10.1002/bjs.8887; Lee J, 2009, J SURG ONCOL, V100, P693, DOI 10.1002/jso.21400; Chen XZ, 2009, SURG LAPARO ENDO PER, V19, P277, DOI 10.1097/SLE.0b013e3181b080d3; Lee JH, 2009, SURG ENDOSC, V23, P1759, DOI 10.1007/s00464-008-0198-0; Hur H, 2010, J LAPAROENDOSC ADV S, V20, P693, DOI 10.1089/lap.2010.0246; Eom BW, 2012, EJSO-EUR J SURG ONC, V38, P57, DOI 10.1016/j.ejso.2011.09.006; Stefanidis D, 2010, SURG ENDOSC, V24, P377, DOI 10.1007/s00464-009-0578-0; Huang KH, 2012, J GASTROINTEST SURG, V16, P1303, DOI 10.1007/s11605-012-1874-x; Song J, 2009, SURG ENDOSC, V23, P1204, DOI 10.1007/s00464-009-0351-4; Pugliese R, 2010, SURG ENDOSC, V24, P2594, DOI 10.1007/s00464-010-1014-1; Douglass HO, 2007, SURG ONCOL CLIN N AM, V16, P133, DOI 10.1016/j.soc.2006.10.005; Marutsuka T, 2003, CLIN CANCER RES, V9, P678; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Kim MC, 2005, J SURG ONCOL, V91, P90, DOI 10.1002/jso.20271; Hayashi H, 2005, SURG ENDOSC, V19, P1172, DOI 10.1007/s00464-04-8207-4; Son T, 2014, SURG ENDOSC, V28, P2606, DOI 10.1007/s00464-014-3511-0; Han TS, 2011, ANN SURG ONCOL, V18, P2818, DOI 10.1245/s10434-011-1620-8; Kim MC, 2010, SURG ENDOSC, V24, P610, DOI 10.1007/s00464-009-0618-9; Hiki N, 2006, BRIT J SURG, V93, P195, DOI 10.1002/bjs.5224; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Caruso S, 2011, INT J MED ROBOT COMP, V7, P452, DOI 10.1002/rcs.416; Pugliese R, 2007, SURG ENDOSC, V21, P21, DOI 10.1007/s00464-005-0409-x; Yoon HM, 2012, SURG ENDOSC, V26, P1377, DOI 10.1007/s00464-011-2043-0; Vinuela EF, 2012, ANN SURG, V255, P446, DOI 10.1097/SLA.0b013e31824682f4; Byrn JC, 2007, AM J SURG, V193, P519, DOI 10.1016/j.amjsurg.2006.06.042; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Deng JY, 2009, EJSO-EUR J SURG ONC, V35, P814, DOI 10.1016/j.ejso.2008.11.007; Junfeng Zhou, 2014, Surg Endosc, V28, P1779, DOI 10.1007/s00464-013-3385-6; Kang Byung Hee, 2012, J Gastric Cancer, V12, P156, DOI 10.5230/jgc.2012.12.3.156; Kitano S, 2002, SURGERY, V131, pS306, DOI 10.1067/msy.2002.120115; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Liu CG, 2009, SURG ONCOL, V18, P379, DOI 10.1016/j.suronc.2008.09.002; Montgomery Marissa, 2013, Gastroenterol Rep (Oxf), V1, P105, DOI 10.1093/gastro/got016; Parisi A., 2015, SURGERY IN PRESS; Tanimura S, 2008, SURG ENDOSC, V22, P1161, DOI 10.1007/s00464-008-9786-2; Tokunaga M, 2009, ANN SURG ONCOL, V16, P1514, DOI 10.1245/s10434-009-0404-x	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	MAY	2015	17						34	40		10.1016/j.ijsu.2015.02.021		7	Surgery	Surgery	CH4EQ	WOS:000353986200008		
J	Sato, N; Kohi, S; Tamura, T; Minagawa, N; Shibao, K; Higure, A				Sato, Norihiro; Kohi, Shiro; Tamura, Toshihisa; Minagawa, Noritaka; Shibao, Kazunori; Higure, Aiichiro			Single-incision laparoscopic cholecystectomy for acute cholecystitis: A retrospective cohort study of 52 consecutive patients	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Single-incision laparoscopic cholecystectomy; Acute cholecystitis; Early cholecystectomy; Grade of acute cholecystitis	BILE-DUCT INJURY; RANDOMIZED CONTROLLED-TRIAL; INTRAOPERATIVE CHOLANGIOGRAPHY; MULTIPORT CHOLECYSTECTOMY	Background: Single-incision laparoscopic cholecystectomy (SILC) has become increasingly popular but its role in acute cholecystitis remains controversial. Methods: We compared the clinical features and outcomes of SILC procedures between 52 patients with acute cholecystitis (the AC group) and 308 patients without acute cholecystitis (the NAC group). We also analyzed clinical variables to identify factors affecting difficulties associated with SILC for acute cholecystitis. Results: The patients in the AC group were significantly older than those in the NAC group (72 vs. 61 years, median, P = 0.0005). The preoperative levels of white blood cell counts were significantly higher in the AC group than in the NAC group (6600 vs. 5500/mu L, P = 0.0004). The operative time was significantly longer in the AC group than in the NAC group (188 vs. 135 min, P < 0.0001). The volume of intraoperative blood loss was significantly larger in the AC group than in the NAC group (20 vs. 5 mL, P < 0.001). Furthermore, additional trocar insertion was required in 12% in the NAC group, whereas it was required in 60% in the AC group (P < 0.0001). Regarding the difficulties of SILC for acute cholecystitis, delayed operation (after 72 h from the onset) was significantly associated with a prolonged operative time, while a higher grade of acute cholecystitis (grade II or III) was significantly associated with an increased blood loss during surgery. Conclusions: These findings suggest that when compared to SILC for gallbladder diseases without acute inflammation, SILC for acute cholecystitis was associated with a longer operative time, increased blood loss, higher rate of additional trocar requirement, higher rate of postoperative complications, and longer hospital stay. The difficulties associated with SILC for acute cholecystitis were affected by the timing of surgery and the grade of inflammation. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Sato, Norihiro; Kohi, Shiro; Tamura, Toshihisa; Minagawa, Noritaka; Shibao, Kazunori; Higure, Aiichiro] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 8078555, Japan	Sato, N (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 8078555, Japan.	norisato@med.uoeh-u.ac.jp					Andersen LPH, 2012, SURG LAPARO ENDO PER, V22, P73, DOI 10.1097/SLE.0b013e3182420acf; Nuzzo G, 2005, ARCH SURG-CHICAGO, V140, P986, DOI 10.1001/archsurg.140.10.986; Sasaki K, 2012, WORLD J GASTROENTERO, V18, P944, DOI 10.3748/wjg.v18.i9.944; Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; Phillips MS, 2012, SURG ENDOSC, V26, P1296, DOI 10.1007/s00464-011-2028-z; Jacob D, 2011, HEPATOB PANCREAT DIS, V10, P521, DOI 10.1016/S1499-3872(11)60088-X; Buddingh KT, 2011, SURG ENDOSC, V25, P2449, DOI 10.1007/s00464-011-1639-8; Sato N, 2013, J GASTROINTEST SURG, V17, P668, DOI 10.1007/s11605-012-2123-z; Joseph M, 2012, ANN SURG, V256, P1, DOI 10.1097/SLA.0b013e3182583fde; Garg P, 2012, J GASTROINTEST SURG, V16, P1618, DOI 10.1007/s11605-012-1906-6; Kimura Y, 2013, J HEPATO-BIL-PAN SCI, V20, P8, DOI 10.1007/s00534-012-0564-0; Markar SR, 2012, SURG ENDOSC, V26, P1205, DOI 10.1007/s00464-011-2051-0; Glavic Z, 2001, SURG ENDOSC-ULTRAS, V15, P398, DOI 10.1007/s004640000333; Navez B, 2012, SURG ENDOSC, V26, P2436, DOI 10.1007/s00464-012-2206-7; Chuang SH, 2013, WORLD J GASTROENTERO, V19, P7743, DOI 10.3748/wjg.v19.i43.7743; Banz V, 2011, ANN SURG, V254, P964, DOI 10.1097/SLA.0b013e318228d31c; Strasberg SM, 2010, J AM COLL SURGEONS, V211, P132, DOI 10.1016/j.jamcollsurg.2010.02.053; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Waage A, 2006, ARCH SURG-CHICAGO, V141, P1207, DOI 10.1001/archsurg.141.12.1207; Tsimoyiannis EC, 2010, SURG ENDOSC, V24, P1842, DOI 10.1007/s00464-010-0887-3; Beninato T, 2015, SURG LAPARO ENDO PER, V25, P10, DOI 10.1097/SLE.0000000000000095; Cao ZG, 2011, SURG LAPARO ENDO PER, V21, P311, DOI 10.1097/SLE.0b013e31822cfacd; Flum DR, 2003, JAMA-J AM MED ASSOC, V289, P1639, DOI 10.1001/jama.289.13.1639; Kumar S S, 1992, J Laparoendosc Surg, V2, P247, DOI 10.1089/lps.1992.2.247; Marks J, 2011, AM J SURG, V201, P369, DOI 10.1016/j.amjsurg.2010.09.012	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	MAY	2015	17						48	53		10.1016/j.ijsu.2015.03.013		6	Surgery	Surgery	CH4EQ	WOS:000353986200010		
J	Takeuchi, D; Koide, N; Komatsu, D; Suzuki, A; Miyagawa, S				Takeuchi, Daisuke; Koide, Naohiko; Komatsu, Daisuke; Suzuki, Akira; Miyagawa, Shinichi			Prevalence and management of colorectal neoplasia in surgically treated esophageal cancer patients	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Esophageal cancer; Colorectal cancer; Colorectal adenoma	MULTIPLE PRIMARY CANCERS; METABOLIC SYNDROME; RISK; CARCINOMA; ADENOCARCINOMA; INTERPOSITION; METAANALYSIS; PREVENTION; MALIGNANCY; OUTCOMES	Aims: The existence of other primary tumors during the treatment of esophageal cancer patients has been an important issue. Our aim is to investigate the prevalence and management of colorectal neoplasia (CRN) in surgically treated esophageal cancer patients. Methods: Between 2002 and 2008, 93 patients with esophageal cancer were surgically treated. Seventy-three patients underwent subtotal esophagectomy and 20 underwent lower esophagectomy for esophageal cancer. Colonoscopy was available for detecting CRN before and after surgery. Results: Eighty-nine (95.7%) of the 93 patients were screened by colonoscopy preoperatively or within a year from the operation. Thirty-nine patients (43.8%) with CRN were synchronously identified: adenoma in 34 (38.2%) and adenocarcinoma in 5 patients (5.6%). Eleven adenomas with high grade-dysplasia and 8 adenomas with low grade-dysplasia were removed endoscopically. Three superficial adenocarcinomas were endoscopically removed before surgery, and 2 adenocarcinomas were surgically removed. Seventy-four patients (83.1%) were followed using colonoscopy, and 11 subsequent CRN, including 2 superficial adenocarcinomas, were endoscopically detected in 8 patients (10.8%). The size of esophageal cancer was larger in the patients with than without CRN (p = 0.036). The body mass index in esophageal cancer patients with CRN tended to be higher than in those without CRN (p = 0.065). Conclusions: We noted that esophageal cancer is frequently associated with synchronous and/or metachronous colorectal cancer and adenomas. Colonoscopy is useful to detect and manage CRN before and after esophagectomy, although a few limitations exist. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Takeuchi, Daisuke; Koide, Naohiko; Komatsu, Daisuke; Suzuki, Akira; Miyagawa, Shinichi] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 3908621, Japan	Takeuchi, D (reprint author), Shinshu Univ, Sch Med, Dept Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	takeuchi_daichan@yahoo.co.jp					Ahmed RL, 2006, CANCER, V107, P28, DOI 10.1002/cncr.21950; Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Kahi CJ, 2008, GASTROENTEROLOGY, V135, P380, DOI 10.1053/j.gastro.2008.06.026; Sturmer T, 2006, CANCER EPIDEM BIOMAR, V15, P2391, DOI 10.1158/1055-9965.EPI-06-0391; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Hyodo I, 2010, JPN J CLIN ONCOL, V40, pi38, DOI 10.1093/jjco/hyq125; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Kim JH, 2007, CANCER EPIDEM BIOMAR, V16, P1543, DOI 10.1158/1055-9965; Larsson SC, 2007, AM J CLIN NUTR, V86, P556; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Mansour KA, 1997, ANN THORAC SURG, V64, P752, DOI 10.1016/S0003-4975(97)00616-4; Bollschweiler E, 2009, DIS COLON RECTUM, V52, P299, DOI 10.1007/DCR.0b013e318197d06f; Doki Y, 2008, DIS ESOPHAGUS, V21, P132, DOI 10.1111/j.1442-2050.2007.00738.x; Koide N, 2010, HEPATO-GASTROENTEROL, V57, P513; Kokawa A, 2001, BRIT J SURG, V88, P439, DOI 10.1046/j.1365-2168.2001.01696.x; Kumagai Y, 2001, SURG TODAY, V31, P872; Kuwano H, 1996, EUR J SURG, V162, P797; Motoyama S, 2003, J AM COLL SURGEONS, V197, P914, DOI 10.1016/j.jamcollsurg.2003.07.014; Nagasawa S, 2000, DIS ESOPHAGUS, V13, P226, DOI 10.1046/j.1442-2050.2000.00116.x; Natsugoe S, 2005, WORLD J SURG, V29, P46, DOI 10.1007/s00268-004-7525-y; Ozawa S, 2011, ESOPHAGUS-TOKYO, V8, P9, DOI 10.1007/s10388-011-0266-8; Poon RTP, 1998, ANN THORAC SURG, V65, P1529, DOI 10.1016/S0003-4975(98)00177-5; POSTLETHWAIT RW, 1983, SURG GYNECOL OBSTET, V156, P377; Sato Y, 2005, J AM COLL SURGEONS, V201, P188, DOI 10.1016/j.jamcollsurg.2005.03.013; SHIBUYA H, 1995, CANCER, V76, P101, DOI 10.1002/1097-0142(19950701)76:1<101::AID-CNCR2820760115>3.0.CO;2-D; Suzuki S, 2002, J AM COLL SURGEONS, V195, P23, DOI 10.1016/S1072-7515(02)01147-X; Terry MB, 2002, CANCER EPIDEM BIOMAR, V11, P622; van Westreenen HL, 2005, J NUCL MED, V46, P1321; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P93; Warren S, 1932, AM J CANCER, V16, P1358	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	MAY	2015	17						60	66		10.1016/j.ijsu.2015.02.022		7	Surgery	Surgery	CH4EQ	WOS:000353986200012		
J	Ishibashi, K; Ito, Y; Fujii, K; Masaki, A; Beppu, S; Kawakita, D; Ijichi, K; Shimozato, K; Inagaki, H				Ishibashi, Kenichiro; Ito, Yohei; Fujii, Kana; Masaki, Ayako; Beppu, Shintaro; Kawakita, Daisuke; Ijichi, Kei; Shimozato, Kazuo; Inagaki, Hiroshi			Androgen Receptor-Positive Mucoepidermoid Carcinoma: Case Report and Literature Review	INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY			English	Article						mucoepidermoid carcinoma; androgen receptor; GCDFP-15; HER2; salivary duct carcinoma	SALIVARY-GLAND CANCERS; CLINICOPATHOLOGICAL SIGNIFICANCE; FUSION TRANSCRIPT; EXPRESSION; PROSTATE; SUBSET; TUMORS	Androgen receptor (AR) is usually expressed in salivary duct carcinoma (SDC), but only infrequently in other carcinoma types including mucoepidermoid carcinoma (MEC). The clinicopathological characteristics of AR-positive MEC remain to be clarified. Here we report a case of AR-positive MEC. A 76-year-old man presented with a growing painless tumor of the right parotid. The resected tumor was a high-grade tumor with necroses. Since the tumor was positive for AR, GCDFP-15, and HER2, SDC was first suspected, but it was also positive for CK5/6 and P63, and negative for S-100 protein and -smooth muscle actin. In addition, scattered mucous secreting tumor cells were found in the tumor nests, and they were positive for Alcian blue. A diagnosis of AR-positive MEC was finally made. The patient died of the tumor 5 years after the surgery. The present case may expand the histopathological spectrum of high-grade MEC.	[Ishibashi, Kenichiro; Ito, Yohei; Fujii, Kana; Masaki, Ayako; Beppu, Shintaro; Kawakita, Daisuke; Ijichi, Kei; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Ishibashi, Kenichiro; Ito, Yohei; Shimozato, Kazuo] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 464, Japan	Inagaki, H (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pathol & Mol Diagnost, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hinagaki@med.nagoya-cu.ac.jp					Jaspers HCJ, 2011, J CLIN ONCOL, V29, pE473, DOI 10.1200/JCO.2010.32.8351; Nasser SM, 2003, AM J CLIN PATHOL, V119, P801, DOI 10.1309/RVTP1G0Q727WJUQD; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; Okabe M, 2006, CLIN CANCER RES, V12, P3902, DOI 10.1158/1078-0432.CCR-05-2376; Laurie SA, 2006, J CLIN ONCOL, V24, P2673, DOI 10.1200/JCO.2005.05.3026; BERCHEM GJ, 1995, CANCER RES, V55, P735; Williams MD, 2007, AM J SURG PATHOL, V31, P1645; Fan CY, 2001, ARCH OTOLARYNGOL, V127, P1075; Cros J, 2013, ANN ONCOL, V24, P2624, DOI 10.1093/annonc/mdt338; Toda I, 1998, CLIN IMMUNOL IMMUNOP, V86, P59, DOI 10.1006/clin.1997.4466; Nakayama T, 2009, MODERN PATHOL, V22, P1575, DOI 10.1038/modpathol.2009.126; Brandwein-Gensler MS, 2005, PATHOLOGY GENETICS H, P236; Butler Randall T, 2014, Head Neck Pathol, V8, P133, DOI 10.1007/s12105-013-0493-5; Ellis GL, 2008, TUMOURS SALIVARY GLA, P173; Goode RK, 2005, PATHOLOGY GENETICS H, P219; Ito Fabio Augusto, 2009, Braz Oral Res, V23, P393, DOI 10.1590/S1806-83242009000400008; QUARMBY VE, 1987, MOL ENDOCRINOL, V1, P865; Sygut D, 2008, POL J PATHOL, V59, P205	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1066-8969	1940-2465		INT J SURG PATHOL	Int. J. Surg. Pathol.	MAY	2015	23	3					243	247		10.1177/1066896914565024		5	Pathology; Surgery	Pathology; Surgery	CH4GC	WOS:000353990900014		
J	Isotani, S; Shimoyama, H; Yokota, I; China, T; Hisasue, S; Ide, H; Muto, S; Yamaguchi, R; Ukimura, O; Horie, S				Isotani, Shuji; Shimoyama, Hirofumi; Yokota, Isao; China, Toshiyuki; Hisasue, Shin-ichi; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo; Ukimura, Osamu; Horie, Shigeo			Feasibility and accuracy of computational robot-assisted partial nephrectomy planning by virtual partial nephrectomy analysis	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						robot-assisted partial nephrectomy; simulation; three-dimensional anatomical model; virtual operation; volumetry	LAPAROSCOPIC PARTIAL NEPHRECTOMY; RENAL-FUNCTION; COMPLICATIONS; VASCULATURE; SIMULATION; SOFTWARE; CENTERS; ANATOMY; TRENDS	ObjectivesTo evaluate the feasibility and accuracy of virtual partial nephrectomy analysis, including a color-coded three-dimensional virtual surgical planning and a quantitative functional analysis, in predicting the surgical outcomes of robot-assisted partial nephrectomy. MethodsBetween 2012 and 2014, 20 patients underwent virtual partial nephrectomy analysis before undergoing robot-assisted partial nephrectomy. Virtual partial nephrectomy analysis was carried out with the following steps: (i) evaluation of the arterial branch for selective clamping by showing the vascular-supplied area; (ii) simulation of the optimal surgical margin in precise segmented three-dimensional model for prediction of collecting system opening; and (iii) detailed volumetric analyses and estimates of postoperative renal function based on volumetric change. At operation, the surgeon identified the targeted artery and determined the surgical margin according to the virtual partial nephrectomy analysis. The surgical outcomes between the virtual partial nephrectomy analysis and the actual robot-assisted partial nephrectomy were compared. ResultsAll 20 patients had negative cancer surgical margins and no urological complications. The tumor-specific renal arterial supply areas were shown in color-coded three-dimensional model visualization in all cases. The prediction value of collecting system opening was 85.7% for sensitivity and 100% for specificity. The predicted renal resection volume was significantly correlated with actual resected specimen volume (r(2)=0.745, P<0.001). The predicted estimated glomerular filtration rate was significantly correlated with actual postoperative estimated glomerular filtration rate (r(2)=0.736, P<0.001). ConclusionsVirtual partial nephrectomy analysis is able to provide the identification of tumor-specific renal arterial supply, prediction of collecting system opening and prediction of postoperative renal function. This technique might allow urologists to compare various arterial clamping methods and resection margins with surgical outcomes in a non-invasive manner.	[Isotani, Shuji; Shimoyama, Hirofumi; Ide, Hisamitsu; Muto, Satoru; Yamaguchi, Raizo] Teikyo Univ, Dept Urol, Tokyo 1738605, Japan; [Yokota, Isao] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [China, Toshiyuki; Hisasue, Shin-ichi; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Ukimura, Osamu] Univ So Calif, Inst Urol, Los Angeles, CA USA	Isotani, S (reprint author), Teikyo Univ, Dept Urol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	sisotan@med.teikyo-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kutikov A, 2011, EUR UROL, V60, P241, DOI 10.1016/j.eururo.2011.03.029; Hughes-Hallett A, 2014, UROLOGY, V84, P237, DOI 10.1016/j.urology.2014.02.051; Ohshima S, 2014, J HEPATO-BIL-PAN SCI, V21, P235, DOI 10.1002/jhbp.81; Ukimura O, 2012, EUR UROL, V61, P211, DOI 10.1016/j.eururo.2011.07.068; Komai Y, 2014, UROLOGY, V83, P500, DOI 10.1016/j.urology.2013.09.053; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Spana G, 2011, J UROLOGY, V186, P417, DOI 10.1016/j.juro.2011.03.127; Patel HD, 2013, J UROLOGY, V189, P1229, DOI 10.1016/j.juro.2012.10.024; Tanagho YS, 2013, UROLOGY, V81, P573, DOI 10.1016/j.urology.2012.10.067; Patel SG, 2012, J UROLOGY, V187, P816, DOI 10.1016/j.juro.2011.10.173; Selle D, 2002, IEEE T MED IMAGING, V21, P1344, DOI 10.1109/TMI.2002.801166; Takamoto T, 2013, AM J SURG, V206, P530, DOI 10.1016/j.amjsurg.2013.01.041; Gill IS, 2012, J UROLOGY, V187, P807, DOI 10.1016/j.juro.2011.10.146; Meeks JJ, 2008, J UROLOGY, V180, P2375, DOI 10.1016/j.juro.2008.08.018; Gill IS, 2010, NEW ENGL J MED, V362, P624, DOI 10.1056/NEJMcp0910041; Chan AA, 2010, UROLOGY, V75, P295, DOI 10.1016/j.urology.2009.09.027; Bruner B, 2011, BJU INT, V108, P67, DOI 10.1111/j.1464-410X.2010.09837.x; Shao PF, 2013, EUR UROL, V63, P1072, DOI 10.1016/j.eururo.2012.10.017; Muto NS, 2011, EUR J RADIOL, V78, P151, DOI 10.1016/j.ejrad.2009.10.005; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Bourquain H, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P341; Huang XH, 2013, HEPATO-GASTROENTEROL, V60, P225, DOI [10.5754/hge, 10.5754/hge12630]; Mirs MC, 2013, UROLOGY, V82, P263; Tomaszewskis JJ, 2013, EUROPEAN UROLOGY, V66, P949; Uenos D, 2014, BMC UROLOGY, V14, P1	26	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					439	446		10.1111/iju.12714		8	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300002		
J	Yuasa, T				Yuasa, Takeshi			Editorial Comment to p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan	Yuasa, T (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan.	takeshi.yuasa@jfcr.or.jp					Tsui KH, 2000, J UROLOGY, V163, P1090, DOI 10.1016/S0022-5347(05)67699-9; Kattan MW, 2001, J UROLOGY, V166, P63, DOI 10.1016/S0022-5347(05)66077-6; Zisman A, 2001, J CLIN ONCOL, V19, P1649; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tsui KH, 2000, J UROLOGY, V163, P295; Zhus Y, 2015, INT J UROL, V22, P447	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					453	454		10.1111/iju.12732		2	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300005		
J	Fukushima, H; Koga, F				Fukushima, Hiroshi; Koga, Fumitaka			Editorial Comment to Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material							BODY-MASS INDEX		[Fukushima, Hiroshi; Koga, Fumitaka] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan	Fukushima, H (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Urol, Tokyo, Japan.	fukuuro@cick.jp					Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Fukushima H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115895; Lees HW, 2015, INT J UROL, V22, P455; Park YH, 2014, J UROLOGY, V192, P1043, DOI 10.1016/j.juro.2014.03.107	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					461	462		10.1111/iju.12731		2	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300007		
J	Fujita, K; Ujike, T; Nagahara, A; Uemura, M; Tanigawa, G; Shimazu, K; Fushimi, H; Yamaguchi, S; Nonomura, N				Fujita, Kazutoshi; Ujike, Takeshi; Nagahara, Akira; Uemura, Motohide; Tanigawa, Go; Shimazu, Kohki; Fushimi, Hiroaki; Yamaguchi, Seiji; Nonomura, Norio			Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						endoglin; immunohistochemistry; intravesical recurrence; nephroureterectomy; upper urinary tract urothelial carcinoma	ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; CD105 EXPRESSION; BLADDER-TUMORS; CANCER; PROGRESSION; METASTASIS; MARKERS; BREAST	ObjectivesTo evaluate the expression and prognostic significance of endoglin in patients with upper urinary tract urothelial carcinoma. MethodszArchival formalin-fixed and paraffin-embedded tissues from 99 cases of primary upper urinary tract urothelial carcinomas treated with nephroureterectomy were retrieved. Tissue microarrays were constructed with triplicate tumor samples and paired non-neoplastic urothelium. Tissue microarrays were analyzed using immunohistochemistry for endoglin, and the associations between clinicopathological parameters and outcome were studied. ResultsEndoglin expression was significantly higher in the endothelium of upper urinary tract urothelial carcinomas than in paired benign urothelium (P<0.001). Endoglin expression was not associated with pathological Tstage or tumor grade, and it was not associated with increased hazard ratios for cancer-specific mortality, tumor recurrence in the lymph node or distant metastasis. However, expression of endoglin was significantly associated with intravesical recurrence, when adjusting for other relevant clinicopathological variables (P=0.015). ConclusionsEndoglin is overexpressed in the endothelium of upper urinary tract urothelial carcinomas when compared with normal urothelium, and this overexpression seems to be associated with a higher risk of intravesical recurrence. Therefore, endoglin could be a biomarker for the prediction of intravesical recurrence, as well as a potential therapeutic target.	[Fujita, Kazutoshi; Ujike, Takeshi; Nagahara, Akira; Uemura, Motohide; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan; [Tanigawa, Go; Yamaguchi, Seiji] Osaka Gen Med Ctr, Dept Urol, Osaka, Japan; [Shimazu, Kohki; Fushimi, Hiroaki] Osaka Gen Med Ctr, Dept Pathol, Osaka, Japan	Fujita, K (reprint author), Osaka Univ, Grad Sch Med, Dept Urol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	kazufujita2@gmail.com			Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases	This study was funded by the Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases.	Agrawal U, 2011, PATHOL ONCOL RES, V17, P91, DOI 10.1007/s12253-010-9287-1; Saad RS, 2004, MODERN PATHOL, V17, P197, DOI 10.1038/modpathol.3800034; Munari E, 2013, HUM PATHOL, V44, P2668, DOI 10.1016/j.humpath.2013.07.008; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Zijlmans HJ, 2009, BRIT J CANCER, V100, P1617, DOI 10.1038/sj.bjc.6605009; Fujita K, 2013, INT J UROL, V20, P594, DOI 10.1111/j.1442-2042.2012.03228.x; Dales JP, 2003, AM J CLIN PATHOL, V119, P374, DOI 10.1309/1KF54L6RB625556W; Takahashi N, 2001, CLIN CANCER RES, V7, P524; Miyazaki Y, 2012, CLIN CANCER RES, V18, P4145, DOI 10.1158/1078-0432.CCR-12-0073; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Fujita K, 2009, INT J CANCER, V124, P664, DOI 10.1002/ijc.24007; Crew JP, 1997, CANCER RES, V57, P5281; Santos L, 2003, ANN ONCOL, V14, P1419, DOI 10.1093/annonc/mdg377; Dubinski W, 2012, HUM PATHOL, V43, P1037, DOI 10.1016/j.humpath.2011.08.012; Fujita K, 2015, INT J CLIN ONCOL, V20, P156, DOI 10.1007/s10147-014-0695-1; Greens DA, 2012, J UROLOGY, V189, P1214; Inoue K, 2002, CLIN CANCER RES, V8, P1863; Jeon SH, 2001, ONCOL REP, V8, P1265; Kyzas PA, 2006, VIRCHOWS ARCH, V448, P768, DOI 10.1007/s00428-006-0195-4; Lis DY, 1999, SCIENCE, V284, P1534; Oyas M, 2015, INT J UROL, V22, P3; Sandlund J, 2006, BJU INT, V97, P706, DOI 10.1111/j.1464-410X.2006.06006.x; Shirotakes S, 2011, UROLOGY, V77	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					463	467		10.1111/iju.12719		5	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300008		
J	Sumitomo, M; Kanao, K; Kato, Y; Yoshizawa, T; Watanabe, M; Zennami, K; Nakamura, K				Sumitomo, Makoto; Kanao, Kent; Kato, Yoshiharu; Yoshizawa, Takahiko; Watanabe, Masahito; Zennami, Kenji; Nakamura, Kogenta			Comparative investigation on clinical outcomes of robot-assisted radical prostatectomy between experienced open prostatic surgeons and novice open surgeons in a laparoscopically naive center with a limited caseload	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						clinical outcomes; learning curve; novice open radical prostatectomy surgeon; parallel learning; robot-assisted radical prostatectomy	VATTIKUTI-INSTITUTE PROSTATECTOMY; 1ST 100 PATIENTS; FOLLOW-UP; LEARNING-CURVE; CARCINOMA; SERIES	ObjectivesTo compare perioperative, oncological and functional outcomes of robot-assisted radical prostatectomy between experienced and novice open radical prostatectomy surgeons in a laparoscopically naive center with a limited caseload. MethodsSix surgeons carried out robot-assisted radical prostatectomy in 154 patients, which were divided into the following three groups: group1 (n=90), including patients operated on by a surgeon with experience in both open radical prostatectomy and robot-assisted radical prostatectomy; group2 (n=36), including patients operated on by two surgeons with experience in open radical prostatectomy only; and group3 (n=28), including patients operated on by three surgeons with limited experience in both open radical prostatectomy or robot-assisted radical prostatectomy. ResultsGroups2 and 3 did not differ significantly in their median values of external blood loss (P=0.165) or console time (P=0.103). Positive surgical margin rates for pT2 patients were also similar in these two groups: 21.2% (7/33) in group 2 and 22.7% (5/22) in group 3 (P=0.894). Kaplan-Meier analysis showed that 12months after robot-assisted radical prostatectomy the prostate-specific antigen-free rate for pT2 patients was 96.0% in group2 and 100% in group3, but the pad-free continence rate was just 91.0% in group1, 88.0% in group2 and 75.5% in group3 (group1 vs group3, P=0.037; group2 vs group3, P=0.239). The major complication rate after robot-assisted radical prostatectomy was 3.3% (3/90) in group1, 11.1% (4/36) in group2 and 17.9% (5/28) in group3 (group1 vs group3, P=0.008; group2 vs group3; P=0.441). ConclusionsRobot-assisted radical prostatectomy offers satisfactory postoperative outcomes even when carried out by surgeons with limited experience in open radical prostatectomy.	[Sumitomo, Makoto; Kanao, Kent; Kato, Yoshiharu; Yoshizawa, Takahiko; Watanabe, Masahito; Zennami, Kenji; Nakamura, Kogenta] Aichi Med Univ, Sch Med, Dept Urol, Nagakute, Aichi 4801195, Japan	Sumitomo, M (reprint author), Aichi Med Univ, Sch Med, Dept Urol, Nagakute, Aichi 4801195, Japan.	sumitomo@aichi-med-u.ac.jp					Menon M, 2004, UROL CLIN N AM, V31, P701, DOI 10.1016/j.ucl.2004.06.011; Liss MA, 2012, J UROLOGY, V188, P2205, DOI 10.1016/j.juro.2012.08.009; Rocco B, 2009, BJU INT, V104, P991, DOI 10.1111/j.1464-410X.2009.08532.x; Suardi N, 2012, UROLOGY, V79, P133, DOI 10.1016/j.urology.2011.08.045; Patel VR, 2005, J UROLOGY, V174, P269, DOI 10.1097/01.ju.0000162082.12962.40; Ahlering TE, 2003, J UROLOGY, V170, P1738, DOI 10.1097/01.ju.0000092881.24608.5e; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Menon M, 2010, EUR UROL, V58, P838, DOI 10.1016/j.eururo.2010.09.010; Menon M, 2003, J UROLOGY, V169, P2289, DOI 10.1097/01.ju.0000067464.53313.dd; Montorsi F, 2012, EUR UROL, V62, P368, DOI 10.1016/j.eururo.2012.05.057; Sahabudin RM, 2006, WORLD J UROL, V24, P161, DOI 10.1007/s00345-006-0069-z; Devs H, 2012, BJU INT, V109, P1074; Gumus E, 2011, J ENDOUROL, V25, P1633, DOI 10.1089/end.2011.0071; Liss MA, 2013, UROLOGY, V81, P319, DOI 10.1016/j.urology.2012.09.033; Matsunaga GS, 2006, THESCIENTIFICWORLDJO, V6, P2542, DOI 10.1100/tsw.2006.394; Mikhail AA, 2006, UROLOGY, V68, P1275, DOI 10.1016/j.urology.2006.08.1060; Ozdemir Ahmet Tunc, 2014, Cent European J Urol, V67, P19, DOI 10.5173/ceju.2014.01.art4; Pick DL, 2011, BJU INT, V108, P1492, DOI 10.1111/j.1464-410X.2010.10015.x; Sejima Takehiro, 2013, BMC Res Notes, V6, P436, DOI 10.1186/1756-0500-6-436; Sejima T, 2013, INT J UROL, V20, P382, DOI 10.1111/j.1442-2042.2012.03176.x; Skareckys DW, 2013, ISRN UROL, V2013	21	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					469	474		10.1111/iju.12711		6	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300010		
J	Shiroki, R				Shiroki, Ryoichi			Editorial Comment from Dr Shiroki to Comparative investigation on clinical outcomes of robot-assisted radical prostatectomy between experienced open prostatic surgeons and novice open surgeons in a laparoscopically naive center with a limited caseload	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 47011, Japan	Shiroki, R (reprint author), Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi 47011, Japan.	rshiroki@fujita-hu.ac.jp					Davis JW, 2014, J ENDOUROL, V28, P560, DOI 10.1089/end.2013.0534; Farivars BS, 2014, J SURG EDUC, V7204, P2059; Sejima Takehiro, 2013, BMC Res Notes, V6, P436, DOI 10.1186/1756-0500-6-436; Sumitomo M, 2015, INT J UROL, V22, P469, DOI 10.1111/iju.12711	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					475	475		10.1111/iju.12726		1	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300011		
J	Kobayashi, M; Hatano, K; Fukasawa, S; Komaru, A; Namekawa, T; Imagumbai, T; Araki, H; Hara, R; Ichikawa, T; Ueda, T				Kobayashi, Masayuki; Hatano, Kazuo; Fukasawa, Satoshi; Komaru, Atsushi; Namekawa, Takeshi; Imagumbai, Toshiyuki; Araki, Hitoshi; Hara, Ryusuke; Ichikawa, Tomohiko; Ueda, Takeshi			Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						androgen-deprivation therapy; fiducial markers; intensity-modulated radiation therapy; neoadjuvant treatment; prostatic cancer	RANDOMIZED CONTROLLED-TRIAL; DOSE-ESCALATION TRIAL; PHASE-III TRIAL; RADIOTHERAPY; TOXICITY; SUPPRESSION; SURVIVAL; ADENOCARCINOMA; IRRADIATION; DURATION	ObjectivesTo investigate the therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate- and high-risk prostate cancer. MethodsThis was a retrospective study of 325 patients with intermediate- or high-risk prostate cancer according to the National Comprehensive Cancer Network guidelines who underwent androgen-deprivation therapy and intensity-modulated radiation therapy (76Gy) after gold marker implantation between 2001 and 2010. ResultsThe 5-year distant metastasis-free survival rate was significantly lower for very high-risk patients than for intermediate- and high-risk patients (82.6% vs 99.4% and 96.5%, respectively; P<0.01). The 5-year biochemical relapse-free survival rates significantly declined with increasing prostate cancer risk (P<0.01), and were 95.9%, 87.2%, and 73.1% for the intermediate-risk, high-risk and very high-risk patients, respectively. Acute genitourinary and gastrointestinal toxicity grade 3 were not observed in any of the patients. Late grade3 genitourinary toxicity occurred in 0.3% of patients. ConclusionCombination androgen-deprivation therapy and 76-Gy intensity-modulated radiation therapy with gold marker implantation offers good therapeutic outcomes with few serious complications in patients with intermediate- and high-risk prostate cancer.	[Kobayashi, Masayuki; Fukasawa, Satoshi; Komaru, Atsushi; Namekawa, Takeshi; Ueda, Takeshi] Chiba Canc Ctr, Prostate Ctr, Chiba 2608717, Japan; [Kobayashi, Masayuki; Fukasawa, Satoshi; Komaru, Atsushi; Namekawa, Takeshi; Ueda, Takeshi] Chiba Canc Ctr, Div Urol, Chiba 2608717, Japan; [Hatano, Kazuo; Imagumbai, Toshiyuki; Araki, Hitoshi; Hara, Ryusuke] Chiba Canc Ctr, Div Radiat Oncol, Chiba 2608717, Japan; [Ichikawa, Tomohiko] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan	Ueda, T (reprint author), Chiba Canc Ctr, Prostate Ctr, Chuo Ku, 666-2 Nitonacho, Chiba 2608717, Japan.	urolccc@yahoo.co.jp					Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470204S(07)70143-2; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Al-Mamgani A, 2008, INT J RADIAT ONCOL, V72, P980, DOI 10.1016/j.ijrobp.2008.02.073; Talcott JA, 2010, JAMA-J AM MED ASSOC, V303, P1046, DOI 10.1001/jama.2010.287; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Alicikus ZA, 2011, CANCER-AM CANCER SOC, V117, P1429, DOI 10.1002/cncr.25467; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029; Denham JW, 2011, LANCET ONCOL, V12, P451, DOI 10.1016/S1470-2045(11)70063-8; Crook J, 2009, INT J RADIAT ONCOL, V73, P327, DOI 10.1016/j.ijrobp.2008.04.075; Mohler JL, 2012, J NATL COMPR CANC NE, V10, P1081; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Zelefsky MJ, 2002, INT J RADIAT ONCOL, V53, P1111, DOI 10.1016/S0360-3016(02)02857-2; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Kuban DA, 2011, INT J RADIAT ONCOL, V79, P1310, DOI 10.1016/j.ijrobp.2010.01.006; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Vora SA, 2013, J UROLOGY, V190, P521, DOI 10.1016/j.juro.2013.02.012; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Cahlon O, 2008, INT J RADIAT ONCOL, V71, P330, DOI 10.1016/j.ijrobp.2007.10.004; Lawton CA, 2008, INT J RADIAT ONCOL, V70, P437, DOI 10.1016/j.ijrobp.2007.06.050; Lips IM, 2009, BJU INT, V103, P762, DOI 10.1111/j.1464-410X.2008.08117.x; Martin JM, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-50; Takeda K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-105; Viani GA, 2009, INT J RADIAT ONCOL, V74, P1405, DOI 10.1016/j.ijrobp.2008.10.091; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					477	482		10.1111/iju.12707		6	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300013		
J	Yoshioka, Y				Yoshioka, Yasuo			Editorial Comment to Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Editorial Material									Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan	Yoshioka, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan.	yoshioka@radonc.med.osaka-u.ac.jp					Cahlon O, 2008, SEMIN RADIAT ONCOL, V18, P48, DOI 10.1016/j.semradonc.2007.09.007; Sheets NC, 2012, JAMA-J AM MED ASSOC, V307, P1611, DOI 10.1001/jama.2012.460; Kobayashi M, 2015, INT J UROL, V22, P477, DOI 10.1111/iju.12707; Yoshioka Y, 2013, J RADIAT RES, V54, P113, DOI 10.1093/jrr/rrs083; Zhus S, 2005, INT J CLIN ONCOL, V10, P398	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					482	483		10.1111/iju.12713		2	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300014		
J	Muto, S; Abe, H; Noguchi, T; Sugiura, S; Kitamura, K; Isotani, S; Ide, H; Yamaguchi, R; Kamai, T; Horie, S				Muto, Satoru; Abe, Hideyuki; Noguchi, Takahiro; Sugiura, Sho-ichiro; Kitamura, Kousuke; Isotani, Shuji; Ide, Hisamitsu; Yamaguchi, Raizo; Kamai, Takao; Horie, Shigeo			Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						bladder cancer; chemotherapy; gemcitabine; maintenance therapy; metastasis	TRANSITIONAL-CELL CARCINOMA; LONG-TERM-SURVIVAL; BLADDER-CANCER; LUNG-CANCER; RANDOMIZED-TRIAL; CISPLATIN; THERAPY; METHOTREXATE; VINBLASTINE; DOXORUBICIN	ObjectivesTo investigate the outcomes of gemcitabine maintenance monotherapy treatment for metastatic urothelial cancer. MethodsGemcitabine maintenance monotherapy was used for metastatic urothelial cancer patients after standard platinum-based chemotherapy. A standard dose of 1000mg/m(2)/month was given. If patients suffered adverse events or a noticeably compromised quality of life, treatment intervals were extended and doses lowered. Patients with metastatic urothelial cancer receiving only best supportive care after standard chemotherapy served as the retrospective control group. ResultsA total of 33 patients were included in the study group as well as in the control group. Maintenance therapy was administered a median of nine times (range 2-49 times) with a median dose of 984.2mg (range 500-1400mg) per time. An adverse event of the Common Terminology Criteria of Adverse Events grade3 or greater was observed in 10 (30.3%) patients, while nine patients (27.3%) experienced hematotoxicity. After standard chemotherapy pretreatment, disease-specific survival in the maintenance therapy group was an average of 15.0months, significantly more favorable (P<0.001) than that of the control group (4.0months). On multivariate analysis, efficacy of prior chemotherapy (P=0.018), visceral metastasis (P=0.007) and gemcitabine maintenance therapy (P<0.001) were statistically significant prognostic parameters of disease-specific survival. ConclusionThe present study findings suggest that gemcitabine maintenance monotherapy in metastatic urothelial cancer might not only be useful as a palliative treatment, but it could also have a certain level of therapeutic effectiveness.	[Muto, Satoru; Noguchi, Takahiro; Sugiura, Sho-ichiro; Kitamura, Kousuke; Isotani, Shuji; Ide, Hisamitsu; Yamaguchi, Raizo] Teikyo Univ, Sch Med, Dept Urol, Tokyo 1738605, Japan; [Horie, Shigeo] Juntendo Univ, Sch Med, Dept Urol, Tokyo 113, Japan; [Abe, Hideyuki; Kamai, Takao] Dokkyo Med Univ, Sch Med, Dept Urol, Mibu, Tochigi, Japan	Muto, S (reprint author), Teikyo Univ, Sch Med, Dept Urol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	muto@med.teikyo-u.ac.jp			Teikyo Academic Research Center (TARC)	This study was supported in part by Teikyo Academic Research Center (TARC).	Akaza H, 2007, JPN J CLIN ONCOL, V37, P201, DOI 10.1093/jjco/hym011; Saito K, 2013, INT J UROL, V20, P161, DOI 10.1111/j.1442-2042.2012.03121.x; LOEHRER PJ, 1992, J CLIN ONCOL, V10, P1066; Galsky MD, 2013, CANCER-AM CANCER SOC, V119, P3012, DOI 10.1002/cncr.28146; Bajorin DF, 1999, J CLIN ONCOL, V17, P3173; Rosenberg JE, 2005, J UROLOGY, V174, P14, DOI 10.1097/01.ju.0000162039.38023.5f; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; GOLDIE JH, 1982, CANCER TREAT REP, V66, P439; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.tungcan.2006.01.006; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446; Bozcuk H, 2005, CANCER, V104, P2650, DOI 10.1002/cncr.21540; Days RS, 1986, CANCER RES, V46, P3876; Herzog TJ, 2006, GYNECOL ONCOL, V102, P218, DOI 10.1016/j.ygyno.2005.12.001; Hitier-Berthault M, 2013, INT J UROL, V20, P788, DOI 10.1111/iju.12045; Lehmann J, 2006, INT J UROL, V13, P1035, DOI 10.1111/j.1442-2042.2006.01471.x; LOGOTHETIS CJ, 1995, J CLIN ONCOL, V13, P2272; Maru S, 2012, INT J UROL, V19, P110, DOI 10.1111/j.1442-2042.2011.02913.x; Matsuyamas H, 2002, INT J UROL, V9, P272; R Development Core Team, 2011, R LANG ENV STAT COMP; Rinaldi M, 2006, ANN ONCOL, V17, P67, DOI 10.1093/annonc/mdj928; Shelley MD, 2011, BJU INT, V108, P168, DOI 10.1111/j.1464-410X.2011.10341.x; Ss LH, 2009, TNM CLASSIFICATION M, P262; Sternberg CN, 2003, CRIT REV ONCOL HEMAT, V46, pS105, DOI 10.1016/S1040-8428(03)00068-4; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; von der Maase H, 2001, SEMIN ONCOL, V28, P1, DOI 10.1053/sonc.2001.22541	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					490	494		10.1111/iju.12727		5	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300016		
J	Fujimura, T; Yamada, Y; Sugihara, T; Azuma, T; Suzuki, M; Fukuhara, H; Nakagawa, T; Kume, H; Igawa, Y; Homma, Y				Fujimura, Tetsuya; Yamada, Yuta; Sugihara, Toru; Azuma, Takeshi; Suzuki, Motofumi; Fukuhara, Hiroshi; Nakagawa, Tohru; Kume, Haruki; Igawa, Yasuhiko; Homma, Yukio			Nocturia in men is a chaotic condition dominated by nocturnal polyuria	INTERNATIONAL JOURNAL OF UROLOGY			English	Article						lower urinary tract symptoms; nocturia; nocturnal polyuria; pain and sleep disorder	URINARY-TRACT SYMPTOMS; SLEEP QUALITY INDEX; OVERACTIVE BLADDER; VALIDATION; INSTRUMENT; VOLUME; ADULT; WOMEN	ObjectiveTo characterize nocturia in men based on frequency volume chart data and symptom profiles assessed using the Core Lower Urinary Tract Symptom Score and Athens Insomnia Scale questionnaires. MethodsThe Core Lower Urinary Tract Symptom Score and Athens Insomnia Scale questionnaires were administered to 299 consecutive treatment naive men with nocturia (one time per night). Frequency volume chart data were recorded for 2days. Correlations between nocturia and clinical characteristics including symptom scores, clinical diagnosis, Charlson Comorbidity Index, estimated glomerular filtration rate, uroflowmetry and prostate volume were analyzed. ResultsPatients were divided into five groups: one time (n=36), two times (n=65), three times (n=85), four times (n=78) and five times (n=34) of nocturia. Age, prevalence or severity of chronic kidney disease, hyperlipidemia, low bladder capacity, nocturnal polyuria, urgency, bladder pain and sleep disorders were significantly correlated with the severity of nocturia. The Spearman correlation analysis identified eight possible independent factors for nocturia: age, estimated glomerular filtration rate, urgency, bladder pain, sleep quality, sleepiness during the day, average voided volume and nocturnal volume divided by body weight. Logistic regression analysis showed that nocturnal volume divided by body weight was the strongest factor of nocturia, and 7, 9 and 9.7mL/kg were practical cut-off values of three, four and five times per night of nocturia, respectively. ConclusionsNocturia in men is a chaotic condition dominated by nocturnal polyuria, and related to multiple factors including age, renal function, urgency, bladder pain, insomnia and bladder volume.	[Fujimura, Tetsuya; Yamada, Yuta; Sugihara, Toru; Azuma, Takeshi; Fukuhara, Hiroshi; Nakagawa, Tohru; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo 1138655, Japan; [Suzuki, Motofumi] Tokyo Teishin Hosp, Dept Urol, Tokyo, Japan	Fujimura, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	FUJIMURAT-URO@h.u-tokyo.ac.jp					Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Tikkinen KAO, 2009, AM J EPIDEMIOL, V170, P361, DOI 10.1093/aje/kwp133; Farrahi J, 2009, SLEEP BREATH, V13, P259, DOI 10.1007/s11325-008-0233-3; Tikkinen KAO, 2006, J UROLOGY, V175, P596, DOI 10.1016/S0022-5347(05)00245-4; Asplund R, 2005, BJU INT, V95, P816, DOI 10.1111/j.1464-410X.2005.05407.x; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Asplund R, 1999, BJU INT, V84, P297; Soldatos CR, 2005, SLEEP MED, V6, P5, DOI 10.1016/j.sleep.2004.10.006; Alvarez-Nebreda ML, 2008, BONE, V42, P278, DOI 10.1016/j.bone.2007.10.001; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Hashim H, 2008, BJU INT, V102, P62, DOI 10.1111/j.1464-410X.2008.07463.x; Tikkinen KAO, 2010, EUR UROL, V57, P488, DOI 10.1016/j.eururo.2009.03.080; BARRY MJ, 1992, J UROLOGY, V148, P1549; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; De Groats WC, 2006, BRIT J PHARMACOL, V147, P25; Homma Y, 2000, J UROLOGY, V163, P777, DOI 10.1016/S0022-5347(05)67802-0; Homma Y, 2008, INT J UROL, V15, P816, DOI 10.1111/j.1442-2042.2008.02121.x; Shinohara Y, 2004, INT J STROKE, V3, P55; Shyh-Chyis C, 2006, UROLOGY, V67, P541; Soda T, 2010, J UROLOGY, V184, P1000, DOI 10.1016/j.juro.2010.05.038; Udos Y, 2010, BJU INT, V107, P791; Yokoyama O, 2011, WORLD J UROL, V29, P233, DOI 10.1007/s00345-010-0544-4	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					496	501		10.1111/iju.12710		6	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300018		
J	Yoshida, S; Fukui, N; Saito, K; Fujii, Y; Kageyama, Y; Kihara, K				Yoshida, Soichiro; Fukui, Naotaka; Saito, Kazutaka; Fujii, Yasuhisa; Kageyama, Yukio; Kihara, Kazunori			Novel image monitoring system using a head-mounted display for assistants in da Vinci surgery	INTERNATIONAL JOURNAL OF UROLOGY			English	Article									[Yoshida, Soichiro; Saito, Kazutaka; Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo, Japan; [Fukui, Naotaka; Kageyama, Yukio] Saitama Canc Ctr, Dept Urol, Saitama, Japan	Yoshida, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Urol, Tokyo, Japan.	k-kihara.uro@tmd.ac.jp			Sony Corporation (Tokyo, Japan)	Dr Kihara has received research funding from Sony Corporation (Tokyo, Japan), but the sponsor had no control over the interpretation, writing or publication of this work.	Binder J, 2004, BJU INT, V94, P1183, DOI 10.1111/j.1464-410X.2004.05130.x; Inoue M, 2015, J ULTRAS MED, V34, P29, DOI 10.7863/ultra.34.1.29; Kihara K, 2012, INT J UROL, V19, P886, DOI 10.1111/j.1442-2042.2012.03044.x; Takeshita H, 2014, J ULTRAS MED, V33, P1499, DOI 10.7863/ultra.33.8.1499; Yoshida S, 2015, UROL INT, V94, P117, DOI 10.1159/000356987; Yoshida Soichiro, 2014, Wideochir Inne Tech Maloinwazyjne, V9, P449, DOI 10.5114/wiitm.2014.44132; Yoshida Soichiro, 2014, Wideochir Inne Tech Maloinwazyjne, V9, P644, DOI 10.5114/wiitm.2014.43040	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-8172	1442-2042		INT J UROL	Int. J. Urol.	MAY	2015	22	5					520	521		10.1111/iju.12735		2	Urology & Nephrology	Urology & Nephrology	CH7IU	WOS:000354210300024		
J	Hashizume, M; Tan, SL; Takano, J; Ohsawa, K; Hasada, I; Hanasaki, A; Ito, I; Mihara, M; Nishida, K				Hashizume, Misato; Tan, Seng-Lai; Takano, Junichi; Ohsawa, Kazunori; Hasada, Ikuo; Hanasaki, Akira; Ito, Ichiro; Mihara, Masahiko; Nishida, Keiichiro			Tocilizumab, A Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights	INTERNATIONAL REVIEWS OF IMMUNOLOGY			English	Review						actermra; anemia; atherosclerosis; inflammation; interleukin-6; rheumatoid arthritis; tocilizumab; tumor necrosis factor-alpha	ENDOTHELIAL GROWTH-FACTOR; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; COLLAGEN-INDUCED ARTHRITIS; RANGE THERMAL-STRESS; CARDIOVASCULAR-DISEASE; INFLAMMATORY ARTHRITIS; IL-6 RECEPTOR; OSTEOCLAST DIFFERENTIATION; INTERLEUKIN-6 RECEPTOR; INADEQUATE RESPONSE	Pro-inflammatory cytokines play a major role in the initiation andmaintenance of joint inflammation and destruction in rheumatoid arthritis (RA). The therapeutic success of biologics targeting tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) and interleukin (IL)-6 receptor (IL-6R) has broadened the treatment options for RA. These agents have potential overlapping and discriminating biologic effects, as well as different pharmacological features. Tocilizumab (TCZ) is a humanized monoclonal antibody that binds and neutralizes IL-6R, resulting in the inhibition of various IL-6-mediated biological activities, including inflammation-related, immunomodulatory and tissue/matrix remodelling effects. Randomized, double-blind, controlled phase III studies and a number of early clinical observational studies have shown that treatment with TCZ results in rapid and sustained improvement in the signs and symptoms of RA among different patient populations. These studies have established the efficacy and safety of TCZ. Here, we review the pleiotropic functions of IL-6 and how it impinges on many aspects of RA pathogenesis, and highlight the clinical experience to date with TCZ as an emerging new treatment option for RA.	[Hashizume, Misato; Mihara, Masahiko] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Gotemba, Japan; [Takano, Junichi; Ohsawa, Kazunori] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Tan, Seng-Lai] Hoffmann La Roche Inc, Inflammat Discovery & Therapeut Area, Nutley, NJ 07110 USA; [Hasada, Ikuo; Hanasaki, Akira; Ito, Ichiro] Sakura Mot Picture Co Ltd, Tokyo, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, Okayama 7008530, Japan	Hashizume, M (reprint author), Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Gotemba, Japan.	hashizumemst@chugai-pharm.co.jp					Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Henriksen K, 2011, ENDOCR REV, V32, P31, DOI 10.1210/er.2010-0006; MADHOK R, 1993, ANN RHEUM DIS, V52, P232, DOI 10.1136/ard.52.3.232; Garnero P, 2010, ARTHRITIS RHEUM-US, V62, P33, DOI 10.1002/art.25053; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Sondergaard BC, 2006, OSTEOARTHR CARTILAGE, V14, P738, DOI 10.1016/j.joca.2006.01.016; Rojas JR, 2005, J PHARMACOL EXP THER, V313, P578, DOI 10.1124/jpet.104.079277; Ballara S, 2001, ARTHRITIS RHEUM, V44, P2055, DOI 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2; Protogerou AD, 2011, ATHEROSCLEROSIS, V219, P734, DOI 10.1016/j.atherosclerosis.2011.09.015; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1571, DOI 10.1093/rheumatology/kes093; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Bendtzen K, 2006, ARTHRITIS RHEUM, V54, P3782, DOI 10.1002/art.22214; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Schett G, 2005, NAT CLIN PRACT RHEUM, V1, P47, DOI 10.1038/ncprheum0036; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Nakahara H, 2003, ARTHRITIS RHEUM, V48, P1521, DOI 10.1002/art.11143; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Nowell MA, 2009, J IMMUNOL, V182, P613; Smolen JS, 2012, NAT REV RHEUMATOL, V8, P235, DOI 10.1038/nrrheum.2012.23; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Hallert E, 2012, RHEUMATOLOGY, V51, P338, DOI 10.1093/rheumatology/ker332; Richards PJ, 2006, ARTHRITIS RHEUM, V54, P1662, DOI 10.1002/art.21818; Gravallese EM, 1998, AM J PATHOL, V152, P943; Krieckaert CL, 2012, ANN RHEUM DIS, V71, P1914, DOI 10.1136/annrheumdis-2012-201544; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W; Rose-John S, 2004, IMMUNITY, V20, P2, DOI 10.1016/S1074-7613(04)00003-2; Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Bessant R, 2006, ARTHRIT RHEUM-ARTHR, V55, P892, DOI 10.1002/art.22343; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Boekholdt SM, 2012, LANCET, V379, P1176, DOI 10.1016/S0140-6736(12)60361-4; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Strand V, 2012, RHEUMATOLOGY, V51, P1860, DOI 10.1093/rheumatology/kes131; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Hashizume M, 2009, RHEUMATOL INT, V29, P1449, DOI 10.1007/s00296-009-0885-8; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Moreland LW, 2009, SEMIN ARTHRITIS RHEU, V39, P132, DOI 10.1016/j.semarthrit.2008.08.003; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Kong YY, 1999, NATURE, V397, P315; Atzeni F, 2009, CURR OPIN INVEST DR, V10, P1204; Atzeni F, 2008, EXPERT REV CLIN IMMU, V4, P275, DOI 10.1586/1744666X.4.2.275; Besada E, 2012, CLIN RHEUMATOL, V31, P1263, DOI 10.1007/s10067-012-2007-3; Carpenter John, 2010, Biologicals, V38, P602, DOI 10.1016/j.biologicals.2010.07.002; Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Chirino AJ, 2004, NAT BIOTECHNOL, V22, P1383, DOI 10.1038/nbt1030; Choe JY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4162; Cronstein Bruce N, 2007, Bull NYU Hosp Jt Dis, V65 Suppl 1, pS11; Davis MC, 2008, BRAIN BEHAV IMMUN, V22, P24, DOI 10.1016/j.bbi.2007.06.013; Fujikawa Y, 1996, BRIT J RHEUMATOL, V35, P213; Gonzalez-Gay MA, 2006, BIOMED PHARMACOTHER, V60, P673, DOI 10.1016/j.biopha.2006.09.006; Hashizume, 2011, ARTHRITIS, V2011; Hashizume M, 2010, RHEUMATOL INT, V30, P917, DOI 10.1007/s00296-009-1075-4; Jessup W, 2000, CURR OPIN LIPIDOL, V11, P473, DOI 10.1097/00041433-200010000-00005; Kaplan MJ, 2009, NAT REV RHEUMATOL, V5, P208, DOI 10.1038/nrrheum.2009.29; Kaplan MJ, 2006, CURR OPIN RHEUMATOL, V18, P289, DOI 10.1097/01.bor.0000218951.65601.bf; Kremers Hilal Maradit, 2006, Curr Heart Fail Rep, V3, P57, DOI 10.1007/s11897-006-0003-0; Kume K, 2011, ARTHRIT CARE RES, V63, P1477, DOI 10.1002/acr.20537; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Paleolog Ewa M, 2002, Arthritis Res, V4 Suppl 3, pS81, DOI 10.1186/ar575; Roche Registration Limited, 2011, ROACTEMRA 20 MG ML C; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI [10.1359/jbmr.090533, 10.1359/JBMR.090402]; Silacci P, 1998, J BIOL CHEM, V273, P13625, DOI 10.1074/jbc.273.22.13625; Sone H, 2001, LIFE SCI, V69, P1861, DOI 10.1016/S0024-3205(01)01264-4; Tan SL, 2013, ARTHRITIS RHEUM S, V65; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Uchiyama Y, 2008, BIOL PHARM BULL, V31, P1159, DOI 10.1248/bpb.31.1159; Weeiss G, 2005, NEW ENGL J MED, V352, P1011; Wilson PWF, 2008, AM J MED, V121, P15, DOI 10.1016/j.amjmed.2008.06.012	82	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0883-0185	1563-5244		INT REV IMMUNOL	Int. Rev. Immunol.	MAY	2015	34	3					265	279		10.3109/08830185.2014.938325		15	Immunology	Immunology	CH7BX	WOS:000354191700003		
J	Sekine, M				Sekine, Masaru			Yeats and Japan: The Dreaming of the Bones	IRISH UNIVERSITY REVIEW			English	Article								Yeats and Japan: The Dreaming of the Bones' first investigates how the Noh came to influence Yeats, then analyzes Yeats's Four Plays for Dancers, focusing on The Dreaming of the Bones, and explains how this Yeats play is adapted into a new Noh play, Hone-no-Yume, in which the places, names and situations were changed to Japanese ones. An account is then given of the latter's production. Fenolossa came to Japan with an appointment to teach Ethics and Logic at the University of Tokyo in 1987, where he studied Noh with Minoru Umewaka, a Noh master. He also translated some Noh plays with the help of his students. After his death in London, his manuscripts were handed over to Ezra Pound by his second wife, Mary, and it is through Pound that Yeats came to read them. Inspired by them Yeats wrote Four Plays for Dancers. At the Hawk's Well was later translated into two different Noh plays by Mario Yokomichi, thus completing the circle from Japan to Ireland and back.	[Sekine, Masaru] Waseda Univ, Tokyo, Tokyo, Japan; [Sekine, Masaru] Roma Kyogen Ichiza Theatre Co, Tokyo, Japan; [Sekine, Masaru] Theatre Project Si, Beijing, Peoples R China; [Sekine, Masaru] IASAIL JAPAN, Toronto, ON, Canada	Sekine, M (reprint author), Waseda Univ, Tokyo, Tokyo, Japan.						Sekine Masaru, 1990, YEATS NOH COMP STUDY, V38; Yeats, 1972, COLLECTED PLAYS, P444; Yeats William Butler, 1959, CLASSIC NOH THEATRE, P151	3	0	0	EDINBURGH UNIV PRESS	EDINBURGH	THE TUN-HOLYROOD RD, 12 2F JACKSONS ENTRY, EDINBURGH EH8 8PJ, ENGLAND	0021-1427	2047-2153		IRISH UNIV REV	Irish Univ. Rev.	MAY	2015	45	1					54	68		10.3366/iur.2015.0150		15	Literary Reviews	Literature	CH3BY	WOS:000353902500007		
J	Nagamoto, T; Oshika, T; Fujikado, T; Ishibashi, T; Sato, M; Kondo, M; Kurosaka, D; Azuma, N				Nagamoto, Toshiyuki; Oshika, Tetsuro; Fujikado, Takashi; Ishibashi, Tatsuro; Sato, Miho; Kondo, Mineo; Kurosaka, Daijiro; Azuma, Noriyuki			Clinical characteristics of congenital and developmental cataract undergoing surgical treatment	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Congenital cataract; Developmental cataract; White pupil; Family history; Cataract surgery	INFANTILE CATARACTS; PEDIATRIC CATARACT; ETIOLOGY; CHILDREN; PERIOD	To analyze the clinical characteristics of congenital/developmental cataract undergoing surgery. A mail questionnaire was sent to 49 facilities engaged in surgical treatment of congenital cataracts, and data on preoperative clinical features were collected. Twenty nine facilities reported on 864 eyes of 521 patients with congenital/infantile cataract, ranging in age at initial visit from 0 to 18.8 years (2.6 +/- A 3.3 years, mean +/- A standard deviation). Among the patients, 65.8 % had bilateral cataracts and 34.2 % were unilaterally affected. Family history was found for 22.4 % of cases, of which 98.1 % were bilateral. Family history was positive for 33.1 % of bilateral and 1.3 % of unilateral cases. The most common main complaint was white pupil for 35.7 % of bilateral cases and 32.7 % for unilateral cases. Concomitant systemic abnormalities were more frequently associated with bilateral cases (31.6 %) than with unilateral cases (16.7 %). Associated ocular diseases, such as strabismus, persistent fetal vasculature, and posterior lenticonus, were more frequently seen among unilateral cases whereas nystagmus was more common among bilateral cases. Among congenital/developmental cataracts, the ratio of bilateral and unilateral cases was approximately 2:1. Almost all patients with a family history of congenital cataract were bilateral. Initial visits to a physician were rather late, 2.6 years from birth; this should be improved.	[Nagamoto, Toshiyuki] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nagamoto, Toshiyuki] Nagamoto Eye Clin, Tokyo, Japan; [Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki 3058575, Japan; [Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Osaka, Japan; [Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med, Dept Ophthalmol, Fukuoka, Japan; [Sato, Miho] Hamamatsu Univ Sch Med, Dept Ophthalmol, Shizuoka, Japan; [Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie, Japan; [Kurosaka, Daijiro] Iwate Med Univ, Dept Ophthalmol, Morioka, Iwate, Japan; [Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol & Cell Biol, Tokyo, Japan	Oshika, T (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	oshika@eye.ac			Health and Labour Sciences Research Grant, Research on Measures for Intractable Diseases, The Ministry of Health Labour and Welfare, Japan	Supported by the Health and Labour Sciences Research Grant, Research on Measures for Intractable Diseases, The Ministry of Health Labour and Welfare, Japan. We thank all physicians who contributed to this study by providing valuable information, those from National Center for Child Health and Development, Hyogo Prefectural Kobe Children's Hospital, Aichi Children's Health and Medical Center, Osaka City General Hospital, Kyorin University School of Medicine, Fukushima Medical University, Osaka Medical Center and Research Institute for Maternal and Child Health, Iwate Medical University, University of Tsukuba Faculty of Medicine, Dokkyo Medical University, Kagoshima University Faculty of Medicine, Kanagawa Children's Medical Center, Hamamatsu University School of Medicine, Osaka University Medical School, Keio University School of Medicine, Kurume University School of Medicine, Wakayama Medical University, Kagawa University Faculty of Medicine, Kanazawa University School of Medicine, University of Fukui Faculty of Medical Science, Shiga University of Medical Science, Ehime University School of Medicine, Toho University Omori Medical Center, Shinshu University School of Medicine, Kyushu University School of Medicine, Kobe University School of Medicine, Nagoya University School of Medicine, Hokkaido Children's Hospital and Medical Center, and Kagawa National Children's Hospital.	Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, P2108; Zetterstrom C, 2005, J CATARACT REFR SURG, V31, P824, DOI 10.1016/j.jcrs.2005.01.012; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Taylor D, 1998, EYE, V12, P9; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Haargaard B, 2004, OPHTHALMOLOGY, V111, P2292, DOI 10.1016/j.ophtha.2004.06.024; Birch EE, 1996, INVEST OPHTH VIS SCI, V37, P1532; DEWEESE MW, 1962, AM J OPHTHALMOL, V53, P853; Eckstein M, 1996, BRIT J OPHTHALMOL, V80, P628, DOI 10.1136/bjo.80.7.628; GELBART SS, 1982, AM J OPHTHALMOL, V93, P615; HILES D A, 1977, International Ophthalmology Clinics, V17, P15, DOI 10.1097/00004397-197701740-00004; HILES DA, 1983, PEDIATR ANN, V12, P556; Jain I S, 1983, J Pediatr Ophthalmol Strabismus, V20, P238; Kim Kuk Hyoe, 2008, Korean J Ophthalmol, V22, P87, DOI 10.3341/kjo.2008.22.2.87; Lambert SR, 2006, J AAPOS, V10, P30, DOI 10.1016/j.jaapops.2005.10.002; Ledoux DM, 2007, J AAPOS, V11, P218, DOI 10.1016/j.jaapos.2006.11.003; Plager DA, 2002, J CATARACT REFR SURG, V28, P810, DOI 10.1016/S0886-3350(01)01156-7; SanGiovanni JP, 2002, ARCH OPHTHALMOL-CHIC, V120, P1559; Thylefors B, 1998, Community Eye Health, V11, P1; Wirth MG, 2002, BRIT J OPHTHALMOL, V86, P782, DOI 10.1136/bjo.86.7.782; Yang ML, 2006, KOREAN J OPHTHALMOL, V244, P1485	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					148	156		10.1007/s10384-015-0370-8		9	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700002		
J	Iwahashi, C; Okuno, K; Hashida, N; Nakai, K; Ohguro, N; Nishida, K				Iwahashi, Chiharu; Okuno, Kensuke; Hashida, Noriyasu; Nakai, Kei; Ohguro, Nobuyuki; Nishida, Kohji			Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Vogt-Koyanagi-Harada disease; Uveitis; Corticosteroid; Tapering; Recurrence	PROGNOSTIC-FACTORS; INFLAMMATION; UVEITIS; ASSOCIATION	Our aim was to determine the recurrence rate of inflammation in Vogt-Koyanagi-Harada (VKH) disease and to describe its clinical features. We retrospectively evaluated patients diagnosed as having VKH disease with exudative retinal detachment at the Osaka University Hospital or the Japanese Community Healthcare Organization, Osaka Hospital, between 1998 and 2012. All patients received high-dose corticosteroid therapy as the initial treatment and were followed for at least 6 months. Demographic data, including age, sex, visual acuity (VA) levels at initial presentation and at 1 year after initial therapy, treatment received, and recurrent episodes were reviewed. Fifty-five consecutive patients with VKH disease were identified (36 women; mean age 38.6 +/- A 10.4 years). Fourteen patients (25.5 %) had recurrent inflammation, which manifested as posterior uveitis in eight and as anterior uveitis in six of the patients. Recurrent posterior segment inflammation was more likely to develop in patients whose VA at initial presentation was poor (P = 0.039) and in whom orally administered corticosteroid was tapered rapidly (to 30 mg within 3 weeks or less, to 20 mg within 2 months or less, and to 10 mg within 3 months or less) (P = 0.006, P = 0.066, and P = 0.041, respectively). About 25 % of patients with VKH disease had recurrent inflammation. Poor initial VA and rapid tapering of the corticosteroid were associated with posterior recurrence.	[Iwahashi, Chiharu; Hashida, Noriyasu; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Okuno, Kensuke; Ohguro, Nobuyuki] Japanese Community Healthcare Org Osaka Hosp, Dept Ophthalmol, Fukushima Ku, Osaka 5530003, Japan; [Nakai, Kei] Yodogawa Christians Hosp, Dept Ophthalmol, Osaka, Japan	Ohguro, N (reprint author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan.	nohguro@okn.gr.jp					WEISZ JM, 1995, OPHTHALMOLOGY, V102, P1012; Al-Kharashi Abdullah S., 2007, International Ophthalmology, V27, P201, DOI 10.1007/s10792-007-9062-9; MOORTHY RS, 1995, SURV OPHTHALMOL, V39, P265, DOI 10.1016/S0039-6257(05)80105-5; Galor A, 2006, OPHTHALMOLOGY, V113, P2317, DOI 10.1016/j.ophtha.2006.04.038; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; RUBSAMEN PE, 1991, ARCH OPHTHALMOL-CHIC, V109, P682; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Sachdev Nishant, 2008, International Ophthalmology, V28, P339, DOI 10.1007/s10792-007-9144-8; Lai TYY, 2009, EYE, V23, P543, DOI 10.1038/eye.2008.89; Read RW, 2001, AM J OPHTHALMOL, V131, P599, DOI 10.1016/S0002-9394(01)00937-0; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Ohguro N, 2012, JPN J OPHTHALMOL, V56, P432, DOI 10.1007/s10384-012-0158-z; Callanan DG, 2008, ARCH OPHTHALMOL-CHIC, V126, P1191, DOI 10.1001/archopht.126.9.1191; SHINDO Y, 1994, BRIT J OPHTHALMOL, V78, P223, DOI 10.1136/bjo.78.3.223; Bacsal K, 2008, AM J OPHTHALMOL, V145, P480, DOI 10.1016/j.ajo.2007.10.012; Errera MH, 2011, ACTA OPHTHALMOL, V89, P357; ISLAM SMM, 1994, INVEST OPHTH VIS SCI, V35, P752; Kondo Y, 2012, JPN J OPHTHALMOL, V56, P104, DOI 10.1007/s10384-011-0092-5; Nakao K, 2012, INVEST OPHTH VIS SCI, V53, P1917, DOI 10.1167/iovs.11-8984; Read Russell W, 2002, Ophthalmol Clin North Am, V15, P333, DOI 10.1016/S0896-1549(02)00025-1; Taylor S, 2004, ARCH OPHTHALMOL-CHIC, V122, P922, DOI 10.1001/archopht.122.6.922; Yamaki K, 2000, J IMMUNOL, V165, P7323; Yamaki K, 2000, EXP EYE RES, V71, P361, DOI 10.1006/exer.2000.0893	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					157	163		10.1007/s10384-015-0377-1		7	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700003		
J	Suzuki, S; Aihara, Y; Fujiwara, M; Sano, S; Kaneko, A				Suzuki, Shigenobu; Aihara, Yukiko; Fujiwara, Miyuki; Sano, Shuichi; Kaneko, Akihiro			Intravitreal injection of melphalan for intraocular retinoblastoma	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Intravitreal injection; Melphalan; Retinoblastoma; Vitreous seeds	EXTERNAL-BEAM RADIOTHERAPY; INTRAARTERIAL CHEMOTHERAPY; THERAPY; CARBOPLATIN; DELIVERY	To investigate the safety and efficacy of intravitreal injection of melphalan for retinoblastoma. A retrospective chart review of all patients who were administered intravitreal injections of melphalan for retinoblastoma between 1990 and 2011. A total of 264 eyes of 250 patients were included. All ocular adverse events, systemic prognosis, ocular prognosis, and visual acuity were investigated. The total number of intravitreal injections administered was 1,067; each eye received between one and 25 injections. A postoperative subconjunctival tumor developed in one eye. None of the eyes suffered infections or uveitis, and all other adverse events including chorioretinal atrophy displayed incidences of less than 1.5 %. At 5 postoperative years, the cumulative incidence of cataract surgery was 3.1 % among the eyes that were treated without ocular hyperthermia. Distant metastasis or intracranial invasion occurred in 11 patients, all of whom had high-risk pathological factors for metastasis such as optic nerve invasion, but refused to receive adjuvant chemotherapy. Sixty-eight percent of the eyes achieved complete vitreous seed remission, but recurrence occurred in 19 % of these eyes after 10.0 +/- A 4.9 months. In addition, 47 and 27 % of the eyes without primary macular tumors retained visual acuity of > 0.5 and > 1.0, respectively. The risk of extraocular tumor spreading following intravitreal injections is low, and other adverse events are rare. Sixty-eight percent of the treated eyes achieved complete vitreous seed remission, and about half of them retained practical levels of vision. The intravitreal injection of melphalan is a safe and effective treatment for vitreous seeds.	[Suzuki, Shigenobu; Aihara, Yukiko; Fujiwara, Miyuki; Sano, Shuichi; Kaneko, Akihiro] Natl Canc Ctr, Dept Ophthalm Oncol, Chuo Ku, Tokyo 1040045, Japan; [Kaneko, Akihiro] Yokohama City Univ Med, Dept Ophthalmol, Yokohama, Kanagawa, Japan	Suzuki, S (reprint author), Natl Canc Ctr, Dept Ophthalm Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sgsuzuki@ncc.go.jp			National Cancer Center Research and Development Fund [26-A-25]	This study was supported by the National Cancer Center Research and Development Fund (26-A-25).	Akihiro Kaneko, 2002, J EYE, V19, P585; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Kivela T, 2011, OPHTHALMOLOGY, V118, P1689, DOI 10.1016/j.ophtha.2011.02.005; Aiello LP, 2004, RETINA-J RET VIT DIS, V24, pS3, DOI 10.1097/00006982-200410001-00002; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Abramson DH, 2012, BRIT J OPHTHALMOL, V96, P499, DOI 10.1136/bjophthalmol-2011-300498; Shields CL, 2002, AM J OPHTHALMOL, V133, P657, DOI 10.1016/S0002-9394(02)01348-X; Kaneko A, 2003, JPN J CLIN ONCOL, V33, P601, DOI 10.1093/jjco/hyg113; Wilson TW, 1996, ARCH OPHTHALMOL-CHIC, V114, P1390; Brodie SE, 2013, DOC OPHTHALMOL, V126, P79, DOI 10.1007/s10633-012-9358-6; Eljarrat-Binstock E, 2008, CURR EYE RES, V33, P269, DOI 10.1080/02713680701871140; Ghassemi F, 2012, ARCH OPHTHALMOL-CHIC, V130, P1268, DOI 10.1001/archophthalmol.2012.1983; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1084, DOI 10.1136/bjophthalmol-2011-301016; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1078, DOI 10.1136/bjophthalmol-2011-301450; Ong SJ, 2014, JPN J OPHTHALMOL; Shields CL, 2006, OPHTHALMOLOGY, V113, P276; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1399, DOI 10.1001/archophthalmol.2011.150; Shields CL, 2014, JAMA OPHTHALMOL, V132, P319, DOI 10.1001/jamaophthalmol.2013.7666; Smith SJ, 2014, BRIT J OPHTHALMOL, V98, P292, DOI 10.1136/bjophthalmol-2013-303885; Smith SJ, 2012, BRIT J OPHTHALMOL, V96, P1073, DOI 10.1136/bjophthalmol-2011-300829; Sobin LH, 2010, TNM CLASSIFICATION M, V7th, P291; Ueda Mitsuyuki, 1995, Nippon Ganka Gakkai Zasshi, V99, P1230	25	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					164	172		10.1007/s10384-015-0378-0		9	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700004		
J	Inoue, M; Kadonosono, K; Arakawa, A; Yamane, S; Ishibashi, T				Inoue, Maiko; Kadonosono, Kazuaki; Arakawa, Akira; Yamane, Shin; Ishibashi, Tatsuro			Long-term outcome of intravitreal pegaptanib sodium as maintenance therapy in Japanese patients with neovascular age-related macular degeneration	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Age-related macular degeneration; Pegaptanib sodium; Ranibizumab; Maintenance therapy	RANIBIZUMAB; MARINA; LEVEL; EYE	To evaluate the results of a 3-year follow-up of intravitreal pegaptanib sodium injection as maintenance therapy for the treatment of neovascular age-related macular degeneration (AMD) in Japanese patients. In this prospective, uncontrolled interventional study, 20 eyes of 19 patients with treatment-na < ve AMD who had received 3 consecutive monthly injections of 0.5 mg/0.05 mL ranibizumab as the induction treatment and had shown clinical/anatomical improvement were enrolled. An intravitreal injection of 0.3 mg/0.09 mL pegaptanib sodium was administered as the maintenance therapy every 6 weeks. Booster treatments using ranibizumab were allowed if clinical deterioration was judged to be present. The primary outcome measures were the best-corrected visual acuity (BCVA) and the central foveal thickness (CFT) as evaluated using spectral-domain optical coherence tomography. Sixteen of the 20 eyes (80 %) were assessed at the 3-year follow-up. The mean logMAR BCVA improved significantly from 0.56 +/- A 0.31 before the induction treatment to 0.24 +/- A 0.25 at baseline (P < 0.001) and was well maintained at 156 weeks (0.25 +/- A 0.28, P = 0.938). Moreover, the mean CFT also decreased significantly from 346 +/- A 111 mu m before the induction treatment to 232 +/- A 54 mu m at baseline (P < 0.001) and was well preserved at 156 weeks (210 +/- A 59 mu m, P = 0.278). Thirteen eyes (81.3 %) received an unscheduled booster treatment, and no severe systemic or ocular side effects occurred during follow-up. Intravitreal pegaptanib sodium injection as the maintenance therapy was effective in stabilizing the vision of patients with AMD in whom induction treatment led to improved BCVA, as evaluated at the 3-year follow-up.	[Inoue, Maiko; Kadonosono, Kazuaki; Arakawa, Akira; Yamane, Shin] Yokohama City Univ, Med Ctr, Dept Ophthalmol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; [Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Fukuoka 812, Japan	Inoue, M (reprint author), Yokohama City Univ, Med Ctr, Dept Ophthalmol, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	maicoo@urahp.yokohama-cu.ac.jp			Pfizer	M. Inoue, Grant (Pfizer); K. Kadonosono, Grant (Pfizer); A. Arakawa, None; S. Yamane, None; T. Ishibashi, Grant (Pfizer).	Gonzales CR, 2005, RETINA-J RET VIT DIS, V25, P815; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Kaiser PK, 2007, OPHTHALMOLOGY, V114, P1868, DOI 10.1016/j.ophtha.2007.04.030; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Friberg TR, 2010, BRIT J OPHTHALMOL, V94, P1611, DOI 10.1136/bjo.2009.174946; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Brown DM, 2009, OPHTHALMOLOGY, V116, pe55; Ishibashi T, 2013, JPN J OPHTHALMOL, V57, P417, DOI 10.1007/s10384-013-0255-7; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Shiragami C, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000116; Ueta T, 2014, OPHTHALMOLOGY, V121, pE5, DOI 10.1016/j.ophtha.2013.09.019	19	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					173	178		10.1007/s10384-015-0374-4		6	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700005		
J	Matsumoto, C; Eura, M; Okuyama, S; Takada, S; Arimura-Koike, E; Hashimoto, S; Tanabe, F; Shimomura, Y				Matsumoto, Chota; Eura, Mariko; Okuyama, Sachiko; Takada, Sonoko; Arimura-Koike, Eiko; Hashimoto, Shigeki; Tanabe, Fumi; Shimomura, Yoshikazu			CLOCK CHART(A (R)): a novel multi-stimulus self-check visual field screener	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						CLOCK CHART (R); Self-check; Glaucoma; Multi-Stimulus; Screening	GLAUCOMA; DEFECTS	CLOCK CHART(A (R)) is a multi-stimulus-type self-check visual field screening sheet developed by our group. The test chart is rotated during the examination, and the visual field abnormalities are pointed out by the patients themselves. In this study, we evaluated the clinical usefulness of this chart in patients with glaucoma. We studied 114 eyes of 114 glaucoma patients (average age 60.0 +/- A 11.1 years) and 45 eyes of 45 normal individuals (average age 45.0 +/- A 16.4 years) using CLOCK CHART(A (R)). The static visual fields were obtained using the Octopus 101 G2 program and classified using the Aulhorn classification as modified by Greve (stages 0-I to IV) and by mean defect (MD; early < 6 dB; moderate 6 a parts per thousand currency sign MD a parts per thousand currency sign12 dB; severe > 12 dB).The sensitivity and specificity of CLOCK CHART(A (R)) for detecting visual field abnormalities were evaluated within the entire 25A degrees field and at the 5A degrees, 10A degrees, 15A degrees, 20A degrees, and 25A degrees eccentricity zones. The visual field agreement between the results of CLOCK CHART(A (R)) and the static visual fields were also evaluated. In glaucomatous eyes, the sensitivity of CLOCK CHART(A (R)) was 85, 93, and 100 % for Greve stages I, II and III-VI, respectively, and 87, 93, and 97 % for the MD value in early, moderate, and severe eyes, respectively. The agreement of the visual field defect area in CLOCK CHART(A (R)) with the static fields was 85 and 100 % with Greve stages 0-I to I and II-VI, respectively, and 91, 96, and 96 % in early, moderate and severe glaucomatous eyes according to MD, respectively. The specificity of CLOCK CHART(A (R)) was 89 %. CLOCK CHART(A (R)) is a simple and reliable self-check screening chart for detecting visual field abnormalities in patients with glaucoma.	[Matsumoto, Chota; Eura, Mariko; Okuyama, Sachiko; Takada, Sonoko; Hashimoto, Shigeki; Tanabe, Fumi; Shimomura, Yoshikazu] Kinki Univ, Fac Med, Dept Ophthalmol, Osaka 5898511, Japan; [Arimura-Koike, Eiko] Kinki Univ, Fac Med, Dept Ophthalmol, Sakai Hosp, Osaka 5898511, Japan	Matsumoto, C (reprint author), Kinki Univ, Fac Med, Dept Ophthalmol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	chota@med.kindai.ac.jp			Pfizer	C. Matsumoto, Lecture fee (Pfizer), Patent (CLOCK CHART (R)); M. Eura, None; S. Okuyama, None; S. Takada, None; E. Arimura-Koike, None; S. Hashimoto, None; F. Tanabe, None; Y. Shimomura, None.	ADACHI M, 1994, JPN J OPHTHALMOL, V38, P392; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Crabb DP, 2013, OPHTHALMOLOGY, V120, P1120, DOI 10.1016/j.ophtha.2012.11.043; Aulhon E, 1989, PERIMETRY UPDATE 198, P331; Aulhorn E, 1977, DOC OPHTHALMOL P SER, V14, P75; Bedwell CH, 1982, VISUAL FIELDS BASIS; Harrington DO, 1976, VISUAL FIELDS TXB AT, V6th; Henson DB, 1986, DOC OPHTHALMOL P SER, V49, P233; Inoue K, 2005, GANKARINSHOIHO, V99, P214; Katsushima Harumi, 2004, Rinsho Ganka, V58, P345; SHIRATO S, 1991, JPN J OPHTHALMOL, V35, P273; Takada S, 1997, FOLIA OPHTHALMOL JPN, V48, P672	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					187	193		10.1007/s10384-014-0368-7		7	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700007		
J	Komoto, S; Higaki, S; Fukuda, M; Shimomura, Y				Komoto, Shohei; Higaki, Shiro; Fukuda, Masahiko; Shimomura, Yoshikazu			Effects of antiviral medications on herpetic epithelial keratitis in mice	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Article						Herpetic keratitis; Aciclovir; Valaciclovir; Famciclovir	VIRUS EYE DISEASE; SIMPLEX-VIRUS; IN-VIVO; REACTIVATION; ACYCLOVIR; LATENCY; RABBITS; MODEL; VALACYCLOVIR; FAMCICLOVIR	Aciclovir (ACV), valaciclovir (VACV) and famciclovir (FCV) are used for systemic infections caused by herpes virus. In Japan, only topical ACV is permitted for use against herpetic keratitis. We investigated the effectiveness of topical ACV, oral VACV and oral FCV on mouse epithelial herpetic keratitis. C57/BL76 mice were inoculated with HSV-1 McKrae strain in the cornea. Once infection was confirmed 4 days after inoculation, topical ACV, oral VACV and FCV were started and administered for 5 days. Control groups were given either topical or oral saline. On days 2, 4, 6 and 10 after medication started, tears, eyeballs, and trigeminal ganglia were examined using viral culture and real-time PCR. Viral culture of tears detected no HSV in the topical ACV group on day 4 after administration start; with similar results for the oral VACV group on day 4; and the oral FCV group on day 6. Real-time PCR of the eyeballs showed significant decrease of HSV DNA copy number in the topical ACV group on days 4 and 6 compared to the topical saline group. Real-time PCR of the trigeminal ganglia showed significant decrease of HSV DNA copy number in the oral VACV group on days 4 and 6, and in the oral FCV group on day 6 compared to the oral saline group. We suggest that 5-day administration of topical ACV, oral VACV and oral FCV are effective for mouse epithelial herpetic keratitis and sufficiently decrease HSV amounts in the ocular surface and eyeballs.	[Komoto, Shohei; Fukuda, Masahiko; Shimomura, Yoshikazu] Kinki Univ, Fac Med, Dept Ophthalmol, Osaka 5898511, Japan; [Higaki, Shiro] Kinki Univ, Sakai Hosp, Dept Ophthalmol, Fac Med,Minami Ward, Sakai, Osaka 5900132, Japan	Higaki, S (reprint author), Kinki Univ, Sakai Hosp, Dept Ophthalmol, Fac Med,Minami Ward, 2-7-1 Harayamadai, Sakai, Osaka 5900132, Japan.	higaki@sakai.med.kindai.ac.jp					Romanowski EG, 1999, INVEST OPHTH VIS SCI, V40, P378; Higaki S, 2003, CURR EYE RES, V26, P231, DOI 10.1076/ceyr.26.3.231.14892; SAWTELL NM, 1992, J VIROL, V66, P2150; Beck RW, 2000, ARCH OPHTHALMOL-CHIC, V118, P1030; Cohrs RJ, 2001, BRAIN PATHOL, V11, P465; Higaki S, 2002, INVEST OPHTH VIS SCI, V43, P1862; COOK SD, 1991, INVEST OPHTH VIS SCI, V32, P1558; Bacon TH, 1996, J ANTIMICROB CHEMOTH, V37, P303, DOI 10.1093/jac/37.2.303; HARUTA Y, 1989, INVEST OPHTH VIS SCI, V30, P371; Wilhelmus KR, 1998, NEW ENGL J MED, V339, P300, DOI 10.1056/NEJM199807303390503; Higaki S, 2006, CORNEA, V25, pS64, DOI 10.1097/01.ico.0000247216.08886.9d; Higaki S, 2009, CURR EYE RES, V34, P171, DOI 10.1080/02713680802650377; Hill JM, 1996, ANAL BIOCHEM, V235, P44, DOI 10.1006/abio.1996.0089; Itahashi Motoki, 2008, Semin Ophthalmol, V23, P241, DOI 10.1080/08820530802111291; LeBlanc RA, 1999, J INFECT DIS, V180, P594, DOI 10.1086/314962; Loutsch JM, 2001, ANTIMICROB AGENTS CH, V45, P2044, DOI 10.1128/AAC.45.7.2044-2053.2001; NESBURN AB, 1976, INVEST OPHTH VISUAL, V15, P726; OBRIEN JJ, 1989, DRUGS, V37, P233; Purifoy D J, 1993, J Med Virol, VSuppl 1, P139; Sawtell NM, 2001, J INFECT DIS, V184, P964, DOI 10.1086/323551; Shimomura Y, 2010, JPN J OPHTHALMOL, V54, P187, DOI 10.1007/s10384-010-0803-3; Sozen E, 2006, CHEMOTHERAPY, V52, P29, DOI 10.1159/000090239; STEVENS JG, 1989, MICROBIOL REV, V53, P318; VARNELL ED, 1995, INVEST OPHTH VIS SCI, V36, P1181; Vere Hodge RA, 1989, J ANTIMICROB AGENTS, V33, P1765	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					194	200		10.1007/s10384-015-0375-3		7	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700008		
J	Goto, H; Takahira, M; Azumi, A				Goto, Hiroshi; Takahira, Masayuki; Azumi, Atsushi		Japanese Study Grp For IgG4	Diagnostic criteria for IgG4-related ophthalmic disease (vol 59, pg 1, 2015)	JAPANESE JOURNAL OF OPHTHALMOLOGY			English	Correction									[Goto, Hiroshi] Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo 1600023, Japan; [Takahira, Masayuki] Kanazawa Univ, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Azumi, Atsushi] Kobe Kaisei Hosp, Dept Ophthalmol, Kobe, Hyogo, Japan	Goto, H (reprint author), Tokyo Med Univ, Dept Ophthalmol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	goto1115@tokyo-med.ac.jp					Goto H, 2015, JPN J OPHTHALMOL, V59, P1, DOI 10.1007/s10384-014-0352-2	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0021-5155	1613-2246		JPN J OPHTHALMOL	Jpn. J. Ophthalmol.	MAY	2015	59	3					201	201		10.1007/s10384-015-0376-2		1	Ophthalmology	Ophthalmology	CH8OC	WOS:000354294700009		
J	Kim, YC; Tamura, Y				Kim, Yong Chul; Tamura, Yukio			Simulation of Wind Pressures on a Target Low-Rise Building in Large Group by RANS Turbulence Model	JOURNAL OF AEROSPACE ENGINEERING			English	Article						Low-rise buildings; Wind tunnel test; Numerical simulation; Pressure coefficient	SURROUNDING BUILDINGS; BOUNDARY-LAYER; PART I; FLOW; CFD; TUNNEL; LOADS; ARRAY	Characteristics of wind pressures on a low-rise building immersed in various building area densities were investigated using three-dimensional Reynolds-Averaged Navier-Stokes (RANS) turbulence models. Wind pressure coefficients obtained from the numerical simulations were compared with those of wind pressure measurements. The results show that for wind pressure coefficients for an isolated model, more reasonable results were obtained when the renormalization group (RNG) k-epsilon model was used, but for a target model in a large group, there was little difference between wind pressure coefficients obtained from different turbulence models and the effect of different incident flows on wind pressure coefficients was found to be small. Lastly, the effect of area density and building distance was separately examined, showing that the effect of an upstream building was larger than that of any other buildings and area densities. (C) 2014 American Society of Civil Engineers.	[Kim, Yong Chul] Korea Univ, Sch Civil Environm & Architectural Engn, Seoul 136701, South Korea; [Tamura, Yukio] Tokyo Polytech Univ, Wind Engn Res Ctr, Atsugi, Kanagawa 2430297, Japan	Kim, YC (reprint author), Korea Univ, Sch Civil Environm & Architectural Engn, 145 Anam Ro, Seoul 136701, South Korea.	gentle95@gmail.com			Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program	This study was funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program, 2008-2012. The authors gratefully acknowledge their support.	Liu XP, 2013, BUILD SIMUL-CHINA, V6, P151, DOI 10.1007/s12273-012-0097-0; Chang CH, 2003, J WIND ENG IND AEROD, V91, P1039, DOI 10.1016/S0167-6105(03)00051-5; Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P1749, DOI 10.1016/j.jweia.2008.02.058; MURAKAMI S, 1993, J WIND ENG IND AEROD, V46-7, P21, DOI 10.1016/0167-6105(93)90112-2; Santiago JL, 2007, BOUND-LAY METEOROL, V122, P609, DOI 10.1007/s10546-006-9123-z; Kim YC, 2012, ENG STRUCT, V35, P18, DOI 10.1016/j.engstruct.2011.10.024; Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P389, DOI 10.1016/j.jweia.2008.01.004; Blocken B, 2007, J WIND ENG IND AEROD, V95, P941, DOI 10.1016/j.jweia.2007.01.013; HO TCE, 1991, J WIND ENG IND AEROD, V38, P297, DOI 10.1016/0167-6105(91)90049-3; Chang CH, 2003, J WIND ENG IND AEROD, V91, P1141, DOI 10.1016/S0167-6105(03)00056-4; PETERKA JA, 1976, J STRUCT DIV-ASCE, V102, P533; Chang C. H., 2001, THESIS COLORADO STAT; Gad I. A. M., 2009, 13 INT C AER SCI AV, P1; Kim YC, 2013, J STRUCT ENG-ASCE, V139, P275, DOI 10.1061/(ASCE)ST.1943-541X.0000625; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, DOI 10.1016/0045-7825(74)90029-2; Lee Y. S., 2009, 7 INT C URB CLIM TOK, P1; Lien FS, 2004, BOUND-LAY METEOROL, V112, P427, DOI 10.1023/B:BOUN.0000030654.15263.35; Meroney R. N., 2001, P WIND HAZ MIT URB A, P1; Yakhot V., 1986, Journal of Scientific Computing, V1, DOI 10.1007/BF01061452	19	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0893-1321	1943-5525		J AEROSPACE ENG	J. Aerosp. Eng.	MAY	2015	28	3							04014082	10.1061/(ASCE)AS.1943-5525.0000417		13	Engineering, Aerospace; Engineering, Civil	Engineering	CH2YJ	WOS:000353891200010		
J	Soken, HE; Sakai, S				Soken, Halil Ersin; Sakai, Shin-ichiro			Adaptive Tuning of the Unscented Kalman Filter for Satellite Attitude Estimation	JOURNAL OF AEROSPACE ENGINEERING			English	Article						Attitude estimation; Adaptive unscented Kalman filtering (UKF); Process noise covariance; Magnetometer bias		Determining the process noise covariance of the unscented Kalman filter (UKF) is a difficult procedure. The analytical approximation method gives satisfactory results in certain cases, but it fails when generalized for the estimation of the extended states, such as the case that sensor biases or scale factors are included in the state vector. The main aim of this research is to find an appropriate tuning algorithm for the process noise covariance of the UKF when the magnetometer biases are estimated, as well as attitude and gyro biases. In this sense, an adaptive tuning method for an UKF that is used for satellite attitude estimation is given and the adaptive UKF algorithm is tested in various scenarios for the attitude and sensor bias estimation. The given adaptation method is an easy way of tuning the filter, especially in the absence of any analytical approximation for the calculation of the process noise covariance, and the performed simulations show that by using the adaptive UKF, it is possible to get accurate estimates that are close to optimal. (C) 2014 American Society of Civil Engineers.	[Soken, Halil Ersin] Grad Univ Adv Studies Sokendai, Dept Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Sakai, Shin-ichiro] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa 2525210, Japan	Soken, HE (reprint author), Grad Univ Adv Studies Sokendai, Dept Space & Astronaut Sci, Yoshinodai 3-1-1, Sagamihara, Kanagawa 2525210, Japan.	ersin_soken@ac.jaxa.jp; sakai@isas.jaxa.jp			Japanese government with the MONBUKAGAKUSHO scholarship; Japan Aerospace Exploration Agency (JAXA)	This work was supported in part by the Japanese government with the MONBUKAGAKUSHO scholarship, and also by the Japan Aerospace Exploration Agency (JAXA) with a research grant.	JULIER SJ, 1995, PROCEEDINGS OF THE 1995 AMERICAN CONTROL CONFERENCE, VOLS 1-6, P1628; Soken HE, 2012, IEEE T AERO ELEC SYS, V48, P2614, DOI 10.1109/TAES.2012.6237612; Crassidis JL, 2003, J GUID CONTROL DYNAM, V26, P536, DOI 10.2514/2.5102; Julier S, 2000, IEEE T AUTOMAT CONTR, V45, P477, DOI 10.1109/9.847726; Busse F. D., 2003, J I NAVIGATION, V50, P79; Dunik J., 2009, P 15 IFAC S SYST ID, P972; Farrenkopf R., 1978, J GUIDANCE CONTROL, V1, P282, DOI DOI 10.2514/3.55779; Fosbury A. M., 2011, P AIAA GUID NAV CONT; Inamori T., 2009, P AIAA GUID NAV CONT; Julier S., 1996, GEN METHOD APPROXIMA; Lee D. J., 2004, P AIAA AAS ASTR SPEC; Markley FL, 2000, J GUID CONTROL DYNAM, V23, P1065, DOI 10.2514/2.4648; Maybeck P. S., 1982, STOCHASTIC MODELS ES, V2; Mohamed AH, 1999, J GEODESY, V73, P193, DOI 10.1007/s001900050236; Sekhavat P., 2007, P 2007 AM CONTR C NE, P4445, DOI DOI 10.1109/ACC.2007.4283031; Vinther K., 2011, AUTOM CONT AEROSP, V4; Wertz J. R., 1988, SPACECRAFT ATTITUDE	17	1	1	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0893-1321	1943-5525		J AEROSPACE ENG	J. Aerosp. Eng.	MAY	2015	28	3							04014088	10.1061/(ASCE)AS.1943-5525.0000412		8	Engineering, Aerospace; Engineering, Civil	Engineering	CH2YJ	WOS:000353891200016		
J	Minami, T; Fukutomi, Y; Saito, A; Sekiya, K; Tsuburai, T; Taniguchi, M; Akiyama, K				Minami, Takafumi; Fukutomi, Yuma; Saito, Akemi; Sekiya, Kiyoshi; Tsuburai, Takahiro; Taniguchi, Masami; Akiyama, Kazuo			Frequent episodes of adult soybean allergy during and following the pollen season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE			English	Letter							GLY M 4; BIRCH POLLEN; DIAGNOSIS; SOY		[Minami, Takafumi; Fukutomi, Yuma; Saito, Akemi; Sekiya, Kiyoshi; Tsuburai, Takahiro; Taniguchi, Masami; Akiyama, Kazuo] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 2520392, Japan	Minami, T (reprint author), Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa 2520392, Japan.	minami0008@mhp.suita.osaka.jp					Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Berneder M, 2013, INT ARCH ALLERGY IMM, V161, P229, DOI 10.1159/000345970; Mittag D, 2004, J ALLERGY CLIN IMMUN, V113, P148, DOI 10.1016/j.jaci.2003.09.030; Kleine-Tebbe J, 2002, J ALLERGY CLIN IMMUN, V110, P797, DOI 10.1067/mai.2002.12946; Kosma P, 2011, ACTA PAEDIATR, V100, P305, DOI 10.1111/j.1651-2227.2010.02049.x; Asero R, 1996, J ALLERGY CLIN IMMUN, V97, P611, DOI 10.1016/S0091-6749(96)70306-8; Fukutomi Y, 2012, J ALLERGY CLIN IMMUN, V129, P860, DOI 10.1016/j.jaci.2012.01.031; Hansen KS, 2001, J CHROMATOGR B, V756, P19	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2198	2213-2201		J ALLER CL IMM-PRACT	J. Allergy Clin. Immunol.-Pract.	MAY-JUN	2015	3	3					441	+		10.1016/j.jaip.2014.11.024		3	Allergy; Immunology	Allergy; Immunology	CH7JS	WOS:000354212900023		
J	Minoda, Y; Nakagawa, S; Sugama, R; Ikawa, T; Noguchi, T; Hirakawa, M				Minoda, Yukihide; Nakagawa, Shigeru; Sugama, Ryo; Ikawa, Tessyu; Noguchi, Takahiro; Hirakawa, Masashi			Midflexion Laxity After Implantation Was Influenced by the Joint Gap Balance Before Implantation in TKA	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; midflexion laxity; tensor device; joint gap before implantation; joint gap after implantation	TOTAL KNEE ARTHROPLASTY; FLEXION GAP; TIBIOFEMORAL INSTABILITY; FEMORAL COMPONENT; REPLACEMENT; POSITION; PROSTHESIS	The relationship between the joint gap before and after implantation in 259 knees during the total knee arthroplasty was investigated using a tensor device which can attach the polyethylene insert trial. Patients were divided into following 3 groups according to the joint gap balance before implantation (flexion joint gap - extension joint gap); group 1: >1 mm; group 2: -1 to 1 mm, and group 3: <-1 mm. Joint gap after implantation was loose at 30 degrees, 60 degrees, 90 degrees, and 120 degrees of flexion in group 1 and 2, but loose only at 30 degrees of flexion in group 3 (p < 0.01). This study showed that loose flexion joint gap before implantation increased the risk of joint gap laxity after implantation especially at midflexion ranges. (C) 2014 Elsevier Inc. All rights reserved.	[Minoda, Yukihide] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan; [Nakagawa, Shigeru] Osaka Rosai Hosp, Dept Orthopaed Surg, Sakai, Osaka, Japan; [Sugama, Ryo] Osaka Gen Hosp, Dept Orthopaed Surg, Sumiyoshi Ku, Osaka, Japan; [Ikawa, Tessyu] Hanwa Joint Reconstruct Ctr, Sakai, Osaka, Japan; [Noguchi, Takahiro] Shinbeppu Hosp, Dept Orthopaed Surg, Beppu, Oita, Japan; [Hirakawa, Masashi] Oita Univ, Fac Med, Grad Sch Med, Dept Orthopaed Surg, Yufu, Oita, Japan	Minoda, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.						Del Gaizo DJ, 2011, ORTHOPEDICS, V34, pE519, DOI 10.3928/01477447-20110714-46; Asano H, 2004, J ARTHROPLASTY, V19, P558, DOI 10.1016/j.arth.2004.01.003; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; Matsumoto T, 2009, J BONE JOINT SURG BR, V91B, P475, DOI 10.1302/0301-620X.91B4.21862; Jennings LM, 2007, P I MECH ENG H, V221, P305, DOI 10.1243/09544119JEIM215; Yercan HS, 2005, KNEE, V12, P336, DOI 10.1016/j.knee.2005.01.005; Gejo R, 2008, CLIN ORTHOP RELAT R, V466, P946, DOI 10.1007/s11999-008-0154-2; Hananouchi T, 2012, KNEE, V19, P601, DOI 10.1016/j.knee.2011.08.001; Kurita M, 2012, INT ORTHOP, V36, P2465, DOI 10.1007/s00264-012-1673-8; MARTIN JW, 1990, CLIN ORTHOP RELAT R, P146; Matsui Y, 2014, ARCH ORTHOP TRAUM SU, V134, P699, DOI 10.1007/s00402-014-1945-4; McPherson Edward J, 2008, Surg Technol Int, V17, P249; Minoda Y, 2014, KNEE, V21, P810, DOI 10.1016/j.knee.2014.04.010; Minoda Y, 2012, KNEE, V19, P832, DOI 10.1016/j.knee.2012.03.007; Moro-oka T, 2010, KNEE SURG SPORT TR A, V18, P375, DOI 10.1007/s00167-009-0977-8; Tsukeoka T, 2012, J ARTHROPLASTY, V27, P1094, DOI 10.1016/j.arth.2011.10.015; Yercan HS, 2005, KNEE, V12, P257, DOI 10.1016/j.knee.2005.01.004; Yoshino N, 2009, KNEE SURG SPORT TR A, V17, P484, DOI 10.1007/s00167-008-0656-1	18	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	MAY	2015	30	5					762	765		10.1016/j.arth.2014.11.011		4	Orthopedics	Orthopedics	CH4JB	WOS:000353998700009		
J	Kamada, T; Imai, H; Mashima, N; Takeba, J; Okumura, H; Miura, H				Kamada, Tomomi; Imai, Hiroshi; Mashima, Naohiko; Takeba, Jun; Okumura, Hideo; Miura, Hiromasa			Long Term Results With the Interlocking Uncemented Long Stem in Revision Hip Arthroplasty: A Mean 15-Year Follow-Up	JOURNAL OF ARTHROPLASTY			English	Article						interlocking cementless stem; revision total hip arthroplasty; femoral stem survival; proximal bone defect; bone ingrowth	POROUS-COATED STEMS; FEMORAL COMPONENTS; REPLACEMENT; PROSTHESIS; FAILURE; FRACTURES; FIXATION; FEMUR	Stem fixation is difficult to achieve in severe proximal bone loss in revision hip surgery. In this study, we sought to present the results of distally-locked stem with screws (HUCKESTEP HIP stem) in 21 revision hips with mean follow-up period of 15 years. The preoperative mean Japanese Orthopaedic Association hip score had improved from 54 to 75 points. Further revisions were required for 2 stems, in one because of infection and the other because of screws fracture and subsidence. With removal of the stem for any reason as an end-point, the cumulative survival at 15 years was 90.4%. While this study had small number, the use of this interlocking stem for revision hips with extensive proximal bone defects provided satisfactory 15-year clinical and radiographic results. (C) 2015 Elsevier Inc. All rights reserved.	[Kamada, Tomomi; Imai, Hiroshi; Mashima, Naohiko; Takeba, Jun; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan; [Okumura, Hideo] Rakuyo Hosp, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan	Kamada, T (reprint author), Ehime Univ, Grad Sch Med, Dept Bone & Joint Surg, Toon, Ehime 7910295, Japan.						Hamilton WG, 2007, J ARTHROPLASTY, V22, P106, DOI 10.1016/j.arth.2007.01.002; Friesecke C, 2005, J BONE JOINT SURG AM, V87A, P2693, DOI 10.2106/JBJS.D.02770; Moreland JR, 2001, CLIN ORTHOP RELAT R, P194; Paprosky WG, 1999, CLIN ORTHOP RELAT R, P230; Learmonth ID, 2004, J BONE JOINT SURG BR, V86B, P13, DOI 10.1302/0301-620X.86B1.14864; CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1074; Cameron HU, 2002, J ARTHROPLASTY, V17, P138, DOI 10.1054/arth.2002.32462; Weeden SH, 2002, J ARTHROPLASTY, V17, P134, DOI 10.1054/arth.2002.32461; Pekkarinen J, 2000, J BONE JOINT SURG BR, V82B, P103, DOI 10.1302/0301-620X.82B1.9802; HASEGAWA Y, 1992, ARCH ORTHOP TRAUM SU, V111, P187, DOI 10.1007/BF00571474; Toomey HE, 1998, J ARTHROPLASTY, V13, P647, DOI 10.1016/S0883-5403(98)80008-9; Regis D, 2011, J BONE JOINT SURG BR, V93B, P1320, DOI 10.1302/0301-620X.93B10.25927; Parvizi J, 2004, CLIN ORTHOP RELAT R, P169; Bernd F, 2010, J ARTHROPLASTY, V25, P759; CHANDLER H, 1994, CLIN ORTHOP RELAT R, P67; Chen WM, 2000, J BONE JOINT SURG AM, V82A, P1215; Eisler T, 2000, J ARTHROPLASTY, V15, P974, DOI 10.1054/arth.2000.9825; ENGH CA, 1990, CLIN ORTHOP RELAT R, P107; Fink Bernd, 2007, Oper Orthop Traumatol, V19, P32, DOI 10.1007/s00064-007-1194-6; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; HARRIS WH, 1992, CLIN ORTHOP RELAT R, P120; HUCKSTEP RL, 1986, CLIN ORTHOP RELAT R, P48; HUCKSTEP RL, 1987, CLIN ORTHOP RELAT R, P12; Kim YM, 2004, J ARTHROPLASTY, V19, P27, DOI 10.1016/j.arth.2003.08.012; Mahomed N, 1993, J Arthroplasty, V8, P129, DOI 10.1016/S0883-5403(06)80051-3; Maron MC, 1996, J ARTHROPLASTY, V11, P981; Mertl P, 2011, INT ORTHOP, V35, P275, DOI 10.1007/s00264-010-1182-6; NAITO M, 1994, J BONE JOINT SURG BR, V76B, P428; Paprosky Wayne G, 2002, Am J Orthop (Belle Mead NJ), V31, P459; Schmale GA, 2000, J ARTHROPLASTY, V15, P718, DOI 10.1054/arth.2000.6623; Sexton SA, 2006, J BONE JOINT SURG BR, V88B, P310, DOI 10.1302/0301-620X.88B3.17087; Sotereanos N, 2006, J BONE JOINT SURG AM, V88A, P1079, DOI 10.2106/JBJS.E.00141; Volkmann R, 2003, INT ORTHOP S1, V27, P24	33	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	MAY	2015	30	5					835	839		10.1016/j.arth.2014.12.023		5	Orthopedics	Orthopedics	CH4JB	WOS:000353998700023		
J	Hamai, S; Okazaki, K; Shimoto, T; Nakahara, H; Higaki, H; Iwamoto, Y				Hamai, Satoshi; Okazaki, Ken; Shimoto, Takeshi; Nakahara, Hiroyuki; Higaki, Hidehiko; Iwamoto, Yukihide			Continuous Sagittal Radiological Evaluation of Stair-Climbing in Cruciate-Retaining and Posterior-Stabilized Total Knee Arthroplasties Using Image-Matching Techniques	JOURNAL OF ARTHROPLASTY			English	Article						kinematics; stair-climbing; posterior cruciate ligament; post-cam mechanism; total knee arthroplasty	IN-VIVO DETERMINATION; CAM-POST ENGAGEMENT; TIBIAL POST; FEMORAL ROLLBACK; FLUOROSCOPIC ANALYSIS; KINEMATIC ANALYSIS; DEEP FLEXION; REPLACEMENT; BEARING; IMPINGEMENT	In this study, we evaluated the in vivo kinematics of stair-climbing after posterior stabilized (PS) and cruciate retaining (CR) total knee arthroplasty (TKA) using radiographic-based image-matching techniques. Mid-flexion anteroposterior stability was demonstrated in all knees after CR TKA. However, paradoxical femoral translation at low flexion angles was seen in both designs. The post-cam mechanism did not function after PS TKA. Larger posterior tibial slope in PS TKA was linked to forward sliding of the femur at mid-flexion and unintended anterior tibial post impingement at knee extension. CR TKA is more sagittally stable in mid-flexion during stair climbing and attention must be given to minimize posterior tibial slope when using late cam-post engaging PS TKA designs. (C) 2015 Elsevier Inc. All rights reserved.	[Hamai, Satoshi] Kyushu Univ, Fac Med Sci, Dept Artificial Joints & Biomat, Fukuoka 8128582, Japan; [Hamai, Satoshi; Okazaki, Ken; Nakahara, Hiroyuki; Iwamoto, Yukihide] Kyushu Univ, Fac Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan; [Shimoto, Takeshi] Fukuoka Inst Technol, Fac Informat Engn, Dept Informat & Syst Engn, Fukuoka, Japan; [Higaki, Hidehiko] Kyushu Sangyo Univ, Fac Engn, Dept Mech Engn, Fukuoka, Japan	Hamai, S (reprint author), Kyushu Univ, Fac Med Sci, Dept Artificial Joints & Biomat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.						Victor J, 2005, J BONE JOINT SURG BR, V87B, P646, DOI 10.1302/0301-620X.87B5.15602; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Kuroyanagi Y, 2012, J ARTHROPLASTY, V27, P122, DOI 10.1016/j.arth.2011.03.005; Bertin KC, 2002, J ARTHROPLASTY, V17, P1040, DOI 10.1054/arth.2002.35793; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; EWALD FC, 1989, CLIN ORTHOP RELAT R, P9; INSALL JN, 1982, J BONE JOINT SURG AM, V64, P1317; Hamai S, 2010, J BONE JOINT SURG AM, V92A, P1765, DOI 10.2106/JBJS.I.00479; Shimizu N, 2013, J ARTHROPLASTY, V28, P1707, DOI 10.1016/j.arth.2013.03.026; Hamai S, 2008, J ORTHOP RES, V26, P435, DOI 10.1002/jor.20512; Scott RD, 2008, J ARTHROPLASTY, V23, P605, DOI 10.1016/j.arth.2007.11.018; Fantozzi S, 2006, J ORTHOP RES, V24, P2222, DOI 10.1002/jor.20306; Suggs JF, 2008, KNEE SURG SPORT TR A, V16, P290, DOI 10.1007/s00167-007-0467-9; Kelly MA, 2002, CLIN ORTHOP RELAT R, P51, DOI 10.1097/01.blo.0000030486.77561.8c; Clary CW, 2013, J BIOMECH, V46, P1351, DOI 10.1016/j.jbiomech.2013.01.025; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Browne C, 2005, KNEE, V12, P81, DOI 10.1016/j.knee.2004.05.006; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328; [Anonymous], 2005, CLIN ORTHOPS REL RES; Puloski SKT, 2001, J BONE JOINT SURG AM, V83A, P390; Collins M, 2012, ORTHOP TRAUMATOL-SUR, V98, P275, DOI 10.1016/j.otsr.2011.08.021; Zingde SM, 2014, CLIN ORTHOP RELAT R, V472, P254, DOI 10.1007/s11999-013-3257-3; Banks SA, 2002, J BONE JOINT SURG AM, V84A, P37; Banks SA, 2004, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000138956.04316.ac; Chiu YS, 2004, J ARTHROPLASTY, V19, P1045, DOI 10.1016/j.arth.2004.04.013; Conditt MA, 2004, J ARTHROPLASTY, V19, P107, DOI 10.1016/j.arth.2004.06.006; Draganich LF, 2002, J ARTHROPLASTY, V17, P723, DOI 10.1054/arth.2002.33558; Haas BD, 2006, ORTHOPEDICS, V29, pS83; Hamai S, 2008, J BONE JOINT SURG BR, V90B, P1180, DOI 10.1302/0301-620X.90B9.20298; Harman MK, 2001, CLIN ORTHOP RELAT R, P383; Hino K, 2013, BONE JOINT J, V95B, P493, DOI 10.1302/0301-620X.95B4.30664; Horiuchi H, 2012, J ARTHROPLASTY, V27, P1196, DOI 10.1016/j.arth.2012.01.017; Kessler O, 2007, CLIN BIOMECH, V22, P52, DOI 10.1016/j.clinbiomech.2006.07.011; Komistek RD, 2008, J ARTHROPLASTY, V23, P41, DOI 10.1016/j.arth.2007.01.016; Mahoney OM, 2009, J ARTHROPLASTY, V24, P641, DOI 10.1016/j.arth.2008.03.009; Matsuda S, 1997, CLIN ORTHOP RELAT R, P257; Miyazaki Y, 2011, J ARTHROPLASTY, V26, P1038, DOI 10.1016/j.arth.2010.08.015; Piazza SJ, 1998, J ORTHOPAED RES, V16, P264, DOI 10.1002/jor.1100160214; Roberts VI, 2007, J BONE JOINT SURG BR, V89B, P1452, DOI 10.1302/0301-620X.89B11.19783; Scuderi GR, 2001, J ORTHOP SURG, V9, P81	41	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	MAY	2015	30	5					864	869		10.1016/j.arth.2014.12.027		6	Orthopedics	Orthopedics	CH4JB	WOS:000353998700029		
J	Mizu-uchi, H; Colwell, CW; Flores-Hernandez, C; Fregly, BJ; Matsuda, S; D'Lima, DD				Mizu-uchi, Hideki; Colwell, Clifford W., Jr.; Flores-Hernandez, Cesar; Fregly, Benjamin J.; Matsuda, Shuichi; D'Lima, Darryl D.			Patient-Specific Computer Model of Dynamic Squatting After Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; squatting; computer model; knee contact force; patient-specific	KINETIC-CHAIN EXERCISES; TIBIOFEMORAL JOINT FORCES; IN-VIVO; CONTACT FORCES; TIBIAL FORCES; FLEXION; PREDICTION; MUSCLE; OSTEOARTHRITIS; KINEMATICS	Knee forces are highly relevant to performance after total knee arthroplasty especially during high flexion activities such as squatting. We constructed subject-specific models of two patients implanted with instrumented knee prostheses that measured knee forces in vivo. In vivo peak forces ranged from 2.2 to 2.3 times bodyweight but peaked at different flexion angles based on the type of squatting activity. Our model predicted tibiofemoral contact force with reasonable accuracy in both subjects. This model can be a very useful tool to predict the effect of surgical techniques and component alignment on contact forces. In addition, this model could be used for implant design development, to enhance knee function, to predict forces generated during other activities, and for predicting clinical outcomes. (C) 2015 Elsevier Inc. All rights reserved.	[Mizu-uchi, Hideki; Colwell, Clifford W., Jr.; Flores-Hernandez, Cesar; D'Lima, Darryl D.] Scripps Hlth, Scripps Clin, Shiley Ctr Orthopaed Res & Educ, La Jolla, CA 92037 USA; [Mizu-uchi, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 812, Japan; [Matsuda, Shuichi] Kyoto Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kyoto, Japan; [Fregly, Benjamin J.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL USA	D'Lima, DD (reprint author), Scripps Hlth, Scripps Clin, Shiley Ctr Orthopaed Res & Educ, 11025 N Torrey Pines Rd,Suite 200, La Jolla, CA 92037 USA.				National Institutes of Health [R01 EB009351]	In support of their research two of the authors (DD, BF) received, in any one year, outside funding in excess of $10,000 from the National Institutes of Health (R01 EB009351). None of the authors or their immediate families received payments or benefits to fund this research from a commercial entity, foundation, or any other source.	Fishkin Z, 2002, J ORTHOPAED RES, V20, P204, DOI 10.1016/S0736-0266(01)00087-0; D'Lima DD, 2005, J BIOMECH, V38, P299, DOI 10.1016/j.jbiomech.2004.02.011; Escamilla RF, 1998, MED SCI SPORT EXER, V30, P556, DOI 10.1097/00005768-199804000-00014; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Lin YC, 2010, J BIOMECH, V43, P945, DOI 10.1016/j.jbiomech.2009.10.048; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418; LUTZ GE, 1993, J BONE JOINT SURG AM, V75A, P732; Devers BN, 2011, J ARTHROPLASTY, V26, P178, DOI 10.1016/j.arth.2010.02.008; Taylor WR, 2004, J ORTHOPAED RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Kirking B, 2006, J BIOMECH, V39, P1744, DOI 10.1016/j.jbiomech.2005.05.023; D'Lima DD, 2012, P I MECH ENG H, V226, P95, DOI 10.1177/0954411911433372; Sharma A, 2008, J BIOMECH, V41, P642, DOI 10.1016/j.jbiomech.2007.09.027; Colwell CW, 2011, CLIN BIOMECH, V26, P52, DOI 10.1016/j.clinbiomech.2010.08.009; Smith SM, 2008, GAIT POSTURE, V27, P376, DOI 10.1016/j.gaitpost.2007.05.004; Rodricks DJ, 2007, J BONE JOINT SURG AM, V89A, P89, DOI 10.2106/JBJS.E.00492; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; MIKOSZ RP, 1988, J ORTHOPAED RES, V6, P205, DOI 10.1002/jor.1100060207; Vessely MB, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000229356.81749.11; Li K, 2013, GAIT POSTURE, V38, P79, DOI 10.1016/j.gaitpost.2012.10.018; Kinney AL, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023255; [Anonymous], 2005, CLIN ORTHOPS REL RES; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; Nagura T, 2006, J APPL BIOMECH, V22, P305; Dionisio VC, 2008, J ELECTROMYOGR KINES, V18, P134, DOI 10.1016/j.jelekin.2006.07.010; D'Lima DD, 2007, J BIOMECH, V40, pS11, DOI 10.1016/j.jbiomech.2007.03.004; Dahlkvist N J, 1982, Eng Med, V11, P69; D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x; D'Lima DD, 2011, CLIN ORTHOP RELAT R, V469, P2953, DOI 10.1007/s11999-011-1916-9; D'Lima Darryl D, 2005, Clin Orthop Relat Res, V440, P45, DOI 10.1097/01.blo.0000186559.62942.8c; Mizu-uchi H, 2012, J ARTHROPLASTY, V27, P1710, DOI 10.1016/j.arth.2012.03.041; Ninos JC, 1997, J ORTHOP SPORT PHYS, V25, P307; OHKOSHI Y, 1991, AM J SPORT MED, V19, P605, DOI 10.1177/036354659101900609; Shelburne Kevin B, 2002, Comput Methods Biomech Biomed Engin, V5, P149, DOI 10.1080/10255840290010265; Stylianou AP, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023982; Sumino T, 2013, KNEE, V20, P376, DOI 10.1016/j.knee.2013.03.002; Varadarajan KM, 2008, J BIOMECH, V41, P2159, DOI 10.1016/j.jbiomech.2008.04.021; Weight volume and center ofmass of segments of the human body, 1969, WEIGHT VOL CTR MASS, P69	37	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	MAY	2015	30	5					870	874		10.1016/j.arth.2014.12.021		5	Orthopedics	Orthopedics	CH4JB	WOS:000353998700030		
J	Muraoka, K; Naito, M; Nakamura, Y; Hagio, T; Takano, K				Muraoka, Kunihide; Naito, Masatoshi; Nakamura, Yoshinari; Hagio, Tomonobu; Takano, Koichi			Usefulness of Ultrasonography for Detection of Pseudotumors After Metal-On-Metal Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; metal-on-metal bearings; adverse local tissue reaction (ALTR); pseudotumor; ultrasonography	LARGE-DIAMETER METAL; RESURFACING ARTHROPLASTY; INFLAMMATORY PSEUDOTUMOR; DIAGNOSTIC-ACCURACY; JOHN CHARNLEY; WEAR; REPLACEMENT; ULTRASOUND; COMPONENT; BEARINGS	We retrospectively analyzed 83 metal-on-metal total hip arthroplasties in 74 patients. Ultrasonography and magnetic resonance imaging (MRI) of each hip were performed to detect abnormal patterns and pseudotumors. We examined the reliability of ultrasonography for detecting pseudotumors in comparison with MRI. We also compared the acetabular component inclination between patients with and without pseudotumors. The mean positive and negative predictive values for pseudotumor detection by ultrasonography were 65% and 91%, respectively. The mean positive and negative likelihood ratios were 5.78 and 0.32, respectively. There was no clear association between pseudotumor presence and acetabular component inclination. We concluded that ultrasonography is a suitable technique to screen for the presence of pseudotumors. We also need to distinguish between bearing-related and taper junction corrosion-related complications. (C) 2014 Elsevier Inc. All rights reserved.	[Muraoka, Kunihide; Naito, Masatoshi; Nakamura, Yoshinari; Hagio, Tomonobu] Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Fukuoka 8140180, Japan; [Takano, Koichi] Fukuoka Univ, Fac Med, Dept Radiol, Fukuoka 8140180, Japan	Muraoka, K (reprint author), Fukuoka Univ, Fac Med, Dept Orthopaed Surg, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.						Kwon YM, 2010, J BONE JOINT SURG BR, V92B, P356, DOI 10.1302/0301-620X.92B3.23281; Matthies AK, 2012, CLIN ORTHOP RELAT R, V470, P1895, DOI 10.1007/s11999-011-2201-7; Munro JT, 2014, CLIN ORTHOP RELAT R, V472, P523, DOI 10.1007/s11999-013-2979-6; Tannast M, 2005, CLIN ORTHOP RELAT R, P144, DOI 10.1097/01.blo.00001576957.22894.29; Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884; Grammatopoulos G, 2010, J BONE JOINT SURG BR, V92B, P1527, DOI 10.1302/0301-620X.92B11.24640; Hart AJ, 2012, J BONE JOINT SURG AM, V94A, P317, DOI 10.2106/JBJS.J.01508; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pivec R, 2014, J ARTHROPLASTY, V29, P1, DOI 10.1016/j.arth.2013.08.026; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Haddad FS, 2013, BONE JOINT J, V95B, P1009, DOI 10.1302/0301-620X.95B8.32673; Glyn-Jones S, 2009, J BONE JOINT SURG BR, V91B, P1566, DOI 10.1302/0301-620X.91B12.22287; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Hart AJ, 2013, J BONE JOINT SURG AM, V95A, P678, DOI 10.2106/JBJS.J.01447; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Toms AP, 2010, CLIN RADIOL, V65, P447, DOI 10.1016/j.crad.2009.12.014; Levy YD, 2013, J ARTHROPLASTY, V28, P1212, DOI 10.1016/j.arth.2012.10.005; Langton DJ, 2009, J BONE JOINT SURG BR, V91B, P1287, DOI 10.1302/0301-620X.91B10.22308; Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; Cook RB, 2013, J ARTHROPLASTY, V28, P1430, DOI 10.1016/j.arth.2013.02.009; Hasegawa M, 2012, J ARTHROPLASTY, V27, P990, DOI 10.1016/j.arth.2011.12.016; De Haan R, 2008, J BONE JOINT SURG BR, V90B, P1291, DOI 10.1302/0301-620X.90B10.20533; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Garbuz DS, 2014, CLIN ORTHOP RELAT R, V472, P417, DOI 10.1007/s11999-013-3181-6; Nishii T, 2012, J ARTHROPLASTY, V27, P895, DOI 10.1016/j.arth.2011.09.015; Jacobs JJ, 2014, J ARTHROPLASTY, V29, P668, DOI 10.1016/j.arth.2014.02.014; Shimmin AJ, 2010, J BONE JOINT SURG BR, V92B, P469, DOI 10.1302/0301-620X.92B4.22967; Kwon YM, 2014, J ARTHROPLASTY, V29, P653, DOI 10.1016/j.arth.2014.02.007; Lombardi AV, 2012, J BONE JOINT SURG BR, V94B, P14, DOI 10.1302/0301-620X.94B11.30680; Sabah SA, 2011, J ARTHROPLASTY, V26, P71, DOI 10.1016/j.arth.2009.11.008; Siddiqui IA, 2014, ACTA ORTHOP, V85, P375, DOI 10.3109/17453674.2014.908345	33	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	MAY	2015	30	5					879	884		10.1016/j.arth.2014.12.005		6	Orthopedics	Orthopedics	CH4JB	WOS:000353998700032		
J	Muramatsu, R; Kuroda, M; Matoba, K; Lin, HY; Takahashi, C; Koyama, Y; Yamashita, T				Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide			Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; SPINAL-CORD DEMYELINATION; NEURONAL DAMAGE; CELLS; REMYELINATION; RECRUITMENT; DISRUPTION; INTEGRITY; RECOVERY; DISEASE	Pericytes play pivotal roles in physiological and pathophysiological conditions in the central nervous system. As pericytes prevent vascular leakage, they can halt neuronal damage stemming from a compromised blood-brain barrier. Therefore, pericytes may be a good target for the treatment of neurodegenerative disorders, although evidence is lacking. In this study, we show that prostacyclin attenuates lysophosphatidylcholine (LPC)-mediated vascular dysfunction through pericyte protection in the adult mouse spinal cord. LPC decreased the number of pericytes in an in vitro blood-brain barrier model, and this decrease was prevented by iloprost treatment, a prostacyclin analog. Intrathecal administration of iloprost attenuated vascular barrier disruption after LPC injection in the mouse spinal cord. Furthermore, iloprost treatment diminished demyelination and motor function deficits in mice injected with LPC. These results support the notion that prostacyclin acts on pericytes to maintain vascular barrier integrity.	[Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Muramatsu, Rieko; Kuroda, Mariko; Matoba, Ken; Lin, Hsiaoyun; Takahashi, Chisato; Koyama, Yoshihisa; Yamashita, Toshihide] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Muramatsu, Rieko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Muramatsu, R (reprint author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	muramatsu@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp			Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science [25221309]	This work was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare (to R. M.) and Grant-in-aid for Scientific Research (S) 25221309 from Japan Society for the Promotion of Science (to T. Y.).	Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Ousman SS, 2001, J NEUROSCI, V21, P4649; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Fortin D, 2012, CURR CANCER DRUG TAR, V12, P247; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Cui YL, 1999, BIOCHEM BIOPH RES CO, V265, P301, DOI 10.1006/bbrc.1999.1671; Garbuzova-Davis S., 2014, FRONT CELL NEUROSCI, V8, P21; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Takahashi C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.335; Takamatsu H, 2002, BRAIN RES, V925, P176, DOI 10.1016/S0006-8993(01)03280-2; TERAWAKI T, 1988, EUR J PHARMACOL, V152, P63, DOI 10.1016/0014-2999(88)90836-9; Vane J. R., 1995, AM J CARDIOL, V75, p3A	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11515	11525		10.1074/jbc.M114.587253		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH0OA	WOS:000353719400027		
J	Inaguma, A; Tsukamoto, H; Kato, HE; Kimura, T; Ishizuka, T; Oishi, S; Yawo, H; Nureki, O; Furutani, Y				Inaguma, Asumi; Tsukamoto, Hisao; Kato, Hideaki E.; Kimura, Tetsunari; Ishizuka, Toru; Oishi, Satomi; Yawo, Hiromu; Nureki, Osamu; Furutani, Yuji			Chimeras of Channelrhodopsin-1 and-2 from Chlamydomonas reinhardtii Exhibit Distinctive Light-induced Structural Changes from Channelrhodopsin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CATION CHANNEL; PHARAONIS PHOBORHODOPSIN; RETINAL CHROMOPHORE; PROTONATION CHANGES; CHLORIDE CHANNEL; RESONANCE RAMAN; WATER-MOLECULES; OPTICAL CONTROL; GREEN-ALGAE; SPECTROSCOPY	Channelrhodopsin-2 (ChR2) from the green alga Chlamydomonas reinhardtii functions as a light-gated cation channel that has been developed as an optogenetic tool to stimulate specific nerve cells in animals and control their behavior by illumination. The molecular mechanism of ChR2 has been extensively studied by a variety of spectroscopic methods, including light-induced difference Fourier transform infrared (FTIR) spectroscopy, which is sensitive to structural changes in the protein upon light activation. An atomic structure of channelrhodopsin was recently determined by x-ray crystallography using a chimera of channelrhodopsin-1 (ChR1) and ChR2. Electrophysiological studies have shown that ChR1/ChR2 chimeras are less desensitized upon continuous illumination than native ChR2, implying that there are some structural differences between ChR2 and chimeras. In this study, we applied light-induced difference FTIR spectroscopy to ChR2 and ChR1/ChR2 chimeras to determine the molecular basis underlying these functional differences. Upon continuous illumination, ChR1/ChR2 chimeras exhibited structural changes distinct from those in ChR2. In particular, the protonation state of a glutamate residue, Glu-129 (Glu-90 in ChR2 numbering), in the ChR chimeras is not changed as dramatically as in ChR2. Moreover, using mutants stabilizing particular photointermediates as well as time-resolved measurements, we identified some differences between the major photointermediates of ChR2 and ChR1/ChR2 chimeras. Taken together, our data indicate that the gating and desensitizing processes in ChR1/ChR2 chimeras are different from those in ChR2 and that these differences should be considered in the rational design of new optogenetic tools based on channelrhodopsins.	[Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Inaguma, Asumi; Furutani, Yuji] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inaguma, Asumi; Tsukamoto, Hisao; Kimura, Tetsunari; Furutani, Yuji] Grad Univ Adv Studies SOKENDAI, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan; [Kato, Hideaki E.; Oishi, Satomi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 9808577, Japan	Furutani, Y (reprint author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	furutani@ims.ac.jp	Yawo, Hiromu/I-4871-2015	Yawo, Hiromu/0000-0002-4299-3288	Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" from the Japan Science and Technology Agency (JST); Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST); KAKENHI Japan Society for Promotion of Science (JSPS) [22770159, 24650203]	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST) Program of "Creation of Nanosystems with Novel Function through Process Integration" and the Precursory Research for Embryonic Science and Technology (PRESTO) Program of "Chemical Conversion of Light Energy" from the Japan Science and Technology Agency (JST). This work was also supported in part by KAKENHI Japan Society for Promotion of Science (JSPS) Grant 22770159 and 24650203 (to Y. F.).	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Furutani Y, 2012, J PHYS CHEM LETT, V3, P2964, DOI 10.1021/jz301287n; Furutani Y, 2013, J PHYS CHEM B, V117, P3449, DOI 10.1021/jp308765t; Furutani Y, 2002, BIOPHYS J, V83, P3482; Hososhima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119558; Kandori H, 2002, BIOCHEMISTRY-US, V41, P4554, DOI 10.1021/bi0120749; Kuhne J, 2015, ANGEW CHEM INT EDIT, V54, P4953, DOI 10.1002/anie.201410180; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Muders V, 2014, FEBS LETT, V588, P2301, DOI 10.1016/j.febslet.2014.05.019; Ogren JI, 2014, BIOCHEMISTRY-US, V53, P3961, DOI 10.1021/bi500445c; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893	41	4	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11623	11634		10.1074/jbc.M115.642256		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH0OA	WOS:000353719400037		
J	Johjima, A; Noi, K; Nishikori, S; Ogi, H; Esaki, M; Ogura, T				Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Ogi, Hirotsugu; Esaki, Masatoshi; Ogura, Teru			Microtubule Severing by Katanin p60 AAA+ ATPase Requires the C-terminal Acidic Tails of Both alpha- and beta-Tubulins and Basic Amino Acid Residues in the AAA plus Ring Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUARTZ-CRYSTAL MICROBALANCE; SPASTIC PARAPLEGIA PROTEIN; RECOGNITION; ENZYME; IDENTIFICATION; DEPOLYMERASE; SENSITIVITY; DIVERSITY; MACHINERY; FIDGETIN	The microtubule (MT) network is highly dynamic and undergoes dramatic reorganizations during the cell cycle. Dimers of alpha- and beta-tubulins rapidly polymerize to and depolymerize from the end of MT fibrils in an intrinsic GTP-dependent manner. MT severing by ATP-driven enzymes such as katanin and spastin contributes significantly to microtubule dynamics, and it has been shown that katanin p60, a AAA+ family protein, has ATPase and MT-severing activities. The mechanism of MT severing by katanin p60 is poorly understood, and the residues in katanin p60 and tubulins important for severing activity were therefore explored in this study. MT-severing activity, but not ATPase activity, was inhibited by mutations of the conserved aromatic residue and the flanking basic residues in the pore region of the katanin p60 hexameric ring. When the acidic residue-rich C-terminal unstructured segment of either alpha- or beta-tubulin was removed, polymerized MTs were resistant to katanin p60 treatment. Interactions between katanin p60 and the mutant MTs, on the other hand, were unaffected. Taken together, these findings led us to propose that the interactions between the positively charged residues of katanin p60 and the acidic tails of both tubulins are essential for efficient severing of MTs.	[Johjima, Ai; Noi, Kentaro; Nishikori, Shingo; Esaki, Masatoshi; Ogura, Teru] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan; [Noi, Kentaro; Esaki, Masatoshi; Ogura, Teru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Noi, Kentaro; Ogi, Hirotsugu] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan	Esaki, M (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8600811, Japan.	esaki@kumamoto-u.ac.jp; ogura@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science; MEXT of Japan; CREST program of JST	This work was supported in part by grants-in-aid from Japan Society for the Promotion of Science, from MEXT of Japan, and from the CREST program of JST.	Ando T, 2014, CURR OPIN STRUC BIOL, V28, P63, DOI 10.1016/j.sbi.2014.07.011; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206; Srayko M, 2000, GENE DEV, V14, P1072; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Davis LJ, 2002, BIOPHYS J, V82, P2916; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Dymek EE, 2012, J CELL SCI, V125, P3357, DOI 10.1242/jcs.096941; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; McNally KP, 2000, J CELL SCI, V113, P1623; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Diaz-Valencia J. D., 2011, BIOPHYS J, V100, P2440; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Gupta ML, 2003, P NATL ACAD SCI USA, V100, P6394, DOI 10.1073/pnas.1131967100; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; Iwaya N, 2012, FEBS J, V279, P1339, DOI 10.1111/j.1742-4658.2012.08528.x; Kannegaard E, 2014, MOL BIOL CELL, V25, P3686, DOI 10.1091/mbc.E14-06-1116; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MARYA PK, 1994, J CELL SCI, V107, P339; Matsushita-Ishiodori Y, 2009, GENES CELLS, V14, P925, DOI 10.1111/j.1365-2443.2009.01320.x; Matsushita-Ishiodori Y, 2007, BIOCHEM BIOPH RES CO, V359, P157, DOI 10.1016/j.bbrc.2007.05.086; Ogi H, 2009, ANAL CHEM, V81, P4015, DOI 10.1021/ac9004524; Ogi H, 2008, ANAL CHEM, V80, P5494, DOI 10.1021/ac800459g; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; SHIINA N, 1995, TRENDS CELL BIOL, V5, P283, DOI 10.1016/S0962-8924(00)89040-6; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444	50	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11762	11770		10.1074/jbc.M114.614768		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CH0OA	WOS:000353719400048		
J	Kazama, JJ; Matsuo, K; Iwasaki, Y; Fukagawa, M				Kazama, Junichiro James; Matsuo, Koji; Iwasaki, Yoshiko; Fukagawa, Masafumi			Chronic kidney disease and bone metabolism	JOURNAL OF BONE AND MINERAL METABOLISM			English	Review						Chronic kidney disease (CKD); Chronic kidney disease-related mineral and bone disease (CKD-MBD); Uremic osteoporosis; Material property	FIBROBLAST-GROWTH-FACTOR; COLLAGEN CROSS-LINKS; MINERAL DENSITY; RENAL OSTEODYSTROPHY; VASCULAR CALCIFICATION; PARATHYROID-HORMONE; RISK-FACTORS; SECONDARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS	Chronic kidney disease-related mineral and bone disease (CKD-MBD) is a syndrome defined as a systemic mineral metabolic disorder associated with CKD, and the term renal osteodystrophy indicates a pathomorphological concept of bone lesions associated with CKD-MBD. Cortical bone thinning, abnormalities in bone turnover and primary/secondary mineralization, elevated levels of circulating sclerostin, increased apoptosis in osteoblasts and osteocytes, disturbance of the coupling phenomenon, iatrogenic factors, accumulated micro-crackles, crystal/collagen disorientation, and chemical modification of collagen crosslinks are all possible candidates found in CKD that could promote osteopenia and/or bone fragility. Some of above factors are the consequences of abnormal systemic mineral metabolism but for others it seem unlikely. We have used the term uremic osteoporosis to describe the uremia-induced bone fragility which is not derived from abnormal systemic mineral metabolism. Interestingly, the disease aspect of uremic osteoporosis appears to be similar to that of senile osteoporosis.	[Kazama, Junichiro James; Matsuo, Koji] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9518510, Japan; [Kazama, Junichiro James] Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Chuo Ku, Niigata 9518510, Japan; [Iwasaki, Yoshiko] Oita Univ Nursing & Hlth Sci, Dept Hlth Sci, Oita, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol & Metab, Isehara, Kanagawa 25911, Japan	Kazama, JJ (reprint author), Niigata Univ, Med & Dent Hosp, Div Blood Purificat Therapy, Chuo Ku, 1-754 Asahimachi Dori, Niigata 9518510, Japan.	jjkaz@med.niigata-u.ac.jp					Amerling R, 2010, BLOOD PURIFICAT, V29, P293, DOI 10.1159/000276666; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Tanaka H, 2012, J RENAL NUTR, V22, P98, DOI 10.1053/j.jrn.2011.10.031; Seibel MJ, 2013, LANCET DIABETES ENDO, V1, P59, DOI 10.1016/S2213-8587(13)70045-7; Westenfeld R, 2011, NEPHROL DIAL TRANSPL, V26, P4115, DOI 10.1093/ndt/gfr214; Kazama JJ, 2013, KIDNEY INT SUPPL, V3, P446, DOI 10.1038/kisup.2013.93; Aggarwal HK, 2013, RENAL FAILURE, V35, P1105, DOI 10.3109/0886022X.2013.815102; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791; Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309; Evenepoel P, 2010, CLIN J AM SOC NEPHRO, V5, P1268, DOI 10.2215/CJN.08241109; Iwasaki Y, 2013, BONE, V57, P477, DOI 10.1016/j.bone.2013.07.037; Hernandez E, 2003, KIDNEY INT, V63, P2269, DOI 10.1046/j.1523-1755.2003.00005.x; Kazama JJ, 2011, THER APHER DIAL, V15, P23, DOI 10.1111/j.1744-9987.2011.00923.x; Iwasaki Y, 2011, BONE, V48, P1260, DOI 10.1016/j.bone.2011.03.672; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014; Danese MD, 2006, AM J KIDNEY DIS, V47, P149, DOI 10.1053/j.ajkd.2005.09.024; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Massy ZA, 2013, CURR OPIN NEPHROL HY, V22, P405, DOI 10.1097/MNH.0b013e328362155b; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; McCormick BB, 2012, AM J KIDNEY DIS, V60, P626, DOI 10.1053/j.ajkd.2012.06.019; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Stein MS, 1996, AM J KIDNEY DIS, V28, P515, DOI 10.1016/S0272-6386(96)90461-8; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Koizumi M, 2013, CONTRIB NEPHROL, V180, P110, DOI 10.1159/000346791; Jadoul M, 2006, KIDNEY INT, V70, P1358, DOI 10.1038/sk.ki.5001754; Mitome J, 2011, CALCIFIED TISSUE INT, V88, P521, DOI 10.1007/s00223-011-9488-y; Jamal SA, 2011, J BONE MINER RES, V26, P1829, DOI 10.1002/jbmr.403; Ballanti P, 2001, HISTOPATHOLOGY, V38, P571, DOI 10.1046/j.1365-2559.2001.01139.x; COURNOTWITMER G, 1981, KIDNEY INT, V20, P375, DOI 10.1038/ki.1981.149; Frazao JM, 2009, CURR OPIN NEPHROL HY, V18, P303, DOI 10.1097/MNH.0b013e32832c4df0; Fukagawa M, 2001, AM J KIDNEY DIS, V38, pS152, DOI 10.1053/ajkd.2001.27426; Fukagawa M, 2002, NEPHROL DIAL TRANSPL, V17, P2; Fukumoto S, 2001, ENDOCR J, V48, P603, DOI 10.1507/endocrj.48.603; Gal-Moscovici A, 2005, CLIN NEPHROL, V63, P284; Glorieux G, 2013, BLOOD PURIFICAT, V35, P45; Iwasaki Y, 2006, KIDNEY INT, V70, pS34, DOI 10.1038/sj.ki.5001600; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P1191, DOI 10.1007/s00198-011-1781-0; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; Kazama JJ, 2011, THER APHER DIAL, V15, P9, DOI 10.1111/j.1744-9987.2011.00919.x; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kazama JJ, 2001, AM J KIDNEY DIS, V38, pS156, DOI 10.1053/ajkd.2001.27427; Lomashvili KA, 2014, ARTERIOSCL THROM VAS, V34, P146, DOI 10.1161/ATVBAHA.113.302525; MCCARTHY JT, 1991, CUTIS, V48, P17; Meng Y, 2014, BONE, V58, P168, DOI 10.1016/j.bone.2013.10.010; Miller PD, 2007, SEMIN DIALYSIS, V20, P186, DOI 10.1111/j.1525-139X.2007.00271.x; Nakamura T, 2014, OSTEOPOROSIS INT, V25, P367, DOI 10.1007/s00198-013-2398-2; PARSONS V, 1971, BRIT MED J, V4, P273; QUARLES LD, 1992, J CLIN ENDOCR METAB, V75, P145, DOI 10.1210/jc.75.1.145; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Saito M, 2006, OSTEOPOROSIS INT, V17, P986, DOI 10.1007/s00198-006-0087-0; Shiraki M, 2008, J BONE MINER METAB, V26, P93, DOI 10.1007/s00774-007-0784-6; Sprague SM, 2004, SEMIN NEPHROL, V24, P82, DOI 10.1053/j.semnephrol.2003.08.012; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Tamler R, 2006, ANN NY ACAD SCI, V1068, P284, DOI 10.1196/annals.1346.032; Westeel FP, 2000, KIDNEY INT, V58, P1788, DOI 10.1046/j.1523-1755.2000.00341.x; Yamamoto S, 2009, BONE, V45, pS39, DOI 10.1016/j.bone.2009.03.655	64	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	MAY	2015	33	3					245	252		10.1007/s00774-014-0639-x		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	CH8OH	WOS:000354295200001		
